Citrus Sinensis ID: 000343
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1630 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FY48 | 1625 | E3 ubiquitin-protein liga | yes | no | 0.991 | 0.994 | 0.780 | 0.0 | |
| Q8NFD2 | 765 | Ankyrin repeat and protei | yes | no | 0.353 | 0.754 | 0.231 | 3e-25 | |
| Q8BZ25 | 745 | Ankyrin repeat and protei | yes | no | 0.336 | 0.736 | 0.234 | 2e-24 | |
| G5E8K5 | 1961 | Ankyrin-3 OS=Mus musculus | no | no | 0.185 | 0.154 | 0.277 | 6e-23 | |
| Q12955 | 4377 | Ankyrin-3 OS=Homo sapiens | no | no | 0.185 | 0.068 | 0.271 | 7e-23 | |
| Q01484 | 3957 | Ankyrin-2 OS=Homo sapiens | no | no | 0.176 | 0.072 | 0.293 | 1e-22 | |
| Q8C8R3 | 3898 | Ankyrin-2 OS=Mus musculus | no | no | 0.176 | 0.073 | 0.290 | 7e-22 | |
| P53355 | 1430 | Death-associated protein | no | no | 0.378 | 0.431 | 0.217 | 3e-21 | |
| Q80YE7 | 1442 | Death-associated protein | no | no | 0.376 | 0.425 | 0.216 | 4e-21 | |
| Q54KA7 | 986 | Ankyrin repeat, PH and SE | yes | no | 0.164 | 0.271 | 0.295 | 5e-20 |
| >sp|Q9FY48|KEG_ARATH E3 ubiquitin-protein ligase KEG OS=Arabidopsis thaliana GN=KEG PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 2605 bits (6752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1270/1627 (78%), Positives = 1446/1627 (88%), Gaps = 11/1627 (0%)
Query: 2 KMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGN 61
++KVPCCSVC TRYNE ERVPLLLQCGHGFCK+CLS+MFS S+DTTL+CPRCRHVSVVGN
Sbjct: 4 RVKVPCCSVCHTRYNEDERVPLLLQCGHGFCKDCLSKMFSTSSDTTLTCPRCRHVSVVGN 63
Query: 62 SVTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSS 121
SV LRKN+A+LALI +A+ N + ++ D + DD++D D++ RG H SSS
Sbjct: 64 SVQGLRKNYAMLALIHAASGGA---NFDCDYTDDEDDDDEEDGSDEDGARAARGFHASSS 120
Query: 122 GVGVCGPVIEVGVHHDVKLVKKLGE----GRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI 177
+CGPVIEVG H ++KLV+++GE G GVE+W A + GG GRC+H VAVKK+ +
Sbjct: 121 INSLCGPVIEVGAHPEMKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCKHRVAVKKMTL 180
Query: 178 AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR 237
E+M+ +W+ GQL++LRRASMWCRNVCTFHGV++MD L L+MDRC+GSVQ MQRNEGR
Sbjct: 181 TEDMDVEWMQGQLESLRRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEMQRNEGR 240
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LTLEQILRYGAD+ARGV ELHAAGV+CMNIKPSNLLLDASG AVVSDYGLA ILKKP C+
Sbjct: 241 LTLEQILRYGADVARGVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQ 300
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
K RPE DSS++ DC LSP+YTAPEAW PVKK LFW+DA G+SPESDAWSFGCTL
Sbjct: 301 KTRPEFDSSKVTLYTDCVTLSPHYTAPEAWGPVKK---LFWEDASGVSPESDAWSFGCTL 357
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
VEMCTGS PW GLS EEI++AVVK RK+PPQY IVGVGIPRELWKMIGECLQFK SKRP
Sbjct: 358 VEMCTGSTPWDGLSREEIFQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRP 417
Query: 418 TFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVS 477
TF+AMLATFLRHLQE+PRSP ASPD G K N + A+++ VFQDNPNNLH++V
Sbjct: 418 TFNAMLATFLRHLQEIPRSPSASPDNGIAKICEVNIVQAPRATNIGVFQDNPNNLHRVVL 477
Query: 478 EGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQEN 537
EGD GVR++L+K A+G SS+ SLL+AQNADGQ+ALHLACRRGSAELVEAILEY + N
Sbjct: 478 EGDFEGVRNILAKAAAGGGGSSVRSLLEAQNADGQSALHLACRRGSAELVEAILEYGEAN 537
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
VD++DKDGDPPLVFALAAGSP+CVH LIK+GANV SRLREG GPSVAHVC+YHGQPDCMR
Sbjct: 538 VDIVDKDGDPPLVFALAAGSPQCVHVLIKKGANVRSRLREGSGPSVAHVCSYHGQPDCMR 597
Query: 598 ELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA 657
ELL+AGADPNAVDDEGE+VLHRAVAKKYTDCAIVILENGG RSM + N+K LTPLH+CVA
Sbjct: 598 ELLVAGADPNAVDDEGETVLHRAVAKKYTDCAIVILENGGSRSMTVSNAKCLTPLHMCVA 657
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
TWNVAV+KRWVEV+SPEEI I+IP PVGTALCMAA+++KDHE EGRELV+ILL AGA+
Sbjct: 658 TWNVAVIKRWVEVSSPEEISQAINIPSPVGTALCMAASIRKDHEKEGRELVQILLAAGAD 717
Query: 718 PTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGL 776
PTAQDAQ+ RTALH A+MAN+VELV++ILDAGV+ NIRNVHNTIPLH+ALARGA SCV L
Sbjct: 718 PTAQDAQHGRTALHTAAMANNVELVRVILDAGVNANIRNVHNTIPLHMALARGANSCVSL 777
Query: 777 LLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836
LL +G+DCN QDDEGDNAFHIAADAAKMIRENL+WLIVML PDAAV+VRNHSGKT+RDF
Sbjct: 778 LLESGSDCNIQDDEGDNAFHIAADAAKMIRENLDWLIVMLRSPDAAVDVRNHSGKTVRDF 837
Query: 837 LEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAKHKSVGFVQ 896
LE LPREWISEDLMEAL+ RGVHLSPTI+E+GDWVKFKR +TTP +GWQGAK KSVGFVQ
Sbjct: 838 LEALPREWISEDLMEALLKRGVHLSPTIYEVGDWVKFKRGITTPLHGWQGAKPKSVGFVQ 897
Query: 897 SVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRFGWRGQSRDSIGTV 956
++L+K+++I++FCSGE RVLA+EV+KLIPLDRGQHV+L+ DVKEPRFGWRGQSRDS+GTV
Sbjct: 898 TILEKEDMIIAFCSGEARVLANEVVKLIPLDRGQHVRLRADVKEPRFGWRGQSRDSVGTV 957
Query: 957 LCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSI 1016
LCVD+DGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIR LT+AKHG GSV PGS+
Sbjct: 958 LCVDEDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRQNLTSAKHGFGSVVPGSM 1017
Query: 1017 GIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSVAEPRYAWGGETH 1076
GIVYC+RPDSSLL+ELSYLPNPWHCEPEEVEPV PFRIG+RVCVKRSVAEPRYAWGGETH
Sbjct: 1018 GIVYCVRPDSSLLVELSYLPNPWHCEPEEVEPVAPFRIGDRVCVKRSVAEPRYAWGGETH 1077
Query: 1077 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWED 1136
HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEK++DFKVGDWVRVKASVSSPKYGWED
Sbjct: 1078 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKIDDFKVGDWVRVKASVSSPKYGWED 1137
Query: 1137 ITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLG 1196
ITRNSIG++HSL+EDGDVGIAFCFRSKPF CSVTDVEKV PF VGQEIH+ PS+TQPRLG
Sbjct: 1138 ITRNSIGVMHSLDEDGDVGIAFCFRSKPFSCSVTDVEKVTPFHVGQEIHMTPSITQPRLG 1197
Query: 1197 WSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTR 1256
WS ETPAT+GK+++IDMDG L+ +V GR +LW+VSPGDAE LSGFEVGDWVRSKPS+G R
Sbjct: 1198 WSNETPATIGKVMRIDMDGTLSAQVTGRQTLWRVSPGDAELLSGFEVGDWVRSKPSLGNR 1257
Query: 1257 PSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSG 1316
PSYDW+ VG+ES+AVVHSIQ+ GYLELACCFRKGRWSTHYTD+EKIP+ KVGQ V F+ G
Sbjct: 1258 PSYDWSNVGRESIAVVHSIQETGYLELACCFRKGRWSTHYTDLEKIPALKVGQFVHFQKG 1317
Query: 1317 LAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRL 1376
+ EPRWGWR A+ DSRGIIT+VHADGEVRVAFFGLPGLW+GDPADLE+ MFEVGEWVRL
Sbjct: 1318 ITEPRWGWRAAKPDSRGIITTVHADGEVRVAFFGLPGLWRGDPADLEVEPMFEVGEWVRL 1377
Query: 1377 RDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQ 1436
R+ S WKS+GPGSVGVV G+G++ D WDG+T V+FC EQERW GPTSHLE+ +LVVGQ
Sbjct: 1378 REGVSCWKSVGPGSVGVVHGVGYEGDEWDGTTSVSFCGEQERWAGPTSHLEKAKKLVVGQ 1437
Query: 1437 RVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSEVEVVEEEE 1496
+ RVKL+VKQPRFGWSGHSH SVG +SAIDADGKLRIYTP GSKTWMLDPSEVE +EEEE
Sbjct: 1438 KTRVKLAVKQPRFGWSGHSHGSVGTISAIDADGKLRIYTPAGSKTWMLDPSEVETIEEEE 1497
Query: 1497 LQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAWEMERV 1556
L+IGDWVRV+AS+TTPTYQWGEV+ SS GVVHRME G+L V+FCF++RLWLCKA E+ER+
Sbjct: 1498 LKIGDWVRVKASITTPTYQWGEVNPSSTGVVHRMEDGDLCVSFCFLDRLWLCKAGELERI 1557
Query: 1557 RPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWIGDPAD 1616
RPF++GD+V+IK+GLVTPRWGWGMETHASKG VVGVDANGKLRIKF WREGRPWIGDPAD
Sbjct: 1558 RPFRIGDRVKIKDGLVTPRWGWGMETHASKGHVVGVDANGKLRIKFLWREGRPWIGDPAD 1617
Query: 1617 IVLDECS 1623
IVLDE S
Sbjct: 1618 IVLDETS 1624
|
Mediates E2-dependent protein ubiquitination. Acts as a negative regulator of abscisic acid signaling. Required for ABI5 degradation. Arabidopsis thaliana (taxid: 3702) EC: 6EC: .EC: 3EC: .EC: 2EC: .EC: - |
| >sp|Q8NFD2|ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 155/669 (23%), Positives = 276/669 (41%), Gaps = 92/669 (13%)
Query: 201 RNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
+++ + +GV + LG+VM+ GS++ + + L + + +A +
Sbjct: 81 QHIVSIYGVCKQP--LGIVMEFMANGSLEKVLSTHSLCWKLRFRIIHETSLAMNFLHSIK 138
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
++ +++KP N+LLD++ +SD+GL+ +++ + R E + R MLS
Sbjct: 139 PPLLHLDLKPGNILLDSNMHVKISDFGLSKWMEQ-STRMQYIERSALR-------GMLS- 189
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
Y PE +F + P+ D +SF + E+ T P++G + I V
Sbjct: 190 -YIPPE----------MFLESNKAPGPKYDVYSFAIVIWELLTQKKPYSGFNMMMIIIRV 238
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF------SAMLATFLRHLQEL 433
+ Q S +++ ++ C KRP F + +L + L+ +
Sbjct: 239 AAGMRPSLQPVSDQWPSEAQQMVDLMKRCWDQDPKKRPCFLDITIETDILLSLLQSRVAV 298
Query: 434 PRSPPAS-------------------------PDTG-FTK--FSTSNETEPSPA-SDVEV 464
P S + D+G + K S+ P ++ +
Sbjct: 299 PESKALARKVSCKLSLRQPGEVNEDISQELMDSDSGNYLKRALQLSDRKNLVPRDEELCI 358
Query: 465 FQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSA 524
+++ LH LV++G V VR LL+ + Q A G T L +A +
Sbjct: 359 YENKVTPLHFLVAQGSVEQVRLLLAHEVD----------VDCQTASGYTPLLIAAQDQQP 408
Query: 525 ELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVA 584
+L +L + + + +D+DG PL FA G L+ GA V ++ REG+ P
Sbjct: 409 DLCALLLAHG-ADANRVDEDGWAPLHFAAQNGDDGTARLLLDHGACVDAQEREGWTP--L 465
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
H+ A + + R L+ ADPN + EG++ LH VA + ++V L +
Sbjct: 466 HLAAQNNFENVARLLVSRQADPNLHEAEGKTPLH--VAAYFGHVSLVKLLTSQGAELDAQ 523
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
TPLHL V V ++ ++ + + ++ GP+ TA G
Sbjct: 524 QRNLRTPLHLAVERGKVRAIQHLLKSGAVPDALDQSGY-GPLHTA-----------AARG 571
Query: 705 RELV-RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLH 763
+ L+ ++LL GA Q T LH+A+ +E++ ++ ++ ++ N PLH
Sbjct: 572 KYLICKMLLRYGASLELPTHQGWTPLHLAAYKGHLEIIHLLAESHANMGALGAVNWTPLH 631
Query: 764 VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAV 823
+A G ++ V LL GAD N + G H+A R +I +L H A V
Sbjct: 632 LAARHGEEAVVSALLQCGADPNAAEQSGWTPLHLAVQ-----RSTFLSVINLLEH-HANV 685
Query: 824 EVRNHSGKT 832
RN G T
Sbjct: 686 HARNKVGWT 694
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8BZ25|ANKK1_MOUSE Ankyrin repeat and protein kinase domain-containing protein 1 OS=Mus musculus GN=Ankk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 115 bits (289), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 148/631 (23%), Positives = 266/631 (42%), Gaps = 82/631 (12%)
Query: 201 RNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
+++ + +GV + LG+VM+ GS++ + + L+ + + +A +
Sbjct: 93 QHIVSIYGVCKQP--LGIVMEFMASGSLEKTLPTHSLCWPLKLRIIHETSLAMNFLHSIK 150
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
++ +++KP N+LLD + +SD+GL+ +++ + +K E S + T+
Sbjct: 151 PPLLHLDLKPGNILLDNNMHVKISDFGLSKWMEQ-STQKQYIE------RSALRGTL--- 200
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+Y PE +F ++ PE D +SF + E+ T P+AGL+ I V
Sbjct: 201 SYIPPE----------MFLENNKAPGPEYDVYSFAIVIWEILTQKKPYAGLNMMTIIIRV 250
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF------SAMLATFLRH---- 429
+ Q S ++ ++ C KRP F + ML + +
Sbjct: 251 AAGMRPSLQDVSDEWPEEVHQMVNLMKRCWDQDPKKRPCFLNVAVETDMLLSLFQSPMTD 310
Query: 430 ------LQELPRSPPASPDTGFTKFSTSNETEPSPASD----------------VEVFQD 467
Q++ P S +K + E S +SD +V+++
Sbjct: 311 PGCEALTQKVSCKPSLSQPHKVSK-EVNQEIADSVSSDSLKWILQLSDSKSLVASDVYEN 369
Query: 468 NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELV 527
LH LV+ G + VR LLS + + Q A G T L +A + +L
Sbjct: 370 RVTPLHFLVAGGSLEQVRLLLSHDVD----------VDCQTASGYTPLLIATQDQQPDLC 419
Query: 528 EAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVC 587
+L + + ++ D+DG PL FA G L+ GA V +R EG+ P H+
Sbjct: 420 ALLLAHG-ADTNLADEDGWAPLHFAAQNGDDHTARLLLDHGALVNAREHEGWTP--LHLA 476
Query: 588 AYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK 647
A + + R L+ AD + + EG++ LH VA + +V L +G +
Sbjct: 477 AQNNFENVARLLVSRQADLSPHEAEGKTPLH--VAAYFGHIGLVKLLSGQGAELDAQQRN 534
Query: 648 ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
TPLHL V V ++ ++ + + + +D G + L +AAA KD +
Sbjct: 535 LRTPLHLAVERGKVRAIQHLLKCGA---LPDALDHSG--YSPLHIAAARGKD------LI 583
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
++LL GA + Q T LH+A+ +E++ + + VD++ PLH+A
Sbjct: 584 FKMLLRYGASLELRTQQGWTPLHLATYKGHLEIIHQLAKSHVDLDALGSMQWTPLHLAAF 643
Query: 768 RGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798
+G + + LL GA+ N + G H+A
Sbjct: 644 QGEEGVMLALLQCGANPNAAEQSGWTPLHLA 674
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus GN=Ank3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 111 bits (277), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 90/324 (27%), Positives = 149/324 (45%), Gaps = 22/324 (6%)
Query: 504 LKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA 563
++A G T +H+A G +V ++ + + + + G+ L A +G E V
Sbjct: 409 IQAVTESGLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARSGQAEVVRY 467
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623
L++ GA V ++ ++ P H+ A G+ D +++LL GA PNA G + LH A +
Sbjct: 468 LVQDGAQVEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLAARE 525
Query: 624 KYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE-VASPEEIVNVIDI 682
+ D A +L++G S++I K TPLH+ + V ++ ASP D
Sbjct: 526 GHEDVAAFLLDHGA--SLSITTKKGFTPLHVAAKYGKLEVASLLLQKSASP-------DA 576
Query: 683 PGPVG-TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741
G G T L +AA + +++ +LL GA P A T LHIA+ N +++
Sbjct: 577 AGKSGLTPLHVAA------HYDNQKVALLLLDQGASPHAAAKNGYTPLHIAAKKNQMDIA 630
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADA 801
+L+ G D N +H+A G V LLLS A+ N + G H+AA
Sbjct: 631 TSLLEYGADANAVTRQGIASVHLAAQEGHVDMVSLLLSRNANVNLSNKSGLTPLHLAAQE 690
Query: 802 AKMIRENLEWLIVMLSHPDAAVEV 825
++ E L+ +H DA ++
Sbjct: 691 DRV--NVAEVLVNQGAHVDAQTKM 712
|
Membrane-cytoskeleton linker. May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments (By similarity). In skeletal muscle, required for costamere localization of DMD and betaDAG1. Mus musculus (taxid: 10090) |
| >sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 110 bits (276), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 88/324 (27%), Positives = 148/324 (45%), Gaps = 22/324 (6%)
Query: 504 LKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA 563
++A G T +H+A G +V ++ + + + + G+ L A +G E V
Sbjct: 426 IQAVTESGLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARSGQAEVVRY 484
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623
L++ GA V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + +
Sbjct: 485 LVQDGAQVEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSARE 542
Query: 624 KYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE-VASPEEIVNVIDI 682
+ D A +L++G S++I K TPLH+ + V ++ ASP D
Sbjct: 543 GHEDVAAFLLDHGA--SLSITTKKGFTPLHVAAKYGKLEVANLLLQKSASP-------DA 593
Query: 683 PGPVG-TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741
G G T L +AA + +++ +LL GA P A T LHIA+ N +++
Sbjct: 594 AGKSGLTPLHVAA------HYDNQKVALLLLDQGASPHAAAKNGYTPLHIAAKKNQMDIA 647
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADA 801
+L+ G D N +H+A G V LLL A+ N + G H+AA
Sbjct: 648 TTLLEYGADANAVTRQGIASVHLAAQEGHVDMVSLLLGRNANVNLSNKSGLTPLHLAAQE 707
Query: 802 AKMIRENLEWLIVMLSHPDAAVEV 825
++ E L+ +H DA ++
Sbjct: 708 DRV--NVAEVLVNQGAHVDAQTKM 729
|
Membrane-cytoskeleton linker. May participate in the maintenance/targeting of ion channels and cell adhesion molecules at the nodes of Ranvier and axonal initial segments. Homo sapiens (taxid: 9606) |
| >sp|Q01484|ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 110 bits (275), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 91/310 (29%), Positives = 144/310 (46%), Gaps = 22/310 (7%)
Query: 496 YSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAA 555
Y +SI ++ ++ G T +H+A G +V +L+ + DV + G+ L A A
Sbjct: 420 YGASIQAITES----GLTPIHVAAFMGHLNIVLLLLQNGA-SPDVTNIRGETALHMAARA 474
Query: 556 GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGES 615
G E V L++ GA V +R RE P H+ + G+ + ++ LL A P+A G +
Sbjct: 475 GQVEVVRCLLRNGALVDARAREEQTP--LHIASRLGKTEIVQLLLQHMAHPDAATTNGYT 532
Query: 616 VLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEE 675
LH + + D A V+LE G S+A K TPLH+ ++ V K ++ +
Sbjct: 533 PLHISAREGQVDVASVLLEAGAAHSLA--TKKGFTPLHVAAKYGSLDVAKLLLQRRA--- 587
Query: 676 IVNVIDIPGPVG-TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASM 734
D G G T L +AA + +++ +LL GA P A T LHIA+
Sbjct: 588 ---AADSAGKNGLTPLHVAA------HYDNQKVALLLLEKGASPHATAKNGYTPLHIAAK 638
Query: 735 ANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNA 794
N +++ +L+ G + NI PLH+A G V LLL GA+ + G +
Sbjct: 639 KNQMQIASTLLNYGAETNIVTKQGVTPLHLASQEGHTDMVTLLLDKGANIHMSTKSGLTS 698
Query: 795 FHIAADAAKM 804
H+AA K+
Sbjct: 699 LHLAAQEDKV 708
|
Attaches integral membrane proteins to cytoskeletal elements. Also binds to cytoskeletal proteins. Required for coordinate assembly of Na/Ca exchanger, Na/K ATPase and InsP3 receptor at sarcoplasmic reticulum sites in cardiomyocytes. Required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) in the inner segment of rod photoreceptors. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate. Homo sapiens (taxid: 9606) |
| >sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus GN=Ank2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 107 bits (268), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 90/310 (29%), Positives = 143/310 (46%), Gaps = 22/310 (7%)
Query: 496 YSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAA 555
Y +SI ++ ++ G T +H+A G +V +L+ + DV + G+ L A A
Sbjct: 420 YGASIQAITES----GLTPIHVAAFMGHLNIVLLLLQNGA-SPDVTNIRGETALHMAARA 474
Query: 556 GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGES 615
G E V L++ GA V +R RE P H+ + G+ + ++ LL A P+A G +
Sbjct: 475 GQVEVVRCLLRNGALVDARAREEQTP--LHIASRLGKTEIVQLLLQHMAHPDAATTNGYT 532
Query: 616 VLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEE 675
LH + + D A V+LE G S+A K TPLH+ ++ V K ++ +
Sbjct: 533 PLHISAREGQVDVASVLLEAGAAHSLA--TKKGFTPLHVAAKYGSLDVAKLLLQRRA--- 587
Query: 676 IVNVIDIPGPVG-TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASM 734
D G G T L +AA + +++ +LL GA P A T LHIA+
Sbjct: 588 ---AADSAGKNGLTPLHVAA------HYDNQKVALLLLEKGASPHATAKNGYTPLHIAAK 638
Query: 735 ANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNA 794
N +++ +L+ G + N PLH+A G V LLL GA+ + G +
Sbjct: 639 KNQMQIASTLLNYGAETNTVTKQGVTPLHLASQEGHTDMVTLLLDKGANIHMSTKSGLTS 698
Query: 795 FHIAADAAKM 804
H+AA K+
Sbjct: 699 LHLAAQEDKV 708
|
Attaches integral membrane proteins to cytoskeletal elements. Also binds to cytoskeletal proteins. Required for coordinate assembly of Na/Ca exchanger, Na/K ATPase and InsP3 receptor at sarcoplasmic reticulum sites in cardiomyocytes (By similarity). Required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) in the inner segment of rod photoreceptors. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate. Mus musculus (taxid: 10090) |
| >sp|P53355|DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | Back alignment and function description |
|---|
Score = 105 bits (262), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 151/693 (21%), Positives = 265/693 (38%), Gaps = 76/693 (10%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
NV T H V + + L+++ G + LT E+ + I GV LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 262 VVCMNIKPSN-LLLDAS---GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML 317
+ ++KP N +LLD + R + D+GLA + +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFG 179
Query: 318 SPNYTAPEA--WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
+P + APE +EP +G+ E+D WS G + +G+ P+ G + +E
Sbjct: 180 TPEFVAPEIVNYEP------------LGL--EADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 376 YRAV-VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434
V N + +Y S + +++ K P + L+H P
Sbjct: 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLL--------VKDPKKRMTIQDSLQH----P 273
Query: 435 RSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASG 494
P ++ +++ E L L R LS+ ++
Sbjct: 274 WIKPKDTQQALSRKASAVNMEKFKKFAARKKWKQSVRLISLCQRLS----RSFLSR-SNM 328
Query: 495 NYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALA 554
+ + S +L + + + +H L + S +V+ +K G PPL+ A
Sbjct: 329 SVARSDDTLDEEDSFVMKAIIHAINDDNVPGLQHLLGSLSNYDVNQPNKHGTPPLLIAAG 388
Query: 555 AGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGE 614
G+ + + LIKRG+ + +++ G + + A HG D ++ L + D GE
Sbjct: 389 CGNIQILQLLIKRGSRI--DVQDKGGSNAVYWAARHGHVDTLKFLSENKCPLDVKDKSGE 446
Query: 615 SVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPE 674
LH A + D A ++ G + I + +E TPLH +V K E
Sbjct: 447 MALHVAARYGHADVAQLLCSFGS--NPNIQDKEEETPLHCAAWHGYYSVAKALCEAGCN- 503
Query: 675 EIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASM 734
++I G + A+ + H++ V L GA+ A D ALH+A
Sbjct: 504 -----VNIKNREGETPLLTASARGYHDI-----VECLAEHGADLNACDKDGHIALHLAVR 553
Query: 735 ANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNA 794
+E++K +L G V+ ++ H PLHVA G V L A + + + G
Sbjct: 554 RCQMEVIKTLLSQGCFVDYQDRHGNTPLHVACKDGNMPIVVALCEANCNLDISNKYGRTP 613
Query: 795 FHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALM 854
H+AA+ I + + +L +M A+VE GKT D E ++ L A +
Sbjct: 614 LHLAANNG--ILDVVRYLCLM----GASVEALTTDGKTAEDLARSEQHEHVAGLL--ARL 665
Query: 855 NRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGA 887
+ H I ++ + R+ +G G+
Sbjct: 666 RKDTHRGLFIQQLRPTQNLQPRIKLKLFGHSGS 698
|
Isoform 2 cannot induce apoptosis but can induce membrane blebbing. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus GN=Dapk1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 105 bits (261), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 151/696 (21%), Positives = 267/696 (38%), Gaps = 82/696 (11%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
NV T H V + + L+++ G + LT E+ + I GV LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILSGVYYLHSLQ 134
Query: 262 VVCMNIKPSN-LLLDAS---GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML 317
+ ++KP N +LLD + R + D+GLA + +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFG 179
Query: 318 SPNYTAPEA--WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
+P + APE +EP +G+ E+D WS G + +G+ P+ G + +E
Sbjct: 180 TPEFVAPEIVNYEP------------LGL--EADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 376 YRAVVKNRKLPPQYASIVGVGIPRELWK----MIGECLQFKASKRPTFSAMLATFLRHLQ 431
V S V E ++ + + ++ K P + L+H
Sbjct: 226 LANV-----------SAVNYDFEEEFFRNTSTLAKDFIRRLLVKDPKKRMTIQDSLQH-- 272
Query: 432 ELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKN 491
P P ++ +++ E L L R LS+
Sbjct: 273 --PWIKPKDTQQALSRKASAVNMEKFKKFAARKKWKQSVRLISLCQRLS----RSFLSR- 325
Query: 492 ASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVF 551
++ + + S +L + + + +H L + S +V+ +K G PPL+
Sbjct: 326 SNMSVARSDDTLDEEDSFVMKAIIHAINDDNVPGLQHLLGSLSSYDVNQPNKHGTPPLLI 385
Query: 552 ALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD 611
A G+ + + LIKRG+ + +++ G + + + HG D ++ L + D
Sbjct: 386 AAGCGNIQMLQLLIKRGSRI--DVQDKGGSNAIYWASRHGHVDTLKFLNENKCPLDVKDK 443
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVA 671
GE+ LH VA +Y +V L + + +E TPLH +V K EV
Sbjct: 444 SGETALH--VAARYGHADVVQLLCSFGSNPDFQDKEEETPLHCAAWHGYYSVAKALCEVG 501
Query: 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHI 731
++I G + A+ + H++ V L GA+ A D ALH+
Sbjct: 502 CN------VNIKNREGETPLLTASARGYHDI-----VECLAEHGADLNASDKDGHIALHL 550
Query: 732 ASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEG 791
A +E++K +L G V+ ++ H PLHVA G+ V L A + + + G
Sbjct: 551 AVRRCQMEVIKTLLGHGSFVDFQDRHGNTPLHVACKDGSAPIVVALCEASCNLDISNKYG 610
Query: 792 DNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLME 851
H+AA+ I + + +L +M A VE GKT D + E ++ L
Sbjct: 611 RTPLHLAANNG--ILDVVRYLCLM----GANVEALTSDGKTAEDLAKAEQHEHVAGLL-- 662
Query: 852 ALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGA 887
A + + H I ++ + R+ +G G+
Sbjct: 663 ARLRKDTHRGLFIQQLRPTQNLQPRIKLKLFGHSGS 698
|
Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Phosphorylates PIN1 resulting in inhibition of its catalytic activity, nuclear localization, and cellular function. Phosphorylates TPM1, enhancing stress fiber formation in endothelial cells. Phosphorylates STX1A and significantly decreases its binding to STXBP1. Phosphorylates PRKD1 and regulates JNK signaling by binding and activating PRKD1 under oxidative stress. Phosphorylates BECN1, reducing its interaction with BCL2 and BCL2L1 and promoting the induction of autophagy. Phosphorylates TSC2, disrupting the TSC1-TSC2 complex and stimulating mTORC1 activity in a growth factor-dependent pathway. Phosphorylates RPS6, MYL9 and DAPK3 (By similarity). Acts as a signaling amplifier of NMDA receptors at extrasynaptic sites for mediating brain damage in stroke. Cerebral ischemia recruits DAPK1 into the NMDA receptor complex and it phosphorylates GRINB at Ser-1303 inducing injurious Ca(2+) influx through NMDA receptor channels, resulting in an irreversible neuronal death. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54KA7|SECG_DICDI Ankyrin repeat, PH and SEC7 domain containing protein secG OS=Dictyostelium discoideum GN=secG PE=2 SV=1 | Back alignment and function description |
|---|
Score = 101 bits (252), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 23/291 (7%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
T LH A SAE V +L + + + +G+ PL A A G+P+CV LIK + V
Sbjct: 138 TPLHKASLFASAECVLYLLN-GKADPRAVTTNGETPLHHASAGGNPQCVELLIKADSKVN 196
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI 632
+ + P H ++ G C+ LL GA + D G S LH A + Y DC +
Sbjct: 197 AVDNDCITP--LHQASFSGHSSCVSLLLKKGAKVDPRDIHGISPLHNAASAGYVDCVEQL 254
Query: 633 LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCM 692
+ NG ++ ++ + +TPLH N+ + KR +E+ + +N++D G T L
Sbjct: 255 VRNG--ENINCVDIEGVTPLHHTCFNGNLQLTKRLIELGAK---INMVDEMGE--TPLHK 307
Query: 693 AAALKKDHEVEG-RELVRILLTAGAEPTA---QDAQNRTALHIASMANDVELVKIILDAG 748
AA G +E+ LL +PT +D++ T+LH+A+ +++V +++
Sbjct: 308 AA-------FNGHKEVCEYLLYL--DPTMIDCRDSRQSTSLHLAAFNGLLDMVDLLIRYK 358
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
+NI++ PLH A G SC LL+ GA D +G H AA
Sbjct: 359 AQINIKDEEGATPLHKASFNGHSSCAKLLVDKGAPICIVDSQGATPLHKAA 409
|
Dictyostelium discoideum (taxid: 44689) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1630 | ||||||
| 255543935 | 1617 | ankyrin-repeat containing protein, putat | 0.973 | 0.980 | 0.816 | 0.0 | |
| 356539563 | 1637 | PREDICTED: E3 ubiquitin-protein ligase K | 0.992 | 0.987 | 0.818 | 0.0 | |
| 225465817 | 1631 | PREDICTED: E3 ubiquitin-protein ligase K | 0.993 | 0.992 | 0.834 | 0.0 | |
| 147836207 | 1662 | hypothetical protein VITISV_007720 [Viti | 0.993 | 0.974 | 0.818 | 0.0 | |
| 356508302 | 1642 | PREDICTED: E3 ubiquitin-protein ligase K | 0.992 | 0.985 | 0.813 | 0.0 | |
| 186522588 | 1625 | E3 ubiquitin-protein ligase KEG [Arabido | 0.991 | 0.994 | 0.780 | 0.0 | |
| 334187662 | 1624 | E3 ubiquitin-protein ligase KEG [Arabido | 0.990 | 0.994 | 0.779 | 0.0 | |
| 449449266 | 1612 | PREDICTED: E3 ubiquitin-protein ligase K | 0.974 | 0.985 | 0.744 | 0.0 | |
| 449487126 | 1612 | PREDICTED: LOW QUALITY PROTEIN: E3 ubiqu | 0.974 | 0.985 | 0.743 | 0.0 | |
| 413945241 | 1681 | putative protein kinase superfamily prot | 0.985 | 0.955 | 0.667 | 0.0 |
| >gi|255543935|ref|XP_002513030.1| ankyrin-repeat containing protein, putative [Ricinus communis] gi|223548041|gb|EEF49533.1| ankyrin-repeat containing protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 2736 bits (7092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1347/1649 (81%), Positives = 1472/1649 (89%), Gaps = 63/1649 (3%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MKVPCCSVCQTRYNE+ERVPLLLQCGHGFCKECLSRMFS+S DTTL+CPRCRHVSVVGNS
Sbjct: 1 MKVPCCSVCQTRYNEEERVPLLLQCGHGFCKECLSRMFSSSLDTTLACPRCRHVSVVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHH-------NSNTNHFDSDVTDDDDDDEDDEVDEFGRG 115
V ALRKN+AVL+L+ +A + + ++ + + + +D +DEDDE + RG
Sbjct: 61 VNALRKNYAVLSLLSAATSASPNNFDCDYTDDEEDDDDNISNNNDAKNDEDDE-ERCSRG 119
Query: 116 THVSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV 175
+H SSSG GPVIEVGVHH+VKL+KK+GEGRRAGV+ W IGGG G+C+H VAVK+V
Sbjct: 120 SHASSSGGACGGPVIEVGVHHEVKLLKKIGEGRRAGVDTWTGVIGGG-GKCKHKVAVKRV 178
Query: 176 MIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNE 235
+ E+ME +++ GQL+NLRR SMWCRNVC FHGV++M+ CLGLVMDRCYGSVQ M RNE
Sbjct: 179 EVGEDMELEYVLGQLENLRRGSMWCRNVCKFHGVVKMEGCLGLVMDRCYGSVQSEMLRNE 238
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
GRLTL+QILRYGADIARGV ELHAAGVVCMNIKPSNLLLD++GRAVVSDYGLAAILKKPA
Sbjct: 239 GRLTLDQILRYGADIARGVAELHAAGVVCMNIKPSNLLLDSNGRAVVSDYGLAAILKKPA 298
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
CRKAR EC+S++IHSCMDC MLSP+YTAPEAWEPVKKSLNLFWDDAIGIS ESDAWSFGC
Sbjct: 299 CRKARSECESAKIHSCMDCIMLSPHYTAPEAWEPVKKSLNLFWDDAIGISAESDAWSFGC 358
Query: 356 TLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK 415
TLVEMCTGSIPWAGLSAEEIYRAVVK +KLPPQYAS+VGVG+PRELWKMIGECLQFKAS+
Sbjct: 359 TLVEMCTGSIPWAGLSAEEIYRAVVKGKKLPPQYASVVGVGMPRELWKMIGECLQFKASR 418
Query: 416 RPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQL 475
RP+F+ MLA FLRHLQELPRSPPASPD F K+S SN TEPSPA D+E+FQDNP++LH+L
Sbjct: 419 RPSFNQMLAIFLRHLQELPRSPPASPDNSFAKYSGSNVTEPSPAPDLEIFQDNPSHLHRL 478
Query: 476 VSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQ 535
VSEGDV+GVRDLL+K ASGN SS+S LL+AQNADGQTALHLACRRGSAELV ILEY Q
Sbjct: 479 VSEGDVTGVRDLLAKAASGNDGSSLSLLLEAQNADGQTALHLACRRGSAELVGTILEYKQ 538
Query: 536 ENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDC 595
+ DVLDKDGDPPLVFALAAGS CV ALI RGANV SRLR+GFGPSVAHVCAYHGQPDC
Sbjct: 539 ADADVLDKDGDPPLVFALAAGSATCVRALIVRGANVRSRLRDGFGPSVAHVCAYHGQPDC 598
Query: 596 MRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655
MRELLLAGADPNAVDDEGE+VLHRAVAKKYTDCA+VILENGGCRSMA+ NSK LTPLHLC
Sbjct: 599 MRELLLAGADPNAVDDEGETVLHRAVAKKYTDCALVILENGGCRSMAVRNSKNLTPLHLC 658
Query: 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG 715
VATWNVAVV+RW+E+AS EEI IDIP PVGTALCMAAA+KKDHE+EGRELVRILL AG
Sbjct: 659 VATWNVAVVRRWLEIASIEEIAGTIDIPSPVGTALCMAAAVKKDHEIEGRELVRILLAAG 718
Query: 716 AEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
A+PTAQDAQ+ RTALH A+MANDV+LVKIILDAGVDVNIRN+HNTIPLHVALARGAKSCV
Sbjct: 719 ADPTAQDAQHGRTALHTAAMANDVDLVKIILDAGVDVNIRNMHNTIPLHVALARGAKSCV 778
Query: 775 GLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHS----- 829
GLLLS+GA CN QDDEGDNAFHIAADAAKMIRENL+WLIVML +PDAAV+VRNH
Sbjct: 779 GLLLSSGASCNLQDDEGDNAFHIAADAAKMIRENLDWLIVMLRNPDAAVDVRNHRQVPTI 838
Query: 830 -----------------GKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVK 872
GKTLRDFLE LPREWISEDLMEAL++RGVHLSPTIFE+GDWVK
Sbjct: 839 DFFLFQCLHIGSLGFSFGKTLRDFLEALPREWISEDLMEALVDRGVHLSPTIFEVGDWVK 898
Query: 873 FKRRVTTPTYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHV 932
FKR VT PT+GWQGAKHKSVGFVQ+V+DK+N++VSFC+GE VL +EVLK+IPLDRGQHV
Sbjct: 899 FKRTVTAPTHGWQGAKHKSVGFVQNVVDKENIVVSFCTGEAHVLVNEVLKVIPLDRGQHV 958
Query: 933 KLKPDVKEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVG 992
+LKPDVKEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVG
Sbjct: 959 RLKPDVKEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVG 1018
Query: 993 DWVRIRPTLTTAKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPF 1052
DWVRIRPTLTTAKHGLG VTPGSIGIVYC+RPDSSLLLELSYLPNPWHCEPEEVE VPPF
Sbjct: 1019 DWVRIRPTLTTAKHGLGLVTPGSIGIVYCVRPDSSLLLELSYLPNPWHCEPEEVELVPPF 1078
Query: 1053 RIGNRVCVKRSVAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKV 1112
R IENDGLLIIEIP+RPIPWQADPSDMEKV
Sbjct: 1079 R-------------------------------IENDGLLIIEIPSRPIPWQADPSDMEKV 1107
Query: 1113 EDFKVGDWVRVKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDV 1172
EDFKVGDWVRVKASVSSP+YGWEDITRNSIGIIHSLEEDG +G+AFCFRSKPF CSVTDV
Sbjct: 1108 EDFKVGDWVRVKASVSSPQYGWEDITRNSIGIIHSLEEDGVMGVAFCFRSKPFRCSVTDV 1167
Query: 1173 EKVPPFEVGQEIHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSP 1232
EKVPPFEVGQEI VMPSVTQPRLGWS E+PATVGKIV+IDMDGALNVKVAGRH+ WKVSP
Sbjct: 1168 EKVPPFEVGQEIRVMPSVTQPRLGWSNESPATVGKIVRIDMDGALNVKVAGRHNPWKVSP 1227
Query: 1233 GDAERLSGFEVGDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRW 1292
GDAERLSGFEVGDWVRSKPS+GTRPSYDWN++GKESLAVVHS+Q+ GYLELACCFRKGRW
Sbjct: 1228 GDAERLSGFEVGDWVRSKPSLGTRPSYDWNSIGKESLAVVHSVQETGYLELACCFRKGRW 1287
Query: 1293 STHYTDVEKIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLP 1352
HYTDVEK+P +KVGQHVRFR+GLA+PRWGWRG + DSRGIITSVHADGEVRVAFFGLP
Sbjct: 1288 IAHYTDVEKVPCFKVGQHVRFRTGLADPRWGWRGTRPDSRGIITSVHADGEVRVAFFGLP 1347
Query: 1353 GLWKGDPADLEIGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAF 1412
GLW+GDPADLEI QMFEVGEWVRL++ A NWKSIGPGS+GVVQGIG+ D WDGST+V F
Sbjct: 1348 GLWRGDPADLEIEQMFEVGEWVRLKEGAGNWKSIGPGSIGVVQGIGYDGDEWDGSTYVGF 1407
Query: 1413 CCEQERWVGPTSHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLR 1472
C EQERWVGPTSHLERV+RL VGQ+VRVKLSVKQPRFGWSGHSHASVG ++AIDADGK+R
Sbjct: 1408 CGEQERWVGPTSHLERVERLTVGQKVRVKLSVKQPRFGWSGHSHASVGTIAAIDADGKMR 1467
Query: 1473 IYTPVGSKTWMLDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMES 1532
IYTPVGSKTWMLDP+EVE+V E+EL IGDWVRVRASV+TPT+QWGEVSHSSIGVVHRME
Sbjct: 1468 IYTPVGSKTWMLDPTEVELVMEQELGIGDWVRVRASVSTPTHQWGEVSHSSIGVVHRMED 1527
Query: 1533 GELWVAFCFMERLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGV 1592
ELWVAFCFMERLWLCKAWEME VRPFKVGDKVRI+EGLVTPRWGWGMETHASKG+VVGV
Sbjct: 1528 EELWVAFCFMERLWLCKAWEMEWVRPFKVGDKVRIREGLVTPRWGWGMETHASKGKVVGV 1587
Query: 1593 DANGKLRIKFQWREGRPWIGDPADIVLDE 1621
DANGKLRIKFQWREGRPWIGDPADIVLDE
Sbjct: 1588 DANGKLRIKFQWREGRPWIGDPADIVLDE 1616
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356539563|ref|XP_003538267.1| PREDICTED: E3 ubiquitin-protein ligase KEG-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2733 bits (7084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1341/1638 (81%), Positives = 1476/1638 (90%), Gaps = 21/1638 (1%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MK+PCCSVCQTRYNE+ERVPLLLQCGHGFC+ECLSRMFSAS+D TL+CPRCRHVS VGNS
Sbjct: 1 MKIPCCSVCQTRYNEEERVPLLLQCGHGFCRECLSRMFSASSDATLACPRCRHVSTVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEF--------GR 114
V ALRKN+AVLAL+ SA N ++ FD D TDD+D D E +E R
Sbjct: 61 VQALRKNYAVLALLNSAAAANGGGGGRSS-FDCDCTDDEDGDGGGEDEEEDDEKRRRNSR 119
Query: 115 GTHVSSSGVGVCGPVIEVG-----VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQG----- 164
+ SSSG G C PVIE+G H+D+KLV+++GEGRRAGVE+W A I GG G
Sbjct: 120 ESQASSSGGG-CAPVIELGGGGGGAHNDLKLVQRIGEGRRAGVEMWMAVISGGGGEVGRQ 178
Query: 165 RCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCY 224
RCRH+VAVKKV +AE M+ DW+ G+L++LRRASMWCRNVCTFHG +R++ L LVMD+CY
Sbjct: 179 RCRHNVAVKKVAVAEGMDLDWVQGKLEDLRRASMWCRNVCTFHGTMRVEDSLCLVMDKCY 238
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
GSVQ MQRNEGRLTLEQ+LRYGADIARGVVELHAAGVVCMN+KPSNLLLDA+G AVVSD
Sbjct: 239 GSVQSEMQRNEGRLTLEQVLRYGADIARGVVELHAAGVVCMNLKPSNLLLDANGHAVVSD 298
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344
YGLA ILKKP+C KARPECDS++IHSCM+C MLSP+YTAPEAWEPVKKSLNLFWDD IGI
Sbjct: 299 YGLATILKKPSCWKARPECDSAKIHSCMECIMLSPHYTAPEAWEPVKKSLNLFWDDGIGI 358
Query: 345 SPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKM 404
S ESDAWSFGCTLVEMCTG+IPWAGLSAEEIYRAV+K +KLPPQYAS+VG GIPRELWKM
Sbjct: 359 SSESDAWSFGCTLVEMCTGAIPWAGLSAEEIYRAVIKAKKLPPQYASVVGGGIPRELWKM 418
Query: 405 IGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEV 464
IGECLQFK SKRPTFSAMLA FLRHLQE+PRSPPASPD G K S SN EPSP ++EV
Sbjct: 419 IGECLQFKPSKRPTFSAMLAIFLRHLQEIPRSPPASPDNGLDKGSVSNVMEPSPVPELEV 478
Query: 465 FQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSA 524
Q+NPN+LH+LVSEGD +GVRDLL+K AS + S+ +S LL+AQNADGQTALHLACRRGSA
Sbjct: 479 PQENPNHLHRLVSEGDTAGVRDLLAKAASESGSNYLSMLLEAQNADGQTALHLACRRGSA 538
Query: 525 ELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVA 584
ELVE ILE + NVDVLDKDGDPPLVFALAAGSPECV +LIKR ANV SRLR+GFGPSVA
Sbjct: 539 ELVETILECREANVDVLDKDGDPPLVFALAAGSPECVRSLIKRNANVRSRLRDGFGPSVA 598
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA+AKKYTDCA+VILENGGCRSMAIL
Sbjct: 599 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAIAKKYTDCALVILENGGCRSMAIL 658
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
N K LTPLHLCVATWNVAVVKRWVEVA+ +EI IDIP P+GTALCMAAA KKDHE EG
Sbjct: 659 NPKNLTPLHLCVATWNVAVVKRWVEVATSDEIAESIDIPSPIGTALCMAAASKKDHENEG 718
Query: 705 RELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLH 763
RELV+ILL AGA+P+AQD+QN RTALH A+M NDV+LVK+IL AGVDVNIRNVHN+IPLH
Sbjct: 719 RELVQILLAAGADPSAQDSQNGRTALHTAAMTNDVDLVKVILGAGVDVNIRNVHNSIPLH 778
Query: 764 VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAV 823
+ALARGAK+CVGLLL+AGAD N QDD+GDNAFHIAAD AKMIRENL+WLIVML +P+A +
Sbjct: 779 LALARGAKACVGLLLAAGADYNLQDDDGDNAFHIAADTAKMIRENLDWLIVMLRNPNADI 838
Query: 824 EVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYG 883
EVRNH GKTLRD LE LPREW+SEDLMEALMNRGVHL PT+FE+GDWVKFKR VT P +G
Sbjct: 839 EVRNHCGKTLRDILEALPREWLSEDLMEALMNRGVHLFPTVFEVGDWVKFKRSVTKPKHG 898
Query: 884 WQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRF 943
WQGAK KSVGFVQSV D+DNLIVSFCSGEV VLA+EV+K+IPLDRGQHV+LK DVKEPRF
Sbjct: 899 WQGAKPKSVGFVQSVPDRDNLIVSFCSGEVHVLANEVIKVIPLDRGQHVQLKEDVKEPRF 958
Query: 944 GWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTT 1003
GWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLT+
Sbjct: 959 GWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTS 1018
Query: 1004 AKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRS 1063
AKHGLGSVTPGSIGIVYCIRPDSSLL+ELSYLPNPWHCEPEEVE V PFRIG+RVCVKRS
Sbjct: 1019 AKHGLGSVTPGSIGIVYCIRPDSSLLIELSYLPNPWHCEPEEVEHVAPFRIGDRVCVKRS 1078
Query: 1064 VAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRV 1123
VAEPRYAWGGETHHSVG+ISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRV
Sbjct: 1079 VAEPRYAWGGETHHSVGRISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRV 1138
Query: 1124 KASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQE 1183
KASVSSPKYGWEDITR SIG+IHSLEEDGD+G+AFCFRSKPF CSVTDVEKVPPFEVGQE
Sbjct: 1139 KASVSSPKYGWEDITRTSIGVIHSLEEDGDMGVAFCFRSKPFSCSVTDVEKVPPFEVGQE 1198
Query: 1184 IHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEV 1243
IH+MPSVTQPRLGWS E+ ATVGKIV+IDMDGALNV+V GR SLWKVSPGDAERL GFEV
Sbjct: 1199 IHLMPSVTQPRLGWSNESAATVGKIVRIDMDGALNVRVTGRQSLWKVSPGDAERLPGFEV 1258
Query: 1244 GDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIP 1303
GDWVRSKPS+GTRPSYDWN+VG+ESLAVVHS+QD+GYLELACCFRKG+W THYTDVEK+P
Sbjct: 1259 GDWVRSKPSLGTRPSYDWNSVGRESLAVVHSVQDSGYLELACCFRKGKWITHYTDVEKVP 1318
Query: 1304 SYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLE 1363
S+KVGQ+VRFR+GL EPRWGWRGAQ +S+G+ITS+HADGEVRVAFFGLPGLW+GDP+DLE
Sbjct: 1319 SFKVGQYVRFRTGLVEPRWGWRGAQPESQGVITSIHADGEVRVAFFGLPGLWRGDPSDLE 1378
Query: 1364 IGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPT 1423
I QMFEVGEWVRL D A+NWKSIG GSVGVVQGIG++ D D S FV FC EQE+WVGP+
Sbjct: 1379 IEQMFEVGEWVRLNDNANNWKSIGAGSVGVVQGIGYEGDELDRSIFVGFCGEQEKWVGPS 1438
Query: 1424 SHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWM 1483
SHLER D+L VGQ+VRVK VKQPRFGWSGH+HAS+G + AIDADGKLRIYTP GSKTWM
Sbjct: 1439 SHLERFDKLSVGQKVRVKQYVKQPRFGWSGHTHASIGTIQAIDADGKLRIYTPAGSKTWM 1498
Query: 1484 LDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFME 1543
LDPSEV+VVEE+EL IGDWVRV+AS++TPT+ WGEVSHSSIGVVHRM +LWVAFCF E
Sbjct: 1499 LDPSEVKVVEEKELCIGDWVRVKASISTPTHHWGEVSHSSIGVVHRMADEDLWVAFCFTE 1558
Query: 1544 RLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQ 1603
RLWLCKAWEMERVRPFKVGDKVRI++GLVTPRWGWGMETHASKGQVVGVDANGKLRIKF+
Sbjct: 1559 RLWLCKAWEMERVRPFKVGDKVRIRDGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFR 1618
Query: 1604 WREGRPWIGDPADIVLDE 1621
WREGRPWIGDPAD+ LDE
Sbjct: 1619 WREGRPWIGDPADLALDE 1636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465817|ref|XP_002263469.1| PREDICTED: E3 ubiquitin-protein ligase KEG [Vitis vinifera] gi|296087851|emb|CBI35107.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 2728 bits (7071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1367/1638 (83%), Positives = 1488/1638 (90%), Gaps = 19/1638 (1%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MK+PCC VCQTRYNE+ERVPLLLQCGHGFCKECLSR+FSAS DT LSCPRCRHVS VGNS
Sbjct: 1 MKIPCCLVCQTRYNEEERVPLLLQCGHGFCKECLSRLFSASPDTNLSCPRCRHVSSVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFG--------- 113
V ALRKN+ VLALI Q ++ ++ FD D TD+D+D+ED+ ++E
Sbjct: 61 VQALRKNYGVLALI-------QSSSAPSSAFDCDFTDEDEDNEDELLNEEEEDDESHRRR 113
Query: 114 RGTHVSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVK 173
R + S + CGPVIE+ H D++LVK++GEGRRAGVE+W A + GG GRCRH VA K
Sbjct: 114 RCSRGSYTSSSSCGPVIELASHQDLRLVKRIGEGRRAGVEMWAAVLSGGSGRCRHGVAAK 173
Query: 174 KVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQR 233
KV++ E+ + W+ +LDNLRRASMWCRNVCTFHG +M+ L L+MDRC GSVQ MQR
Sbjct: 174 KVVVGEDTDLGWVQNRLDNLRRASMWCRNVCTFHGATKMEGSLCLIMDRCNGSVQSEMQR 233
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293
NEGRLTLEQILRYGADIARGV ELHAAGVVCMN+KPSNLLLDA+G AVVSDYGL AILKK
Sbjct: 234 NEGRLTLEQILRYGADIARGVAELHAAGVVCMNLKPSNLLLDANGHAVVSDYGLPAILKK 293
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEP-VKKSLNLFWDDAIGISPESDAWS 352
PACRKA+ ECDSS IHSCMDCTMLSP+YTAPEAWEP VKK LN+FWDDAIGISPESDAWS
Sbjct: 294 PACRKAQSECDSSGIHSCMDCTMLSPHYTAPEAWEPPVKKPLNIFWDDAIGISPESDAWS 353
Query: 353 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFK 412
FGCTLVEMCTGSIPWAGLSAEEIYRAVVK+R+ PPQYA +VGVGIPRELWKMIGECLQFK
Sbjct: 354 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKSRRQPPQYAGVVGVGIPRELWKMIGECLQFK 413
Query: 413 ASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNL 472
ASKRPTF+AMLATFLRHLQE+PRSPPASP+ F + +N +EP+PA +EVFQDNPN+L
Sbjct: 414 ASKRPTFNAMLATFLRHLQEIPRSPPASPENEFPRPPGTNVSEPAPAP-LEVFQDNPNHL 472
Query: 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILE 532
HQLVSEGD++GVRDLL+K ASG S SI SL +AQN+DGQTALHLACRRGSAELVEAILE
Sbjct: 473 HQLVSEGDLNGVRDLLAKAASGGSSISIYSLFEAQNSDGQTALHLACRRGSAELVEAILE 532
Query: 533 YSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592
Y + NVDVLD+DGDPPLVFALAAGSPECV ALI+RGANV SRLREGFGPSVAHVCA+HGQ
Sbjct: 533 YREANVDVLDRDGDPPLVFALAAGSPECVQALIRRGANVRSRLREGFGPSVAHVCAFHGQ 592
Query: 593 PDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPL 652
PDCMRELLLAGADPNAVDDEGESVLHRA+AKKYTDCA+V+LENGGC SMA+LNSK LTPL
Sbjct: 593 PDCMRELLLAGADPNAVDDEGESVLHRAIAKKYTDCALVLLENGGCESMAVLNSKTLTPL 652
Query: 653 HLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
HLCVATWNVAVV+RWVEVASPEEI IDIP VGTALCMAAALKKDHE+EGRELVRILL
Sbjct: 653 HLCVATWNVAVVRRWVEVASPEEIAEAIDIPSAVGTALCMAAALKKDHEIEGRELVRILL 712
Query: 713 TAGAEPTAQDAQNR-TALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 771
TAGA+PTAQD Q+R TALH A+MANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK
Sbjct: 713 TAGADPTAQDVQHRRTALHTAAMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 772
Query: 772 SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGK 831
SCVGLLLSAGA+CN QDDEGDNAFHIAADAAKMIRENLEWLI+ML +PDAAVEVRNH+GK
Sbjct: 773 SCVGLLLSAGANCNLQDDEGDNAFHIAADAAKMIRENLEWLIIMLRNPDAAVEVRNHNGK 832
Query: 832 TLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAKHKS 891
TLRDFLE LPREWISEDLMEALMNRG+HLS T+FEIGDWVKFKR ++TP+YGWQGAKHKS
Sbjct: 833 TLRDFLEALPREWISEDLMEALMNRGIHLSTTVFEIGDWVKFKRSISTPSYGWQGAKHKS 892
Query: 892 VGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRFGWRGQSRD 951
VGFVQSV D+DNLIV+FCSGE RVLA+EV+K+IPLDRGQHVKLKPD+KEPRFGWRGQSRD
Sbjct: 893 VGFVQSVPDRDNLIVAFCSGEARVLANEVIKVIPLDRGQHVKLKPDIKEPRFGWRGQSRD 952
Query: 952 SIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSV 1011
SIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSV
Sbjct: 953 SIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSV 1012
Query: 1012 TPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSVAEPRYAW 1071
TPGSIGIVYC+RPDSSLLLELSYLPNPWHCEPEEVEPV PFRIG+RVCVKRSVAEPRYAW
Sbjct: 1013 TPGSIGIVYCVRPDSSLLLELSYLPNPWHCEPEEVEPVVPFRIGDRVCVKRSVAEPRYAW 1072
Query: 1072 GGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPK 1131
GGETHHSVG+IS IENDGLLIIEIP RPIPWQADPSDMEKVEDFKV DWVRVKASVSSPK
Sbjct: 1073 GGETHHSVGRISGIENDGLLIIEIPKRPIPWQADPSDMEKVEDFKVRDWVRVKASVSSPK 1132
Query: 1132 YGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVT 1191
YGWED+TRNSIG+IHSLEEDGDVGIAFCFRSKPF CSVTDVEKVPPFEVGQEIHVMPS++
Sbjct: 1133 YGWEDVTRNSIGLIHSLEEDGDVGIAFCFRSKPFRCSVTDVEKVPPFEVGQEIHVMPSIS 1192
Query: 1192 QPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKP 1251
QPRLGWS ET ATVGKIV+IDMDGALNVKV GR SLWKVSPGDAE+LSGF VGDWVRSKP
Sbjct: 1193 QPRLGWSNETAATVGKIVRIDMDGALNVKVPGRLSLWKVSPGDAEKLSGFAVGDWVRSKP 1252
Query: 1252 SIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHV 1311
S+GTRPSYDWNT GKESLAVVHSIQD GYLELACCFRKGRW THYTDVEK+P +KVGQHV
Sbjct: 1253 SLGTRPSYDWNTFGKESLAVVHSIQDTGYLELACCFRKGRWITHYTDVEKVPCFKVGQHV 1312
Query: 1312 RFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVG 1371
+FRSGL EPRWGWRG + DSRG+ITSVHADGE+RVAFFGLPGLW+GDPAD EI QMFEVG
Sbjct: 1313 QFRSGLHEPRWGWRGTRSDSRGVITSVHADGEMRVAFFGLPGLWRGDPADFEIMQMFEVG 1372
Query: 1372 EWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDR 1431
EWVR+RD A +WK+IG GS+G+VQGIG++ D WDG+ V FC EQERWVGPTSHLE VDR
Sbjct: 1373 EWVRIRDDAGSWKTIGAGSIGIVQGIGYEGDEWDGTISVGFCGEQERWVGPTSHLESVDR 1432
Query: 1432 LVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSEVEV 1491
L+VGQ+VRVKLSVKQPRFGWSGHSH S+G +SAIDADGKLRIYTP GSK WMLD +EVE+
Sbjct: 1433 LMVGQKVRVKLSVKQPRFGWSGHSHGSIGTISAIDADGKLRIYTPAGSKAWMLDAAEVEL 1492
Query: 1492 VEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAW 1551
VEEEEL IGDWVRVRASV+TPT+ WGEVSH+SIGVVHRME+ ELWVAFCFMERLWLCKAW
Sbjct: 1493 VEEEELGIGDWVRVRASVSTPTHHWGEVSHASIGVVHRMENDELWVAFCFMERLWLCKAW 1552
Query: 1552 EMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWI 1611
EME+VRPFKVGD+VRI+EGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGR W+
Sbjct: 1553 EMEKVRPFKVGDRVRIREGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRTWL 1612
Query: 1612 GDPADIVLDECSSCRTGT 1629
GDPADIVLDE TGT
Sbjct: 1613 GDPADIVLDETIPGTTGT 1630
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147836207|emb|CAN73176.1| hypothetical protein VITISV_007720 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 2706 bits (7013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1366/1668 (81%), Positives = 1484/1668 (88%), Gaps = 48/1668 (2%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MK+PCC VCQTRYNE+ERVPLLLQCGHGFCKECLSR+FSAS DT LSCPRCRHVS VGNS
Sbjct: 1 MKIPCCLVCQTRYNEEERVPLLLQCGHGFCKECLSRLFSASPDTNLSCPRCRHVSSVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFG--------- 113
V ALRKN+ VLALI Q ++ ++ FD D TD+D+D+ED+ ++E
Sbjct: 61 VQALRKNYGVLALI-------QSSSAPSSAFDCDFTDEDEDNEDELLNEEEEDDESHRRR 113
Query: 114 RGTHVSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVK 173
R + S + CGPVIE+ H D++LVK++GEGRRAGVE+W A + GG GRCRH VA K
Sbjct: 114 RCSRGSYTSSSSCGPVIELASHQDLRLVKRIGEGRRAGVEMWAAVLSGGSGRCRHGVAAK 173
Query: 174 KVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQR 233
KV++ E+ + W+ +LDNLRRASMWCRNVCTFHG +M+ L L+MDRC GSVQ MQR
Sbjct: 174 KVVVGEDTDLGWVQNRLDNLRRASMWCRNVCTFHGATKMEGSLCLIMDRCNGSVQSEMQR 233
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293
NEGRLTLEQILRYGADIARGV ELHAAGVVCMN+KPSNLLLDA+G AVVSDYGL AILKK
Sbjct: 234 NEGRLTLEQILRYGADIARGVAELHAAGVVCMNLKPSNLLLDANGHAVVSDYGLPAILKK 293
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEP-VKKSLNLFWDDAIGISPESDAWS 352
PACRKA+ ECDSS IHSCMDCTMLSP+YTAPEAWEP VKK LN+FWDDAIGISPESDAWS
Sbjct: 294 PACRKAQSECDSSGIHSCMDCTMLSPHYTAPEAWEPPVKKPLNIFWDDAIGISPESDAWS 353
Query: 353 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFK 412
FGCTLVEMCTGSIPWAGLSAEEIYRAVVK+R+ PPQYA +VGVGIPRELWKMIGECLQFK
Sbjct: 354 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKSRRQPPQYAXVVGVGIPRELWKMIGECLQFK 413
Query: 413 ASKRPTFSAMLATFLRHLQELPRSPPASPDT--------------------GFTKFSTSN 452
ASKRPTF+AMLATFLRHLQE+PRSPPASP+ G T + SN
Sbjct: 414 ASKRPTFNAMLATFLRHLQEIPRSPPASPENLSRHWSRYLYFIGSDISGTLGETVGARSN 473
Query: 453 ETEPSP----------ASDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISS 502
S V+VFQDNPN+LHQLVSEGD++GVRDLL+K ASG S SI S
Sbjct: 474 LAAASALIGLQKQIFRCVHVQVFQDNPNHLHQLVSEGDLNGVRDLLAKAASGGSSISIYS 533
Query: 503 LLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVH 562
L +AQN+DGQTALHLACRRGSAELVEAILEY + NVDVLD+DGDPPLVFALAAGSPECV
Sbjct: 534 LFEAQNSDGQTALHLACRRGSAELVEAILEYREANVDVLDRDGDPPLVFALAAGSPECVQ 593
Query: 563 ALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVA 622
ALI+RGANV SRLREGFGPSVAHVCA+HGQPDCMRELLLAGADPNAVDDEGESVLHRA+A
Sbjct: 594 ALIRRGANVRSRLREGFGPSVAHVCAFHGQPDCMRELLLAGADPNAVDDEGESVLHRAIA 653
Query: 623 KKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682
KKYTDCA+V+LENGGC SMA+LNSK LTPLHLCVATWNVAVV+RWVEVASPEEI IDI
Sbjct: 654 KKYTDCALVLLENGGCESMAVLNSKTLTPLHLCVATWNVAVVRRWVEVASPEEIAEAIDI 713
Query: 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNR-TALHIASMANDVELV 741
P VGTALCMAAALKKDHE+EGRELVRILLTAGA+PTAQD Q+R TALH A+MANDVELV
Sbjct: 714 PSAVGTALCMAAALKKDHEIEGRELVRILLTAGADPTAQDVQHRRTALHTAAMANDVELV 773
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADA 801
KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA+CN QDDEGDNAFHIAADA
Sbjct: 774 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGANCNLQDDEGDNAFHIAADA 833
Query: 802 AKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861
AKMIRENLEWLI+ML +PDAAVEVRNH+GKTLRDFLE LPREWISEDLMEALMNRG+HLS
Sbjct: 834 AKMIRENLEWLIIMLRNPDAAVEVRNHNGKTLRDFLEALPREWISEDLMEALMNRGIHLS 893
Query: 862 PTIFEIGDWVKFKRRVTTPTYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVL 921
T+FEIGDWVKFKR ++TP+YGWQGAKHKSVGFVQSV D+DNLIV+FCSGE RVLA+EV+
Sbjct: 894 TTVFEIGDWVKFKRSISTPSYGWQGAKHKSVGFVQSVPDRDNLIVAFCSGEARVLANEVI 953
Query: 922 KLIPLDRGQHVKLKPDVKEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPA 981
K+IPLDRGQHVKLKPD+KEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPA
Sbjct: 954 KVIPLDRGQHVKLKPDIKEPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPA 1013
Query: 982 EMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHC 1041
EMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSIGIVYC+RPDSSLLLELSYLPNPWHC
Sbjct: 1014 EMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSIGIVYCVRPDSSLLLELSYLPNPWHC 1073
Query: 1042 EPEEVEPVPPFRIGNRVCVKRSVAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIP 1101
EPEEVEPV PFRIG+RVCVKRSVAEPRYAWGGETHHSVG+IS IENDGLLIIEIP RPIP
Sbjct: 1074 EPEEVEPVVPFRIGDRVCVKRSVAEPRYAWGGETHHSVGRISGIENDGLLIIEIPKRPIP 1133
Query: 1102 WQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFR 1161
WQADPSDMEKVEDFKV DWVRVKASVSSPKYGWED+TRNSIG+IHSLEEDGDVGIAFCFR
Sbjct: 1134 WQADPSDMEKVEDFKVRDWVRVKASVSSPKYGWEDVTRNSIGLIHSLEEDGDVGIAFCFR 1193
Query: 1162 SKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKV 1221
SKPF CSVTDVEKVPPFEVGQEIHVMPS++QPRLGWS ET ATVGKIV+IDMDGALNVKV
Sbjct: 1194 SKPFRCSVTDVEKVPPFEVGQEIHVMPSISQPRLGWSNETAATVGKIVRIDMDGALNVKV 1253
Query: 1222 AGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYL 1281
GR SLWKVSPGDAE+LSGF VGDWVRSKPS+GTRPSYDWNT GKESLAVVHSIQD GYL
Sbjct: 1254 PGRLSLWKVSPGDAEKLSGFAVGDWVRSKPSLGTRPSYDWNTFGKESLAVVHSIQDTGYL 1313
Query: 1282 ELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHAD 1341
ELACCFRKGRW THYTDVEK+P +KVGQHV+FRSGL EPRWGWRG + DSRG+ITSVHAD
Sbjct: 1314 ELACCFRKGRWITHYTDVEKVPCFKVGQHVQFRSGLHEPRWGWRGTRSDSRGVITSVHAD 1373
Query: 1342 GEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQD 1401
GE+RVAFFGLPGLW+GDPAD EI QMFEVGEWVR+RD A +WK+IG GS+G+VQGIG++
Sbjct: 1374 GEMRVAFFGLPGLWRGDPADFEIMQMFEVGEWVRIRDDAGSWKTIGAGSIGIVQGIGYEG 1433
Query: 1402 DNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGI 1461
D WDG+ V FC EQERWVGPTSHLE VDRL+VGQ+VRVKLSVKQPRFGWSGHSH S+G
Sbjct: 1434 DEWDGTISVGFCGEQERWVGPTSHLESVDRLMVGQKVRVKLSVKQPRFGWSGHSHGSIGT 1493
Query: 1462 VSAIDADGKLRIYTPVGSKTWMLDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSH 1521
+SAIDADGKLRIYTP GSK WMLD +EVE+VEEEEL IGDWVRVRASV+TPT+ WGEVSH
Sbjct: 1494 ISAIDADGKLRIYTPAGSKAWMLDAAEVELVEEEELGIGDWVRVRASVSTPTHHWGEVSH 1553
Query: 1522 SSIGVVHRMESGELWVAFCFMERLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGME 1581
+SIGVVHRME+ ELWVAFCFMERLWLCKAWEME+VRPFKVGD+VRI+EGLVTPRWGWGME
Sbjct: 1554 ASIGVVHRMENDELWVAFCFMERLWLCKAWEMEKVRPFKVGDRVRIREGLVTPRWGWGME 1613
Query: 1582 THASKGQVVGVDANGKLRIKFQWREGRPWIGDPADIVLDECSSCRTGT 1629
THASKGQVVGVDANGKLRIKFQWREGR W+GDPADIVLDE TGT
Sbjct: 1614 THASKGQVVGVDANGKLRIKFQWREGRTWLGDPADIVLDETIPGTTGT 1661
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508302|ref|XP_003522897.1| PREDICTED: E3 ubiquitin-protein ligase KEG-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2704 bits (7010), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1335/1642 (81%), Positives = 1474/1642 (89%), Gaps = 24/1642 (1%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MK+PCCSVCQTRYNE+ERVPLLLQCGHGFC+ECLSRMFSAS+D TL+CPRCRHVS VGNS
Sbjct: 1 MKIPCCSVCQTRYNEEERVPLLLQCGHGFCRECLSRMFSASSDATLACPRCRHVSTVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEF---------- 112
V ALRKN+AVLAL+ SA ++FD D TDD++D + DE
Sbjct: 61 VQALRKNYAVLALLQSAAAAANGGGGGRSNFDCDYTDDEEDGDGGREDEDEEDDEKRRRN 120
Query: 113 GRGTHVSSSGVGVCGPVIEVG-----VHHDVKLVKKLGEGRRAGVEVWGAWIGGG----- 162
R + SSSG G C PVIE+G H+D+KLV+++GEGRRAGVE+W A IGGG
Sbjct: 121 SRESQASSSGGG-CAPVIELGGGGGGAHNDLKLVRRIGEGRRAGVEMWMAVIGGGGGGEG 179
Query: 163 --QGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220
+ RCRH+VAVKKV +AE ++ DW+ G+L++LRRASMWCRNVCTFHG +R++ L LVM
Sbjct: 180 GGRQRCRHNVAVKKVAVAEGIDLDWVQGKLEDLRRASMWCRNVCTFHGTMRVEDSLCLVM 239
Query: 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRA 280
D+CYGSVQ MQRNEGRLTLEQ+LRYGADIARGVVELHAAGVVCMN+KPSNLLLDA+G A
Sbjct: 240 DKCYGSVQSEMQRNEGRLTLEQVLRYGADIARGVVELHAAGVVCMNLKPSNLLLDANGHA 299
Query: 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD 340
VVSDYGLA ILKKP+C KARPECDS++IHSCM+C MLSP+YTAPEAWEPVKKSLNLFWDD
Sbjct: 300 VVSDYGLATILKKPSCWKARPECDSAKIHSCMECIMLSPHYTAPEAWEPVKKSLNLFWDD 359
Query: 341 AIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRE 400
IGIS ESDAWSFGCTLVEMCTG+IPWAGLSAEEIYRAVVK +KLPPQYAS+VG GIPRE
Sbjct: 360 GIGISSESDAWSFGCTLVEMCTGAIPWAGLSAEEIYRAVVKAKKLPPQYASVVGGGIPRE 419
Query: 401 LWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPAS 460
LWKMIGECLQFK SKRPTFSAMLA FLRHLQE+PRSPPASPD G K S SN EPSP
Sbjct: 420 LWKMIGECLQFKPSKRPTFSAMLAVFLRHLQEIPRSPPASPDNGLDKGSVSNVMEPSPVP 479
Query: 461 DVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACR 520
++EV Q NPN+LH+LVSEGD +GVRDLL+K AS N S+ +SSLL+AQNADGQTALHLACR
Sbjct: 480 EMEVPQQNPNHLHRLVSEGDTAGVRDLLAKAASENGSNYLSSLLEAQNADGQTALHLACR 539
Query: 521 RGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFG 580
RGSAELVE ILE S+ NVDVLDKDGDPPLVFALAAGSPECV LI R ANV SRLR+GFG
Sbjct: 540 RGSAELVETILECSEANVDVLDKDGDPPLVFALAAGSPECVRILINRNANVRSRLRDGFG 599
Query: 581 PSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRS 640
PSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA+AKKYTDCA+VILENGGCRS
Sbjct: 600 PSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAIAKKYTDCALVILENGGCRS 659
Query: 641 MAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700
MAILNSK LTPLH CVA WNVAVVKRWVEVA+ +EI IDIP P+GTALCMAAA KKDH
Sbjct: 660 MAILNSKNLTPLHHCVAIWNVAVVKRWVEVATSDEIAEAIDIPSPIGTALCMAAASKKDH 719
Query: 701 EVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNT 759
E EGRELVRILL AGA+P+AQD+QN RTALH A+M NDV+LVK+IL AGVDVNIRNVHN+
Sbjct: 720 ENEGRELVRILLAAGADPSAQDSQNGRTALHTAAMTNDVDLVKVILGAGVDVNIRNVHNS 779
Query: 760 IPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHP 819
IPLH+ALARGAK+CVGLLL AGAD N +DD+GDNAFHIAA+ AKMIRENL+WLIVML P
Sbjct: 780 IPLHLALARGAKACVGLLLDAGADYNLKDDDGDNAFHIAAETAKMIRENLDWLIVMLMKP 839
Query: 820 DAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTT 879
DA +EVRNHSGKTLRD LE LPREW+SEDLMEAL+N+GVHL PTIF++GDWVKFKR VTT
Sbjct: 840 DADIEVRNHSGKTLRDILEALPREWLSEDLMEALVNKGVHLFPTIFKVGDWVKFKRSVTT 899
Query: 880 PTYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVK 939
PT+GWQGAK KSVGFVQSVLD+DNLIVSFCSGEV VLA+EV+K++PLDRGQHV LK DVK
Sbjct: 900 PTHGWQGAKPKSVGFVQSVLDRDNLIVSFCSGEVHVLANEVIKVVPLDRGQHVHLKEDVK 959
Query: 940 EPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRP 999
EPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRP
Sbjct: 960 EPRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRP 1019
Query: 1000 TLTTAKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVC 1059
TLT+AKHGLGSVTPGSIGIVYCIRPDSSLL+ELSYLPNPWHCEPEEVE V PFRIG++VC
Sbjct: 1020 TLTSAKHGLGSVTPGSIGIVYCIRPDSSLLIELSYLPNPWHCEPEEVEHVAPFRIGDQVC 1079
Query: 1060 VKRSVAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGD 1119
VKRSVAEPRYAWGGETHHSVG+ISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGD
Sbjct: 1080 VKRSVAEPRYAWGGETHHSVGRISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGD 1139
Query: 1120 WVRVKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFE 1179
WVRVKASVSSPKYGWED+TR SIG+IHSLEEDGD+G+AFCFRSKPF CSVTD+EKVPPFE
Sbjct: 1140 WVRVKASVSSPKYGWEDVTRTSIGVIHSLEEDGDMGVAFCFRSKPFSCSVTDMEKVPPFE 1199
Query: 1180 VGQEIHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLS 1239
VGQEIHVMPSVTQPRLGWS E+PATVGKI+KIDMDGALNV+V GR +LWKVSPGDAER+
Sbjct: 1200 VGQEIHVMPSVTQPRLGWSNESPATVGKILKIDMDGALNVRVTGRQNLWKVSPGDAERVP 1259
Query: 1240 GFEVGDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDV 1299
GFEVGDWVRSKPS+GTRPSYDWN+VG+ESLAVVHS+QD+GYLELACCFRKG+W THYTDV
Sbjct: 1260 GFEVGDWVRSKPSLGTRPSYDWNSVGRESLAVVHSVQDSGYLELACCFRKGKWITHYTDV 1319
Query: 1300 EKIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDP 1359
EK+PS+KVGQ+VRFR+GL EPRWGWRGA+ +S G+ITS+HADGEVR AFFGLPGLW+GDP
Sbjct: 1320 EKVPSFKVGQYVRFRTGLVEPRWGWRGAEPESHGVITSIHADGEVRFAFFGLPGLWRGDP 1379
Query: 1360 ADLEIGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERW 1419
+DLEI QMFEVGEWVRL A+NWKSIGPGSVGVVQGIG++ D D S FV FC EQE+W
Sbjct: 1380 SDLEIEQMFEVGEWVRLNYNANNWKSIGPGSVGVVQGIGYEGDELDRSIFVGFCGEQEKW 1439
Query: 1420 VGPTSHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGS 1479
VGP+SHLER D+L VGQ+VRVK VKQPRFGWSGH+HAS+G + AIDADGKLRIYTP GS
Sbjct: 1440 VGPSSHLERFDKLFVGQKVRVKQYVKQPRFGWSGHTHASIGTIQAIDADGKLRIYTPAGS 1499
Query: 1480 KTWMLDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAF 1539
KTW+LDPSEVEVVEE+EL IGDWVRV+AS++TPT+ WGEVSHSSIGVVHRME +LWV+F
Sbjct: 1500 KTWVLDPSEVEVVEEKELCIGDWVRVKASISTPTHHWGEVSHSSIGVVHRMEDEDLWVSF 1559
Query: 1540 CFMERLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLR 1599
CF ERLWLCKAWEME VRPFKVGDKVRI++GLVTPRWGWGMETHASKGQVVGVDANGKLR
Sbjct: 1560 CFTERLWLCKAWEMEWVRPFKVGDKVRIRDGLVTPRWGWGMETHASKGQVVGVDANGKLR 1619
Query: 1600 IKFQWREGRPWIGDPADIVLDE 1621
IKF+WREGRPWIGDPAD+ LDE
Sbjct: 1620 IKFRWREGRPWIGDPADLALDE 1641
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186522588|ref|NP_196857.2| E3 ubiquitin-protein ligase KEG [Arabidopsis thaliana] gi|218526495|sp|Q9FY48.2|KEG_ARATH RecName: Full=E3 ubiquitin-protein ligase KEG; AltName: Full=Protein KEEP ON GOING; AltName: Full=RING finger protein KEG gi|83817349|gb|ABC46683.1| RING E3 ligase protein [Arabidopsis thaliana] gi|332004525|gb|AED91908.1| E3 ubiquitin-protein ligase KEG [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 2605 bits (6752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1270/1627 (78%), Positives = 1446/1627 (88%), Gaps = 11/1627 (0%)
Query: 2 KMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGN 61
++KVPCCSVC TRYNE ERVPLLLQCGHGFCK+CLS+MFS S+DTTL+CPRCRHVSVVGN
Sbjct: 4 RVKVPCCSVCHTRYNEDERVPLLLQCGHGFCKDCLSKMFSTSSDTTLTCPRCRHVSVVGN 63
Query: 62 SVTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSS 121
SV LRKN+A+LALI +A+ N + ++ D + DD++D D++ RG H SSS
Sbjct: 64 SVQGLRKNYAMLALIHAASGGA---NFDCDYTDDEDDDDEEDGSDEDGARAARGFHASSS 120
Query: 122 GVGVCGPVIEVGVHHDVKLVKKLGE----GRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI 177
+CGPVIEVG H ++KLV+++GE G GVE+W A + GG GRC+H VAVKK+ +
Sbjct: 121 INSLCGPVIEVGAHPEMKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCKHRVAVKKMTL 180
Query: 178 AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR 237
E+M+ +W+ GQL++LRRASMWCRNVCTFHGV++MD L L+MDRC+GSVQ MQRNEGR
Sbjct: 181 TEDMDVEWMQGQLESLRRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEMQRNEGR 240
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LTLEQILRYGAD+ARGV ELHAAGV+CMNIKPSNLLLDASG AVVSDYGLA ILKKP C+
Sbjct: 241 LTLEQILRYGADVARGVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQ 300
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
K RPE DSS++ DC LSP+YTAPEAW PVKK LFW+DA G+SPESDAWSFGCTL
Sbjct: 301 KTRPEFDSSKVTLYTDCVTLSPHYTAPEAWGPVKK---LFWEDASGVSPESDAWSFGCTL 357
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
VEMCTGS PW GLS EEI++AVVK RK+PPQY IVGVGIPRELWKMIGECLQFK SKRP
Sbjct: 358 VEMCTGSTPWDGLSREEIFQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRP 417
Query: 418 TFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVS 477
TF+AMLATFLRHLQE+PRSP ASPD G K N + A+++ VFQDNPNNLH++V
Sbjct: 418 TFNAMLATFLRHLQEIPRSPSASPDNGIAKICEVNIVQAPRATNIGVFQDNPNNLHRVVL 477
Query: 478 EGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQEN 537
EGD GVR++L+K A+G SS+ SLL+AQNADGQ+ALHLACRRGSAELVEAILEY + N
Sbjct: 478 EGDFEGVRNILAKAAAGGGGSSVRSLLEAQNADGQSALHLACRRGSAELVEAILEYGEAN 537
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
VD++DKDGDPPLVFALAAGSP+CVH LIK+GANV SRLREG GPSVAHVC+YHGQPDCMR
Sbjct: 538 VDIVDKDGDPPLVFALAAGSPQCVHVLIKKGANVRSRLREGSGPSVAHVCSYHGQPDCMR 597
Query: 598 ELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA 657
ELL+AGADPNAVDDEGE+VLHRAVAKKYTDCAIVILENGG RSM + N+K LTPLH+CVA
Sbjct: 598 ELLVAGADPNAVDDEGETVLHRAVAKKYTDCAIVILENGGSRSMTVSNAKCLTPLHMCVA 657
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
TWNVAV+KRWVEV+SPEEI I+IP PVGTALCMAA+++KDHE EGRELV+ILL AGA+
Sbjct: 658 TWNVAVIKRWVEVSSPEEISQAINIPSPVGTALCMAASIRKDHEKEGRELVQILLAAGAD 717
Query: 718 PTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGL 776
PTAQDAQ+ RTALH A+MAN+VELV++ILDAGV+ NIRNVHNTIPLH+ALARGA SCV L
Sbjct: 718 PTAQDAQHGRTALHTAAMANNVELVRVILDAGVNANIRNVHNTIPLHMALARGANSCVSL 777
Query: 777 LLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836
LL +G+DCN QDDEGDNAFHIAADAAKMIRENL+WLIVML PDAAV+VRNHSGKT+RDF
Sbjct: 778 LLESGSDCNIQDDEGDNAFHIAADAAKMIRENLDWLIVMLRSPDAAVDVRNHSGKTVRDF 837
Query: 837 LEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAKHKSVGFVQ 896
LE LPREWISEDLMEAL+ RGVHLSPTI+E+GDWVKFKR +TTP +GWQGAK KSVGFVQ
Sbjct: 838 LEALPREWISEDLMEALLKRGVHLSPTIYEVGDWVKFKRGITTPLHGWQGAKPKSVGFVQ 897
Query: 897 SVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRFGWRGQSRDSIGTV 956
++L+K+++I++FCSGE RVLA+EV+KLIPLDRGQHV+L+ DVKEPRFGWRGQSRDS+GTV
Sbjct: 898 TILEKEDMIIAFCSGEARVLANEVVKLIPLDRGQHVRLRADVKEPRFGWRGQSRDSVGTV 957
Query: 957 LCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSI 1016
LCVD+DGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIR LT+AKHG GSV PGS+
Sbjct: 958 LCVDEDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRQNLTSAKHGFGSVVPGSM 1017
Query: 1017 GIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSVAEPRYAWGGETH 1076
GIVYC+RPDSSLL+ELSYLPNPWHCEPEEVEPV PFRIG+RVCVKRSVAEPRYAWGGETH
Sbjct: 1018 GIVYCVRPDSSLLVELSYLPNPWHCEPEEVEPVAPFRIGDRVCVKRSVAEPRYAWGGETH 1077
Query: 1077 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWED 1136
HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEK++DFKVGDWVRVKASVSSPKYGWED
Sbjct: 1078 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKIDDFKVGDWVRVKASVSSPKYGWED 1137
Query: 1137 ITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLG 1196
ITRNSIG++HSL+EDGDVGIAFCFRSKPF CSVTDVEKV PF VGQEIH+ PS+TQPRLG
Sbjct: 1138 ITRNSIGVMHSLDEDGDVGIAFCFRSKPFSCSVTDVEKVTPFHVGQEIHMTPSITQPRLG 1197
Query: 1197 WSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTR 1256
WS ETPAT+GK+++IDMDG L+ +V GR +LW+VSPGDAE LSGFEVGDWVRSKPS+G R
Sbjct: 1198 WSNETPATIGKVMRIDMDGTLSAQVTGRQTLWRVSPGDAELLSGFEVGDWVRSKPSLGNR 1257
Query: 1257 PSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSG 1316
PSYDW+ VG+ES+AVVHSIQ+ GYLELACCFRKGRWSTHYTD+EKIP+ KVGQ V F+ G
Sbjct: 1258 PSYDWSNVGRESIAVVHSIQETGYLELACCFRKGRWSTHYTDLEKIPALKVGQFVHFQKG 1317
Query: 1317 LAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRL 1376
+ EPRWGWR A+ DSRGIIT+VHADGEVRVAFFGLPGLW+GDPADLE+ MFEVGEWVRL
Sbjct: 1318 ITEPRWGWRAAKPDSRGIITTVHADGEVRVAFFGLPGLWRGDPADLEVEPMFEVGEWVRL 1377
Query: 1377 RDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQ 1436
R+ S WKS+GPGSVGVV G+G++ D WDG+T V+FC EQERW GPTSHLE+ +LVVGQ
Sbjct: 1378 REGVSCWKSVGPGSVGVVHGVGYEGDEWDGTTSVSFCGEQERWAGPTSHLEKAKKLVVGQ 1437
Query: 1437 RVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSEVEVVEEEE 1496
+ RVKL+VKQPRFGWSGHSH SVG +SAIDADGKLRIYTP GSKTWMLDPSEVE +EEEE
Sbjct: 1438 KTRVKLAVKQPRFGWSGHSHGSVGTISAIDADGKLRIYTPAGSKTWMLDPSEVETIEEEE 1497
Query: 1497 LQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAWEMERV 1556
L+IGDWVRV+AS+TTPTYQWGEV+ SS GVVHRME G+L V+FCF++RLWLCKA E+ER+
Sbjct: 1498 LKIGDWVRVKASITTPTYQWGEVNPSSTGVVHRMEDGDLCVSFCFLDRLWLCKAGELERI 1557
Query: 1557 RPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWIGDPAD 1616
RPF++GD+V+IK+GLVTPRWGWGMETHASKG VVGVDANGKLRIKF WREGRPWIGDPAD
Sbjct: 1558 RPFRIGDRVKIKDGLVTPRWGWGMETHASKGHVVGVDANGKLRIKFLWREGRPWIGDPAD 1617
Query: 1617 IVLDECS 1623
IVLDE S
Sbjct: 1618 IVLDETS 1624
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334187662|ref|NP_001190303.1| E3 ubiquitin-protein ligase KEG [Arabidopsis thaliana] gi|332004526|gb|AED91909.1| E3 ubiquitin-protein ligase KEG [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 2599 bits (6736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1269/1627 (77%), Positives = 1446/1627 (88%), Gaps = 12/1627 (0%)
Query: 2 KMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGN 61
++KVPCCSVC TRYNE ERVPLLLQCGHGFCK+CLS+MFS S+DTTL+CPRCRHVSVVGN
Sbjct: 4 RVKVPCCSVCHTRYNEDERVPLLLQCGHGFCKDCLSKMFSTSSDTTLTCPRCRHVSVVGN 63
Query: 62 SVTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSS 121
SV LRKN+A+LALI +A+ N + ++ D + DD++D D++ RG H SSS
Sbjct: 64 SVQGLRKNYAMLALIHAASGGA---NFDCDYTDDEDDDDEEDGSDEDGARAARGFHASSS 120
Query: 122 GVGVCGPVIEVGVHHDVKLVKKLGE----GRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI 177
+CGPVIEVG H ++KLV+++GE G GVE+W A + GG GRC+H VAVKK+ +
Sbjct: 121 INSLCGPVIEVGAHPEMKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCKHRVAVKKMTL 180
Query: 178 AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR 237
E+M+ +W+ GQL++LRRASMWCRNVCTFHGV++MD L L+MDRC+GSVQ MQRNEGR
Sbjct: 181 TEDMDVEWMQGQLESLRRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEMQRNEGR 240
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LTLEQILRYGAD+ARGV ELHAAGV+CMNIKPSNLLLDASG AVVSDYGLA ILKKP C+
Sbjct: 241 LTLEQILRYGADVARGVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQ 300
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
K RPE DSS++ DC LSP+YTAPEAW PVKK LFW+DA G+SPESDAWSFGCTL
Sbjct: 301 KTRPEFDSSKVTLYTDCVTLSPHYTAPEAWGPVKK---LFWEDASGVSPESDAWSFGCTL 357
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
VEMCTGS PW GLS EEI++AVVK RK+PPQY IVGVGIPRELWKMIGECLQFK SKRP
Sbjct: 358 VEMCTGSTPWDGLSREEIFQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRP 417
Query: 418 TFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVS 477
TF+AMLATFLRHLQE+PRSP ASPD G K N + A+++ VFQDNPNNLH++V
Sbjct: 418 TFNAMLATFLRHLQEIPRSPSASPDNGIAKICEVNIVQAPRATNIGVFQDNPNNLHRVVL 477
Query: 478 EGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQEN 537
EGD GVR++L+K A+G SS+ SLL+AQNADGQ+ALHLACRRGSAELVEAILEY + N
Sbjct: 478 EGDFEGVRNILAKAAAGGGGSSVRSLLEAQNADGQSALHLACRRGSAELVEAILEYGEAN 537
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
VD++DKDGDPPLVFALAAGSP+CVH LIK+GANV SRLREG GPSVAHVC+YHGQPDCMR
Sbjct: 538 VDIVDKDGDPPLVFALAAGSPQCVHVLIKKGANVRSRLREGSGPSVAHVCSYHGQPDCMR 597
Query: 598 ELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA 657
ELL+AGADPNAVDDEGE+VLHRAVAKKYTDCAIVILENGG RSM + N+K LTPLH+CVA
Sbjct: 598 ELLVAGADPNAVDDEGETVLHRAVAKKYTDCAIVILENGGSRSMTVSNAKCLTPLHMCVA 657
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
TWNVAV+KRWVEV+SPEEI I+IP PVGTALCMAA+++KDHE +GRELV+ILL AGA+
Sbjct: 658 TWNVAVIKRWVEVSSPEEISQAINIPSPVGTALCMAASIRKDHE-KGRELVQILLAAGAD 716
Query: 718 PTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGL 776
PTAQDAQ+ RTALH A+MAN+VELV++ILDAGV+ NIRNVHNTIPLH+ALARGA SCV L
Sbjct: 717 PTAQDAQHGRTALHTAAMANNVELVRVILDAGVNANIRNVHNTIPLHMALARGANSCVSL 776
Query: 777 LLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836
LL +G+DCN QDDEGDNAFHIAADAAKMIRENL+WLIVML PDAAV+VRNHSGKT+RDF
Sbjct: 777 LLESGSDCNIQDDEGDNAFHIAADAAKMIRENLDWLIVMLRSPDAAVDVRNHSGKTVRDF 836
Query: 837 LEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAKHKSVGFVQ 896
LE LPREWISEDLMEAL+ RGVHLSPTI+E+GDWVKFKR +TTP +GWQGAK KSVGFVQ
Sbjct: 837 LEALPREWISEDLMEALLKRGVHLSPTIYEVGDWVKFKRGITTPLHGWQGAKPKSVGFVQ 896
Query: 897 SVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRFGWRGQSRDSIGTV 956
++L+K+++I++FCSGE RVLA+EV+KLIPLDRGQHV+L+ DVKEPRFGWRGQSRDS+GTV
Sbjct: 897 TILEKEDMIIAFCSGEARVLANEVVKLIPLDRGQHVRLRADVKEPRFGWRGQSRDSVGTV 956
Query: 957 LCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSI 1016
LCVD+DGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIR LT+AKHG GSV PGS+
Sbjct: 957 LCVDEDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRQNLTSAKHGFGSVVPGSM 1016
Query: 1017 GIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSVAEPRYAWGGETH 1076
GIVYC+RPDSSLL+ELSYLPNPWHCEPEEVEPV PFRIG+RVCVKRSVAEPRYAWGGETH
Sbjct: 1017 GIVYCVRPDSSLLVELSYLPNPWHCEPEEVEPVAPFRIGDRVCVKRSVAEPRYAWGGETH 1076
Query: 1077 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWED 1136
HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEK++DFKVGDWVRVKASVSSPKYGWED
Sbjct: 1077 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKIDDFKVGDWVRVKASVSSPKYGWED 1136
Query: 1137 ITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLG 1196
ITRNSIG++HSL+EDGDVGIAFCFRSKPF CSVTDVEKV PF VGQEIH+ PS+TQPRLG
Sbjct: 1137 ITRNSIGVMHSLDEDGDVGIAFCFRSKPFSCSVTDVEKVTPFHVGQEIHMTPSITQPRLG 1196
Query: 1197 WSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTR 1256
WS ETPAT+GK+++IDMDG L+ +V GR +LW+VSPGDAE LSGFEVGDWVRSKPS+G R
Sbjct: 1197 WSNETPATIGKVMRIDMDGTLSAQVTGRQTLWRVSPGDAELLSGFEVGDWVRSKPSLGNR 1256
Query: 1257 PSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSG 1316
PSYDW+ VG+ES+AVVHSIQ+ GYLELACCFRKGRWSTHYTD+EKIP+ KVGQ V F+ G
Sbjct: 1257 PSYDWSNVGRESIAVVHSIQETGYLELACCFRKGRWSTHYTDLEKIPALKVGQFVHFQKG 1316
Query: 1317 LAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRL 1376
+ EPRWGWR A+ DSRGIIT+VHADGEVRVAFFGLPGLW+GDPADLE+ MFEVGEWVRL
Sbjct: 1317 ITEPRWGWRAAKPDSRGIITTVHADGEVRVAFFGLPGLWRGDPADLEVEPMFEVGEWVRL 1376
Query: 1377 RDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQ 1436
R+ S WKS+GPGSVGVV G+G++ D WDG+T V+FC EQERW GPTSHLE+ +LVVGQ
Sbjct: 1377 REGVSCWKSVGPGSVGVVHGVGYEGDEWDGTTSVSFCGEQERWAGPTSHLEKAKKLVVGQ 1436
Query: 1437 RVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSEVEVVEEEE 1496
+ RVKL+VKQPRFGWSGHSH SVG +SAIDADGKLRIYTP GSKTWMLDPSEVE +EEEE
Sbjct: 1437 KTRVKLAVKQPRFGWSGHSHGSVGTISAIDADGKLRIYTPAGSKTWMLDPSEVETIEEEE 1496
Query: 1497 LQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAWEMERV 1556
L+IGDWVRV+AS+TTPTYQWGEV+ SS GVVHRME G+L V+FCF++RLWLCKA E+ER+
Sbjct: 1497 LKIGDWVRVKASITTPTYQWGEVNPSSTGVVHRMEDGDLCVSFCFLDRLWLCKAGELERI 1556
Query: 1557 RPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWIGDPAD 1616
RPF++GD+V+IK+GLVTPRWGWGMETHASKG VVGVDANGKLRIKF WREGRPWIGDPAD
Sbjct: 1557 RPFRIGDRVKIKDGLVTPRWGWGMETHASKGHVVGVDANGKLRIKFLWREGRPWIGDPAD 1616
Query: 1617 IVLDECS 1623
IVLDE S
Sbjct: 1617 IVLDETS 1623
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449266|ref|XP_004142386.1| PREDICTED: E3 ubiquitin-protein ligase KEG-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2496 bits (6470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1222/1642 (74%), Positives = 1382/1642 (84%), Gaps = 54/1642 (3%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MKVPCCSVCQ RYNE++RVPLLL CGHGFC +C+SRMF AS+D+ LSCPRCR+VSVVGNS
Sbjct: 1 MKVPCCSVCQNRYNEEDRVPLLLHCGHGFCADCMSRMFLASSDSRLSCPRCRYVSVVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDD-----DDDDEDDEVDEFGRGTH 117
+ ALRKNFAVLALI S++ T + F D DD + D+E + G+
Sbjct: 61 IQALRKNFAVLALIHSSSKTAVATSEFDCDFTDDDGDDGEGEVNGDEESLSRRRWSGGSC 120
Query: 118 VSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGG---GQGRCRHSVAVKK 174
S+SG CGPVI++GVH D+KL++++GEGRR GVE+W A +GG G RCRH VAVKK
Sbjct: 121 TSTSGG--CGPVIDIGVHKDLKLLRQIGEGRRDGVEIWTAMLGGRGSGSTRCRHQVAVKK 178
Query: 175 VMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRN 234
V + ++M+ W+ QL++L RASMWCRNVCTFHG + MD L LVMDRCYGSVQ MQ N
Sbjct: 179 VAVGDDMDLGWVLEQLESLHRASMWCRNVCTFHGAMEMDGSLYLVMDRCYGSVQSKMQEN 238
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
EGRLTLEQILRYGAD+ARGV ELHAAGVVCMNIKPSNLLLDA+G AVVSDYGLAAILKKP
Sbjct: 239 EGRLTLEQILRYGADVARGVAELHAAGVVCMNIKPSNLLLDATGHAVVSDYGLAAILKKP 298
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
C K R +CDSSR+H CM+C MLSP+Y APEAWEPVKKSL FWDD +G+S ESDAWSF
Sbjct: 299 MCSKGRSDCDSSRMHLCMECAMLSPHYAAPEAWEPVKKSLT-FWDDGLGMSVESDAWSFA 357
Query: 355 CTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
CTLVEMCTGSIPW+GL +EIYRAVVK +KLPPQY+SIVGVGIPRELWKMIG+CLQFK+
Sbjct: 358 CTLVEMCTGSIPWSGLCTDEIYRAVVKAKKLPPQYSSIVGVGIPRELWKMIGDCLQFKSL 417
Query: 415 KRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFS--TSNETEPSPASDVEVFQDNPNNL 472
KRPTF+ ML TFLR+LQE+PRSP A+PD KFS ++E S SD+EVF+ N +L
Sbjct: 418 KRPTFNKMLTTFLRYLQEIPRSPSANPDNDLAKFSGLYITDSETSLMSDLEVFRYNLGHL 477
Query: 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILE 532
H+LV +GD +GVRDLL K A N SS IS LL+AQN +GQTALHLACRRG AE+VE ILE
Sbjct: 478 HRLVFDGDFNGVRDLLVKAAFRNSSSFISKLLEAQNDEGQTALHLACRRGFAEIVEVILE 537
Query: 533 YSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592
+ + VD+LDKDGDPPLVFALAAGSPECV LI+RGANV SRLREGFGPSVAHVCAYHGQ
Sbjct: 538 FREAKVDILDKDGDPPLVFALAAGSPECVRILIERGANVCSRLREGFGPSVAHVCAYHGQ 597
Query: 593 PDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPL 652
PDCMRELLLAGADPN VDDEGESVLHRAV KKY+DCA+VILENGGCRSMA+LN+K LTPL
Sbjct: 598 PDCMRELLLAGADPNVVDDEGESVLHRAVTKKYSDCALVILENGGCRSMALLNAKHLTPL 657
Query: 653 HLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
H+CV+T NV VVK+W+E+A+ EEI IDIP GTALCMAAALKKD E EGR LV++LL
Sbjct: 658 HMCVSTCNVIVVKKWIEIATAEEIAEAIDIPSSAGTALCMAAALKKDREREGRSLVKLLL 717
Query: 713 TAGAEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 771
AGA+P +QDAQ+ RTALH A+MANDVELVK+IL+AGVDVNI NVHNTIPLHVALARGA
Sbjct: 718 HAGADPASQDAQHGRTALHTAAMANDVELVKLILNAGVDVNICNVHNTIPLHVALARGAN 777
Query: 772 SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHS-- 829
SCVGLLLS+GA+ N QDDEGD AFHIAADAAKMIRENL+WLIVML + DAAVEVRNH
Sbjct: 778 SCVGLLLSSGANYNLQDDEGDTAFHIAADAAKMIRENLQWLIVMLRNADAAVEVRNHRQV 837
Query: 830 ---------GKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTP 880
GK LRDFLE LPREWISE+L EAL RG+HLSPTIFEIGDWVKFKR + P
Sbjct: 838 PIGCCVLLIGKMLRDFLEALPREWISEELWEALACRGIHLSPTIFEIGDWVKFKRTIAAP 897
Query: 881 TYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKE 940
TYGWQGAKHKSVGFVQ++LDKDNL+VSFCSGEV VLA+EV+K+IPLDRGQHV+LK DVKE
Sbjct: 898 TYGWQGAKHKSVGFVQNILDKDNLMVSFCSGEVHVLANEVIKVIPLDRGQHVQLKNDVKE 957
Query: 941 PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT 1000
PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT
Sbjct: 958 PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT 1017
Query: 1001 LTTAKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCV 1060
LTTAKHGLGSVTPGSIGIVYC RPD SLLLELSYLPNPWHCEPEEVEPV PFR
Sbjct: 1018 LTTAKHGLGSVTPGSIGIVYCNRPDGSLLLELSYLPNPWHCEPEEVEPVIPFR------- 1070
Query: 1061 KRSVAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDW 1120
+ EIE+DGLLII++P+RPIPWQADPSDMEKV+DFKVGDW
Sbjct: 1071 ---------------------VIEIESDGLLIIDLPDRPIPWQADPSDMEKVDDFKVGDW 1109
Query: 1121 VRVKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEV 1180
VRVK SVSSPKYGWEDI+RNSIG+IH LEED ++GIAFCFRSK F CSVTDVEKVPPFE+
Sbjct: 1110 VRVKTSVSSPKYGWEDISRNSIGVIHILEEDVEMGIAFCFRSKLFICSVTDVEKVPPFEI 1169
Query: 1181 GQEIHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSG 1240
GQEIH++PSVTQPRLGWS E+PATVGKI ++DMDGALNVKVAGR SLWKV PGDAE+LSG
Sbjct: 1170 GQEIHILPSVTQPRLGWSNESPATVGKISRVDMDGALNVKVAGRQSLWKVCPGDAEQLSG 1229
Query: 1241 FEVGDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVE 1300
FEVGDWVRSKP+ G RP+YDWN G++S AVVHS+QD +LELACC R+ RW H +DVE
Sbjct: 1230 FEVGDWVRSKPNTGNRPTYDWNIAGRDSFAVVHSVQDCLFLELACCTRRNRWLAHASDVE 1289
Query: 1301 KIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPA 1360
K+PSYKVGQ+V+FR GL+EP WGWRG Q DSRGIITSVH+DGEVRVAFFG+ GLW+GDPA
Sbjct: 1290 KVPSYKVGQYVQFRPGLSEPMWGWRGVQSDSRGIITSVHSDGEVRVAFFGVSGLWRGDPA 1349
Query: 1361 DLEIGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWV 1420
DLEI QMFE GEWVRLR+ + WKSIGPGSVGVVQG+ F+ D W+G V FC EQE WV
Sbjct: 1350 DLEIEQMFEAGEWVRLRENTNKWKSIGPGSVGVVQGLRFEGDEWNGRISVLFCGEQESWV 1409
Query: 1421 GPTSHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSK 1480
G +HLERVDRLVVGQ V+VK S+ QPRFGWS HS +SV ++SAID DGKL++YT GSK
Sbjct: 1410 GSITHLERVDRLVVGQMVQVKSSISQPRFGWSVHSSSSVAMISAIDGDGKLKVYTAAGSK 1469
Query: 1481 TWMLDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFC 1540
WMLDP+EVE V+EEE + DWVRV+ SV+TPTYQWGEV+HSSIGVVHR E+GEL+++FC
Sbjct: 1470 AWMLDPAEVESVQEEEFHVRDWVRVKTSVSTPTYQWGEVNHSSIGVVHRKENGELFISFC 1529
Query: 1541 FME-RLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLR 1599
FME +LWLCKAWEMERVR F++GDKVRI++GLV PRWGWGMET+ASKGQVVGVDANGKLR
Sbjct: 1530 FMEKKLWLCKAWEMERVRQFRIGDKVRIRQGLVAPRWGWGMETYASKGQVVGVDANGKLR 1589
Query: 1600 IKFQWREGRPWIGDPADIVLDE 1621
IKFQWREG+PWIGDPADIVLDE
Sbjct: 1590 IKFQWREGKPWIGDPADIVLDE 1611
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449487126|ref|XP_004157504.1| PREDICTED: LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase KEG-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2494 bits (6464), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1221/1642 (74%), Positives = 1380/1642 (84%), Gaps = 54/1642 (3%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
MKVPCCSVCQ RYNE++RVPLLL CGHGFC +C+SRMF AS+D+ LSCPRCR+VSVVGNS
Sbjct: 1 MKVPCCSVCQNRYNEEDRVPLLLHCGHGFCADCMSRMFLASSDSRLSCPRCRYVSVVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDD-----DDDDEDDEVDEFGRGTH 117
+ ALRKNFAVLALI S++ T + F D DD + D+E + G+
Sbjct: 61 IQALRKNFAVLALIHSSSKTAVATSEFDCDFTDDDGDDGEGEVNGDEESLSRRRWSGGSC 120
Query: 118 VSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGG---GQGRCRHSVAVKK 174
S+SG CGPVI++GVH D+KL++++GEGRR GVE+W A +GG G RCRH VAVKK
Sbjct: 121 TSTSGG--CGPVIDIGVHKDLKLLRQIGEGRRDGVEIWTAMLGGRGSGSTRCRHQVAVKK 178
Query: 175 VMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRN 234
V + ++M+ W+ QL++L RASMWCRNVCTFHG + MD L LVMDRCYGSVQ MQ N
Sbjct: 179 VAVGDDMDLGWVLEQLESLHRASMWCRNVCTFHGAMEMDGSLYLVMDRCYGSVQSKMQEN 238
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
EGRLTLEQILRYGAD+ARGV ELHAAGVVCMNIKPSNLLLDA+G AVVSDYGLAAILKKP
Sbjct: 239 EGRLTLEQILRYGADVARGVAELHAAGVVCMNIKPSNLLLDATGHAVVSDYGLAAILKKP 298
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
C K R +CDSSR+H CM+C MLSP+Y APEAWEPVKKSL FWDD +G+S ESDAWSF
Sbjct: 299 MCSKGRSDCDSSRMHLCMECAMLSPHYAAPEAWEPVKKSLT-FWDDGLGMSVESDAWSFA 357
Query: 355 CTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
CTLVEMCTGSIPW+GL +EIYRAVVK +KLPPQY+SIVGVGIPRELWKMIG+CLQFK+
Sbjct: 358 CTLVEMCTGSIPWSGLCTDEIYRAVVKAKKLPPQYSSIVGVGIPRELWKMIGDCLQFKSL 417
Query: 415 KRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFS--TSNETEPSPASDVEVFQDNPNNL 472
KRPTF+ ML TFLR+LQE+PRSP A+PD KFS ++E S SD+EVF+ N +L
Sbjct: 418 KRPTFNKMLTTFLRYLQEIPRSPSANPDNDLAKFSGLYITDSETSLMSDLEVFRYNLGHL 477
Query: 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILE 532
H+LV +GD +GVRDLL K A N SS IS LL+AQN +GQTALHLACRRG AE+VE ILE
Sbjct: 478 HRLVFDGDFNGVRDLLVKAAFRNSSSFISKLLEAQNDEGQTALHLACRRGFAEIVEVILE 537
Query: 533 YSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592
+ + VD+LDKDGDPPLVFALAAGSPECV LI+RGANV SRLREGFGPSVAHVCAYHGQ
Sbjct: 538 FREAKVDILDKDGDPPLVFALAAGSPECVRILIERGANVCSRLREGFGPSVAHVCAYHGQ 597
Query: 593 PDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPL 652
PDCMRELLLAGADPN VDDEGESVLHRAV KKY+DCA+VILENGGCRSMA+LN+K LTPL
Sbjct: 598 PDCMRELLLAGADPNVVDDEGESVLHRAVTKKYSDCALVILENGGCRSMALLNAKHLTPL 657
Query: 653 HLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
H+CV+T NV VVK+W+E+A+ EEI IDIP GTALCMAAALKKD E EGR LV++LL
Sbjct: 658 HMCVSTCNVIVVKKWIEIATAEEIAEAIDIPSSAGTALCMAAALKKDREREGRSLVKLLL 717
Query: 713 TAGAEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 771
AGA+P +QDAQ+ RTALH A+MANDVELVK++ GVDVNI NVHNTIPLHVALARGA
Sbjct: 718 HAGADPASQDAQHGRTALHTAAMANDVELVKVLKQCGVDVNICNVHNTIPLHVALARGAN 777
Query: 772 SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHS-- 829
SCVGLLLS+GA+ N QDDEGD AFHIAADAAKMIRENL+WLIVML + DAAVEVRNH
Sbjct: 778 SCVGLLLSSGANYNLQDDEGDTAFHIAADAAKMIRENLQWLIVMLRNADAAVEVRNHRQV 837
Query: 830 ---------GKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTP 880
GK LRDFLE LPREWISE+L EAL RG+HLSPTIFEIGDWVKFKR + P
Sbjct: 838 PIGCCVLLIGKMLRDFLEALPREWISEELWEALAYRGIHLSPTIFEIGDWVKFKRTIAAP 897
Query: 881 TYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKE 940
TYGWQGAKHKSVGFVQ++LDKDNL+VSFCSGEV VLA+EV+K+IPLDRGQHV+LK DVKE
Sbjct: 898 TYGWQGAKHKSVGFVQNILDKDNLMVSFCSGEVHVLANEVIKVIPLDRGQHVQLKNDVKE 957
Query: 941 PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT 1000
PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT
Sbjct: 958 PRFGWRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPT 1017
Query: 1001 LTTAKHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCV 1060
LTTAKHGLGSVTPGSIGIVYC RPD SLLLELSYLPNPWHCEPEEVEPV PFR
Sbjct: 1018 LTTAKHGLGSVTPGSIGIVYCNRPDGSLLLELSYLPNPWHCEPEEVEPVIPFR------- 1070
Query: 1061 KRSVAEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDW 1120
+ EIE+DGLLII++P+RPIPWQADPSDMEKV+DFKVGDW
Sbjct: 1071 ---------------------VIEIESDGLLIIDLPDRPIPWQADPSDMEKVDDFKVGDW 1109
Query: 1121 VRVKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEV 1180
VRVK SVSSPKYGWEDI+RNSIG+IH LEED ++GIAFCFRSK F CSVTDVEKVPPFE+
Sbjct: 1110 VRVKTSVSSPKYGWEDISRNSIGVIHILEEDVEMGIAFCFRSKLFICSVTDVEKVPPFEI 1169
Query: 1181 GQEIHVMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSG 1240
GQEIH++PSVTQPRLGWS E+PATVGKI ++DMDGALNVKVAGR SLWKV PGDAE+LSG
Sbjct: 1170 GQEIHILPSVTQPRLGWSNESPATVGKISRVDMDGALNVKVAGRQSLWKVCPGDAEQLSG 1229
Query: 1241 FEVGDWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVE 1300
FEVGDWVRSKP+ G RP+YDWN G++S AVVHS+QD +LELACC R+ RW H +DVE
Sbjct: 1230 FEVGDWVRSKPNTGNRPTYDWNIAGRDSFAVVHSVQDCLFLELACCTRRNRWLAHASDVE 1289
Query: 1301 KIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPA 1360
K+PSYKVGQ+V+FR GL+EP WGWRG Q DSRGIITSVH+DGEVRVAFFG+ GLW+GDPA
Sbjct: 1290 KVPSYKVGQYVQFRPGLSEPMWGWRGVQSDSRGIITSVHSDGEVRVAFFGVSGLWRGDPA 1349
Query: 1361 DLEIGQMFEVGEWVRLRDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWV 1420
DLEI QMFE GEWVRLR+ + WKSIGPGSVGVVQG+ F+ D W+G V FC EQE WV
Sbjct: 1350 DLEIEQMFEAGEWVRLRENTNKWKSIGPGSVGVVQGLRFEGDEWNGRISVLFCGEQESWV 1409
Query: 1421 GPTSHLERVDRLVVGQRVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSK 1480
G +HLERVDRLVVGQ V+VK S+ QPRFGWS HS +SVG++SAID DGKL++YT GSK
Sbjct: 1410 GSITHLERVDRLVVGQMVQVKSSISQPRFGWSVHSSSSVGMISAIDGDGKLKVYTAAGSK 1469
Query: 1481 TWMLDPSEVEVVEEEELQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFC 1540
WMLDP+EVE V+EEE + DWVRV+ASV+TPTYQWGEV+HSSIGVVHR E GEL+++FC
Sbjct: 1470 AWMLDPAEVESVQEEEFHVRDWVRVKASVSTPTYQWGEVNHSSIGVVHRKEXGELFISFC 1529
Query: 1541 FME-RLWLCKAWEMERVRPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLR 1599
FME +LWLCKAWEMERVR F++GDKVRI++GLV PRWGWGMET+ASKGQVVGVDANGKLR
Sbjct: 1530 FMEKKLWLCKAWEMERVRQFRIGDKVRIRQGLVAPRWGWGMETYASKGQVVGVDANGKLR 1589
Query: 1600 IKFQWREGRPWIGDPADIVLDE 1621
IKFQWREG+PWIGDPADIVLDE
Sbjct: 1590 IKFQWREGKPWIGDPADIVLDE 1611
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413945241|gb|AFW77890.1| putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 2258 bits (5850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1120/1678 (66%), Positives = 1333/1678 (79%), Gaps = 71/1678 (4%)
Query: 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNS 62
M+VPCCS+C RY+E+ER PLLL CGHGFC+ CLSRM +A+ TL CPRCRH++ VGNS
Sbjct: 1 MRVPCCSLCNVRYDEEERTPLLLHCGHGFCRACLSRMLAAAPGATLPCPRCRHLTAVGNS 60
Query: 63 VTALRKNFAVLALILSANNTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSSG 122
V+ALRKNF + + + + + H DS + D +DEDD R + +
Sbjct: 61 VSALRKNFPI-----LSLLSTSPSSPSFLHSDSGSSSDGSEDEDDFFARPSRRPAPAPAA 115
Query: 123 VGVCGPVIEVGVHHDVKLVKKLGEGRR--AGVEVWGAWI--GGGQGRCRHSVAVKKVMIA 178
++ H D+KL +++G G AG EVW + GGG RC+H VAVK+V +A
Sbjct: 116 APPGCSFFDLASHPDLKLARRIGSGPPGPAGQEVWAGTLSRGGGVKRCKHQVAVKRVPLA 175
Query: 179 EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRL 238
+ + +++ LRRAS WCRNVCTFHG +R+ L VMDR GSVQ M++N GRL
Sbjct: 176 AGDGLEVVQEEVERLRRASTWCRNVCTFHGAVRVGGHLCFVMDRYVGSVQAEMRQNGGRL 235
Query: 239 TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298
TLEQILRYGADIARG+ ELHAAG+VCM+IKPSN+LLDA G A VSDYGL+AILK R+
Sbjct: 236 TLEQILRYGADIARGIAELHAAGIVCMSIKPSNILLDAHGHAFVSDYGLSAILKNLTSRR 295
Query: 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
P+ S+ I D T+LSPNYTAPEAW P+KKSLN+FWD A GISPESDAWSFGCTLV
Sbjct: 296 V-PDDSSAGI----DATLLSPNYTAPEAWGPLKKSLNMFWDSANGISPESDAWSFGCTLV 350
Query: 359 EMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
EMCTG++PWAGLSAEEI ++VVK +K PPQY+ +VGVG+P ELWKMIGECLQF+AS+RP+
Sbjct: 351 EMCTGAVPWAGLSAEEICKSVVKEKKPPPQYSRVVGVGLPGELWKMIGECLQFRASRRPS 410
Query: 419 FSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSE 478
F ML TFLRHL ++PRSPPASP+ F + N +P S +E+ DNPN LH LV E
Sbjct: 411 FQDMLKTFLRHLLDIPRSPPASPEIDFANENLPNGMQPPTTSILEMVHDNPNALHHLVCE 470
Query: 479 GDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENV 538
GD +GVRDLL+K AS S I SLL+AQN DG TALHLACRRGSAELVEAI+ Y QENV
Sbjct: 471 GDAAGVRDLLAKAASERNDSLIRSLLEAQNTDGLTALHLACRRGSAELVEAIVAY-QENV 529
Query: 539 DVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRE 598
D+LDKD DPP+VFALAAGSP CV AL+ R A++ SRLREG GP++AHVCA+HGQP+CM+E
Sbjct: 530 DILDKDEDPPIVFALAAGSPRCVRALVGRSASINSRLREGLGPTLAHVCAHHGQPECMQE 589
Query: 599 LLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVAT 658
LL+AGADPNAVD EGESVLH AVA++YTDCAIVILENGGCRSM I NS+ TPLHLC+ T
Sbjct: 590 LLMAGADPNAVDGEGESVLHIAVARRYTDCAIVILENGGCRSMGISNSQHKTPLHLCIET 649
Query: 659 WNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE----------------- 701
WN AVV+RWVEVAS E+I ID+P PVGTALCMAAALKK+HE
Sbjct: 650 WNTAVVRRWVEVASLEDIAETIDVPSPVGTALCMAAALKKEHEKEFHKVQDYWTIMFFHL 709
Query: 702 --------------VEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIILD 746
EGRELVRILL AGA+ TAQD + RTALH A+M +DVELVKIIL+
Sbjct: 710 FQTLFVLIVKLLLLAEGRELVRILLAAGADSTAQDDPHCRTALHTAAMIDDVELVKIILE 769
Query: 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIR 806
AGVDVNIRN NT PLHVAL RGA SCVGLLL+AGA+CN QDD+GDNAFHIAADAAKMIR
Sbjct: 770 AGVDVNIRNAQNTTPLHVALNRGANSCVGLLLAAGANCNIQDDDGDNAFHIAADAAKMIR 829
Query: 807 ENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFE 866
ENL W+ ML P AV+VRNH G TLRDFLE LPREWI E+LME L ++GVHLSPTI+E
Sbjct: 830 ENLAWIAQMLLQPSPAVDVRNHRGWTLRDFLERLPREWIYEELMETLEDKGVHLSPTIYE 889
Query: 867 IGDWVKFKRRVTTPTYGWQGAKHKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPL 926
+ DWVKF+R VT+P +GWQGA +S+GFVQSV+D D+L VSFC+GE VL SEV+K+IPL
Sbjct: 890 VADWVKFRRTVTSPAFGWQGAGPRSIGFVQSVVDNDHLAVSFCTGEAHVLTSEVIKVIPL 949
Query: 927 DRGQHVKLKPDVKEPR-----------------------FGWRGQSRDSIGTVLCVDDDG 963
+RGQHV+LKP V EP FGWRGQSRDSIGTVLCVDDDG
Sbjct: 950 NRGQHVQLKPGVSEPSIYLDAEIIELVGILNWRSTMCLLFGWRGQSRDSIGTVLCVDDDG 1009
Query: 964 ILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSIGIVYCIR 1023
ILRVGFPGASRGW+ADPAE+ERVEE+KVG+WVRIRP+LT A HG+ S+TPGS+GIVY IR
Sbjct: 1010 ILRVGFPGASRGWRADPAEIERVEEYKVGNWVRIRPSLTVAVHGMESITPGSVGIVYSIR 1069
Query: 1024 PDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSVAEPRYAWGGETHHSVGKIS 1083
PDSSLLL L YL NPW CEPEEVE V PF+IG++VCVKRSVAEPRYAWGGETHHSVGKI
Sbjct: 1070 PDSSLLLGLCYLSNPWLCEPEEVEHVDPFKIGDQVCVKRSVAEPRYAWGGETHHSVGKII 1129
Query: 1084 EIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWEDITRNSIG 1143
+IE+DGLLII+IPNR PWQADPSDMEK+E+FKVGDW+RVKA+V SPKYGWED+TRNSIG
Sbjct: 1130 DIESDGLLIIDIPNRAAPWQADPSDMEKIENFKVGDWIRVKATVPSPKYGWEDVTRNSIG 1189
Query: 1144 IIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLGWSKETPA 1203
I+HSL++DGDVG+AFCFRS+ F CSV DVEK PFEVG+++HV PS+++PRLGW ET A
Sbjct: 1190 IVHSLQDDGDVGVAFCFRSRLFLCSVADVEKAQPFEVGEKVHVSPSISEPRLGWLSETAA 1249
Query: 1204 TVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTRPSYDWNT 1263
T+G I +IDMDG LN+KV+GR LWKV+PGDAERLS FEVGDWVR KPSIG+RP+YDWN+
Sbjct: 1250 TIGAISRIDMDGTLNIKVSGRKGLWKVAPGDAERLSAFEVGDWVRLKPSIGSRPTYDWNS 1309
Query: 1264 VGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSGLAEPRWG 1323
VG+ S+AVVHSIQD+GYLELA CFR G+W TH TD+EK+ + K+GQHVRFR+G++EPRWG
Sbjct: 1310 VGRISIAVVHSIQDSGYLELAGCFRNGKWLTHNTDIEKVQTLKIGQHVRFRAGISEPRWG 1369
Query: 1324 WRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRLRDFASNW 1383
WR A DSRG+I VHADGEVRVAFFG+PGLW+GDPADLEI +FEVGEWVRL + W
Sbjct: 1370 WRDANPDSRGVIAGVHADGEVRVAFFGVPGLWRGDPADLEIENIFEVGEWVRLTNDVEQW 1429
Query: 1384 KSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQRVRVKLS 1443
+S+ PGS+GVV G+G+Q D WDG+ VAFC EQERW+GP+S LE V + VVGQRVR++
Sbjct: 1430 RSLKPGSIGVVHGVGYQGDAWDGTIHVAFCGEQERWIGPSSQLEGVSKFVVGQRVRIRGC 1489
Query: 1444 VKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSEVEVVEEEELQIGDWV 1503
++QPRFGWS H+H+S+G +S+IDADGKLRI+TP G++ W++DP+EVE VEEEE+ +GDWV
Sbjct: 1490 IRQPRFGWSNHNHSSIGTISSIDADGKLRIHTPAGARAWLIDPAEVEEVEEEEVCVGDWV 1549
Query: 1504 RVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAWEMERVRPFKVGD 1563
+V+ SV TP YQWG+V+HSSIGVVHR + GELW+AFCF ERLWLCKAWE+E+VRPF+ GD
Sbjct: 1550 KVKDSVGTPVYQWGDVNHSSIGVVHRADDGELWIAFCFCERLWLCKAWEVEKVRPFRQGD 1609
Query: 1564 KVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWIGDPADIVLDE 1621
KVRI+ GLV+PRWGWGMET+ASKG+VVGVDANGKLRIKF+WR+ R WIGDPADIVLD+
Sbjct: 1610 KVRIRPGLVSPRWGWGMETYASKGEVVGVDANGKLRIKFRWRD-RLWIGDPADIVLDD 1666
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1630 | ||||||
| TAIR|locus:2185061 | 1625 | KEG "AT5G13530" [Arabidopsis t | 0.991 | 0.994 | 0.758 | 0.0 | |
| TAIR|locus:2116545 | 611 | AT4G32250 [Arabidopsis thalian | 0.101 | 0.270 | 0.310 | 1.2e-22 | |
| UNIPROTKB|F1NJ80 | 1699 | ANK3 "Uncharacterized protein" | 0.182 | 0.175 | 0.293 | 7.6e-21 | |
| UNIPROTKB|F1NNX8 | 1737 | ANK3 "Uncharacterized protein" | 0.182 | 0.171 | 0.293 | 8.1e-21 | |
| UNIPROTKB|F1NNX6 | 1824 | ANK3 "Uncharacterized protein" | 0.182 | 0.163 | 0.293 | 9.2e-21 | |
| UNIPROTKB|F1NNX7 | 1915 | ANK3 "Uncharacterized protein" | 0.182 | 0.155 | 0.293 | 1e-20 | |
| ZFIN|ZDB-GENE-041001-120 | 618 | ftr78 "finTRIM family, member | 0.122 | 0.322 | 0.345 | 1.9e-20 | |
| UNIPROTKB|F1NA51 | 2890 | ANK3 "Uncharacterized protein" | 0.182 | 0.103 | 0.293 | 4.5e-20 | |
| UNIPROTKB|Q8NFD2 | 765 | ANKK1 "Ankyrin repeat and prot | 0.184 | 0.393 | 0.282 | 9.3e-20 | |
| MGI|MGI:3045301 | 745 | Ankk1 "ankyrin repeat and kina | 0.341 | 0.746 | 0.233 | 1.2e-19 |
| TAIR|locus:2185061 KEG "AT5G13530" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 6733 (2375.2 bits), Expect = 0., P = 0.
Identities = 1234/1627 (75%), Positives = 1395/1627 (85%)
Query: 2 KMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGN 61
++KVPCCSVC TRYNE ERVPLLLQCGHGFCK+CLS+MFS S+DTTL+CPRCRHVSVVGN
Sbjct: 4 RVKVPCCSVCHTRYNEDERVPLLLQCGHGFCKDCLSKMFSTSSDTTLTCPRCRHVSVVGN 63
Query: 62 SVTALRKNFAVLALILSAXXXXXXXXXXXXXFXXXXXXXXXXXXXXXXXXFGRGTHXXXX 121
SV LRKN+A+LALI +A RG H
Sbjct: 64 SVQGLRKNYAMLALIHAASGGANFDCDYTDDEDDDDEEDGSDEDGARAA---RGFHASSS 120
Query: 122 XXXXXXPVIEVGVHHDVKLVKKLGE----GRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI 177
PVIEVG H ++KLV+++GE G GVE+W A + GG GRC+H VAVKK+ +
Sbjct: 121 INSLCGPVIEVGAHPEMKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCKHRVAVKKMTL 180
Query: 178 AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR 237
E+M+ +W+ GQL++LRRASMWCRNVCTFHGV++MD L L+MDRC+GSVQ MQRNEGR
Sbjct: 181 TEDMDVEWMQGQLESLRRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEMQRNEGR 240
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LTLEQILRYGAD+ARGV ELHAAGV+CMNIKPSNLLLDASG AVVSDYGLA ILKKP C+
Sbjct: 241 LTLEQILRYGADVARGVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQ 300
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
K RPE DSS++ DC LSP+YTAPEAW PVKK LFW+DA G+SPESDAWSFGCTL
Sbjct: 301 KTRPEFDSSKVTLYTDCVTLSPHYTAPEAWGPVKK---LFWEDASGVSPESDAWSFGCTL 357
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
VEMCTGS PW GLS EEI++AVVK RK+PPQY IVGVGIPRELWKMIGECLQFK SKRP
Sbjct: 358 VEMCTGSTPWDGLSREEIFQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRP 417
Query: 418 TFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVS 477
TF+AMLATFLRHLQE+PRSP ASPD G K N + A+++ VFQDNPNNLH++V
Sbjct: 418 TFNAMLATFLRHLQEIPRSPSASPDNGIAKICEVNIVQAPRATNIGVFQDNPNNLHRVVL 477
Query: 478 EGDVSGVRDLLXXXXXXXXXXXXXXXXXXQNADGQTALHLACRRGSAELVEAILEYSQEN 537
EGD GVR++L QNADGQ+ALHLACRRGSAELVEAILEY + N
Sbjct: 478 EGDFEGVRNILAKAAAGGGGSSVRSLLEAQNADGQSALHLACRRGSAELVEAILEYGEAN 537
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
VD++DKDGDPPLVFALAAGSP+CVH LIK+GANV SRLREG GPSVAHVC+YHGQPDCMR
Sbjct: 538 VDIVDKDGDPPLVFALAAGSPQCVHVLIKKGANVRSRLREGSGPSVAHVCSYHGQPDCMR 597
Query: 598 ELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA 657
ELL+AGADPNAVDDEGE+VLHRAVAKKYTDCAIVILENGG RSM + N+K LTPLH+CVA
Sbjct: 598 ELLVAGADPNAVDDEGETVLHRAVAKKYTDCAIVILENGGSRSMTVSNAKCLTPLHMCVA 657
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
TWNVAV+KRWVEV+SPEEI I+IP PVGTALCMAA+++KDHE EGRELV+ILL AGA+
Sbjct: 658 TWNVAVIKRWVEVSSPEEISQAINIPSPVGTALCMAASIRKDHEKEGRELVQILLAAGAD 717
Query: 718 PTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGL 776
PTAQDAQ+ RTALH A+MAN+VELV++ILDAGV+ NIRNVHNTIPLH+ALARGA SCV L
Sbjct: 718 PTAQDAQHGRTALHTAAMANNVELVRVILDAGVNANIRNVHNTIPLHMALARGANSCVSL 777
Query: 777 LLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836
LL +G+DCN QDDEGDNAFHIAADAAKMIRENL+WLIVML PDAAV+VRNHSGKT+RDF
Sbjct: 778 LLESGSDCNIQDDEGDNAFHIAADAAKMIRENLDWLIVMLRSPDAAVDVRNHSGKTVRDF 837
Query: 837 LEGLPREWISEDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAKHKSVGFVQ 896
LE LPREWISEDLMEAL+ RGVHLSPTI+E+GDWVKFKR +TTP +GWQGAK KSVGFVQ
Sbjct: 838 LEALPREWISEDLMEALLKRGVHLSPTIYEVGDWVKFKRGITTPLHGWQGAKPKSVGFVQ 897
Query: 897 SVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPRFGWRGQSRDSIGTV 956
++L+K+++I++FCSGE RVLA+EV+KLIPLDRGQHV+L+ DVKEPRFGWRGQSRDS+GTV
Sbjct: 898 TILEKEDMIIAFCSGEARVLANEVVKLIPLDRGQHVRLRADVKEPRFGWRGQSRDSVGTV 957
Query: 957 LCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTAKHGLGSVTPGSI 1016
LCVD+DGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIR LT+AKHG GSV PGS+
Sbjct: 958 LCVDEDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRQNLTSAKHGFGSVVPGSM 1017
Query: 1017 GIVYCIRPDSSLLLELSYLPNPWHCXXXXXXXXXXFRIGNRVCVKRSVAEPRYAWGGETH 1076
GIVYC+RPDSSLL+ELSYLPNPWHC FRIG+RVCVKRSVAEPRYAWGGETH
Sbjct: 1018 GIVYCVRPDSSLLVELSYLPNPWHCEPEEVEPVAPFRIGDRVCVKRSVAEPRYAWGGETH 1077
Query: 1077 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKVEDFKVGDWVRVKASVSSPKYGWED 1136
HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEK++DFKVGDWVRVKASVSSPKYGWED
Sbjct: 1078 HSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKIDDFKVGDWVRVKASVSSPKYGWED 1137
Query: 1137 ITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDVEKVPPFEVGQEIHVMPSVTQPRLG 1196
ITRNSIG++HSL+EDGDVGIAFCFRSKPF CSVTDVEKV PF VGQEIH+ PS+TQPRLG
Sbjct: 1138 ITRNSIGVMHSLDEDGDVGIAFCFRSKPFSCSVTDVEKVTPFHVGQEIHMTPSITQPRLG 1197
Query: 1197 WSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERLSGFEVGDWVRSKPSIGTR 1256
WS ETPAT+GK+++IDMDG L+ +V GR +LW+VSPGDAE LSGFEVGDWVRSKPS+G R
Sbjct: 1198 WSNETPATIGKVMRIDMDGTLSAQVTGRQTLWRVSPGDAELLSGFEVGDWVRSKPSLGNR 1257
Query: 1257 PSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWSTHYTDVEKIPSYKVGQHVRFRSG 1316
PSYDW+ VG+ES+AVVHSIQ+ GYLELACCFRKGRWSTHYTD+EKIP+ KVGQ V F+ G
Sbjct: 1258 PSYDWSNVGRESIAVVHSIQETGYLELACCFRKGRWSTHYTDLEKIPALKVGQFVHFQKG 1317
Query: 1317 LAEPRWGWRGAQLDSRGIITSVHADGEVRVAFFGLPGLWKGDPADLEIGQMFEVGEWVRL 1376
+ EPRWGWR A+ DSRGIIT+VHADGEVRVAFFGLPGLW+GDPADLE+ MFEVGEWVRL
Sbjct: 1318 ITEPRWGWRAAKPDSRGIITTVHADGEVRVAFFGLPGLWRGDPADLEVEPMFEVGEWVRL 1377
Query: 1377 RDFASNWKSIGPGSVGVVQGIGFQDDNWDGSTFVAFCCEQERWVGPTSHLERVDRLVVGQ 1436
R+ S WKS+GPGSVGVV G+G++ D WDG+T V+FC EQERW GPTSHLE+ +LVVGQ
Sbjct: 1378 REGVSCWKSVGPGSVGVVHGVGYEGDEWDGTTSVSFCGEQERWAGPTSHLEKAKKLVVGQ 1437
Query: 1437 RVRVKLSVKQPRFGWSGHSHASVGIVSAIDADGKLRIYTPVGSKTWMLDPSXXXXXXXXX 1496
+ RVKL+VKQPRFGWSGHSH SVG +SAIDADGKLRIYTP GSKTWMLDPS
Sbjct: 1438 KTRVKLAVKQPRFGWSGHSHGSVGTISAIDADGKLRIYTPAGSKTWMLDPSEVETIEEEE 1497
Query: 1497 LQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCFMERLWLCKAWEMERV 1556
L+IGDWVRV+AS+TTPTYQWGEV+ SS GVVHRME G+L V+FCF++RLWLCKA E+ER+
Sbjct: 1498 LKIGDWVRVKASITTPTYQWGEVNPSSTGVVHRMEDGDLCVSFCFLDRLWLCKAGELERI 1557
Query: 1557 RPFKVGDKVRIKEGLVTPRWGWGMETHASKGQVVGVDANGKLRIKFQWREGRPWIGDPAD 1616
RPF++GD+V+IK+GLVTPRWGWGMETHASKG VVGVDANGKLRIKF WREGRPWIGDPAD
Sbjct: 1558 RPFRIGDRVKIKDGLVTPRWGWGMETHASKGHVVGVDANGKLRIKFLWREGRPWIGDPAD 1617
Query: 1617 IVLDECS 1623
IVLDE S
Sbjct: 1618 IVLDETS 1624
|
|
| TAIR|locus:2116545 AT4G32250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 212 (79.7 bits), Expect = 1.2e-22, Sum P(2) = 1.2e-22
Identities = 55/177 (31%), Positives = 91/177 (51%)
Query: 168 HSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSV 227
H VA+K + +E + + + ++L NVC GV ++ + +VM GS+
Sbjct: 69 HEVAIKMLYPIKEDQRRVVVDKFEDLFSKCQGLENVCLLRGVSSINGKICVVMKFYEGSL 128
Query: 228 QLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286
M R +G +L+L +LRYG D+A G++ELH+ G + +N+KPSN LL + +A++ D G
Sbjct: 129 GDKMARLKGGKLSLPDVLRYGVDLATGILELHSKGFLILNLKPSNFLLSDNDKAILGDVG 188
Query: 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
+ +L P D + + +PNY APE W+P + F D+ G
Sbjct: 189 IPYLLLSIPL----PSSDMTE-------RLGTPNYMAPEQWQPDVRGPMSFETDSWG 234
|
|
| UNIPROTKB|F1NJ80 ANK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 7.6e-21, Sum P(2) = 7.6e-21
Identities = 95/324 (29%), Positives = 154/324 (47%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T +H+A G +V ++ + + + + G+ L A AG E V L++ GA
Sbjct: 391 GLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARAGQTEVVRYLVQNGAQ 449
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + + + D A
Sbjct: 450 VEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSAREGHEDVAS 507
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVG-T 688
V+LE+G S+AI+ K TPLH+ + V ++ ASP D G G T
Sbjct: 508 VLLEHGA--SLAIITKKGFTPLHVAAKYGKIEVANLLLQKNASP-------DASGKSGLT 558
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
L +AA H + +++ +LL GA P A T LHIA+ N +++ +L+ G
Sbjct: 559 PLHVAA-----H-YDNQKVALLLLDQGASPHASAKNGYTPLHIAAKKNQMDIATTLLEYG 612
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808
D N P+H+A G V LLL+ A+ N + G H+AA ++ N
Sbjct: 613 ADANAVTRQGIAPVHLASQDGHVDMVSLLLTRNANVNLSNKSGLTPLHLAAQEDRV---N 669
Query: 809 LEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++V + AAV+ + G T
Sbjct: 670 VAEVLV---NQGAAVDAQTKMGYT 690
|
|
| UNIPROTKB|F1NNX8 ANK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 8.1e-21, Sum P(2) = 8.1e-21
Identities = 95/324 (29%), Positives = 154/324 (47%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T +H+A G +V ++ + + + + G+ L A AG E V L++ GA
Sbjct: 391 GLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARAGQTEVVRYLVQNGAQ 449
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + + + D A
Sbjct: 450 VEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSAREGHEDVAS 507
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVG-T 688
V+LE+G S+AI+ K TPLH+ + V ++ ASP D G G T
Sbjct: 508 VLLEHGA--SLAIITKKGFTPLHVAAKYGKIEVANLLLQKNASP-------DASGKSGLT 558
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
L +AA H + +++ +LL GA P A T LHIA+ N +++ +L+ G
Sbjct: 559 PLHVAA-----H-YDNQKVALLLLDQGASPHASAKNGYTPLHIAAKKNQMDIATTLLEYG 612
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808
D N P+H+A G V LLL+ A+ N + G H+AA ++ N
Sbjct: 613 ADANAVTRQGIAPVHLASQDGHVDMVSLLLTRNANVNLSNKSGLTPLHLAAQEDRV---N 669
Query: 809 LEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++V + AAV+ + G T
Sbjct: 670 VAEVLV---NQGAAVDAQTKMGYT 690
|
|
| UNIPROTKB|F1NNX6 ANK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 9.2e-21, Sum P(2) = 9.2e-21
Identities = 95/324 (29%), Positives = 154/324 (47%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T +H+A G +V ++ + + + + G+ L A AG E V L++ GA
Sbjct: 391 GLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARAGQTEVVRYLVQNGAQ 449
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + + + D A
Sbjct: 450 VEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSAREGHEDVAS 507
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVG-T 688
V+LE+G S+AI+ K TPLH+ + V ++ ASP D G G T
Sbjct: 508 VLLEHGA--SLAIITKKGFTPLHVAAKYGKIEVANLLLQKNASP-------DASGKSGLT 558
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
L +AA H + +++ +LL GA P A T LHIA+ N +++ +L+ G
Sbjct: 559 PLHVAA-----H-YDNQKVALLLLDQGASPHASAKNGYTPLHIAAKKNQMDIATTLLEYG 612
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808
D N P+H+A G V LLL+ A+ N + G H+AA ++ N
Sbjct: 613 ADANAVTRQGIAPVHLASQDGHVDMVSLLLTRNANVNLSNKSGLTPLHLAAQEDRV---N 669
Query: 809 LEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++V + AAV+ + G T
Sbjct: 670 VAEVLV---NQGAAVDAQTKMGYT 690
|
|
| UNIPROTKB|F1NNX7 ANK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 1.0e-20, Sum P(2) = 1.0e-20
Identities = 95/324 (29%), Positives = 154/324 (47%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T +H+A G +V ++ + + + + G+ L A AG E V L++ GA
Sbjct: 391 GLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARAGQTEVVRYLVQNGAQ 449
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + + + D A
Sbjct: 450 VEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSAREGHEDVAS 507
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVG-T 688
V+LE+G S+AI+ K TPLH+ + V ++ ASP D G G T
Sbjct: 508 VLLEHGA--SLAIITKKGFTPLHVAAKYGKIEVANLLLQKNASP-------DASGKSGLT 558
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
L +AA H + +++ +LL GA P A T LHIA+ N +++ +L+ G
Sbjct: 559 PLHVAA-----H-YDNQKVALLLLDQGASPHASAKNGYTPLHIAAKKNQMDIATTLLEYG 612
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808
D N P+H+A G V LLL+ A+ N + G H+AA ++ N
Sbjct: 613 ADANAVTRQGIAPVHLASQDGHVDMVSLLLTRNANVNLSNKSGLTPLHLAAQEDRV---N 669
Query: 809 LEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++V + AAV+ + G T
Sbjct: 670 VAEVLV---NQGAAVDAQTKMGYT 690
|
|
| ZFIN|ZDB-GENE-041001-120 ftr78 "finTRIM family, member 78" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 243 (90.6 bits), Expect = 1.9e-20, Sum P(3) = 1.9e-20
Identities = 82/237 (34%), Positives = 108/237 (45%)
Query: 1384 KSIGPGSVGVVQG----IGFQDD-NWDGSTFVAFCCEQERWVGPTSHLERVDRLV---VG 1435
KSIG V +QG + F + NW G E E S L + V VG
Sbjct: 387 KSIGV--VKKIQGEFLTVDFPEQKNWTGVVL-----EMENVTSAGSDLATPNASVNIKVG 439
Query: 1436 QRVRVKLSVKQPRFGWSGH-SHASVGIVSAIDADGKLRIYTPVGSKTW--ML-------- 1484
RV+VK SV P W + +H SVG+V AI D L + P G W +L
Sbjct: 440 DRVKVKPSVTTPEHNWGRNVTHKSVGVVKAIKDDDSLLVDFP-GHANWKGILSEMELAND 498
Query: 1485 ---DPSXXXXXXXXXLQIGDWVRVRASVTTPTYQWGEVSHSSIGVVHRMESGELWVAFCF 1541
D ++IGD VRV+ SV TP ++WG V+H SIG+V +++ L V F
Sbjct: 499 DDDDDESGSASQDSNIKIGDKVRVKPSVVTPAHKWGAVTHKSIGIVKKIQGDSLTVDFS- 557
Query: 1542 MERLWLCKAWEMERVR------PFKVGDKVRIKEGLVTPRWGWGME-THASKGQVVG 1591
++ W EME V KVGD+VR+K + TP WG TH S G + G
Sbjct: 558 EQKNWTGILSEMEIVANASGLADMKVGDRVRVKASVTTPMHNWGSNVTHKSVGVIKG 614
|
|
| UNIPROTKB|F1NA51 ANK3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 4.5e-20, Sum P(2) = 4.5e-20
Identities = 95/324 (29%), Positives = 154/324 (47%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T +H+A G +V ++ + + + + G+ L A AG E V L++ GA
Sbjct: 433 GLTPIHVAAFMGHVNIVSQLMHHGA-SPNTTNVRGETALHMAARAGQTEVVRYLVQNGAQ 491
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V ++ ++ P H+ A G+ D +++LL GA PNA G + LH + + + D A
Sbjct: 492 VEAKAKDDQTP--LHISARLGKADIVQQLLQQGASPNAATTSGYTPLHLSAREGHEDVAS 549
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVG-T 688
V+LE+G S+AI+ K TPLH+ + V ++ ASP D G G T
Sbjct: 550 VLLEHGA--SLAIITKKGFTPLHVAAKYGKIEVANLLLQKNASP-------DASGKSGLT 600
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
L +AA H + +++ +LL GA P A T LHIA+ N +++ +L+ G
Sbjct: 601 PLHVAA-----H-YDNQKVALLLLDQGASPHASAKNGYTPLHIAAKKNQMDIATTLLEYG 654
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808
D N P+H+A G V LLL+ A+ N + G H+AA ++ N
Sbjct: 655 ADANAVTRQGIAPVHLASQDGHVDMVSLLLTRNANVNLSNKSGLTPLHLAAQEDRV---N 711
Query: 809 LEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++V + AAV+ + G T
Sbjct: 712 VAEVLV---NQGAAVDAQTKMGYT 732
|
|
| UNIPROTKB|Q8NFD2 ANKK1 "Ankyrin repeat and protein kinase domain-containing protein 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 253 (94.1 bits), Expect = 9.3e-20, Sum P(2) = 9.3e-20
Identities = 93/329 (28%), Positives = 152/329 (46%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
Q A G T L +A + +L +L + + + +D+DG PL FA G L+
Sbjct: 391 QTASGYTPLLIAAQDQQPDLCALLLAHGAD-ANRVDEDGWAPLHFAAQNGDDGTARLLLD 449
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626
GA V ++ REG+ P H+ A + + R L+ ADPN + EG++ LH VA +
Sbjct: 450 HGACVDAQEREGWTP--LHLAAQNNFENVARLLVSRQADPNLHEAEGKTPLH--VAAYFG 505
Query: 627 DCAIV-ILENGGCRSMAILNSKEL-TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPG 684
++V +L + G A + L TPLHL V V ++ ++ + + ++ G
Sbjct: 506 HVSLVKLLTSQGAELDA--QQRNLRTPLHLAVERGKVRAIQHLLKSGAVPDALDQSGY-G 562
Query: 685 PVGTALCMAAALKKDHEVEGRELV-RILLTAGAEPTAQDAQNRTALHIASMANDVELVKI 743
P+ TA AA G+ L+ ++LL GA Q T LH+A+ +E++ +
Sbjct: 563 PLHTA---AA--------RGKYLICKMLLRYGASLELPTHQGWTPLHLAAYKGHLEIIHL 611
Query: 744 ILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAK 803
+ ++ ++ N PLH+A G ++ V LL GAD N + G H+A +
Sbjct: 612 LAESHANMGALGAVNWTPLHLAARHGEEAVVSALLQCGADPNAAEQSGWTPLHLAVQRST 671
Query: 804 MIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ +I +L H A V RN G T
Sbjct: 672 FLS-----VINLLEH-HANVHARNKVGWT 694
|
|
| MGI|MGI:3045301 Ankk1 "ankyrin repeat and kinase domain containing 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 273 (101.2 bits), Expect = 1.2e-19, P = 1.2e-19
Identities = 146/624 (23%), Positives = 262/624 (41%)
Query: 201 RNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
+++ + +GV + LG+VM+ GS++ + + L+ + + +A +
Sbjct: 93 QHIVSIYGVCKQP--LGIVMEFMASGSLEKTLPTHSLCWPLKLRIIHETSLAMNFLHSIK 150
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
++ +++KP N+LLD + +SD+GL+ +++ + +K E S + T+
Sbjct: 151 PPLLHLDLKPGNILLDNNMHVKISDFGLSKWMEQ-STQKQYIE------RSALRGTL--- 200
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+Y PE +F ++ PE D +SF + E+ T P+AGL+ I V
Sbjct: 201 SYIPPE----------MFLENNKAPGPEYDVYSFAIVIWEILTQKKPYAGLNMMTIIIRV 250
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIG---ECLQFKASKRPTFS--AMLATFLRHLQELP 434
+ P + P E+ +M+ C KRP F A+ L L + P
Sbjct: 251 AAGMR--PSLQDVSDEW-PEEVHQMVNLMKRCWDQDPKKRPCFLNVAVETDMLLSLFQSP 307
Query: 435 RSPPA----------SPDTGFT-KFS--TSNETEPSPASD----VEVFQDNPNNLHQLVS 477
+ P P K S + E S +SD + D+ + + V
Sbjct: 308 MTDPGCEALTQKVSCKPSLSQPHKVSKEVNQEIADSVSSDSLKWILQLSDSKSLVASDVY 367
Query: 478 EGDVSGVRDLLXXXXXXXXXXXXXXXXXX--QNADGQTALHLACRRGSAELVEAILEYSQ 535
E V+ + L+ Q A G T L +A + +L +L +
Sbjct: 368 ENRVTPLHFLVAGGSLEQVRLLLSHDVDVDCQTASGYTPLLIATQDQQPDLCALLLAHGA 427
Query: 536 ENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDC 595
+ ++ D+DG PL FA G L+ GA V +R EG+ P H+ A + +
Sbjct: 428 DT-NLADEDGWAPLHFAAQNGDDHTARLLLDHGALVNAREHEGWTP--LHLAAQNNFENV 484
Query: 596 MRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655
R L+ AD + + EG++ LH VA + +V L +G + TPLHL
Sbjct: 485 ARLLVSRQADLSPHEAEGKTPLH--VAAYFGHIGLVKLLSGQGAELDAQQRNLRTPLHLA 542
Query: 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV-RILLTA 714
V V ++ ++ + + + +D G + L +AAA G++L+ ++LL
Sbjct: 543 VERGKVRAIQHLLKCGA---LPDALDHSGY--SPLHIAAA-------RGKDLIFKMLLRY 590
Query: 715 GAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
GA + Q T LH+A+ +E++ + + VD++ PLH+A +G + +
Sbjct: 591 GASLELRTQQGWTPLHLATYKGHLEIIHQLAKSHVDLDALGSMQWTPLHLAAFQGEEGVM 650
Query: 775 GLLLSAGADCNWQDDEGDNAFHIA 798
LL GA+ N + G H+A
Sbjct: 651 LALLQCGANPNAAEQSGWTPLHLA 674
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FY48 | KEG_ARATH | 6, ., 3, ., 2, ., - | 0.7805 | 0.9914 | 0.9944 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 6.3.2 | 0.983 |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1630 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-30 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-28 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-27 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-25 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-24 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-22 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 7e-22 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 8e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-19 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-18 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 2e-18 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-16 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 4e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 8e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-14 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 1e-13 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-13 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 5e-13 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 6e-13 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 8e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-12 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-10 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 8e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-10 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-09 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 5e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-09 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 5e-09 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 6e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 1e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-08 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-07 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-07 | |
| pfam13639 | 46 | pfam13639, zf-RING_2, Ring finger domain | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd00162 | 45 | cd00162, RING, RING-finger (Really Interesting New | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 4e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 6e-07 | |
| smart00184 | 40 | smart00184, RING, Ring finger | 6e-07 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 6e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-07 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 8e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-07 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-07 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 1e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-06 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-06 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-06 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 4e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-06 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 8e-06 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 8e-06 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 8e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-06 | |
| PHA02791 | 284 | PHA02791, PHA02791, ankyrin-like protein; Provisio | 9e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-06 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 1e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| pfam13923 | 45 | pfam13923, zf-C3HC4_2, Zinc finger, C3HC4 type (RI | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 4e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-05 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 5e-05 | |
| pfam00097 | 40 | pfam00097, zf-C3HC4, Zinc finger, C3HC4 type (RING | 5e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-05 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 6e-05 | |
| pfam13920 | 49 | pfam13920, zf-C3HC4_3, Zinc finger, C3HC4 type (RI | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-05 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-04 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-04 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 4e-04 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 4e-04 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 4e-04 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 4e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-04 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-04 | |
| PHA02989 | 494 | PHA02989, PHA02989, ankyrin repeat protein; Provis | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| PHA02736 | 154 | PHA02736, PHA02736, Viral ankyrin protein; Provisi | 0.001 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.001 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.001 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.001 | |
| PHA02859 | 209 | PHA02859, PHA02859, ankyrin repeat protein; Provis | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 0.002 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 0.003 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.003 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.003 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 0.004 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.004 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 63/299 (21%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIAEEMEPDWLSGQLDNL 193
++++KLGEG + +V+ R VA+K + + + +
Sbjct: 2 EILEKLGEG--SFGKVY---------LARDKKTGKLVAIKVIKKKKI------KKDRERI 44
Query: 194 RR-ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYG 247
R + + N+ + V + L LVM+ C G + +++ GRL+ ++ Y
Sbjct: 45 LREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYL 103
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
I + LH+ G+V ++KP N+LLD G ++D+GLA L
Sbjct: 104 RQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--------- 154
Query: 308 IHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
T + +P Y APE L G D WS G L E+ TG P
Sbjct: 155 -------TFVGTPEYMAPEV---------LLGK---GYGKAVDIWSLGVILYELLTGKPP 195
Query: 367 WAG-LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
+ G E+++ + K + P I E +I + L KR T L
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEW----DISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 51/299 (17%)
Query: 138 VKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNLRR 195
++L KKLGEG EV+ G G G+G VAVK + A E E + + L
Sbjct: 1 LELGKKLGEGAFG--EVYKGTLKGDGEGTETK-VAVKTLKEGASEEE------REEFLEE 51
Query: 196 ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADI 250
AS+ + N+ GV L +V + G + ++++ +LTL+ +L+ I
Sbjct: 52 ASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA-AILKKPACRKARPECDSSRIH 309
A+G+ L + V ++ N L+ + +SD+GL+ I + RK
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK----------- 160
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368
L + APE+ F + +SD WSFG L E+ T G P+
Sbjct: 161 --RGGGKLPIKWMAPESL-----KDGKF-------TSKSDVWSFGVLLWEIFTLGEQPYP 206
Query: 369 GLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
G+S EE+ + +LP P+ P EL++++ +C + RPTFS ++
Sbjct: 207 GMSNEEVLELLEDGYRLPRPENC-------PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 43/291 (14%)
Query: 139 KLVKKLGEGRRAGVEVWGA-WIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR-- 195
+L++KLG G + V+ A G G+ VAVK + E S + RR
Sbjct: 2 ELLRKLGSG--SFGTVYKAKHKGTGK-----IVAVKILKKRSEK-----SKKDQTARREI 49
Query: 196 ---ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
+ N+ L LVM+ C G G L+ ++ + I R
Sbjct: 50 RILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILR 109
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH+ G++ ++KP N+LLD +G ++D+GLA L K + +
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGT------- 161
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
P Y APE L G P+ D WS G L E+ TG P++G +
Sbjct: 162 ------PWYMAPEV-------LL----GGNGYGPKVDVWSLGVILYELLTGKPPFSGENI 204
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ + + + P ++ E +I +CL SKRPT +L
Sbjct: 205 LDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 47/128 (36%), Positives = 72/128 (56%), Gaps = 3/128 (2%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
A++ DG+T LHLA G E+V+ +LE +V+ D DG PL A G E V L+
Sbjct: 2 ARDEDGRTPLHLAASNGHLEVVKLLLENG-ADVNAKDNDGRTPLHLAAKNGHLEIVKLLL 60
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
++GA+V +R ++G P H+ A +G D ++ LL GAD NA D +G + LH A +
Sbjct: 61 EKGADVNARDKDGNTP--LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGH 118
Query: 626 TDCAIVIL 633
+ ++L
Sbjct: 119 LEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 46/123 (37%), Positives = 67/123 (54%), Gaps = 11/123 (8%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L +AA H E+V++LL GA+ A+D RT LH+A+ +E+VK++L+
Sbjct: 9 TPLHLAA--SNGHL----EVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEK 62
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA-----DAA 802
G DVN R+ PLH+A G V LLL GAD N +D +G H+AA +
Sbjct: 63 GADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVV 122
Query: 803 KMI 805
K++
Sbjct: 123 KLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 85/284 (29%)
Query: 159 IG-GGQG---RCRHS-----VAVKKVMIAEEMEPDWLSGQLDNLRR-ASMWCR----NVC 204
+G GG G R VA+K ++ + S L+ L R + + N+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI------IKKEDSSSLLEELLREIEILKKLNHPNIV 54
Query: 205 TFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV 263
+GV ++ L LVM+ C GS++ ++ NEG+L+ ++ILR I G+ LH+ G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 264 CMNIKPSNLLLDA-SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYT 322
++KP N+LLD+ +G+ ++D+GL+ +L S + + +P Y
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSD--------------KSLLKTIVGTPAYM 160
Query: 323 APEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKN 382
APE S +SD WS G L E+
Sbjct: 161 APEVLL-----------GKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 383 RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
EL +I + LQ KRP+ +L
Sbjct: 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRAS 197
+ L KKLGEG A EV+ + G G+ + VAVK + + E + LR A
Sbjct: 1 LTLGKKLGEG--AFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASE----QQIEEFLREAR 53
Query: 198 MWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIAR 252
+ + NV GV + L +VM+ G + +++N +L+L +L + IAR
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ L + + ++ N L+ + +SD+GL+ + + D R
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---------RDLYDDDYYRKRGGK 164
Query: 313 DCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGL 370
P + APE+ + F + +SD WSFG L E+ T G P+ G+
Sbjct: 165 -----LPIRWMAPESLK-----EGKF-------TSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 371 SAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
S EE+ + +LP P P EL+ ++ +C RPTFS ++
Sbjct: 208 SNEEVLEYLKNGYRLPQPPNC-------PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 81/379 (21%), Positives = 137/379 (36%), Gaps = 40/379 (10%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLD--NLRRA 196
++++KLGEG EV+ R R VA+K + E + + L + +
Sbjct: 3 RILRKLGEGSFG--EVY-------LARDRKLVALKVLAKKLESKSKEVERFLREIQILAS 53
Query: 197 SMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRN---EGRLTLEQILRYGADIARG 253
N+ + + + L LVM+ G + + +G L+ + L A I
Sbjct: 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVV-SDYGLAAILKKPACRKARPECDSSRIHSCM 312
+ LH+ G++ +IKP N+LLD GR V D+GLA +L P + P S+ +
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG--- 170
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+P Y APE + + S SD WS G TL E+ TG P+ G
Sbjct: 171 -----TPGYMAPEVLLGLSLA---------YASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 373 EEIYRAVVKN------RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
+K L + I + ++ + L R + S+ L+
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 427 LRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPN--NLHQLVSEGDVSGV 484
L +L S + PS + + + +L +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 485 RDLLSKNASGNYSSSISSL 503
++ N SS + S
Sbjct: 337 APNGVSSSPHNSSSLLLST 355
|
Length = 384 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 138 VKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR- 195
+ L KKLGEG A EV+ G G G G+ VAVK + + Q++ R
Sbjct: 1 LTLGKKLGEG--AFGEVYKGTLKGKGDGKEV-EVAVKTLKEDASEQ------QIEEFLRE 51
Query: 196 ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGR-LTLEQILRYGAD 249
A + + N+ GV + L +VM+ G + +++N + L+L +L +
Sbjct: 52 ARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
IARG+ L + + ++ N L+ + +SD+GL+ + + D ++
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---------RDLYDDDYYKVK 162
Query: 310 SCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPW 367
P + APE+ + F + +SD WSFG L E+ T G P+
Sbjct: 163 GGK-----LPIRWMAPESLK-----EGKF-------TSKSDVWSFGVLLWEIFTLGEEPY 205
Query: 368 AGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
G+S E+ + K +LP P P EL+K++ +C RPTFS ++
Sbjct: 206 PGMSNAEVLEYLKKGYRLPKPPNC-------PPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 46/172 (26%)
Query: 607 NAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKR 666
NA D++G + LH A + + + ++LENG + ++ TPLHL
Sbjct: 1 NARDEDGRTPLHLAASNGHLEVVKLLLENGA--DVNAKDNDGRTPLHL------------ 46
Query: 667 WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNR 726
A K H E+V++LL GA+ A+D
Sbjct: 47 ----------------------------AAKNGHL----EIVKLLLEKGADVNARDKDGN 74
Query: 727 TALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
T LH+A+ ++++VK++L G DVN R+ PLH+A G V LLL
Sbjct: 75 TPLHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 4/127 (3%)
Query: 539 DVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRE 598
+ D+DG PL A + G E V L++ GA+V ++ +G P H+ A +G + ++
Sbjct: 1 NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPL--HLAAKNGHLEIVKL 58
Query: 599 LLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVAT 658
LL GAD NA D +G + LH A D ++L++G + + TPLHL
Sbjct: 59 LLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGA--DVNARDKDGRTPLHLAAKN 116
Query: 659 WNVAVVK 665
++ VVK
Sbjct: 117 GHLEVVK 123
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 61/258 (23%), Positives = 109/258 (42%), Gaps = 44/258 (17%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDN----LRRASMWCRNVCTFHGVLR--MDSCLGLVMDRC 223
+AVK V ++ + E + L+ L N+ ++G R + L + ++
Sbjct: 28 MAVKSVELSGDSEEE--LEALEREIRILSSLQ--HPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 224 -YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282
GS+ +++ G+L I +Y I G+ LH+ G+V +IK +N+L+D+ G +
Sbjct: 84 SGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKL 142
Query: 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAI 342
+D+G A L + S +P + APE ++
Sbjct: 143 ADFGCAKRLGDIETGEG--------TGSVRG----TPYWMAPEV---IRGE--------- 178
Query: 343 GISPESDAWSFGCTLVEMCTGSIPWAGL--SAEEIYRAVVKNRKLPPQYASIVGVGIPRE 400
+D WS GCT++EM TG PW+ L +Y+ + + PP+ + E
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--IGSSGEPPEIPE----HLSEE 232
Query: 401 LWKMIGECLQFKASKRPT 418
+ +CL+ KRPT
Sbjct: 233 AKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-22
Identities = 42/113 (37%), Positives = 63/113 (55%), Gaps = 6/113 (5%)
Query: 720 AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
A+D RT LH+A+ +E+VK++L+ G DVN ++ PLH+A G V LLL
Sbjct: 2 ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLE 61
Query: 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
GAD N +D +G+ H+AA NL+ + ++L H A V R+ G+T
Sbjct: 62 KGADVNARDKDGNTPLHLAA-----RNGNLDVVKLLLKH-GADVNARDKDGRT 108
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 8e-22
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 46/161 (28%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
H+ A +G + ++ LL GAD NA D++G + LH A + + ++LE G +
Sbjct: 12 HLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGA--DVNAR 69
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
+ TPLHL N+
Sbjct: 70 DKDGNTPLHLAARNGNL------------------------------------------- 86
Query: 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIIL 745
++V++LL GA+ A+D RT LH+A+ +E+VK++L
Sbjct: 87 -DVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 9e-22
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 58/297 (19%)
Query: 142 KKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWC 200
KKLGEG EV+ G G VAVK + + E + + D L+ A +
Sbjct: 1 KKLGEGAFG--EVYKGKLKGKDGKTTE--VAVK-TLKEDASEEE----RKDFLKEARVMK 51
Query: 201 ----RNVCTFHGVLRMDSCLGLVMDRC-YGSVQ--------LAMQRNEGRLTLEQILRYG 247
NV GV + L LV++ G + + + L+L+ +L +
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
IA+G+ L + V ++ N L+ +SD+GL+ R +
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------RDVYDD----- 158
Query: 308 IHSCMDCTMLSPN-YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSI 365
+ P + APE+ +K +F + +SD WSFG L E+ T G+
Sbjct: 159 DYYRKKTGGKLPIRWMAPES---LKD--GIF-------TSKSDVWSFGVLLWEIFTLGAT 206
Query: 366 PWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
P+ GLS EE+ + K +LP P+Y P EL++++ C Q RPTFS
Sbjct: 207 PYPGLSNEEVLEYLRKGYRLPKPEYC-------PDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277
LV++ G + EGR + E+ Y A+I + LH+ G++ ++KP N+LLDA
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD 129
Query: 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLF 337
G ++D+GLA L + SR ++ C +P Y APE V
Sbjct: 130 GHIKLTDFGLAKELSS----------EGSRTNT--FCG--TPEYLAPE----VLLGK--- 168
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR-KLPPQYASIVGVG 396
G D WS G L EM TG P+ +EIY ++K+ + P
Sbjct: 169 -----GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--------F 215
Query: 397 IPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
+ E +I LQ +KR S H
Sbjct: 216 LSPEARDLISGLLQKDPTKRLG-SGGAEEIKAH 247
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 26/224 (11%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ ++GV + + M+ C G + + L I Y + G+ LH+ G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+V +IKP+N+ LD +G + D+G A LK ++ + + +P Y
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN----------TTTMGEEVQSLAGTPAY 169
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE--IYRAV 379
APE K G +D WS GC ++EM TG PW+ L E ++
Sbjct: 170 MAPEVITGGKGK---------GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
++ P + G + CL+ KRPT S +L
Sbjct: 221 AGHKPPIPDSLQLSPEGK-----DFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 50/239 (20%)
Query: 196 ASMWCRNVCTFHGVLRMDSC-LGLVM------DRCYGSVQLAMQRNEGRLTLEQILRYGA 248
AS+ N+ ++ +D L +VM D + +R + ++I R
Sbjct: 54 ASVNHPNIISYKEAF-LDGNKLCIVMEYAPFGDLSKAISKRKKKRKL--IPEQEIWRIFI 110
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
+ RG+ LH ++ ++K +N+LL A+ + D G++ +LKK +
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----------- 159
Query: 309 HSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
T + +P+Y APE W+ S SD WS GC L EM T + P+
Sbjct: 160 ------TQIGTPHYMAPEVWKGRPYSYK------------SDIWSLGCLLYEMATFAPPF 201
Query: 368 AGLSAEEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
S +++ V + + +PP Y+ ++L I LQ K RP +LA
Sbjct: 202 EARSMQDLRYKVQRGKYPPIPPIYS--------QDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-19
Identities = 77/293 (26%), Positives = 130/293 (44%), Gaps = 54/293 (18%)
Query: 138 VKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRA 196
++L++KLG G+ EVW G W VAVK + M+P D L A
Sbjct: 8 IQLLRKLGAGQFG--EVWEGLWNN------TTPVAVKTLK-PGTMDPK------DFLAEA 52
Query: 197 SMWCR----NVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGR-LTLEQILRYGADI 250
+ + + + V ++ + +V + YGS+ +Q GR L L Q++ A +
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
A G+ L A + ++ N+L+ + V+D+GLA ++K+ +AR
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREG-------- 163
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369
+TAPEA N F S +SD WSFG L E+ T G +P+ G
Sbjct: 164 ----AKFPIKWTAPEA-----ALYNRF-------SIKSDVWSFGILLTEIVTYGRMPYPG 207
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
++ E+ + V + ++P G P+EL+ ++ +C + RPTF +
Sbjct: 208 MTNAEVLQQVDQGYRMPCP------PGCPKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-18
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 692 MAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDV 751
AA + E LV++LL GA+ D TALH+A+ ++E+VK++L+ G DV
Sbjct: 2 HLAAKNGNLE-----LVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADV 54
Query: 752 NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
N ++ LH+A G V LLL GAD N
Sbjct: 55 NAKDKDGNTALHLAARNGNLEIVKLLLEHGADIN 88
|
Length = 91 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-18
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 5/96 (5%)
Query: 515 LHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISR 574
LHLA + G+ ELV+ +LE DV D D L A G+ E V L++ GA+V ++
Sbjct: 1 LHLAAKNGNLELVKLLLEK---GADVNLGDTDTALHLAARNGNLEIVKLLLEHGADVNAK 57
Query: 575 LREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVD 610
++G + H+ A +G + ++ LL GAD N D
Sbjct: 58 DKDGN--TALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 1e-17
Identities = 32/85 (37%), Positives = 50/85 (58%), Gaps = 7/85 (8%)
Query: 729 LHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQD 788
LH+A+ ++ELVK++L+ G DVN+ + LH+A G V LLL GAD N +D
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 789 DEGDNAFHIAA-----DAAKMIREN 808
+G+ A H+AA + K++ E+
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEH 83
|
Length = 91 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 56/302 (18%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRC---RHSVAVKKVMIAEEMEPDWLSGQLDNL 193
D +L++ +G G A V+ A C VA+K++ + E+ + +D L
Sbjct: 2 DYELIEVIGVGATA--VVYAA-------ICLPNNEKVAIKRIDL-EKCQTS-----VDEL 46
Query: 194 RR-ASMWCR----NVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYG 247
R+ + NV ++ + L LVM GS+ M+ + R L++ +
Sbjct: 47 RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII-- 104
Query: 248 ADIARGVVE----LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
A + + V++ LH+ G + +IK N+LL G ++D+G++A L R +
Sbjct: 105 ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK--- 161
Query: 304 DSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ T + +P + APE E V G ++D WSFG T +E+ T
Sbjct: 162 --------VRKTFVGTPCWMAPEVMEQVH-----------GYDFKADIWSFGITAIELAT 202
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVG-IPRELWKMIGECLQFKASKRPTFSA 421
G+ P++ ++ ++N PP + + KMI CLQ SKRPT
Sbjct: 203 GAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
Query: 422 ML 423
+L
Sbjct: 261 LL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-16
Identities = 74/313 (23%), Positives = 125/313 (39%), Gaps = 61/313 (19%)
Query: 480 DVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGS---AELVEAILEYSQE 536
V VR LL+ A N+ G+T LHL S ++V +LE
Sbjct: 26 TVEEVRRLLAAGADVNFRGEY----------GKTPLHLYLHYSSEKVKDIVRLLLEAGA- 74
Query: 537 NVDVLDKDGDPPL-VFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDC 595
+V+ ++ G PL ++ A + + + LIK GA+V ++ + G P ++ ++ P
Sbjct: 75 DVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKVGRTPLHVYLSGFNINPKV 134
Query: 596 MRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655
+R LL GAD NA+D G + L V+L++
Sbjct: 135 IRLLLRKGADVNALDLYGMTPLA------------VLLKSRNA----------------- 165
Query: 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTAL-CMAAALKKDHEVEGRELVRILLTA 714
NV +++ ++ + V+ + L + K + VR L+ A
Sbjct: 166 ----NVELLRLLIDAGADVYAVDDRFR-----SLLHHHLQSFKPRARI-----VRELIRA 211
Query: 715 GAEPTAQDAQNRTALHIASMANDVELVKII--LDAGVDVNIRNVHNTIPLHVALARGAKS 772
G +P A D T LH + + + ++ L AG+ +N RN + PLH A
Sbjct: 212 GCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPR 271
Query: 773 CVGLLLSAGADCN 785
L++ GAD N
Sbjct: 272 ACRRLIALGADIN 284
|
Length = 471 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 64/304 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
++++K+G+G EV+ + R + + VA+K + + + + + + ++ L
Sbjct: 1 LFEILEKIGKG--GFGEVY-------KARHKRTGKEVAIKVIKLESKEKKEKIINEIQIL 51
Query: 194 RRASMWCR--NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADI 250
++ C+ N+ ++G L +VM+ C GS++ ++ LT QI A +
Sbjct: 52 KK----CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI----AYV 103
Query: 251 ARGVVE----LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
+ +++ LH+ G++ +IK +N+LL + G + D+GL+A L R
Sbjct: 104 CKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------- 155
Query: 307 RIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
TM+ +P + APE + ++D WS G T +E+ G
Sbjct: 156 --------TMVGTPYWMAPEVI------------NGKPYDYKADIWSLGITAIELAEGKP 195
Query: 366 PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
P S +A+ K P E + +CLQ KRPT + L
Sbjct: 196 P---YSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPT-AEQL-- 248
Query: 426 FLRH 429
L+H
Sbjct: 249 -LKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 52/229 (22%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYG---SVQLAMQRNEGRLTLE-QILRYGADIARGVVEL 257
N+ ++ L +VM+ G S ++ Q+ EG+ E QIL + + + L
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 258 HAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC--T 315
H+ ++ +IKP N+ L ++G + D+G++ +L S +D T
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----------------SSTVDLAKT 162
Query: 316 ML-SPNYTAPEAWEPV---KKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
++ +P Y +PE + KS D WS GC L E+CT P+ G +
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKS---------------DIWSLGCVLYELCTLKHPFEGEN 207
Query: 372 AEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
E+ ++K +P QY EL ++ LQ +RP+
Sbjct: 208 LLELALKILKGQYPPIPSQY--------SSELRNLVSSLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 46/207 (22%)
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
GS+ +++ G I Y I G+ LH V +IK +N+L+D +G ++D
Sbjct: 87 GSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLAD 145
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344
+G+A + + + K S SP + APE + L
Sbjct: 146 FGMAKQVVEFSFAK-----------SFKG----SPYWMAPEVIAQ-QGGYGL-------- 181
Query: 345 SPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV---VKNRKLPPQYASIVGVGIP--- 398
+D WS GCT++EM TG PW S E AV ++++LPP IP
Sbjct: 182 --AADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPP---------IPDHL 227
Query: 399 -RELWKMIGECLQFKASKRPTFSAMLA 424
E I +CLQ S RPT + +L
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 5e-15
Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 549 LVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNA 608
L A G+ E V L+++GA+V G + H+ A +G + ++ LL GAD NA
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADV----NLGDTDTALHLAARNGNLEIVKLLLEHGADVNA 56
Query: 609 VDDEGESVLHRAVAKKYTDCAIVILENG 636
D +G + LH A + ++LE+G
Sbjct: 57 KDKDGNTALHLAARNGNLEIVKLLLEHG 84
|
Length = 91 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 66/294 (22%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+ L +KLG G EVW G W R VA+K + + ++ ++ L
Sbjct: 5 REEFTLERKLGSGYFG--EVWEGLWKN------RVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLV---MDRCYGSVQLAMQRNEGR-LTLEQILRYGAD 249
+R + +++ + V + + ++ M++ GS+ ++ EG+ L + ++
Sbjct: 57 KR--LRHKHLISLFAVCSVGEPVYIITELMEK--GSLLAFLRSPEGQVLPVASLIDMACQ 112
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
+A G+ L + ++ N+L+ V+D+GLA ++K+ ++
Sbjct: 113 VAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-------------VY 159
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368
D + +TAPEA S +SD WSFG L EM T G +P+
Sbjct: 160 LSSD-KKIPYKWTAPEAASHGTFST------------KSDVWSFGILLYEMFTYGQVPYP 206
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
G++ E+Y + ++P P+E++K++ EC + RP+F A+
Sbjct: 207 GMNNHEVYDQITAGYRMPCPAKC------PQEIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 50/291 (17%)
Query: 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRA----- 196
KKLG+G GV G W G G+ VAVK + + D LS +D+ +
Sbjct: 1 KKLGDGS-FGVVRRGEWSTSG-GK-VIPVAVKCL------KSDKLSDIMDDFLKEAAIMH 51
Query: 197 SMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGV 254
S+ N+ +GV+ L +V + L R + G + + Y IA G+
Sbjct: 52 SLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM 110
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L + + ++ N+LL + + + D+GL +A P+ + D
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLM---------RALPQNE--------DH 153
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
++ + P AW + SL S SD W FG TL EM T G PWAGLS
Sbjct: 154 YVMEEHLKVPFAWCAPE-SLR-----TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
Query: 374 EIYRAVVKN-RKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
+I + + K +L P+ P++++ ++ +C + RPTF+A+
Sbjct: 208 QILKKIDKEGERLERPEAC-------PQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-15
Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 13/102 (12%)
Query: 466 QDNPNN--LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGS 523
+DN LH G + V+ LL K A N A++ DG T LHLA R G+
Sbjct: 36 KDNDGRTPLHLAAKNGHLEIVKLLLEKGADVN----------ARDKDGNTPLHLAARNGN 85
Query: 524 AELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
++V+ +L++ +V+ DKDG PL A G E V L+
Sbjct: 86 LDVVKLLLKHGA-DVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR--LTLEQILRYGADIARGVVELHA 259
N+ GV+ + L +V + + R+ GR +TL Q L + D+ G+ L
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
V ++ N+L+ A VSD+GLA ++A DS + L
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLA--------KEASQGQDSGK---------LPV 163
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRA 378
+TAPEA F S +SD WSFG L E+ + G +P+ + +++
Sbjct: 164 KWTAPEALR-----EKKF-------STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211
Query: 379 VVKNRKL-PPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
V K ++ P+ G P E++K++ +C + +KRPTF
Sbjct: 212 VEKGYRMEAPE-------GCPPEVYKVMKDCWELDPAKRPTF 246
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 40/234 (17%)
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQ-ILRYGADIARG 253
A M N+ F D L +VM+ C G + ++ G+L E IL++ + G
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
V +H V+ +IK N+ L +G+ + D+G A +L P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---------------AYA 157
Query: 314 CTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
CT + +P Y PE WE N+ +++ +SD WS GC L E+CT P+ S
Sbjct: 158 CTYVGTPYYVPPEIWE------NMPYNN------KSDIWSLGCILYELCTLKHPFQANSW 205
Query: 373 EEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
+ + V + + LP Y+ EL +I + + RP+ + +L+
Sbjct: 206 KNLILKVCQGSYKPLPSHYSY--------ELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 3e-14
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 13/103 (12%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G++ V+ LL K A N + TALHLA R G+ E+V+ +L
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGDT------------DTALHLAARNGNLEIVKLLL 48
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISR 574
E+ +V+ DKDG+ L A G+ E V L++ GA++ +
Sbjct: 49 EHGA-DVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLK 90
|
Length = 91 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 63/261 (24%), Positives = 110/261 (42%), Gaps = 46/261 (17%)
Query: 170 VAVKKVMIAEEMEPDWLSGQ-----LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC- 223
VA+K++ + + E S L NL+ N+ + G + L ++++
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHP-----NIVKYIGSIETSDSLYIILEYAE 82
Query: 224 YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283
GS++ +++ G + Y + +G+ LH GV+ +IK +N+L G ++
Sbjct: 83 NGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLA 141
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
D+G+A L S S + +P + APE E G
Sbjct: 142 DFGVATKLND----------VSKDDASVVG----TPYWMAPEVIEMS------------G 175
Query: 344 ISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELW 402
S SD WS GCT++E+ TG+ P+ L+ +V++ P P+ GI EL
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPE-------GISPELK 228
Query: 403 KMIGECLQFKASKRPTFSAML 423
+ +C Q + RPT +L
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-13
Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 58/218 (26%)
Query: 596 MRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI---LENGGCRSMAILNSKE---L 649
+R LL AGAD N + G++ LH + ++ LE G A +N+ E
Sbjct: 30 VRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAG-----ADVNAPERCGF 84
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVR 709
TPLHL + ++++
Sbjct: 85 TPLHLYLYNATTL-------------------------------------------DVIK 101
Query: 710 ILLTAGAEPTAQDAQNRTALHI--ASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
+L+ AGA+ A+D RT LH+ + + ++++++L G DVN +++ PL V L
Sbjct: 102 LLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTPLAVLLK 161
Query: 768 RGAKS--CVGLLLSAGADCNWQDDEGDNAFHIAADAAK 803
+ + LL+ AGAD DD + H + K
Sbjct: 162 SRNANVELLRLLIDAGADVYAVDDRFRSLLHHHLQSFK 199
|
Length = 471 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 71.8 bits (175), Expect = 1e-13
Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
PLH + + +VK + +AS + VN D G T L AAL + E+
Sbjct: 74 RLPLHSAASKGDDKIVK--LLLASGAD-VNAKDADGD--TPL-HLAALNGNPPEGNIEVA 127
Query: 709 RILLTAGAE---PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVA 765
++LL AGA+ +D T LH A++ D ++V+++L+AG D N RN + L A
Sbjct: 128 KLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPA 187
Query: 766 LARGAKSCVGLLLSAGADCNWQDDEGDN 793
G V LLL G + +
Sbjct: 188 AKNGRIELVKLLLDKGLHLSLLKFNLEG 215
|
Length = 235 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 63/291 (21%)
Query: 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNLR 194
+++KLGEG V + H VA+K V + E+++ + ++ L+
Sbjct: 7 ILEKLGEGSYGSVY-----------KAIHKETGQVVAIKVVPVEEDLQE--IIKEISILK 53
Query: 195 RASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARG 253
+ + ++G ++ L +VM+ C GSV M+ LT E+I +G
Sbjct: 54 QCD--SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
+ LH+ + +IK N+LL+ G+A ++D+G++ L K
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRN------------- 157
Query: 314 CTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
T++ +P + APE + IG + ++D WS G T +EM G P++ +
Sbjct: 158 -TVIGTPFWMAPEVIQE------------IGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWK-----MIGECLQFKASKRPT 418
RA+ PP + P E W + +CL +RP+
Sbjct: 205 ---MRAIFMIPNKPPP-----TLSDP-EKWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
L LVM+ G ++ N G L + Y A+I + LH+ G++ ++KP N+
Sbjct: 65 KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124
Query: 273 LLDASGRAVVSDYGLA-AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331
L+D++G ++D+GL+ L + E + RI T P+Y APE
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV----GT---PDYIAPE------ 171
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
+ G S D WS GC L E G P+ G + EEI+ + N K+
Sbjct: 172 -VILGQ-----GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-QNILNGKIEW---- 220
Query: 392 IVGVGIPRELWKMIGECLQFKASKRP 417
V + E +I + L KR
Sbjct: 221 PEDVEVSDEAIDLISKLLVPDPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI--AEEMEPDWLSGQLDNLRRA 196
K++ ++GEG G+ G+ +VA+KKV + E P+ ++ L+
Sbjct: 3 KILGRIGEGA-HGIVFKAKDRETGE-----TVALKKVALRRLEGGIPNQALREIKALQAC 56
Query: 197 SMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVE 256
V V S LVM+ + ++ E L Q+ Y + +GV
Sbjct: 57 Q--HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+HA G++ ++KP+NLL+ A G ++D+GLA + + R + +
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW--------- 165
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
Y APE L + A P D W+ GC E+ GS
Sbjct: 166 ----YRAPE----------LLY-GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 54/250 (21%)
Query: 190 LDNLRRASMWCRNVCTFHG--VLRMDSCLGLVMDRCYGSVQLAM-----QRNEGRLTLEQ 242
L L+ N+ ++ + R + L +VM+ C G LA ++ + E
Sbjct: 53 LRELKH-----PNIVRYYDRIIDRSNQTLYIVMEYCEGG-DLAQLIQKCKKERKYIEEEF 106
Query: 243 ILRYGADIARGVVELHAAG-----VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
I R + + E H V+ ++KP+N+ LDA+ + D+GLA IL
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL------ 160
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
DSS + + +P Y +PE + ++ +D+ SD WS GC +
Sbjct: 161 ----GHDSSFAKTYVG----TPYYMSPE------QLNHMSYDEK------SDIWSLGCLI 200
Query: 358 VEMCTGSIPWAGLSAEEIYRAVV--KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK 415
E+C S P+ + ++ + K R++P +Y+S EL ++I L K
Sbjct: 201 YELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS--------ELNEVIKSMLNVDPDK 252
Query: 416 RPTFSAMLAT 425
RP+ +L
Sbjct: 253 RPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-13
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 33/251 (13%)
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
D K PL A A + + V L+ GA++ S + P + D
Sbjct: 28 NDYSYKKPVLPLYLAKEARNIDVVKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKE 87
Query: 598 --ELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIV-ILENGGCRSMAILNSKELTPLH 653
+LLL GA+ NA D+ G + L A++KK +IV L + G + I NS LH
Sbjct: 88 IVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGAN-VNIKNSDGENLLH 146
Query: 654 LCVATWNVAVVKRWVEVASPE-EIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
L ++E + +I+ ++ + K ++ + V LL
Sbjct: 147 L------------YLESNKIDLKILKLL---------------IDKGVDINAKNRVNYLL 179
Query: 713 TAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKS 772
+ G +D T LH A N+ E VK +LD G + N+ N + PLH+A+ K
Sbjct: 180 SYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKE 239
Query: 773 CVGLLLSAGAD 783
LLL+ G
Sbjct: 240 IFKLLLNNGPS 250
|
Length = 422 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 25/69 (36%), Positives = 43/69 (62%), Gaps = 6/69 (8%)
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
TAL AA + E+ V++LL GA+ A+D TALH+A+ ++E+VK++L+
Sbjct: 29 DTAL-HLAARNGNLEI-----VKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLE 82
Query: 747 AGVDVNIRN 755
G D+N+++
Sbjct: 83 HGADINLKD 91
|
Length = 91 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 69.5 bits (169), Expect = 8e-13
Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 21/193 (10%)
Query: 690 LCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGV 749
L + AL + L I A+D R LH A+ D ++VK++L +G
Sbjct: 41 LYLELALLPAASLSELLLKLI---VDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGA 97
Query: 750 DVNIRNVHNTIPLHVALARGAKS-----CVGLLLSAGADC---NWQDDEGDNAFHIAADA 801
DVN ++ PLH+A G LLL AGAD N +D++G+ H AA
Sbjct: 98 DVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAA-- 155
Query: 802 AKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861
+ + + + ++L A RN G T D R +L++ L+++G+HLS
Sbjct: 156 ---LNGDADIVELLLEAG-ADPNSRNSYGVTALDPAAKNGR----IELVKLLLDKGLHLS 207
Query: 862 PTIFEIGDWVKFK 874
F +
Sbjct: 208 LLKFNLEGVANAN 220
|
Length = 235 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 64/288 (22%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMW 199
++KK+GEG + ++ + H V +K++ + + + + + + + A M
Sbjct: 4 IIKKIGEGSFGKI-----YLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 200 CRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLE-QILRYGADIARGVVEL 257
N+ TF + + L +VM+ C G + + R G L E QIL + I+ G+ +
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 258 HAAGVVCMNIKPSNLLLDASGR-AVVSDYGLAAILKKPACRKARPECDSSRI-HSCMDCT 315
H ++ +IK N+ L +G A + D+G+A L DS + ++C+
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-----------DSMELAYTCVG-- 164
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
+P Y +PE + + N ++D WS GC L E+CT P+ G + ++
Sbjct: 165 --TPYYLSPEICQ--NRPYN----------NKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
Query: 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ + P + R+L +I + + RP+ +++L
Sbjct: 211 VLKICQGYFAP------ISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-12
Identities = 47/183 (25%), Positives = 94/183 (51%), Gaps = 16/183 (8%)
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTAL 690
+I G C ++++ + TPL + + + +V+ +++ + +N IP P+ TA+
Sbjct: 20 IIKNKGNCINISV--DETTTPLIDAIRSGDAKIVELFIKHGADINHINT-KIPHPLLTAI 76
Query: 691 CMAA----ALKKDHEVE---------GRELVRILLTAGAEPTAQDAQNRTALHIASMAND 737
+ A L D+ V+ +++++ +L G + +DA+ +T LH A D
Sbjct: 77 KIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGD 136
Query: 738 VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHI 797
+E +K++ + G DVNI + + P+H+A+ + LLL GA N +D+ G++ H
Sbjct: 137 LESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHN 196
Query: 798 AAD 800
AA+
Sbjct: 197 AAE 199
|
Length = 434 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 35/235 (14%)
Query: 204 CTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGV 262
TF + L V++ G + +++ G L + Y A+I + LH+ G+
Sbjct: 69 YTFQD----EENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGI 123
Query: 263 VCMNIKPSNLLLDASGRAVVSDYGLAAIL---KKPACRKARPECDSSRIHSCMDCTMLS- 318
+ ++KP N+LLD ++D+G A +L P K S+I S
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK-NRRRFASF 182
Query: 319 ---PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
Y +PE LN + SD W+ GC + +M TG P+ G +
Sbjct: 183 VGTAEYVSPEL-------LN----EKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 376 YRAVVK-NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
++ ++K PP P + +I + L R + H
Sbjct: 231 FQKILKLEYSFPP--------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 40/191 (20%)
Query: 233 RNEGR--LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
R GR +++ Q+L++ D+A G+ L + +V ++ N+L+ G A VSD+GLA +
Sbjct: 90 RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
D + L +TAPEA + K S +SD
Sbjct: 150 GSMGV-----------------DNSKLPVKWTAPEALKHKK------------FSSKSDV 180
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGEC 408
WS+G L E+ + G P+ +S +E+ V K ++ PP+ G P +++ ++ C
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE-------GCPADVYVLMTSC 233
Query: 409 LQFKASKRPTF 419
+ + KRP+F
Sbjct: 234 WETEPKKRPSF 244
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 216 LGLVMDRCY-GSVQ--LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
L +VM+ G + L MQR L +Q+ R+ I G+ LH+ ++ +IK NL
Sbjct: 74 LNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVK 331
LDA + D G+A +L A T++ +P Y +PE E
Sbjct: 133 FLDAYDNVKIGDLGVAKLL-SDNTNFAN--------------TIVGTPYYLSPELCE--D 175
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
K N +SD W+ G L E CTG P+ + + +++ PP
Sbjct: 176 KPYN----------EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-FPP---- 220
Query: 392 IVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
V ++L ++I +CL +RP +L
Sbjct: 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQL----DNL 193
+KLVKKLG G+ EVW + VAVK ++P +S Q NL
Sbjct: 8 IKLVKKLGAGQFG--EVWMGYYNNST-----KVAVKT------LKPGTMSVQAFLEEANL 54
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIAR 252
+ + V + V + + + GS+ ++ +EG ++ L +++ + A IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ + + +++ +N+L+ S ++D+GLA +++ ++
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-------------YTAR 161
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371
+ +TAPEA +N + +SD WSFG L E+ T G IP+ G+S
Sbjct: 162 EGAKFPIKWTAPEA-------INFG-----SFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
++ A+ + ++P P EL+ ++ C + KA +RPTF
Sbjct: 210 NSDVMSALQRGYRMPRME------NCPDELYDIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 66.4 bits (161), Expect = 1e-11
Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 58/270 (21%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKD--GDPPLVFALAAGSPECVHALIKRGAN 570
L + LV +L S + + DK L AA E + LI
Sbjct: 7 ALLLINKCFLDLLLVALLLLLSLDLSNPSDKKLNLYLELALLPAASLSELLLKLIVDRHL 66
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
R+ G H A G ++ LL +GAD NA D +G++ LH A
Sbjct: 67 ---AARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALN------- 116
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTAL 690
+ N+ V K +E + ++ N+ D G T L
Sbjct: 117 --------------GNPPEG---------NIEVAKLLLEAGADLDVNNLRDEDGN--TPL 151
Query: 691 CMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD---- 746
AA ++V +LL AGA+P ++++ TAL A+ +ELVK++LD
Sbjct: 152 HWAAL------NGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKGLH 205
Query: 747 -----------AGVDVNIRNVHNTIPLHVA 765
A +V+ RN+ N L +A
Sbjct: 206 LSLLKFNLEGVANANVSKRNILNLTSLIIA 235
|
Length = 235 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 67/289 (23%), Positives = 126/289 (43%), Gaps = 47/289 (16%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLD--NLRR 195
+KL KKLG G+ EVW A +H+ K M M + L N+ +
Sbjct: 8 LKLEKKLGAGQFG--EVWMATYN------KHTKVAVKTMKPGSMS---VEAFLAEANVMK 56
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGV 254
+ + H V+ + + GS+ ++ +EG + L +++ + A IA G+
Sbjct: 57 T-LQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
+ + +++ +N+L+ AS ++D+GLA +++ ++ +
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-------------YTAREG 162
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
+TAPEA + + +SD WSFG L+E+ T G IP+ G+S
Sbjct: 163 AKFPIKWTAPEAI------------NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
Query: 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
E+ RA+ + ++P P EL+ ++ C + + +RPTF +
Sbjct: 211 EVIRALERGYRMPRPENC------PEELYNIMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L LVM+ G ++ + G L + +Y A++ GV +LH G++ +IKP NLL+D
Sbjct: 72 LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
+G ++D+GL SR + +P+Y APE
Sbjct: 132 QTGHLKLTDFGL------------------SRNGLENKKFVGTPDYLAPETIL------- 166
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
+G SD WS GC + E G P+ + + ++ ++ R
Sbjct: 167 -----GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 76/304 (25%), Positives = 134/304 (44%), Gaps = 62/304 (20%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRAS 197
+KLVKKLG G+ EVW + G VA+K + M P+ + NL +
Sbjct: 8 LKLVKKLGAGQFG--EVWMGYYNGHT-----KVAIKS-LKQGSMSPEAFLAEA-NLMKQL 58
Query: 198 MWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVE 256
R V + V+ + + GS+ ++ EG +LT+ +++ A IA G+
Sbjct: 59 QHPRLV-RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+ + +++ +N+L+ + ++D+GLA +++
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIE------------------------ 153
Query: 317 LSPNYTAPE-AWEPVKKSLNLFWD--DAIG---ISPESDAWSFGCTLVEMCT-GSIPWAG 369
YTA E A P+K W +AI + +SD WSFG L E+ T G IP+ G
Sbjct: 154 -DNEYTAREGAKFPIK------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
Query: 370 LSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
++ E+ + + + ++P P P EL++++ C + K +RPTF +LR
Sbjct: 207 MTNPEVIQNLERGYRMPRPD-------NCPEELYELMRLCWKEKPEERPTFE-----YLR 254
Query: 429 HLQE 432
+ E
Sbjct: 255 SVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 60/308 (19%)
Query: 138 VKLVKKLGEGRRAGVEVWGAW--IGGGQGRCRHSVAVKKVMIAEEMEPDWLSG---QLDN 192
+K +K+LGEG VE+ + +G G VAVK + E S +++
Sbjct: 6 LKFIKQLGEGHFGKVEL-CRYDPLGDNTGE---QVAVK--SLNHSGEEQHRSDFEREIEI 59
Query: 193 LRRASMWCRNVCTFHGVLRMDSC--LGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
LR N+ + GV L L+M+ GS++ +QR+ ++ L+++L + +
Sbjct: 60 LRTLDH--ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I +G+ L + + ++ N+L+++ +SD+GLA +L + E S I
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT------- 362
+ APE + F S SD WSFG TL E+ T
Sbjct: 178 -----------WYAPECL-----RTSKF-------SSASDVWSFGVTLYELFTYGDPSQS 214
Query: 363 --------GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
I + + + + +LP P E++ ++ C + +
Sbjct: 215 PPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP------PSCPDEVYDLMKLCWEAEPQ 268
Query: 415 KRPTFSAM 422
RP+F+ +
Sbjct: 269 DRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 39/170 (22%)
Query: 220 MDRCY--------GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
MDR Y G + +Q+ G+ + Y A+IA G+ LH+ G++ ++K N
Sbjct: 73 MDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPE--AWEP 329
++LDA G ++D+G+ C++ ++R C +P+Y APE A++P
Sbjct: 132 VMLDAEGHIKIADFGM--------CKENIFGGKTTRTF----CG--TPDYIAPEIIAYQP 177
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
KS+ D W+FG L EM G P+ G +E+++++
Sbjct: 178 YGKSV--------------DWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 72/316 (22%), Positives = 123/316 (38%), Gaps = 73/316 (23%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIA-EEMEPDWLSGQL 190
D++ VK LG+G V + RH A+KK+ + +E L +L
Sbjct: 2 DLERVKVLGQGSSGVVY-----------KVRHKPTGKIYALKKIHVDGDEEFRKQLLREL 50
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCY---GSVQLAMQRNEGRLTLEQILRYG 247
LR V +G + + +V++ Y GS+ +++ E +L
Sbjct: 51 KTLRSCE--SPYVVKCYGAFYKEGEISIVLE--YMDGGSLADLLKKVGK--IPEPVL--- 101
Query: 248 ADIAR----GVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
A IAR G+ LH ++ +IKPSNLL+++ G ++D+G++ +L
Sbjct: 102 AYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLD--- 155
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
++ + + Y +PE + S +D WS G TL+E
Sbjct: 156 QCNTFVGTVT--------YMSPERIQGESYSYA------------ADIWSLGLTLLECAL 195
Query: 363 GSIPWA---GLSAEEIYRAVVKNRK--LPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
G P+ S E+ +A+ LP + S E I CLQ KRP
Sbjct: 196 GKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP-------EFRDFISACLQKDPKKRP 248
Query: 418 TFSAMLAT-FLRHLQE 432
+ + +L F++
Sbjct: 249 SAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 40/201 (19%)
Query: 211 RMDSCLGLVMDRCY--------GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGV 262
++ SC MDR Y G + +Q+ GR + Y A+IA G+ LH+ G+
Sbjct: 65 QLHSCFQ-TMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 263 VCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYT 322
+ ++K N++LD+ G ++D+G+ C++ + +++ C +P+Y
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGM--------CKENMWDGVTTKTF----CG--TPDYI 168
Query: 323 APE--AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
APE A++P KS+ D W+FG L EM G P+ G +E++++++
Sbjct: 169 APEIIAYQPYGKSV--------------DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
Query: 381 KNRKLPPQYASIVGVGIPREL 401
++ P+ S V I + L
Sbjct: 215 EHNVAYPKSMSKEAVAICKGL 235
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-11
Identities = 88/366 (24%), Positives = 153/366 (41%), Gaps = 68/366 (18%)
Query: 504 LKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA 563
+ A++ T +H A RG+A++V +L Y + V+++ D L A+ + + + + A
Sbjct: 171 VNAKDIYCITPIHYAAERGNAKMVNLLLSYGAD-VNIIALDDLSVLECAVDSKNIDTIKA 229
Query: 564 LIKRGANV----ISRLREGFGPSVAHVCAYHGQPDCMRELLL--AGADPNAVDDEGESVL 617
+I +N+ +S L+ D LLL AG N++DD + L
Sbjct: 230 IIDNRSNINKNDLSLLKA------------IRNEDLETSLLLYDAGFSVNSIDDCKNTPL 277
Query: 618 HRAV-AKKYTDCAIVILENGGCRSMAILNSKEL---TPLHLCVA----TWNV-AVVKRWV 668
H A A + +LE G A +N+K + TPL+L T N+ ++
Sbjct: 278 HHASQAPSLSRLVPKLLERG-----ADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332
Query: 669 EVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTA 728
+V + + + T L A+ L ++ +++V LL GA A+D ++T
Sbjct: 333 DVNAADRLYI---------TPLHQASTLDRN-----KDIVITLLELGANVNARDYCDKTP 378
Query: 729 LHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVAL-ARGAKSCVGLLLSAGADCNWQ 787
+H A++ N+V ++ +LD G D+ + LH AL V L+ GA+ N +
Sbjct: 379 IHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSK 438
Query: 788 DDEGDNAFHIAA------DAAKM------------IRENLEWLIVMLSHPDAAVEVRNHS 829
+ + H A D +M I+ LI + H V + H
Sbjct: 439 NKDLSTPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYPLLIALEYH--GIVNILLHY 496
Query: 830 GKTLRD 835
G LRD
Sbjct: 497 GAELRD 502
|
Length = 682 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 30/167 (17%)
Query: 239 TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP--AC 296
T E + Y A++A + LH+ G++ ++KP N+LLD G ++D+GL+ K+
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS---KESIDHE 152
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+KA C + Y APE V + G + +D WSFG
Sbjct: 153 KKAYSFCGTVE-------------YMAPEV---VNRR---------GHTQSADWWSFGVL 187
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK 403
+ EM TGS+P+ G +E ++K + PQ+ S + R L+K
Sbjct: 188 MFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK 234
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 73/307 (23%), Positives = 130/307 (42%), Gaps = 61/307 (19%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+KL +KLG G+ EVW G W G + VAVK + M P+ L
Sbjct: 5 RESLKLERKLGAGQFG--EVWMGTWNGTTK------VAVK-TLKPGTMSPE------AFL 49
Query: 194 RRASMW--CR--NVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGR-LTLEQILRYG 247
+ A + R + + V + + +V + GS+ ++ EG+ L L Q++
Sbjct: 50 QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
A IA G+ L + + ++ N+L+ + ++D+GLA +++
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE-------------DD 156
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
++ + +TAPEA + F + +SD WSFG L E+ T G +P
Sbjct: 157 EYTAREGAKFPIKWTAPEA-----ANYGRF-------TIKSDVWSFGILLTEIVTYGRVP 204
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+ G++ E+ V + ++P P P EL+ ++ +C +RPTF
Sbjct: 205 YPGMTNREVLEQVERGYRMPRPP-------NCPEELYDLMLQCWDKDPEERPTFE----- 252
Query: 426 FLRHLQE 432
+L+ E
Sbjct: 253 YLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 40/201 (19%)
Query: 211 RMDSCLGLVMDRCY--------GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGV 262
++ SC V DR Y G + +Q+ G+ Q + Y A+I+ G+ LH G+
Sbjct: 65 QLHSCFQTV-DRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 263 VCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYT 322
+ ++K N++LD+ G ++D+G+ C++ + ++R C +P+Y
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGM--------CKEHMVDGVTTRTF----CG--TPDYI 168
Query: 323 APE--AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
APE A++P KS+ D W++G L EM G P+ G +E++++++
Sbjct: 169 APEIIAYQPYGKSV--------------DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 381 KNRKLPPQYASIVGVGIPREL 401
++ P+ S V I + L
Sbjct: 215 EHNVSYPKSLSKEAVSICKGL 235
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 70/322 (21%), Positives = 134/322 (41%), Gaps = 80/322 (24%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---------VAVKKVMIAEEMEPDWLSG 188
+K ++ LGEG VE+ CR+ VAVK ++P+
Sbjct: 6 LKRIRDLGEGHFGKVEL-----------CRYDPEGDNTGEQVAVK------SLKPESGGN 48
Query: 189 QLDNLRRA-----SMWCRNVCTFHGVLRMD--SCLGLVMDRC-YGSVQLAMQRNEGRLTL 240
+ +L++ +++ N+ + G+ D + + L+M+ GS++ + RN+ ++ L
Sbjct: 49 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108
Query: 241 EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA-AILKKPACRKA 299
+Q L+Y I +G+ L + V ++ N+L+++ + + D+GL AI
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
+ + DS +C + S Y A SD WSFG TL E
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIA------------------------SDVWSFGVTLYE 204
Query: 360 MCT----GSIPWA-----------GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKM 404
+ T S P ++ + R + + ++LP P E++++
Sbjct: 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP------RPPNCPEEVYQL 258
Query: 405 IGECLQFKASKRPTFSAMLATF 426
+ +C +F+ SKR TF ++ F
Sbjct: 259 MRKCWEFQPSKRTTFQNLIEGF 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 37/204 (18%)
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
GSV A+ N G + + I +G+ LH G++ +IK +N+L+D G +SD
Sbjct: 91 GSVA-ALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149
Query: 285 YGLAAILK----KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD 340
+G++ L+ ARP S + APE VK++
Sbjct: 150 FGISKKLEANSLSTKTNGARPSLQGSVF------------WMAPEV---VKQTSY----- 189
Query: 341 AIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-EEIYRAVVKNRKLPPQYASIVGVGIPR 399
+ ++D WS GC +VEM TG P+ + + I++ P S
Sbjct: 190 ----TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS------- 238
Query: 400 ELWKMIGECLQFKASKRPTFSAML 423
E + + + +KRPT + +L
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 55/306 (17%)
Query: 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVK----KVMIAEEMEPDWLSGQLD 191
K +K LG+G V + R K KV+ +EM +
Sbjct: 1 KHFKKIKLLGKGDVGRVFL-----------VRLKGTGKLFALKVLDKKEMIKR------N 43
Query: 192 NLRRASMWCRNVC---------TFHGVLRMDSCLGLVMDRCYG-SVQLAMQRNEGRLTLE 241
++R + + T + + ++ L LVMD C G + +QR G+ E
Sbjct: 44 KVKRVL-TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSE 102
Query: 242 QILR-YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
++ R Y A++ + LH G+V ++KP N+LL SG ++SD+ L+ K+
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS---KQSDVEPPP 159
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPE----------SDA 350
+ P+ T E EP +S N F I+PE D
Sbjct: 160 VSKALRKGSRRSS-VNSIPSETFSE--EPSFRS-NSFVGTEEYIAPEVISGDGHGSAVDW 215
Query: 351 WSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQ 410
W+ G L EM G+ P+ G + +E + ++K P + +I + L
Sbjct: 216 WTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS-----PPVSSSARDLIRKLLV 270
Query: 411 FKASKR 416
SKR
Sbjct: 271 KDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 74/309 (23%), Positives = 123/309 (39%), Gaps = 63/309 (20%)
Query: 137 DVKLVKKLGEGRRAGV-EVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ L+++LG+G V E + G+ R VA+K V M +++ L
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETR--VAIKTVNENASM-----RERIEFLNE 59
Query: 196 ASMW----CRNVCTFHGVLRMDSCLGLVMD-------RCYGSVQLAMQRNEGR------- 237
AS+ C +V GV+ +VM+ + Y L +R E
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY----LRSRRPEAENNPGLGP 115
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-ILKKPAC 296
TL++ ++ A+IA G+ L A V ++ N ++ + D+G+ I +
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
RK +L + APE SL D + + +SD WSFG
Sbjct: 176 RKGGK-------------GLLPVRWMAPE-------SLK----DGV-FTTKSDVWSFGVV 210
Query: 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK 415
L EM T P+ GLS EE+ + V+ L P +L +++ C Q+
Sbjct: 211 LWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKM 264
Query: 416 RPTFSAMLA 424
RPTF +++
Sbjct: 265 RPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
GS+ ++++ L +++L + IA+G+ L +V N+ N+LL + ++D
Sbjct: 93 GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344
+G+A +L P +K Y E P+K W I
Sbjct: 153 FGVADLLY-PDDKK----------------------YFYSEHKTPIK------WMALESI 183
Query: 345 -----SPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGI 397
+ +SD WS+G T+ EM + G+ P+AG+ E+ + K +L PQ +I
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI----- 238
Query: 398 PRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435
+++ ++ +C + RPTF + F R ++ PR
Sbjct: 239 --DVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-10
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+ L + Y A+I G+ LH+ G+V ++K N+LLD G ++D+G+
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM--------- 142
Query: 297 RKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
C + + CT +P+Y APE K + ++ W WSFG
Sbjct: 143 ------CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW------------WSFGV 184
Query: 356 TLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
L EM G P+ G EE+++++ + P++ +
Sbjct: 185 LLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLT 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 40/301 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDN-LRRAS 197
+ +K LG G V G WI G+ VA+K ++ EE P LD AS
Sbjct: 10 EKIKVLGSGAFGTVYK-GVWIPEGEKVK-IPVAIK--VLREETSPKANKEILDEAYVMAS 65
Query: 198 MWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVE 256
+ +V G+ + S + L+ G + ++ ++ + + +L + IA+G+
Sbjct: 66 VDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
L +V ++ N+L+ ++D+GLA +L + D H+ +
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----------DVDEKEYHA--EGGK 172
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEI 375
+ + A E S+ + +SD WS+G T+ E+ T G+ P+ G+ A EI
Sbjct: 173 VPIKWMALE-------SILHR-----IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
Query: 376 YRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434
+ K +LP P +I +++ ++ +C A RPTF ++ F + ++
Sbjct: 221 PDLLEKGERLPQPPICTI-------DVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273
Query: 435 R 435
R
Sbjct: 274 R 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 65/276 (23%), Positives = 98/276 (35%), Gaps = 63/276 (22%)
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-ILK 292
N G L+ + Y A++ V LH G + ++KP N L+DASG ++D+GL+ I+
Sbjct: 94 NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV- 152
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
+ +S + SP+Y APE G D WS
Sbjct: 153 -------------TYANSVVG----SPDYMAPEVLR------------GKGYDFTVDYWS 183
Query: 353 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGECL- 409
GC L E G P++G + E + + ++ P Y + E W +I + +
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFNLSDEAWDLITKLIN 242
Query: 410 ----------QFKASKRPTFSAMLATFLRHLQELPRSPPASP------DTG-FTKFSTSN 452
K P F + LR L PP P DTG F F
Sbjct: 243 DPSRRFGSLEDIK--NHPFFKEVDWNELREL-----KPPFVPELESEIDTGYFDDF---- 291
Query: 453 ETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVRDLL 488
E E A +V + + D R +
Sbjct: 292 ENEDDMAKYKDVHEKKKAAGKGGANGRDPGNRRKFV 327
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 32/150 (21%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK--KPA 295
L +E+++ Y A I G++ LH+ +V ++KP N+LLD G +SD GLA LK K
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI 151
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
++A + Y APE + S + W ++ GC
Sbjct: 152 TQRAG-----------------TNGYMAPEILKEEPYSYPVDW------------FAMGC 182
Query: 356 TLVEMCTGSIPWAGLSAEEIYRAVVKNRKL 385
++ EM G P+ E++ + +K R L
Sbjct: 183 SIYEMVAGRTPFKDHK-EKVAKEELKRRTL 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 40/266 (15%)
Query: 164 GRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR-NVCTFHGVLRMDSCLGLV 219
GR R VAVK E + PD + L R + N+ GV + +V
Sbjct: 14 GRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71
Query: 220 MDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
M+ G L R EG RL ++++++ + A G+ L + + ++ N L+
Sbjct: 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN 131
Query: 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLF 337
+SD+G++ R E D +++ P +TAPEA +
Sbjct: 132 VLKISDFGMS-----------REEEDG--VYASTGGMKQIPVKWTAPEALNYGR------ 172
Query: 338 WDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVG 396
S ESD WSFG L E + G++P+A LS ++ A+ + +LP
Sbjct: 173 ------YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC----- 221
Query: 397 IPRELWKMIGECLQFKASKRPTFSAM 422
P +++++ C ++ +RP+FS +
Sbjct: 222 -PDAVYRLMERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 28/191 (14%)
Query: 203 VCTFHGVLR--MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
+ ++G LR M+ L + M+ G ++ G LT +Y I GV LH+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
+V +IK +N+L D+ G + D+G A ++ + C S + M +P
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFG--------ASKRLQTICLSG---TGMKSVTGTPY 174
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-EEIYRAV 379
+ +PE G ++D WS GCT+VEM T PWA A I++
Sbjct: 175 WMSPEVIS------------GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222
Query: 380 VK--NRKLPPQ 388
+ N LPP
Sbjct: 223 TQPTNPVLPPH 233
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 34/225 (15%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGS--VQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
N+ ++ D+ L + M+ G +++ E +L Y I V +H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
AG++ +IK N+ L +G + D+G++ IL + S + + +P
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS----------EYSMAETVVG----TP 165
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
Y +PE + VK + +SD W+ GC L E+ T + + + +
Sbjct: 166 YYMSPELCQGVKYNF------------KSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
V+ Y +V EL ++ LQ KRPT +L
Sbjct: 214 VQG-----NYTPVVS-VYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 70/291 (24%), Positives = 129/291 (44%), Gaps = 63/291 (21%)
Query: 159 IGGGQ------------GRCRHSVAVK--KVMIAEEMEPDWLS-----GQLDNLRRASMW 199
IGGG+ G+ VA+K K +++ D+L+ GQ D+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH------- 64
Query: 200 CRNVCTFHGVLRMDSCLGLVMDRCY---GSVQLAMQRNEGRLTLEQILRYGADIARGVVE 256
N+ GV+ + ++ + Y GS+ ++ N+G+ T+ Q++ IA G+
Sbjct: 65 -PNIIRLEGVVTKSRPVMIITE--YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
L V ++ N+L++++ VSD+GL+ L+ +A +I
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS---EATYTTKGGKI-------- 170
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEI 375
+TAPEA K + SD WSFG + E+ + G P+ +S +++
Sbjct: 171 -PIRWTAPEAIAYRK------------FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV 217
Query: 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
+AV +LPP + P L++++ +C Q ++RPTFS +++T
Sbjct: 218 IKAVEDGYRLPPP------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 60/284 (21%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR----NVCTFHGVLRMDSCLGLVMDRCYG 225
VA+KK+ + E E LR + N+ V R L LV +
Sbjct: 27 VAIKKIKLRFESEGI----PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82
Query: 226 SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285
+ ++ + L I Y + +G+ H+ G++ ++KP NLL++ G ++D+
Sbjct: 83 DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADF 142
Query: 286 GLAAILKKPACRKARPECD--SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
GLA P RP +R Y APE L D G
Sbjct: 143 GLARSFGSP----VRPYTHYVVTRW------------YRAPEL---------LLGDK--G 175
Query: 344 ISPESDAWSFGCTLVEMCTGSIPWAGLS-AEEIYR-------------AVVKNRKLP--P 387
S D WS GC E+ + + G S +++++ +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 388 QYASIVGVGIPR-------ELWKMIGECLQFKASKRPTFSAMLA 424
+ G+ +P+ + ++ + L + KR T LA
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 56/227 (24%), Positives = 85/227 (37%), Gaps = 46/227 (20%)
Query: 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCM 265
++G LR D L + M+ G + G LT +Y I GV LH+ +V
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 266 NIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLS-----P 319
+IK +N+L D++G + D+G S R+ + C T + P
Sbjct: 129 DIKGANILRDSAGNVKLGDFG-----------------ASKRLQTICSSGTGMKSVTGTP 171
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+ +PE G ++D WS GCT+VEM T PWA A +
Sbjct: 172 YWMSPEVI------------SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219
Query: 380 VK---NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
N +LP + R + A KRP+ +L
Sbjct: 220 ATQPTNPQLPSHVSPDA-----RNFLRR---TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 7e-10
Identities = 72/275 (26%), Positives = 109/275 (39%), Gaps = 57/275 (20%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR------MDSCLGLVMDRC 223
VA+K +M E E + + + + LR+ S N+ TF+G D L LVM+ C
Sbjct: 34 VAIK-IMDIIEDEEEEIKEEYNILRKYSNH-PNIATFYGAFIKKNPPGNDDQLWLVMELC 91
Query: 224 YGS-----VQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
G V+ ++ + RL E I + RG+ LH V+ +IK N+LL +
Sbjct: 92 GGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA 150
Query: 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPV---KKSLN 335
+ D+G++A L R ++ + +P + APE V + +
Sbjct: 151 EVKLVDFGVSAQLDST----------LGRRNTFIG----TPYWMAPE----VIACDEQPD 192
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK-NRKLPPQYASIVG 394
+D SD WS G T +E+ G P L RA+ K R PP S
Sbjct: 193 ASYDA------RSDVWSLGITAIELADGKPP---LCDMHPMRALFKIPRNPPPTLKS--- 240
Query: 395 VGIPRELWK-----MIGECLQFKASKRPTFSAMLA 424
E W I ECL +RP +L
Sbjct: 241 ----PENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 60.6 bits (146), Expect = 8e-10
Identities = 36/204 (17%), Positives = 72/204 (35%), Gaps = 15/204 (7%)
Query: 413 ASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPN-- 470
+ FL L + + + + E + + +
Sbjct: 2 KPSLSALLLINKCFLDLLLVALLLLLSLDLSNPSDKKLNLYLELALLPAASLSELLLKLI 61
Query: 471 ----NLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGS--- 523
+ + + + + + A++ADG T LHLA G+
Sbjct: 62 VDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPE 121
Query: 524 --AELVEAILEY--SQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGF 579
E+ + +LE + ++ D+DG+ PL +A G + V L++ GA+ SR G
Sbjct: 122 GNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGV 181
Query: 580 GPSVAHVCAYHGQPDCMRELLLAG 603
+ A +G+ + ++ LL G
Sbjct: 182 --TALDPAAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 9e-10
Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 204 CTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV 263
CTF + L VM+ G + +++GR L + Y A+I G+ LH+ G++
Sbjct: 63 CTF----QTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 264 CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTA 323
++K N++LD G ++D+G+ K D+ C +P+Y A
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMC---------KENVFGDNRASTFCG-----TPDYIA 164
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
PE + +K + ++ W WSFG L EM G P+ G +E++ ++ R
Sbjct: 165 PEILQGLKYTFSVDW------------WSFGVLLYEMLIGQSPFHGDDEDELFESI---R 209
Query: 384 KLPPQY 389
P Y
Sbjct: 210 VDTPHY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-10
Identities = 56/241 (23%), Positives = 109/241 (45%), Gaps = 42/241 (17%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYG-SVQLAMQRNEGRLTLEQILRYGADIARGVVE---- 256
N+ ++G L ++M+ G SV+ M+ + + +Y + I R V+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAE--KYISVIIREVLVALKY 116
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+H GV+ +IK +N+L+ +G + D+G+AA+L + +S S T
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-----------NSSKRSTFVGT- 164
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
P + APE K ++D ++D WS G T+ EM TG+ P++ + A
Sbjct: 165 --PYWMAPEVITEGK-----YYD------TKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
Query: 377 RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRHLQELPR 435
+ K++ PP+ + G + L + + CL + +R + +L + +++ + P
Sbjct: 212 MLIPKSK--PPR---LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266
Query: 436 S 436
S
Sbjct: 267 S 267
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-09
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 10/84 (11%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
H+ A +G + ++ LL GAD N D + + LH A + ++LE+G A +
Sbjct: 2 HLAAKNGNLELVKLLLEKGADVNLGDTD--TALHLAARNGNLEIVKLLLEHG-----ADV 54
Query: 645 NSKEL---TPLHLCVATWNVAVVK 665
N+K+ T LHL N+ +VK
Sbjct: 55 NAKDKDGNTALHLAARNGNLEIVK 78
|
Length = 91 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-09
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 38/276 (13%)
Query: 485 RDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKD 544
+ + K + Y L L+LA + ++V+ +L+ +++ K+
Sbjct: 9 KSRIIKVKNIKYIIMEDDLNDYSYKKPVLPLYLAKEARNIDVVKILLDNGA-DINSSTKN 67
Query: 545 GDPPLVFALAAGS-----PECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMREL 599
PL + E V L++ GANV + G P + + + L
Sbjct: 68 NSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYL 127
Query: 600 LLAGADPNAVDDEGESVLHRAVAKKYTDCAIV--ILENGGCRSMAILNSKELTPLHLCVA 657
L GA+ N + +GE++LH + D I+ +++ G +N+K
Sbjct: 128 LDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKG-----VDINAKN--------- 173
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
V + P +N+ D+ G T L A ++ E V+ LL GA
Sbjct: 174 -----RVNYLLSYGVP---INIKDVYG--FTPLHYAV--YNNNP----EFVKYLLDLGAN 217
Query: 718 PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNI 753
P + T LHIA + N+ E+ K++L+ G +
Sbjct: 218 PNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKT 253
|
Length = 422 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 37/203 (18%)
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
GS+ +++ + RLT++++L+ D A G+ L + + ++ N L+ + +SD
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISD 136
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIG 343
+G+ +R E I++ D P +TAPEA LN G
Sbjct: 137 FGM-----------SREEEGG--IYTVSDGLKQIPIKWTAPEA-------LNY------G 170
Query: 344 -ISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRE 400
+ ESD WS+G L E + G P+ G+S ++ + ++P PQ P E
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ-------LCPEE 223
Query: 401 LWKMIGECLQFKASKRPTFSAML 423
+++++ +C + RP+FS +
Sbjct: 224 IYRLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 26/192 (13%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L L+M+ G + + + LT E+ Y A+ + +H G + +IKP NLLLD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC-MDCTMLSPNYT-APEAWEPVKKS 333
+ G +SD+GL LKK R E + HS D T + N E W+ ++
Sbjct: 136 SKGHVKLSDFGLCTGLKK----AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 334 LNLFWDDAIG----ISPE----------SDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
L +G I+PE D WS G + EM G P+ + +E Y+ V
Sbjct: 192 LAF---STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
Query: 380 VKNRK---LPPQ 388
+ ++ PP+
Sbjct: 249 MNWKETLIFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 30/192 (15%)
Query: 200 CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
CTF + L VM+ G + ++ GR + Y A+I G+ LH
Sbjct: 59 THLFCTF----QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
G++ ++K N+LLD G ++D+G+ KA C +P
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCG-------------TP 160
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+Y APE + K + ++ W WSFG L EM G P+ G +E++ ++
Sbjct: 161 DYIAPEILKGQKYNESVDW------------WSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
Query: 380 VKNRKLPPQYAS 391
+ +R P++ S
Sbjct: 209 LNDRPHFPRWIS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 752 NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEW 811
N R+ PLH+A + G V LLL GAD N +D++G H+AA +LE
Sbjct: 1 NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAA-----KNGHLEI 55
Query: 812 LIVMLSHPDAAVEVRNHSGKT 832
+ ++L A V R+ G T
Sbjct: 56 VKLLLEK-GADVNARDKDGNT 75
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 21/186 (11%)
Query: 200 CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAM-QRNEGRLTLEQILRYGADIARGVVELH 258
C+ + T H + ++ L LVMD G L + + E RL + Y A++ + +H
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 259 AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318
V +IKP N+LLD +G ++D+G +C K + S + + +
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG--------SCLKMN---QDGTVQSSV--AVGT 166
Query: 319 PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378
P+Y +PE + ++ + + PE D WS G + EM G P+ S E Y
Sbjct: 167 PDYISPEILQAMEDGMGKY-------GPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 379 VVKNRK 384
++ + +
Sbjct: 220 IMNHEE 225
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 31/203 (15%)
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
L+ +RR C + T H + D+ L L++D G T ++ Y A+
Sbjct: 58 LEAVRR----CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE 113
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I + LH G++ +IK N+LLD+ G V++D+GL+ +A C +
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE-- 171
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-- 367
Y APE V + + D A+ D WS G E+ TG+ P+
Sbjct: 172 -----------YMAPE----VIRGGSGGHDKAV------DWWSLGVLTFELLTGASPFTV 210
Query: 368 --AGLSAEEIYRAVVKNRKLPPQ 388
S EI R ++K++ P+
Sbjct: 211 DGEQNSQSEISRRILKSKPPFPK 233
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-09
Identities = 46/167 (27%), Positives = 65/167 (38%), Gaps = 36/167 (21%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
T E+ Y A+ + +H G + +IKP NLLLDA G +SD+GL LKK
Sbjct: 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 298 -------KARPECDSSRIHSCMD-----------------CTMLSPNYTAPEAWEPVKKS 333
A P I M T+ +P+Y APE +
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ---- 213
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
G + E D WS G + EM G P+ + +E YR ++
Sbjct: 214 --------TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLA-MQRNEGRLTLEQILRYGADIARGVVELHAA 260
N+ GV + +VM+ G L+ +++ + L +Q++++ D A G+ L +
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
+ ++ N L+ + +SD+G+ +R E D I+S +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM-----------SRQEDDG--IYSSSGLKQIPIK 159
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAV 379
+TAPEA + S ESD WS+G L E + G P+ G++ ++ V
Sbjct: 160 WTAPEALNYGR------------YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
Query: 380 VKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
K ++ PQ P +++K++ C +K RP FS +
Sbjct: 208 EKGYRMSCPQKC-------PDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 65/323 (20%), Positives = 106/323 (32%), Gaps = 83/323 (25%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGN---------------------YSSSISSLLKAQNAD 510
LHQ V ++ V+ LL++ + N I S+ K
Sbjct: 41 LHQAVEARNLDVVKSLLTRGHNVNQPDHRDLTPLHIICKEPNKLGMKEMIRSINKCSVFY 100
Query: 511 GQTALHLACRRGSAELVEAIL------EYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
A+ A + E+ + IL + + V + K D + E L
Sbjct: 101 TLVAIKDAFNNRNVEIFKIILTNRYKNIQTIDLVYIDKKSKDDII-------EAEITKLL 153
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624
+ GA+ I+ G + H + LL GA+ N D S LH AV
Sbjct: 154 LSYGAD-INMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHY 212
Query: 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPG 684
++LENG S + TPLH+ V D
Sbjct: 213 NKPIVHILLENGA--STDARDKCGNTPLHISVGY--------------------CKDY-- 248
Query: 685 PVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDA-QNRTALHIASMANDVELVKI 743
+++++LL G + A+ TALH + + +K+
Sbjct: 249 ---------------------DILKLLLEHGVDVNAKSYILGLTALHSSIKSERK--LKL 285
Query: 744 ILDAGVDVNIRNVHNTIPLHVAL 766
+L+ G D+N N + PL A+
Sbjct: 286 LLEYGADINSLNSYKLTPLSSAV 308
|
Length = 477 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 44/197 (22%), Positives = 68/197 (34%), Gaps = 39/197 (19%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
+ + EQ+ + +I + LH+ G++ +IKP N+LLD G ++D+ +A +
Sbjct: 95 VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--- 151
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
+ S T +P Y APE S+ D WS G
Sbjct: 152 --------PDTLTTS----TSGTPGYMAPEVLCRQGYSV------------AVDWWSLGV 187
Query: 356 TLVEMCTGSIPWAGLS---AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFK 412
T E G P+ G S ++I L P E I + L+
Sbjct: 188 TAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP-------ATWSTEAIDAINKLLERD 240
Query: 413 ASKRPTFSAMLATFLRH 429
KR L H
Sbjct: 241 PQKR--LGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 47/295 (15%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRR 195
D+ +K+LG G+ GV +G W G ++ VA+K MI E M D + + +
Sbjct: 5 DLTFLKELGTGQ-FGVVKYGKWRG------QYDVAIK--MIKEGSMSEDEFIEEAKVMMK 55
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGV 254
S + +GV + +V + L R G R Q+L D+ G+
Sbjct: 56 LSH--EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L + + ++ N L+D G VSD+GL+ R D S
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-----------RYVLDDEYTSSV--G 160
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
+ ++ PE K S +SD W+FG + E+ + G +P+ +
Sbjct: 161 SKFPVRWSPPEVLLYSK------------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208
Query: 374 EIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427
E V + +L P AS +++ ++ C KA +RPTF +L++
Sbjct: 209 ETVEKVSQGLRLYRPHLAS-------EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 37/211 (17%)
Query: 241 EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
E+ L Y A+I G+ +LH V ++KP N+LLD G +SD GLA +
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI--------- 152
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
PE +S R + + Y APE + +SP D W GC + EM
Sbjct: 153 PEGESIR------GRVGTVGYMAPEVLN----------NQRYTLSP--DYWGLGCLIYEM 194
Query: 361 CTGSIPWAG----LSAEEIYRAVVKNR-----KLPPQYASIVGVGIPRELWKMIGECLQF 411
G P+ G + EE+ R V++ K + SI + + ++ + +G C +
Sbjct: 195 IEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLG-CQEE 253
Query: 412 KASKRPTFSAMLATFLRHLQELPRSPPASPD 442
A + + L+ PP PD
Sbjct: 254 GAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-09
Identities = 52/199 (26%), Positives = 80/199 (40%), Gaps = 40/199 (20%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L L+M+ G + + + L+ E Y A+ + +H G + +IKP NLLLD
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD 135
Query: 276 ASGRAVVSDYGLAAILKKP-----------------------ACRKARPECDSSRIHSCM 312
A G +SD+GL LKK + RKA + R
Sbjct: 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRR--QLA 193
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
T+ +P+Y APE + G + D WS G + EM G P+ +
Sbjct: 194 YSTVGTPDYIAPEVFMQT------------GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 373 EEIYRAVVKNRK---LPPQ 388
+E YR V+ ++ PP+
Sbjct: 242 QETYRKVMNWKETLVFPPE 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-09
Identities = 63/297 (21%), Positives = 99/297 (33%), Gaps = 70/297 (23%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L LVM+ G + + + E Y A++ + +H G + +IKP N+L+D
Sbjct: 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML------------------ 317
A G ++D+GL + K E + H+ + +
Sbjct: 136 ADGHIKLADFGLCKKMNK----AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTV 191
Query: 318 -SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
+P+Y APE V + E D WS G L EM G P+ + +E Y
Sbjct: 192 GTPDYIAPE----VLRGT--------PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 377 RAVVKNRK---LPPQYASIVGVGIPRELWKMIGECLQ--------FKASKR-PTFSAMLA 424
++ ++ PP + E +I L F+ K P F +
Sbjct: 240 NKIINWKESLRFPPD------PPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293
Query: 425 TFLRHLQELPRSPPASP------DTG-FTKFSTSNETEPSPASDVEVFQDNPNNLHQ 474
LR PP P DT F F + SD N +
Sbjct: 294 ENLRE-----TKPPFVPELSSPLDTSNFDDF-----EDDKDLSDYLSQNSKKLNKGK 340
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-09
Identities = 72/318 (22%), Positives = 130/318 (40%), Gaps = 50/318 (15%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWC-------------RNVCTFHGVLRMDSCL 216
VAV K+ A+++ + + + L+RA C + + T H + ++ L
Sbjct: 17 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL 76
Query: 217 GLVMDRCYGSVQLAM-QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
LVMD G L + + E RL + Y A++ + +H V +IKP N+L+D
Sbjct: 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
+G ++D+G +C K + + S + + +P+Y +PE + ++
Sbjct: 137 MNGHIRLADFG--------SCLKLM---EDGTVQSSV--AVGTPDYISPEILQAMEDGKG 183
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR---KLPPQYASI 392
+ PE D WS G + EM G P+ S E Y ++ ++ + P Q +
Sbjct: 184 KY-------GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 393 V--GVGIPRELW----KMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFT 446
+ R L +G+ + P F+ + +R+ E P P S T +
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNC-EAPYIPEVSSPTDTS 295
Query: 447 KFST------SNETEPSP 458
F ++ET P P
Sbjct: 296 NFDVDDDCLKNSETMPPP 313
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 4e-09
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 29/171 (16%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
DS L LVM+ G + R GR Y A + + LH+ +V ++KP NL
Sbjct: 73 DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKK 332
LLD+ G ++D+G A +K + C +P Y APE
Sbjct: 133 LLDSDGYIKITDFGFAKRVKG---------------RTYTLCG--TPEYLAPE------I 169
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
L+ + A+ D W+ G + EM G P+ + +IY +++ +
Sbjct: 170 ILSKGYGKAV------DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 152 VEVWGAWIGGGQGRCRH----SVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFH 207
VEV G G + RH +A KVM E E + + +++ L++ S RN+ T++
Sbjct: 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH-RNIATYY 79
Query: 208 GVL------RMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRY-GADIARGVVELHA 259
G D L LVM+ C GSV ++ +G E + Y +I RG+ LHA
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
V+ +IK N+LL + + D+G++A L + R+ + + +P
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--------------NTFIGTP 185
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ APE ++ + +D SD WS G T +EM G+ P
Sbjct: 186 YWMAPEVI-ACDENPDATYD------YRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-09
Identities = 40/122 (32%), Positives = 64/122 (52%), Gaps = 6/122 (4%)
Query: 698 KDHEVEGRELVRILLTAGAEPTAQDA-QNRTALHIASMANDVELVKIILDAGVDVNIRNV 756
KD +E E+ ++LL+ GA+ +D + TALH A+ D L +++L G +VNI +
Sbjct: 141 KDDIIEA-EITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDK 199
Query: 757 HNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVML 816
N PLH A+ K V +LL GA + +D G+ HI+ K + + L ++L
Sbjct: 200 TNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCK----DYDILKLLL 255
Query: 817 SH 818
H
Sbjct: 256 EH 257
|
Length = 477 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 138 VKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRA 196
++L+KKLG G+ EVW G W G + VAVK + M P+ + +++
Sbjct: 8 LQLIKKLGNGQFG--EVWMGTWNGNTK------VAVK-TLKPGTMSPESFLEEAQIMKKL 58
Query: 197 SMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR-LTLEQILRYGADIARGVV 255
+ + V+ + + GS+ ++ EGR L L ++ A +A G+
Sbjct: 59 RH--DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
+ + +++ +N+L+ ++D+GLA +++ ++
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-------------YTARQGA 163
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374
+TAPEA L+ I +SD WSFG L E+ T G +P+ G++ E
Sbjct: 164 KFPIKWTAPEA--------ALYGRFTI----KSDVWSFGILLTELVTKGRVPYPGMNNRE 211
Query: 375 IYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427
+ V + ++P PQ P L +++ +C + +RPTF L +FL
Sbjct: 212 VLEQVERGYRMPCPQ-------DCPISLHELMLQCWKKDPEERPTFE-YLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-09
Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 216 LGLVMDRCYG-SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
L VM+ G + +QR GR + Y A+I G+ LH G++ ++K N+LL
Sbjct: 71 LFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPE--AWEPVKK 332
D+ G ++D+G+ C++ ++ C +P+Y APE +++P
Sbjct: 130 DSEGHIKIADFGM--------CKEGILGGVTTSTF----CG--TPDYIAPEILSYQPYGP 175
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASI 392
++ D W+ G L EM G P+ G +E++++++++ P++ S
Sbjct: 176 AV--------------DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSK 221
Query: 393 VGVGIPREL 401
I +
Sbjct: 222 EAKSILKSF 230
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 5e-09
Identities = 22/54 (40%), Positives = 32/54 (59%)
Query: 725 NRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
RTALH A+++ +ELVK +L+ GVD+N + LH+A G + LLL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-09
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 31/179 (17%)
Query: 588 AYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK 647
A G + ELL A DP+ D +G + LH A +K Y DC +V+L++ C
Sbjct: 533 ASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKH-ACN-------- 583
Query: 648 ELTPLHLCVATWNVAVVKRWVEVASP-EEIVNV------IDIPGPVGTALCMAAALKKDH 700
+H+ A N A+ W +++ +I + I P G LC AA K +
Sbjct: 584 ----VHIRDANGNTAL---WNAISAKHHKIFRILYHFASISDPHAAGDLLCTAA---KRN 633
Query: 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAND-VELVKIILDAGVDVNIRNVHN 758
++ ++ LL G ++D Q TAL +A MA D V++V++++ G DV+ N +
Sbjct: 634 DL---TAMKELLKQGLNVDSEDHQGATALQVA-MAEDHVDMVRLLIMNGADVDKANTDD 688
|
Length = 823 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 170 VAVKKVMI------AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC 223
+AVK+V + A E E + L ++D L+ S+ N+ + G D+ + + M+
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLK--SLKHVNIVQYLGTCLDDNTISIFMEFV 84
Query: 224 YG-SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282
G S+ + R G L +Y I GV LH VV +IK +N++L +G +
Sbjct: 85 PGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL 143
Query: 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDA 341
D+G C + HS M +M +P + APE + +S
Sbjct: 144 IDFG---------CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV---INES-------- 183
Query: 342 IGISPESDAWSFGCTLVEMCTGSIPWAGL 370
G +SD WS GCT+ EM TG P A +
Sbjct: 184 -GYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 70/289 (24%), Positives = 114/289 (39%), Gaps = 65/289 (22%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR--NVCTFH 207
IG G + R + VA+K + + + + + ++ L+ CR N+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE----CRHPNIVAYF 66
Query: 208 GVLRMDSCLGLVMDRCYG-SVQLAMQRNEGRLTLEQILRYGADIAR----GVVELHAAGV 262
G L +VM+ C G S+Q Q G L+ QI A + R G+ LH G
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI----AYVCRETLKGLAYLHETGK 122
Query: 263 VCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYT 322
+ +IK +N+LL G ++D+G++A L ++ S I +P +
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR------KSFIG--------TPYWM 168
Query: 323 APEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV-- 380
APE +K G + D W+ G T +E+ P L RA+
Sbjct: 169 APEVAAVERKG---------GYDGKCDIWALGITAIELAELQPPMFDL---HPMRALFLI 216
Query: 381 -KNRKLPPQYASIVGVGIPRELWK-----MIGECLQFKASKRPTFSAML 423
K+ PP+ +E W I +CL KRPT + +L
Sbjct: 217 SKSNFPPPKLKD-------KEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 9e-09
Identities = 60/283 (21%), Positives = 115/283 (40%), Gaps = 60/283 (21%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR-----ASMWCRNVC 204
IG G + + + VA+K + + EE E + ++++++ + +
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDL-EEAEDE-----IEDIQQEIQFLSQCRSPYIT 62
Query: 205 TFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQ---ILRYGADIARGVVELHAA 260
++G S L ++M+ C GS ++ G+L ILR ++ G+ LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILR---EVLLGLEYLHEE 117
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
G + +IK +N+LL G ++D+G++ L + + + +P
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--------------RNTFVGTPF 163
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
+ APE +K+S G ++D WS G T +E+ G P + L + +
Sbjct: 164 WMAPEV---IKQS---------GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP 211
Query: 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
KN PP + G + + CL +RP+ +L
Sbjct: 212 KNN--PPS---LEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 76/284 (26%), Positives = 115/284 (40%), Gaps = 59/284 (20%)
Query: 171 AVKKV-MIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS----CLGLV---MDR 222
AVK++ +E E L LD + R+S C + F+G L + C+ L+ +D+
Sbjct: 33 AVKRIRSTVDEKEQKRLLMDLDVVMRSSD-CPYIVKFYGALFREGDCWICMELMDISLDK 91
Query: 223 CYGSVQLAMQRNEGRLTLEQILRYGADIARGVV--------ELHAAGVVCMNIKPSNLLL 274
Y + + + + E+IL IA V EL ++ ++KPSN+LL
Sbjct: 92 FY---KYVYEVLKSVIP-EEILGK---IAVATVKALNYLKEELK---IIHRDVKPSNILL 141
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD--CTMLSPNYTAPEAWEPVKK 332
D +G + D+G++ L DS I D C P Y APE +P +
Sbjct: 142 DRNGNIKLCDFGISGQLV-----------DS--IAKTRDAGC---RP-YMAPERIDPSAR 184
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-SAEEIYRAVVKNRKLPPQYAS 391
G SD WS G TL E+ TG P+ S + VVK PP ++
Sbjct: 185 D---------GYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD--PPILSN 233
Query: 392 IVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRHLQELP 434
I CL SKRP + +L F++ +E
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 27/168 (16%)
Query: 213 DSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
DS L LV D G + +Q+ EGR + ++ Y A++ + LH +V ++KP N
Sbjct: 68 DSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331
+LLDA+G + D+GL+ KA + + C + Y APE
Sbjct: 127 ILLDATGHIALCDFGLS---------KANLTDNKTTNTFCG-----TTEYLAPE------ 166
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+ D+ G + D WS G + EMC G P+ +++YR +
Sbjct: 167 ----VLLDEK-GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-08
Identities = 48/202 (23%), Positives = 70/202 (34%), Gaps = 36/202 (17%)
Query: 684 GPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN----------RTALHIAS 733
G VG L A +L+ VE ++ LL A + + N TALH+A+
Sbjct: 79 GAVGDTLLHAISLEYVDAVE--AILLHLLAAFRKSGPLELANDQYTSEFTPGITALHLAA 136
Query: 734 MANDVELVKIILDAGVDVNIRNV--------------HNTIPLHVALARGAKSCVGLLLS 779
+ E+VK++L+ G V R H PL+ A G+ S V LL
Sbjct: 137 HRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNAAACLGSPSIVALLSE 196
Query: 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVM-------LSHPDAAVE---VRNHS 829
AD D G+ H+ + E E M L + E + NH
Sbjct: 197 DPADILTADSLGNTLLHLLVMENEFKAEYEELSCQMYNFALSLLDKLRDSKELEVILNHQ 256
Query: 830 GKTLRDFLEGLPREWISEDLME 851
G T R + +
Sbjct: 257 GLTPLKLAAKEGRIVLFRLKLA 278
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 42/206 (20%)
Query: 232 QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA--- 288
L+ +Q+L + AD+ARG+ L + ++ N+L+ + A ++D+GL+
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 174
Query: 289 -AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPE 347
+KK R P W ++ SLN +
Sbjct: 175 EVYVKKTMGR-------------------------LPVRWMAIE-SLNYSV-----YTTN 203
Query: 348 SDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIG 406
SD WS+G L E+ + G P+ G++ E+Y KLP Y + E++ ++
Sbjct: 204 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQGYRLEKPLNCDDEVYDLMR 257
Query: 407 ECLQFKASKRPTFSAMLATFLRHLQE 432
+C + K +RP+F+ +L + R L+E
Sbjct: 258 QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 38/192 (19%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG--RAV-VSDYGLAA-ILKK 293
LT++ +L D+A+G L + +I N LL G R ++D+G+A I +
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI-SPESDAWS 352
RK ML + PEA F D GI + ++D WS
Sbjct: 173 SYYRKG-------------GRAMLPIKWMPPEA----------FLD---GIFTSKTDVWS 206
Query: 353 FGCTLVE-MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411
FG L E G +P+ G + +E+ V +L P G P +++++ +C Q
Sbjct: 207 FGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK------GCPGPVYRIMTDCWQH 260
Query: 412 KASKRPTFSAML 423
RP F+ +L
Sbjct: 261 TPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-08
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
RILLT GA+P +D RT LHIA V++V+++L+ G D + + PL +A
Sbjct: 98 ARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEE 157
Query: 768 RGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPD 820
G + V LL + G NA D+ +LE + HPD
Sbjct: 158 NGFREVVQLLSRH---SQCHFELGANA---KPDSFTGKPPSLEDSPISSHHPD 204
|
Length = 664 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 75/314 (23%), Positives = 124/314 (39%), Gaps = 69/314 (21%)
Query: 172 VKKVMIAEEMEPDWLSGQLDNLRRASMWCRN--VCTFHGVLRMDSCLGLVMDRCYG-SVQ 228
VKK ++ ++ + DW+ + +AS N + H + S L LV++ G +
Sbjct: 28 VKKELVHDDEDIDWVQTEKHVFEQAS---SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLM 84
Query: 229 LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288
MQR +L E Y A+I + LH G++ ++K N+LLDA G ++DYG+
Sbjct: 85 FHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGM- 142
Query: 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
C++ D++ C +PNY APE + ++ W
Sbjct: 143 -------CKEGLGPGDTTSTF----CG--TPNYIAPEILRGEEYGFSVDW---------- 179
Query: 349 DAWSFGCTLVEMCTGSIPW------AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELW 402
W+ G + EM G P+ ++ E+ V+ + + IPR L
Sbjct: 180 --WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPRFLS 227
Query: 403 KMIGECLQFKASKRPT----------FSAMLA-TFLR-----HLQELPRSPPASP----D 442
L+ +K P FS + + TF R L++ +PP P D
Sbjct: 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287
Query: 443 TGFTKFSTSNETEP 456
G F T +EP
Sbjct: 288 YGLENFDTQFTSEP 301
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 16/123 (13%)
Query: 459 ASDVEVFQDNPNN---LHQLVSEGDVSG-----VRDLLSKNASGNYSSSISSLLKAQNAD 510
AS +V + + LH G+ + LL A + ++ D
Sbjct: 94 ASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD-------LDVNNLRDED 146
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G T LH A G A++VE +LE + + + G L A G E V L+ +G +
Sbjct: 147 GNTPLHWAALNGDADIVELLLEAGA-DPNSRNSYGVTALDPAAKNGRIELVKLLLDKGLH 205
Query: 571 VIS 573
+
Sbjct: 206 LSL 208
|
Length = 235 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 2e-08
Identities = 38/135 (28%), Positives = 56/135 (41%), Gaps = 28/135 (20%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+ E + T QI Y + G+ LH+ G++ +IK SN+L++ G ++D+GLA
Sbjct: 90 LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARP 149
Query: 291 LKKPACRKARPECDSSRIHSCMDCT--MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
K D T +++ Y PE L L A PE
Sbjct: 150 YTKRNSA---------------DYTNRVITLWYRPPE--------LLL---GATRYGPEV 183
Query: 349 DAWSFGCTLVEMCTG 363
D WS GC L E+ G
Sbjct: 184 DMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 38/260 (14%)
Query: 167 RHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS 226
RH K ++ A E + L LD+L N+ + G + L + ++ G
Sbjct: 43 RHDSRQKDMVKALRSEIETLKD-LDHL--------NIVQYLGFETTEEYLSIFLEYVPGG 93
Query: 227 VQLAMQRNEGRLTLEQILRY-GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285
+ R GR EQ++R+ + G+ LH+ G++ ++K NLL+DA G +SD+
Sbjct: 94 SIGSCLRTYGRFE-EQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF 152
Query: 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS 345
G++ +K+ D+ + S M ++ + APE + + G S
Sbjct: 153 GIS--------KKSDDIYDNDQNMS-MQGSVF---WMAPE----------VIHSYSQGYS 190
Query: 346 PESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK--NRKLPPQYASIVGVGIPRELWK 403
+ D WS GC ++EM G PW S EE A+ K N++ P V + +
Sbjct: 191 AKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALD 247
Query: 404 MIGECLQFKASKRPTFSAML 423
+ C RPT +L
Sbjct: 248 FLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 152 VEVWGAWIGGGQGRCRH----SVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFH 207
VE+ G G + RH +A KVM E + + +++ L++ S RN+ T++
Sbjct: 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH-RNIATYY 69
Query: 208 GVL------RMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRY-GADIARGVVELHA 259
G MD L LVM+ C GSV ++ +G E+ + Y +I RG+ LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
V+ +IK N+LL + + D+G++A L + R+ + + +P
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--------------NTFIGTP 175
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ APE ++ + +D +SD WS G T +EM G+ P
Sbjct: 176 YWMAPEVI-ACDENPDATYDF------KSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-08
Identities = 49/205 (23%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE-- 648
G+ D R LL G +PN +G S + A+ + ++ +++++G AI + K
Sbjct: 13 GELDIARRLLDIGINPNFEIYDGISPIKLAMKFRDSEAIKLLMKHG-----AIPDVKYPD 67
Query: 649 -LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
+ LH V +V V+ ++ + +V G T L +A LKK ++
Sbjct: 68 IESELHDAVEEGDVKAVEELLD--LGKFADDVFYKDG--MTPLHLATILKK------LDI 117
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
+++L+ GA+P + + LH+A M D++ +++++D ++I + PL +A+A
Sbjct: 118 MKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177
Query: 768 RGAKSCVGLLLSAGADCNWQDDEGD 792
+G + +LL +GA+ ++ G
Sbjct: 178 KGDIAICKMLLDSGANIDYFGKNGC 202
|
Length = 413 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-08
Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 52/205 (25%)
Query: 598 ELLLA-GADPNAVD-DEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655
+LLL+ GAD N D +G + LH A K ++L G ++ I + +PLH
Sbjct: 151 KLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGA--NVNIPDKTNNSPLHHA 208
Query: 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG 715
V +N +V ILL G
Sbjct: 209 VKHYNKPIVH--------------------------------------------ILLENG 224
Query: 716 AEPTAQDAQNRTALHIA-SMANDVELVKIILDAGVDVNIRN-VHNTIPLHVALARGAKSC 773
A A+D T LHI+ D +++K++L+ GVDVN ++ + LH ++ K
Sbjct: 225 ASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERK-- 282
Query: 774 VGLLLSAGADCNWQDDEGDNAFHIA 798
+ LLL GAD N + A
Sbjct: 283 LKLLLEYGADINSLNSYKLTPLSSA 307
|
Length = 477 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 46/273 (16%)
Query: 163 QGRCRHSVAVK--KVMIAEEMEPDWLS-----GQLDNLRRASMWCRNVCTFHGVLRMDSC 215
G+ VA+K K E+ D+LS GQ D+ N+ GV+
Sbjct: 28 PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH--------PNIIHLEGVVTKSKP 79
Query: 216 LGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
+ +V + GS+ +++++G+ T+ Q++ IA G+ L G V ++ N+L+
Sbjct: 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
+++ VSD+GL+ +L+ D + +TAPEA K
Sbjct: 140 NSNLVCKVSDFGLSRVLE-----------DDPEAAYTTRGGKIPIRWTAPEAIAYRK--- 185
Query: 335 NLFWDDAIGISPESDAWSFGCTLVE-MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ SD WS+G + E M G P+ +S +++ +A+ + +LP
Sbjct: 186 ---------FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP----- 231
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
+ P L +++ +C Q ++RP F +++
Sbjct: 232 -MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 73/303 (24%), Positives = 133/303 (43%), Gaps = 40/303 (13%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR-R 195
++K VK LG G G G WI G+ + VA+K ++ E P LD
Sbjct: 8 ELKKVKVLGSGA-FGTVYKGIWIPDGEN-VKIPVAIK--VLRENTSPKANKEILDEAYVM 63
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
A + VC G+ + S + LV YG + ++ N+ R+ + +L + IA+G+
Sbjct: 64 AGVGSPYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L +V ++ N+L+ + ++D+GLA +L + D + H+
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL----------DIDETEYHA---- 168
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
P W ++ L+ + + +SD WS+G T+ E+ T G+ P+ G+ A
Sbjct: 169 ----DGGKVPIKWMALESILHRRF------THQSDVWSYGVTVWELMTFGAKPYDGIPAR 218
Query: 374 EIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
EI + K +LP P +I +++ ++ +C + RP F ++ F R ++
Sbjct: 219 EIPDLLEKGERLPQPPICTI-------DVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271
Query: 433 LPR 435
R
Sbjct: 272 PSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 35/198 (17%)
Query: 225 GSVQLAMQRNEGR-LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283
GS+ ++ +G+ L L Q++ A IA G+ + + +++ +N+L+ + ++
Sbjct: 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIA 144
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
D+GLA +++ ++ +TAPEA L+ I
Sbjct: 145 DFGLARLIEDNE-------------YTARQGAKFPIKWTAPEA--------ALYGRFTI- 182
Query: 344 ISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPREL 401
+SD WSFG L E+ T G +P+ G+ E+ V + ++P PQ G P L
Sbjct: 183 ---KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ-------GCPESL 232
Query: 402 WKMIGECLQFKASKRPTF 419
+++ C + +RPTF
Sbjct: 233 HELMKLCWKKDPDERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-08
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 172 VKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG-SVQLA 230
VKK ++ ++ + DW+ + +AS + H + +S L V++ G +
Sbjct: 28 VKKELVNDDEDIDWVQTEKHVFEQASNH-PFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 86
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
MQR +L E Y A+I+ + LH G++ ++K N+LLD+ G ++DYG+
Sbjct: 87 MQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM--- 142
Query: 291 LKKPACRKA-RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
C++ RP +S C +PNY APE ++ W
Sbjct: 143 -----CKEGLRPGDTTSTF-----CG--TPNYIAPEILRGEDYGFSVDW----------- 179
Query: 350 AWSFGCTLVEMCTGSIPW 367
W+ G + EM G P+
Sbjct: 180 -WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-08
Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR-R 195
+ K +K LG G G G WI G+ + VA+K + E P LD
Sbjct: 8 EFKKIKVLGSGA-FGTVYKGLWIPEGEK-VKIPVAIK--ELREATSPKANKEILDEAYVM 63
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
AS+ +VC G+ + S + L+ +G + ++ ++ + + +L + IA+G+
Sbjct: 64 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L +V ++ N+L+ ++D+GLA +L D H+
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG----------ADEKEYHA---- 168
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
P W ++ L+ + + +SD WS+G T+ E+ T GS P+ G+ A
Sbjct: 169 ----EGGKVPIKWMALESILHRIY------THQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
Query: 374 EIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
EI + K +LP P +I +++ ++ +C A RP F ++ F
Sbjct: 219 EISSILEKGERLPQPPICTI-------DVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 27/128 (21%)
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPACRKARP 301
I+ Y + RG+ LH ++ ++K +NLL+D++G+ + ++D+G AA L
Sbjct: 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG---- 160
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAW--EPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
+ + T+ + APE E +S D WS GC ++E
Sbjct: 161 ---AGEFQGQLLGTI---AFMAPEVLRGEQYGRS--------------CDVWSVGCVIIE 200
Query: 360 MCTGSIPW 367
M T PW
Sbjct: 201 MATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 9e-08
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 59/238 (24%)
Query: 201 RNVCTFHGVLRMDSCLGLVMDRCY---GSVQLAMQRNEGRLTLEQILRYGADIARGVVEL 257
N+ ++ + L +VM+ Y GS+ + +N R+ QI ++ +G+ L
Sbjct: 75 PNIVDYYDSYLVGDELWVVME--YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 258 HAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML 317
H+ V+ +IK N+LL G ++D+G AA L K ++ +++
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---------------SVV 177
Query: 318 -SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
+P + APE V K + P+ D WS G +EM G P+
Sbjct: 178 GTPYWMAPE----VIKRKDY--------GPKVDIWSLGIMCIEMAEGEPPYL-------- 217
Query: 377 RAVVKNRKLPPQYA--SIVGVGIPR---------ELWKMIGECLQFKASKRPTFSAML 423
+ PP A I GIP E + +CL KRP+ +L
Sbjct: 218 -------REPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 35/273 (12%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI---AEEMEPDWLSGQ-LDN 192
+ +L+K LG G V + G G+ +KK I A+ E Q L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
+R++ + T H + D+ L L++D G R +++ Y +I
Sbjct: 61 IRQSPF----LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+ LH G++ +IK N+LLD++G V++D+GL+ + +A C +
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE----- 171
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA---- 368
Y AP+ + + + D A+ D WS G + E+ TG+ P+
Sbjct: 172 --------YMAPD----IVRGGDGGHDKAV------DWWSMGVLMYELLTGASPFTVDGE 213
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPREL 401
S EI R ++K+ PQ S + I + L
Sbjct: 214 KNSQAEISRRILKSEPPYPQEMSALAKDIIQRL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 41/202 (20%)
Query: 233 RNEGRLTL--EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
R+ GR L + +L++ D+ + L A V ++ N+L+ A VSD+GL
Sbjct: 92 RSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--- 148
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
+ S D L +TAPEA K S +SD
Sbjct: 149 --------------TKEASSTQDTGKLPVKWTAPEALREKK------------FSTKSDV 182
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGEC 408
WSFG L E+ + G +P+ + +++ V K K+ P G P ++ ++ +C
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GCPPVVYDVMKQC 235
Query: 409 LQFKASKRPTFSAMLATFLRHL 430
A+ RP+F L L H+
Sbjct: 236 WHLDAATRPSFL-QLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 200 CRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELH 258
R + H + ++ L LVMD G + + + E RL + Y A++ + +H
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 259 AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318
G V +IKP N+LLD +G ++D+G +C + D T+ S
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG--------SCLRLLA-----------DGTVQS 160
Query: 319 ------PNYTAPEAWEPVKKSLNLFWDDAIG-ISPESDAWSFGCTLVEMCTGSIPWAGLS 371
P+Y +PE + + +D G PE D WS G + EM G P+ S
Sbjct: 161 NVAVGTPDYISPEILQAM--------EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212
Query: 372 AEEIYRAVV--KNR-KLPPQ 388
E Y ++ K + PP
Sbjct: 213 LVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 68/315 (21%), Positives = 118/315 (37%), Gaps = 70/315 (22%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMI-AEEMEPDWLSGQLDNLR 194
K ++KLGEG A V +GR R + VA+K++ + AEE P ++ ++
Sbjct: 3 KQLEKLGEGTYATVY---------KGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMK 53
Query: 195 RASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQR--NEGRLTLEQILRYGADIAR 252
N+ H V+ ++ L LV + ++ M G L + + + +
Sbjct: 54 ELKH--ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ H V+ ++KP NLL++ G ++D+GLA P +
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--------------NTF 157
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG---ISPESDAWSFGCTLVEMCTGSIPWAG 369
+++ Y AP D +G S D WS GC + EM TG + G
Sbjct: 158 SNEVVTLWYRAP--------------DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203
Query: 370 LSAEE----IYR-------AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
+ E+ I+R + P+Y P++L ++ P
Sbjct: 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLF-----------PH 252
Query: 419 FSAMLATFLRHLQEL 433
+ L L +L
Sbjct: 253 ADPLGIDLLHRLLQL 267
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 61/298 (20%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSG-----Q 189
++ +K+LG G+ GV G W G + VA+K MI E E D++ +
Sbjct: 5 ELTFLKELGSGQ-FGVVHLGKWRG------KIDVAIK--MIREGAMSEDDFIEEAKVMMK 55
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILRYGA 248
L + ++ VCT + +V + G + ++ +G+L E +L +
Sbjct: 56 LSHPNLVQLY--GVCTKQRPIF------IVTEYMANGCLLNYLRERKGKLGTEWLLDMCS 107
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
D+ + L + G + ++ N L+ VSD+GLA +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----------------- 150
Query: 309 HSCMDCTMLSPNYTAPEAWE-PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
L YT+ + + PVK + +D + S +SD WSFG + E+ + G +P
Sbjct: 151 --------LDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMP 201
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ S E+ +V +L P+ A P E++ ++ C K RP F +L
Sbjct: 202 YERFSNSEVVESVSAGYRLYRPKLA-------PTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-07
Identities = 20/56 (35%), Positives = 29/56 (51%), Gaps = 1/56 (1%)
Query: 711 LLTAGAE-PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVA 765
LL G A D T LH+A+ +ELV+ +L GVD+N+R+ L +A
Sbjct: 1 LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTALDLA 56
|
Length = 56 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 50/190 (26%)
Query: 190 LDNLRRASMWCRNVCTF--HGVLRMDSCLGLVMDRCYGSVQLAMQRNEG----------- 236
L LR++S + R T H V M ++ SV L +Q EG
Sbjct: 23 LKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISKFL 80
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+ E + R+ A++ + LH G+VC ++ P+N+LLD G ++ +
Sbjct: 81 NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--------RW 132
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA---WSF 353
+ CD + + Y APE GIS E++A WS
Sbjct: 133 SEVEDSCDGEAVENM---------YCAPEVG---------------GISEETEACDWWSL 168
Query: 354 GCTLVEMCTG 363
G L E+ TG
Sbjct: 169 GAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 30/185 (16%)
Query: 190 LDNLRRASMWCRNVCTFHGVLR--MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG 247
L NL+ + ++G LR + L + M+ G + G LT +Y
Sbjct: 58 LKNLQH-----ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
I G+ LH+ +V +IK +N+L D++G + D+G A ++ + C S
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG--------ASKRLQTICMSG- 163
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + +P + +PE G ++D WS GCT+VEM T PW
Sbjct: 164 --TGIRSVTGTPYWMSPEVIS------------GEGYGRKADVWSLGCTVVEMLTEKPPW 209
Query: 368 AGLSA 372
A A
Sbjct: 210 AEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-07
Identities = 41/166 (24%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 478 EGDVSGVRDLLSKNASGNYSSSISSLLKAQ------NADGQTALHLACRRGSAELVEAIL 531
D + +LL+ ++GN ++ + LLKA+ ++ G+T LH+A +G + V +L
Sbjct: 520 HDDPNMASNLLTVASTGN-AALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLL 578
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGF-GPSVAHVCAYH 590
+++ NV + D +G+ L A++A H I R + + + + A
Sbjct: 579 KHAC-NVHIRDANGNTALWNAISAK-----HHKIFRILYHFASISDPHAAGDLLCTAAKR 632
Query: 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
M+ELL G + ++ D +G + L A+A+ + D +++ NG
Sbjct: 633 NDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNG 678
|
Length = 823 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-07
Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 33/173 (19%)
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
GV+ ++KPSN+LLDASG + D+G++ L KA+ +R C
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAK-----TRSAGC-------AA 179
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE-EIYRAV 379
Y APE +P + +D +D WS G +LVE+ TG P+ E E+ +
Sbjct: 180 YMAPERIDPPDPNPK--YD------IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
Query: 380 VKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-TFLRH 429
++ LPP G + + CL KRP + +L F+R
Sbjct: 232 LQEEPPSLPP------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 23/80 (28%), Positives = 37/80 (46%), Gaps = 11/80 (13%)
Query: 347 ESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR---KLPPQYASIVGVGIPRELWK 403
+ D +S G L E+ TG IP+ L+ +EIY ++ KLP + P E+
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--------LDCPLEIKC 253
Query: 404 MIGECLQFKASKRPTFSAML 423
++ C + KRP +L
Sbjct: 254 IVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 2e-07
Identities = 36/168 (21%), Positives = 61/168 (36%), Gaps = 35/168 (20%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ V+ + L LV + C ++ + + G L+ I + RG+ H+
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN- 320
++ ++KP N+L++ G ++D+GLA P + +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----------------LRT--YTHEV 159
Query: 321 ----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
Y APE L + D WS GC EM TG
Sbjct: 160 VTLWYRAPEI---------LLGSKHYSTA--VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 42/143 (29%), Positives = 60/143 (41%), Gaps = 35/143 (24%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
G LT RY I +GV LH+ +V +IK +N+L D++G + D+G
Sbjct: 101 GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA-------- 152
Query: 296 CRKARPECDSSRIHS-CMDCTML-----SPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
S RI + CM T + +P + +PE G ++D
Sbjct: 153 ---------SKRIQTICMSGTGIKSVTGTPYWMSPEVI------------SGEGYGRKAD 191
Query: 350 AWSFGCTLVEMCTGSIPWAGLSA 372
WS CT+VEM T PWA A
Sbjct: 192 VWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 49/186 (26%), Positives = 73/186 (39%), Gaps = 37/186 (19%)
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKKPACRKARP 301
I+ Y I G+ LH +V +IK N+L++ SG +SD+G + L
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---------- 159
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
+ I+ C + + Y APE + K G +D WS GCT+VEM
Sbjct: 160 ----AGINPCTETFTGTLQYMAPEV---IDKGPR-------GYGAPADIWSLGCTIVEMA 205
Query: 362 TGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELW----KMIGECLQFKASKRP 417
TG P+ L + V K+ P+ IP L I C + KR
Sbjct: 206 TGKPPFIELGEPQAAMFKVGMFKIHPE--------IPESLSAEAKNFILRCFEPDPDKRA 257
Query: 418 TFSAML 423
+ +L
Sbjct: 258 SAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|222279 pfam13639, zf-RING_2, Ring finger domain | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-07
Identities = 17/50 (34%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 6 PCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + E V ++L CGH F KECL + ++ +CP CR
Sbjct: 1 DECPICLDEFEPGEEV-VVLPCGHVFHKECLDKWL----RSSNTCPLCRA 45
|
Length = 46 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 36/168 (21%)
Query: 225 GSVQLAMQRNEGRLTLEQILR-YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283
G + +QR R LE R Y A++A + LH+ ++ ++KP N+LLD+ G V++
Sbjct: 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLT 138
Query: 284 DYGLAAILKKPACRKA-RPECDSSRIHSCMDCTMLSPNYTAPEAW--EPVKKSLNLFWDD 340
D+GL C++ PE +S C +P Y APE EP +++
Sbjct: 139 DFGL--------CKEGVEPEETTSTF-----CG--TPEYLAPEVLRKEPYDRTV------ 177
Query: 341 AIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV-KNRKLPP 387
D W G L EM G P+ ++Y ++ K +LP
Sbjct: 178 --------DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 34/161 (21%)
Query: 231 MQRNEGRLTLEQILR-YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289
+QR R LE R Y A+IA + LH+ +V ++KP N+LLD+ G V++D+GL
Sbjct: 87 LQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC- 143
Query: 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAW--EPVKKSLNLFWDDAIGISPE 347
K E + + C +P Y APE +P +++
Sbjct: 144 --------KENIEHNGTTSTFCG-----TPEYLAPEVLHKQPYDRTV------------- 177
Query: 348 SDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV-KNRKLPP 387
D W G L EM G P+ + E+Y ++ K +L P
Sbjct: 178 -DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|238093 cd00162, RING, RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in mediating protein-protein interactions; identified in a proteins with a wide range of functions such as viral replication, signal transduction, and development; has two variants, the C3HC4-type and a C3H2C3-type (RING-H2 finger), which have different cysteine/histidine pattern; a subset of RINGs are associated with B-Boxes (C-X2-H-X7-C-X7-C-X2-C-H-X2-H) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-07
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 6/50 (12%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHV 56
C +C + E +LL CGH FC+ C+ + + +T CP CR
Sbjct: 1 ECPICLEEFRE---PVVLLPCGHVFCRSCIDKWLKSGKNT---CPLCRTP 44
|
Length = 45 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-07
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 51/211 (24%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A+IA + LH+ +V ++KP N+LLD+ G V++D+GL C++ + D+
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL--------CKEGIAQSDT 152
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ C +P Y APE ++K +D+ + D W G L EM G
Sbjct: 153 TTTF----CG--TPEYLAPEV---IRKQP---YDNTV------DWWCLGAVLYEMLYGLP 194
Query: 366 PWAGLSAEEIYRAVV-KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR-------- 416
P+ E+Y ++ K L P G W ++ E L+ +R
Sbjct: 195 PFYCRDVAEMYDNILHKPLVLRP--------GASLTAWSILEELLEKDRQRRLGAKEDFL 246
Query: 417 -----PTFSAMLATFLRHLQELPRSPPASPD 442
P F ++ T L +++P PP +P+
Sbjct: 247 EIQEHPFFESLSWTDLEQ-KKIP--PPFNPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-07
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 204 CTFHG--VLRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAA 260
CT G ++ + C CYG + ++R E LTLE +L + +A+G+ L +
Sbjct: 108 CTIGGPILVITEYC-------CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
+ ++ N+LL + D+GLA + DS+ + L
Sbjct: 161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN----------DSNYV--VKGNARLPVK 208
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAV 379
+ APE+ +F + + + ESD WS+G L E+ + GS P+ G+ + + +
Sbjct: 209 WMAPES---------IF--NCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256
Query: 380 VKN--RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420
+K R P++A P E++ ++ C KRPTF
Sbjct: 257 IKEGYRMAQPEHA-------PAEIYDIMKTCWDADPLKRPTFK 292
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 39/190 (20%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L L+ ++R+ DIA G+ L + + ++ N +L+ + V+D+GL
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL---------- 159
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWDDAIGISPESDAWSFGC 355
S +I+S D P W ++ SL N++ + SD W+FG
Sbjct: 160 -------SKKIYSG-DYYRQGCASKLPVKWLALE-SLADNVY-------TTHSDVWAFGV 203
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGECLQFK 412
T+ E+ T G P+AG+ EIY ++K +L PP ++++++ +C +
Sbjct: 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD--------CLEDVYELMCQCWSPE 255
Query: 413 ASKRPTFSAM 422
RP+F +
Sbjct: 256 PKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 38/122 (31%), Positives = 50/122 (40%), Gaps = 27/122 (22%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A I G+ LH +V ++KP N+LLD G +SD GLA LK K R
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG--- 156
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+P Y APE + + S D ++ GCTL EM G
Sbjct: 157 ------------TPGYMAPE----------VLQGEVYDFSV--DWFALGCTLYEMIAGRS 192
Query: 366 PW 367
P+
Sbjct: 193 PF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 46/195 (23%), Positives = 78/195 (40%), Gaps = 49/195 (25%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L L+ +L++ DIA G+ L + ++ N +L V+D+GL
Sbjct: 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL---------- 159
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWE-PVK----KSL--NLFWDDAIGISPESDA 350
S +I+S Y + PVK +SL ++ + +SD
Sbjct: 160 -------SKKIYS-------GDYYRQGRIAKMPVKWIAIESLADRVY-------TSKSDV 198
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGE 407
W+FG T+ E+ T G P+ G+ EIY + +L P EL+ ++
Sbjct: 199 WAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED--------CLDELYDLMYS 250
Query: 408 CLQFKASKRPTFSAM 422
C + RPTF+ +
Sbjct: 251 CWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 63/273 (23%), Positives = 117/273 (42%), Gaps = 46/273 (16%)
Query: 164 GRCRHSVAVK--KVMIAEEMEPDWLS-----GQLDNLRRASMWCRNVCTFHGVLRMDSCL 216
G+ VA+K K E+ D+LS GQ D+ N+ GV+ S
Sbjct: 29 GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH--------PNIIHLEGVV-TKSRP 79
Query: 217 GLVMDRCY--GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
+++ G++ +++N+G+ T+ Q++ IA G+ L V ++ N+L+
Sbjct: 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV 139
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
+++ VSD+GL+ L+ +I +TAPEA K
Sbjct: 140 NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI---------PIRWTAPEAIAYRK--- 187
Query: 335 NLFWDDAIGISPESDAWSFGCTLVE-MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ SD WS+G + E M G P+ +S +++ A+ ++ +LPP
Sbjct: 188 ---------FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP----- 233
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426
+ P L +++ +C Q + RP F +++T
Sbjct: 234 -MDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 74/313 (23%), Positives = 130/313 (41%), Gaps = 70/313 (22%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---------VAVKKVMIAEEMEPDWLSG 188
+K +++LG+G VE+ CR+ VAVKK+ +
Sbjct: 6 LKFIQQLGKGNFGSVEL-----------CRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER 54
Query: 189 QLDNLRRASMWCRNVCTFHGVLRMDSC-------LGLVMDRC-YGSVQLAMQRNEGRLTL 240
+++ L+ S+ N+ + GV C L LVM+ YGS++ +Q++ RL
Sbjct: 55 EIEILK--SLQHDNIVKYKGV-----CYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH 107
Query: 241 EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
++L Y + I +G+ L + V ++ N+L+++ R + D+GL +L +
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
E S I + APE SL ++ S SD WSFG L E+
Sbjct: 168 REPGESPIF-----------WYAPE-------SLT----ESK-FSVASDVWSFGVVLYEL 204
Query: 361 CTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGV-----------GIPRELWKMIGECL 409
T S A E R + +++ ++ + G P E++ ++ EC
Sbjct: 205 FTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECW 263
Query: 410 QFKASKRPTFSAM 422
S+RP+FS +
Sbjct: 264 NNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-07
Identities = 34/95 (35%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L QL + GD G R LL+ A N ++ DG+T LH+AC G ++V +L
Sbjct: 86 LCQLAASGDAVGARILLTGGADPN----------CRDYDGRTPLHIACANGHVQVVRVLL 135
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
E+ + +LDKDG PL A G E V L +
Sbjct: 136 EFGAD-PTLLDKDGKTPLELAEENGFREVVQLLSR 169
|
Length = 664 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-07
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 27/192 (14%)
Query: 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVC 264
T H + ++ L L++D G + +++ Y +I + LH G+V
Sbjct: 69 TLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVY 128
Query: 265 MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAP 324
+IK N+LLD+ G V++D+GL+ K + R +S Y AP
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLS---------KEFLSEEKERTYSFCGTI----EYMAP 175
Query: 325 EAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR- 383
E G D WS G + E+ TG+ P+ L E ++ V R
Sbjct: 176 EIIR-----------GKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRI 223
Query: 384 -KLPPQYASIVG 394
K P + S +G
Sbjct: 224 LKCDPPFPSFIG 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 33/221 (14%)
Query: 202 NVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
N+ GV+ + + +V + G++ ++++EG+L Q++ +A G+ L
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
G V + +L+++ +S + E S I++ M
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRL------------QEDKSEAIYTTMSGKSPVL- 173
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE-MCTGSIPWAGLSAEEIYRAV 379
+ APEA + S SD WSFG + E M G P+ +S +++ +AV
Sbjct: 174 WAAPEAIQYHH------------FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
Query: 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420
+LP P L +++ +C Q + +RP FS
Sbjct: 222 EDGFRLPAP------RNCPNLLHQLMLDCWQKERGERPRFS 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 46/190 (24%), Positives = 83/190 (43%), Gaps = 36/190 (18%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L L Q++ A IA G+ + V +++ +N+L+ + V+D+GLA +++
Sbjct: 99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 156
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
++ +TAPEA L+ I +SD WSFG L
Sbjct: 157 -----------YTARQGAKFPIKWTAPEA--------ALYGRFTI----KSDVWSFGILL 193
Query: 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGECLQFKAS 414
E+ T G +P+ G+ E+ V + ++ PP+ P L ++ +C + +
Sbjct: 194 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--------CPESLHDLMCQCWRKEPE 245
Query: 415 KRPTFSAMLA 424
+RPTF + A
Sbjct: 246 ERPTFEYLQA 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWC 200
++K+G+G +G G R + VA+K ++ EE E + Q + +
Sbjct: 9 LEKIGKGS------FGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 201 RNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
V ++G D+ L ++M+ G L + G L QI +I +G+ LH+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSE 120
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
+ +IK +N+LL G ++D+G+A L ++ + + +P
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--------------NTFVGTPF 166
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
+ APE +K+S ++D WS G T +E+ G P + L ++ +
Sbjct: 167 WMAPEV---IKQS---------AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214
Query: 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
KN PP + L + + CL + S RPT +L
Sbjct: 215 KNN--PPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-07
Identities = 14/52 (26%), Positives = 25/52 (48%)
Query: 582 SVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVIL 633
+ H A G+ + ++ LL G D N D++G + LH A + ++L
Sbjct: 3 TALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|214546 smart00184, RING, Ring finger | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-07
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 6/46 (13%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRC 53
C +C Y + P++L CGH FC+ C+ + + +T CP C
Sbjct: 1 CPICLEEY---LKDPVILPCGHTFCRSCIRKWLESGNNT---CPIC 40
|
E3 ubiquitin-protein ligase activity is intrinsic to the RING domain of c-Cbl and is likely to be a general function of this domain; Various RING fingers exhibit binding activity towards E2 ubiquitin-conjugating enzymes (Ubc' s). Length = 40 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-07
Identities = 14/30 (46%), Positives = 22/30 (73%)
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRN 755
T LH+A+ +E+VK++L+AG DVN R+
Sbjct: 3 NTPLHLAARNGHLEVVKLLLEAGADVNARD 32
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 57/267 (21%), Positives = 101/267 (37%), Gaps = 41/267 (15%)
Query: 166 CRHSVAVKKVMI----AEEMEPDWLSGQLDNLRRASMWCR-NVCTFHGVLRMDSCLGLVM 220
CR K V+I E+M D + + + N+ ++ D L +VM
Sbjct: 19 CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78
Query: 221 DRCYGSV--QLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
+ G + +R L + IL + I + +H ++ ++K N+LLD
Sbjct: 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK 138
Query: 279 RAV-VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLF 337
V + D+G++ IL SS+ S + +P Y +PE E K N
Sbjct: 139 MVVKIGDFGISKIL-------------SSK--SKAYTVVGTPCYISPELCE--GKPYN-- 179
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGI 397
+SD W+ GC L E+ + + + + ++ P +
Sbjct: 180 --------QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP------ISDRY 225
Query: 398 PRELWKMIGECLQFKASKRPTFSAMLA 424
+L ++I L SKRP S ++A
Sbjct: 226 SPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-07
Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 29/184 (15%)
Query: 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
VM+ G L M + + + + Y A + G+ LH +V ++K NLLLD G
Sbjct: 80 VMEYAAGG-DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138
Query: 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLF 337
++D+GL C T +P + APE
Sbjct: 139 FVKIADFGL---------------CKEGMGFGDRTSTFCGTPEFLAPEVL------TETS 177
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGI 397
+ A+ D W G + EM G P+ G EE++ ++V + P++ S + I
Sbjct: 178 YTRAV------DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISI 231
Query: 398 PREL 401
R L
Sbjct: 232 MRRL 235
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 48/212 (22%)
Query: 213 DSCLGLVMDRCYG-SVQLAMQRNEGRLTLE-QILRYGADIARGVVELHAAGVVCMNIKPS 270
D L +VM C G + ++ +G+L E Q++ + IA + LH ++ ++K
Sbjct: 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ 131
Query: 271 NLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEP 329
N+ L + V D G+A +L+ +CD M T++ +P Y +PE +
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLEN--------QCD-------MASTLIGTPYYMSPELFS- 175
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE----IYRAVVKNRKL 385
K N +SD W+ GC + EM T +A++ +YR + KL
Sbjct: 176 -NKPYNY----------KSDVWALGCCVYEMATLK---HAFNAKDMNSLVYRII--EGKL 219
Query: 386 PPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
PP +P++ +GE + SKRP
Sbjct: 220 PP---------MPKDYSPELGELIATMLSKRP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 172 VKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG-SVQLA 230
+KK ++ ++ + DW+ + AS V H + +S L V++ G +
Sbjct: 28 IKKELVNDDEDIDWVQTEKHVFETASNHPFLV-GLHSCFQTESRLFFVIEFVSGGDLMFH 86
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
MQR +L E Y A+I+ + LH G++ ++K N+LLDA G ++DYG+
Sbjct: 87 MQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM--- 142
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
C++ D++ C +PNY APE + + G S D
Sbjct: 143 -----CKEGIRPGDTTSTF----CG--TPNYIAPE----------ILRGEDYGFS--VDW 179
Query: 351 WSFGCTLVEMCTGSIPW 367
W+ G + EM G P+
Sbjct: 180 WALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 35/153 (22%), Positives = 64/153 (41%), Gaps = 28/153 (18%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A+I ++ LH G++ ++K N+LLD G ++D+G+ C
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM---------------CKE 145
Query: 306 SRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
+ T +P+Y APE + + P D W+ G L EM G
Sbjct: 146 GIFNGKTTSTFCGTPDYIAPEILQEML------------YGPSVDWWAMGVLLYEMLCGH 193
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGI 397
P+ + ++++ A++ + + P + S V I
Sbjct: 194 APFEAENEDDLFEAILNDEVVYPTWLSQDAVDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 34/150 (22%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A+I G+ +LH +V ++KP N+LLD G +SD GLA + + K R
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----- 161
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ + Y APE VK F SP D W+ GC L EM G
Sbjct: 162 ----------VGTVGYMAPEV---VKNERYTF-------SP--DWWALGCLLYEMIAGQS 199
Query: 366 PWA----GLSAEEIYRAVVKNRKLPPQYAS 391
P+ + EE+ R V +++ +Y+
Sbjct: 200 PFQQRKKKIKREEVERLV---KEVQEEYSE 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-07
Identities = 48/177 (27%), Positives = 71/177 (40%), Gaps = 44/177 (24%)
Query: 498 SSISSLLKAQNAD--------GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPL 549
+ I+ LL + AD G TALH A L E +L Y NV++ DK + PL
Sbjct: 147 AEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGA-NVNIPDKTNNSPL 205
Query: 550 VFALAAGSPECVHALIKRGANVISRLREGFGP---SVAHVCAY--------HG------- 591
A+ + VH L++ GA+ +R + G P SV + Y HG
Sbjct: 206 HHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKS 265
Query: 592 -------------QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD---CAIVI 632
++ LL GAD N+++ + L AV K+Y I+I
Sbjct: 266 YILGLTALHSSIKSERKLKLLLEYGADINSLNSYKLTPLSSAV-KQYLCINIGRILI 321
|
Length = 477 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-07
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 27/152 (17%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+QR EGR L + Y A++ + LH V+ ++KP N+LLD G + D+GL
Sbjct: 84 LQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL--- 139
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
C+ + D + + +P Y APE G + D
Sbjct: 140 -----CKLNMKDDDKT------NTFCGTPEYLAPELLL------------GHGYTKAVDW 176
Query: 351 WSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKN 382
W+ G L EM TG P+ + E+YR +++
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 8e-07
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 66/251 (26%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIAEEMEPDWLSGQLDNL 193
+++ +GEG A V +CR+ VA+KK +E+ E ++
Sbjct: 4 EVLGVVGEG--AYGVVL---------KCRNKATGEIVAIKKFKESEDDE---------DV 43
Query: 194 RRASMWCR-----------NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQ 242
++ ++ R N+ R L LV + ++ ++ + G L +
Sbjct: 44 KKTAL--REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA 101
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
+ Y + + + H+ ++ +IKP N+L+ SG + D+G A L R A P
Sbjct: 102 VRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL---RARPASPL 158
Query: 303 CD--SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
D ++R Y APE L D G D W+ GC + E+
Sbjct: 159 TDYVATRW------------YRAPEL---------LVGDTNYG--KPVDVWAIGCIMAEL 195
Query: 361 CTGSIPWAGLS 371
G + G S
Sbjct: 196 LDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-07
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 34/166 (20%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGN-----------YSSSIS-------SLLK------AQ 507
LH V EGDV V +LL + + ++I L+
Sbjct: 72 LHDAVEEGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIP 131
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
N D + LHLA G + +E ++++ + +D+ D G PL+ A+A G L+
Sbjct: 132 NTDKFSPLHLAVMMGDIKGIELLIDH-KACLDIEDCCGCTPLIIAMAKGDIAICKMLLDS 190
Query: 568 GANV--ISRLREGFGPSVAHVCA--YHGQPDCMRELLLAGADPNAV 609
GAN+ + VA +C + + D +R + GAD N +
Sbjct: 191 GANIDYFGK-----NGCVAALCYAIENNKIDIVRLFIKRGADCNIM 231
|
Length = 413 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-07
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 42/236 (17%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNLRRASMW 199
++KLGEG A V + I G VA+K + M EE P +R AS+
Sbjct: 10 LEKLGEGSYATVYKGISRING------QLVALKVISMKTEEGVP------FTAIREASLL 57
Query: 200 ----CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
N+ H ++ L V + + + M ++ G L + + + RG+
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
+H ++ ++KP NLL+ G ++D+GLA R + S+ +S T
Sbjct: 118 YIHGQHILHRDLKPQNLLISYLGELKLADFGLA-----------RAKSIPSQTYSSEVVT 166
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
+ Y P+ A S D W GC +EM G + G+S
Sbjct: 167 LW---YRPPDVLL-----------GATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 66/276 (23%), Positives = 109/276 (39%), Gaps = 65/276 (23%)
Query: 170 VAVKKV-MIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVL-----------RMDSCLG 217
+AVK++ E L LD R+ C TF+G L MD+ L
Sbjct: 29 MAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGALFREGDVWICMEVMDTSL- 86
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVE----LHAA-GVVCMNIKPSNL 272
D+ Y V +G E IL IA +V+ LH+ V+ ++KPSN+
Sbjct: 87 ---DKFYKKVYD-----KGLTIPEDIL---GKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKK 332
L++ +G+ + D+G++ L + C Y APE P
Sbjct: 136 LINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------------YMAPERINPEL- 179
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA--GLSAEEIYRAVVKNR--KLPPQ 388
+ G +SD WS G T++E+ TG P+ +++ + VV+ +LP +
Sbjct: 180 -------NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQVVEEPSPQLPAE 231
Query: 389 YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
S E + +CL+ +RP + +L
Sbjct: 232 KFSP-------EFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 9e-07
Identities = 38/120 (31%), Positives = 52/120 (43%), Gaps = 32/120 (26%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I RG+ +H+A V+ ++KPSNLLL+ + + D+GLA R A PE D +
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA--------RIADPEHDHTG-- 164
Query: 310 SCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
L+ Y APE K + AI D WS GC L EM +
Sbjct: 165 ------FLTEYVATRWYRAPEIMLNSKG-----YTKAI------DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-06
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 18/130 (13%)
Query: 736 NDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSC---VGLLLSAGADCNWQDDEGD 792
VE V+ +L AG DVN R + PLH+ L ++ V LLL AGAD N + G
Sbjct: 25 VTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGF 84
Query: 793 NAFHI---AADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT-LRDFLEGLPREWISED 848
H+ A +I+ +++ A V ++ G+T L +L G I+
Sbjct: 85 TPLHLYLYNATTLDVIK-------LLIKA-GADVNAKDKVGRTPLHVYLSGF---NINPK 133
Query: 849 LMEALMNRGV 858
++ L+ +G
Sbjct: 134 VIRLLLRKGA 143
|
Length = 471 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 63/305 (20%), Positives = 124/305 (40%), Gaps = 67/305 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIA-EEMEPDWLSGQL 190
D++ + +LG G V + H +AVK + + E + +L
Sbjct: 2 DLEYLGELGAG--NSGVVS---------KVLHRPTGKIMAVKTIRLEINEAIQKQILREL 50
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
D L + + + F+G + + + M+ GS+ ++ +GR+ E+IL
Sbjct: 51 DILHKCN--SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP-ERIL---GK 104
Query: 250 IARGVV----ELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
IA V+ LH ++ ++KPSN+L+++ G+ + D+G++ L
Sbjct: 105 IAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------------- 151
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
++S + + +Y APE + S+ +SD WS G +L+E+ TG
Sbjct: 152 ---VNSLAKTFVGTSSYMAPERIQGNDYSV------------KSDIWSLGLSLIELATGR 196
Query: 365 IPWAGLSAE-----EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
P+ + E+ + +V PP+ S + + CL +RP++
Sbjct: 197 FPYPPENDPPDGIFELLQYIVNEP--PPRLPSGK---FSPDFQDFVNLCLIKDPRERPSY 251
Query: 420 SAMLA 424
+L
Sbjct: 252 KELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 41/175 (23%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A+IA + LH+ ++ ++KP N+LLD+ G V++D+GL C
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---------------CKE 145
Query: 306 SRIHSCMDCTML-SPNYTAPEAW--EPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
HS T +P Y APE +P +++ D W G L EM
Sbjct: 146 GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV--------------DWWCLGAVLYEMLY 191
Query: 363 GSIPWAGLSAEEIYRAVV-KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR 416
G P+ E+Y ++ K +L P I ++ LQ +KR
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLRLKP--------NISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-06
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 33/189 (17%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L+ +Q++ IA G+ LH GV+ +I N ++D + ++D L+ R
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS--------R 165
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
P MD L N P W ++ +N + A SD WSFG L
Sbjct: 166 DLFP----------MDYHCLGDNENRPVKWMALESLVNKEYSSA------SDVWSFGVLL 209
Query: 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASK 415
E+ T G P+ + E+ + +L P + P EL+ ++ C +
Sbjct: 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP-------INCPDELFAVMACCWALDPEE 262
Query: 416 RPTFSAMLA 424
RP+FS ++
Sbjct: 263 RPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 30/170 (17%)
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTL---EQILRYGADIAR 252
++M N+ + + L +VMD C G L + N R L +QIL + I
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGG-DLYKKINAQRGVLFPEDQILDWFVQICL 112
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+ +H ++ +IK N+ L G + D+G+A +L AR +C+
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELAR---------TCI 162
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+P Y +PE E + N +SD W+ GC L EMCT
Sbjct: 163 G----TPYYLSPEICE--NRPYN----------NKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 28/143 (19%)
Query: 241 EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
E+ + Y A+I G+ +LH +V ++KP N+LLD G +SD GLA + + + R
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
+ + Y APE VK ++ SP D W GC + EM
Sbjct: 162 ---------------VGTVGYMAPEV---VK-------NERYTFSP--DWWGLGCLIYEM 194
Query: 361 CTGSIPWAGLSAEEIYRAVVKNR 383
G P+ E++ R V+ R
Sbjct: 195 IEGKSPFRQ-RKEKVKREEVERR 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 206 FHGVLRMDSCLGLVM--------DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVEL 257
F+G ++ + + M D+ Y E L R + +G+ L
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 258 HAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
++ ++KP+N+L++ +G+ + D+G++ L + K C S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTNIGCQS----------- 166
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
Y APE KS + + +SD WS G +++EM G P+ + I+
Sbjct: 167 ----YMAPERI----KSGGP--NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216
Query: 377 ---RAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
A+V LP Y+ + + +CL ++RPT++ +L
Sbjct: 217 AQLSAIVDGDPPTLPSGYSD--------DAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-06
Identities = 25/93 (26%), Positives = 45/93 (48%)
Query: 706 ELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVA 765
E +++L GA+ +D +HIA N +++K++L+ G N+++ + PLH A
Sbjct: 138 ESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNA 197
Query: 766 LARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798
G +C+ LL+ G + G H A
Sbjct: 198 AEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNA 230
|
Length = 434 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 68/322 (21%), Positives = 133/322 (41%), Gaps = 48/322 (14%)
Query: 522 GSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGP 581
G E +E I++ +++ + PL+ A+ +G + V IK GA++
Sbjct: 12 GDIEAIEKIIKNKGNCINISVDETTTPLIDAIRSGDAKIVELFIKHGADI-----NHINT 66
Query: 582 SVAH---VCAYHGQPDCMRELLLAGADPNAV---DDEGESVLHRAVAKKYTDCAIVILEN 635
+ H G D ++ L+ G D + + E + + K DC I
Sbjct: 67 KIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMI------KTILDCGI----- 115
Query: 636 GGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPG--PVGTALCMA 693
+ I +++ T LH + ++ +K E + VN+ D G P+ A+
Sbjct: 116 ----DVNIKDAELKTFLHYAIKKGDLESIKMLFEYGAD---VNIEDDNGCYPIHIAI--- 165
Query: 694 AALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNI 753
+ +++++LL GA +D + LH A+ D +K+++D G +
Sbjct: 166 -------KHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMN 218
Query: 754 RNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLI 813
+ + PLH A+ +S + LL++ A N QD +G H A + I +I
Sbjct: 219 KCKNGFTPLHNAIIHN-RSAIELLIN-NASINDQDIDGSTPLHHAINPPCDID-----II 271
Query: 814 VMLSHPDAAVEVRNHSGKTLRD 835
+L + A + ++++ G+ D
Sbjct: 272 DILLYHKADISIKDNKGENPID 293
|
Length = 434 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-06
Identities = 19/53 (35%), Positives = 29/53 (54%), Gaps = 1/53 (1%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
TALH A G ELV+ +LE +++ D+DG+ L A G+ E + L+
Sbjct: 3 TALHKAAISGRLELVKYLLEKG-VDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 11/45 (24%), Positives = 22/45 (48%), Gaps = 2/45 (4%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPR 52
C + + ++E P++L CGH + ++ L ++ A CP
Sbjct: 13 CPISKEVMTDEENPPVMLPCGHVYSRKALEKL--AKNGGKFKCPY 55
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 62/278 (22%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR----NVCTFHGVLRMDSCLG----LVMD 221
VAVK + +E +G+ + LR AS+ + + GV C G LVM+
Sbjct: 26 VAVK--TLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGV-----CKGEPLMLVME 75
Query: 222 RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV 281
L + + + + +A G+ L + V ++ N+LL +A
Sbjct: 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK 135
Query: 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEA--WEPVK----KSLN 335
+SD+G++ R D Y A A W P+K + +N
Sbjct: 136 ISDFGMS--------RALGAGSDY---------------YRATTAGRW-PLKWYAPECIN 171
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIV 393
S +SD WS+G TL E + G+ P+ + E+ + +LP P+
Sbjct: 172 YG-----KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE----- 221
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431
P+E++ ++ C +++ RPTFS + +TF R +
Sbjct: 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 28/152 (18%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
R+ EQI + + + LHA GV+ +IK ++LL GR +SD+G A + K
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
R+ + +P + APE + PE D WS G
Sbjct: 172 RRKS--------------LVGTPYWMAPELIS------------RLPYGPEVDIWSLGIM 205
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ 388
++EM G P+ + + + N LPP+
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDN--LPPK 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 51/192 (26%), Positives = 80/192 (41%), Gaps = 46/192 (23%)
Query: 245 RYGADIAR----GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
++ AD+AR G+ LH +V +IKPSNLL++++ ++D+G++ IL +
Sbjct: 168 QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA-----QTM 222
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNL-FWDDAIGISPESDAWSFGCTLVE 359
C+SS + + Y +PE + LN +D G D WS G +++E
Sbjct: 223 DPCNSS---------VGTIAYMSPER---INTDLNHGAYDGYAG-----DIWSLGVSILE 265
Query: 360 MCTGSIP--------WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411
G P WA L P AS RE I CLQ
Sbjct: 266 FYLGRFPFGVGRQGDWASLMCAICM----SQPPEAPATAS-------REFRHFISCCLQR 314
Query: 412 KASKRPTFSAML 423
+ +KR + +L
Sbjct: 315 EPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-06
Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 50/232 (21%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKV-MIAEEMEPDWLSGQ------- 189
KKLGEG A V + R + + VA+KK+ + + D ++
Sbjct: 5 GKKLGEGTYAVVY---------KARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKL 55
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
L L+ N+ V S + LV + ++ ++ LT I Y
Sbjct: 56 LQELKHP-----NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
RG+ LH+ ++ ++KP+NLL+ + G ++D+GL AR +R
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL-----------ARSFGSPNRK- 158
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
M +++ Y APE LF A D WS GC E+
Sbjct: 159 --MTHQVVTRWYRAPEL---------LF--GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 9/82 (10%)
Query: 343 GISPESDAWSFGCTLVEMC-TGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPREL 401
+S +D WSFG TL+E+C G +P + E R K +LP +EL
Sbjct: 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSC--------KEL 248
Query: 402 WKMIGECLQFKASKRPTFSAML 423
+I +CL ++ ++RP+F +L
Sbjct: 249 ATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 33/184 (17%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILR-YGADIARGVVELHAAGVVCMNIKPSNLLL 274
L VM+ G +L + R+ E+ R YGA+I + LH+ VV +IK NL+L
Sbjct: 70 LCFVMEYANGG-ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
D G ++D+GL C++ + + M +P Y APE E
Sbjct: 129 DKDGHIKITDFGL--------CKEGISD------GATMKTFCGTPEYLAPEVLE------ 168
Query: 335 NLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKN-----RKLPPQY 389
D+ G + D W G + EM G +P+ E ++ ++ R L P+
Sbjct: 169 ----DNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222
Query: 390 ASIV 393
S++
Sbjct: 223 KSLL 226
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-06
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 45/237 (18%)
Query: 202 NVCTFHG--VLRMDSCLGLVMDRCYG----SVQLAMQRNEGRLTLEQILRYGADIARGVV 255
+ ++G + S +G+ M+ C G S+ +++ GR+ + + + + +G+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
LH+ ++ +IKPSN+LL G+ + D+G+ S + + + T
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV-----------------SGELVNSLAGT 162
Query: 316 MLSPN-YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-----AG 369
+ Y APE + S+ SD WS G TL+E+ P+
Sbjct: 163 FTGTSFYMAPERIQGKPYSIT------------SDVWSLGLTLLEVAQNRFPFPPEGEPP 210
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGI--PRELWKMIGECLQFKASKRPTFSAMLA 424
L E+ +V P+ G GI E I +CL+ ++RPT ML
Sbjct: 211 LGPIELLSYIV--NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 28/135 (20%)
Query: 241 EQILR-YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299
E +R Y A+I G+ +H VV ++KP+N+LLD G +SD GLA
Sbjct: 96 EAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----------- 144
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
CD S+ ++ + Y APE + + +D +S GC L +
Sbjct: 145 ---CDFSKKKP--HASVGTHGYMAPEVLQ-----------KGVAYDSSADWFSLGCMLFK 188
Query: 360 MCTGSIPWAGLSAEE 374
+ G P+ ++
Sbjct: 189 LLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 29/154 (18%)
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293
++ RL EQI + + + LH+ GV+ +IK ++LL GR +SD+G A + K
Sbjct: 110 SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
++ + +P + APE + ++ E D WS
Sbjct: 170 DVPKRKS--------------LVGTPYWMAPEV---ISRTP---------YGTEVDIWSL 203
Query: 354 GCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPP 387
G ++EM G P+ ++ +A+ + R PP
Sbjct: 204 GIMVIEMVDGEPPYF---SDSPVQAMKRLRDSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 217 GLVMDRCYGSVQLAMQRNEGR----LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
G V ++ V+ E LTLE ++ Y +A+G+ L + + ++ N+
Sbjct: 151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNI 210
Query: 273 LLDASGRAVVSDYGLAA-ILKKPA-CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPV 330
LL + + D+GLA I K P RK L + APE
Sbjct: 211 LLSENNVVKICDFGLARDIYKDPDYVRKGDAR--------------LPLKWMAPET---- 252
Query: 331 KKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVK--NRKLPP 387
+D I +SD WSFG L E+ + G+ P+ G+ +E + +K R P
Sbjct: 253 ------IFDRVYTI--QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 304
Query: 388 QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
Y + E+++ + +C + S+RPTFS ++
Sbjct: 305 DYTT-------PEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 38/200 (19%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-ILKKPA- 295
LT+E ++ Y +ARG+ L + + ++ N+LL + + D+GLA I K P
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
RK S+R L + APE+ +F D + + +SD WSFG
Sbjct: 231 VRKG-----SAR---------LPLKWMAPES---------IF--DKVYTT-QSDVWSFGV 264
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFK 412
L E+ + G+ P+ G+ E + +K+ R P+ A+ E+++++ C Q
Sbjct: 265 LLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENAT-------PEIYRIMLACWQGD 317
Query: 413 ASKRPTFSAMLATFLRHLQE 432
+RPTFSA++ LQE
Sbjct: 318 PKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-06
Identities = 38/147 (25%), Positives = 72/147 (48%), Gaps = 7/147 (4%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
++A+ +T LH A ++G E ++ + EY +V++ D +G P+ A+ + + L++
Sbjct: 120 KDAELKTFLHYAIKKGDLESIKMLFEY-GADVNIEDDNGCYPIHIAIKHNFFDIIKLLLE 178
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626
+GA + +++ G S H A +G C++ L+ G G + LH A+ +
Sbjct: 179 KGA--YANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAII--HN 234
Query: 627 DCAIVILENGGCRSMAILNSKELTPLH 653
AI +L N S+ + TPLH
Sbjct: 235 RSAIELLINN--ASINDQDIDGSTPLH 259
|
Length = 434 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-06
Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 49/217 (22%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+++ L ++ +Y I RG+ H+ ++ +IKP N+L+ SG + D+G A
Sbjct: 90 LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 149
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
L P D + + Y APE L D G + D
Sbjct: 150 LAAPG-------------EVYTD-YVATRWYRAPEL---------LVGDTKYGRA--VDI 184
Query: 351 WSFGCTLVEMCTGSIPWAGLS-AEEIYRAVVKNRKLPPQYASI-------VGVGIPR--- 399
W+ GC + EM TG + G S +++Y + L P++ I G+ +P
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244
Query: 400 -------------ELWKMIGECLQFKASKRPTFSAML 423
+ + +CL+ RP+ S +L
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 27/147 (18%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
YGA+I + LH+ +V ++K NL+LD G ++D+GL C++ +
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGL--------CKEGITDA-- 149
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ M +P Y APE E D+ G + D W G + EM G +
Sbjct: 150 ----ATMKTFCGTPEYLAPEVLE----------DNDYGRA--VDWWGLGVVMYEMMCGRL 193
Query: 366 PWAGLSAEEIYRAVV-KNRKLPPQYAS 391
P+ E+++ ++ ++ K P ++
Sbjct: 194 PFYNQDHEKLFELILMEDIKFPRTLSA 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-06
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYG-SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
N+ + ++ L ++++ C G ++ M E LT QI + + LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN 320
V+ ++K N+LL G ++D+G++A K ++ D + +P
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--------------DTFIGTPY 168
Query: 321 YTAPE--AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378
+ APE A E K D+ ++D WS G TL+E+ P L+ +
Sbjct: 169 WMAPEVVACETFK-------DNP--YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219
Query: 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
++K+ PP + CL RPT + +L
Sbjct: 220 ILKSE--PPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 47/198 (23%)
Query: 197 SMWC-----RNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251
SM+C R++C +VM+ G + +N G L ++ Y A+
Sbjct: 65 SMFCSFETKRHLC-------------MVMEYVEGGDCATLLKNIGALPVDMARMYFAETV 111
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI-LKKPACR--KARPECDSSRI 308
+ LH G+V ++KP NLL+ + G ++D+GL+ I L + E D+
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 309 HSCMDCTMLSPNYTAPEA------WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
C +P Y APE +PV D W+ G L E
Sbjct: 172 LDKQVCG--TPEYIAPEVILRQGYGKPV------------------DWWAMGIILYEFLV 211
Query: 363 GSIPWAGLSAEEIYRAVV 380
G +P+ G + EE++ V+
Sbjct: 212 GCVPFFGDTPEELFGQVI 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 20/162 (12%)
Query: 216 LGLVMDRCYGSVQLA-MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
L LVM+ G L+ + R E + + Y A++ + +H G V +IKP N+L+
Sbjct: 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
D +G ++D+G AA L ++ + +P+Y APE V ++
Sbjct: 136 DRTGHIKLADFGSAARL-------------TANKMVNSKLPVGTPDYIAPE----VLTTM 178
Query: 335 NLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
N G+ E D WS G EM G P+ ++ + Y
Sbjct: 179 NGDGKGTYGV--ECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-06
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 32/191 (16%)
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELH 258
+C N+ +G + +S L LV++ G R R + Y A I L
Sbjct: 92 FCVNL---YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 259 AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318
+ +V ++KP NLLLD G ++D+G A ++ +R ++ C +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-------------TRTYTL--CG--T 191
Query: 319 PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378
P Y APE LN +G +D W+ G + E+ G P+ IY+
Sbjct: 192 PEYIAPEIL------LN------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK 239
Query: 379 VVKNRKLPPQY 389
+++ P++
Sbjct: 240 ILEGIIYFPKF 250
|
Length = 340 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 44/196 (22%), Positives = 84/196 (42%), Gaps = 30/196 (15%)
Query: 225 GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284
G++ ++ ++G + Q++ IA G+ L V ++ N+L++++ VSD
Sbjct: 91 GALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSD 150
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344
+GL+ +L+ D + +TAPEA K
Sbjct: 151 FGLSRVLE-----------DDPEGTYTTSGGKIPIRWTAPEAIAYRK------------F 187
Query: 345 SPESDAWSFGCTLVE-MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK 403
+ SD WSFG + E M G P+ +S E+ +A+ +LP + P +++
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP------MDCPSAVYQ 241
Query: 404 MIGECLQFKASKRPTF 419
++ +C Q ++RP F
Sbjct: 242 LMLQCWQQDRARRPRF 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 72/306 (23%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCR---HSVAVKKVMIAEEMEPDW---------L 186
K+ KK+G+G+ + V+ + C VA+KKV I E M+ L
Sbjct: 5 KIEKKIGKGQFS--VVY-------KAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDL 55
Query: 187 SGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM---DRCYGSVQLAMQRNEGRLTLE-Q 242
QLD+ NV + ++ L +V+ D S + + + RL E
Sbjct: 56 LKQLDH--------PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
I +Y + + +H+ ++ +IKP+N+ + A+G + D GL
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--------- 158
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
++ HS + +P Y +PE + ++ G + +SD WS GC L EM
Sbjct: 159 -KTTAAHSLVG----TPYYMSPER---IHEN---------GYNFKSDIWSLGCLLYEMAA 201
Query: 363 GSIPWAGLSAEEIYRAVVKNRK-----LPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
P+ G +Y K K LP + S EL ++ C+ KRP
Sbjct: 202 LQSPFYG-DKMNLYSLCKKIEKCDYPPLPADHYS-------EELRDLVSRCINPDPEKRP 253
Query: 418 TFSAML 423
S +L
Sbjct: 254 DISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-06
Identities = 20/56 (35%), Positives = 25/56 (44%), Gaps = 8/56 (14%)
Query: 761 PLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN---LEWLI 813
LH A G V LL G D N D++G+ A HIAA N L+ L+
Sbjct: 4 ALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAA-----ENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-06
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 6/58 (10%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIIL 745
TAL AA ELV+ LL G + D TALHIA+ ++E++K++L
Sbjct: 3 TALHKAA--ISGRL----ELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-06
Identities = 16/57 (28%), Positives = 28/57 (49%), Gaps = 1/57 (1%)
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA 620
L++ G + +G G + H+ A +G + ++ LL G D N D +G + L A
Sbjct: 1 LLEHGPIDL-NATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTALDLA 56
|
Length = 56 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 34/196 (17%)
Query: 233 RNEGR-LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-I 290
R+E T++ ++ +G +A+G+ L + V ++ N +LD S V+D+GLA I
Sbjct: 89 RSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
K E S H+ L + A E+ + K + +SD
Sbjct: 149 YDK--------EYYSVHNHTG---AKLPVKWMALESLQTQK------------FTTKSDV 185
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGEC 408
WSFG L E+ T G+ P+ + + +I +++ R+L P+Y P L++++ C
Sbjct: 186 WSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC-------PDPLYEVMLSC 238
Query: 409 LQFKASKRPTFSAMLA 424
K RPTFS +++
Sbjct: 239 WHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 57/304 (18%)
Query: 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ L ++LGEG V + G + VAVK + +E + + D R
Sbjct: 5 DTIVLKRELGEGAFGKVFL-GECYHLEPENDKELVAVKTL---KETASN--DARKDFERE 58
Query: 196 ASMWC----RNVCTFHGVLRMDSCLGLVMD-----------RCYG--SVQLAMQRNE-GR 237
A + N+ F+GV +V + R +G + L + G
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LTL Q+L+ IA G+V L + V ++ N L+ + D+G++ +
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT---- 174
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
D R+ TML + PE+ K + ESD WSFG L
Sbjct: 175 -----TDYYRVGGH---TMLPIRWMPPESIMYRKFTT------------ESDVWSFGVVL 214
Query: 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGECLQFKASK 415
E+ T G PW GLS EE+ + + R L P+ P E++ ++ C + +
Sbjct: 215 WEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR-------TCPSEVYDIMLGCWKRDPQQ 267
Query: 416 RPTF 419
R
Sbjct: 268 RINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-06
Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 65/314 (20%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV------LRMDSCLGLVMDRC 223
V K VM+ +E + + R+ + C C G+ + D L L+M+
Sbjct: 96 VVAKFVMLNDERQAAY--------ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME-- 145
Query: 224 YGS----VQLAMQRNEGRLTLEQ----ILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
YGS + QR + L ++ +L Y I + E+H+ ++ ++K +N+ L
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFY--QIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
+G + D+G + K + S + S T P Y APE WE +
Sbjct: 204 PTGIIKLGDFGFS---------KQYSDSVSLDVASSFCGT---PYYLAPELWERKR---- 247
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGV 395
S ++D WS G L E+ T P+ G S EI + V+ + P
Sbjct: 248 --------YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP------FPC 293
Query: 396 GIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRHL----QELPR-SPPASPDTG---FT 446
+ + ++ L + RPT +L T FL+++ Q++ R S SP
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILR 353
Query: 447 KFSTSNETEPSPAS 460
+ S E P P+S
Sbjct: 354 QLQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-06
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 29/168 (17%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
L ++M+ G + RN GR + L Y ++I + LH+ +V ++KP N+
Sbjct: 73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKK 332
LLD G ++D+G A K + C +P Y APE +
Sbjct: 133 LLDKEGHIKLTDFGFA----KKLRDRTWTLCG-------------TPEYLAPEVIQ---- 171
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380
+ G + D W+ G + EM G P+ + IY ++
Sbjct: 172 --------SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 26/180 (14%)
Query: 218 LVMDRC-YGSVQLAMQRNEGRLTLEQ----ILRYGADIARGVVELHAAGVVCMNIKPSNL 272
LV++ C G ++ ++ N G + + R ++A G++ LH A + ++ N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKK 332
L A + DYGLA + PE + DC + + APE E +
Sbjct: 132 QLTADLSVKIGDYGLAL------EQ--YPE----DYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNR--KLP-PQ 388
L + +S+ WS G T+ E+ T P+ LS E++ + VV+ + KLP PQ
Sbjct: 180 DLL-----PKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165154 PHA02791, PHA02791, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 2/83 (2%)
Query: 722 DAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781
D +AL+ A N+V LV +L+AG N+ + N PLH A V +LL +G
Sbjct: 27 DVHGHSALYYAIADNNVRLVCTLLNAGALKNL--LENEFPLHQAATLEDTKIVKILLFSG 84
Query: 782 ADCNWQDDEGDNAFHIAADAAKM 804
D + DD+G+ A + A D+ M
Sbjct: 85 MDDSQFDDKGNTALYYAVDSGNM 107
|
Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA-EEMEPDWLSGQ---LDNL 193
VKL KLGEG A V G + VA+K++ + EE P + L NL
Sbjct: 8 VKL-DKLGEGTYATV------FKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARG 253
+ A N+ T H ++ + CL LV + ++ + +++ + + + RG
Sbjct: 61 KHA-----NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRG 115
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
+ H ++ ++KP NLL++ G ++D+GLA P K + + D
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPD 173
Query: 314 CTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373
+ S Y+ P D W GC L EM TG + G + +
Sbjct: 174 VLLGSTEYSTP-----------------------IDMWGVGCILYEMATGRPMFPGSTVK 210
Query: 374 E 374
E
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-06
Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
+ +G L L Q+L + IA G+V L + V ++ N L+ A+ + D+G++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--- 171
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
+ S+ + TML + PE+ K + ESD WS
Sbjct: 172 ---------DVYSTDYYRVGGHTMLPIRWMPPESIMYRK------------FTTESDVWS 210
Query: 353 FGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQ 410
FG L E+ T G PW LS E+ + + R L P+ P+E++ ++ C Q
Sbjct: 211 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-------PKEVYDIMLGCWQ 263
Query: 411 FKASKR 416
+ +R
Sbjct: 264 REPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 20/56 (35%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 744 ILDAG-VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798
+L+ G +D+N + + PLH+A GA V LL G D N +D +G A +A
Sbjct: 1 LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTALDLA 56
|
Length = 56 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 70/315 (22%), Positives = 128/315 (40%), Gaps = 68/315 (21%)
Query: 138 VKLVKKLGEGRRAGVEVW---GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLSGQLDN 192
+K ++ LGEG V ++ A G G+ VAVK K ++ W +++
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGE-----MVAVKTLKRECGQQNTSGWK-KEINI 59
Query: 193 LRRASMWCRNVCTFHGVL--RMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
L+ +++ N+ + G + L L+M+ GS++ + ++ +L L Q+L +
Sbjct: 60 LK--TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQ 115
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I G+ LH+ + ++ N+LLD + D+GLA KA PE
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA---------KAVPEGH----- 161
Query: 310 SCMDCTMLSPNYTAPEAWEPVK--KSLNLFWDDAIGISPESDAWSFGCTLVEMCTG---- 363
+ + + +P W V+ K + SD WSFG TL E+ T
Sbjct: 162 ---EYYRVREDGDSPVFWYAVECLKENKFSY--------ASDVWSFGVTLYELLTHCDSK 210
Query: 364 -SIPWAGLSAEEIYRAVV----------KNRKLP-PQYASIVGVGIPRELWKMIGECLQF 411
S P + + + +LP P+ P+E++ ++ C +
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK-------NCPQEVYILMKNCWET 263
Query: 412 KASKRPTFSAMLATF 426
+A RPTF +++
Sbjct: 264 EAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 43/197 (21%), Positives = 80/197 (40%), Gaps = 34/197 (17%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+++ +G+L+ + +L D+ G+ L + ++ N L+ ++G VSD+G+
Sbjct: 90 LRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-- 147
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
R D S ++ PE + K S +SD
Sbjct: 148 ---------RYVLDDEYTSSS--GAKFPVKWSPPEVFNFSK------------YSSKSDV 184
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVK-NRKLPPQYASIVGVGIPRELWKMIGEC 408
WSFG + E+ T G +P+ S E+ + + R P+ AS +++++ C
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS-------MTVYEVMYSC 237
Query: 409 LQFKASKRPTFSAMLAT 425
K RPTF+ +L
Sbjct: 238 WHEKPEGRPTFAELLRA 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 45/202 (22%), Positives = 87/202 (43%), Gaps = 37/202 (18%)
Query: 223 CYGSVQLAMQRNEGRLTLEQI--LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRA 280
YG++ L R R + + L I+ + L + ++ N L+ +
Sbjct: 85 TYGNL-LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 143
Query: 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD 340
V+D+GL+ ++ D+ H+ + +TAPE+ + N F
Sbjct: 144 KVADFGLSRLMTG----------DTYTAHAGAKFPI---KWTAPESL-----AYNKF--- 182
Query: 341 AIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIP 398
S +SD W+FG L E+ T G P+ G+ ++Y + K ++ P+ G P
Sbjct: 183 ----SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE-------GCP 231
Query: 399 RELWKMIGECLQFKASKRPTFS 420
++++++ C Q+ S RP+F+
Sbjct: 232 PKVYELMRACWQWNPSDRPSFA 253
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-05
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 21/138 (15%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A++ + +H+ G + ++KP N+LLD SG ++D+G + K + CD+
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR----CDT 202
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ + +P+Y +PE V KS D G E D WS G L EM G
Sbjct: 203 A---------VGTPDYISPE----VLKSQG--GDGYYG--RECDWWSVGVFLYEMLVGDT 245
Query: 366 PWAGLSAEEIYRAVVKNR 383
P+ S Y ++ ++
Sbjct: 246 PFYADSLVGTYSKIMNHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 54/263 (20%)
Query: 177 IAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV-----LRMDSCLGLVMDRCYGS----- 226
I EE+E ++ N+ +A NV F+G+ ++ L LV++ C G
Sbjct: 57 IDEEIEAEY------NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL 110
Query: 227 VQLAMQRNEGRLTLEQILRYGADIA-RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285
V+ ++R E R+ E I+ Y A G+ LH + ++K +N+LL G + D+
Sbjct: 111 VKGFLKRGE-RME-EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168
Query: 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS 345
G++A L R+ + ++ +P + APE ++ L+ +D
Sbjct: 169 GVSAQLTSTRLRR--------------NTSVGTPFWMAPEVI-ACEQQLDSTYDA----- 208
Query: 346 PESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK-- 403
D WS G T +E+ G P A L RA+ K + PP ELW
Sbjct: 209 -RCDVWSLGITAIELGDGDPPLADLHP---MRALFKIPRNPPPTLH------QPELWSNE 258
Query: 404 ---MIGECLQFKASKRPTFSAML 423
I +CL KRPT S +L
Sbjct: 259 FNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 43/140 (30%), Positives = 58/140 (41%), Gaps = 33/140 (23%)
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
LH G++ ++KP NLLLD++G + D+G A LK +K C
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCG------------ 154
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE--- 373
+P Y APE K + D WS G L E+ TG P+ E
Sbjct: 155 -TPEYVAPEIIL--NKGYDFS----------VDYWSLGILLYELLTGRPPFGE-DDEDPM 200
Query: 374 EIYRAVVK-NRKLP-PQYAS 391
EIY ++K N KL P Y
Sbjct: 201 EIYNDILKGNGKLEFPNYID 220
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-05
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
+L + IA+G++ L +V ++ N+L+ + ++D+GLA +L E
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL----------E 160
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
D ++ D + + A E K + +SD WS+G T+ E+ T
Sbjct: 161 GDEKEYNA--DGGKMPIKWMALECIHYRK------------FTHQSDVWSYGVTIWELMT 206
Query: 363 -GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420
G P+ G+ EI + K +LP P +I +++ ++ +C A RP F
Sbjct: 207 FGGKPYDGIPTREIPDLLEKGERLPQPPICTI-------DVYMVMVKCWMIDADSRPKFK 259
Query: 421 AMLATFLRHLQELPR 435
+ A F R ++ R
Sbjct: 260 ELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-05
Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 23/149 (15%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A++ + +H+ G++ ++KP N+LLD G ++D+G C K D
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG--------TCMKM----DE 194
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ + C D + +P+Y +PE V KS D G E D WS G L EM G
Sbjct: 195 TGMVRC-DTAVGTPDYISPE----VLKSQG--GDGYYG--RECDWWSVGVFLFEMLVGDT 245
Query: 366 PWAGLSAEEIYRAVV--KNRKLPPQYASI 392
P+ S Y ++ KN P+ I
Sbjct: 246 PFYADSLVGTYSKIMDHKNSLNFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|206094 pfam13923, zf-C3HC4_2, Zinc finger, C3HC4 type (RING finger) | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-05
Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 9/50 (18%)
Query: 7 CCSVCQTRYNEKERVPL-LLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + R P+ L CGH FC+EC+ R + CP CR
Sbjct: 4 ECPICL----DLLRDPVVLTPCGHVFCRECILRYLKKKS----KCPICRT 45
|
Length = 45 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 47/243 (19%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRC---RHSVAVKKVMIAEEMEPDWLSG---QL 190
+ ++ KK+G G+ + EV+ A C R VA+KKV I E M+ ++
Sbjct: 3 NFQIEKKIGRGQFS--EVYRA-------TCLLDRKPVALKKVQIFEMMDAKARQDCVKEI 53
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG---SVQLAMQRNEGRLTLEQ-ILRY 246
D L++ + NV + D+ L +V++ S + + + RL E+ + +Y
Sbjct: 54 DLLKQLNH--PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
+ V +H+ V+ +IKP+N+ + A+G + D GL ++
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS----------KTT 161
Query: 307 RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
HS + +P Y +PE G + +SD WS GC L EM P
Sbjct: 162 AAHSLVG----TPYYMSPERIHEN------------GYNFKSDIWSLGCLLYEMAALQSP 205
Query: 367 WAG 369
+ G
Sbjct: 206 FYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 39/187 (20%), Positives = 75/187 (40%), Gaps = 33/187 (17%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-ILKKPAC 296
L + ++++ DIA G+ L + + ++ N +L+ + V+D+GL+ I
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
R+ R P W ++ + + + +SD WSFG T
Sbjct: 169 RQGRIA-------------------KMPVKWIAIESLADRVY------TTKSDVWSFGVT 203
Query: 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK 415
+ E+ T G P+ G+ EIY + + +L + G L+ ++ C
Sbjct: 204 MWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDG------LYSLMSSCWLLNPKD 257
Query: 416 RPTFSAM 422
RP+F +
Sbjct: 258 RPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 13/30 (43%), Positives = 21/30 (70%)
Query: 724 QNRTALHIASMANDVELVKIILDAGVDVNI 753
RT LH+A+ ++E+VK++LD G D+N
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADINA 30
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 48/260 (18%)
Query: 170 VAVKKVMIAEEMEPDWLSG---QLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG- 225
VA+KKV I + M+ + ++D L++ + NV ++ D+ L +V++
Sbjct: 30 VALKKVQIFDLMDAKARADCIKEIDLLKQLNH--PNVIKYYASFIEDNELNIVLELADAG 87
Query: 226 --SVQLAMQRNEGRLTLEQ-ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282
S + + + RL E+ + +Y + + +H+ V+ +IKP+N+ + A+G +
Sbjct: 88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 147
Query: 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAI 342
D GL ++ HS + +P Y +PE
Sbjct: 148 GDLGLGRFFSS----------KTTAAHSLVG----TPYYMSPERIHEN------------ 181
Query: 343 GISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRK-----LPPQYASIVGVGI 397
G + +SD WS GC L EM P+ G +Y K + LP + S
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYS------ 234
Query: 398 PRELWKMIGECLQFKASKRP 417
EL +++ C+ KRP
Sbjct: 235 -EELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 39/220 (17%)
Query: 218 LVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
+VM+ G ++ +Q N+ L L ++ Y ++ + L + V +I N+L+ +
Sbjct: 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS 142
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNL 336
+ D+GL+ L+ + KA S+ L + APE S+N
Sbjct: 143 PDCVKLGDFGLSRYLEDESYYKA------SK-------GKLPIKWMAPE-------SINF 182
Query: 337 --FWDDAIGISPESDAWSFGCTLVE-MCTGSIPWAGLSAEEIYRAVVKNRKLP-PQYASI 392
F + SD W FG + E + G P+ G+ ++ + +LP P
Sbjct: 183 RRF-------TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC-- 233
Query: 393 VGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
P L+ ++ +C + SKRP F+ + A LQE
Sbjct: 234 -----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-05
Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 42/199 (21%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA----AILKK 293
LT +Q+L++ +D+A G+ L + ++ N+L+ + + ++D+GL+ +KK
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
R P W ++ SLN + +SD WSF
Sbjct: 176 TMGR-------------------------LPVRWMAIE-SLNYSV-----YTTKSDVWSF 204
Query: 354 GCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFK 412
G L E+ + G P+ G++ E+Y KLP Y E+++++ +C + +
Sbjct: 205 GVLLWEIVSLGGTPYCGMTCAELY------EKLPQGYRMEKPRNCDDEVYELMRQCWRDR 258
Query: 413 ASKRPTFSAMLATFLRHLQ 431
+RP F+ + R L+
Sbjct: 259 PYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 36/204 (17%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y +I G+ +H VV ++KP+N+LLD G +SD GLA CD
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--------------CDF 147
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
S+ ++ + Y APE + +D +S GC L ++ G
Sbjct: 148 SKKKP--HASVGTHGYMAPEVLQ-----------KGTAYDSSADWFSLGCMLFKLLRGHS 194
Query: 366 PWAGLSAE---EIYRAVVK-NRKLP----PQYASIVGVGIPRELWKMIGECLQFKASKRP 417
P+ + EI R + N +LP P+ S++ + R++ K +G CL A +
Sbjct: 195 PFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLG-CLGRGAQEVK 253
Query: 418 TFSAMLATFLRHLQELPRSPPASP 441
+ + PP P
Sbjct: 254 EHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 86/303 (28%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIA-EEMEPDWLSGQ---L 190
+KL +KLGEG A V +GR + + VA+K++ + EE P + L
Sbjct: 9 IKL-EKLGEGTYATVF---------KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 58
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLV-----------MDRCYGSVQLAMQRNEGRLT 239
+L+ A N+ T H ++ D L LV MD C G++ M + ++
Sbjct: 59 KDLKHA-----NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDC-GNI---MSMHNVKIF 109
Query: 240 LEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299
L QILR G+ H V+ ++KP NLL++ G ++D+GL A
Sbjct: 110 LYQILR-------GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGL-----------A 151
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES---DAWSFGCT 356
R + ++ +S T+ Y P D +G S S D W GC
Sbjct: 152 RAKSVPTKTYSNEVVTLW---YRPP--------------DVLLGSSEYSTQIDMWGVGCI 194
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR 416
EM +G + G + E+ + + P + E W I +FK
Sbjct: 195 FFEMASGRPLFPGSTVEDELHLIFRLLGTPTE-----------ETWPGISSNDEFKNYNF 243
Query: 417 PTF 419
P +
Sbjct: 244 PKY 246
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-05
Identities = 50/215 (23%), Positives = 69/215 (32%), Gaps = 49/215 (22%)
Query: 485 RDLLSKNASGNYSSSISSLLKAQNAD---GQTALHLACRRGSAELVEAILEYSQENVDVL 541
R L A N + ++ LL + G T LH + VEAIL +
Sbjct: 53 RSALFVAAIENENLELTELLLNLSCRGAVGDTLLHAI-SLEYVDAVEAILLH-LLAAF-- 108
Query: 542 DKDGDPPLVFALAAGSP----------------ECVHALIKRGANVISRLREGFGPSVAH 585
K G L E V L++RGA+V +R F
Sbjct: 109 RKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQG 168
Query: 586 V-CAYHG-----------QPDCMRELLLAGADPNAVDDEGESVLH--------RAVAKKY 625
V YHG P + L AD D G ++LH +A ++
Sbjct: 169 VDSFYHGESPLNAAACLGSPSIVALLSEDPADILTADSLGNTLLHLLVMENEFKAEYEEL 228
Query: 626 -TDCA--IVILENGGCRSM---AILNSKELTPLHL 654
+ L + S ILN + LTPL L
Sbjct: 229 SCQMYNFALSLLDKLRDSKELEVILNHQGLTPLKL 263
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-05
Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 27/143 (18%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y ++I+ + LH G++ ++KP N+LLDA G ++D+GL C+++ E
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL--------CKESIHE--G 154
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ H+ C + Y APE + +S G D WS G + +M TG+
Sbjct: 155 TVTHTF--CGTIE--YMAPEI---LMRS---------GHGKAVDWWSLGALMYDMLTGAP 198
Query: 366 PWAGLSAEEIYRAVVKNR-KLPP 387
P+ + ++ ++K + LPP
Sbjct: 199 PFTAENRKKTIDKILKGKLNLPP 221
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 36/276 (13%)
Query: 149 RAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFH 207
R G +G G R + VA+K + + E E E + + ++ L + V ++
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYY 68
Query: 208 GVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNI 267
G + L ++M+ G L + R G QI +I +G+ LH+ + +I
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 268 KPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAW 327
K +N+LL G ++D+G+A L ++ + + +P + APE
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKR--------------NTFVGTPFWMAPEV- 172
Query: 328 EPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPP 387
+++S ++D WS G T +E+ G P + + + + KN PP
Sbjct: 173 --IQQS---------AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN--PP 219
Query: 388 QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
++ G + + I CL S RPT +L
Sbjct: 220 ---TLTG-EFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 35/153 (22%), Positives = 67/153 (43%), Gaps = 28/153 (18%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A++ ++ LH GV+ ++K N+LLDA G ++D+G+ C
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGM---------------CKE 145
Query: 306 SRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
++ T +P+Y APE + ++ P D W+ G + EM G
Sbjct: 146 GILNGVTTTTFCGTPDYIAPEILQELE------------YGPSVDWWALGVLMYEMMAGQ 193
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGI 397
P+ + ++++ +++ + L P + S V I
Sbjct: 194 PPFEADNEDDLFESILHDDVLYPVWLSKEAVSI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 46/237 (19%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMW- 199
++KLGEG A V + + G VA+K + + EE + + +R AS+
Sbjct: 10 LEKLGEGSYATVYKGKSKVNG------KLVALKVIRLQEEEGTPFTA-----IREASLLK 58
Query: 200 ---CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVE 256
N+ H ++ L LV + + + M ++ G L E + + + RG+
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+H ++ ++KP NLL+ +G ++D+GL AR + S +S T+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGL-----------ARAKSVPSHTYSNEVVTL 167
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPES---DAWSFGCTLVEMCTGSIPWAGL 370
Y P D +G + S D W GC VEM G + G+
Sbjct: 168 W---YRPP--------------DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 42/199 (21%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA----AILKK 293
L+ +Q+L + AD+ARG+ L + ++ N+L+ + A ++D+GL+ +KK
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 168
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
R P W ++ SLN + SD WS+
Sbjct: 169 TMGR-------------------------LPVRWMAIE-SLNYSV-----YTTNSDVWSY 197
Query: 354 GCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFK 412
G L E+ + G P+ G++ E+Y KLP Y + E++ ++ +C + K
Sbjct: 198 GVLLWEIVSLGGTPYCGMTCAELY------EKLPQGYRLEKPLNCDDEVYDLMRQCWREK 251
Query: 413 ASKRPTFSAMLATFLRHLQ 431
+RP+F+ +L + R L+
Sbjct: 252 PYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-05
Identities = 17/47 (36%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFA 552
A + +G T LHLA + G+ ELV+ +L+ ++++ D DG L A
Sbjct: 11 ATDGNGNTPLHLAAKYGALELVQWLLKP-GVDLNLRDSDGLTALDLA 56
|
Length = 56 |
| >gnl|CDD|215715 pfam00097, zf-C3HC4, Zinc finger, C3HC4 type (RING finger) | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-05
Identities = 12/46 (26%), Positives = 19/46 (41%), Gaps = 6/46 (13%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRC 53
C +C + +L CGH FC +C+ ++CP C
Sbjct: 1 CPICLEEP---KDPVTILPCGHLFCSKCILSWLE---SGNVTCPLC 40
|
The C3HC4 type zinc-finger (RING finger) is a cysteine-rich domain of 40 to 60 residues that coordinates two zinc ions, and has the consensus sequence: C-X2-C-X(9-39)-C-X(1-3)-H-X(2-3)-C-X2-C-X(4-48)-C-X2-C where X is any amino acid. Many proteins containing a RING finger play a key role in the ubiquitination pathway. Length = 40 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 30/134 (22%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
R+ EQI + + + LHA GV+ +IK ++LL + GR +SD+G A + K
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-- 167
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPE--AWEPVKKSLNLFWDDAIGISPESDAWSF 353
+ R S + +P + APE + P E D WS
Sbjct: 168 --------EVPRRKSLVG----TPYWMAPEVISRLPY--------------GTEVDIWSL 201
Query: 354 GCTLVEMCTGSIPW 367
G ++EM G P+
Sbjct: 202 GIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-05
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 28/152 (18%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
R+ EQI + R + LH GV+ +IK ++LL + GR +SD+G A + K
Sbjct: 114 RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
++ + +P + APE + E D WS G
Sbjct: 174 KRKS--------------LVGTPYWMAPEVIS------------RLPYGTEVDIWSLGIM 207
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ 388
++EM G P+ + R + N LPP+
Sbjct: 208 VIEMIDGEPPYFNEPPLQAMRRIRDN--LPPR 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-05
Identities = 16/34 (47%), Positives = 21/34 (61%), Gaps = 1/34 (2%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
DG T LHLA R G E+V+ +LE +V+ DK
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAG-ADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|222454 pfam13920, zf-C3HC4_3, Zinc finger, C3HC4 type (RING finger) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 6e-05
Identities = 17/49 (34%), Positives = 22/49 (44%), Gaps = 10/49 (20%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGH-GFCKECLSRMFSASTDTTLSCPRCR 54
C +C E+ R + L CGH C+EC R+ S CP CR
Sbjct: 4 LCVICL----ERPRNVVFLPCGHLCLCEECAKRLRSKKK-----CPICR 43
|
Length = 49 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-05
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 220 MDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279
M+ CY Q+ ++ L+ + ++ +ARG+ L + + ++ N+L+
Sbjct: 123 MEYCYNPTQVPEEQ----LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178
Query: 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT--MLSPNYTAPEAWEPVKKSLNLF 337
++D+GLA D I T L + APEA LF
Sbjct: 179 MKIADFGLAR--------------DIHHIDYYKKTTNGRLPVKWMAPEA---------LF 215
Query: 338 WDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGV 395
D I + +SD WSFG L E+ T G P+ G+ EE+++ + + ++ P +
Sbjct: 216 --DRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---- 268
Query: 396 GIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
EL+ M+ +C S+RPTF ++ R L
Sbjct: 269 ---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-05
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 38/200 (19%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA-ILKKPA- 295
LTLE ++ Y +ARG+ L + + ++ N+LL + + D+GLA I K P
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
RK +R L + APE+ +F D + + +SD WSFG
Sbjct: 230 VRKG-----DAR---------LPLKWMAPES---------IF--DKV-YTTQSDVWSFGV 263
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFK 412
L E+ + G+ P+ G+ +E + +K R P+YA+ E++ ++ +C
Sbjct: 264 LLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT-------PEIYSIMLDCWHNN 316
Query: 413 ASKRPTFSAMLATFLRHLQE 432
RPTFS ++ LQE
Sbjct: 317 PEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-05
Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 28/114 (24%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I RG+ +H+AGVV ++KPSN+L++ + + D+GLA R +
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA-----------RIQ------D 159
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
M + + Y APE + L W E D WS GC EM G
Sbjct: 160 PQMTGYVSTRYYRAPE--------IMLTWQK---YDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-05
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 34/185 (18%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILR-YGADIARGVVELHAA-GVVCMNIKPSNLL 273
L VM+ G +L + R+ E R YGA+I + LH+ VV ++K NL+
Sbjct: 70 LCFVMEYANGG-ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 274 LDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKS 333
LD G ++D+GL C++ + + M +P Y APE E
Sbjct: 129 LDKDGHIKITDFGL--------CKEGIKD------GATMKTFCGTPEYLAPEVLE----- 169
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKN-----RKLPPQ 388
D+ G + D W G + EM G +P+ E+++ ++ R L P+
Sbjct: 170 -----DNDYGRA--VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 222
Query: 389 YASIV 393
S++
Sbjct: 223 AKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-05
Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 23/124 (18%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LT E I + + RG+ +H+A V+ ++KPSNLL++ + D+G+A
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA--------- 154
Query: 298 KARPECDSSRIHSC-MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
R S H M + + Y APE + SL + AI D WS GC
Sbjct: 155 --RGLSSSPTEHKYFMTEYVATRWYRAPE----LLLSLPEY-TTAI------DMWSVGCI 201
Query: 357 LVEM 360
EM
Sbjct: 202 FAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-05
Identities = 36/151 (23%), Positives = 57/151 (37%), Gaps = 20/151 (13%)
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277
LVMD ++ + R RLT Q+ I G+ LH + ++ P+N+ +++
Sbjct: 97 LVMDIMASDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN----YTAPEAWEPVKKS 333
G ++D+GLA ++ S M S Y APE
Sbjct: 156 GICKIADFGLA---RRYGYPPYSDTL-SKDETMQRREEMTSKVVTLWYRAPEL------- 204
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
L + + D WS GC E+ TG
Sbjct: 205 --LMGAEKYHFA--VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-05
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 34/193 (17%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
++ +E L E +L + +A+G+ L + + ++ N+LL + D+GLA
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
++ DS+ + + N P W + N + + ESD
Sbjct: 264 IRN----------DSNYV--------VKGNARLPVKWMAPESIFNCVY------TFESDV 299
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGE 407
WS+G L E+ + GS P+ G+ + + ++K R L P+ A P E++ ++
Sbjct: 300 WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECA-------PSEMYDIMKS 352
Query: 408 CLQFKASKRPTFS 420
C KRPTF
Sbjct: 353 CWDADPLKRPTFK 365
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-05
Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 26/152 (17%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L VM+ G E + ++ YGA+I + LH+ VV ++K NL+LD
Sbjct: 70 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD 129
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
G ++D+GL C++ + + + C +P Y APE E
Sbjct: 130 KDGHIKITDFGL--------CKEGISDGATMKTF----CG--TPEYLAPEVLE------- 168
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
D+ G + D W G + EM G +P+
Sbjct: 169 ---DNDYGRA--VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-05
Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 38/216 (17%)
Query: 165 RCRHS-----VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR----NVCTFHGVLRMDSC 215
+CR+ VA+KK + E E D + ++ LR M + N+ V R
Sbjct: 19 KCRNRETGQIVAIKKFV---ESEDDPVIKKI-ALREIRMLKQLKHPNLVNLIEVFRRKRK 74
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L LV + C +V +++N + I + + V H + ++KP N+L+
Sbjct: 75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
G+ + D+G A IL P + ++R Y APE
Sbjct: 135 KQGQIKLCDFGFARILTGPG--DDYTDYVATRW------------YRAPEL--------- 171
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
L D G P D W+ GC E+ TG W G S
Sbjct: 172 LVGDTQYG--PPVDVWAIGCVFAELLTGQPLWPGKS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-05
Identities = 54/249 (21%), Positives = 99/249 (39%), Gaps = 37/249 (14%)
Query: 220 MDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279
MD + + +L E +LT + ++ +ARG+ L + + ++ N+L+
Sbjct: 117 MDYSFDTCKLP----EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172
Query: 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWD 339
++D+GLA +H+ +D + N P W + + +
Sbjct: 173 MKIADFGLA-----------------RDVHN-IDYYKKTTNGRLPVKWMAPEALFDRVY- 213
Query: 340 DAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIP 398
+ +SD WSFG L E+ T G P+ G+ EE+++ + + ++
Sbjct: 214 -----THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP------ANCT 262
Query: 399 RELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSP 458
EL+ ++ EC S+RPTF ++ R L F ++S PS
Sbjct: 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSS 322
Query: 459 AS--DVEVF 465
S D VF
Sbjct: 323 CSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-05
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 9/76 (11%)
Query: 347 ESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKM 404
+SD WSFG L E+ T G P+ G+ EE+++ + + ++ PQ +EL+ +
Sbjct: 214 QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNC-------TQELYHL 266
Query: 405 IGECLQFKASKRPTFS 420
+ +C S+RPTF
Sbjct: 267 MRDCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 34/127 (26%), Positives = 55/127 (43%), Gaps = 27/127 (21%)
Query: 241 EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
++ + Y A++ G+ +L +V ++KP N+LLD G +SD GLA +
Sbjct: 102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--------- 152
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
PE ++ R + + Y APE ++ SP D W GC + EM
Sbjct: 153 PEGETVR------GRVGTVGYMAPEVIN----------NEKYTFSP--DWWGLGCLIYEM 194
Query: 361 CTGSIPW 367
G P+
Sbjct: 195 IQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-04
Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 736 NDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
+++ + +++L+ G DVN ++++ P+H A RG V LLLS GAD N
Sbjct: 156 DELLIAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVN 205
|
Length = 682 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
+ ++T + ++ +ARG+ L + + ++ N+L+ + ++D+GLA
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 185
Query: 295 ACRKARPECDSSRIHSCMDCT--MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
D + I T L + APEA LF D + + +SD WS
Sbjct: 186 ---------DVNNIDYYKKTTNGRLPVKWMAPEA---------LF--DRV-YTHQSDVWS 224
Query: 353 FGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411
FG + E+ T G P+ G+ EE+++ + + ++ EL+ M+ +C
Sbjct: 225 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP------ANCTNELYMMMRDCWHA 278
Query: 412 KASKRPTFSAMLATFLRHL 430
S RPTF ++ R L
Sbjct: 279 IPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 31/182 (17%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
G+LTL Q+L + IA G+V L + V ++ N L+ + D+G++
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------ 170
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
+ S+ + TML + PE+ K + ESD WSFG
Sbjct: 171 ------DIYSTDYYRVGGRTMLPIRWMPPESILYRK------------FTTESDIWSFGV 212
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
L E+ T G PW LS E + + R+L P E++ ++ C Q +
Sbjct: 213 VLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC------PPEVYAIMQGCWQREPQ 266
Query: 415 KR 416
+R
Sbjct: 267 QR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-04
Identities = 41/164 (25%), Positives = 66/164 (40%), Gaps = 31/164 (18%)
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG---RAVVSDYGLAAI 290
+G L + R + + H G+V ++KP N+++ +G A V D+G+ +
Sbjct: 72 ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAW--EPVKKSLNLFWDDAIGISPES 348
L P R A +R + +P Y APE EPV +P S
Sbjct: 132 L--PGVRDA-DVATLTRTTEVLG----TPTYCAPEQLRGEPV--------------TPNS 170
Query: 349 DAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASI 392
D +++G +E TG G S EI ++L P S+
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGASVAEILY-----QQLSPVDVSL 209
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 1e-04
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 725 NRTALHIASMANDVELVKIILDAGVDVNI 753
T LH+A+ ++ELVK++L+ G D+N
Sbjct: 2 GNTPLHLAARNGNLELVKLLLEHGADINA 30
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-04
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 44/203 (21%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPAC 296
LT +L + +ARG+ L + V ++ N+LL A G+ V + D+GLA +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL-AQGKIVKICDFGLARDIMH--- 289
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
DS+ + T L + APE+ NL+ + SD WS+G
Sbjct: 290 -------DSNYVSK--GSTFLPVKWMAPESIFD-----NLY-------TTLSDVWSYGIL 328
Query: 357 LVEMCT-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFKA 413
L E+ + G P+ G+ + + +K+ R P +A +E++ ++ +C +
Sbjct: 329 LWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHA-------TQEVYDIMVKCWNSEP 381
Query: 414 SKRPTFSAMLATFLRHLQELPRS 436
KRP+F HL ++ S
Sbjct: 382 EKRPSF--------LHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 36/225 (16%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASM 198
V+K+GEG +G VA+KK+ + E E P ++ L+ +
Sbjct: 5 VEKIGEG------TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVEL 257
N+ V+ ++ L LV + + ++ M + L I Y + +G+
Sbjct: 59 --PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 258 HAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML 317
H+ V+ ++KP NLL++ G ++D+GLA P R ++ T+
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----------RTYTHEVVTLW 165
Query: 318 SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
Y APE K ++ A+ D WS GC EM T
Sbjct: 166 ---YRAPEILLGCK-----YYSTAV------DIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 64/242 (26%), Positives = 93/242 (38%), Gaps = 74/242 (30%)
Query: 143 KLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMI-AEEMEPDWL---SGQLDNLRR 195
KLGEG A V +GR + + VA+K++ + EE P + L +L+
Sbjct: 12 KLGEGSYATVY---------KGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLV-----------MDRCYGSVQLAMQRNEGRLTLEQIL 244
A N+ T H ++ L LV MD C G + + RL L Q+L
Sbjct: 63 A-----NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGG----GLSMHNVRLFLFQLL 113
Query: 245 RYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
R G+ H V+ ++KP NLL+ G ++D+GL AR +
Sbjct: 114 R-------GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL-----------ARAKSV 155
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG---ISPESDAWSFGCTLVEMC 361
S+ +S T+ Y P D +G S D W GC EM
Sbjct: 156 PSKTYSNEVVTLW---YRPP--------------DVLLGSTEYSTSLDMWGVGCIFYEMA 198
Query: 362 TG 363
TG
Sbjct: 199 TG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 2e-04
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 10/60 (16%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH+ G + V+ LL K N + DG TALH+A G+ E+++ +L
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINR----------TDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-04
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 12/157 (7%)
Query: 480 DVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVD 539
D ++ L+ A + + D ++ LH A G + VE +L+ + D
Sbjct: 47 DSEAIKLLMKHGAIPDV----------KYPDIESELHDAVEEGDVKAVEELLDLGKFADD 96
Query: 540 VLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMREL 599
V KDG PL A + + LI RGA+ + F P H+ G + L
Sbjct: 97 VFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSP--LHLAVMMGDIKGIELL 154
Query: 600 LLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
+ A + D G + L A+AK ++L++G
Sbjct: 155 IDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSG 191
|
Length = 413 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-04
Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 53/231 (22%)
Query: 165 RCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVL-----RMDSCLG-- 217
C VAVKK+++ + ++ +RR + N+ + VL + +G
Sbjct: 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRR--LDHDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 218 -------LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPS 270
+V + Y LA +G L+ E + + RG+ +H+A V+ ++KP+
Sbjct: 86 TELNSVYIVQE--YMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPA 143
Query: 271 NLLLDASGRAV-VSDYGLAAILKKPACRKARPECDSSRIHSC-MDCTMLSPNYTAPEAWE 328
N+ ++ + + D+GLA I+ D H + +++ Y +P
Sbjct: 144 NVFINTEDLVLKIGDFGLARIV------------DPHYSHKGYLSEGLVTKWYRSPR--- 188
Query: 329 PVKKSLNLFWDDAIGISPES-----DAWSFGCTLVEMCTGSIPWAGLSAEE 374
+ +SP + D W+ GC EM TG +AG E
Sbjct: 189 -------------LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-04
Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 86/305 (28%)
Query: 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIA-EEMEPDWLSGQ---L 190
+KL KLGEG A V +GR + + VA+K++ + EE P + L
Sbjct: 9 IKL-DKLGEGTYATVY---------KGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL 58
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLV-----------MDRCYGSVQLAMQRNEGRLT 239
+L+ A N+ T H ++ + L LV +D C S+ + + +L
Sbjct: 59 KDLKHA-----NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM----HNVKLF 109
Query: 240 LEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299
L Q+LR G+ H V+ ++KP NLL++ G ++D+GL A
Sbjct: 110 LFQLLR-------GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGL-----------A 151
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG---ISPESDAWSFGCT 356
R + ++ +S T+ Y P D +G S + D W GC
Sbjct: 152 RAKSIPTKTYSNEVVTLW---YRPP--------------DILLGSTDYSTQIDMWGVGCI 194
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR 416
EM TG + G + EE + + P + E W I +FK+
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE-----------ETWPGILSNEEFKSYNY 243
Query: 417 PTFSA 421
P + A
Sbjct: 244 PKYRA 248
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-04
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 24/129 (18%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
L+ + + + I RG+ LH+AG++ +IKP NLL++++ + D+GLA
Sbjct: 99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-------- 150
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
R P D S+ M +++ Y APE + + A+ D WS GC
Sbjct: 151 RVEEP--DESKH---MTQEVVTQYYRAPEILMGSRH-----YTSAV------DIWSVGCI 194
Query: 357 LVEMCTGSI 365
E+ I
Sbjct: 195 FAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 37/193 (19%)
Query: 232 QRNEGRL--TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289
+ N GR TL+++++ A+IA G+ L+A V ++ N ++ + D+G+
Sbjct: 108 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
Query: 290 -ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
I + RK +L + APE+ + D + + S
Sbjct: 168 DIYETDYYRKGGK-------------GLLPVRWMAPESLK-----------DGV-FTTSS 202
Query: 349 DAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIG 406
D WSFG L E+ + P+ GLS E++ + V+ L P P + ++
Sbjct: 203 DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD-------NCPERVTDLMR 255
Query: 407 ECLQFKASKRPTF 419
C QF RPTF
Sbjct: 256 MCWQFNPKMRPTF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 41/206 (19%)
Query: 224 YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283
+G + L M R LT + +A + L +V N+ N+LL G +
Sbjct: 88 FGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREG--IDG 145
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
+ G L P P SR +C P + APE V+ S NL
Sbjct: 146 ECGPFIKLSDPGI----PITVLSR----QECVERIP-WIAPEC---VEDSKNL------- 186
Query: 344 ISPESDAWSFGCTLVEMC-TGSIPWAGLSAEEIYRAVVKNRKLPPQ---YASIVGVGIP- 398
S +D WSFG TL E+C G IP +K++ L + Y + P
Sbjct: 187 -SIAADKWSFGTTLWEICYNGEIP-------------LKDKTLAEKERFYEGQCMLVTPS 232
Query: 399 -RELWKMIGECLQFKASKRPTFSAML 423
+EL ++ C+ + ++RP F A++
Sbjct: 233 CKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 42/178 (23%), Positives = 68/178 (38%), Gaps = 46/178 (25%)
Query: 241 EQILR-YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA---------AI 290
E + R Y A+ + +H G + +IKP N+L+D G +SD+GL+ A
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 291 LKKPACRKARPECDSSRIHSCMD------------------------CTMLSPNYTAPEA 326
+K K+ +R +D T+ +P+Y APE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE- 218
Query: 327 WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRK 384
+F G E D WS G + E G P+ ++ E YR ++ R+
Sbjct: 219 ---------IFLQQ--GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE 265
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 31/114 (27%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
+ RG+ +H+A V+ ++KPSNLLL+A+ + D+GL AR +
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-----------ARTTSEKGDF- 164
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD---AIGISPESDAWSFGCTLVEM 360
M +++ Y APE L L + AI D WS GC E+
Sbjct: 165 --MTEYVVTRWYRAPE--------LLLNCSEYTTAI------DVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-04
Identities = 57/256 (22%), Positives = 96/256 (37%), Gaps = 70/256 (27%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSV-QLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
N+ V R + L V + G++ QL R + I I +G+ +H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLA-AILKKP------ACRKAR-PECDSSRIHSCM 312
G ++KP NLL+ ++D+GLA I +P + R R PE
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPE---------- 168
Query: 313 DCTML--SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
+L S +Y++P D W+ GC + E+ T + G
Sbjct: 169 ---ILLRSTSYSSP-----------------------VDIWALGCIMAELYTLRPLFPGS 202
Query: 371 SA-EEIYR--AVV---KNRKLP--PQYASIVGVGIPR---------------ELWKMIGE 407
S +++Y+ +V+ + P + AS +G P+ E +I +
Sbjct: 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKD 262
Query: 408 CLQFKASKRPTFSAML 423
L++ KRPT S L
Sbjct: 263 MLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 38/189 (20%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG----RAV-VSDYGLAAILK 292
LTL+++L D+A+G V L + ++ N L+ G R V + D+GLA +
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
K + E +L + APE+ D + +SD WS
Sbjct: 163 KSDYYRKEGE------------GLLPVRWMAPESLL-----------DGK-FTTQSDVWS 198
Query: 353 FGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGECLQ 410
FG + E+ T G P+ L+ +E+ + V +L P+ P ++++++ C
Sbjct: 199 FGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE-------NCPDKIYQLMTNCWA 251
Query: 411 FKASKRPTF 419
S+RPTF
Sbjct: 252 QDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 43.7 bits (102), Expect = 4e-04
Identities = 39/176 (22%), Positives = 70/176 (39%), Gaps = 25/176 (14%)
Query: 693 AAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVN 752
K ++ L+ +L + P+ + L + A+ EL+ ++
Sbjct: 9 LLINKCFLDLLLVALLLLLSLDLSNPSDKKLNLYLELALLPAASLSELLLKLIVDRHL-A 67
Query: 753 IRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAK-------MI 805
R++ +PLH A ++G V LLL++GAD N +D +GD H+AA +
Sbjct: 68 ARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVA 127
Query: 806 RENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWIS----EDLMEALMNRG 857
+ LE + +R+ G T P W + D++E L+ G
Sbjct: 128 KLLLEAGADL-----DVNNLRDEDGNT--------PLHWAALNGDADIVELLLEAG 170
|
Length = 235 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-04
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 9/113 (7%)
Query: 467 DNPNNLHQLVS--EGDVSGVRDLLSKNASGNYSSSISSLLK------AQNADGQTALHLA 518
D N LH + + D+ ++ L+ K N + ++ LL ++ G T LH A
Sbjct: 140 DGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGVPINIKDVYGFTPLHYA 199
Query: 519 CRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANV 571
+ E V+ +L+ N ++++K GD PL A+ + E L+ G ++
Sbjct: 200 VYNNNPEFVKYLLDLGA-NPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSI 251
|
Length = 422 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-04
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 16/126 (12%)
Query: 711 LLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGA 770
LL A +P D++ RT LHIA+ + V ++L +V+IR+ + L A++
Sbjct: 544 LLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKH 603
Query: 771 KSCVGLLLSAGADCNWQDDEGDNAFHIAAD----AAKMIRENLEWLIVMLSHPDAAVEVR 826
+L + + H A D AAK R +L + +L V+
Sbjct: 604 HKIFRILYHFASISD---------PHAAGDLLCTAAK--RNDLTAMKELLKQ-GLNVDSE 651
Query: 827 NHSGKT 832
+H G T
Sbjct: 652 DHQGAT 657
|
Length = 823 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 4e-04
Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 3/57 (5%)
Query: 599 LLLAG-ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHL 654
LL G D NA D G + LH A + +L+ G + + +S LT L L
Sbjct: 1 LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGV--DLNLRDSDGLTALDL 55
|
Length = 56 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-04
Identities = 37/144 (25%), Positives = 57/144 (39%), Gaps = 29/144 (20%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A++ LH+ ++ ++KP NLLLD G V+D+G A K P+
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA---------KKVPD--- 170
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
R + C +P Y APE + + G D W+ G L E G
Sbjct: 171 -RTFTL--CG--TPEYLAPEVIQ------------SKGHGKAVDWWTMGVLLYEFIAGYP 213
Query: 366 PWAGLSAEEIYRAVVKNRKLPPQY 389
P+ + IY ++ R P +
Sbjct: 214 PFFDDTPFRIYEKILAGRLKFPNW 237
|
Length = 329 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-04
Identities = 44/191 (23%), Positives = 84/191 (43%), Gaps = 35/191 (18%)
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
E +L+ + ++ +ARG+ L + + ++ N+L+ ++D+GLA +
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
K + + R L + APEA LF D + + +SD WSFG
Sbjct: 188 DYYK---KTSNGR---------LPVKWMAPEA---------LF--DRV-YTHQSDVWSFG 223
Query: 355 CTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGECLQF 411
+ E+ T G P+ G+ EE+++ + + ++ P EL+ ++ EC
Sbjct: 224 ILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSN--------CTHELYMLMRECWHA 275
Query: 412 KASKRPTFSAM 422
++RPTF +
Sbjct: 276 VPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 48/238 (20%)
Query: 202 NVCTFHGVL-RMDSCLG----LVMDRCYGS-----VQLAMQRNEGRLTLEQI--LRYGAD 249
NV F+G+ + D +G LV++ C G V+ + + RL I + YGA
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGAL 138
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
+ G+ LH ++ ++K +N+LL G + D+G++A L R+
Sbjct: 139 L--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR----------- 185
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
+ ++ +P + APE ++ + +D D WS G T +E+ G P
Sbjct: 186 ---NTSVGTPFWMAPEVI-ACEQQYDYSYD------ARCDVWSLGITAIELGDGDPPLFD 235
Query: 370 LSAEEIYRAVVKNR----KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ + + +N P ++ R I +CL RP+ + +L
Sbjct: 236 MHPVKTLFKIPRNPPPTLLHPEKWC--------RSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 37/207 (17%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
LT Q+L IA G+V L + V ++ N L+ + + D+G++
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-------- 168
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
+ S+ + TML + PE+ K + ESD WS G L
Sbjct: 169 ----DVYSTDYYRVGGHTMLPIRWMPPESIMYRK------------FTTESDVWSLGVVL 212
Query: 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASK 415
E+ T G PW LS E+ + + R L P+ P+E++ ++ C Q +
Sbjct: 213 WEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC-------PKEVYDLMLGCWQ----R 261
Query: 416 RPTFSAMLATFLRHLQELPRSPPASPD 442
P + LQ L ++ P D
Sbjct: 262 EPHMRLNIKEIHSLLQNLAKASPVYLD 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 67/307 (21%), Positives = 116/307 (37%), Gaps = 61/307 (19%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
V+ +++LGEG +V+ G G + SVA+K + E EP Q + +
Sbjct: 6 AVRFLEELGEGAFG--KVYKGELTGPNERLSATSVAIKT--LKENAEPKV---QQEFRQE 58
Query: 196 ASMWCR----NVCTFHGVLRMD--SCL------------GLVMDRCYGSVQLAMQRNEGR 237
A + N+ GV + +C+ LV + + V +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 238 LTLEQ--ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKP 294
+L+ L IA G+ L + V ++ N L+ G V +SD+GL+
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSR----- 172
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
+ S+ + ++L + PEA K + ESD WSFG
Sbjct: 173 -------DIYSADYYRVQSKSLLPVRWMPPEAILYGK------------FTTESDIWSFG 213
Query: 355 CTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKA 413
L E+ + G P+ G S +E+ + + LP P ++ ++ EC
Sbjct: 214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIP 267
Query: 414 SKRPTFS 420
++RP F
Sbjct: 268 ARRPRFK 274
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 5e-04
Identities = 12/27 (44%), Positives = 17/27 (62%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDD 611
H+ A +G + ++ LL AGAD NA D
Sbjct: 7 HLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-04
Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 44/240 (18%)
Query: 194 RRASMWCRNVCTFHGVLRMDSCLG----LVMDRC-YGSVQLAMQRNEGRLTLEQILRYGA 248
AS+ + H V C+ +V + +G + + + R + ++L L
Sbjct: 50 ETASLM-SQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA---CRKARPECDS 305
+A + L +V N+ N+L+ G Y L P +R E
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLN--EGYVPFIKLSDPGIPITVLSREERVE 166
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
P + APE + SL + +D WSFG TL+E+C+ G
Sbjct: 167 R-----------IP-WIAPECIRNGQASLTIA----------ADKWSFGTTLLEICSNGE 204
Query: 365 IPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
P + LS+ E R +LP P A EL +I +C + +KRP+F A+L
Sbjct: 205 EPLSTLSSSEKERFYQDQHRLPMPDCA---------ELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-04
Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 27/134 (20%)
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH+AG++ ++KPSN+++ + + D+GLA + AC + M
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAC-----------TNFMM 179
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+++ Y APE + N+ D WS GC + E+ GS+ + G
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENV------------DIWSVGCIMGELVKGSVIFQGTDH 227
Query: 373 EEIYRAVVKNRKLP 386
+ + V++ P
Sbjct: 228 IDQWNKVIEQLGTP 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 43/185 (23%)
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
ILR +I +G+ LH+ + +IK +N+LL G ++D+G+A L ++
Sbjct: 106 ILR---EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR---- 158
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ + +P + APE +K+S F ++D WS G T +E+
Sbjct: 159 ----------NTFVGTPFWMAPEV---IKQSAYDF---------KADIWSLGITAIELAK 196
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPP----QYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G P + L + + KN PP QY+ + + + CL RPT
Sbjct: 197 GEPPNSDLHPMRVLFLIPKNS--PPTLEGQYS--------KPFKEFVEACLNKDPRFRPT 246
Query: 419 FSAML 423
+L
Sbjct: 247 AKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-04
Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 55/238 (23%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEME--PDWLSGQLDNLRR 195
++K+GEG V + + R + VA+K+V + ++ E P ++ L+
Sbjct: 5 LEKIGEGTYGTVF---------KAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK- 54
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-------YGSVQLAMQRNEGRLTLEQILRYGA 248
+ +N+ + VL D L LV + C + S + + + Q+L+
Sbjct: 55 -ELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK--- 110
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
G+ H+ V+ ++KP NLL++ +G ++D+GLA P
Sbjct: 111 ----GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------------- 153
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
C +++ Y P+ LF A S D WS GC E+ P
Sbjct: 154 -RCYSAEVVTLWYRPPDV---------LF--GAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 48/180 (26%), Positives = 70/180 (38%), Gaps = 37/180 (20%)
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
L IA G+ L + V ++ N+L+ +SD GL
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL---------------- 170
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAI---GISPESDAWSFGCTLVEM 360
S I+S D + P P W P +AI S +SD WSFG L E+
Sbjct: 171 -SREIYSA-DYYRVQPKSLLPIRWMP---------PEAIMYGKFSSDSDIWSFGVVLWEI 219
Query: 361 CT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
+ G P+ G S +E+ V K + LP P ++ ++ EC Q S+RP F
Sbjct: 220 FSFGLQPYYGFSNQEVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRF 273
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 7e-04
Identities = 38/136 (27%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
QILR G+ LH+A V+ ++KPSN+L++++ + D+GLA R P
Sbjct: 111 QILR-------GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA--------RGVDP 155
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDD---AIGISPESDAWSF 353
+ D L+ Y APE L L AI D WS
Sbjct: 156 DEDEKG--------FLTEYVVTRWYRAPE--------LLLSSSRYTKAI------DIWSV 193
Query: 354 GCTLVEMCTGSIPWAG 369
GC E+ T + G
Sbjct: 194 GCIFAELLTRKPLFPG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-04
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 50/210 (23%)
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH+AG++ ++KPSN+++ + + D+GLA ++ M
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------TAGTSFMM 175
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+++ Y APE +G D WS GC + EM I + G
Sbjct: 176 TPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
+ + V++ +G P E K + ++ RP ++ + TF
Sbjct: 224 IDQWNKVIEQ----------LGTPCP-EFMKKLQPTVRNYVENRPKYAGL--TF------ 264
Query: 433 LPRSPPASPDTGFTKFSTSNETEPSPASDV 462
P PD+ F S N+ + S A D+
Sbjct: 265 ----PKLFPDSLFPADSEHNKLKASQARDL 290
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 8e-04
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 28/152 (18%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+L+ ++I + +G+ +HAAG++ ++KP NL ++ + D+GLA
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------- 165
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
R+ E M +++ Y APE + L W + + D WS GC
Sbjct: 166 RQTDSE---------MTGYVVTRWYRAPE--------VILNW---MHYTQTVDIWSVGCI 205
Query: 357 LVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ 388
+ EM TG + G + ++K P +
Sbjct: 206 MAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 8e-04
Identities = 51/211 (24%), Positives = 75/211 (35%), Gaps = 46/211 (21%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A I G+ LH ++ ++KP N+LLD G +SD GLA LK K +
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAG- 159
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+P + APE L + S D ++ G TL EM
Sbjct: 160 ------------TPGFMAPE----------LLQGEEYDFS--VDYFALGVTLYEMIAARG 195
Query: 366 PWAGLSAEEIYRAVVKNR----------KLPPQYASIVGVGIPRELWKMIG----ECLQF 411
P+ E++ +K R K P S + ++ K +G C
Sbjct: 196 PFRA-RGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254
Query: 412 KASKRPTFSAMLATFLRHLQELPRSPPASPD 442
+ P F + R L+ PP PD
Sbjct: 255 RT--HPLFRDL---NWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|222954 PHA02989, PHA02989, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-04
Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 29/141 (20%)
Query: 736 NDV--ELVKIILDAGVDVNIRNVHNTIPLHVAL------ARGAKSCVGLLLSAGADCNWQ 787
DV ++VK+++D G DVN + T PL L + K V LLL GAD N +
Sbjct: 46 KDVKIKIVKLLIDNGADVNYKGYIET-PLCAVLRNREITSNKIKKIVKLLLKFGADINLK 104
Query: 788 DDEGDNA-------FHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSG-KTLRDFLEG 839
G + +I N + L +LS +V+N G L +LE
Sbjct: 105 TFNGVSPIVCFIYNSNI---------NNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLES 155
Query: 840 LPREWISEDLMEALMNRGVHL 860
+ +D+++ L++ GV+L
Sbjct: 156 FS---VKKDVIKILLSFGVNL 173
|
Length = 494 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 0.001
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 48/209 (22%)
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
L VMD G +++ G + Y A++ V +H G + +IKP N+L+D
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135
Query: 276 ASGRAVVSDYGLAAILK---------------------------KPACR---KARP-ECD 304
G ++D+GL + CR + +P E
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 305 SSRIHS-CMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
++R H C+ +++ +PNY APE G + D WS G L EM
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLL------------RTGYTQLCDWWSVGVILYEMLV 243
Query: 363 GSIPWAGLSAEEIYRAVVK---NRKLPPQ 388
G P+ + E V+ + +PPQ
Sbjct: 244 GQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 3/96 (3%)
Query: 691 CMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIILDA-G 748
C+ D + + +E +++L+ GA+ ++ T LHIA + EL + + G
Sbjct: 58 CVHIVSNPD-KADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPG 116
Query: 749 VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784
V++ I N P +VA R + +L + GA C
Sbjct: 117 VNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQC 152
|
Length = 154 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 17/53 (32%), Positives = 31/53 (58%), Gaps = 3/53 (5%)
Query: 706 ELVRILLTAGAEPTAQDAQNRTALHIASMAN---DVELVKIILDAGVDVNIRN 755
E++ ++ GA+ T D T L + +N D+E++K++L+ GVD+N N
Sbjct: 126 EILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178
|
Length = 489 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 26/187 (13%)
Query: 203 VCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGV 262
V F LR D L + M+ C G + G L+ QI + +G+ LH+ G
Sbjct: 69 VAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 263 VCMNIKPSNLLLDASGRAVVSDYGLAA-ILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+ +IK +N+LL +G ++D+G++A I A RK+ + +P +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS---------------FIGTPYW 172
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK 381
APE +K G + D W+ G T +E+ P L + K
Sbjct: 173 MAPEVAAVERKG---------GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK 223
Query: 382 NRKLPPQ 388
+ PP+
Sbjct: 224 SNFQPPK 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 28/103 (27%)
Query: 266 NIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPE 325
+IKPSN+L+++ G+ + D+G++ L I+S D + + Y +PE
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGEL----------------INSIADTFVGTSTYMSPE 172
Query: 326 AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+ K ++ +SD WS G +++E+ G P+A
Sbjct: 173 RIQGGKYTV------------KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165195 PHA02859, PHA02859, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 650 TPLHLCVATWNVAV--VKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
TP+ C+ V V +K +E + VN +AL + K+ E E +
Sbjct: 53 TPIFSCLEKDKVNVEILKFLIENGAD---VNFK-TRDNNLSALHHYLSFNKNVEPE---I 105
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMAN---DVELVKIILDAGVDV-NIRNVHNTIPLH 763
++IL+ +G+ T +D + LH+ M N + ++K+++D+GV N +N I
Sbjct: 106 LKILIDSGSSITEEDEDGKNLLHM-YMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYS 164
Query: 764 VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHI 797
L K L S G D N + G N + +
Sbjct: 165 YILFHSDKKIFDFLTSLGIDINETNKSGYNCYDL 198
|
Length = 209 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 21/122 (17%)
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
Y A++ + +H+ G + ++KP N+LLD SG ++D+G C K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKMDAN--- 195
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ D + +P+Y +PE V KS D G E D WS G L EM G
Sbjct: 196 GMVRC--DTAVGTPDYISPE----VLKSQGG--DGYYG--RECDWWSVGVFLYEMLVGDT 245
Query: 366 PW 367
P+
Sbjct: 246 PF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 31/172 (18%)
Query: 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQIL-RYGADIARGVVELHAA-GVV 263
F+G D + + M+ G + + GR+ EQIL + + +G+ L ++
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTYLREKHKIM 126
Query: 264 CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTA 323
++KPSN+L+++ G + D+G++ L I S + + + +Y +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL----------------IDSMANSFVGTRSYMS 170
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
PE + S+ +SD WS G +LVEM G P A+E+
Sbjct: 171 PERLQGTHYSV------------QSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 14/24 (58%), Positives = 18/24 (75%)
Query: 510 DGQTALHLACRRGSAELVEAILEY 533
DG T LHLA R G+ ELV+ +LE+
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEH 24
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 345 SPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK 403
S +SD WSFG + E+ T G +P+ GLS EE ++ KL G P L+K
Sbjct: 196 STKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQAGKLELPVPE----GCPSRLYK 250
Query: 404 MIGECLQFKASKRPTFSAMLA 424
++ C RP+FS +++
Sbjct: 251 LMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQIL-RYGADIARGVVELHAA-GVV 263
F+G D + + M+ G L E + E+IL + + RG+ L ++
Sbjct: 68 FYGAFYSDGEISICMEHMDGG-SLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 264 CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTA 323
++KPSN+L+++ G + D+G++ L I S + + + +Y +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL----------------IDSMANSFVGTRSYMS 170
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
PE + S+ +SD WS G +LVE+ G P A+E+
Sbjct: 171 PERLQGTHYSV------------QSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 48/209 (22%), Positives = 70/209 (33%), Gaps = 46/209 (22%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILR-YGADIARGVVELHAAGVVCMNIKPSN 271
L VMD G +++ G E + R Y A++ + +H G + +IKP N
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRLGIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDN 131
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC-------------------- 311
+L+D G ++D+GL + K + D R S
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 312 -----MDCTMLS----PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
C S PNY APE G + D WS G L EM
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLL------------RTGYTQLCDWWSVGVILYEMLV 239
Query: 363 GSIPWAGLSAEEIYRAVVKNRK---LPPQ 388
G P+ + E V+ +P Q
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQ 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 23/87 (26%), Positives = 45/87 (51%), Gaps = 11/87 (12%)
Query: 339 DDAIGISPESDAWSFGCTLVEMCTG-SIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVG 396
++ +S +D WSFG TL E+ +G P + L +++ + +LP P++
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT------ 230
Query: 397 IPRELWKMIGECLQFKASKRPTFSAML 423
EL +I +C+ ++ RP+F A++
Sbjct: 231 ---ELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 30/134 (22%), Positives = 55/134 (41%), Gaps = 27/134 (20%)
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH+AG++ ++KPSN+++ + + D+GLA ++ M
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------TAGTSFMM 182
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+++ Y APE +G D WS GC + EM G + + G
Sbjct: 183 TPYVVTRYYRAPEVIL------------GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
Query: 373 EEIYRAVVKNRKLP 386
+ + V++ P
Sbjct: 231 IDQWNKVIEQLGTP 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 37.2 bits (87), Expect = 0.003
Identities = 14/56 (25%), Positives = 27/56 (48%), Gaps = 2/56 (3%)
Query: 545 GDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELL 600
G L A +G E V L+++G ++ +G + H+ A +G + ++ LL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGN--TALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 11/24 (45%), Positives = 17/24 (70%)
Query: 510 DGQTALHLACRRGSAELVEAILEY 533
DG+T LHLA G+ E+V+ +L+
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDK 24
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.003
Identities = 33/154 (21%), Positives = 63/154 (40%), Gaps = 32/154 (20%)
Query: 223 CYGSVQLAMQRN--EG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
YGS + ++ + EG L + IL+ D+ + +H+ G + ++K S++LL G
Sbjct: 82 AYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHSKGFIHRSVKASHILLSGDG 138
Query: 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP----NYTAPEAWEPVKKSL 334
+ V+S GL R + + + S + +PE
Sbjct: 139 KVVLS--GL---------RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE--------- 178
Query: 335 NLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+ + G + +SD +S G T E+ G +P+
Sbjct: 179 -VLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.003
Identities = 37/161 (22%), Positives = 70/161 (43%), Gaps = 42/161 (26%)
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+V ++ P+N++L + ++D+GLA ++ +PE S++ S + T+L Y
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLA--------KQKQPE---SKLTSVVG-TIL---Y 179
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK 381
+ PE + K+ ++D W+FGC L +MCT P+ + + +V+
Sbjct: 180 SCPE----IVKNEPY--------GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 382 NRKLPPQYASIVGVGIPRELWK-----MIGECLQFKASKRP 417
P +P ++ +I CL A RP
Sbjct: 228 AVYEP----------LPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 33/219 (15%)
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277
LVM+ C GS ++ ++ L +I +G+ LH+ ++ +IK N+LL
Sbjct: 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161
Query: 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLF 337
G+ ++D+G A+I PA + + +P + APE +
Sbjct: 162 GQVKLADFGSASIA-SPA-----------------NSFVGTPYWMAPEV---------IL 194
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGI 397
D + D WS G T +E+ P ++A + +N P S
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDY 252
Query: 398 PRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRS 436
R + CLQ RPT +L L+E P +
Sbjct: 253 FRNF---VDSCLQKIPQDRPTSEELLKHMFV-LRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 15/29 (51%), Positives = 17/29 (58%)
Query: 761 PLHVALARGAKSCVGLLLSAGADCNWQDD 789
PLH+A G V LLL AGAD N +D
Sbjct: 5 PLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.004
Identities = 41/200 (20%), Positives = 68/200 (34%), Gaps = 72/200 (36%)
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+H+ V+ ++KPSN+LL++ R ++D+GLA R S ++
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLA------------------RSLSELEENP 164
Query: 317 LSPN---------YTAPEAWEPVKKSLNLFWDDAIGISPES-----DAWSFGCTLVEMCT 362
+P Y APE I + D WS GC L EM
Sbjct: 165 ENPVLTDYVATRWYRAPE----------------ILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 363 GSIPWAG----------------LSAEEI------YRAVVKNRKLPPQYASIVGV--GIP 398
G + G SAE+I + A + + + +
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS 268
Query: 399 RELWKMIGECLQFKASKRPT 418
+ ++ + L F +KR T
Sbjct: 269 DDALDLLKKLLVFNPNKRLT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.004
Identities = 47/207 (22%), Positives = 84/207 (40%), Gaps = 57/207 (27%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L L+ +LR+ + +A+G+ L + + ++ N+LL A + D+GLA +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI------ 262
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAP-EAWEPVKKSLNLFWDDAIGISPES-------- 348
M NY A PVK W ++PES
Sbjct: 263 ------------------MNDSNYVVKGNARLPVK------W-----MAPESIFDCVYTV 293
Query: 349 --DAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWK 403
D WS+G L E+ + G P+ G+ + +VK + P +A P E++
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFA-------PPEIYS 346
Query: 404 MIGECLQFKASKRPTFSAMLATFLRHL 430
++ C + ++RPTFS ++ ++
Sbjct: 347 IMKMCWNLEPTERPTFS-QISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.004
Identities = 19/81 (23%), Positives = 37/81 (45%), Gaps = 11/81 (13%)
Query: 345 SPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKL--PPQYASIVGVGIPREL 401
S +SD WSFG + E + G P+ G+ E+ + + ++ P P E+
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ--------RCPPEM 227
Query: 402 WKMIGECLQFKASKRPTFSAM 422
+ ++ C + +RP F+ +
Sbjct: 228 YDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.004
Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 14/127 (11%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+LT QI Y + G+ LH ++ +IK +N+L+D G ++D+GLA P
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+R ++ + T Y PE L L + D W GC
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRW---YRPPE--------LLLGERR---YTTAVDIWGIGCV 216
Query: 357 LVEMCTG 363
EM T
Sbjct: 217 FAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1630 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 100.0 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 100.0 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 100.0 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 100.0 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 100.0 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 100.0 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 100.0 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.94 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.94 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.94 | |
| KOG4369 | 2131 | consensus RTK signaling protein MASK/UNC-44 [Signa | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0507 | 854 | consensus CASK-interacting adaptor protein (caskin | 99.91 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG4369 | 2131 | consensus RTK signaling protein MASK/UNC-44 [Signa | 99.91 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.9 | |
| TIGR00870 | 743 | trp transient-receptor-potential calcium channel p | 99.9 | |
| TIGR00870 | 743 | trp transient-receptor-potential calcium channel p | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0507 | 854 | consensus CASK-interacting adaptor protein (caskin | 99.88 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.85 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.83 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.83 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.78 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.78 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.77 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.73 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.73 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG3676 | 782 | consensus Ca2+-permeable cation channel OSM-9 and | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| KOG3676 | 782 | consensus Ca2+-permeable cation channel OSM-9 and | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.54 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.54 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.53 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.5 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=424.02 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=224.8
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC-------hhHHHHHHHHHHHhccCCCCcc
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-------PDWLSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~-------~~~~~~Ei~iL~~l~l~HpNIV 204 (1630)
..+.+.|.+.+.||+|+||.|-+ |.++.|++.||||++++..... ....++|+++|++++ |||||
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkl------a~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~--HP~IV 239 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKL------AYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS--HPNIV 239 (475)
T ss_pred chhcceeEeeeeecCCceeEEEE------EEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC--CCCEE
Confidence 34678899999999999888755 7789999999999998764322 334579999999986 99999
Q ss_pred eeEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC---CcEE
Q 000343 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS---GRAV 281 (1630)
Q Consensus 205 ~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~---g~vK 281 (1630)
+++++|+...+.||||||+.||.|++.+-.++.+.+...+.+++|++.||.|||++||+||||||+|||++.+ ..+|
T Consensus 240 ~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 240 RIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred EEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence 9999999999999999999999999888778889999999999999999999999999999999999999866 6799
Q ss_pred EeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHh
Q 000343 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyeml 361 (1630)
|+|||+|+..++. ..+.+.||||.|.|||++...... .+..++||||+||+||-++
T Consensus 320 ItDFGlAK~~g~~---------------sfm~TlCGTpsYvAPEVl~~kg~~---------~~~~kVDiWSlGcvLfvcL 375 (475)
T KOG0615|consen 320 ITDFGLAKVSGEG---------------SFMKTLCGTPSYVAPEVLASKGVE---------YYPSKVDIWSLGCVLFVCL 375 (475)
T ss_pred ecccchhhccccc---------------eehhhhcCCccccChhheecCCee---------cccchheeeeccceEEEEe
Confidence 9999999987532 346778999999999999875421 2456999999999999999
Q ss_pred hCCCCCCCCCHHH-HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 362 TGSIPWAGLSAEE-IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 362 tG~~PF~~~~~~e-i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
+|.+||.+..... +.+.|.++.... .++.+..+++++.+||.+||..||++|||+.|+|+|..-
T Consensus 376 sG~pPFS~~~~~~sl~eQI~~G~y~f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 376 SGYPPFSEEYTDPSLKEQILKGRYAF---GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred ccCCCcccccCCccHHHHHhcCcccc---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 9999998876555 777888776432 223345689999999999999999999999999999553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=431.87 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=230.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.+|+..+.||+|+|+++| .+.+..+|+.||+|++.+.. ....+.+.+||+|.+.++ |||||+|+++|++
T Consensus 18 ~~Y~~g~~LGkGgFA~cY------e~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~--HpnIV~f~~~FED 89 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCY------EARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK--HPNIVQFYHFFED 89 (592)
T ss_pred ceeeeeeeeccCcceEEE------EEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC--CCcEEeeeeEeec
Confidence 689999999999988775 47788999999999998753 334677889999999976 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+++|||+|+|..++|..+.++.+.|+|.+++.|++||+.||.|||+++|||||||..|+||+++.++||+|||||..+.
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999999999888888899999999999999999999999999999999999999999999999999999887
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.+. ....+.||||.|.|||++.... ++..+||||+||+||.||.|++||...+.
T Consensus 170 ~~~--------------Erk~TlCGTPNYIAPEVl~k~g------------HsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 170 YDG--------------ERKKTLCGTPNYIAPEVLNKSG------------HSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred Ccc--------------cccceecCCCcccChhHhccCC------------CCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 542 1234589999999999998543 88999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCCC
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRS 436 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~s 436 (1630)
++.+.+|.......|. .++.++++||.++|+.||.+|||++++|.|-+-.-...|..
T Consensus 224 kety~~Ik~~~Y~~P~-------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 224 KETYNKIKLNEYSMPS-------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred HHHHHHHHhcCccccc-------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 9999999888766554 57899999999999999999999999999966544444433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=413.22 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=221.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.++|++++.||+|+||+|++. +.+.+++.+|+|++++... .+.....+|..+|..++ ||+||+++..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~V------rk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~--hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQV------RKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK--HPFIVKLIYSFQ 95 (357)
T ss_pred hhheeeeeeeeccCCceEEEE------EEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC--CCcEeeeEEecc
Confidence 469999999999999999873 4568999999999988743 34667888999999964 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+...+|||+||+.||.|+.++++++.+++..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||+|+..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ...+.+.+||+.|||||++.+.. |+.++|+||+|+++|||++|.+||.+.+
T Consensus 176 ~~~--------------~~~t~tfcGT~eYmAPEil~~~g------------y~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 176 LKD--------------GDATRTFCGTPEYMAPEILLGKG------------YDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred ccC--------------CCccccccCCccccChHHHhcCC------------CCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 321 12244589999999999998765 8999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC----ChhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP----TFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP----Sa~evL~~ 425 (1630)
..+++.+|.++....+ +..++.++++|+.++|+.||++|. ++.++-+|
T Consensus 230 ~~~~~~~I~~~k~~~~------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 230 VKKMYDKILKGKLPLP------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHHHhcCcCCCC------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 9999999998872222 124789999999999999999996 45666555
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=452.26 Aligned_cols=353 Identities=22% Similarity=0.262 Sum_probs=315.9
Q ss_pred CCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCH
Q 000343 469 PNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPP 548 (1630)
Q Consensus 469 ~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TP 548 (1630)
.+.|+.|+..|+.+.++.|++.++++ +.+|..|.||||+||..|+.++|++|++. +++++..+.+|.||
T Consensus 146 ~~~l~~~i~~~~~~i~k~Ll~~Gadv----------n~~d~~G~TpLh~Aa~~G~~~iv~~LL~~-Gad~n~~~~~g~t~ 214 (682)
T PHA02876 146 MKLIKERIQQDELLIAEMLLEGGADV----------NAKDIYCITPIHYAAERGNAKMVNLLLSY-GADVNIIALDDLSV 214 (682)
T ss_pred hHHHHHHHHCCcHHHHHHHHhCCCCC----------CCCCCCCCCHHHHHHHCCCHHHHHHHHHC-CCCcCccCCCCCCH
Confidence 45789999999999999999999886 47889999999999999999999999995 68899999999999
Q ss_pred HHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCCh-H
Q 000343 549 LVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT-D 627 (1630)
Q Consensus 549 Lh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~-e 627 (1630)
||+|+..|+.+++++|++.+++++. +.++|+.|+..++.+++++|+++|+++|..|..|.||||+|+..++. +
T Consensus 215 L~~A~~~~~~~ivk~Ll~~~~~~~~------~~~~L~~ai~~~~~~~~~~Ll~~g~~vn~~d~~g~TpLh~Aa~~~~~~~ 288 (682)
T PHA02876 215 LECAVDSKNIDTIKAIIDNRSNINK------NDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSR 288 (682)
T ss_pred HHHHHHcCCHHHHHHHHhcCCCCCC------CcHHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHhCCCHHH
Confidence 9999999999999999999988753 34789999999999999999999999999999999999999999986 5
Q ss_pred HHHHHHHcCCccccccccCCCCcHHHHHHHcC-CHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHH
Q 000343 628 CAIVILENGGCRSMAILNSKELTPLHLCVATW-NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706 (1630)
Q Consensus 628 iv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g-~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~e 706 (1630)
++++|++.|+ +++..|..|.||||+|+..| +.++++.|+..++.... .+ ....++++.|+... +..+
T Consensus 289 iv~lLl~~ga--din~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~---~d--~~g~TpLh~A~~~~-----~~~~ 356 (682)
T PHA02876 289 LVPKLLERGA--DVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNA---AD--RLYITPLHQASTLD-----RNKD 356 (682)
T ss_pred HHHHHHHCCC--CCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCC---cc--cCCCcHHHHHHHhC-----CcHH
Confidence 8999999997 67888999999999999999 59999999998876432 22 23468888877643 3468
Q ss_pred HHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCC-HHHHHHHHhCCCCCC
Q 000343 707 LVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGA-KSCVGLLLSAGADCN 785 (1630)
Q Consensus 707 iVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~-~eiVklLLe~GADiN 785 (1630)
++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+..|.||||+|+..++ ..++++|+++|+|+|
T Consensus 357 iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin 436 (682)
T PHA02876 357 IVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVN 436 (682)
T ss_pred HHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999998765 567999999999999
Q ss_pred cCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCC
Q 000343 786 WQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 786 ~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~ 861 (1630)
.+|.+|+||||+|+..+. ...++.+|++.|+++|++|..|.||+++|.... .+++.|+..|+++.
T Consensus 437 ~~d~~G~TpLh~Aa~~~~-----~~~iv~lLl~~Gad~n~~d~~g~tpl~~a~~~~------~~v~~Ll~~~a~~~ 501 (682)
T PHA02876 437 SKNKDLSTPLHYACKKNC-----KLDVIEMLLDNGADVNAINIQNQYPLLIALEYH------GIVNILLHYGAELR 501 (682)
T ss_pred cCCCCCChHHHHHHHhCC-----cHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhC------CHHHHHHHCCCCCC
Confidence 999999999999997531 235778888999999999999999999988643 57889999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=406.70 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=227.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
..+|++.++||.|+|+.| |+|+++.++..||||.+.+.. ....+.+..|+.+|+.++ |||||+|+++++.
T Consensus 9 ~~~y~~~~~iG~GsfavV------ykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~--H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVV------YKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK--HPNIVRLLDCIED 80 (429)
T ss_pred cccceehhhccCcceEEE------EEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC--CcceeeEEEEEec
Confidence 468999999999997766 558899999999999998874 334667789999999987 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC------CcEEEeecc
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS------GRAVVSDYG 286 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~------g~vKL~DFG 286 (1630)
++++|||||||+||+|..++++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999864 358999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+|+.+.+.. ...+.+|++.|||||++...+ |+.|+|+||+|+|||+|++|+.|
T Consensus 161 fAR~L~~~~---------------~a~tlcGSplYMAPEV~~~~~------------YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 161 FARFLQPGS---------------MAETLCGSPLYMAPEVIMSQQ------------YDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred hhhhCCchh---------------HHHHhhCCccccCHHHHHhcc------------ccchhhHHHHHHHHHHHHhCCCC
Confidence 999876432 345689999999999998766 89999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
|...+..+++..+.++....+... ..++.+..+|+...|+.+|.+|.++.+-+.+.+....
T Consensus 214 f~a~t~~eL~~~~~k~~~~~~~~~----~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 214 FDAETPKELLLYIKKGNEIVPVLP----AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccccCHHHHHHHHhccccccCchh----hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 999999999998888776655443 3466778899999999999999999988777554433
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=452.33 Aligned_cols=358 Identities=21% Similarity=0.261 Sum_probs=295.0
Q ss_pred CCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHH-----------------------------
Q 000343 469 PNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLAC----------------------------- 519 (1630)
Q Consensus 469 ~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa----------------------------- 519 (1630)
.|+||+|+..|+++.|+.|++..++. +...|..|.||||+|+
T Consensus 42 ~t~LH~A~~~g~~e~V~~ll~~~~~~---------~~~~~~~~~tpLh~a~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 112 (682)
T PHA02876 42 FTAIHQALQLRQIDIVEEIIQQNPEL---------IYITDHKCHSTLHTICIIPNVMDIVISLTLDCDIILDIKYASIIL 112 (682)
T ss_pred chHHHHHHHHHhhhHHHHHHHhCccc---------chhhchhhccccccccCCCCccccccccccchhhcccccHHHHHH
Confidence 57999999999999999999987652 3466777888888666
Q ss_pred -----------------------------------------HcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCH
Q 000343 520 -----------------------------------------RRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSP 558 (1630)
Q Consensus 520 -----------------------------------------~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~ 558 (1630)
..|+.+++++|++. ++++|..|..|.||||+||..|+.
T Consensus 113 ~~~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~~~~i~k~Ll~~-Gadvn~~d~~G~TpLh~Aa~~G~~ 191 (682)
T PHA02876 113 NKHKLDEACIHILKEAISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEG-GADVNAKDIYCITPIHYAAERGNA 191 (682)
T ss_pred HHHHHHHHHHHHHHHHhcCCcccHHhhccchhhhHHHHHHHHCCcHHHHHHHHhC-CCCCCCCCCCCCCHHHHHHHCCCH
Confidence 55677777777774 567788888888888888888888
Q ss_pred HHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCc
Q 000343 559 ECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGC 638 (1630)
Q Consensus 559 eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~ 638 (1630)
++|++|+++||+++... ..|.||||+|+..++.+++++|++++++++. +.++|+.|+..++.+++++|++.|+
T Consensus 192 ~iv~~LL~~Gad~n~~~--~~g~t~L~~A~~~~~~~ivk~Ll~~~~~~~~----~~~~L~~ai~~~~~~~~~~Ll~~g~- 264 (682)
T PHA02876 192 KMVNLLLSYGADVNIIA--LDDLSVLECAVDSKNIDTIKAIIDNRSNINK----NDLSLLKAIRNEDLETSLLLYDAGF- 264 (682)
T ss_pred HHHHHHHHCCCCcCccC--CCCCCHHHHHHHcCCHHHHHHHHhcCCCCCC----CcHHHHHHHHcCCHHHHHHHHHCCC-
Confidence 88888888888776543 3456778888888888888888877777653 3467888888888888888888886
Q ss_pred cccccccCCCCcHHHHHHHcCCH-HHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCC
Q 000343 639 RSMAILNSKELTPLHLCVATWNV-AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717 (1630)
Q Consensus 639 ~~i~~~d~~G~TPLh~Aa~~g~~-eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAd 717 (1630)
+++..+..|.||||+|+..++. ++++.|++.++... ..+ ..+.|+++.|+... ...+++++|+..|++
T Consensus 265 -~vn~~d~~g~TpLh~Aa~~~~~~~iv~lLl~~gadin---~~d--~~g~TpLh~Aa~~g-----~~~~~v~~Ll~~gad 333 (682)
T PHA02876 265 -SVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGADVN---AKN--IKGETPLYLMAKNG-----YDTENIRTLIMLGAD 333 (682)
T ss_pred -CCCCCCCCCCCHHHHHHhCCCHHHHHHHHHHCCCCCC---CcC--CCCCCHHHHHHHhC-----CCHHHHHHHHHcCCC
Confidence 6677788999999999999986 68899999887533 222 23578888887532 136899999999999
Q ss_pred CCcccccCccchhhhhhc-CCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHH
Q 000343 718 PTAQDAQNRTALHIASMA-NDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFH 796 (1630)
Q Consensus 718 vn~~D~~G~TpLH~Aa~~-g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLh 796 (1630)
+|.+|..|.||||+|+.. ++.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+|++..+..|.||||
T Consensus 334 in~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh 413 (682)
T PHA02876 334 VNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALH 413 (682)
T ss_pred CCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHH
Confidence 999999999999999985 5789999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCC
Q 000343 797 IAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSP 862 (1630)
Q Consensus 797 lAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~ 862 (1630)
+|+..+. ...++++|+..|+++|.+|.+|+|||++|...+. ..+++++|++.|++++.
T Consensus 414 ~A~~~~~-----~~~~vk~Ll~~gadin~~d~~G~TpLh~Aa~~~~---~~~iv~lLl~~Gad~n~ 471 (682)
T PHA02876 414 FALCGTN-----PYMSVKTLIDRGANVNSKNKDLSTPLHYACKKNC---KLDVIEMLLDNGADVNA 471 (682)
T ss_pred HHHHcCC-----HHHHHHHHHhCCCCCCcCCCCCChHHHHHHHhCC---cHHHHHHHHHCCCCCCC
Confidence 9986543 3456678889999999999999999999986431 45899999999999775
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=415.44 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=232.1
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc---CcCChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
.-..+|.+++.||.|+|++|++ |+++.+++.||||++.+. .+.....+.+|.++|.++. +||.|++||..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~------A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-~hPgivkLy~T 142 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVL------AREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-GHPGIVKLYFT 142 (604)
T ss_pred CChhhcchhheeccccceeEEE------eeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-CCCCeEEEEEE
Confidence 3457999999999999888765 888999999999998876 3445677889999999997 79999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
|++...+|+|+||+++|+|..++.+.+.|++..++.|+.||+.||+|||++|||||||||+|||||+++++||+|||.|+
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+.........+. ...........++||..|.+||+|.... .++.+|||+||||||.|+.|++||.+
T Consensus 223 ~l~~~~~~~~~~~-~~~~a~s~~~SFVGTAeYVSPElL~~~~------------~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 223 ILSPSQKSQENPV-DPNQASSRRSSFVGTAEYVSPELLNDSP------------AGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred cCChhhccccCcc-CcccccCcccceeeeecccCHHHhcCCC------------CCcccchHHHHHHHHHHhcCCCCCcc
Confidence 8875432211111 1111111125689999999999998765 78999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.++.-++++|.......+ +++++.+++||.++|..||++|+++.++.+|.+
T Consensus 290 ~NeyliFqkI~~l~y~fp-------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 290 ANEYLIFQKIQALDYEFP-------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred ccHHHHHHHHHHhcccCC-------CCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 999999999987765433 468899999999999999999999999999855
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=400.72 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=219.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+.+.++.||+|..|.| |+++++.|++.+|+|.|.... .....++.+|+++++.++ |||||++|+.|..+
T Consensus 78 ~~dle~~~~lG~G~gG~V------~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~--spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTV------YKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ--SPYIVGFYGAFYSN 149 (364)
T ss_pred HHHhhhhhhcccCCCcEE------EEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC--CCCeeeEeEEEEeC
Confidence 357889999999996655 558899999999999995542 233678899999999985 99999999999999
Q ss_pred C-EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 S-CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~-~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
. .++|+||||++|+|+.++...+++++.....|+.+|++||.|||+ ++||||||||+|||++..|.+||||||.+..+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 8 599999999999999999888899999999999999999999995 89999999999999999999999999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC-
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL- 370 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~- 370 (1630)
-+. ...+.+||..|||||.+.+.. |+.++||||||++++|+++|++||...
T Consensus 230 vnS----------------~a~tfvGT~~YMsPERi~g~~------------Ys~~sDIWSLGLsllE~a~GrfP~~~~~ 281 (364)
T KOG0581|consen 230 VNS----------------IANTFVGTSAYMSPERISGES------------YSVKSDIWSLGLSLLELAIGRFPYPPPN 281 (364)
T ss_pred hhh----------------hcccccccccccChhhhcCCc------------CCcccceecccHHHHHHhhCCCCCCCcC
Confidence 532 235678999999999999876 899999999999999999999999764
Q ss_pred ----CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 ----SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ----~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
...+++..|..+.. |..+. ..+++++++||..||+.||.+|||+.|+++|-+
T Consensus 282 ~~~~~~~~Ll~~Iv~~pp--P~lP~---~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 282 PPYLDIFELLCAIVDEPP--PRLPE---GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCCCCHHHHHHHHhcCCC--CCCCc---ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 55677888876542 22211 148999999999999999999999999999955
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=426.59 Aligned_cols=373 Identities=18% Similarity=0.160 Sum_probs=295.6
Q ss_pred CCCCccchhhccC---ChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcC--CHHHHHHHHHhc-CCCccc
Q 000343 467 DNPNNLHQLVSEG---DVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRG--SAELVEAILEYS-QENVDV 540 (1630)
Q Consensus 467 ~~~t~Lh~Aa~~G---dl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G--~~eiVk~LL~~~-~~dvn~ 540 (1630)
++.|+||.|+.+| +.+.++.||+.||++ +++|.+|+||||+|+..+ +.++|++||+.+ +++++.
T Consensus 40 ~G~TaLh~A~~~~~~~~~eivklLLs~GAdi----------n~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~ 109 (672)
T PHA02730 40 RGNNALHCYVSNKCDTDIKIVRLLLSRGVER----------LCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNEL 109 (672)
T ss_pred CCCcHHHHHHHcCCcCcHHHHHHHHhCCCCC----------cccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccc
Confidence 3568999999997 599999999999986 478999999999999977 799999999964 356688
Q ss_pred CCCCCCCHHHHHHH--cCCHHHHHHHHH-CCCCcccccc---cCCCchHHHHHHHcCCHHHHHHHHHcCCCCC-------
Q 000343 541 LDKDGDPPLVFALA--AGSPECVHALIK-RGANVISRLR---EGFGPSVAHVCAYHGQPDCMRELLLAGADPN------- 607 (1630)
Q Consensus 541 ~D~~G~TPLh~Aa~--~G~~eiVk~LL~-~GAdvn~~~~---d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn------- 607 (1630)
.+..+.+|||.++. +++.++|++||. .++|++.... .+.|-+|+++|+..++.++|++|+++||+++
T Consensus 110 ~~~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~~~~~~~~~~~~~~~yl~~~~~~~eIvklLi~~g~~v~g~~~~~~ 189 (672)
T PHA02730 110 TSNINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSKNTNYYIHCLGLVDIYVTTPNPRPEVLLWLLKSECYSTGYVFRSC 189 (672)
T ss_pred ccccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhhhhhhhccccchhhhhHhcCCCchHHHHHHHHcCCcccccccccc
Confidence 88889999999998 999999999996 7788876522 1478899999999999999999999999996
Q ss_pred CCCCCCCCh-hhhh------hhcCChHHHHHHHHcCCccccccccCCCCcHHHH--HHHcCCHHHHHHHHH---------
Q 000343 608 AVDDEGESV-LHRA------VAKKYTDCAIVILENGGCRSMAILNSKELTPLHL--CVATWNVAVVKRWVE--------- 669 (1630)
Q Consensus 608 ~~D~~G~TP-LH~A------a~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~--Aa~~g~~eivk~LLe--------- 669 (1630)
..+..+.|| ||++ ..+++.+++++|+++|+ +++..|..|.||||+ |+..++.+++++|++
T Consensus 190 ~~~~~~c~~~l~~~il~~~~~~~n~~eiv~lLIs~Ga--dIN~kd~~G~TpLh~~~~~~~~~~eiv~~Li~~~~~~~~~~ 267 (672)
T PHA02730 190 MYDSDRCKNSLHYYILSHRESESLSKDVIKCLIDNNV--SIHGRDEGGSLPIQYYWSCSTIDIEIVKLLIKDVDTCSVYD 267 (672)
T ss_pred cccCCccchhHHHHHHhhhhhhccCHHHHHHHHHCCC--CCCCCCCCCCCHHHHHHHcCcccHHHHHHHHhccccccccc
Confidence 244555544 4433 46689999999999998 889999999999995 555677999999999
Q ss_pred -----------------------hcCccccccc-----------------cCCCCCCc---c------------H--HHH
Q 000343 670 -----------------------VASPEEIVNV-----------------IDIPGPVG---T------------A--LCM 692 (1630)
Q Consensus 670 -----------------------~ga~~~~~n~-----------------~d~~~~~~---t------------~--l~~ 692 (1630)
.+.+..+++. .+..+... . . -.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~i~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~i~~~~~~~~~~~~q~~l 347 (672)
T PHA02730 268 DISQPYIRGVLADYLNKRFRVTPYNVDMEIVNLLIEGRHTLIDVMRSITSYDSREYNHYIIDNILKRFRQQDESIVQAML 347 (672)
T ss_pred cccchhhhhhHHHhhhhhhhcccCCcchHHHHHHhhccCcchhhhhccccccccccchhHHHHHHHhhhccchhHHHHHH
Confidence 3443333110 11111100 0 0 011
Q ss_pred HHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCC----HHHHHHHHHCCC--CcccccCCCCCHHHH--
Q 000343 693 AAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAND----VELVKIILDAGV--DVNIRNVHNTIPLHV-- 764 (1630)
Q Consensus 693 aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~----~eiVklLL~~GA--DvN~~d~~G~TPLH~-- 764 (1630)
...+.. ......+++++|+++|||+|.. ..|.||||+|+..++ .+++++||++|| |+|.+|..|.||||.
T Consensus 348 ~~Y~~~-~~~v~ieIvelLIs~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i 425 (672)
T PHA02730 348 INYLHY-GDMVSIPILRCMLDNGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLI 425 (672)
T ss_pred HHHHhc-CCcCcHHHHHHHHHCCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHH
Confidence 111111 1124689999999999999986 799999999998875 899999999998 699999999999994
Q ss_pred -HHHcC---------CHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCC-CCCCH
Q 000343 765 -ALARG---------AKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH-SGKTL 833 (1630)
Q Consensus 765 -Aa~~G---------~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~-~G~Tp 833 (1630)
|...+ ..+++++|+++|||+|++|..|+||||+|+..++ ..++.+|+..||++|++|+ .|.||
T Consensus 426 ~a~~~n~~~~~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~------~eive~LI~~GAdIN~~d~~~g~Ta 499 (672)
T PHA02730 426 LSRFNNCGYHCYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNN------IQFARRLLEYGASVNTTSRSIINTA 499 (672)
T ss_pred HHHhccccccccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCC------HHHHHHHHHCCCCCCCCCCcCCcCH
Confidence 33332 2357999999999999999999999999997643 3567788899999999997 69999
Q ss_pred HHHHhhCCCCCcHHHHHHHHHhcCCCCC
Q 000343 834 RDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 834 LdlA~~~~~~~~~~~lve~Ll~~Ga~l~ 861 (1630)
+++|..... ...+++++|+++|+++.
T Consensus 500 L~~Aa~~~~--~~~eIv~~LLs~ga~i~ 525 (672)
T PHA02730 500 IQKSSYRRE--NKTKLVDLLLSYHPTLE 525 (672)
T ss_pred HHHHHHhhc--CcHHHHHHHHHcCCCHH
Confidence 999875321 24689999999999865
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=420.58 Aligned_cols=338 Identities=20% Similarity=0.242 Sum_probs=256.8
Q ss_pred CCccchhh--ccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCC
Q 000343 469 PNNLHQLV--SEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGD 546 (1630)
Q Consensus 469 ~t~Lh~Aa--~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~ 546 (1630)
.+.||.++ ..++.+.++.|++.++++ +.+|.+|.||||+||..|+.+++++||+. ++++|..|.+|.
T Consensus 38 ~~~Lh~~~~~~~~~~~iv~~Ll~~Gadv----------n~~d~~G~TpLh~Aa~~g~~eiv~lLL~~-GAdin~~d~~g~ 106 (446)
T PHA02946 38 YHILHAYCGIKGLDERFVEELLHRGYSP----------NETDDDGNYPLHIASKINNNRIVAMLLTH-GADPNACDKQHK 106 (446)
T ss_pred ChHHHHHHHhcCCCHHHHHHHHHCcCCC----------CccCCCCCCHHHHHHHcCCHHHHHHHHHC-cCCCCCCCCCCC
Confidence 45677655 444678889999888875 46788899999999999999999999985 578888999999
Q ss_pred CHHHHHHHcC--CHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC
Q 000343 547 PPLVFALAAG--SPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624 (1630)
Q Consensus 547 TPLh~Aa~~G--~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g 624 (1630)
||||+|+..+ ..+++++|+++|++++.. .+..|.|||| ||..++.+++++|+++|++++.+|..|+||||+|+..+
T Consensus 107 TpLh~A~~~~~~~~e~v~lLl~~Gadin~~-~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~ 184 (446)
T PHA02946 107 TPLYYLSGTDDEVIERINLLVQYGAKINNS-VDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSD 184 (446)
T ss_pred CHHHHHHHcCCchHHHHHHHHHcCCCcccc-cCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCCCHHHHHHHhc
Confidence 9999888765 478899999999988743 3456788887 66678889999999999999999999999999887755
Q ss_pred C--hHHHHHHHHcCCccccccccCCCCcHHHHHHHcC--CHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCc
Q 000343 625 Y--TDCAIVILENGGCRSMAILNSKELTPLHLCVATW--NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700 (1630)
Q Consensus 625 ~--~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g--~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~ 700 (1630)
+ .+++++|+++|+ +++..|..|.||||+|+..+ +.+++++|+. +++ .+..|. .+.|++++|+...
T Consensus 185 ~~~~~~v~~Ll~~Ga--din~~d~~G~TpLH~Aa~~~~~~~~iv~lLl~-gad---in~~d~--~G~TpLh~A~~~~--- 253 (446)
T PHA02946 185 NPKASTISWMMKLGI--SPSKPDHDGNTPLHIVCSKTVKNVDIINLLLP-STD---VNKQNK--FGDSPLTLLIKTL--- 253 (446)
T ss_pred CCCHHHHHHHHHcCC--CCcccCCCCCCHHHHHHHcCCCcHHHHHHHHc-CCC---CCCCCC--CCCCHHHHHHHhC---
Confidence 4 578889999887 67778888999999998765 6667776663 322 222222 2356666655421
Q ss_pred cchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhC
Q 000343 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSA 780 (1630)
Q Consensus 701 ~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~ 780 (1630)
...+++++|+++|++++ ++| +|+|+..+..+++++|.++|. ..|.||||+|+.+|+.+++++||++
T Consensus 254 --~~~~~~~~Ll~~g~~~~-----~~~-~~~a~~~~~~~~~e~l~~~g~------~~~~TpLh~Aa~~g~~eivk~Ll~~ 319 (446)
T PHA02946 254 --SPAHLINKLLSTSNVIT-----DQT-VNICIFYDRDDVLEIINDKGK------QYDSTDFKMAVEVGSIRCVKYLLDN 319 (446)
T ss_pred --ChHHHHHHHHhCCCCCC-----CcH-HHHHHHcCchHHHHHHHHcCc------ccCCCHHHHHHHcCCHHHHHHHHHC
Confidence 11356667777766544 223 666666666666666666653 3578999999999999999999998
Q ss_pred CCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCC
Q 000343 781 GADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHL 860 (1630)
Q Consensus 781 GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l 860 (1630)
|+ .|+||||+|+..+ ...++.+|+..|+++|.+ .+|+|||++|.... ..++++.|+....+.
T Consensus 320 ~~-------~~~t~L~~A~~~~------~~~~v~~Ll~~ga~~n~~-~~G~t~l~~a~~~~----~~~~~~~ll~~~~~~ 381 (446)
T PHA02946 320 DI-------ICEDAMYYAVLSE------YETMVDYLLFNHFSVDSV-VNGHTCMSECVRLN----NPVILSKLMLHNPTS 381 (446)
T ss_pred CC-------ccccHHHHHHHhC------HHHHHHHHHHCCCCCCCc-cccccHHHHHHHcC----CHHHHHHHHhcCccH
Confidence 75 4789999999754 346778888899999996 57999999998776 568889998877765
Q ss_pred CC
Q 000343 861 SP 862 (1630)
Q Consensus 861 ~~ 862 (1630)
+.
T Consensus 382 ~~ 383 (446)
T PHA02946 382 ET 383 (446)
T ss_pred HH
Confidence 43
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=413.28 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=222.6
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHG 208 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~ 208 (1630)
..-.++|.+++.||+|+||+|+| +..+.+++.+|||.+++.. ..+.+....|.+|+..+. +||++++|+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~l------ae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~ 436 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLL------AELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFS 436 (694)
T ss_pred cccccceEEEEEeccCcCceEEE------EEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeeccc
Confidence 34457999999999999999977 5567789999999999874 334677788999999987 7999999999
Q ss_pred EEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 209 VLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 209 ~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.|++..++|+||||+.||++. +..+...|++..++.|+++|+.||+|||++||||||||.+|||||..|.+||+|||++
T Consensus 437 ~fQT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred ccccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccc
Confidence 999999999999999999944 3444568999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+.... ....+++.+|||.|||||++.+.. |+.++|+|||||+|||||.|+.||.
T Consensus 516 Ke~m~--------------~g~~TsTfCGTpey~aPEil~e~~------------Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 516 KEGMG--------------QGDRTSTFCGTPEFLAPEVLTEQS------------YTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred cccCC--------------CCCccccccCChhhcChhhhccCc------------ccchhhHHHHHHHHHHHHcCCCCCC
Confidence 75321 122467799999999999999876 8999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-----hhHHHH
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF-----SAMLAT 425 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-----~evL~~ 425 (1630)
+.++++++..|+......|. .++.++.++|+++|..+|++|..+ .++..|
T Consensus 570 gddEee~FdsI~~d~~~yP~-------~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 570 GDDEEEVFDSIVNDEVRYPR-------FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred CCCHHHHHHHHhcCCCCCCC-------cccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 99999999999988766554 478999999999999999999876 455555
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=382.43 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=222.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.++|++++.||.|+||.|.| .+++.+|..+|+|.+.+..-.. .+...+|..+|+.+. ||+++++++.|.
T Consensus 43 l~dfe~~~tlGtGSFGrV~L------Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~--~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHL------VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS--HPFLVKLYGTFK 114 (355)
T ss_pred hhhhhheeeeccCccceEEE------EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc--CceeEEEEEeec
Confidence 46999999999999999988 4577889999999998875433 455678999999986 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+.+.+||||||.+||.++.++++.+++++..++.|+.||+.||+|||+++||+|||||+|||||.+|.+||+|||+|+..
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... +-+.||||.|+|||+++... |+.++|.|||||++|||+.|.+||.+.+
T Consensus 195 ~~r-----------------T~TlCGTPeYLAPEii~sk~------------ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 195 SGR-----------------TWTLCGTPEYLAPEIIQSKG------------YNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred cCc-----------------EEEecCCccccChHHhhcCC------------CCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 531 34689999999999998765 8999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~ 425 (1630)
+..++++|+.++...|. .++.++++||+++|+.|-.+|. ...++.+|
T Consensus 246 ~~~iY~KI~~~~v~fP~-------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 246 PIQIYEKILEGKVKFPS-------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred hHHHHHHHHhCcccCCc-------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 99999999999877665 4789999999999999999993 34455554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=381.97 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=217.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+.|+.+.++|+|+|| .||+|+++.||+.||||++.-.++.. .+...|||++|++++ |||+|.|+++|...
T Consensus 2 ekYE~LgkvGEGSYG------vV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk--H~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYG------VVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK--HENLVNLIEVFRRK 73 (396)
T ss_pred cHHhhhhccccCcce------EEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc--cchHHHHHHHHHhc
Confidence 479999999999954 55779999999999999987654322 556779999999986 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..++||+|||+...|..+.+....++.+.++.|++|++.|+.|+|+++||||||||+||||+.+|.+||||||+|+.+..
T Consensus 74 rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 74 RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999998763
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
+. ..++..+.|..|+|||++.+.. .|++++||||+||++.||++|.+.|++.+.-
T Consensus 154 pg--------------d~YTDYVATRWYRaPELLvGDt-----------qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 154 PG--------------DNYTDYVATRWYRAPELLVGDT-----------QYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred Cc--------------chhhhhhhhhhccChhhhcccC-----------cCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 21 2345677899999999998743 2999999999999999999999999998887
Q ss_pred HHHHHHHhc--CCCC---------CCc----------cc---ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 374 EIYRAVVKN--RKLP---------PQY----------AS---IVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~--~~~~---------~~~----------~~---~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+++..|.+. ...| +.+ .. ...+.++.-+.+|+++||+.||++|++.+++|.|
T Consensus 209 DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 209 DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 766655442 1110 000 00 0123456678999999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=399.69 Aligned_cols=270 Identities=24% Similarity=0.302 Sum_probs=224.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
..++|++++.||+|+||.||| |+.+.||+.+|+|++++.... +.+.++.|..+|... .+|+||+||..|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrL------arKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~--ds~~vVKLyYsF 210 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRL------ARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV--DSPWVVKLYYSF 210 (550)
T ss_pred CcccchhheeeccccceeEEE------EEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc--CCCcEEEEEEEe
Confidence 457999999999999999887 778899999999999987543 355677899999885 499999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
++..++||||||++||++..++.+.+.|++..++.|+.+++.|++-||+.|||||||||+|+|||..|++||+|||||.-
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999965
Q ss_pred ecCccccC------------------CCCC---CCC------------CCcccccccccCCCCCCCcccccccccccccc
Q 000343 291 LKKPACRK------------------ARPE---CDS------------SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLF 337 (1630)
Q Consensus 291 ~~~~~~~~------------------~~~~---~~~------------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~ 337 (1630)
+....... ..+. ... ..........+|||-|+|||++.+..
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg------ 364 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG------ 364 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC------
Confidence 43211000 0000 000 00011123578999999999999865
Q ss_pred ccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC
Q 000343 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417 (1630)
Q Consensus 338 ~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP 417 (1630)
|+..+|+|||||||||||.|.+||...++.+.+.+|...+.....+. ...+++++++||.+||. ||.+|.
T Consensus 365 ------Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 365 ------YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred ------CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cCcccHHHHHHHHHHhc-CHHHhc
Confidence 89999999999999999999999999999999999988764332221 23477999999999999 999997
Q ss_pred C---hhhHHHHhh
Q 000343 418 T---FSAMLATFL 427 (1630)
Q Consensus 418 S---a~evL~~L~ 427 (1630)
. ++||-+|-+
T Consensus 435 G~~G~~EIK~HPf 447 (550)
T KOG0605|consen 435 GSKGAEEIKKHPF 447 (550)
T ss_pred CcccHHHHhcCCc
Confidence 5 777777633
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=400.64 Aligned_cols=267 Identities=20% Similarity=0.250 Sum_probs=225.9
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
..+.++|+++++||.|+||.||+ |..+.+++.||||++++.... +.-.-.||+..|+++. .|||||+|++++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~l------a~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-~hpniikL~Evi 78 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYL------AKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-PHPNIIKLKEVI 78 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEE------eeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-CCCcchhhHHHh
Confidence 45678999999999999988866 778899999999999876332 2334457899988875 499999999999
Q ss_pred EeCC-EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 211 RMDS-CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 211 ~~~~-~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
.+.+ .+|+|||||+.++++.+..++..|++..++.|+.||++||+|+|.+|+.||||||+|||+.....+||+|||+|+
T Consensus 79 ~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 79 RDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred hccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence 9887 999999999999999998888889999999999999999999999999999999999999999999999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+.+. ..++..+-|..|+|||++.+..+ |+.+.||||+|||++|+.+-++.|.+
T Consensus 159 ev~Sk---------------pPYTeYVSTRWYRAPEvLLrs~~-----------Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 159 EVRSK---------------PPYTEYVSTRWYRAPEVLLRSGY-----------YSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred ccccC---------------CCcchhhhcccccchHHhhhccc-----------cCCchHHHHHHHHHHHHHHhcccCCC
Confidence 76542 22455677999999999987542 99999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCC-------------------c----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 370 LSAEEIYRAVVKNRKLPPQ-------------------Y----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~-------------------~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.++.+.+.+|+.--..|.. . ...+-+.++.++.+||.+||++||.+||||+|+|+|.
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 9998888888763322211 0 0011234788999999999999999999999999996
Q ss_pred hhccc
Q 000343 427 LRHLQ 431 (1630)
Q Consensus 427 ~~~l~ 431 (1630)
+-...
T Consensus 293 ffq~~ 297 (538)
T KOG0661|consen 293 FFQVG 297 (538)
T ss_pred ccccc
Confidence 65443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=404.29 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=227.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.-|++.+.||+|+-|.|-+ |.+..||+.+|||+|.+.. ...+..+++||-+|+.+. ||||++||+++++
T Consensus 12 GpwkLgkTLG~Gstg~vrl------akh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~--HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRL------AKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE--HPNVLRLYDVWEN 83 (786)
T ss_pred cceeccccccCCCCceehh------hhcccccceeEEEeeccccccccccccchhhhhHHHHHhc--CCCeeeeeeeecc
Confidence 3588999999999887765 8899999999999998762 223667899999999986 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++|||+||++||.|++++-.+++|++.++..+++||+.|+.|+|..+|+||||||+|+|||.++++||+|||+|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999998654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
++ ....+.||+|.|+|||++.+.+| -+.++||||+|||||.||||++||.+.+.
T Consensus 164 ~g---------------klLeTSCGSPHYA~PEIV~G~pY-----------dG~~sDVWSCGVILfALLtG~LPFdDdNi 217 (786)
T KOG0588|consen 164 PG---------------KLLETSCGSPHYAAPEIVSGRPY-----------DGRPSDVWSCGVILFALLTGKLPFDDDNI 217 (786)
T ss_pred CC---------------ccccccCCCcccCCchhhcCCCC-----------CCCccccchhHHHHHHHHhCCCCCCCccH
Confidence 32 24567899999999999999885 47899999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..++.++.+|....|. +++.++++||.+||..||++|.|.+|+++|.+.
T Consensus 218 r~LLlKV~~G~f~MPs-------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 218 RVLLLKVQRGVFEMPS-------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred HHHHHHHHcCcccCCC-------cCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 9999999988766553 589999999999999999999999999999663
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=408.90 Aligned_cols=313 Identities=21% Similarity=0.337 Sum_probs=262.5
Q ss_pred CccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHH
Q 000343 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPL 549 (1630)
Q Consensus 470 t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPL 549 (1630)
..|+.|+..||++.++.|+..+.. .++..+.+|.||||.|++.|+.++|++|++. ++++|..+..|.|||
T Consensus 3 ~~l~~ai~~gd~~~v~~ll~~~~~---------~~n~~~~~~~tpL~~A~~~g~~~iv~~Ll~~-Ga~~n~~~~~~~t~L 72 (434)
T PHA02874 3 QDLRMCIYSGDIEAIEKIIKNKGN---------CINISVDETTTPLIDAIRSGDAKIVELFIKH-GADINHINTKIPHPL 72 (434)
T ss_pred HHHHHHHhcCCHHHHHHHHHcCCC---------CCCCcCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCCCHH
Confidence 468899999999999999986543 2356788999999999999999999999985 688999999999999
Q ss_pred HHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHH
Q 000343 550 VFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629 (1630)
Q Consensus 550 h~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv 629 (1630)
|+|+..|+.+++++|+++|+++... +....+.+++++|+++|+|+|..|..|.||||+|+..|+.+++
T Consensus 73 ~~A~~~~~~~iv~~Ll~~g~~~~~~------------~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v 140 (434)
T PHA02874 73 LTAIKIGAHDIIKLLIDNGVDTSIL------------PIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESI 140 (434)
T ss_pred HHHHHcCCHHHHHHHHHCCCCCCcc------------hhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCHHHH
Confidence 9999999999999999999986431 2334578999999999999999999999999999999999999
Q ss_pred HHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHH
Q 000343 630 IVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVR 709 (1630)
Q Consensus 630 ~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVk 709 (1630)
++|+++|+ +++..|..|.||||+|+..++. ++++
T Consensus 141 ~~Ll~~ga--d~n~~d~~g~tpLh~A~~~~~~--------------------------------------------~iv~ 174 (434)
T PHA02874 141 KMLFEYGA--DVNIEDDNGCYPIHIAIKHNFF--------------------------------------------DIIK 174 (434)
T ss_pred HHHHhCCC--CCCCcCCCCCCHHHHHHHCCcH--------------------------------------------HHHH
Confidence 99999997 6788899999999999876554 4566
Q ss_pred HHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCC
Q 000343 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD 789 (1630)
Q Consensus 710 lLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~ 789 (1630)
+|+++|++++..|..|.||||+|+..|+.+++++|+++|++++.++..|.||||+|+..+. +++++|+ .|+++|.+|.
T Consensus 175 ~Ll~~g~~~n~~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~TpL~~A~~~~~-~~i~~Ll-~~~~in~~d~ 252 (434)
T PHA02874 175 LLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIHNR-SAIELLI-NNASINDQDI 252 (434)
T ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCCHHHHHHHCCh-HHHHHHH-cCCCCCCcCC
Confidence 6677778888888888889998888888888888888888888888888889988888765 5666666 5888888888
Q ss_pred CCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCC
Q 000343 790 EGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHL 860 (1630)
Q Consensus 790 ~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l 860 (1630)
+|+||||+|+..+ +...++.+|+..|++++++|+.|+|||++|..... ...+++.|+..++.+
T Consensus 253 ~G~TpLh~A~~~~-----~~~~iv~~Ll~~gad~n~~d~~g~TpL~~A~~~~~---~~~~ik~ll~~~~~~ 315 (434)
T PHA02874 253 DGSTPLHHAINPP-----CDIDIIDILLYHKADISIKDNKGENPIDTAFKYIN---KDPVIKDIIANAVLI 315 (434)
T ss_pred CCCCHHHHHHhcC-----CcHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCC---ccHHHHHHHHhcCch
Confidence 8889999888643 12356777778888888888888899888876542 235677777777653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=395.85 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=225.1
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
...+.|+.+++||+|+||.| |+|++..+|+.||+|++.... ........|||.||+++. ||||++|.+..
T Consensus 114 r~~~~feki~kIGeGTyg~V------YkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~--HpNIikL~eiv 185 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQV------YKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD--HPNIIKLEEIV 185 (560)
T ss_pred cchHHHHHHHHhcCcchhhe------eEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC--CCcccceeeEE
Confidence 34578999999999997766 569999999999999999875 344778899999999976 99999999998
Q ss_pred EeC--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 211 RMD--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
... ..+|||+|||+.+|.-.+....-.|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||
T Consensus 186 t~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 766 689999999999988877766668999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+++.... ...++..+-|..|+|||++.+.. .|++++|+||.||||.||++|++.|+
T Consensus 266 r~y~~~~-------------~~~~T~rVvTLWYRpPELLLG~t-----------~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 266 RFYTPSG-------------SAPYTSRVVTLWYRPPELLLGAT-----------SYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred eeccCCC-------------CcccccceEEeeccChHHhcCCc-----------ccccceeehhhhHHHHHHHcCCCCcC
Confidence 9876432 12256677799999999999876 29999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCc--c--------c------------ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQY--A--------S------------IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~--~--------~------------~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+.++.+++..|.+....|... . . +....++..+.+|+..||..||++|.||.++|++-
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 999999988888754333210 0 0 01225778899999999999999999999999874
Q ss_pred h
Q 000343 427 L 427 (1630)
Q Consensus 427 ~ 427 (1630)
+
T Consensus 402 y 402 (560)
T KOG0600|consen 402 Y 402 (560)
T ss_pred c
Confidence 3
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=415.44 Aligned_cols=367 Identities=18% Similarity=0.186 Sum_probs=249.8
Q ss_pred CCCccchhhcc---CChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHc-----------------------
Q 000343 468 NPNNLHQLVSE---GDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRR----------------------- 521 (1630)
Q Consensus 468 ~~t~Lh~Aa~~---Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~----------------------- 521 (1630)
+.++||.|+.. |+.+.++.||+.+++++ .+|.+|.||||+|+..
T Consensus 32 g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~----------~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~ 101 (661)
T PHA02917 32 KNNALHAYLFNEHCNNVEVVKLLLDSGTNPL----------HKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNIN 101 (661)
T ss_pred CCcHHHHHHHhhhcCcHHHHHHHHHCCCCcc----------ccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCC
Confidence 45789986444 78999999998888764 4455566666655554
Q ss_pred ------------CCHHHHHHHHHhcCCCcccCCCCCCCHHHHHH--HcCCHHHHHHHHHCCCCcccccc-cCCC------
Q 000343 522 ------------GSAELVEAILEYSQENVDVLDKDGDPPLVFAL--AAGSPECVHALIKRGANVISRLR-EGFG------ 580 (1630)
Q Consensus 522 ------------G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa--~~G~~eiVk~LL~~GAdvn~~~~-d~~g------ 580 (1630)
|+.++|++||+. ++++|..|.+|+||||+|+ .+|+.+++++||++||++|..+. +..|
T Consensus 102 ~~~~~~~~a~~~~~~e~vk~Ll~~-Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~ 180 (661)
T PHA02917 102 DFNIFSYMKSKNVDVDLIKVLVEH-GFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDY 180 (661)
T ss_pred CcchHHHHHhhcCCHHHHHHHHHc-CCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccc
Confidence 455666666653 5667777777777777443 35677777777777777764322 1222
Q ss_pred -----chHHHHHHH-----------cCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCCh--HHHHHHHHcCCccc--
Q 000343 581 -----PSVAHVCAY-----------HGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT--DCAIVILENGGCRS-- 640 (1630)
Q Consensus 581 -----~T~Lh~Aa~-----------~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~--eiv~~LL~~Ga~~~-- 640 (1630)
.||||+|+. +++.+++++|+++|||+|..|.+|.||||+|+..++. +++++|++ |+..+
T Consensus 181 ~~~~~~t~L~~a~~~~~~~~~~~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~~~~ 259 (661)
T PHA02917 181 QPRNCGTVLHLYIISHLYSESDTRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDNTAY 259 (661)
T ss_pred cccccccHHHHHHhhcccccccccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCccccc
Confidence 377777764 3467777777777777777777777777777777764 57777764 54211
Q ss_pred cccccCCCCcHHHHHHHc-------C--CHHHHHHHHHhcCccccccc---cCCCCC-----------CccHHHHHH-Hh
Q 000343 641 MAILNSKELTPLHLCVAT-------W--NVAVVKRWVEVASPEEIVNV---IDIPGP-----------VGTALCMAA-AL 696 (1630)
Q Consensus 641 i~~~d~~G~TPLh~Aa~~-------g--~~eivk~LLe~ga~~~~~n~---~d~~~~-----------~~t~l~~aa-a~ 696 (1630)
....+..+.+|+|+|+.- . +.++++.|++.|+....... ....+. ..+.++.+. +.
T Consensus 260 ~~~~~~~~~~~~~~a~yl~~~~~~~~~v~~~iv~~Li~~Ga~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 339 (661)
T PHA02917 260 SYIDDLTCCTRGIMADYLNSDYRYNKDVDLDLVKLFLENGKPHGIMCSIVPLWRNDKETISLILKTMNSDVLQHILIEYM 339 (661)
T ss_pred ccccCcccccchHHHHHHHhhccccccchHHHHHHHHhCCCCCceeEeeecccccchHHHHHHHHHhchHHHHHHHHHHH
Confidence 112345566777777631 1 56777777777753211000 000000 001111111 11
Q ss_pred ccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHH-CCCCcccccCCCCCHHHHHHHcC------
Q 000343 697 KKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTIPLHVALARG------ 769 (1630)
Q Consensus 697 ~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~-~GADvN~~d~~G~TPLH~Aa~~G------ 769 (1630)
..+ ....+++++|+++|||+|.++..|.|++ ...+.+++++||. .|++++.++.+|.||||.|++.+
T Consensus 340 ~~g--~~~~~~v~~Ll~~GAdvn~~~~~g~~~~----~~~~~~~i~~LL~~~ga~~~~~~~~G~TpL~~a~~~~~~~~~~ 413 (661)
T PHA02917 340 TFG--DIDIPLVECMLEYGAVVNKEAIHGYFRN----INIDSYTMKYLLKKEGGDAVNHLDDGEIPIGHLCKSNYGCYNF 413 (661)
T ss_pred HcC--CCcHHHHHHHHHcCCCCCCCCccccchh----hcCCHHHHHHHHHhcCCCccccCCCCCChhHHHHHhcccchhh
Confidence 111 1136799999999999999999998854 3667888888887 69998888888999999998533
Q ss_pred -----------------CHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCC
Q 000343 770 -----------------AKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832 (1630)
Q Consensus 770 -----------------~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~T 832 (1630)
..+++++|+++|||+|.+|..|+||||+|+..++ ..++++|.+.|+++|++|..|+|
T Consensus 414 ~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~------~~~v~~Ll~~GAdin~~d~~G~T 487 (661)
T PHA02917 414 YTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK------QSLVSLLLESGSDVNIRSNNGYT 487 (661)
T ss_pred hhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC------HHHHHHHHHCcCCCCCCCCCCCC
Confidence 3567899999999999999999999999997543 35677888999999999999999
Q ss_pred HHHHHhhCCCCCcHHHHHHHHHhcCCCCC
Q 000343 833 LRDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 833 pLdlA~~~~~~~~~~~lve~Ll~~Ga~l~ 861 (1630)
||++|.... ...+++++|+.+|+++.
T Consensus 488 ~L~~A~~~~---~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 488 CIAIAINES---RNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHhC---CCHHHHHHHHHcCCChh
Confidence 999997421 14689999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=397.94 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=224.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc----Cc-CChhHHHHHHHHHHHhccCCCCcceeEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA----EE-MEPDWLSGQLDNLRRASMWCRNVCTFHG 208 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~----~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~ 208 (1630)
....|.+.+.||+|+||+|++ |.+..+++.||+|.+.+. .. ...+.+.+|+.+++.+. .||||+++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~------a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~-~HpnI~~l~e 87 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKL------AKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR-SHPNIIRLLE 87 (370)
T ss_pred ccCceeeeeeecCCCCeeEEE------eeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc-cCCCEeEEEE
Confidence 456999999999999998865 778889999999977664 22 23567778999999986 5999999999
Q ss_pred EEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecce
Q 000343 209 VLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYGL 287 (1630)
Q Consensus 209 ~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFGl 287 (1630)
++.....+|+|||||.||.|..++.+.+++.+.+++.+++|+++|++|||++||+||||||+|||++.+ +++||+|||+
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999998888887778899999999999999999999999999999999999999999 9999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCcccccccc-ccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK-KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+..... ........+||+.|+|||++.+.. | -+.++||||+|++||.|++|..|
T Consensus 168 s~~~~~--------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y-----------~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 168 SAISPG--------------EDGLLKTFCGSPAYAAPEVLSGKGTY-----------SGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred ccccCC--------------CCCcccCCCCCcccCCHHHhCCCCCc-----------CCchhhhhhhHHHHHHHHhCCCC
Confidence 987631 112345689999999999998754 2 36899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCC-CHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGI-PRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l-~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|.+.+...++..|..+....|. .+ +++++.|+.+||..||.+|+|+.++++|-.-..
T Consensus 223 F~d~~~~~l~~ki~~~~~~~p~-------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 223 FDDSNVPNLYRKIRKGEFKIPS-------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCccHHHHHHHHhcCCccCCC-------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999988899998887665554 34 899999999999999999999999998754433
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=400.78 Aligned_cols=311 Identities=19% Similarity=0.218 Sum_probs=241.1
Q ss_pred ccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHH--cCCHHHHHHHHHhcCCCcccCCCCCCCH
Q 000343 471 NLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACR--RGSAELVEAILEYSQENVDVLDKDGDPP 548 (1630)
Q Consensus 471 ~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~--~G~~eiVk~LL~~~~~dvn~~D~~G~TP 548 (1630)
+|+.++..++++.++.+|.... ...+.++||.++. .++.++|++||+. ++++|..|.+|.||
T Consensus 12 sl~~~~~~~n~~~~~~~l~~~~---------------~~g~~~~Lh~~~~~~~~~~~iv~~Ll~~-Gadvn~~d~~G~Tp 75 (446)
T PHA02946 12 SLYAKYNSKNLDVFRNMLQAIE---------------PSGNYHILHAYCGIKGLDERFVEELLHR-GYSPNETDDDGNYP 75 (446)
T ss_pred HHHHHHccCcHHHHHHHHhccC---------------CCCCChHHHHHHHhcCCCHHHHHHHHHC-cCCCCccCCCCCCH
Confidence 3567778888888888886421 1224799998874 4578999999985 68999999999999
Q ss_pred HHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCC--HHHHHHHHHcCCCCCC-CCCCCCChhhhhhhcCC
Q 000343 549 LVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ--PDCMRELLLAGADPNA-VDDEGESVLHRAVAKKY 625 (1630)
Q Consensus 549 Lh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~--~eivk~LL~~GADvn~-~D~~G~TPLH~Aa~~g~ 625 (1630)
||+||..|+.+++++||++||++|.. +..|.||||+|+..++ .+++++|+++|||+|. .|.+|.|||| |+..++
T Consensus 76 Lh~Aa~~g~~eiv~lLL~~GAdin~~--d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~ 152 (446)
T PHA02946 76 LHIASKINNNRIVAMLLTHGADPNAC--DKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPS 152 (446)
T ss_pred HHHHHHcCCHHHHHHHHHCcCCCCCC--CCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCC
Confidence 99999999999999999999999864 5668899999988764 8999999999999995 6899999998 667799
Q ss_pred hHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhH
Q 000343 626 TDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGR 705 (1630)
Q Consensus 626 ~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~ 705 (1630)
.+++++|++.|+ +++..|..|.||||+|+..++. ..
T Consensus 153 ~~vv~~Ll~~ga--d~~~~d~~G~t~Lh~A~~~~~~------------------------------------------~~ 188 (446)
T PHA02946 153 ERVFKKIMSIGF--EARIVDKFGKNHIHRHLMSDNP------------------------------------------KA 188 (446)
T ss_pred hHHHHHHHhccc--cccccCCCCCCHHHHHHHhcCC------------------------------------------CH
Confidence 999999999997 7788899999999999764331 13
Q ss_pred HHHHHHHhcCCCCCcccccCccchhhhhhcC--CHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCC-HHHHHHHHhCCC
Q 000343 706 ELVRILLTAGAEPTAQDAQNRTALHIASMAN--DVELVKIILDAGVDVNIRNVHNTIPLHVALARGA-KSCVGLLLSAGA 782 (1630)
Q Consensus 706 eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g--~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~-~eiVklLLe~GA 782 (1630)
+++++|+++|+++|.+|..|+||||+|+..+ +.+++++|++ |+|+|.+|..|.||||+|+..++ .+++++|+++|+
T Consensus 189 ~~v~~Ll~~Gadin~~d~~G~TpLH~Aa~~~~~~~~iv~lLl~-gadin~~d~~G~TpLh~A~~~~~~~~~~~~Ll~~g~ 267 (446)
T PHA02946 189 STISWMMKLGISPSKPDHDGNTPLHIVCSKTVKNVDIINLLLP-STDVNKQNKFGDSPLTLLIKTLSPAHLINKLLSTSN 267 (446)
T ss_pred HHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCCcHHHHHHHHc-CCCCCCCCCCCCCHHHHHHHhCChHHHHHHHHhCCC
Confidence 4556666666666666666777777766654 5666666663 66677666667777777666665 356666666665
Q ss_pred CCC--------------------cC-CCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCC
Q 000343 783 DCN--------------------WQ-DDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLP 841 (1630)
Q Consensus 783 DiN--------------------~~-D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~ 841 (1630)
+++ .. +..|+||||+|+..++ . .++++|+..|+ +|+|||++|...+
T Consensus 268 ~~~~~~~~~a~~~~~~~~~e~l~~~g~~~~~TpLh~Aa~~g~-----~-eivk~Ll~~~~-------~~~t~L~~A~~~~ 334 (446)
T PHA02946 268 VITDQTVNICIFYDRDDVLEIINDKGKQYDSTDFKMAVEVGS-----I-RCVKYLLDNDI-------ICEDAMYYAVLSE 334 (446)
T ss_pred CCCCcHHHHHHHcCchHHHHHHHHcCcccCCCHHHHHHHcCC-----H-HHHHHHHHCCC-------ccccHHHHHHHhC
Confidence 432 11 2358899999998764 3 45566666653 6899999998765
Q ss_pred CCCcHHHHHHHHHhcCCCCCC
Q 000343 842 REWISEDLMEALMNRGVHLSP 862 (1630)
Q Consensus 842 ~~~~~~~lve~Ll~~Ga~l~~ 862 (1630)
+.+++++|+.+|++++.
T Consensus 335 ----~~~~v~~Ll~~ga~~n~ 351 (446)
T PHA02946 335 ----YETMVDYLLFNHFSVDS 351 (446)
T ss_pred ----HHHHHHHHHHCCCCCCC
Confidence 67999999999999775
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=410.08 Aligned_cols=293 Identities=26% Similarity=0.354 Sum_probs=255.9
Q ss_pred chhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcC---CHHHHHHHHHhcCCCcccCCCCCCCHH
Q 000343 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRG---SAELVEAILEYSQENVDVLDKDGDPPL 549 (1630)
Q Consensus 473 h~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G---~~eiVk~LL~~~~~dvn~~D~~G~TPL 549 (1630)
..++..++++.++.|++.++++| .++..|.||||+|+..| +.+++++|++. ++++|..|..|.|||
T Consensus 19 ~~~~~~~~~~~v~~Ll~~ga~vn----------~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~-Gadin~~~~~g~TpL 87 (471)
T PHA03095 19 LLNASNVTVEEVRRLLAAGADVN----------FRGEYGKTPLHLYLHYSSEKVKDIVRLLLEA-GADVNAPERCGFTPL 87 (471)
T ss_pred HHcCCCCCHHHHHHHHHcCCCcc----------cCCCCCCCHHHHHHHhcCCChHHHHHHHHHC-CCCCCCCCCCCCCHH
Confidence 45678899999999999988764 67888999999999998 99999999985 689999999999999
Q ss_pred HHHHHcC-CHHHHHHHHHCCCCcccccccCCCchHHHHHH--HcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC--
Q 000343 550 VFALAAG-SPECVHALIKRGANVISRLREGFGPSVAHVCA--YHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK-- 624 (1630)
Q Consensus 550 h~Aa~~G-~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa--~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g-- 624 (1630)
|+|+..| +.+++++|+++|++++.. +..|.||||+|+ ..++.+++++|+++|+|++..|..|.||||+|+..+
T Consensus 88 h~A~~~~~~~~iv~lLl~~ga~in~~--~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~tpL~~a~~~~~~ 165 (471)
T PHA03095 88 HLYLYNATTLDVIKLLIKAGADVNAK--DKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNA 165 (471)
T ss_pred HHHHHcCCcHHHHHHHHHcCCCCCCC--CCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCC
Confidence 9999999 599999999999999875 456889999999 566899999999999999999999999999998766
Q ss_pred ChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchh
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704 (1630)
Q Consensus 625 ~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~ 704 (1630)
+.+++++|++.|+ +++..+..|.||||+|+.... ..
T Consensus 166 ~~~iv~~Ll~~g~--~~~~~d~~g~t~Lh~~~~~~~------------------------------------------~~ 201 (471)
T PHA03095 166 NVELLRLLIDAGA--DVYAVDDRFRSLLHHHLQSFK------------------------------------------PR 201 (471)
T ss_pred CHHHHHHHHHcCC--CCcccCCCCCCHHHHHHHHCC------------------------------------------Cc
Confidence 6789999999997 555668899999999875311 12
Q ss_pred HHHHHHHHhcCCCCCcccccCccchhhhhhcCCH--HHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCC
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDV--ELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782 (1630)
Q Consensus 705 ~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~--eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GA 782 (1630)
.+++++|+++|++++.+|..|+||||+||..++. .++++|++.|+++|.+|..|+||||+|+..|+.+++++||++||
T Consensus 202 ~~i~~~Ll~~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~ga 281 (471)
T PHA03095 202 ARIVRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGA 281 (471)
T ss_pred HHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence 4678899999999999999999999999999875 68889999999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCC
Q 000343 783 DCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH 828 (1630)
Q Consensus 783 DiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~ 828 (1630)
|+|.+|.+|+||||+|+..++ ..++.+|+..+++++..+.
T Consensus 282 d~n~~~~~g~tpl~~A~~~~~------~~~v~~LL~~~~~~~~~~~ 321 (471)
T PHA03095 282 DINAVSSDGNTPLSLMVRNNN------GRAVRAALAKNPSAETVAA 321 (471)
T ss_pred CCcccCCCCCCHHHHHHHhCC------HHHHHHHHHhCCCHHHHHH
Confidence 999999999999999997654 2456667777777765544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=376.28 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=219.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEE-EEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHG-VLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~-~f~ 211 (1630)
..+|+++++||+|+||+|| ++.+..+|..+|.|.++..... ..+....|+.+|++++ |||||++|+ .|.
T Consensus 18 l~~y~Il~~IG~GsFg~vy------kv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~--HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVY------KVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN--HPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHHcCCcchheE------EeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC--CchHHHHHHHhhh
Confidence 3589999999999988774 5778899999999999965333 2456778999999976 999999999 565
Q ss_pred eCCE-EEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccccccccceEECCCCcEEE
Q 000343 212 MDSC-LGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHA--AG--VVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 212 ~~~~-~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs--~g--IIHRDLKP~NILld~~g~vKL 282 (1630)
.++. ++||||||.+|+|..+++ ....++++.++.++.|++.||.++|+ .+ |+||||||.||||+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 999999999999887764 34569999999999999999999999 55 999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+++.+... .......+|||.||+||.+.... |+.++||||+||++|||+.
T Consensus 170 GDfGL~r~l~s~--------------~tfA~S~VGTPyYMSPE~i~~~~------------Y~~kSDiWslGCllyEMca 223 (375)
T KOG0591|consen 170 GDFGLGRFLSSK--------------TTFAHSLVGTPYYMSPERIHESG------------YNFKSDIWSLGCLLYEMCA 223 (375)
T ss_pred ccchhHhHhcch--------------hHHHHhhcCCCcccCHHHHhcCC------------CCcchhHHHHHHHHHHHHh
Confidence 999999987653 22345689999999999998765 9999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
-++||.+.+..++..+|.++...|.. ...+|.++..||..|+..||+.||+...++..+...+.
T Consensus 224 L~~PF~g~n~~~L~~KI~qgd~~~~p-----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~ 287 (375)
T KOG0591|consen 224 LQSPFYGDNLLSLCKKIEQGDYPPLP-----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD 287 (375)
T ss_pred cCCCcccccHHHHHHHHHcCCCCCCc-----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence 99999999888888898887543221 13578899999999999999999998777777665544
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=409.97 Aligned_cols=364 Identities=14% Similarity=0.092 Sum_probs=279.8
Q ss_pred ccCChhhhhhhhccc-CCCCCCcchhhhhhhc-ccCCChHHHHHHH--cCCHHHHHHHHHhcCCCcccCCCCCCCHHHHH
Q 000343 477 SEGDVSGVRDLLSKN-ASGNYSSSISSLLKAQ-NADGQTALHLACR--RGSAELVEAILEYSQENVDVLDKDGDPPLVFA 552 (1630)
Q Consensus 477 ~~Gdl~~Vk~LL~~~-a~~n~~~si~~ll~~~-d~~G~TpLH~Aa~--~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~A 552 (1630)
..++++.++.|++.+ +++| .+ |..|.||||+|+. +++.+++++|++. ++++|..|.+|.||||+|
T Consensus 151 ~~v~leiVk~LLe~G~ADIN----------~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~-GADVN~kD~~G~TPLH~A 219 (764)
T PHA02716 151 RGIDLDLIKYMVDVGIVNLN----------YVCKKTGYGILHAYLGNMYVDIDILEWLCNN-GVNVNLQNNHLITPLHTY 219 (764)
T ss_pred cCCCHHHHHHHHHCCCCCcc----------cccCCCCCcHHHHHHHhccCCHHHHHHHHHc-CCCCCCCCCCCCCHHHHH
Confidence 468999999999998 7754 56 8899999999875 4678999999985 689999999999999999
Q ss_pred HHcCC--HHHHHHHHHCCCCcccccccCCCchHHHHHH---HcCCHHHHHHHHHcCCCCCCCCCCCCChhh---hhhhcC
Q 000343 553 LAAGS--PECVHALIKRGANVISRLREGFGPSVAHVCA---YHGQPDCMRELLLAGADPNAVDDEGESVLH---RAVAKK 624 (1630)
Q Consensus 553 a~~G~--~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa---~~G~~eivk~LL~~GADvn~~D~~G~TPLH---~Aa~~g 624 (1630)
+..|+ .++|++||++||++|.. +..|.||||.|+ .+++.+++++|++.+..-... ...++|| .|+..|
T Consensus 220 a~~g~~~~eIVklLLe~GADVN~k--D~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~--~~~~~L~~~i~AA~~g 295 (764)
T PHA02716 220 LITGNVCASVIKKIIELGGDMDMK--CVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVK--NIPMILHSYITLARNI 295 (764)
T ss_pred HHcCCCCHHHHHHHHHcCCCCCCC--CCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccc--cchhhhHHHHHHHHcC
Confidence 99995 59999999999999875 566899999875 567899999999875432221 1223444 378899
Q ss_pred ChHHHHHHHHcCCccccccccCCCCcHHHHHHH--cCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhcc----
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVA--TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKK---- 698 (1630)
Q Consensus 625 ~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~--~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~---- 698 (1630)
+.+++++|+++|+ +++..|..|.||||+|+. .++.+++++|++.++.. +..|. .+.|+++.++....
T Consensus 296 ~leiVklLLe~GA--dIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADI---N~kD~--~G~TPLH~A~~~lav~~~ 368 (764)
T PHA02716 296 DISVVYSFLQPGV--KLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDL---NEPDN--IGNTVLHTYLSMLSVVNI 368 (764)
T ss_pred CHHHHHHHHhCCC--ceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCC---ccCCC--CCCCHHHHHHHhhhhhcc
Confidence 9999999999997 678889999999999865 45789999999988753 33333 34688887653200
Q ss_pred ----CccchhHHHHHHHHhcCCCCCcccccCccchhh----hhhcCCHHHHHHHHHCCCCccccc--------CCCCCH-
Q 000343 699 ----DHEVEGRELVRILLTAGAEPTAQDAQNRTALHI----ASMANDVELVKIILDAGVDVNIRN--------VHNTIP- 761 (1630)
Q Consensus 699 ----~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~----Aa~~g~~eiVklLL~~GADvN~~d--------~~G~TP- 761 (1630)
....++.+++++|+++|+|++.+|..|.||||. |...++.+++++|++.|+..+.++ ..+.+|
T Consensus 369 ld~~~~~~~~~eVVklLL~~GADIn~kn~~G~TPLh~y~~~a~n~~~~dIvklLis~~~~~~~~~~~~q~ll~~~d~~~~ 448 (764)
T PHA02716 369 LDPETDNDIRLDVIQCLISLGADITAVNCLGYTPLTSYICTAQNYMYYDIIDCLISDKVLNMVKHRILQDLLIRVDDTPC 448 (764)
T ss_pred ccccccccChHHHHHHHHHCCCCCCCcCCCCCChHHHHHHHHHhcChHHHHHHHHhCcchhhhhhhhhhhhhhccCcchh
Confidence 011246899999999999999999999999993 223578999999999987654332 233344
Q ss_pred -HHHHHHcCCH------------------HHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCc
Q 000343 762 -LHVALARGAK------------------SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAA 822 (1630)
Q Consensus 762 -LH~Aa~~G~~------------------eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gad 822 (1630)
+|.++..+.. +++.+++..++++|.+|..|+||||+|+..++.. .....++++|++.||+
T Consensus 449 ~lhh~~a~~~~~~~~~~~~~~~~~~~~~~~v~~~~ii~~~nvN~~D~~G~TPLh~Aa~~g~~~-~v~~e~~k~LL~~GAD 527 (764)
T PHA02716 449 IIHHIIAKYNIPTDLYTDEYEPYDSTKIHDVYHCAIIERYNNAVCETSGMTPLHVSIISHTNA-NIVMDSFVYLLSIQYN 527 (764)
T ss_pred hHHHHHHhcCcchhhhhhhhhhccccccchhhHHHHHhhccccccCCCCCCHHHHHHHcCCcc-chhHHHHHHHHhCCCC
Confidence 4555544332 3445556678899999999999999999765421 0012345677888999
Q ss_pred ccccCCCCCCHHHHHhhCCCC-CcHHHHHHHHHhcCCCCCCc
Q 000343 823 VEVRNHSGKTLRDFLEGLPRE-WISEDLMEALMNRGVHLSPT 863 (1630)
Q Consensus 823 vn~~n~~G~TpLdlA~~~~~~-~~~~~lve~Ll~~Ga~l~~~ 863 (1630)
+|++|++|+|||++|...++. ....+++++|+++|+++...
T Consensus 528 IN~~d~~G~TPLh~A~~~g~~~~~~~eIvk~LL~~ga~~~~~ 569 (764)
T PHA02716 528 INIPTKNGVTPLMLTMRNNRLSGHQWYIVKNILDKRPNVDIV 569 (764)
T ss_pred CcccCCCCCCHHHHHHHcCCccccHHHHHHHHHhcCCCcchH
Confidence 999999999999999887653 44568999999999987653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=358.58 Aligned_cols=259 Identities=20% Similarity=0.297 Sum_probs=220.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.+|..+++||+|+||.| |+|++..||+.||||+|+..+..+ .....|||+.|+.++ ||||+.|+++|-+.
T Consensus 2 ~rY~~~~~lGEG~~gvV------yka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~--h~nIi~LiD~F~~~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVV------YKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK--HPNIIELIDVFPHK 73 (318)
T ss_pred chhhhhhhhcCcceEEE------EEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc--CcchhhhhhhccCC
Confidence 47999999999996655 558899999999999999875443 567789999999986 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+.+.||+||++.++...+..+.-.|+..+++.|+.|+++||+|||++.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 74 ~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 74 SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99999999999998888877777899999999999999999999999999999999999999999999999999998875
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
+.. .....+-|..|+|||++.+.+ .|+..+||||.|||+.||+.|.+-|++.++-
T Consensus 154 p~~--------------~~~~~V~TRWYRAPELLfGsr-----------~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 154 PNR--------------IQTHQVVTRWYRAPELLFGSR-----------QYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred CCc--------------ccccceeeeeccChHHhccch-----------hcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 431 112225699999999999876 2999999999999999999999999999988
Q ss_pred HHHHHHHhcCCCC--CCccc-------------------ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLP--PQYAS-------------------IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~--~~~~~-------------------~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+++..|...-..| ..++. ...+..+.++.+|+.+||.+||.+|+++.|+|+|-.
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 8887777643322 11110 112345678899999999999999999999999844
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=394.46 Aligned_cols=338 Identities=27% Similarity=0.378 Sum_probs=287.3
Q ss_pred CCCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCC
Q 000343 468 NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDP 547 (1630)
Q Consensus 468 ~~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~T 547 (1630)
..+++|.|+..+-. +.+. ....+.|..|.||||+|+.....+.+++|+++ +++.+..|.++.+
T Consensus 61 gd~~~~~~~~~~y~------~~~~----------~~~~a~D~~~n~~l~~a~~~~~~~~i~~Lls~-gad~~~~n~~~~a 123 (929)
T KOG0510|consen 61 GDTELHHASARNYI------LSKL----------AISYAKDSADNTPLHAAVEYNQGDKIQVLLSY-GADTPLRNLNKNA 123 (929)
T ss_pred chhHHHHHHhhcch------hhhh----------hhhhhhhcccCchhHHHhhcchHHHHHHHHhc-CCCCChhhhhccC
Confidence 34678888776643 2221 23467899999999999999999999999995 6889999999999
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChH
Q 000343 548 PLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627 (1630)
Q Consensus 548 PLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~e 627 (1630)
|||+|+..|+.++++.|+++|+|+|.. +..+.||||+||.+++.|..+.|+.+|||+-..|.+|++|+|.|+..+..+
T Consensus 124 plh~A~~~~~~s~L~~Ll~~~~dvnl~--de~~~TpLh~A~~~~~~E~~k~Li~~~a~~~K~~~~~~~~iH~aa~s~s~e 201 (929)
T KOG0510|consen 124 PLHLAADSGNYSCLKLLLDYGADVNLE--DENGFTPLHLAARKNKVEAKKELINKGADPCKSDIDGNFPIHEAARSGSKE 201 (929)
T ss_pred chhhccccchHHHHHHHHHhcCCcccc--ccCCCchhhHHHhcChHHHHHHHHhcCCCCCcccCcCCchHHHHHHhcchh
Confidence 999999999999999999999999875 566889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCC---ccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCcccccc----------ccCCCCCCccHHHHHH
Q 000343 628 CAIVILENGG---CRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVN----------VIDIPGPVGTALCMAA 694 (1630)
Q Consensus 628 iv~~LL~~Ga---~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n----------~~d~~~~~~t~l~~aa 694 (1630)
+.++.+...+ ...+|..+..+.||||.|+..|+.++++.+|+.++..+.+. ..+....+.+++|+++
T Consensus 202 ~mEi~l~~~g~~r~~~in~~~n~~~~pLhlAve~g~~e~lk~~L~n~~~~a~~~~~~~~q~kelv~~~d~dg~tpLH~a~ 281 (929)
T KOG0510|consen 202 CMEIFLPEHGYERQTHINFDNNEKATPLHLAVEGGDIEMLKMCLQNGKKIADVQLDAMQQEKELVNDEDNDGCTPLHYAA 281 (929)
T ss_pred hhhhhhccccchhhcccccccCCCCcchhhhhhcCCHHHHHHHHhCccccchhhhHHHHHHHHHhhcccccCCchHHHHH
Confidence 9999998222 13677889999999999999999999999999876543322 1233445578888887
Q ss_pred HhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHH-CC-CCcccccCCCCCHHHHHHHcCCHH
Q 000343 695 ALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AG-VDVNIRNVHNTIPLHVALARGAKS 772 (1630)
Q Consensus 695 a~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~-~G-ADvN~~d~~G~TPLH~Aa~~G~~e 772 (1630)
. .++.+.+..|+..||++|.++.++.||||.||..|+++.|+.||+ .| ...|..|-.|.||||+|+.+||..
T Consensus 282 r------~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~ 355 (929)
T KOG0510|consen 282 R------QGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDR 355 (929)
T ss_pred H------cCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHH
Confidence 5 356788999999999999999999999999999999999999998 55 568889999999999999999999
Q ss_pred HHHHHHhCCCCCC---cCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHH
Q 000343 773 CVGLLLSAGADCN---WQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836 (1630)
Q Consensus 773 iVklLLe~GADiN---~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdl 836 (1630)
++++||+.||+.+ ..|.+|+||||+|+..|+ ...+.+|...||++..+|+.|+|++++
T Consensus 356 v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~------~~av~~Li~~Ga~I~~~n~~g~SA~~~ 416 (929)
T KOG0510|consen 356 VVQLLLNKGALFLNMSEADSDGNTALHLAAKYGN------TSAVQKLISHGADIGVKNKKGKSAFDT 416 (929)
T ss_pred HHHHHHhcChhhhcccccccCCchhhhHHHHhcc------HHHHHHHHHcCCceeeccccccccccc
Confidence 9999999999877 458999999999997654 355667777899999999999999884
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=380.66 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=216.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS- 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~- 214 (1630)
.++...+.||+|+||.||+ +.+..+|+..|||.+...+....+.+.+|+.+|.+++ |||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l------~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~--~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYL------ATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN--HPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEE------EEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC--CCCEEeeCCccccccC
Confidence 4788999999999999876 4566779999999998764434667899999999987 999999999755444
Q ss_pred -EEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CCcEEEeecceeeee
Q 000343 215 -CLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAIL 291 (1630)
Q Consensus 215 -~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g~vKL~DFGla~~~ 291 (1630)
.+++.|||+++|.+..++.+.+ +|++..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||+++..
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 6999999999999998887766 7999999999999999999999999999999999999999 699999999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC-C
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG-L 370 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~-~ 370 (1630)
.... ..........||+.|||||++.... ...+++|||||||++.||+||++||.. .
T Consensus 169 ~~~~-----------~~~~~~~~~~Gtp~~maPEvi~~g~-----------~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~ 226 (313)
T KOG0198|consen 169 ESKG-----------TKSDSELSVQGTPNYMAPEVIRNGE-----------VARRESDIWSLGCTVVEMLTGKPPWSEFF 226 (313)
T ss_pred cccc-----------ccccccccccCCccccCchhhcCCC-----------cCCccchhhhcCCEEEeccCCCCcchhhc
Confidence 5310 1112234578999999999998522 134699999999999999999999987 4
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
...+.+..+......| .++..+++++++||.+|+..||++||||.++|+|.+......
T Consensus 227 ~~~~~~~~ig~~~~~P-----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 227 EEAEALLLIGREDSLP-----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred chHHHHHHHhccCCCC-----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 4444444444444233 344569999999999999999999999999999988655443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=377.90 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=222.2
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--------------CChhHHHHHHHHHHHhccC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--------------MEPDWLSGQLDNLRRASMW 199 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--------------~~~~~~~~Ei~iL~~l~l~ 199 (1630)
..++|++++.||+|.||.|-| |++..+++.||||++.+... ...+...+||.+|+++.
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkL------ar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-- 166 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKL------ARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-- 166 (576)
T ss_pred ehhheehhhhhcCCccceEEE------EeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC--
Confidence 457999999999999888765 77899999999999976521 12357889999999986
Q ss_pred CCCcceeEEEEEeC--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 200 CRNVCTFHGVLRMD--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 200 HpNIV~l~~~f~~~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
|||||+|+++..+. +.+|||+|||..|.+...-.....|++.+++.|++.++.||.|||.+|||||||||+|+||+++
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 99999999999875 4699999999988776543332239999999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
|++||+|||.+....... ......+....+|||.|+|||++.++. .....+.+.||||+||+|
T Consensus 247 g~VKIsDFGVs~~~~~~~---------~~~~d~~L~~tvGTPAF~APE~c~~~~--------~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGS---------DEGSDDQLSRTVGTPAFFAPELCSGGN--------SFSYSGFALDIWALGVTL 309 (576)
T ss_pred CcEEeeccceeeecccCC---------ccccHHHHhhcCCCccccchHhhcCCC--------CccccchhhhhhhhhhhH
Confidence 999999999998764321 111223445589999999999998744 122357899999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 358 yemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|.|+.|+.||.+....+++.+|.......|.. +.+.+++++||.+||..||++|++..++..|.+-..
T Consensus 310 YCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~-----pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFELELFDKIVNDPLEFPEN-----PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHhhhccCCcccchHHHHHHHHhcCcccCCCc-----ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 99999999999999999999998876554443 246789999999999999999999999988866443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=389.76 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=227.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
...|+...+||+|+-|.||+ |.+..+++.||||++........+.+.+|+.+|+..+ |+|||++++.|...+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~------A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~--H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYV------ARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH--HPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhcchhhhccccccceee------eeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc--chHHHHHHHHhcccc
Confidence 36799999999999888766 7788899999999999998888999999999999976 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.++.||||++|+.|.+.... ..+++.++..|++++++||+|||.+||||||||.+|||++.+|.+||+|||+|..+...
T Consensus 344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999999999888765 35999999999999999999999999999999999999999999999999999887643
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. ......+|||+|||||++.... |++++||||||++++||+-|.+||-..++-.
T Consensus 423 ~--------------~KR~TmVGTPYWMAPEVvtrk~------------YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 423 Q--------------SKRSTMVGTPYWMAPEVVTRKP------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred c--------------CccccccCCCCccchhhhhhcc------------cCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 2 1235678999999999998766 8999999999999999999999999888877
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.++.|......... .+..+++++++|+.+||+.||.+|+++.|+|+|-+..+
T Consensus 477 AlyLIa~ng~P~lk----~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 477 ALYLIATNGTPKLK----NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHhhcCCCCcC----CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 77777655433222 23468999999999999999999999999999977533
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=386.08 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=223.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|.+.+.||+|+||.| |||+.+.+.+.||||.+.+....+ ...+.+|++|++.++ |||||.++++|++.
T Consensus 2 e~yhv~e~iG~Gsfg~V------YKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk--Hpniv~m~esfEt~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRV------YKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK--HPNIVEMLESFETS 73 (808)
T ss_pred cchhHHHHhcCCcccee------eecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC--CcchhhHHHhhccc
Confidence 57999999999997766 569999999999999998765443 456889999999986 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.++++|+|||.| +|+.++..++.|+++.++.+++|++.||.|||+.+|+|||+||.|||++..+.+|+||||+|+.++.
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999999999999 6777777788999999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
. ....+...|||.|||||++.+.. |+..+|+||+|||+|||++|++||...+..
T Consensus 153 ~--------------t~vltsikGtPlYmAPElv~e~p------------yd~~sDlWslGcilYE~~~G~PPF~a~si~ 206 (808)
T KOG0597|consen 153 N--------------TSVLTSIKGTPLYMAPELVEEQP------------YDHTSDLWSLGCILYELYVGQPPFYARSIT 206 (808)
T ss_pred C--------------ceeeeeccCcccccCHHHHcCCC------------ccchhhHHHHHHHHHHHhcCCCCchHHHHH
Confidence 2 12345678999999999998765 899999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
++...|......+|. ..+..+.+|+..+|..||.+|.|-.+++.|-+-
T Consensus 207 ~Lv~~I~~d~v~~p~-------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 207 QLVKSILKDPVKPPS-------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred HHHHHHhcCCCCCcc-------cccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 888888877655543 578999999999999999999999999999664
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=361.71 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=219.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEE-
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLR- 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~- 211 (1630)
.++|+.+.+|++|+|| .||+|++++|++.||+|+++.....+ +..-.|||++|.+++ |||||.+.++..
T Consensus 75 v~efe~lnrI~EGtyG------iVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~--H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYG------VVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR--HPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHHhhcccCcce------eEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC--CCCeeeeEEEEec
Confidence 4689999999999955 45679999999999999998775333 667789999999986 999999999875
Q ss_pred -eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 -MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 -~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+-+.+|||||||..++-..+..-..+|.+.+++.++.|+++||+|||.+.|+||||||+|+|++..|.+||+|||+|+.
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 3456999999999988777766666899999999999999999999999999999999999999999999999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
++++. ..++..+-|..|+|||++.+.+ .|++++|+||+|||+.||+++++.|.+.
T Consensus 227 ygsp~--------------k~~T~lVVTLWYRaPELLLG~~-----------tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 227 YGSPL--------------KPYTPLVVTLWYRAPELLLGAK-----------TYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred hcCCc--------------ccCcceEEEeeecCHHHhcCCc-----------ccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 87542 2245566799999999999866 2999999999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCC-----ccc-------------------ccC-CCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 371 SAEEIYRAVVKNRKLPPQ-----YAS-------------------IVG-VGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~-----~~~-------------------~~~-~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
++.+++.+|++....|.. +.. .+. ..+++...+|+..+|.+||.+|.||+|.|+|
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 998888888764333210 000 001 1256889999999999999999999999998
Q ss_pred hh
Q 000343 426 FL 427 (1630)
Q Consensus 426 L~ 427 (1630)
=+
T Consensus 362 ~~ 363 (419)
T KOG0663|consen 362 EY 363 (419)
T ss_pred cc
Confidence 43
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=397.40 Aligned_cols=289 Identities=25% Similarity=0.299 Sum_probs=260.9
Q ss_pred HHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcC---CHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC-
Q 000343 516 HLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAG---SPECVHALIKRGANVISRLREGFGPSVAHVCAYHG- 591 (1630)
Q Consensus 516 H~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G---~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G- 591 (1630)
..|+..++.++|++|++. ++++|..+..|.||||+|+..+ +.+++++|+++|+++|..+ ..|.||||+|+..|
T Consensus 19 ~~~~~~~~~~~v~~Ll~~-ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~--~~g~TpLh~A~~~~~ 95 (471)
T PHA03095 19 LLNASNVTVEEVRRLLAA-GADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPE--RCGFTPLHLYLYNAT 95 (471)
T ss_pred HHcCCCCCHHHHHHHHHc-CCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCC--CCCCCHHHHHHHcCC
Confidence 567788999999999985 6899999999999999999999 9999999999999998764 46899999999999
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCChhhhhh--hcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHH
Q 000343 592 QPDCMRELLLAGADPNAVDDEGESVLHRAV--AKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE 669 (1630)
Q Consensus 592 ~~eivk~LL~~GADvn~~D~~G~TPLH~Aa--~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe 669 (1630)
+.+++++|+++|+|+|.+|..|.||||+|+ ..++.+++++|+++|+ +++..|..|.||||+|+..++
T Consensus 96 ~~~iv~lLl~~ga~in~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~ga--d~~~~d~~g~tpL~~a~~~~~--------- 164 (471)
T PHA03095 96 TLDVIKLLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGA--DVNALDLYGMTPLAVLLKSRN--------- 164 (471)
T ss_pred cHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCC--CCCccCCCCCCHHHHHHHcCC---------
Confidence 599999999999999999999999999999 5568899999999997 678889999999999876431
Q ss_pred hcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhc--CCHHHHHHHHHC
Q 000343 670 VASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMA--NDVELVKIILDA 747 (1630)
Q Consensus 670 ~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~--g~~eiVklLL~~ 747 (1630)
...+++++|+++|++++..|..|.||||+|+.. ++.+++++|+++
T Consensus 165 ---------------------------------~~~~iv~~Ll~~g~~~~~~d~~g~t~Lh~~~~~~~~~~~i~~~Ll~~ 211 (471)
T PHA03095 165 ---------------------------------ANVELLRLLIDAGADVYAVDDRFRSLLHHHLQSFKPRARIVRELIRA 211 (471)
T ss_pred ---------------------------------CCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHHCCCcHHHHHHHHHc
Confidence 135789999999999999999999999999875 789999999999
Q ss_pred CCCcccccCCCCCHHHHHHHcCCH--HHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccc
Q 000343 748 GVDVNIRNVHNTIPLHVALARGAK--SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEV 825 (1630)
Q Consensus 748 GADvN~~d~~G~TPLH~Aa~~G~~--eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~ 825 (1630)
|+++|.+|..|+||||+||..|+. .++++|+++|+|+|.+|..|+||||+|+..++ . .++.+|+..||++++
T Consensus 212 g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~-----~-~~v~~LL~~gad~n~ 285 (471)
T PHA03095 212 GCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNN-----P-RACRRLIALGADINA 285 (471)
T ss_pred CCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCC-----H-HHHHHHHHcCCCCcc
Confidence 999999999999999999999875 68999999999999999999999999997654 2 566777788999999
Q ss_pred cCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCC
Q 000343 826 RNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 826 ~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~ 861 (1630)
+|.+|+|||++|...+ ..++++.|++.++++.
T Consensus 286 ~~~~g~tpl~~A~~~~----~~~~v~~LL~~~~~~~ 317 (471)
T PHA03095 286 VSSDGNTPLSLMVRNN----NGRAVRAALAKNPSAE 317 (471)
T ss_pred cCCCCCCHHHHHHHhC----CHHHHHHHHHhCCCHH
Confidence 9999999999998776 4689999999998864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=372.00 Aligned_cols=256 Identities=19% Similarity=0.332 Sum_probs=229.2
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
....+|++.++||+|+||+|-+ |++...|+.||||.|.+.... +.-.+++||+||..++ ||||+++|++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~------A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN--HPhII~IyEV 121 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKL------AYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN--HPHIIQIYEV 121 (668)
T ss_pred chhhHHHHHHHhcCCcccceee------hhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC--CCceeehhhh
Confidence 4567999999999999887754 778889999999999877433 3556889999999865 9999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
|+..+.+.|||||..+|.|.+|+...+.|++.+++.+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++-
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence 99999999999999999999999988999999999999999999999999999999999999999999999999999997
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+... ....++||++-|.+||++.+..| -++.+|.||||++||.|+.|..||.+
T Consensus 202 ly~~~---------------kfLqTFCGSPLYASPEIvNG~PY-----------~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 202 LYADK---------------KFLQTFCGSPLYASPEIVNGTPY-----------KGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred hhccc---------------cHHHHhcCCcccCCccccCCCCC-----------CCCccchhhHHHHHHHHhhcccccCC
Confidence 76532 24567899999999999988774 47899999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.+...++..|..+....|. .|.++.-||+.||..||++|.|+.++..|+.-.+
T Consensus 256 ~Dhk~lvrQIs~GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 256 RDHKRLVRQISRGAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred chHHHHHHHhhcccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 9999999999888765543 4567899999999999999999999999987544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=381.75 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=218.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcE-EEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-VAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~-VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+..+.+.||+|+||+|| ...|++ .. ||||++....... ...+.+|+.+|.+++ |||||+|++++...
T Consensus 42 ~l~~~~~iG~G~~g~V~--~~~~~g------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~--HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVY--KGKWRG------TDVVAVKIISDPDFDDESRKAFRREASLLSRLR--HPNIVQFYGACTSP 111 (362)
T ss_pred HhhhhhhcccCCceeEE--EEEeCC------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcCC
Confidence 55566779999999995 456654 34 9999998764333 448999999999965 99999999999988
Q ss_pred C-EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccccccceEECCCC-cEEEeeccee
Q 000343 214 S-CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAG-VVCMNIKPSNLLLDASG-RAVVSDYGLA 288 (1630)
Q Consensus 214 ~-~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~g-IIHRDLKP~NILld~~g-~vKL~DFGla 288 (1630)
. .++|||||+++|+|..++.. +..|+...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 79999999999999988866 578999999999999999999999999 99999999999999997 9999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+...... ...+...||+.|||||++.+. ...|+.++||||||++||||+||..||.
T Consensus 192 r~~~~~~--------------~~~~~~~GT~~wMAPEv~~~~----------~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 192 REKVISK--------------TSMTSVAGTYRWMAPEVLRGE----------KSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred eeecccc--------------ccccCCCCCccccChhhhcCC----------CCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 8754321 123346799999999999853 1128999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCC
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~ 435 (1630)
+....++...+......+... ..+++.+..||.+||+.||++||++.+++..|.........
T Consensus 248 ~~~~~~~~~~v~~~~~Rp~~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 248 DLAPVQVASAVVVGGLRPPIP-----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCHHHHHHHHHhcCCCCCCC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 998877777776665555432 24889999999999999999999999999998877665543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=356.31 Aligned_cols=258 Identities=19% Similarity=0.204 Sum_probs=223.6
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
..+.++|++.+.||+|.|+.| +++.++.+|+.+|+|.+..... ...+.+++|+.|-+.++ ||||++|++.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvV------rRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq--HP~IvrL~~t 78 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVV------RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ--HPNIVRLHDS 78 (355)
T ss_pred cccchhhhHHHHHccCchHHH------HHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC--CCcEeehhhh
Confidence 346789999999999998766 4577899999999999876633 35678899999999987 9999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC---cEEEeecc
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG---RAVVSDYG 286 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g---~vKL~DFG 286 (1630)
+....+.|||+|++.|+.+..-+-.+..+++..+..+++||++||+|+|.+||||||+||+|+|+-+.. -+||+|||
T Consensus 79 i~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 79 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred hcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence 999999999999999988876554445689999999999999999999999999999999999996443 58999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+|..+.... ...+.+|||.|||||++...+ |+..+||||.|+|||-|+.|.+|
T Consensus 159 vAi~l~~g~---------------~~~G~~GtP~fmaPEvvrkdp------------y~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 159 LAIEVNDGE---------------AWHGFAGTPGYLSPEVLKKDP------------YSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred eEEEeCCcc---------------ccccccCCCcccCHHHhhcCC------------CCCcchhhhhhHHHHHHHhCCCC
Confidence 998876321 234678999999999998765 89999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|.+.+...+++.|.++....+ ...++.+++++++|+++||..||.+|.|+.|+|+|-.
T Consensus 212 F~~~~~~rlye~I~~g~yd~~---~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 212 FWDEDQHRLYEQIKAGAYDYP---SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred CCCccHHHHHHHHhccccCCC---CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 999999999999998864332 2334578999999999999999999999999999843
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=365.66 Aligned_cols=267 Identities=23% Similarity=0.306 Sum_probs=222.2
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
-.++|++...||.|.-+.| |.|+.+.+++.||||++..++-+. .+.+++|+..|..+. ||||++++..|..
T Consensus 24 n~~~YeL~e~IG~G~sa~V------~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~--HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVV------YLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID--HPNIVTYHCSFVV 95 (516)
T ss_pred CccceeEEEEEeccceeEe------eeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC--CCCcceEEEEEEe
Confidence 3479999999999986555 457788899999999999875444 588999999999976 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+..+++||.||.+|++.+++... ..|++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999988888777542 3499999999999999999999999999999999999999999999999999877
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+..... ..... ....+||+.|||||++.... .+|+.|+||||||++..||.+|..||...
T Consensus 176 l~~~G~---------R~~~r-f~tfvgtp~wmAPEvl~q~~----------~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 176 LFDSGD---------RQVTR-FNTFVGTPCWMAPEVLMQQL----------HGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred ecccCc---------eeeEe-eccccCcccccChHHhhhcc----------cCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 654321 11111 26788999999999976533 35999999999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCC---cccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 371 SAEEIYRAVVKNRKLPPQ---YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~---~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
++.+++...+++.+..+. ........++..++++|..||..||++|||++++|+|-+-
T Consensus 236 pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 236 PPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred ChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 998887777666543222 0111123467789999999999999999999999998553
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=398.92 Aligned_cols=363 Identities=15% Similarity=0.171 Sum_probs=282.5
Q ss_pred CCCCccchhhc--cCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCC--HHHHHHHHHhcCCCcccCC
Q 000343 467 DNPNNLHQLVS--EGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGS--AELVEAILEYSQENVDVLD 542 (1630)
Q Consensus 467 ~~~t~Lh~Aa~--~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~--~eiVk~LL~~~~~dvn~~D 542 (1630)
.+.++||.|+. .++.+.++.|++.++++ +.+|.+|.||||+|+..|+ .++|++||+. ++++|.+|
T Consensus 176 ~G~TpLH~A~~n~~~~~eIVklLLe~GADV----------N~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~-GADVN~kD 244 (764)
T PHA02716 176 TGYGILHAYLGNMYVDIDILEWLCNNGVNV----------NLQNNHLITPLHTYLITGNVCASVIKKIIEL-GGDMDMKC 244 (764)
T ss_pred CCCcHHHHHHHhccCCHHHHHHHHHcCCCC----------CCCCCCCCCHHHHHHHcCCCCHHHHHHHHHc-CCCCCCCC
Confidence 35679998764 46889999999999876 4789999999999999995 4899999995 68999999
Q ss_pred CCCCCHHHHHH---HcCCHHHHHHHHHCCCCcccccccCCCchHHH---HHHHcCCHHHHHHHHHcCCCCCCCCCCCCCh
Q 000343 543 KDGDPPLVFAL---AAGSPECVHALIKRGANVISRLREGFGPSVAH---VCAYHGQPDCMRELLLAGADPNAVDDEGESV 616 (1630)
Q Consensus 543 ~~G~TPLh~Aa---~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh---~Aa~~G~~eivk~LL~~GADvn~~D~~G~TP 616 (1630)
..|.||||+|+ .+++.+++++|++.+.... ....+++|| .|+..|+.+++++|+++||++|.+|.+|+||
T Consensus 245 ~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~----~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TP 320 (764)
T PHA02716 245 VNGMSPIMTYIINIDNINPEITNIYIESLDGNK----VKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTC 320 (764)
T ss_pred CCCCCHHHHHHHhhhccCHHHHHHHHHhccccc----cccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCH
Confidence 99999999885 5689999999998754321 112334454 4789999999999999999999999999999
Q ss_pred hhhhhh--cCChHHHHHHHHcCCccccccccCCCCcHHHHHHH--------------cCCHHHHHHHHHhcCcccccccc
Q 000343 617 LHRAVA--KKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA--------------TWNVAVVKRWVEVASPEEIVNVI 680 (1630)
Q Consensus 617 LH~Aa~--~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~--------------~g~~eivk~LLe~ga~~~~~n~~ 680 (1630)
||+|+. .++.+++++|+++|+ +++..|..|.||||+|+. .++.+++++|++.|++... .
T Consensus 321 LH~Aaa~~~~~~eIVklLLe~GA--DIN~kD~~G~TPLH~A~~~lav~~~ld~~~~~~~~~eVVklLL~~GADIn~---k 395 (764)
T PHA02716 321 LHQYILRHNISTDIIKLLHEYGN--DLNEPDNIGNTVLHTYLSMLSVVNILDPETDNDIRLDVIQCLISLGADITA---V 395 (764)
T ss_pred HHHHHHHhCCCchHHHHHHHcCC--CCccCCCCCCCHHHHHHHhhhhhccccccccccChHHHHHHHHHCCCCCCC---c
Confidence 999875 467899999999997 788899999999999875 3689999999999876433 2
Q ss_pred CCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccc--------cCccc--hhhhhhcCCH------------
Q 000343 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDA--------QNRTA--LHIASMANDV------------ 738 (1630)
Q Consensus 681 d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~--------~G~Tp--LH~Aa~~g~~------------ 738 (1630)
+ ..+.|+++.++.... ..+..+++++|++.|+..+..+. .+.+| +|.++..++.
T Consensus 396 n--~~G~TPLh~y~~~a~--n~~~~dIvklLis~~~~~~~~~~~~q~ll~~~d~~~~~lhh~~a~~~~~~~~~~~~~~~~ 471 (764)
T PHA02716 396 N--CLGYTPLTSYICTAQ--NYMYYDIIDCLISDKVLNMVKHRILQDLLIRVDDTPCIIHHIIAKYNIPTDLYTDEYEPY 471 (764)
T ss_pred C--CCCCChHHHHHHHHH--hcChHHHHHHHHhCcchhhhhhhhhhhhhhccCcchhhHHHHHHhcCcchhhhhhhhhhc
Confidence 2 234678874332111 12457999999999986543322 23344 4555544332
Q ss_pred ------HHHHHHHHCCCCcccccCCCCCHHHHHHHcCCH-----HHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHh
Q 000343 739 ------ELVKIILDAGVDVNIRNVHNTIPLHVALARGAK-----SCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRE 807 (1630)
Q Consensus 739 ------eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~-----eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~ 807 (1630)
+++.+++..++++|++|..|+||||+|+..|+. +++++||++|||+|.+|++|+||||+|+..++. ..
T Consensus 472 ~~~~~~~v~~~~ii~~~nvN~~D~~G~TPLh~Aa~~g~~~~v~~e~~k~LL~~GADIN~~d~~G~TPLh~A~~~g~~-~~ 550 (764)
T PHA02716 472 DSTKIHDVYHCAIIERYNNAVCETSGMTPLHVSIISHTNANIVMDSFVYLLSIQYNINIPTKNGVTPLMLTMRNNRL-SG 550 (764)
T ss_pred cccccchhhHHHHHhhccccccCCCCCCHHHHHHHcCCccchhHHHHHHHHhCCCCCcccCCCCCCHHHHHHHcCCc-cc
Confidence 344455667889999999999999999999876 455999999999999999999999999988753 12
Q ss_pred hHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCCcc
Q 000343 808 NLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTI 864 (1630)
Q Consensus 808 n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~~~ 864 (1630)
....++++|++.|+++++. .+.+|+... ..+++..|..+|+.+.+.+
T Consensus 551 ~~~eIvk~LL~~ga~~~~~------~l~~~~~~~----~~~~~~ll~~~~~~~~~~~ 597 (764)
T PHA02716 551 HQWYIVKNILDKRPNVDIV------IIFLDKCYA----NGKFPSLLLSEDDIIKPTL 597 (764)
T ss_pred cHHHHHHHHHhcCCCcchH------HHHHHhhhh----hhHHHHHHHHcchhHHHHH
Confidence 2346778888899988877 367776554 4578888888888765533
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=383.09 Aligned_cols=343 Identities=22% Similarity=0.258 Sum_probs=292.7
Q ss_pred hhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHH
Q 000343 482 SGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECV 561 (1630)
Q Consensus 482 ~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiV 561 (1630)
+..+.+++++... ..++..|+|++|.|+..+.. ++. ....++.|..|.||||+|+.....+.+
T Consensus 42 D~~tli~~kns~~----------~~~~~~gd~~~~~~~~~~y~------~~~-~~~~~a~D~~~n~~l~~a~~~~~~~~i 104 (929)
T KOG0510|consen 42 DRHTLILEKNSST----------PGKRAFGDTELHHASARNYI------LSK-LAISYAKDSADNTPLHAAVEYNQGDKI 104 (929)
T ss_pred HHHHHHHHhcccc----------chhhhhchhHHHHHHhhcch------hhh-hhhhhhhhcccCchhHHHhhcchHHHH
Confidence 3455556654443 45788999999999999865 332 356778899999999999999999999
Q ss_pred HHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCcccc
Q 000343 562 HALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSM 641 (1630)
Q Consensus 562 k~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i 641 (1630)
++|++.||+.+.. +..+.+|+|+|+..|+.++++.|+++|+|+|..|..|.||||+|+..++.+..+.|++.|+ ++
T Consensus 105 ~~Lls~gad~~~~--n~~~~aplh~A~~~~~~s~L~~Ll~~~~dvnl~de~~~TpLh~A~~~~~~E~~k~Li~~~a--~~ 180 (929)
T KOG0510|consen 105 QVLLSYGADTPLR--NLNKNAPLHLAADSGNYSCLKLLLDYGADVNLEDENGFTPLHLAARKNKVEAKKELINKGA--DP 180 (929)
T ss_pred HHHHhcCCCCChh--hhhccCchhhccccchHHHHHHHHHhcCCccccccCCCchhhHHHhcChHHHHHHHHhcCC--CC
Confidence 9999999998764 4557789999999999999999999999999999999999999999999998899999998 56
Q ss_pred ccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCC---
Q 000343 642 AILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEP--- 718 (1630)
Q Consensus 642 ~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdv--- 718 (1630)
...|.+|.+|+|.|+.+|..+..+.++............-.+....++++.|+. .++.+.++.+|++|+.+
T Consensus 181 ~K~~~~~~~~iH~aa~s~s~e~mEi~l~~~g~~r~~~in~~~n~~~~pLhlAve------~g~~e~lk~~L~n~~~~a~~ 254 (929)
T KOG0510|consen 181 CKSDIDGNFPIHEAARSGSKECMEIFLPEHGYERQTHINFDNNEKATPLHLAVE------GGDIEMLKMCLQNGKKIADV 254 (929)
T ss_pred CcccCcCCchHHHHHHhcchhhhhhhhccccchhhcccccccCCCCcchhhhhh------cCCHHHHHHHHhCccccchh
Confidence 778899999999999999999999999733222222222223345678887763 56789999999998643
Q ss_pred ------------CcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHh-CC-CCC
Q 000343 719 ------------TAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS-AG-ADC 784 (1630)
Q Consensus 719 ------------n~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe-~G-ADi 784 (1630)
|..|.+|.||||+||+.|+.+.+..||..||++|.++.++.||||.||..|+.++|+.||+ .| ...
T Consensus 255 ~~~~~~q~kelv~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rll 334 (929)
T KOG0510|consen 255 QLDAMQQEKELVNDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLL 334 (929)
T ss_pred hhHHHHHHHHHhhcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCcccc
Confidence 4568899999999999999999999999999999999999999999999999999999998 44 578
Q ss_pred CcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCccc---ccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCC
Q 000343 785 NWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVE---VRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn---~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~ 861 (1630)
|..|-.|+||||+|+..| ...++++|+..||+.+ -.|.+|.||||+|+..+ ....++.|+.+|+++.
T Consensus 335 ne~D~~g~tpLHlaa~~g------H~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g----~~~av~~Li~~Ga~I~ 404 (929)
T KOG0510|consen 335 NESDLHGMTPLHLAAKSG------HDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYG----NTSAVQKLISHGADIG 404 (929)
T ss_pred ccccccCCCchhhhhhcC------HHHHHHHHHhcChhhhcccccccCCchhhhHHHHhc----cHHHHHHHHHcCCcee
Confidence 999999999999999665 4578899999999888 35999999999999887 4689999999999984
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=384.86 Aligned_cols=344 Identities=15% Similarity=0.154 Sum_probs=271.1
Q ss_pred hhcccCCChHHHHHHHcC---CHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcC--CHHHHHHHHHCCCCcccccccCC
Q 000343 505 KAQNADGQTALHLACRRG---SAELVEAILEYSQENVDVLDKDGDPPLVFALAAG--SPECVHALIKRGANVISRLREGF 579 (1630)
Q Consensus 505 ~~~d~~G~TpLH~Aa~~G---~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G--~~eiVk~LL~~GAdvn~~~~d~~ 579 (1630)
+.+|.+|+||||+|+.+| +.++|++||++ |++++.+|.+|.||||+|+..+ +.|+|++|+++|++.+....+..
T Consensus 35 ~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~-GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~~~ 113 (672)
T PHA02730 35 KHIDRRGNNALHCYVSNKCDTDIKIVRLLLSR-GVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTSNI 113 (672)
T ss_pred hhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhC-CCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccccc
Confidence 378899999999999997 59999999985 7899999999999999999977 79999999999876644444545
Q ss_pred CchHHHHHHH--cCCHHHHHHHHH-cCCCCCCCCC-----CCCChhhhhhhcCChHHHHHHHHcCCccc-c----ccccC
Q 000343 580 GPSVAHVCAY--HGQPDCMRELLL-AGADPNAVDD-----EGESVLHRAVAKKYTDCAIVILENGGCRS-M----AILNS 646 (1630)
Q Consensus 580 g~T~Lh~Aa~--~G~~eivk~LL~-~GADvn~~D~-----~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~-i----~~~d~ 646 (1630)
+.+|||.++. +++.+++++|+. .++|++.... .|.+|+++|+..++.+++++|+++|+..+ . ...+.
T Consensus 114 ~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~~~~~~~~~~~~~~~yl~~~~~~~eIvklLi~~g~~v~g~~~~~~~~~~ 193 (672)
T PHA02730 114 NDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSKNTNYYIHCLGLVDIYVTTPNPRPEVLLWLLKSECYSTGYVFRSCMYDS 193 (672)
T ss_pred CCchHHHHHHhcCCcHHHHHHHHHhcCCChhhhhhhhccccchhhhhHhcCCCchHHHHHHHHcCCcccccccccccccC
Confidence 5667777776 999999999996 7789887643 78999999999999999999999998542 0 12344
Q ss_pred CCCcH-HHHH------HHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHh------
Q 000343 647 KELTP-LHLC------VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLT------ 713 (1630)
Q Consensus 647 ~G~TP-Lh~A------a~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~------ 713 (1630)
...+| ||++ ..+++.+++++|+++|++. |..|. .+.|||+.+.+.. .++.+++++|++
T Consensus 194 ~~c~~~l~~~il~~~~~~~n~~eiv~lLIs~GadI---N~kd~--~G~TpLh~~~~~~----~~~~eiv~~Li~~~~~~~ 264 (672)
T PHA02730 194 DRCKNSLHYYILSHRESESLSKDVIKCLIDNNVSI---HGRDE--GGSLPIQYYWSCS----TIDIEIVKLLIKDVDTCS 264 (672)
T ss_pred CccchhHHHHHHhhhhhhccCHHHHHHHHHCCCCC---CCCCC--CCCCHHHHHHHcC----cccHHHHHHHHhcccccc
Confidence 45544 5533 4557899999999999853 33333 3468888644322 234799999999
Q ss_pred --------------------------cCCCCCc--------------------ccccCcc--------------------
Q 000343 714 --------------------------AGAEPTA--------------------QDAQNRT-------------------- 727 (1630)
Q Consensus 714 --------------------------~GAdvn~--------------------~D~~G~T-------------------- 727 (1630)
+|+|+.. .|..|.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~i~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~i~~~~~~~~~~~~q 344 (672)
T PHA02730 265 VYDDISQPYIRGVLADYLNKRFRVTPYNVDMEIVNLLIEGRHTLIDVMRSITSYDSREYNHYIIDNILKRFRQQDESIVQ 344 (672)
T ss_pred ccccccchhhhhhHHHhhhhhhhcccCCcchHHHHHHhhccCcchhhhhccccccccccchhHHHHHHHhhhccchhHHH
Confidence 7988866 5666654
Q ss_pred -chhhhhhcC---CHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCC----HHHHHHHHhCCC--CCCcCCCCCCcHHHH
Q 000343 728 -ALHIASMAN---DVELVKIILDAGVDVNIRNVHNTIPLHVALARGA----KSCVGLLLSAGA--DCNWQDDEGDNAFHI 797 (1630)
Q Consensus 728 -pLH~Aa~~g---~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~----~eiVklLLe~GA--DiN~~D~~G~TpLhl 797 (1630)
.||.=...+ +.+++++||++|||+|.. ..|.||||+|+..++ .+++++||++|| |+|.+|.+|.||||.
T Consensus 345 ~~l~~Y~~~~~~v~ieIvelLIs~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~ 423 (672)
T PHA02730 345 AMLINYLHYGDMVSIPILRCMLDNGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYG 423 (672)
T ss_pred HHHHHHHhcCCcCcHHHHHHHHHCCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhH
Confidence 555444444 699999999999999986 799999999998875 899999999998 699999999999994
Q ss_pred H--HH-hchHH--Hhh-HHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCCc
Q 000343 798 A--AD-AAKMI--REN-LEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPT 863 (1630)
Q Consensus 798 A--a~-~g~~i--~~n-~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~~ 863 (1630)
+ +. ..... .+. .-.++.+|+.+||++|++|+.|+|||++|+... ..+++++|+++||+++..
T Consensus 424 ~i~a~~~n~~~~~~e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~----~~eive~LI~~GAdIN~~ 491 (672)
T PHA02730 424 LILSRFNNCGYHCYETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVN----NIQFARRLLEYGASVNTT 491 (672)
T ss_pred HHHHHhccccccccchhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhC----CHHHHHHHHHCCCCCCCC
Confidence 2 22 11000 000 123578889999999999999999999998765 458999999999998763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.28 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=226.5
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--------hhHHHHHHHHHHHhccCCCCcce
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--------PDWLSGQLDNLRRASMWCRNVCT 205 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--------~~~~~~Ei~iL~~l~l~HpNIV~ 205 (1630)
+-..|+-.+.||.|..+.| -++.++.++..+|+|++....... .+.-.+|+.||+++. +||+|++
T Consensus 15 fy~~y~pkeilgrgvss~v------rRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-GHP~II~ 87 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVV------RRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-GHPYIID 87 (411)
T ss_pred HHhhcChHHHhcccchhhh------hhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-CCCcEEE
Confidence 3457788889999985544 456788999999999987553221 344567999999986 8999999
Q ss_pred eEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 206 l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
+.++|+.+.++|+|+|.|+.|.|++++...-.+++++++.|++|++.|+.|||.++|+||||||+|||++++.++||+||
T Consensus 88 l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred eeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+|+.+..+. .....||||.|+|||.+...-+ +++.+|+..+|+||+|+|||.++.|.+
T Consensus 168 GFa~~l~~Ge---------------kLrelCGTPgYLAPEtikC~m~------e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 168 GFACQLEPGE---------------KLRELCGTPGYLAPETIKCSMY------ENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred ceeeccCCch---------------hHHHhcCCCcccChhheeeecc------cCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 9999876532 2456899999999999987553 466789999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
||-.....-++..|.+++.. +.++.+.+++.+.++||++||+.||++|.|++|+|.|-+-
T Consensus 227 PFwHRkQmlMLR~ImeGkyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 227 PFWHRKQMLMLRMIMEGKYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred chhHHHHHHHHHHHHhcccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 99877666677777777643 3344556789999999999999999999999999998553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.57 Aligned_cols=250 Identities=19% Similarity=0.240 Sum_probs=221.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.++|++.+.||+|.||.||+ |+.+.++..||+|++.+.+ ...+.++.+|++|-..++ ||||+++|++|.
T Consensus 21 l~dfeigr~LgkgkFG~vYl------arekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~--hpnilrlY~~fh 92 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYL------AREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR--HPNILRLYGYFH 92 (281)
T ss_pred hhhccccccccCCccccEeE------eeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC--CccHHhhhhhee
Confidence 46999999999999998877 7788999999999998774 334678889999977765 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQR--NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~--~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
+....||++||...+.+...++ ...++++..+..|++|++.||.|+|.+++|||||||+|+|++..+.+||+|||-+.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999998776666555 45679999999999999999999999999999999999999999999999999997
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.-+.+ .....+||.-|.+||+..+.. ++..+|+|++|++.||++.|.+||..
T Consensus 173 ~~p~~----------------kR~tlcgt~dyl~pEmv~~~~------------hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 173 HAPSN----------------KRKTLCGTLDYLPPEMVEGRG------------HDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred ecCCC----------------CceeeecccccCCHhhcCCCC------------ccchhhHHHHHHHHHHHHhcCCchhh
Confidence 64422 134578999999999998755 89999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+..+.+++|.+-....| ..++.++++||.+||..+|.+|.+..|+++|..
T Consensus 225 ~~~~etYkrI~k~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 225 QSHSETYKRIRKVDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred hhhHHHHHHHHHccccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 999999999988776555 358899999999999999999999999999854
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=388.29 Aligned_cols=283 Identities=25% Similarity=0.360 Sum_probs=230.1
Q ss_pred ChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHH-----HHH
Q 000343 480 DVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVF-----ALA 554 (1630)
Q Consensus 480 dl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~-----Aa~ 554 (1630)
....++.++..+. +.+..+..+.||||+|+..|+.++|++||+. +++++..+..+.||||+ |+.
T Consensus 14 ~~~~~~~~~~~~~----------~~~~~~~~~~t~L~~A~~~~~~~ivk~Ll~~-g~~~~~~~~~~~t~L~~~~~~~a~~ 82 (480)
T PHA03100 14 KVKNIKYIIMEDD----------LNDYSYKKPVLPLYLAKEARNIDVVKILLDN-GADINSSTKNNSTPLHYLSNIKYNL 82 (480)
T ss_pred HHHHHHHHHhcCc----------cchhhhcccchhhhhhhccCCHHHHHHHHHc-CCCCCCccccCcCHHHHHHHHHHHh
Confidence 3456667775542 2356788999999999999999999999995 68899999999999999 999
Q ss_pred cCCHHHHHHHHHCCCCcccccccCCCchHHHHHH--HcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC--ChHHHH
Q 000343 555 AGSPECVHALIKRGANVISRLREGFGPSVAHVCA--YHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK--YTDCAI 630 (1630)
Q Consensus 555 ~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa--~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g--~~eiv~ 630 (1630)
.++.+++++|+++|++++. .+..|.||||+|+ ..|+.+++++|+++|++++..|..|.||||+|+..+ +.++++
T Consensus 83 ~~~~~iv~~Ll~~ga~i~~--~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~ 160 (480)
T PHA03100 83 TDVKEIVKLLLEYGANVNA--PDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILK 160 (480)
T ss_pred hchHHHHHHHHHCCCCCCC--CCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHH
Confidence 9999999999999999965 4566889999999 999999999999999999999999999999999999 999999
Q ss_pred HHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHH
Q 000343 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRI 710 (1630)
Q Consensus 631 ~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVkl 710 (1630)
+|+++|+ +++..+..|.||||+|+..++.+++ ++
T Consensus 161 ~Ll~~g~--din~~d~~g~tpL~~A~~~~~~~iv--------------------------------------------~~ 194 (480)
T PHA03100 161 LLIDKGV--DINAKNRYGYTPLHIAVEKGNIDVI--------------------------------------------KF 194 (480)
T ss_pred HHHHCCC--CcccccCCCCCHHHHHHHhCCHHHH--------------------------------------------HH
Confidence 9999997 6778888999999999987665544 45
Q ss_pred HHhcCCCCCcccccC------ccchhhhhhcCC--HHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCC
Q 000343 711 LLTAGAEPTAQDAQN------RTALHIASMAND--VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782 (1630)
Q Consensus 711 LL~~GAdvn~~D~~G------~TpLH~Aa~~g~--~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GA 782 (1630)
|+++|++++..+..| .||||+|+..++ .+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++||
T Consensus 195 Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga 274 (480)
T PHA03100 195 LLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGA 274 (480)
T ss_pred HHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence 555566666666666 677777777777 777777777777777777777777777777777777777777777
Q ss_pred CCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccC
Q 000343 783 DCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRN 827 (1630)
Q Consensus 783 DiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n 827 (1630)
|+|.+|..|.||||+|+..++ ..++.+|++.|++++..+
T Consensus 275 d~n~~d~~g~tpl~~A~~~~~------~~iv~~Ll~~g~~i~~i~ 313 (480)
T PHA03100 275 NPNLVNKYGDTPLHIAILNNN------KEIFKLLLNNGPSIKTII 313 (480)
T ss_pred CCCccCCCCCcHHHHHHHhCC------HHHHHHHHhcCCCHHHHH
Confidence 777777777777777765432 245566666677666543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=359.22 Aligned_cols=264 Identities=24% Similarity=0.290 Sum_probs=213.2
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc--CcCChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA--EEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~--~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
......|..++.||+|+||.| -+|.++.+|+.||||++... .....++..||+.+|++++ |+||+.++++
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvV------csA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~--HeNIi~l~di 89 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVV------CSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR--HENIIGLLDI 89 (359)
T ss_pred EeccceecccccccCcceeeE------EEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc--CCCcceEEee
Confidence 345567888999999997765 34778899999999999843 4445677889999999987 9999999999
Q ss_pred EEe-----CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 210 LRM-----DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 210 f~~-----~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
+.. -+.+|+|+|+|+.+ |..+++.+..|+...++.+++||++||.|+|+.+|+||||||+|+|++.+..+||+|
T Consensus 90 ~~p~~~~~f~DvYiV~elMetD-L~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELMETD-LHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccccccccceeEEehhHHhhH-HHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 976 24599999999554 455555555699999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||+|+...... ....++..+-|..|+|||++.... .|+.+.||||.||||.||++|+
T Consensus 169 FGLAR~~~~~~------------~~~~mTeYVaTRWYRAPElll~~~-----------~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 169 FGLARYLDKFF------------EDGFMTEYVATRWYRAPELLLNSS-----------EYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred ccceeeccccC------------cccchhcceeeeeecCHHHHhccc-----------cccchhhhhhhhHHHHHHHcCC
Confidence 99999875420 122345667799999999997654 3999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCC------------------------CCcccccCCCCCHHHHHHHHHhhccCcCCCCChh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLP------------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~------------------------~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
+-|.+.+.-+.+..|..--..| +..-....++.++.+.+|+.+||.+||.+|+|++
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~ 305 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE 305 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence 9999877655444444322221 1111223347889999999999999999999999
Q ss_pred hHHHHhh
Q 000343 421 AMLATFL 427 (1630)
Q Consensus 421 evL~~L~ 427 (1630)
|+|.|..
T Consensus 306 eAL~hPY 312 (359)
T KOG0660|consen 306 EALAHPY 312 (359)
T ss_pred HHhcChh
Confidence 9999955
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=385.71 Aligned_cols=284 Identities=24% Similarity=0.306 Sum_probs=257.2
Q ss_pred CCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHH-----HHHcCCHHHH
Q 000343 522 GSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV-----CAYHGQPDCM 596 (1630)
Q Consensus 522 G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~-----Aa~~G~~eiv 596 (1630)
...++++++++. +...+..+.++.||||+|+..|+.++|++|+++|++++.. +..+.||||+ |+..++.+++
T Consensus 13 ~~~~~~~~~~~~-~~~~~~~~~~~~t~L~~A~~~~~~~ivk~Ll~~g~~~~~~--~~~~~t~L~~~~~~~a~~~~~~~iv 89 (480)
T PHA03100 13 IKVKNIKYIIME-DDLNDYSYKKPVLPLYLAKEARNIDVVKILLDNGADINSS--TKNNSTPLHYLSNIKYNLTDVKEIV 89 (480)
T ss_pred HHHHHHHHHHhc-CccchhhhcccchhhhhhhccCCHHHHHHHHHcCCCCCCc--cccCcCHHHHHHHHHHHhhchHHHH
Confidence 345778888874 4556778899999999999999999999999999999865 4457899999 9999999999
Q ss_pred HHHHHcCCCCCCCCCCCCChhhhhh--hcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCcc
Q 000343 597 RELLLAGADPNAVDDEGESVLHRAV--AKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPE 674 (1630)
Q Consensus 597 k~LL~~GADvn~~D~~G~TPLH~Aa--~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~ 674 (1630)
++|+++|++++..|..|.||||+|+ ..++.+++++|+++|+ +++..+..|.||||+|+..++
T Consensus 90 ~~Ll~~ga~i~~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~--~~~~~~~~g~t~L~~A~~~~~-------------- 153 (480)
T PHA03100 90 KLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGA--NVNIKNSDGENLLHLYLESNK-------------- 153 (480)
T ss_pred HHHHHCCCCCCCCCCCCCchhhHHHhcccChHHHHHHHHHcCC--CCCccCCCCCcHHHHHHHcCC--------------
Confidence 9999999999999999999999999 9999999999999997 678889999999999987652
Q ss_pred ccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccc
Q 000343 675 EIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIR 754 (1630)
Q Consensus 675 ~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~ 754 (1630)
...+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..
T Consensus 154 ----------------------------~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~ 205 (480)
T PHA03100 154 ----------------------------IDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAG 205 (480)
T ss_pred ----------------------------ChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCC
Confidence 1246788888999999999999999999999999999999999999999999
Q ss_pred cCCC------CCHHHHHHHcCC--HHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCccccc
Q 000343 755 NVHN------TIPLHVALARGA--KSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVR 826 (1630)
Q Consensus 755 d~~G------~TPLH~Aa~~G~--~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~ 826 (1630)
+..| .||||+|+..++ .+++++|+++|+|+|.+|..|.||||+|+..++ ..++++|++.||+++.+
T Consensus 206 ~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~------~~iv~~Ll~~gad~n~~ 279 (480)
T PHA03100 206 DIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNN------PEFVKYLLDLGANPNLV 279 (480)
T ss_pred CCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC------HHHHHHHHHcCCCCCcc
Confidence 9999 999999999999 999999999999999999999999999997654 35677888899999999
Q ss_pred CCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCC
Q 000343 827 NHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSP 862 (1630)
Q Consensus 827 n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~ 862 (1630)
|..|.||+++|.... ..+++++|+++|++++.
T Consensus 280 d~~g~tpl~~A~~~~----~~~iv~~Ll~~g~~i~~ 311 (480)
T PHA03100 280 NKYGDTPLHIAILNN----NKEIFKLLLNNGPSIKT 311 (480)
T ss_pred CCCCCcHHHHHHHhC----CHHHHHHHHhcCCCHHH
Confidence 999999999998765 56899999999998764
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=386.05 Aligned_cols=356 Identities=17% Similarity=0.164 Sum_probs=266.6
Q ss_pred hhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHc---CCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcC-
Q 000343 481 VSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRR---GSAELVEAILEYSQENVDVLDKDGDPPLVFALAAG- 556 (1630)
Q Consensus 481 l~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~---G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G- 556 (1630)
++.|+.||.++... +++|.+|+||||+||.. |+.++|++||+. +++++..|.+|.||||+|+..|
T Consensus 12 ~~~~~~l~~~~~~~----------~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~-ga~v~~~~~~g~TpL~~Aa~~g~ 80 (661)
T PHA02917 12 LDELKQMLRDRDPN----------DTRNQFKNNALHAYLFNEHCNNVEVVKLLLDS-GTNPLHKNWRQLTPLEEYTNSRH 80 (661)
T ss_pred HHHHHHHHhccCcc----------cccCCCCCcHHHHHHHhhhcCcHHHHHHHHHC-CCCccccCCCCCCHHHHHHHcCC
Confidence 56788888765543 57799999999998665 889999999984 6899999999999999888654
Q ss_pred ----------------------------------CHHHHHHHHHCCCCcccccccCCCchHHHHH--HHcCCHHHHHHHH
Q 000343 557 ----------------------------------SPECVHALIKRGANVISRLREGFGPSVAHVC--AYHGQPDCMRELL 600 (1630)
Q Consensus 557 ----------------------------------~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~A--a~~G~~eivk~LL 600 (1630)
+.++|++||++|||+|.. +..|.||||.| +..|+.+++++||
T Consensus 81 ~~v~~~~~~~Ll~~~~~~n~~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~--d~~g~T~L~~~~a~~~~~~eivklLi 158 (661)
T PHA02917 81 VKVNKDIAMALLEATGYSNINDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVK--CENHRSVIENYVMTDDPVPEIIDLFI 158 (661)
T ss_pred hhHHHHHHHHHHhccCCCCCCCcchHHHHHhhcCCHHHHHHHHHcCCCCCcc--CCCCccHHHHHHHccCCCHHHHHHHH
Confidence 457788888888888764 45578888854 3468899999999
Q ss_pred HcCCCCCCCCC---CC-----------CChhhhhhh-----------cCChHHHHHHHHcCCccccccccCCCCcHHHHH
Q 000343 601 LAGADPNAVDD---EG-----------ESVLHRAVA-----------KKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655 (1630)
Q Consensus 601 ~~GADvn~~D~---~G-----------~TPLH~Aa~-----------~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~A 655 (1630)
++|||+|..|. .| .||||+|+. .++.+++++|+++|+ +++..|..|.||||+|
T Consensus 159 ~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~~~~~~~~~eiv~~Li~~Ga--dvn~~d~~G~TpLh~A 236 (661)
T PHA02917 159 ENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLYSESDTRAYVRPEVVKCLINHGI--KPSSIDKNYCTALQYY 236 (661)
T ss_pred HcCCCccccccccccccccccccccccccHHHHHHhhcccccccccccCcHHHHHHHHHCCC--CcccCCCCCCcHHHHH
Confidence 99999887654 33 499999875 457889999999987 7788888999999999
Q ss_pred HHcCCH--HHHHHHHHhcCccccccccCCCCC-CccHHHHHHHhccCcc---chhHHHHHHHHhcCCCCCc-------cc
Q 000343 656 VATWNV--AVVKRWVEVASPEEIVNVIDIPGP-VGTALCMAAALKKDHE---VEGRELVRILLTAGAEPTA-------QD 722 (1630)
Q Consensus 656 a~~g~~--eivk~LLe~ga~~~~~n~~d~~~~-~~t~l~~aaa~~~~~~---~~~~eiVklLL~~GAdvn~-------~D 722 (1630)
+.+|+. +++++|++ ++... +..+..+. ..+++++++.+..... ....+++++|+++|++... .+
T Consensus 237 ~~~g~~~~eivk~Li~-g~d~~--~~~~~~~~~~~~~~~~a~yl~~~~~~~~~v~~~iv~~Li~~Ga~~~~~~~~~~~~~ 313 (661)
T PHA02917 237 IKSSHIDIDIVKLLMK-GIDNT--AYSYIDDLTCCTRGIMADYLNSDYRYNKDVDLDLVKLFLENGKPHGIMCSIVPLWR 313 (661)
T ss_pred HHcCCCcHHHHHHHHh-CCccc--ccccccCcccccchHHHHHHHhhccccccchHHHHHHHHhCCCCCceeEeeecccc
Confidence 988874 78888875 44321 11112222 2455666664432111 2267899999999987421 11
Q ss_pred c------------cCccchhhhh---hcCC--HHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHh-CCCCC
Q 000343 723 A------------QNRTALHIAS---MAND--VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS-AGADC 784 (1630)
Q Consensus 723 ~------------~G~TpLH~Aa---~~g~--~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe-~GADi 784 (1630)
. .+.|+||.+. ..|. .+++++||++|||+|.++.+|.|++ ...+.+++++||. .||++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~v~~Ll~~GAdvn~~~~~g~~~~----~~~~~~~i~~LL~~~ga~~ 389 (661)
T PHA02917 314 NDKETISLILKTMNSDVLQHILIEYMTFGDIDIPLVECMLEYGAVVNKEAIHGYFRN----INIDSYTMKYLLKKEGGDA 389 (661)
T ss_pred cchHHHHHHHHHhchHHHHHHHHHHHHcCCCcHHHHHHHHHcCCCCCCCCccccchh----hcCCHHHHHHHHHhcCCCc
Confidence 2 2444544333 3565 5699999999999999999999854 3567788888886 69998
Q ss_pred CcCCCCCCcHHHHHHHhchH---------HHhh--------HHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHH
Q 000343 785 NWQDDEGDNAFHIAADAAKM---------IREN--------LEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISE 847 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa~~g~~---------i~~n--------~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~ 847 (1630)
+.+|.+|+||||.|++.+.. .+++ ...++.+|+.+||++|.+|..|+|||++|.... ..
T Consensus 390 ~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~----~~ 465 (661)
T PHA02917 390 VNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYN----KQ 465 (661)
T ss_pred cccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcC----CH
Confidence 88888999999999854320 0001 233568888999999999999999999998655 55
Q ss_pred HHHHHHHhcCCCCCC
Q 000343 848 DLMEALMNRGVHLSP 862 (1630)
Q Consensus 848 ~lve~Ll~~Ga~l~~ 862 (1630)
+++++|++.|++++.
T Consensus 466 ~~v~~Ll~~GAdin~ 480 (661)
T PHA02917 466 SLVSLLLESGSDVNI 480 (661)
T ss_pred HHHHHHHHCcCCCCC
Confidence 899999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=368.63 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=213.8
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.++|++.+.||+|+||.||+ +.++.+++.||+|.+..... .....+.+|+.+|+.++ ||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~ 88 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRI------AKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS--HPFIVNMMCSFQ 88 (329)
T ss_pred chheEEEEEEEecCCeEEEE------EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCCCcEEEEEE
Confidence 36899999999999888765 66778899999999986432 23456788999999875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..+.+|+||||+.++.|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999999988888877778999999999999999999999999999999999999999999999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+
T Consensus 169 ~~~-----------------~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 169 PDR-----------------TFTLCGTPEYLAPEVIQSKG------------HGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred CCC-----------------cceecCChhhcCHHHHcCCC------------CCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 321 11346899999999987654 7899999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L~ 427 (1630)
..+.+..+..+....+ ..++.++++||.+||+.||.+||+ +.++++|.+
T Consensus 220 ~~~~~~~i~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 220 PFRIYEKILAGRLKFP-------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HHHHHHHHhcCCcCCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 8888888776543222 247889999999999999999997 688888743
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=369.72 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=215.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
..++++++||+|.||.|++ ..|.+ ...||+|.++.. ....+.+.+|+++|++++ |+|||+|++++..+..
T Consensus 206 ~~l~l~~~LG~G~FG~V~~--g~~~~-----~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~--H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWL--GKWNG-----STKVAVKTIKEG-SMSPEAFLREAQIMKKLR--HEKLVKLYGVCTKQEP 275 (468)
T ss_pred HHHHHHHHhcCCccceEEE--EEEcC-----CCcccceEEecc-ccChhHHHHHHHHHHhCc--ccCeEEEEEEEecCCc
Confidence 3456889999999999965 33433 348999998865 455677889999999987 9999999999999889
Q ss_pred EEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+||||||+..|.|.++++. ...+...+.+.++.||++|++||.++++|||||-+.|||++++..+||+|||||+.+..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999987766666654 45799999999999999999999999999999999999999999999999999996544
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
+.+ .......-+..|.|||.+.... ++.+||||||||+||||+| |+.||.+.+.
T Consensus 356 ~~Y-------------~~~~~~kfPIkWtAPEa~~~~~------------FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 356 DEY-------------TASEGGKFPIKWTAPEALNYGK------------FSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred Cce-------------eecCCCCCCceecCHHHHhhCC------------cccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 321 1111222267899999998766 8999999999999999999 9999999999
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.+++..+.+|.+++.. ..+|+++.++|..||+.+|++|||++.+...+....
T Consensus 411 ~ev~~~le~GyRlp~P------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 411 EEVLELLERGYRLPRP------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHHHHHhccCcCCCC------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 9999999999877653 469999999999999999999999998776665544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=363.37 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=212.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+..... .....+.+|+++++.+. ||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~ 72 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHL------VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS--HPFIIRLFWTEHD 72 (291)
T ss_pred CCceeeeeeecCCCeEEEE------EEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC--CCcHhhhHhhhcc
Confidence 4799999999999888764 66778899999999876432 23456778999999875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||+.++.|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999999888887777789999999999999999999999999999999999999999999999999987643
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.. .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.
T Consensus 153 ~~-----------------~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 153 DR-----------------TWTLCGTPEYLAPEVIQSKG------------HNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred CC-----------------cccccCChhhcCHHHHcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 12346899999999987644 78999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L~ 427 (1630)
.+.+..+..+.... +..+++.+++||.+||+.||.+||+ +.++++|.+
T Consensus 204 ~~~~~~i~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 204 FGIYEKILAGKLEF-------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HHHHHHHHhCCcCC-------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 88888877664322 2246789999999999999999995 899988844
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=368.76 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=226.2
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHG 208 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~ 208 (1630)
..+...|++.+.||+|.||.||. +.++.+|+.+|+|.+.+..... .+.+.+|+.+|++++ .|||||++++
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~------~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~-~hpniv~l~~ 103 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYL------CREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS-GHPNIVQLKD 103 (382)
T ss_pred ccccccEEehhhhCCCCceEEEE------EEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc-CCCCEEEEEE
Confidence 34567899999999999888754 7788899999999998875543 468999999999987 5999999999
Q ss_pred EEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC----CcEEEee
Q 000343 209 VLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS----GRAVVSD 284 (1630)
Q Consensus 209 ~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~----g~vKL~D 284 (1630)
+|++...+++|||+|.|+.|++.+... .+++..+..+++|++.|++|||+.||+||||||+|+|+... +.+|++|
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 999999999999999999888877654 49999999999999999999999999999999999999643 4799999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||++...... ......+||+.|+|||++.... |+..+||||+|+++|.|+.|.
T Consensus 183 FGla~~~~~~---------------~~~~~~~Gtp~y~APEvl~~~~------------y~~~~DiWS~Gvi~yiLL~G~ 235 (382)
T KOG0032|consen 183 FGLAKFIKPG---------------ERLHTIVGTPEYVAPEVLGGRP------------YGDEVDVWSIGVILYILLSGV 235 (382)
T ss_pred CCCceEccCC---------------ceEeeecCCccccCchhhcCCC------------CCcccchhHHHHHHHHHhhCC
Confidence 9999886541 1345689999999999998654 899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+||.+.+....+..+..+... +....+..++..+++||.+||..||.+|+|+.++|+|.+
T Consensus 236 ~PF~~~~~~~~~~~i~~~~~~---f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 236 PPFWGETEFEIFLAILRGDFD---FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCcCCChhHHHHHHHcCCCC---CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 999999999999999888653 334455678999999999999999999999999999844
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=356.56 Aligned_cols=259 Identities=21% Similarity=0.341 Sum_probs=208.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.++||.|+||.||+ |.+..+++.||+|.+..... .....+.+|+.+++.++ ||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 75 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFK------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLHDIIHTE 75 (288)
T ss_pred cccceEeeEEecCCCEEEEE------EEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC--CCCEeeEEEEEcCC
Confidence 35899999999999887754 66778899999999875432 23456778999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+++||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 99999999999876665555555689999999999999999999999999999999999999999999999999976432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......|++.|+|||++.+.. .++.++||||+||++|+|++|++||.+.+..
T Consensus 156 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 156 PT--------------KTYSNEVVTLWYRPPDVLLGST-----------EYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred CC--------------ccccCceecccccChHHhcCCc-----------ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11 1123346789999999986532 2788999999999999999999999988776
Q ss_pred HHHHHHHhcCCCCCC-------------------c----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQ-------------------Y----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~-------------------~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+.+..+......++. . .......+++++.+||.+||++||.+|||++|+++|-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 666555432211110 0 0001134678999999999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=370.49 Aligned_cols=280 Identities=22% Similarity=0.328 Sum_probs=248.6
Q ss_pred HHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCH
Q 000343 514 ALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQP 593 (1630)
Q Consensus 514 pLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~ 593 (1630)
.|+.|+..|++++++.|++..+..++..+.+|.||||.|+..|+.++|++|+++|++++.. +..|.||||.|+..|+.
T Consensus 4 ~l~~ai~~gd~~~v~~ll~~~~~~~n~~~~~~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~--~~~~~t~L~~A~~~~~~ 81 (434)
T PHA02874 4 DLRMCIYSGDIEAIEKIIKNKGNCINISVDETTTPLIDAIRSGDAKIVELFIKHGADINHI--NTKIPHPLLTAIKIGAH 81 (434)
T ss_pred HHHHHHhcCCHHHHHHHHHcCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC--CCCCCCHHHHHHHcCCH
Confidence 5999999999999999999878888999999999999999999999999999999999864 45688999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCc
Q 000343 594 DCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASP 673 (1630)
Q Consensus 594 eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~ 673 (1630)
+++++|+++|++++.. +....+.+++++|++.|+ +++..+..|.||||+|+..++.
T Consensus 82 ~iv~~Ll~~g~~~~~~----------~~~~~~~~~i~~ll~~g~--d~n~~~~~g~T~Lh~A~~~~~~------------ 137 (434)
T PHA02874 82 DIIKLLIDNGVDTSIL----------PIPCIEKDMIKTILDCGI--DVNIKDAELKTFLHYAIKKGDL------------ 137 (434)
T ss_pred HHHHHHHHCCCCCCcc----------hhccCCHHHHHHHHHCcC--CCCCCCCCCccHHHHHHHCCCH------------
Confidence 9999999999987532 233456899999999997 6778899999999999876554
Q ss_pred cccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCccc
Q 000343 674 EEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNI 753 (1630)
Q Consensus 674 ~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~ 753 (1630)
+++++|+++|+++|.+|..|.||||+|+..++.+++++|+++|+++|.
T Consensus 138 --------------------------------~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~ 185 (434)
T PHA02874 138 --------------------------------ESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANV 185 (434)
T ss_pred --------------------------------HHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCC
Confidence 556677788899999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCH
Q 000343 754 RNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTL 833 (1630)
Q Consensus 754 ~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~Tp 833 (1630)
+|..|.||||+|+..|+.+++++|+++|++++.++..|.||||+|+..+. .. +.+|. .|+++|.+|.+|.||
T Consensus 186 ~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~TpL~~A~~~~~------~~-i~~Ll-~~~~in~~d~~G~Tp 257 (434)
T PHA02874 186 KDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIHNR------SA-IELLI-NNASINDQDIDGSTP 257 (434)
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCCHHHHHHHCCh------HH-HHHHH-cCCCCCCcCCCCCCH
Confidence 99999999999999999999999999999999999999999999997532 22 33444 489999999999999
Q ss_pred HHHHhhCCCCCcHHHHHHHHHhcCCCCCC
Q 000343 834 RDFLEGLPREWISEDLMEALMNRGVHLSP 862 (1630)
Q Consensus 834 LdlA~~~~~~~~~~~lve~Ll~~Ga~l~~ 862 (1630)
||+|...+. ..+++++|+++|++++.
T Consensus 258 Lh~A~~~~~---~~~iv~~Ll~~gad~n~ 283 (434)
T PHA02874 258 LHHAINPPC---DIDIIDILLYHKADISI 283 (434)
T ss_pred HHHHHhcCC---cHHHHHHHHHCcCCCCC
Confidence 999986432 45899999999999875
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=380.79 Aligned_cols=299 Identities=23% Similarity=0.280 Sum_probs=240.2
Q ss_pred CccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHH
Q 000343 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPL 549 (1630)
Q Consensus 470 t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPL 549 (1630)
+|||.|+..|+.+.|+.|++.++++ +.+|.+|.||||+||..|+.+++++|++... ..+. ..+.+||
T Consensus 39 tPLh~A~~~g~~e~vk~Ll~~gadv----------n~~d~~g~TpLh~A~~~g~~~~v~~Ll~~~~-~~~~--~~~~~~l 105 (477)
T PHA02878 39 IPLHQAVEARNLDVVKSLLTRGHNV----------NQPDHRDLTPLHIICKEPNKLGMKEMIRSIN-KCSV--FYTLVAI 105 (477)
T ss_pred chHHHHHHcCCHHHHHHHHHCCCCC----------CCCCCCCCCHHHHHHHCccHhHHHHHHHHHh-cccc--ccchhhH
Confidence 6899999999999999999998875 4678899999999999999999999998642 2222 5678999
Q ss_pred HHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCC-CCChhhhhhhcCCh
Q 000343 550 VFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG--QPDCMRELLLAGADPNAVDDE-GESVLHRAVAKKYT 626 (1630)
Q Consensus 550 h~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G--~~eivk~LL~~GADvn~~D~~-G~TPLH~Aa~~g~~ 626 (1630)
+.|+..++.+++++|+..+++.+... ....+..+...+ +.+++++|+++|||+|..|.+ |.||||+|+..|+.
T Consensus 106 ~~a~~~~~~ei~~~Ll~~~~~~~~~~----~~~~~~~~~~~~~~~~~iv~~Ll~~gadin~~~~~~g~tpLh~A~~~~~~ 181 (477)
T PHA02878 106 KDAFNNRNVEIFKIILTNRYKNIQTI----DLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKGNTALHYATENKDQ 181 (477)
T ss_pred HHHHHcCCHHHHHHHHhCcccCcccC----cHHHHhhccchhhHHHHHHHHHHHcCCCCCccCCCCCCCHHHHHHhCCCH
Confidence 99999999999999998876543211 111111111222 345999999999999999998 99999999999999
Q ss_pred HHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHH
Q 000343 627 DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706 (1630)
Q Consensus 627 eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~e 706 (1630)
+++++|++.|+ +++..|..|.||||+|+..++ .+
T Consensus 182 ~iv~~Ll~~ga--d~n~~d~~g~tpLh~A~~~~~--------------------------------------------~~ 215 (477)
T PHA02878 182 RLTELLLSYGA--NVNIPDKTNNSPLHHAVKHYN--------------------------------------------KP 215 (477)
T ss_pred HHHHHHHHCCC--CCCCcCCCCCCHHHHHHHhCC--------------------------------------------HH
Confidence 99999999997 677888999999999987654 35
Q ss_pred HHHHHHhcCCCCCcccccCccchhhhhhc-CCHHHHHHHHHCCCCcccccC-CCCCHHHHHHHcCCHHHHHHHHhCCCCC
Q 000343 707 LVRILLTAGAEPTAQDAQNRTALHIASMA-NDVELVKIILDAGVDVNIRNV-HNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 707 iVklLL~~GAdvn~~D~~G~TpLH~Aa~~-g~~eiVklLL~~GADvN~~d~-~G~TPLH~Aa~~G~~eiVklLLe~GADi 784 (1630)
++++|+++|+++|.+|..|.||||+|+.. ++.+++++|+++|+|+|.++. .|.||||+| .++.+++++|+++|||+
T Consensus 216 iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~TpLh~A--~~~~~~v~~Ll~~gadi 293 (477)
T PHA02878 216 IVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSS--IKSERKLKLLLEYGADI 293 (477)
T ss_pred HHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCCCHHHHH--ccCHHHHHHHHHCCCCC
Confidence 66777888999999999999999999975 799999999999999999986 799999999 56789999999999999
Q ss_pred CcCCCCCCcHHHHHHHhchHHHhhHHHH-HHHhhCCCCcccccCCCCCCHH
Q 000343 785 NWQDDEGDNAFHIAADAAKMIRENLEWL-IVMLSHPDAAVEVRNHSGKTLR 834 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa~~g~~i~~n~e~v-i~LL~~~gadvn~~n~~G~TpL 834 (1630)
|.+|.+|+||||+|+..+... +..+.+ ...+....++.+++|..|.++-
T Consensus 294 n~~d~~g~TpL~~A~~~~~~~-~~~~~li~~~~~~~~~~~~~~~~~g~~~n 343 (477)
T PHA02878 294 NSLNSYKLTPLSSAVKQYLCI-NIGRILISNICLLKRIKPDIKNSEGFIDN 343 (477)
T ss_pred CCcCCCCCCHHHHHHHHcCcc-chHHHHHHHHHHHHhccCcccCcHHHHHH
Confidence 999999999999998743210 111111 2223344567888888887653
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=379.15 Aligned_cols=301 Identities=17% Similarity=0.183 Sum_probs=245.6
Q ss_pred cchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHH
Q 000343 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVF 551 (1630)
Q Consensus 472 Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~ 551 (1630)
|..+....+.+.+...++.-... ....+..+..+.||||+||..|+.++|++||+. ++++|..|.+|.||||+
T Consensus 4 ~~~~~~~~~~~~i~~~i~~~~~~------~~~~~~~~~~~~tPLh~A~~~g~~e~vk~Ll~~-gadvn~~d~~g~TpLh~ 76 (477)
T PHA02878 4 LYKSMYTDNYETILKYIEYIDHT------ENYSTSASLIPFIPLHQAVEARNLDVVKSLLTR-GHNVNQPDHRDLTPLHI 76 (477)
T ss_pred HHHHHHhccHHHHHHHHHHHhhh------hhhcCcccccCcchHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCCCHHHH
Confidence 44555566655555555441110 111233456789999999999999999999995 68999999999999999
Q ss_pred HHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC--ChHHH
Q 000343 552 ALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK--YTDCA 629 (1630)
Q Consensus 552 Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g--~~eiv 629 (1630)
||..|+.+++++|++.+++.+. ..+.++|+.|+..++.+++++|+.++++.+.... ...+..+...+ +.+++
T Consensus 77 A~~~g~~~~v~~Ll~~~~~~~~----~~~~~~l~~a~~~~~~ei~~~Ll~~~~~~~~~~~--~~~~~~~~~~~~~~~~iv 150 (477)
T PHA02878 77 ICKEPNKLGMKEMIRSINKCSV----FYTLVAIKDAFNNRNVEIFKIILTNRYKNIQTID--LVYIDKKSKDDIIEAEIT 150 (477)
T ss_pred HHHCccHhHHHHHHHHHhcccc----ccchhhHHHHHHcCCHHHHHHHHhCcccCcccCc--HHHHhhccchhhHHHHHH
Confidence 9999999999999999876543 4567899999999999999999998765432111 11122222222 34599
Q ss_pred HHHHHcCCccccccccCC-CCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHH
Q 000343 630 IVILENGGCRSMAILNSK-ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708 (1630)
Q Consensus 630 ~~LL~~Ga~~~i~~~d~~-G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiV 708 (1630)
++|+++|+ +++..+.. |.||||+|+..++. +++
T Consensus 151 ~~Ll~~ga--din~~~~~~g~tpLh~A~~~~~~--------------------------------------------~iv 184 (477)
T PHA02878 151 KLLLSYGA--DINMKDRHKGNTALHYATENKDQ--------------------------------------------RLT 184 (477)
T ss_pred HHHHHcCC--CCCccCCCCCCCHHHHHHhCCCH--------------------------------------------HHH
Confidence 99999997 67788888 99999999876543 566
Q ss_pred HHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHc-CCHHHHHHHHhCCCCCCcC
Q 000343 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR-GAKSCVGLLLSAGADCNWQ 787 (1630)
Q Consensus 709 klLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~-G~~eiVklLLe~GADiN~~ 787 (1630)
++|+++|+++|.+|..|.||||+|+..++.+++++|+++|+++|.+|..|.||||+|+.. ++.+++++|+++|+|+|.+
T Consensus 185 ~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~ 264 (477)
T PHA02878 185 ELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAK 264 (477)
T ss_pred HHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCcc
Confidence 777888999999999999999999999999999999999999999999999999999976 7899999999999999999
Q ss_pred CC-CCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhh
Q 000343 788 DD-EGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEG 839 (1630)
Q Consensus 788 D~-~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~ 839 (1630)
+. .|.||||+|+.. ..++.+|+.+|||+|+.|.+|.|||++|..
T Consensus 265 ~~~~g~TpLh~A~~~--------~~~v~~Ll~~gadin~~d~~g~TpL~~A~~ 309 (477)
T PHA02878 265 SYILGLTALHSSIKS--------ERKLKLLLEYGADINSLNSYKLTPLSSAVK 309 (477)
T ss_pred CCCCCCCHHHHHccC--------HHHHHHHHHCCCCCCCcCCCCCCHHHHHHH
Confidence 86 899999999532 246788889999999999999999999976
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=354.71 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=208.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+ +.++.+++.||+|++..... .....+.+|+.+++.++ ||||++++++|...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK--QENIVELKEAFRRR 72 (287)
T ss_pred CCceEEEEecccCCEEEEE------EEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC--CccccchhhhEecC
Confidence 4799999999999888754 66778899999999886532 23456778999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+.++++..+......+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++..+..
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99999999999999888776666799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. ........||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..
T Consensus 153 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 153 GS-------------NANYTEYVATRWYRSPELLLGAP------------YGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred cc-------------cccccccccccccCCcHHHcCCC------------CCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 21 01122356899999999987644 789999999999999999999999887665
Q ss_pred HHHHHHHhcCCCC-------------------CCcc------cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLP-------------------PQYA------SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~-------------------~~~~------~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+....... +... ......++.++.+||++||+.||++|||++++++|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred HHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 4433332211000 0000 001123678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=364.44 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=206.2
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||||++..... .....+.+|+.+|+.+. ||||++++++|.....+||
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVIL------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR--HPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCCEEEEEEcCCEEEE
Confidence 4689999888865 56778899999999986532 22345667888888875 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+.+++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 149 (323)
T cd05571 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence 99999999888888777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+....+..
T Consensus 150 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~ 206 (323)
T cd05571 150 -----------ATMKTFCGTPEYLAPEVLEDND------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (323)
T ss_pred -----------CcccceecCccccChhhhcCCC------------CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 1123456899999999987654 78999999999999999999999998888777776
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
+....... +..+++++.+||.+||+.||++|| ++.++++|-+
T Consensus 207 ~~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 207 ILMEEIRF-------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHcCCCCC-------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 65543222 235789999999999999999999 7999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=354.85 Aligned_cols=267 Identities=21% Similarity=0.274 Sum_probs=221.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+.|++++.||.|.-|+||| +..+.++..+|+|++.+.... ...+++.|.+||..+. ||++++||..|+.
T Consensus 77 ~~f~llk~LG~GdiG~VyL------~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD--HPFlPTLYa~fet 148 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYL------VELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD--HPFLPTLYASFET 148 (459)
T ss_pred HHHHHHHHcCCCCceeEEE------EEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC--CCccchhhheeec
Confidence 5899999999999888877 567778899999999887433 3556677999999976 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+.+.||+||||+||+|..+.+++ +.|+++.++.|+.+++.||+|||-+|||+|||||+||||-++|++.|+||-|+..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999998887654 4699999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccC---------C-------CCCC-------C-C------------------CCcccccccccCCCCCCCccccc
Q 000343 291 LKKPACRK---------A-------RPEC-------D-S------------------SRIHSCMDCTMLSPNYTAPEAWE 328 (1630)
Q Consensus 291 ~~~~~~~~---------~-------~~~~-------~-~------------------~~~~~~~~~~~GT~~Y~APEvl~ 328 (1630)
.....+.. . +..| . . -.........+||-.|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 53211000 0 0000 0 0 00012234678999999999999
Q ss_pred cccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHh
Q 000343 329 PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGEC 408 (1630)
Q Consensus 329 ~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~c 408 (1630)
+.. .+.++|+|+|||+||||+.|..||.+.+..+.+.+|+......+... .++..+++||+++
T Consensus 309 G~G------------HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-----~vs~~akDLIr~L 371 (459)
T KOG0610|consen 309 GEG------------HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-----EVSSAAKDLIRKL 371 (459)
T ss_pred cCC------------CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-----cchhHHHHHHHHH
Confidence 864 78999999999999999999999999999999999988765555432 5678999999999
Q ss_pred hccCcCCCCC----hhhHHHHhh
Q 000343 409 LQFKASKRPT----FSAMLATFL 427 (1630)
Q Consensus 409 L~~dP~~RPS----a~evL~~L~ 427 (1630)
|..||++|.. ++||-+|-+
T Consensus 372 LvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hccChhhhhccccchHHhhcCcc
Confidence 9999999998 888888743
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=357.15 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=205.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.++||+|+||.||+ +.+..+++.||||++...... ....+.+|+.+++.++ ||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 75 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYK------GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK--HANIVLLHDIIHTK 75 (303)
T ss_pred cccceEeeeEEecCCEEEEE------EEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC--CCCcCeEEEEEecC
Confidence 46899999999999888764 667788999999998765332 2345678999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
...++||||+.++++..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 76 ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99999999999888887776667799999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA- 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~- 372 (1630)
.. .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+...
T Consensus 156 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 156 PS--------------HTYSNEVVTLWYRPPDVLLGST-----------EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CC--------------ccCCCCcccCCCCChHHHcCCC-----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 11 1122356799999999986533 278899999999999999999999987533
Q ss_pred HHHHHHHHhcCCCCC----------------Cccc---------ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPP----------------QYAS---------IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~----------------~~~~---------~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+.+..+......+. .+.. ......++++.+|+.+||+.||++|||+.++++|-+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 233333222110000 0000 001124578899999999999999999999999844
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=351.95 Aligned_cols=258 Identities=25% Similarity=0.339 Sum_probs=216.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCC-cceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRN-VCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpN-IV~l~~~f~ 211 (1630)
...|+.+++||+|+||.| |+|+++.+|+.||+|++...... .+....+|+.+|+.++ |+| |+.|++++.
T Consensus 10 ~~~~~~~eklGeGtyg~V------ykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~--~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVV------YKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS--HANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHHhCCCCceEE------EEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC--CCcceEEEEeeee
Confidence 347888999999996655 56889999999999999987553 4678889999999987 898 999999998
Q ss_pred eCC------EEEEEEecCCCChHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEE
Q 000343 212 MDS------CLGLVMDRCYGSVQLAMQRNE---GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 212 ~~~------~~~LVmEy~~gglL~~l~~~~---~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL 282 (1630)
+.+ .++|||||++.++-.++.... ..++...++.+++||+.||+|||+++|+||||||+||||+++|.+||
T Consensus 82 ~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred ecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEee
Confidence 877 899999999998887776654 35888999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+|+.+.-+ ....+..++|..|+|||++.+... |++..||||+|||++||++
T Consensus 162 aDFGlAra~~ip--------------~~~yt~evvTlWYRaPEvLlGs~~-----------Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 162 ADFGLARAFSIP--------------MRTYTPEVVTLWYRAPEVLLGSTS-----------YSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred eccchHHHhcCC--------------cccccccEEEeeccCHHHhcCCCc-----------CCCCcchHhHHHHHHHHHh
Confidence 999999865422 122455678999999999998752 9999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCC--Cc---------c----ccc--------CCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPP--QY---------A----SIV--------GVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~--~~---------~----~~~--------~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
++..|.+.++.++...|.+.-.+|. .+ . ... .+..+++..+++.+||+++|.+|.|+
T Consensus 217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa 296 (323)
T KOG0594|consen 217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA 296 (323)
T ss_pred CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH
Confidence 9999999999888888876543331 11 0 000 11233589999999999999999999
Q ss_pred hhHHHH
Q 000343 420 SAMLAT 425 (1630)
Q Consensus 420 ~evL~~ 425 (1630)
..+|.|
T Consensus 297 ~~al~h 302 (323)
T KOG0594|consen 297 KGALTH 302 (323)
T ss_pred HHHhcC
Confidence 999998
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=351.72 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=208.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC--
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD-- 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~-- 213 (1630)
-.|+-.+.+|.|+||.||. |....+++.||||++-..... -.+|+++|+.+. |||||+|.-+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq------~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~--HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQ------AKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLD--HPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEeeEEEeecccceEEE------EEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcC--CcCeeeEEEEEEecCC
Confidence 4789999999999998854 556677999999998865443 357999999765 99999999998753
Q ss_pred C---EEEEEEecCCCChHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecc
Q 000343 214 S---CLGLVMDRCYGSVQLAMQR---NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYG 286 (1630)
Q Consensus 214 ~---~~~LVmEy~~gglL~~l~~---~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFG 286 (1630)
. ++.|||||++.++...+.. .+.+++.-.++.|+.||.+||+|||+.||+||||||+|+|+|.+ |.+||||||
T Consensus 92 ~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred CchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 2 4679999999998877653 35579999999999999999999999999999999999999966 899999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
.|+.+..+. .......|..|+|||++.+... |+.+.||||.||++.||+-|++-
T Consensus 172 SAK~L~~~e---------------pniSYicSRyYRaPELifga~~-----------Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 172 SAKVLVKGE---------------PNISYICSRYYRAPELIFGATE-----------YTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred cceeeccCC---------------CceeEEEeccccCHHHHcCccc-----------cCceeEEhhhhHHHHHHhcCCcc
Confidence 999876432 1233456999999999998762 99999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCC-----------------C-----cccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHH
Q 000343 367 WAGLSAEEIYRAVVKNRKLPP-----------------Q-----YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~-----------------~-----~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~ 424 (1630)
|.+.+..+++..|.+--..|. . +........++++.+|+.++|+++|.+|.++.|++.
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 999988777766665332221 1 111133467899999999999999999999999999
Q ss_pred Hhh
Q 000343 425 TFL 427 (1630)
Q Consensus 425 ~L~ 427 (1630)
|-+
T Consensus 306 h~f 308 (364)
T KOG0658|consen 306 HPF 308 (364)
T ss_pred chh
Confidence 843
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=362.09 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=213.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ |.+..+++.||||++..... .....+.+|++++..++ ||||+++++++..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~ 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFL------AKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQD 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEE------EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC--CCCCccEEEEEEc
Confidence 4799999999999888754 66778899999999986532 23455778999988875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+||||||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999999999888777789999999999999999999999999999999999999999999999999987543
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.
T Consensus 153 ~-----------------~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 153 T-----------------YANSVVGSPDYMAPEVLRGKG------------YDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred c-----------------ccCCcccCccccChhHhcCCC------------CCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 2 123456899999999987654 78999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCcc-cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYA-SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~-~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+.+..+........... ......+++++.+||.+||..+|.+||++.++++|.+
T Consensus 204 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 204 NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred HHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 877776654332111110 0011256899999999999999999999999999844
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.65 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=219.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCCh---hHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEP---DWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~---~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
-.++|+.++.||+|+||+|-| ++.+.+++.+|||++++.-.... ..-..|-++|+..+ ||++..|...|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL------~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~--HPFLt~LKYsF 237 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVIL------CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR--HPFLTSLKYSF 237 (516)
T ss_pred ccchhhHHHHhcCCccceEEE------EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc--CcHHHHhhhhh
Confidence 457999999999999999876 66889999999999987633332 23345777887765 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
++.+.+|+||||++||.|+.++.+...+++..++.|-.+|+.||.|||+++||+||||.+|.|+|.+|++||+|||+++.
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999999999988888899999999999999999999999999999999999999999999999999974
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
--. ....+...||||.|+|||++.... |+.++|+|.+|++||||+.|+.||...
T Consensus 318 ~I~--------------~g~t~kTFCGTPEYLAPEVleDnD------------YgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 318 EIK--------------YGDTTKTFCGTPEYLAPEVLEDND------------YGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ccc--------------ccceeccccCChhhcCchhhcccc------------ccceeehhhhhHHHHHHHhccCccccc
Confidence 221 123456789999999999998654 899999999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATF 426 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L 426 (1630)
+...++..|+......|. .++++++.|+..+|..||.+|.. +.|+..|-
T Consensus 372 dh~kLFeLIl~ed~kFPr-------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFPR-------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred chhHHHHHHHhhhccCCc-------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 999999998877655443 58899999999999999999974 67777763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=362.83 Aligned_cols=265 Identities=25% Similarity=0.322 Sum_probs=205.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
++|++.++||+|+||.||.. ..+......+++.||+|++...... ....+.+|+.+|..+. +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~-~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEA-SAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-NHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEE-EEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-cCcceeeEEeEecCCC
Confidence 58999999999999999652 1122223456788999998754322 2456788999999984 599999999988764
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------------------------------------------------
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE---------------------------------------------------------- 235 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~---------------------------------------------------------- 235 (1630)
..++++|||+++++|..++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999998887766431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccc
Q 000343 236 ----GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311 (1630)
Q Consensus 236 ----~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 311 (1630)
.++++.++..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.+.... ....
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------~~~~ 232 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------DYVR 232 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------chhc
Confidence 247888999999999999999999999999999999999999999999999997653221 0011
Q ss_pred cccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcc
Q 000343 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYA 390 (1630)
Q Consensus 312 ~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~ 390 (1630)
.....+++.|+|||++.+.. ++.++|||||||+||||++ |..||.+....+.+.........+.
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~------------~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 297 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKV------------YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--- 297 (338)
T ss_pred ccCCCCCccccCcHHhhcCC------------CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---
Confidence 12234578899999987644 7899999999999999997 9999987654333333332222111
Q ss_pred cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 391 SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 391 ~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.+..+++++.+|+.+||+.||++|||+.++++.|...+.
T Consensus 298 --~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 --APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123578899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=364.30 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=218.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
...|+..+.||+|+||.| |+|.+..+++.||||++...... +.+.+++|+.+|..++ +|||.++|+.|..+
T Consensus 12 ~~~~~~~~~IgrGsfG~V------yk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~--~~~it~yygsyl~g 83 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEV------YKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD--SPNITEYYGSYLKG 83 (467)
T ss_pred ccccccchhcccccccee------eeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC--cchHHhhhhheeec
Confidence 357888899999998776 45889999999999999987544 3577889999999986 89999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..++++||||.||.+..+++....+++..+..++++++.||.|||+++.||||||+.|||+..+|.+||+|||.+..+..
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999999998888777779999999999999999999999999999999999999999999999999987764
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .....++||+.|||||++.+.. |+.++||||||++.|||++|.+|+.+..++
T Consensus 164 ~~--------------~rr~tfvGTPfwMAPEVI~~~~------------Y~~KADIWSLGITaiEla~GePP~s~~hPm 217 (467)
T KOG0201|consen 164 TV--------------KRRKTFVGTPFWMAPEVIKQSG------------YDTKADIWSLGITAIELAKGEPPHSKLHPM 217 (467)
T ss_pred hh--------------hccccccccccccchhhhcccc------------ccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence 32 1125678999999999998644 999999999999999999999999998886
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..|-+. .||.+ ...+++.+++||..||+.||+.||||.++|+|-+
T Consensus 218 rvlflIpk~--~PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 218 RVLFLIPKS--APPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred eEEEeccCC--CCCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 554444332 23332 2368899999999999999999999999999844
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=365.49 Aligned_cols=268 Identities=24% Similarity=0.296 Sum_probs=213.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++++.||+|+||.||+ +.+..+++.||||++..... .....+.+|+.+|..+. ||||++++++|.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~ 72 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRL------VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD--NPWVVKLYYSFQD 72 (364)
T ss_pred CCceEEEEEEecCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEc
Confidence 4799999999999888865 66788899999999986432 22345678999999875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+||||||+.+++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 73 ~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999999998888777789999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCC------------------------CCcccccccccCCCCCCCccccccccccccccccCcCCCCccc
Q 000343 293 KPACRKARPECDS------------------------SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348 (1630)
Q Consensus 293 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ks 348 (1630)
............. ..........+||+.|+|||++.+.. ++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~ 220 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG------------YNKEC 220 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC------------CCCee
Confidence 3211000000000 00000112356999999999987644 78999
Q ss_pred cchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC---hhhHHHH
Q 000343 349 DAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT---FSAMLAT 425 (1630)
Q Consensus 349 DIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS---a~evL~~ 425 (1630)
|||||||++|||++|..||...+..+.+..+.......... ....+++++.+||.+||. +|.+|++ +.++++|
T Consensus 221 DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 221 DWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFP---DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred eeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCC---CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999988887777776543222111 122478999999999997 9999998 9999988
Q ss_pred hh
Q 000343 426 FL 427 (1630)
Q Consensus 426 L~ 427 (1630)
-+
T Consensus 297 ~~ 298 (364)
T cd05599 297 PF 298 (364)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=362.30 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=210.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccC-CcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC-RHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~-g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
++|++.+.||+|+||.||+ |.+..+ +..||+|.+.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~------a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVIL------ATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN--HPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEE------EEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCCcceEEEEE
Confidence 5899999999999998865 333333 4689999987643 223456778999999875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+...+|+||||+.+++|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999988888877778999999999999999999999999999999999999999999999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+
T Consensus 182 ~~~-----------------~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 182 DTR-----------------TYTLCGTPEYIAPEILLNVG------------HGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCC-----------------cceecCChhhcCHHHHhCCC------------CCccccccchhhHHHHHhcCCCCCCCCC
Confidence 321 12356899999999987644 7899999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
....+..+..+.... +..+++++.++|.+||+.||.+|+ +++++++|.+
T Consensus 233 ~~~~~~~i~~~~~~~-------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 233 PLLIYQKILEGIIYF-------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred HHHHHHHHhcCCCCC-------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 887788877654332 234788999999999999999995 8999988843
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=364.11 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=210.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++++.||+|+||.||+ +.+..+++.||||++..... .....+.+|+.++..++ ||||+++++.|++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~--~~~iv~~~~~~~~ 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRL------VQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD--SLWVVKMFYSFQD 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEE------EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC--CCCcceEEEEEec
Confidence 4799999999999998865 56778899999999976432 22346778899988875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|||||||+|+.|..++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999999988888777889999999999999999999999999999999999999999999999999997653
Q ss_pred CccccCCC-------CC-----C-------C--CCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 293 KPACRKAR-------PE-----C-------D--SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 293 ~~~~~~~~-------~~-----~-------~--~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
........ +. . . ...........+||+.|+|||++.+.. ++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------------~~~~~Dvw 220 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG------------YNKLCDWW 220 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC------------CCCchhhh
Confidence 21100000 00 0 0 000001123457999999999987654 78999999
Q ss_pred hhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcC---CCCChhhHHHHh
Q 000343 352 SFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS---KRPTFSAMLATF 426 (1630)
Q Consensus 352 SlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~---~RPSa~evL~~L 426 (1630)
||||++|||++|..||.+.+..+.+..+......... .. ...+++++++||.+|+. +|. .||+++|+++|-
T Consensus 221 SlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-p~--~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 221 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF-PP--EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccC-CC--cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCC
Confidence 9999999999999999998888888877654322111 11 12368899999999775 444 468999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=358.24 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=215.3
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEe
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD 221 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmE 221 (1630)
-.||+|+||+| |-|+|..|....|||.|........+.+..||.+.++++ |.|||++++.+..++++-|.||
T Consensus 581 vVLGKGTYG~V------YA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr--HkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 581 VVLGKGTYGTV------YAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR--HKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EEeecCceeEE------EeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh--hHhHHHHhhccCCCCeEEEEee
Confidence 46999996665 458999999999999999887777888889999999876 9999999999999999999999
Q ss_pred cCCCChHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC-CCCcEEEeecceeeeecCcccc
Q 000343 222 RCYGSVQLAMQRNE-GRL--TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD-ASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 222 y~~gglL~~l~~~~-~~L--~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld-~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
.++||+|..+++.. ++| .+.++-+|.+||++||.|||++.|||||||-+|+|++ -.|.+||+|||.++.+..
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg---- 728 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG---- 728 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc----
Confidence 99999999887653 567 8999999999999999999999999999999999997 568999999999987642
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC-CHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-SAEEIY 376 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-~~~ei~ 376 (1630)
...++.++.||..|||||++..+. .+|++++|||||||++.||.||++||... ++...+
T Consensus 729 ----------inP~TETFTGTLQYMAPEvIDqG~----------RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 729 ----------INPCTETFTGTLQYMAPEVIDQGP----------RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred ----------CCccccccccchhhhChHhhccCC----------cCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 345677889999999999998765 35999999999999999999999999754 344444
Q ss_pred HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 377 RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 377 ~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.++-.-+.-|+ ++..++.+++.||.+|+.+||.+||++.++|.+-+....
T Consensus 789 FkVGmyKvHP~-----iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 789 FKVGMYKVHPP-----IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhcceecCCC-----CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 44433222222 345688999999999999999999999999998665554
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=357.06 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=205.0
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|++..... .....+.+|+++|+.+. ||||+++++++.....+|+
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR--HPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceEEEEEcCCEEEE
Confidence 4689999888865 66788899999999986532 23445677888888865 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||++++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 v~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--- 149 (328)
T cd05593 73 VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--- 149 (328)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---
Confidence 99999999888877777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....
T Consensus 150 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 150 -----------ATMKTFCGTPEYLAPEVLEDND------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred -----------cccccccCCcCccChhhhcCCC------------CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 1123356899999999987654 78999999999999999999999998887777666
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
+...... .+..+++++.+||.+||+.||++|+ ++.++++|.+
T Consensus 207 ~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 207 ILMEDIK-------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred hccCCcc-------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 6544322 2235789999999999999999997 8999998843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=356.74 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=208.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+|++++.||+|+||.||+ |.+..+++.||||.+.+.. ....+.+..|++++..+. +|++|++++++|...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVML------AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC-CCCceeeeEEEEEcC
Confidence 589999999999888865 6677888999999998642 223455677888888875 456799999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+.+|+||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999998888887777899999999999999999999999999999999999999999999999999864321
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..
T Consensus 154 ~~--------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 154 GG--------------KTTRTFCGTPDYIAPEIIAYQP------------YGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred CC--------------CceeeecCCccccChhhhcCCC------------CCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 10 1123456899999999987654 789999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-----hhHHHH
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF-----SAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-----~evL~~ 425 (1630)
+.+..+....... +..+++++.+|+.+||..||.+|+++ .++++|
T Consensus 208 ~~~~~i~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 208 ELFQSIMEHNVSY-------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHcCCCCC-------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 8888776544322 23578999999999999999999987 566665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=370.84 Aligned_cols=268 Identities=18% Similarity=0.184 Sum_probs=202.6
Q ss_pred cCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHc--CCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC------C
Q 000343 521 RGSAELVEAILEYSQENVDVLDKDGDPPLVFALAA--GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG------Q 592 (1630)
Q Consensus 521 ~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~--G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G------~ 592 (1630)
..+.++|++||+. |+++|.. .+|.||||+++.. ++.++|++||++||++|.. +.+.||||.|+.++ +
T Consensus 13 ~~~~~~v~~LL~~-GadvN~~-~~g~t~l~~~~~~~~~~~~iv~~Ll~~GAdvn~~---~~~~tpL~~a~~~~~~~~~~~ 87 (494)
T PHA02989 13 TVDKNALEFLLRT-GFDVNEE-YRGNSILLLYLKRKDVKIKIVKLLIDNGADVNYK---GYIETPLCAVLRNREITSNKI 87 (494)
T ss_pred cCcHHHHHHHHHc-CCCcccc-cCCCCHHHHHHhcCCCChHHHHHHHHcCCCccCC---CCCCCcHHHHHhccCcchhhH
Confidence 4789999999985 6899998 6799999876654 3789999999999999875 24689999998754 4
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCChhhhhhhc---CChHHHHHHHHcCCcccc-ccccCCCCcHHHHHHHc--CCHHHHHH
Q 000343 593 PDCMRELLLAGADPNAVDDEGESVLHRAVAK---KYTDCAIVILENGGCRSM-AILNSKELTPLHLCVAT--WNVAVVKR 666 (1630)
Q Consensus 593 ~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~---g~~eiv~~LL~~Ga~~~i-~~~d~~G~TPLh~Aa~~--g~~eivk~ 666 (1630)
.+++++|+++|||+|.+|.+|.||||.|+.. ++.+++++|+++|+ ++ +..|..|.||||+|+.. ++.+++++
T Consensus 88 ~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Ga--din~~~d~~g~tpLh~a~~~~~~~~~iv~~ 165 (494)
T PHA02989 88 KKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGI--NVNDVKNSRGYNLLHMYLESFSVKKDVIKI 165 (494)
T ss_pred HHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCC--CcccccCCCCCCHHHHHHHhccCCHHHHHH
Confidence 7899999999999999999999999988755 68999999999998 66 67889999999998754 46777777
Q ss_pred HHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhc------CCHHH
Q 000343 667 WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMA------NDVEL 740 (1630)
Q Consensus 667 LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~------g~~ei 740 (1630)
|++.|++.... . .....++++.++. .+...++.+++++|+++|+++|.+|..+.||||.|+.. +..++
T Consensus 166 Ll~~Gadi~~~--~--~~~g~tpL~~a~~--~~~~~~~~~iv~~Ll~~Ga~vn~~~~~~~t~l~~~~~~~~~~~~~~~~i 239 (494)
T PHA02989 166 LLSFGVNLFEK--T--SLYGLTPMNIYLR--NDIDVISIKVIKYLIKKGVNIETNNNGSESVLESFLDNNKILSKKEFKV 239 (494)
T ss_pred HHHcCCCcccc--c--cccCCChHHHHHh--cccccccHHHHHHHHhCCCCccccCCccccHHHHHHHhchhhcccchHH
Confidence 77777643211 1 1123455555433 22233456777777777777777777777777766543 34566
Q ss_pred HHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhc
Q 000343 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAA 802 (1630)
Q Consensus 741 VklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g 802 (1630)
+++|+. |||+|.+|..|+||||+|+..|+.+++++||++|||+|.+|..|+||||+|+..+
T Consensus 240 l~~l~~-~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~Gadin~~d~~G~TpL~~A~~~~ 300 (494)
T PHA02989 240 LNFILK-YIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLGDDIYNVSKDGDTVLTYAIKHG 300 (494)
T ss_pred HHHHHh-CCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcC
Confidence 665544 5777777777777777777777777777777777777777777777777777654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=356.45 Aligned_cols=243 Identities=22% Similarity=0.304 Sum_probs=203.7
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||+|+||.||+ +.+..+++.||+|.+.... ......+.+|+.+|+.++ ||||++++++|.....+|+||
T Consensus 1 lg~G~~g~Vy~------~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQ------VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CPFIVPLKFSFQSPEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCcEeceeeEEecCCeEEEEE
Confidence 69999888754 6677889999999987642 223455677889988875 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||++++.|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----- 147 (312)
T cd05585 73 AFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----- 147 (312)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-----
Confidence 999999988887777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~ 380 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 148 ---------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 148 ---------DKTNTFCGTPEYLAPELLLGHG------------YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred ---------CccccccCCcccCCHHHHcCCC------------CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 1123456899999999987654 7899999999999999999999999888888877776
Q ss_pred hcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC---hhhHHHHhh
Q 000343 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT---FSAMLATFL 427 (1630)
Q Consensus 381 ~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS---a~evL~~L~ 427 (1630)
..... .+..+++++.+||.+||+.||.+||+ +.++++|.+
T Consensus 207 ~~~~~-------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 207 QEPLR-------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred cCCCC-------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 54322 22357899999999999999999975 677777743
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=390.52 Aligned_cols=359 Identities=27% Similarity=0.344 Sum_probs=255.5
Q ss_pred CCCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCC
Q 000343 468 NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDP 547 (1630)
Q Consensus 468 ~~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~T 547 (1630)
.-++||.|++.|+++.+..|+..++..+ ..+..|.||||.||..+..+++++|++. +++++..+.+..|
T Consensus 242 gl~~lh~a~~~g~~~i~~~l~~~ga~~~----------~~~vr~~tplh~AA~~~~~e~~~~ll~~-ga~~~~~~~~~kt 310 (1143)
T KOG4177|consen 242 GLTPLHVAAFMGHLDIVKLLLQHGASVN----------VSTVRGETPLHMAARAGQVEVCKLLLQN-GADVLAKARDDQT 310 (1143)
T ss_pred CccHHHHHHhccchhHHHHHHhcccccC----------cccccccCcchhhhccchhhhHhhhhcc-CcccccccccccC
Confidence 3578999999999999999999998874 5678899999999999999999999884 5778888888888
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCccccccc-------------------------------CCCchHHHHHHHcCCHHHH
Q 000343 548 PLVFALAAGSPECVHALIKRGANVISRLRE-------------------------------GFGPSVAHVCAYHGQPDCM 596 (1630)
Q Consensus 548 PLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d-------------------------------~~g~T~Lh~Aa~~G~~eiv 596 (1630)
|||.|...|+.++++++++.++.+++..++ ..+.+|+|+|+..|..+++
T Consensus 311 ~l~~a~~~g~~~i~~~~l~~~~~~~aar~~g~t~lHlaa~~~~~~~~~~l~~~~~~~~~a~~k~~~pl~la~~~g~~~~v 390 (1143)
T KOG4177|consen 311 PLHIASRLGHEEIVHLLLQAGATPNAARTAGYTPLHLAAKEGQVEVAGALLEHGAQRRQAEEKGFTPLHLAVKSGRVSVV 390 (1143)
T ss_pred hhhhhcccchHHHHHHHhhccCCccccCcCCcccccHhhhhhhHHHHHHhhccccccCcccccCCcchhhhcccCchhHH
Confidence 888888888888888888888877654322 1233444444444555555
Q ss_pred HHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcC-CHHHHHHHHHhcCccc
Q 000343 597 RELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATW-NVAVVKRWVEVASPEE 675 (1630)
Q Consensus 597 k~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g-~~eivk~LLe~ga~~~ 675 (1630)
++|+.+|+++|..+..|.||||.|+..++..+++.++++|+ +.+..+..|.||+|+|+..+ ..+....+++++.+..
T Consensus 391 ~Lll~~ga~~~~~gk~gvTplh~aa~~~~~~~v~l~l~~gA--~~~~~~~lG~T~lhvaa~~g~~~~~~~~l~~~g~~~n 468 (1143)
T KOG4177|consen 391 ELLLEAGADPNSAGKNGVTPLHVAAHYGNPRVVKLLLKRGA--SPNAKAKLGYTPLHVAAKKGRYLQIARLLLQYGADPN 468 (1143)
T ss_pred HhhhhccCCcccCCCCCcceeeehhhccCcceEEEEeccCC--ChhhHhhcCCChhhhhhhcccHhhhhhhHhhcCCCcc
Confidence 55555555555555555555555555555555555555554 34444555555555555555 4444444444443221
Q ss_pred cccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCccccc
Q 000343 676 IVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN 755 (1630)
Q Consensus 676 ~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d 755 (1630)
. ... .+-|+++.++. .++.+++++|++.++..+.....|-|+||.|+..+...+++.|+++|++++.++
T Consensus 469 ~---~s~--~G~T~Lhlaaq------~Gh~~~~~llle~~~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~ 537 (1143)
T KOG4177|consen 469 A---VSK--QGFTPLHLAAQ------EGHTEVVQLLLEGGANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRT 537 (1143)
T ss_pred h---hcc--ccCcchhhhhc------cCCchHHHHhhhcCCccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhc
Confidence 1 111 11233333332 233455666666666666666666666666666666677777777889999999
Q ss_pred CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHH
Q 000343 756 VHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRD 835 (1630)
Q Consensus 756 ~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLd 835 (1630)
..|.||||.|+..|+.++|++||++|||+|++|+.|+||||.||+.|+ ..++.||.++||++|+.|.+|.|||+
T Consensus 538 ~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~------~~i~~LLlk~GA~vna~d~~g~TpL~ 611 (1143)
T KOG4177|consen 538 GRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGH------NDIAELLLKHGASVNAADLDGFTPLH 611 (1143)
T ss_pred ccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcCh------HHHHHHHHHcCCCCCcccccCcchhH
Confidence 999999999999999999999999999999999999999999998764 36788899999999999999999999
Q ss_pred HHhhCCCCCcHHHHHHHHHhcCCCC
Q 000343 836 FLEGLPREWISEDLMEALMNRGVHL 860 (1630)
Q Consensus 836 lA~~~~~~~~~~~lve~Ll~~Ga~l 860 (1630)
+|..+++ ..+++.|+..|+..
T Consensus 612 iA~~lg~----~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 612 IAVRLGY----LSVVKLLKVVTATP 632 (1143)
T ss_pred HHHHhcc----cchhhHHHhccCcc
Confidence 9998874 47788888888863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=349.78 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=201.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.|++.+.||+|+||.||+ +.+..+++.||+|.+...... ....+.+|+.++..+. ||||++++++|.+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~iv~~~~~~~~~ 72 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCA------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN--SRFVVSLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCEEEEE------EEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC--CCcEEEEEEEEccC
Confidence 388999999999888864 667788999999998764322 2345678999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+.+++||||++++++..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999999999998888765533 336899999999999999999999999999999999999999999999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....
T Consensus 153 ~~~~---------------~~~~~~g~~~y~aPE~~~~~~------------~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 153 PEGE---------------TVRGRVGTVGYMAPEVINNEK------------YTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred CCCC---------------eecCCCCCCCccCHhhhcCCC------------CCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 3211 112346899999999997654 7899999999999999999999998754
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L 426 (1630)
.......+........ ...+..+++++.+|+.+||+.||.+||+ ++++++|-
T Consensus 206 ~~~~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 206 ERVKREEVDRRVKEDQ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred cchhHHHHHHHhhccc---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 4222222211111100 1123457899999999999999999997 78888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=356.23 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=207.3
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhc-cCCCCcceeEEEEEeC
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~ 213 (1630)
|++++.||+|+||.||+ +.+..+++.||||.++... ....+.+.+|++++..++ ++||||++++++|...
T Consensus 1 y~i~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLL------AEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 78899999999888864 5677889999999998653 223456777877776543 4699999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+.+++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999999988877654 5799999999999999999999999999999999999999999999999999864321
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..
T Consensus 154 ~--------------~~~~~~~~g~~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~G~~pf~~~~~~ 207 (324)
T cd05589 154 F--------------GDRTSTFCGTPEFLAPEVLTETS------------YTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207 (324)
T ss_pred C--------------CCcccccccCccccCHhHhcCCC------------CCcccchhhHHHHHHHHHhCCCCCCCCCHH
Confidence 1 01123457899999999987644 789999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L 426 (1630)
+.+..+.......+ ..+++++.+||.+||+.||++|| ++.++++|.
T Consensus 208 ~~~~~i~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 208 EVFDSIVNDEVRYP-------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHHHHHHhCCCCCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 88877766543322 35789999999999999999999 567777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=355.88 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=208.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+|++.+.||+|+||.||+ +.+..+++.||||.+.+.... .......|..++..+. .||+|+++++++...
T Consensus 1 df~~~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVML------AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQLHSCFQTM 73 (323)
T ss_pred CceEEEEEeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCeEeeEEEEEecC
Confidence 589999999999888764 667788999999998865322 2334556777777664 589999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+.+|+||||++++.|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999988888777777899999999999999999999999999999999999999999999999999875332
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..
T Consensus 154 ~~--------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 154 DG--------------VTTKTFCGTPDYIAPEIIAYQP------------YGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred CC--------------CccccCCCChhhcCHHHhcCCC------------CCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 11 1123456899999999987654 789999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-----hhHHHH
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF-----SAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-----~evL~~ 425 (1630)
+++..+....... +..+++++.+|+.+||+.||++|+++ .++++|
T Consensus 208 ~~~~~i~~~~~~~-------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 208 ELFQSIMEHNVAY-------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHhCCCCC-------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 8888877654322 23578999999999999999999986 556555
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.68 Aligned_cols=243 Identities=21% Similarity=0.342 Sum_probs=209.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc---CcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|.+++.||+|+|++|.+ ++.+.|.+.+|+|+++++ +..+.+..+.|..++.+.+ +||++|.|+.+|++
T Consensus 250 ~df~ll~vigrgsyakvl~------~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-n~pflvglhscfqt 322 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLL------VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NNPFLVGLHSCFQT 322 (593)
T ss_pred ccceeeeeecCcchhhhhh------eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-CCCeEEehhhhhcc
Confidence 6999999999999888855 567889999999999876 3344677888999999987 79999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+.+++|.||++||+|..+.+++.+|+++.++.|..+|..||.|||++|||+||||.+|+|+|..|++||+|+|+++.--
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999998888888889999999999999999999999999999999999999999999999999997421
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC----
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA---- 368 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~---- 368 (1630)
.....+++.+|||.|.|||++.+.. |+.++|+|+||++||||+.|+.||.
T Consensus 403 --------------~~gd~tstfcgtpnyiapeilrgee------------ygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 403 --------------GPGDTTSTFCGTPNYIAPEILRGEE------------YGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred --------------CCCcccccccCCCcccchhhhcccc------------cCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 1223456789999999999999876 8999999999999999999999994
Q ss_pred ---CCC-HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC
Q 000343 369 ---GLS-AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418 (1630)
Q Consensus 369 ---~~~-~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS 418 (1630)
+.+ +..+++.|++.+...|. .++-.+..+++..|+.||.+|..
T Consensus 457 ~n~d~ntedylfqvilekqiripr-------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQIRIPR-------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred CCcccchhHHHHHHHhhhcccccc-------eeehhhHHHHHHhhcCCcHHhcC
Confidence 222 33456666665544333 46778899999999999999975
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=364.11 Aligned_cols=266 Identities=21% Similarity=0.221 Sum_probs=209.3
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+|+++++||+|+||.||+ +.+..+++.||+|++..... .....+.+|+.+++.+. ||||+++++.|.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~------a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~--h~~iv~~~~~~~~~ 73 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCL------ARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWVVRLYYSFQDK 73 (382)
T ss_pred CcEEEEEEEeCCCEEEEE------EEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC--CCcCCeEEEEEEeC
Confidence 699999999999888865 66778899999999886432 22456778999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|||||||+++.|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999988888777667899999999999999999999999999999999999999999999999999864321
Q ss_pred ccccCC-CC-------------------CC-------------CCCCcccccccccCCCCCCCccccccccccccccccC
Q 000343 294 PACRKA-RP-------------------EC-------------DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD 340 (1630)
Q Consensus 294 ~~~~~~-~~-------------------~~-------------~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~ 340 (1630)
...... .. .+ ............+||+.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--------- 224 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG--------- 224 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC---------
Confidence 000000 00 00 0000000112357999999999987654
Q ss_pred cCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC--
Q 000343 341 AIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-- 418 (1630)
Q Consensus 341 ~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-- 418 (1630)
++.++|||||||+||||++|++||...+..+....+......... .....+++++.+||.+|+ .+|.+|++
T Consensus 225 ---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 225 ---YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI---PPQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred ---CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC---CCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 789999999999999999999999988877766666543322211 112357899999999987 59999997
Q ss_pred -hhhHHHHh
Q 000343 419 -FSAMLATF 426 (1630)
Q Consensus 419 -a~evL~~L 426 (1630)
+.++++|-
T Consensus 298 ~~~ei~~hp 306 (382)
T cd05625 298 GADEIKAHP 306 (382)
T ss_pred CHHHHhcCC
Confidence 88888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=364.18 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=209.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++++.||+|+||.||+ +.+..+++.||||++..... .....+.+|+++++.+. ||||++++++|.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~ 72 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRL------VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--SPWVVSLYYSFQD 72 (377)
T ss_pred CCceEeEEEeecCCEEEEE------EEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC--CCCcceEEEEEEc
Confidence 4799999999999988865 56778899999999876432 22356778999998865 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++||||||+++++|..++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 73 AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999888887777789999999999999999999999999999999999999999999999999996432
Q ss_pred CccccC----------CCCCCCCCC-----------------------cccccccccCCCCCCCcccccccccccccccc
Q 000343 293 KPACRK----------ARPECDSSR-----------------------IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWD 339 (1630)
Q Consensus 293 ~~~~~~----------~~~~~~~~~-----------------------~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~ 339 (1630)
...... ......... ........+||+.|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------- 224 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-------- 224 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC--------
Confidence 210000 000000000 000011356999999999987644
Q ss_pred CcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCC---
Q 000343 340 DAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR--- 416 (1630)
Q Consensus 340 ~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~R--- 416 (1630)
++.++|||||||++|||++|.+||...+..+.+..+......... . ....++.++.+||.+||. +|.+|
T Consensus 225 ----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p--~~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 225 ----YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF-P--DDIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ----CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC-C--CCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 789999999999999999999999988877777776653221111 1 112478899999999998 67765
Q ss_pred CChhhHHHHhh
Q 000343 417 PTFSAMLATFL 427 (1630)
Q Consensus 417 PSa~evL~~L~ 427 (1630)
+++.+++.|.+
T Consensus 297 ~~~~~~l~hp~ 307 (377)
T cd05629 297 GGAHEIKSHPF 307 (377)
T ss_pred CCHHHHhcCCC
Confidence 59999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=357.52 Aligned_cols=244 Identities=21% Similarity=0.259 Sum_probs=204.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..++..||+|.+..... .....+.+|+++++.++ ||||++++++|.....+||
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred CeeeeCCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCcceeeEEecCCEEEE
Confidence 4689999888865 56778899999999986532 22345567888888875 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 v~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 149 (323)
T cd05595 73 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence 99999999888887777789999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..
T Consensus 150 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~ 206 (323)
T cd05595 150 -----------ATMKTFCGTPEYLAPEVLEDND------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206 (323)
T ss_pred -----------CccccccCCcCcCCcccccCCC------------CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122356899999999987654 78999999999999999999999998887777776
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L 426 (1630)
+....... +..+++++.+||.+||+.||.+|| ++.++++|-
T Consensus 207 ~~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 207 ILMEEIRF-------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HhcCCCCC-------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 65543322 235789999999999999999998 899998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=360.48 Aligned_cols=268 Identities=21% Similarity=0.224 Sum_probs=208.7
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.|++++.||+|+||.||+ +.+..+++.||||++...... ....+.+|+.+|+.++ ||||++++++|.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~------~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~l~~~~~~~ 73 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCL------ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWVVKLYYSFQDK 73 (381)
T ss_pred CceEEEEEeecCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC--CCCeeeeEEEEecC
Confidence 699999999999888865 667889999999999865322 2346778999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||++++.|..++.+...+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||+++.+..
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999998888887777899999999999999999999999999999999999999999999999999864321
Q ss_pred ccccCCC------------C--------CCC-------------CCCcccccccccCCCCCCCccccccccccccccccC
Q 000343 294 PACRKAR------------P--------ECD-------------SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDD 340 (1630)
Q Consensus 294 ~~~~~~~------------~--------~~~-------------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~ 340 (1630)
....... . .+. ...........+||+.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--------- 224 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG--------- 224 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC---------
Confidence 1000000 0 000 000000112457999999999987644
Q ss_pred cCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhh--ccCcCCCCC
Q 000343 341 AIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECL--QFKASKRPT 418 (1630)
Q Consensus 341 ~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL--~~dP~~RPS 418 (1630)
++.++|||||||++|||++|..||...+..+....+......... .....+++++.+||.+|+ ..+|..|++
T Consensus 225 ---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 225 ---YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI---PPQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred ---CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCC---CCCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 789999999999999999999999887776666655543221111 112257899999999955 455556999
Q ss_pred hhhHHHHhh
Q 000343 419 FSAMLATFL 427 (1630)
Q Consensus 419 a~evL~~L~ 427 (1630)
+.++++|-+
T Consensus 299 ~~~~l~hp~ 307 (381)
T cd05626 299 ADDIKAHPF 307 (381)
T ss_pred HHHHhcCcc
Confidence 999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=355.74 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=205.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc----CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE----MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~----~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+|++++.||+|+||.||+. ..+....+++.||+|.+.+... ...+.+.+|+.+++.++ +||||++++++|..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~---~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLV---RKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEE---EEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-CCCCcccEEEEEec
Confidence 5899999999999999763 2333456889999999875422 22455778999998885 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+++||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999998888877766789999999999999999999999999999999999999999999999999987643
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC--
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-- 370 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-- 370 (1630)
... ........||+.|+|||++.+.. .++.++|||||||++|||++|..||...
T Consensus 157 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 157 SEE-------------KERTYSFCGTIEYMAPEIIRGKG-----------GHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred ccC-------------CCccccccCCccccCHHHhcCCC-----------CCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 211 01122356899999999987532 2678999999999999999999999643
Q ss_pred --CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 371 --SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 371 --~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
....+...+...... .+..+++++.+||.+||+.||++|| +++++++|.+
T Consensus 213 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 213 RNTQSEVSRRILKCDPP-------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCHHHHHHHHhcCCCC-------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 223333444332211 2235789999999999999999999 6778888743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=346.79 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=203.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccc-cCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhc-cCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQG-RCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRAS-MWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~-~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~ 211 (1630)
++|++.+.||+|+||.||+ +.+. ..+..||+|.+...... ....+.+|+.+++.++ ..||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~------~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEE------EEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 4799999999999988865 4443 34688999998765322 2345667888888764 46999999999985
Q ss_pred e-----CCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 M-----DSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~-----~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
. ...+++||||+++++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 75 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3 4569999999998766655443 235899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++..... .......||+.|+|||++.+.. ++.++|||||||++|||++|.+
T Consensus 155 g~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 155 GLARIYSFQ---------------MALTSVVVTLWYRAPEVLLQSS------------YATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred cceEeccCC---------------cccccccccccccChHHHhCCC------------CCCccchHHHHHHHHHHHcCCC
Confidence 999765421 1123456899999999987644 7889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCC--c------------------ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQ--Y------------------ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~--~------------------~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
||.+.+..+.+..+......+.. + .....+.+++.+.+|+.+||+.||++|||+.++++|
T Consensus 208 ~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 208 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 99988877777666543221110 0 001123577889999999999999999999999987
Q ss_pred h
Q 000343 426 F 426 (1630)
Q Consensus 426 L 426 (1630)
-
T Consensus 288 p 288 (290)
T cd07862 288 P 288 (290)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=356.03 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=205.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.++.+++.||||.+.+.. ......+.+|..++..+. +||||++++++|.....+|+
T Consensus 1 ~~lg~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVML------ARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEE------EEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-CCCchhceeeEEEcCCEEEE
Confidence 4689999888765 6677889999999988642 223445567778877664 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--- 150 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--- 150 (320)
T ss_pred EEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---
Confidence 99999999888887777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+++..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 151 -----------KTTSTFCGTPDYIAPEILQEML------------YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred -----------CcccccccCccccCHHHHcCCC------------CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 1123356899999999987644 78999999999999999999999999888888888
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh------hhHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF------SAMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa------~evL~~L 426 (1630)
+.......+ ..+++++.+||.+||+.||.+||++ +++++|-
T Consensus 208 i~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 208 ILNDEVVYP-------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred HhcCCCCCC-------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 766543322 3478999999999999999999998 6677763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=360.38 Aligned_cols=268 Identities=21% Similarity=0.271 Sum_probs=214.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||||++..... .....+.+|++++..+. ||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~ 72 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWL------VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD--SPWIVKLYYSFQD 72 (350)
T ss_pred CCceEEEEEEeCCcEEEEE------EEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC--CCCccchhhheec
Confidence 4799999999999888765 66778899999999986532 33456778999998875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||+.++.|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999998888887766789999999999999999999999999999999999999999999999999998654
Q ss_pred CccccCCCC---------------CCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 293 KPACRKARP---------------ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 293 ~~~~~~~~~---------------~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
......... ...............||+.|+|||++.+.. ++.++|||||||+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlG~il 220 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP------------YGLECDWWSLGVIL 220 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC------------CCCceeeEecchhh
Confidence 321000000 000000111233467899999999987654 78999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-hhhHHHHhh
Q 000343 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-FSAMLATFL 427 (1630)
Q Consensus 358 yemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-a~evL~~L~ 427 (1630)
|+|++|+.||...+..+.+..+......... .....+++++.+||.+||. ||.+||+ +.++++|.+
T Consensus 221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 221 YEMLYGFPPFYSDTLQETYNKIINWKESLRF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred hhhccCCCCCCCCCHHHHHHHHhccCCcccC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 9999999999988877777777652211111 1112378999999999997 9999999 999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=355.84 Aligned_cols=246 Identities=20% Similarity=0.292 Sum_probs=206.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||||.+..... .....+..|.+++..+. +||||++++++|.....+|+
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~hp~i~~~~~~~~~~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVML------AELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTALHCCFQTKDRLFF 73 (321)
T ss_pred CccccCCCeEEEE------EEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCeEEE
Confidence 4689999888865 56778899999999886432 22345667888887664 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 74 v~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 150 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--- 150 (321)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---
Confidence 99999999888777777789999999999999999999999999999999999999999999999999987532211
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 151 -----------VTTTTFCGTPDYIAPEILQELE------------YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred -----------ccccccccCccccCHHHHcCCC------------CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 1123356899999999987654 78999999999999999999999999988888888
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-------ChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-------TFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-------Sa~evL~~L~ 427 (1630)
+.......+ ..+++++.+||.+||+.||++|| ++.++++|.+
T Consensus 208 i~~~~~~~p-------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 208 ILHDDVLYP-------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHcCCCCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 876553322 24689999999999999999999 7888888743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=363.02 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=197.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+|++++.||+|+||.||+ +.+..+++.||||.... ..+.+|+++|+.++ ||||++++++|....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~------~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~--HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFA------CIDNKTCEHVVIKAGQR------GGTATEAHILRAIN--HPSIIQLKGTFTYNK 156 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEE------EEECCCCCEEEEechhh------hhhHHHHHHHHhCC--CCCCCCEeEEEEECC
Confidence 35899999999999888765 67889999999997542 34678999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
..+++|||+.++++..+. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 157 ~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 157 FTCLILPRYKTDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred eeEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999999999876655544 4457999999999999999999999999999999999999999999999999998653211
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC---
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS--- 371 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~--- 371 (1630)
. ........||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 236 ~-------------~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 236 N-------------ANKYYGWAGTIATNAPELLARDP------------YGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred c-------------ccccccccCccCCCChhhhcCCC------------CCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 0 01123457899999999987654 7899999999999999999998875321
Q ss_pred ----HHHHHHHHHhcCCC-CCCc------------------------cc---ccCCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 372 ----AEEIYRAVVKNRKL-PPQY------------------------AS---IVGVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 372 ----~~ei~~~i~~~~~~-~~~~------------------------~~---~~~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
....+..+...... +..+ .. .....++.++.+||.+||+.||.+|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 11122222111100 0000 00 0011356789999999999999999999
Q ss_pred hhHHHHhh
Q 000343 420 SAMLATFL 427 (1630)
Q Consensus 420 ~evL~~L~ 427 (1630)
.|+|+|-+
T Consensus 371 ~elL~hp~ 378 (391)
T PHA03212 371 EALLDFAA 378 (391)
T ss_pred HHHhcChh
Confidence 99999854
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=360.39 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=220.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|+.++.+|+|+||.+++ .+++..+..+|+|+|......+ .....+|+.++++++ |||||.+++.|..+
T Consensus 4 ~~Ye~~~~iG~GafG~a~l------vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~--hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALL------VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL--HPNIVEYKDSFEED 75 (426)
T ss_pred chhhhhhhcCccccchhhh------hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc--CCCeeeeccchhcC
Confidence 5899999999999998876 3467778899999998875444 446778999999965 99999999999988
Q ss_pred CE-EEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 214 SC-LGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 214 ~~-~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+. ++|||+||+||++...+... ..++++.+..++.|++.|++|||+++|+|||||+.|||++.++.+||+|||+|+.
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhh
Confidence 88 99999999999988876543 4699999999999999999999999999999999999999999999999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+.+.. ......+||+.||+||++.+.+ |+.++|||||||++|||++-+++|...
T Consensus 156 l~~~~--------------~~a~tvvGTp~YmcPEil~d~p------------Yn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 156 LNPED--------------SLASTVVGTPYYMCPEILSDIP------------YNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred cCCch--------------hhhheecCCCcccCHHHhCCCC------------CCccCcchhhcchHHHHHhcccccCcc
Confidence 76532 2345678999999999999876 899999999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+...++.+|.+....| .+...+.+++.||..||+.+|..||++.++|.+
T Consensus 210 ~m~~Li~ki~~~~~~P------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 210 NMSELILKINRGLYSP------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred chHHHHHHHhhccCCC------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999998876332 234678999999999999999999999999987
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=369.68 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=201.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
..+|++.+.||+|+||.||+ |.+..+++.||||++... .....+|+.+|+.++ ||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~------~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~--h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYE------AICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLN--HINIIFLKDYYYTEC 132 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEE------EEECCCCCEEEEEEEecC----cchHHHHHHHHHhcC--CCCCcceeeeEeecc
Confidence 35899999999999888764 567778999999988643 234567999999875 99999999987542
Q ss_pred -------CEEEEEEecCCCChHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-cEEE
Q 000343 214 -------SCLGLVMDRCYGSVQLAMQ---RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVV 282 (1630)
Q Consensus 214 -------~~~~LVmEy~~gglL~~l~---~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-~vKL 282 (1630)
.++++||||+++++...+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 133 ~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred cccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 2578999999988765543 3445799999999999999999999999999999999999999664 7999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+|+.+.... ......||+.|+|||++.+.. .|+.++|||||||+||||++
T Consensus 213 ~DFGla~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~-----------~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 213 CDFGSAKNLLAGQ---------------RSVSYICSRFYRAPELMLGAT-----------NYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred eccccchhccCCC---------------CcccCCCCcCccCHHHhcCCC-----------CCCcHHHHHHHHHHHHHHHh
Confidence 9999998654211 112346799999999986532 27899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCC----------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPP----------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~----------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
|.+||.+.+..+.+..+......+. ......+...++++.+||.+||++||.+|||+.
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~ 346 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHH
Confidence 9999998877666555543221110 011112335678999999999999999999999
Q ss_pred hHHHHhh
Q 000343 421 AMLATFL 427 (1630)
Q Consensus 421 evL~~L~ 427 (1630)
|+++|-+
T Consensus 347 e~l~hp~ 353 (440)
T PTZ00036 347 EALADPF 353 (440)
T ss_pred HHhCChh
Confidence 9999854
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=353.45 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=201.8
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||||.++.... ...+....|..++.... .||||+++++++.....+|+
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVML------AELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEE
Confidence 4699999888864 56677899999999986532 22344556666666543 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--- 150 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--- 150 (316)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---
Confidence 99999999888888777789999999999999999999999999999999999999999999999999997543211
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+++..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 151 -----------GKASTFCGTPDYIAPEILKGQK------------YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred -----------CccccccCCccccCHHHHcCCC------------CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1123457899999999987654 78999999999999999999999999888887777
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh-hHHHH
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS-AMLAT 425 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~-evL~~ 425 (1630)
+...... .+..++.++.+||.+||+.||++||++. ++++|
T Consensus 208 i~~~~~~-------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 208 ILNDRPH-------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHcCCCC-------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 6554322 1235789999999999999999999975 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=353.14 Aligned_cols=248 Identities=19% Similarity=0.237 Sum_probs=206.2
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc----CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE----MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~----~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||+. .......+++.||+|.+..... .....+.+|+++|+.++ ||||++++++|..++.+|
T Consensus 2 ~~lg~G~~g~V~~~---~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~~~~~~~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQV---RKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK--HPFIVDLIYAFQTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEE---EEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC--CCchhceeeEEecCCeEE
Confidence 68999999999762 2222346789999999886421 22345678999999875 999999999999999999
Q ss_pred EEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcccc
Q 000343 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
+||||+.++.|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred EEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 999999999988888777889999999999999999999999999999999999999999999999999987532111
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~ 377 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....+.
T Consensus 155 ------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~ 210 (323)
T cd05584 155 ------------TVTHTFCGTIEYMAPEILMRSG------------HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210 (323)
T ss_pred ------------CcccccCCCccccChhhccCCC------------CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 1122356899999999987644 7889999999999999999999999888877777
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
.+..+... .+..+++++.+||.+||+.||++|| ++.++++|.+
T Consensus 211 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 211 KILKGKLN-------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHcCCCC-------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 77665422 2235789999999999999999999 7888888743
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=353.57 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=200.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
+|++.+.||+|+||.||+ +.+..++..||||++.... ......+.+|+++++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 72 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCS------AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR--HPDIVEIKHIMLPPS 72 (338)
T ss_pred CeEEEEEEeecCCeEEEE------EEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC--CCCEeeecceEeccC
Confidence 599999999999888754 6678889999999987532 223446778999999875 99999999988643
Q ss_pred ----CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 214 ----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 214 ----~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
..+|+|||||.+++.. ++.....+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~~~~~lv~e~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 73 RREFKDIYVVFELMESDLHQ-VIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred CCCCceEEEEEecCCCCHHH-HHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 3589999999876554 44445679999999999999999999999999999999999999999999999999997
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
....... .........||+.|+|||++.+.. ..++.++|||||||++|+|++|++||.+
T Consensus 152 ~~~~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~----------~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 152 VAFNDTP-----------TAIFWTDYVATRWYRAPELCGSFF----------SKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccccC-----------ccccccCCCCCCCcCCHHHHhccc----------cccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 6432110 001123457899999999986521 1278999999999999999999999987
Q ss_pred CCHHHHHHHHHhcCCC------------------------CCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 370 LSAEEIYRAVVKNRKL------------------------PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~------------------------~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.+.......+...... .+.......+.+++++.+||.+||+.||++|||++++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 211 KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 6644332222111000 0000011123467889999999999999999999999998
Q ss_pred hh
Q 000343 426 FL 427 (1630)
Q Consensus 426 L~ 427 (1630)
-+
T Consensus 291 p~ 292 (338)
T cd07859 291 PY 292 (338)
T ss_pred ch
Confidence 43
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=362.70 Aligned_cols=268 Identities=21% Similarity=0.226 Sum_probs=211.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++++.||+|+||.||+ +.+..+++.||||.+.... ......+.+|+.+|+.+. ||||+++++.|.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~------a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~~iv~~~~~~~~ 72 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCL------VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWVVKLYYSFQD 72 (376)
T ss_pred CCceEEEEEEeCCCeEEEE------EEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEEc
Confidence 3799999999999888865 6677889999999987542 223456778999999875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+.+|||||||++++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999999988888777789999999999999999999999999999999999999999999999999985432
Q ss_pred CccccC------------CCCC--CC---------------CCCcccccccccCCCCCCCccccccccccccccccCcCC
Q 000343 293 KPACRK------------ARPE--CD---------------SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343 (1630)
Q Consensus 293 ~~~~~~------------~~~~--~~---------------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~ 343 (1630)
...... .... .. ...........+||+.|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------ 220 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG------------ 220 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC------------
Confidence 100000 0000 00 000001112457999999999987654
Q ss_pred CCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC---Chh
Q 000343 344 ISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP---TFS 420 (1630)
Q Consensus 344 ~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP---Sa~ 420 (1630)
++.++|||||||++|||++|+.||.+.+..+....+......... .....+++++.+||.+|+ .+|.+|+ ++.
T Consensus 221 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI---PSQAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccC---CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 789999999999999999999999988877766665543222111 112357899999999977 5999999 999
Q ss_pred hHHHHhh
Q 000343 421 AMLATFL 427 (1630)
Q Consensus 421 evL~~L~ 427 (1630)
++++|-+
T Consensus 297 ell~h~~ 303 (376)
T cd05598 297 EIKAHPF 303 (376)
T ss_pred HHhCCCC
Confidence 9999844
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=369.01 Aligned_cols=285 Identities=19% Similarity=0.193 Sum_probs=238.1
Q ss_pred ccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHc--CCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHH
Q 000343 477 SEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRR--GSAELVEAILEYSQENVDVLDKDGDPPLVFALA 554 (1630)
Q Consensus 477 ~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~--G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~ 554 (1630)
...+.+.++.||+.|+++| .+ .+|.||||+++.. ++.++|++||+. |+++|..+ .+.||||.|+.
T Consensus 12 ~~~~~~~v~~LL~~GadvN----------~~-~~g~t~l~~~~~~~~~~~~iv~~Ll~~-GAdvn~~~-~~~tpL~~a~~ 78 (494)
T PHA02989 12 DTVDKNALEFLLRTGFDVN----------EE-YRGNSILLLYLKRKDVKIKIVKLLIDN-GADVNYKG-YIETPLCAVLR 78 (494)
T ss_pred CcCcHHHHHHHHHcCCCcc----------cc-cCCCCHHHHHHhcCCCChHHHHHHHHc-CCCccCCC-CCCCcHHHHHh
Confidence 3578999999999999875 34 5689999876654 478999999995 68999887 57999999987
Q ss_pred cC------CHHHHHHHHHCCCCcccccccCCCchHHHHHHHc---CCHHHHHHHHHcCCCC-CCCCCCCCChhhhhhhc-
Q 000343 555 AG------SPECVHALIKRGANVISRLREGFGPSVAHVCAYH---GQPDCMRELLLAGADP-NAVDDEGESVLHRAVAK- 623 (1630)
Q Consensus 555 ~G------~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~---G~~eivk~LL~~GADv-n~~D~~G~TPLH~Aa~~- 623 (1630)
++ +.+++++|+++|||+|.. +..|.||||.|+.. ++.+++++|+++|||+ +..|..|.||||+|+..
T Consensus 79 ~~~~~~~~~~~iv~~Ll~~Gadin~~--d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~ 156 (494)
T PHA02989 79 NREITSNKIKKIVKLLLKFGADINLK--TFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESF 156 (494)
T ss_pred ccCcchhhHHHHHHHHHHCCCCCCCC--CCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhc
Confidence 54 578999999999999875 45688999988765 6799999999999999 89999999999998764
Q ss_pred -CChHHHHHHHHcCCcccccc-ccCCCCcHHHHHHHcC----CHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhc
Q 000343 624 -KYTDCAIVILENGGCRSMAI-LNSKELTPLHLCVATW----NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALK 697 (1630)
Q Consensus 624 -g~~eiv~~LL~~Ga~~~i~~-~d~~G~TPLh~Aa~~g----~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~ 697 (1630)
++.+++++|+++|+ +++. .+..|.||||+|+..+ +.+++++|++.|+..+..+ . ...++++.++...
T Consensus 157 ~~~~~iv~~Ll~~Ga--di~~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~---~--~~~t~l~~~~~~~ 229 (494)
T PHA02989 157 SVKKDVIKILLSFGV--NLFEKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN---N--GSESVLESFLDNN 229 (494)
T ss_pred cCCHHHHHHHHHcCC--CccccccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC---C--ccccHHHHHHHhc
Confidence 58899999999998 5555 5778999999998764 8999999999998643322 2 2345555544433
Q ss_pred cCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHH
Q 000343 698 KDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLL 777 (1630)
Q Consensus 698 ~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklL 777 (1630)
........+++++|+. |+++|.+|..|.||||+|+..|+.+++++||++|||+|.+|..|.||||+|+.+|+.+++++|
T Consensus 230 ~~~~~~~~~il~~l~~-~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~Gadin~~d~~G~TpL~~A~~~~~~~iv~~L 308 (494)
T PHA02989 230 KILSKKEFKVLNFILK-YIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLGDDIYNVSKDGDTVLTYAIKHGNIDMLNRI 308 (494)
T ss_pred hhhcccchHHHHHHHh-CCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHH
Confidence 3333345678887665 799999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCC
Q 000343 778 LSAGADC 784 (1630)
Q Consensus 778 Le~GADi 784 (1630)
|+.+++.
T Consensus 309 L~~~p~~ 315 (494)
T PHA02989 309 LQLKPGK 315 (494)
T ss_pred HhcCCCh
Confidence 9987543
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=353.12 Aligned_cols=245 Identities=21% Similarity=0.264 Sum_probs=202.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.++.+++.||+|.++... .........|..++.... .||||++++++|.+.+.+|+
T Consensus 1 ~~lg~G~~g~V~~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLL------AELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHLYCTFQTKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCCccCeeEEEEeCCEEEE
Confidence 4699999888865 5677889999999998642 223445666777776653 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+.++.|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--- 150 (316)
T ss_pred EECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---
Confidence 99999998888877777789999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 151 -----------NRASTFCGTPDYIAPEILQGLK------------YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred -----------CceeccCCCcCccCHHHHcCCC------------CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1123456899999999987654 78999999999999999999999998888777776
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh-hHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS-AMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~-evL~~L 426 (1630)
+....... +..++.++++||.+||+.||++||++. ++++|.
T Consensus 208 ~~~~~~~~-------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 208 IRVDTPHY-------PRWITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred HHhCCCCC-------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 65443222 224788999999999999999999984 676663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=347.34 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=208.8
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|.+.++||+|+||.||. +.++.+++.||+|.+...... ....+.+|+++++.++ ||||+++++++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFK------GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIVHTD 76 (309)
T ss_pred CCceEEEEEecccCCEEEEE------EEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC--CCCcceEEEEEeeC
Confidence 46899999999999888754 667788999999998765332 2345678999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+++||||+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 77 KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99999999999877776665555689999999999999999999999999999999999999999999999999876432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..
T Consensus 157 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 211 (309)
T cd07872 157 PT--------------KTYSNEVVTLWYRPPDVLLGSS-----------EYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211 (309)
T ss_pred Cc--------------cccccccccccccCCHHHhCCC-----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 11 0112345689999999886532 2788999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCC-------------------Cc----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 374 EIYRAVVKNRKLPP-------------------QY----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 374 ei~~~i~~~~~~~~-------------------~~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
+.+..+......+. .. .......+++++.+||.+||+.||.+|||+.|+++|.+-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 212 DELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred HHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 55544433211110 00 001123478899999999999999999999999998554
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=356.06 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=204.0
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|.+...... ....+.+|++++..+. ||||++++++|.....+||
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~--hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred CeeeeCCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCCceEEEEEcCCEEEE
Confidence 4689999988865 567788999999999865322 2345567788887764 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeecCcccc
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
||||+++++|..++.+...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 73 v~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-- 150 (325)
T cd05594 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-- 150 (325)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--
Confidence 99999999888887777789999999999999999999997 799999999999999999999999999987532110
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~ 377 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+.
T Consensus 151 ------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~ 206 (325)
T cd05594 151 ------------ATMKTFCGTPEYLAPEVLEDND------------YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206 (325)
T ss_pred ------------cccccccCCcccCCHHHHccCC------------CCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence 1122356899999999987654 7899999999999999999999999888877777
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
.+....... +..+++++.+||.+||+.||++|+ ++.++++|.+
T Consensus 207 ~i~~~~~~~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 207 LILMEEIRF-------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHhcCCCCC-------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 665443222 235789999999999999999997 8999998843
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=352.36 Aligned_cols=258 Identities=19% Similarity=0.305 Sum_probs=208.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++++.||+|+||.||+ +.+..++..||+|.+..... .....+.+|+++|+.++ ||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 75 (331)
T cd06649 4 DDDFERISELGAGNGGVVTK------VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSD 75 (331)
T ss_pred cccceEEEeecCCCCEEEEE------EEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCCCCeEEEEEEEC
Confidence 46899999999999887754 66778899999999876422 22456888999999975 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+.+++||||+++++|..++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999999988887777899999999999999999999986 69999999999999999999999999987543
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus 156 ~~----------------~~~~~~g~~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 156 DS----------------MANSFVGTRSYMSPERLQGTH------------YSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred cc----------------ccccCCCCcCcCCHhHhcCCC------------CCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 112346899999999987654 78999999999999999999999987665
Q ss_pred HHHHHHHHhcCC-----CC------------------------------------CCcccccCCCCCHHHHHHHHHhhcc
Q 000343 373 EEIYRAVVKNRK-----LP------------------------------------PQYASIVGVGIPRELWKMIGECLQF 411 (1630)
Q Consensus 373 ~ei~~~i~~~~~-----~~------------------------------------~~~~~~~~~~l~~el~~LI~~cL~~ 411 (1630)
.++...+..... .+ ..........+++++++||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 287 (331)
T cd06649 208 KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK 287 (331)
T ss_pred HHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC
Confidence 443322211000 00 0000000123678999999999999
Q ss_pred CcCCCCChhhHHHHhhh
Q 000343 412 KASKRPTFSAMLATFLR 428 (1630)
Q Consensus 412 dP~~RPSa~evL~~L~~ 428 (1630)
||++|||+.++++|.+-
T Consensus 288 ~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 288 NPAERADLKMLMNHTFI 304 (331)
T ss_pred CcccCCCHHHHhcChHH
Confidence 99999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=358.15 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=213.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.++.+++.||+|.+..... .....+.+|+.+++.+. ||||+++++++.+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~--h~~iv~~~~~~~~ 114 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQL------VRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN--SEWIVQLHYAFQD 114 (370)
T ss_pred HHcEEEEEEeeCCCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCcceEEEEEec
Confidence 5899999999999888865 66778899999999975422 23345678899988875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||+++++|..++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999988887765 368999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... ........||+.|+|||++.+... ...++.++|||||||++|||++|..||...+.
T Consensus 194 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 194 ANG-------------MVRCDTAVGTPDYISPEVLKSQGG--------DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CCC-------------cccCCCCCCCcCeECHHHhccCCC--------CCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 221 011234568999999999875431 12378999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
...+..+......... .....++.++.+||.+||+.+|.+ |+|+.++++|.+
T Consensus 253 ~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 253 VGTYSKIMDHKNSLTF---PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred HHHHHHHHcCCCcCCC---CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 8788777654322111 112247899999999999999998 999999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=380.11 Aligned_cols=365 Identities=27% Similarity=0.387 Sum_probs=312.6
Q ss_pred CCCCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCC
Q 000343 467 DNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGD 546 (1630)
Q Consensus 467 ~~~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~ 546 (1630)
++.++||.|+..+.++.++-++..++++ ++.|+.|.||||.||..|+++++.+|+.+ ++.+|..+..|.
T Consensus 208 ~~~tpl~~a~~~nri~~~eLll~~gadv----------~a~d~~gl~~lh~a~~~g~~~i~~~l~~~-ga~~~~~~vr~~ 276 (1143)
T KOG4177|consen 208 NGFTPLHIACKKNRIKVVELLLKHGADV----------SAKDESGLTPLHVAAFMGHLDIVKLLLQH-GASVNVSTVRGE 276 (1143)
T ss_pred CCCCchhhhccccccceeeeeeeccCcC----------CcccccCccHHHHHHhccchhHHHHHHhc-ccccCccccccc
Confidence 4457999999999999999999999875 58999999999999999999999999985 678999999999
Q ss_pred CHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCCh
Q 000343 547 PPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626 (1630)
Q Consensus 547 TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~ 626 (1630)
||||.||..+..+++++|+++|+++..... ...|++|+|...|+.+++++++..++.+++.+..|.||||+|+..++.
T Consensus 277 tplh~AA~~~~~e~~~~ll~~ga~~~~~~~--~~kt~l~~a~~~g~~~i~~~~l~~~~~~~aar~~g~t~lHlaa~~~~~ 354 (1143)
T KOG4177|consen 277 TPLHMAARAGQVEVCKLLLQNGADVLAKAR--DDQTPLHIASRLGHEEIVHLLLQAGATPNAARTAGYTPLHLAAKEGQV 354 (1143)
T ss_pred CcchhhhccchhhhHhhhhccCcccccccc--cccChhhhhcccchHHHHHHHhhccCCccccCcCCcccccHhhhhhhH
Confidence 999999999999999999999999977544 467899999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCcccccc----------------------------
Q 000343 627 DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVN---------------------------- 678 (1630)
Q Consensus 627 eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n---------------------------- 678 (1630)
++..+|+..+. .....+..+.||+|+|+.++..++++.++..++..+..+
T Consensus 355 ~~~~~l~~~~~--~~~~a~~k~~~pl~la~~~g~~~~v~Lll~~ga~~~~~gk~gvTplh~aa~~~~~~~v~l~l~~gA~ 432 (1143)
T KOG4177|consen 355 EVAGALLEHGA--QRRQAEEKGFTPLHLAVKSGRVSVVELLLEAGADPNSAGKNGVTPLHVAAHYGNPRVVKLLLKRGAS 432 (1143)
T ss_pred HHHHHhhcccc--ccCcccccCCcchhhhcccCchhHHHhhhhccCCcccCCCCCcceeeehhhccCcceEEEEeccCCC
Confidence 87777777765 334456778888888888888888888887776532211
Q ss_pred --ccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccC
Q 000343 679 --VIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNV 756 (1630)
Q Consensus 679 --~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~ 756 (1630)
..+.. +.|+++.++.... ..++...++..|+++|.....|.||||+|+..|+.++++.|++.+++.+....
T Consensus 433 ~~~~~~l--G~T~lhvaa~~g~-----~~~~~~~l~~~g~~~n~~s~~G~T~Lhlaaq~Gh~~~~~llle~~~~~~~~~~ 505 (1143)
T KOG4177|consen 433 PNAKAKL--GYTPLHVAAKKGR-----YLQIARLLLQYGADPNAVSKQGFTPLHLAAQEGHTEVVQLLLEGGANDNLDAK 505 (1143)
T ss_pred hhhHhhc--CCChhhhhhhccc-----HhhhhhhHhhcCCCcchhccccCcchhhhhccCCchHHHHhhhcCCccCccch
Confidence 11111 2466666654321 46778888888888888888899999999999999999999888888888888
Q ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHH
Q 000343 757 HNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDF 836 (1630)
Q Consensus 757 ~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdl 836 (1630)
.+.|+||+|+..+...+++.|+++|++++.++..|+||||.|+..|+. .+++.|+++|||++++++.|+||||.
T Consensus 506 ~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v------~~VkfLLe~gAdv~ak~~~G~TPLH~ 579 (1143)
T KOG4177|consen 506 KGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNV------DLVKFLLEHGADVNAKDKLGYTPLHQ 579 (1143)
T ss_pred hccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCc------hHHHHhhhCCccccccCCCCCChhhH
Confidence 888999999999999999999999999999999999999999988764 67888999999999999999999999
Q ss_pred HhhCCCCCcHHHHHHHHHhcCCCCCCc
Q 000343 837 LEGLPREWISEDLMEALMNRGVHLSPT 863 (1630)
Q Consensus 837 A~~~~~~~~~~~lve~Ll~~Ga~l~~~ 863 (1630)
|...+ ..+++++|+++||+++..
T Consensus 580 Aa~~G----~~~i~~LLlk~GA~vna~ 602 (1143)
T KOG4177|consen 580 AAQQG----HNDIAELLLKHGASVNAA 602 (1143)
T ss_pred HHHcC----hHHHHHHHHHcCCCCCcc
Confidence 99877 569999999999998763
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=354.76 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=212.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.++.... .....+.+|+.+++.+. ||||+++++++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--~~~i~~~~~~~~~ 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQV------VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQLQYAFQD 72 (330)
T ss_pred CCceEEEEEEeccCEEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCCcceeeEEec
Confidence 4799999999999888865 56778899999999986532 23456778888888764 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
...+||||||+++++|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999988888777654 67999999999999999999999999999999999999999999999999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ........||+.|+|||++..... .....++.++|||||||++|+|++|..||...+
T Consensus 153 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 153 TANK-------------MVNSKLPVGTPDYIAPEVLTTMNG------DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CCCC-------------ceeeecccCCccccCHHHhccccc------cccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 4321 001223468999999999875321 012237899999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+..+........ +. ....+++++.+||.+||+ +|.+||++.++++|-+
T Consensus 214 ~~~~~~~i~~~~~~~~-~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 214 SAKTYNNIMNFQRFLK-FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred HHHHHHHHHcCCCccC-CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 7777777765432211 11 123578999999999998 9999999999998843
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=350.58 Aligned_cols=244 Identities=20% Similarity=0.284 Sum_probs=204.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+|++.+.||+|+||.||+ +.++.+++.||||++..... .....+..|..++..+. +||+|++++++|++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVML------AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQLHSCFQTV 73 (323)
T ss_pred CceEEEEEEecCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCchhheeeEEecC
Confidence 478899999999888865 66778899999999886422 22345667888877765 578999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+++++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999999888887777899999999999999999999999999999999999999999999999999875322
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus 154 ~~--------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 154 DG--------------VTTRTFCGTPDYIAPEIIAYQP------------YGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred CC--------------ccccCccCCccccCHHHHcCCC------------CCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 11 1122356899999999987644 789999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
..+..+....... +..++.++.+|+.+||+.+|.+|+++.
T Consensus 208 ~~~~~i~~~~~~~-------p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 208 ELFQSIMEHNVSY-------PKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHHHHhCCCCC-------CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 8888777654322 235788999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=353.81 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=202.1
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+.++|++.+.||+|+||.||+ +.+..++..||+|++.... ......+.+|+.+++.++ ||||++++++|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 89 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCA------AFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN--HKNIISLLNVF 89 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEE------EEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC--CCCEeeeeeee
Confidence 3557999999999999888765 5677889999999987542 223456678999988875 99999999998
Q ss_pred EeCC------EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 211 RMDS------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 211 ~~~~------~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
.... .+|+||||+.+++...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ccCCCccccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEec
Confidence 7543 579999999988776653 2489999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+
T Consensus 167 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~------------~~~~~DiwSlG~il~el~tg~ 219 (359)
T cd07876 167 FGLARTACTN---------------FMMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGELVKGS 219 (359)
T ss_pred CCCccccccC---------------ccCCCCcccCCCCCchhccCCC------------CCcchhhHHHHHHHHHHHhCC
Confidence 9998754321 1123356799999999987654 789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCC-------------------Ccc----------------cccCCCCCHHHHHHHHHhh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPP-------------------QYA----------------SIVGVGIPRELWKMIGECL 409 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~-------------------~~~----------------~~~~~~l~~el~~LI~~cL 409 (1630)
.||.+.+..+.+..+......+. .+. .......++++++||.+||
T Consensus 220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 299 (359)
T cd07876 220 VIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299 (359)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHh
Confidence 99987765444333322111000 000 0011124578999999999
Q ss_pred ccCcCCCCChhhHHHHhhh
Q 000343 410 QFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 410 ~~dP~~RPSa~evL~~L~~ 428 (1630)
..||++|||+.|+++|.+-
T Consensus 300 ~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 300 VIDPDKRISVDEALRHPYI 318 (359)
T ss_pred ccCcccCCCHHHHhcCchh
Confidence 9999999999999998553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=354.23 Aligned_cols=240 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred EEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 139 ~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
.-++-||.|+-|.||+ |+ ..++.||||+++. ..+.+|+-|++++ |||||.|.+++....++||
T Consensus 127 sELeWlGSGaQGAVF~------Gr--l~netVAVKKV~e-------lkETdIKHLRkLk--H~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFL------GR--LHNETVAVKKVRE-------LKETDIKHLRKLK--HPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hhhhhhccCcccceee------ee--ccCceehhHHHhh-------hhhhhHHHHHhcc--CcceeeEeeeecCCceeEE
Confidence 3467799999777654 43 4568999998773 2345788888876 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
|||||..|-|...++....++......+.++|+.|++|||.+.|||||||.-||||..+..+||+|||.++....-
T Consensus 190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---- 265 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---- 265 (904)
T ss_pred eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh----
Confidence 9999998888888888888999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
...-.++||..|||||++...+ ++.|+|||||||+|||||||..||.+.+...++..
T Consensus 266 -----------STkMSFaGTVaWMAPEvIrneP------------csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG 322 (904)
T KOG4721|consen 266 -----------STKMSFAGTVAWMAPEVIRNEP------------CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG 322 (904)
T ss_pred -----------hhhhhhhhhHhhhCHHHhhcCC------------cccccceehhHHHHHHHHhcCCCccccchheeEEe
Confidence 1223478999999999999876 89999999999999999999999998877666554
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+-... +..+.+..+|+.++-||+.||+..|..|||+.++|.||.
T Consensus 323 VGsNs-----L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 323 VGSNS-----LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCCc-----ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 42221 222345578999999999999999999999999999976
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=367.97 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=210.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccC-CcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC-RHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~-g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..|.+.+.||+|+||.||+ |.+..+ +..||+|++..........+.+|+.+|+.++ ||||++++++|...+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~------a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFV------ATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD--HFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEE------EEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC--CCCEeEEEEEEEECC
Confidence 3599999999999998865 445555 7889999876654444556778999998875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+||||||+++++|..++. ...++++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 9999999999888876543 244689999999999999999999999999999999999999999999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+.... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 219 ~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 219 YSDSV------------SLDVASSFCGTPYYLAPELWERKR------------YSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCCcc------------ccccccccCCCccccCHhHhCCCC------------CCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 64321 011223456899999999987654 789999999999999999999999988
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+..+++..+..+...+. +..+++++.+||.+||..||++||++.+++.+
T Consensus 275 ~~~~~~~~~~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 275 SQREIMQQVLYGKYDPF------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CHHHHHHHHHhCCCCCC------CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 88888887776543321 23578899999999999999999999999876
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=349.77 Aligned_cols=244 Identities=21% Similarity=0.254 Sum_probs=202.3
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||||.++... .........|..++.... .||||+++++++.+...+|+
T Consensus 1 ~~lG~G~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFL------AELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEE------EEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCcCcceEEEEEeCCEEEE
Confidence 4699999888764 6677889999999998652 223345566777776643 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--- 150 (316)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence 99999999888888776789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 151 -----------AKTCTFCGTPDYIAPEILLGQK------------YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred -----------CceeeecCCccccCHHHHcCCC------------CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1123356899999999987654 78999999999999999999999998888877777
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh-hHHHH
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS-AMLAT 425 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~-evL~~ 425 (1630)
+....... +..++.++.+||.+||+.||++||++. ++++|
T Consensus 208 i~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 208 IRMDNPCY-------PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHhCCCCC-------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 65443221 224788999999999999999999997 67666
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=350.55 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=205.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..++..||||.+.+.. ......+.+|++++..+. +||||++++++|.....+|+
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~h~~i~~~~~~~~~~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLL------AELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQLHSCFQTKDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEE
Confidence 4699999888865 5577788999999998653 223455667888888775 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 150 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--- 150 (318)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---
Confidence 99999999888887777789999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..
T Consensus 151 -----------~~~~~~~g~~~y~aPE~~~~~~------------~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 151 -----------VTTSTFCGTPDYIAPEILSYQP------------YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred -----------CcccceecCccccCHHHhcCCC------------CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 1122346899999999987654 78999999999999999999999998888777777
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-----hhHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF-----SAMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-----~evL~~L 426 (1630)
+....... +..+++++.+||.+||+.||++||++ .++++|-
T Consensus 208 i~~~~~~~-------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 208 ILEDEVRY-------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHcCCCCC-------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 76544322 23578999999999999999999999 8888773
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=355.57 Aligned_cols=264 Identities=22% Similarity=0.368 Sum_probs=217.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+++.+...||+|+||+||- |. ..-.||||+++..... ..+.|++|+..+++-+ |.||+-|.+++..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~R-g~--------whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR--H~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYR-GR--------WHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR--HENILLFMGACMNP 460 (678)
T ss_pred HHhhccceeccccccceee-cc--------cccceEEEEEecCCCCHHHHHHHHHHHHHHhhcc--hhhheeeehhhcCC
Confidence 5677999999999999952 22 2347999999876433 3677889999999976 99999999999988
Q ss_pred CEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.. .||+.+|.|+.|..++.- +.+|.+.+...|++||++|+.|||.++|||||||..||||.++++|||+|||++..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 999999999988876643 3579999999999999999999999999999999999999999999999999997533
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.- .-........|...|||||++.... ..+|++.+|||||||++|||++|.+||.....
T Consensus 540 ~w------------~g~~q~~qp~gsilwmAPEvIRmqd---------~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 540 RW------------SGEQQLEQPHGSLLWMAPEVIRMQD---------DNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred ee------------ccccccCCCccchhhhcHHHHhhcc---------cCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 11 0112234456788999999998432 35699999999999999999999999998888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
+.++..+-+|...+... .....+++++++|+..||.+++++||.+.++|..|...+..+|
T Consensus 599 dqIifmVGrG~l~pd~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 599 DQIIFMVGRGYLMPDLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred hheEEEecccccCccch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 88877776665444332 2344688899999999999999999999999999888877554
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=357.40 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=207.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||. +..|...+..++..||+|+++.... ...+.+.+|+.+|..+. +||||+++++++....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~-~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVE-ATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEE-EEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-CCcceeeeeeeeccCC
Confidence 4899999999999999975 3334444566778999999875432 23456788999999984 5999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC-----------------------------------------------------------
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE----------------------------------------------------------- 235 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~----------------------------------------------------------- 235 (1630)
..++|||||++++|..++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999988777665421
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 236 ----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 236 ----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN--- 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc---
Confidence 1478889999999999999999999999999999999999999999999999986543210
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~ 378 (1630)
........++..|+|||++.+.. ++.++|||||||++|||++ |..||........+..
T Consensus 270 ---------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~ 328 (375)
T cd05104 270 ---------YVVKGNARLPVKWMAPESIFNCV------------YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328 (375)
T ss_pred ---------ccccCCCCCCcceeChhHhcCCC------------CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH
Confidence 00112233467899999987654 7899999999999999998 9999987655444433
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.......+. .+...+.++.+||.+||+.||++|||+.++++.|.+.
T Consensus 329 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 329 MIKEGYRML-----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHhCccCC-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 333322211 1224678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=349.73 Aligned_cols=243 Identities=21% Similarity=0.281 Sum_probs=198.7
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHH-HHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNL-RRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL-~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||+ +.+..+++.||||++...... ....+..|...+ +.+ +||||++++++|.....+|
T Consensus 1 ~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l--~hp~iv~~~~~~~~~~~~~ 72 (323)
T cd05575 1 KVIGKGSFGKVLL------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV--KHPFLVGLHYSFQTADKLY 72 (323)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC--CCCCCCCeeEEEEeCCEEE
Confidence 4689999888754 667889999999999864322 223344444433 344 5999999999999999999
Q ss_pred EEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcccc
Q 000343 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
+||||+.++.|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 73 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 99999999988888777778999999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~ 377 (1630)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+.
T Consensus 150 -----------~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 150 -----------SKTTSTFCGTPEYLAPEVLRKQP------------YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred -----------CCccccccCChhhcChhhhcCCC------------CCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 01123456899999999987654 7899999999999999999999999988888877
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh----hHHHH
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS----AMLAT 425 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~----evL~~ 425 (1630)
.+...... .++.+++++.+||.+||+.||.+||++. ++++|
T Consensus 207 ~i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 207 NILNKPLR-------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHcCCCC-------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 77654322 1235789999999999999999999985 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=355.55 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=210.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++++.||+|+||.||+ +.++.+++.||||.+.... ......+.+|+.++..+. ||||+++++.|.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~ 72 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRL------VQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD--GAWVVKMFYSFQD 72 (360)
T ss_pred CCceEEEEEeeCCCEEEEE------EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEc
Confidence 4799999999999888865 5677889999999997543 223456778999988875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+||||||++|+.|..++.+...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999999888888777789999999999999999999999999999999999999999999999999987553
Q ss_pred CccccCC------CCCCC---------------CCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 293 KPACRKA------RPECD---------------SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 293 ~~~~~~~------~~~~~---------------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
....... ..... ...........+||+.|+|||++.+.. ++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~------------~~~~~Diw 220 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG------------YNKLCDWW 220 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC------------CCCcceec
Confidence 2110000 00000 000001122457999999999987654 78999999
Q ss_pred hhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC---hhhHHHHhh
Q 000343 352 SFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT---FSAMLATFL 427 (1630)
Q Consensus 352 SlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS---a~evL~~L~ 427 (1630)
||||++|||++|..||...+..+.+..+........ +. ....+++++++||.+|+. ||.+|++ +.++++|-+
T Consensus 221 SlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~-~p--~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 221 SLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV-FP--PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred cccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee-cC--CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 999999999999999999888887777765322111 11 112368899999999874 9999985 678888843
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=339.26 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=202.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhc-cCCCCcceeEEEEEe-
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRAS-MWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~- 212 (1630)
+|++.+.||+|+||.||+ +.++.+++.||+|.+...... ......+|+.+++.++ .+||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYK------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEE------EEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 589999999999888754 678889999999998764322 2345667888888764 469999999999864
Q ss_pred ----CCEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 213 ----DSCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 213 ----~~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
...++++|||+.+++...+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 75 RTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred cCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 34589999999987666554432 3589999999999999999999999999999999999999999999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF 367 (1630)
++...... ......||..|+|||++.+.. ++.++|||||||++|+|++|.+||
T Consensus 155 ~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 155 ARIYSCQM---------------ALTPVVVTLWYRAPEVLLQST------------YATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cccccCcc---------------cCCCccccccccCchHhhCCC------------CCCcchhhhHHHHHHHHHhCCcCc
Confidence 87654211 112345789999999987644 789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCC--------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 368 AGLSAEEIYRAVVKNRKLPP--------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~--------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
...+..+.+..+......+. .......+.++.++.+||.+||+.||++|||+.+++.|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 88776665555543211100 000111235678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.49 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=219.0
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
....-|++.+.||+|-|..|-| |++..||++||||++.+.+... ...+.+|++-|+..+ |||||+||++.
T Consensus 15 kIAGLYDLekTlG~GHFAVVKL------ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ--HpNiVRLYEVi 86 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKL------ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ--HPNIVRLYEVI 86 (864)
T ss_pred ceeeeehhhhhhcCCceehhhh------hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc--CcCeeeeeehh
Confidence 3456799999999999887755 7788899999999998875443 556788999999987 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC-CCCcEEEeeccee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD-ASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld-~~g~vKL~DFGla 288 (1630)
.+...+|||+|+-++|+|++++. ....+.+..++.|+.||+.|+.|+|+..+|||||||+|+.+- +-|.+||+|||++
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccc
Confidence 99999999999999887777664 455699999999999999999999999999999999999775 5589999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
-.+..+ ...+..+|+..|-|||++.+..| -.+++||||||+|||.|+.|++||+
T Consensus 167 Nkf~PG---------------~kL~TsCGSLAYSAPEILLGDsY-----------DAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 167 NKFQPG---------------KKLTTSCGSLAYSAPEILLGDSY-----------DAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred ccCCCc---------------chhhcccchhhccCchhhhcCcc-----------CCcchhhhHHHHHHHHHHhCCCccc
Confidence 665432 23566899999999999998764 2578999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..+.+..|..-+...|. .++.++++||.+||..||.+|.|.+++..+-+
T Consensus 221 eANDSETLTmImDCKYtvPs-------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 221 EANDSETLTMIMDCKYTVPS-------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred cccchhhhhhhhcccccCch-------hhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 99998988888776655443 57899999999999999999999999987644
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=354.35 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=210.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+.+... .....+.+|+.+++.+. ||||++++++|.+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~ 114 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQL------VRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFCAFQD 114 (370)
T ss_pred HHCeEEEEEEecCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC--CCCEeeEEEEEEc
Confidence 5899999999999988865 66778899999999875322 23445678888888865 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+..+|+||||++++.|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999888877653 68999999999999999999999999999999999999999999999999998754
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... ........||+.|+|||++.+... ...++.++|||||||+||+|++|..||...+.
T Consensus 194 ~~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~--------~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 194 ETG-------------MVRCDTAVGTPDYISPEVLKSQGG--------DGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred cCC-------------ceecccCCCCcccCCHHHHhccCC--------CCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 221 011234578999999999875421 11268899999999999999999999998888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
...+..+......... .....++..+++|+.+||..+|.+ |+++.++++|-+
T Consensus 253 ~~~~~~i~~~~~~~~~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 253 VGTYSKIMDHKNSLNF---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred HHHHHHHHhCCcccCC---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 7777777654322111 112347899999999999865544 899999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=350.12 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=198.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|.++..... ....+.+|..++..+. +||||++++++|.+...+||
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-~hp~Iv~~~~~~~~~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLL------VELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-CCCCCCceEEEEEcCCEEEE
Confidence 4689999888865 567788999999999865322 2345678888888875 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 v~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 149 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---- 149 (329)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC----
Confidence 9999999988887777778999999999999999999999999999999999999999999999999998642211
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-------
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS------- 371 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~------- 371 (1630)
........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||....
T Consensus 150 ----------~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05588 150 ----------GDTTSTFCGTPNYIAPEILRGED------------YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207 (329)
T ss_pred ----------CCccccccCCccccCHHHHcCCC------------CCCccceechHHHHHHHHHCCCCcccccccccccc
Confidence 01123457899999999987654 7899999999999999999999996311
Q ss_pred --HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC------hhhHHHHh
Q 000343 372 --AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT------FSAMLATF 426 (1630)
Q Consensus 372 --~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS------a~evL~~L 426 (1630)
.......+...... .+..++.++.+||.+||+.||.+|++ +.++++|-
T Consensus 208 ~~~~~~~~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05588 208 NTEDYLFQVILEKQIR-------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263 (329)
T ss_pred cchHHHHHHHHcCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence 12233333333221 22357899999999999999999998 57888773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=350.33 Aligned_cols=242 Identities=22% Similarity=0.257 Sum_probs=201.2
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLV 219 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LV 219 (1630)
+.||+|+||.||+.. ......+++.||+|++..... .....+.+|+++|++++ ||||++++++|.....+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~---~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVR---KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN--HPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEE---EeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC--CCCcccEEEEEEcCCEEEEE
Confidence 679999999997632 223456889999999986432 23345667889988875 99999999999999999999
Q ss_pred EecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 220 MDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 220 mEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
|||+.++.|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 9999988888777767789999999999999999999999999999999999999999999999999987543210
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i 379 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 153 ----------~~~~~~~g~~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 153 ----------KKAYSFCGTVEYMAPEVVNRRG------------HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ----------CceecccCChhhcCHHHHcCCC------------CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 1122356899999999987644 788999999999999999999999988888777777
Q ss_pred HhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 380 ~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
....... +..+++++.+||.+||+.||++||++.+
T Consensus 211 ~~~~~~~-------p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 LKAKLGM-------PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HcCCCCC-------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 6544322 2357899999999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=344.23 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=208.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.++.+++.||+|.+.+.. ......+.+|+.++..+ +||||++++++|.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~--~~~~i~~~~~~~~~ 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAV------VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG--DRRWITNLHYAFQD 72 (331)
T ss_pred CCceEEEEEEecCCeEEEE------EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC--CCCCCCceEEEEec
Confidence 4799999999999988865 5677889999999987532 22345577888888876 49999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
...+|+||||+.++.|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999998888877654 457999999999999999999999999999999999999999999999999998765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ........||+.|+|||++..... ....++.++|||||||++|+|++|+.||...+
T Consensus 153 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 153 LADG-------------TVQSNVAVGTPDYISPEILQAMED-------GKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCCC-------------CccccceeccccccCHHHHhhccc-------cccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 4321 001123468999999999874321 11237889999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
..+.+..+.......... .....+++++++||.+||..++.+ |+++.++++|-+
T Consensus 213 ~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 213 LVETYGKIMNHKEHFQFP--PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHHHHHHHcCCCcccCC--CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 777777766543222111 112347899999999998765544 789999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=341.32 Aligned_cols=246 Identities=19% Similarity=0.268 Sum_probs=204.3
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe----CC
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM----DS 214 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~----~~ 214 (1630)
..|++|+++.||. |. .+++.||||.+....... .+.+.+|+.+|++++ ||||+++++++.+ ..
T Consensus 26 ~~i~~g~~~~v~~------~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 26 VLIKENDQNSIYK------GI--FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID--SNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred eEEeeCCceEEEE------EE--ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC--CCCEEEEeeeEEecccCCC
Confidence 6789999887753 32 257899999988654433 356779999999976 9999999999877 45
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++||||+++++|..++.+...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+..
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 7899999999999998887777899999999999999999999984 999999999999999999999999999876432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. ....|+..|+|||++.+.. ..++.++|||||||++|||++|..||.+.+..
T Consensus 176 ~~-----------------~~~~~~~~y~aPE~~~~~~----------~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 176 PP-----------------FKNVNFMVYFSYKMLNDIF----------SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred cc-----------------ccccCcccccCHHHhhhcc----------ccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 11 1245788999999986521 12899999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
+++..+......++. +..+++++.+||.+||+.||++|||+.++++.|.+.
T Consensus 229 ~~~~~i~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 229 EIYDLIINKNNSLKL-----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHhcCCCCCC-----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 887777655433321 235789999999999999999999999999987754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=349.19 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=197.4
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|.+.+.... ....+.+|+.++..+. +||||++++++|.....+|+
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~~~~~~~~~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLL------VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLHSCFQTESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-CCCcCCceeeEEEeCCEEEE
Confidence 4699999888865 667788999999999865322 2345667888877764 69999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--- 150 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--- 150 (329)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---
Confidence 99999999888877777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC--------
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-------- 370 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-------- 370 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 151 -----------DTTSTFCGTPNYIAPEILRGED------------YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred -----------CccccccCCccccCHHHHcCCC------------CCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 1123357899999999987654 789999999999999999999999521
Q ss_pred -CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh------hhHHHHh
Q 000343 371 -SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF------SAMLATF 426 (1630)
Q Consensus 371 -~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa------~evL~~L 426 (1630)
........+...... .+..++.++.+||.+||+.||.+||++ .++++|-
T Consensus 208 ~~~~~~~~~i~~~~~~-------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 208 NTEDYLFQVILEKQIR-------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred ccHHHHHHHHhcCCCC-------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 112233333333221 223578899999999999999999985 6777773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=348.23 Aligned_cols=245 Identities=22% Similarity=0.268 Sum_probs=198.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHH-HHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDN-LRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~i-L~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||+ +.+..+++.||+|.+..... .....+..|... ++.+ .||||++++++|...+.+|
T Consensus 1 ~~lg~G~fg~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~--~h~~Iv~~~~~~~~~~~~~ 72 (325)
T cd05602 1 KVIGKGSFGKVLL------ARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV--KHPFLVGLHFSFQTADKLY 72 (325)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC--CCCCCCceeEEEEcCCeEE
Confidence 4699999888865 66778889999999876432 122233344433 3343 5999999999999999999
Q ss_pred EEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcccc
Q 000343 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
+||||+.++.+..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 73 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 999999999888888777789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~ 377 (1630)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+.+.
T Consensus 151 ------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 151 ------------GTTSTFCGTPEYLAPEVLHKQP------------YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred ------------CCcccccCCccccCHHHHcCCC------------CCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 1123456899999999987654 7899999999999999999999999888888777
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+...... ..+.+++++.+||.+||+.||.+||++.+.+..+.
T Consensus 207 ~i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 207 NILNKPLQ-------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHHhCCcC-------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 77554221 12357899999999999999999999885544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=336.72 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=210.3
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
...+|++.+.||+|+||.||. +.+..+++.||+|++..........+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~------~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~--h~~ii~~~~~~~~~ 78 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYK------ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK--HCNIVAYFGSYLSR 78 (267)
T ss_pred chhhcchhheeecCCCeEEEE------EEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC--CCCeeeeeEEEEeC
Confidence 346899999999999887754 6677788999999988655555567788999998875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+++||||++++.|..++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..+..
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999998888777667899999999999999999999999999999999999999999999999999986542
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......|++.|+|||.+.... ...++.++|+|||||++|+|++|..||......
T Consensus 159 ~~--------------~~~~~~~~~~~y~~PE~~~~~~---------~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 159 TI--------------AKRKSFIGTPYWMAPEVAAVEK---------NGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred cc--------------cccCccccCccccCHhHccccc---------CCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 11 0112345788999999875422 112678999999999999999999999765544
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+....+......++... ....++.++.+||.+||..+|++|||++++++|++
T Consensus 216 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 33332222222222111 12347889999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=337.04 Aligned_cols=222 Identities=19% Similarity=0.196 Sum_probs=196.5
Q ss_pred cCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHH
Q 000343 521 RGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELL 600 (1630)
Q Consensus 521 ~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL 600 (1630)
.++.+++++|++.+ + +..|.+|.||||+|+..|+.+++++|+++|++++.. + +.||||+|+..|+.+++++|+
T Consensus 9 ~~~~~~~~~Lis~~-a--~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~--d--~~TpLh~Aa~~g~~eiV~lLL 81 (284)
T PHA02791 9 WKSKQLKSFLSSKD-A--FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLL--E--NEFPLHQAATLEDTKIVKILL 81 (284)
T ss_pred cCHHHHHHHHHhCC-C--CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCC--C--CCCHHHHHHHCCCHHHHHHHH
Confidence 47889999999853 3 578999999999999999999999999999998764 2 579999999999999999999
Q ss_pred HcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCC-CcHHHHHHHcCCHHHHHHHHHhcCccccccc
Q 000343 601 LAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE-LTPLHLCVATWNVAVVKRWVEVASPEEIVNV 679 (1630)
Q Consensus 601 ~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G-~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~ 679 (1630)
.+|+++|.+|..|.||||+|+..++.+++++|+++|+ +++..+..| .||||+|+..++.+++++|++.+
T Consensus 82 ~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~ga--din~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~-------- 151 (284)
T PHA02791 82 FSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNW--RLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEI-------- 151 (284)
T ss_pred HCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCC--CcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcC--------
Confidence 9999999999999999999999999999999999997 667778777 48999999988887777776532
Q ss_pred cCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCccc-ccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCC
Q 000343 680 IDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD-AQNRTALHIASMANDVELVKIILDAGVDVNIRNVHN 758 (1630)
Q Consensus 680 ~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D-~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G 758 (1630)
.+. .| ..|.||||+|+..|+.+++++||++|||+|.+|..|
T Consensus 152 ------------------------------------~~~--~d~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~g 193 (284)
T PHA02791 152 ------------------------------------PST--FDLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSLL 193 (284)
T ss_pred ------------------------------------Ccc--cccccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccCCC
Confidence 211 12 248999999999999999999999999999999999
Q ss_pred CCH-HHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHH
Q 000343 759 TIP-LHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798 (1630)
Q Consensus 759 ~TP-LH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlA 798 (1630)
.|| ||+|+.+|+.+++++||++|||+|++|..| |+|+.|
T Consensus 194 ~t~~L~~Aa~~~~~e~v~lLl~~Ga~in~~~~~~-~~l~~~ 233 (284)
T PHA02791 194 FIPDIKLAIDNKDLEMLQALFKYDINIYSVNLEN-VLLDDA 233 (284)
T ss_pred CChHHHHHHHcCCHHHHHHHHHCCCCCccCcccC-ccCCCH
Confidence 987 999999999999999999999999999954 888554
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=352.19 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=201.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+..+|++++.||+|+||.||+. .. .+..++..||+|.+... ....+|+++|+.++ ||||++++++|...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~--~~--~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~--h~~iv~~~~~~~~~ 158 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVC--TK--HGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS--HRAIINLIHAYRWK 158 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEE--EE--cCCccceeEEEEecccc-----ccHHHHHHHHHhcC--CCCccceeeeEeeC
Confidence 4568999999999999999752 21 23456789999987653 23568999999975 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|++|||+.++++..+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 159 ~~~~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CEEEEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999999999987766655 5556799999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA- 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~- 372 (1630)
.. .........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+...
T Consensus 238 ~~------------~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 238 HP------------DTPQCYGWSGTLETNSPELLALDP------------YCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred cc------------ccccccccccccCccCHhHhcCCC------------CCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 21 011123457899999999987654 78999999999999999999999976432
Q ss_pred --HHHHHHHHhcCCC-CCC-----------------------c--c-cccCCCCCHHHHHHHHHhhccCcCCCCChhhHH
Q 000343 373 --EEIYRAVVKNRKL-PPQ-----------------------Y--A-SIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 373 --~ei~~~i~~~~~~-~~~-----------------------~--~-~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL 423 (1630)
...+..+.+.... +.. + . ......++.++.+||.+||..||++|||+.++|
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 2222222221100 000 0 0 001124567899999999999999999999999
Q ss_pred HHhh
Q 000343 424 ATFL 427 (1630)
Q Consensus 424 ~~L~ 427 (1630)
.|-+
T Consensus 374 ~~p~ 377 (392)
T PHA03207 374 SLPL 377 (392)
T ss_pred hCch
Confidence 9844
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=333.48 Aligned_cols=222 Identities=29% Similarity=0.405 Sum_probs=190.4
Q ss_pred chhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccC--------CCC
Q 000343 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVL--------DKD 544 (1630)
Q Consensus 473 h~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~--------D~~ 544 (1630)
.+|++.|.+..+..|+.+..+ .-+.++++. ..+|.|||.+||++||.++|++||++.++++... ..+
T Consensus 9 ~naa~~g~l~~l~~ll~~~s~----~ei~~l~~~-~~~g~tPL~iaaRnGH~~vVeyLle~~~a~~e~~GsV~FDge~Ie 83 (615)
T KOG0508|consen 9 INAARDGKLQLLAKLLINSSN----EEIISLIGE-VQNGGTPLLIAARNGHADVVEYLLEHCRASPEQGGSVRFDGETIE 83 (615)
T ss_pred HHHhhhhhHHHHHHHHhCCch----HHHHHHhcc-ccCCCCceeeehhcCcHHHHHHHHHHhcCCccCCceEEeCCcccC
Confidence 478999999999999865332 224444443 5578899999999999999999999877766543 457
Q ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC
Q 000343 545 GDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624 (1630)
Q Consensus 545 G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g 624 (1630)
|.+||-.|+..||+++|+.|+++||++|...+. ..|||..||.-|+++++|+|+++|||++..|..|.|.||+|+.+|
T Consensus 84 gappLWaAsaAGHl~vVk~L~~~ga~VN~tT~T--NStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykG 161 (615)
T KOG0508|consen 84 GAPPLWAASAAGHLEVVKLLLRRGASVNDTTRT--NSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKG 161 (615)
T ss_pred CCchhhHHhccCcHHHHHHHHHhcCcccccccc--CCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccC
Confidence 899999999999999999999999999876433 458999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchh
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704 (1630)
Q Consensus 625 ~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~ 704 (1630)
|.+++++|++.|+ ++|.++..|+|+||.|+..|+++++++|+.+++. ++..+.+.|||..|+. .+.
T Consensus 162 h~~I~qyLle~gA--Dvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~------i~~d~~GmtPL~~Aa~------tG~ 227 (615)
T KOG0508|consen 162 HVDIAQYLLEQGA--DVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAK------IDVDGHGMTPLLLAAV------TGH 227 (615)
T ss_pred chHHHHHHHHhCC--CcchhcccCchHHHhhhhcccHHHHHHHHhCCce------eeecCCCCchHHHHhh------hcc
Confidence 9999999999998 7889999999999999999999999999999875 4455667788887765 345
Q ss_pred HHHHHHHHhcC
Q 000343 705 RELVRILLTAG 715 (1630)
Q Consensus 705 ~eiVklLL~~G 715 (1630)
.++|.+|+..-
T Consensus 228 ~~iVe~L~~~~ 238 (615)
T KOG0508|consen 228 TDIVERLLQCE 238 (615)
T ss_pred hHHHHHHhcCC
Confidence 78999999643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.53 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=222.1
Q ss_pred ccCCeEE-EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 134 VHHDVKL-VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~y~~-~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
|.+-|++ .+.||+|+|+.|-- +....++..+|||+|.+.......++.+|++++.+++ .|+||++|+++|++
T Consensus 75 F~d~YkLt~e~LGeGAyasVqt------cv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-gh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQT------CVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-GHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhHHHHhcCccceeeee------eeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-CCccHHHHHHHhcc
Confidence 4456666 46799999888742 4567889999999999887777889999999999998 79999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC---cEEEeecceee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG---RAVVSDYGLAA 289 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g---~vKL~DFGla~ 289 (1630)
+..+|||||-+.||.+..++.++..|++.++.++.++|+.||+|||.+||.||||||+|||..+.+ -+|||||.+..
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999998888887778899999999999999999999999999999999999997654 48999999876
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
-+... ..+. ........+.+|+..|||||++.- +.++..-|+++.|.||||+|||.|++|++||.+
T Consensus 228 g~k~~------~~~s-pastP~L~tPvGSAEfMAPEVVd~-------fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 228 GIKLN------NDCS-PASTPELLTPVGSAEFMAPEVVDV-------FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred ccccC------CCCC-CCCCccccCcccchhhcchhHHhh-------hccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 54321 1111 112334567889999999998753 223344599999999999999999999999964
Q ss_pred CC---------------HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 370 LS---------------AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~---------------~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.- ...++..|-.+....|. ..+..++.++++|++.+|..|+.+|.++.++++|..
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd---kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD---KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh---hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 31 24577788777765543 234568999999999999999999999999999754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=354.63 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=206.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||.... +.-.+..++..||+|.+...... ....+.+|+++++.+. +||||+++++++....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~-~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATA-FGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-QHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEE-ecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-cCCceeeEeeEecCCC
Confidence 5899999999999999865221 11113445678999998764322 2456778999999874 5999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC-----------------------------------------------------------
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE----------------------------------------------------------- 235 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~----------------------------------------------------------- 235 (1630)
.+|+|||||+++.|..++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999988887765321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCC
Q 000343 236 -----------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304 (1630)
Q Consensus 236 -----------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~ 304 (1630)
.++++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-------- 267 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-------- 267 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--------
Confidence 2478889999999999999999999999999999999999999999999999976543210
Q ss_pred CCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcC
Q 000343 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNR 383 (1630)
Q Consensus 305 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~ 383 (1630)
........++..|+|||++.+.. ++.++|||||||++|+|++ |..||........+..+....
T Consensus 268 ----~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~ 331 (374)
T cd05106 268 ----YVVKGNARLPVKWMAPESIFDCV------------YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331 (374)
T ss_pred ----eeeccCCCCccceeCHHHhcCCC------------CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc
Confidence 01112233567899999986544 7899999999999999997 999998765544444444332
Q ss_pred CCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 384 KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 384 ~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
..+. .+..+++++.+++.+||+.||.+|||+.++++.|.+.+
T Consensus 332 ~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMS-----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCcc-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 2211 12246899999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=347.91 Aligned_cols=242 Identities=22% Similarity=0.297 Sum_probs=197.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|.+..... .....+.+|..++.+. ++||||++++++|...+.+|+
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~-~~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLL------AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN-VKHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHh-CCCCCCccEEEEEecCCEEEE
Confidence 4689999888865 66778899999999876422 2223444555443322 359999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+.++.+..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 150 (325)
T cd05604 74 VLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--- 150 (325)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---
Confidence 99999999888877777789999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+++..
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (325)
T cd05604 151 -----------DTTTTFCGTPEYLAPEVIRKQP------------YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207 (325)
T ss_pred -----------CCcccccCChhhCCHHHHcCCC------------CCCcCccccccceehhhhcCCCCCCCCCHHHHHHH
Confidence 1123456899999999987654 78899999999999999999999998888888777
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHH
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL 423 (1630)
+...... ..+..+.++.++|.+||+.+|.+||++.+.+
T Consensus 208 ~~~~~~~-------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 208 ILHKPLV-------LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHcCCcc-------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 7654321 1235788999999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=351.77 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=209.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.++.+++.||+|.+..... .....+.+|+.+++.+. ||||+++++++.+
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~------~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~--hp~iv~~~~~~~~ 114 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--SPWVVQLFYAFQD 114 (371)
T ss_pred hhcEEEEEEeecCCeEEEE------EEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC--CCCCCeEEEEEEc
Confidence 6999999999999988865 66788999999999875322 22345667888888865 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||++++.|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999988877765 358999999999999999999999999999999999999999999999999998754
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... .......+||+.|+|||++.+... ...++.++|||||||++|||++|..||...+.
T Consensus 194 ~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~--------~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 194 KEG-------------MVRCDTAVGTPDYISPEVLKSQGG--------DGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred cCC-------------cccccCcccCccccCHHHHhccCC--------CccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 221 011234578999999999875421 11278999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
...+..+......... .....++.++++||.+||..++.+ |+++.++++|.+
T Consensus 253 ~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 253 VGTYSKIMNHKNSLTF---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHHHHHHcCCCcccC---CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 8788777654322111 112357899999999999844443 789999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=347.43 Aligned_cols=258 Identities=19% Similarity=0.317 Sum_probs=205.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.++||+|+||.||+ +.+..++..+|+|.+..... .....+.+|+++++.++ ||||++++++|...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 75 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFK------VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSD 75 (333)
T ss_pred hhhhheeccccCCCCEEEEE------EEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC--CCcccceeEEEEEC
Confidence 36899999999999888865 56778899999998876422 22456889999999975 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+.+++||||+.+++|..++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999998888887777899999999999999999999985 79999999999999999999999999986543
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.. ......||..|+|||++.+.. ++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~----------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 156 DS----------------MANSFVGTRSYMSPERLQGTH------------YSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hh----------------ccccCCCCccccCHHHhcCCC------------CCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 21 112346899999999987644 78899999999999999999999976554
Q ss_pred HHHHHHHHh---cCCC-----------------------CC-------------CcccccCCCCCHHHHHHHHHhhccCc
Q 000343 373 EEIYRAVVK---NRKL-----------------------PP-------------QYASIVGVGIPRELWKMIGECLQFKA 413 (1630)
Q Consensus 373 ~ei~~~i~~---~~~~-----------------------~~-------------~~~~~~~~~l~~el~~LI~~cL~~dP 413 (1630)
.+....+.. +... +. .........++.++++||.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 287 (333)
T cd06650 208 KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287 (333)
T ss_pred hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCc
Confidence 333211100 0000 00 00000011356889999999999999
Q ss_pred CCCCChhhHHHHhhh
Q 000343 414 SKRPTFSAMLATFLR 428 (1630)
Q Consensus 414 ~~RPSa~evL~~L~~ 428 (1630)
++|||+.|++.|-+-
T Consensus 288 ~~Rpt~~ell~h~~~ 302 (333)
T cd06650 288 AERADLKQLMVHAFI 302 (333)
T ss_pred ccCcCHHHHhhCHHH
Confidence 999999999998553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=348.84 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=201.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||. +.+..+++.||||++...... ....+.+|+.+++.++ ||||++++++|.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 86 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCA------AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFT 86 (355)
T ss_pred hhhceeEEEEeeecCCEEEEE------EEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC--CCchhceeeeee
Confidence 457999999999999888754 567788999999998764322 2456678898888875 999999999986
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ..+|++|||+++++...+.. .+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 87 PQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeC
Confidence 54 35799999999887765542 4899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 164 g~~~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 164 GLARTAGTSF---------------MMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cccccCCCcc---------------ccCCccccCCccCHHHHcCCC------------CCchhhHHHHHHHHHHHHhCCC
Confidence 9997543211 122356899999999987644 7899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCC-------------------C---------c-------ccccCCCCCHHHHHHHHHhhc
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPP-------------------Q---------Y-------ASIVGVGIPRELWKMIGECLQ 410 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~-------------------~---------~-------~~~~~~~l~~el~~LI~~cL~ 410 (1630)
||.+.+..+.+..+......+. . . ........+.++++||.+||+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 9988765444433322111000 0 0 000112245678999999999
Q ss_pred cCcCCCCChhhHHHHhh
Q 000343 411 FKASKRPTFSAMLATFL 427 (1630)
Q Consensus 411 ~dP~~RPSa~evL~~L~ 427 (1630)
.||++|||+.|+++|.+
T Consensus 297 ~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 297 IDPAKRISVDEALQHPY 313 (355)
T ss_pred CCchhcCCHHHHhcCcc
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=355.00 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=198.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
...|.+.+.||+|+||.||+ +.+..+++.||||.... ..+.+|+++|++++ ||||+++++++....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~------a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~--HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFE------SSHPDYPQRVVVKAGWY------ASSVHEARLLRRLS--HPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEE------EEECCCCCEEEEecccc------cCHHHHHHHHHHCC--CCCCCcEEEEEEECC
Confidence 34799999999999888754 66778899999996432 23568999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
..+|+|||+.++++..+......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99999999988777776665567999999999999999999999999999999999999999999999999999865422
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC---
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS--- 371 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~--- 371 (1630)
. .........||+.|+|||++.+.. ++.++|||||||+||||++|..|+....
T Consensus 314 ~------------~~~~~~~~~GT~~Y~APE~~~~~~------------~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 314 W------------STPFHYGIAGTVDTNAPEVLAGDP------------YTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred c------------ccccccccCCCcCCcCHHHHcCCC------------CCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 1 001122457899999999987654 7899999999999999999876653211
Q ss_pred -----HHHHHHHHHhcCCCCCCcc------------------------ccc---CCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 372 -----AEEIYRAVVKNRKLPPQYA------------------------SIV---GVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 372 -----~~ei~~~i~~~~~~~~~~~------------------------~~~---~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
..++...+.........+. ... ...++.++.+||.+||++||.+|||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence 2233333322221111000 000 01345689999999999999999999
Q ss_pred hhHHHHh
Q 000343 420 SAMLATF 426 (1630)
Q Consensus 420 ~evL~~L 426 (1630)
.|+|+|-
T Consensus 450 ~elL~hp 456 (461)
T PHA03211 450 AELLRLP 456 (461)
T ss_pred HHHhhCc
Confidence 9999984
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=348.63 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=203.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||. +.+..+++.||||++..... .....+.+|+.+++.++ ||||++++++|.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~ 93 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCA------AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIIGLLNVFT 93 (364)
T ss_pred hhcceeEEEEeecCCCeEEEE------EEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC--CCCccccceeec
Confidence 457999999999999887754 56778899999999876432 23456678999988875 999999999886
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ..+|+||||+++++...+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 43 35899999999887766542 4889999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 171 G~a~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~~------------~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 171 GLARTAGTSF---------------MMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred CCccccCCCC---------------cccCCcccCCcCCHHHHhCCC------------CCchhhHHhHHHHHHHHHhCCC
Confidence 9997543211 123356799999999987654 7899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCC-------------------c----------------ccccCCCCCHHHHHHHHHhhc
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQ-------------------Y----------------ASIVGVGIPRELWKMIGECLQ 410 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~-------------------~----------------~~~~~~~l~~el~~LI~~cL~ 410 (1630)
||.+.+..+.+..+......+.. + ........+.++++||.+||+
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 303 (364)
T cd07875 224 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303 (364)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcC
Confidence 99988776666555442211100 0 000011234678999999999
Q ss_pred cCcCCCCChhhHHHHhh
Q 000343 411 FKASKRPTFSAMLATFL 427 (1630)
Q Consensus 411 ~dP~~RPSa~evL~~L~ 427 (1630)
.||++|||+.++|+|-+
T Consensus 304 ~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 304 IDASKRISVDEALQHPY 320 (364)
T ss_pred cCcccCCCHHHHhcCcc
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=354.16 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=204.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||+ +.+..+++.||||++..... .....+.+|+++|+.++ ||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 72 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWS------VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK--HDNVLSALDILQPPH 72 (372)
T ss_pred CCcccceeeeCCCEEEEE------EEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC--CCCcCCHhheecCCC
Confidence 578899999999888864 66778899999999865322 22456778999999875 999999999998776
Q ss_pred -----EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 215 -----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 215 -----~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
.+|+||||+.++++..+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 73 IDPFEEIYVVTELMQSDLHKII-VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred ccccceEEEEeeccccCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 79999999987665554 445679999999999999999999999999999999999999999999999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
...... ........+|+.|+|||++.+.. .++.++|||||||++|||++|+.||.+
T Consensus 152 ~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 152 VEEPDE-------------SKHMTQEVVTQYYRAPEILMGSR-----------HYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ecccCc-------------cccCCCCCcCCCcCCHHHHcCCC-----------CCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 653211 01122345789999999987643 278899999999999999999999988
Q ss_pred CCHHHHHHHHHhcCC-----------------------CCCCccc--ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHH
Q 000343 370 LSAEEIYRAVVKNRK-----------------------LPPQYAS--IVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~-----------------------~~~~~~~--~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~ 424 (1630)
.+..+.+..+..... .++.... ......++++.+||.+||+.||.+|||+.++++
T Consensus 208 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 776655554432111 1111000 122346789999999999999999999999999
Q ss_pred Hhh
Q 000343 425 TFL 427 (1630)
Q Consensus 425 ~L~ 427 (1630)
|.+
T Consensus 288 hp~ 290 (372)
T cd07853 288 HPY 290 (372)
T ss_pred CHh
Confidence 854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=339.93 Aligned_cols=264 Identities=19% Similarity=0.221 Sum_probs=202.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc------------ccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG------------GQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRN 202 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a------------~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpN 202 (1630)
++|.+.++||+|+||.||+. .+.. ....++..||+|.+...... ....+.+|+++|..++ |||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~--~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~n 80 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLC--EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK--DPN 80 (304)
T ss_pred hhCeeeeEecccCCeEEEEE--EeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC--CCC
Confidence 58999999999999999752 2211 11234558999998764322 2456788999999875 999
Q ss_pred cceeEEEEEeCCEEEEEEecCCCChHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 000343 203 VCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNE-------------------GRLTLEQILRYGADIARGVVELHAAGVV 263 (1630)
Q Consensus 203 IV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~-------------------~~L~~~~~~~i~~QIl~aL~yLHs~gII 263 (1630)
|+++++++......+++|||+.++.|..++... ..+++..+..++.||+.||+|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999988887766432 1367788999999999999999999999
Q ss_pred cccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCC
Q 000343 264 CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343 (1630)
Q Consensus 264 HRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~ 343 (1630)
||||||+|||++.++.+||+|||+++.+.... .........++..|+|||++....
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------ 216 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD------------YYRIQGRAVLPIRWMAWECILMGK------------ 216 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc------------eeEecCcCCCCccccCHHHHhcCC------------
Confidence 99999999999999999999999997654321 011122334578899999987644
Q ss_pred CCccccchhhhhHHHHHhh--CCCCCCCCCHHHHHHHHHhcCCCC-CCcccccCCCCCHHHHHHHHHhhccCcCCCCChh
Q 000343 344 ISPESDAWSFGCTLVEMCT--GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 344 ~t~ksDIWSlGvILyemlt--G~~PF~~~~~~ei~~~i~~~~~~~-~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
++.++||||||+++|+|++ +..||...+..+.+..+....... .......+..++..+.+||.+||+.||++|||+.
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 7899999999999999987 678898877666554433211100 0000112235788999999999999999999999
Q ss_pred hHHHHhh
Q 000343 421 AMLATFL 427 (1630)
Q Consensus 421 evL~~L~ 427 (1630)
++.+.|.
T Consensus 297 ~i~~~l~ 303 (304)
T cd05096 297 DIHAFLT 303 (304)
T ss_pred HHHHHHh
Confidence 9987764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=363.20 Aligned_cols=255 Identities=19% Similarity=0.258 Sum_probs=209.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|.+.+.||+|+||.||+ +.+..+++.||||.+...... ....+.+|+..|..+. |+||+++++.|..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~------a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~--h~~iv~~~~~~~~ 102 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLC------AKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD--FFSIVKCHEDFAK 102 (496)
T ss_pred CCCEEEEEEEecCCCEEEEE------EEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC--CCcEEEeecceec
Confidence 35999999999999888864 567788999999998765332 2345667888887764 9999999988754
Q ss_pred CC--------EEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcE
Q 000343 213 DS--------CLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRA 280 (1630)
Q Consensus 213 ~~--------~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~v 280 (1630)
.. .+++||||+++++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 32 37899999998888776543 3469999999999999999999999999999999999999999999
Q ss_pred EEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHH
Q 000343 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360 (1630)
Q Consensus 281 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyem 360 (1630)
||+|||+++.+.... .........||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 183 kL~DFGls~~~~~~~------------~~~~~~~~~Gt~~Y~aPE~~~~~~------------~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 183 KLGDFGFSKMYAATV------------SDDVGRTFCGTPYYVAPEIWRRKP------------YSKKADMFSLGVLLYEL 238 (496)
T ss_pred EEEecccCeeccccc------------cccccccccCCcceeCHHHhCCCC------------CCcHHHHHHHHHHHHHH
Confidence 999999998754321 011123457899999999987654 78999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 361 CTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 361 ltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++|+.||.+.+..+++..+..+...+ .+..+++++.+|+.+||+.||.+||++.++++|..
T Consensus 239 ltG~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 239 LTLKRPFDGENMEEVMHKTLAGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred HHCCCCCCCCCHHHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 99999999988888877776654322 23467899999999999999999999999998843
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=338.11 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=207.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.++||+|+||.||+ +.+..+++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYK------GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK--HANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEE------EEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC--CCCcceEEEEEecC
Confidence 46899999999999887754 66778899999999876532 23456778999999876 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+.++++..+......+++..++.++.||++||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99999999999877766665556799999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......+++.|+|||++.+.. .++.++||||||+++|+|++|++||...+..
T Consensus 157 ~~--------------~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~ 211 (301)
T cd07873 157 PT--------------KTYSNEVVTLWYRPPDILLGST-----------DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211 (301)
T ss_pred CC--------------CcccccceeecccCcHHHhCCC-----------CCccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11 0112345688999999886532 2688999999999999999999999987776
Q ss_pred HHHHHHHhcCCCCC-------------------Cc----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPP-------------------QY----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~-------------------~~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+....+......+. .. .......+++++.+||.+||+.||.+|||++++++|-+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred HHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 65544433211110 00 00112357889999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=344.67 Aligned_cols=243 Identities=20% Similarity=0.269 Sum_probs=196.7
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHH-HHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLD-NLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~-iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||+ +.+..+++.||+|.+..... .....+.+|.. +++.+ +||||++++++|.+.+.+|
T Consensus 1 ~~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~--~h~~iv~~~~~~~~~~~~~ 72 (321)
T cd05603 1 KVIGKGSFGKVLL------AKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL--KHPFLVGLHYSFQTAEKLY 72 (321)
T ss_pred CeeeeCCCEEEEE------EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC--CCCCccceeeEEEcCCEEE
Confidence 4699999888765 66778899999999876432 12233444544 34444 5999999999999999999
Q ss_pred EEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcccc
Q 000343 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~ 297 (1630)
+||||++++.+..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 999999999888777777789999999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHH
Q 000343 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377 (1630)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~ 377 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+....+.
T Consensus 151 ------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 151 ------------ETTSTFCGTPEYLAPEVLRKEP------------YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred ------------CccccccCCcccCCHHHhcCCC------------CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 1123356899999999987644 7889999999999999999999999888877777
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChh----hHHHH
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS----AMLAT 425 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~----evL~~ 425 (1630)
.+...... .+...+.++.++|.+||+.||.+||++. ++++|
T Consensus 207 ~i~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 207 NILHKPLQ-------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHhcCCCC-------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 77654321 1235678999999999999999999875 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=341.27 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=208.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.++.+++.||+|.+.+.. ......+.+|+.++..+. ||||+++++++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~l~~~~~~ 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAV------VKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD--CQWITTLHYAFQD 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEE------EEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEc
Confidence 4799999999999998865 5577889999999987532 222344667788877764 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
.+.+||||||+.|+.|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999888877765 467999999999999999999999999999999999999999999999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ........||+.|+|||++.+... ....++.++|||||||+||+|++|+.||...+
T Consensus 153 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 153 NQDG-------------TVQSSVAVGTPDYISPEILQAMED-------GMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred cCCC-------------ceeeccccCCcccCCHHHHhcccc-------CCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 4321 011123568999999999875321 11127889999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
..+.+..+.......+. .. ....+++++++||.+||..++.+ |++++++++|.+
T Consensus 213 ~~~~~~~i~~~~~~~~~-p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 213 LVETYGKIMNHEERFQF-PS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred HHHHHHHHHcCCCcccC-CC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 87777777654322211 11 11347899999999999876655 468899988843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=347.84 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=200.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+|+++++||+|+||.||+ +.+..+++.||||.+...... ....+.+|+++|+.++ ||||++++++|...
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 144 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYK------VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN--HPNVVKCHDMFDHN 144 (353)
T ss_pred HHHHhhhhhccCCCCeEEEE------EEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC--CCCcceeeeEeccC
Confidence 46899999999999888864 566778999999998754322 2456788999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+.+++|... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 145 ~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999999999877532 2467888899999999999999999999999999999999999999999999986542
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......||..|+|||++.... ......+.++|||||||++|||++|+.||......
T Consensus 221 ~~--------------~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 279 (353)
T PLN00034 221 TM--------------DPCNSSVGTIAYMSPERINTDL-------NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279 (353)
T ss_pred cc--------------ccccccccCccccCcccccccc-------ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 11 0122356899999999875422 11122467999999999999999999999743322
Q ss_pred ---HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 ---EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ---ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.....+..... + .....++.++.+||.+||+.||++|||+.|+++|-+
T Consensus 280 ~~~~~~~~~~~~~~--~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 280 DWASLMCAICMSQP--P----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred cHHHHHHHHhccCC--C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 22222222111 1 122357899999999999999999999999999855
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.63 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=213.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
-..+|.++..||+|+||+|.| |..+.+.+.+|||++++.- ..+.+--..|.++|.... +-|++++|+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlL------aerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~-kppFL~qlHScF 419 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLL------AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLVQLHSCF 419 (683)
T ss_pred eecccceEEEeccCccceeee------ecccCcchhhhhhhhccceeeecCcccceehhhhheecCC-CCchHHHHHHHh
Confidence 346899999999999999976 6678889999999988762 222333345667766654 578999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
++.+.+|+||||+.||+|.+.+++-+++.+..+..|+.+|+-||-|||++|||+||||.+|||+|.+|++||+|||+++.
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999974
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
--- ....+.+.+|||.|+|||++...+ |+.++|+||||++||||+.|++||.+.
T Consensus 500 ni~--------------~~~TTkTFCGTPdYiAPEIi~YqP------------YgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 500 NIF--------------DGVTTKTFCGTPDYIAPEIIAYQP------------YGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred ccc--------------CCcceeeecCCCcccccceEEecc------------cccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 211 122356789999999999998765 899999999999999999999999999
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
++.++++.|.......| ..++.++.++++..|...|.+|..+
T Consensus 554 DE~elF~aI~ehnvsyP-------KslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYP-------KSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred CHHHHHHHHHHccCcCc-------ccccHHHHHHHHHHhhcCCccccCC
Confidence 99999999987765444 3588999999999999999999754
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=332.58 Aligned_cols=237 Identities=14% Similarity=0.154 Sum_probs=207.6
Q ss_pred ccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcC
Q 000343 477 SEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAG 556 (1630)
Q Consensus 477 ~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G 556 (1630)
..++.+.++.|++.+++ .+|.+|.||||+||..|+.+++++|++. +++++.. +|.||||+|+..|
T Consensus 8 ~~~~~~~~~~Lis~~a~------------~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~-ga~~n~~--d~~TpLh~Aa~~g 72 (284)
T PHA02791 8 TWKSKQLKSFLSSKDAF------------KADVHGHSALYYAIADNNVRLVCTLLNA-GALKNLL--ENEFPLHQAATLE 72 (284)
T ss_pred ccCHHHHHHHHHhCCCC------------CCCCCCCcHHHHHHHcCCHHHHHHHHHC-cCCCcCC--CCCCHHHHHHHCC
Confidence 34677888888887653 4789999999999999999999999985 4667765 4789999999999
Q ss_pred CHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-ChhhhhhhcCChHHHHHHHHc
Q 000343 557 SPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGE-SVLHRAVAKKYTDCAIVILEN 635 (1630)
Q Consensus 557 ~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~-TPLH~Aa~~g~~eiv~~LL~~ 635 (1630)
+.+++++|+++|++++.. +..|.||||+|+..|+.+++++|+++|+++|.++..|. ||||+|+..++.+++++|+++
T Consensus 73 ~~eiV~lLL~~Gadvn~~--d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~ 150 (284)
T PHA02791 73 DTKIVKILLFSGMDDSQF--DDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSE 150 (284)
T ss_pred CHHHHHHHHHCCCCCCCC--CCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhc
Confidence 999999999999999874 56789999999999999999999999999999999884 899999999999999999998
Q ss_pred CCcccccccc-CCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhc
Q 000343 636 GGCRSMAILN-SKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTA 714 (1630)
Q Consensus 636 Ga~~~i~~~d-~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~ 714 (1630)
++. . .| ..|.||||+|+..|+. +++++|+++
T Consensus 151 ~~~--~--~d~~~g~TpLh~Aa~~g~~--------------------------------------------eiv~lLL~~ 182 (284)
T PHA02791 151 IPS--T--FDLAILLSCIHITIKNGHV--------------------------------------------DMMILLLDY 182 (284)
T ss_pred CCc--c--cccccCccHHHHHHHcCCH--------------------------------------------HHHHHHHHC
Confidence 752 1 23 3589999999987664 566677788
Q ss_pred CCCCCcccccCccc-hhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCC
Q 000343 715 GAEPTAQDAQNRTA-LHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785 (1630)
Q Consensus 715 GAdvn~~D~~G~Tp-LH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN 785 (1630)
||++|.+|..|.|| ||+|+..|+.+++++||++|||+|++|.. .||| ++.|++++||++-++..
T Consensus 183 gAd~n~~d~~g~t~~L~~Aa~~~~~e~v~lLl~~Ga~in~~~~~-~~~l------~~~e~~~~ll~~~~~~~ 247 (284)
T PHA02791 183 MTSTNTNNSLLFIPDIKLAIDNKDLEMLQALFKYDINIYSVNLE-NVLL------DDAEIAKMIIEKHVEYK 247 (284)
T ss_pred CCCCCcccCCCCChHHHHHHHcCCHHHHHHHHHCCCCCccCccc-CccC------CCHHHHHHHHHhhhhhc
Confidence 89999999999987 99999999999999999999999999984 4777 88899999999977653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=332.34 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=207.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+|++.+.||+|+||.||. ..++ .....+..||+|.++..... ....+.+|+..++.++ ||||+++++++..+.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~--~~~~-~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCR--GCLK-LPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD--HSNIVRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEE--EEEe-cCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEecCC
Confidence 4799999999999999964 2222 12345679999998865322 2346778888888864 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++||||++++++..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999988877655 45799999999999999999999999999999999999999999999999998754321
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
.. ........++..|+|||.+.+.. ++.++|||||||++||+++ |..||...+.
T Consensus 160 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 160 EA-------------IYTTMSGKSPVLWAAPEAIQYHH------------FSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred cc-------------hhcccCCCCceeecCHHHHhhCC------------ccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 10 00111233467899999987654 7899999999999999775 9999998888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.+....+..+...+ .+..++..+.+++.+||+.+|++||++.++++.|..
T Consensus 215 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 215 QDVIKAVEDGFRLP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 77777765543222 134578999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=348.20 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=198.5
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhc-cCCCCcceeEEEEEeCCEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMDSCLGLV 219 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~~~~~LV 219 (1630)
||+|+||.||+ +.++.+++.||||++....... ......|..++.... .+||||++++++|.....+|+|
T Consensus 1 lG~G~~g~Vy~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv 74 (330)
T cd05586 1 IGKGTFGQVYQ------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV 74 (330)
T ss_pred CCCCCceEEEE------EEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence 79999888764 6678889999999987643222 223344556665542 2599999999999999999999
Q ss_pred EecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 220 MDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 220 mEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
|||+.++.|..++.+.+.+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 9999998888777777789999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i 379 (1630)
......+||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+..+.+..+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 151 ----------KTTNTFCGTTEYLAPEVLLDEK-----------GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred ----------CCccCccCCccccCHHHHcCCC-----------CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 1123456899999999986533 2788999999999999999999999988888877777
Q ss_pred HhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC----ChhhHHHH
Q 000343 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP----TFSAMLAT 425 (1630)
Q Consensus 380 ~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP----Sa~evL~~ 425 (1630)
..+....+. ..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 210 ~~~~~~~~~------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 210 AFGKVRFPK------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HcCCCCCCC------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 665433221 24688999999999999999998 46666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=333.94 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=209.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccc-cccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~-~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||.. ...+. ...+...||+|.+...... ....+.+|+.++..++ ||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~--~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKG--ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ--HPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEE--EEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC--CcccceEEEEEcCC
Confidence 48999999999999998652 22211 2344578999988754322 2456788999998875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
...+++|||++++.|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999988887766542 458889999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++...... .........+++.|+|||.+.+.. ++.++|||||||++
T Consensus 161 ~~~~L~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~sDv~slG~il 216 (283)
T cd05048 161 LTVKISDFGLSRDIYSAD------------YYRVQSKSLLPVRWMPPEAILYGK------------FTTESDIWSFGVVL 216 (283)
T ss_pred CcEEECCCcceeeccccc------------cccccCCCcccccccCHHHhccCc------------CchhhhHHHHHHHH
Confidence 999999999997653221 011123345678899999987644 78999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
|||++ |..||.+.+..++...+......+ .+..+++++.+|+.+||+.||.+||++.+++++|..
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 217 WEIFSYGLQPYYGFSNQEVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 99998 999999888888777766543221 134688999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=344.06 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=197.8
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||+ +.+..+++.||+|.+..... .....+.+|+.++.++. +||||++++++|.....+|+
T Consensus 1 ~~lG~G~~g~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLL------VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-SNPFLVGLHSCFQTTSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEE------EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-CCCCEeeEEEEEEeCCEEEE
Confidence 4699999988865 56778899999999986532 22345678888888875 59999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 74 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 150 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--- 150 (327)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---
Confidence 99999999888877776789999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC------C-
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL------S- 371 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~------~- 371 (1630)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||... .
T Consensus 151 -----------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~ 207 (327)
T cd05617 151 -----------DTTSTFCGTPNYIAPEILRGEE------------YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207 (327)
T ss_pred -----------CceecccCCcccCCHHHHCCCC------------CCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence 1123456899999999987654 789999999999999999999999532 1
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh------hhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF------SAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa------~evL~~L 426 (1630)
....+..+...... .+..++..+.++|.+||+.||.+|+++ .++++|.
T Consensus 208 ~~~~~~~~~~~~~~-------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 208 EDYLFQVILEKPIR-------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred HHHHHHHHHhCCCC-------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 22233333322111 223578999999999999999999985 4777763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=350.89 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=225.7
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
....|.+.++||+|.|+.|.+ +++..++..||||.+.+...+. ...+.+|+++|+.+. |||||+++.+..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~L------a~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~--HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKL------ARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN--HPNIVKLFSVIE 125 (596)
T ss_pred cccceeeeeeeccceeEEEEe------eEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC--Ccceeeeeeeee
Confidence 346899999999999988866 6788899999999998875543 244778999999975 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
....+|+||||+.++.++.++.+.+++.+.+++.++.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ......+|+++|.|||++.+..+ -++.+|+||+|++||-|+.|.+||.+.+
T Consensus 206 ~~~---------------~~lqt~cgsppyAaPEl~~g~~y-----------~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 206 DYG---------------LMLQTFCGSPPYAAPELFNGKKY-----------DGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccc---------------ccccccCCCCCccChHhhcCccc-----------CCcceehhhhhhhheeeeecccccCCcc
Confidence 642 23456789999999999998774 4789999999999999999999999998
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..++-...+.+...-+.+ ++.++.+||+++|..+|.+|++++++++|...
T Consensus 260 lk~Lr~rvl~gk~rIp~~-------ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 260 LKELRPRVLRGKYRIPFY-------MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred cccccchheeeeecccce-------eechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 888877777776655543 67899999999999999999999999988543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=326.88 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=209.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-----ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-----EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
++|++.+.||+|+||.||. +.+..+++.||+|.+...... ....+.+|+++++.+. ||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~------~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~ 73 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYL------CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ--HERIVQYYGCL 73 (263)
T ss_pred CcccccceecCCCceEEEE------EEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEE
Confidence 5799999999999887754 556788999999998754321 2346778999998875 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.....++++|||++++.+..++.....+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 74 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 74 RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred ccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999999988888777767899999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
...... .........|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 154 LQTICS-----------SGTGMKSVTGTPYWMSPEVISGEG------------YGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccc-----------ccccccCCCcCccccCcceeccCC------------CCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 542110 000112345788999999987644 789999999999999999999999877
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.......+......+ ..+..++.++.+||.+||..+|.+|||+.++++|.+
T Consensus 211 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 211 EAMAAIFKIATQPTNP-----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred chHHHHHHHhccCCCC-----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 6665555444332221 123457899999999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=349.96 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=211.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhcc----CCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM----WCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l----~HpNIV~l~~~f~~ 212 (1630)
+|++.+.||+|+||.| .+|.+..|++.||||+++.... ...+...|+.+|..++. +--|||+++++|..
T Consensus 187 rY~V~e~LGkGtFGQV------vk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQV------VKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEeccccccee------EEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 8999999999998876 4588999999999999986432 23455678999998872 12399999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC--CcEEEeecceee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS--GRAVVSDYGLAA 289 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~--g~vKL~DFGla~ 289 (1630)
.+++|||+|.+.-++.+.+..++ ..|+...++.|++||+.||.+||+.||||+||||+||||..- ..+||+|||.|+
T Consensus 260 r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 260 RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999999999999988887654 359999999999999999999999999999999999999744 379999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
...... -..+.+..|+|||++.+.+ |+.+.||||||||+.||++|.+.|.+
T Consensus 340 ~~~q~v-----------------ytYiQSRfYRAPEVILGlp------------Y~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRV-----------------YTYIQSRFYRAPEVILGLP------------YDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcc-----------------eeeeeccccccchhhccCC------------CCCccceeehhhhHHhHhcCccccCC
Confidence 765321 1456689999999999977 89999999999999999999999999
Q ss_pred CCHHHHHHHHHhcCCCCCCc------------cc-----------c----------------------cC-------C--
Q 000343 370 LSAEEIYRAVVKNRKLPPQY------------AS-----------I----------------------VG-------V-- 395 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~------------~~-----------~----------------------~~-------~-- 395 (1630)
.++.+++..|.+-...|+.. .. . .+ .
T Consensus 391 ~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~ 470 (586)
T KOG0667|consen 391 DNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGL 470 (586)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhc
Confidence 99988888877543332210 00 0 00 0
Q ss_pred --CCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 396 --GIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 396 --~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.-...+.+||.+||..||.+|+|+.++|+|-+-...
T Consensus 471 ~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 471 PKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred ccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 011357899999999999999999999999775533
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=335.44 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=202.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.|++.+.||+|+||.||+ +.+..+++.||+|++...... ....+.+|+.+++.++ ||||+++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~V~~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 72 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCA------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--SRFVVSLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCeEEEE------EEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC--CCCEeeeeeeecCC
Confidence 489999999999888764 556778999999998754322 2345667999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..+++||||+.+++|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||+++++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999999998888766543 246999999999999999999999999999999999999999999999999998765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......|++.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+
T Consensus 153 ~~~~---------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 153 PEGE---------------TIRGRVGTVGYMAPEVVKNER------------YTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CCCC---------------ccccccCCCCccCcHHhcCCC------------CCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 3211 112346899999999987544 7889999999999999999999998765
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
.......+.......+ ...+..+++.+.+||.+||+.||++|| +++++++|.+
T Consensus 206 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 206 EKVKREEVERRVKEDQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred hhhHHHHHHHHhhhcc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 5433322221110000 112235788999999999999999999 8889988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=335.14 Aligned_cols=242 Identities=21% Similarity=0.210 Sum_probs=194.3
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||+|+||.||+ +.+..+++.||+|++....... .+.+..|+++++.+. ||||++++++|.....+|+||
T Consensus 1 lg~G~~g~Vy~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~~~~~lv~ 72 (280)
T cd05608 1 LGKGGFGEVSA------CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH--SRFIVSLAYAFQTKTDLCLVM 72 (280)
T ss_pred CCCCCceeEEE------EEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC--CCcEeeeeEEEcCCCeEEEEE
Confidence 69999888865 5677889999999987653222 245667889988874 999999999999999999999
Q ss_pred ecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccc
Q 000343 221 DRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296 (1630)
Q Consensus 221 Ey~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 296 (1630)
||+++++|..++. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+....
T Consensus 73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 151 (280)
T cd05608 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ- 151 (280)
T ss_pred eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-
Confidence 9999988876553 23469999999999999999999999999999999999999999999999999997654321
Q ss_pred cCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH---
Q 000343 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE--- 373 (1630)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~--- 373 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 152 -------------~~~~~~~g~~~y~aPE~~~~~~------------~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 206 (280)
T cd05608 152 -------------SKTKGYAGTPGFMAPELLQGEE------------YDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206 (280)
T ss_pred -------------ccccccCCCcCccCHHHhcCCC------------CCccccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence 0122346899999999987654 788999999999999999999999764332
Q ss_pred -HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHh
Q 000343 374 -EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATF 426 (1630)
Q Consensus 374 -ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L 426 (1630)
.....+.... ...+..+++++.+|+.+||+.||++|| +++++++|-
T Consensus 207 ~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 207 KELKQRILNDS-------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred HHHHHhhcccC-------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 2222222111 112335789999999999999999999 678888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=332.34 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=208.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||. +.+..+++.||+|.++.........+.+|+.+++.++ ||||+++++.+.....
T Consensus 9 ~~~~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~--h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYK------ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK--HSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHhCCCCCeEEEE------EEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCE
Confidence 5899999999999887754 6677889999999988765445566788999988875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+|++|||++++.|..++...+.+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999999888887777789999999999999999999999999999999999999999999999999987654211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......|+..|+|||++.... ...++.++|+|||||++|+|++|..||........
T Consensus 161 --------------~~~~~~~~~~~y~aPE~~~~~~---------~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~ 217 (267)
T cd06645 161 --------------AKRKSFIGTPYWMAPEVAAVER---------KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred --------------cccccccCcccccChhhhcccc---------CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh
Confidence 1122346889999999874211 11278899999999999999999999976555444
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
..........++... ....++..+.+||.+||+.+|++||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 218 LFLMTKSNFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHhhhccCCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 333333332222211 122467889999999999999999999999887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=342.23 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=208.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.++||+|+||.||+ +..+.+++.+|+|.+.+.. ......+.+|+.++..+ +||||+++++++.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~--~~~~i~~~~~~~~~ 72 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG--DNQWITTLHYAFQD 72 (332)
T ss_pred CCceEEEEEEeCCCeEEEE------EEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC--CCCCEeeEEEEEec
Confidence 4799999999999998865 5567788999999987532 22234466788887775 49999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
...+|+||||+.++.|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999998888777755 467999999999999999999999999999999999999999999999999998764
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... .......+||+.|+|||++..... ....++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~-------~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 153 MEDG-------------TVQSSVAVGTPDYISPEILQAMED-------GKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ccCC-------------cceecccccCccccCHHHHhcccc-------CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 3211 011223568999999999864320 11237899999999999999999999999988
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCC--CCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK--RPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~--RPSa~evL~~L~ 427 (1630)
..+.+..+.......+.. .....+++++++||.+||..+|.+ |+++.++++|-+
T Consensus 213 ~~~~~~~i~~~~~~~~~p--~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 213 LVETYGKIMNHKERFQFP--AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred HHHHHHHHhCCCccccCC--CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 888887776543222111 112357899999999999765555 689999999843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=364.80 Aligned_cols=272 Identities=22% Similarity=0.317 Sum_probs=213.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEE-EEe--
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV-LRM-- 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~-f~~-- 212 (1630)
.++++.+.|.+|||+.||| |.+...+..||+|++-..+......+.+|+++|++|+ +|||||.|++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYl------a~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYL------AQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-GHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEEEEEEccCCcEEEEE------EEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-CCCceeeEecccccccc
Confidence 5789999999999999987 4555556899999999887777888999999999998 89999999993 221
Q ss_pred ----CCEEEEEEecCCC-ChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccceEECCCCcEEEee
Q 000343 213 ----DSCLGLVMDRCYG-SVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 213 ----~~~~~LVmEy~~g-glL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~g--IIHRDLKP~NILld~~g~vKL~D 284 (1630)
..+++|+||||.| ++++.+..+ ...|++.++++|+.|+++|+++||... |||||||-+||||+.+|.+||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1358999999985 666655432 345999999999999999999999997 99999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||.+........ ... ....-...-...-|+.|+|||++.- ..+.+++.|+|||||||+||.|+...
T Consensus 190 FGSatt~~~~~~---~~~--e~~~ve~eI~k~TTp~YRsPEMIDl---------ysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 190 FGSATTKILSPT---SAQ--EVNYVEEEIEKYTTPQYRSPEMIDL---------YSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred ccccccccCCCc---cHH--HHHHHHHHHHhhCCccccChHHHhh---------hcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 999875432210 000 0000001112234999999999854 33566999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCCCC
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSP 437 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~sp 437 (1630)
.||.....- .|+.+....|.+ +.++..+.+||..||+.||++||++-+++.++.++.....+.+
T Consensus 256 ~PFe~sg~l----aIlng~Y~~P~~-----p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 256 TPFEESGKL----AILNGNYSFPPF-----PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred CCcCcCcce----eEEeccccCCCC-----ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 999875332 344555444433 3578999999999999999999999999999998887665533
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=346.92 Aligned_cols=252 Identities=17% Similarity=0.222 Sum_probs=195.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+|++++.||+|+||.||+ |.+..+++.||+|..... ....|+.+++.++ ||||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~------~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFV------ATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVN--HPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEE------EEECCCCceEEEEeCCcc------ccHHHHHHHHhCC--CCCCcChhheEEeCC
Confidence 35799999999999988865 567778899999975432 2346888888875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
..++||||+.++++..+......+++..++.|+.||+.||.|||++||+||||||+|||++..+.+||+|||+++.....
T Consensus 131 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred eeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99999999998888777766678999999999999999999999999999999999999999999999999998643211
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC-CCCCCH-
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP-WAGLSA- 372 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P-F~~~~~- 372 (1630)
.......||+.|+|||++.+.. ++.++|||||||++|||+++..| |.....
T Consensus 211 ---------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 211 ---------------PAFLGLAGTVETNAPEVLARDK------------YNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred ---------------cccccccccccccCCeecCCCC------------CCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 1122356899999999987654 78999999999999999985544 433211
Q ss_pred --------HHHHHHHHhc-CCCCCCcc--------------------------cccCCCCCHHHHHHHHHhhccCcCCCC
Q 000343 373 --------EEIYRAVVKN-RKLPPQYA--------------------------SIVGVGIPRELWKMIGECLQFKASKRP 417 (1630)
Q Consensus 373 --------~ei~~~i~~~-~~~~~~~~--------------------------~~~~~~l~~el~~LI~~cL~~dP~~RP 417 (1630)
...+..+... ...+..+. ......++.++.+||.+||+.||.+||
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 343 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc
Confidence 1111111111 11111100 001124567888999999999999999
Q ss_pred ChhhHHHHhh
Q 000343 418 TFSAMLATFL 427 (1630)
Q Consensus 418 Sa~evL~~L~ 427 (1630)
|+.|+|+|-+
T Consensus 344 ta~e~l~hp~ 353 (357)
T PHA03209 344 SAEEILNYPM 353 (357)
T ss_pred CHHHHhcCch
Confidence 9999999843
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=334.03 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=213.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|.+.+.||+|+||.||+. ..+.+....++..+|+|.+..........+.+|+++++.++ ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~-~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEee-EeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEecCCc
Confidence 57999999999999999753 22232334566789999887654444567889999999975 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEE
Q 000343 216 LGLVMDRCYGSVQLAMQRNEG-------------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~-------------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL 282 (1630)
++++|||++++.|..++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999888877765332 4899999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+++.+.... .........++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 162 ~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 162 GDFGMSRDVYSTD------------YYRVGGHTMLPIRWMPPESIMYRK------------FTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ccCCccccccCCc------------eeecCCCCCccccccCHHHhccCC------------CCchhhHHHHHHHHHHHHh
Confidence 9999987653221 011122344578899999987644 7899999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 363 -GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 363 -G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|..||......+....+..+..... +..++.++.+|+.+||+.||.+|||+.++++.|....
T Consensus 218 ~g~~p~~~~~~~~~~~~i~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 218 YGKQPWYQLSNNEVIECITQGRVLQR------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 9999988888777777766543221 2347789999999999999999999999988876655
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=346.64 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=216.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
..|.-++.||.|+||.||. |++..+.+.||||++.....+. -..+..|+.+|+++. |||+|.+.++|-.
T Consensus 26 klf~dLrEIGHGSFGAVYf------Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~--HPntieYkgCyLr 97 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYF------ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR--HPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHHhcCCccceeEE------eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc--CCCcccccceeec
Confidence 4677889999999998875 7899999999999998775444 345677999999976 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
....+||||||-|+-.+.+.-...+|-+.++..|+.+.+.||+|||+.+.||||||+-|||+++.|.|||+|||.|....
T Consensus 98 e~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 98 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred cchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 99999999999887665555555679999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
+ ...++|||+|||||++.-.. ...|+-++||||||++..||...++|+.+.+.
T Consensus 178 P------------------AnsFvGTPywMAPEVILAMD---------EGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 178 P------------------ANSFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred c------------------hhcccCCccccchhHheecc---------ccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 2 34689999999999997653 22399999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
...+.-|.....+... ...++..++.|+..||+.-|.+|||.+++|.|.+
T Consensus 231 MSALYHIAQNesPtLq-----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHHHHHhcCCCCCC-----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 8877777665432221 3468899999999999999999999999998855
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=362.31 Aligned_cols=268 Identities=24% Similarity=0.326 Sum_probs=227.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+..+.++||+|+||+||+ +..|.--.......||||.++..... ....|+||+++|..++ |||||+|++++..+
T Consensus 485 r~~i~~~~eLGegaFGkVf~-a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~--H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFL-AEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ--HPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhh-hhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc--CCCeEEEEEEEccC
Confidence 46788999999999999975 33333333456678999999987665 6788999999999987 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCc
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--------------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--------------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~ 279 (1630)
+.+|||+|||..|+|..+++. +.+|+..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 999999999998888877642 123889999999999999999999999999999999999999999
Q ss_pred EEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHH
Q 000343 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359 (1630)
Q Consensus 280 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILye 359 (1630)
|||+|||+++.+=...+ +.......-..+|||||.+...+ ++++||||||||+|||
T Consensus 642 VKIsDfGLsRdiYssDY------------Yk~~~~t~lPIRWMppEsIly~k------------FTteSDVWs~GVvLWE 697 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY------------YKVRGNTLLPIRWMPPESILYGK------------FTTESDVWSFGVVLWE 697 (774)
T ss_pred EEecccccchhhhhhhh------------hcccCCceeeeecCCHHHhhcCc------------ccchhhhhhhhhhhhh
Confidence 99999999986543322 22222344478999999999877 8999999999999999
Q ss_pred Hhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCC
Q 000343 360 MCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435 (1630)
Q Consensus 360 mlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~ 435 (1630)
+++ |..||.+.+.+++++.|..++..+. +.++|.++.+||..||+.+|.+||+++||-..|+...+..+.
T Consensus 698 IFsyG~QPy~glSn~EVIe~i~~g~lL~~------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 698 IFSYGKQPYYGLSNQEVIECIRAGQLLSC------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred hhccccCcccccchHHHHHHHHcCCcccC------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 999 9999999999999999988876433 357999999999999999999999999998888776655543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=332.02 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=210.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|.+.+.||+|+||.||+. ..+......+++.||+|.+...... ....+.+|+++|+.+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~-~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLG-ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ--HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeee-eeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC--CCCchheeeEEecCC
Confidence 57999999999999988752 2222222356789999998765443 3467889999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcE
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRA 280 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~v 280 (1630)
..+++|||++++.|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 999999999999888877543 247899999999999999999999999999999999999999999
Q ss_pred EEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHH
Q 000343 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360 (1630)
Q Consensus 281 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyem 360 (1630)
||+|||+++....... ........+++.|+|||++.+.. ++.++|||||||++|+|
T Consensus 162 kl~d~g~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~e~ 217 (280)
T cd05049 162 KIGDFGMSRDVYTTDY------------YRVGGHTMLPIRWMPPESIMYRK------------FTTESDVWSFGVVLWEI 217 (280)
T ss_pred EECCcccceecccCcc------------eecCCCCcccceecChhhhccCC------------cchhhhHHHHHHHHHHH
Confidence 9999999976532210 01112334578899999987654 78999999999999999
Q ss_pred hh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 361 CT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 361 lt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++ |..||...+..+....+..+....+ +..++.++.+|+.+||+.||++||++.|+++.|.
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSNEEVIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 9999988887777777665433221 2357899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=332.01 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=213.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+-|+++.+||+|+|| .||+|.++.+|+.+|||++... .+...+..|+.||+++. .|+||++|+.|.....
T Consensus 33 EVFDi~~KLGEGSYG------SV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~--S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYG------SVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCK--SKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcch------HHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcC--CchhhhhhhhhccCCc
Confidence 468999999999955 5577999999999999999864 34567889999999987 8999999999999999
Q ss_pred EEEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+++|||||..|+..++++ ++.+|+++++..+++..+.||+|||...-||||||+.|||++.+|.+||+|||.|-.+...
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999998777766554 5568999999999999999999999999999999999999999999999999999765431
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
.......+|||.|||||+++.-. |+.++||||||++..||..|++||.+..+..
T Consensus 183 --------------MAKRNTVIGTPFWMAPEVI~EIG------------Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 183 --------------MAKRNTVIGTPFWMAPEVIEEIG------------YDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred --------------HHhhCccccCcccccHHHHHHhc------------cchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 22345678999999999997643 8999999999999999999999999887765
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+..|-. ..||.+. .+..++.++.+|+++||..+|++|-|+.++++|-+
T Consensus 237 AIFMIPT--~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 237 AIFMIPT--KPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred eeEeccC--CCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 4433311 1222222 24467889999999999999999999999999854
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=348.85 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=219.7
Q ss_pred CChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHc
Q 000343 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH 590 (1630)
Q Consensus 511 G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~ 590 (1630)
.+++||.|++.|+.+++++|++. ++++|..+.+|.||||+|+..|+.+++++|+++|++++... ..+.||||.|+..
T Consensus 2 ~~~~L~~A~~~g~~~iv~~Ll~~-g~~~n~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~--~~~~t~L~~A~~~ 78 (413)
T PHA02875 2 DQVALCDAILFGELDIARRLLDI-GINPNFEIYDGISPIKLAMKFRDSEAIKLLMKHGAIPDVKY--PDIESELHDAVEE 78 (413)
T ss_pred CchHHHHHHHhCCHHHHHHHHHC-CCCCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCccccC--CCcccHHHHHHHC
Confidence 57899999999999999999995 68899999999999999999999999999999999987643 4467999999999
Q ss_pred CCHHHHHHHHHcCCCCC-CCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHH
Q 000343 591 GQPDCMRELLLAGADPN-AVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE 669 (1630)
Q Consensus 591 G~~eivk~LL~~GADvn-~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe 669 (1630)
|+.+++++|+++|++++ ..+.+|.||||+|+..++.+++++|+++|+ +++..+..|.||||+|+..|+.
T Consensus 79 g~~~~v~~Ll~~~~~~~~~~~~~g~tpL~~A~~~~~~~iv~~Ll~~ga--d~~~~~~~g~tpLh~A~~~~~~-------- 148 (413)
T PHA02875 79 GDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGA--DPDIPNTDKFSPLHLAVMMGDI-------- 148 (413)
T ss_pred CCHHHHHHHHHcCCcccccccCCCCCHHHHHHHhCCHHHHHHHHhCCC--CCCCCCCCCCCHHHHHHHcCCH--------
Confidence 99999999999998875 457789999999999999999999999997 6778889999999999987654
Q ss_pred hcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCC
Q 000343 670 VASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGV 749 (1630)
Q Consensus 670 ~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GA 749 (1630)
+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|+
T Consensus 149 ------------------------------------~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga 192 (413)
T PHA02875 149 ------------------------------------KGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGA 192 (413)
T ss_pred ------------------------------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCC
Confidence 45667777889999999999999999999999999999999999
Q ss_pred CcccccCCCC-CHHHHHHHcCCHHHHHHHHhCCCCCCcC---CCCCCcHHHHHHHh
Q 000343 750 DVNIRNVHNT-IPLHVALARGAKSCVGLLLSAGADCNWQ---DDEGDNAFHIAADA 801 (1630)
Q Consensus 750 DvN~~d~~G~-TPLH~Aa~~G~~eiVklLLe~GADiN~~---D~~G~TpLhlAa~~ 801 (1630)
++|..+..|. ||||+|+..|+.+++++|+++|||+|.. +.++.|||++++..
T Consensus 193 ~~n~~~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~~~~~~~~~~t~l~~~~~~ 248 (413)
T PHA02875 193 NIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGADCNIMFMIEGEECTILDMICNM 248 (413)
T ss_pred CCCcCCCCCCchHHHHHHHcCCHHHHHHHHHCCcCcchHhhcCCCchHHHHHHHhh
Confidence 9999998874 8999999999999999999999999975 67899999988754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=347.30 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=222.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+-|+++..||.|+||.| |+|..+.++-..|-|.|......+.+.+.-||+||..+. ||+||+|++.|...+
T Consensus 31 ~d~WeIiGELGDGAFGKV------yKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd--HP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKV------YKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD--HPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhh------hhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC--ChHHHHHHHHHhccC
Confidence 356889999999998877 457888899999999998877777788888999999987 999999999999999
Q ss_pred EEEEEEecCCCChHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~-~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.++|+.|||.||-.+.+. .-...|++.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+.....
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999999999777543 4455799999999999999999999999999999999999999999999999999865332
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
. ......++|||+|||||++..... ...+|++++||||||++|.||..+.+|-...++.
T Consensus 183 t--------------~qkRDsFIGTPYWMAPEVvmCET~-------KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 183 T--------------RQKRDSFIGTPYWMAPEVVMCETF-------KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred H--------------HhhhccccCCcccccchheeeccc-------cCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 1 122356889999999999987541 2345999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.++.+|.+..+ |. ...+..++..+.+|+.+||..||..||+++++|+|.+
T Consensus 242 RVllKiaKSeP--PT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 242 RVLLKIAKSEP--PT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHHHHhhcCC--Cc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 88888866542 22 1234568899999999999999999999999999865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.90 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=204.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||+ +.. ..+..+|+|.+... ......+.+|+++|+.++ ||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~------~~~-~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHL------GKW-RAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLS--HPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHcEEeeEecCCcCceEEE------EEe-ccCceEEEEecccC-CccHHHHHHHHHHHHHCC--CCCceeEEEEEccCCC
Confidence 4799999999999998875 222 23468999987643 334567888999999975 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
++++|||++++.+..++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999998877776643 456899999999999999999999999999999999999999999999999998765322
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ 373 (1630)
. ........++..|+|||++.+.. ++.++|+||||+++|+|++ |+.||...+..
T Consensus 154 ~-------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 154 E-------------YTSSSGAKFPVKWSPPEVFNFSK------------YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred c-------------eeccCCCCCchhhCChhhcccCc------------cchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 1 01112233567899999987544 7889999999999999999 99999988888
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+.+..+..+..... +...+.++.+|+.+||+.+|++||++.++++.|
T Consensus 209 ~~~~~i~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 209 EVVEMISRGFRLYR------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHCCCCCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 88777766543211 123578899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=332.04 Aligned_cols=264 Identities=24% Similarity=0.306 Sum_probs=213.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|.+.+.||+|+||.||+. ..+......++..+|+|.+..........+.+|+++++.++ ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~-~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLA-ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEe-EeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCc
Confidence 47999999999999999752 22222234566779999887654444567889999999875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCc
Q 000343 216 LGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~ 279 (1630)
+++||||++++.+..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 99999999988888776532 24889999999999999999999999999999999999999999
Q ss_pred EEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHH
Q 000343 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359 (1630)
Q Consensus 280 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILye 359 (1630)
+||+|||++....... .........++..|+|||++.+.. ++.++||||||+++|+
T Consensus 162 ~~l~dfg~a~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~e 217 (291)
T cd05094 162 VKIGDFGMSRDVYSTD------------YYRVGGHTMLPIRWMPPESIMYRK------------FTTESDVWSFGVILWE 217 (291)
T ss_pred EEECCCCcccccCCCc------------eeecCCCCCcceeecChHHhccCC------------CCchhhHHHHHHHHHH
Confidence 9999999997654321 011122345678999999887644 7889999999999999
Q ss_pred Hhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccC
Q 000343 360 MCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 360 mlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~ 432 (1630)
|++ |..||...+..+.+..+..+..... ...+|.++.+|+.+||+.+|++|||+.++++.|......
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLER------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCC------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 999 9999988887777766654432211 224688999999999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=348.10 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=207.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|.+.+.||+|+||.||. +..+......++..||||++..... ...+.+.+|+++|+++. .||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~-~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVE-GTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-PHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEE-EEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-CCCCeeeEEEEEccC
Confidence 35899999999999999964 2223222344566899999875432 23457888999999875 599999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------------------------------------------------
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE---------------------------------------------------------- 235 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~---------------------------------------------------------- 235 (1630)
..+|||||||+++.|..++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999988877655321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 236 --------------------------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 236 --------------------------------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 247888899999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++.+.... .........+++.|+|||++.+.. ++.++|||||||++
T Consensus 274 ~~~kL~DfGla~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwSlGvil 329 (400)
T cd05105 274 KIVKICDFGLARDIMHDS------------NYVSKGSTFLPVKWMAPESIFDNL------------YTTLSDVWSYGILL 329 (400)
T ss_pred CEEEEEeCCcceeccccc------------cccccCCcCCCcceEChhhhcCCC------------CCchhhHHHHHHHH
Confidence 999999999998654321 011122345678899999987644 78999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
|+|++ |..||........+.........++ .+..++.++.+++.+||+.||++||++.++.+.|.+.+.
T Consensus 330 ~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 330 WEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHCCCCCCcccchhHHHHHHHhcCCCCC-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 99997 9999987654433333333322221 123578999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.72 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=210.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||. +.+..++..+|+|.+..........+.+|+++++.++ ||||+++++++.....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYK------ARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGSYLRRDK 74 (262)
T ss_pred cceEEEEEecCCCceEEEE------eEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC--CCChhceEEEEEeCCE
Confidence 5899999999999887754 5566788899999998765556678889999999875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+|++|||++++.+..+.... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999998888877654 68999999999999999999999999999999999999999999999999998765421
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||++.+... ..++.++|+||||+++|+|++|.+||...+..+
T Consensus 155 ~--------------~~~~~~~~~~~y~~Pe~~~~~~~---------~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 155 I--------------AKRKSFIGTPYWMAPEVAAVERK---------GGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred h--------------hccccccCCccccCchhhccccc---------CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 01123467889999999876410 127889999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
....+......++.. ......+.++.+|+.+||..+|.+|||+.+++.|
T Consensus 212 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 212 ALFLISKSNFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHhccCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 554444332222211 1123467889999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=345.88 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=218.8
Q ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcC
Q 000343 545 GDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624 (1630)
Q Consensus 545 G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g 624 (1630)
.+++||.|+..|+.+++++|+++|++++.. +..|.||||+|+..|+.+++++|+++|++++..+.++.||||+|+..|
T Consensus 2 ~~~~L~~A~~~g~~~iv~~Ll~~g~~~n~~--~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~t~L~~A~~~g 79 (413)
T PHA02875 2 DQVALCDAILFGELDIARRLLDIGINPNFE--IYDGISPIKLAMKFRDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEG 79 (413)
T ss_pred CchHHHHHHHhCCHHHHHHHHHCCCCCCcc--CCCCCCHHHHHHHcCCHHHHHHHHhCCCCccccCCCcccHHHHHHHCC
Confidence 479999999999999999999999999875 345889999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchh
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704 (1630)
Q Consensus 625 ~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~ 704 (1630)
+.+++++|++.|+. ..+..+..|.||||+|+..++.
T Consensus 80 ~~~~v~~Ll~~~~~-~~~~~~~~g~tpL~~A~~~~~~------------------------------------------- 115 (413)
T PHA02875 80 DVKAVEELLDLGKF-ADDVFYKDGMTPLHLATILKKL------------------------------------------- 115 (413)
T ss_pred CHHHHHHHHHcCCc-ccccccCCCCCHHHHHHHhCCH-------------------------------------------
Confidence 99999999999873 2344567899999999876543
Q ss_pred HHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCC
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 705 ~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADi 784 (1630)
+++++|+++|+|+|.++..|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|||+
T Consensus 116 -~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~ 194 (413)
T PHA02875 116 -DIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANI 194 (413)
T ss_pred -HHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCC
Confidence 5667778889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCC-cHHHHHHHhchHHHhhHHHHHHHhhCCCCccccc---CCCCCCHHHHHhhC
Q 000343 785 NWQDDEGD-NAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVR---NHSGKTLRDFLEGL 840 (1630)
Q Consensus 785 N~~D~~G~-TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~---n~~G~TpLdlA~~~ 840 (1630)
|..+..|. ||||+|+..++ ..++.+|++.|+++|+. +..+.||++++...
T Consensus 195 n~~~~~~~~t~l~~A~~~~~------~~iv~~Ll~~gad~n~~~~~~~~~~t~l~~~~~~ 248 (413)
T PHA02875 195 DYFGKNGCVAALCYAIENNK------IDIVRLFIKRGADCNIMFMIEGEECTILDMICNM 248 (413)
T ss_pred CcCCCCCCchHHHHHHHcCC------HHHHHHHHHCCcCcchHhhcCCCchHHHHHHHhh
Confidence 99998875 89999997654 35778888999999875 67899999987643
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=332.91 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=203.2
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||+ +.+..+|+.||+|.+...... ....+.+|+++++.++ ||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~------~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~~~~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFK------AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLYDVLHSDK 72 (284)
T ss_pred CceeEEEecccCCeEEEE------EEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC--CCCeeeHHHHhccCC
Confidence 589999999999887754 667788999999998764322 2355778999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.++++|||+.++++..+....+.+++..++.++.||++||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 73 KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99999999998887777665677999999999999999999999999999999999999999999999999998765321
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC-CCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-AGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF-~~~~~~ 373 (1630)
. .......+++.|+|||++.+.. .++.++|||||||++|+|++|..|| .+.+..
T Consensus 153 ~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 153 V--------------RCYSAEVVTLWYRPPDVLFGAK-----------LYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred C--------------CCcCCCccccCCcChHHHhCCc-----------ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 1 1122345688999999986533 2688999999999999999988885 444544
Q ss_pred HHHHHHHhcCCCC-----------------CCcc-----cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLP-----------------PQYA-----SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~-----------------~~~~-----~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+.+..+......+ +... ....+.+++++.+||.+||+.||.+|||++++++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 4444433211100 0000 011234778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=322.64 Aligned_cols=249 Identities=22% Similarity=0.389 Sum_probs=206.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+|++.+.||+|+||.||+ +.+..++..+|+|.+.... ....+.+.+|+.+++.++ ||||+++++.|.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALL------VQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK--HPNIVAFKESFEADGH 72 (255)
T ss_pred CceEEEEeeccCCeEEEE------EEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC--CCCcceEEEEEEECCE
Confidence 589999999999888865 5577789999999987543 233566778889888875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+|++|||++++.+..++.. ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999999988877665543 34589999999999999999999999999999999999999999999999999876543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+..
T Consensus 153 ~~--------------~~~~~~~~~~~~~aPE~~~~~~------------~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 206 (255)
T cd08219 153 PG--------------AYACTYVGTPYYVPPEIWENMP------------YNNKSDIWSLGCILYELCTLKHPFQANSWK 206 (255)
T ss_pred cc--------------cccccccCCccccCHHHHccCC------------cCchhhhhhhchhheehhhccCCCCCCCHH
Confidence 21 0112346788999999987644 789999999999999999999999988777
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.....+..+...+ .+..++.++.+||.+||+.||++||++.+++..
T Consensus 207 ~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 207 NLILKVCQGSYKP------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHhcCCCCC------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 7766665543322 123578899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=328.65 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=201.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||. +.+..++..||||++...... ....+.+|+.+++.+. ||||+++++++..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYK------GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ--HPNIVCLQDVLMQES 72 (285)
T ss_pred CceEeeEecccCceEEEE------EEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC--CCCEeeeEEEEeeCC
Confidence 589999999999887754 667788999999998764322 2456788999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+|+||||+.+++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 73 ~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 73 RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred eEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 99999999997665554432 2569999999999999999999999999999999999999999999999999997643
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... .......+++.|+|||++.+.. .++.++|||||||++|+|++|++||...+.
T Consensus 153 ~~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 153 IPV--------------RVYTHEVVTLWYRAPEVLLGSP-----------RYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred CCc--------------ccccCCcccccccChHHhcCCC-----------CcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 211 1112335688999999886533 268899999999999999999999987665
Q ss_pred HHHHHHHHhcCCCC----------------------CCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLP----------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~----------------------~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
......+......+ ..........+++++.+||.+||+.||++|||+.++++|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~ 283 (285)
T cd07861 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283 (285)
T ss_pred HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCC
Confidence 44333322211000 0000011234788999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=368.54 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=222.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc---CcCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.++|++++.||+|+||.|.|. +.+.|++.||+|++++- ...+...|..|..+|.... .+.|++|+..|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lV------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n--s~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALV------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN--SEWIVQLHYAFQ 145 (1317)
T ss_pred HHhhHHHHHhcccccceeEEE------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC--cHHHHHHHHHhc
Confidence 369999999999999999873 47889999999999873 3445677888899988864 799999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
++.++||||||++||++..++.+..++++..+++|+.+|+.||+-||+.|+|||||||+|||||..|++||+|||.|-.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999999888888779999999999999999999999999999999999999999999999999999877
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
..+. .-.....+|||-|.|||++..... +...|++.+|+||+||++|||+.|..||...+
T Consensus 226 ~~dG-------------~V~s~~aVGTPDYISPEvLqs~~~-------~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 226 DADG-------------TVRSSVAVGTPDYISPEVLQSQGD-------GKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred CCCC-------------cEEeccccCCCCccCHHHHHhhcC-------CccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 6432 112345789999999999986541 12449999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC---hhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT---FSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS---a~evL~~L~ 427 (1630)
..+.|-+|..-..... ++. ...+|+++++||.+++. +|+.|.. ++++-.|.+
T Consensus 286 lveTY~KIm~hk~~l~-FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 286 LVETYGKIMNHKESLS-FPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred HHHHHHHHhchhhhcC-CCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 9999999876532222 111 12489999999999884 6888988 999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=324.88 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=208.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|.+.++||+|+||.||+ +..+.++..||+|.+... ......+.+|+++++.++ ||||+++++++.....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~------~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYE------GVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPP 76 (263)
T ss_pred HHeEEeeecCCcccceEEE------EEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCC--CCChhheEEEEcCCCC
Confidence 4799999999999887754 556678899999988753 334566788999999975 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
++++|||++++.|..++.. ...+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999988887776643 23589999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
... .......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+.
T Consensus 157 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 157 DTY-------------TAHAGAKFPIKWTAPESLAYNK------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred cee-------------eccCCCCCccccCCHHHhccCC------------CCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 210 0111223356799999887654 7889999999999999998 9999998887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+.+..+...... ..+..++.++.+++.+||+.||++|||+.++++.|...
T Consensus 212 ~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 212 SQVYELLEKGYRM------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHCCCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 7776666543211 12345789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.13 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=205.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccc-cccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~-~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.+.||+|+||.||. ....+. ...++..||||++..... .....+.+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~--~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~iv~~~~~~~~ 80 (277)
T cd05062 5 REKITMSRELGQGSFGMVYE--GIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQ 80 (277)
T ss_pred HHHceeeeeeccccCCeEEE--EEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcC
Confidence 46899999999999998864 223221 224567899998864322 12345778999988865 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEE
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE----------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~----------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL 282 (1630)
....++||||++++.|..++.+. ..+++..+..++.|++.||+|||+.|++||||||+|||+++++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999998888776532 23577889999999999999999999999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+++.+..... ........+++.|+|||++.+.. ++.++|||||||++|||++
T Consensus 161 ~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 161 GDFGMTRDIYETDY------------YRKGGKGLLPVRWMSPESLKDGV------------FTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred CCCCCccccCCcce------------eecCCCCccCHhhcChhHhhcCC------------cCchhHHHHHHHHHHHHHc
Confidence 99999876543210 00111234577899999987644 7899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 363 -GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 363 -G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|..||...+..+....+....... .+..++..+.+++.+||+.||++|||+.+++++|.
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 217 LAEQPYQGMSNEQVLRFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 799999888777776665543221 12357889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=329.20 Aligned_cols=243 Identities=23% Similarity=0.255 Sum_probs=192.7
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||+|+||.||+ +.++.+++.||+|.+..... .....+..|+++++.++ ||||++++++|..+..+|+||
T Consensus 1 lg~G~~g~Vy~------~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05607 1 LGKGGFGEVCA------VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN--SPFIVNLAYAFESKTHLCLVM 72 (277)
T ss_pred CCCCCceEEEE------EEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC--CCcEEEEEEEEecCCeEEEEE
Confidence 69999888865 55777899999999875322 12344566899999875 999999999999999999999
Q ss_pred ecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 221 DRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||++|+.|..++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 73 e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 73 SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred ecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence 999988887665432 358999999999999999999999999999999999999999999999999987654311
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH----HH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA----EE 374 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~----~e 374 (1630)
......|+..|+|||++.+.. ++.++|||||||++|+|++|..||..... .+
T Consensus 150 ------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~ 205 (277)
T cd05607 150 ------------TITQRAGTNGYMAPEILKEEP------------YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE 205 (277)
T ss_pred ------------eeeccCCCCCccCHHHHccCC------------CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH
Confidence 112345789999999987654 78999999999999999999999976432 23
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+........... ....+++++.+||.+||+.||.+||++.|+++++.
T Consensus 206 ~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 206 LKRRTLEDEVKF------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHhhcccccc------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 333332222111 11357899999999999999999999977664433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=327.30 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=206.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+|++.+.||+|+||.||+. .........+..||+|.+...... ....+.+|+++++.++ ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~--~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKG--HLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH--HPNIVCLLGVVTQEQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEE--EEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCCeeeEEEEEecCC
Confidence 47999999999999998652 222223456789999998753322 2356788999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE-----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~-----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
..|++|||++++.+..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999988877766321 247889999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++....... ........++..|+|||++.+.. ++.++|+||||+++
T Consensus 161 ~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il 216 (283)
T cd05090 161 LHVKISDLGLSREIYSADY------------YRVQPKSLLPIRWMPPEAIMYGK------------FSSDSDIWSFGVVL 216 (283)
T ss_pred CcEEeccccccccccCCcc------------eecccCCCccceecChHHhccCC------------CCchhhhHHHHHHH
Confidence 9999999999976532210 11122334567899999987644 78999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|||++ |..||.+.+..++...+......+ .+..+++++.+++.+||+.||.+||++.+++++|.
T Consensus 217 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQEVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 99999 999998877776666665433221 22357899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=330.17 Aligned_cols=254 Identities=18% Similarity=0.277 Sum_probs=209.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+|++.+.||+|+||.||+ +.+..+++.||+|.+..........+.+|+.+++.+. ||||+++++.|....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~------~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~--h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYT------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEE------EEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC--CCCEeeEEEEEEeCC
Confidence 46899999999999887754 5677889999999998766666677888999998865 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
..|+||||++++++..++.+ ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999888887754 46899999999999999999999999999999999999999999999999998754321
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.......
T Consensus 170 ~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 170 Q--------------SKRSTMVGTPYWMAPEVVTRKA------------YGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred c--------------cccCcccCCccccCHHHHcCCC------------CCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 0112345789999999987643 6789999999999999999999998776644
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+......+. ..+..++..+.+||.+||..+|++||++.++++|-+
T Consensus 224 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 224 ALYLIATNGTPEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred hHHHHhcCCCCCC----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 4333332221111 122357889999999999999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=341.56 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=200.3
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++++.||+|+||.||+ +.+..++..||||++..... .....+.+|+.+|+.++ ||||++++++|.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 84 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCS------AYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK--HENVIGLLDVFT 84 (343)
T ss_pred hhhhhhhheecccCCCeEEEE------EEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC--CCchhhhhhhhc
Confidence 457899999999999888754 66778899999999875422 22445678999999875 999999999886
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ...|++||++.+++ ..+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l-~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 85 PATSIENFNEVYLVTNLMGADL-NNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccccccccCcEEEEeecCCCCH-HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCC
Confidence 43 34799999985554 44443 346999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.
T Consensus 163 g~~~~~~~~-----------------~~~~~~t~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~el~~g~~ 214 (343)
T cd07878 163 GLARQADDE-----------------MTGYVATRWYRAPEIMLNWM-----------HYNQTVDIWSVGCIMAELLKGKA 214 (343)
T ss_pred ccceecCCC-----------------cCCccccccccCchHhcCCc-----------cCCchhhhHhHHHHHHHHHHCCC
Confidence 999764321 12346899999999987532 27899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCC--------------------c----ccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQ--------------------Y----ASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~--------------------~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||.+.+..+.+..+......+.. . ........++.+.+||.+||+.||.+|||+.+
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99877665554444332111100 0 00011235677899999999999999999999
Q ss_pred HHHHhh
Q 000343 422 MLATFL 427 (1630)
Q Consensus 422 vL~~L~ 427 (1630)
+++|-+
T Consensus 295 ll~hp~ 300 (343)
T cd07878 295 ALAHPY 300 (343)
T ss_pred HhcCcc
Confidence 999844
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=340.52 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=205.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEe-C
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-D 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-~ 213 (1630)
++|++.+.||+|+||.||+. ..+.-.+..+++.||+|++...... ....+.+|+.+++++. .||||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a-~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQA-SAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-HHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEec-cccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-cCcchhheeeeEecCC
Confidence 58999999999999998652 1111124456789999998754322 2345678999998874 59999999998764 4
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------------------------------------------------
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE---------------------------------------------------------- 235 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~---------------------------------------------------------- 235 (1630)
..++++|||++++.+..++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5789999999998887765321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCccccc
Q 000343 236 ---GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312 (1630)
Q Consensus 236 ---~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 312 (1630)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.... .....
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------~~~~~ 232 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------DYVRK 232 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc------------chhhc
Confidence 258899999999999999999999999999999999999999999999999998653221 00112
Q ss_pred ccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCccc
Q 000343 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391 (1630)
Q Consensus 313 ~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~ 391 (1630)
....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+.........+.
T Consensus 233 ~~~~~~~~y~aPE~~~~~~------------~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---- 296 (337)
T cd05054 233 GDARLPLKWMAPESIFDKV------------YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---- 296 (337)
T ss_pred cCCCCCccccCcHHhcCCC------------CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC----
Confidence 2344577899999987654 8899999999999999998 9999987554444433333222211
Q ss_pred ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 392 IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 392 ~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.+...++++.+++.+||+.+|++||++.+++++|...++
T Consensus 297 -~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 -APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123567899999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=344.85 Aligned_cols=339 Identities=12% Similarity=0.081 Sum_probs=212.6
Q ss_pred hcccCCChHHHH-HHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHH-cCCHHHHHHHHHCCCCcccc---------
Q 000343 506 AQNADGQTALHL-ACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALA-AGSPECVHALIKRGANVISR--------- 574 (1630)
Q Consensus 506 ~~d~~G~TpLH~-Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~-~G~~eiVk~LL~~GAdvn~~--------- 574 (1630)
..|.+|.+++|+ |+.+|++++|++|+++ |+++|.++..|.||||+|+. .++.|++++||++||++++.
T Consensus 66 ~~n~~~~~~~~~~~s~n~~lElvk~LI~~-GAdvN~~~n~~~~~l~ya~~~~~~~eivk~Ll~~Gad~~~~~~~g~~~~~ 144 (631)
T PHA02792 66 YKNINDFDIFEYLCSDNIDIELLKLLISK-GLEINSIKNGINIVEKYATTSNPNVDVFKLLLDKGIPTCSNIQYGYKIII 144 (631)
T ss_pred cCccCCccHHHHHHHhcccHHHHHHHHHc-CCCcccccCCCCcceeEeecCCCChHHHHHHHHCCCCcccccccCcchhh
Confidence 345566666664 3445666666666664 56666666666666666644 46666666666666653221
Q ss_pred -------------------------cccCCCchHHHHHHHcC-------CHHHHHHHHHcCCCCCCCCCCCCChhhhhhh
Q 000343 575 -------------------------LREGFGPSVAHVCAYHG-------QPDCMRELLLAGADPNAVDDEGESVLHRAVA 622 (1630)
Q Consensus 575 -------------------------~~d~~g~T~Lh~Aa~~G-------~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~ 622 (1630)
..+..|.||||+|+.++ +.+++++||++||+++..|..|.||||+|+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~t~L~~~i~~~s~~~~~~~~~v~k~Li~~g~~~~~~d~~g~t~l~~~~~ 224 (631)
T PHA02792 145 EQITRAEYYNWDDELDDYDYDYTTDYDDRMGKTVLYYYIITRSQDGYATSLDVINYLISHEKEMRYYTYREHTTLYYYVD 224 (631)
T ss_pred hhcccccccchhhhccccccccccccCCCCCCchHHHHHhhCCcccccCCHHHHHHHHhCCCCcCccCCCCChHHHHHHH
Confidence 12233555666666655 5566666666666666666666666666665
Q ss_pred cC--ChHHHHHHHHcCCccccccccCCCCcHH-HHHH-Hc----C--CHHHHHHHHHhcCccccccccCCCCCCccH---
Q 000343 623 KK--YTDCAIVILENGGCRSMAILNSKELTPL-HLCV-AT----W--NVAVVKRWVEVASPEEIVNVIDIPGPVGTA--- 689 (1630)
Q Consensus 623 ~g--~~eiv~~LL~~Ga~~~i~~~d~~G~TPL-h~Aa-~~----g--~~eivk~LLe~ga~~~~~n~~d~~~~~~t~--- 689 (1630)
+. ..+++++|+...- +. .+. ..-| ++-- .. . +..+|..|++.+.+..+...+......-+-
T Consensus 225 ~~~i~~ei~~~L~~~~~--~~--~~~--~~~l~~y~~~~~~~~~~~id~~iv~~ll~~~~~~~i~~~~~~~~~~~~~~~~ 298 (631)
T PHA02792 225 KCDIKREIFDALFDSNY--SG--NEL--MNILSNYLRKQYRNKNHKIDNYIVDKLLSGHDTFYILELCNSLRNNIIISSI 298 (631)
T ss_pred cccchHHHHHHHHhccc--cc--cch--HhHHHHHHHHHhccCccCccHHHHHHHHhCCCccchhhhhhhhhhhhHHHHH
Confidence 55 5555665555311 00 000 0011 1110 00 0 122555555544332222111100000000
Q ss_pred ---------HHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCC--
Q 000343 690 ---------LCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHN-- 758 (1630)
Q Consensus 690 ---------l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G-- 758 (1630)
-.+...+... .-..+++++|+++|++++ ......++|.||..|+.++|++|+++|||+|.+|.+|
T Consensus 299 ~~~~~~~~q~~l~~Yl~~~--~v~ieiIK~LId~Ga~~~--r~~~~n~~~~Aa~~gn~eIVelLIs~GADIN~kD~~g~~ 374 (631)
T PHA02792 299 LKRYTDSIQDLLSEYVSYH--TVYINVIKCMIDEGATLY--RFKHINKYFQKFDNRDPKVVEYILKNGNVVVEDDDNIIN 374 (631)
T ss_pred HHHHhHHHHHHHHHHHhcC--CccHHHHHHHHHCCCccc--cCCcchHHHHHHHcCCHHHHHHHHHcCCchhhhcCCCCC
Confidence 0001111111 245799999999999986 2235667999999999999999999999999999885
Q ss_pred CCHHHHHHHcCCHH---HHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHH
Q 000343 759 TIPLHVALARGAKS---CVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRD 835 (1630)
Q Consensus 759 ~TPLH~Aa~~G~~e---iVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLd 835 (1630)
.||||+|+.....+ ++++|+++|||+|.+|..|.||||+|+..++ ..++++|.+.||++|.+|..|+|||+
T Consensus 375 ~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n------~eivelLLs~GADIN~kD~~G~TpL~ 448 (631)
T PHA02792 375 IMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHS------VSLVEWLIDNGADINITTKYGSTCIG 448 (631)
T ss_pred hhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCC------HHHHHHHHHCCCCCCCcCCCCCCHHH
Confidence 69999988876654 6889999999999999999999999997543 35667788889999999999999999
Q ss_pred HHhhCCCC------CcHHHHHHHHHhcCCCCC
Q 000343 836 FLEGLPRE------WISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 836 lA~~~~~~------~~~~~lve~Ll~~Ga~l~ 861 (1630)
+|...... ....+++++|+++|+++.
T Consensus 449 ~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i~ 480 (631)
T PHA02792 449 ICVILAHACIPEIAELYIKILEIILSKLPTIE 480 (631)
T ss_pred HHHHHHhcccHHHHHHHHHHHHHHHhcCCChh
Confidence 98652211 123468999999998865
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=319.97 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=207.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||+ +.+..+++.||+|.+.... ......+.+|+++++.++ ||||+++++++....
T Consensus 1 ~~~~~~~l~~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFK------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD--SSYIIRYYESFLDKG 72 (256)
T ss_pred CceEeEEecCCCCeEEEE------EEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC--CCCeehheeeeccCC
Confidence 588999999999887754 6677889999999987542 233566778899988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+|++|||++++.+..++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999999998888777654 3568999999999999999999999999999999999999999999999999988654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... .......|++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+.
T Consensus 153 ~~~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 153 DNT--------------NFANTIVGTPYYLSPELCEDKP------------YNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred Ccc--------------chhhccccCccccCHHHhcCCC------------CCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 321 1112345788999999987644 78899999999999999999999988887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
......+..+...+. ...++.++.+++.+||+.+|++||++.+++++
T Consensus 207 ~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 207 GALILKIIRGVFPPV------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHcCCCCCC------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 777766655432221 12478899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=351.17 Aligned_cols=283 Identities=16% Similarity=0.243 Sum_probs=209.9
Q ss_pred ChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHH--cCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHc--
Q 000343 480 DVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACR--RGSAELVEAILEYSQENVDVLDKDGDPPLVFALAA-- 555 (1630)
Q Consensus 480 dl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~--~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~-- 555 (1630)
+++.|+.||..+. .+ .. ..+.|+++.+.. .++.++|++||++ |+++|..|..|.||||.|+.+
T Consensus 17 ~~~~v~~ll~~~~-~~----------~~-~~~~~~~~~yl~~~~~~~~iv~~Ll~~-Gadvn~~d~~g~TpL~~~~~n~~ 83 (489)
T PHA02798 17 KLSTVKLLIKSCN-PN----------EI-VNEYSIFQKYLQRDSPSTDIVKLFINL-GANVNGLDNEYSTPLCTILSNIK 83 (489)
T ss_pred cHHHHHHHHhcCC-hh----------hh-cccchHHHHHHhCCCCCHHHHHHHHHC-CCCCCCCCCCCCChHHHHHHhHH
Confidence 5778999996542 21 11 457787774444 4589999999995 679999999999999999864
Q ss_pred ---CCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCC---h
Q 000343 556 ---GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG---QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY---T 626 (1630)
Q Consensus 556 ---G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G---~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~---~ 626 (1630)
++.+++++|+++|||+|.. +..|.||||+|+.++ +.+++++|+++|||+|..|.+|.||||+|+..++ .
T Consensus 84 ~~~~~~~iv~~Ll~~GadiN~~--d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~ 161 (489)
T PHA02798 84 DYKHMLDIVKILIENGADINKK--NSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDI 161 (489)
T ss_pred hHHhHHHHHHHHHHCCCCCCCC--CCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchH
Confidence 6799999999999999875 456889999999986 7899999999999999999999999999999988 9
Q ss_pred HHHHHHHHcCCcccccccc-CCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhH
Q 000343 627 DCAIVILENGGCRSMAILN-SKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGR 705 (1630)
Q Consensus 627 eiv~~LL~~Ga~~~i~~~d-~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~ 705 (1630)
+++++|+++|+ +++..+ ..|.||||.++..+. ...+.
T Consensus 162 ~vv~~Ll~~ga--din~~~~~~~~t~Lh~~~~~~~----------------------------------------~~~~~ 199 (489)
T PHA02798 162 EIIKLLLEKGV--DINTHNNKEKYDTLHCYFKYNI----------------------------------------DRIDA 199 (489)
T ss_pred HHHHHHHHhCC--CcccccCcCCCcHHHHHHHhcc----------------------------------------ccCCH
Confidence 99999999997 566554 578999998865320 01234
Q ss_pred HHHHHHHhcCCCCCcccccCccchh-------hhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHH
Q 000343 706 ELVRILLTAGAEPTAQDAQNRTALH-------IASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778 (1630)
Q Consensus 706 eiVklLL~~GAdvn~~D~~G~TpLH-------~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLL 778 (1630)
+++++|+++|++++..+..|.|+++ ++...++.+++.+|+. ++|+|.+|..|.||||+|+..|+.+++++||
T Consensus 200 ~ivk~Li~~Ga~i~~~~~~~~~~~~~~l~~l~~~~~~~~~~i~~~l~~-~~dvN~~d~~G~TPL~~A~~~~~~~~v~~LL 278 (489)
T PHA02798 200 DILKLFVDNGFIINKENKSHKKKFMEYLNSLLYDNKRFKKNILDFIFS-YIDINQVDELGFNPLYYSVSHNNRKIFEYLL 278 (489)
T ss_pred HHHHHHHHCCCCcccCCccccchHHHHHHHHHhhcccchHHHHHHHHh-cCCCCCcCcCCccHHHHHHHcCcHHHHHHHH
Confidence 5666677777777776666666655 2334455666666554 4677777777777777777777777777777
Q ss_pred hCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCccccc
Q 000343 779 SAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVR 826 (1630)
Q Consensus 779 e~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~ 826 (1630)
++|||+|.+|..|+||||+|+..++ ..++.+|+..+++++..
T Consensus 279 ~~GAdin~~d~~G~TpL~~A~~~~~------~~iv~~lL~~~~~~~~i 320 (489)
T PHA02798 279 QLGGDINIITELGNTCLFTAFENES------KFIFNSILNKKPNKNTI 320 (489)
T ss_pred HcCCcccccCCCCCcHHHHHHHcCc------HHHHHHHHccCCCHHHH
Confidence 7777777777777777777765432 23444555666666543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.58 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=209.1
Q ss_pred eccccCCeEE-EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 131 EVGVHHDVKL-VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 131 ~~~~~~~y~~-~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
+..+.++|.+ -+.||-|-.|.|.. +.+++|++++|+|++.- ....++|+++.-..+ .|||||+++++
T Consensus 56 ~~~itedY~is~qvLG~GinGkV~~------C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s-~h~~iV~IidV 123 (400)
T KOG0604|consen 56 EYSITEDYSISWQVLGAGINGKVVQ------CVHKRTQEKFALKVLLD-----SPKARREVELHWMAS-GHPHIVSIIDV 123 (400)
T ss_pred cccchhhheehhhhhccccCCceEE------EEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhc-CCCceEEeehh
Confidence 3445678887 46799999888743 56889999999998763 345678888877766 79999999999
Q ss_pred EEe----CCEEEEEEecCCCChHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC---CcE
Q 000343 210 LRM----DSCLGLVMDRCYGSVQLAMQRNEGR--LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS---GRA 280 (1630)
Q Consensus 210 f~~----~~~~~LVmEy~~gglL~~l~~~~~~--L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~---g~v 280 (1630)
|++ ..++.+|||.+.||.|+..++.++. +++.++..|++||..|++|||+.+|.||||||+|+|+... -.+
T Consensus 124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred hhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence 864 4679999999999999988876654 9999999999999999999999999999999999999754 368
Q ss_pred EEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHH
Q 000343 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360 (1630)
Q Consensus 281 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyem 360 (1630)
||+|||+|+.-..+ ....+.+-||+|.|||++...+ |+...|+||+||+||-|
T Consensus 204 KLtDfGFAK~t~~~---------------~~L~TPc~TPyYvaPevlg~eK------------ydkscdmwSlgVimYIl 256 (400)
T KOG0604|consen 204 KLTDFGFAKETQEP---------------GDLMTPCFTPYYVAPEVLGPEK------------YDKSCDMWSLGVIMYIL 256 (400)
T ss_pred EecccccccccCCC---------------ccccCCcccccccCHHHhCchh------------cCCCCCccchhHHHHHh
Confidence 99999999864321 1234456699999999998776 89999999999999999
Q ss_pred hhCCCCCCCCC----HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 361 CTGSIPWAGLS----AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 361 ltG~~PF~~~~----~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.|.+||.... ...+-.+|..+....|. +.+..+|++++++|+.+|+.+|++|.|+.++++|-.
T Consensus 257 LCGyPPFYS~hg~aispgMk~rI~~gqy~FP~---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 257 LCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred hcCCCcccccCCccCChhHHhHhhccCccCCC---hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 99999996432 23455677666654443 345578999999999999999999999999999844
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=321.97 Aligned_cols=252 Identities=24% Similarity=0.425 Sum_probs=206.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.++||+|+||.||+ |.. ..+..||+|.+.... ...+.+.+|+.+++.++ ||||+++++.+.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~------~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWM------GYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ--HDKLVRLYAVVTKEEP 75 (261)
T ss_pred HHeEEeeecCCcCCceEEE------EEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCC--CCCeeeEEEEEcCCCC
Confidence 5899999999999998865 322 345679999877533 34567888999999975 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++|||+.++.+..++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999988877776643 34689999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
.. ........++..|+|||.+.... ++.++|||||||++|+|++ |..||.....
T Consensus 156 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 156 NE-------------YTAREGAKFPIKWTAPEAINFGS------------FTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred Cc-------------eeccCCCccceecCCHHHhccCC------------CChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 21 00112234567899999986644 7889999999999999998 9999998877
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.+....+......+. ...++.++.+|+.+||+.+|++||+++++++.|..
T Consensus 211 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 211 SDVMSALQRGYRMPR------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 777766655432221 23578899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=322.01 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=205.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||. +.+..+++.||||.+....... ...+.+|+++++.++ ||||+++++++..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYR------ATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN--HPNVIKYLDSFIE 73 (267)
T ss_pred cceeeeeeeccCCCeeEEE------EEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC--CcceeeeeeeEEE
Confidence 4899999999999887754 6677789999999887543222 345678999999875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.+..+++|||++++.+..++. ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999887776553 2345899999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
....... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 154 ~~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~~------------~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 154 RFFSSKT--------------TAAHSLVGTPYYMSPERIHENG------------YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred eeccchh--------------HHHhcCCCCccccChhhhccCC------------CCchhhHHHHHHHHHHHhcCCCCCc
Confidence 8754321 0112345788999999987543 6889999999999999999999996
Q ss_pred CCC--HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 369 GLS--AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 369 ~~~--~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
... .......+.... .++. .....+..+.+||.+||+.+|++||++.++++.+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 208 GDKMNLFSLCQKIEQCD-YPPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cccccHHHHHHHHhcCC-CCCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 543 234444443322 2221 1224678899999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=325.10 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=206.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||. +.++.+++.||+|++...... ....+.+|+.+++.++ ||||+++++++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~ 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFK------CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK--HPNLVNLIEVFRRK 72 (286)
T ss_pred CceeeeeeecccCCeEEEE------EEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC--CCCEeeeeeEEeeC
Confidence 4799999999999887754 667778999999998754322 2355778999999976 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..++++|||++++++..+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..+..
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999999999999998887767799999999999999999999999999999999999999999999999999987643
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
... ......++..|+|||++.+.. .++.++||||||+++|+|++|.+||.+.+..
T Consensus 153 ~~~--------------~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 153 PGD--------------DYTDYVATRWYRAPELLVGDT-----------QYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred Ccc--------------cccCcccccccCCHHHHhCCC-----------CcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 210 112345688999999986532 1678999999999999999999999877665
Q ss_pred HHHHHHHhcCC-------------------CCCCcc-----cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRK-------------------LPPQYA-----SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~-------------------~~~~~~-----~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+..... ..+... ......++..+.+|+.+||+.+|++||++.+++.|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 208 DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 44433322100 000000 001134678899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=326.84 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=202.1
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChh--HHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPD--WLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~--~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
|++.+.||+|+||.||+ +.+..+++.||+|.+......... ...+|+.+++.++ ||||+++++++.....
T Consensus 1 y~~~~~lg~G~~g~v~~------~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYK------AKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR--HPNIVQILDVFQDDNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEE------EEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT--BTTBCHEEEEEEESSE
T ss_pred CEEeEEEEeCCCEEEEE------EEECCCCeEEEEEEeccccccccccchhhhhhhcccccc--cccccccccccccccc
Confidence 88999999999888755 678888999999999976433322 2345888998885 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
.+++|||+.++.+..++.+...+++..+..++.||++||+|||+.+|+||||||+|||++.++.++|+|||++......
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999888777766678999999999999999999999999999999999999999999999999998764211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccc-cccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH-
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWE-PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE- 373 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~-~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~- 373 (1630)
........++..|+|||++. ... ++.++|+||+|+++|+|++|..||......
T Consensus 152 -------------~~~~~~~~~~~~y~aPE~~~~~~~------------~~~~~Di~slG~il~~l~~~~~p~~~~~~~~ 206 (260)
T PF00069_consen 152 -------------NENFNPFVGTPEYMAPEVLQQGKK------------YTRKSDIWSLGIILYELLTGKLPFEESNSDD 206 (260)
T ss_dssp -------------TSEBSSSSSSGGGSCHHHHTTTSS------------BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred -------------cccccccccccccccccccccccc------------ccccccccccccccccccccccccccccchh
Confidence 11233456789999999987 333 789999999999999999999999987332
Q ss_pred --HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 --EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 --ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+........... .......+.++.+||.+||+.||++|||+.++++|-
T Consensus 207 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 207 QLEIIEKILKRPLPSS---SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp HHHHHHHHHHTHHHHH---TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred hhhhhhhccccccccc---ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 23332222111000 000111237899999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=328.02 Aligned_cols=258 Identities=20% Similarity=0.233 Sum_probs=209.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
-|++.++||+|+||.||. +.+..++..+|+|.+..........+.+|+++++.+. ||||++++++|......
T Consensus 6 ~~~i~~~lg~g~~g~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYK------AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEE------EEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC--CCCeeeEEEEEeeCCEE
Confidence 478899999999887754 6677788999999987654444566778999998875 99999999999999999
Q ss_pred EEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 217 GLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
|+||||++++++..++. ....+++..+..++.|+++||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999988877654 34579999999999999999999999999999999999999999999999999987543211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......+++.|+|||++..... ....++.++|+|||||++|+|++|++||...+..+.
T Consensus 158 --------------~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 158 --------------QRRDSFIGTPYWMAPEVVMCETS-------KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred --------------cccccccccccccCHhhccccCC-------CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 11223457899999999864221 122378899999999999999999999998877666
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
...+........ ..+..++.++.+||.+||+.||++||++.++++|.+
T Consensus 217 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 217 LLKIAKSEPPTL----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHhhcCCCCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 665544332111 122357889999999999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=332.28 Aligned_cols=257 Identities=19% Similarity=0.301 Sum_probs=204.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+ +.+..++..+|+|.+..... .....+.+|+++++.++ ||||++++++|..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTK------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN--SPYIVGFYGAFYSDG 72 (308)
T ss_pred CCceEEeeccCCCCeEEEE------EEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEeeCC
Confidence 3799999999999888765 55777889999998875422 12355778999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|++|||+++++|..++.+...+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999999999999998888777789999999999999999999998 5999999999999999999999999999865432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
. ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..
T Consensus 153 ~----------------~~~~~~~~~~~~aPE~~~~~~------------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 153 S----------------MANSFVGTRSYMSPERLQGTH------------YTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred c----------------ccccCCCCcCccChhHhcCCC------------CCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 1 112346789999999986543 788999999999999999999999765543
Q ss_pred HHHHHHHhcCCCCC------------------------------C-cccccCCCCCHHHHHHHHHhhccCcCCCCChhhH
Q 000343 374 EIYRAVVKNRKLPP------------------------------Q-YASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 374 ei~~~i~~~~~~~~------------------------------~-~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ev 422 (1630)
.....+........ . ........++.++.+|+.+||..+|++||++.++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 205 ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred hHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 33222211100000 0 0000011367789999999999999999999999
Q ss_pred HHHhhh
Q 000343 423 LATFLR 428 (1630)
Q Consensus 423 L~~L~~ 428 (1630)
++|.+-
T Consensus 285 l~~~~~ 290 (308)
T cd06615 285 TKHPFI 290 (308)
T ss_pred hcChhh
Confidence 998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=321.80 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=208.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||. ...+. ...+...||||.+...... ....+.+|+.+++.++ ||||+++++.+....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~--~~~~~-~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCR--GRLKL-PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD--HPNIIRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEE--EEEcc-CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC--CCCcceEeEEEecCC
Confidence 5899999999999998864 11111 1233568999988754322 2446778999998875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.++++|||++++.|..++.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999998888777644 45799999999999999999999999999999999999999999999999999987642
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
... ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.....
T Consensus 159 ~~~------------~~~~~~~~~~~~y~~Pe~~~~~~------------~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 159 SEA------------TYTTKGGKIPIRWTAPEAIAYRK------------FTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ccc------------ceeccCCCCCccccChhhhccCC------------CccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 110 00011223467899999987644 7899999999999999998 9999988887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+....+......+. +..+++.+.+|+.+||+.+|++||++.+++++|...
T Consensus 215 ~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 215 QDVIKAVEDGYRLPP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 777777765433222 235789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=329.09 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=212.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.++||.|+||.||. +.+..++..||+|.+........+.+.+|+++++.++ ||||+++++.+..+.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYK------AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK--HPNIVGLYEAYFYEN 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEE------EEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEecCC
Confidence 46899999999999888754 5566688999999988655445567788999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|+||||++++++..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999888877654 45699999999999999999999999999999999999999999999999998865432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......+++.|+|||++..... ....++.++|+||||+++|+|++|..||...+..
T Consensus 156 ~~--------------~~~~~~~~~~~y~~PE~~~~~~~-------~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~ 214 (280)
T cd06611 156 TL--------------QKRDTFIGTPYWMAPEVVACETF-------KDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214 (280)
T ss_pred cc--------------cccceeecchhhcCHHHHhhccc-------CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence 11 11223467899999999864321 1223788999999999999999999999888776
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.+..+...... .. ..+..++.++.+||.+||+.+|++||++.++++|-+
T Consensus 215 ~~~~~~~~~~~~--~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 215 RVLLKILKSEPP--TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred HHHHHHhcCCCC--Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 666665443221 11 123357889999999999999999999999999844
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=327.26 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=208.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcccc-ccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQ-GRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~-~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+. ..+... ......+|+|.+..... .....+.+|+.+++.+. +||||+++++++...
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~--~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~~~~~~~ 88 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGVCTQE 88 (293)
T ss_pred hHeEEeeEecccccccEEEE--EEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEcCC
Confidence 58999999999999988652 222211 23447899998875422 12345778999988874 599999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN----------------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~----------------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
..++++|||+.++.+..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999998888777642 2458999999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++.+..... ........++..|+|||++.+.. ++.++|||||||++
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il 224 (293)
T cd05053 169 HVMKIADFGLARDIHHIDY------------YRKTTNGRLPVKWMAPEALFDRV------------YTHQSDVWSFGVLL 224 (293)
T ss_pred CeEEeCccccccccccccc------------eeccCCCCCCccccCHHHhccCC------------cCcccceeehhhHH
Confidence 9999999999986543210 00111223467799999886544 78999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|+|++ |..||...+..+.+..+....... .+...+.++.+|+.+||..||++|||+.+++++|...+
T Consensus 225 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEELFKLLKEGYRME------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99998 999999888777776665443221 12356789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=333.36 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=188.4
Q ss_pred EEEeCcCCceeEEEeeEEEccc--cccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe--CCEE
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGG--QGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM--DSCL 216 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~--~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~--~~~~ 216 (1630)
.++||+|+||.||+ |. +..+++.||+|.+.... ....+.+|+++|+.++ ||||++++++|.. ...+
T Consensus 6 ~~~lG~G~~g~Vy~------~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYK------AKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELK--HPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEE------EEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcC--CCCCcceeeeEecCCCcEE
Confidence 46899999998865 33 33567899999987532 2345778999999975 9999999999864 4578
Q ss_pred EEEEecCCCChHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEE----CCCCcEEEee
Q 000343 217 GLVMDRCYGSVQLAMQRN--------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL----DASGRAVVSD 284 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~--------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILl----d~~g~vKL~D 284 (1630)
|++|||+.+++...+... ...+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 76 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 999999988766554321 1258999999999999999999999999999999999999 4557899999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||+++.+..... .........||+.|+|||++.+.. .++.++||||+||++|+|++|+
T Consensus 156 fG~a~~~~~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~el~~g~ 213 (317)
T cd07868 156 MGFARLFNSPLK-----------PLADLDPVVVTFWYRAPELLLGAR-----------HYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred cCceeccCCCCc-----------cccccCCccccccccCCHHHcCCC-----------CcCchhhHHHHHHHHHHHHhCC
Confidence 999987643210 011223457899999999987643 2788999999999999999999
Q ss_pred CCCCCCCH---------HHHHHHHHhcCCCCCC-------------------------------cccccCCCCCHHHHHH
Q 000343 365 IPWAGLSA---------EEIYRAVVKNRKLPPQ-------------------------------YASIVGVGIPRELWKM 404 (1630)
Q Consensus 365 ~PF~~~~~---------~ei~~~i~~~~~~~~~-------------------------------~~~~~~~~l~~el~~L 404 (1630)
+||..... .+.+..+......+.. +........+.++.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 293 (317)
T cd07868 214 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293 (317)
T ss_pred CCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHH
Confidence 99964321 1122222211100000 0000011235678999
Q ss_pred HHHhhccCcCCCCChhhHHHHh
Q 000343 405 IGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 405 I~~cL~~dP~~RPSa~evL~~L 426 (1630)
|.+||++||.+|||++|+|+|-
T Consensus 294 i~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 294 LQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhccCcccCCCHHHHhcCC
Confidence 9999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.79 Aligned_cols=209 Identities=31% Similarity=0.448 Sum_probs=175.0
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHH
Q 000343 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDK-DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCA 588 (1630)
Q Consensus 510 ~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~-~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa 588 (1630)
.+.++.+.+|......-++.|++.....++..+. +|+||||+||..|+.+|+++|++ -++++..++|..|.||||+||
T Consensus 2 e~~~~~~~~~~~~~~~kveel~~s~~kSL~~r~dqD~Rt~LHwa~S~g~~eiv~fLls-q~nv~~ddkDdaGWtPlhia~ 80 (226)
T KOG4412|consen 2 EYASLGKAICENCEEFKVEELIQSDPKSLNARDDQDGRTPLHWACSFGHVEIVYFLLS-QPNVKPDDKDDAGWTPLHIAA 80 (226)
T ss_pred CccchHHHHHhhchHHHHHHHHhcChhhhhccccccCCceeeeeeecCchhHHHHHHh-cCCCCCCCccccCCchhhhhh
Confidence 3567899999999999999999877766777665 99999999999999999999996 355555566788888999999
Q ss_pred HcCCHHHHHHHHHc-CCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHH
Q 000343 589 YHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRW 667 (1630)
Q Consensus 589 ~~G~~eivk~LL~~-GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~L 667 (1630)
..|+.++|+.|+.+ |+|+|+.+..|.||||||+.+|..+++++|+++|
T Consensus 81 s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~g------------------------------- 129 (226)
T KOG4412|consen 81 SNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKG------------------------------- 129 (226)
T ss_pred hcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcC-------------------------------
Confidence 99999999999888 8899888888888888888777666666666555
Q ss_pred HHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHC
Q 000343 668 VEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747 (1630)
Q Consensus 668 Le~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~ 747 (1630)
+.++.+|..|+||||.||..|+++++++|+..
T Consensus 130 ------------------------------------------------a~i~~kD~~~qtplHRAAavGklkvie~Li~~ 161 (226)
T KOG4412|consen 130 ------------------------------------------------ALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQ 161 (226)
T ss_pred ------------------------------------------------CCCcccccccCchhHHHHhccchhhHHHHHhc
Confidence 44566777888888888888888888888888
Q ss_pred CCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHH
Q 000343 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799 (1630)
Q Consensus 748 GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa 799 (1630)
||.+|.+|..|+||||.|...|+.++..+|+++|||++..|++| |||-.|+
T Consensus 162 ~a~~n~qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~edke~-t~~~~a~ 212 (226)
T KOG4412|consen 162 GAPLNTQDKYGFTPLHHALAEGHPDVAVLLVRAGADTDREDKEG-TALRIAC 212 (226)
T ss_pred CCCCCcccccCccHHHHHHhccCchHHHHHHHhccceeeccccC-chHHHHH
Confidence 88899999999999999988888889889999999999888888 8888876
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=328.07 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=209.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+.|+++++||.|+||.||+ +.+..++..||+|.+..........+.+|+.+++.++ ||||+++++.+..+.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYK------AKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN--HPYIVKLLGAFYWDG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEE------EEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCcEeeeEEEEEeCC
Confidence 36799999999999887754 6677889999999988655444566778999988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|+||||++++++..+.. ....+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999999988876553 345699999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......+++.|+|||++..... ....++.++|+|||||++|+|++|..||...+..
T Consensus 163 ~~--------------~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 221 (292)
T cd06644 163 TL--------------QRRDSFIGTPYWMAPEVVMCETM-------KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221 (292)
T ss_pred cc--------------cccceecCCccccCceeeccccc-------cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence 11 11123457889999999864321 1123788999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..+...... . ...+..++.++.+||.+||+.+|++||++.++++|-+
T Consensus 222 ~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 222 RVLLKIAKSEPP--T--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred HHHHHHhcCCCc--c--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 555555433211 1 1123357789999999999999999999999998744
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=325.67 Aligned_cols=259 Identities=25% Similarity=0.311 Sum_probs=209.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|.+.++||+|+||.||.... .......++..+|+|.+..........+.+|+++++.++ ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEE-ecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC--CCCCceEEEEEecCCc
Confidence 5789999999999999975321 111234567789999887655555667889999999875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcE
Q 000343 216 LGLVMDRCYGSVQLAMQRNE---------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRA 280 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~---------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~v 280 (1630)
++++|||++++.|..++... ..+++..++.++.||+.||+|||+.||+||||||+|||+++++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 99999999988887776543 248899999999999999999999999999999999999999999
Q ss_pred EEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHH
Q 000343 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360 (1630)
Q Consensus 281 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyem 360 (1630)
||+|||++....... .........+++.|+|||.+.+.. ++.++|||||||++|+|
T Consensus 162 kL~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~el 217 (280)
T cd05092 162 KIGDFGMSRDIYSTD------------YYRVGGRTMLPIRWMPPESILYRK------------FTTESDIWSFGVVLWEI 217 (280)
T ss_pred EECCCCceeEcCCCc------------eeecCCCccccccccCHHHhccCC------------cCchhhHHHHHHHHHHH
Confidence 999999997654221 011112234578899999887654 78999999999999999
Q ss_pred hh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 361 CT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 361 lt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++ |.+||......+....+..+.... .+..+++.+.+||.+||+.||.+||++.++++.|.
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECITQGRELE------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCHHHHHHHHHcCccCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 999998887777776665543221 12357899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=321.54 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=204.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||+ +.. ..+..+|+|.+... ....+.+.+|+.+++.+. ||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~------~~~-~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKY------GKW-RGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLS--HEKLVQLYGVCTKQRP 73 (256)
T ss_pred HHeEEeeEecCcccceEEE------EEe-cCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCC--CCCeeeEEEEEccCCC
Confidence 4799999999999998865 222 22346999988753 334567888999999875 9999999999998889
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
++++|||+.++.+..++.. ...+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||+++....+
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999998877777654 346899999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ 373 (1630)
. ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..
T Consensus 154 ~-------------~~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 154 E-------------YTSSVGSKFPVRWSPPEVLLYSK------------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred c-------------eeecCCCccChhhCCHHHHhcCc------------ccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 1 01112234567899999987544 7889999999999999999 99999888777
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+..+...+. +...+..+.+++.+||+.+|.+||++.++++++
T Consensus 209 ~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 209 ETVEKVSQGLRLYR------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 77777765533221 123578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=327.42 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=211.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|++.+.||.|+||.||. +.+..+++.||+|.+........+.+.+|+.+++.++ ||||+++++.+.....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFT------AIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK--NPNIVNFLDSFLVGDE 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEE------EEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC--CCceeeeeeeEecCce
Confidence 5799999999999887754 6677889999999998766556677888999998875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+|+||||++++++..++.. ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999999998887764 369999999999999999999999999999999999999999999999999987643211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....
T Consensus 170 --------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 170 --------------SKRSTMVGTPYWMAPEVVTRKA------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred --------------ccCCCcCCCccccCcchhcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112345788999999987644 68899999999999999999999988776555
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
...+........ ..+..+++.+.+||.+||..||++||++.+++.|-+-
T Consensus 224 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 224 LYLIATNGTPEL----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred HHHHHhcCCccc----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 444433321111 1233578899999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=326.30 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=201.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.|+..+.||+|+||.||. +.+..+++.||+|.+...... ....+.+|+++|+.++ |+||+.+++.|..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~ 72 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCA------CQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN--SQFVVNLAYAYETK 72 (285)
T ss_pred CceEEEEEecCCCeEEEE------EEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC--CcCceeEEEEEecC
Confidence 378889999999888764 567778999999998764322 2345678999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+..+++|||+.++++..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 999999999998887766543 336999999999999999999999999999999999999999999999999998764
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 153 ~~~~---------------~~~~~~g~~~~~aPE~~~~~~------------~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 153 PEGE---------------SIRGRVGTVGYMAPEVLNNQR------------YTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred CCCC---------------cccCCCCCcCccChHHhcCCC------------CCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 112346899999999987644 7899999999999999999999998766
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~ 425 (1630)
.......+........ ......++.++.+|+.+||+.||++||+ +.++++|
T Consensus 206 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 206 EKVKREEVDRRVLETE---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHHHhhhccc---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 5443333322111111 1123457889999999999999999999 6677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=363.51 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=201.9
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+..+|+++++||+|+||.||+ +.+..++..||+|.+...... ....+.+|+.+|+.++ ||||++++++|.
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYL------Akdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~--HPNIVrl~d~f~ 82 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFL------VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK--HKNIVRYIDRFL 82 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEE------EEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC--CCCcCeEEEEEE
Confidence 346999999999999998876 567788999999998765322 3456788999999976 999999999986
Q ss_pred e--CCEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccccccccceEECC--
Q 000343 212 M--DSCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAA-------GVVCMNIKPSNLLLDA-- 276 (1630)
Q Consensus 212 ~--~~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~-------gIIHRDLKP~NILld~-- 276 (1630)
. ...+||||||+++++|..++.. ...|++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 5 4579999999998887766643 35699999999999999999999984 4999999999999964
Q ss_pred ---------------CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCc
Q 000343 277 ---------------SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDA 341 (1630)
Q Consensus 277 ---------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~ 341 (1630)
...+||+|||++..+.... ......||+.|+|||++.+..
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------------~~~s~vGTp~YmAPEvL~ge~---------- 217 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------------MAHSCVGTPYYWSPELLLHET---------- 217 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc---------------cccccCCCccccCHHHHhccC----------
Confidence 2358999999997653211 123356899999999986532
Q ss_pred CCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 342 IGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 342 ~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
..++.++||||||||||+|++|..||...+....+...+......+ ....+.++.+||.+||..+|.+||++.+
T Consensus 218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP------IKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC------cCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 1278999999999999999999999986654443333333221111 1246789999999999999999999999
Q ss_pred HHHHhh
Q 000343 422 MLATFL 427 (1630)
Q Consensus 422 vL~~L~ 427 (1630)
+|.+.+
T Consensus 292 lL~h~~ 297 (1021)
T PTZ00266 292 CLGYQI 297 (1021)
T ss_pred HhccHH
Confidence 998744
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=321.59 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=206.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---------hhHHHHHHHHHHHhccCCCCcceeE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---------PDWLSGQLDNLRRASMWCRNVCTFH 207 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---------~~~~~~Ei~iL~~l~l~HpNIV~l~ 207 (1630)
+|.+.+.||+|+||.||. |.+..++..+|+|.+....... .+.+.+|+.+++.++ ||||++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~------a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~ 72 (267)
T cd06628 1 KWIKGALIGSGSFGSVYL------GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ--HENIVQYL 72 (267)
T ss_pred CccccceeecCCCeEEEE------EEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC--CCCeeeEE
Confidence 477889999999887754 6667788999999887653322 245778899999875 99999999
Q ss_pred EEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 208 GVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 208 ~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
+++......+++|||++++.+..++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 73 GSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred EEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999998888887777899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF 367 (1630)
++.+....... ..........|+..|+|||.+.+.. ++.++|+||||+++|+|++|+.||
T Consensus 153 ~~~~~~~~~~~--------~~~~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 153 SKKLEANSLST--------KTNGARPSLQGSVFWMAPEVVKQTS------------YTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred CcccccccccC--------CccccccccCCCcCccChhHhccCC------------CCchhhhHHHHHHHHHHhhCCCCC
Confidence 98765321000 0011122345788999999987644 678999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
...+....+..+..... +. .+..++.++.++|.+||+.||.+||++.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 213 PDCTQLQAIFKIGENAS--PE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCccHHHHHHHHhccCC--Cc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 88766555544433211 11 223578999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=329.61 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=208.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|.+.+.||+|+||.||+ +..+......++..||+|.+...... ..+.+.+|+++++++. +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~-~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVE-ATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEE-EEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-CCCCcceEEEEEecCC
Confidence 5899999999999999975 33333334556779999988754322 2456788999999874 5999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+|++|||+.++.|..++... ..+++.++..++.|++.||+|||+++|+|+||||+|||++.++.+||+|||+++.+.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999988887776542 238999999999999999999999999999999999999999999999999987654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
.... ........++..|+|||.+.+.. ++.++|||||||++|+|++ |..||....
T Consensus 193 ~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 193 NDSN------------YVVKGNARLPVKWMAPESIFNCV------------YTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CCCc------------eeecCCCCcccccCCHhhhccCC------------CCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 3210 00112234578899999987654 7889999999999999998 999998776
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
..+.+.........+. .+...++++.+|+.+||+.+|++|||+.++++.|.+.
T Consensus 249 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 249 VDSKFYKLIKEGYRMA-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chHHHHHHHHcCCcCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 6555544443322211 1234678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=352.95 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=195.7
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhcc----CCCCcceeEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM----WCRNVCTFHGVL 210 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l----~HpNIV~l~~~f 210 (1630)
.++|+++++||+|+||.||+ +.+..+++.||||++.... ........|+.+++.++. .|++|++++++|
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~------a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVE------AWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCcEEEEEEEEeccCEEEEE------EEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 46899999999999888864 6677889999999987432 223445678888877652 356799999998
Q ss_pred EeC-CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCC----------
Q 000343 211 RMD-SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASG---------- 278 (1630)
Q Consensus 211 ~~~-~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g---------- 278 (1630)
... .++|||||++.++++..+. +.+.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 765 5799999999776666554 44679999999999999999999998 5999999999999998665
Q ss_pred ------cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchh
Q 000343 279 ------RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352 (1630)
Q Consensus 279 ------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWS 352 (1630)
.+||+|||++..... .....+||+.|+|||++.+.. |+.++||||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~-----------------~~~~~~gt~~Y~APE~~~~~~------------~~~~~DiwS 330 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH-----------------SRTAIVSTRHYRSPEVVLGLG------------WMYSTDMWS 330 (467)
T ss_pred cCCCCceEEECCCCccccCcc-----------------ccccccCCccccCcHHhhcCC------------CCcHHHHHH
Confidence 499999998753211 123457899999999997754 889999999
Q ss_pred hhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCC-cc------------------------c----------ccCCCC
Q 000343 353 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ-YA------------------------S----------IVGVGI 397 (1630)
Q Consensus 353 lGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~-~~------------------------~----------~~~~~l 397 (1630)
|||++|||++|++||...+..+.+..+.......+. +. . ......
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 999999999999999887765554443322111000 00 0 000011
Q ss_pred CHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 398 PRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 398 ~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++.+.+||.+||++||.+|||++|+|+|-+
T Consensus 411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 355789999999999999999999999854
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=317.50 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=210.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||.|+||.|++ +.+..+++.+|+|.+.... ......+.+|++++++++ ||||+++++++....
T Consensus 1 ~y~~~~~ig~g~~g~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATL------YRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ--HPNIIAYYNHFMDDN 72 (256)
T ss_pred CceEeeEecccCCceEEE------EEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC--CCCeeEEEeEEecCC
Confidence 589999999999998876 3356788999999987653 223456778999999975 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.++++|||++++.+..++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 999999999988887776543 468999999999999999999999999999999999999999999999999998664
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.
T Consensus 153 ~~~--------------~~~~~~~~~~~y~ape~~~~~~------------~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 153 SEY--------------SMAETVVGTPYYMSPELCQGVK------------YNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred ccc--------------ccccccCCCccccCHhhcCCCC------------CCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 321 0122346789999999987644 67899999999999999999999998888
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+....+..+...+. ...++.++.++|.+||+.+|++||++.+++++++
T Consensus 207 ~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 207 LNLVVKIVQGNYTPV------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred HHHHHHHHcCCCCCC------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 777777765543322 1357899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=331.39 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=204.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+|++.+.||+|+||.||. ..+..........||+|.++.... .....+.+|+.+++.+. ||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~--~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~g~~~~~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS 81 (316)
T ss_pred hhhceeeeeeecCCCceEEE--EEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEcCC
Confidence 35899999999999998854 222222223344699999875432 23456778889888875 99999999998764
Q ss_pred CEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++++||++++.+..++.. ...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 57799999988777666544 4568999999999999999999999999999999999999999999999999998765
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
.... ........++..|+|||++.+.. ++.++||||||+++|||++ |..||.+.+
T Consensus 161 ~~~~------------~~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 161 ADEK------------EYHAEGGKVPIKWMALESILHRI------------YTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCCc------------ceeccCCccceeecChHHhccCC------------CCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 3210 00111223467899999987644 7899999999999999998 999999877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
..++...+..+... +. +..++.++.+++.+||..+|++||++.+++.++.......
T Consensus 217 ~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 217 ASEISSILEKGERL-PQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHhCCCCC-CC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 76655444333222 21 2346789999999999999999999999999987765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=327.53 Aligned_cols=250 Identities=21% Similarity=0.253 Sum_probs=200.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.|++.+.||+|+||.||+ +.+..+++.||+|.+....... ...+.+|+.+++.++ |+||+.+++.+.+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~--~~~i~~~~~~~~~~ 72 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCA------CQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN--SRFVVSLAYAYETK 72 (285)
T ss_pred CceeeEEeecCCCeEEEE------EEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC--CCCeeeeeEEEecC
Confidence 478889999999888754 6677889999999987653222 245667999998875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+.+|+||||+.+++|..++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999999998888766543 235999999999999999999999999999999999999999999999999998764
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......|+..|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 153 ~~~~---------------~~~~~~g~~~y~aPE~~~~~~------------~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 153 PEGQ---------------TIKGRVGTVGYMAPEVVKNER------------YTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCc---------------cccCCCCCccccChHHHcCCC------------CCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 112346899999999987654 7899999999999999999999998653
Q ss_pred HH---HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHhh
Q 000343 372 AE---EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFL 427 (1630)
Q Consensus 372 ~~---ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L~ 427 (1630)
.. +....+.... . ...+..+++++.+|+.+||+.||++||| +.++++|-+
T Consensus 206 ~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 206 KKIKREEVERLVKEV--Q----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ccchHHHHHhhhhhh--h----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 22 2222221111 1 1123357889999999999999999999 889998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=321.29 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=202.3
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
|++.+.||+|+||.||.. .. ..+..++..||+|+++..... ....+.+|++.++.+. ||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~--~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEG--QL-SQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD--HPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEE--EE-ecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEeeeccCCc
Confidence 578899999999988641 11 112235588999998864322 2356788999988865 9999999998765443
Q ss_pred ------EEEEEecCCCChHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEe
Q 000343 216 ------LGLVMDRCYGSVQLAMQRN------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 216 ------~~LVmEy~~gglL~~l~~~------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
.+++|||++++++..++.. ...+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 8999999998887766532 2358999999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||+++.+..... ........++..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 156 dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 156 DFGLSKKIYSGDY------------YRQGRIAKMPVKWIAIESLADRV------------YTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred Cccceeecccccc------------ccccccccCCccccCHhhcccCC------------CCcccchHHHHHHHHHHHhC
Confidence 9999987643211 00111223467899999986544 7899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
|..||.+.+..+.+..+..+.... .+..+++++.+++.+||+.||++|||+.+++++|.+.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENHEIYDYLRHGNRLK------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCC------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999888777777665543221 1235788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=330.51 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=204.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCc--EEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH--SVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~--~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ |.+..++. .+|+|.++.... .....+.+|++++.++. +||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~------a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLK------ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEE------EEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-CCCCcceEEEEECC
Confidence 5899999999999888765 55555554 457777654321 22456778999998884 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~ 276 (1630)
.+.+|++|||++++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 99999999999988777766532 25789999999999999999999999999999999999999
Q ss_pred CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhH
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvI 356 (1630)
++.+||+|||++...... .......++..|+|||++.+.. ++.++|||||||+
T Consensus 160 ~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~i 212 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY---------------VKKTMGRLPVRWMAIESLNYSV------------YTTNSDVWSYGVL 212 (303)
T ss_pred CCcEEeCccccCcccchh---------------hhcccCCCcccccCHHHHhccC------------CcccccchhhhhH
Confidence 999999999998532110 0011122356799999886543 7899999999999
Q ss_pred HHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 357 Lyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
+|+|+| |..||...+..+.+..+...... ..+..+++++.+|+.+||+.+|++||++.+++.++...+....
T Consensus 213 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 213 LWEIVSLGGTPYCGMTCAELYEKLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcCCcC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 999998 99999887777666655332111 1123467899999999999999999999999999887765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=316.94 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=204.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEe-C
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-D 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-~ 213 (1630)
+|++.+.||+|+||.||+ +.++.+++.||+|++..... ...+.+.+|+++++.++ ||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSL------VRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK--HPNIVAYRESWEGED 72 (257)
T ss_pred CceEEEEecCCCCeEEEE------EEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC--CCCeeeeeeeecCCC
Confidence 589999999999888765 55677889999999876432 23456778888888875 9999999998864 4
Q ss_pred CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..+|++|||++++.+..++.. ...+++.++..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+
T Consensus 73 ~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 73 GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 468999999998877766643 345899999999999999999999999999999999999999999999999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... .......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 153 ~~~~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 153 ENQC--------------DMASTLIGTPYYMSPELFSNKP------------YNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred cccC--------------CccccccCCcCccChhHhcCCC------------CCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 4321 1122345788999999987654 7889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.......+..+.... .+...++++.+|+.+||+.||++||++.++++|-
T Consensus 207 ~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 255 (257)
T cd08223 207 MNSLVYRIIEGKLPP------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255 (257)
T ss_pred HHHHHHHHHhcCCCC------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 766666655443211 1235789999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=328.25 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=205.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCC--cEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCR--HSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g--~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||. +....++ ..+|+|.++... ......+.+|++++.++. +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIR------AMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-HHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEE------EEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-CCCchhheEEEEcc
Confidence 5899999999999988864 4444444 357888876422 222456778999998874 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~ 276 (1630)
...+|++|||++++.+..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 99999999999888777766432 24889999999999999999999999999999999999999
Q ss_pred CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhH
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvI 356 (1630)
++.+||+|||++...... ........+..|+|||++.+.. ++.++|||||||+
T Consensus 155 ~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwSlG~i 207 (297)
T cd05089 155 NLASKIADFGLSRGEEVY---------------VKKTMGRLPVRWMAIESLNYSV------------YTTKSDVWSFGVL 207 (297)
T ss_pred CCeEEECCcCCCccccce---------------eccCCCCcCccccCchhhccCC------------CCchhhHHHHHHH
Confidence 999999999998532210 0011122245799999886544 7899999999999
Q ss_pred HHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 357 Lyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
+|+|++ |..||...+..+.+..+..+.... .+..++.++.+|+.+||+.+|.+||+++++++.|...+...
T Consensus 208 l~el~t~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 208 LWEIVSLGGTPYCGMTCAELYEKLPQGYRME------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 999998 999999888877777665442211 12357899999999999999999999999999988777554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=327.42 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=205.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+|.+.++||+|+||.||. +..........+..||||.+....... ...+.+|+.++..++ ||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~-~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYK-GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ--HPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEE-EEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEcCCCc
Confidence 688889999999999874 222222233456789999987543221 345777888888765 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN----------------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~----------------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~ 279 (1630)
.++++||+.++.+..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 9999999998877766532 234888999999999999999999999999999999999999999
Q ss_pred EEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHH
Q 000343 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359 (1630)
Q Consensus 280 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILye 359 (1630)
+||+|||+++...... .........+++.|+|||.+.+.. ++.++|||||||++||
T Consensus 163 ~kl~Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~~l~e 218 (283)
T cd05091 163 VKISDLGLFREVYAAD------------YYKLMGNSLLPIRWMSPEAIMYGK------------FSIDSDIWSYGVVLWE 218 (283)
T ss_pred eEecccccccccccch------------heeeccCccCCccccCHHHHhcCC------------CCcchhHHHHHHHHHH
Confidence 9999999987653211 011122344578899999986544 7889999999999999
Q ss_pred Hhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 360 MCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 360 mlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|++ |..||.+....+.+..+......+ .+..++.++.+|+.+||+.+|.+||++.+++..|.
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 219 VFSYGLQPYCGYSNQDVIEMIRNRQVLP------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 998 899999888887777776554322 12457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=328.67 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=208.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccc---cCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQG---RCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~---~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
++|.+.+.||+|+||.||+.. ..+.++ .+...+|+|.+..... .....+.+|+++++.+. +||||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~--~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~ 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAE--AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACT 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeE--EeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEe
Confidence 589999999999999997532 122111 2346799999875422 22446778999998874 5999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld 275 (1630)
....+|+||||++++.|..++... ..+++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 999999999999988887776542 2488999999999999999999999999999999999999
Q ss_pred CCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhh
Q 000343 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355 (1630)
Q Consensus 276 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGv 355 (1630)
.++.+||+|||++........ ........+++.|+|||++.+.. ++.++|+|||||
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~ 230 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDY------------YKKTTNGRLPVKWMAPEALFDRI------------YTHQSDVWSFGV 230 (307)
T ss_pred CCCcEEECCCcccccccccch------------hhccccCCCccceeChHHhccCC------------CCcHHHHHHHHH
Confidence 999999999999876532110 00111223456899999887644 789999999999
Q ss_pred HHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccC
Q 000343 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 356 ILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~ 432 (1630)
++|+|++ |..||...+..+....+....... .+..++.++.+|+.+||+.+|++|||+.+++++|.+.+..
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCC------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 9999998 999998877777666654433211 1235788999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=319.87 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=200.7
Q ss_pred EeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
+||+|+||.||. .+++ ...++..+|+|++...... ..+.+.+|+.+++.+. ||||+++++++. ....++||
T Consensus 2 ~lg~G~~g~v~~--~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKK--GMYK--MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD--NPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEE--eEEe--cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC--CCCcceEEEEEc-CCCcEEEE
Confidence 689999998864 2222 3456789999988754322 2456778899988875 999999999875 45678999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||++++.+..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~---- 150 (257)
T cd05116 75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---- 150 (257)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC----
Confidence 9999988888777667899999999999999999999999999999999999999999999999999976543210
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAV 379 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i 379 (1630)
.........++..|+|||.+.... ++.++|+|||||++|||++ |..||...+..+....+
T Consensus 151 -------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 151 -------YYKAKTHGKWPVKWYAPECMNYYK------------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred -------eeeecCCCCCCccccCHhHhccCC------------cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 001112233467899999886543 7889999999999999998 99999988887777776
Q ss_pred HhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 380 ~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..+...+ .+..+++++.+||.+||+.||++||++.++...|..
T Consensus 212 ~~~~~~~------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 212 ESGERME------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HCCCCCC------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 6543221 223578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=325.08 Aligned_cols=247 Identities=18% Similarity=0.353 Sum_probs=199.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+...... ....+.+|+++++++. ||||+++++.|....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYK------AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD--SPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEE------EEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEECC
Confidence 3789999999999887754 667788999999998764222 2356778999988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
..++||||++++++..+. .+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++..+...
T Consensus 73 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 73 RISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEEEEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999999999886552 4789999999999999999999999999999999999999999999999998765321
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH--
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-- 372 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~-- 372 (1630)
......||..|+|||++.+.. ++.++|+||||+++|+|++|+.||.....
T Consensus 149 ----------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 200 (279)
T cd06619 149 ----------------IAKTYVGTNAYMAPERISGEQ------------YGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200 (279)
T ss_pred ----------------cccCCCCChhhcCceeecCCC------------CCCcchHHHHHHHHHHHHhCCCCchhhcccc
Confidence 122346889999999987644 78999999999999999999999964321
Q ss_pred -----HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 -----EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 -----~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
......+.... ++. ......++++.+||.+||+.+|.+||++.++++|.+
T Consensus 201 ~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 201 GSLMPLQLLQCIVDED--PPV---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred cccchHHHHHHHhccC--CCC---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 12222222211 111 112346789999999999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=322.02 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=205.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
.+.|++.+.||+|+||.||. |....+++.||+|.+.... .....+.+|+.+++.+. +||||++++++|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~------~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYK------GRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYS-HHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhhHHHheeecCCeEEEE------EEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhc-CCCCeeeEeeEEeecC
Confidence 35799999999999887754 6677889999999987643 34567888999998874 599999999998753
Q ss_pred -----CEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecc
Q 000343 214 -----SCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 214 -----~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFG 286 (1630)
..+|++|||+.++.+..++.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 468999999998888777654 2468999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
++....... .......|++.|+|||++.+... ....++.++|+|||||++|+|++|..|
T Consensus 157 ~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~~~-------~~~~~~~~~Dv~slGv~l~el~~g~~p 215 (272)
T cd06637 157 VSAQLDRTV--------------GRRNTFIGTPYWMAPEVIACDEN-------PDATYDFKSDLWSLGITAIEMAEGAPP 215 (272)
T ss_pred Cceeccccc--------------ccCCcccccccccCHhHhccccC-------cCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 987653211 11233568899999999864321 112378899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
|...........+...... ......++.++.+||.+||..||.+|||+.++++|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 216 LCDMHPMRALFLIPRNPAP-----RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred ccccCHHHHHHHHhcCCCC-----CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 9876655444433322111 112235788999999999999999999999999873
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=319.02 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=198.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
+.||+|+||.||. +.++.+++.||+|.+..... .....+.+|+++++.++ ||||+++++++.....+++||
T Consensus 1 ~~lg~g~~g~vy~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 72 (252)
T cd05084 1 ERIGRGNFGEVFS------GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS--HPNIVRLIGVCTQKQPIYIVM 72 (252)
T ss_pred CccCcccCccEEE------EEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEcCCCCeEEEE
Confidence 3689999887754 66777899999998764322 22456888999999875 999999999999999999999
Q ss_pred ecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 221 DRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 221 Ey~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
||+.++++..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 73 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 149 (252)
T cd05084 73 ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--- 149 (252)
T ss_pred eeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc---
Confidence 99998888877654 34689999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~ 378 (1630)
........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......
T Consensus 150 ---------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~ 208 (252)
T cd05084 150 ---------ASTGGMKQIPVKWTAPEALNYGR------------YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208 (252)
T ss_pred ---------cccCCCCCCceeecCchhhcCCC------------CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH
Confidence 00011122356799999987654 7889999999999999998 9999987777665555
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+......+ .+..++.++.+|+.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 IEQGVRLP------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHcCCCCC------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 54332211 22356889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=327.57 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=211.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
..+|++.+.||+|+||.||+....-.. .....+..||+|.+.... ......+.+|+.+++.+. +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-cCCCchheeEEEec
Confidence 468999999999999999753211110 112345689999887542 223456888999998874 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~ 276 (1630)
...+|++|||++++.|..++.+. ..++...+..++.||+.||+|||++||+||||||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 99999999999988887776542 24788899999999999999999999999999999999999
Q ss_pred CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhH
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvI 356 (1630)
++.+||+|||+++.+..... ........+++.|+|||++.+.. ++.++||||||++
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~ 228 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDY------------YKKTTNGRLPVKWMAPEALFDRV------------YTHQSDVWSFGVL 228 (304)
T ss_pred CCcEEECCCccceecccccc------------cccccCCCCCceeeCchhhccCC------------CCchhhHHHHHHH
Confidence 99999999999987643210 01112234567899999986644 7899999999999
Q ss_pred HHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 357 Lyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
+|+|++ |..||...+..+.+..+....... .+..++.++.+|+.+||+.+|++|||+.++++.|.+.+.
T Consensus 229 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 229 MWEIFTLGGSPYPGIPVEELFKLLKEGHRMD------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 999998 899999888888777765443221 123578999999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=324.12 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=201.3
Q ss_pred EEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 139 ~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
++.+.||.|+||.|| .+.+.......+..|+||.++..... ..+.+.+|++.+++++ ||||+++++++.....++
T Consensus 2 ~~~~~ig~G~fg~v~--~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVY--RAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR--HPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEE--EEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS--BTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEE--EEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc--cccccccccccccccccc
Confidence 578999999999995 34454345566789999999653222 2577888999999874 999999999999888899
Q ss_pred EEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 218 LVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+||||++++.|..++... ..+++..+..|+.||++||+|||+++|+|+||+|+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999988777766554 679999999999999999999999999999999999999999999999999998763211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~e 374 (1630)
.............|+|||.+.... ++.++||||||+++|||++ |+.||.+.+..+
T Consensus 158 ------------~~~~~~~~~~~~~~~aPE~~~~~~------------~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 158 ------------KYKNDSSQQLPLRYLAPEVLKDGE------------YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp ------------SEEESTTSESGGGGS-HHHHHHSE------------ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred ------------cccccccccccccccccccccccc------------cccccccccccccccccccccccccccccccc
Confidence 011122334567899999987755 7899999999999999999 789999998888
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+...+..+...+. +..++..+.++|.+||+.||++|||+.++++.|
T Consensus 214 ~~~~~~~~~~~~~------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 IIEKLKQGQRLPI------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHTTEETTS------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccccee------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 8888765544322 235789999999999999999999999998865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=324.43 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=203.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccc-cccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~-~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||.. ..+.. ...++..||+|.+...... ....+.+|+.+++.++ ||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~--~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEG--LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN--HQNIVRLIGVSFER 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEE--EEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEccC
Confidence 57999999999999988652 22210 1126788999987654322 2345778899988875 99999999999988
Q ss_pred CEEEEEEecCCCChHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC---cEEEe
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEG-------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG---RAVVS 283 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~-------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g---~vKL~ 283 (1630)
...+++|||+.++.|..++.... .+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999888887765432 589999999999999999999999999999999999998654 59999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||+++.+..... .........+..|+|||++.+.. ++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 162 DFGMARDIYRASY------------YRKGGRAMLPIKWMPPEAFLDGI------------FTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred cCccccccCCccc------------eecCCCCCccHhhCCHHHHhcCC------------cCchhHHHHHHHHHHHHHcC
Confidence 9999986532210 00111223356899999987654 7899999999999999997
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|..||...+..+....+....... .+..++.++.+++.+||+.+|++|||+.+++++|.
T Consensus 218 g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 218 GYMPYPGRTNQEVMEFVTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999999888777666554432211 13457899999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=319.48 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=202.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|++.+.||+|+||.||+ +.++ ++..+|+|.+.... .....+.+|+++++.++ ||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~------~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 4 SELTFLKELGSGQFGVVHL------GKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLS--HPNLVQLYGVCTKQRP 73 (256)
T ss_pred HHcchhhhhccCCCceEEE------eEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCC--CCCEEEEEEEEcCCCc
Confidence 4789999999999998865 3332 45689999876433 34456778999999875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.|+||||++++.+..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999988877776643 457899999999999999999999999999999999999999999999999998765422
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ 373 (1630)
. ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..
T Consensus 154 ~-------------~~~~~~~~~~~~y~~Pe~~~~~~------------~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 154 Q-------------YTSSQGTKFPVKWAPPEVFDYSR------------FSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred c-------------ccccCCCCCCccccCHHHhccCC------------CCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 1 00111222356799999987654 7889999999999999999 89999888777
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+....... .+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus 209 ~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 209 EVVESVSAGYRLY------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7776665442211 1234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=325.66 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=207.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEc----------cccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcc
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIG----------GGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~----------a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV 204 (1630)
++|++.+.||+|+||.||+...... ..+...+..||+|.+...... ..+.+.+|+++++.++ ||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS--DPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC--CCCEe
Confidence 5899999999999999975321110 122234567999998764322 3456788999999976 99999
Q ss_pred eeEEEEEeCCEEEEEEecCCCChHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceE
Q 000343 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-----------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLL 273 (1630)
Q Consensus 205 ~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~-----------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NIL 273 (1630)
++++++..+..++++|||+.++.|..++.+.. .+++..++.++.|++.||+|||+.||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999888887775544 6899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhh
Q 000343 274 LDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353 (1630)
Q Consensus 274 ld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSl 353 (1630)
++.++.+||+|||+++...... .........+++.|+|||.+.+.. ++.++|||||
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~sl 218 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSD------------YYRVQGRAPLPIRWMAWESVLLGK------------FTTKSDVWAF 218 (296)
T ss_pred ecCCCceEEccccceeecccCc------------ceeecCcCCCCceecCHHHhhcCC------------CCccchhhhh
Confidence 9999999999999987653221 011122344578899999987644 7899999999
Q ss_pred hhHHHHHhh--CCCCCCCCCHHHHHHHHHhcCCCC-CCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 354 GCTLVEMCT--GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 354 GvILyemlt--G~~PF~~~~~~ei~~~i~~~~~~~-~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
||++|+|++ +..||...+..+.+..+....... .......+..++.++.+|+.+||+.||++|||+.++++.|.
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 999999998 788998877776666554331110 00001122356789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=322.73 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=210.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+|++.++||.|+||.||+ +.+.. +..+|+|.+..........+.+|+.+++.++ ||||+++++++....
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~------~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWE------GLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR--HKHLISLFAVCSVGE 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEE------eEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC--CcchhheeeeEecCC
Confidence 35899999999999888864 44444 7899999988766556677889999998875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.++++|||++++.|..++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999888877654 2468999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... .......++..|+|||.+.... ++.++||||||+++|+|++ |..||...+
T Consensus 156 ~~~--------------~~~~~~~~~~~~~~PE~~~~~~------------~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 156 EDV--------------YLSSDKKIPYKWTAPEAASHGT------------FSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred Ccc--------------ccccCCCCceEecCHHHHccCC------------CCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 321 0111233567899999886544 7889999999999999998 899999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..+.+..+......+ .+..+++.+.++|.+||+.||++|||+.++++.|..
T Consensus 210 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 210 NHEVYDQITAGYRMP------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHHHhCCcCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 777777766442221 123578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=322.09 Aligned_cols=265 Identities=21% Similarity=0.264 Sum_probs=202.3
Q ss_pred CCe-EEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDV-KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y-~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++| ++.+.||+|+||.||+ ..|.+....++..||+|.+..... .....+.+|+++|+.++ ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~--~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY--HENIVKYKGCCSEQ 78 (283)
T ss_pred hhhceeceecccCCCcEEEE--eeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEecC
Confidence 456 9999999999999976 335555667888999999876432 23456778999999975 99999999987653
Q ss_pred --CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 --SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 --~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..++++|||+.++.+..++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 468999999999988887765 35999999999999999999999999999999999999999999999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
..... .........++..|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 158 ~~~~~-----------~~~~~~~~~~~~~~~~PE~~~~~~------------~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 158 PEGHE-----------YYRVREDGDSPVFWYAVECLKENK------------FSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred CCcch-----------hhccCCCCCCCceeeCHhHhcccC------------CCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 43210 000111223466799999886544 7899999999999999999999986533
Q ss_pred HH--HHHHHHHhcCCCC--------CCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 372 AE--EIYRAVVKNRKLP--------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 372 ~~--ei~~~i~~~~~~~--------~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.. +..... .+.... .......+..++.++.+++.+||+.+|++|||++++++.|...
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 215 KKFEEMIGPK-QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred chhhhhhccc-ccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 21 111000 000000 0000112345788999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=322.34 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=200.2
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC--C
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD--S 214 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~--~ 214 (1630)
|++.++||+|+||.||. +.+..+++.||+|+++.... .......+|+.++.++. +||||+++++++.+. +
T Consensus 1 y~~~~~lg~g~~~~v~~------~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLK------AQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-PHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEE------EEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-CCCCccceEEEEecCCCC
Confidence 78899999999887754 66778899999999876422 22233446777777764 599999999999987 8
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+++||||+.++++..+......+++..+..++.|++.||+|||+.||+||||||+||+++. +.+||+|||+++.+...
T Consensus 74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 74 RLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 89999999998887777665567999999999999999999999999999999999999999 99999999999765422
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. ......++..|+|||.+.... .++.++|||||||++|||++|..||.+.+..+
T Consensus 153 ~---------------~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 153 P---------------PYTEYISTRWYRAPECLLTDG-----------YYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred C---------------CcCCCCCCcccCChhHhhcCC-----------CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 1 011235688999999865432 16789999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCC---------------ccc-------ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQ---------------YAS-------IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~---------------~~~-------~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+..+......++. +.. .....++.++.+||.+||+++|++||++.++++|-
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 55444331111100 000 01235678999999999999999999999999873
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=324.68 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=208.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+..... ...+.+.+|+++++.+. ||||+++++++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVML------VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--HPFLVNLYGSFQD 72 (290)
T ss_pred CceEEEEEeecCCCeEEEE------EEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC--CCCccceeeEEEc
Confidence 4799999999999888764 55667889999999876432 23456778999999876 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||++++.+..++.....+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++....
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999888888877777789999999999999999999999999999999999999999999999999987653
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.. .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.
T Consensus 153 ~~-----------------~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 153 GR-----------------TYTLCGTPEYLAPEIILSKG------------YGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred CC-----------------CCCCCCCccccChhhhcCCC------------CCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 12345789999999986543 67899999999999999999999988877
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L 426 (1630)
.+....+..+... .+..++..+.++|.+||..||.+|+ +++++++|-
T Consensus 204 ~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 204 IQIYEKILEGKVR-------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred HHHHHHHhcCCcc-------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 6666666644322 1234689999999999999999999 788888774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=327.75 Aligned_cols=254 Identities=18% Similarity=0.275 Sum_probs=208.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+|++.+.||+|+||.||+ +.+..+++.||+|.+........+.+.+|+.+++.+. ||||++++++|....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~ 89 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYT------AIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhceeeeeeccCCCeEEEE------EEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC--CCCEeeEEEEEecCC
Confidence 46899999999999887754 6677889999999998766566677888999988865 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|+||||++++++..+..+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999988887754 46899999999999999999999999999999999999999999999999998765322
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+...
T Consensus 169 ~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 169 Q--------------SKRSTMVGTPYWMAPEVVTRKA------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred c--------------cCcCcccCCccccCHHHHcCCC------------CCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 1 0112345788999999987644 6889999999999999999999998765543
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+........ ..+..++..+.+|+.+||..+|++||++.++++|-+
T Consensus 223 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 223 ALYLIATNGTPEL----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred heeeeccCCCCCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 3322222211111 123357788999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=319.17 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=207.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.+.||+|+||.||+ +.++.+++.+|+|.+..... ..+.+.+|+.+++.+. .||||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYK------ARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYS-NHPNIATFYGAFIKKN 76 (275)
T ss_pred hhheeheeeecCCCCeEEEE------EEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhc-CCCChheEEEEEEecC
Confidence 46999999999999887754 56677889999998876533 4567889999999874 5999999999997644
Q ss_pred ------EEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 215 ------CLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 215 ------~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
.++++|||++++.+..+... ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999877766543 35799999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||++....... .......|+..|+|||++..... ....++.++||||||++||+|++|+
T Consensus 157 ~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 157 FGVSAQLDSTL--------------GRRNTFIGTPYWMAPEVIACDEQ-------PDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred Cccceecccch--------------hhhcCccccccccCHhHhccccc-------ccCCccccccHHHhHHHHHHHHhCC
Confidence 99987654321 11223457899999999865431 1234788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.||...........+..... +.. .....++.++.+||.+||..||++|||+.++++|-
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~ 273 (275)
T cd06608 216 PPLCDMHPMRALFKIPRNPP--PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP 273 (275)
T ss_pred CCccccchHHHHHHhhccCC--CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence 99987666555555544321 111 11224678999999999999999999999999873
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=321.09 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=205.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.+.||+|+||.||... ........++..||+|.+..... .....+.+|+.+++.+. ||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~-~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGL-AKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEE-EeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC--CCceeEEEEEEcCC
Confidence 3689999999999999886521 11111134568999999865432 22345678888888865 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEe
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE----------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~----------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
...+++|||++++.|..++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999988887766432 247888999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||+++.+..... ........++..|+|||.+.... ++.++|||||||++|||++
T Consensus 162 dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~el~t~ 217 (277)
T cd05032 162 DFGMTRDIYETDY------------YRKGGKGLLPVRWMAPESLKDGV------------FTTKSDVWSFGVVLWEMATL 217 (277)
T ss_pred CcccchhhccCcc------------cccCCCCCccccccCHHHHhcCC------------CCcccchHHHHHHHHHhhcc
Confidence 9999876543210 11122344678899999986543 7889999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|..||...+..+....+...... . .+..++.++.+|+.+||+.+|++|||+.++++.|.
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 218 AEQPYQGLSNEEVLKFVIDGGHL-D-----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCccCCHHHHHHHHhcCCCC-C-----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 99999988887777666533221 1 12346899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=316.48 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=205.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||+ +.. ..+..||+|.++... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~------~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWE------GLW-NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR--HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hheeeEEEecccCCccEEE------EEe-cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC--CCCccceeEEEecCCC
Confidence 5799999999999998864 332 234689999987643 34566888999999976 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
++++|||+.++.+..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999888777776543 3689999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
... ........+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 156 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 156 DIY-------------EAREGAKFPIKWTAPEAALYNR------------FSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred Ccc-------------cccCCCcCceeccCccccccCC------------CCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 210 0111122346799999887644 7889999999999999999 9999998887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
...+..+......+ .+..++..+.+++.+||+.+|++||++.++++.|..
T Consensus 211 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 211 AEVLQQVDQGYRMP------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHcCCCCC------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 77776665443221 123578899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.94 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=218.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..|+-+++||+|+||+| |+|++..+++.||+|.+...+.. -+....+|+.+|+.++ |.|||+++++...+
T Consensus 2 ~~ydkmekigegtygtv------fkarn~~t~eivalkrvrlddddegvpssalreicllkelk--hknivrl~dvlhsd 73 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTV------FKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSD 73 (292)
T ss_pred cchHHHHhhcCCcceee------EecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh--hcceeehhhhhccC
Confidence 36888899999995554 67999999999999999887544 3778899999999987 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+.+|+|||..++-.++..-++.++.+.++.++.|+++||.|+|+++++||||||+|.||+.+|.+||+|||+++.++-
T Consensus 74 kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 74 KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999999999998888887788999999999999999999999999999999999999999999999999999987754
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
+ ..+.+..+-|..|++|.++.+.+ -|+++.|+||.|||+.|+.. |.+.|++.+.
T Consensus 154 p--------------vrcysaevvtlwyrppdvlfgak-----------ly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 154 P--------------VRCYSAEVVTLWYRPPDVLFGAK-----------LYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred c--------------eEeeeceeeeeeccCcceeeeee-----------hhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 2 23455566799999999998866 28999999999999999998 8888999998
Q ss_pred HHHHHHHHhcCCCCC--Ccccc--------------------cCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLPP--QYASI--------------------VGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~--~~~~~--------------------~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+.+.+|...-..+. .+++. +-+.+...-++|++++|.-+|.+|.+++++++|.
T Consensus 209 ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 209 DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred HHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 888888876432221 11100 0123445678999999999999999999998873
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=332.97 Aligned_cols=265 Identities=16% Similarity=0.212 Sum_probs=198.7
Q ss_pred EEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 140 ~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+++.||+|.++ ++.+|++.++.+++.||+|++...... ....+.+|+++++.++ ||||++++++|..++..|
T Consensus 2 ~~~~ig~G~~~----~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFED----LMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN--HPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccc----eEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEECCEEE
Confidence 56789999543 233455778899999999998765322 2456778999988875 999999999999999999
Q ss_pred EEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 218 LVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+||||++++.+..++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999998888777643 3458999999999999999999999999999999999999999999999998765432211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.. .. ..........++..|+|||++.+.. ..++.++|||||||++|+|++|..||........
T Consensus 156 ~~-~~------~~~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 156 QR-LR------VVHDFPKYSVKVLPWLSPEVLQQNL----------QGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cc-cc------ccccccccccceecccChHHhhccc----------CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 00 00 0001112345678899999986532 1278999999999999999999999987665444
Q ss_pred HHHHHhcCCCCC---------------------------------------CcccccCCCCCHHHHHHHHHhhccCcCCC
Q 000343 376 YRAVVKNRKLPP---------------------------------------QYASIVGVGIPRELWKMIGECLQFKASKR 416 (1630)
Q Consensus 376 ~~~i~~~~~~~~---------------------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~R 416 (1630)
......+..... .........+++++.+||.+||+.||++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 298 (327)
T cd08227 219 LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDAR 298 (327)
T ss_pred HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhc
Confidence 333332211000 00000112356789999999999999999
Q ss_pred CChhhHHHHhh
Q 000343 417 PTFSAMLATFL 427 (1630)
Q Consensus 417 PSa~evL~~L~ 427 (1630)
||++++++|.+
T Consensus 299 pt~~ell~~p~ 309 (327)
T cd08227 299 PSASTLLNHSF 309 (327)
T ss_pred CCHHHHhcChh
Confidence 99999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=322.19 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=204.5
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEE--
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR-- 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~-- 211 (1630)
..++|++.+.||+|+||.||. +.+..+++.+|+|.+.... .....+.+|+.+++.+. +||||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~------~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~-~h~~i~~~~~~~~~~ 87 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFK------VLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALS-DHPNVVKFYGMYYKK 87 (286)
T ss_pred cccceeeeeeeccCCCcEEEE------EEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHh-cCCCeeeeeeeeeec
Confidence 457999999999999887754 6677889999999876532 23456788999998874 5999999999874
Q ss_pred ---eCCEEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 212 ---MDSCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 212 ---~~~~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
.+..++++|||++++.|..++. ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 3467999999999988876543 234689999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||++..+.... .......|++.|+|||++..... ....++.++|||||||++|+|++|+
T Consensus 168 fg~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 168 FGVSAQLTSTR--------------LRRNTSVGTPFWMAPEVIACEQQ-------LDSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred CCceeecccCC--------------CccccccCCCcccChhhhchhhh-------ccccccchhhhhhHHHHHHHHhcCC
Confidence 99987654211 01123457899999999864321 1123788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.||........+..+..... +.. ..+..++.++.+||.+||+.||++|||+.++++|++
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 227 PPLADLHPMRALFKIPRNPP--PTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred CCCCCCchhHHHhhccccCC--Ccc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 99987765444433322211 111 112346788999999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=325.32 Aligned_cols=258 Identities=22% Similarity=0.247 Sum_probs=203.2
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-----ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-----EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+|++.+.||+|+||.||+ |.+..+++.||||++...... ....+..|+++++.++ ||||+++++++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~ 72 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYK------ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK--HPNIIGLLDVFG 72 (298)
T ss_pred CceeeeeeeeccccEEEE------EEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC--CCCChhhhheee
Confidence 588999999999887754 667778999999999865433 2345667889988876 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+...+++||||+ ++.+..++.... .+++..+..++.||++||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 73 ~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 73 HKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred cCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 999999999999 666666665544 799999999999999999999999999999999999999999999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
..... .......+++.|+|||.+.+.. .++.++|+|||||++|+|++|.+||...
T Consensus 152 ~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 152 FGSPN--------------RKMTHQVVTRWYRAPELLFGAR-----------HYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred ccCCC--------------ccccccccceeeeCHHHHhCCC-----------CCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 64321 0112234578899999885432 2688999999999999999998888877
Q ss_pred CHHHHHHHHHhcCCCCC---------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 371 SAEEIYRAVVKNRKLPP---------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~---------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
+..+.+..+......+. ..........+.++.+||.+||+.||++|||+.++++|-+-
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 207 SDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred ccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 66555544433211110 00001123457889999999999999999999999998443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=318.83 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=205.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC------ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM------EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~------~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
+|++.+.||+|+||.||+ +.. .+++.+|+|.+...... ....+.+|+++++.++ ||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~------~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~ 71 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYC------GLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK--HVNIVQYLGTC 71 (265)
T ss_pred CccccceEeccCCeEEEE------EEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC--CCCEeeEeeEe
Confidence 588899999999998865 322 46889999998754321 1345778999998875 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.....++++|||++++.+..++.+..++++..+..++.|++.||+|||+.+|+|+||||+||++++++.+||+|||++..
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 72 LDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999999999999999988887767899999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
........ ..........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~--------~~~~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Dv~slG~~~~~l~~g~~p~~~~ 211 (265)
T cd06631 152 LAWVGLHG--------THSNMLKSMHGTPYWMAPEVINESG------------YGRKSDIWSIGCTVFEMATGKPPLASM 211 (265)
T ss_pred hhhccccc--------cccccccccCCCccccChhhhcCCC------------CcchhhHHHHHHHHHHHHhCCCccccC
Confidence 53211000 0011123346899999999987644 788999999999999999999999876
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+.......+.......+. .+..++.++.+||.+||+.+|++||++.++++|-
T Consensus 212 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 212 DRLAAMFYIGAHRGLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred ChHHHHHHhhhccCCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 655444443333222111 2335789999999999999999999999998873
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=328.85 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=209.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccc-cCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQG-RCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~-~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.+|++.+.||+|+||.||+....-...+. .....||+|.+..... .....+.+|+++++++. +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-CCCCeeeeeEEEccC
Confidence 47999999999999999753211111111 2234799998775322 22456788999998874 599999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
..++++|||++++.|..++... ..++...+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999988887776532 247888999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++....... ........++..|+|||++.+.. ++.++||||||+++
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il 226 (334)
T cd05100 171 NVMKIADFGLARDVHNIDY------------YKKTTNGRLPVKWMAPEALFDRV------------YTHQSDVWSFGVLL 226 (334)
T ss_pred CcEEECCcccceecccccc------------cccccCCCcCceEcCHHHhccCC------------cCchhhhHHHHHHH
Confidence 9999999999976543210 01112233456799999987654 78899999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
|||++ |..||...+..+.+..+....... .+..++.++.+|+.+||+.+|++|||+.+++++|........
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 227 WEIFTLGGSPYPGIPVEELFKLLKEGHRMD------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 99998 899999888887777665443221 123567899999999999999999999999999988775443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=317.95 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=204.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.++||+|+||.||+ +.+..+ ..||+|++.... ...+.+.+|+++++.++ ||||+++++.+.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~------~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~-~ 73 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWM------GTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-E 73 (262)
T ss_pred hHHeeEeeecCCCCCCcEEE------EEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCC--CCCcceEEEEECC-C
Confidence 35899999999999988865 333333 469999987533 34567889999999975 9999999998754 5
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+++|||++++.+..++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 68999999998877777654 2358999999999999999999999999999999999999999999999999997664
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
.... .......++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+..
T Consensus 154 ~~~~-------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 154 DNEY-------------TARQGAKFPIKWTAPEAALYGR------------FTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred cccc-------------ccccCCcccceecCHhHhccCC------------CCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 3210 0112234577899999876544 7899999999999999999 899998887
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
..+.+..+......+ ....++..+.+|+.+||+.||++||++.++++.|...+
T Consensus 209 ~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 209 NREVLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred hHHHHHHHhcCCCCC------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 777776665443221 12357899999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=320.63 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=198.6
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCc--EEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH--SVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~--~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
|.+.+.||+|+||.||. |....++. .+|+|.++... ......+.+|+++++.++ ||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~------~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 72 (272)
T cd05075 1 LALGKTLGEGEFGSVME------GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD--HPNVMRLIGVCLQT 72 (272)
T ss_pred CccccccCcccCceEEE------eEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEccC
Confidence 35678999999888854 44444443 69999887542 223456778899988875 99999999976432
Q ss_pred ------CEEEEEEecCCCChHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEE
Q 000343 214 ------SCLGLVMDRCYGSVQLAMQR------NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV 281 (1630)
Q Consensus 214 ------~~~~LVmEy~~gglL~~l~~------~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vK 281 (1630)
...+++|||+.++.+..++. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEE
Confidence 24789999998887766542 223589999999999999999999999999999999999999999999
Q ss_pred EeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHh
Q 000343 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyeml 361 (1630)
|+|||+++.+..... ........+++.|+|||.+.+.. ++.++||||||+++|+|+
T Consensus 153 l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Di~slG~il~el~ 208 (272)
T cd05075 153 VADFGLSKKIYNGDY------------YRQGRIAKMPVKWIAIESLADRV------------YTTKSDVWSFGVTMWEIA 208 (272)
T ss_pred ECCCCcccccCcccc------------eecCCcccCCcccCCHHHccCCC------------cChHHHHHHHHHHHHHHH
Confidence 999999987543210 00112234567899999987644 789999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 362 T-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 362 t-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
+ |..||......+++..+..+...+ .+..++..+.++|.+||+.||++|||+.+++++|...
T Consensus 209 ~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 209 TRGQTPYPGVENSEIYDYLRQGNRLK------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9 899999888777777666543321 1235778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=324.28 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=208.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+..... .....+.+|+++++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~------~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~ 72 (305)
T cd05609 1 EDFETIKLISNGAYGAVYL------VRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVSMFCSFET 72 (305)
T ss_pred CCceEeeEeecCCCeeEEE------EEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeeEEEEec
Confidence 3799999999999887754 66778899999999876532 22345678889888865 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+..+++||||++|++|..++...+.+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999999998888777789999999999999999999999999999999999999999999999999987422
Q ss_pred CccccCCCCC-CCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 293 KPACRKARPE-CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~-~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.......... ..............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG------------YGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1110000000 00000011112345788999999986543 7899999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh---hhHHHH
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF---SAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa---~evL~~ 425 (1630)
..+.+..+.......+.. ...++.++.+||.+||+.||++||++ .++++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 PEELFGQVISDDIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHHhcccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 887777766554322221 12478899999999999999999985 455555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=322.16 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=205.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.+.||+|+||.||+. ..+. .....+..||+|.+...... ....+.+|+.+++.+. ||||+++++++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~--~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT--CHHVVRLLGVVSK 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEE--EEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEcC
Confidence 468999999999999998752 1111 11234568999987654322 2335667888888875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEE
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE----------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~----------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL 282 (1630)
....|++|||++++.|..++.+. ..++...+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999988888776532 23567788999999999999999999999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+++....... ........++..|+|||.+.+.. ++.++|+|||||++|||++
T Consensus 161 ~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~~pE~~~~~~------------~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 161 GDFGMTRDIYETDY------------YRKGGKGLLPVRWMAPESLKDGV------------FTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred CcCCcccccccccc------------ccccCCCcccccccCHHHhccCC------------CChHhHHHHHHHHHHHHHh
Confidence 99999876532210 01112234567899999987644 7899999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 363 -GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 363 -G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|..||.+....+....+..+.... .+...++++.+++.+||+.||++|||+.++++.+...+
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 217 LAEQPYQGLSNEQVLKFVMDGGYLD------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 899999888777776665543221 12346789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=318.74 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=206.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCC---cEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCR---HSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g---~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
++|+..+.||+|+||.||. +....++ ..+|+|.+..... .....+.+|+++++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~------~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 76 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFR------GILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS--HHNIIRLEGVVT 76 (268)
T ss_pred HHceEeeEecCCCCccEEE------EEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CCCeeEEEEEEc
Confidence 5899999999999988864 3333333 4799998875422 22456778888888875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.....|+||||+++++|..++.. .+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999888877654 45799999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
...... ..........+..|+|||++.... ++.++|||||||++|||++ |..||..
T Consensus 157 ~~~~~~-----------~~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 157 LEDDPE-----------GTYTTSGGKIPIRWTAPEAIAYRK------------FTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred cccccc-----------cceeccCCCcCceecCHHHhhcCC------------cChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 543210 000111122356799999886543 7899999999999999998 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+..+....+......+. ...++.++.+++.+||+.+|++||++.++++.|.+.
T Consensus 214 ~~~~~~~~~i~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 214 MSNHEVMKAINDGFRLPA------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 877777777765432222 224788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=324.06 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=207.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.+.||+|+||.||. +.+..+++.||+|++....... .....+|+.++++++ ||||+++++++..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~ 77 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYR------ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR--HPNIVELKEVVVG 77 (309)
T ss_pred ccceeEeeeeeecCCEEEEE------EEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC--CCCCcceEEEEec
Confidence 46899999999999887754 6677889999999987653222 334567999999876 9999999999876
Q ss_pred C--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 213 D--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 213 ~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
. ..+++||||+.+++...+......+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 78 KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 5 56899999999876666655556799999999999999999999999999999999999999999999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
..... .......+++.|+|||++.+.. .++.++||||||+++|+|++|.+||...
T Consensus 158 ~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 158 YGLPA--------------KPMTPKVVTLWYRAPELLLGCT-----------TYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cCCcc--------------CCCCcccccccccChhhhcCCC-----------CcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 64321 0112234578899999986533 2688999999999999999999999988
Q ss_pred CHHHHHHHHHhcCCCCCC--------------cc---------cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 SAEEIYRAVVKNRKLPPQ--------------YA---------SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~--------------~~---------~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+..+.+..+......+.. +. .......++++.+||.+||+.||++|||+.+++.|-+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred CHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 887776666542211100 00 0001135788999999999999999999999999855
Q ss_pred hc
Q 000343 428 RH 429 (1630)
Q Consensus 428 ~~ 429 (1630)
-.
T Consensus 293 f~ 294 (309)
T cd07845 293 FK 294 (309)
T ss_pred hc
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=326.07 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=209.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+...... ....+.+|+++++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~ 72 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFL------VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTLYASFQT 72 (316)
T ss_pred CceEEeeeecCCccEEEEE------EEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC--CCCchhheeeeec
Confidence 4799999999999887765 556678999999999875433 3456778999998876 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
....|++|||+.++.|..++... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 73 ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 99999999999988887776543 4699999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCC---------------CCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhh
Q 000343 291 LKKPACRKARPECD---------------SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGv 355 (1630)
.............. ............||..|+|||++.+.. ++.++||||||+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------------~~~~~Di~slG~ 220 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG------------HGSAVDWWTLGI 220 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC------------CCchHHHHHHHH
Confidence 54321100000000 000001122456899999999987644 788999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC----hhhHHHH
Q 000343 356 TLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT----FSAMLAT 425 (1630)
Q Consensus 356 ILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS----a~evL~~ 425 (1630)
++|+|++|..||...+....+..+.......+. ...+++++.++|.+||..||++||| +.++++|
T Consensus 221 ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 221 LLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG-----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHhhCCCCCCCCchHHHHHHHhcCCccCCC-----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999999999999988877776666543322221 1236899999999999999999999 8888887
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=320.29 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=205.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||. |.+..++..||+|++..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFK------AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--HPYVVKLLDVFPHGS 72 (286)
T ss_pred CceEEeecccCCCcEEEE------EEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC--CCCCcceeeEEecCC
Confidence 589999999999887754 66777899999999887542 23567888999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~-~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++||||+ ++.+..++ .....+++..++.++.||++||+|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 999999999 66665554 3445799999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
... .......|+..|+|||++.+.. .++.++||||+|+++|+|++|.+||...+..
T Consensus 152 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~ 207 (286)
T cd07832 152 EEP-------------RLYSHQVATRWYRAPELLYGAR-----------KYDPGVDLWAVGCIFAELLNGSPLFPGENDI 207 (286)
T ss_pred CCC-------------CccccccCcccccCceeeeccc-----------cCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence 210 1122346789999999886533 2688999999999999999999999877766
Q ss_pred HHHHHHHhcCCCCCC-----------------------cccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQ-----------------------YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~-----------------------~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..+......+.. ......+..+.++.+||.+||+.+|++|||+++++.|.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 555554432111100 000111346788999999999999999999999999843
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.79 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=205.1
Q ss_pred EEeCcCCceeEEEeeEEEccccc---cCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQG---RCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~---~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||. +.+. ..+..||+|.+....... ...+.+|++.++.++ ||||+++++++.....++
T Consensus 1 ~~ig~g~~g~v~~------~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~ 72 (262)
T cd00192 1 KKLGEGAFGEVYK------GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLY 72 (262)
T ss_pred CccccCCceEEEE------EEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC--CCChheeeeeecCCCceE
Confidence 4689999988854 3333 338899999988764433 567888999999976 999999999999999999
Q ss_pred EEEecCCCChHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 218 LVMDRCYGSVQLAMQRNE---------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~---------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
++|||++++.+..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.+
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccc
Confidence 999999888888777654 67999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPW 367 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF 367 (1630)
........ ........++..|+|||.+.... ++.++||||||+++|+|++ |..||
T Consensus 153 ~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 153 RDVYDDDY------------YRKKTGGKLPIRWMAPESLKDGI------------FTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred cccccccc------------cccccCCCcCccccCHHHhccCC------------cchhhccHHHHHHHHHHHhcCCCCC
Confidence 87653210 11123345688999999887643 7899999999999999999 69999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
...+..+....+..+.... .+..++.++.+++.+||+.+|++|||+.+++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 209 PGLSNEEVLEYLRKGYRLP------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCHHHHHHHHHcCCCCC------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9988888777776533221 2235689999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=318.71 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=201.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCc----EEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH----SVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~----~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
..+|++.+.||+|+||.||. |....+++ .||+|.+...... ....+.+|+.++..+. ||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~------~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~ 77 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYK------GIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG--SPYVCRLLGI 77 (279)
T ss_pred hhheeeeeecCCCCCceEEE------EEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC--CCCCceEEEE
Confidence 46899999999999988854 33333333 5899988754322 2456778888888765 9999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
+.. ...+++|||++++.+..++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 78 CLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence 875 457899999987777666644 457999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPW 367 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF 367 (1630)
+....... ........+++.|+|||.+.+.. ++.++|||||||++|||++ |..||
T Consensus 157 ~~~~~~~~------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 157 RLLDIDET------------EYHADGGKVPIKWMALESILHRR------------FTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred eecccccc------------eeecCCCccchhhCCHHHhccCC------------CCchhHHHHHHHHHHHHHcCCCCCC
Confidence 87643210 00111233467899999986544 7899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
...........+..+...+. +..++.++.+++.+||+.||++||++.++++.|....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 213 DGIPAREIPDLLEKGERLPQ------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCCHHHHHHHHHCCCcCCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 88777666655544332221 2357889999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=355.50 Aligned_cols=273 Identities=19% Similarity=0.199 Sum_probs=204.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.++||+|+||.||+ |.+..+++.||||++....... ...+.+|+++++.++ ||||+++++++.+
T Consensus 2 grYeIi~~LGkGgfG~VYl------A~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~--HPNIVkl~~v~~d 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYL------AYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI--HPGIVPVYSICSD 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEE------EEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC--CcCcCeEEEEEee
Confidence 5899999999999888764 6678889999999987543222 456778999998875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEE
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN-----------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV 281 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~-----------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vK 281 (1630)
.+..|++|||++|++|..++.+ ...++...+..++.||++||+|||++||+||||||+|||++.++.+|
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE
Confidence 9999999999999888776642 12356678899999999999999999999999999999999999999
Q ss_pred EeecceeeeecCccccCCC--CCCC--CCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 282 VSDYGLAAILKKPACRKAR--PECD--SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
|+|||+++........... .... ...........+||+.|+|||++.+.. ++.++|||||||++
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~------------~S~kSDIWSLGVIL 221 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP------------ASESTDIYALGVIL 221 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC------------CCcHhHHHHHHHHH
Confidence 9999999876321100000 0000 000111223457999999999987654 78999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-hhHHHHhhhcccC
Q 000343 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF-SAMLATFLRHLQE 432 (1630)
Q Consensus 358 yemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-~evL~~L~~~l~~ 432 (1630)
|||++|..||............... .+... .....+|+.+.+++.+||+.||++||+. +++++.|...++.
T Consensus 222 yELLTG~~PF~~~~~~ki~~~~~i~--~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 222 YQMLTLSFPYRRKKGRKISYRDVIL--SPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHCCCCCCCcchhhhhhhhhcc--Chhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999876554433221111 11111 1123578999999999999999999765 4455556555543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=329.34 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=209.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.+.|..-+.||+|+||.|+- ++.+.||+.+|.|++.+.. ........+|..+|.+++ .|+||.+-..|+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~a------cqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~--s~FiVslaYAfe 255 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCA------CQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS--SPFIVSLAYAFE 255 (591)
T ss_pred ccceeeeEEEecccccceeE------EEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc--cCcEEEEeeeec
Confidence 36789999999999998853 5566789999999887653 233556678999999976 799999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
+.+.+||||..|+||+|.+++.+.+ .|+++.++.|+.||+.||.+||+.+||+|||||+|||+|+.|++.|+|+|+|.
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence 9999999999999999998887655 69999999999999999999999999999999999999999999999999999
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+.... .....+||..|||||++.+.. |+.+.|+|||||+||||+.|+.||..
T Consensus 336 ei~~g~---------------~~~~rvGT~GYMAPEvl~ne~------------Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 336 EIPEGK---------------PIRGRVGTVGYMAPEVLQNEV------------YDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ecCCCC---------------ccccccCcccccCHHHHcCCc------------ccCCccHHHHHhHHHHHHcccCchhh
Confidence 887542 134468999999999999876 89999999999999999999999976
Q ss_pred CCH----HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHH
Q 000343 370 LSA----EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLAT 425 (1630)
Q Consensus 370 ~~~----~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~ 425 (1630)
... +++-+.+.... ..++..+++++++|.+.+|..||++|.. +.++-+|
T Consensus 389 ~KeKvk~eEvdrr~~~~~-------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 389 RKEKVKREEVDRRTLEDP-------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hhhhhhHHHHHHHHhcch-------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 433 23333333322 1233578999999999999999999986 4466665
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.48 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=199.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|++.+.||+|+||.||+ +.++.+++.||||.+...... ....+.+|+++++.++ ||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYK------GRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK--HANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEE------EEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC--CcceeeEEEEEecC
Confidence 46899999999999887754 667778899999998764322 2345668999999975 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
...|+||||+.+++...+......+++..++.++.|+++||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 99999999999866665555555789999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-H
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS-A 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~-~ 372 (1630)
.. .......++..|+|||++.+.. .++.++||||||+++|+|++|..||.... .
T Consensus 156 ~~--------------~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 210 (291)
T cd07844 156 PS--------------KTYSNEVVTLWYRPPDVLLGST-----------EYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210 (291)
T ss_pred CC--------------ccccccccccccCCcHHhhcCc-----------ccCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 11 0011234578899999886532 26889999999999999999999997654 2
Q ss_pred HHHHHHHHhcCCCC-----------------------CCcccccCCCCC--HHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLP-----------------------PQYASIVGVGIP--RELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~-----------------------~~~~~~~~~~l~--~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+.+..+......+ +.........++ .++.+++.+||+.+|++|||+.+++.|-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 211 EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 23222222110000 000000011233 7889999999999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=367.08 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=220.2
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+.-++...-+||.|.||.||- |.+..+|+..|+|-++..... ....+.+|+.+|..+. |||+|++|++-
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYt------avN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln--HpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYT------AVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN--HPNLVRYYGVE 1303 (1509)
T ss_pred cceeeeccccccCCcceeeeEE------eecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc--CccccccCcee
Confidence 3556788889999999888754 678899999999988765332 2456778999998875 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
-+.+.++|.||||.+|.|..+.+...-.++...+.|..|++.||+|||+.|||||||||.||||+.+|.+|++|||.|..
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999999999998877788889999999999999999999999999999999999999999999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+.++.. .........+||+.|||||++.+.. ..+..-++||||+||+..||+||+.||...
T Consensus 1384 i~~~~~----------~~~~el~~~~GT~~YMAPEvit~t~---------~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1384 IKNNAQ----------TMPGELQSMMGTPMYMAPEVITGTK---------GKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred ecCchh----------cCCHHHHhhcCCchhcCchhhcccc---------cCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 875420 0112345788999999999998865 234678999999999999999999999876
Q ss_pred CH-HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 371 SA-EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 371 ~~-~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
+. ..++..+..+.. |+. +..++.+.++||.+||..||.+|+++.|+++|-+.
T Consensus 1445 dne~aIMy~V~~gh~-Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1445 DNEWAIMYHVAAGHK-PQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred cchhHHHhHHhccCC-CCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 54 455555555543 332 33589999999999999999999999999998654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=327.06 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=209.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.+|++.++||+|+||.||+....-.. ........+|+|.+..... .....+.+|+++++.+. .||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-CCCCeeeEEEEEccC
Confidence 58999999999999998753211000 1123456799998875422 22345778999988874 599999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~ 277 (1630)
..+|++|||++++.|..++... ..+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999988888776532 348899999999999999999999999999999999999999
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
+.+||+|||+++....... ........++..|+|||++.+.. ++.++||||||+++
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DiwslG~~l 226 (314)
T cd05099 171 NVMKIADFGLARGVHDIDY------------YKKTSNGRLPVKWMAPEALFDRV------------YTHQSDVWSFGILM 226 (314)
T ss_pred CcEEEcccccccccccccc------------ccccccCCCCccccCHHHHccCC------------cCccchhhHHHHHH
Confidence 9999999999976542110 00111223456799999987644 78999999999999
Q ss_pred HHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 358 yemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
|+|++ |..||...+..+.+..+....... .+..++.++.+|+.+||+.+|++|||+.++++.|.......
T Consensus 227 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 227 WEIFTLGGSPYPGIPVEELFKLLREGHRMD------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 99999 999999888877777665543211 12357889999999999999999999999999988766544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=324.40 Aligned_cols=258 Identities=18% Similarity=0.345 Sum_probs=205.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++++.||+|+||.||+ +.+..++..||+|.+..... .....+.+|++++++++ ||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYK------VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV--SPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEE------EEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC--CCcHHhhhhheecCC
Confidence 3789999999999887754 56677899999998875421 22456778999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE---GRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~---~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+|+||||++++.+..++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999999999888776552 369999999999999999999997 5999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+.... .....+++.|+|||++.+... .....++.++|+|||||++|+|++|..||...
T Consensus 153 ~~~~~----------------~~~~~~~~~y~aPE~~~~~~~------~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 153 LVASL----------------AKTNIGCQSYMAPERIKSGGP------NQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ccCCc----------------cccCCCccCccCcchhcCCCC------CccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 53211 122357889999999865431 12233688999999999999999999999776
Q ss_pred CHHHHHHHHHhcCC-CCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 SAEEIYRAVVKNRK-LPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~-~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.....+..+..... .++. .+..+++++.+||.+||+.+|++||++.++++|.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 211 TYANIFAQLSAIVDGDPPT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred chhhHHHHHHHHhhcCCCC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 55444433322111 1111 23357899999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=322.33 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=206.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.+...... ..+.+.+|+++++.++ ||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMK------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR--HENLVNLIEVFRRK 72 (286)
T ss_pred CceeEeeeeccCCCeEEEE------EEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC--CcchhhHHHhcccC
Confidence 4799999999999888754 556778899999987754332 2456778999998875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||++++++..+......+++..++.++.||+.||+|||+.+|+||||+|+||++++++.+||+|||++..+..
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999999999999988877666799999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......++..|+|||++.+.. .++.++||||||+++|+|++|.+||...+..
T Consensus 153 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 153 PG--------------EVYTDYVATRWYRAPELLVGDT-----------KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred Cc--------------cccCcccceeeccCcHHhcccc-----------ccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 21 1122345788999999986532 1678999999999999999999999876654
Q ss_pred HHHHHHHhcCCC-------------------CCCc-----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKL-------------------PPQY-----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~-------------------~~~~-----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+...... .+.. .....+.++..+.+|+.+||+.+|++||++.+++.|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 443333321000 0000 0011235788999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=318.46 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=206.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcccccc---CCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGR---CRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~---~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.+|++.+.||+|+||.||+ +.+.. .+..+|+|.+...... ....+.+|+.+++.++ ||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 75 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCS------GRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVT 75 (267)
T ss_pred HHeEeeeeecccCCCceEE------EEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEe
Confidence 5899999999999998865 33332 3347999988754322 2456788999998875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+..+|++|||+++++|..++.. .+.+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999998888777654 35689999999999999999999999999999999999999999999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
+..... .........++..|+|||.+.+.. ++.++|+||||+++|++++ |..||..
T Consensus 156 ~~~~~~-----------~~~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 156 LEDDPE-----------AAYTTRGGKIPIRWTAPEAIAYRK------------FTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccccc-----------eeeecCCCccceeecCHhHhccCc------------cCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 643210 000111223356899999987644 7899999999999999887 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+..+....+..+...+ ....+++.+.+++.+||+.+|.+||++.++++.|...
T Consensus 213 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQDVIKAIEEGYRLP------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHhCCCcCC------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 87777776665543221 1235788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=319.60 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=208.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||.|+||.||. +.+..+++.||+|.+.... ......+.+|+++++.++ ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYK------AIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--SPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEE------EEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC--CCCeeeeeEEEEECC
Confidence 3789999999999887754 6677789999999987653 223456788999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|+||||+.++.+..++... ++++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||+++.+...
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 73 KLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998888877654 7999999999999999999999999999999999999999999999999999876532
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+...
T Consensus 152 ~--------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 152 M--------------SKRNTFVGTPFWMAPEVIKQSG------------YDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred c--------------cccccccCCccccChhhhccCC------------CCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 1 1122345788999999987654 7899999999999999999999998776665
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+..... +... ...+++++.+++.+||..+|++|||++++++|-+
T Consensus 206 ~~~~~~~~~~--~~~~---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 206 VLFLIPKNNP--PSLE---GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred HHHHhhhcCC--CCCc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 5555444321 1111 1127889999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=320.19 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=198.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCc----EEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH----SVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~----~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
++|++.+.||+|+||.||. |....+++ .+|+|.+...... ....+..|+..+..+ .||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~------~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l--~h~~iv~~~~~~ 78 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHK------GIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL--DHAYIVRLLGIC 78 (279)
T ss_pred hhceeccccCccCCcceEE------EEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC--CCCCcceEEEEE
Confidence 5899999999999998854 33333343 5888877533211 123455566666665 599999999987
Q ss_pred EeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
. ....+++|||++++.+..++.. ...+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 79 ~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 79 P-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred C-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 5 4567899999988777766643 4579999999999999999999999999999999999999999999999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~ 368 (1630)
....... ........++..|+|||.+.+.. ++.++||||||+++|||++ |..||.
T Consensus 158 ~~~~~~~------------~~~~~~~~~~~~y~~pE~~~~~~------------~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 158 LLYPDDK------------KYFYSEHKTPIKWMALESILFGR------------YTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred eccCCCc------------ccccCCCCCcccccCHHHhccCC------------cCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 6543210 01122345677899999987654 7899999999999999998 999998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
+.........+..+...+. +..++.++.+++.+||..||++|||+.++++.|.......
T Consensus 214 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 214 GMRPHEVPDLLEKGERLAQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCCHHHHHHHHHCCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 8777665554443332221 1235778999999999999999999999999887766433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=313.85 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=205.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|++.+.||+|+||.||. +.+..+++.||+|.++..... ....+.+|+++++.++ |+||+++++++..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~--~~~i~~~~~~~~~ 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYK------AICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD--HPNVIKYLASFIE 73 (267)
T ss_pred CceeeeeeeccCCceEEEE------EEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCeeeeeeeeec
Confidence 5899999999999887753 666778999999988754322 2557888999999875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.+..+++|||++++.|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 9999999999998887766542 345899999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
..+.... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 154 ~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 154 RFFSSKT--------------TAAHSLVGTPYYMSPERIHENG------------YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred eeccCCC--------------cccceecCCccccCHHHhccCC------------CCchhcHHHHHHHHHHHHHCCCCcc
Confidence 7654321 0112345788999999986544 7889999999999999999999996
Q ss_pred CCC--HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 369 GLS--AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 369 ~~~--~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
... ..+....+..+... +. ....++.++.++|.+||..+|++|||+.++++.+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 208 GDKMNLYSLCKKIEKCDYP-PL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cCCccHHHHHhhhhcCCCC-CC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 543 23344444333221 11 1124678999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=322.12 Aligned_cols=259 Identities=23% Similarity=0.286 Sum_probs=202.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+ +.+..+++.||||++...... ....+.+|+.+++.+. +||||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~------~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYK------ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEE------EEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc-CCCCccceeeeEeec
Confidence 4799999999999887754 667788999999987764322 2356778999999986 589999999998876
Q ss_pred CE-----EEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CCcEEEe
Q 000343 214 SC-----LGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVS 283 (1630)
Q Consensus 214 ~~-----~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g~vKL~ 283 (1630)
.. .|++|||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 74 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 74 EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 65 8999999998766655432 235899999999999999999999999999999999999998 8899999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhC
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG 363 (1630)
|||+++.+.... .......+++.|+|||++.+.. .++.++|+||||+++|+|++|
T Consensus 154 dfg~~~~~~~~~--------------~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 154 DLGLGRAFSIPV--------------KSYTHEIVTLWYRAPEVLLGST-----------HYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred ecccceecCCCc--------------cccCCcccccCCCChHHhhCCC-----------CCCchHHHHHHHHHHHHHHcC
Confidence 999987653211 0112234688899999886532 268899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCC---------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhH
Q 000343 364 SIPWAGLSAEEIYRAVVKNRKLPP---------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~i~~~~~~~~---------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ev 422 (1630)
..||.+.+..+....+......+. .......+.+++++.+||.+||.+||.+||++.++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 209 QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 999988776555544433211110 00011123578899999999999999999999999
Q ss_pred HHHh
Q 000343 423 LATF 426 (1630)
Q Consensus 423 L~~L 426 (1630)
+.|-
T Consensus 289 l~~~ 292 (295)
T cd07837 289 LTHP 292 (295)
T ss_pred hcCC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=316.85 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=203.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-----ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-----EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+|++.+.||+|+||.||+ +.+..++..||||.+...... ....+.+|+++++.+. ||||+++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~------~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~ 73 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYL------CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL--HERIVQYYGCL 73 (265)
T ss_pred CcceEeeEEecCCceEEEE------EEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC--CCCeeeEEeEe
Confidence 5899999999999887764 567788999999988643211 1346778999999875 99999999998
Q ss_pred EeC--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 211 RMD--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.+. ..++++|||++++.|..++.+...+++..++.++.|++.||+|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 74 RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred ccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 763 568999999999888888776677999999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+....... .........|+..|+|||++.+.. ++.++|+||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 154 KRLQTICL-----------SGTGMKSVTGTPYWMSPEVISGEG------------YGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred cccccccc-----------cccccccCCCCccccChhhhcCCC------------CCcchhHHHHHHHHHHHhhCCCCCC
Confidence 76532110 001122345788999999987543 6889999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+....+..+......+ ..+..++..+.++|.+||. +|.+||+++++++|.
T Consensus 211 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 211 EFEAMAAIFKIATQPTNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred ccchHHHHHHHhcCCCCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 776555544443222111 1233567889999999995 999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=320.71 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=207.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|.++.... .....+.+|+++++.++ ||||+++++++...
T Consensus 1 ~~y~~~~~i~~g~~~~v~~------~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 72 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLK------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR--HENIVNLKEAFRRK 72 (288)
T ss_pred CceeEEEEecccCCeeEEE------EEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC--CCCeeehhheEEEC
Confidence 3799999999999887754 66777899999998875432 23467889999999986 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+.++++|||++++++..+..+...+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99999999999999988877777799999999999999999999999999999999999999999999999999877543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
... .......++..|+|||++.... .++.++|+||||+++|+|++|.+||...+..
T Consensus 153 ~~~-------------~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 208 (288)
T cd07833 153 RPA-------------SPLTDYVATRWYRAPELLVGDT-----------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208 (288)
T ss_pred Ccc-------------ccccCcccccCCcCCchhcCCC-----------CcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 210 1122346788999999987642 2788999999999999999999999876654
Q ss_pred HHHHHHHhcC-CCC-------------------CCc-----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 374 EIYRAVVKNR-KLP-------------------PQY-----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~-~~~-------------------~~~-----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+....+.... ..+ ... ....+..++.++.+||++||..+|++|||++++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 4433322110 000 000 001122358889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=332.25 Aligned_cols=264 Identities=25% Similarity=0.302 Sum_probs=202.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEe-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~- 212 (1630)
++|++.+.||+|+||.||+ ....+ ....+++.||||.+...... ....+.+|+.+|..+. +||||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~--~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~ 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIE--ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKP 83 (343)
T ss_pred hHhcccccccCCccceEEE--EeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-CCccHhhhcceeecC
Confidence 5899999999999999965 22222 23467889999998754322 2346778999999985 58999999998765
Q ss_pred CCEEEEEEecCCCChHHHHHHcC---------------------------------------------------------
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE--------------------------------------------------------- 235 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~--------------------------------------------------------- 235 (1630)
...++++||||+++.|..++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999998887765431
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCC
Q 000343 236 ----------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305 (1630)
Q Consensus 236 ----------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 305 (1630)
..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~---------- 233 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP---------- 233 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc----------
Confidence 236788889999999999999999999999999999999999999999999987653211
Q ss_pred CCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcCC
Q 000343 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRK 384 (1630)
Q Consensus 306 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~~ 384 (1630)
.........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+........
T Consensus 234 --~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 299 (343)
T cd05103 234 --DYVRKGDARLPLKWMAPETIFDRV------------YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299 (343)
T ss_pred --chhhcCCCCCCcceECcHHhcCCC------------CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC
Confidence 001112233567899999986544 7899999999999999997 9999987554333332222222
Q ss_pred CCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 385 LPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 385 ~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
..+. +...++++.+++.+||+.||++|||+.+++++|...++
T Consensus 300 ~~~~-----~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 300 RMRA-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 22367889999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=343.99 Aligned_cols=281 Identities=18% Similarity=0.209 Sum_probs=236.7
Q ss_pred CHHHHHHHHHhcCCCcccCCCCCCCHHHHHHH--cCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHc-----CCHHH
Q 000343 523 SAELVEAILEYSQENVDVLDKDGDPPLVFALA--AGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH-----GQPDC 595 (1630)
Q Consensus 523 ~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~--~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~-----G~~ei 595 (1630)
..+.|+.||+.+ +++.. ..+.|+++.+.. .++.++|++|+++|+++|.. +..|.||||.|+.+ ++.++
T Consensus 17 ~~~~v~~ll~~~--~~~~~-~~~~~~~~~yl~~~~~~~~iv~~Ll~~Gadvn~~--d~~g~TpL~~~~~n~~~~~~~~~i 91 (489)
T PHA02798 17 KLSTVKLLIKSC--NPNEI-VNEYSIFQKYLQRDSPSTDIVKLFINLGANVNGL--DNEYSTPLCTILSNIKDYKHMLDI 91 (489)
T ss_pred cHHHHHHHHhcC--Chhhh-cccchHHHHHHhCCCCCHHHHHHHHHCCCCCCCC--CCCCCChHHHHHHhHHhHHhHHHH
Confidence 467999999742 33333 457787774444 45899999999999999875 46688999998864 67999
Q ss_pred HHHHHHcCCCCCCCCCCCCChhhhhhhcC---ChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcC
Q 000343 596 MRELLLAGADPNAVDDEGESVLHRAVAKK---YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVAS 672 (1630)
Q Consensus 596 vk~LL~~GADvn~~D~~G~TPLH~Aa~~g---~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga 672 (1630)
+++|+++|||+|.+|.+|.||||+|+..+ +.+++++|+++|+ +++..|..|.||||+|+..++.
T Consensus 92 v~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Ga--dvn~~d~~g~tpL~~a~~~~~~----------- 158 (489)
T PHA02798 92 VKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGA--DTTLLDKDGFTMLQVYLQSNHH----------- 158 (489)
T ss_pred HHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCC--CccccCCCCCcHHHHHHHcCCc-----------
Confidence 99999999999999999999999999875 7899999999997 7788999999999999875430
Q ss_pred ccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCccc-ccCccchhhhhhc----CCHHHHHHHHHC
Q 000343 673 PEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD-AQNRTALHIASMA----NDVELVKIILDA 747 (1630)
Q Consensus 673 ~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D-~~G~TpLH~Aa~~----g~~eiVklLL~~ 747 (1630)
...+++++|+++|+|+|.++ ..|.||||.|+.. ++.+++++|+++
T Consensus 159 ------------------------------~~~~vv~~Ll~~gadin~~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~ 208 (489)
T PHA02798 159 ------------------------------IDIEIIKLLLEKGVDINTHNNKEKYDTLHCYFKYNIDRIDADILKLFVDN 208 (489)
T ss_pred ------------------------------chHHHHHHHHHhCCCcccccCcCCCcHHHHHHHhccccCCHHHHHHHHHC
Confidence 12577889999999999885 5799999998764 589999999999
Q ss_pred CCCcccccCCCCCHHH-------HHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCC
Q 000343 748 GVDVNIRNVHNTIPLH-------VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPD 820 (1630)
Q Consensus 748 GADvN~~d~~G~TPLH-------~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~g 820 (1630)
|+++|..+..+.|+++ ++...++.+++++|+. |+|+|.+|..|+||||+|+..++ ..++++|++.|
T Consensus 209 Ga~i~~~~~~~~~~~~~~l~~l~~~~~~~~~~i~~~l~~-~~dvN~~d~~G~TPL~~A~~~~~------~~~v~~LL~~G 281 (489)
T PHA02798 209 GFIINKENKSHKKKFMEYLNSLLYDNKRFKKNILDFIFS-YIDINQVDELGFNPLYYSVSHNN------RKIFEYLLQLG 281 (489)
T ss_pred CCCcccCCccccchHHHHHHHHHhhcccchHHHHHHHHh-cCCCCCcCcCCccHHHHHHHcCc------HHHHHHHHHcC
Confidence 9999999999999987 2445677888988776 69999999999999999997653 35677888899
Q ss_pred CcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCC
Q 000343 821 AAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSP 862 (1630)
Q Consensus 821 advn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~ 862 (1630)
||+|++|..|+|||++|...+ ...+++.|++++++++.
T Consensus 282 Adin~~d~~G~TpL~~A~~~~----~~~iv~~lL~~~~~~~~ 319 (489)
T PHA02798 282 GDINIITELGNTCLFTAFENE----SKFIFNSILNKKPNKNT 319 (489)
T ss_pred CcccccCCCCCcHHHHHHHcC----cHHHHHHHHccCCCHHH
Confidence 999999999999999998765 56899999999998653
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=314.16 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=205.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||.|+||.||. +. ..++.||+|.+..... ....+.+|+.+++.++ ||||+++++++.....
T Consensus 6 ~~~~~~~~ig~g~~g~v~~------~~--~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 6 KELKLGATIGKGEFGDVML------GD--YRGQKVAVKCLKDDST-AAQAFLAEASVMTTLR--HPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhccceeeeecCCCceEEE------EE--ecCcEEEEEEeccchh-HHHHHHHHHHHHHhcC--CcceeeeEEEEcCCCC
Confidence 5899999999999988864 32 2378999999886543 4567888999999976 9999999999998899
Q ss_pred EEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.++||||++++.+..++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999888877765544 699999999999999999999999999999999999999999999999999976532
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
.. .....+..|+|||.+.... ++.++|+||||+++|+|++ |..||...+.
T Consensus 155 ~~-----------------~~~~~~~~~~ape~~~~~~------------~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 155 GQ-----------------DSGKLPVKWTAPEALREKK------------FSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cc-----------------ccCCCcccccCchhhcCCc------------CCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 11 1122356799999986544 7789999999999999997 9999998887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.+....+...... ..+..+++++.++|.+||+.+|++|||+.++++.|..
T Consensus 206 ~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 206 KDVVPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7766655443221 1123578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=336.40 Aligned_cols=267 Identities=28% Similarity=0.348 Sum_probs=216.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
..++.++.++||+|+||.||. | .++.........||||..+... ......+.+|.++|++++ |||||+|||+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~-G-~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~--H~NVVr~yGVa 230 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFK-G-KLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN--HPNVVRFYGVA 230 (474)
T ss_pred eccCccccceeecccccEEEE-E-EEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC--CCCEEEEEEEE
Confidence 347788889999999999974 3 3332222222339999988633 334566778999999965 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
.....++||||+|+||.|..++++.+ .++..+...++.|.+.||+|||++++|||||-..|+|++.++.+||+|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999998888877655 59999999999999999999999999999999999999999999999999987
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~ 368 (1630)
.-..-. .......-+..|+|||.+.... |++++|||||||++||+++ |..||.
T Consensus 311 ~~~~~~--------------~~~~~~klPirWLAPEtl~~~~------------~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 311 AGSQYV--------------MKKFLKKLPIRWLAPETLNTGI------------FSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred CCccee--------------eccccccCcceecChhhhccCc------------cccccchhheeeeEEeeeccCCCCCC
Confidence 532100 0000112367899999998754 8999999999999999999 899999
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCC
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~ 435 (1630)
+....++...|.......+. +...|.++..++.+||..+|++||++.++.+.+.........
T Consensus 365 g~~~~~v~~kI~~~~~r~~~-----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 365 GMKNYEVKAKIVKNGYRMPI-----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCHHHHHHHHHhcCccCCC-----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999554433332 225678999999999999999999999999988776655443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=324.24 Aligned_cols=266 Identities=21% Similarity=0.222 Sum_probs=201.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEE--------ccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCccee
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWI--------GGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTF 206 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy--------~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l 206 (1630)
.+|++.+.||+|+||.||+....- ..........||+|.+...... ....+.+|+++++.++ ||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK--NPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCCcCeE
Confidence 589999999999999987521100 0000112346999998754221 2346788999999976 9999999
Q ss_pred EEEEEeCCEEEEEEecCCCChHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEE
Q 000343 207 HGVLRMDSCLGLVMDRCYGSVQLAMQRNEG------------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274 (1630)
Q Consensus 207 ~~~f~~~~~~~LVmEy~~gglL~~l~~~~~------------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILl 274 (1630)
++++......++||||+.++++..++.... .+++..+..++.|++.||+|||++|++||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999988877764321 36888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhh
Q 000343 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354 (1630)
Q Consensus 275 d~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlG 354 (1630)
+.++.+||+|||++....... .........++..|+|||++.+.. ++.++|+||||
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwSlG 218 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGD------------YYRIQGRAVLPIRWMAWESILLGK------------FTTASDVWAFG 218 (295)
T ss_pred cCCCcEEecccccccccccCc------------ceeccCcCcCceeecChhhhccCC------------cCchhhHHHHH
Confidence 999999999999987643211 011122334577899999887644 78999999999
Q ss_pred hHHHHHhh--CCCCCCCCCHHHHHHHHHhcCCC-CCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 355 CTLVEMCT--GSIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 355 vILyemlt--G~~PF~~~~~~ei~~~i~~~~~~-~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
|++|+|++ +..||...+..+.+..+...... ........+..+|+.+.+|+.+||+.||++|||+.++++.|.
T Consensus 219 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 99999988 77899887776665544321100 000001122347889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.66 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=200.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++|.+.+.||+|+||.||. |.+..++..||+|.+....... ...+.+|+++++.++ ||||+++++++..+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~ 75 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYK------GISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK--HANIVLLHDIIHTK 75 (291)
T ss_pred cceeEEEEEEEecCCEEEEE------EEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC--CCCEeEEEEEEecC
Confidence 46899999999999887754 6677788999999987653322 345678999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
...|+||||+.++++..+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99999999999888877766666789999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA- 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~- 372 (1630)
.. .......+++.|+|||++.+.. .++.++||||||+++|+|++|..||...+.
T Consensus 156 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 156 PS--------------QTYSSEVVTLWYRPPDVLLGAT-----------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred CC--------------CCCCCccccccccCCceeecCC-----------CCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 11 0112234688999999986432 267889999999999999999999976543
Q ss_pred HHHHHHHHhcCCCC-----------C----Cc--------cccc--CCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLP-----------P----QY--------ASIV--GVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~-----------~----~~--------~~~~--~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+.+..+......+ + .. .... ....+.++.+|+.+||..||++|||+.+++.|-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 211 FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 22222221110000 0 00 0000 011356889999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=317.96 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=205.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCC---cEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCR---HSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g---~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.+|++.+.||+|+||.||. |..+.++ ..||||.+.... ......+..|+.+++.+. ||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~------~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~ 75 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCR------GRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNIIHLEGVVT 75 (269)
T ss_pred HHeEEEeEecCCCCCeEEE------EEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC--CcCcceEEEEEC
Confidence 4799999999999998864 3333333 479999887542 223456788999998875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+..++++|||++++++..++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999999888777654 45689999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
....... ...........+..|+|||.+.+.. ++.++|||||||++|||++ |..||..
T Consensus 156 ~~~~~~~---------~~~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 156 LEDDTSD---------PTYTSSLGGKIPIRWTAPEAIAYRK------------FTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cccCccc---------cccccccCCCcceeecCHhHhccCc------------ccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 5432100 0000011111245799999987644 7889999999999999887 9999988
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+..+....+......+. +..++..+.+++.+||+.+|++||++.+++..|...
T Consensus 215 ~~~~~~~~~i~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 215 MSNQDVINAIEQDYRLPP------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHHcCCcCCC------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 877777776654332221 235788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.83 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=205.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+|++.+.||+|+||.||+... ...........+|+|.+...... ....+.+|+.+++.++ ||||+++++.+.....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~-~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATA-FRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN--HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEE-ecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCC
Confidence 478899999999998865211 11111223467999988754322 2456778999998875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccc
Q 000343 216 LGLVMDRCYGSVQLAMQRNE------------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~------------------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~N 271 (1630)
.+++|||+.++.+..++... ..+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999988887765421 247889999999999999999999999999999999
Q ss_pred eEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 272 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
||+++++.+||+|||+++....... ........++..|+|||.+.+.. ++.++|||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~ 213 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS------------YVKRSKGRIPVKWMAIESLFDHI------------YTTQSDVW 213 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc------------hhcccCCCCCccccCHHHHccCC------------cchHhHHH
Confidence 9999999999999999876532210 00112234467899999886544 78999999
Q ss_pred hhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 352 SFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 352 SlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|||+++|+|++ |..||.+....++...+......+ .+..++.++.+|+.+||+.+|++||++.++++.|.+.+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 99999999998 999999888777766654432221 12357889999999999999999999999999998766
Q ss_pred c
Q 000343 431 Q 431 (1630)
Q Consensus 431 ~ 431 (1630)
.
T Consensus 288 ~ 288 (290)
T cd05045 288 V 288 (290)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=315.34 Aligned_cols=252 Identities=21% Similarity=0.390 Sum_probs=203.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.++||+|+||.||. +.. ..+..+|+|.+..... ..+.+.+|+.+++.++ ||||+++++++. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~------~~~-~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~--~~~i~~~~~~~~-~~ 73 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWM------GTW-NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLR--HDKLVQLYAVVS-EE 73 (260)
T ss_pred hHHhhhhheeccccCceEEE------EEe-cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcC--CCceEEEEeEEC-CC
Confidence 35899999999999998864 322 3456799999876433 4567889999999975 999999999875 45
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..|++|||+.++.+..++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++..+.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 68999999998887776653 2358999999999999999999999999999999999999999999999999998754
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||.+.+
T Consensus 154 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 154 DNE-------------YTARQGAKFPIKWTAPEAALYGR------------FTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred Ccc-------------cccccCCCCCccccChHHHhcCC------------CcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 321 00111233566899999886544 7899999999999999999 999998887
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..+....+...... + .+...+.++.+|+.+||..+|++|||+.++++.|.+
T Consensus 209 ~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 209 NREVLEQVERGYRM-P-----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHHcCCCC-C-----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 77777666543222 1 123578899999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=327.30 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=210.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+.|+....||+|+||.||+ +.+..++..||||.+........+.+.+|+.+++.++ ||||+++++.+...
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~ii~~~~~~~~~ 91 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCI------ATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH--HENVVDMYNSYLVG 91 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEE------EEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC--CCcHHHHHHheecC
Confidence 345777788999999888764 5566788999999987655555667888999988875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+..|+||||++++++..++.. ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 999999999999988887754 4699999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......|+..|+|||.+.+.. ++.++|+||||+++|||++|..||...+..
T Consensus 171 ~~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 171 EV--------------PKRKSLVGTPYWMAPEVISRLP------------YGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred cc--------------ccCceeecCccccCHHHHccCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11 1112345789999999986544 788999999999999999999999887776
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
..+..+..... +... ....++..+.+|+.+||..||++|||+.++++|-+-..
T Consensus 225 ~~~~~~~~~~~--~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 225 QAMRRIRDNLP--PRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHhcCC--Cccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 66555443221 1111 12246788999999999999999999999999854433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=308.48 Aligned_cols=270 Identities=23% Similarity=0.279 Sum_probs=204.6
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe-
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~- 212 (1630)
-.++|.+.+.||+|+|+.||+. ....+++.+|+|++......+.+...+|++..++++ ||||++++++.-.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~--s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLV------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN--SPNVLRLVDHQLRE 90 (302)
T ss_pred cCceEEEeeeecCCCceeeeee------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhC--CcchHHHHHHHHHh
Confidence 3579999999999999999873 366789999999999988777888999999999986 8999999987432
Q ss_pred ----CCEEEEEEecCCCC-hHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccceEECCCCcEEE
Q 000343 213 ----DSCLGLVMDRCYGS-VQLAMQR---NEGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 213 ----~~~~~LVmEy~~gg-lL~~l~~---~~~~L~~~~~~~i~~QIl~aL~yLHs~g--IIHRDLKP~NILld~~g~vKL 282 (1630)
....||+++|...| +++.+.. +...+++.+++.|+.+|++||.+||+.. +.||||||.|||+++.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 34599999999655 5444332 2336999999999999999999999998 999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
.|||.+....-.... +...-..+.+ .....|.+|+|||++.-.. +...+.++|||||||+||+|+.
T Consensus 171 ~D~GS~~~a~i~i~~--~~~a~~lQe~---a~e~Ct~pyRAPELf~vk~---------~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEG--SRQALRLQEW---AEERCTIPYRAPELFNVKS---------HCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred EeccCccccceEeec--hHHHHHHHHH---HHHhCCCcccCchheeccc---------CcccccccchhhhhHHHHHHHH
Confidence 999998754321100 0000001111 1223488999999987654 3448999999999999999999
Q ss_pred CCCCCCCCCHH--HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 363 GSIPWAGLSAE--EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 363 G~~PF~~~~~~--ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|..||...-.. .+.-.+..++...|. ...+++.+.+||+.||+.||.+||++.+++.++...+
T Consensus 237 ~~sPfe~~~~~GgSlaLAv~n~q~s~P~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 237 GESPFERIYQQGGSLALAVQNAQISIPN-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCcchHHhhcCCeEEEeeeccccccCC-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 99999532110 000111111222221 1237899999999999999999999999999876543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=318.64 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=199.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+ +.++.+++.||||++..... .....+..|+.++.+.. +||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDK------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEE------EEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHc-CCCCeeeeeEEEecCC
Confidence 4799999999999887754 66778899999999876532 22345556766655543 6999999999999999
Q ss_pred EEEEEEecCCCChHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAMQR---NEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~---~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+|++|||+++++...+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 74 DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred cEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999876554432 234699999999999999999999997 999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+.... ......|+..|+|||++.+... ...++.++|+|||||++|+|++|+.||...
T Consensus 154 ~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 154 LVDSV---------------AKTIDAGCKPYMAPERINPELN--------QKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred ccccc---------------ccccccCCccccChhhcCCccc--------ccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 53211 1122457889999998865321 123788999999999999999999999753
Q ss_pred C-HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 371 S-AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 371 ~-~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
. ..+.+..+..... +.. ....+|.++.+||.+||..+|++||++.++++|.+-
T Consensus 211 ~~~~~~~~~~~~~~~--~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 211 KTPFQQLKQVVEEPS--PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred ccCHHHHHHHHhcCC--CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 2 2233333332211 111 112478999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=313.71 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=199.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEE-EeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVL-RMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f-~~~~ 214 (1630)
.+|++.+.||+|+||.||+ +. ..+..||+|.+... ...+.+.+|+.+++.++ ||||+++++++ ....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~------~~--~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 6 KELKLLQTIGKGEFGDVML------GD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEKG 73 (256)
T ss_pred HhCeeeeeecccCCCeEEE------EE--EcCCcEEEEEeCCC--chHHHHHHHHHHHHhCC--CCCeeeEEEEEEcCCC
Confidence 4899999999999998865 22 24778999987643 33567888999999975 99999999975 4556
Q ss_pred EEEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+++|||++++.+..++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 7999999999877776665432 48899999999999999999999999999999999999999999999999987543
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... ....++..|+|||++.... ++.++|||||||++|+|++ |+.||...+
T Consensus 154 ~~~-----------------~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 154 STQ-----------------DTGKLPVKWTAPEALREKK------------FSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ccC-----------------CCCccceeecCHHHHccCC------------CCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 210 1122356799999886543 7889999999999999998 999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..+....+..+... .....+++.+.+++.+||+.+|++|||+.++++.|..
T Consensus 205 ~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 205 LKDVVPRVEKGYKM------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHhcCCCC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 77776666543221 1234578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=312.93 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=207.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.+|+ +.+..+++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAIL------VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK--HPNIVQYQESFEENG 72 (256)
T ss_pred CceEEEEeccCCceEEEE------EEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC--CCCeeeeEeeecCCC
Confidence 589999999999998865 45667889999999875432 23456788999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++||||+.++.+..++... ..+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++....
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 999999999887776665432 358999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
... .......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 153 ~~~--------------~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08218 153 STV--------------ELARTCIGTPYYLSPEICENRP------------YNNKSDIWALGCVLYEMCTLKHAFEAGNM 206 (256)
T ss_pred cch--------------hhhhhccCCccccCHHHhCCCC------------CCCccchhHHHHHHHHHHcCCCCccCCCH
Confidence 321 0112245788999999987644 67899999999999999999999988887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+....+..+...+ .+..++.++.++|.+||+.+|++||++.++++|-
T Consensus 207 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~ 254 (256)
T cd08218 207 KNLVLKIIRGSYPP------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN 254 (256)
T ss_pred HHHHHHHhcCCCCC------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence 77777776554322 1235788999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=317.43 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=204.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.+|++.+.||+|+||.||. +.+..+++.+|||.+...... ....+.+|+.+++.+. ||||++++++|..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~------~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~ 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYR------ATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN--HPNVIKYYASFIE 73 (267)
T ss_pred chhhhhhhhcccCCeEEEE------EeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc--CCchhhhhheeEe
Confidence 4789999999999887754 667778999999988764322 2346678999998875 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
+..++++|||++++.+..++.. ...+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999999998887776542 346899999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
..+.... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.
T Consensus 154 ~~~~~~~--------------~~~~~~~~~~~~~ape~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 154 RFFSSKT--------------TAAHSLVGTPYYMSPERIHENG------------YNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hccccCC--------------cccccccCCcCccCHHHhcCCC------------ccchhhHHHHHHHHHHHHhCCCCcc
Confidence 7654221 0112345788999999986543 7889999999999999999999997
Q ss_pred CCCH--HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 369 GLSA--EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 369 ~~~~--~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
+... ......+..... ++ .....+++++.+|+.+||+.||++|||+.++++.+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 208 GDKMNLYSLCKKIEQCDY-PP----LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cccchHHHHhhhhhcCCC-CC----CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 5433 233333332221 11 11234788999999999999999999999998887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=330.22 Aligned_cols=274 Identities=22% Similarity=0.287 Sum_probs=204.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc--CcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA--EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~--~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
...|+++++||.|+.+.||.. . ......||+|++... +.....-+.+|+..|.+++ +|.+||+||+|-..
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV--~-----~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk-g~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKV--L-----NSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLK-GHDKIIQLYDYEVT 431 (677)
T ss_pred cchhhHHHhhcCCCcceeeee--e-----cCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc-CCceEEEEeeeecc
Confidence 368999999999999998652 1 233467888876644 2333567889999999998 79999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
++++||||||-+.++-..+.++...++.-.++.|.+|||.|+.++|..||||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 432 d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 432 DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999999999977766666655544455458999999999999999999999999999999995 6899999999998876
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.+.+ .-.....+||+.|||||.+....++.+-. ......+.++||||||||||+|+.|+.||.....
T Consensus 511 ~DTT------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~-~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 511 PDTT------------SIVKDSQVGTVNYMSPEALTDMSSSRENG-KSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred cccc------------ceeeccccCcccccCHHHHhhccccccCC-CcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 5431 12234568999999999998766431110 0112268999999999999999999999976432
Q ss_pred HHHHHHHHhcCCCCCCcccccCCC-CCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVG-IPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~-l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
.+.++..... |...-+++.. -..++.++|+.||..||.+|||+.++|+|-+......+
T Consensus 578 --~~aKl~aI~~--P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 578 --QIAKLHAITD--PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred --HHHHHHhhcC--CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 2222222111 1000011111 12349999999999999999999999999775554333
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=312.94 Aligned_cols=251 Identities=23% Similarity=0.421 Sum_probs=203.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.++||+|+||.||+ +.. ..++.||+|.+.... .....+.+|+.+++.++ ||||+++++++. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~------~~~-~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~ 73 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWM------GYY-NGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQ--HPRLVRLYAVVT-QE 73 (260)
T ss_pred hHHceeeeeeccCccceEEe------eec-CCCceEEEEEecCCC-CcHHHHHHHHHHHHhcC--CcCeeeEEEEEc-cC
Confidence 46899999999999998865 332 346789999887543 44567889999999975 999999999875 45
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.++++|||+.++.+..++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 68999999988877766543 2368999999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... ........++..|+|||++.... ++.++||||||+++|+|++ |.+||.+.+
T Consensus 154 ~~~-------------~~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 154 DNE-------------YTAREGAKFPIKWTAPEAINYGT------------FTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred CCC-------------cccccCCcccccccCHHHhccCC------------cCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 211 01112234567899999886544 7889999999999999999 999999887
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+....+......+ .+...+.++.+++.+||+.+|++||+++++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 209 NPEVIQNLERGYRMP------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred hHHHHHHHHcCCCCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 777666654443221 12356789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=326.67 Aligned_cols=256 Identities=20% Similarity=0.254 Sum_probs=187.3
Q ss_pred EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe--CCEEEE
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM--DSCLGL 218 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~--~~~~~L 218 (1630)
.++||+|+||.||+. ..+ +..++..||+|.+.... ....+.+|+++|+.++ ||||+++++++.. ...+++
T Consensus 6 g~~lG~G~~g~Vy~~--~~~--~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKA--KRK--DGKDEKEYALKQIEGTG--ISMSACREIALLRELK--HPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEE--Eec--CCCccceEEEEEecCCC--CcHHHHHHHHHHHhCC--CCCeeeEEEEEeccCCCeEEE
Confidence 368999999988652 111 33467899999887542 2345778999999976 9999999999854 567899
Q ss_pred EEecCCCChHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEE----CCCCcEEEeecc
Q 000343 219 VMDRCYGSVQLAMQRN--------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL----DASGRAVVSDYG 286 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~--------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILl----d~~g~vKL~DFG 286 (1630)
+|||+.++++..+... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9999998876655321 2248899999999999999999999999999999999999 456789999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+++....... .........||+.|+|||++.+.. .++.++|||||||++|||+||.+|
T Consensus 158 ~a~~~~~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~-----------~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 158 FARLFNSPLK-----------PLADLDPVVVTFWYRAPELLLGAR-----------HYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred ceeccCCCcc-----------cccccCcceecccccCcHHhcCCC-----------ccCcHHHHHhHHHHHHHHHhCCCC
Confidence 9987643210 011223456899999999986533 278999999999999999999999
Q ss_pred CCCCCHH---------HHHHHHHhcCCCC-----------CCc--------------------ccccCCCCCHHHHHHHH
Q 000343 367 WAGLSAE---------EIYRAVVKNRKLP-----------PQY--------------------ASIVGVGIPRELWKMIG 406 (1630)
Q Consensus 367 F~~~~~~---------ei~~~i~~~~~~~-----------~~~--------------------~~~~~~~l~~el~~LI~ 406 (1630)
|...... ..+..+......+ +.+ ........+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 295 (317)
T cd07867 216 FHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295 (317)
T ss_pred cccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHH
Confidence 9643221 1111111100000 000 00011123567889999
Q ss_pred HhhccCcCCCCChhhHHHHh
Q 000343 407 ECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 407 ~cL~~dP~~RPSa~evL~~L 426 (1630)
+||+.||.+|||+.|+|+|-
T Consensus 296 ~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 296 KLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHhccCcccccCHHHHhcCC
Confidence 99999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=330.84 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=197.3
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
-+++|.--..||+|+||.||. |. ...+..||||++..........+.+|+.+|.+++ |||+|+|+++|.+.
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYk------G~-l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~--H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYK------GV-LSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR--HPNLVKLLGYCLEG 143 (361)
T ss_pred HHhCCchhcceecCCCeEEEE------EE-ECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC--CcCcccEEEEEecC
Confidence 347888889999999998853 32 2344899999888654431344999999999986 99999999999998
Q ss_pred C-EEEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CccccccccceEECCCCcEEEeecce
Q 000343 214 S-CLGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAG---VVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 214 ~-~~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~g---IIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
+ ..+||+||+..|.|.+++.... .|+|..+..|+.++++||+|||... ||||||||+|||||++..+||+|||+
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 8 5999999998888877765443 8999999999999999999999854 99999999999999999999999999
Q ss_pred eeeecC-ccccCCCCCCCCCCcccccccc-cCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 288 AAILKK-PACRKARPECDSSRIHSCMDCT-MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 288 a~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+.... .. ..... .||..|+|||++.... .+.++||||||++|.|++||+.
T Consensus 224 a~~~~~~~~---------------~~~~~~~gt~gY~~PEy~~~g~------------lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 224 AKLGPEGDT---------------SVSTTVMGTFGYLAPEYASTGK------------LTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred cccCCcccc---------------ceeeecCCCCccCChhhhccCC------------cCcccccccchHHHHHHHhCCc
Confidence 965432 11 01111 7899999999987654 7899999999999999999998
Q ss_pred CCCCCC---HHHHH---HHHHhcCCCCCCcccccC-CCCC-----HHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 366 PWAGLS---AEEIY---RAVVKNRKLPPQYASIVG-VGIP-----RELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 366 PF~~~~---~~ei~---~~i~~~~~~~~~~~~~~~-~~l~-----~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|..... ...+. ................+. ...+ ..+..+..+|++.+|.+||++.|+++.|....
T Consensus 277 ~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 277 AVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred ccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 876432 11111 112222111111111111 1222 23567888999999999999999988884433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=319.98 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=201.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++++.||.|+||.||+ |.+..++..||||++...... ....+.+|++++++++ ||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYK------ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTEN 72 (284)
T ss_pred CceeeeeecCCCceEEEE------EEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC--CCCCcchhhhcccCC
Confidence 589999999999887754 667788999999998754322 2356788999999986 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+++|||+.+++...+... ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..+..
T Consensus 73 ~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 73 KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999987655544332 35689999999999999999999999999999999999999999999999999876532
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......+++.|+|||++.+.. .++.++||||||+++|+|+||+.||...+..
T Consensus 153 ~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 153 PV--------------RTYTHEVVTLWYRAPEILLGCK-----------YYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred Cc--------------cccccccccccccCCeEEecCC-----------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 11 0112234688899999886533 1578899999999999999999999877665
Q ss_pred HHHHHHHhcCCCCCC----------------------cccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQ----------------------YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~----------------------~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+......+.. ........+++++.++|.+||+.||++|||++++++|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 208 DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 544443332111110 00011234678899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=313.68 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=201.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
++||+|+||.||+ ..+... ..++..+|+|.+...... ....+.+|+.+++.+. ||||+++++++. ...++++|
T Consensus 1 ~~ig~G~~g~v~~--~~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVK--GVYLMK-SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD--HPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEE--eEeecc-CCCcceEEEEecccccchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEc-CCceEEEE
Confidence 4799999998854 333321 113479999998865432 3456788999998875 999999999876 45689999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||++++.+..++.+...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~---- 150 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD---- 150 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc----
Confidence 9999888887777666899999999999999999999999999999999999999999999999999987643210
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAV 379 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i 379 (1630)
.........++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+
T Consensus 151 -------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 151 -------YYRATTAGRWPLKWYAPECINYGK------------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred -------ccccccCccccccccCHHHhcCCC------------CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 001111223456899999886544 7889999999999999998 99999888777766666
Q ss_pred HhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 380 ~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
......+ .+..++..+.++|.+||+.+|++||++.++++.|....
T Consensus 212 ~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 ESGERLP------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HcCCcCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 5443221 22357889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=336.97 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=205.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|.+.++||+|+||.||. ....+ ....++..||+|+++...... ...+.+|+++|..+. .||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~--~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-~H~niv~~~~~~~~~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVE--ATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-PHLNIVNLLGACTKG 113 (401)
T ss_pred HHeehhhhccCCCceeEEE--EEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-CCCCeEEEEEEEccC
Confidence 4789999999999999864 22222 134566789999998643222 346778999999874 499999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------------------------------------------------
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE---------------------------------------------------------- 235 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~---------------------------------------------------------- 235 (1630)
..+++||||+.++.|..++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999988887766431
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC
Q 000343 236 ----------------------------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275 (1630)
Q Consensus 236 ----------------------------------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld 275 (1630)
..+++..+..|+.||+.||+|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 1367778899999999999999999999999999999999
Q ss_pred CCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhh
Q 000343 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355 (1630)
Q Consensus 276 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGv 355 (1630)
.++.+||+|||+++.+..... ........++..|+|||.+.+.. ++.++||||||+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslGv 329 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSN------------YISKGSTFLPLKWMAPESIFNNL------------YTTLSDVWSFGI 329 (401)
T ss_pred CCCEEEEEecCcceecccccc------------cccCCCcCCCCceeChHHhcCCC------------CCcHhHHHHHHH
Confidence 999999999999986532110 00112235678899999987644 788999999999
Q ss_pred HHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 356 ILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
++|||++ |..||......+...........++ .+..++.++.+|+.+||+.+|.+||++.++++.|...+
T Consensus 330 il~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 330 LLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9999998 8999987665554444333322211 12357899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=321.68 Aligned_cols=253 Identities=20% Similarity=0.306 Sum_probs=206.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.+.|++.+.||+|+||.||+ +.+..+++.||+|.+....... ...+.+|+++++.++ ||||+++++++.
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~~~~~~~ 85 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYF------ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR--HPNTIEYKGCYL 85 (307)
T ss_pred chhhhhheeecCCCCeEEEE------EEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC--CCCEEEEEEEEE
Confidence 35799999999999888764 5566788999999987543322 245778999999875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
.....|+||||+.++++..+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999999999998887777655667999999999999999999999999999999999999999999999999998654
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ....+++.|+|||++.+.. ...++.++||||||+++|+|++|+.||.+.+
T Consensus 166 ~~~------------------~~~~~~~~y~aPE~~~~~~---------~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 166 SPA------------------NSFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred CCC------------------CCccCCccccCceeeeccC---------CCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 321 1235688999999885321 1127889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.......+..... +.. ....++.++.+||.+||+.+|++||++.+++.|.+
T Consensus 219 ~~~~~~~~~~~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 219 AMSALYHIAQNDS--PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHHHhcCCC--CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 6655544433221 111 12246789999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=315.22 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-----ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-----EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+|+..+.||+|+||.||+ +.+..++..||+|++...... ....+.+|+.+++.++ ||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 73 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYL------CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ--HERIVQYYGCL 73 (266)
T ss_pred CCccccceecCCCCEEEEE------EEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC--CCCeeeEEEEE
Confidence 4799999999999887754 667788999999998754321 2345778999999875 99999999998
Q ss_pred Ee--CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 211 RM--DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~--~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.. ...++++|||++++.|..++.+...+++...+.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 74 RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 76 3678999999998888877776667999999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+.+..... .........++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.
T Consensus 154 ~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 154 KRLQTICM-----------SGTGIRSVTGTPYWMSPEVISGEG------------YGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred cccccccc-----------cCCccccCCccccccCHHHhCCCC------------CCchhhhHHHHHHHHHHHHCCCCcc
Confidence 76532110 001112345788999999987644 7889999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.....+.+..+..... .+. .+..+++.+.+|+ +||..+|++||+++++++|-+
T Consensus 211 ~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 211 EYEAMAAIFKIATQPT-NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred ccchHHHHHHHhcCCC-CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 7765554444332221 111 2234678889998 688899999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=316.48 Aligned_cols=259 Identities=21% Similarity=0.342 Sum_probs=206.3
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC----------hhHHHHHHHHHHHhccCCCCccee
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME----------PDWLSGQLDNLRRASMWCRNVCTF 206 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~----------~~~~~~Ei~iL~~l~l~HpNIV~l 206 (1630)
+|.+.+.||+|+||.||+ |.+..+++.||+|.+....... .+.+.+|+.+++.++ ||||+++
T Consensus 2 ~~~~~~~lg~g~~~~vy~------~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~ 73 (272)
T cd06629 2 KWVKGELIGKGTYGRVYL------ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD--HLNIVQY 73 (272)
T ss_pred ceeecceecccCceEEEE------EeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC--CCCcceE
Confidence 588999999999888764 6667789999999886432111 235677888888875 9999999
Q ss_pred EEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecc
Q 000343 207 HGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 207 ~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFG 286 (1630)
++++.....+++||||++++.+..++.+.+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 74 LGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred EEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 99999999999999999999888888777789999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
++....... .........|+..|+|||.+.... ..++.++|+||||+++|+|++|..|
T Consensus 154 ~~~~~~~~~------------~~~~~~~~~~~~~y~~PE~~~~~~----------~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 154 ISKKSDDIY------------DNDQNMSMQGSVFWMAPEVIHSYS----------QGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred ccccccccc------------cccccccccCCccccCHHHhcccc----------CCCCccchhHHHHHHHHHHHhCCCC
Confidence 987543211 001123345788999999876532 1278899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
|......+....+......+ .........++.++.+||.+||..+|++|||+.++++|.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 212 WSDEEAIAAMFKLGNKRSAP-PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred CcCcchHHHHHHhhccccCC-cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 98766554444433222211 111222345789999999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=330.81 Aligned_cols=256 Identities=20% Similarity=0.277 Sum_probs=200.4
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||+ +.+..+++.||||.+.... ......+.+|+.+++.++ ||||++++++|.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 85 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCA------AYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN--HKNIIGLLNVFT 85 (353)
T ss_pred hhcceEEEEEeccCCCEEEEE------EEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC--CCCCcceeeeec
Confidence 457999999999999888754 6678899999999986532 222345668999998875 999999999986
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ..+|+||||+.+++...+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 86 PQKSLEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCCCccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 44 35799999998876665543 2899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++...... ......++..|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 163 g~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 163 GLARTAGTSF---------------MMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred ccceeCCCCC---------------CCCCCcccccccCHHHHhCCC------------CCCchhhHhHHHHHHHHHHCCC
Confidence 9997654211 112345788999999987644 7899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCC------------------------ccc------------ccCCCCCHHHHHHHHHhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQ------------------------YAS------------IVGVGIPRELWKMIGECL 409 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~------------------------~~~------------~~~~~l~~el~~LI~~cL 409 (1630)
||...+....+..+......++. +.. ......++++++||.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 99877655544444321111100 000 001134567899999999
Q ss_pred ccCcCCCCChhhHHHHhh
Q 000343 410 QFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 410 ~~dP~~RPSa~evL~~L~ 427 (1630)
+.||++|||+.|+|+|-+
T Consensus 296 ~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 296 VIDPEKRISVDDALQHPY 313 (353)
T ss_pred CCChhhCcCHHHHhcChh
Confidence 999999999999999844
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=314.52 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=205.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||+ +....++..+|+|.+..... .+.+.+|+++++.+ +||||+++++.+.....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l--~~~~i~~~~~~~~~~~~ 72 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYK------AIHKETGQVVAIKVVPVEED--LQEIIKEISILKQC--DSPYIVKYYGSYFKNTD 72 (256)
T ss_pred ccchhhhhhcCCCCeEEEE------EEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhC--CCCcEeeeeeeeecCCc
Confidence 6899999999999887754 55666789999999876533 67888999999997 49999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+|++|||+.++.+..++.. ...+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999888877654 457899999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+...
T Consensus 153 ~--------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 153 M--------------AKRNTVIGTPFWMAPEVIQEIG------------YNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred c--------------cccccccCCccccCHHHHhcCC------------CCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 1 0112344788999999987644 7889999999999999999999998776654
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
....+.... .+.. ..+..++.++.++|.+||+.||++|||+.+++.|-
T Consensus 207 ~~~~~~~~~--~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~ 254 (256)
T cd06612 207 AIFMIPNKP--PPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254 (256)
T ss_pred hhhhhccCC--CCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence 443332211 1111 11234678999999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=321.99 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=204.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++++.||+|+||.||+ +.+..++..||+|++..... .....+.+|+++++.++ ||||+++++.+....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~------~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~ 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSK------VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR--SPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEE------EEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC--CCCcceEeeeEecCC
Confidence 5799999999999888864 55677889999998876432 23567888999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++||||++++++..++...+.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999998888777789999999999999999999997 5999999999999999999999999999865422
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .....|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......
T Consensus 157 ~~----------------~~~~~~~~~~~aPE~~~~~~------------~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 157 SI----------------ADTFVGTSTYMSPERIQGGK------------YTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred hc----------------cCccccCcccCCHHHHccCC------------CCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 11 12346789999999986543 788999999999999999999999865431
Q ss_pred -----------HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 -----------EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 -----------ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.+..+.... ++.. ....++.++.+|+.+||+.||++|||+.+++++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEP--PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhcc--CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2222322221 1111 11236789999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=310.35 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=205.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||+ +.+..+++.+|+|.+..... .....+.+|+++|+.++ ||||+++++.+....
T Consensus 1 ~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHL------CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS--HPNIIEYYENFLEDK 72 (256)
T ss_pred CceEEEEecccCceEEEE------EEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC--CCchhheeeeEecCC
Confidence 589999999999887754 55667899999999876532 23557788999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecceeeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYGLAAIL 291 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFGla~~~ 291 (1630)
.+++||||++++.+..++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999999998887776542 358999999999999999999999999999999999999865 46899999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 153 ~~~~---------------~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 153 SSKS---------------KAYTVVGTPCYISPELCEGKP------------YNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred CCCc---------------cccccccCCcccCchhccCCC------------CCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 4321 112245788999999987543 6889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.......+......+ .+..+++++.+++.+||+.+|++|||+.+++.|
T Consensus 206 ~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 206 LPALVLKIMSGTFAP------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred hHHHHHHHHhcCCCC------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 776666655443221 123478899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.58 Aligned_cols=206 Identities=26% Similarity=0.326 Sum_probs=177.7
Q ss_pred chHHHHHHHcCCHHHHHHHHHcCC-CCCCCCC-CCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHc
Q 000343 581 PSVAHVCAYHGQPDCMRELLLAGA-DPNAVDD-EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVAT 658 (1630)
Q Consensus 581 ~T~Lh~Aa~~G~~eivk~LL~~GA-Dvn~~D~-~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~ 658 (1630)
.++.+.+|......-++.|++... ..|.++. +|+||||+|+..|+.+++.+|++.-. ..++..|..|+||||+|+..
T Consensus 4 ~~~~~~~~~~~~~~kveel~~s~~kSL~~r~dqD~Rt~LHwa~S~g~~eiv~fLlsq~n-v~~ddkDdaGWtPlhia~s~ 82 (226)
T KOG4412|consen 4 ASLGKAICENCEEFKVEELIQSDPKSLNARDDQDGRTPLHWACSFGHVEIVYFLLSQPN-VKPDDKDDAGWTPLHIAASN 82 (226)
T ss_pred cchHHHHHhhchHHHHHHHHhcChhhhhccccccCCceeeeeeecCchhHHHHHHhcCC-CCCCCccccCCchhhhhhhc
Confidence 355666777777777777776655 5677766 99999999999999999999997433 46777888999999999988
Q ss_pred CCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhc-CCCCCcccccCccchhhhhhcCC
Q 000343 659 WNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTA-GAEPTAQDAQNRTALHIASMAND 737 (1630)
Q Consensus 659 g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~-GAdvn~~D~~G~TpLH~Aa~~g~ 737 (1630)
|+.++|+. |+.+ |+|+|+.+..|+||||||+..|.
T Consensus 83 g~~evVk~--------------------------------------------Ll~r~~advna~tn~G~T~LHyAagK~r 118 (226)
T KOG4412|consen 83 GNDEVVKE--------------------------------------------LLNRSGADVNATTNGGQTCLHYAAGKGR 118 (226)
T ss_pred CcHHHHHH--------------------------------------------HhcCCCCCcceecCCCcceehhhhcCCh
Confidence 76655554 4444 89999999999999999999999
Q ss_pred HHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhh
Q 000343 738 VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLS 817 (1630)
Q Consensus 738 ~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~ 817 (1630)
.+|+++|+++||.++++|..|+||||.||.-|+.+++++|++.||.+|.+|+.|+||||+|..-+ ...+..+|.
T Consensus 119 ~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL~~al~e~------~~d~a~lLV 192 (226)
T KOG4412|consen 119 LEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPLHHALAEG------HPDVAVLLV 192 (226)
T ss_pred hhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHHHHHHhcc------CchHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999995433 335677889
Q ss_pred CCCCcccccCCCCCCHHHHHh
Q 000343 818 HPDAAVEVRNHSGKTLRDFLE 838 (1630)
Q Consensus 818 ~~gadvn~~n~~G~TpLdlA~ 838 (1630)
+.||+++..|+.| ||+-.|.
T Consensus 193 ~~gAd~~~edke~-t~~~~a~ 212 (226)
T KOG4412|consen 193 RAGADTDREDKEG-TALRIAC 212 (226)
T ss_pred HhccceeeccccC-chHHHHH
Confidence 9999999999999 9987764
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=312.96 Aligned_cols=260 Identities=26% Similarity=0.367 Sum_probs=210.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||.|+||.||. +....++..+|+|++..... .....+.+|++.|+.++ ||||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYA------AICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN--HPNVVKYYTSFVVGD 72 (267)
T ss_pred CcceeeeeecCCCCeEEEE------EEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC--CCCEEEEEEEEeeCC
Confidence 4799999999999887754 55566788999999875432 24567888999988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE---GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~---~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
.++++|||++++.+..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++..+
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 999999999998888877543 45899999999999999999999999999999999999999999999999998766
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
...... .........|+..|+|||++.... .++.++|+||||+++|+|++|+.||...+
T Consensus 153 ~~~~~~----------~~~~~~~~~~~~~y~~Pe~~~~~~-----------~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 153 ADGGDR----------TRKVRKTFVGTPCWMAPEVMEQVH-----------GYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccCccc----------cccccccccCChhhcChHHHcccc-----------CcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 532210 001123346789999999987642 27889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccc-cCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASI-VGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~-~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+.+..+...... .+... ....+++++.+|+.+||..||++||++.++++|-
T Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p 265 (267)
T cd06610 212 PMKVLMLTLQNDPP--SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265 (267)
T ss_pred hhhhHHHHhcCCCC--CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence 76666665544221 11111 1235788999999999999999999999999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=319.00 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=203.2
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe--
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-- 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-- 212 (1630)
.+.|++.+.||+|+||.||+ +.+..+++.+|+|.+.... .....+..|+.+++++. +||||++++++|..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~------~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYK------GRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYS-HHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhheeeccCCCeEEEE------EEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhc-CCCcEEEEeeehhccc
Confidence 36899999999999888764 6677889999999887543 23456778889888875 59999999999853
Q ss_pred ----CCEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecc
Q 000343 213 ----DSCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 213 ----~~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFG 286 (1630)
...+|++|||++++++..++.. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4679999999998877776654 2458899999999999999999999999999999999999999999999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
++....... .......|++.|+|||++..... ....++.++|+|||||++|+|++|..|
T Consensus 167 ~~~~~~~~~--------------~~~~~~~~~~~y~aPE~l~~~~~-------~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 167 VSAQLDRTV--------------GRRNTFIGTPYWMAPEVIACDEN-------PDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred chhhhhccc--------------cCCCcccccccccCHhhcCcccC-------cCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 987543211 01223567899999999864220 112378899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
|...........+.... ++ ......++.++.+||.+||+.||.+||++.++++|-
T Consensus 226 ~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 226 LCDMHPMRALFLIPRNP--PP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred ccccCHHhhhhhHhhCC--CC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 98766544443332221 11 112235789999999999999999999999998873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=316.37 Aligned_cols=259 Identities=24% Similarity=0.328 Sum_probs=206.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+.... ..........||+|.+...... ....+.+|++++++++ ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAK-GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS--HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEec-cCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC--CcceeeeEEEECCCC
Confidence 58999999999999988753211 1112335578999987654332 2456888999999975 999999999999989
Q ss_pred EEEEEEecCCCChHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEG---------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~---------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
..++||||++++.|..++.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999888887776544 6899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~ 364 (1630)
|++....... ........++..|+|||.+.+.. ++.++||||||+++|+|++ |.
T Consensus 162 ~~~~~~~~~~-------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 162 SLSKDVYNSE-------------YYKLRNALIPLRWLAPEAVQEDD------------FSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred ccccccCccc-------------ccccCCceeEEeecChhhhccCC------------CCchhhHHHHHHHHHHHHhCCC
Confidence 9986543211 11122334577899999886543 6789999999999999999 89
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.||........+..+..+....+ ....++..+.+++.+||+.+|++|||+.+++..|.
T Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDEEVLNRLQAGKLELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchHHHHHHHHcCCcCCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 99988777666666554332211 12357889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=316.72 Aligned_cols=199 Identities=25% Similarity=0.330 Sum_probs=174.3
Q ss_pred ccccCCCCccchhhccCChhhhhhhhccc-CCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccC
Q 000343 463 EVFQDNPNNLHQLVSEGDVSGVRDLLSKN-ASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVL 541 (1630)
Q Consensus 463 ~~~~~~~t~Lh~Aa~~Gdl~~Vk~LL~~~-a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~ 541 (1630)
+.-++..+||..||++|+.+.|+.||+.. +++ ....+--++-.+.+|-+||-.|+..||+++|+.|++.+ +++|..
T Consensus 37 ~~~~~g~tPL~iaaRnGH~~vVeyLle~~~a~~--e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~g-a~VN~t 113 (615)
T KOG0508|consen 37 GEVQNGGTPLLIAARNGHADVVEYLLEHCRASP--EQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRG-ASVNDT 113 (615)
T ss_pred ccccCCCCceeeehhcCcHHHHHHHHHHhcCCc--cCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhc-Cccccc
Confidence 44466779999999999999999999853 222 11122223455678999999999999999999999975 899999
Q ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhh
Q 000343 542 DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAV 621 (1630)
Q Consensus 542 D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa 621 (1630)
.....|||--||.-|++++|++|+++|||++.. +..|.|-||+||+.||.+|+++|++.|||+|.++..|+|+||.|+
T Consensus 114 T~TNStPLraACfDG~leivKyLvE~gad~~Ia--nrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~ca 191 (615)
T KOG0508|consen 114 TRTNSTPLRAACFDGHLEIVKYLVEHGADPEIA--NRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCA 191 (615)
T ss_pred cccCCccHHHHHhcchhHHHHHHHHcCCCCccc--ccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhh
Confidence 999999999999999999999999999999765 566889999999999999999999999999999999999999999
Q ss_pred hcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHH
Q 000343 622 AKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE 669 (1630)
Q Consensus 622 ~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe 669 (1630)
..|+++++++|+.+|+..+ .|..|.|||..|+..|+.++|++|++
T Consensus 192 EsG~vdivq~Ll~~ga~i~---~d~~GmtPL~~Aa~tG~~~iVe~L~~ 236 (615)
T KOG0508|consen 192 ESGSVDIVQLLLKHGAKID---VDGHGMTPLLLAAVTGHTDIVERLLQ 236 (615)
T ss_pred hcccHHHHHHHHhCCceee---ecCCCCchHHHHhhhcchHHHHHHhc
Confidence 9999999999999998432 46679999999999999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=320.55 Aligned_cols=262 Identities=20% Similarity=0.253 Sum_probs=201.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc------------ccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG------------GQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRN 202 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a------------~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpN 202 (1630)
++|++.++||+|+||.||+.. ... ....+...||+|.+...... ....+.+|+++|+.++ |||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~--~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~--~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCE--AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK--DPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecc--cccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCC
Confidence 579999999999999997521 110 12234557999998754222 2456788999999975 999
Q ss_pred cceeEEEEEeCCEEEEEEecCCCChHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccc
Q 000343 203 VCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEG-----------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271 (1630)
Q Consensus 203 IV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~-----------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~N 271 (1630)
|+++++++......+++|||+.++++..++.... .+++..+..++.|++.||+|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999888877765422 36778999999999999999999999999999999
Q ss_pred eEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 272 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
||++.++.+||+|||+++.+..... ........++..|+|||...+.. ++.++|+|
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Diw 216 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY------------YRIQGRAVLPIRWMSWESILLGK------------FTTASDVW 216 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc------------eeccCcCcCccccCCHHHHhcCC------------ccchhhhh
Confidence 9999999999999999876532210 01112233467899999876544 78999999
Q ss_pred hhhhHHHHHhh--CCCCCCCCCHHHHHHHHHhc---CCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 352 SFGCTLVEMCT--GSIPWAGLSAEEIYRAVVKN---RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 352 SlGvILyemlt--G~~PF~~~~~~ei~~~i~~~---~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
||||++|||++ |..||...+..+.+...... ...... ...+..+++.+.+|+.+||+.||++||++.++++.|
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVY--LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcccccc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999998 78999877766655433221 000000 111234778999999999999999999999999887
Q ss_pred h
Q 000343 427 L 427 (1630)
Q Consensus 427 ~ 427 (1630)
.
T Consensus 295 ~ 295 (296)
T cd05095 295 L 295 (296)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=316.98 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=201.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe--C
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM--D 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~--~ 213 (1630)
.+|++++.||+|+||.||. ..+++.+..++..||+|++..........+.+|+++++.++ ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~--~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVEL--CRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ--HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEE--EEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC--CCCeeEEEEEEccCCC
Confidence 5899999999999999854 45555567789999999987655444567889999999975 9999999998754 3
Q ss_pred CEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+++||||++++.|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 468999999998888777654 4568999999999999999999999999999999999999999999999999998764
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.... .........++..|+|||++.+.. ++.++||||||+++|||++|..|+.....
T Consensus 160 ~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 160 QDKE-----------YYKVREPGESPIFWYAPESLTESK------------FSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred CCCc-----------ceeecCCCCCceEeeCHHHhccCC------------cChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 3210 000111122355699999986544 78899999999999999998877644322
Q ss_pred HHH---------------HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEI---------------YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei---------------~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
... +..+.......+ ....++.++.+|+.+||+.+|++|||+.++++.|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLP-----APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 100 011111111111 123578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=316.64 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=204.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC------ChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM------EPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~------~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
+|+..+.||+|+||.||. +.+..+++.||+|.+...... ....+.+|++.++.++ ||||+++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~------~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~ 72 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQ------ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN--HPHIIRMLGAT 72 (268)
T ss_pred CccccceecCcCceEEEE------EEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC--CCceehhhcee
Confidence 478889999999887754 567788999999998754321 2356788999999975 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-cEEEeecceee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDYGLAA 289 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-~vKL~DFGla~ 289 (1630)
.+.+.+++||||+.+++|..++.+..++++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 73 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 73 CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred ccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999999999988887777899999999999999999999999999999999999998776 59999999997
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+...... .........|+..|+|||++.+.. ++.++|+||+|+++|+|++|..||..
T Consensus 153 ~~~~~~~~----------~~~~~~~~~~~~~~~~PE~~~~~~------------~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 153 RLAAKGTG----------AGEFQGQLLGTIAFMAPEVLRGEQ------------YGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred cccccccc----------CCccccccccccceeCHhHhccCC------------CCcccchHHHHHHHHHHHhCCCCCCC
Confidence 76532100 011123346789999999986543 78899999999999999999999975
Q ss_pred CCHHH---HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 370 LSAEE---IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 370 ~~~~e---i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..... ....+...... ...+..+++++.+++.+||..+|++||++.++++|-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 211 EKHSNHLALIFKIASATTA-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred CCCcchHHHHHHHhccCCC-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 44322 22222211111 112335788999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=352.01 Aligned_cols=270 Identities=22% Similarity=0.318 Sum_probs=222.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccC-CcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC-RHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~-g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
....++.+.||+|.||.|| ...|...+... ...||||.+.+.. ..+...+.+|..+|..+. |||||++++++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY--~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~--HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVY--EGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD--HPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceE--EEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC--CcceeeEEEeecC
Confidence 4678999999999999995 45566543322 4569999988763 345677889999999976 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE-------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~-------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
....+|++|||.||+|..++++. ..|+..+...++.||++|++||+++++|||||-..|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999988888777653 35999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~ 364 (1630)
|+|+.+-...+. .......-...|||||.+.... ++.++|||||||+|||++| |.
T Consensus 847 GlArDiy~~~yy------------r~~~~a~lPvkWm~PEsl~d~i------------FtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 847 GLARDIYDKDYY------------RKHGEAMLPVKWMPPESLKDGI------------FTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred chhHhhhhchhe------------eccCccccceecCCHHHHhhcc------------cccccchhhhHHHHHHHHhCCC
Confidence 999944322211 1111123367899999998755 8999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCCCCC
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPP 438 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~sp~ 438 (1630)
.||.+.+..+++.....+.+.++ +..+|..+.++|..||+.+|++||++..+++.+....+.......
T Consensus 903 ~PY~~~~n~~v~~~~~~ggRL~~------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 903 TPYPSRSNFEVLLDVLEGGRLDP------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred CCCCCcchHHHHHHHHhCCccCC------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 99999999999887777764443 346899999999999999999999999999977776665544433
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=316.94 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=203.3
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+|++.++||.|+||.|| +|.+..++..||||.+...... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~------~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVY------KGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK--HENIVRLHDVIHTENK 72 (284)
T ss_pred CceEeeeeccCCceEEE------EEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc--CCCEeeeeeeEeeCCc
Confidence 58999999999988765 4677788999999998865432 3456778999999875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+++||||+.++++..+.... ..+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++.....
T Consensus 73 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 73 LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99999999987666554432 4689999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......++..|+|||++.+.. .++.++|+||||+++|+|++|+.||.+.+..
T Consensus 153 ~~--------------~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 153 PV--------------NTFSNEVVTLWYRAPDVLLGSR-----------TYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred Cc--------------cccccccccccccChHHhcCCC-----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 11 0112234688999999886532 2678999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCC-----------cc-----------cccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 374 EIYRAVVKNRKLPPQ-----------YA-----------SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~-----------~~-----------~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+.+..+......+.. +. ....+.++.++.+++.+||+.||.+||++.++++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 655554432111100 00 00112457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=323.07 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=207.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
.|+...+||+|+||.||. +.+..++..||+|.+........+.+.+|+.+++.+. ||||+++++.|..+..+
T Consensus 22 ~~~~~~~ig~g~~g~v~~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 22 LLENYIKIGEGSTGIVCI------AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ--HQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hHHhhhhcCCCCceeEEE------EEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC--CCchhhhhhheeeCCeE
Confidence 455667899999887754 5567788999999987765555677888999988875 99999999999999999
Q ss_pred EEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccc
Q 000343 217 GLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 296 (1630)
|++|||++++++..+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 999999999888877654 468999999999999999999999999999999999999999999999999986543211
Q ss_pred cCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHH
Q 000343 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376 (1630)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~ 376 (1630)
.......|+..|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+
T Consensus 172 -------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 172 -------------PKRKSLVGTPYWMAPEVISRTP------------YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred -------------ccccceecCccccCHHHHccCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112346789999999987644 788999999999999999999999887766665
Q ss_pred HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 377 RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 377 ~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
..+....... ......++.++.++|.+||+.+|++||++.++++|-+..
T Consensus 227 ~~~~~~~~~~----~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 227 KRLRDSPPPK----LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHHhccCCCC----ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 5543322111 112235778999999999999999999999999975533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=318.38 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=187.2
Q ss_pred EeCcCCceeEEEeeEEEc------------------cccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcc
Q 000343 143 KLGEGRRAGVEVWGAWIG------------------GGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~------------------a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV 204 (1630)
+||+|+||.||.-..... ..+......||+|.+..........+.+|+.+++.++ ||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~--h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC--CCCee
Confidence 689999999975211110 1112223469999887644333445667788877765 99999
Q ss_pred eeEEEEEeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-----
Q 000343 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG----- 278 (1630)
Q Consensus 205 ~l~~~f~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g----- 278 (1630)
++++++......+|||||++++++..++.. .+.+++..+..++.||++||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999988877754 56799999999999999999999999999999999999997543
Q ss_pred --cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhH
Q 000343 279 --RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 279 --~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvI 356 (1630)
.+|++|||++...... ....++..|+|||.+.+.. .++.++||||||++
T Consensus 160 ~~~~kl~d~g~~~~~~~~------------------~~~~~~~~~~aPe~~~~~~-----------~~~~~~Dv~slG~~ 210 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR------------------EERVERIPWIAPECVPGGN-----------SLSTAADKWSFGTT 210 (274)
T ss_pred cceeeecCCccccccccc------------------cccccCCcccCchhhcCCC-----------CCCcHHHHHHHHHH
Confidence 4899999987543211 1234678899999886532 27899999999999
Q ss_pred HHHHh-hCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 357 LVEMC-TGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 357 Lyeml-tG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+|||+ +|..||......+........... + ...++++.++|.+||+.+|++|||+.+++++|
T Consensus 211 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~-------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 211 LLEICFDGEVPLKERTPSEKERFYEKKHRL-P-------EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhCCCCCccccChHHHHHHHHhccCC-C-------CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99995 699999876655443322221111 1 12457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=319.46 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=203.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||.|+||.||. |.+..+++.+|+|.++..... ....+.+|+.+++.++ ||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~ 76 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYR------ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--HPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhcCCCCeEEEE------EEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC--CCCEEEEEEEEEec
Confidence 5799999999999887754 667778899999999865322 2335567999999876 99999999998877
Q ss_pred --CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 --SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 --~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..+|+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 77 NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred CCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 889999999998665555544456999999999999999999999999999999999999999999999999999866
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... .......+++.|+|||.+.+.. .++.++|+||||+++|+|++|.+||...+
T Consensus 157 ~~~~--------------~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 157 GSPL--------------KPYTQLVVTLWYRAPELLLGAK-----------EYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred cCCc--------------cccccccccccccCchhhcCCc-----------cccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 0112345688999999886533 15789999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCC------------------------CcccccCCC-CCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPP------------------------QYASIVGVG-IPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~------------------------~~~~~~~~~-l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
..+.+.++......+. ......+.. +++.+.+||.+||+.+|++|||+.|++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 6665555433211100 000111112 57889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=338.33 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=210.1
Q ss_pred EEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC----ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC-
Q 000343 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM----EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS- 214 (1630)
Q Consensus 140 ~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~- 214 (1630)
.-..||+|+ +.+||+|.|..+|-.||--.++..+.. ..+++..|+++|+.|+ |||||+||+++.+..
T Consensus 44 ~~evLGrGa------fKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~--H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 44 FDEVLGRGA------FKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK--HPNIIRFYDSWVDTDN 115 (632)
T ss_pred hhhhccccc------ceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC--CCceeeeeeheecCCC
Confidence 346899999 566788999999999998766654322 2377889999999976 999999999998754
Q ss_pred -EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccceEECCC-CcEEEeecceeee
Q 000343 215 -CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDAS-GRAVVSDYGLAAI 290 (1630)
Q Consensus 215 -~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~g--IIHRDLKP~NILld~~-g~vKL~DFGla~~ 290 (1630)
++.+|+|++.+|.|..|+++.++++.+.++.|++||++||.|||++. |||||||.+||||+.+ |.|||+|+|||..
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 48999999999999999999899999999999999999999999985 9999999999999855 8999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC-
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG- 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~- 369 (1630)
+..+ .....+|||.|||||+... . |+..+||||||++|.||+|+.+||..
T Consensus 196 ~r~s----------------~aksvIGTPEFMAPEmYEE-~------------YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 196 LRKS----------------HAKSVIGTPEFMAPEMYEE-N------------YNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred hhcc----------------ccceeccCccccChHHHhh-h------------cchhhhhhhhhHHHHHHHhccCChhhh
Confidence 6532 1234789999999999873 2 89999999999999999999999975
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
.++.++|.++..|..+ ..+.. --++++++||.+||.. .++|||+.|+|+|-+......
T Consensus 247 ~n~AQIYKKV~SGiKP-~sl~k----V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 247 TNPAQIYKKVTSGIKP-AALSK----VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred CCHHHHHHHHHcCCCH-HHhhc----cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 4567788888776543 22222 2368999999999999 999999999999866555433
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=316.53 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=201.7
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC--
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD-- 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~-- 213 (1630)
-|++++.||+|+||.||+ ..+.+..+.++..||+|.+..... .....+.+|+++++.+. ||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~--~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVEL--CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY--HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhceecCCCCceeEEE--EEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC--CCCeeeeeeEEecCCC
Confidence 578999999999999965 344444567889999999875432 23457888999999975 99999999998875
Q ss_pred CEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++++|||++++.|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 5689999999998888776543 468999999999999999999999999999999999999999999999999998654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS- 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~- 371 (1630)
.... .........++..|+|||.+.+.. ++.++||||||+++|+|+++..|+....
T Consensus 161 ~~~~-----------~~~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 161 TDKE-----------YYTVKDDLDSPVFWYAPECLIQSK------------FYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred cCcc-----------ceeecCCCCCCccccCHHHhccCC------------CCccccchhhhhhhhhhhcCCCCCccccc
Confidence 3210 011122345677899999886543 7889999999999999999877653211
Q ss_pred --------------HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 372 --------------AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 372 --------------~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.......+..+.. .+ .+..++.++.+|+.+||+.||++|||+.++++.+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKR-LP-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCcc-CC-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111111111111 11 1235789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=318.91 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=205.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEcc-ccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGG-GQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a-~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.++||+|+||.||... ..+ ....++..||+|.+...... ....+.+|+.+++.+. ||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~--h~~iv~~~~~~~~~ 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--HPNIVKLLGVCAVG 80 (288)
T ss_pred HhceecccccccccccEEEEE--EcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC--CCchheEEEEEcCC
Confidence 589999999999999986522 111 12346789999988754321 2456778999999875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccc
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE----------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~----------------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~N 271 (1630)
..++++|||++++.|..++... ..+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 9999999999988877766432 237888999999999999999999999999999999
Q ss_pred eEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 272 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
||++.++.+||+|||++..+..... .........+..|+|||.+.+.. ++.++|||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~ 216 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY------------YKASENDAIPIRWMPPESIFYNR------------YTTESDVW 216 (288)
T ss_pred eEecCCCceEECccccceecccCcc------------ccccCCCccChhhcCHHHHhcCC------------CCchhHHH
Confidence 9999999999999999876532210 00111223466799999886644 78999999
Q ss_pred hhhhHHHHHhh-CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 352 SFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 352 SlGvILyemlt-G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
||||++|+|++ |..||.+.+..+....+..+...+ .+..++.++.+||.+||+.+|++|||+.|+++.|+
T Consensus 217 slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 217 AYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 99999999998 889998888877777665544321 12357889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=311.87 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=198.6
Q ss_pred EeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEe
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD 221 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmE 221 (1630)
.||+|+||.||. .++. ....+..||+|.+...... ..+.+.+|+.++++++ ||||+++++++. ...+++|||
T Consensus 2 ~ig~G~~g~v~~--~~~~--~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~--h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKK--GVYK--MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD--NPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEE--EEEe--cCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC--CCCeEEEEEEEc-CCCeEEEEE
Confidence 489999998864 2222 2244567999988765322 2456788999999975 999999999876 457899999
Q ss_pred cCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 222 RCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 222 y~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
|+++++|..++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 150 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---- 150 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc----
Confidence 999888877665 345799999999999999999999999999999999999999999999999999976543210
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAV 379 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~i 379 (1630)
.........++..|+|||++.... ++.++||||||+++|+|++ |..||.+....+....+
T Consensus 151 -------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05115 151 -------YYKARSAGKWPLKWYAPECINFRK------------FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211 (257)
T ss_pred -------ceeccCCCCCCcccCCHHHHccCC------------CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 001112223467899999987544 7889999999999999996 99999988887777666
Q ss_pred HhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 380 VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 380 ~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
..+.... .+...++++.++|.+||..+|++||++.++.+.|...
T Consensus 212 ~~~~~~~------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 EQGKRLD------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HCCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 5544221 2235789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=308.91 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=204.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.+|++.+.||+|+||.||+ +.+. .+..+|+|.+... ......+.+|+++++.+. ||||+++++++.....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~------~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWL------GYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLS--HPKLVQLYGVCTERSP 73 (256)
T ss_pred hHeEEEeeecCcccceEEE------EEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCC--CCCeeeEEEEEccCCc
Confidence 4799999999999988864 3332 3568999988753 334567888999999975 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
++++|||+.++.|..++.. .+.+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999998888877654 456899999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ 373 (1630)
. ........++..|+|||.+.+.. ++.++||||||+++|||++ |..||......
T Consensus 154 ~-------------~~~~~~~~~~~~~~aPe~~~~~~------------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 154 Q-------------YTSSTGTKFPVKWSSPEVFSFSK------------YSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred c-------------ccccCCCccchhhcCHhHhccCC------------cChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 1 00112233467899999887644 7889999999999999998 99999988877
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+....+..+..... +...+.++.+|+.+||+.+|++|||+.+++++|
T Consensus 209 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 209 EVVETINAGFRLYK------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHhCCCCCCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 77777655432211 123578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=309.92 Aligned_cols=252 Identities=23% Similarity=0.411 Sum_probs=206.0
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.+.||+|+||.||. +... .+..||||.+... ......+.+|+.+++.++ ||||+++++++....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~------~~~~-~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 74 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWM------GTWN-GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLR--HDKLVQLYAVCSEEE 74 (261)
T ss_pred hhheeeeeeeccCcceEEEE------EEEc-CCceEEEEEecCC-ccCHHHHHHHHHHHhhCC--CCCEeeeeeeeecCC
Confidence 36899999999999988864 3332 3477999988754 344567889999999976 999999999999989
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+++|||+.++.+..++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..+.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999988887776543 368999999999999999999999999999999999999999999999999997764
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+
T Consensus 155 ~~~-------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 155 DDE-------------YTAREGAKFPIKWTAPEAANYGR------------FTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred chh-------------hhhhhccCCCccccCHHHhccCC------------cCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 321 00111223456899999887644 7889999999999999998 999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+..+......+. +...+.++.+++.+||+.+|++||++.++++-|.
T Consensus 210 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 210 NREVLEQVERGYRMPR------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 7777777655432221 2346889999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=325.06 Aligned_cols=246 Identities=21% Similarity=0.285 Sum_probs=207.7
Q ss_pred EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
-+.||+|.||.| |.|.++.+|+.||||+|.+... ...+++++|+.||+.+. ||.||.|...|++.+.+|.
T Consensus 569 devLGSGQFG~V------Ygg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~--HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 569 DEVLGSGQFGTV------YGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH--HPGIVNLECMFETPERVFV 640 (888)
T ss_pred HhhccCCcceee------ecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC--CCCeeEEEEeecCCceEEE
Confidence 478999998876 4588999999999999987643 33678999999999975 9999999999999999999
Q ss_pred EEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC---cEEEeecceeeeecCc
Q 000343 219 VMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG---RAVVSDYGLAAILKKP 294 (1630)
Q Consensus 219 VmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g---~vKL~DFGla~~~~~~ 294 (1630)
|||-+.|+.|..++. ..++|++...++++.||+.||+|||.++|+|+||||+|||+.+.. .+||||||+|+.+++.
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999999999987765 457899999999999999999999999999999999999997543 7999999999998865
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC-CHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-SAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-~~~ 373 (1630)
.. ....+|||.|+|||++.+.. |+..-|+||.|+|+|--++|.+||... +..
T Consensus 721 sF---------------RrsVVGTPAYLaPEVLrnkG------------yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 721 SF---------------RRSVVGTPAYLAPEVLRNKG------------YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hh---------------hhhhcCCccccCHHHHhhcc------------ccccccceeeeEEEEEEecccccCCCccchh
Confidence 42 24578999999999998754 899999999999999999999999643 333
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.+++ ...+.| ...+.++++++.+||..+|+..-.+|.|+.+.|.|..
T Consensus 774 dQIQN---AaFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 774 DQIQN---AAFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHhhc---cccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 33333 222222 2234578999999999999999999999999988744
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=318.67 Aligned_cols=263 Identities=19% Similarity=0.259 Sum_probs=200.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.++||+|+||.||+ +.+..+++.||||.+...... ....+.+|+++++.++ ||||+++++++..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 82 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFK------ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRT 82 (310)
T ss_pred hhheEEEEEeecCCCEEEEE------EEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC--CCCccceEEEEec
Confidence 35899999999999887754 667788999999998754322 2335567999999875 9999999999875
Q ss_pred CC--------EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 213 DS--------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 213 ~~--------~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
.. ..++||||+.+++...+......+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 43 4699999999877666665555799999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||++..+...... .........++..|+|||++.+.. .++.++||||||+++|+|++|.
T Consensus 163 fg~~~~~~~~~~~----------~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 163 FGLARAFSLSKNS----------KPNRYTNRVVTLWYRPPELLLGER-----------DYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred CCCcccccCCccc----------CCCCccCcccCccccCcHHhcCCc-----------ccCchhhhHHHHHHHHHHHhCC
Confidence 9999866432100 011123456788999999886533 1678999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCC--CCCCcc-----------------------cccCCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 365 IPWAGLSAEEIYRAVVKNRK--LPPQYA-----------------------SIVGVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~--~~~~~~-----------------------~~~~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
.||...+.......+..... .+..+. .......+..+.+||.+||+.||++|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~ 301 (310)
T cd07865 222 PIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301 (310)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence 99987765544333222110 000000 00011134678899999999999999999
Q ss_pred hhHHHHh
Q 000343 420 SAMLATF 426 (1630)
Q Consensus 420 ~evL~~L 426 (1630)
+++++|-
T Consensus 302 ~e~l~h~ 308 (310)
T cd07865 302 DTALNHD 308 (310)
T ss_pred HHHhcCC
Confidence 9999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=314.92 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=204.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
.++|++.+.||+|+||.||. +.+..+++.+|+|.+.... .....+.+|+.+++.+. +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~------~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~-~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYK------VTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLP-NHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCeEEEEEeecCCCeEEEE------EEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhc-CCCCeEEEEEEEEecc
Confidence 57899999999999887754 5677889999999886532 23466778999988874 599999999998753
Q ss_pred ----CEEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 214 ----SCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 214 ----~~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
..+|+||||+++++|..++. ....+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 35899999999988877654 3456899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|++....... .......|+..|+|||.+..... ....++.++|||||||++|+|++|++
T Consensus 173 g~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 173 GVSAQLTSTR--------------LRRNTSVGTPFWMAPEVIACEQQ-------YDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred ccchhccccc--------------ccccCccCCccccChhhhcCCCC-------cccccCCccchHHHHHHHHHHhhCCC
Confidence 9987654211 01122457889999999864321 01236899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
||......+.+..+....... . ..+...+..+.+||.+||+.+|++||++.++++|-
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 232 PLFDMHPVKTLFKIPRNPPPT--L--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred CCCCCcHHHHHHHHhcCCCCC--C--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 998877655555544332211 1 11234667899999999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=325.76 Aligned_cols=262 Identities=23% Similarity=0.252 Sum_probs=200.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+.++|++.+.||+|+||.||. +.+..+++.||||++..... .....+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 74 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCS------ATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK--HENIIGILDIIRP 74 (336)
T ss_pred cccceEEEEEEEecCCeEEEE------EEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC--CCCcCchhheeec
Confidence 457999999999999887754 66778899999999874322 23455677999999876 9999999998765
Q ss_pred C-----CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 213 D-----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 213 ~-----~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
. ..+|++|||+.+++...+. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 75 PSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ccccccceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 4 3589999999886655443 34699999999999999999999999999999999999999999999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF 367 (1630)
+........ .........||+.|+|||.+.+.. .++.++|||||||++|+|++|+.||
T Consensus 153 ~~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DvwslGvil~el~~G~~~f 210 (336)
T cd07849 153 ARIADPEHD-----------HTGFLTEYVATRWYRAPEIMLNSK-----------GYTKAIDIWSVGCILAEMLSNRPLF 210 (336)
T ss_pred eeecccccc-----------ccCCcCCcCcCCCccChHHhhCCC-----------CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 976543210 001123356799999999875432 2788999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCC------------------------CCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHH
Q 000343 368 AGLSAEEIYRAVVKNRKLP------------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~------------------------~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL 423 (1630)
.+.+....+..+......+ ........+..++++.+||.+||+.+|++|||+.+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 211 PGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 8765543333222111000 0000001134578899999999999999999999999
Q ss_pred HHhh
Q 000343 424 ATFL 427 (1630)
Q Consensus 424 ~~L~ 427 (1630)
+|-+
T Consensus 291 ~hp~ 294 (336)
T cd07849 291 AHPY 294 (336)
T ss_pred cCcc
Confidence 9843
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=324.31 Aligned_cols=281 Identities=20% Similarity=0.228 Sum_probs=209.8
Q ss_pred ccCCeEE-EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--------------hhHHHHHHHHHHHhcc
Q 000343 134 VHHDVKL-VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--------------PDWLSGQLDNLRRASM 198 (1630)
Q Consensus 134 ~~~~y~~-~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--------------~~~~~~Ei~iL~~l~l 198 (1630)
+.++|.. .+.||.|+||.||+ +.+..+++.||||++....... ...+.+|+++++.++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 78 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEK------AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK- 78 (335)
T ss_pred cccchhhhhhcccCCCceeEEE------EEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-
Confidence 3467865 57799999887754 6677889999999987643222 124678999999875
Q ss_pred CCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC
Q 000343 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278 (1630)
Q Consensus 199 ~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g 278 (1630)
||||+++++++......+++|||+.+++... +.....+++..+..++.|++.||+|||+.||+||||||+|||++.++
T Consensus 79 -h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~-l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 79 -HENIMGLVDVYVEGDFINLVMDIMASDLKKV-VDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG 156 (335)
T ss_pred -CcceeeeeEEEecCCcEEEEEeccccCHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC
Confidence 9999999999999999999999998765544 44556799999999999999999999999999999999999999999
Q ss_pred cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHH
Q 000343 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358 (1630)
Q Consensus 279 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILy 358 (1630)
.+||+|||++............................+++.|+|||.+.+.. .++.++|+|||||++|
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-----------KYHFAVDMWSVGCIFA 225 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC-----------CCCcHHHHHHHHHHHH
Confidence 99999999998765322111100000000111223345688999999986532 2688999999999999
Q ss_pred HHhhCCCCCCCCCHHHHHHHHHhcCCCCCCc---------------------ccccCCCCCHHHHHHHHHhhccCcCCCC
Q 000343 359 EMCTGSIPWAGLSAEEIYRAVVKNRKLPPQY---------------------ASIVGVGIPRELWKMIGECLQFKASKRP 417 (1630)
Q Consensus 359 emltG~~PF~~~~~~ei~~~i~~~~~~~~~~---------------------~~~~~~~l~~el~~LI~~cL~~dP~~RP 417 (1630)
+|++|.+||...+..+.+..+......+... ........+.++.+||.+||+.+|++||
T Consensus 226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 305 (335)
T PTZ00024 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305 (335)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence 9999999999887766655554322111100 0001124578899999999999999999
Q ss_pred ChhhHHHHhhhcccCCC
Q 000343 418 TFSAMLATFLRHLQELP 434 (1630)
Q Consensus 418 Sa~evL~~L~~~l~~lp 434 (1630)
|+++++.|.+-....++
T Consensus 306 s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 306 SAKEALKHEYFKSDPLP 322 (335)
T ss_pred CHHHHhcCcccCCCCCC
Confidence 99999998665443333
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=320.42 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=209.7
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
.....|+..+.||+|+||.||+ +.+..++..||+|.+....... ...+.+|+++++.++ |||+++++++
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~------~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~ 93 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYF------ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK--HPNSIEYKGC 93 (317)
T ss_pred CchhhhhhhheeccCCCeEEEE------EEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC--CCCEEEEEEE
Confidence 3445689999999999887754 5567788999999987643322 345777888888875 9999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
+..+...++||||+.|+++..+.....++++..+..++.|++.||.|||+++|+||||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 94 YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 99999999999999988777666556679999999999999999999999999999999999999999999999999886
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.... .....|++.|+|||++.... ...++.++|+|||||++|+|++|..||..
T Consensus 174 ~~~~------------------~~~~~~~~~y~aPE~~~~~~---------~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 174 IASP------------------ANSFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ccCC------------------cccccCCccccChhhhhcCC---------CCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4321 12245788999999975321 11278899999999999999999999988
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.........+......... ...+++.+.+|+.+||+.+|.+||++.++++|++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 227 MNAMSALYHIAQNESPTLQ-----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ccHHHHHHHHHhccCCCCC-----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 7766666666554332211 2246788999999999999999999999999877644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=315.35 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=196.6
Q ss_pred EeCcCCceeEEEeeEEEccccccCCc--EEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEE
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRH--SVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLV 219 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~--~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LV 219 (1630)
.||+|+||.||. +.+..++. .+|+|.+.... ......+.+|++++.++. .||||+++++++.....++++
T Consensus 2 ~lg~g~~g~v~~------~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~~~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLK------ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEHRGYLYLA 74 (270)
T ss_pred cCCCCCCceEEE------EEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-cCCCeeeEEEEEecCCCceEE
Confidence 589999888764 44555554 56888876432 223456778999999885 599999999999999999999
Q ss_pred EecCCCChHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEe
Q 000343 220 MDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 220 mEy~~gglL~~l~~~~----------------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
|||++++.|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 9999988777776532 247899999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||++...... ........+..|+|||++.... ++.++||||||+++|||++
T Consensus 155 dfgl~~~~~~~---------------~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 155 DFGLSRGQEVY---------------VKKTMGRLPVRWMAIESLNYSV------------YTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred CCCCccccchh---------------hhccCCCCccccCChHHHccCC------------CCchhhHHHHHHHHHHHHcC
Confidence 99997532110 0011122356799999886543 7899999999999999997
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
|..||.+.+..+.+..+....... .+..++.++.+|+.+||+.||.+|||+.+++..|.+++
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCccccCHHHHHHHHhCCCCCC------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 999998887777666664432211 12346789999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=313.28 Aligned_cols=247 Identities=20% Similarity=0.239 Sum_probs=203.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+|++.+.||.|+||.||. +.+..++..||+|.+..... .....+.+|++++++++ ||||+++++.+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCI------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN--HPFLVNLWYSFQDE 72 (258)
T ss_pred CceEEEEeccCCCceEEE------EEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC--CCChHHHHHhhcCC
Confidence 589999999999887754 56778899999999986532 23567788999998875 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+|+||||+.++.|..++.....+++..+..++.||++||.|||+++|+|+||||+|||+++++.++|+|||++.....
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999999999988887667899999999999999999999999999999999999999999999999999876543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA- 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~- 372 (1630)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||...+.
T Consensus 153 ~~---------------~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 153 DT---------------LTTSTSGTPGYMAPEVLCRQG------------YSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred Cc---------------cccccCCChhhcCHHHHcccC------------CCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 21 112345788999999987644 78999999999999999999999987663
Q ss_pred --HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh--hhHHHH
Q 000343 373 --EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF--SAMLAT 425 (1630)
Q Consensus 373 --~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa--~evL~~ 425 (1630)
.......... .. ..+..++.++.++|.+||+.||.+||++ .++++|
T Consensus 206 ~~~~~~~~~~~~---~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 206 IRDQIRAKQETA---DV----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHHHHHHHhccc---cc----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 3333222211 11 1233578999999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.77 Aligned_cols=258 Identities=23% Similarity=0.386 Sum_probs=210.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.++.+.+..||.|+.|.|+ +++.+.+|...|||.+.... ..+.+++...+.++.+.. .+|+||+.+++|..+
T Consensus 91 indl~~l~dlGsGtcG~V~------k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVW------KMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVQCFGYFITN 163 (391)
T ss_pred hHHhhhHHhhcCCCccceE------EEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-CCCeeeeeeeEEeeC
Confidence 3577888999999977663 46677889999999998763 334556666677766653 589999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+++.||.+..-.-..+.+-.+++++.-+-.+...+++||.||-.+ +|||||+||+|||+|..|.+||||||++-++-
T Consensus 164 ~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 164 TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 99999999987665555666667899999999999999999999975 89999999999999999999999999997765
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC-C
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-S 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-~ 371 (1630)
.+. ..+...|-+.|||||-+.-. +...|+.++||||||++++||.||++||.+. .
T Consensus 244 dSk---------------AhtrsAGC~~YMaPERidp~---------~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 244 DSK---------------AHTRSAGCAAYMAPERIDPP---------DKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred ccc---------------ccccccCCccccCccccCCC---------CCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 432 23345678999999988643 2345999999999999999999999999874 5
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.+.+.+++...+ |.+.. ..++++.+++|+..||..|+.+||.+.++|+|-+
T Consensus 300 dFe~ltkvln~eP--P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 300 DFEVLTKVLNEEP--PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred cHHHHHHHHhcCC--CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 6778888877443 33322 2348999999999999999999999999999854
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=312.45 Aligned_cols=259 Identities=20% Similarity=0.328 Sum_probs=205.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+|.+.+.||+|+||.||. ..+.. .......||||...... ....+.+.+|+.+++.+. ||||+++++++.+ .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~--~~~~~-~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~-~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQ--GVYMS-PENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD--HPHIVKLIGVITE-N 79 (270)
T ss_pred hhceeeeeeCCccceeEEE--EEEec-CCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCchhceeEEEcC-C
Confidence 4799999999999998864 22221 11234579999887543 223457788999999875 9999999999875 4
Q ss_pred EEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+++|||++++.+..++.+ ...+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999998888777654 34589999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
... .......++..|+|||.+.... ++.++||||||+++|+|++ |..||...+.
T Consensus 160 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 160 ESY-------------YKASKGKLPIKWMAPESINFRR------------FTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ccc-------------eecCCCCccccccChhhhccCC------------CCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 210 0111223456899999876543 7899999999999999996 9999998887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.+....+..+...+ .+..++.++.++|.+||..+|++|||+.++++.|.....
T Consensus 215 ~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 215 NDVIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 77766665544322 123578999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=316.46 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=201.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|++...... ....+.+|+++++.++ ||||+++++++...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYK------ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSE 73 (294)
T ss_pred CceEEEEEecCCCCEEEEE------EEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc--CCCEeeEEEEEecC
Confidence 5799999999999887754 667788999999998754322 2356778999999975 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g~vKL~DFGla~~~ 291 (1630)
..+|+||||++++++..+..... .+++..+..++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++...
T Consensus 74 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 74 KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999999998876666554332 3688899999999999999999999999999999999985 457999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... .......+++.|+|||.+.+.. .++.++||||||+++|+|++|.+||...+
T Consensus 154 ~~~~--------------~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 154 GIPV--------------RTFTHEVVTLWYRAPEILLGSR-----------HYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred CCCc--------------cccccCceeecccCHHHHhCCC-----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3211 0112345688999999876532 26889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCC----------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 372 AEEIYRAVVKNRKLPP----------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~----------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
..+.+..+......+. .......+.+++++.+++.+||+.+|++||++.++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6665555433211110 00001123578899999999999999999999999987
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=309.70 Aligned_cols=251 Identities=22% Similarity=0.387 Sum_probs=200.4
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|.+.++||+|+||.||+ +.+.. +..+|+|.+.... ...+.+.+|+++++.+. ||||+++++++. ...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~------~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWM------GTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLR--HDKLVPLYAVVS-EEP 74 (260)
T ss_pred HHeeeeeeecCcCCCeEEE------EEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCC--CCCeeeEEEEEc-CCC
Confidence 5799999999999998864 33323 3469999876543 34567788999999975 999999999875 456
Q ss_pred EEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++|||+.++.+..++... ..+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 89999999887776666432 3488999999999999999999999999999999999999999999999999976543
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+...
T Consensus 155 ~~~-------------~~~~~~~~~~~y~~Pe~~~~~~------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 155 NEY-------------TARQGAKFPIKWTAPEAALYGR------------FTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred Ccc-------------cccCCCccchhhCCHHHhccCC------------cChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 210 0111233567899999886544 7889999999999999999 9999998877
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.+....+...... + .+...+..+.+|+.+||+.||++||++.++++.|..
T Consensus 210 ~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 210 REVLEQVERGYRM-P-----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHcCCCC-C-----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 7776666543221 1 123578899999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=312.00 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=195.4
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
++||+|+||.||+ +..+. ......+|+|.+...... ....+.+|+.+++.++ ||||+++++.+.....+|+||
T Consensus 1 ~~lg~G~fg~v~~-~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLL-GEAHR---GMSKARVVVKELRASATPDEQLLFLQEVQPYRELN--HPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEE-EEEec---CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC--CCCcceEEEEECCCCceEEEE
Confidence 4689999999975 33332 245568999987654322 2345678888888864 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 221 DRCYGSVQLAMQRNEG-----RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~-----~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
||+++++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9999988887765422 24678889999999999999999999999999999999999999999999986532211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~e 374 (1630)
.........++..|+|||++...... .....++.++|||||||++|||++ |..||......+
T Consensus 155 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 155 ------------YYITKDCHAVPLRWLAPELVEIRGQD-----LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred ------------heeccCCCCCcccccCHHHHhhcccc-----ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 00011233457789999998643210 012237889999999999999999 889998877766
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.+..+......... .......+++.+.+++..|| .||++|||++++++.|
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 218 VLKQVVREQDIKLP-KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHhhccCccCC-CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 66655544322111 11233467888999999999 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=316.18 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=206.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..|+..+.||+|+||.||. |.+..++..||||.+.... ......+.+|+.+++.+. ||||+++++++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFK------GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEE------EEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC--CCCEeeEEEEEEECC
Confidence 4788999999999887754 6677788999999887543 223456778899888875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|+||||++++.+..++.. .++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999999999888887764 56999999999999999999999999999999999999999999999999999765431
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+...
T Consensus 155 ~--------------~~~~~~~~~~~y~apE~~~~~~------------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 155 Q--------------IKRNTFVGTPFWMAPEVIQQSA------------YDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred c--------------cccccccCcccccCHhHhccCC------------CccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 1 0112345788999999986544 7889999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+.... ++ .....++.++.+|+.+||+.+|++||++.+++.|.+
T Consensus 209 ~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 209 VLFLIPKNN--PP----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HhhhhhcCC--CC----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 554443222 11 122346788999999999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=323.99 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=203.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
..+|++.+.||+|+||.||+ +.++.+++.||+|++..... .....+.+|+.+|+.++ ||||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~------~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 75 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCS------AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK--HDNIIAIRDILRP 75 (334)
T ss_pred hhceeeeeeeecCCCeEEEE------EEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC--CCCccCHHHhccc
Confidence 46899999999999887754 66788899999999876432 23456778999999976 9999999998863
Q ss_pred ----CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 ----DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ----~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
...+|+||||+.++ +..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 76 PGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred cCCCCceEEEEEehhhhh-HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 35689999999765 4555555567999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
......... .........|+..|+|||.+.+.. .++.++||||||+++|+|++|+.||.
T Consensus 155 ~~~~~~~~~----------~~~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 155 RGLSSSPTE----------HKYFMTEYVATRWYRAPELLLSLP-----------EYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred eeecccCcC----------CCcccccccccccccChHHhcCCc-----------ccccccchHHHHHHHHHHHcCCCccC
Confidence 765432100 011123356889999999986532 27899999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCC------------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHH
Q 000343 369 GLSAEEIYRAVVKNRKLPP------------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~ 424 (1630)
+.+....+..+......++ ..........++++.++|.+||+.+|++||++++++.
T Consensus 214 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred CCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 7665443333222111100 0000112346889999999999999999999999999
Q ss_pred Hhhh
Q 000343 425 TFLR 428 (1630)
Q Consensus 425 ~L~~ 428 (1630)
|.+-
T Consensus 294 ~~~~ 297 (334)
T cd07855 294 HPFL 297 (334)
T ss_pred Chhh
Confidence 8553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=328.89 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=216.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc---CcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.+++++..||-|+||.|.|.. +. .....+|+|.+++. +...++.+..|.+||..+. .|+||+||-.|.+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~--~~----~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~--s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVK--VN----SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR--SDFIVRLYRTFRD 491 (732)
T ss_pred hhhhhhhhcccCccceEEEEE--ec----ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC--chHHHHHHHHhcc
Confidence 478899999999999998842 11 11124788777665 3444677788999999986 8999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++|++||-|-||.+-.+++.++.|+...+++|+..+++|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999999999887
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.+. .+-+.+|||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.++
T Consensus 572 ~g~---------------KTwTFcGTpEYVAPEIILnKG------------HD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 572 SGR---------------KTWTFCGTPEYVAPEIILNKG------------HDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred cCC---------------ceeeecCCcccccchhhhccC------------cchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 542 234589999999999998754 78899999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATF 426 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L 426 (1630)
...+..|+++-.... ++..++..+.+||+++.+.+|.+|.. +.++-+|-
T Consensus 625 mktYn~ILkGid~i~-----~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 625 MKTYNLILKGIDKIE-----FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHHHhhhhhhh-----cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 999999998753322 23357899999999999999999986 67777773
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=313.62 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=187.4
Q ss_pred EEeCcCCceeEEEeeEEEccc------cccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGG------QGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~------~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+.||+|+||.||......+.. .......||+|.+..........+..|+.++..++ ||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~--hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS--HKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC--CCCEeeEEEEEecCCC
Confidence 368999999887521100000 01233468999877654444556777888888865 9999999999999889
Q ss_pred EEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCc-------EEEeecce
Q 000343 216 LGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR-------AVVSDYGL 287 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~-------vKL~DFGl 287 (1630)
.+++|||++++.+..++.. ...+++..+..++.||++||+|||+++|+||||||+|||++.++. +|++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999888777654 456999999999999999999999999999999999999986654 89999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHh-hCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC-TGSIP 366 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyeml-tG~~P 366 (1630)
+..... .....++..|+|||.+.... .++.++|||||||++|+|+ +|..|
T Consensus 159 ~~~~~~------------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 159 PITVLS------------------RQECVERIPWIAPECVEDSK-----------NLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred CccccC------------------cccccccccccChhhhcCCC-----------CCCchhHHHHHHHHHHHHHhCCCCC
Confidence 865421 12245688899999876322 2788999999999999998 59999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
|......+... ........ ....++++.+||.+||+.||++||++.++++++
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 210 LKDKTLAEKER-FYEGQCML-------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCcchhHHHH-HHhcCccC-------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 98765443322 22221110 112457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=315.37 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
..|...+.||+|+||.||. +.+..+++.+|+|++........+.+.+|+.+++.+. ||||+++++++.....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~--h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCI------ATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HPNIVEMYSSYLVGDE 90 (285)
T ss_pred HhhhcceEeccCCCeEEEE------EEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC--CCChheEEEEEEcCCe
Confidence 3566778999999887754 5567788999999987655455566788999988875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
.+++|||+.++.+..++.. .++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999888887766 579999999999999999999999999999999999999999999999999886543211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+....
T Consensus 170 --------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 170 --------------PRRKSLVGTPYWMAPEVISRLP------------YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred --------------cccccccCCccccCHHHhcCCC------------CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 1112345789999999986543 78899999999999999999999988777666
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+..+..... +... ....++..+.+||.+||+.+|++||++.++++|-+
T Consensus 224 ~~~~~~~~~--~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 224 MKRIRDNLP--PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred HHHHHhcCC--CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 666554421 1111 12247789999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=308.46 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=199.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||. + ..+++.||+|.+... .....+.+|+.+++.++ ||||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~------~--~~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~-~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQ------G--EYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLH--HKNLVRLLGVILHN-G 72 (254)
T ss_pred HHceeeeeeccCCCCceEe------c--ccCCCceEEEeecCc--chHHHHHHHHHHHHhCC--CCCcCeEEEEEcCC-C
Confidence 5799999999999998864 2 346788999988653 23467788999998875 99999999998754 4
Q ss_pred EEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++|||+.++.+..++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 79999999988777766543 3589999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
.. .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+.
T Consensus 153 ~~-----------------~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 153 GV-----------------DNSKLPVKWTAPEALKHKK------------FSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred cC-----------------CCCCCCceecCHHHhccCC------------cCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 10 1122356799999886544 7889999999999999998 9999998887
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.+....+..+....+ ...++.++.+|+.+||+.+|++||++.++++.|..
T Consensus 204 ~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 204 KEVKECVEKGYRMEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHhCCCCCCC------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 777666654432211 23578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=309.76 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=205.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-----cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-----EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-----~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+|.+.+.||+|+||.||+ +.+..++..||+|.+.... ......+.+|+++++.++ ||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~--h~~i~~~~~~~ 73 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYL------CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR--HDRIVQYYGCL 73 (264)
T ss_pred CceeeeeeEccCCCeEEEE------EEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC--CCCcceEEEEE
Confidence 4899999999999887754 6677889999999876431 122346778999999976 99999999998
Q ss_pred EeC--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 211 RMD--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
.+. ..++++|||++++.+..++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 74 RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 764 468999999999888877776667999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+....... .........|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.
T Consensus 154 ~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 154 KRIQTICM-----------SGTGIKSVTGTPYWMSPEVISGEG------------YGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred cccccccc-----------cCccccccCCcccccCHhhhcCCC------------CCccccHHHHHHHHHHHHhCCCCCC
Confidence 76532110 001112345789999999987643 6789999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.....+.+..+...... + ..+..+++++.+++.+||+ +|.+||++.+++.|.+
T Consensus 211 ~~~~~~~~~~~~~~~~~-~----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 211 EYEAMAAIFKIATQPTK-P----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred ccCHHHHHHHHHcCCCC-C----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 87666555544322211 1 1334678999999999999 5799999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=315.64 Aligned_cols=246 Identities=20% Similarity=0.229 Sum_probs=191.7
Q ss_pred EeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhc-cCCCCcceeEEEEEeCCEEEE
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~~~~~L 218 (1630)
.||+|+||.||+ +.+..+++.+|+|.+...... ......+|..+++.+. ..||||+.+++++...+.+++
T Consensus 1 ~lg~G~~g~Vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF 74 (279)
T ss_pred CcccCCCeEEEE------EEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence 389999888764 556778999999988764322 1223344554444432 369999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+++++|..++...+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 75 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999999998888777789999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH--HHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE--EIY 376 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~--ei~ 376 (1630)
.....||+.|+|||.+.... .++.++|||||||++|+|++|..||...... ...
T Consensus 152 -------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 207 (279)
T cd05633 152 -------------PHASVGTHGYMAPEVLQKGT-----------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (279)
T ss_pred -------------ccCcCCCcCccCHHHhcCCC-----------CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH
Confidence 11235799999999875322 2788999999999999999999999754321 112
Q ss_pred HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 377 RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 377 ~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
...... . ....+..+++++.++|.+||+.||++|| |++++++|.+
T Consensus 208 ~~~~~~--~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 208 DRMTLT--V----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred HHHhhc--C----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 211111 1 1112345789999999999999999999 5999999844
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=318.12 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=206.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
++|++.+.||+|+||.||. +.+..++..||+|.+........+.+.+|+.+++.++ ||||+++++++.....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYT------AIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK--HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhceeeeEecCCCCeEEEE------EEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC--CCCeeehhheeeeCCc
Confidence 6899999999999887754 5566788999999987655555677888999988875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
.|+||||++++.+..++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999999888887764 358999999999999999999999999999999999999999999999999987554211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......|++.|+|||.+.... ++.++|+||||+++|+|++|..||...+..+.
T Consensus 170 --------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 170 --------------SKRSTMVGTPYWMAPEVVTRKA------------YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred --------------cccccccCChhhcCchhhccCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 0112345788999999986543 68899999999999999999999987665444
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
...+..... +.. ..+..++..+.+||.+||..+|++||++.+++.|-+
T Consensus 224 ~~~~~~~~~--~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 224 LYLIATNGT--PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred eeehhcCCC--CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 333222211 111 112346788999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=308.35 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=205.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-----ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-----EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-----~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+|+..+.||+|+||.||. |.+..+++.||+|.+...... ....+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~ 72 (258)
T cd06632 1 RWRKGELLGSGSFGSVYE------GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIVQYLGTER 72 (258)
T ss_pred CccccceeeecCCceEEE------EEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC--CCCchheeeeEe
Confidence 477889999999887754 566778899999998765421 2456778999988875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
....++++|||++++++..++.+...+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 73 EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999999888888877677999999999999999999999999999999999999999999999999998765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... ......|+..|+|||.+.... .++.++|+||||+++|+|++|..||....
T Consensus 153 ~~~~---------------~~~~~~~~~~y~~pe~~~~~~-----------~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 153 VEFS---------------FAKSFKGSPYWMAPEVIAQQG-----------GYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cccc---------------cccccCCCcceeCHHHhcCCC-----------CCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 4321 122345788999999875432 26889999999999999999999998766
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+....+......+. .+..+++++.+|+.+||+.+|++||++.+++.|-
T Consensus 207 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~ 256 (258)
T cd06632 207 GVAAVFKIGRSKELPP-----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256 (258)
T ss_pred HHHHHHHHHhcccCCC-----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCC
Confidence 5554444433222211 2345789999999999999999999999998873
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=307.44 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=204.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEe--
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-- 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-- 212 (1630)
+|++.+.||.|+||.||. +.+..++..||+|.+...... ..+.+.+|+++++.++ ||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (265)
T cd08217 1 DYEVLETIGKGSFGTVRK------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK--HPNIVRYYDRIIDRS 72 (265)
T ss_pred CceeeeeeccCCCeEEEE------eeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC--CCccceeeeeeecCC
Confidence 589999999999887754 667788999999998764322 2456778899998876 9999999998764
Q ss_pred CCEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccccccccceEECCCCcEEEe
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELH-----AAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLH-----s~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
...++++|||++++.+..++.. ..++++..+..++.||+.||+||| +.+|+|+||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 73 NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 4568999999998877766543 457999999999999999999999 8999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhC
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG 363 (1630)
|||++....... .......+++.|+|||++.... ++.++|+||||+++|+|++|
T Consensus 153 d~g~~~~~~~~~--------------~~~~~~~~~~~~~~pE~~~~~~------------~~~~~Dv~slG~il~~l~~g 206 (265)
T cd08217 153 DFGLAKILGHDS--------------SFAKTYVGTPYYMSPEQLNHMS------------YDEKSDIWSLGCLIYELCAL 206 (265)
T ss_pred cccccccccCCc--------------ccccccccCCCccChhhhcCCC------------CCchhHHHHHHHHHHHHHHC
Confidence 999998654321 0112345789999999987644 78899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 364 SIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..||...+.......+..+... ..+..++.++.+++.+||+.+|++||++.++++|-
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 207 SPPFTARNQLQLASKIKEGKFR------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred CCcccCcCHHHHHHHHhcCCCC------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 9999988766666665444321 12335789999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=307.73 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=203.8
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
+++.+.||.|+||.||. ..........+..||+|.+...... ....+.+|+..++.+ +||||+++++++.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~--~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYK--GTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL--DHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEE--EEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc--CCCchheEEEEEcCCCee
Confidence 35678999999998864 2222111123489999998765433 456788899999987 499999999999999999
Q ss_pred EEEEecCCCChHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 217 GLVMDRCYGSVQLAMQRNEGR--LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~~~--L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+++|||++++.+..++..... +++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999998888777654333 999999999999999999999999999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ 373 (1630)
.. . ......+++.|+|||.+.+.. ++.++|+||||+++|+|++ |.+||...+..
T Consensus 157 ~~------------~-~~~~~~~~~~y~~Pe~~~~~~------------~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~ 211 (258)
T smart00219 157 DY------------Y-KKKGGKLPIRWMAPESLKDGK------------FTSKSDVWSFGVLLWEIFTLGESPYPGMSNE 211 (258)
T ss_pred cc------------c-ccccCCCcccccChHHhccCC------------CCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 10 0 001122678999999885443 7899999999999999998 89999888887
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+..+........ +...+.++.+++.+||+.||++|||+.++++.|
T Consensus 212 ~~~~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 212 EVLEYLKKGYRLPK------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHhcCCCCCC------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 77777765543221 234789999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=311.50 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=206.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
..+|++.+.||+|+||.||. ...+.........+|+|.+...... ....+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~--~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYK--GVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD--HPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEE--EEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC--CCCcceEEEEEec-
Confidence 46899999999999998864 2222111222347999987765332 2356778999998875 9999999999887
Q ss_pred CEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+++|||+.++.+..++.+ ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999988877776654 4569999999999999999999999999999999999999999999999999998754
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
.... ........++..|+|||.+.... ++.++|+||||+++||+++ |..||....
T Consensus 161 ~~~~------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 161 VDEK------------EYHAEGGKVPIKWMALESILHRI------------YTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred Cccc------------ceecCCCcccccccCHHHhhcCC------------cCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 3210 00011222366899999886543 7889999999999999998 999999888
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccC
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~ 432 (1630)
..++...+..+...+. +...+.++.+++.+||..+|.+||++.++++.|.+....
T Consensus 217 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 217 AVEIPDLLEKGERLPQ------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 8777776665433222 224678899999999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=317.81 Aligned_cols=270 Identities=21% Similarity=0.242 Sum_probs=205.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.++||+|+||.||+ +.++.+++.+|||++...... ....+.+|+++++.++ ||||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 78 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYK------ARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK--HPNVVPLIDMAVE 78 (311)
T ss_pred cccEEEEEEeccCCCEEEEE------EEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC--CCCccchhhheec
Confidence 46999999999999887754 667788999999998765322 2345678999999875 9999999998754
Q ss_pred C--------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 213 D--------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 213 ~--------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
. ..++++|||+.++++..+......+++..++.++.|+++||+|||++||+||||||+|||+++++.+||+|
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 3 35799999999887777665556799999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||++............. ............+++.|+|||++.+.. .++.++|||||||++|+|++|.
T Consensus 159 fg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~il~el~~g~ 224 (311)
T cd07866 159 FGLARPYDGPPPNPKGG---GGGGTRKYTNLVVTRWYRPPELLLGER-----------RYTTAVDIWGIGCVFAEMFTRR 224 (311)
T ss_pred CccchhccCCCcccccC---CcccccccccceeccCcCChHHhhCCC-----------ccCchhHhHHHHHHHHHHHhCC
Confidence 99998654322100000 000111223456788999999876532 2688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCC--c------------------c---cccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQ--Y------------------A---SIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~--~------------------~---~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
+||.+.+.......+......+.. . . ......+++++.+||.+||+.||++|||+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 225 PILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 999887766555544332111100 0 0 0001234578899999999999999999999
Q ss_pred HHHHh
Q 000343 422 MLATF 426 (1630)
Q Consensus 422 vL~~L 426 (1630)
++.|-
T Consensus 305 ll~~~ 309 (311)
T cd07866 305 ALEHP 309 (311)
T ss_pred HhcCC
Confidence 99874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.29 Aligned_cols=264 Identities=19% Similarity=0.276 Sum_probs=213.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~- 212 (1630)
..|+.+.+||+|.||.| |+|+.+.+++.||+|++..++ ........+|+.+|..++ |+|++.+++.+..
T Consensus 17 ~~yek~~kigqGtfgeV------FkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk--Henv~nliEic~tk 88 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEV------FKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTK 88 (376)
T ss_pred hHHHHHHhcCCchHHHH------HHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc--chhHHHHHHHHhhc
Confidence 47889999999998866 568999999999999876643 333677889999999986 9999999987653
Q ss_pred -------CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 213 -------DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 213 -------~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
...+||||.+|..++.-.+....-+++..+++.++++++.||.|+|...|+|||+||+|+||+.+|.+||+||
T Consensus 89 ~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 2359999999998887776655568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++.+..+. .......+..+-|..|++||.+.+.+ .|+++.|||+.||||.||.|+.+
T Consensus 169 Glar~fs~~~----------n~~kprytnrvvTLwYrppEllLG~r-----------~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 169 GLARAFSTSK----------NVVKPRYTNRVVTLWYRPPELLLGDR-----------EYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ccccceeccc----------ccCCCCcccceeeeecCCHHHhhccc-----------ccCCcchhHhHHHHHHHHHccCc
Confidence 9998765432 11122356677799999999999865 29999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhc--CCCCCCccc---------c----c-------------CCCCCHHHHHHHHHhhccCcCCCC
Q 000343 366 PWAGLSAEEIYRAVVKN--RKLPPQYAS---------I----V-------------GVGIPRELWKMIGECLQFKASKRP 417 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~--~~~~~~~~~---------~----~-------------~~~l~~el~~LI~~cL~~dP~~RP 417 (1630)
.|++.+....+..|... ...+..++. . . +-.-++++.+|+.++|.+||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 99999888777766542 221111100 0 0 112345788999999999999999
Q ss_pred ChhhHHHHhhh
Q 000343 418 TFSAMLATFLR 428 (1630)
Q Consensus 418 Sa~evL~~L~~ 428 (1630)
++.++++|-+-
T Consensus 308 ~ad~alnh~~F 318 (376)
T KOG0669|consen 308 DADQALNHDFF 318 (376)
T ss_pred chHhhhchhhh
Confidence 99999999653
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=306.54 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=206.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||. +.+..+++.||+|.++..... ....+.+|+++++.++ ||||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYT------AVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK--HPNLVKYYGVEVHRE 72 (264)
T ss_pred CceeeeEeecCCCcEEEE------EEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC--CCChhheeeeEecCC
Confidence 589999999999887754 556678899999998876543 4567888999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+++|+||++++++..++.+...+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999999999888877667999999999999999999999999999999999999999999999999998876432
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-H
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-E 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~-~ 373 (1630)
... .........++..|+|||++.+.. ...++.++||||||+++|+|++|+.||..... .
T Consensus 153 ~~~----------~~~~~~~~~~~~~~~~PE~~~~~~---------~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 153 TTT----------MGEEVQSLAGTPAYMAPEVITGGK---------GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred CCc----------ccccccCCcCCcCccChhhccCCC---------CCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 210 000022356788999999987532 12268899999999999999999999976533 3
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.....+... . .+... ....+++.+.+||.+||+.+|++||++.+++.|
T Consensus 214 ~~~~~~~~~-~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 214 QIMFHVGAG-H-KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHhcC-C-CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 333333221 1 11111 122358899999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=307.53 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+ +.+..+++.||+|++..... .....+.+|+..+..++ ||||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~------~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYK------VRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPYVVKCYGAFYKEG 72 (264)
T ss_pred CcceeeeeeeecCCeEEEE------EEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC--CCCeeeEEEEEccCC
Confidence 3789999999999887754 66777899999999887543 33567888999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.++++|||++++.|..++.....+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999988888888766789999999999999999999999 9999999999999999999999999999886643
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC---
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL--- 370 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~--- 370 (1630)
.. .......++..|+|||.+.... ++.++|+||||+++|+|++|..||...
T Consensus 153 ~~--------------~~~~~~~~~~~y~~pE~~~~~~------------~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 206 (264)
T cd06623 153 TL--------------DQCNTFVGTVTYMSPERIQGES------------YSYAADIWSLGLTLLECALGKFPFLPPGQP 206 (264)
T ss_pred CC--------------CcccceeecccccCHhhhCCCC------------CCchhhHHHHHHHHHHHHhCCCCCcccccc
Confidence 21 0112345788999999986643 788999999999999999999999776
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCC-CCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVG-IPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~-l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
...+....+...... . .... ++..+.++|.+||+.+|++||++.++++|
T Consensus 207 ~~~~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 207 SFFELMQAICDGPPP-S-----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CHHHHHHHHhcCCCC-C-----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 344444444432211 1 1223 78899999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=312.37 Aligned_cols=262 Identities=21% Similarity=0.234 Sum_probs=204.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe-C
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-D 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-~ 213 (1630)
++|++.+.||+|+||.||. .........++..||+|++.... ......+.+|+.+++.++ ||||+++++++.. .
T Consensus 6 ~~~~~~~~i~~g~~g~V~~--~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~ 81 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFY--GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS--HQNILPILHVCIEDG 81 (280)
T ss_pred hheEEeeeecccCCceEEE--EEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC--CCCCCeEEEEEecCC
Confidence 5899999999999998864 22221111246889999876432 222456778888888875 9999999998665 5
Q ss_pred CEEEEEEecCCCChHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE--------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~--------~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
...++++||++++.+..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 6789999999888777766432 35899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~ 364 (1630)
|+++.+...... .......++..|+|||++.+.. ++.++||||||+++|++++ |.
T Consensus 162 g~~~~~~~~~~~------------~~~~~~~~~~~y~apE~~~~~~------------~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 162 ALSRDLFPMDYH------------CLGDNENRPVKWMALESLVNKE------------YSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred CCcccccCCceE------------EeCCCCCcchhccCHHHHhcCC------------CCchhhHHHhHHHHHHHhcCCC
Confidence 999765432100 0011234567899999986543 7899999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.||...+..++...+..+... .. ...+++++.+++.+||+.||++|||+.++++.|....+
T Consensus 218 ~p~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 218 TPYVEIDPFEMAAYLKDGYRL-AQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCcCcCCHHHHHHHHHcCCCC-CC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 999988777766655544321 11 23468899999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=308.92 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=199.8
Q ss_pred EEeCcCCceeEEEeeEEEcccccc---CCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGR---CRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~---~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
+.||+|+||.||. +.+.. ....||||.+..... .....+.+|+.++++++ ||||+++++.+.. ..++
T Consensus 1 ~~ig~g~~~~v~~------~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~-~~~~ 71 (257)
T cd05040 1 KKLGDGSFGVVRR------GEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD--HENLIRLYGVVLT-HPLM 71 (257)
T ss_pred CcCCccCcccEEe------eeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC--CCCccceeEEEcC-CeEE
Confidence 4689999888754 33322 234799999887655 44567888999999876 9999999999988 8899
Q ss_pred EEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 218 LVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
++|||++++.|..++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 999999888777766543 368999999999999999999999999999999999999999999999999998764321
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~e 374 (1630)
. .........++..|+|||.+.... ++.++|||||||++|+|++ |..||...+..+
T Consensus 152 ~-----------~~~~~~~~~~~~~y~~pE~~~~~~------------~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 152 D-----------HYVMEEHLKVPFAWCAPESLRTRT------------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred c-----------ceecccCCCCCceecCHHHhcccC------------cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 011112345678899999887544 7889999999999999999 999998888777
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+.......+ .+..+|..+.+++.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 209 ILKKIDKEGERLE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHhcCCcCC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7666654222111 12357889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=309.51 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=196.7
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
+.||+|+||.||. |.+..+++.||+|.+....... ...+..|..++... ..||||+++++++...+.+|+
T Consensus 2 ~~l~~g~~~~v~~------a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYL------AKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-GESPYVAKLYYSFQSKDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEE------EEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhc-CCCCCeeeeeeeEEcCCeEEE
Confidence 5789999887754 6677789999999987543222 12233444444332 369999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
+|||++++.|..++.....+++..+..++.|++.||.|||+.+|+||||+|+|||++.++.+||+|||++.....
T Consensus 75 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999999988887777899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
.....|+..|+|||.+.+.. ++.++||||||+++|+|++|..||...+....+..
T Consensus 150 -------------~~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 150 -------------NKKFVGTPDYLAPETILGVG------------DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred -------------cccCCCCcCccChhhhcCCC------------CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 12235688999999987643 68899999999999999999999998887777766
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh---hhHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF---SAMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa---~evL~~L 426 (1630)
+.......+ ......+++++.++|.+||+.+|++||++ +|++.|.
T Consensus 205 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 205 ILSRRINWP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred HHhcccCCC---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 655432221 11223578999999999999999999966 5776663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=310.97 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=197.5
Q ss_pred EEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEE
Q 000343 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 139 ~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~L 218 (1630)
.....||+|+||.|| ++.+..++..||+|.+..........+.+|+.+++.++ ||||+++++++.....+++
T Consensus 11 ~~~~~lg~g~~g~v~------~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 11 GERVVLGKGTYGIVY------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK--HRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred CceEEEecCCceEEE------EeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC--CCCeeeeeeeeccCCEEEE
Confidence 344689999988775 46677788999999988765555667889999999875 9999999999999999999
Q ss_pred EEecCCCChHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CCcEEEeecceeeeecCc
Q 000343 219 VMDRCYGSVQLAMQRNE-GRL--TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~-~~L--~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g~vKL~DFGla~~~~~~ 294 (1630)
+|||++++.|..++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. .+.+||+|||++..+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999988888776543 455 88899999999999999999999999999999999986 678999999998765321
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......|++.|+|||++.... ..++.++|+||||+++|+|++|..||.......
T Consensus 163 ~--------------~~~~~~~~~~~~~aPE~~~~~~----------~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~ 218 (268)
T cd06624 163 N--------------PCTETFTGTLQYMAPEVIDKGP----------RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ 218 (268)
T ss_pred C--------------CccccCCCCccccChhhhcccc----------ccCCchhhhHHHHHHHHHHHhCCCCCccccChh
Confidence 1 0112234688999999986533 126789999999999999999999997543221
Q ss_pred -HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 -IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 -i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.......... .+ ..+..+++++.+|+.+||+.+|++|||+.+++.|-
T Consensus 219 ~~~~~~~~~~~-~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 219 AAMFKVGMFKI-HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred hhHhhhhhhcc-CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 1111111111 11 12345788999999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=307.10 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=202.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.++|++.++||+|+||.||+ +.. ..+..+|+|.+.... ...+.+.+|+++++.++ |+||+++++.+.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~------~~~-~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~-~ 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWM------ATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQ--HDKLVKLHAVVTK-E 73 (260)
T ss_pred ccceeEEeEecCccceEEEE------EEe-cCCccEEEEecCCCh-hHHHHHHHHHHHHHhcC--CCCcceEEEEEcC-C
Confidence 46899999999999998865 322 234679999887542 33567888999999875 9999999999887 7
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.++++|||++++.+..++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++..+.+||+|||++..+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 78999999988777776654 3357889999999999999999999999999999999999999999999999997654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
... ........++..|+|||++.... ++.++|+||||+++|+|++ |..||...+
T Consensus 154 ~~~-------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 154 DNE-------------YTAREGAKFPIKWTAPEAINFGS------------FTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred CCC-------------cccccCCcccccccCHhHhccCC------------cCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 321 01112234567799999986543 7889999999999999999 999999887
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.......+..+...+ .....+.++.+++.+||+.+|++||++.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 209 NPEVIRALERGYRMP------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred HHHHHHHHhCCCCCC------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 777666665443221 12357889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=312.24 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=205.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhc-cCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~~ 214 (1630)
.|++.+.||+|+||.||. |.+..+++.||+|.+.... ......+.+|+.+++.+. ..||||+++++++....
T Consensus 2 ~y~~~~~l~~g~~g~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYR------GKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEE------EEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence 588899999999887754 6677889999999987542 233456788999988874 24999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|++|||++++.|..++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999888887765 47999999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......|+..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+...
T Consensus 155 ~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 155 S--------------SKRSTFVGTPYWMAPEVITEGK-----------YYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred c--------------cccccccCCcceeCHHHhccCC-----------ccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 1 1122346788999999886432 26889999999999999999999998776655
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+... .++.. ....++.++.+++.+||+.||++||++.+++.|-+
T Consensus 210 ~~~~~~~~--~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 210 AMMLIPKS--KPPRL---EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred hhhccccC--CCCCC---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 44333222 11111 11237789999999999999999999999998744
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=311.69 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=202.8
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC--
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD-- 213 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~-- 213 (1630)
|++.++||.|+||.||+ +.+..+++.+|+|++.... ......+.+|+++++.+. ||||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~------~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYK------ARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR--HPNIVRLKEIVTSKGK 72 (287)
T ss_pred CeeeEEeccCCCeEEEE------EEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc--CCCeeeheeeEecCCC
Confidence 78899999999887754 6667788999999998763 223456778999999876 99999999999988
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
...++||||+++++...+......+++..++.++.||+.||+|||++|++|+||||+|||+++++.+||+|||++.....
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 73 GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred CcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 88999999999866555554445799999999999999999999999999999999999999999999999999987643
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
... .......++..|+|||.+.+.. .++.++||||||+++|+|++|..||...+..
T Consensus 153 ~~~-------------~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 153 RNS-------------ADYTNRVITLWYRPPELLLGAT-----------RYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred CCc-------------ccccccccccccCCceeeEccc-----------cCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 210 0112335678899999876432 2688999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCC--c----------------------ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 374 EIYRAVVKNRKLPPQ--Y----------------------ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~--~----------------------~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.....+......+.. + .......+++++.+++.+||+.+|++||++.+++++-
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 555554432111100 0 0001111378899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=323.33 Aligned_cols=262 Identities=20% Similarity=0.293 Sum_probs=201.8
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+..+|.+.+.||.|+||.||+ +.+..++..||+|++..........+.+|+++++.++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~------~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~ 74 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFS------AVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD--HDNIVKVYEVLGPS 74 (342)
T ss_pred cCcceEEEEEecCCCCEEEEE------EEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC--CCcchhhHhhhccc
Confidence 346999999999999887754 6688899999999998766655677888999999975 99999999876643
Q ss_pred --------------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CC
Q 000343 214 --------------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SG 278 (1630)
Q Consensus 214 --------------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g 278 (1630)
..+|++|||+++++. .+.. ...+++..++.++.||++||+|||+.||+||||||+|||++. ++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~-~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYMETDLA-NVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccccceEEEEeecccccHH-HHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 358999999987544 4433 346999999999999999999999999999999999999984 45
Q ss_pred cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHH
Q 000343 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358 (1630)
Q Consensus 279 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILy 358 (1630)
.+||+|||+++.+..... .........++..|+|||++.+.. .++.++|||||||++|
T Consensus 153 ~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwSlGvil~ 210 (342)
T cd07854 153 VLKIGDFGLARIVDPHYS-----------HKGYLSEGLVTKWYRSPRLLLSPN-----------NYTKAIDMWAAGCIFA 210 (342)
T ss_pred eEEECCcccceecCCccc-----------cccccccccccccccCHHHHhCcc-----------ccCchhhHHHHHHHHH
Confidence 789999999976542110 000112235788999999875422 2788999999999999
Q ss_pred HHhhCCCCCCCCCHHHHHHHHHhcCCCC-----------------------CCcccccCCCCCHHHHHHHHHhhccCcCC
Q 000343 359 EMCTGSIPWAGLSAEEIYRAVVKNRKLP-----------------------PQYASIVGVGIPRELWKMIGECLQFKASK 415 (1630)
Q Consensus 359 emltG~~PF~~~~~~ei~~~i~~~~~~~-----------------------~~~~~~~~~~l~~el~~LI~~cL~~dP~~ 415 (1630)
+|++|+.||...+..+....+....... ..........++.++.+||.+||+.||.+
T Consensus 211 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 290 (342)
T cd07854 211 EMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290 (342)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchh
Confidence 9999999998776655444433221110 00001112357789999999999999999
Q ss_pred CCChhhHHHHhh
Q 000343 416 RPTFSAMLATFL 427 (1630)
Q Consensus 416 RPSa~evL~~L~ 427 (1630)
|||+.+++.|-+
T Consensus 291 R~t~~ell~h~~ 302 (342)
T cd07854 291 RLTAEEALMHPY 302 (342)
T ss_pred ccCHHHHhCCCc
Confidence 999999999844
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=342.55 Aligned_cols=261 Identities=18% Similarity=0.232 Sum_probs=188.9
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEE------------------EEEEeeccCcCChhHHHHHHHHHHH
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSV------------------AVKKVMIAEEMEPDWLSGQLDNLRR 195 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~V------------------AIK~i~~~~~~~~~~~~~Ei~iL~~ 195 (1630)
+.++|+++++||+|+||.||+.. .+. .++..+ +.|++.. .......+.+|+.+|+.
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICA--LRA---STEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGR 219 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEE--Eec---cchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHh
Confidence 55789999999999999998632 111 111111 1222221 11224567889999999
Q ss_pred hccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccc
Q 000343 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNE----GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271 (1630)
Q Consensus 196 l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~----~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~N 271 (1630)
++ ||||+++++++......|++||++.++++..+.... .......++.|+.||+.||+|||++|||||||||+|
T Consensus 220 l~--HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~N 297 (501)
T PHA03210 220 LN--HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLEN 297 (501)
T ss_pred CC--CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 75 999999999999999999999999888777654321 234567788999999999999999999999999999
Q ss_pred eEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccch
Q 000343 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351 (1630)
Q Consensus 272 ILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIW 351 (1630)
||++.++.+||+|||+++.+.... ........||..|+|||++.+.. ++.++|||
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~Diw 352 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKER-------------EAFDYGWVGTVATNSPEILAGDG------------YCEITDIW 352 (501)
T ss_pred EEECCCCCEEEEeCCCceecCccc-------------ccccccccCCcCCCCchhhcCCC------------CCcHHHHH
Confidence 999999999999999998764321 01122357899999999987654 78999999
Q ss_pred hhhhHHHHHhhCCC-CCCCC--CHHHHHHHHHhcCC-----CCC-------------------Cccc-ccCCCCCHHHHH
Q 000343 352 SFGCTLVEMCTGSI-PWAGL--SAEEIYRAVVKNRK-----LPP-------------------QYAS-IVGVGIPRELWK 403 (1630)
Q Consensus 352 SlGvILyemltG~~-PF~~~--~~~ei~~~i~~~~~-----~~~-------------------~~~~-~~~~~l~~el~~ 403 (1630)
||||+||||++|.. ||... .....+..+..... .+. .... .....++.++.+
T Consensus 353 SlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (501)
T PHA03210 353 SCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEY 432 (501)
T ss_pred HHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHH
Confidence 99999999999875 44322 22222222222100 000 0000 011246678889
Q ss_pred HHHHhhccCcCCCCChhhHHHHhh
Q 000343 404 MIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 404 LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+|.+||++||.+|||+.|+|.|-+
T Consensus 433 li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 433 PLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHhccCcccCcCHHHHhhChh
Confidence 999999999999999999999844
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=309.72 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=194.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
+.||+|+||.||. .... +..++..+|+|.+...... ....+.+|+.+++.++ ||||+++++++.+...+++||
T Consensus 1 ~~lg~G~~g~Vy~--~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVIL--GEVN--SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ--HSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEE--EEEc--CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC--CCCEeeEEEEEcCCCCcEEEE
Confidence 3689999998864 2111 3456678999988765432 2346778999999875 999999999999999999999
Q ss_pred ecCCCChHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 221 DRCYGSVQLAMQRNE-----GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~-----~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
||+++++|..++... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 999988887776432 245677888999999999999999999999999999999999999999999986533211
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~e 374 (1630)
.........++..|+|||++.+.... .....++.++||||||+++|||++ |..||......+
T Consensus 155 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 155 ------------YYVTPDQLWVPLRWIAPELVDEVHGN-----LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred ------------eeecCCCcCCcccccCHhHhcccccc-----ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 01112234567889999998643210 001236889999999999999996 999998877666
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.............. ........++.+.+++.+|| .+|++|||+.+++..|
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 218 VLTYTVREQQLKLP-KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred HHHHHhhcccCCCC-CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 54443332221111 11122346788999999999 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=316.28 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=203.9
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.+.||+|+||.||+ +.++.+++.||+|.+..... .....+.+|+++++.++ ||||+++++++.+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~~i~~~~~~~~~ 77 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYK------ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN--HRNIVNLKEIVTD 77 (302)
T ss_pred hhhhheeeeecccCCEEEEE------EEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC--CCCeeeeeheecC
Confidence 46899999999999888754 56677889999999976532 23456678999999875 9999999999876
Q ss_pred CC----------EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEE
Q 000343 213 DS----------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 213 ~~----------~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL 282 (1630)
.. .++++|||++++++..+......+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence 54 79999999999877776655557999999999999999999999999999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||++..+..... .......++..|+|||++.+.. .++.++|||||||++|+|++
T Consensus 158 ~dfg~~~~~~~~~~-------------~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~~Di~slG~~~~el~~ 213 (302)
T cd07864 158 ADFGLARLYNSEES-------------RPYTNKVITLWYRPPELLLGEE-----------RYGPAIDVWSCGCILGELFT 213 (302)
T ss_pred CcccccccccCCcc-------------cccccceeccCccChHHhcCCC-----------CCCchhHHHHHHHHHHHHHh
Confidence 99999976543210 0112234577899999876432 16789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCC--CCcc---------------------cccCCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLP--PQYA---------------------SIVGVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~--~~~~---------------------~~~~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
|++||...+..+.+..+......+ ..+. ......+|..+.+|+.+||+.||++||++
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999998776655544443321111 0000 00122468899999999999999999999
Q ss_pred hhHHHH
Q 000343 420 SAMLAT 425 (1630)
Q Consensus 420 ~evL~~ 425 (1630)
.+++.|
T Consensus 294 ~~il~~ 299 (302)
T cd07864 294 EEALNS 299 (302)
T ss_pred HHHhcC
Confidence 999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=314.46 Aligned_cols=240 Identities=19% Similarity=0.255 Sum_probs=187.4
Q ss_pred EEeCcCCceeEEEeeEEEcccccc-------CCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGR-------CRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~-------~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+.||+|+||.||. +.+.. ....||+|.+........+.+..|+.+++.+. ||||+++++++..+.
T Consensus 1 ~~lg~G~~~~Vy~------~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~--h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFK------GIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhhee------eeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC--CCChhheeeEEEeCC
Confidence 3689999998865 33322 34469999876554444566778888888865 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCc--------EEEeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR--------AVVSDY 285 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~--------vKL~DF 285 (1630)
..++||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++||
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999888777543 45899999999999999999999999999999999999987664 689999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhC-C
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG-S 364 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG-~ 364 (1630)
|++..... .....++..|+|||++.+.. .++.++||||||+++|+|++| .
T Consensus 153 g~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 153 GISITVLP------------------KEILLERIPWVPPECIENPQ-----------NLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred ccccccCC------------------chhccccCCccCchhccCCC-----------CCCchhhHHHHHHHHHHHHcCCC
Confidence 98754321 12245688999999987532 268899999999999999998 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.||...+........ ..... .+...+.++.+||.+||+.||++|||++++++.|
T Consensus 204 ~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 204 KPLSALDSQKKLQFY-EDRHQ-------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CChhhccHHHHHHHH-Hcccc-------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 777666554433322 22111 1123557899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=318.91 Aligned_cols=260 Identities=18% Similarity=0.218 Sum_probs=197.7
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEcccccc--CCcEEEEEEeeccC---cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGR--CRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~--~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+|++.++||+|+||.||. |.+.. +++.||+|.+.... ......+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~------~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 72 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYK------AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK--HENVVSLVEVFL 72 (316)
T ss_pred CceEEEEeccCCcEEEEE------EEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC--CCCccceEEEEe
Confidence 489999999999888754 55555 78999999988743 333456778999999875 999999999999
Q ss_pred eC--CEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC----CCcEE
Q 000343 212 MD--SCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA----SGRAV 281 (1630)
Q Consensus 212 ~~--~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~----~g~vK 281 (1630)
.. ..+++||||++++++..+... ...+++..++.++.||+.||+|||+++|+||||||+|||++. ++.+|
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 73 EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred CCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEE
Confidence 88 889999999998777655322 236899999999999999999999999999999999999998 89999
Q ss_pred EeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHh
Q 000343 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyeml 361 (1630)
|+|||++..+..... .........+++.|+|||++.+.. .++.++||||||+++|+|+
T Consensus 153 l~Dfg~~~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 153 IGDLGLARLFNAPLK-----------PLADLDPVVVTIWYRAPELLLGAR-----------HYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred ECCCccccccCCCcc-----------cccccCCccccccccCHHHHhCCC-----------CCCcHHHHHHHHHHHHHHH
Confidence 999999986543210 011123456789999999876532 2688999999999999999
Q ss_pred hCCCCCCCCCHHH---------HHHHHHhcCCC-----------------------CCCcc-----cccC--CCCCHHHH
Q 000343 362 TGSIPWAGLSAEE---------IYRAVVKNRKL-----------------------PPQYA-----SIVG--VGIPRELW 402 (1630)
Q Consensus 362 tG~~PF~~~~~~e---------i~~~i~~~~~~-----------------------~~~~~-----~~~~--~~l~~el~ 402 (1630)
+|.+||....... .+..+...... ...+. .... ...+.++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 9999997544321 11111110000 00000 0000 14567899
Q ss_pred HHHHHhhccCcCCCCChhhHHHHh
Q 000343 403 KMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 403 ~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+++.+||+.||++|||+.++++|-
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCC
Confidence 999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=312.65 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=200.0
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
|++.+.||.|++|.|| ++.+..++..||+|++...... ....+.+|+++++.++ ||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~vy------~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~iv~~~~~~~~~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVY------KARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN--HPNIVRLLDVVHSENK 72 (283)
T ss_pred CchheEecCCCCeEEE------EEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC--CCCccCHhheeccCCe
Confidence 6788999999987775 4667778999999998865322 2356778999999976 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 216 LGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.|++|||+++++...+.... ..+++..+..++.|+++||+|||+++++||||+|+|||++.++.+||+|||++..+...
T Consensus 73 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 73 LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred EEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 99999999765554443332 36899999999999999999999999999999999999999999999999998754321
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||++.+.. .++.++|+||||+++|+|++|++||...+...
T Consensus 153 ~--------------~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 153 V--------------RTYTHEVVTLWYRAPEILLGSR-----------QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred c--------------cccCccccccCCCCCceeecCc-----------ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 0112234688999999876532 16789999999999999999999998776655
Q ss_pred HHHHHHhcCCCCC----------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPP----------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~----------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
....+.+....+. .........++.++.++|.+||+.||++|||+.++++|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 4444333211110 000111345778999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=306.29 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=198.4
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
++||+|+||.||. +.+.. ++.||+|.+...... ....+.+|+++++.+. ||||+++++++......+++|
T Consensus 1 ~~lg~g~~g~v~~------~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYK------GVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD--HPNIVKLIGVCVQKQPIYIVM 71 (251)
T ss_pred CccccCCCceEEE------EEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCeEEEEEEEecCCCeEEEE
Confidence 4689999888754 44545 899999988765433 3456788999999875 999999999999999999999
Q ss_pred ecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 221 DRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 221 Ey~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
||+.++.+..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--- 148 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--- 148 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---
Confidence 99998887776644 45689999999999999999999999999999999999999999999999999876542110
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~ 378 (1630)
........++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........
T Consensus 149 ---------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~ 207 (251)
T cd05041 149 ---------TVSDGLKQIPIKWTAPEALNYGR------------YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207 (251)
T ss_pred ---------eeccccCcceeccCChHhhccCC------------CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence 00001122356799999987644 7899999999999999999 8999988877666655
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+......+ .+..++.++.+++.+||+.+|++|||+.++++.|.
T Consensus 208 ~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 208 IESGYRMP------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HhcCCCCC------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 54332111 12357889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=321.97 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=200.9
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+..+|.+.+.||+|+||.||. +.+..++..||||.+.... ......+.+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~ 74 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCS------AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD--HENVIAIKDIMP 74 (337)
T ss_pred cccceeEEEEeccCCCeEEEE------EEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC--CCCccchHHhee
Confidence 346899999999999887754 6677899999999987542 223455678999998875 999999999886
Q ss_pred eC-----CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecc
Q 000343 212 MD-----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 212 ~~-----~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFG 286 (1630)
.. ..+|++|||+.++++. ++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~L~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 75 PPHREAFNDVYIVYELMDTDLHQ-IIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cccccccCcEEEEEeCCCCCHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 54 3589999999876554 44455679999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+++...... .......++..|+|||.+.+.. .++.++|||||||++|+|++|..|
T Consensus 154 ~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 154 LARTTSEKG--------------DFMTEYVVTRWYRAPELLLNCS-----------EYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred cccccCCCc--------------ccccccccccCccChHHHhcCC-----------CCCCcccHHHHHHHHHHHHcCCCC
Confidence 997654211 1112345688999999876432 178899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCC------------------------CCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhH
Q 000343 367 WAGLSAEEIYRAVVKNRKL------------------------PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~------------------------~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ev 422 (1630)
|.+.+....+..+...... +........+.+++++.+||.+||+.+|++|||+.++
T Consensus 209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 9876543333222211000 0000011123578899999999999999999999999
Q ss_pred HHHhh
Q 000343 423 LATFL 427 (1630)
Q Consensus 423 L~~L~ 427 (1630)
++|-+
T Consensus 289 l~h~~ 293 (337)
T cd07858 289 LAHPY 293 (337)
T ss_pred HcCcc
Confidence 99843
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=316.47 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=199.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|+..+.||+|+||.||. +.+..++..||+|.+...... ....+.+|+.++.++. .||||+++++++..+.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNK------MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEE------EEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-CCCCEeeeeeEEecCC
Confidence 4677788999999888754 567788999999998764322 3456778888888864 5999999999999999
Q ss_pred EEEEEEecCCCChHHHH----HHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceee
Q 000343 215 CLGLVMDRCYGSVQLAM----QRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l----~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
..+++|||+..++...+ ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 77 DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred cEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 99999999987643322 12235799999999999999999999975 99999999999999999999999999987
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+.... ......|++.|+|||++.+.. ...++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~---------~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 157 QLVDSI---------------AKTRDAGCRPYMAPERIDPSA---------RDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred HhccCC---------------ccccccCccCccCHHHhcccc---------ccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 543211 112235788999999987541 01278999999999999999999999976
Q ss_pred CCH-HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 370 LSA-EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~~-~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
... .+.+..+..+. ++.........++.++.+||.+||+.+|++|||+.+++.|-+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 213 WNSVFDQLTQVVKGD--PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred cchHHHHHhhhcCCC--CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 542 12222222221 122222222457899999999999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=304.78 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=196.6
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
+.||+|+||.||+ +.. ..+..+|+|.+...... ....+.+|+++++.+. ||||+++++++......++||
T Consensus 1 ~~ig~g~~g~vy~------~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 71 (250)
T cd05085 1 ELLGKGNFGEVFK------GTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD--HPNIVKLIGVCTQRQPIYIVM 71 (250)
T ss_pred CccCCCCCceEEE------EEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC--CCCcCeEEEEEecCCccEEEE
Confidence 3689999988864 332 35789999988754322 2345778999998875 999999999999999999999
Q ss_pred ecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCC
Q 000343 221 DRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299 (1630)
Q Consensus 221 Ey~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 299 (1630)
||++++.+..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 72 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---- 147 (250)
T cd05085 72 ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---- 147 (250)
T ss_pred ECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----
Confidence 99988887776643 4468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHHH
Q 000343 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 300 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~~ 378 (1630)
........++..|+|||++.... ++.++||||||+++|+|++ |..||...........
T Consensus 148 ---------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~ 206 (250)
T cd05085 148 ---------YSSSGLKQIPIKWTAPEALNYGR------------YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ 206 (250)
T ss_pred ---------cccCCCCCCcccccCHHHhccCC------------CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 00111123356799999987644 7889999999999999998 9999988877766666
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+...... ..+..++.++.+|+.+||+.+|++||++.++++.|.
T Consensus 207 ~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 207 VEKGYRM------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5443221 122357899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=311.63 Aligned_cols=246 Identities=19% Similarity=0.242 Sum_probs=193.2
Q ss_pred cCCeEEEEEe--CcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKL--GEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~L--G~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.++|++.+.+ |+|+||.||+ +.++.++..+|+|.+....... .|+.....+. +||||+++++.|..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~-~h~~iv~~~~~~~~ 80 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSV------LKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMK-DNPNFIKLYYSVTT 80 (267)
T ss_pred HHhhccccceeecCCCceEEEE------EEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhh-cCCCEEEEEEEEec
Confidence 3467776766 9999888865 5577889999999987643222 1333332222 69999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-cEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-~vKL~DFGla~~~ 291 (1630)
.+.+|+||||++++.|..++.....+++..++.++.|+++||.|||+.||+||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999888888877666899999999999999999999999999999999999999888 9999999998765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ....++..|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 161 ~~~------------------~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 161 GTP------------------SCYDGTLDYFSPEKIKGHN------------YDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCC------------------ccCCCCCcccChhhhcCCC------------CCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 421 1234688999999987644 7889999999999999999999998654
Q ss_pred HHHHH-HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-hhhHHHHh
Q 000343 372 AEEIY-RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-FSAMLATF 426 (1630)
Q Consensus 372 ~~ei~-~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-a~evL~~L 426 (1630)
..... ..+........ .....+++.+.+||.+||+.+|.+||+ ++++++|-
T Consensus 211 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 211 DEELDLESLLKRQQKKL----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred cchhhHHHHHHhhcccC----CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 43321 11111111111 122358899999999999999999996 69999873
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=306.74 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=206.2
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccC----CcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCccee
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC----RHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTF 206 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~----g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l 206 (1630)
.....|+.+++||+|+||.||. |..+.+ ...+|||+++.+.... .....||+.+++.++ ||||+.|
T Consensus 21 e~l~~ye~ig~Ig~GTYG~Vyk------A~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~--h~nvi~L 92 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYK------AVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK--HPNVISL 92 (438)
T ss_pred HHHHHhhccceecccccceeeE------eeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc--CCcchhH
Confidence 3456899999999999887754 433322 2379999998764332 456779999999987 9999999
Q ss_pred EEEEEe-CCEEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC----
Q 000343 207 HGVLRM-DSCLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS---- 277 (1630)
Q Consensus 207 ~~~f~~-~~~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~---- 277 (1630)
..+|.. +..++|++||++.+++..+.-. ...++...++.|+.||+.|+.|||++=|+||||||.|||+..+
T Consensus 93 v~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 93 VKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred HHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCcc
Confidence 999877 8899999999999998876432 2359999999999999999999999999999999999999866
Q ss_pred CcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHH
Q 000343 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357 (1630)
Q Consensus 278 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvIL 357 (1630)
|.+||+|||+++.+.++. .........+-|..|+|||++.+.+. |+++.||||.|||+
T Consensus 173 G~VKIaDlGlaR~~~~pl-----------kpl~s~d~VVVTiWYRAPELLLGa~h-----------YT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPL-----------KPLASLDPVVVTIWYRAPELLLGARH-----------YTKAIDVWAIGCIF 230 (438)
T ss_pred CeeEeecccHHHHhhccc-----------cccccCCceEEEEEecChHHhccccc-----------ccchhhhHHHHHHH
Confidence 899999999999887542 11122344566999999999998763 99999999999999
Q ss_pred HHHhhCCCCCCCCCH---------HHHHHHHHhcCCCCC-----------Cccc-------cc------------CCCCC
Q 000343 358 VEMCTGSIPWAGLSA---------EEIYRAVVKNRKLPP-----------QYAS-------IV------------GVGIP 398 (1630)
Q Consensus 358 yemltG~~PF~~~~~---------~ei~~~i~~~~~~~~-----------~~~~-------~~------------~~~l~ 398 (1630)
.||+|-.+.|.+... .+.+.+|++--..|. .+.. .. ...-+
T Consensus 231 aElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~ 310 (438)
T KOG0666|consen 231 AELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKD 310 (438)
T ss_pred HHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCC
Confidence 999999999875432 234445544322221 1100 00 01234
Q ss_pred HHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 399 RELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 399 ~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
+...+|+.+||.+||-+|.|++++|+|..-
T Consensus 311 ~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 311 PSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred chHHHHHHHHhccCchhhccHHHHhccccc
Confidence 558899999999999999999999998553
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=307.35 Aligned_cols=256 Identities=21% Similarity=0.268 Sum_probs=195.1
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEE-eCCEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR-MDSCLGLV 219 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~-~~~~~~LV 219 (1630)
+.||+|+||.||.. .... .......||||.+.... ......+.+|+.+++.++ ||||+++++++. .+...+++
T Consensus 1 ~~lg~g~~g~v~~~--~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHG--TLID-SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS--HPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEE--EEec-CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC--CCCcceEEEEeecCCCCcEEE
Confidence 36899999988642 2111 22345689999876432 223456677888888765 999999999765 45668999
Q ss_pred EecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 220 MDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 220 mEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
|||+.++++..++.+ ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-
Confidence 999998888777654 345788888999999999999999999999999999999999999999999998765321100
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYR 377 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei~~ 377 (1630)
.........++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+...
T Consensus 155 ---------~~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~ 213 (262)
T cd05058 155 ---------SVHNHTGAKLPVKWMALESLQTQK------------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV 213 (262)
T ss_pred ---------eecccccCcCCccccChhHhccCc------------cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 000112234567899999886544 7889999999999999999 577788777766666
Q ss_pred HHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 378 AVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 378 ~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.+..+...+. +..+++.+.+++.+||+.+|++||++.++++.|...+
T Consensus 214 ~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 214 YLLQGRRLLQ------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHhcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 6554432221 2246789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=320.79 Aligned_cols=259 Identities=23% Similarity=0.291 Sum_probs=207.2
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||.|+||.||+ +.+..+++.||||++.... ......+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCS------AVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR--HENIIGLLDILRPPS 72 (330)
T ss_pred CceeeeeecCCCCeEEEE------EEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC--CcchhhhhhhhcccC
Confidence 589999999999887754 5667779999999988653 334567888999999976 999999999988775
Q ss_pred -----EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 215 -----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 215 -----~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
.+|++|||+.+++ ..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 73 ~~~~~~~~lv~e~~~~~l-~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 73 PEDFNDVYIVTELMETDL-HKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred cccccceEEEecchhhhH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 7999999998754 4444555589999999999999999999999999999999999999999999999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
........ ........+++.|+|||++.+.. .++.++|+||||+++|+|++|.+||..
T Consensus 152 ~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 152 GVDPDEDE-----------KGFLTEYVVTRWYRAPELLLSSS-----------RYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred eecccccc-----------cccccccccccCcCCceeeeccc-----------CCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 76543100 01123345788999999987652 278999999999999999999999998
Q ss_pred CCHHHHHHHHHhcCCCCCCc------------------------ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 370 LSAEEIYRAVVKNRKLPPQY------------------------ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~------------------------~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.+..+.+..+......++.. .......++.++.+||.+||+.+|++||++.+++.|
T Consensus 210 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 210 RDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 88776666655432221110 000123467889999999999999999999999998
Q ss_pred h
Q 000343 426 F 426 (1630)
Q Consensus 426 L 426 (1630)
.
T Consensus 290 ~ 290 (330)
T cd07834 290 P 290 (330)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=311.76 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=199.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEe--
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-- 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-- 212 (1630)
++|+..+.||.|+||.||+ +.+..+++.+|+|.+..... .....+.+|+++++.++ ||||++++++|..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTK------CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK--SPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEE------EEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC--CCCeeeeeeEEEccC
Confidence 4799999999999887754 55667899999999886433 23566888999998875 9999999999865
Q ss_pred CCEEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
...+|+||||++++.|..++. ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence 347899999999887766543 3446899999999999999999999999999999999999999999999999998
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.
T Consensus 153 ~~~~~~~----------------~~~~~~~~~y~~pE~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 153 GELVNSL----------------AGTFTGTSFYMAPERIQGKP------------YSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred ccccccc----------------cccccCCccccCHHHhcCCC------------CCchhhHHHHHHHHHHHHhCCCCCC
Confidence 6543211 11234678899999987644 7889999999999999999999997
Q ss_pred CC-----CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GL-----SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~-----~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.. ...+....+.................+++++.+||.+||..+|++|||+.|++.|-+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred cccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 65 223333333322111110001111235678999999999999999999999999855
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=311.52 Aligned_cols=245 Identities=21% Similarity=0.236 Sum_probs=192.1
Q ss_pred EeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhc-cCCCCcceeEEEEEeCCEEEE
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMDSCLGL 218 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~~~~~L 218 (1630)
.||+|+||.||+ +.+..+++.||+|.+....... ......|..+++.++ ..||||++++++|.....+|+
T Consensus 1 ~ig~g~~g~Vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 74 (278)
T ss_pred CcccCCCeEEEE------EEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence 379999887764 5567789999999987653221 222344544444432 369999999999999999999
Q ss_pred EEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 219 VMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 219 VmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||||+.|++|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 75 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999999888888777789999999999999999999999999999999999999999999999999987543210
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC---HHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS---AEEI 375 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~---~~ei 375 (1630)
.....|+..|+|||++.+.. .++.++||||+|+++|+|++|..||.... ....
T Consensus 152 -------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~ 207 (278)
T cd05606 152 -------------PHASVGTHGYMAPEVLQKGV-----------AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (278)
T ss_pred -------------CcCcCCCcCCcCcHHhcCCC-----------CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 12246899999999986432 27889999999999999999999997653 2222
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFL 427 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L~ 427 (1630)
...+... .. ..+..++.++.+++.+||..+|.+|| ++.++++|-+
T Consensus 208 ~~~~~~~---~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 208 DRMTLTM---AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred HHHhhcc---CC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 2222111 11 12234689999999999999999999 9999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=309.03 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=200.7
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhc-cCCCCcceeEEEEEeCC
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRAS-MWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~-l~HpNIV~l~~~f~~~~ 214 (1630)
|++.+.||+|+||.||+ +.++.++..||+|.+....... ...+.+|+.++++++ .+||||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYK------ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEE------EEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 78899999999888754 5566688999999997543322 345667888887764 46999999999998877
Q ss_pred E-----EEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 215 C-----LGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 215 ~-----~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
. ++++|||+.+++...+.... ..+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 75 TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred CCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 6 99999999886555444332 35999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
..+.... ......++..|+|||++.+.. ++.++|+|||||++|+|++|.+||.
T Consensus 155 ~~~~~~~---------------~~~~~~~~~~~~~PE~~~~~~------------~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 155 RIYSFEM---------------ALTSVVVTLWYRAPEVLLQSS------------YATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred eeccCCc---------------ccccccccccccChHHhccCC------------CCCcchhhhHHHHHHHHHhCCCccc
Confidence 7764321 011234688999999987654 7889999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCC-------------c-------ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 369 GLSAEEIYRAVVKNRKLPPQ-------------Y-------ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~-------------~-------~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
..+..+.+..+......+.. + .....+.+++++.+||.+||+.||++||++.+++.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 208 GTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 88877766666542211100 0 000112356788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=315.60 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=201.5
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCc----EEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH----SVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~----~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
.++|+..+.||+|+||.||. +.+..++. .||+|.+....... ...+.+|+.+++.+. ||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~------~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~ 77 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYK------GIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD--HPHLVRLLGV 77 (303)
T ss_pred hhhceeccccccCCCccEEE------EEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcccEEEE
Confidence 46899999999999888864 44444444 57999877543221 335678888888875 9999999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
+... ..+++|||++++.+..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccc
Confidence 8754 46799999987766666544 446899999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPW 367 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF 367 (1630)
+.+..... ........++..|+|||.+.+.. ++.++||||||+++|||++ |..||
T Consensus 157 ~~~~~~~~------------~~~~~~~~~~~~y~~PE~~~~~~------------~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 157 RLLEGDEK------------EYNADGGKMPIKWMALECIHYRK------------FTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ccccCccc------------ccccCCCccccccCCHHHhccCC------------CChHHHHHHHHHHHHHHHhCCCCCC
Confidence 86543210 01112234577899999987544 7899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
.+....+....+..+... +. +..++..+.+++.+||..+|++||++.++++.|.......
T Consensus 213 ~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 213 DGIPTREIPDLLEKGERL-PQ-----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCCHHHHHHHHHCCCCC-CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 887666555444333222 21 2346788999999999999999999999999888765443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=309.62 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=196.5
Q ss_pred EeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEe
Q 000343 143 KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD 221 (1630)
Q Consensus 143 ~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmE 221 (1630)
.||+|+||.||.....-.......+..+|||.+..... .....+.+|+++++.++ ||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN--HPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC--CCCeeeEeeeecCCCCeEEEEe
Confidence 58999999886521110001123346899998865432 23556778999998875 9999999999999999999999
Q ss_pred cCCCChHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-----cEEEeecceee
Q 000343 222 RCYGSVQLAMQRN-------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-----RAVVSDYGLAA 289 (1630)
Q Consensus 222 y~~gglL~~l~~~-------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-----~vKL~DFGla~ 289 (1630)
|++++.|..++.. ...+++..+..++.|++.||+|||+++++|+||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9998887776643 23478899999999999999999999999999999999999877 89999999997
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~ 368 (1630)
.+..... ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.
T Consensus 160 ~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 160 DIYKSDY------------YRKEGEGLLPVRWMAPESLLDGK------------FTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ccccccc------------cccCcccCCCccccCHHHHccCC------------cccchhHHHHHHHHHHHHHcCCCCCc
Confidence 6543210 01112234577899999987654 7899999999999999998 999998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..+....+..+.... .+..+|..+.+||.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 216 ALNNQEVLQHVTAGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccCHHHHHHHHhcCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 877766666554332211 12357889999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=311.35 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=205.3
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
|++.+.||+|++|.||. +.+..+++.+|+|.+...... ....+.+|+++++.++ ||||+++++++..+..
T Consensus 1 y~~~~~i~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYK------ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN--HPNIIKLLDVFRHKGD 72 (283)
T ss_pred CccceeeecCCCceEEE------EEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc--CCCcchHHHhhccCCC
Confidence 67789999999887754 667778999999998765433 3567778999999876 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
++++|||+++++...+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||.+.......
T Consensus 73 ~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 73 LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 99999999987777766655689999999999999999999999999999999999999999999999999997765321
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......++..|+|||.+.+.. .++.++|+||||+++|+|++|+.||...+..+.
T Consensus 153 --------------~~~~~~~~~~~~~~PE~~~~~~-----------~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 153 --------------RPYTHYVVTRWYRAPELLLGDK-----------GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred --------------ccccCccCcccccCcHHHhcCC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112245688999999986542 278999999999999999999999988776555
Q ss_pred HHHHHhcCCCCC-----------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 376 YRAVVKNRKLPP-----------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 376 ~~~i~~~~~~~~-----------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+..+......+. .........++.++.+||.+||+.||++||++.+++.|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 544433211100 000011234678999999999999999999999999873
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=306.99 Aligned_cols=244 Identities=22% Similarity=0.270 Sum_probs=200.6
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||.|+||.||+ +.+..++..||+|.+..... ...+.+.+|+.+++.++ ||||+++++.+.++..+|++|
T Consensus 1 lg~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 72 (262)
T cd05572 1 LGVGGFGRVEL------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN--HPFIVKLYRTFKDKKYIYMLM 72 (262)
T ss_pred CCCCCceEEEE------EEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC--CCCEeeeeeeEEcCCccEEEE
Confidence 68999887754 56677899999999876532 23466888999988875 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||++++.|..++.+...+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 73 EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred ecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence 999999888888776779999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC--HHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS--AEEIYRA 378 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~--~~ei~~~ 378 (1630)
......|++.|+|||.+.... ++.++|+||||+++|+|++|..||.... ..+.+..
T Consensus 148 ----------~~~~~~~~~~~~~PE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 205 (262)
T cd05572 148 ----------KTWTFCGTPEYVAPEIILNKG------------YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205 (262)
T ss_pred ----------ccccccCCcCccChhHhcCCC------------CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH
Confidence 112345788999999986543 7889999999999999999999998766 5666666
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC-----hhhHHHHhh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFL 427 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS-----a~evL~~L~ 427 (1630)
+..+..... .+...++++.++|.+||+.+|++||+ +.|+++|-+
T Consensus 206 ~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 206 ILKGNGKLE-----FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HhccCCCCC-----CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 553222211 12245789999999999999999999 788887643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=316.15 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=204.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+.|+..+.||+|+||.||. |.+..++..||+|.+..... .....+.+|+.+++.+. ||||++++++|....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYK------GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEE------EEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC--CCccHhhhcccccCC
Confidence 4577788999999887754 56677889999998875432 23456788999998875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|+||||++++.+..++.. ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++..+...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999999888877654 56899999999999999999999999999999999999999999999999998765421
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||.......
T Consensus 155 ~--------------~~~~~~~~~~~y~aPE~~~~~~------------~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 155 Q--------------IKRNTFVGTPFWMAPEVIKQSA------------YDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred c--------------hhhhcccCcccccCHHHhCcCC------------CchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 1 0112245788999999987644 7889999999999999999999998766555
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
....+.... ++. ....++.++.+++.+||+.+|++||++.++++|.+
T Consensus 209 ~~~~~~~~~--~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 209 VLFLIPKNS--PPT----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHhhhhcCC--CCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 444433222 111 22346788999999999999999999999999844
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=310.56 Aligned_cols=251 Identities=21% Similarity=0.377 Sum_probs=203.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||.|+||.||+ +.++.+++.+|+|.+..... .....+.+|+++++.+. ||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~ 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSK------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNG 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEE------EEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC--CCchhhhheeeecCC
Confidence 3688899999999887754 66778899999999887532 23456788999998876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.++++|||++++.|..++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||.+....
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999988888777654 679999999999999999999999 999999999999999999999999999986543
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC--
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-- 370 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-- 370 (1630)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 153 ~~~----------------~~~~~~~~~y~~PE~~~~~~------------~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 204 (265)
T cd06605 153 NSL----------------AKTFVGTSSYMAPERIQGND------------YSVKSDIWSLGLSLIELATGRFPYPPEND 204 (265)
T ss_pred HHH----------------hhcccCChhccCHHHHcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence 211 11155788999999987643 789999999999999999999999754
Q ss_pred ---CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 ---SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ---~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
...+....+..... +... ...+++++.+||.+||..||++|||+.+++.|-+
T Consensus 205 ~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 205 PPDGIFELLQYIVNEPP--PRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred ccccHHHHHHHHhcCCC--CCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 22333333333221 1111 1127889999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=304.46 Aligned_cols=250 Identities=22% Similarity=0.395 Sum_probs=204.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.||. +.+..++..||+|.+..... ...+.+.+|+++++.++ ||||+++++.+....
T Consensus 1 ~~~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~--h~~i~~~~~~~~~~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYL------AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK--HPNIVTFFASFQENG 72 (257)
T ss_pred CceEEEEecCCCcceEEE------EEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC--CCChhhhhheeccCC
Confidence 589999999999887754 66777889999999876422 23457788999999875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-cEEEeecceeeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDYGLAAIL 291 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-~vKL~DFGla~~~ 291 (1630)
.++++|||+.++.+..++... ..+++..+..++.|++.||.|||+.+|+|+||||+||++++++ .+||+|||.+...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 999999999888777766442 2589999999999999999999999999999999999999876 4699999998765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
.... .......|++.|+|||++.... ++.++|+||||+++|+|++|..||...+
T Consensus 153 ~~~~--------------~~~~~~~~~~~~~ape~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 153 NDSM--------------ELAYTCVGTPYYLSPEICQNRP------------YNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred cCCc--------------ccccccCCCccccCHHHHcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 4321 0112245788999999886543 7889999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+....+......+ ....++.++.++|.+||..+|++|||+.++++|.
T Consensus 207 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 207 LHQLVLKICQGYFAP------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred HHHHHHHHhcccCCC------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 766666554433211 1235778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=299.87 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
+|++.+.||+|+||.||. +.+..++..+|+|++..........+.+|++.++.+. ||||+++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYK------ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK--HPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEE------EEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC--CCCEeEEEEEEecCCeE
Confidence 588999999999887754 5566788999999998765545678889999999876 99999999999999999
Q ss_pred EEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 217 GLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+++|||++++.+..++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||.+.......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999988888776554 579999999999999999999999999999999999999999999999999987654321
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
. .....++..|+|||.+.... ++.++|+||||+++|+|++|..||...+....
T Consensus 153 ~---------------~~~~~~~~~~~~PE~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 153 A---------------RNTMVGTPYWMAPEVINGKP------------YDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred c---------------ccceecCCcccCHHHHcCCC------------CCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 0 22345788999999987543 68899999999999999999999988755544
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
...+.... .+... ....++.++.++|.+||+.||++|||+.++++|
T Consensus 206 ~~~~~~~~--~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 206 LFKIATNG--PPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHhcC--CCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 44433311 11111 122347899999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=308.54 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=202.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEe--
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-- 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-- 212 (1630)
.+|++.+.||+|+||.||+ ..+......++..||+|.+...... ....+.+|+++++.+. ||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~--~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~--~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVEL--CRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEE--eeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC--CCChheEEeeeecCC
Confidence 4788999999999999865 3333333557889999998865443 3567889999998875 9999999999887
Q ss_pred CCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
....+++|||++++.+..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 5679999999988877776654 336999999999999999999999999999999999999999999999999999876
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
..... .........++..|+|||.+.+.. ++.++||||||+++|||++|..||....
T Consensus 160 ~~~~~-----------~~~~~~~~~~~~~~~~Pe~~~~~~------------~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 160 PEDKD-----------YYYVKEPGESPIFWYAPECLRTSK------------FSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccCCc-----------ceeccCCCCCcccccCcHHHccCC------------CCcccchHHHhhhhheeeccCCCccccc
Confidence 53210 011111233456799999886544 7889999999999999999999986543
Q ss_pred HHH--------------HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 372 AEE--------------IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 372 ~~e--------------i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
... .+..........+ .+..++.++.+|+.+||+.+|++|||+.++++.|...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLP-----RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCC-----CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 221 1111112111111 1234678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=308.94 Aligned_cols=245 Identities=24% Similarity=0.231 Sum_probs=192.3
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||+|+||.||+ +.+..+++.||+|.+..... .....+.+|+++|+.++ ||||++++++|...+.+|+||
T Consensus 1 lg~g~~g~vy~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 72 (277)
T cd05577 1 LGKGGFGEVCA------CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS--SRFIVSLAYAFETKDDLCLVM 72 (277)
T ss_pred CCCCCceeEEE------EEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC--CCCEeeeeeEEecCCeEEEEE
Confidence 68999888764 55677899999999875432 22345567999998875 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccC
Q 000343 221 DRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 298 (1630)
||++++.|..++.+.. .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 149 (277)
T cd05577 73 TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--- 149 (277)
T ss_pred ecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence 9999888887765544 69999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHH
Q 000343 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378 (1630)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~ 378 (1630)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........
T Consensus 150 ------------~~~~~~~~~~y~~PE~~~~~~------------~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 205 (277)
T cd05577 150 ------------KIKGRAGTPGYMAPEVLQGEV------------YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE 205 (277)
T ss_pred ------------ccccccCCCCcCCHHHhcCCC------------CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH
Confidence 112345688999999987644 78899999999999999999999976543211112
Q ss_pred HHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHHh
Q 000343 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATF 426 (1630)
Q Consensus 379 i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~L 426 (1630)
+....... ....+..+++++.++|.+||+.||++|| ++.++++|.
T Consensus 206 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 206 LKRRTLEM---AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred HHhccccc---cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 21111110 1112335789999999999999999999 666677763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=301.07 Aligned_cols=249 Identities=21% Similarity=0.368 Sum_probs=208.7
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||.|+||.||. +.+..++..||+|++..... .....+.+|+++++.++ |||++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~~~~~~~~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYL------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--HPNIIKYYESFEEKG 72 (258)
T ss_pred CceEEeeeccCCCeEEEE------EEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC--CCChhheEEEEecCC
Confidence 589999999999888765 55667889999999887543 34567888999999876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.++++|||++++.+..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999998877776654 26799999999999999999999999999999999999999999999999999976
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
..... .......|++.|+|||.+.... ++.++|+||+|+++|+|++|..||...
T Consensus 153 ~~~~~--------------~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 153 LSSTV--------------DLAKTVVGTPYYLSPELCQNKP------------YNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred cccCc--------------ceecceeeeecccChhHhccCC------------CCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 54321 1122346788999999876544 788999999999999999999999888
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+..++...+......+ .+..++.++.+++.+||+.+|++|||+.++++|
T Consensus 207 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 207 NLLELALKILKGQYPP------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cHHHHHHHHhcCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 7777666665443211 223578999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=308.15 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=205.3
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+-|++.+.||.|+||.||+ +.+..++..||||.+..... .....+.+|+.++..+. ||||+++++++..+.
T Consensus 4 ~~~~~~~~ig~G~~~~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 75 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFK------GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD--SPYVTKYYGSYLKDT 75 (277)
T ss_pred HhhhhheeEeecCCeEEEE------EEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC--CCCEeEEEEEEEeCC
Confidence 4588899999999888764 55667889999998765432 22456778899988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+|+||||++++++..++.+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..+...
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999999888877754 46899999999999999999999999999999999999999999999999998765431
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||.+.... ++.++|+|||||++|+|++|..||.......
T Consensus 155 ~--------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 155 Q--------------IKRNTFVGTPFWMAPEVIKQSA------------YDSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred h--------------hhhccccCCccccChhhhccCC------------CCchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 1 0112245788999999986543 6789999999999999999999998877666
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
....+.... .+ .....++.++.+++.+||+.+|++||++.++++|-
T Consensus 209 ~~~~~~~~~--~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 209 VLFLIPKNN--PP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred HHHHHhcCC--CC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 555543322 11 12335788999999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=300.12 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=207.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.+.||+|+||.+|. +.+..+++.||+|.+..... .....+.+|++++.++. ||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYK------GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--HPNIVKYIGSIETSD 72 (254)
T ss_pred CceeeeEEcccCCeEEEE------EEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC--CCCccEEEEEEEeCC
Confidence 589999999999887754 56677889999999987644 23567788999988875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCc
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.++++|||++++.|..++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 99999999999888888777678999999999999999999999999999999999999999999999999999876532
Q ss_pred cccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHH
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~e 374 (1630)
. .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+...
T Consensus 153 ~--------------~~~~~~~~~~~y~~pe~~~~~~------------~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~ 206 (254)
T cd06627 153 S--------------KDDASVVGTPYWMAPEVIEMSG------------ASTASDIWSLGCTVIELLTGNPPYYDLNPMA 206 (254)
T ss_pred c--------------ccccccccchhhcCHhhhcCCC------------CCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 1 0122345788999999886543 6789999999999999999999998776655
Q ss_pred HHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 375 i~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
....+..... + ..+..++.++.+++.+||..+|++|||+.+++.+
T Consensus 207 ~~~~~~~~~~-~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 207 ALFRIVQDDH-P-----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHhccCC-C-----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 5544432221 1 1233578999999999999999999999999876
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=309.69 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=208.7
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
.+.|++.+.||+|+||.||. +.+..++..+|+|.+..... ....+.+|++.++.++ ||||+++++.+....
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYK------ATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK--HPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEE------EEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC--CCCeeEEEEEEEECC
Confidence 45799999999999887754 55666789999999886544 4567888999998875 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..|++|||++++.|..++.... .++...+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999888888777655 799999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ 373 (1630)
.. .......++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+..
T Consensus 169 ~~--------------~~~~~~~~~~~y~~PE~~~~~~------------~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 169 EK--------------SKRNSVVGTPYWMAPEVIKRKD------------YGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred ch--------------hhhccccCCcccCCHhHhcCCC------------CCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11 0112234688999999886543 789999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.....+........ .....++.++.+||.+||+.+|.+||++.++++|.+
T Consensus 223 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 223 RALFLITTKGIPPL----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred HHHHHHHhcCCCCC----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 55554443322111 112347889999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=312.88 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=205.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
..+.|...++||+|+||.||. +.+..++..||+|++....... ...+.+|+++++.++ ||||+++++++
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~------~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~ 90 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYF------ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK--HPNTIEYKGCY 90 (313)
T ss_pred HHHHhhcceeeccCCCeEEEE------EEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC--CCCCccEEEEE
Confidence 345688889999999887754 6677889999999987653332 245677889988875 99999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+....|++|||+.++++..+.....++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 91 LKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 99999999999999887777766666799999999999999999999999999999999999999999999999998753
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
... .....|+..|+|||++.... ...++.++||||||+++|+|++|..||...
T Consensus 171 ~~~------------------~~~~~~~~~y~aPE~~~~~~---------~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 171 SSP------------------ANSFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred cCC------------------CCCccccccccChhhccccC---------CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 12345788999999985321 112788999999999999999999999887
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.......+...... .. ....++..+.+|+.+||+.+|.+||++.+++.|-+
T Consensus 224 ~~~~~~~~~~~~~~~-~~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 224 NAMSALYHIAQNDSP-TL----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ChHHHHHHHHhcCCC-CC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 766555555433221 11 12346788999999999999999999999998733
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=308.66 Aligned_cols=265 Identities=20% Similarity=0.291 Sum_probs=211.8
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|.+.+.||+|+||.||. +.+..++..||+|.+..... .....+.+|+++++.+. +||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~ 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVL------AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGIIKLYYTFQD 73 (280)
T ss_pred CCceEeeeecCCCceEEEE------EEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-cCCCchhHHHHhcC
Confidence 4799999999999887754 56677899999999876422 22456778888888875 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...++++|||+.++.+..++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999888888887777789999999999999999999999999999999999999999999999999998765
Q ss_pred CccccCCCCC------CCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 293 KPACRKARPE------CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 293 ~~~~~~~~~~------~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
.......... ..............++..|+|||++.... ++.++|+||||+++|++++|..|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~------------~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP------------AGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC------------CChhhhHHHHHHHHHHHHhCCCC
Confidence 4321100000 00000112234456789999999876543 78899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh----hhHHHHh
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF----SAMLATF 426 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa----~evL~~L 426 (1630)
|...+....+..+...... .+..+++.+.+||.+||+.+|++||++ .++++|.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 222 FRGSNEYLTFQKILKLEYS-------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred CCCccHHHHHHHHHhcCCC-------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 9988766666665533222 123568999999999999999999999 8888774
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=344.01 Aligned_cols=271 Identities=21% Similarity=0.233 Sum_probs=202.4
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+...+|+.++.||+|+||.|| +++++-+|+.||||+|.... ......+.+|+..|.++. |||||++|..+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~Vv------kVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn--HpNVVRYysAW 546 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVV------KVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN--HPNVVRYYSAW 546 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEE------EEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC--Ccceeeeehhh
Confidence 3566899999999999988775 47899999999999998763 333567888999999975 99999986443
Q ss_pred E-----------------------------------------------------------e-------------------
Q 000343 211 R-----------------------------------------------------------M------------------- 212 (1630)
Q Consensus 211 ~-----------------------------------------------------------~------------------- 212 (1630)
- +
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 0 0
Q ss_pred ---------------------------------C--------CEEEEEEecCCCChHHHHHHcCCCC-CHHHHHHHHHHH
Q 000343 213 ---------------------------------D--------SCLGLVMDRCYGSVQLAMQRNEGRL-TLEQILRYGADI 250 (1630)
Q Consensus 213 ---------------------------------~--------~~~~LVmEy~~gglL~~l~~~~~~L-~~~~~~~i~~QI 250 (1630)
. ..+||=||||+..++..++..+... ....+.++++||
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREI 706 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHH
Confidence 0 2378999999999999998876544 478899999999
Q ss_pred HHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC----ccccCCCCCCCCCCcccccccccCCCCCCCccc
Q 000343 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK----PACRKARPECDSSRIHSCMDCTMLSPNYTAPEA 326 (1630)
Q Consensus 251 l~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~----~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEv 326 (1630)
++||.|+|++|||||||||.|||+++++.|||+|||+|..... ...................+..+||.-|+|||+
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999999999999999999999999999999999987321 000000000011112224567899999999999
Q ss_pred cccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC-CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHH
Q 000343 327 WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL-SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMI 405 (1630)
Q Consensus 327 l~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~-~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI 405 (1630)
+.+... ..|+.|+|+||||||||||+ +||... ....++..+..+....+ . .+...--+.-..+|
T Consensus 787 l~~~~~---------~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~--~-~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 787 LSDTSS---------NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP--A-DFFDPEHPEEASLI 851 (1351)
T ss_pred hccccc---------ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC--c-ccccccchHHHHHH
Confidence 986541 24999999999999999998 567543 23334444443332222 1 11112234567999
Q ss_pred HHhhccCcCCCCChhhHHHH
Q 000343 406 GECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 406 ~~cL~~dP~~RPSa~evL~~ 425 (1630)
+.||+.||++||||.|+|++
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=305.57 Aligned_cols=239 Identities=23% Similarity=0.283 Sum_probs=187.5
Q ss_pred EEeCcCCceeEEEeeEEEccccccCC----------cEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCR----------HSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g----------~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.||+|+||.||. +.+..++ ..+++|.+...... ...+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~------~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYK------GVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS--HKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEE------EEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC--CcchhheeeEEe
Confidence 4689999998854 3333333 46888877654433 677888999998875 999999999988
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-------cEEEe
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEG-RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-------RAVVS 283 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~-~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-------~vKL~ 283 (1630)
. ...++||||+.+++|..++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 72 R-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred c-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeC
Confidence 7 77899999999998888776544 799999999999999999999999999999999999999877 79999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||++...... ....++..|+|||++.... ..++.++||||||+++|+|++
T Consensus 151 Dfg~a~~~~~~------------------~~~~~~~~y~aPE~~~~~~----------~~~~~~~Di~slG~~~~~l~~~ 202 (259)
T cd05037 151 DPGIPITVLSR------------------EERVERIPWIAPECIRNGQ----------ASLTIAADKWSFGTTLLEICSN 202 (259)
T ss_pred CCCcccccccc------------------cccccCCCccChhhhcCCC----------CCcchhhHHHHHHHHHHHHHhC
Confidence 99998764321 1234567899999987641 127899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
|..||...+..+........... + .....++.++|.+||..+|++|||+.++++.|
T Consensus 203 ~~~p~~~~~~~~~~~~~~~~~~~-~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 203 GEEPLSTLSSSEKERFYQDQHRL-P-------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCcccCCchhHHHHHhcCCCC-C-------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 68888776543333222211111 1 11237899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=324.22 Aligned_cols=321 Identities=15% Similarity=0.086 Sum_probs=240.8
Q ss_pred hhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHH-cCCHHHHHHHHHhcCCCc--------------
Q 000343 474 QLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACR-RGSAELVEAILEYSQENV-------------- 538 (1630)
Q Consensus 474 ~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~-~G~~eiVk~LL~~~~~dv-------------- 538 (1630)
.|..+|+++.|+.|+..||++| .+++.|.||||+|+. .++.+++++||+.+ +++
T Consensus 78 ~~s~n~~lElvk~LI~~GAdvN----------~~~n~~~~~l~ya~~~~~~~eivk~Ll~~G-ad~~~~~~~g~~~~~~~ 146 (631)
T PHA02792 78 LCSDNIDIELLKLLISKGLEIN----------SIKNGINIVEKYATTSNPNVDVFKLLLDKG-IPTCSNIQYGYKIIIEQ 146 (631)
T ss_pred HHHhcccHHHHHHHHHcCCCcc----------cccCCCCcceeEeecCCCChHHHHHHHHCC-CCcccccccCcchhhhh
Confidence 4567899999999999999874 667789999999976 69999999999974 442
Q ss_pred ----------------------ccCCCCCCCHHHHHHHcC-------CHHHHHHHHHCCCCcccccccCCCchHHHHHHH
Q 000343 539 ----------------------DVLDKDGDPPLVFALAAG-------SPECVHALIKRGANVISRLREGFGPSVAHVCAY 589 (1630)
Q Consensus 539 ----------------------n~~D~~G~TPLh~Aa~~G-------~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~ 589 (1630)
|..|..|.||||+|+.++ +.+++++||++||+++.. +..|.||||+|+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~t~L~~~i~~~s~~~~~~~~~v~k~Li~~g~~~~~~--d~~g~t~l~~~~~ 224 (631)
T PHA02792 147 ITRAEYYNWDDELDDYDYDYTTDYDDRMGKTVLYYYIITRSQDGYATSLDVINYLISHEKEMRYY--TYREHTTLYYYVD 224 (631)
T ss_pred cccccccchhhhccccccccccccCCCCCCchHHHHHhhCCcccccCCHHHHHHHHhCCCCcCcc--CCCCChHHHHHHH
Confidence 244667999999999999 899999999999999875 4568999999999
Q ss_pred cC--CHHHHHHHHHcCCCCCCCCCCCCChhhhhhh--c----CChH--HHHHHHHcCCcccc----ccccCC--------
Q 000343 590 HG--QPDCMRELLLAGADPNAVDDEGESVLHRAVA--K----KYTD--CAIVILENGGCRSM----AILNSK-------- 647 (1630)
Q Consensus 590 ~G--~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~--~----g~~e--iv~~LL~~Ga~~~i----~~~d~~-------- 647 (1630)
+. ..|++++|++. ++.. .+-+..|+--.. . .+++ ++..||+.+...++ +..+..
T Consensus 225 ~~~i~~ei~~~L~~~-~~~~---~~~~~~l~~y~~~~~~~~~~~id~~iv~~ll~~~~~~~i~~~~~~~~~~~~~~~~~~ 300 (631)
T PHA02792 225 KCDIKREIFDALFDS-NYSG---NELMNILSNYLRKQYRNKNHKIDNYIVDKLLSGHDTFYILELCNSLRNNIIISSILK 300 (631)
T ss_pred cccchHHHHHHHHhc-cccc---cchHhHHHHHHHHHhccCccCccHHHHHHHHhCCCccchhhhhhhhhhhhHHHHHHH
Confidence 99 89999999984 2211 111223332222 1 1233 88888887752221 111111
Q ss_pred -----CCcHHHHHHHcC--CHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCc
Q 000343 648 -----ELTPLHLCVATW--NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTA 720 (1630)
Q Consensus 648 -----G~TPLh~Aa~~g--~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~ 720 (1630)
=+--||.=..++ +.+++++|++.|+... .......++.+ + ..++.+++++|+++|||+|.
T Consensus 301 ~~~~~~q~~l~~Yl~~~~v~ieiIK~LId~Ga~~~-------r~~~~n~~~~A-a-----~~gn~eIVelLIs~GADIN~ 367 (631)
T PHA02792 301 RYTDSIQDLLSEYVSYHTVYINVIKCMIDEGATLY-------RFKHINKYFQK-F-----DNRDPKVVEYILKNGNVVVE 367 (631)
T ss_pred HHhHHHHHHHHHHHhcCCccHHHHHHHHHCCCccc-------cCCcchHHHHH-H-----HcCCHHHHHHHHHcCCchhh
Confidence 011344444455 6799999999988632 01112223333 2 23568999999999999999
Q ss_pred ccccC--ccchhhhhhcCCH---HHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHH
Q 000343 721 QDAQN--RTALHIASMANDV---ELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAF 795 (1630)
Q Consensus 721 ~D~~G--~TpLH~Aa~~g~~---eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpL 795 (1630)
+|.+| .||||+|+..... +++++|+++|||+|.+|..|.||||+|+..++.+++++|+++|||+|.+|..|+|||
T Consensus 368 kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD~~G~TpL 447 (631)
T PHA02792 368 DDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITTKYGSTCI 447 (631)
T ss_pred hcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 99875 6999998877664 468999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhch----HHHhhHHHHHHHhhCCCCccc
Q 000343 796 HIAADAAK----MIRENLEWLIVMLSHPDAAVE 824 (1630)
Q Consensus 796 hlAa~~g~----~i~~n~e~vi~LL~~~gadvn 824 (1630)
|+|+.... .+++....+..+|++.+++++
T Consensus 448 ~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i~ 480 (631)
T PHA02792 448 GICVILAHACIPEIAELYIKILEIILSKLPTIE 480 (631)
T ss_pred HHHHHHHhcccHHHHHHHHHHHHHHHhcCCChh
Confidence 99976221 123344557778888887665
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=318.41 Aligned_cols=265 Identities=21% Similarity=0.251 Sum_probs=201.8
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
.+.++|++.+.||+|+||.||. |.+..++..+|+|++.... ......+.+|+.+++.+. +||||++++++|
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~------~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~ni~~~~~~~ 76 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWK------AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-DHPNIVKLLNVI 76 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEE------EEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc-CCCCccceeeee
Confidence 4567999999999999887754 6677788999999886532 223345667999998873 499999999998
Q ss_pred EeC--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 211 RMD--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 211 ~~~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
... ..+|+||||+++++. .++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~-~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 77 KAENDKDIYLVFEYMETDLH-AVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred ccCCCceEEEEecccccCHH-HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 653 468999999987554 444433 7899999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
..+....... .........||..|+|||++.+.. .++.++|+||||+++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 155 RSLSELEENP---------ENPVLTDYVATRWYRAPEILLGST-----------RYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred hccccccccc---------cCcchhcccccccccCceeeeccc-----------cccccchHHHHHHHHHHHHhCCCCCC
Confidence 8664321000 011223346799999999876532 16789999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCC------------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHH
Q 000343 369 GLSAEEIYRAVVKNRKLPP------------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~ 424 (1630)
+.+..+....+......+. .......+.++.++.+||.+||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 215 GTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 7765544443322211100 0001112246889999999999999999999999999
Q ss_pred Hh
Q 000343 425 TF 426 (1630)
Q Consensus 425 ~L 426 (1630)
|-
T Consensus 295 ~~ 296 (337)
T cd07852 295 HP 296 (337)
T ss_pred Ch
Confidence 83
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=305.11 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=199.4
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC-
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS- 214 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~- 214 (1630)
|++.+.||+|+||.||. ...+ .+..++..||||.+...... ..+.+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~--~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVRE--AQLK-SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD--HPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEe--eEee-ccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC--CCCcceEEEEEccCCC
Confidence 67788999999998864 2211 13456789999998764322 2456778999988875 999999999886532
Q ss_pred -----EEEEEEecCCCChHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEe
Q 000343 215 -----CLGLVMDRCYGSVQLAMQRN------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 215 -----~~~LVmEy~~gglL~~l~~~------~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
..++++||+.++.+..++.. ...++...++.++.|++.||+|||+.||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 35789999988877655421 1247899999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt- 362 (1630)
|||+++....... ........+++.|++||.+.... ++.++|||||||++|+|++
T Consensus 156 dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~pe~~~~~~------------~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 156 DFGLSKKIYSGDY------------YRQGCASKLPVKWLALESLADNV------------YTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred cccccccccCCcc------------eecCCCccCchhhcCHhHHhcCc------------cchhhhhHHHHHHHHHHhhC
Confidence 9999886543210 00111233467899999886544 6889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
|.+||...+..+.+..+........ ....+..+.+++.+||+.+|++|||+.+++..|...
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 212 GQTPYAGVENSEIYNYLIKGNRLKQ------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999988877777666655432211 134678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=304.59 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=202.6
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||.|+||.||+ +.+..+++.+|+|.+..... .....+.+|+++++.++ ||||+++++.+.....+|++|
T Consensus 1 lg~g~~~~vy~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~ 72 (265)
T cd05579 1 ISKGAYGRVFL------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ--SPYVVKLYYSFQGKKNLYLVM 72 (265)
T ss_pred CCCCCceEEEE------EEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC--CcchhHHHHheecCcEEEEEE
Confidence 68899887754 55677899999999876533 23556778888888876 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||+.++.+..++.+.+.+++..+..++.||+.||+|||+.+|+||||+|+|||++.++.+||+|||++...........
T Consensus 73 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~- 151 (265)
T cd05579 73 EYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL- 151 (265)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-
Confidence 9999988888877766899999999999999999999999999999999999999999999999999875432210000
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~ 380 (1630)
...........++..|+|||.+.... ++.++|+||||+++|+|++|..||......+.+..+.
T Consensus 152 -----~~~~~~~~~~~~~~~~~~Pe~~~~~~------------~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 152 -----NDDEKEDKRIVGTPDYIAPEVILGQG------------HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred -----ccccccccCcccCccccCHHHhcCCC------------CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 00011223456788999999986543 6889999999999999999999999888888777776
Q ss_pred hcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh---hhHHHH
Q 000343 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF---SAMLAT 425 (1630)
Q Consensus 381 ~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa---~evL~~ 425 (1630)
.+....+.. ..++..+.+|+.+||+.+|++|||+ .++++|
T Consensus 215 ~~~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 215 NGKIEWPED-----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCcCCCcc-----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 544332221 1258999999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=314.31 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=205.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
...|+..+.||+|+||.||. +.+..++..+|+|.+....... ...+.+|+++++.++ |||++++++++.
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 85 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYF------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHHheeeCCCEEEEE------EEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC--CCCcccEEEEEE
Confidence 35688899999999887754 6677788999999987542222 345667899998875 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
.....++||||+.++++..+......+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred cCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 99999999999988776666555567999999999999999999999999999999999999999999999999998764
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ....+++.|+|||.+.... ...++.++|||||||++|+|++|..||...+
T Consensus 166 ~~~------------------~~~~~~~~y~aPE~~~~~~---------~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 166 APA------------------NXFVGTPYWMAPEVILAMD---------EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred cCc------------------ccccCCccccCHHHHhhcc---------cCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 321 1235688999999975321 0126789999999999999999999998776
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
..+....+........ ....++..+.+||.+||+.+|++||++.++++|.+...
T Consensus 219 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 219 AMSALYHIAQNESPAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHhhcCCCCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 6555544444332111 12357788999999999999999999999999865444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=319.71 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=217.2
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+..++.+.||.|.||.|| ..+|-.-.+...-.||||..+.... ...+.|.+|..+|+.+. |||||+|++++.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy--~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd--HphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVY--KGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD--HPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhccHHHhhcCCccccee--eeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC--Ccchhheeeeeec-c
Confidence 466778899999999995 4677654455556799999987543 34677889999999987 9999999999875 5
Q ss_pred EEEEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..+||||+++-|.|..+++ +...|+......|+.||..||+|||+++++||||-..|||+.+...+||+|||+++.+..
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 6899999999888877665 455799999999999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
+.+.. .+...-+..|||||.+.... ++.++|||-||++|||++. |..||++...
T Consensus 544 ~~yYk-------------aS~~kLPIKWmaPESINfRr------------FTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 544 DAYYK-------------ASRGKLPIKWMAPESINFRR------------FTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred cchhh-------------ccccccceeecCccccchhc------------ccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 54221 12223367899999886544 8999999999999999998 9999999988
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.+++-.+.+|.+.|. ++++|+.+..|+.+||.++|.+||.+.++...|...++
T Consensus 599 sDVI~~iEnGeRlP~------P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 599 SDVIGHIENGERLPC------PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cceEEEecCCCCCCC------CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 888888877776553 35799999999999999999999999998776655443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=307.64 Aligned_cols=255 Identities=21% Similarity=0.262 Sum_probs=200.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc----CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE----MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~----~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+|++.+.||+|+||.||+.. ......++..||+|.+..... ...+.+.+|+++++.+. +||||+++++.|+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~---~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVR---KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEE---eccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-cCCChhceeeEeec
Confidence 48999999999999887622 112235789999999875422 22456778999999885 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+..+|+||||++++.+..++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999998888877766789999999999999999999999999999999999999999999999999987653
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS- 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~- 371 (1630)
... ........|+..|+|||.+.... ..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 157 EDE-------------VERAYSFCGTIEYMAPDIVRGGD----------GGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred ccc-------------ccccccccCCcccCChhhccCCC----------CCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 221 00112345788999999986532 126789999999999999999999996432
Q ss_pred ---HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCC-----ChhhHHHH
Q 000343 372 ---AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLAT 425 (1630)
Q Consensus 372 ---~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RP-----Sa~evL~~ 425 (1630)
..++...+...... .+..+++.+.+|+.+||+.||++|| ++.+++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 214 KNSQAEISRRILKSEPP-------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cccHHHHHHHhhccCCC-------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 23333333222211 1234788999999999999999997 67777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=304.34 Aligned_cols=261 Identities=19% Similarity=0.233 Sum_probs=194.4
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
++||+|+||.||+. ..+ .......+++|.+..... .....+.+|+.+++.++ ||||+++++.+.....+|+||
T Consensus 1 ~~lg~G~~g~v~~~-~~~---~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~--h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLS-EIY---TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEE-EEE---cCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC--CcchhheEEEecCCCccEEEE
Confidence 36999999999752 222 222345677887665432 23567788888888765 999999999999999999999
Q ss_pred ecCCCChHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccc
Q 000343 221 DRCYGSVQLAMQRNE----GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~----~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 296 (1630)
||++++.|..++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~- 153 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED- 153 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch-
Confidence 999988887766542 246777889999999999999999999999999999999999999999999975422110
Q ss_pred cCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCHHHH
Q 000343 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEI 375 (1630)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~~ei 375 (1630)
.........++..|+|||++...... .....++.++||||||+++|||++ |..||...+..+.
T Consensus 154 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 217 (268)
T cd05086 154 -----------YIETEDDKCVPLRWLAPELVGEFHGG-----LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217 (268)
T ss_pred -----------hhhcccCCcCcccccCchhcccccCc-----cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 00112235678899999998642210 011236789999999999999997 6789988777777
Q ss_pred HHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 376 ~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+..+....... .........+++.+.+++..|| .+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKDQQVK-LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhhcccc-cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 76665443221 1112223357788999999999 78999999999988753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=309.62 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=200.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++|++.+.||+|+||.||+ +.+..+++.||||.++..... ....+.+|+.++.... .||||+++++++....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~------~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYK------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYGYFITDS 87 (296)
T ss_pred chheeeeEeeccCCeEEEE------EEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-CCCchHhhheeeecCC
Confidence 6899999999999887754 556677899999998764322 2344556777666654 6999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|++|||+.+.+...+......+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++..+..
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999999876655555545679999999999999999999997 5999999999999999999999999999876532
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA- 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~- 372 (1630)
.. ......++..|+|||.+.+... ...++.++||||||+++|+|++|+.||.....
T Consensus 168 ~~---------------~~~~~~~~~~y~aPE~~~~~~~--------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 224 (296)
T cd06618 168 SK---------------AKTRSAGCAAYMAPERIDPPDP--------NPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224 (296)
T ss_pred CC---------------cccCCCCCccccCHhhcCCCCC--------ccccccchhHHHHHHHHHHHHhCCCCCCcchhH
Confidence 11 0112346788999999875421 12378899999999999999999999976433
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+.+..+...... ... ....++.++.+|+.+||+.||++||++.+++.|.+
T Consensus 225 ~~~~~~~~~~~~~--~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 225 FEVLTKILQEEPP--SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHHHHHHhcCCCC--CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 3444444433211 111 11246889999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=317.58 Aligned_cols=261 Identities=18% Similarity=0.195 Sum_probs=193.9
Q ss_pred EEeCcC--CceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 142 KKLGEG--RRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 142 ~~LG~G--~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
..||+| +|+.| |.+.+..+++.||+|.+...... ..+.+.+|+.+++.++ ||||++++++|..+..++
T Consensus 4 ~~ig~g~~~~~~v------~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~--h~niv~~~~~~~~~~~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSV------YLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR--HPNIMTSWTVFTTGSWLW 75 (328)
T ss_pred HHhCCcccCceeE------EEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC--CCCcceEeeeEecCCceE
Confidence 457777 65555 44778889999999998764322 2356777888877765 999999999999999999
Q ss_pred EEEecCCCChHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 218 LVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~--~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
++|||+.++.+..++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++||+.+.......
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 999999988877766542 358999999999999999999999999999999999999999999999998654332111
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.. ............++..|+|||++.+.. ..++.++|||||||++|+|++|..||........
T Consensus 156 ~~-------~~~~~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 218 (328)
T cd08226 156 QK-------AKVVYDFPQFSTSVLPWLSPELLRQDL----------YGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218 (328)
T ss_pred cc-------ccccccccccccCccCccChhhhcCCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH
Confidence 00 000001111223567899999987532 1278999999999999999999999987765544
Q ss_pred HHHHHhcCCCCCC----------------------------------------cccccCCCCCHHHHHHHHHhhccCcCC
Q 000343 376 YRAVVKNRKLPPQ----------------------------------------YASIVGVGIPRELWKMIGECLQFKASK 415 (1630)
Q Consensus 376 ~~~i~~~~~~~~~----------------------------------------~~~~~~~~l~~el~~LI~~cL~~dP~~ 415 (1630)
...........+. ........+++++.+||++||+.||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 4433322111000 000011235678999999999999999
Q ss_pred CCChhhHHHHhh
Q 000343 416 RPTFSAMLATFL 427 (1630)
Q Consensus 416 RPSa~evL~~L~ 427 (1630)
|||+.++++|.+
T Consensus 299 Rpta~e~l~~~~ 310 (328)
T cd08226 299 RPSASSLLSHAF 310 (328)
T ss_pred CCCHHHHhhCHH
Confidence 999999998855
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=304.67 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=200.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEcccccc-CCcEEEEEEeeccCcC----------ChhHHHHHHHHHHHhccCCCCcce
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGR-CRHSVAVKKVMIAEEM----------EPDWLSGQLDNLRRASMWCRNVCT 205 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~-~g~~VAIK~i~~~~~~----------~~~~~~~Ei~iL~~l~l~HpNIV~ 205 (1630)
.|++.+.||+|+||.||. +.+.. +++.+|+|.+...... ....+.+|+.++... .+||||++
T Consensus 1 ~y~~~~~ig~G~~~~v~~------~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~~h~~i~~ 73 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYK------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-LRHPNIVR 73 (269)
T ss_pred CchhhhhhcCCCCceEEE------EEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-CCCCCeee
Confidence 488899999999888864 44444 6789999988643211 123355666666553 36999999
Q ss_pred eEEEEEeCCEEEEEEecCCCChHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceEECCCCcE
Q 000343 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQ----RNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRA 280 (1630)
Q Consensus 206 l~~~f~~~~~~~LVmEy~~gglL~~l~----~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NILld~~g~v 280 (1630)
+++++.....++++|||+.++.+..++ .....+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcE
Confidence 999999999999999999987776554 234569999999999999999999996 689999999999999999999
Q ss_pred EEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHH
Q 000343 281 VVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360 (1630)
Q Consensus 281 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyem 360 (1630)
||+|||++....... ......|+..|+|||.+.+.. ++.++|+||||+++|+|
T Consensus 154 ~l~dfg~~~~~~~~~---------------~~~~~~~~~~~~~Pe~~~~~~------------~~~~~Dv~slG~ll~~l 206 (269)
T cd08528 154 TITDFGLAKQKQPES---------------KLTSVVGTILYSCPEIVKNEP------------YGEKADVWAFGCILYQM 206 (269)
T ss_pred EEecccceeeccccc---------------ccccccCcccCcChhhhcCCC------------CchHHHHHHHHHHHHHH
Confidence 999999997654211 123356788999999987644 78899999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 361 CTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 361 ltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++|..||...........+......+.. ...+++++.+||.+||+.||++||++.|+..++.
T Consensus 207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 207 CTLQPPFYSTNMLSLATKIVEAVYEPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HhCCCcccccCHHHHHHHHhhccCCcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999877766666555544332211 1246789999999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=310.40 Aligned_cols=258 Identities=14% Similarity=0.175 Sum_probs=183.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccC---CcEEEEEEeeccCcCChhH--------HHHHHHHHHHh-ccCCCC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC---RHSVAVKKVMIAEEMEPDW--------LSGQLDNLRRA-SMWCRN 202 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~---g~~VAIK~i~~~~~~~~~~--------~~~Ei~iL~~l-~l~HpN 202 (1630)
.++|++.+.||+|+||.||. |....+ +..+|+|............ ...++..+..+ ...|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~------~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYE------TQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEE------EEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 46899999999999998864 333344 5677777644332211000 01122222222 246999
Q ss_pred cceeEEEEEeCC----EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC
Q 000343 203 VCTFHGVLRMDS----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278 (1630)
Q Consensus 203 IV~l~~~f~~~~----~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g 278 (1630)
|+++++.+.... ..+++||++..++...+. .....++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 999999765543 467899988766554433 333468889999999999999999999999999999999999999
Q ss_pred cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHH
Q 000343 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358 (1630)
Q Consensus 279 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILy 358 (1630)
.+||+|||+|+.+....... ...........||+.|+|||++.+.. ++.++|||||||+||
T Consensus 164 ~~~l~DFGla~~~~~~~~~~-------~~~~~~~~~~~gt~~y~ape~~~~~~------------~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHI-------EYSKEQKDLHRGTLYYAGLDAHNGAC------------VTRRGDLESLGYCML 224 (294)
T ss_pred cEEEEEcCCceeeccCCccc-------ccccccccccCCCccccCHHHhCCCC------------CCcHHHHHHHHHHHH
Confidence 99999999998764321000 00001122346899999999987654 789999999999999
Q ss_pred HHhhCCCCCCCCCH-HHHH--------HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 359 EMCTGSIPWAGLSA-EEIY--------RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 359 emltG~~PF~~~~~-~ei~--------~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
||++|++||.+... ...+ ..+..+.. .....++++.+++..||+.+|++||++.++++.+
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999999987632 2222 22221111 1234678999999999999999999999998754
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=310.87 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=205.1
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
.|+...+||+|+||.||. +..+.+++.||||++..........+.+|+.+++.++ ||||+++++.|...+..
T Consensus 21 ~~~~~~~lg~g~~g~v~~------~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCI------ATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ--HENVVEMYNSYLVGDEL 92 (292)
T ss_pred HhhhHHHcCCCCCeEEEE------EEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC--CcchhheeeEEEeCCEE
Confidence 455567899999887754 5566789999999987554445667888999988875 99999999999999999
Q ss_pred EEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccc
Q 000343 217 GLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~ 296 (1630)
+++|||++++++..+... ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~- 170 (292)
T cd06657 93 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 170 (292)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence 999999999988877654 468999999999999999999999999999999999999999999999999987653211
Q ss_pred cCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHH
Q 000343 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376 (1630)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~ 376 (1630)
.......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+..
T Consensus 171 -------------~~~~~~~~~~~y~~pE~~~~~~------------~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 171 -------------PRRKSLVGTPYWMAPELISRLP------------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred -------------ccccccccCccccCHHHhcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112345788999999886544 688999999999999999999999887766655
Q ss_pred HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 377 RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 377 ~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+..... +... ....+++++.+++.+||..+|.+||++.+++.|-+
T Consensus 226 ~~~~~~~~--~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 226 KMIRDNLP--PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred HHHHhhCC--cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 55433221 1111 11346889999999999999999999999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=339.14 Aligned_cols=147 Identities=22% Similarity=0.318 Sum_probs=130.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
++|.++++||+|+||.||+ |.+..+++.||||++....... ...+.+|+.++..++ ||||+++++++..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~------a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~--hp~Iv~~~~~~~~ 75 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYL------GRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHLYYSLQS 75 (669)
T ss_pred CCEEEEEEEecCCCeEEEE------EEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC--CCCcCeEEEEEEE
Confidence 5899999999999888865 5677789999999998654322 356778888888765 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
...+||||||+.++.|..++...+.+++..++.|+.||+.||+|||+++||||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999999988888887767899999999999999999999999999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=301.52 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=205.6
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+|++.++||.|+||.||+ +.+..+++.+|+|.+...... ....+.+|+.+++.++ ||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYK------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN--HPNIISYKEAFLDGN 72 (256)
T ss_pred CceEeeeecCCCceeEEE------EEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC--CCCchhhhhhhccCC
Confidence 589999999999887764 556778899999998865322 2445667888888876 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAMQRN----EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~----~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
..|+||||++++.+..++.+ ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 99999999998888776544 34689999999999999999999999999999999999999999999999999876
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
.... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 153 ~~~~----------------~~~~~~~~~~~~~Pe~~~~~~------------~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 153 LKKN----------------MAKTQIGTPHYMAPEVWKGRP------------YSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred hccC----------------CcccccCCccccCHHHHCCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5432 112245688999999987644 788999999999999999999999988
Q ss_pred CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+..+....+...... + ....++.++.+++.+||+.+|++||++.++++|.
T Consensus 205 ~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 205 SMQDLRYKVQRGKYP-P-----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred CHHHHHHHHhcCCCC-C-----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 877666655443322 1 1225788999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=313.14 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=198.4
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccC--CcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRC--RHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~--g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+|++.+.||+|+||.||+ +.+..+ +..||+|++...... ....+.+|+.+++++. +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~------~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCS------ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-GHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEE------EEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCChheeeeeeee
Confidence 589999999999988865 444555 789999998753222 2456678999998875 59999999997543
Q ss_pred C----CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeeccee
Q 000343 213 D----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288 (1630)
Q Consensus 213 ~----~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla 288 (1630)
. ..+|++|||+.+++...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~~~~~~~~e~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 74 FPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred ccccCCcEEEEEecccCCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 2 458899999987655444 44567999999999999999999999999999999999999999999999999999
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
+.+...... .........||+.|+|||++.+.. .++.++||||||+++|+|++|.+||.
T Consensus 153 ~~~~~~~~~----------~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 153 RGFSENPGE----------NAGFMTEYVATRWYRAPEIMLSFQ-----------SYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred eeccccccc----------ccccccCcccCccccCcHHHhCCC-----------CCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 876532100 011123356899999999876432 27899999999999999999999998
Q ss_pred CCCHHHHHHHHHhcCCCCC------------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHH
Q 000343 369 GLSAEEIYRAVVKNRKLPP------------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~ 424 (1630)
..+....+..+......++ .......+..+.++.+|+.+||+.||++|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 212 GKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 7665444443332211110 0001112345788999999999999999999999998
Q ss_pred Hhh
Q 000343 425 TFL 427 (1630)
Q Consensus 425 ~L~ 427 (1630)
|-+
T Consensus 292 ~~~ 294 (332)
T cd07857 292 HPY 294 (332)
T ss_pred Chh
Confidence 743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=315.90 Aligned_cols=256 Identities=22% Similarity=0.245 Sum_probs=200.7
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||. +.+..++..||||++...... ....+.+|+++|+.++ ||||++++++|.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 84 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCS------ALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK--HENVIGLLDVFT 84 (343)
T ss_pred cccceEEEEEeeecCCeEEEE------EEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC--CCCccceeeeec
Confidence 567899999999999888754 567788999999998654222 2346778999999875 999999999987
Q ss_pred eCC------EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MDS------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~~------~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
... .+++||||+. +++..+... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFMG-TDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred CCccccccceEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 653 4699999994 455555543 46999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|++...... .....+++.|+|||++.+.. .++.++|+||||+++|+|++|..
T Consensus 163 g~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Di~slG~ll~~l~~g~~ 214 (343)
T cd07880 163 GLARQTDSE-----------------MTGYVVTRWYRAPEVILNWM-----------HYTQTVDIWSVGCIMAEMLTGKP 214 (343)
T ss_pred ccccccccC-----------------ccccccCCcccCHHHHhCCC-----------CCCcHHHHHHHHHHHHHHHhCCC
Confidence 998754321 12235688999999986422 16889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCC------------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPP------------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||...+....+..+......++ .........+++++.++|.+||+.||++|||+.+
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 9987766555444433211110 0000112357788999999999999999999999
Q ss_pred HHHHhh
Q 000343 422 MLATFL 427 (1630)
Q Consensus 422 vL~~L~ 427 (1630)
++.|-+
T Consensus 295 ~l~~~~ 300 (343)
T cd07880 295 ALAHPY 300 (343)
T ss_pred HhcCcc
Confidence 998743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=296.33 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=207.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeC-
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~- 213 (1630)
+|.+.+.||+|+||.||. +.+..++..|++|.+..... ...+.+.+|+..++++. ||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYL------ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ--HPNIVRYYGSERDEE 72 (260)
T ss_pred CceeeeEeeecCceEEEE------EEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC--CCCEeeEEEEEecCC
Confidence 588899999999887754 66777899999999876543 34667888999999976 99999999999988
Q ss_pred -CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 214 -SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 -~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..++++|||++++.+..++.+...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.+....
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 73 KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 8999999999888888887766689999999999999999999999999999999999999999999999999998765
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS- 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~- 371 (1630)
..... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||....
T Consensus 153 ~~~~~------------~~~~~~~~~~~y~~pE~~~~~~------------~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (260)
T cd06606 153 DIETG------------EGTGSVRGTPYWMAPEVIRGEE------------YGRAADIWSLGCTVIEMATGKPPWSELGN 208 (260)
T ss_pred ccccc------------ccccCCCCCccccCHhhhcCCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 43200 0122345788999999987644 6899999999999999999999998765
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.......+......+ ..+..++.++.+||.+||..||++||++.+++.|-
T Consensus 209 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 209 PMAALYKIGSSGEPP-----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred hHHHHHhccccCCCc-----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 233333332211111 12335689999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=315.34 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=212.6
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
.+...+.++||+|.||.|.+. .+ ..+.+||+|+++...... ...+.+|+++|.+++ ||||++|++++..+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLC-ev------eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk--hPNIveLvGVC~~D 607 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLC-EV------EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK--HPNIVELLGVCVQD 607 (807)
T ss_pred hhheehhhhhcCcccceeEEE-Ee------cCceEEEEeecCcccchhHHHHHHHHHHHHhccC--CCCeeEEEeeeecC
Confidence 356788999999999999873 22 235799999998775443 478899999999985 99999999999999
Q ss_pred CEEEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+.+++||||+..|+|..++.... .+......+|+.||++|++||-+.+++||||-+.|+|++.++++||+|||+++.+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 99999999998888887776542 2355667789999999999999999999999999999999999999999999855
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh--CCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT--GSIPWAG 369 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt--G~~PF~~ 369 (1630)
-.... +......+-+.+|||||.+..++ +++++|+|+||++|||+++ ...||..
T Consensus 688 ysg~y------------y~vqgr~vlpiRwmawEsillgk------------FttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 688 YSGDY------------YRVQGRAVLPIRWMAWESILLGK------------FTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred ccCCc------------eeeecceeeeeeehhHHHHHhcc------------ccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 33221 22223344578999999998777 8999999999999999887 7899999
Q ss_pred CCHHHHHHHHHhcCCCC-CCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 370 LSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~-~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
.+.+++..+...-.... ...-...+.-+|.++.+||.+||+.+..+|||++++..+|++.
T Consensus 744 lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 744 LTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 88888776654322111 1111223456889999999999999999999999999888764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=314.83 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=197.2
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+..+|.+.+.||+|+||.||. |.+..+++.||||++..... .....+.+|+.+++.+. ||||++++++|.
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~ 84 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCS------AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--HENVIGLLDVFT 84 (342)
T ss_pred cccceEEEEEeeecCCeEEEE------EEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC--CCCccchhheec
Confidence 456899999999999887754 66777899999999875422 22345778999999875 999999999987
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ..+|+||||+...+ ..+. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~l-~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQTDL-QKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ccccCCCCceEEEEecccccCH-HHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 54 34799999997644 3333 236899999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|+++..... .....++..|+|||++.+.. .++.++|||||||++|||++|+.
T Consensus 162 g~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 162 GLARHADAE-----------------MTGYVVTRWYRAPEVILNWM-----------HYNQTVDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred CCCcCCCCC-----------------CCCceeeecccChhhhcCcc-----------ccCchHHHHHHHHHHHHHHhCCC
Confidence 998653211 12345688999999986532 16889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCC--------------------Cc----ccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPP--------------------QY----ASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~--------------------~~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||.+.+....+..+......+. .. .....+..++++.+||.+||+.||++||++.+
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e 293 (342)
T cd07879 214 LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE 293 (342)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9988776555544443211110 00 00011246788999999999999999999999
Q ss_pred HHHH
Q 000343 422 MLAT 425 (1630)
Q Consensus 422 vL~~ 425 (1630)
++.|
T Consensus 294 ~l~h 297 (342)
T cd07879 294 ALEH 297 (342)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=324.98 Aligned_cols=246 Identities=23% Similarity=0.278 Sum_probs=203.4
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.+.+.|++...+|.|+|+.+. .+.+..+++..|+|++.... ....+|+.++.... +||||+++++++.+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~------~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~-~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVK------YCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVR-DHPNIVKSHDVYED 387 (612)
T ss_pred CcchhhccccccCCCCcccee------eeeccccccchhheeccccc----cccccccchhhhhc-CCCcceeecceecC
Confidence 467899999999999987663 35688899999999998752 22345777777765 69999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEE-CCCCcEEEeecceeeee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL-DASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILl-d~~g~vKL~DFGla~~~ 291 (1630)
..+.|+|||++.|+.+...+.....+. .++..|++||+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++..
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999999999988777666554444 7888999999999999999999999999999999 58899999999999765
Q ss_pred cCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
... ....+-|..|.|||++.... |+.++||||||++||+|++|+.||...+
T Consensus 467 ~~~-----------------~~tp~~t~~y~APEvl~~~~------------yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 467 ERS-----------------CDTPALTLQYVAPEVLAIQE------------YTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred chh-----------------hcccchhhcccChhhhccCC------------CCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 432 11234488999999998543 9999999999999999999999998766
Q ss_pred HH-HHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~-ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
.. ++...+..+. +. ..+|.++++||+.||+.||.+||++.+++.|-+.
T Consensus 518 ~~~ei~~~i~~~~-----~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 518 AGIEIHTRIQMPK-----FS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred chHHHHHhhcCCc-----cc----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 55 4444443322 11 4689999999999999999999999999998665
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=323.11 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=221.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccC---CcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC---RHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~---g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
...++.+.||.|.||.|+. |+-+.. ...||||.++..-.. ....|..|..||-++. ||||++|.++..
T Consensus 629 s~i~Ie~VIGaGEFGEVc~------GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd--HPNIIrLEGVVT 700 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCS------GRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD--HPNIIRLEGVVT 700 (996)
T ss_pred hheEEEEEEecccccceec------ccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC--CCcEEEEEEEEe
Confidence 4567999999999998863 444433 358999999976433 3556888999999987 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~-~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
....++||+|||+++.|+.+++ +++.|+.-+..-+++.|+.|++||-++|+|||||-+.|||++.+-.+|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999998887776654 567899999999999999999999999999999999999999999999999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
+.++.. ..+. +.+..=..+|.|||.+...+ ++.++||||||++|||.++ |..||-+
T Consensus 781 ledd~~----------~~yt-t~GGKIPiRWTAPEAIa~RK------------FTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 781 LEDDPE----------AAYT-TLGGKIPIRWTAPEAIAYRK------------FTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred cccCCC----------cccc-ccCCccceeecChhHhhhcc------------cCchhhccccceEEEEecccCCCcccc
Confidence 765320 0111 11112267899999998766 8999999999999999888 9999999
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
.+.++++..|.++...|+. .++|..+..||..||+.|-.+||.+.+++.+|.+.+...
T Consensus 838 mSNQdVIkaIe~gyRLPpP------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLPPP------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cchHHHHHHHHhccCCCCC------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999887764 368999999999999999999999999999988877543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=311.62 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=187.8
Q ss_pred cccCCcEEEEEEeecc--CcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHc--CCCC
Q 000343 163 QGRCRHSVAVKKVMIA--EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRN--EGRL 238 (1630)
Q Consensus 163 ~~~~g~~VAIK~i~~~--~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~--~~~L 238 (1630)
...+++.||||++... .......+.+|+++++.++ ||||++++++|.....++++|||++++++..++.. ...+
T Consensus 21 ~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~ 98 (314)
T cd08216 21 HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ--HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL 98 (314)
T ss_pred ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC--CcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCC
Confidence 4568999999998865 2334567889999999976 99999999999999999999999999888877654 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCC
Q 000343 239 TLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318 (1630)
Q Consensus 239 ~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 318 (1630)
++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+|||.+.......... ...........++
T Consensus 99 ~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 171 (314)
T cd08216 99 PELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-------RVVHDFPKSSVKN 171 (314)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc-------ccccccccccccc
Confidence 999999999999999999999999999999999999999999999999987654321100 0011112334568
Q ss_pred CCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC-------C----
Q 000343 319 PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLP-------P---- 387 (1630)
Q Consensus 319 ~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~-------~---- 387 (1630)
..|+|||++.... ..++.++|+|||||++|+|++|..||..............+.... +
T Consensus 172 ~~y~aPE~~~~~~----------~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 172 LPWLSPEVLQQNL----------QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccCHHHhcCCC----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 8899999986532 237899999999999999999999998765543332222111000 0
Q ss_pred ----------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 388 ----------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 388 ----------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.........++.++.+|+.+||+.||++|||+.++++|.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000011123467889999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=311.67 Aligned_cols=256 Identities=20% Similarity=0.365 Sum_probs=212.5
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
.++++..+||-|.||.||. |..++..-.||||.++. +.++.+.|..|..+|+.+. |||+|+|+++|.....
T Consensus 267 tdItMkhKLGGGQYGeVYe------GvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeik--HpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYE------GVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hheeeeeccCCCcccceee------eeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhc--CccHHHHhhhhccCCC
Confidence 4567788999999888853 44445667899998875 5667788999999999986 9999999999999999
Q ss_pred EEEEEecCC-CChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecC
Q 000343 216 LGLVMDRCY-GSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~-gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+|||+|||. |++|+++... +..++.-..++++.||.+|+.||..+++|||||-..|.|+.++..+|++|||+++++..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999985 4555555433 23478888899999999999999999999999999999999999999999999999875
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
+.+. ...+..=.+.|.|||-+.... ++.++|||+||++|||+.| |..||.+.+.
T Consensus 418 DTYT-------------AHAGAKFPIKWTAPEsLAyNt------------FSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 418 DTYT-------------AHAGAKFPIKWTAPESLAYNT------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred Ccee-------------cccCccCcccccCcccccccc------------cccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 4321 111122256799999987655 7899999999999999999 9999999999
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.++|..+.++..+.. ++++|+.+.+||+.||+.+|++||+++|+.+.|...+.
T Consensus 473 SqVY~LLEkgyRM~~------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDG------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHhccccccC------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 988887777655432 35799999999999999999999999999887776553
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=312.24 Aligned_cols=256 Identities=21% Similarity=0.243 Sum_probs=198.0
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||+ +.+..+++.||+|++..... .....+.+|+++++.++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~~iv~~~~~~~ 86 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCA------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFT 86 (345)
T ss_pred ccCceEEEEEeeecCCeEEEE------EEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC--CCcccceeeeee
Confidence 557999999999999888754 55678899999999875422 22456778999998875 999999999986
Q ss_pred eC------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MD------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.. ...|++++++.+ .+..++.. ..+++..++.++.|+++||+|||++||+||||||+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~~~lv~~~~~~-~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 87 PARSLEEFNDVYLVTHLMGA-DLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred ecccccccccEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecc
Confidence 43 347889998755 44555443 36999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|++...... .....++..|+|||.+.+.. .++.++|||||||++|+|++|+.
T Consensus 165 g~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DvwslG~il~el~~g~~ 216 (345)
T cd07877 165 GLARHTDDE-----------------MTGYVATRWYRAPEIMLNWM-----------HYNQTVDIWSVGCIMAELLTGRT 216 (345)
T ss_pred ccccccccc-----------------ccccccCCCccCHHHHhCcc-----------CCCchhhHHHHHHHHHHHHhCCC
Confidence 998753211 12345688999999876522 26889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCC------------------------CcccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPP------------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~------------------------~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||...+....+..+......++ ..........++++.+||.+||+.||.+||++.+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 217 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 9987665554444333211110 0000011235788999999999999999999999
Q ss_pred HHHHhh
Q 000343 422 MLATFL 427 (1630)
Q Consensus 422 vL~~L~ 427 (1630)
++.|-+
T Consensus 297 ~l~h~~ 302 (345)
T cd07877 297 ALAHAY 302 (345)
T ss_pred HhcChh
Confidence 999844
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=316.19 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=206.7
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc---CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE---MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~---~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.-|..++.||-|+||+|.|. +...|...||+|.+.+.+- +.....+.|..||.... .+.||+||..|++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD--n~WVVrLyySFQD 700 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLV------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD--NEWVVRLYYSFQD 700 (1034)
T ss_pred cceEEEeeecccccceeEEE------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC--CcceEEEEEEecc
Confidence 46889999999999999873 3456788999999987643 33556778999999976 7999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
++.+|+||+|++||++..++-+.+-|++..+++|+.++.+|+++.|++|+|||||||+|||||.+|++||+|||||.-+.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999988877777889999999999999999999999999999999999999999999999999996431
Q ss_pred ---Ccccc------C-----------CCCCCCCC--------CcccccccccCCCCCCCccccccccccccccccCcCCC
Q 000343 293 ---KPACR------K-----------ARPECDSS--------RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344 (1630)
Q Consensus 293 ---~~~~~------~-----------~~~~~~~~--------~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~ 344 (1630)
+..+. + ....|... .........+||+.|+|||++.... |
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g------------~ 848 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG------------Y 848 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC------------c
Confidence 11110 0 00001000 0011123568999999999997643 8
Q ss_pred CccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC---hhh
Q 000343 345 SPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT---FSA 421 (1630)
Q Consensus 345 t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS---a~e 421 (1630)
+..+|+||.|||||||+.|++||...++.+...++...+...- -....++++++.+||.+++ -+++.|.. +.+
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~---~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~ 924 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH---IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQ 924 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc---cccccccCHHHHHHHHHHh-cChhhhhcccchhh
Confidence 8999999999999999999999988877666555554432211 1123468999999998866 35677764 445
Q ss_pred HHHH
Q 000343 422 MLAT 425 (1630)
Q Consensus 422 vL~~ 425 (1630)
+-.|
T Consensus 925 vKaH 928 (1034)
T KOG0608|consen 925 VKAH 928 (1034)
T ss_pred hhcC
Confidence 6555
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=303.37 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=198.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc----CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE----MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~----~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+|++.+.||+|+||.||... ......++..||||.+..... .....+.+|++++..++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~---~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVR---KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-RCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEE---EeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-CCcchhhhheeeec
Confidence 48999999999999987521 122345778999999875422 22456778999999885 59999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||+.++.+..++.....+++..++.++.|+++||+|||+.+++||||||+||+++.++.++|+|||+++.+.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999988887777666679999999999999999999999999999999999999999999999999987653
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC-
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS- 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~- 371 (1630)
... ........|+..|+|||.+.+.. ...+.++|+||||+++|+|++|..||....
T Consensus 157 ~~~-------------~~~~~~~~~~~~y~aPE~~~~~~----------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 157 AEE-------------EERAYSFCGTIEYMAPEVIRGGS----------GGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred ccc-------------ccccccccCCccccCHHHhcCCC----------CCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 221 01112345788999999976532 125789999999999999999999996432
Q ss_pred ---HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhH
Q 000343 372 ---AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 372 ---~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~ev 422 (1630)
..+....+...... .+..++.++.++|.+||+.||++|||+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 214 QNSQSEISRRILKSKPP-------FPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred cchHHHHHHHHHccCCC-------CCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 23333333332211 123477899999999999999999997655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=306.50 Aligned_cols=271 Identities=17% Similarity=0.215 Sum_probs=214.2
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-------ChhHHHHHHHHHHHhccCCCCcc
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-------EPDWLSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-------~~~~~~~Ei~iL~~l~l~HpNIV 204 (1630)
+.+.++|-++..||+|+|+.| |+|.+....+.||+|+-+..... .....-+|..|.+.+. ||.||
T Consensus 459 ptLn~RYLlLhLLGrGGFSEV------yKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD--HpRIV 530 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEV------YKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD--HPRIV 530 (775)
T ss_pred cchHHHHHHHHHhccccHHHH------HHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC--cceee
Confidence 446789999999999998877 56889999999999976554322 2344567888988876 99999
Q ss_pred eeEEEEEe-CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccceEEC---CCC
Q 000343 205 TFHGVLRM-DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLD---ASG 278 (1630)
Q Consensus 205 ~l~~~f~~-~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~g--IIHRDLKP~NILld---~~g 278 (1630)
++|++|.- ...+|-|+|||+|++|+.+++....+++++++.|+.||+.||.||.... |||-||||.|||+- ..|
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 99999975 4569999999999999999998888999999999999999999999874 99999999999995 347
Q ss_pred cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHH
Q 000343 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358 (1630)
Q Consensus 279 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILy 358 (1630)
.+||+|||+++.+..+.... ..-...+....||..|++||.+.-.+ .+..++.++||||+|||+|
T Consensus 611 eIKITDFGLSKIMdddSy~~-------vdGmeLTSQgAGTYWYLPPEcFvVgk--------ePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNS-------VDGMELTSQGAGTYWYLPPECFVVGK--------EPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred eeEeeecchhhhccCCccCc-------ccceeeecccCceeeecCcceeecCC--------CCCccccceeeEeeehhhh
Confidence 89999999999987654221 11233456788999999999987653 3445899999999999999
Q ss_pred HHhhCCCCCCC-CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 359 EMCTGSIPWAG-LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 359 emltG~~PF~~-~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+.|+.||.. .+..++++...-.....-.++ ..+.++.++++||++||.+.-++|..+.++..+-.
T Consensus 676 QClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY 743 (775)
T ss_pred hhhccCCCCCCchhHHHHHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence 99999999965 344444432211111111111 12457899999999999999999999998877633
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=303.01 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=198.1
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
|++.+.||+|+||.||. |....+++.||||++...... ......+|+..++.+. +||||+++++++..+...
T Consensus 1 y~~~~~ig~g~~g~v~~------~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYL------ARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-EHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEE------EEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-CCCCchhHHHHhhcCCcE
Confidence 67889999999887754 666677899999998764322 2334456888877764 499999999999999999
Q ss_pred EEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 217 GLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
++||||+.++++..+.... ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 74 YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred EEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9999999666665555443 468999999999999999999999999999999999999999999999999987654311
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
......++..|+|||++.... .++.++|+||||+++|+|++|.+||...+..+.
T Consensus 154 ---------------~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~ 207 (283)
T cd07830 154 ---------------PYTDYVSTRWYRAPEILLRST-----------SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207 (283)
T ss_pred ---------------CcCCCCCcccccCceeeecCc-----------CcCCccchhhHHHHHHHHHhCCCccCCCChHHH
Confidence 112345788999999885432 268899999999999999999999987766555
Q ss_pred HHHHHhcCCCCCC-----------------------cccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 376 YRAVVKNRKLPPQ-----------------------YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 376 ~~~i~~~~~~~~~-----------------------~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+..+......+.. .........+.++.+||.+||+.+|++|||+.|++.|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~ 281 (283)
T cd07830 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281 (283)
T ss_pred HHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence 5444322111100 00001112367899999999999999999999998873
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=308.41 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=198.1
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
..++|++.+.||.|+||.||+ +.+..+++.||+|++..... .....+.+|+++++.++ ||||++++++|.
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~ 79 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCS------ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR--HENIISLSDIFI 79 (328)
T ss_pred cccceEEEEeecccCCeEEEE------EEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC--CCCeeeEeeeEe
Confidence 467899999999999887754 66788999999998865322 23456778999999876 999999999987
Q ss_pred e-CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 M-DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~-~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
. ...+|++|||+.++ +..++. ..++++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~~~lv~e~~~~~-L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 80 SPLEDIYFVTELLGTD-LHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cCCCcEEEEeehhccC-HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 6 56789999999765 444443 34689999999999999999999999999999999999999999999999999864
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
.... .....++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~-----------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQ-----------------MTGYVSTRYYRAPEIMLTWQ-----------KYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCC-----------------cCCCcccccccCceeeeccC-----------CcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3211 12235688899999875422 2789999999999999999999999876
Q ss_pred CHHHHHHHHHhcCC------------------------CCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 371 SAEEIYRAVVKNRK------------------------LPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 371 ~~~ei~~~i~~~~~------------------------~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
.....+..+.+... ..+.......+.+++++.++|.+||+.+|++||++.+++.|-
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 210 DHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 55332222211100 000000111235678999999999999999999999999985
Q ss_pred h
Q 000343 427 L 427 (1630)
Q Consensus 427 ~ 427 (1630)
+
T Consensus 290 ~ 290 (328)
T cd07856 290 Y 290 (328)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=301.63 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=201.0
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
|++.+.||+|.||.||. +....+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 y~~~~~ig~g~~~~vy~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYK------ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK--HPNIVKLLDVIHTERK 72 (282)
T ss_pred CeeehcccccCcceEEE------eeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC--CCCHHHHHhhhhcCCc
Confidence 67789999999887754 6677889999999988753 223456778999998875 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+++||||+++++...+......+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus 73 ~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 73 LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred eEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 99999999976544444433579999999999999999999999999999999999999999999999999987654321
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHH
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei 375 (1630)
.......++..|+|||.+.+.. .++.++|+||||+++|+|++|.+||...+..+.
T Consensus 153 --------------~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 153 --------------RTYTHEVVTLWYRAPEILLGSK-----------HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred --------------cccCccccCcCcCChHHhcCCc-----------CCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 0112234577899999986542 278899999999999999999999988776555
Q ss_pred HHHHHhcCCCC------------------CCc----ccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 376 YRAVVKNRKLP------------------PQY----ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 376 ~~~i~~~~~~~------------------~~~----~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
+..+......+ +.. .....+.++.++.++|.+||..||++||++.+++.|-
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 44443211100 000 0011123578899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=314.23 Aligned_cols=255 Identities=22% Similarity=0.260 Sum_probs=200.7
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+.++|++.+.||+|+||.||+ +.+..++..||||++..... .....+.+|+.+++.+. ||||+++++++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 84 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCS------AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD--HENVIGLLDVFT 84 (343)
T ss_pred ccCceEEEEEeccCCceEEEE------EEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc--CCCHHHHHHHhh
Confidence 567999999999999887754 66777899999998875321 22355667999998875 999999999887
Q ss_pred eCCE------EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 212 MDSC------LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~~~------~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
.... +++||||+.+++ ..++.. .++++..+..++.|+++||+|||++||+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~L-~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 85 PASSLEDFQDVYLVTHLMGADL-NNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccccccEEEEEecCCCCH-HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence 6554 899999996644 444443 46999999999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|++...... .....++..|+|||.+.+.. .++.++||||||+++|+|++|+.
T Consensus 163 g~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 163 GLARHTDDE-----------------MTGYVATRWYRAPEIMLNWM-----------HYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred ccccccccc-----------------ccCCcccccccCHHHHhCCC-----------CCCchHhHHHHHHHHHHHHhCCC
Confidence 998764321 12235688999999876422 26889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCc------------------------ccccCCCCCHHHHHHHHHhhccCcCCCCChhh
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQY------------------------ASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~~------------------------~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||.+.+..+.+..+......++.. ........++++.+||.+||+.||++|||+.+
T Consensus 215 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 215 LFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 998877666655554432211100 00011245889999999999999999999999
Q ss_pred HHHHh
Q 000343 422 MLATF 426 (1630)
Q Consensus 422 vL~~L 426 (1630)
++.|-
T Consensus 295 ll~h~ 299 (343)
T cd07851 295 ALAHP 299 (343)
T ss_pred HhcCC
Confidence 99884
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=294.96 Aligned_cols=259 Identities=22% Similarity=0.287 Sum_probs=209.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++.+-+..||.|+||+|+ +=.++.+|+..|||+|..... .++.++..|.+...+.. ++||||+||+....++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~------KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVN------KMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-NCPNIVKFYGALFSEG 136 (361)
T ss_pred chHHHHHHhcCCcchhhh------hhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-CCcHHHHHhhhhhcCC
Confidence 455667889999988774 356889999999999997755 45778888888887776 7999999999988888
Q ss_pred EEEEEEecCCCChHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceee
Q 000343 215 CLGLVMDRCYGSVQLAMQ----RNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~----~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
..+|.||+|+-++-..+. -++..++++-+-.|.--.+.||+||-.. .|||||+||+|||++..|.+||||||++-
T Consensus 137 dcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 137 DCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred ceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 999999999887655443 2345799999999999999999999975 89999999999999999999999999986
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+-.+. ..+.-+|-.+|||||-+.... .+|+.++|+||||++|||+.||.+||..
T Consensus 217 qLv~Si---------------AkT~daGCrpYmAPERi~p~~----------~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 217 QLVDSI---------------AKTVDAGCRPYMAPERIDPSD----------KGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hHHHHH---------------HhhhccCCccccChhccCCcc----------CCcchhhhhhhhcceEeeeecCCCCcch
Confidence 654321 223456788999999987643 3599999999999999999999999987
Q ss_pred CC-HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 370 LS-AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~-~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+ ..+.+..+..+.+.... ........+..+..+|.-||..|-+.||.+.+++++-+
T Consensus 272 w~svfeql~~Vv~gdpp~l~-~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 272 WDSVFEQLCQVVIGDPPILL-FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred HHHHHHHHHHHHcCCCCeec-CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 64 35556666666533221 12222357889999999999999999999999987643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=292.76 Aligned_cols=241 Identities=27% Similarity=0.345 Sum_probs=199.8
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC---ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEE
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM---EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~---~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVm 220 (1630)
||+|+||.||. +.+..+++.+|+|.+...... ....+.+|+.+++.++ ||||+++++.++.+..+|++|
T Consensus 1 lg~G~~~~v~~------~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLL------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--HPFIVKLHYAFQTEEKLYLVL 72 (250)
T ss_pred CCCCCceEEEE------EEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC--CCcHHHHHHHeecCCeeEEEE
Confidence 68999888764 455667899999998865432 3457788999998876 999999999999999999999
Q ss_pred ecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCC
Q 000343 221 DRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 221 Ey~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
||+.++.+..++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 73 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----- 147 (250)
T cd05123 73 EYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----- 147 (250)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----
Confidence 999888888777766679999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~ 380 (1630)
.......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.
T Consensus 148 ---------~~~~~~~~~~~~~~Pe~~~~~~------------~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 148 ---------SRTNTFCGTPEYLAPEVLLGKG------------YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred ---------CcccCCcCCccccChHHhCCCC------------CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 1123345788999999986543 6789999999999999999999998877766666665
Q ss_pred hcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh---hhHHHH
Q 000343 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF---SAMLAT 425 (1630)
Q Consensus 381 ~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa---~evL~~ 425 (1630)
..... .+..++.++.++|.+||..||++||++ .++++|
T Consensus 207 ~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 207 KDPLR-------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred cCCCC-------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 53221 223468899999999999999999999 677665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=319.03 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=198.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
..+..-+.||+|+||.||. ++++.+|+.||||.++... ....+..-+|+++|++++ |||||+++++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~r------grnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn--h~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYR------GRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN--HPNIVKLFDIEETKF 84 (732)
T ss_pred cceeehhhhcCCccceeee------ecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC--chhhhhhcccCCccc
Confidence 3567788999999887754 7889999999999988754 334678889999999986 999999999865543
Q ss_pred ------EEEEEEecCCCChHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC--CCC--cEE
Q 000343 215 ------CLGLVMDRCYGSVQLAMQRNE---GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD--ASG--RAV 281 (1630)
Q Consensus 215 ------~~~LVmEy~~gglL~~l~~~~---~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld--~~g--~vK 281 (1630)
...++||||.||+|+..++++ ..|++.+.+.++..+..||.|||++||+||||||.||++- .+| ..|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence 478999999999999887653 3599999999999999999999999999999999999984 223 479
Q ss_pred EeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHh
Q 000343 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyeml 361 (1630)
|+|||.|+.++.+. ......||..|++||++.... .|+..+|.|||||++|+.+
T Consensus 165 LtDfG~Arel~d~s---------------~~~S~vGT~~YLhPel~E~q~-----------~y~~tVDLWS~GvtlY~ca 218 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---------------LFTSLVGTEEYLHPELYERQK-----------KYTATVDLWSFGVTLYECA 218 (732)
T ss_pred eecccccccCCCCC---------------eeeeecCchhhcChHHHhhcc-----------CcCceeehhhhhhHHHHHh
Confidence 99999999876432 356788999999999998522 2889999999999999999
Q ss_pred hCCCCCCCC----CHHHHHHHHHhcCCC------------CCCccccc--CCCCC----HHHHHHHHHhhccCcCCCC--
Q 000343 362 TGSIPWAGL----SAEEIYRAVVKNRKL------------PPQYASIV--GVGIP----RELWKMIGECLQFKASKRP-- 417 (1630)
Q Consensus 362 tG~~PF~~~----~~~ei~~~i~~~~~~------------~~~~~~~~--~~~l~----~el~~LI~~cL~~dP~~RP-- 417 (1630)
||..||-.. +..++...+....+. |-.+...+ +..++ ..+-..+..+|..+|.+|.
T Consensus 219 TG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~ 298 (732)
T KOG4250|consen 219 TGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHE 298 (732)
T ss_pred ccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCC
Confidence 999999432 233344444433211 11111111 11222 3355778889999999999
Q ss_pred ChhhHHHHhhh
Q 000343 418 TFSAMLATFLR 428 (1630)
Q Consensus 418 Sa~evL~~L~~ 428 (1630)
.+.+....+..
T Consensus 299 ~~~~~Fa~~~d 309 (732)
T KOG4250|consen 299 GFDRFFAEVDD 309 (732)
T ss_pred CcchHHHHHHH
Confidence 65555444443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=312.96 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=213.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++.++.++||+|.||.|+ ...|.. -..+.-.||||.+...... ....|.+|+.+|.+++ |||+|+||++..+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~--rg~Wt~-psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~--H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVK--RGTWTQ-PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ--HPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEe--eccccC-CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc--CcceeEEeeeecc-c
Confidence 577888999999999884 333432 2223347999999876555 5788999999999976 9999999999987 6
Q ss_pred EEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 215 CLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...||||++++|+|.+.+.+ ...|.......|+.||+.|+.||-++++|||||-..|+|+-....+||+||||.+.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999988777665544 4568899999999999999999999999999999999999999999999999999887
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~ 371 (1630)
.... .+.......-...|+|||.+...+ ++.++|+|+|||+||||+| |..||.+..
T Consensus 264 ~ned-----------~Yvm~p~rkvPfAWCaPEsLrh~k------------FShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 264 ENED-----------MYVMAPQRKVPFAWCAPESLRHRK------------FSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred CCCc-----------ceEecCCCcCcccccCHhHhcccc------------ccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 5431 112222333467899999998765 8999999999999999999 999999999
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhh
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~ 428 (1630)
..+++++|-.+...+.. ..+++++.+++.+||..+|.+|||+..+.+++..
T Consensus 321 g~qIL~~iD~~erLpRP------k~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 321 GIQILKNIDAGERLPRP------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHHhccccccCCCC------CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99999998866655432 3589999999999999999999999999866553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=316.57 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=217.4
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe--
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-- 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~-- 212 (1630)
.+-|++...||.|.+|.||. +..+.+++..|+|++..... ..+.++.|+++|+... .|||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k------~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~-~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYK------GRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYS-HHPNVATFYGAFIKKD 89 (953)
T ss_pred CCccEEEEEEeeccceeEEE------EeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhcc-CCCCcceEEEEEEEec
Confidence 45799999999999777654 56778899999998776544 4567888999999987 79999999999864
Q ss_pred ---CCEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 213 ---DSCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 213 ---~~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
++.++||||||.||+..++.++ ..++.+..+.+|++.++.||.|||...+||||||-.|||++.++.+||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 4679999999999999888764 45799999999999999999999999999999999999999999999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF 367 (1630)
+..+.... ....+.+|||.|||||++..... -...|+..+|+||||++..||..|.+|+
T Consensus 170 SaQldsT~--------------grRnT~iGtP~WMAPEViac~e~-------~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 170 SAQLDSTV--------------GRRNTFIGTPYWMAPEVIACDES-------PDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred eeeeeccc--------------ccccCcCCCcccccceeeecccC-------CCCCcccccchhhccceeehhcCCCCCc
Confidence 98876432 22356789999999999987652 1234899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.+.-+...+..|-+. .||. ..-+..+++++.+||..||..|..+||+..++|+|-+
T Consensus 229 ~DmHPmraLF~IpRN--PPPk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 229 CDMHPMRALFLIPRN--PPPK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred cCcchhhhhccCCCC--CCcc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 998887666555332 2222 2224568899999999999999999999999999855
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=295.02 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=196.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-----cCChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-----EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-----~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
+|.+.+.||+|+||.||+ +.+..++..+++|.++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~y~i~~~ig~g~~g~v~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 72 (260)
T cd08222 1 RYILQQRLGKGSFGTVYL------VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD--HPAIVKFHASFL 72 (260)
T ss_pred CceeeeeecCCCCceEEE------EEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC--CCcHHHHHHHHh
Confidence 589999999999998865 4455555566666554321 122345667888888765 999999999999
Q ss_pred eCCEEEEEEecCCCChHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~~----~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
.....+++|||++++.+..++. ....+++..++.++.|++.||+|||++|++|+||||+||+++. +.+||+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence 9999999999999888776653 2346999999999999999999999999999999999999975 6799999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF 367 (1630)
+....... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||
T Consensus 152 ~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~------------~~~~~Dv~slG~~~~~l~~~~~~~ 205 (260)
T cd08222 152 SRLLMGSC--------------DLATTFTGTPYYMSPEALKHQG------------YDSKSDIWSLGCILYEMCCLAHAF 205 (260)
T ss_pred eeecCCCc--------------ccccCCCCCcCccCHHHHccCC------------CCchhhHHHHHHHHHHHHhCCCCC
Confidence 87654321 0112345688999999876533 678999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 368 ~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
...........+..+.. +. .+..++.++.++|.+||+.+|++||++.++++|-
T Consensus 206 ~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 258 (260)
T cd08222 206 EGQNFLSVVLRIVEGPT--PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP 258 (260)
T ss_pred CCccHHHHHHHHHcCCC--CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence 87776666655544321 11 1235778999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=282.26 Aligned_cols=256 Identities=18% Similarity=0.277 Sum_probs=204.4
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+..++|++++++|+|.|+.| |.|....+.++++||.+++. ....+.+|+.||+.+. +||||++|+++..+
T Consensus 35 g~~ddYeivrk~GRGKYSEV------Feg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~-gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEV------FEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLR-GGPNIIKLLDIVKD 104 (338)
T ss_pred cccchHHHHHHHcCccHhhH------hcccccCCCceEEEeeechH---HHHHHHHHHHHHHhcc-CCCCeeehhhhhcC
Confidence 34579999999999996665 56888899999999999864 4567899999999997 79999999999987
Q ss_pred C--CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecceee
Q 000343 213 D--SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYGLAA 289 (1630)
Q Consensus 213 ~--~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFGla~ 289 (1630)
. ....||+||.++.+...+.. .|+..+++.++.|++.||.|+|++||+|||+||.|++||.. ..++|+|+|+|.
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 5 45889999999988877764 48999999999999999999999999999999999999955 579999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC-
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA- 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~- 368 (1630)
++.... .....+.+..|.-||++...+ .|+.+-|+|||||+|..|+..+.||.
T Consensus 182 FYHp~~---------------eYnVRVASRyfKGPELLVdy~-----------~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 182 FYHPGK---------------EYNVRVASRYFKGPELLVDYQ-----------MYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred hcCCCc---------------eeeeeeehhhcCCchheeech-----------hccccHHHHHHHHHHHHHHhccCcccC
Confidence 876532 233456688899999987644 38999999999999999999999984
Q ss_pred CCCHHHHHHHHHhc--------------CCCCCCccc---------------ccCC-CCCHHHHHHHHHhhccCcCCCCC
Q 000343 369 GLSAEEIYRAVVKN--------------RKLPPQYAS---------------IVGV-GIPRELWKMIGECLQFKASKRPT 418 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~--------------~~~~~~~~~---------------~~~~-~l~~el~~LI~~cL~~dP~~RPS 418 (1630)
+.+..+++-+|.+- -..++.+.. .... -.++++.+|+.++|.+|.++|+|
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 44443333322210 011222111 0111 24589999999999999999999
Q ss_pred hhhHHHHhh
Q 000343 419 FSAMLATFL 427 (1630)
Q Consensus 419 a~evL~~L~ 427 (1630)
+.|++.|..
T Consensus 316 akEam~Hpy 324 (338)
T KOG0668|consen 316 AKEAMAHPY 324 (338)
T ss_pred hHHHhcCch
Confidence 999999843
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=311.19 Aligned_cols=222 Identities=27% Similarity=0.335 Sum_probs=191.4
Q ss_pred ChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC
Q 000343 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591 (1630)
Q Consensus 512 ~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G 591 (1630)
.+.++.|+++|.++.|+.|++..+.+++..|.+|.|+||+||.+++++++++||++||++|...- ..+.||||+||++|
T Consensus 45 ~~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG-~l~stPLHWAar~G 123 (600)
T KOG0509|consen 45 LDDIVKATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGG-VLGSTPLHWAARNG 123 (600)
T ss_pred hhhhhhHhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCC-CCCCCcchHHHHcC
Confidence 45689999999999999999976889999999999999999999999999999999999998643 56889999999999
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhc
Q 000343 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVA 671 (1630)
Q Consensus 592 ~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~g 671 (1630)
+..++++|+++|||++.+|.+|.||||+|+..++.-.+-|||.+++ +++.+|.+|.||||+|+.+++.
T Consensus 124 ~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~--d~d~~D~~grTpLmwAaykg~~---------- 191 (600)
T KOG0509|consen 124 HISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGA--DIDLRDNNGRTPLMWAAYKGFA---------- 191 (600)
T ss_pred cHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcc--cCCCcCCCCCCHHHHHHHhccc----------
Confidence 9999999999999999999999999999999999999999999985 7788899999999999876542
Q ss_pred CccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCccc-ccCccchhhhhhcCCHHHHHHHHHCCCC
Q 000343 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD-AQNRTALHIASMANDVELVKIILDAGVD 750 (1630)
Q Consensus 672 a~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D-~~G~TpLH~Aa~~g~~eiVklLL~~GAD 750 (1630)
..++.||+.|++++.+| .+|+||||+|+..|+..++.+|++.|++
T Consensus 192 ----------------------------------~~v~~LL~f~a~~~~~d~~~g~TpLHwa~~~gN~~~v~Ll~~g~~~ 237 (600)
T KOG0509|consen 192 ----------------------------------LFVRRLLKFGASLLLTDDNHGNTPLHWAVVGGNLTAVKLLLEGGAD 237 (600)
T ss_pred ----------------------------------HHHHHHHHhcccccccccccCCchHHHHHhcCCcceEehhhhcCCc
Confidence 12667777788888887 7899999999999999988877788888
Q ss_pred cccccCCCCCHHHHHHHcCCHHHHHHHHhCCCC
Q 000343 751 VNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783 (1630)
Q Consensus 751 vN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GAD 783 (1630)
.+.+|.+|.||+.+|..+ .++..+...+.+
T Consensus 238 ~d~~~~~g~tp~~LA~~~---~~~~~~~h~~~~ 267 (600)
T KOG0509|consen 238 LDKTNTNGKTPFDLAQER---KLVAALHHDVVE 267 (600)
T ss_pred ccccccCCCCHHHHHHHh---hhHHHhhccHHH
Confidence 999888899999998877 344444433443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=291.94 Aligned_cols=226 Identities=19% Similarity=0.261 Sum_probs=177.1
Q ss_pred CCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEecCCCC
Q 000343 147 GRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS 226 (1630)
Q Consensus 147 G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gg 226 (1630)
|.|+.||+ +.+..+++.||+|++..... ..+|...+.. ..||||+++++++.....++++|||++++
T Consensus 4 g~~~~v~~------~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLL------VMDTRTQQTFILKGLRKSSE-----YSRERLTIIP--HCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEE------EEEccCCcEEEEEeecchhh-----hhhHHHHHHh--cCCCceeehhhheecCCeEEEEEecCCCC
Confidence 66666654 67889999999999986432 2234333333 35999999999999999999999999998
Q ss_pred hHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCC
Q 000343 227 VQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306 (1630)
Q Consensus 227 lL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~ 306 (1630)
.|..++.+...+++..+..++.|+++||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------------ 138 (237)
T cd05576 71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------------ 138 (237)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------------
Confidence 88877766667999999999999999999999999999999999999999999999999987654321
Q ss_pred CcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCC
Q 000343 307 RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLP 386 (1630)
Q Consensus 307 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~ 386 (1630)
.....++..|+|||.+.... ++.++|+||+|+++|+|++|..||...... + ... ..
T Consensus 139 -----~~~~~~~~~y~aPE~~~~~~------------~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~-~~ 194 (237)
T cd05576 139 -----CDGEAVENMYCAPEVGGISE------------ETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTH-TT 194 (237)
T ss_pred -----cccCCcCccccCCcccCCCC------------CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccc-cc
Confidence 11233467899999876543 788999999999999999999987643221 0 000 00
Q ss_pred CCcccccCCCCCHHHHHHHHHhhccCcCCCCCh-----hhHHHH
Q 000343 387 PQYASIVGVGIPRELWKMIGECLQFKASKRPTF-----SAMLAT 425 (1630)
Q Consensus 387 ~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa-----~evL~~ 425 (1630)
...+..+++++++||.+||+.||++||++ +++++|
T Consensus 195 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 195 ----LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred ----cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 01223578899999999999999999997 555554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=296.78 Aligned_cols=284 Identities=21% Similarity=0.272 Sum_probs=215.4
Q ss_pred CCCCCCcCCc-eeccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhcc
Q 000343 120 SSGVGVCGPV-IEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM 198 (1630)
Q Consensus 120 ss~~~~~~~~-~~~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l 198 (1630)
+|+++++.|. .+..+..+..+.+.||+|.||.| |...| .|+.||||++.. .++....+|.+|.+..-+
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEV--wrG~w------rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmL 262 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEV--WRGRW------RGEDVAVKIFSS---RDERSWFRETEIYQTVML 262 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccce--eeccc------cCCceEEEEecc---cchhhhhhHHHHHHHHHh
Confidence 4555555555 45678899999999999999998 44444 368999999885 345667889999998778
Q ss_pred CCCCcceeEEEEEeCC----EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccc
Q 000343 199 WCRNVCTFHGVLRMDS----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA--------GVVCMN 266 (1630)
Q Consensus 199 ~HpNIV~l~~~f~~~~----~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~--------gIIHRD 266 (1630)
+|+||+.|++.=..+. .++||++|.+.|+|++++.+ ..++...+.+++..+++||+|||.. .|.|||
T Consensus 263 RHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 263 RHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred ccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 8999999998754332 59999999999999888876 5799999999999999999999952 499999
Q ss_pred ccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCc
Q 000343 267 IKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISP 346 (1630)
Q Consensus 267 LKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ 346 (1630)
||..|||+.+++++.|+|||||....+.. .......+..+||.+|||||++..... ...+..-.
T Consensus 342 lKSKNILVKkn~~C~IADLGLAv~h~~~t----------~~idi~~N~rVGTKRYMAPEvLdetin------~~~Fesyk 405 (513)
T KOG2052|consen 342 LKSKNILVKKNGTCCIADLGLAVRHDSDT----------DTIDIPPNPRVGTKRYMAPEVLDETIN------MKHFESYK 405 (513)
T ss_pred cccccEEEccCCcEEEeeceeeEEecccC----------CcccCCCCCccceeeccChHHhhhhcC------hhhhhhhh
Confidence 99999999999999999999998766431 122334567899999999999975431 12333456
Q ss_pred cccchhhhhHHHHHhhC----------CCCCCCC-----CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhcc
Q 000343 347 ESDAWSFGCTLVEMCTG----------SIPWAGL-----SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411 (1630)
Q Consensus 347 ksDIWSlGvILyemltG----------~~PF~~~-----~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~ 411 (1630)
.+||||||.+|||++.. ++||.+. +.+++..-+.-.+..|.....+.....-..+.+||+.||..
T Consensus 406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~ 485 (513)
T KOG2052|consen 406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYA 485 (513)
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcC
Confidence 79999999999998863 5788542 33444433333444444333322222234577899999999
Q ss_pred CcCCCCChhhHHHHhhhccc
Q 000343 412 KASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 412 dP~~RPSa~evL~~L~~~l~ 431 (1630)
||.-|.|+-.+-+.|.+..+
T Consensus 486 Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 486 NPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CchhhhHHHHHHHHHHHHhc
Confidence 99999999988777766553
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=309.00 Aligned_cols=208 Identities=30% Similarity=0.403 Sum_probs=183.2
Q ss_pred CCHHHHHHHcCCHHHHHHHHHC-CCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCChhhhhhhc
Q 000343 546 DPPLVFALAAGSPECVHALIKR-GANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVD-DEGESVLHRAVAK 623 (1630)
Q Consensus 546 ~TPLh~Aa~~G~~eiVk~LL~~-GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D-~~G~TPLH~Aa~~ 623 (1630)
.+.++.|++.|.++-|+.|++. |.+++..++ .|.|+||+||.+++++++++||++|||+|+.+ .-+.||||+|+++
T Consensus 45 ~~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~--~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~ 122 (600)
T KOG0509|consen 45 LDDIVKATQYGELETVKELVESEGESVNNPDR--EGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARN 122 (600)
T ss_pred hhhhhhHhhcchHHHHHHHHhhcCcCCCCCCc--CCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHc
Confidence 4678889999999999999998 888887654 57788999999999999999999999999988 6688999999999
Q ss_pred CChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccch
Q 000343 624 KYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703 (1630)
Q Consensus 624 g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~ 703 (1630)
|+..++++|+++|| +++..|.+|.||||+|+..++.
T Consensus 123 G~~~vv~lLlqhGA--dpt~~D~~G~~~lHla~~~~~~------------------------------------------ 158 (600)
T KOG0509|consen 123 GHISVVDLLLQHGA--DPTLKDKQGLTPLHLAAQFGHT------------------------------------------ 158 (600)
T ss_pred CcHHHHHHHHHcCC--CCceecCCCCcHHHHHHHhCch------------------------------------------
Confidence 99999999999998 6788899999999999876542
Q ss_pred hHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCccccc-CCCCCHHHHHHHcCCHHHHHHHHhCCC
Q 000343 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN-VHNTIPLHVALARGAKSCVGLLLSAGA 782 (1630)
Q Consensus 704 ~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d-~~G~TPLH~Aa~~G~~eiVklLLe~GA 782 (1630)
.++.+||.+|+|+|.+|.+|+||||+||.+|+...++.||..|++++.+| ..|.||||+|+..|+..++.+|++.|+
T Consensus 159 --~~vayll~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~TpLHwa~~~gN~~~v~Ll~~g~~ 236 (600)
T KOG0509|consen 159 --ALVAYLLSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTPLHWAVVGGNLTAVKLLLEGGA 236 (600)
T ss_pred --HHHHHHHHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCchHHHHHhcCCcceEehhhhcCC
Confidence 45678889999999999999999999999999888999999999999888 889999999999999999997788889
Q ss_pred CCCcCCCCCCcHHHHHHHh
Q 000343 783 DCNWQDDEGDNAFHIAADA 801 (1630)
Q Consensus 783 DiN~~D~~G~TpLhlAa~~ 801 (1630)
+.+.+|.+|.||+.+|.+.
T Consensus 237 ~~d~~~~~g~tp~~LA~~~ 255 (600)
T KOG0509|consen 237 DLDKTNTNGKTPFDLAQER 255 (600)
T ss_pred cccccccCCCCHHHHHHHh
Confidence 9999999999999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=314.74 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=195.5
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG 217 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~ 217 (1630)
|.-.+.+|.|+-|+| +|..+|. ++.||||++-.+ -.+.+.+|+..|+... .|||||++|+.-++..+.|
T Consensus 511 ~~~~eilG~Gs~Gt~-Vf~G~ye------~R~VAVKrll~e---~~~~A~rEi~lL~eSD-~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTV-VFRGVYE------GREVAVKRLLEE---FFDFAQREIQLLQESD-EHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcE-EEEEeeC------CceehHHHHhhH---hHHHHHHHHHHHHhcc-CCCceEEEEeeccCCceEE
Confidence 444567899999988 4677776 459999988753 2467889999999987 7999999999999999999
Q ss_pred EEEecCCCChHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC---C--CcEEEeecceee
Q 000343 218 LVMDRCYGSVQLAMQRNEGR---LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA---S--GRAVVSDYGLAA 289 (1630)
Q Consensus 218 LVmEy~~gglL~~l~~~~~~---L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~---~--g~vKL~DFGla~ 289 (1630)
|.+|.|..++.+.+...... ........++.|+++||+|||+.+||||||||+||||+. + .+++|+|||+++
T Consensus 580 IalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 580 IALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99999998887766542111 111456788999999999999999999999999999975 3 478999999999
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWA 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~ 368 (1630)
.+..+.. ......+..||-.|+|||++.... -+.++||||+||++|+.++ |.+||.
T Consensus 660 kl~~~~s-----------S~~r~s~~sGt~GW~APE~L~~~~------------~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 660 KLAGGKS-----------SFSRLSGGSGTSGWQAPEQLREDR------------KTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred ccCCCcc-----------hhhcccCCCCcccccCHHHHhccc------------cCcccchhhcCceEEEEecCCccCCC
Confidence 8865421 122356678999999999998765 4569999999999999999 599998
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
+.-.. -.+|+.+......... ....++.+||.+|++++|..||++.++|.|.+
T Consensus 717 d~~~R--~~NIl~~~~~L~~L~~----~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 717 DSLER--QANILTGNYTLVHLEP----LPDCEAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred chHHh--hhhhhcCccceeeecc----CchHHHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 65332 2355555433322211 11228999999999999999999999999843
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=294.13 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=198.5
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCC----CcceeEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCR----NVCTFHGV 209 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~Hp----NIV~l~~~ 209 (1630)
+..+|++++.+|+|+||.|. .+.+..++..||||+++.... ..+...-|+++|.++...-| -++++.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~------ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVV------ECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred cccceehhhhhcCCcccceE------EEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 46799999999999999883 255777799999998876432 24566679999999863334 47888999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC------------
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA------------ 276 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~------------ 276 (1630)
|...++.|||+|.+.-++.+.+..+ ..+++...++.+++|++++++|||+.+++|.||||+|||+-+
T Consensus 160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999877777666553 346999999999999999999999999999999999999931
Q ss_pred --------CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccc
Q 000343 277 --------SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348 (1630)
Q Consensus 277 --------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ks 348 (1630)
+..+||+|||.|....+. ....+.|..|+|||++.+.. ++.++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----------------hs~iVsTRHYRAPEViLgLG------------wS~pC 290 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----------------HSTIVSTRHYRAPEVILGLG------------WSQPC 290 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----------------cceeeeccccCCchheeccC------------cCCcc
Confidence 235899999999875432 14466799999999998754 89999
Q ss_pred cchhhhhHHHHHhhCCCCCCCCCHHH---HHHHHHhcCCCCCCcc-----------------cc----------------
Q 000343 349 DAWSFGCTLVEMCTGSIPWAGLSAEE---IYRAVVKNRKLPPQYA-----------------SI---------------- 392 (1630)
Q Consensus 349 DIWSlGvILyemltG~~PF~~~~~~e---i~~~i~~~~~~~~~~~-----------------~~---------------- 392 (1630)
||||+||||+|+.||...|+..+..+ +++.|+. +.|.... ..
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG--p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl 368 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILG--PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL 368 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC--CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccH
Confidence 99999999999999999998765433 3333332 1110000 00
Q ss_pred --c---CCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 393 --V---GVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 393 --~---~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
. ...-..++.+||++||.+||.+|+|+.|+|.|-+
T Consensus 369 ~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 369 KKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 0 0011235889999999999999999999999855
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=286.85 Aligned_cols=134 Identities=18% Similarity=0.201 Sum_probs=116.1
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccC---C---CCcceeEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMW---C---RNVCTFHG 208 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~---H---pNIV~l~~ 208 (1630)
..+|.+.++||-|-|++||| |.|.++.+.||+|+++.. ....+....||++|++++.. | .+||+|++
T Consensus 77 ~gRY~v~rKLGWGHFSTVWL------awDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWL------AWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred CceEEEEEeccccccceeEE------EeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 38999999999999999987 779999999999988764 34456778899999998632 2 47999999
Q ss_pred EEEe----CCEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEEC
Q 000343 209 VLRM----DSCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLD 275 (1630)
Q Consensus 209 ~f~~----~~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld 275 (1630)
.|.. +.++|||+|++..+||..++... ..++...++.|++|||.||.|||.. ||||.||||+|||+.
T Consensus 150 ~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9985 45799999999999999887654 3599999999999999999999986 999999999999993
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=314.72 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=210.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEcccccc---CCcEEEEEEeeccCc-CChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGR---CRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~---~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
+.++.+.||+|.||.|+. ....+.... ....||||.++.... .+.+.+..|+++|+.+. .||||+.+++++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~--~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVK--ALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-KHPNIVNLLGACTQ 373 (609)
T ss_pred hccccceeecccccceEe--EEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-CCcchhhheeeecc
Confidence 446777999999999953 333333333 267899998886533 35678899999999987 69999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEG----------------RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~----------------~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~ 276 (1630)
...+++|+||+..|+|..+++... .|+..+...++.||+.|++||++.++|||||-+.|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999998776666655432 4999999999999999999999999999999999999999
Q ss_pred CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccC--CCCCCCccccccccccccccccCcCCCCccccchhhh
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML--SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlG 354 (1630)
+..+||+|||+|+......... .....| ...|||||.+.... |+.++||||||
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~-------------~~~~~~~LP~kWmApEsl~~~~------------ft~kSDVWSfG 508 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYR-------------TKSSAGTLPVKWMAPESLFDRV------------FTSKSDVWSFG 508 (609)
T ss_pred CCEEEEccccceeccCCCCceE-------------ecCCCCccceeecCHHHhccCc------------ccccchhhHHH
Confidence 9999999999998654332111 111122 44599999988744 89999999999
Q ss_pred hHHHHHhh-CCCCCCCCC-HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 355 CTLVEMCT-GSIPWAGLS-AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 355 vILyemlt-G~~PF~~~~-~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
++|||++| |..||.+.. ..+++..+..|..... +..+++++.++|+.||+.+|++||++.++.+.+...+.
T Consensus 509 I~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 509 ILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQ------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99999999 999999866 6777776666655433 23578999999999999999999999999998888654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=288.72 Aligned_cols=268 Identities=20% Similarity=0.244 Sum_probs=204.9
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS- 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~- 214 (1630)
...++.+.||+|.||.|| +|. -.++.||||++.. .+.+.+.+|.+|.....+.|+||++|+++-+...
T Consensus 210 ~pl~l~eli~~Grfg~V~------Kaq--L~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVW------KAQ--LDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceee------hhh--ccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 467788999999988774 343 4568999999885 4567788999999998899999999999876554
Q ss_pred ---EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCCccccccccceEECCCCcEEE
Q 000343 215 ---CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA---------AGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 215 ---~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs---------~gIIHRDLKP~NILld~~g~vKL 282 (1630)
.+.||+||.+.|+|.+++.. ..+++.+..+|+..+++||+|||+ ..|+|||||.+|||+.+++++.|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 79999999998888888765 369999999999999999999996 25999999999999999999999
Q ss_pred eecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt 362 (1630)
+|||+|..+.... + .....+.+||.+|||||++.+... +.+ ...=.+.||||+|.+||||++
T Consensus 358 aDFGLAl~~~p~~-----~-------~~d~~~qVGT~RYMAPEvLEgain-----l~d-~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 358 ADFGLALRLEPGK-----P-------QGDTHGQVGTRRYMAPEVLEGAIN-----LQD-RDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred eccceeEEecCCC-----C-------CcchhhhhhhhhhcCHHHHhhhcc-----ccc-HHHHHHHHHHHHHHHHHHHHh
Confidence 9999999886432 1 112234789999999999998652 111 113357999999999999998
Q ss_pred CC------------CCCC-----CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 363 GS------------IPWA-----GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 363 G~------------~PF~-----~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.- .||. ..+.+++...+.+.+..|..........-..-+.+.+..||..||+-|.|+.-+.+.
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 53 2332 123345555555555544433222222233457899999999999999999988777
Q ss_pred hhhcccCC
Q 000343 426 FLRHLQEL 433 (1630)
Q Consensus 426 L~~~l~~l 433 (1630)
+.+.....
T Consensus 500 ~~~l~~~~ 507 (534)
T KOG3653|consen 500 MAELMMLW 507 (534)
T ss_pred HHHHhccC
Confidence 66655433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=278.64 Aligned_cols=257 Identities=19% Similarity=0.271 Sum_probs=203.4
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--ChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
.....+|.-++.+|.|.= . +-.+.|..+++.||||++...... ...+..+|...+..+. |+||++++.+
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~------v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~--~~nii~l~n~ 83 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-I------VVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN--HKNIISLLNV 83 (369)
T ss_pred eeeeeeeeeecccCCCCc-e------EEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc--ccceeeeeec
Confidence 345679999999999983 2 233678899999999998776322 3556778888888865 9999999999
Q ss_pred EEeCC------EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEe
Q 000343 210 LRMDS------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 210 f~~~~------~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~ 283 (1630)
|.... .+|+||||+..++-..... .++-+++.+|+.|+++|++|||+.||+||||||+||++..+..+||.
T Consensus 84 ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 84 FTPQKTLEEFQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred cCccccHHHHHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeec
Confidence 97654 4899999999988777663 37889999999999999999999999999999999999999999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhC
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG 363 (1630)
|||+|+.... ...++..+.|..|.|||++.+.. |...+||||+||++.||++|
T Consensus 161 dfg~ar~e~~---------------~~~mtpyVvtRyyrapevil~~~------------~ke~vdiwSvGci~gEli~~ 213 (369)
T KOG0665|consen 161 DFGLARTEDT---------------DFMMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGELILG 213 (369)
T ss_pred cchhhcccCc---------------ccccCchhheeeccCchheeccC------------CcccchhhhhhhHHHHHhhc
Confidence 9999975332 12356677899999999998865 88999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCC-------------------Cc-----cccc-----------CCCCCHHHHHHHHHh
Q 000343 364 SIPWAGLSAEEIYRAVVKNRKLPP-------------------QY-----ASIV-----------GVGIPRELWKMIGEC 408 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~i~~~~~~~~-------------------~~-----~~~~-----------~~~l~~el~~LI~~c 408 (1630)
..-|.+.+.-+.+.++...-..+. ++ ...+ ...-+..+++|+.+|
T Consensus 214 ~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~M 293 (369)
T KOG0665|consen 214 TVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKM 293 (369)
T ss_pred eEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHh
Confidence 999988776555555443211110 00 0000 001223588999999
Q ss_pred hccCcCCCCChhhHHHHhh
Q 000343 409 LQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 409 L~~dP~~RPSa~evL~~L~ 427 (1630)
|..||++|.|+.++|.|..
T Consensus 294 Lvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 294 LVIDPEKRISVDDALRHPY 312 (369)
T ss_pred hccChhhcccHHHHhcCCe
Confidence 9999999999999999944
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=309.95 Aligned_cols=263 Identities=20% Similarity=0.206 Sum_probs=170.3
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccC----CcEEEEEEeeccCcCChhHHHHHHHHHHHhc-cCCCCcceeEEE
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC----RHSVAVKKVMIAEEMEPDWLSGQLDNLRRAS-MWCRNVCTFHGV 209 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~----g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~-l~HpNIV~l~~~ 209 (1630)
.++|++.+.||+|+||.||+ |.+..+ +..||+|++..... . |......+. ..+.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYk------a~~~~~~~~~~~~vAvK~~~~~~~--~-----e~~~~e~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYK------ASLVNKQSKKEGKYVLKKATEYGA--V-----EIWMNERVRRACPNSCADFVYG 197 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEE------EEEcCCccccCcEEEEEEecccch--h-----HHHHHHHHHhhchhhHHHHHHh
Confidence 46899999999999998864 555566 89999998764321 1 111111111 112233333222
Q ss_pred E------EeCCEEEEEEecCCCChHHHHHHcCC-C-------------------CCHHHHHHHHHHHHHHHHHHHhCCCc
Q 000343 210 L------RMDSCLGLVMDRCYGSVQLAMQRNEG-R-------------------LTLEQILRYGADIARGVVELHAAGVV 263 (1630)
Q Consensus 210 f------~~~~~~~LVmEy~~gglL~~l~~~~~-~-------------------L~~~~~~~i~~QIl~aL~yLHs~gII 263 (1630)
| .....++|||||+.++.|..++.... . .....+..++.||+.||+|||+++|+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 2 34567999999999888777664321 1 12345678999999999999999999
Q ss_pred cccccccceEECC-CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCcccccccccccc-------
Q 000343 264 CMNIKPSNLLLDA-SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN------- 335 (1630)
Q Consensus 264 HRDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~------- 335 (1630)
||||||+|||++. ++.+||+|||+|+.+.... ........+|+.|+|||.+........
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~ 344 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA 344 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-------------ccCCcccccCCCccChHHhhccCCCCCCcccccc
Confidence 9999999999985 5799999999997654221 112234578999999997654321100
Q ss_pred -----ccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCC---------CCCcccc------cCC
Q 000343 336 -----LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKL---------PPQYASI------VGV 395 (1630)
Q Consensus 336 -----~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~---------~~~~~~~------~~~ 395 (1630)
.+| ...++.++|||||||+||||+++..|+... ...+..++..... .+..... ...
T Consensus 345 ~~~sp~l~--~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 420 (566)
T PLN03225 345 TALSPVLW--QLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD 420 (566)
T ss_pred ccccchhc--cccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcc
Confidence 000 112566789999999999999977765432 1122222111100 0000000 000
Q ss_pred CCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 396 GIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 396 ~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+...++||.+||++||++|||+.++|+|-+
T Consensus 421 ~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 421 LDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452 (566)
T ss_pred ccchHHHHHHHHHccCCcccCCCHHHHhCCcC
Confidence 12334669999999999999999999999844
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=260.48 Aligned_cols=217 Identities=24% Similarity=0.355 Sum_probs=178.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeecc-CcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA-EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~-~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
++..-+..||+|++|.|..+ ++..+|...|+|.+... +.+++.++.+|+++..... .+|++|+||+.+....
T Consensus 46 d~L~~i~elGrGayG~vekm------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~-~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKM------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTV-DCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhhcCCccchhhhe------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCC-CCCeEEEeehhhhccc
Confidence 45666789999998877654 36678899999999865 3344667777888877765 6999999999999999
Q ss_pred EEEEEEecCCCChHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccccccceEECCCCcEEEeecceeee
Q 000343 215 CLGLVMDRCYGSVQLAM---QRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l---~~~~~~L~~~~~~~i~~QIl~aL~yLHs~-gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+++.||.+..++-..+ +.+.+.+++.-+-+|+-.++.||.|||++ .+||||+||+||||+..|++||||||++-.
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999988765544 34567899999999999999999999987 899999999999999999999999999987
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC-
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG- 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~- 369 (1630)
+.++. ..+...|-.+|||||.+..+. ...+|+.++||||||++++||.++++||..
T Consensus 199 L~dSi---------------Akt~daGCkpYmaPEri~~e~--------n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 199 LVDSI---------------AKTMDAGCKPYMAPERINPEL--------NQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ehhhh---------------HHHHhcCCCccCChhhcCccc--------Ccccceeehhhhhhhhhhhhhhhcccccccc
Confidence 75432 122345778999999987654 234699999999999999999999999975
Q ss_pred CCHHHHHHHHHhc
Q 000343 370 LSAEEIYRAVVKN 382 (1630)
Q Consensus 370 ~~~~ei~~~i~~~ 382 (1630)
.++.+++..+.+.
T Consensus 256 ~tpF~qLkqvVee 268 (282)
T KOG0984|consen 256 GTPFQQLKQVVEE 268 (282)
T ss_pred CCHHHHHHHHhcC
Confidence 4677777777654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-30 Score=276.81 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=202.0
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+.+--+.||.|+||.||- ..|.++|+.||+|++..... ..-+.+.+|++.|...+ |.|++..++..+...
T Consensus 54 Di~PDRPIGYGAFGVVWs------VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk--HdNVLSaLDILQPph 125 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWS------VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR--HDNVLSLLDILQPAN 125 (449)
T ss_pred cCCCCCcccccceeEEEe------ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc--cccHHHHHHhcCCCC
Confidence 444457899999887743 56889999999999875432 23566778999988876 999999999987654
Q ss_pred -----EEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceee
Q 000343 215 -----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289 (1630)
Q Consensus 215 -----~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~ 289 (1630)
.+|.++|++..++...+.. ...|+...++-+++||++||+|||+.+|+||||||.|.|++++..+||||||+++
T Consensus 126 ~dfFqEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred chHHHHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccc
Confidence 3788899888776665553 4579999999999999999999999999999999999999999999999999998
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
....+. ...++..+-|.+|+|||++.+... |+.++||||.|||+.|++..+..|+.
T Consensus 205 vee~d~-------------~~hMTqEVVTQYYRAPEiLMGaRh-----------Ys~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 205 TWDQRD-------------RLNMTHEVVTQYYRAPELLMGARR-----------YTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccchhh-------------hhhhHHHHHHHHhccHHHhhcchh-----------hcCccceehhhHHHHHHHhhhhhhhc
Confidence 644321 223445566899999999998763 99999999999999999999999987
Q ss_pred CCHHHHHHHHHhcC-----------------------CCCCCccccc----CCCCCHHHHHHHHHhhccCcCCCCChhhH
Q 000343 370 LSAEEIYRAVVKNR-----------------------KLPPQYASIV----GVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~-----------------------~~~~~~~~~~----~~~l~~el~~LI~~cL~~dP~~RPSa~ev 422 (1630)
.++-+.++.|...- ..+|.+.... +..-..+...++.++|.+||++|.+.++.
T Consensus 261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 77655544443321 1122221111 11234567889999999999999999999
Q ss_pred HHHhhh
Q 000343 423 LATFLR 428 (1630)
Q Consensus 423 L~~L~~ 428 (1630)
+.|+..
T Consensus 341 ~~~~~~ 346 (449)
T KOG0664|consen 341 LQHRYL 346 (449)
T ss_pred cccccc
Confidence 988654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=265.73 Aligned_cols=236 Identities=25% Similarity=0.361 Sum_probs=192.7
Q ss_pred EEEccccccCCcEEEEEEeeccCcCC-hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcC
Q 000343 157 AWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNE 235 (1630)
Q Consensus 157 ~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~ 235 (1630)
.+|++....+++.+|+|.+....... ...+.+|++.++.+ +|+||+++++.+......+++|||+.++.+..++...
T Consensus 4 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l--~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~ 81 (244)
T smart00220 4 KVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL--KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR 81 (244)
T ss_pred EEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC--CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc
Confidence 44556667788999999988765544 67888999999987 4999999999999999999999999997777776655
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccc
Q 000343 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315 (1630)
Q Consensus 236 ~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (1630)
..+++..+..++.|++.+|.|||+.+|+|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 82 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~ 146 (244)
T smart00220 82 GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------------LLTTF 146 (244)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------ccccc
Confidence 558999999999999999999999999999999999999999999999999998765321 12234
Q ss_pred cCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC-CCHHHHHHHHHhcCCCCCCcccccC
Q 000343 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG-LSAEEIYRAVVKNRKLPPQYASIVG 394 (1630)
Q Consensus 316 ~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~-~~~~ei~~~i~~~~~~~~~~~~~~~ 394 (1630)
.++..|+|||.+.... ++.++||||||+++|+|++|..||.. .........+......... ..
T Consensus 147 ~~~~~~~~pE~~~~~~------------~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 210 (244)
T smart00220 147 VGTPEYMAPEVLLGKG------------YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP----PE 210 (244)
T ss_pred cCCcCCCCHHHHccCC------------CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc----cc
Confidence 5688899999887543 68899999999999999999999987 4444444444333222111 11
Q ss_pred CCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 395 VGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 395 ~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
..++.++.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 1277899999999999999999999999885
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=324.33 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=187.0
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
..|...+.||+|+||.||. |....++..||||++...... ...|++++++++ |||||++++++.+...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~------~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~--HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 690 SSLKEENVISRGKKGASYK------GKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQ--HPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhCCcccEEccCCCeeEEE------EEECCCCcEEEEEEccCCccc----cHHHHHHHhhCC--CCCcceEEEEEEcCCC
Confidence 3566778999999887754 666778899999998753322 234677888764 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELH---AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLH---s~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.|+||||++++.+..+++. +++..+..|+.|+++||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 9999999999999888753 899999999999999999999 6799999999999999988887775 65543221
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
. .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||.....
T Consensus 834 ~------------------~~~~~~t~~y~aPE~~~~~~------------~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 834 T------------------DTKCFISSAYVAPETRETKD------------ITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred c------------------CCCccccccccCcccccCCC------------CCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 1 11235789999999987654 88999999999999999999999853211
Q ss_pred -----HHHHHHHHhcCC----CCCCccc--ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhccc
Q 000343 373 -----EEIYRAVVKNRK----LPPQYAS--IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 -----~ei~~~i~~~~~----~~~~~~~--~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~ 431 (1630)
.+.......... ..+.... ........++.+++.+||+.||++|||+.|+++.|....+
T Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 111111110000 0000000 0001112357789999999999999999999999887654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=293.72 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=215.4
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEE
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~ 211 (1630)
.........++||+|+||+||. |.+|-- ...-+.+||||++...... ....+..|.-+|..+. |||+++|++++.
T Consensus 693 ~kEtelkk~kvLGsgAfGtV~k-Giw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld--Hpnl~RLLgvc~ 768 (1177)
T KOG1025|consen 693 LKETELKKDKVLGSGAFGTVYK-GIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD--HPNLLRLLGVCM 768 (1177)
T ss_pred chhhhhhhhceeccccceeEEe-eeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC--CchHHHHhhhcc
Confidence 3445677889999999999973 555543 4455679999988765333 3556777777777765 999999999988
Q ss_pred eCCEEEEEEecCCCChHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gglL~~l~-~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
... +.||++|+++|.|.++. .++..+..+..+.|..||++||.|||.++++||||-..|+|+.+-..+||+|||+++.
T Consensus 769 ~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 769 LST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred cch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 655 88999999877665554 4566899999999999999999999999999999999999999999999999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
+..+.. ........-.+.|||-|.+.... |++++|||||||++||++| |..||.+
T Consensus 848 l~~d~~------------ey~~~~gK~pikwmale~i~~~~------------~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 848 LAPDEK------------EYSAPGGKVPIKWMALESIRIRK------------YTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred cCcccc------------cccccccccCcHHHHHHHhhccC------------CCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 765421 11122233367889999887665 8999999999999999999 9999999
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
.+.+++-..+..+.+.+. ++.++-++.-+|.+||..|+..||+++++...+.+....+.
T Consensus 904 i~~~eI~dlle~geRLsq------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 904 IPAEEIPDLLEKGERLSQ------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred CCHHHhhHHHhccccCCC------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 999988777777765432 34688999999999999999999999999888777665443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=284.56 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=203.8
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCC----CCcceeEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWC----RNVCTFHGV 209 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~H----pNIV~l~~~ 209 (1630)
+..+|.+....|+|-|++| ..|.+...+..||||+|.....+ ...=.+|++||++|.-.- -|+++|+-.
T Consensus 430 LD~RY~V~~~~GkGvFs~V------vra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTV------VRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hcceeEEEeccccceeeee------eeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 5689999999999988877 34788888999999999865433 455568999999986322 389999999
Q ss_pred EEeCCEEEEEEecCCCChHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecc
Q 000343 210 LRMDSCLGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYG 286 (1630)
Q Consensus 210 f~~~~~~~LVmEy~~gglL~~l~~~--~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFG 286 (1630)
|...+++|||||-+.-++-..+..- +-.|....++.|++|+..||..|-..||+|.||||+|||+++. ..+||||||
T Consensus 503 F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999999887776655442 2248899999999999999999999999999999999999866 568999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
.|....... .+...-+..|.|||++.+.. |++..|+||.||+||||.||+..
T Consensus 583 SA~~~~ene----------------itPYLVSRFYRaPEIiLG~~------------yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 583 SASFASENE----------------ITPYLVSRFYRAPEIILGLP------------YDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccccc----------------ccHHHHHHhccCcceeecCc------------ccCCccceeeceeeEEeecccee
Confidence 998765432 12233477899999999876 89999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCC------------Cccc-----------------------cc-----------CCCCC--
Q 000343 367 WAGLSAEEIYRAVVKNRKLPP------------QYAS-----------------------IV-----------GVGIP-- 398 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~------------~~~~-----------------------~~-----------~~~l~-- 398 (1630)
|++.+..+++..........| .|.. .. .+.++
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 999887665544332211110 0000 00 01122
Q ss_pred -----HHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 399 -----RELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 399 -----~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
..+++|+.+||..||++|.|+.++|.|.+
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence 35889999999999999999999999965
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=294.91 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=224.7
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
.-.++|++++.+|.|+||. +|+|+++.+++..|+|.++.........+++|+-+++.++ ||||+.+++.|-.
T Consensus 12 nP~ddyellqrvgsgTygd------vyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~--h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGD------VYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR--HPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccc------hhhhcccccCchhhheeeeccCCccccccccceeeeecCC--CcChHHHHhhhhh
Confidence 3457999999999999554 5679999999999999999988888888899999999987 9999999999999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+++.||||.||.++++..-.++|++.++.+++++.++||+|||++|-+|||||-.|||+++.|.+|++|||.+..+.
T Consensus 84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999999998887777899999999999999999999999999999999999999999999999999987654
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~ 372 (1630)
.. .......+||+.|||||+-.-+.. -+|+..+|||++|++..|+-.-++|..+.-+
T Consensus 164 at--------------i~KrksfiGtpywmapEvaaverk---------ggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 164 AT--------------IAKRKSFIGTPYWMAPEVAAVERK---------GGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred hh--------------hhhhhcccCCccccchhHHHHHhc---------ccccccccccccccchhhhhhcCCcccccch
Confidence 32 122345789999999998765442 2489999999999999999999999888777
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
........+....++... ....+++-+.+|++.+|..+|.+||+++.+|.|-+
T Consensus 221 mr~l~LmTkS~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred HHHHHHhhccCCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence 766665555544444432 23457889999999999999999999999988744
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=286.69 Aligned_cols=202 Identities=20% Similarity=0.266 Sum_probs=175.7
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCCh--------hHHHHHHHHHHHhc-cCCCCcce
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEP--------DWLSGQLDNLRRAS-MWCRNVCT 205 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~--------~~~~~Ei~iL~~l~-l~HpNIV~ 205 (1630)
-.+|+.++.+|.|+||.|.+ |.++.....|+||.|.+++.... -.+-.||+||..++ ..|+||++
T Consensus 560 ~s~yttlq~lG~GAyGkV~l------ai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNL------AIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred cccceeeeeccccccceEEE------eeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 35799999999999998865 55677789999999988743332 23446999999976 45999999
Q ss_pred eEEEEEeCCEEEEEEecC-CCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEee
Q 000343 206 FHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 206 l~~~f~~~~~~~LVmEy~-~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~D 284 (1630)
++++|++++++||+||-- +|=+|++++..+..+++.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 999999999999999987 4558888888888999999999999999999999999999999999999999999999999
Q ss_pred cceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCC
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~ 364 (1630)
||.|....++ .....+||..|+|||++.+.+| .+...|||++|++||.++...
T Consensus 714 fgsaa~~ksg----------------pfd~f~gtv~~aapevl~g~~y-----------~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 714 FGSAAYTKSG----------------PFDVFVGTVDYAAPEVLGGEKY-----------LGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred ccchhhhcCC----------------CcceeeeeccccchhhhCCCcc-----------CCCcchhhhhhheeeEEEecc
Confidence 9999776543 2456789999999999999885 588999999999999999999
Q ss_pred CCCCC
Q 000343 365 IPWAG 369 (1630)
Q Consensus 365 ~PF~~ 369 (1630)
.||.+
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 99864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=285.08 Aligned_cols=277 Identities=17% Similarity=0.150 Sum_probs=181.3
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEc------------cccccCCcEEEEEEeeccCcCChh--------------HHH
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIG------------GGQGRCRHSVAVKKVMIAEEMEPD--------------WLS 187 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~------------a~~~~~g~~VAIK~i~~~~~~~~~--------------~~~ 187 (1630)
-.++|++.++||+|+||.||. .+.. -.....++.||||++........+ ...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYk--G~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFE--GLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEE--EEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 357999999999999999864 2110 112345678999998754322222 222
Q ss_pred HHHHHHHHhcc---CCCCcceeEEEEEe--------CCEEEEEEecCCCChHHHHHHcC---------------------
Q 000343 188 GQLDNLRRASM---WCRNVCTFHGVLRM--------DSCLGLVMDRCYGSVQLAMQRNE--------------------- 235 (1630)
Q Consensus 188 ~Ei~iL~~l~l---~HpNIV~l~~~f~~--------~~~~~LVmEy~~gglL~~l~~~~--------------------- 235 (1630)
.|+..+.+++. .++++++++++|.. ....+|||||+.++.|..++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 35555555541 12345677777653 35689999999988777665421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCccccc
Q 000343 236 ---GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312 (1630)
Q Consensus 236 ---~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 312 (1630)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-------------~~~~ 367 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-------------NFNP 367 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-------------ccCc
Confidence 124567889999999999999999999999999999999999999999999987543211 0011
Q ss_pred ccccCCCCCCCccccccccccccccc----------cCcCCCCccccchhhhhHHHHHhhCCC-CCCCCCHHHH----H-
Q 000343 313 DCTMLSPNYTAPEAWEPVKKSLNLFW----------DDAIGISPESDAWSFGCTLVEMCTGSI-PWAGLSAEEI----Y- 376 (1630)
Q Consensus 313 ~~~~GT~~Y~APEvl~~~~~~~~~~~----------~~~~~~t~ksDIWSlGvILyemltG~~-PF~~~~~~ei----~- 376 (1630)
....+|+.|+|||++........... ....+...+.||||+||++|+|++|.. ||.+...... +
T Consensus 368 ~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~ 447 (507)
T PLN03224 368 LYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD 447 (507)
T ss_pred cccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc
Confidence 22345889999999864321000000 000112345799999999999999876 7754321110 0
Q ss_pred ---HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCc---CCCCChhhHHHHhh
Q 000343 377 ---RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKA---SKRPTFSAMLATFL 427 (1630)
Q Consensus 377 ---~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP---~~RPSa~evL~~L~ 427 (1630)
............+ ......++..++|+.+||..+| .+|+|++|+|+|-+
T Consensus 448 ~~~~~~r~~~~~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 448 NDLNRWRMYKGQKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred chHHHHHhhcccCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 0000000011111 1223468899999999999766 68999999999965
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=259.64 Aligned_cols=258 Identities=17% Similarity=0.244 Sum_probs=199.2
Q ss_pred eeccccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEE
Q 000343 130 IEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209 (1630)
Q Consensus 130 ~~~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~ 209 (1630)
....+.+.|++.+.||+|.||.+.| +.++.++..+|+|.++.. ......+.+|...-..++ .|.||+.-|++
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL------~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls-~H~hIi~tY~v 89 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILL------AEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLS-PHQHIIDTYEV 89 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEe------eeccCCceEEEeeccCcc-hhhHHHHHHHhccceeec-cchhhhHHHHH
Confidence 3456789999999999999998866 778999999999998864 445677888888777776 59999999986
Q ss_pred -EEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC--CcEEEeecc
Q 000343 210 -LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS--GRAVVSDYG 286 (1630)
Q Consensus 210 -f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~--g~vKL~DFG 286 (1630)
|++.+.++++|||++.++|..-... ..+.+...+.++.|+++||.|+|++++||||||.+||||-.. -++||||||
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence 8899999999999999888776654 348999999999999999999999999999999999999532 379999999
Q ss_pred eeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
+++..+... ...--+..|.+||++.... +..+..++.+|+|.||+++|..+||.+|
T Consensus 169 ~t~k~g~tV-----------------~~~~~~~~y~~pe~~~~~~-------ne~~~~~ps~D~WqfGIi~f~cltG~~P 224 (378)
T KOG1345|consen 169 LTRKVGTTV-----------------KYLEYVNNYHAPELCDTVV-------NEKLVVNPSTDIWQFGIIFFYCLTGKFP 224 (378)
T ss_pred cccccCcee-----------------hhhhhhcccCCcHHHhhcc-------ccceEecccccchheeeeeeeeecCCCc
Confidence 987644211 1112266799999887543 3455579999999999999999999999
Q ss_pred CCCCCH----HHHHHHHHhcC--CCCCCcccccCCCCCHHHHHHHHHhhccCcCCC---CChhhHHHH
Q 000343 367 WAGLSA----EEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKR---PTFSAMLAT 425 (1630)
Q Consensus 367 F~~~~~----~ei~~~i~~~~--~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~R---PSa~evL~~ 425 (1630)
|+.... .--+.+..++. ..|..+ .-+++.+..+.++-|..+|++| .+++.....
T Consensus 225 WQka~~~d~~Y~~~~~w~~rk~~~~P~~F-----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 225 WQKASIMDKPYWEWEQWLKRKNPALPKKF-----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred chhhhccCchHHHHHHHhcccCccCchhh-----cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 974322 11122222221 122222 2478899999999999999999 444444443
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=277.17 Aligned_cols=214 Identities=18% Similarity=0.096 Sum_probs=175.4
Q ss_pred CHHH-HHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccc----ccccCCCchHHHHHHH--cCCHHH
Q 000343 523 SAEL-VEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVIS----RLREGFGPSVAHVCAY--HGQPDC 595 (1630)
Q Consensus 523 ~~ei-Vk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~----~~~d~~g~T~Lh~Aa~--~G~~ei 595 (1630)
..++ -++++. .++++|..+.+| +||..+..|++++|+.+|+++|. ..++...+|+||+|+. .|+.++
T Consensus 60 ~~~~~~~~~~~-~~~~i~~~~~~~-----~~~~~~~k~~~~~l~s~~~~~~~~~~~~~~~~~~~~~L~~~~~n~~n~~ei 133 (437)
T PHA02795 60 PVDVLYDYFRI-HRDNIDQYIVDR-----LFAYITYKDIISALVSKNYMEDIFSIIIKNCNSVQDLLLYYLSNAYVEIDI 133 (437)
T ss_pred HHHHHHHHHHH-cCcchhhhhhhh-----HHhhcchHHHHHHHHhcccccchhhhhhhccccccHHHHHHHHhcCCCHHH
Confidence 3443 356666 467899888887 89999999999999999999871 1145568899999999 899999
Q ss_pred HHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCcccccccc-----CCCCcHHHHHHHcCCHHHHHHHHHh
Q 000343 596 MRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILN-----SKELTPLHLCVATWNVAVVKRWVEV 670 (1630)
Q Consensus 596 vk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d-----~~G~TPLh~Aa~~g~~eivk~LLe~ 670 (1630)
+++|+++|||+|.. ++.||||.|+..++.+++++|+++|+. +.+..+ ..+.||+|.|+.
T Consensus 134 V~~LI~~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~-~~n~~~~~l~~~~~~t~l~~a~~------------- 197 (437)
T PHA02795 134 VDFMVDHGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIP-DENDVKLDLYKIIQYTRGFLVDE------------- 197 (437)
T ss_pred HHHHHHCCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCc-ccccccchhhhhhccchhHHHHh-------------
Confidence 99999999999984 458999999999999999999999972 221111 123334444332
Q ss_pred cCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCC
Q 000343 671 ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVD 750 (1630)
Q Consensus 671 ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GAD 750 (1630)
.+..+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++|||
T Consensus 198 -------------------------------~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAd 246 (437)
T PHA02795 198 -------------------------------PTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGAN 246 (437)
T ss_pred -------------------------------cCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCC
Confidence 2346888999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCHHHHHHHcC--------CHHHHHHHHhCCCCCCcCCC
Q 000343 751 VNIRNVHNTIPLHVALARG--------AKSCVGLLLSAGADCNWQDD 789 (1630)
Q Consensus 751 vN~~d~~G~TPLH~Aa~~G--------~~eiVklLLe~GADiN~~D~ 789 (1630)
+|.+|..|.||||+|+.+| +.+++++|+++|++++..+.
T Consensus 247 IN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~~~~ 293 (437)
T PHA02795 247 VNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSIDCIKL 293 (437)
T ss_pred CCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCchhH
Confidence 9999999999999999988 46999999999999987654
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=277.71 Aligned_cols=242 Identities=14% Similarity=0.109 Sum_probs=197.1
Q ss_pred HHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCC------CCCCCCCChhhhhhh--cCChHHHHHH
Q 000343 561 VHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPN------AVDDEGESVLHRAVA--KKYTDCAIVI 632 (1630)
Q Consensus 561 Vk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn------~~D~~G~TPLH~Aa~--~g~~eiv~~L 632 (1630)
-++++.+|+++|....++ +|+..+..|++++|+.+|+++| ..+..++|+||+|+. .++.+++++|
T Consensus 65 ~~~~~~~~~~i~~~~~~~-------~~~~~~~k~~~~~l~s~~~~~~~~~~~~~~~~~~~~~L~~~~~n~~n~~eiV~~L 137 (437)
T PHA02795 65 YDYFRIHRDNIDQYIVDR-------LFAYITYKDIISALVSKNYMEDIFSIIIKNCNSVQDLLLYYLSNAYVEIDIVDFM 137 (437)
T ss_pred HHHHHHcCcchhhhhhhh-------HHhhcchHHHHHHHHhcccccchhhhhhhccccccHHHHHHHHhcCCCHHHHHHH
Confidence 489999999999877664 7999999999999999999999 788999999999999 8999999999
Q ss_pred HHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHH
Q 000343 633 LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712 (1630)
Q Consensus 633 L~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL 712 (1630)
+++|| +++. .++.||||.|+..++.+++++|+++|+... +.
T Consensus 138 I~~GA--DIn~--~~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~--n~--------------------------------- 178 (437)
T PHA02795 138 VDHGA--VIYK--IECLNAYFRGICKKESSVVEFILNCGIPDE--ND--------------------------------- 178 (437)
T ss_pred HHCCC--CCCC--CCCCCHHHHHHHcCcHHHHHHHHhcCCccc--cc---------------------------------
Confidence 99998 5554 355899999999888888888877765210 00
Q ss_pred hcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCC
Q 000343 713 TAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGD 792 (1630)
Q Consensus 713 ~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~ 792 (1630)
.+.+..+..+.||+|.|+..++.+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++|||+|.+|..|.
T Consensus 179 ---~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~ 255 (437)
T PHA02795 179 ---VKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGY 255 (437)
T ss_pred ---ccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCC
Confidence 01112234578999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhchH--HHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCC
Q 000343 793 NAFHIAADAAKM--IRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHL 860 (1630)
Q Consensus 793 TpLhlAa~~g~~--i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l 860 (1630)
||||+|+..|.. .++....++++|++.|++++.....+ +.. .....++++.|+++...+
T Consensus 256 TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~~~~~~---~~~------~~~n~~~ik~lI~y~~~l 316 (437)
T PHA02795 256 TCLDVAVDRGSVIARRETHLKILEILLREPLSIDCIKLAI---LNN------TIENHDVIKLCIKYFMMV 316 (437)
T ss_pred CHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCchhHHh---hhc------ccchHHHHHHHHHHHHhc
Confidence 999999987742 12233467778888999888754322 111 112457888888877654
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=255.46 Aligned_cols=97 Identities=24% Similarity=0.388 Sum_probs=86.9
Q ss_pred HHHHHHHHhcCCCCCcccccCccchhhhhh--cCCHHHHHHHHHCCCCcccccCCCCCHHHH-HHHcCCHHHHHHHHhCC
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASM--ANDVELVKIILDAGVDVNIRNVHNTIPLHV-ALARGAKSCVGLLLSAG 781 (1630)
Q Consensus 705 ~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~--~g~~eiVklLL~~GADvN~~d~~G~TPLH~-Aa~~G~~eiVklLLe~G 781 (1630)
.+++++|+++|+++|.+|..|.||||+|+. .++.+++++|+++|+|+|.+|.+|.||||. |+..++.+++++|+++|
T Consensus 103 ~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~G 182 (209)
T PHA02859 103 PEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLG 182 (209)
T ss_pred HHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcC
Confidence 467888889999999999999999999875 468999999999999999999999999995 56678999999999999
Q ss_pred CCCCcCCCCCCcHHHHHHHh
Q 000343 782 ADCNWQDDEGDNAFHIAADA 801 (1630)
Q Consensus 782 ADiN~~D~~G~TpLhlAa~~ 801 (1630)
+|+|.+|..|+||||+|+..
T Consensus 183 adi~~~d~~g~tpl~la~~~ 202 (209)
T PHA02859 183 IDINETNKSGYNCYDLIKFR 202 (209)
T ss_pred CCCCCCCCCCCCHHHHHhhh
Confidence 99999999999999999854
|
|
| >KOG4369 consensus RTK signaling protein MASK/UNC-44 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=285.51 Aligned_cols=319 Identities=21% Similarity=0.212 Sum_probs=278.8
Q ss_pred cccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHH
Q 000343 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV 586 (1630)
Q Consensus 507 ~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~ 586 (1630)
...+-.|+|-.||..|+.|+|++|+.. ++++...|+.|.+||.+|+-.||..+|+.|+++-|++... .|..+.|+|.+
T Consensus 753 Te~n~~t~LT~acaggh~e~vellv~r-ganiehrdkkgf~plImaatagh~tvV~~llk~ha~veaQ-sdrtkdt~lSl 830 (2131)
T KOG4369|consen 753 TEPNIKTNLTSACAGGHREEVELLVVR-GANIEHRDKKGFVPLIMAATAGHITVVQDLLKAHADVEAQ-SDRTKDTMLSL 830 (2131)
T ss_pred cCccccccccccccCccHHHHHHHHHh-cccccccccccchhhhhhcccCchHHHHHHHhhhhhhhhh-cccccCceEEE
Confidence 445567999999999999999999985 6899999999999999999999999999999999999875 56778899999
Q ss_pred HHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHH
Q 000343 587 CAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKR 666 (1630)
Q Consensus 587 Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~ 666 (1630)
||..|..+++++||.+||+-..++-...|||-+|...|+.+++.+||.+|+..+-..-.+.|.+||++|.++||....+.
T Consensus 831 acsggr~~vvelLl~~gankehrnvsDytPlsla~Sggy~~iI~~llS~GseInSrtgSklgisPLmlatmngh~~at~~ 910 (2131)
T KOG4369|consen 831 ACSGGRTRVVELLLNAGANKEHRNVSDYTPLSLARSGGYTKIIHALLSSGSEINSRTGSKLGISPLMLATMNGHQAATLS 910 (2131)
T ss_pred ecCCCcchHHHHHHHhhccccccchhhcCchhhhcCcchHHHHHHHhhcccccccccccccCcchhhhhhhccccHHHHH
Confidence 99999999999999999999999999999999999999999999999999854444445679999999999999999999
Q ss_pred HHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHH
Q 000343 667 WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746 (1630)
Q Consensus 667 LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~ 746 (1630)
|++.+++.+ ..+..+..++|.++... +..+++.+||.+.+++..+-..|.|||+-+|..|.+++-++||.
T Consensus 911 ll~~gsdiN----aqIeTNrnTaltla~fq------gr~evv~lLLa~~anvehRaktgltplme~AsgGyvdvg~~li~ 980 (2131)
T KOG4369|consen 911 LLQPGSDIN----AQIETNRNTALTLALFQ------GRPEVVFLLLAAQANVEHRAKTGLTPLMEMASGGYVDVGNLLIA 980 (2131)
T ss_pred Hhcccchhc----cccccccccceeecccc------CcchHHHHHHHHhhhhhhhcccCCcccchhhcCCccccchhhhh
Confidence 999887532 12334445666555432 34689999999999999999999999999999999999999999
Q ss_pred CCCCccccc--CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCccc
Q 000343 747 AGVDVNIRN--VHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVE 824 (1630)
Q Consensus 747 ~GADvN~~d--~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn 824 (1630)
+|||+|+.- ....|+|-+++..||...+.+|+...|-+..+|++|+|+|.+|+..|.. ....+|...+||++
T Consensus 981 ~gad~nasPvp~T~dtalti~a~kGh~kfv~~lln~~atv~v~NkkG~T~Lwla~~Gg~l------ss~~il~~~~ad~d 1054 (2131)
T KOG4369|consen 981 AGADTNASPVPNTWDTALTIPANKGHTKFVPKLLNGDATVRVPNKKGCTVLWLASAGGAL------SSCPILVSSVADAD 1054 (2131)
T ss_pred cccccccCCCCCcCCccceeecCCCchhhhHHhhCCccceecccCCCCcccchhccCCcc------ccchHHhhcccChh
Confidence 999999753 3457999999999999999999999999999999999999999976653 45677888999999
Q ss_pred ccCCCCCCHHHHHhhCCCC
Q 000343 825 VRNHSGKTLRDFLEGLPRE 843 (1630)
Q Consensus 825 ~~n~~G~TpLdlA~~~~~~ 843 (1630)
..|+.-.|++..|.+.++.
T Consensus 1055 ~qdnr~~S~~maafRKgh~ 1073 (2131)
T KOG4369|consen 1055 QQDNRTNSRTMAAFRKGHF 1073 (2131)
T ss_pred hhhcccccccHHHHHhchh
Confidence 9999888888777665543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=268.09 Aligned_cols=271 Identities=25% Similarity=0.347 Sum_probs=202.5
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEcccccc---CCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEE
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGR---CRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~---~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f 210 (1630)
..+.|..+.+||.|+|+.||. +.+.. ..+.||+|.+... ..+.++.+|++.|..+. ++.||+++.+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~------a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~g-G~~ni~~~~~~~ 104 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYK------ATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLG-GSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhccccccchhhhhh------hhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhc-cchhhhcchhhh
Confidence 456899999999999888754 55555 7889999998864 45678999999999997 799999999999
Q ss_pred EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-CcEEEeecceee
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYGLAA 289 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-g~vKL~DFGla~ 289 (1630)
..++...+||||++......+... ++..+++.|++.++.||+|+|.+|||||||||+|+|.+.. +.-.|.|||+|.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999999999888888765 7899999999999999999999999999999999999854 678999999998
Q ss_pred eecCccc-----c----CCCC--------------CCC-------CCCcccccccccCCCCCCCcccccccccccccccc
Q 000343 290 ILKKPAC-----R----KARP--------------ECD-------SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWD 339 (1630)
Q Consensus 290 ~~~~~~~-----~----~~~~--------------~~~-------~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~ 339 (1630)
....... . ...+ ... ............||+.|+|||++.....
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~------- 254 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR------- 254 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-------
Confidence 3221100 0 0000 000 0001112335689999999999987652
Q ss_pred CcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-----HHH--------HHHH--HhcC--CCC----------------
Q 000343 340 DAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-----EEI--------YRAV--VKNR--KLP---------------- 386 (1630)
Q Consensus 340 ~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~-----~ei--------~~~i--~~~~--~~~---------------- 386 (1630)
.++++||||.|+|+.-++++.+||..... .++ +.+. ..+. ...
T Consensus 255 ----QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s 330 (418)
T KOG1167|consen 255 ----QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFET 330 (418)
T ss_pred ----cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhc
Confidence 68999999999999999999999954322 010 0000 0011 000
Q ss_pred ---------CC--ccc-ccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 387 ---------PQ--YAS-IVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 387 ---------~~--~~~-~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
.. ... ......+..+.+|+.+||..||.+|.|++++|+|.+
T Consensus 331 ~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 331 LHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred cChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 00 000 011124457899999999999999999999999855
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=250.17 Aligned_cols=182 Identities=18% Similarity=0.220 Sum_probs=124.2
Q ss_pred hcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcC--CHHHHHHHHHCCCCcccccccCCCchH
Q 000343 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAG--SPECVHALIKRGANVISRLREGFGPSV 583 (1630)
Q Consensus 506 ~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G--~~eiVk~LL~~GAdvn~~~~d~~g~T~ 583 (1630)
.-...+.||||+|+..|+.++|+.|++. ++..|..|.||||+|+.++ +.+++++|+++|+++|..+ +..|.||
T Consensus 16 ~~~~~~~~pL~~A~~~~~~~~vk~Li~~----~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~-~~~g~Tp 90 (209)
T PHA02859 16 YLFYRYCNPLFYYVEKDDIEGVKKWIKF----VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKT-RDNNLSA 90 (209)
T ss_pred HHhhccCcHHHHHHHhCcHHHHHHHHHh----hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccC-CCCCCCH
Confidence 3345567777777777777777777652 4556666777777776643 6666666666666665432 2235566
Q ss_pred HHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCC
Q 000343 584 AHVCAYH---GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWN 660 (1630)
Q Consensus 584 Lh~Aa~~---G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~ 660 (1630)
||+|+.. ++.+++++|+++|+|+|.+|.+|.||||+|+...
T Consensus 91 Lh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~------------------------------------ 134 (209)
T PHA02859 91 LHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNF------------------------------------ 134 (209)
T ss_pred HHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhc------------------------------------
Confidence 6665542 3456666666666666666555555555543210
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhh-hhhcCCHH
Q 000343 661 VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHI-ASMANDVE 739 (1630)
Q Consensus 661 ~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~-Aa~~g~~e 739 (1630)
.+..+++++|+++|+++|.+|..|.||||. |+..++.+
T Consensus 135 -----------------------------------------~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~a~~~~~~~ 173 (209)
T PHA02859 135 -----------------------------------------NVRINVIKLLIDSGVSFLNKDFDNNNILYSYILFHSDKK 173 (209)
T ss_pred -----------------------------------------cCCHHHHHHHHHcCCCcccccCCCCcHHHHHHHhcCCHH
Confidence 012467788888889999999999999995 56678899
Q ss_pred HHHHHHHCCCCcccccCCCCCHHHHHHHcC
Q 000343 740 LVKIILDAGVDVNIRNVHNTIPLHVALARG 769 (1630)
Q Consensus 740 iVklLL~~GADvN~~d~~G~TPLH~Aa~~G 769 (1630)
++++|+++|+|+|.+|..|.||||+|+.++
T Consensus 174 iv~~Ll~~Gadi~~~d~~g~tpl~la~~~~ 203 (209)
T PHA02859 174 IFDFLTSLGIDINETNKSGYNCYDLIKFRN 203 (209)
T ss_pred HHHHHHHcCCCCCCCCCCCCCHHHHHhhhh
Confidence 999999999999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=250.19 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=205.6
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEE-eC
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR-MD 213 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~-~~ 213 (1630)
.++++...+-+|+||.|| +|.+.....-.+.+.|-+|.++... ......+..|-..|..+. |||+..+.++.. +.
T Consensus 284 ~Rv~l~~llqEGtFGri~-~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s--H~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIY-RGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS--HPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhhee-eeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc--CCCccceeEEEeecc
Confidence 578888899999999996 3433322222334567777766432 223445555666666654 999999999865 45
Q ss_pred CEEEEEEecCCCChHHHHHH-----c---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQR-----N---EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~-----~---~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DF 285 (1630)
...+.++.+..-+.|..++. . ...++..+...++.|++.|++|||+.||||.||-..|.+||+.-++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 66888999998777777665 1 124788889999999999999999999999999999999999999999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~ 364 (1630)
.+++.+-...+ .| ...+...+..|||||.+.... |+.++|+||||++||||+| |+
T Consensus 441 aLSRDLFP~DY-----hc-------LGDnEnRPvkWMslEal~n~~------------yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 441 ALSRDLFPGDY-----HC-------LGDNENRPVKWMSLEALQNSH------------YSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred hhccccCcccc-----cc-------cCCCCCCcccccCHHHHhhhh------------hcchhhhHHHHHHHHHHHhcCC
Confidence 99987654321 11 112223467899999998876 8999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
.||...++.++...+..|.+....+ ++|+++..+|.-||...|++||+++|+..-|.+..
T Consensus 497 ~PyaeIDPfEm~~ylkdGyRlaQP~------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 497 LPYAEIDPFEMEHYLKDGYRLAQPF------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CCccccCHHHHHHHHhccceecCCC------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 9999999999999998887665433 68999999999999999999999999987776543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=231.11 Aligned_cols=212 Identities=29% Similarity=0.481 Sum_probs=178.2
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEec
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDR 222 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmEy 222 (1630)
||+|++|.||. +....+++.+++|++...... ....+.+|++.++.++ |++|+++++++......+++|||
T Consensus 1 l~~g~~~~v~~------~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~~~e~ 72 (215)
T cd00180 1 LGEGGFGTVYL------ARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYGVFEDENHLYLVMEY 72 (215)
T ss_pred CCcCCceEEEE------EEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC--CCCeeeEeeeeecCCeEEEEEec
Confidence 68899877754 555567899999998865432 2467889999999986 89999999999999999999999
Q ss_pred CCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC-CCcEEEeecceeeeecCccccCCC
Q 000343 223 CYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKKPACRKAR 300 (1630)
Q Consensus 223 ~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~~ 300 (1630)
+++..+..++... ..++...+..++.+++++|+|||+.|++|+||+|.||+++. .+.++|+|||.+........
T Consensus 73 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 73 CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9988887777654 46899999999999999999999999999999999999998 89999999999987643210
Q ss_pred CCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Q 000343 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV 380 (1630)
Q Consensus 301 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~ 380 (1630)
......+...|++||.+.... .++.++|+||+|+++++|
T Consensus 149 ----------~~~~~~~~~~~~~pe~~~~~~-----------~~~~~~D~~~lg~~~~~l-------------------- 187 (215)
T cd00180 149 ----------LLKTIVGTPAYMAPEVLLGKG-----------YYSEKSDIWSLGVILYEL-------------------- 187 (215)
T ss_pred ----------hhhcccCCCCccChhHhcccC-----------CCCchhhhHHHHHHHHHH--------------------
Confidence 122344678899999886541 268899999999999999
Q ss_pred hcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHh
Q 000343 381 KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 381 ~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L 426 (1630)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5689999999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=258.74 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=220.3
Q ss_pred hHHHHHHHcCCHHHHHHHHHhcC------------CCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCC
Q 000343 513 TALHLACRRGSAELVEAILEYSQ------------ENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFG 580 (1630)
Q Consensus 513 TpLH~Aa~~G~~eiVk~LL~~~~------------~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g 580 (1630)
+=|.-||..|+.+.+..||+... .++|..|.+|.|+||.|+.+|+.+++++|+++.+-++.. +..|
T Consensus 5 qel~~a~ka~d~~tva~ll~~~~~r~~~l~~~trsds~n~qd~~gfTalhha~Lng~~~is~llle~ea~ldl~--d~kg 82 (854)
T KOG0507|consen 5 QELIDACKAGDYDTVALLLSSKKGRSGLLFFTTRSDSHNLQDYSGFTLLHHAVLNGQNQISKLLLDYEALLDLC--DTKG 82 (854)
T ss_pred hhHHHhhhcccHHHHHHhccCCCCCCCCCCCCCCCccccccCccchhHHHHHHhcCchHHHHHHhcchhhhhhh--hccC
Confidence 34788999999999999998532 246788999999999999999999999999998877654 4678
Q ss_pred chHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCC
Q 000343 581 PSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWN 660 (1630)
Q Consensus 581 ~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~ 660 (1630)
.+|||+|+.+|+.+++++|+.++..+|+.+..|.||||.|++.+|.+++.+||.+|+ +..+.|..+.|+|.+|+..|.
T Consensus 83 ~~plhlaaw~g~~e~vkmll~q~d~~na~~~e~~tplhlaaqhgh~dvv~~Ll~~~a--dp~i~nns~~t~ldlA~qfgr 160 (854)
T KOG0507|consen 83 ILPLHLAAWNGNLEIVKMLLLQTDILNAVNIENETPLHLAAQHGHLEVVFYLLKKNA--DPFIRNNSKETVLDLASRFGR 160 (854)
T ss_pred cceEEehhhcCcchHHHHHHhcccCCCcccccCcCccchhhhhcchHHHHHHHhcCC--CccccCcccccHHHHHHHhhh
Confidence 899999999999999999999999999999999999999999999999999999998 667789999999999999999
Q ss_pred HHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHH
Q 000343 661 VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740 (1630)
Q Consensus 661 ~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~ei 740 (1630)
.++++.|+...- .+.+++..| -..++-.+-+|||+|+.+|+.++
T Consensus 161 ~~Vvq~ll~~~~----------------------------------~~~~~~~~~--~~~~~~~~~~plHlaakngh~~~ 204 (854)
T KOG0507|consen 161 AEVVQMLLQKKF----------------------------------PVQSSLRVG--DIKRPFPAIYPLHLAAKNGHVEC 204 (854)
T ss_pred hHHHHHHhhhcc----------------------------------chhhcccCC--CCCCCCCCcCCcchhhhcchHHH
Confidence 999999986511 011122334 34567789999999999999999
Q ss_pred HHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhc
Q 000343 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAA 802 (1630)
Q Consensus 741 VklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g 802 (1630)
++.|+++|.|+|....+| |+||-|+..|..++|.+|++.|.+.+++|.+|+|+|.+-.+..
T Consensus 205 ~~~ll~ag~din~~t~~g-talheaalcgk~evvr~ll~~gin~h~~n~~~qtaldil~d~~ 265 (854)
T KOG0507|consen 205 MQALLEAGFDINYTTEDG-TALHEAALCGKAEVVRFLLEIGINTHIKNQHGQTALDIIIDLQ 265 (854)
T ss_pred HHHHHhcCCCcccccccc-hhhhhHhhcCcchhhhHHHhhccccccccccchHHHHHHHhcc
Confidence 999999999999987665 7999999999999999999999999999999999999987653
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=232.37 Aligned_cols=237 Identities=24% Similarity=0.234 Sum_probs=121.3
Q ss_pred ccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHH
Q 000343 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVC 587 (1630)
Q Consensus 508 d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~A 587 (1630)
+..|..-+--|.+.|+.+++..++...+.-++..+.+|+.++|.|+-.++...+..+|.+|+..|.. +..+.+|+.++
T Consensus 59 ~~lge~~~~~~~~s~nsd~~v~s~~~~~~~~~~t~p~g~~~~~v~ap~~s~~k~sttltN~~rgnev--s~~p~s~~sls 136 (296)
T KOG0502|consen 59 NALGESLLTVAVRSGNSDVAVQSAQLDPDAIDETDPEGWSALLVAAPCGSVDKVSTTLTNGARGNEV--SLMPWSPLSLS 136 (296)
T ss_pred HhcCCcccchhhhcCCcHHHHHhhccCCCCCCCCCchhhhhhhhcCCCCCcceeeeeecccccCCcc--ccccCChhhHH
Confidence 3444555555666666666655555444444555555666666666666666666666555555442 23344555555
Q ss_pred HHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHH
Q 000343 588 AYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRW 667 (1630)
Q Consensus 588 a~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~L 667 (1630)
+...+++.+..|.+ +.+|..|+.|.|||++|+..|++.+|++||+.|+ +++...+...|+|.+|+..|
T Consensus 137 Vhql~L~~~~~~~~--n~VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GA--dp~~lgk~resALsLAt~gg-------- 204 (296)
T KOG0502|consen 137 VHQLHLDVVDLLVN--NKVNACDEFGFTPLIWAAAKGHIPVVQFLLNSGA--DPDALGKYRESALSLATRGG-------- 204 (296)
T ss_pred HHHHHHHHHHHHhh--ccccCccccCchHhHHHHhcCchHHHHHHHHcCC--ChhhhhhhhhhhHhHHhcCC--------
Confidence 55555444443333 2345555555555555555555555555555554 33334444444444444321
Q ss_pred HHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHC
Q 000343 668 VEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747 (1630)
Q Consensus 668 Le~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~ 747 (1630)
..+||++||+++.|+|..|.+|-|||.||++.|+.++++.||+.
T Consensus 205 ------------------------------------ytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvkcve~Ll~s 248 (296)
T KOG0502|consen 205 ------------------------------------YTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVKCVESLLNS 248 (296)
T ss_pred ------------------------------------hHHHHHHHHhcCCCcceeccCCCceeeeeecCChHHHHHHHHhc
Confidence 12344444444455555555555555555555555555555555
Q ss_pred CCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHH
Q 000343 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAF 795 (1630)
Q Consensus 748 GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpL 795 (1630)
|||++..+..|.+++.+|+..|+. +|+..|++-++.+.+|..-+|||
T Consensus 249 GAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~lkl~Q~~~~~~~~ 295 (296)
T KOG0502|consen 249 GADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHALKLCQDSEKRTPL 295 (296)
T ss_pred CCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHHHHhhcccCCCCC
Confidence 555555555555555555555543 45555555455555554444444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=232.59 Aligned_cols=213 Identities=27% Similarity=0.365 Sum_probs=175.1
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC-ChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEE
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCL 216 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~ 216 (1630)
|.+.+.||.|+||.||. +....+++.+|+|.+...... ....+.+|++.++.++ |+|++++++.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~------~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~--~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYL------ARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK--HPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEE------EEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC--CCChhhheeeeecCCce
Confidence 67789999999887754 555667899999999876554 5678888999998875 99999999999998999
Q ss_pred EEEEecCCCChHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCcc
Q 000343 217 GLVMDRCYGSVQLAMQRNEGR-LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 217 ~LVmEy~~gglL~~l~~~~~~-L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+++|||++++.+..++..... +++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 73 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 999999999777777765555 8999999999999999999999999999999999999999999999999998765321
Q ss_pred ccCCCCCCCCCCcccccccccCCCCCCCccccc-cccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC-CCH-
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWE-PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG-LSA- 372 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~-~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~-~~~- 372 (1630)
........++..|++||.+. .. .++.++|+||||+++|+|++|+.||.. ...
T Consensus 153 -------------~~~~~~~~~~~~~~~pe~~~~~~------------~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 153 -------------AALLKTVKGTPFYLAPEVLLGGK------------GYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred -------------cccccceeccCCcCCHhHhcCCC------------CCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 00122345678899999984 22 267799999999999999999999977 344
Q ss_pred HHHHHHHHhcC
Q 000343 373 EEIYRAVVKNR 383 (1630)
Q Consensus 373 ~ei~~~i~~~~ 383 (1630)
..+.+.+..+.
T Consensus 208 ~~~~~~~~~~~ 218 (225)
T smart00221 208 SLLSDVWSFGV 218 (225)
T ss_pred HHHHHHHhcCC
Confidence 45666665554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4369 consensus RTK signaling protein MASK/UNC-44 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=265.83 Aligned_cols=313 Identities=22% Similarity=0.235 Sum_probs=269.9
Q ss_pred CCCCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCccc-CCCCC
Q 000343 467 DNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDV-LDKDG 545 (1630)
Q Consensus 467 ~~~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~-~D~~G 545 (1630)
+-.++|-.|+..|+.+.++.|+.+|+++ +.+|..|.+||.+|+-.||..+|+.||... +++++ .|+.+
T Consensus 756 n~~t~LT~acaggh~e~vellv~rgani----------ehrdkkgf~plImaatagh~tvV~~llk~h-a~veaQsdrtk 824 (2131)
T KOG4369|consen 756 NIKTNLTSACAGGHREEVELLVVRGANI----------EHRDKKGFVPLIMAATAGHITVVQDLLKAH-ADVEAQSDRTK 824 (2131)
T ss_pred cccccccccccCccHHHHHHHHHhcccc----------cccccccchhhhhhcccCchHHHHHHHhhh-hhhhhhccccc
Confidence 3467899999999999999999999975 578999999999999999999999999864 45654 58999
Q ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCC--CCCCChhhhhhhc
Q 000343 546 DPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVD--DEGESVLHRAVAK 623 (1630)
Q Consensus 546 ~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D--~~G~TPLH~Aa~~ 623 (1630)
.|+|.+||..|+.++|++||.+||+-..+ +-...|||.+|...|..+++++||.+|+.+|.+. +.|-+||++|+.+
T Consensus 825 dt~lSlacsggr~~vvelLl~~gankehr--nvsDytPlsla~Sggy~~iI~~llS~GseInSrtgSklgisPLmlatmn 902 (2131)
T KOG4369|consen 825 DTMLSLACSGGRTRVVELLLNAGANKEHR--NVSDYTPLSLARSGGYTKIIHALLSSGSEINSRTGSKLGISPLMLATMN 902 (2131)
T ss_pred CceEEEecCCCcchHHHHHHHhhcccccc--chhhcCchhhhcCcchHHHHHHHhhcccccccccccccCcchhhhhhhc
Confidence 99999999999999999999999987554 3445688999999999999999999999999864 5689999999999
Q ss_pred CChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccch
Q 000343 624 KYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703 (1630)
Q Consensus 624 g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~ 703 (1630)
||...++.||+.|...+.+ ...+-+|+|-+|+..|..+++.+||.+.++.+.... .+-|+|+..|. .+
T Consensus 903 gh~~at~~ll~~gsdiNaq-IeTNrnTaltla~fqgr~evv~lLLa~~anvehRak-----tgltplme~As------gG 970 (2131)
T KOG4369|consen 903 GHQAATLSLLQPGSDINAQ-IETNRNTALTLALFQGRPEVVFLLLAAQANVEHRAK-----TGLTPLMEMAS------GG 970 (2131)
T ss_pred cccHHHHHHhcccchhccc-cccccccceeeccccCcchHHHHHHHHhhhhhhhcc-----cCCcccchhhc------CC
Confidence 9999999999999733322 244678999999999999999999998876554321 12345544433 24
Q ss_pred hHHHHHHHHhcCCCCCccc--ccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCC
Q 000343 704 GRELVRILLTAGAEPTAQD--AQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781 (1630)
Q Consensus 704 ~~eiVklLL~~GAdvn~~D--~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~G 781 (1630)
+.++-++||..|||+|+-- ..-.|+|-+++..||...+++||+..|.+.++|.+|.|+|-+|+..|++..+.+|++++
T Consensus 971 yvdvg~~li~~gad~nasPvp~T~dtalti~a~kGh~kfv~~lln~~atv~v~NkkG~T~Lwla~~Gg~lss~~il~~~~ 1050 (2131)
T KOG4369|consen 971 YVDVGNLLIAAGADTNASPVPNTWDTALTIPANKGHTKFVPKLLNGDATVRVPNKKGCTVLWLASAGGALSSCPILVSSV 1050 (2131)
T ss_pred ccccchhhhhcccccccCCCCCcCCccceeecCCCchhhhHHhhCCccceecccCCCCcccchhccCCccccchHHhhcc
Confidence 5688899999999999753 33569999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCCCCCcHHHHHHHhchH
Q 000343 782 ADCNWQDDEGDNAFHIAADAAKM 804 (1630)
Q Consensus 782 ADiN~~D~~G~TpLhlAa~~g~~ 804 (1630)
||++.+|+.-+|++..|...|++
T Consensus 1051 ad~d~qdnr~~S~~maafRKgh~ 1073 (2131)
T KOG4369|consen 1051 ADADQQDNRTNSRTMAAFRKGHF 1073 (2131)
T ss_pred cChhhhhcccccccHHHHHhchh
Confidence 99999999999999999887763
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=230.82 Aligned_cols=240 Identities=25% Similarity=0.288 Sum_probs=205.8
Q ss_pred ChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcC
Q 000343 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591 (1630)
Q Consensus 512 ~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G 591 (1630)
-..|..++..|-.+--..|+....+ ..+..|..-+-.|...|+.+++..++...++.+... +..|..++|.|+-.+
T Consensus 32 ~a~~~~~~~m~~t~p~~~l~~~~s~---~~~~lge~~~~~~~~s~nsd~~v~s~~~~~~~~~~t-~p~g~~~~~v~ap~~ 107 (296)
T KOG0502|consen 32 IAELFEQVEMGTTEPRCALTAEISA---LRNALGESLLTVAVRSGNSDVAVQSAQLDPDAIDET-DPEGWSALLVAAPCG 107 (296)
T ss_pred HHHHHHHhhccccchhHHHHHHHHH---HHHhcCCcccchhhhcCCcHHHHHhhccCCCCCCCC-CchhhhhhhhcCCCC
Confidence 3457777777777666666653222 223456677778899999999988888777655443 344889999999999
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhc
Q 000343 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVA 671 (1630)
Q Consensus 592 ~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~g 671 (1630)
+.+.+..+|.+|+..|..+.-+.+|+.+++.+.+++.+..|.++ .+|..|..|.|||.||+..|++
T Consensus 108 s~~k~sttltN~~rgnevs~~p~s~~slsVhql~L~~~~~~~~n----~VN~~De~GfTpLiWAaa~G~i---------- 173 (296)
T KOG0502|consen 108 SVDKVSTTLTNGARGNEVSLMPWSPLSLSVHQLHLDVVDLLVNN----KVNACDEFGFTPLIWAAAKGHI---------- 173 (296)
T ss_pred CcceeeeeecccccCCccccccCChhhHHHHHHHHHHHHHHhhc----cccCccccCchHhHHHHhcCch----------
Confidence 99999999999999999999999999999999999988877775 4688899999999999987765
Q ss_pred CccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCc
Q 000343 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDV 751 (1630)
Q Consensus 672 a~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADv 751 (1630)
++|++||+.|||+++..+...|+|++|+..|..+||++||..+.|+
T Consensus 174 ----------------------------------~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdV 219 (296)
T KOG0502|consen 174 ----------------------------------PVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDV 219 (296)
T ss_pred ----------------------------------HHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCc
Confidence 4566677778888888889999999999999999999999999999
Q ss_pred ccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhch
Q 000343 752 NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAK 803 (1630)
Q Consensus 752 N~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~ 803 (1630)
|.-|.+|-|||-||++.+|.+|++.||+.|||++..|..|++++.+|+..|+
T Consensus 220 NvyDwNGgTpLlyAvrgnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGy 271 (296)
T KOG0502|consen 220 NVYDWNGGTPLLYAVRGNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGY 271 (296)
T ss_pred ceeccCCCceeeeeecCChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhh
Confidence 9999999999999999999999999999999999999999999999998875
|
|
| >TIGR00870 trp transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=278.63 Aligned_cols=239 Identities=21% Similarity=0.194 Sum_probs=185.6
Q ss_pred CCChHHHHHHHcCCHHHHHHHHHhc-CCCcccCCCCCCCHHH-HHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHH
Q 000343 510 DGQTALHLACRRGSAELVEAILEYS-QENVDVLDKDGDPPLV-FALAAGSPECVHALIKRGANVISRLREGFGPSVAHVC 587 (1630)
Q Consensus 510 ~G~TpLH~Aa~~G~~eiVk~LL~~~-~~dvn~~D~~G~TPLh-~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~A 587 (1630)
.++++|+.||+.|+.+.++.+|+.. +.++|..|..|+|||| .|+.+++.+++++|+++|+ .+..|.||||.|
T Consensus 16 ~~~~~~l~A~~~g~~~~v~~lL~~~~~~~in~~d~~G~t~Lh~~A~~~~~~eiv~lLl~~g~------~~~~G~T~Lh~A 89 (743)
T TIGR00870 16 DEEKAFLPAAERGDLASVYRDLEEPKKLNINCPDRLGRSALFVAAIENENLELTELLLNLSC------RGAVGDTLLHAI 89 (743)
T ss_pred HHHHHHHHHHHcCCHHHHHHHhccccccCCCCcCccchhHHHHHHHhcChHHHHHHHHhCCC------CCCcChHHHHHH
Confidence 5678999999999999999999852 5789999999999999 8999999999999999997 345688999999
Q ss_pred HHcC---CHHHHHHHHHcCCC------CCC----CCCCCCChhhhhhhcCChHHHHHHHHcCCcccccccc---------
Q 000343 588 AYHG---QPDCMRELLLAGAD------PNA----VDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILN--------- 645 (1630)
Q Consensus 588 a~~G---~~eivk~LL~~GAD------vn~----~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d--------- 645 (1630)
+.++ ...+++.|+..+.+ ++. .+..|.||||+|+.+++.+++++|+++|+. ++..+
T Consensus 90 ~~~~~~~v~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~G~TpLhlAa~~~~~eiVklLL~~GAd--v~~~~~~~~~~~~~ 167 (743)
T TIGR00870 90 SLEYVDAVEAILLHLLAAFRKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGAS--VPARACGDFFVKSQ 167 (743)
T ss_pred HhccHHHHHHHHHHHhhcccccCchhhhccccccccCCCCcHHHHHHHhCCHHHHHHHHhCCCC--CCcCcCCchhhcCC
Confidence 8732 23444444444432 111 234699999999999999999999999973 43321
Q ss_pred -----CCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCc
Q 000343 646 -----SKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTA 720 (1630)
Q Consensus 646 -----~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~ 720 (1630)
..|.||||+|+..+ +.+++++|+++|+|+|.
T Consensus 168 ~~~~~~~g~tpL~~Aa~~~--------------------------------------------~~~iv~lLl~~gadin~ 203 (743)
T TIGR00870 168 GVDSFYHGESPLNAAACLG--------------------------------------------SPSIVALLSEDPADILT 203 (743)
T ss_pred CCCcccccccHHHHHHHhC--------------------------------------------CHHHHHHHhcCCcchhh
Confidence 23566666665433 35678888899999999
Q ss_pred ccccCccchhhhhhcC---------CHHHHHHHHHCCCCc-------ccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCC
Q 000343 721 QDAQNRTALHIASMAN---------DVELVKIILDAGVDV-------NIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 721 ~D~~G~TpLH~Aa~~g---------~~eiVklLL~~GADv-------N~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADi 784 (1630)
+|..|+||||+|+..+ ...+.+++++.+++. +++|.+|.||||+|+..|+.+++++|++.+++.
T Consensus 204 ~d~~g~T~Lh~A~~~~~~~~~~~~l~~~~~~~l~~ll~~~~~~~el~~i~N~~g~TPL~~A~~~g~~~l~~lLL~~~~~~ 283 (743)
T TIGR00870 204 ADSLGNTLLHLLVMENEFKAEYEELSCQMYNFALSLLDKLRDSKELEVILNHQGLTPLKLAAKEGRIVLFRLKLAIKYKQ 283 (743)
T ss_pred HhhhhhHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCChHhhhhhcCCCCCCchhhhhhcCCccHHHHHHHHHHhc
Confidence 9999999999999987 234556666665543 778999999999999999999999999976665
Q ss_pred CcCCCCCCcHHHHHHH
Q 000343 785 NWQDDEGDNAFHIAAD 800 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa~ 800 (1630)
+......+.|.+++..
T Consensus 284 kk~~a~~~~~~~~~~~ 299 (743)
T TIGR00870 284 KKFVAWPNGQQLLSLY 299 (743)
T ss_pred ceeeccCcchHhHhhh
Confidence 5555666677776654
|
after chronic exposure to capsaicin. (McCleskey and Gold, 1999). |
| >TIGR00870 trp transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=278.69 Aligned_cols=282 Identities=17% Similarity=0.104 Sum_probs=210.9
Q ss_pred ccCCCCccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHH-HHHHcCCHHHHHHHHHhcCCCcccCCC
Q 000343 465 FQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALH-LACRRGSAELVEAILEYSQENVDVLDK 543 (1630)
Q Consensus 465 ~~~~~t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH-~Aa~~G~~eiVk~LL~~~~~dvn~~D~ 543 (1630)
+.+....|+.|+..||++.++.+++.+... .+|..|..|+|||| .|+.+++.+++++|++.+. .+.
T Consensus 14 ~~~~~~~~l~A~~~g~~~~v~~lL~~~~~~--------~in~~d~~G~t~Lh~~A~~~~~~eiv~lLl~~g~-----~~~ 80 (743)
T TIGR00870 14 LSDEEKAFLPAAERGDLASVYRDLEEPKKL--------NINCPDRLGRSALFVAAIENENLELTELLLNLSC-----RGA 80 (743)
T ss_pred CCHHHHHHHHHHHcCCHHHHHHHhcccccc--------CCCCcCccchhHHHHHHHhcChHHHHHHHHhCCC-----CCC
Confidence 345567899999999999999999883321 13578899999999 8999999999999998543 678
Q ss_pred CCCCHHHHHHHc---CCHHHHHHHHHCCCC------ccc--ccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCC--
Q 000343 544 DGDPPLVFALAA---GSPECVHALIKRGAN------VIS--RLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVD-- 610 (1630)
Q Consensus 544 ~G~TPLh~Aa~~---G~~eiVk~LL~~GAd------vn~--~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D-- 610 (1630)
.|.||||.|+.. +...++.+|+..+.+ ++. ......|.||||+||.+|+.+++++|+++|||+|..+
T Consensus 81 ~G~T~Lh~A~~~~~~~v~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~G~TpLhlAa~~~~~eiVklLL~~GAdv~~~~~~ 160 (743)
T TIGR00870 81 VGDTLLHAISLEYVDAVEAILLHLLAAFRKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGASVPARACG 160 (743)
T ss_pred cChHHHHHHHhccHHHHHHHHHHHhhcccccCchhhhccccccccCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCcCcCC
Confidence 899999999972 223344555554432 111 1123468999999999999999999999999999763
Q ss_pred ------------CCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCcccccc
Q 000343 611 ------------DEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVN 678 (1630)
Q Consensus 611 ------------~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n 678 (1630)
..|.||||+|+..++.+++++|+++|+ +++..|..|.||||+|+..+....-.
T Consensus 161 ~~~~~~~~~~~~~~g~tpL~~Aa~~~~~~iv~lLl~~ga--din~~d~~g~T~Lh~A~~~~~~~~~~------------- 225 (743)
T TIGR00870 161 DFFVKSQGVDSFYHGESPLNAAACLGSPSIVALLSEDPA--DILTADSLGNTLLHLLVMENEFKAEY------------- 225 (743)
T ss_pred chhhcCCCCCcccccccHHHHHHHhCCHHHHHHHhcCCc--chhhHhhhhhHHHHHHHhhhhhhHHH-------------
Confidence 258999999999999999999999997 78889999999999998765211000
Q ss_pred ccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhc---CCCC----CcccccCccchhhhhhcCCHHHHHHHHHCCCCc
Q 000343 679 VIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTA---GAEP----TAQDAQNRTALHIASMANDVELVKIILDAGVDV 751 (1630)
Q Consensus 679 ~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~---GAdv----n~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADv 751 (1630)
+. ....+.+++++. +.+. +..|.+|.||||+|+..|+.+++++|++.+++.
T Consensus 226 ---------~~-------------l~~~~~~~l~~ll~~~~~~~el~~i~N~~g~TPL~~A~~~g~~~l~~lLL~~~~~~ 283 (743)
T TIGR00870 226 ---------EE-------------LSCQMYNFALSLLDKLRDSKELEVILNHQGLTPLKLAAKEGRIVLFRLKLAIKYKQ 283 (743)
T ss_pred ---------HH-------------HHHHHHHHHHHHHhccCChHhhhhhcCCCCCCchhhhhhcCCccHHHHHHHHHHhc
Confidence 00 001233334433 3333 677999999999999999999999999987776
Q ss_pred ccccCCCCCHHHHHHHc--------CCHHHHHHHHhCCCC---CCcCCCCCCcHHH
Q 000343 752 NIRNVHNTIPLHVALAR--------GAKSCVGLLLSAGAD---CNWQDDEGDNAFH 796 (1630)
Q Consensus 752 N~~d~~G~TPLH~Aa~~--------G~~eiVklLLe~GAD---iN~~D~~G~TpLh 796 (1630)
+.-......|.+.+..- ....++++|+..++. ++..+..+.+|+.
T Consensus 284 kk~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~~~~p~~~~~~~~~P~~ 339 (743)
T TIGR00870 284 KKFVAWPNGQQLLSLYWLEELDGWRRKQSVLELIVVFVIGLKFPELSDMYLIAPLS 339 (743)
T ss_pred ceeeccCcchHhHhhhccccCCcccccccHHHHHHHHHHhhcChHHHHHHHHhhhH
Confidence 66677788888887763 233567777776553 4555566666665
|
after chronic exposure to capsaicin. (McCleskey and Gold, 1999). |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=284.63 Aligned_cols=206 Identities=16% Similarity=0.096 Sum_probs=140.9
Q ss_pred CCcceeEEEE-------EeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceE
Q 000343 201 RNVCTFHGVL-------RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLL 273 (1630)
Q Consensus 201 pNIV~l~~~f-------~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NIL 273 (1630)
+||++++++| .....++++|||+.+++...+......+++.+++.|++||++||+|||++||+||||||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 6888888887 233468888999877655544443456999999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecceeeeecCccccCC----------------------CCCCCCCCcccccccccCCCCCCCcccccccc
Q 000343 274 LDASGRAVVSDYGLAAILKKPACRKA----------------------RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331 (1630)
Q Consensus 274 ld~~g~vKL~DFGla~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~ 331 (1630)
|+..+.+|++|||++........... ..... ..........+||+.|||||++.+..
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKK-QPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhcccc-CCCcccccccCCCcceEChhhhccCC
Confidence 97655555555554433211100000 00000 00000112246899999999987654
Q ss_pred ccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhcc
Q 000343 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411 (1630)
Q Consensus 332 ~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~ 411 (1630)
|+.++|||||||+||||++|.+||.... ..+..+... ..++... ...++..+++.+||++
T Consensus 192 ------------~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 192 ------------SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPPQIL-----LNWPKEASFCLWLLHP 251 (793)
T ss_pred ------------CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcChhhh-----hcCHHHHHHHHHhCCC
Confidence 8899999999999999999998875422 222222221 1222111 1235677999999999
Q ss_pred CcCCCCChhhHHHHhh
Q 000343 412 KASKRPTFSAMLATFL 427 (1630)
Q Consensus 412 dP~~RPSa~evL~~L~ 427 (1630)
+|.+||++.|+++|.+
T Consensus 252 ~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 252 EPSCRPSMSELLQSEF 267 (793)
T ss_pred ChhhCcChHHHhhchh
Confidence 9999999999999843
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=270.33 Aligned_cols=193 Identities=23% Similarity=0.288 Sum_probs=164.5
Q ss_pred CCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHc
Q 000343 556 GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILEN 635 (1630)
Q Consensus 556 G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~ 635 (1630)
...++-.+|.+.++.. .+..+.++||.||..|+.++++.|+++|+|+|..|.+|+||||+|+..|+.+++++|+++
T Consensus 505 ~~l~v~~ll~~~~~~~----~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~ 580 (823)
T PLN03192 505 HDLNVGDLLGDNGGEH----DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKH 580 (823)
T ss_pred ccccHHHHHhhccccc----CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhc
Confidence 4445556666666532 222356789999999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcC
Q 000343 636 GGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG 715 (1630)
Q Consensus 636 Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~G 715 (1630)
|+ +++..|.+|.||||+|+..|+.+++++|++.+
T Consensus 581 ga--din~~d~~G~TpL~~A~~~g~~~iv~~L~~~~-------------------------------------------- 614 (823)
T PLN03192 581 AC--NVHIRDANGNTALWNAISAKHHKIFRILYHFA-------------------------------------------- 614 (823)
T ss_pred CC--CCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcC--------------------------------------------
Confidence 86 67888999999999999988887777776432
Q ss_pred CCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCC-CcH
Q 000343 716 AEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEG-DNA 794 (1630)
Q Consensus 716 Advn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G-~Tp 794 (1630)
+..+ ...|.|+||.||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|||+|..|..| .||
T Consensus 615 ~~~~--~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g~~t~ 692 (823)
T PLN03192 615 SISD--PHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDDDFSP 692 (823)
T ss_pred cccC--cccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCCCCCH
Confidence 2111 2346789999999999999999999999999999999999999999999999999999999999999988 999
Q ss_pred HHHHHH
Q 000343 795 FHIAAD 800 (1630)
Q Consensus 795 LhlAa~ 800 (1630)
++++..
T Consensus 693 ~~l~~~ 698 (823)
T PLN03192 693 TELREL 698 (823)
T ss_pred HHHHHH
Confidence 999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=221.40 Aligned_cols=165 Identities=18% Similarity=0.200 Sum_probs=124.8
Q ss_pred hHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCC
Q 000343 227 VQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305 (1630)
Q Consensus 227 lL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~ 305 (1630)
+|..++.. ...+++.+++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------- 62 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------- 62 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----------
Confidence 34444443 456999999999999999999999998 999999999999999 9998765421
Q ss_pred CCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCH-HHHHHHHHhcCC
Q 000343 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA-EEIYRAVVKNRK 384 (1630)
Q Consensus 306 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~-~ei~~~i~~~~~ 384 (1630)
...||+.|||||++.+.. ++.++|||||||++|||++|..||..... ...+..+.....
T Consensus 63 --------~~~g~~~y~aPE~~~~~~------------~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 63 --------QSRVDPYFMAPEVIQGQS------------YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred --------cCCCcccccChHHhcCCC------------CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 125789999999997654 78999999999999999999999976543 233333333221
Q ss_pred CCCCcccccCCCCCH--HHHHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 385 LPPQYASIVGVGIPR--ELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 385 ~~~~~~~~~~~~l~~--el~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
............++. ++.++|.+||+.+|.+||++.++++|++...
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 123 ADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 111000001112333 6999999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-23 Score=248.67 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=213.6
Q ss_pred CccchhhccCChhhhhhhhcccCCCC---CCcchhhhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCC
Q 000343 470 NNLHQLVSEGDVSGVRDLLSKNASGN---YSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGD 546 (1630)
Q Consensus 470 t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n---~~~si~~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~ 546 (1630)
+-|..|+..||.+.+..||+...... ....-+.-.+.+|.+|.|+||.||.+|+.+++++|+++ .+.++..|..|.
T Consensus 5 qel~~a~ka~d~~tva~ll~~~~~r~~~l~~~trsds~n~qd~~gfTalhha~Lng~~~is~llle~-ea~ldl~d~kg~ 83 (854)
T KOG0507|consen 5 QELIDACKAGDYDTVALLLSSKKGRSGLLFFTTRSDSHNLQDYSGFTLLHHAVLNGQNQISKLLLDY-EALLDLCDTKGI 83 (854)
T ss_pred hhHHHhhhcccHHHHHHhccCCCCCCCCCCCCCCCccccccCccchhHHHHHHhcCchHHHHHHhcc-hhhhhhhhccCc
Confidence 35778999999999999997543211 11111223578999999999999999999999999996 466899999999
Q ss_pred CHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCCh
Q 000343 547 PPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626 (1630)
Q Consensus 547 TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~ 626 (1630)
+|||+||.+|+.+++++|+.++..+|+. ...|.||||.|+++||.+++.+||.+|+|+-..|+.+.|+|-+|++-|..
T Consensus 84 ~plhlaaw~g~~e~vkmll~q~d~~na~--~~e~~tplhlaaqhgh~dvv~~Ll~~~adp~i~nns~~t~ldlA~qfgr~ 161 (854)
T KOG0507|consen 84 LPLHLAAWNGNLEIVKMLLLQTDILNAV--NIENETPLHLAAQHGHLEVVFYLLKKNADPFIRNNSKETVLDLASRFGRA 161 (854)
T ss_pred ceEEehhhcCcchHHHHHHhcccCCCcc--cccCcCccchhhhhcchHHHHHHHhcCCCccccCcccccHHHHHHHhhhh
Confidence 9999999999999999999999887765 45688999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCccc------cccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCc
Q 000343 627 DCAIVILENGGCRS------MAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700 (1630)
Q Consensus 627 eiv~~LL~~Ga~~~------i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~ 700 (1630)
++++.|+...-+.. ....+..+.+|||+|+.+||
T Consensus 162 ~Vvq~ll~~~~~~~~~~~~~~~~~~~~~~~plHlaakngh---------------------------------------- 201 (854)
T KOG0507|consen 162 EVVQMLLQKKFPVQSSLRVGDIKRPFPAIYPLHLAAKNGH---------------------------------------- 201 (854)
T ss_pred HHHHHHhhhccchhhcccCCCCCCCCCCcCCcchhhhcch----------------------------------------
Confidence 99999998721100 11123345566676666554
Q ss_pred cchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcC---CHHHHHHH
Q 000343 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARG---AKSCVGLL 777 (1630)
Q Consensus 701 ~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G---~~eiVklL 777 (1630)
.++++.|+++|.|+|.....| |+||-|+..|..++|++||+.|++..++|.+|+|+|.+-.... ..+++-++
T Consensus 202 ----~~~~~~ll~ag~din~~t~~g-talheaalcgk~evvr~ll~~gin~h~~n~~~qtaldil~d~~~~~~~ei~ga~ 276 (854)
T KOG0507|consen 202 ----VECMQALLEAGFDINYTTEDG-TALHEAALCGKAEVVRFLLEIGINTHIKNQHGQTALDIIIDLQENRRYEIAGAV 276 (854)
T ss_pred ----HHHHHHHHhcCCCcccccccc-hhhhhHhhcCcchhhhHHHhhccccccccccchHHHHHHHhcchhhhhhhhhhh
Confidence 456667778889999887776 9999999999999999999999999999999999998776543 34555554
Q ss_pred Hh
Q 000343 778 LS 779 (1630)
Q Consensus 778 Le 779 (1630)
..
T Consensus 277 ~~ 278 (854)
T KOG0507|consen 277 KN 278 (854)
T ss_pred hc
Confidence 43
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=242.00 Aligned_cols=230 Identities=27% Similarity=0.359 Sum_probs=172.5
Q ss_pred HHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHH
Q 000343 515 LHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPD 594 (1630)
Q Consensus 515 LH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~e 594 (1630)
+.-||..|..+-++.||.. ++++|..|.+|.|+||-|+...+.+||++|+++|++||.. +..+.||||.|+..|+.+
T Consensus 44 ~l~A~~~~d~~ev~~ll~~-ga~~~~~n~DglTalhq~~id~~~e~v~~l~e~ga~Vn~~--d~e~wtPlhaaascg~~~ 120 (527)
T KOG0505|consen 44 FLEACSRGDLEEVRKLLNR-GASPNLCNVDGLTALHQACIDDNLEMVKFLVENGANVNAQ--DNEGWTPLHAAASCGYLN 120 (527)
T ss_pred HHhccccccHHHHHHHhcc-CCCccccCCccchhHHHHHhcccHHHHHHHHHhcCCcccc--ccccCCcchhhcccccHH
Confidence 6667777888888887774 4566777777777777777777777777777777777764 444667777777777777
Q ss_pred HHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCcc
Q 000343 595 CMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPE 674 (1630)
Q Consensus 595 ivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~ 674 (1630)
++++|+.+||++-+.|.+|..|+-+|...-..+++..-... .|.+ +- |+..
T Consensus 121 i~~~li~~gA~~~avNsdg~~P~dl~e~ea~~~~l~~~~~r-----------~gi~-ie-a~R~---------------- 171 (527)
T KOG0505|consen 121 IVEYLIQHGANLLAVNSDGNMPYDLAEDEATLDVLETEMAR-----------QGID-IE-AARK---------------- 171 (527)
T ss_pred HHHHHHHhhhhhhhccCCCCCccccccCcchhHHHHHHHHH-----------hccc-HH-HHhh----------------
Confidence 77777777777777777777777766544433333222221 1111 11 1100
Q ss_pred ccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccc
Q 000343 675 EIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIR 754 (1630)
Q Consensus 675 ~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~ 754 (1630)
..+..-+.=++..+..|.+.++.+..|.|+||.|+.+|..++.++||++|.+++++
T Consensus 172 ------------------------~~e~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~ 227 (527)
T KOG0505|consen 172 ------------------------AEEQTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGYSVNIK 227 (527)
T ss_pred ------------------------hhHHHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhccCcccc
Confidence 00001122244555689999999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHH
Q 000343 755 NVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800 (1630)
Q Consensus 755 d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~ 800 (1630)
|.+|+||||.||.-|..+++++|+++|++++.....|.|||.+|..
T Consensus 228 D~dgWtPlHAAA~Wg~~~~~elL~~~ga~~d~~t~~g~~p~dv~de 273 (527)
T KOG0505|consen 228 DYDGWTPLHAAAHWGQEDACELLVEHGADMDAKTKMGETPLDVADE 273 (527)
T ss_pred cccCCCcccHHHHhhhHhHHHHHHHhhcccchhhhcCCCCccchhh
Confidence 9999999999999999999999999999999999999999999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=214.54 Aligned_cols=278 Identities=20% Similarity=0.228 Sum_probs=216.3
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
-+...|.++++||.|+||.+|+ |....+|+.||||.-.. .....++..|..+.+.++ ....|..+..++.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~------~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~-~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYL------GISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQ-GGVGIPHIRHYGTE 82 (341)
T ss_pred eeccceEEEEeecCCchhheee------eeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhc-cCCCCchhhhhccc
Confidence 3557999999999999998876 66778999999997554 334556778888888887 46788888889999
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC---CcEEEeecceee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS---GRAVVSDYGLAA 289 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~---g~vKL~DFGla~ 289 (1630)
..+-.|||+++.-++-+.+.--...++.++++-++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+
T Consensus 83 ~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 83 KDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 99999999999777666555445579999999999999999999999999999999999999633 468999999999
Q ss_pred eecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
.+....+.... .+.......||..|++--...+.. .+.+.|+=|+|.+|.++..|..||++
T Consensus 163 ky~d~~t~~HI-------pyre~r~ltGTaRYASinAh~g~e------------qSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 163 KYRDIRTRQHI-------PYREDRNLTGTARYASINAHLGIE------------QSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred hhccccccccC-------ccccCCccceeeeehhhhhhhhhh------------hhhhhhhhhhcceeeeeecCCCcccc
Confidence 87654332222 233456678999999998877654 56788999999999999999999998
Q ss_pred CCH---HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCCCCCCCC
Q 000343 370 LSA---EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPAS 440 (1630)
Q Consensus 370 ~~~---~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp~sp~~~ 440 (1630)
... .+-+.+|.+.+...+ ...+..++|.|+.-.+.-|-..--++-|...-+-+.+.-.+..+...+...
T Consensus 224 lka~tk~QKyEkI~EkK~s~~--ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~i 295 (341)
T KOG1163|consen 224 LKAATKKQKYEKISEKKMSTP--IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYI 295 (341)
T ss_pred cchhhHHHHHHHHHHhhcCCC--HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeE
Confidence 643 445666666543322 233456789999999999999988999998765554444444444444433
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=263.25 Aligned_cols=194 Identities=18% Similarity=0.236 Sum_probs=165.6
Q ss_pred CCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHH
Q 000343 522 GSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLL 601 (1630)
Q Consensus 522 G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~ 601 (1630)
.+.++-..|.+.. + ...+.++.++||.||..|+.++++.|+++|+|+|.. |..|.||||+||.+|+.+++++|++
T Consensus 505 ~~l~v~~ll~~~~-~--~~~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~--d~~G~TpLh~Aa~~g~~~~v~~Ll~ 579 (823)
T PLN03192 505 HDLNVGDLLGDNG-G--EHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIG--DSKGRTPLHIAASKGYEDCVLVLLK 579 (823)
T ss_pred ccccHHHHHhhcc-c--ccCCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCC--CCCCCCHHHHHHHcChHHHHHHHHh
Confidence 3444444444422 2 234456789999999999999999999999999874 5678999999999999999999999
Q ss_pred cCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccC
Q 000343 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVID 681 (1630)
Q Consensus 602 ~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d 681 (1630)
+|+|+|.+|.+|+||||+|+..|+.+++++|+..++.. ....+.++||.|+..|+.
T Consensus 580 ~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~----~~~~~~~~L~~Aa~~g~~-------------------- 635 (823)
T PLN03192 580 HACNVHIRDANGNTALWNAISAKHHKIFRILYHFASIS----DPHAAGDLLCTAAKRNDL-------------------- 635 (823)
T ss_pred cCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCccc----CcccCchHHHHHHHhCCH--------------------
Confidence 99999999999999999999999999999999887632 234577999999877654
Q ss_pred CCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCC-CC
Q 000343 682 IPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHN-TI 760 (1630)
Q Consensus 682 ~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G-~T 760 (1630)
+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|||+|..|..| .|
T Consensus 636 ------------------------~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g~~t 691 (823)
T PLN03192 636 ------------------------TAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDDDFS 691 (823)
T ss_pred ------------------------HHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCCCCC
Confidence 45667778899999999999999999999999999999999999999999998 99
Q ss_pred HHHHHHHc
Q 000343 761 PLHVALAR 768 (1630)
Q Consensus 761 PLH~Aa~~ 768 (1630)
|++++...
T Consensus 692 ~~~l~~~~ 699 (823)
T PLN03192 692 PTELRELL 699 (823)
T ss_pred HHHHHHHH
Confidence 99888553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-21 Score=231.05 Aligned_cols=267 Identities=19% Similarity=0.196 Sum_probs=201.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccC-CcEEEEEEeeccCcCChhHHHHHHHHHHHhcc--CCCCcceeEEEE-Ee
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRC-RHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM--WCRNVCTFHGVL-RM 212 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~-g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l--~HpNIV~l~~~f-~~ 212 (1630)
+|++.++||+|+||.||+ +.+..+ ...+|+|............+..|..++..+.. .-+++.++++.+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~------v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYL------VSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEE------EEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 899999999999999876 444444 36789998776544444478889999998862 246999999999 57
Q ss_pred CCEEEEEEecCCCChHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-----CcEEEeecc
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-----GRAVVSDYG 286 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~-~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-----g~vKL~DFG 286 (1630)
..+.|+||+.+..++.+...... +.++..++..|+.|++.+|.+||+.|+|||||||+|+++... ..++|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 88999999998777777664444 679999999999999999999999999999999999999855 469999999
Q ss_pred eee--eecCccccCCCCCCCCCCcc-cccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhC
Q 000343 287 LAA--ILKKPACRKARPECDSSRIH-SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 287 la~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG 363 (1630)
+++ .+....... .... .......||..|+++.+..+.. .+.+.|+||++.++.+++.|
T Consensus 173 lar~~~~~~~~~~~-------~~~~r~~~~~~rGT~ry~S~~~H~~~e------------~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 173 LARRFKYVGDSGGN-------LRPPRPQKGLFRGTLRYASINVHLGIE------------QGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred CCccccccCCCCcc-------cccCCCCccCCCCccccccHHHhCCCc------------cCCchhhhhHHHHHHHHhcC
Confidence 998 332211000 0111 1124566999999999888765 78999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHH---hcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCC
Q 000343 364 SIPWAGLSAEEIYRAVV---KNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~i~---~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~l 433 (1630)
..||...........+. ....... .....+.++..+...+-..+...+|....+...+.......
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 99997765322222222 2211111 12235678888888888899999999999988877666544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=217.39 Aligned_cols=269 Identities=17% Similarity=0.215 Sum_probs=217.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
-.|.+.++||.|+||..+ .|.+.-+++.||||.-... .+..++..|....+.+. ..+.|.+.|.+.+.+.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf------~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~-g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLF------LGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLG-GTEGIPQVYYFGQEGKY 98 (449)
T ss_pred ccceeccccccCcceeee------cccccccCceEEEEecccc--CCcchHHHHHHHHHHHc-CCCCCCceeeeccccch
Confidence 479999999999987664 4788889999999975543 34557888999999887 78999999999999999
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCC-----CcEEEeecceeee
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-----GRAVVSDYGLAAI 290 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~-----g~vKL~DFGla~~ 290 (1630)
-.||||++.-++-+.+.--..+|+.+++.-++.|++.-++|+|++.+|+|||||+|+||..- ..+.|.|||+|+.
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99999999777666555555679999999999999999999999999999999999999743 3689999999998
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~ 370 (1630)
+..+.+.... .+.......||.+||+.-...+.. .+.+.|+=|||-++++.|.|.+||++.
T Consensus 179 YrDp~TkqHI-------PYrE~KSLsGTARYMSINTHlGrE------------QSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 179 YRDPKTKQHI-------PYREHKSLSGTARYMSINTHLGRE------------QSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hcCccccccC-------ccccccccccceeeeEeeccccch------------hhhhhhHHHhhhhhhhhccCCCccccc
Confidence 8765533322 334456678999999999888766 578899999999999999999999875
Q ss_pred ---CHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhcccCCC
Q 000343 371 ---SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 371 ---~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~l~~lp 434 (1630)
+..+-+++|-..+..-+. ..+..++|.++...+.-.-+.+-.+-|..+-+..-+...+....
T Consensus 240 KA~tnK~kYeKIGe~Kr~T~i--~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 240 KADTNKEKYEKIGETKRSTPI--EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred cCcchHHHHHHhccccccCCH--HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 456777887655443332 23456789999999998888889999998876555555554443
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=218.06 Aligned_cols=157 Identities=32% Similarity=0.477 Sum_probs=139.9
Q ss_pred CCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCC
Q 000343 606 PNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGP 685 (1630)
Q Consensus 606 vn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~ 685 (1630)
+|..|.+|+|+||||+...|.++|+.||+.|.| +++..|+-|.||+++|+...
T Consensus 261 VNlaDsNGNTALHYsVSHaNF~VV~~LLDSgvC-~VD~qNrAGYtpiMLaALA~-------------------------- 313 (452)
T KOG0514|consen 261 VNLADSNGNTALHYAVSHANFDVVSILLDSGVC-DVDQQNRAGYTPVMLAALAK-------------------------- 313 (452)
T ss_pred hhhhcCCCCeeeeeeecccchHHHHHHhccCcc-cccccccccccHHHHHHHHh--------------------------
Confidence 578899999999999999999999999999986 78999999999999987420
Q ss_pred CccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccc-cCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHH
Q 000343 686 VGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDA-QNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHV 764 (1630)
Q Consensus 686 ~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~-~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~ 764 (1630)
++ .....++|..|...| |+|++-. .|+|+|++|+..|+.++|+.||..|||||++|.+|.|+||.
T Consensus 314 ----------lk---~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMC 379 (452)
T KOG0514|consen 314 ----------LK---QPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMC 379 (452)
T ss_pred ----------hc---chhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhh
Confidence 11 012357787787775 7888755 59999999999999999999999999999999999999999
Q ss_pred HHHcCCHHHHHHHHhC-CCCCCcCCCCCCcHHHHHHHhch
Q 000343 765 ALARGAKSCVGLLLSA-GADCNWQDDEGDNAFHIAADAAK 803 (1630)
Q Consensus 765 Aa~~G~~eiVklLLe~-GADiN~~D~~G~TpLhlAa~~g~ 803 (1630)
||..||.||+++||.. ++|+...|.+|.|+|.+|.++|+
T Consensus 380 A~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleagh 419 (452)
T KOG0514|consen 380 AAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAGH 419 (452)
T ss_pred hhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcCc
Confidence 9999999999999976 89999999999999999999886
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=219.55 Aligned_cols=166 Identities=23% Similarity=0.373 Sum_probs=152.3
Q ss_pred hhhhhcccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHc-----CCHHHHHHHHHCCCCcccccc
Q 000343 502 SLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAA-----GSPECVHALIKRGANVISRLR 576 (1630)
Q Consensus 502 ~ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~-----G~~eiVk~LL~~GAdvn~~~~ 576 (1630)
..+|.-|.||+|+||||+.++|+++|+.||+.+-.++|..|+-|+||+|+||.. .+.++|..|...| |||++..
T Consensus 259 yvVNlaDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAs 337 (452)
T KOG0514|consen 259 YVVNLADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKAS 337 (452)
T ss_pred HHhhhhcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-Ccchhhh
Confidence 356888999999999999999999999999999999999999999999999874 5788999999886 8888754
Q ss_pred cCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHH
Q 000343 577 EGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCV 656 (1630)
Q Consensus 577 d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa 656 (1630)
..|.|+|++|+.+|+.++++.||..|||+|.+|.+|.|+|++|+..||.+++++||....| ++...|.+|.|+|.+|.
T Consensus 338 -Q~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~c-d~sLtD~DgSTAl~IAl 415 (452)
T KOG0514|consen 338 -QHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSC-DISLTDVDGSTALSIAL 415 (452)
T ss_pred -hhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcc-cceeecCCCchhhhhHH
Confidence 4599999999999999999999999999999999999999999999999999999998875 77889999999999999
Q ss_pred HcCCHHHHHHHHHh
Q 000343 657 ATWNVAVVKRWVEV 670 (1630)
Q Consensus 657 ~~g~~eivk~LLe~ 670 (1630)
..|+.+|.-+|-.+
T Consensus 416 eagh~eIa~mlYa~ 429 (452)
T KOG0514|consen 416 EAGHREIAVMLYAH 429 (452)
T ss_pred hcCchHHHHHHHHH
Confidence 99999988776543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-20 Score=210.75 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=197.8
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCC-CcceeEEEEEeC
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCR-NVCTFHGVLRMD 213 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~Hp-NIV~l~~~f~~~ 213 (1630)
|.+.+.||.|+|+.||. +.+. ..+|+|.+....... ...+.+|+.++..+. |+ +|+++++.+...
T Consensus 2 ~~~~~~l~~g~~~~v~~------~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~--~~~~i~~~~~~~~~~ 70 (384)
T COG0515 2 YRILRKLGEGSFGEVYL------ARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN--HPPNIVKLYDFFQDE 70 (384)
T ss_pred ceeEEeecCCCCeEEEE------EEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc--CCcceeeEEEEEecC
Confidence 78899999999987764 3232 789999988775443 667888999888876 55 899999999888
Q ss_pred CEEEEEEecCCCChHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCC-cEEEeecceee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEG---RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDYGLAA 289 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~---~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g-~vKL~DFGla~ 289 (1630)
...+++++|+.++.+..+..... .++......++.|++.+|.|+|+.+++||||||+||+++..+ .++++|||+++
T Consensus 71 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 71 GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 88999999999988887666554 699999999999999999999999999999999999999888 79999999998
Q ss_pred eecCccccCCCCCCCCCCcc-cccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 290 ILKKPACRKARPECDSSRIH-SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
.+....... .. .......||..|+|||.+.+.. ...++...|+||+|++++++++|..||.
T Consensus 151 ~~~~~~~~~---------~~~~~~~~~~~t~~~~~pe~~~~~~---------~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 151 LLPDPGSTS---------SIPALPSTSVGTPGYMAPEVLLGLS---------LAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred ecCCCCccc---------cccccccccccccccCCHHHhcCCC---------CCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 554321000 00 1345678899999999987631 0127889999999999999999999987
Q ss_pred CCCH----HHHHHHHHhcCCC--CCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 369 GLSA----EEIYRAVVKNRKL--PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 369 ~~~~----~ei~~~i~~~~~~--~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.... ......+...... ...............+.+++.+++..+|..|.+..+...+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 213 GEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 7653 3444444333211 1110000000112578999999999999999999988776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-21 Score=228.99 Aligned_cols=175 Identities=18% Similarity=0.173 Sum_probs=131.0
Q ss_pred ccccCCeEEEEEeCcCCceeEEEeeEEEcccccc-CCcEEEEEEeeccC-----cCChhHHHHHHHHHHHhccCCCCcce
Q 000343 132 VGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGR-CRHSVAVKKVMIAE-----EMEPDWLSGQLDNLRRASMWCRNVCT 205 (1630)
Q Consensus 132 ~~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~-~g~~VAIK~i~~~~-----~~~~~~~~~Ei~iL~~l~l~HpNIV~ 205 (1630)
..+..+|.+.+.||+|+||.||+ |+++. +++.||||++.... ......+.+|+++|+.++ |+||+.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~------a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~--h~~iv~ 85 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVER------GYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR--GIGVVP 85 (365)
T ss_pred ccccCCceEccEEeecCcEEEEE------EEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc--CCCCCc
Confidence 34667999999999999988864 54554 67778999876331 112456889999999986 999884
Q ss_pred -eEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-cccceEECCCCcEEEe
Q 000343 206 -FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNI-KPSNLLLDASGRAVVS 283 (1630)
Q Consensus 206 -l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDL-KP~NILld~~g~vKL~ 283 (1630)
+++. ...||||||++|++|.... . .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+
T Consensus 86 ~l~~~----~~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 86 QLLAT----GKDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred EEEEc----CCcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEE
Confidence 5542 4579999999999886331 1 11 2568899999999999999999999 9999999989999999
Q ss_pred ecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCcccccccc
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~ 331 (1630)
|||+|+.+...... .............+++.|+|||.+....
T Consensus 155 DFGlA~~~~~~~~~------~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 155 DFQLASVFRRRGAL------YRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ECccceecccCcch------hhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99999987542210 0000111224677899999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-22 Score=251.85 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=184.4
Q ss_pred cCCe-EEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeec---cCcCChhH---HHHHHHHHHHhccCCCCcceeE
Q 000343 135 HHDV-KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMI---AEEMEPDW---LSGQLDNLRRASMWCRNVCTFH 207 (1630)
Q Consensus 135 ~~~y-~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~---~~~~~~~~---~~~Ei~iL~~l~l~HpNIV~l~ 207 (1630)
.+.| .....+|.|++|.|+. .......+..+.|.... ........ +..|+.+- ..+.|||++..+
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~------~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~--~~l~h~~~~e~l 387 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRI------AKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIG--SSLSHPNIIETL 387 (601)
T ss_pred ccccCCccceeeecccCceEE------EEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeec--ccccCCchhhhH
Confidence 3445 4578899999885543 22223334444443321 11111111 12222222 235699998888
Q ss_pred EEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecce
Q 000343 208 GVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 208 ~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGl 287 (1630)
..+++....+-.||||++ +|+.++...+.++..++..+++|++.|++|||++||.||||||+|+++...|.+||+|||.
T Consensus 388 ~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 388 DIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred HHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCc
Confidence 877766655555999999 8888887767899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCC-ccccchhhhhHHHHHhhCCCC
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS-PESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t-~ksDIWSlGvILyemltG~~P 366 (1630)
+..+..+.. .......+.+|+.+|+|||++.+.. |+ ...||||.|++++.|.+|+.|
T Consensus 467 ~~vf~~~~e----------~~~~~~~g~~gS~pY~apE~~~~~~------------ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 467 ASVFRYPWE----------KNIHESSGIVGSDPYLAPEVLTGKE------------YDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred ceeeccCcc----------hhhhhhcCcccCCcCcCcccccccc------------cCcchhhhhhccceEEEEecCCCc
Confidence 977654320 1123456789999999999998876 44 469999999999999999999
Q ss_pred CCCCCHHHHH--HHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 367 WAGLSAEEIY--RAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 367 F~~~~~~ei~--~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
|......+.. ............-...+...++.+.+.+|.+||+.||.+|.|++++++.
T Consensus 525 Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 9765443221 1111111111111111233578899999999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=235.38 Aligned_cols=229 Identities=22% Similarity=0.263 Sum_probs=192.3
Q ss_pred eCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--hhHHHHHHHHHHHhccCCCCcceeEEEEEeCCEEEEEEe
Q 000343 144 LGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD 221 (1630)
Q Consensus 144 LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~~~LVmE 221 (1630)
+|+|+||.|++.+. +.....+..+|+|..++..... ......|..++..++ +||++++++..|+.+..++++++
T Consensus 2 lg~g~~gkvfLvrk---~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRK---AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-NTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHH---hccccccchhhhhcccccccccccccccccHHHHHhhcc-CCCceeeeeeeeccccchhHhhh
Confidence 78999999988543 3345678899999887663222 124445777777776 69999999999999999999999
Q ss_pred cCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeecCccccCCCC
Q 000343 222 RCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301 (1630)
Q Consensus 222 y~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~ 301 (1630)
|..|+.+.....+...+++...+.+...++.|++++|+.+|+|||+|++||+++.+|++|+.|||+++..-..
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------- 150 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------- 150 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh-------
Confidence 9999999988887788999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 000343 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK 381 (1630)
Q Consensus 302 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~ 381 (1630)
...+||..|||||++.+ ...++|.||||+++|+|+||..||.. ++...|.+
T Consensus 151 -----------~~~cgt~eymApEI~~g--------------h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 151 -----------KIACGTYEYRAPEIING--------------HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred -----------hhcccchhhhhhHhhhc--------------cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 11288999999999874 56899999999999999999999988 66677776
Q ss_pred cCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCCh
Q 000343 382 NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419 (1630)
Q Consensus 382 ~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa 419 (1630)
.....|. .++..+++++..++..+|..|.-.
T Consensus 202 ~~~~~p~-------~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEMPR-------ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCCch-------hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 5544443 467899999999999999999865
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=223.96 Aligned_cols=226 Identities=25% Similarity=0.337 Sum_probs=182.0
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChH
Q 000343 548 PLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627 (1630)
Q Consensus 548 PLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~e 627 (1630)
-+.-|+..|..+-++.||..|+++|..+.| |.|+||-||.-.+.+||++|+++||++|+.|.+|+||||.|+..+|+.
T Consensus 43 ~~l~A~~~~d~~ev~~ll~~ga~~~~~n~D--glTalhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~ 120 (527)
T KOG0505|consen 43 VFLEACSRGDLEEVRKLLNRGASPNLCNVD--GLTALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLN 120 (527)
T ss_pred HHHhccccccHHHHHHHhccCCCccccCCc--cchhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHH
Confidence 455677889999999999999998765444 779999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHH
Q 000343 628 CAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707 (1630)
Q Consensus 628 iv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~ei 707 (1630)
++.+|+.+|+ ++...|.+|..|+.+|..... .++
T Consensus 121 i~~~li~~gA--~~~avNsdg~~P~dl~e~ea~--------------------------------------------~~~ 154 (527)
T KOG0505|consen 121 IVEYLIQHGA--NLLAVNSDGNMPYDLAEDEAT--------------------------------------------LDV 154 (527)
T ss_pred HHHHHHHhhh--hhhhccCCCCCccccccCcch--------------------------------------------hHH
Confidence 9999999998 666778888888876632110 011
Q ss_pred HHH-HHhcCCCCCcccccCccchhhhhhc-CC---HHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCC
Q 000343 708 VRI-LLTAGAEPTAQDAQNRTALHIASMA-ND---VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782 (1630)
Q Consensus 708 Vkl-LL~~GAdvn~~D~~G~TpLH~Aa~~-g~---~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GA 782 (1630)
+.. .-..|.+++ |+.. -. +.=++..+..|.+.++++..|.|.||.|+.+|+.++.++||++|.
T Consensus 155 l~~~~~r~gi~ie------------a~R~~~e~~ml~D~~q~l~~G~~~d~~~~rG~T~lHvAaa~Gy~e~~~lLl~ag~ 222 (527)
T KOG0505|consen 155 LETEMARQGIDIE------------AARKAEEQTMLDDARQWLNAGAELDARHARGATALHVAAANGYTEVAALLLQAGY 222 (527)
T ss_pred HHHHHHHhcccHH------------HHhhhhHHHHHHHHHHHHhccccccccccccchHHHHHHhhhHHHHHHHHHHhcc
Confidence 111 111222221 2211 11 122445566999999999999999999999999999999999999
Q ss_pred CCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhh
Q 000343 783 DCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEG 839 (1630)
Q Consensus 783 DiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~ 839 (1630)
+++++|.+|+||||.||..|+ +.+..+|..+|++.+++++.|.||+++|..
T Consensus 223 ~~~~~D~dgWtPlHAAA~Wg~------~~~~elL~~~ga~~d~~t~~g~~p~dv~de 273 (527)
T KOG0505|consen 223 SVNIKDYDGWTPLHAAAHWGQ------EDACELLVEHGADMDAKTKMGETPLDVADE 273 (527)
T ss_pred CcccccccCCCcccHHHHhhh------HhHHHHHHHhhcccchhhhcCCCCccchhh
Confidence 999999999999999998764 356678999999999999999999999864
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=201.25 Aligned_cols=148 Identities=18% Similarity=0.243 Sum_probs=122.6
Q ss_pred cCCCCCCCCCCCCChhhhhhhcCCh----HHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccc
Q 000343 602 AGADPNAVDDEGESVLHRAVAKKYT----DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIV 677 (1630)
Q Consensus 602 ~GADvn~~D~~G~TPLH~Aa~~g~~----eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~ 677 (1630)
+|+|++..+.++.++||.|++.|+. +++++|++.|+ .++..|..|.||||+|+..++.+.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~--~~~~~d~~g~t~Lh~Aa~~g~~~~-------------- 72 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGH--LLHRYDHHGRQCTHMVAWYDRANA-------------- 72 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcch--hhhccCCCCCcHHHHHHHhCccCH--------------
Confidence 5778888888888889988888887 55566777775 566778888899998887654321
Q ss_pred cccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCccc-ccCccchhhhhhcCCHHHHHHHHH-CCCCccccc
Q 000343 678 NVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD-AQNRTALHIASMANDVELVKIILD-AGVDVNIRN 755 (1630)
Q Consensus 678 n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D-~~G~TpLH~Aa~~g~~eiVklLL~-~GADvN~~d 755 (1630)
.+++++|+++|+++|.+| ..|.||||+|+..++.+++++|+. .|++++.+|
T Consensus 73 ---------------------------~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 125 (166)
T PHA02743 73 ---------------------------VMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN 125 (166)
T ss_pred ---------------------------HHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence 245678888999999988 479999999999999999999995 799999999
Q ss_pred CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCC
Q 000343 756 VHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGD 792 (1630)
Q Consensus 756 ~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~ 792 (1630)
..|.||||+|+..++.+++++|+++||++|.++..|.
T Consensus 126 ~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~ 162 (166)
T PHA02743 126 YQHETAYHIAYKMRDRRMMEILRANGAVCDDPLSIGL 162 (166)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcccCCc
Confidence 9999999999999999999999999999999888775
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=191.42 Aligned_cols=147 Identities=16% Similarity=0.219 Sum_probs=123.6
Q ss_pred ccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCCCCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCC
Q 000343 640 SMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT 719 (1630)
Q Consensus 640 ~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn 719 (1630)
+++..+.++.++||.|+..|+++.++ +++++|++.|++++
T Consensus 12 ~~~~~~~~~~~~l~~a~~~g~~~~l~----------------------------------------~~~~~l~~~g~~~~ 51 (166)
T PHA02743 12 GAVEIDEDEQNTFLRICRTGNIYELM----------------------------------------EVAPFISGDGHLLH 51 (166)
T ss_pred HHhhhccCCCcHHHHHHHcCCHHHHH----------------------------------------HHHHHHhhcchhhh
Confidence 44556777888999999887754332 45667788899999
Q ss_pred cccccCccchhhhhhcCCHH---HHHHHHHCCCCccccc-CCCCCHHHHHHHcCCHHHHHHHHh-CCCCCCcCCCCCCcH
Q 000343 720 AQDAQNRTALHIASMANDVE---LVKIILDAGVDVNIRN-VHNTIPLHVALARGAKSCVGLLLS-AGADCNWQDDEGDNA 794 (1630)
Q Consensus 720 ~~D~~G~TpLH~Aa~~g~~e---iVklLL~~GADvN~~d-~~G~TPLH~Aa~~G~~eiVklLLe-~GADiN~~D~~G~Tp 794 (1630)
.+|..|+||||+||..|+.+ ++++|+++|+++|.+| ..|.||||+|+..++.+++++|++ .|+|++.+|..|.||
T Consensus 52 ~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tp 131 (166)
T PHA02743 52 RYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETA 131 (166)
T ss_pred ccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCH
Confidence 99999999999999998765 4899999999999998 589999999999999999999995 799999999999999
Q ss_pred HHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCC
Q 000343 795 FHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832 (1630)
Q Consensus 795 LhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~T 832 (1630)
||+|+..++ ..++.+|..+|++++.++..|..
T Consensus 132 L~~A~~~~~------~~iv~~Ll~~ga~~~~~~~~~~~ 163 (166)
T PHA02743 132 YHIAYKMRD------RRMMEILRANGAVCDDPLSIGLS 163 (166)
T ss_pred HHHHHHcCC------HHHHHHHHHcCCCCCCcccCCcc
Confidence 999987653 35677888899999999888754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=227.69 Aligned_cols=225 Identities=22% Similarity=0.269 Sum_probs=167.0
Q ss_pred cccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
....+|+.++.|..|+||.||+ .+++.+.+.+|+ ++++.+..- |- +|... ..|++|
T Consensus 80 p~e~df~~IklisngAygavyl------vrh~~trqrfa~-kiNkq~lil-----Rn--ilt~a--~npfvv-------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYL------VRHKETRQRFAM-KINKQNLIL-----RN--ILTFA--GNPFVV-------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceee------eeccccccchhh-cccccchhh-----hc--ccccc--CCccee--------
Confidence 3457999999999999888876 458889999999 455432111 10 22222 134444
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeeeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
++-..+.++-++++..- +.+++|||+.||+|||+||+|.||+.-|++|++|||+++...
T Consensus 136 -------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 44445555555565433 789999999999999999999999999999999999998654
Q ss_pred CccccCCCCCCCCC-CcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCC
Q 000343 293 KPACRKARPECDSS-RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~ 371 (1630)
............+. .........+||+.|.|||++.... |++.+|+|++|+|+||.+.|..||.+.+
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg------------ygkpvdwwamGiIlyeFLVgcvpffGdt 262 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG------------YGKPVDWWAMGIILYEFLVGCVPFFGDT 262 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc------------cCCCccHHHHHHHHHHHheeeeeccCCC
Confidence 33222111111111 1112234568999999999987643 9999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCC
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418 (1630)
Q Consensus 372 ~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPS 418 (1630)
+++++..++......+.- ...++++++++|.++|+.+|..|.-
T Consensus 263 peelfg~visd~i~wpE~----dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 263 PEELFGQVISDDIEWPEE----DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred HHHHHhhhhhhhcccccc----CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 999998888776655543 3357899999999999999999954
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=179.79 Aligned_cols=141 Identities=25% Similarity=0.272 Sum_probs=120.7
Q ss_pred HHHHHHHHhcCC-CCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCC
Q 000343 705 RELVRILLTAGA-EPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783 (1630)
Q Consensus 705 ~eiVklLL~~GA-dvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GAD 783 (1630)
+..|+.||+--| -+|.+|.+|.||||.|+++|+.+||+.||..|||++++...|+||||-||.-++.+++.+||++|||
T Consensus 76 l~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaD 155 (228)
T KOG0512|consen 76 LTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGAD 155 (228)
T ss_pred HHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCc
Confidence 344555554433 4799999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHH
Q 000343 784 CNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEA 852 (1630)
Q Consensus 784 iN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~ 852 (1630)
+|++.+...||||+||... +....+..||...+.+...+|+.+.||+++|.+.. ++..|.+.
T Consensus 156 VnA~t~g~ltpLhlaa~~r----n~r~t~~~Ll~dryi~pg~~nn~eeta~~iARRT~---~s~~lfe~ 217 (228)
T KOG0512|consen 156 VNAQTKGLLTPLHLAAGNR----NSRDTLELLLHDRYIHPGLKNNLEETAFDIARRTS---MSHYLFEI 217 (228)
T ss_pred ccccccccchhhHHhhccc----chHHHHHHHhhccccChhhhcCccchHHHHHHHhh---hhHHHHHH
Confidence 9999999999999999763 33456667788888999999999999999998543 44444444
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=188.54 Aligned_cols=134 Identities=18% Similarity=0.257 Sum_probs=118.2
Q ss_pred hhhhcccCCChHHHHHHHcCCHHHHHHHHHh-----cCCCcccCCCCCCCHHHHHHHcCC----HHHHHHHHHCCCCccc
Q 000343 503 LLKAQNADGQTALHLACRRGSAELVEAILEY-----SQENVDVLDKDGDPPLVFALAAGS----PECVHALIKRGANVIS 573 (1630)
Q Consensus 503 ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~-----~~~dvn~~D~~G~TPLh~Aa~~G~----~eiVk~LL~~GAdvn~ 573 (1630)
+++.+|..|.||||+||+.|+.++++.|+.. .+++++..|..|.||||+|+..|+ .+++++|+++|+++|.
T Consensus 13 ~~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~ 92 (169)
T PHA02741 13 MIAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINA 92 (169)
T ss_pred HhhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCC
Confidence 4567889999999999999999999998653 247789999999999999999999 5889999999999986
Q ss_pred ccccCCCchHHHHHHHcCCHHHHHHHHH-cCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCC
Q 000343 574 RLREGFGPSVAHVCAYHGQPDCMRELLL-AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGG 637 (1630)
Q Consensus 574 ~~~d~~g~T~Lh~Aa~~G~~eivk~LL~-~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga 637 (1630)
.+. ..|.||||+|+..++.+++++|+. .|++++..|.+|.||||+|+..++.+++++|++.++
T Consensus 93 ~~~-~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~ 156 (169)
T PHA02741 93 QEM-LEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVA 156 (169)
T ss_pred CCc-CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHH
Confidence 531 368899999999999999999997 599999999999999999999999999999998765
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=187.85 Aligned_cols=137 Identities=20% Similarity=0.292 Sum_probs=96.9
Q ss_pred CCCCCCCCChhhhhhhcCChHHHHHHHHcC----CccccccccCCCCcHHHHHHHcCCHHHHHHHHHhcCccccccccCC
Q 000343 607 NAVDDEGESVLHRAVAKKYTDCAIVILENG----GCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682 (1630)
Q Consensus 607 n~~D~~G~TPLH~Aa~~g~~eiv~~LL~~G----a~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ga~~~~~n~~d~ 682 (1630)
+.+|.+|.||||+|+..|+.+++++|+... ...+++..|..|.||||+|+..++..++
T Consensus 15 ~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~------------------ 76 (169)
T PHA02741 15 AEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLA------------------ 76 (169)
T ss_pred hccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHH------------------
Confidence 456677778888888777777777765421 0125566677777777777766553221
Q ss_pred CCCCccHHHHHHHhccCccchhHHHHHHHHhcCCCCCcccc-cCccchhhhhhcCCHHHHHHHHH-CCCCcccccCCCCC
Q 000343 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDA-QNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTI 760 (1630)
Q Consensus 683 ~~~~~t~l~~aaa~~~~~~~~~~eiVklLL~~GAdvn~~D~-~G~TpLH~Aa~~g~~eiVklLL~-~GADvN~~d~~G~T 760 (1630)
.+++++|+++|+++|.+|. +|+||||+|+..++.+++++||+ .|++++.+|.+|.|
T Consensus 77 ----------------------~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~t 134 (169)
T PHA02741 77 ----------------------AEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKS 134 (169)
T ss_pred ----------------------HHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCC
Confidence 2456677777777777774 77888888888888888887776 47788877777888
Q ss_pred HHHHHHHcCCHHHHHHHHhCCCC
Q 000343 761 PLHVALARGAKSCVGLLLSAGAD 783 (1630)
Q Consensus 761 PLH~Aa~~G~~eiVklLLe~GAD 783 (1630)
|||+|+..++.+++++|+++++.
T Consensus 135 pL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 135 PFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred HHHHHHHCCCHHHHHHHHHHHHH
Confidence 88888888877888887776654
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-19 Score=187.94 Aligned_cols=79 Identities=28% Similarity=0.452 Sum_probs=45.6
Q ss_pred HHHHHHhcCCCCCccc-ccCccchhhhhhcCCHHHHHHHHH-CCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCC
Q 000343 707 LVRILLTAGAEPTAQD-AQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 707 iVklLL~~GAdvn~~D-~~G~TpLH~Aa~~g~~eiVklLL~-~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADi 784 (1630)
++++|+++|+++|.+| ..|+||||+|+..++.+++++|++ .|+++|.+|..|.||||+|+..|+.+++++|+++||++
T Consensus 73 ~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 73 KLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred HHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 4455555555555555 255666666666566666665555 35556555555666666666555556666666555554
Q ss_pred C
Q 000343 785 N 785 (1630)
Q Consensus 785 N 785 (1630)
+
T Consensus 153 ~ 153 (154)
T PHA02736 153 K 153 (154)
T ss_pred C
Confidence 3
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=190.46 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=106.5
Q ss_pred EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcC--C------------------------hhHHHHHHHHHH
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--E------------------------PDWLSGQLDNLR 194 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~--~------------------------~~~~~~Ei~iL~ 194 (1630)
...||+|+||.||. |.+. +|+.||||+++..... . .....+|+++|.
T Consensus 2 ~~~ig~G~~~~Vy~------a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05147 2 NGCISTGKEANVYH------ATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK 74 (190)
T ss_pred CCccccccceEEEE------EECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 36799999888865 6565 8999999999865221 1 112345889999
Q ss_pred HhccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccccccccceE
Q 000343 195 RASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVEL-HAAGVVCMNIKPSNLL 273 (1630)
Q Consensus 195 ~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yL-Hs~gIIHRDLKP~NIL 273 (1630)
.+. ++++...+.+... ..+|||||++|+.+.........++..++..++.|++.+|.|| |+.||+||||||+|||
T Consensus 75 ~l~--~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl 150 (190)
T cd05147 75 RLV--TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL 150 (190)
T ss_pred HHH--HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 886 5665433332222 2389999999876654433446799999999999999999999 7999999999999999
Q ss_pred ECCCCcEEEeecceeeeec
Q 000343 274 LDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 274 ld~~g~vKL~DFGla~~~~ 292 (1630)
++ ++.++|+|||+|....
T Consensus 151 i~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EE-CCcEEEEEccccccCC
Confidence 98 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=196.17 Aligned_cols=157 Identities=20% Similarity=0.248 Sum_probs=133.3
Q ss_pred hhhcccCCChH-HHHHHHcCCHHHHHHHHHhcCCCcccC----CCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccC
Q 000343 504 LKAQNADGQTA-LHLACRRGSAELVEAILEYSQENVDVL----DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREG 578 (1630)
Q Consensus 504 l~~~d~~G~Tp-LH~Aa~~G~~eiVk~LL~~~~~dvn~~----D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~ 578 (1630)
+..+|..|.|+ ||.|+..|+.+++++||+. |+++|.. +..|.||||+|+..|+.+++++|+++||++|... +.
T Consensus 25 ~~~~d~~~~~~lL~~A~~~~~~eivk~LL~~-GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~-~~ 102 (300)
T PHA02884 25 IKKKNKICIANILYSSIKFHYTDIIDAILKL-GADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYA-EE 102 (300)
T ss_pred hhccCcCCCCHHHHHHHHcCCHHHHHHHHHC-CCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCccc-CC
Confidence 56788888875 5556667999999999995 6789987 4689999999999999999999999999998642 34
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHc
Q 000343 579 FGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVAT 658 (1630)
Q Consensus 579 ~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~ 658 (1630)
.|.||||+|+..++.+++++|+++|||+|.+|.+|.||||+|+..++.+++..+...+ .+..+.+|++++
T Consensus 103 ~g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~--- 172 (300)
T PHA02884 103 AKITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTPIELALMICNNFLAFMICDNE-------ISNFYKHPKKIL--- 172 (300)
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhcCCc-------ccccccChhhhh---
Confidence 5889999999999999999999999999999999999999999999888876554321 356778999976
Q ss_pred CCHHHHHHHHHhcC
Q 000343 659 WNVAVVKRWVEVAS 672 (1630)
Q Consensus 659 g~~eivk~LLe~ga 672 (1630)
++.++++.|+.+..
T Consensus 173 ~n~ei~~~Lish~v 186 (300)
T PHA02884 173 INFDILKILVSHFI 186 (300)
T ss_pred ccHHHHHHHHHHHH
Confidence 46899999987653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.5e-18 Score=188.94 Aligned_cols=139 Identities=12% Similarity=0.123 Sum_probs=111.8
Q ss_pred ccCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhH---------HHHHHHHHHHhccCCCCcc
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDW---------LSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 134 ~~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~---------~~~Ei~iL~~l~l~HpNIV 204 (1630)
+..+|.+++.||.|+||.||+ . +. ++..+|||.+.......+.. +++|++.+.++. ||+|.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l------~-~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~--~~GI~ 98 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSL------I-DT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR--SEGLA 98 (232)
T ss_pred hhCceEEEEEecCCCceEEEE------E-ec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH--HCCCC
Confidence 457999999999999999976 1 22 36689999987654333333 578888888875 99999
Q ss_pred eeEEEEEeC--------CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECC
Q 000343 205 TFHGVLRMD--------SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 205 ~l~~~f~~~--------~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~ 276 (1630)
.+.+++... ...+|+|||++|..+..+. .+++ ....|++.+|..||+.|++|||+||+||+++.
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 999987643 3488999999998887663 2333 34669999999999999999999999999998
Q ss_pred CCcEEEeecceeeee
Q 000343 277 SGRAVVSDYGLAAIL 291 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~ 291 (1630)
++ ++|+|||.....
T Consensus 171 ~g-i~liDfg~~~~~ 184 (232)
T PRK10359 171 NG-LRIIDLSGKRCT 184 (232)
T ss_pred CC-EEEEECCCcccc
Confidence 88 999999987654
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=193.12 Aligned_cols=124 Identities=18% Similarity=0.206 Sum_probs=106.6
Q ss_pred cccCCCCCCCHH-HHHHHcCCHHHHHHHHHCCCCcccccc--cCCCchHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCC
Q 000343 538 VDVLDKDGDPPL-VFALAAGSPECVHALIKRGANVISRLR--EGFGPSVAHVCAYHGQPDCMRELLLAGADPNAV-DDEG 613 (1630)
Q Consensus 538 vn~~D~~G~TPL-h~Aa~~G~~eiVk~LL~~GAdvn~~~~--d~~g~T~Lh~Aa~~G~~eivk~LL~~GADvn~~-D~~G 613 (1630)
+..+|.+|.|++ |.|+..|+.+++++|+++||++|.... +..|.||||+|+..++.+++++|+++|||+|.. +..|
T Consensus 25 ~~~~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g 104 (300)
T PHA02884 25 IKKKNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAK 104 (300)
T ss_pred hhccCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCC
Confidence 455677787755 556666899999999999999987542 457899999999999999999999999999986 4679
Q ss_pred CChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHH
Q 000343 614 ESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAV 663 (1630)
Q Consensus 614 ~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~ei 663 (1630)
.||||+|+..++.+++++|+.+|+ +++..|..|.||||+|+..++..+
T Consensus 105 ~TpLh~Aa~~~~~eivklLL~~GA--din~kd~~G~TpL~~A~~~~~~~~ 152 (300)
T PHA02884 105 ITPLYISVLHGCLKCLEILLSYGA--DINIQTNDMVTPIELALMICNNFL 152 (300)
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCC--CCCCCCCCCCCHHHHHHHhCChhH
Confidence 999999999999999999999997 777889999999999987665543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-18 Score=217.48 Aligned_cols=264 Identities=20% Similarity=0.212 Sum_probs=184.5
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC-cCChhHHHHHHHHHHHhccCCCCcceeEEEEEeCCE
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~~ 215 (1630)
+|...+.||.+.|-+| .+|.+. ...|+||++-+.. ...-..+.++++..+...++|||.+.+.-+..+...
T Consensus 24 e~~~~~~LGstRFlKv------~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKV------ARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhh------hhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHH
Confidence 7889999999997665 334433 3359999877654 445556666666666655689999999999888888
Q ss_pred EEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee--ecC
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI--LKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~--~~~ 293 (1630)
.|||=+|...++++.+- .+.-|..-+.+.|+.|++.||..+|..||+|+|||.+||||++=+=+.|+||..-+. +++
T Consensus 96 AylvRqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 99999999888776654 334578889999999999999999999999999999999999888899999987542 221
Q ss_pred ccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCCCCH
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~~~~ 372 (1630)
+. .. .......+...-.-|.|||-+-.......+..+.+. .+++.||||+||+++|+++ |++||.-
T Consensus 175 DN------Pa---df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~-L~paMDIFS~GCViaELf~Eg~PlF~L--- 241 (1431)
T KOG1240|consen 175 DN------PA---DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPL-LTPAMDIFSAGCVIAELFLEGRPLFTL--- 241 (1431)
T ss_pred CC------cc---cceEEEecCCceeeecChHhhhccccccccCCcccc-cChhhhhhhhhHHHHHHHhcCCCcccH---
Confidence 11 00 011122222234469999988652211111122221 7899999999999999999 8999842
Q ss_pred HHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 373 ~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
.+++..-..+...+... +..--+..+++||..|++.||++|.|+++.|+.
T Consensus 242 SQL~aYr~~~~~~~e~~---Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 242 SQLLAYRSGNADDPEQL---LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhHhccCccCHHHH---HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 12221111111111100 111123468999999999999999999999887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=182.76 Aligned_cols=140 Identities=21% Similarity=0.161 Sum_probs=108.3
Q ss_pred EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--------------------------hhHHHHHHHHHH
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--------------------------PDWLSGQLDNLR 194 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--------------------------~~~~~~Ei~iL~ 194 (1630)
.+.||+|+||.||+ |.+. +|+.||||.+....... .....+|.+.+.
T Consensus 2 ~~~ig~G~~~~Vy~------a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05145 2 NGCISTGKEANVYH------ARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK 74 (190)
T ss_pred CceeecCCCcEEEE------EEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence 46899999888865 5555 89999999988652110 122357888888
Q ss_pred HhccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccccccceE
Q 000343 195 RASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLL 273 (1630)
Q Consensus 195 ~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs-~gIIHRDLKP~NIL 273 (1630)
++. |++|.....+.... .||||||++|+.+.........++..++..++.|++.+|.|||+ +||+||||||+|||
T Consensus 75 ~l~--~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 75 RLY--EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred HHH--hCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 876 78875554443332 48999999887443322234568899999999999999999999 99999999999999
Q ss_pred ECCCCcEEEeecceeeeec
Q 000343 274 LDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 274 ld~~g~vKL~DFGla~~~~ 292 (1630)
++ ++.++|+|||++..+.
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 98 7899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-18 Score=179.47 Aligned_cols=133 Identities=15% Similarity=0.229 Sum_probs=111.2
Q ss_pred hhhhcccCCChHHHHHHHcCCHHHHHHHHHhc------CCCcccCCCCCCCHHHHHHHcCCH---HHHHHHHHCCCCccc
Q 000343 503 LLKAQNADGQTALHLACRRGSAELVEAILEYS------QENVDVLDKDGDPPLVFALAAGSP---ECVHALIKRGANVIS 573 (1630)
Q Consensus 503 ll~~~d~~G~TpLH~Aa~~G~~eiVk~LL~~~------~~dvn~~D~~G~TPLh~Aa~~G~~---eiVk~LL~~GAdvn~ 573 (1630)
..+.+|.+|.||||+||+.|+. +++|+... +..++..|.+|.||||+|+..|+. +++++|+++|++++.
T Consensus 9 ~~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~ 86 (154)
T PHA02736 9 FASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADING 86 (154)
T ss_pred HHHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccc
Confidence 4567899999999999999984 33332211 112345689999999999999987 468999999999987
Q ss_pred ccccCCCchHHHHHHHcCCHHHHHHHHH-cCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCc
Q 000343 574 RLREGFGPSVAHVCAYHGQPDCMRELLL-AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGC 638 (1630)
Q Consensus 574 ~~~d~~g~T~Lh~Aa~~G~~eivk~LL~-~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~ 638 (1630)
.+ +..|.||||+|+..|+.+++++|+. .|+|+|.+|..|.||||+|+..++.+++++|+.+|+.
T Consensus 87 ~~-~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~~~~~~~i~~~Ll~~ga~ 151 (154)
T PHA02736 87 KE-RVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVACERHDAKMMNILRAKGAQ 151 (154)
T ss_pred cC-CCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 42 2368999999999999999999998 4999999999999999999999999999999999873
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=167.04 Aligned_cols=143 Identities=24% Similarity=0.211 Sum_probs=125.5
Q ss_pred HHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCH
Q 000343 514 ALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQP 593 (1630)
Q Consensus 514 pLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~ 593 (1630)
-+.+|+..+.+..|+.||+..+.-+|.+|.+|.||||-|+++|+++||+.|+..|||.+++. ..|.||||-||..++.
T Consensus 66 l~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T--~~GWTPLhSAckWnN~ 143 (228)
T KOG0512|consen 66 LLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKT--NEGWTPLHSACKWNNF 143 (228)
T ss_pred HHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCccccc--ccCccchhhhhcccch
Confidence 37799999999999999998888899999999999999999999999999999999998865 4478999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHH-HHHHHHcCCccccccccCCCCcHHHHHHHcC
Q 000343 594 DCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC-AIVILENGGCRSMAILNSKELTPLHLCVATW 659 (1630)
Q Consensus 594 eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~ei-v~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g 659 (1630)
+++-+||.+|||+|+......||||+|+...+... +.+|+...+ ...-..+..+.||+.+|-+.+
T Consensus 144 ~va~~LLqhgaDVnA~t~g~ltpLhlaa~~rn~r~t~~~Ll~dry-i~pg~~nn~eeta~~iARRT~ 209 (228)
T KOG0512|consen 144 EVAGRLLQHGADVNAQTKGLLTPLHLAAGNRNSRDTLELLLHDRY-IHPGLKNNLEETAFDIARRTS 209 (228)
T ss_pred hHHHHHHhccCcccccccccchhhHHhhcccchHHHHHHHhhccc-cChhhhcCccchHHHHHHHhh
Confidence 99999999999999999999999999998776554 555555433 445567788999999997654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.9e-17 Score=180.63 Aligned_cols=136 Identities=16% Similarity=0.123 Sum_probs=107.8
Q ss_pred EEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCChhHHHHHHHHHHHhcc---CCCCcceeEEEEEeCC---
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM---WCRNVCTFHGVLRMDS--- 214 (1630)
Q Consensus 141 ~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l---~HpNIV~l~~~f~~~~--- 214 (1630)
.+.||+|+|+.||. +..+... +||++........+.+.+|+.+++.+.. .||||+++|++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--------hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYA--------HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEE--------CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 47899999888863 4455555 6999887655566789999999999853 5899999999999874
Q ss_pred EEE-EEEec--CCCChHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccccccccceEECCC----CcEEEeecc
Q 000343 215 CLG-LVMDR--CYGSVQLAMQRNEGRLTLEQILRYGADIARGV-VELHAAGVVCMNIKPSNLLLDAS----GRAVVSDYG 286 (1630)
Q Consensus 215 ~~~-LVmEy--~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL-~yLHs~gIIHRDLKP~NILld~~----g~vKL~DFG 286 (1630)
.++ +|||| +.+++|..++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+||+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 444 78999 457888888765 356665 46688888888 99999999999999999999743 379999954
Q ss_pred ee
Q 000343 287 LA 288 (1630)
Q Consensus 287 la 288 (1630)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=181.00 Aligned_cols=143 Identities=27% Similarity=0.337 Sum_probs=126.5
Q ss_pred hcCCCCCcccccCccchhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCC
Q 000343 713 TAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGD 792 (1630)
Q Consensus 713 ~~GAdvn~~D~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~ 792 (1630)
+..-|.|.-|..|.+|||+||+.|+..+++.||..|+.+|..|....||||+||..||.++|+.||++.||+|+.|..|+
T Consensus 22 ~tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgn 101 (448)
T KOG0195|consen 22 DTEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGN 101 (448)
T ss_pred CcccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCC
Confidence 34467888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHHHHhchHHHhhHHHHHHHhhCCCCcccccCCCCCCHHHHHhhCCCCCcHHHHHHHHHhcCCCCCCccc
Q 000343 793 NAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIF 865 (1630)
Q Consensus 793 TpLhlAa~~g~~i~~n~e~vi~LL~~~gadvn~~n~~G~TpLdlA~~~~~~~~~~~lve~Ll~~Ga~l~~~~~ 865 (1630)
|||||||-.|. +.+.+-|...||.+++.|++|.|||+-|+. .....+.+...+.|-.++...+
T Consensus 102 tplhyacfwgy------dqiaedli~~ga~v~icnk~g~tpldkakp----~l~~~l~e~aek~gq~~nripf 164 (448)
T KOG0195|consen 102 TPLHYACFWGY------DQIAEDLISCGAAVNICNKKGMTPLDKAKP----MLKNTLLEIAEKHGQSPNRIPF 164 (448)
T ss_pred CchhhhhhhcH------HHHHHHHHhccceeeecccCCCCchhhhch----HHHHHHHHHHHHhCCCCCcccc
Confidence 99999998764 456677788999999999999999998753 2345677778889988775333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=179.11 Aligned_cols=200 Identities=16% Similarity=0.035 Sum_probs=140.3
Q ss_pred eEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC----hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME----PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 138 y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~----~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+.+...|++|+||+|++. ...+.+++.+.+....... ...+.+|+++|+++. +|++|++++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~--------~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~-~~~~vP~ll~~---- 70 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLV--------RGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD-GLPRTPRLLHW---- 70 (218)
T ss_pred cccceeecCCCcceEEEe--------ecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC-CCCCCCEEEEE----
Confidence 345688999999999751 2367788888776543321 125789999999986 47899999886
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-cccceEECCCCcEEEeecceeeeec
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNI-KPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDL-KP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...|++|||+.|.+|...... . ...++.|++.+|.|+|++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 346999999999887643211 1 2457899999999999999999999 7999999999999999999998644
Q ss_pred CccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCC-ccccchhhhhHHHHHhhCCCCCCC
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS-PESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t-~ksDIWSlGvILyemltG~~PF~~ 369 (1630)
...... +--...............++.|++|+.-.... ..+ ...+.++.|..+|.++|+..|+-.
T Consensus 144 ~~~~~~-r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-----------~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 144 PRARWM-RLLAREDLRHLLKHKRMYCPAALTPVERRVLK-----------RTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred CcchHH-HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-----------cchhHHHHHHHhcchHHHHHhccCCccc
Confidence 321000 00000000000011233678888887544321 023 567889999999999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=185.12 Aligned_cols=207 Identities=18% Similarity=0.174 Sum_probs=147.0
Q ss_pred CCCCcceeEEEEEe---------------------------CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHH
Q 000343 199 WCRNVCTFHGVLRM---------------------------DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251 (1630)
Q Consensus 199 ~HpNIV~l~~~f~~---------------------------~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl 251 (1630)
.|||||+++.+|.+ +..+|+||..++.++..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHH
Confidence 69999999988752 2358999998888776665543 367888899999999
Q ss_pred HHHHHHHhCCCccccccccceEEC--CCC--cEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCcccc
Q 000343 252 RGVVELHAAGVVCMNIKPSNLLLD--ASG--RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAW 327 (1630)
Q Consensus 252 ~aL~yLHs~gIIHRDLKP~NILld--~~g--~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl 327 (1630)
+|+.|||.+||.|||||.+|||+. +++ .+.|+|||++-.-.+.. ............-|....||||+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG--------lqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG--------LQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccc--------cccccccccccCCCcceecchhhh
Confidence 999999999999999999999994 333 57999999985433211 001111223344567789999998
Q ss_pred ccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHH
Q 000343 328 EPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE 407 (1630)
Q Consensus 328 ~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~ 407 (1630)
...+.-.. .. --.++|.|+.|.+.||++....||......-+-....+....|. ++..+|+.+++|+..
T Consensus 424 ta~PGp~a-----vv-ny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa-----lp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 424 TAVPGPNA-----VV-NYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA-----LPSRVPPVARQLVFD 492 (598)
T ss_pred hcCCCCce-----ee-ccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC-----CcccCChHHHHHHHH
Confidence 76541100 00 13489999999999999999999976433211111112222222 334688999999999
Q ss_pred hhccCcCCCCChhhHHHHh
Q 000343 408 CLQFKASKRPTFSAMLATF 426 (1630)
Q Consensus 408 cL~~dP~~RPSa~evL~~L 426 (1630)
+|+.||++|+|..-..+-+
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999977555443
|
|
| >KOG3676 consensus Ca2+-permeable cation channel OSM-9 and related channels (OTRPC family) [Inorganic ion transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.2e-17 Score=201.28 Aligned_cols=200 Identities=31% Similarity=0.371 Sum_probs=167.4
Q ss_pred CccchhhccCChhhhhhhhcccCCCCCCcchhhhhhhcccCCChHHHHHHHc---CCHHHHHHHHHhcCCCcccC----C
Q 000343 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRR---GSAELVEAILEYSQENVDVL----D 542 (1630)
Q Consensus 470 t~Lh~Aa~~Gdl~~Vk~LL~~~a~~n~~~si~~ll~~~d~~G~TpLH~Aa~~---G~~eiVk~LL~~~~~dvn~~----D 542 (1630)
..+..|...++++.+..++.....-.+ .-....++.+..-|.|.||.|.-+ ++.++++.||+..+.-+|.. .
T Consensus 103 ~~~~~~~~~~~l~~l~~l~~~~~~~k~-r~~~w~~~~RGa~GET~Lh~~lL~~~~~~n~la~~LL~~~p~lind~~~~ee 181 (782)
T KOG3676|consen 103 DALFIADSEGALSDLDGLLKFLRKSKY-RLTDWKLNERGATGETLLHKALLNLSDGHNELARVLLEIFPKLINDIYTSEE 181 (782)
T ss_pred hhhhhccccccHHHHhccchhhhhhhh-hhhhhccccccchhhhHHHHHHhcCchhHHHHHHHHHHHhHHHhhhhhhhHh
Confidence 467888888888888887765532100 011123566677899999999974 56699999999776656543 4
Q ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccc-------c--------------CCCchHHHHHHHcCCHHHHHHHHH
Q 000343 543 KDGDPPLVFALAAGSPECVHALIKRGANVISRLR-------E--------------GFGPSVAHVCAYHGQPDCMRELLL 601 (1630)
Q Consensus 543 ~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~-------d--------------~~g~T~Lh~Aa~~G~~eivk~LL~ 601 (1630)
..|.||||+|+.+.+.++|++|+++||||+++.. | -+|..||.+||..++.+|+++|++
T Consensus 182 Y~GqSaLHiAIv~~~~~~V~lLl~~gADV~aRa~G~FF~~~dqk~~rk~T~Y~G~~YfGEyPLSfAAC~nq~eivrlLl~ 261 (782)
T KOG3676|consen 182 YYGQSALHIAIVNRDAELVRLLLAAGADVHARACGAFFCPDDQKASRKSTNYTGYFYFGEYPLSFAACTNQPEIVRLLLA 261 (782)
T ss_pred hcCcchHHHHHHhccHHHHHHHHHcCCchhhHhhccccCcccccccccccCCcceeeeccCchHHHHHcCCHHHHHHHHh
Confidence 6799999999999999999999999999986521 1 147789999999999999999999
Q ss_pred cCCCCCCCCCCCCChhhhhhhcCChHHHHHHHHcCCccccccccCCCCcHHHHHHHcCCHHHHHHHHHh
Q 000343 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV 670 (1630)
Q Consensus 602 ~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL~~Ga~~~i~~~d~~G~TPLh~Aa~~g~~eivk~LLe~ 670 (1630)
+|||+|++|.+|+|.||..+..-..++..++|+.|+.......|..|.|||.+|+..|..++.+.+++.
T Consensus 262 ~gAd~~aqDS~GNTVLH~lVi~~~~~My~~~L~~ga~~l~~v~N~qgLTPLtLAaklGk~emf~~ile~ 330 (782)
T KOG3676|consen 262 HGADPNAQDSNGNTVLHMLVIHFVTEMYDLALELGANALEHVRNNQGLTPLTLAAKLGKKEMFQHILER 330 (782)
T ss_pred cCCCCCccccCCChHHHHHHHHHHHHHHHHHHhcCCCccccccccCCCChHHHHHHhhhHHHHHHHHHh
Confidence 999999999999999999999999999999999998544778899999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=182.88 Aligned_cols=242 Identities=21% Similarity=0.255 Sum_probs=145.9
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhc--------cCCCCcce
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRAS--------MWCRNVCT 205 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~--------l~HpNIV~ 205 (1630)
.+...+.||.|+|+.|| .+.+..|++.+|+|+........ .+.+++|.-....+. ..|-.++-
T Consensus 13 ~l~~~~~i~~g~~~~v~------~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVF------EVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEETTEEEE------EEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred EEEEccccccCCceEEE------EEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 67889999999987764 46789999999999987665322 222333321111110 00212333
Q ss_pred eEEEEE---------eCC--------EEEEEEecCCCChHHHHH---HcCC---CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 000343 206 FHGVLR---------MDS--------CLGLVMDRCYGSVQLAMQ---RNEG---RLTLEQILRYGADIARGVVELHAAGV 262 (1630)
Q Consensus 206 l~~~f~---------~~~--------~~~LVmEy~~gglL~~l~---~~~~---~L~~~~~~~i~~QIl~aL~yLHs~gI 262 (1630)
.++... ... ..+++|+-+.+++..... .... .+.......+..|+++.+++||+.||
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 333322 111 247888888777655432 1111 13344456667999999999999999
Q ss_pred ccccccccceEECCCCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcC
Q 000343 263 VCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAI 342 (1630)
Q Consensus 263 IHRDLKP~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~ 342 (1630)
+|+||||+|+|++.+|.++|+||+.....+... .....+..|.+||....... ......
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----------------~~~~~~~~~~PPe~~~~~~~----~~~~~~ 225 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----------------RCSEFPVAFTPPELESCAGQ----FGQNNA 225 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----------------EGGGS-TTTS-HHHHHHHTS----CHHSEE
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee-----------------eccCCCcccCChhhhhhhcc----cCcccc
Confidence 999999999999999999999999887654321 11223577999997754310 000122
Q ss_pred CCCccccchhhhhHHHHHhhCCCCCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCC
Q 000343 343 GISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKR 416 (1630)
Q Consensus 343 ~~t~ksDIWSlGvILyemltG~~PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~R 416 (1630)
.++.+.|.|++|+++|.|..+..||........... .+.. .. .+|+.++.||.++|+.||.+|
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence 379999999999999999999999976543211100 1111 12 588999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=175.49 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=184.2
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCc--CChhHHHHHHHHHHHhccCCCCcceeEEEEEeCC
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~~ 214 (1630)
+..++-+|.+.-.|+. ++|+ --|..++.|++...+- .....+..|.-.|+.++ ||||+.+++.+..+.
T Consensus 191 ~lnl~tkl~e~hsgel------wrgr--wqgndivakil~vr~~t~risrdfneefp~lrifs--hpnilpvlgacnspp 260 (448)
T KOG0195|consen 191 SLNLITKLAESHSGEL------WRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFS--HPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhhccCCCccc------cccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeec--CCchhhhhhhccCCC
Confidence 4445566666654443 3333 2345677777765422 12344566777777766 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CccccccccceEECCCCcEEEe--eccee
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEG--RLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDASGRAVVS--DYGLA 288 (1630)
Q Consensus 215 ~~~LVmEy~~gglL~~l~~~~~--~L~~~~~~~i~~QIl~aL~yLHs~g--IIHRDLKP~NILld~~g~vKL~--DFGla 288 (1630)
.+.++..|++.++|+..+.... .++..++.+++..|++|++|||+.. |.---|....++||++.+++|. |--++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999888887765433 3678899999999999999999974 3344688889999998876663 32222
Q ss_pred eeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCCCC
Q 000343 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368 (1630)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~PF~ 368 (1630)
- ...+.+-.|.||+||.++..+.+.+ -.++|+|||.+++||+.|...||.
T Consensus 341 f---------------------qe~gr~y~pawmspealqrkped~n---------~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 341 F---------------------QEVGRAYSPAWMSPEALQRKPEDLN---------IRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred e---------------------eccccccCcccCCHHHHhcCchhcc---------hhhhhHHHHHHHHHHhhccccccc
Confidence 1 1223445889999999998764322 357999999999999999999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhhhc
Q 000343 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 369 ~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~~~ 429 (1630)
+.++.+.-.+|.-....+ .++++++..+..||.-|++.||.+||.+..++-.|.+.
T Consensus 391 dlspmecgmkialeglrv-----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 391 DLSPMECGMKIALEGLRV-----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCchhhhhhhhhccccc-----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999988877765443322 24567899999999999999999999999887766543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.1e-16 Score=176.15 Aligned_cols=145 Identities=19% Similarity=0.089 Sum_probs=111.8
Q ss_pred CeEEEEEeCcCCceeEEEeeEEEccc-cccCCcEEEEEEeeccCcCC------------------------hhHHHHHHH
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEEME------------------------PDWLSGQLD 191 (1630)
Q Consensus 137 ~y~~~~~LG~G~fg~V~l~g~vy~a~-~~~~g~~VAIK~i~~~~~~~------------------------~~~~~~Ei~ 191 (1630)
-|.+.+.||+|+||.||. |. +..+|+.||||.+....... ...+.+|++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~------a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 29 LSAIGGCISTGKEANVYH------ALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred hHHhCCeeccCcceeEEE------EEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 588899999999887754 65 56789999999988643210 123568999
Q ss_pred HHHHhccCCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-Ccccccccc
Q 000343 192 NLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG-VVCMNIKPS 270 (1630)
Q Consensus 192 iL~~l~l~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~g-IIHRDLKP~ 270 (1630)
++.++...+..+.++++. . ..+|||||++|.++.........+...++..++.||+.+|.|||+.| |+||||||+
T Consensus 103 ~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 999986222334444432 2 35899999999877655433445677778899999999999999999 999999999
Q ss_pred ceEECCCCcEEEeecceeeeec
Q 000343 271 NLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 271 NILld~~g~vKL~DFGla~~~~ 292 (1630)
|||++ ++.++|+|||++....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-16 Score=187.42 Aligned_cols=178 Identities=19% Similarity=0.285 Sum_probs=134.1
Q ss_pred CEEEEEEecCCCChHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEG---RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~---~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.++||.|++|.-+.|.+++..+. ..+....+.++.|++.|++| ++.||||+||.||+...+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999886432 47788999999999999999 9999999999999999999999999999877
Q ss_pred ecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhh-CCCCCCC
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemlt-G~~PF~~ 369 (1630)
...... ........+...||..||+||++.+.. |+.++||||||+||||++. -..+|..
T Consensus 406 ~~~~~~--------~~~~~a~~t~~~gt~~YmsPEQi~g~~------------y~~kvdIyaLGlil~EL~~~f~T~~er 465 (516)
T KOG1033|consen 406 QDKDET--------VAPAAASHTQQVGTLLYMSPEQIRGQQ------------YSEKVDIYALGLILAELLIQFSTQFER 465 (516)
T ss_pred cccCCc--------ccchhhhhhhcccccccCCHHHHhhhh------------hhhhcchhhHHHHHHHHHHHhccHHHH
Confidence 654320 001123345678999999999998866 8999999999999999986 3333321
Q ss_pred CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHH
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 370 ~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL 423 (1630)
...+..+ +....|+.+.. +. ++-..|+.+||.+.|.+||++.+..
T Consensus 466 ---~~t~~d~-r~g~ip~~~~~----d~-p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 466 ---IATLTDI-RDGIIPPEFLQ----DY-PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ---HHhhhhh-hcCCCChHHhh----cC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence 1222222 33333333221 23 3457999999999999999665543
|
|
| >KOG3676 consensus Ca2+-permeable cation channel OSM-9 and related channels (OTRPC family) [Inorganic ion transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=186.12 Aligned_cols=122 Identities=30% Similarity=0.385 Sum_probs=104.4
Q ss_pred ccCccchhhhhhcCCHHHHHHHHHCCCCcccc---------cC--------------CCCCHHHHHHHcCCHHHHHHHHh
Q 000343 723 AQNRTALHIASMANDVELVKIILDAGVDVNIR---------NV--------------HNTIPLHVALARGAKSCVGLLLS 779 (1630)
Q Consensus 723 ~~G~TpLH~Aa~~g~~eiVklLL~~GADvN~~---------d~--------------~G~TPLH~Aa~~G~~eiVklLLe 779 (1630)
..|+||||+|+.+.+.++|++||++|||||++ |. .|..||-+||.-++.+|+++|++
T Consensus 182 Y~GqSaLHiAIv~~~~~~V~lLl~~gADV~aRa~G~FF~~~dqk~~rk~T~Y~G~~YfGEyPLSfAAC~nq~eivrlLl~ 261 (782)
T KOG3676|consen 182 YYGQSALHIAIVNRDAELVRLLLAAGADVHARACGAFFCPDDQKASRKSTNYTGYFYFGEYPLSFAACTNQPEIVRLLLA 261 (782)
T ss_pred hcCcchHHHHHHhccHHHHHHHHHcCCchhhHhhccccCcccccccccccCCcceeeeccCchHHHHHcCCHHHHHHHHh
Confidence 46999999999999999999999999999976 21 36789999999999999999999
Q ss_pred CCCCCCcCCCCCCcHHHHHHHhchHHHhhHHHHHHHhhCCCCc--ccccCCCCCCHHHHHhhCCCCCcHHHHH
Q 000343 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAA--VEVRNHSGKTLRDFLEGLPREWISEDLM 850 (1630)
Q Consensus 780 ~GADiN~~D~~G~TpLhlAa~~g~~i~~n~e~vi~LL~~~gad--vn~~n~~G~TpLdlA~~~~~~~~~~~lv 850 (1630)
+|||+|++|.+|||.||..+.. .+ -.+..+++..|++ ..++|+.|-|||.+|+++++..+...|+
T Consensus 262 ~gAd~~aqDS~GNTVLH~lVi~-----~~-~~My~~~L~~ga~~l~~v~N~qgLTPLtLAaklGk~emf~~il 328 (782)
T KOG3676|consen 262 HGADPNAQDSNGNTVLHMLVIH-----FV-TEMYDLALELGANALEHVRNNQGLTPLTLAAKLGKKEMFQHIL 328 (782)
T ss_pred cCCCCCccccCCChHHHHHHHH-----HH-HHHHHHHHhcCCCccccccccCCCChHHHHHHhhhHHHHHHHH
Confidence 9999999999999999999854 22 2456677788888 8999999999999999998653333333
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=181.37 Aligned_cols=212 Identities=23% Similarity=0.289 Sum_probs=159.6
Q ss_pred CCCCcceeEEEEEeCCEEEEEEecCCCChHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccccccccceEECC
Q 000343 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGV-VCMNIKPSNLLLDA 276 (1630)
Q Consensus 199 ~HpNIV~l~~~f~~~~~~~LVmEy~~gglL~~l~~~-~~~L~~~~~~~i~~QIl~aL~yLHs~gI-IHRDLKP~NILld~ 276 (1630)
.|.|+.+|++.+.++...+.|-+||..+++.+.+.+ .-.++..-...+++.|+.||+|||+..| .|+.|++.|.++|.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~ 84 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS 84 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence 499999999999999999999999988888777765 4468888899999999999999999866 99999999999999
Q ss_pred CCcEEEeecceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhH
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvI 356 (1630)
...+||+|||+........ . ........-..-|.|||++...... ......+.+.||||||++
T Consensus 85 ~w~lklt~~Gl~~~~~~~~----~--------~~~~~~~~~~~lw~aPellr~~~~~-----~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 85 RWVLKLTDFGLNSLLEETA----E--------PEAHHPIRKALLWTAPELLRGALSQ-----SLESALTQKGDIYSFGII 147 (484)
T ss_pred eEEEEechhhhcccccccc----c--------ccccchhHHHHhccCHHHhcccccc-----cccccccccCCeehHHHH
Confidence 9999999999987654200 0 0000111124569999999875311 011225778999999999
Q ss_pred HHHHhhCCCCCCC----CCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHHhh
Q 000343 357 LVEMCTGSIPWAG----LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 357 LyemltG~~PF~~----~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~L~ 427 (1630)
++|+++.+.||.. .++.+++..+..+...+...........++++..++.+||..+|.+||+++++-..+.
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred HHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 9999999999975 2335666666652322222111111256678999999999999999999999866544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.2e-15 Score=190.25 Aligned_cols=246 Identities=17% Similarity=0.158 Sum_probs=173.1
Q ss_pred CCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC---hhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
..|.+-+.||+|+||.||. |.+.. ++.||+|+-++....+ -.++...++ ..+ -+-|.++...+.-
T Consensus 698 ~~~~I~~e~G~g~y~~vy~------a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk----~~~-~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYV------ATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK----PQM-LPSIMHISSAHVF 765 (974)
T ss_pred eeEEEEeeeccccceEEEE------eecCC-CcEEEEEeecCCCceeeeehHHHHHhhc----hhh-hcchHHHHHHHcc
Confidence 6899999999999888764 55555 9999999877664433 112222222 111 2567777777666
Q ss_pred CCEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEEC-------CCCcEEEeec
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD-------ASGRAVVSDY 285 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld-------~~g~vKL~DF 285 (1630)
.+..+||+||.+.|.|.++.+..+.+++..+..++.|++.-+++||..+|||+||||+|+||. ..-.++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 777889999999888888888777899999999999999999999999999999999999994 2235999999
Q ss_pred ceeeeecCccccCCCCCCCCCCcccccccccCCCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCC
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~ 365 (1630)
|.+..+.--. .........+|-.+-.+|+..+.. +++++|.|.|..+++-||.|++
T Consensus 846 G~siDm~lfp------------~~~~F~~~~~td~f~C~EM~~grp------------WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFP------------DGTKFKAVWHTDLFDCIEMREGRP------------WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcC------------CCcEEeeeeccccchhHHHhcCCC------------CchhhhhHHHHHHHHHHHHHHH
Confidence 9987654210 012345567788999999988765 8999999999999999999875
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHH-HHHHHHhhccCcCCCCChhhHHHHhhhcc
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPREL-WKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 366 PF~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el-~~LI~~cL~~dP~~RPSa~evL~~L~~~l 430 (1630)
. + ...+....... . ++..+..++ .+|+..+|+.|-..=|...++...|.+.+
T Consensus 902 ~----------q-~~~g~~~~~~~-~-~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 902 M----------E-VKNGSSWMVKT-N-FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred H----------H-hcCCcceeccc-c-chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 3 1 22221111110 0 111223343 46888888844444455555555544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-16 Score=200.40 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=197.8
Q ss_pred cCCeEEEEEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccC--cCChhHHHHHHHHHHHhccCCCCcceeEEEEEe
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~y~~~~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~ 212 (1630)
...|.+.+.||+|+|+.|-+. .....+...+|.|.+.... ......+..|..+-..+. +|+|++++++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~-----~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s-~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALA-----SNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS-KHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhh-----hhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc-ccccccccCCccCC
Confidence 457899999999999988441 1123455678888777654 222344445666666665 49999999999999
Q ss_pred CCEEEEEEecCCCChHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCccccccccceEECCCC-cEEEeeccee
Q 000343 213 DSCLGLVMDRCYGSVQLAMQ-RNEG-RLTLEQILRYGADIARGVVELH-AAGVVCMNIKPSNLLLDASG-RAVVSDYGLA 288 (1630)
Q Consensus 213 ~~~~~LVmEy~~gglL~~l~-~~~~-~L~~~~~~~i~~QIl~aL~yLH-s~gIIHRDLKP~NILld~~g-~vKL~DFGla 288 (1630)
....++.+||..|+.+...+ .... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999999999888777 5444 5788899999999999999999 99999999999999999999 9999999999
Q ss_pred eeecC-ccccCCCCCCCCCCcccccccccC-CCCCCCccccccccccccccccCcCCCCccccchhhhhHHHHHhhCCCC
Q 000343 289 AILKK-PACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 289 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~G-T~~Y~APEvl~~~~~~~~~~~~~~~~~t~ksDIWSlGvILyemltG~~P 366 (1630)
..+.. .. ........+| ++.|+|||.+.+..+ ..+..|+||.|+++.-|++|..|
T Consensus 173 t~~~~~~g------------~~~~~~~~~g~s~~y~a~E~~~~~~~-----------~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 173 TAYRNKNG------------AERSLKDRCGSSPPYGAPEHLSGKAY-----------RGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred ccccccCC------------cceeeecccCCCCCCCCcccccchhh-----------cCCCcccccccccccccccCCCC
Confidence 87654 11 1222344567 999999999987532 57899999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcccccCCCCCHHHHHHHHHhhccCcCCCCChhhHHHH
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 367 F~~~~~~ei~~~i~~~~~~~~~~~~~~~~~l~~el~~LI~~cL~~dP~~RPSa~evL~~ 425 (1630)
+...........-..... ..+.......++....+++.+++..+|+.|.+.+++-.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 230 WDFPSRKDGRYSSWKSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccccccccceeecccc--cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 976544331111111111 111122345678899999999999999999999987554
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.5e-14 Score=138.24 Aligned_cols=89 Identities=39% Similarity=0.626 Sum_probs=58.1
Q ss_pred hhhhhhcCCHHHHHHHHHCCCCcccccCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCcHHHHHHHhchHHHhh
Q 000343 729 LHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN 808 (1630)
Q Consensus 729 LH~Aa~~g~~eiVklLL~~GADvN~~d~~G~TPLH~Aa~~G~~eiVklLLe~GADiN~~D~~G~TpLhlAa~~g~~i~~n 808 (1630)
||+||+.|+.+++++|++.+++++. |+||||+|+.+|+.+++++|+++|+|+|.+|.+|+||||+|+..++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~----- 71 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGN----- 71 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTH-----
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCC-----
Confidence 5677777777777777777766665 6667777777777777777777777777777777777777765542
Q ss_pred HHHHHHHhhCCCCcccccC
Q 000343 809 LEWLIVMLSHPDAAVEVRN 827 (1630)
Q Consensus 809 ~e~vi~LL~~~gadvn~~n 827 (1630)
. .++++|.++|++++.+|
T Consensus 72 ~-~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 72 L-EIVKLLLEHGADVNIRN 89 (89)
T ss_dssp H-HHHHHHHHTTT-TTSS-
T ss_pred H-HHHHHHHHcCCCCCCcC
Confidence 2 34455556677766665
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-14 Score=158.55 Aligned_cols=134 Identities=21% Similarity=0.259 Sum_probs=108.8
Q ss_pred EEeCcCCceeEEEeeEEEccccccCCcEEEEEEeeccCcCC--------hhHHHHHHHHHHHhccCCCCcceeEEEEEeC
Q 000343 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--------PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 142 ~~LG~G~fg~V~l~g~vy~a~~~~~g~~VAIK~i~~~~~~~--------~~~~~~Ei~iL~~l~l~HpNIV~l~~~f~~~ 213 (1630)
+.||+|++|.||. |.. .+..|++|+........ ...+.+|+.++..+. |++|.....++...
T Consensus 2 ~~l~~G~~~~vy~------~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~p~~~~~~~ 71 (211)
T PRK14879 2 KLIKRGAEAEIYL------GDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR--KAGVNVPAVYFVDP 71 (211)
T ss_pred cccccCceEEEEE------Eee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH--HCCCCCCeEEEEeC
Confidence 5799999888864 332 67789999766432211 235678888988876 78888777777777
Q ss_pred CEEEEEEecCCCChHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCccccccccceEECCCCcEEEeecceeee
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 214 ~~~~LVmEy~~gglL~~l~~~~~~L~~~~~~~i~~QIl~aL~yLHs~gIIHRDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
...+++|||++|..+..++.... . ....++.+++.+|.+||+.+++|||++|.|||++ ++.++|+|||++..
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 88899999999998887775432 2 8889999999999999999999999999999999 78899999999864
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.5e-14 Score=140.02 Aligned_cols=124 Identities=36% Similarity=0.550 Sum_probs=104.3
Q ss_pred cccCCChHHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHH
Q 000343 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV 586 (1630)
Q Consensus 507 ~d~~G~TpLH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~ 586 (1630)
+|.+|.||||+|+..|+.+++++|++. +.+.+..+..|.||||+|+..++.+++++|++.|++++.. +..+.||+|.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~-~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~--~~~~~~~l~~ 79 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLEN-GADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNAR--DKDGNTPLHL 79 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHc-CCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc--CCCCCCHHHH
Confidence 457788999999999999999999885 4556788888999999999999999999999998877654 3567788999
Q ss_pred HHHcCCHHHHHHHHHcCCCCCCCCCCCCChhhhhhhcCChHHHHHHH
Q 000343 587 CAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVIL 633 (1630)
Q Consensus 587 Aa~~G~~eivk~LL~~GADvn~~D~~G~TPLH~Aa~~g~~eiv~~LL 633 (1630)
|+..++.+++++|+.+|.+++..|..|.|||++|+..++.+++++|+
T Consensus 80 a~~~~~~~~~~~L~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~Ll 126 (126)
T cd00204 80 AARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126 (126)
T ss_pred HHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCHHHHHHhC
Confidence 99999999999999988888888888889999988888888888764
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.1e-14 Score=135.08 Aligned_cols=89 Identities=30% Similarity=0.515 Sum_probs=57.7
Q ss_pred HHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcccccccCCCchHHHHHHHcCCHH
Q 000343 515 LHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPD 594 (1630)
Q Consensus 515 LH~Aa~~G~~eiVk~LL~~~~~dvn~~D~~G~TPLh~Aa~~G~~eiVk~LL~~GAdvn~~~~d~~g~T~Lh~Aa~~G~~e 594 (1630)
||+||+.|+.+++++|++. +.+++. |.||||+|+.+|+.+++++|+++|++++.. +..|.||||+|+.+|+.+
T Consensus 1 L~~A~~~~~~~~~~~ll~~-~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~--~~~g~t~L~~A~~~~~~~ 73 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEK-GADINL----GNTALHYAAENGNLEIVKLLLENGADINSQ--DKNGNTALHYAAENGNLE 73 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHT-TSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-B--STTSSBHHHHHHHTTHHH
T ss_pred CHHHHHcCCHHHHHHHHHC-cCCCCC----CCCHHHHHHHcCCHHHHHHHHHhccccccc--CCCCCCHHHHHHHcCCHH
Confidence 6677777777777777763 344444 666777777777777777777777766553 345667777777777777
Q ss_pred HHHHHHHcCCCCCCCC
Q 000343 595 CMRELLLAGADPNAVD 610 (1630)
Q Consensus 595 ivk~LL~~GADvn~~D 610 (1630)
++++|+++|+++|.+|
T Consensus 74 ~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 74 IVKLLLEHGADVNIRN 89 (89)
T ss_dssp HHHHHHHTTT-TTSS-
T ss_pred HHHHHHHcCCCCCCcC
Confidence 7777777777776654
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1630 | ||||
| 1n11_A | 437 | D34 Region Of Human Ankyrin-R And Linker Length = 4 | 8e-20 | ||
| 1n11_A | 437 | D34 Region Of Human Ankyrin-R And Linker Length = 4 | 5e-08 | ||
| 1k1b_A | 241 | Crystal Structure Of The Ankyrin Repeat Domain Of B | 2e-16 | ||
| 1k1b_A | 241 | Crystal Structure Of The Ankyrin Repeat Domain Of B | 2e-08 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 2e-16 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-15 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 3e-15 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 5e-15 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 5e-15 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 6e-15 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 6e-15 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 1e-14 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 2e-14 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-14 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 3e-14 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 3e-14 | ||
| 3noc_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 5e-14 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 5e-14 | ||
| 2j8s_D | 169 | Drug Export Pathway Of Multidrug Exporter Acrb Reve | 5e-14 | ||
| 3nog_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2v5q_C | 167 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3zuv_B | 136 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 9e-13 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 1e-12 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3hg0_D | 136 | Crystal Structure Of A Darpin In Complex With Orf49 | 1e-12 | ||
| 2p2c_P | 169 | Inhibition Of Caspase-2 By A Designed Ankyrin Repea | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 2y1l_E | 169 | Caspase-8 In Complex With Darpin-8.4 Length = 169 | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 4e-12 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 4e-12 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 7e-12 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 2e-05 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 2e-11 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 9e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1uoh_A | 226 | Human Gankyrin Length = 226 | 2e-11 | ||
| 1uoh_A | 226 | Human Gankyrin Length = 226 | 1e-10 | ||
| 1uoh_A | 226 | Human Gankyrin Length = 226 | 8e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 1qym_A | 227 | X-Ray Structure Of Human Gankyrin Length = 227 | 3e-11 | ||
| 1qym_A | 227 | X-Ray Structure Of Human Gankyrin Length = 227 | 1e-10 | ||
| 1qym_A | 227 | X-Ray Structure Of Human Gankyrin Length = 227 | 9e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-11 | ||
| 2bkk_B | 169 | Crystal Structure Of Aminoglycoside Phosphotransfer | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-11 | ||
| 4grg_A | 135 | Crystal Structure Of Ige Complexed With E2_79, An A | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-11 | ||
| 3b7b_A | 237 | Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Le | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3aji_A | 231 | Structure Of Gankyrin-S6atpase Photo-Cross-Linked S | 4e-10 | ||
| 3aji_A | 231 | Structure Of Gankyrin-S6atpase Photo-Cross-Linked S | 6e-09 | ||
| 3aji_A | 231 | Structure Of Gankyrin-S6atpase Photo-Cross-Linked S | 2e-07 | ||
| 2dvw_A | 231 | Structure Of The Oncoprotein Gankyrin In Complex Wi | 4e-10 | ||
| 2dvw_A | 231 | Structure Of The Oncoprotein Gankyrin In Complex Wi | 4e-09 | ||
| 2dvw_A | 231 | Structure Of The Oncoprotein Gankyrin In Complex Wi | 7e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-10 | ||
| 2jab_A | 136 | A Designed Ankyrin Repeat Protein Evolved To Picomo | 5e-10 | ||
| 2jab_A | 136 | A Designed Ankyrin Repeat Protein Evolved To Picomo | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-10 | ||
| 2f8y_A | 223 | Crystal Structure Of Human Notch1 Ankyrin Repeats T | 7e-10 | ||
| 2f8y_A | 223 | Crystal Structure Of Human Notch1 Ankyrin Repeats T | 2e-05 | ||
| 2f8y_A | 223 | Crystal Structure Of Human Notch1 Ankyrin Repeats T | 2e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 1yyh_A | 253 | Crystal Structure Of The Human Notch 1 Ankyrin Doma | 8e-10 | ||
| 1yyh_A | 253 | Crystal Structure Of The Human Notch 1 Ankyrin Doma | 2e-06 | ||
| 1yyh_A | 253 | Crystal Structure Of The Human Notch 1 Ankyrin Doma | 2e-04 | ||
| 2f8x_K | 256 | Crystal Structure Of Activated Notch, Csl And Maml | 8e-10 | ||
| 2f8x_K | 256 | Crystal Structure Of Activated Notch, Csl And Maml | 2e-06 | ||
| 2f8x_K | 256 | Crystal Structure Of Activated Notch, Csl And Maml | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 2qc9_A | 210 | Mouse Notch 1 Ankyrin Repeat Intracellular Domain L | 1e-09 | ||
| 2qc9_A | 210 | Mouse Notch 1 Ankyrin Repeat Intracellular Domain L | 2e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2he0_A | 253 | Crystal Structure Of A Human Notch1 Ankyrin Domain | 1e-08 | ||
| 2he0_A | 253 | Crystal Structure Of A Human Notch1 Ankyrin Domain | 1e-06 | ||
| 2he0_A | 253 | Crystal Structure Of A Human Notch1 Ankyrin Domain | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 3utm_A | 351 | Crystal Structure Of A Mouse Tankyrase-Axin Complex | 3e-08 | ||
| 3utm_A | 351 | Crystal Structure Of A Mouse Tankyrase-Axin Complex | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 4b93_B | 269 | Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyri | 5e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-07 | ||
| 1s70_B | 299 | Complex Between Protein Ser/thr Phosphatase-1 (delt | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-07 | ||
| 3v2x_A | 167 | Crystal Structure Of The Peptide Bound Complex Of T | 3e-07 | ||
| 3v2o_A | 183 | Crystal Structure Of The Peptide Bound Complex Of T | 3e-07 | ||
| 3so8_A | 162 | Crystal Structure Of Ankra Length = 162 | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 4e-07 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 4e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-07 | ||
| 3twq_A | 175 | Crystal Structure Of Arc4 From Human Tankyrase 2 (A | 7e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 1ot8_A | 239 | Structure Of The Ankyrin Domain Of The Drosophila N | 8e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1awc_B | 153 | Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 1 | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 3twr_A | 165 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3twu_A | 167 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 3f6q_A | 179 | Crystal Structure Of Integrin-Linked Kinase Ankyrin | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 2kbx_A | 171 | Solution Structure Of Ilk-Pinch Complex Length = 17 | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2ct2_A | 88 | Solution Structure Of The Ring Domain Of The Tripar | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 2zgg_A | 92 | Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 3eu9_A | 240 | The Ankyrin Repeat Domain Of Huntingtin Interacting | 3e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-06 | ||
| 2xen_A | 91 | Structural Determinants For Improved Thermal Stabil | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-06 | ||
| 3aaa_C | 123 | Crystal Structure Of Actin Capping Protein In Compl | 8e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3v30_A | 172 | Crystal Structure Of The Peptide Bound Complex Of T | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-05 | ||
| 3uxg_A | 172 | Crystal Structure Of Rfxank Length = 172 | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-05 | ||
| 2zgd_A | 110 | Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom | 2e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-05 | ||
| 2rfm_A | 192 | Structure Of A Thermophilic Ankyrin Repeat Protein | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 1bd8_A | 156 | Structure Of Cdk Inhibitor P19ink4d Length = 156 | 3e-05 | ||
| 1bi8_B | 166 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 2rfa_A | 232 | Crystal Structure Of The Mouse Trpv6 Ankyrin Repeat | 3e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-05 | ||
| 1oy3_D | 282 | Crystal Structure Of An IkbbetaNF-Kb P65 Homodimer | 3e-05 | ||
| 1k3z_D | 282 | X-Ray Crystal Structure Of The IkbbNF-Kb P65 Homodi | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-05 | ||
| 1myo_A | 118 | Solution Structure Of Myotrophin, Nmr, 44 Structure | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 3deo_A | 183 | Structural Basis For Specific Substrate Recognition | 5e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 3hra_A | 201 | Crystal Structure Of Ef0377 An Ankyrin Repeat Prote | 5e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 1ap7_A | 168 | P19-Ink4d From Mouse, Nmr, 20 Structures Length = 1 | 5e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-05 | ||
| 3ui2_A | 244 | Crystal Structure Of The Cpsrp54 Tail Bound To Cpsr | 5e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-05 | ||
| 1blx_B | 166 | P19ink4dCDK6 COMPLEX Length = 166 | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-05 | ||
| 1wg0_A | 243 | Structural Comparison Of Nas6p Protein Structures I | 6e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 2dzn_A | 228 | Crystal Structure Analysis Of Yeast Nas6p Complexed | 8e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-05 | ||
| 1nfi_E | 213 | I-Kappa-B-AlphaNF-Kappa-B Complex Length = 213 | 8e-05 | ||
| 1nfi_E | 213 | I-Kappa-B-AlphaNF-Kappa-B Complex Length = 213 | 7e-04 | ||
| 1ikn_D | 236 | IkappabalphaNF-Kappab Complex Length = 236 | 8e-05 | ||
| 1ikn_D | 236 | IkappabalphaNF-Kappab Complex Length = 236 | 7e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 1ixv_A | 231 | Crystal Structure Analysis Of Homolog Of Oncoprotei | 9e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 1mx4_A | 168 | Structure Of P18ink4c (F82q) Length = 168 | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 1mx2_A | 168 | Structure Of F71n Mutant Of P18ink4c Length = 168 | 1e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 1mx6_A | 168 | Structure Of P18ink4c (F92n) Length = 168 | 2e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-04 | ||
| 1wdy_A | 285 | Crystal Structure Of Ribonuclease Length = 285 | 3e-04 | ||
| 1wdy_A | 285 | Crystal Structure Of Ribonuclease Length = 285 | 3e-04 | ||
| 1wdy_A | 285 | Crystal Structure Of Ribonuclease Length = 285 | 5e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-04 | ||
| 1bu9_A | 168 | Solution Structure Of P18-Ink4c, 21 Structures Leng | 3e-04 | ||
| 1ihb_A | 162 | Crystal Structure Of P18-Ink4c(Ink6) Length = 162 | 3e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-04 | ||
| 4hbd_A | 276 | Crystal Structure Of Kank2 Ankyrin Repeats Length = | 4e-04 | ||
| 4g8k_A | 337 | Intact Sensor Domain Of Human Rnase L In The Inacti | 4e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-04 | ||
| 3c5r_A | 137 | Crystal Structure Of The Bard1 Ankyrin Repeat Domai | 6e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-04 |
| >pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437 | Back alignment and structure |
|
| >pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437 | Back alignment and structure |
|
| >pdb|1K1B|A Chain A, Crystal Structure Of The Ankyrin Repeat Domain Of Bcl-3: A Unique Member Of The Ikappab Protein Family Length = 241 | Back alignment and structure |
|
| >pdb|1K1B|A Chain A, Crystal Structure Of The Ankyrin Repeat Domain Of Bcl-3: A Unique Member Of The Ikappab Protein Family Length = 241 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169 | Back alignment and structure |
|
| >pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136 | Back alignment and structure |
|
| >pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1UOH|A Chain A, Human Gankyrin Length = 226 | Back alignment and structure |
|
| >pdb|1UOH|A Chain A, Human Gankyrin Length = 226 | Back alignment and structure |
|
| >pdb|1UOH|A Chain A, Human Gankyrin Length = 226 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QYM|A Chain A, X-Ray Structure Of Human Gankyrin Length = 227 | Back alignment and structure |
|
| >pdb|1QYM|A Chain A, X-Ray Structure Of Human Gankyrin Length = 227 | Back alignment and structure |
|
| >pdb|1QYM|A Chain A, X-Ray Structure Of Human Gankyrin Length = 227 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3B7B|A Chain A, Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Length = 237 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3AJI|A Chain A, Structure Of Gankyrin-S6atpase Photo-Cross-Linked Site-Specifically, And Incoporated By Genetic Code Expansion Length = 231 | Back alignment and structure |
|
| >pdb|3AJI|A Chain A, Structure Of Gankyrin-S6atpase Photo-Cross-Linked Site-Specifically, And Incoporated By Genetic Code Expansion Length = 231 | Back alignment and structure |
|
| >pdb|3AJI|A Chain A, Structure Of Gankyrin-S6atpase Photo-Cross-Linked Site-Specifically, And Incoporated By Genetic Code Expansion Length = 231 | Back alignment and structure |
|
| >pdb|2DVW|A Chain A, Structure Of The Oncoprotein Gankyrin In Complex With S6 Atpase Of The 26s Proteasome Length = 231 | Back alignment and structure |
|
| >pdb|2DVW|A Chain A, Structure Of The Oncoprotein Gankyrin In Complex With S6 Atpase Of The 26s Proteasome Length = 231 | Back alignment and structure |
|
| >pdb|2DVW|A Chain A, Structure Of The Oncoprotein Gankyrin In Complex With S6 Atpase Of The 26s Proteasome Length = 231 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136 | Back alignment and structure |
|
| >pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F8Y|A Chain A, Crystal Structure Of Human Notch1 Ankyrin Repeats To 1.55a Resolution. Length = 223 | Back alignment and structure |
|
| >pdb|2F8Y|A Chain A, Crystal Structure Of Human Notch1 Ankyrin Repeats To 1.55a Resolution. Length = 223 | Back alignment and structure |
|
| >pdb|2F8Y|A Chain A, Crystal Structure Of Human Notch1 Ankyrin Repeats To 1.55a Resolution. Length = 223 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YYH|A Chain A, Crystal Structure Of The Human Notch 1 Ankyrin Domain Length = 253 | Back alignment and structure |
|
| >pdb|1YYH|A Chain A, Crystal Structure Of The Human Notch 1 Ankyrin Domain Length = 253 | Back alignment and structure |
|
| >pdb|1YYH|A Chain A, Crystal Structure Of The Human Notch 1 Ankyrin Domain Length = 253 | Back alignment and structure |
|
| >pdb|2F8X|K Chain K, Crystal Structure Of Activated Notch, Csl And Maml On Hes-1 Promoter Dna Sequence Length = 256 | Back alignment and structure |
|
| >pdb|2F8X|K Chain K, Crystal Structure Of Activated Notch, Csl And Maml On Hes-1 Promoter Dna Sequence Length = 256 | Back alignment and structure |
|
| >pdb|2F8X|K Chain K, Crystal Structure Of Activated Notch, Csl And Maml On Hes-1 Promoter Dna Sequence Length = 256 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QC9|A Chain A, Mouse Notch 1 Ankyrin Repeat Intracellular Domain Length = 210 | Back alignment and structure |
|
| >pdb|2QC9|A Chain A, Mouse Notch 1 Ankyrin Repeat Intracellular Domain Length = 210 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HE0|A Chain A, Crystal Structure Of A Human Notch1 Ankyrin Domain Mutant Length = 253 | Back alignment and structure |
|
| >pdb|2HE0|A Chain A, Crystal Structure Of A Human Notch1 Ankyrin Domain Mutant Length = 253 | Back alignment and structure |
|
| >pdb|2HE0|A Chain A, Crystal Structure Of A Human Notch1 Ankyrin Domain Mutant Length = 253 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351 | Back alignment and structure |
|
| >pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4B93|B Chain B, Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyrin Repeat Domain Of Varp Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S70|B Chain B, Complex Between Protein Ser/thr Phosphatase-1 (delta) And The Myosin Phosphatase Targeting Subunit 1 (mypt1) Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3V2X|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 167 | Back alignment and structure |
|
| >pdb|3V2O|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 183 | Back alignment and structure |
|
| >pdb|3SO8|A Chain A, Crystal Structure Of Ankra Length = 162 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OT8|A Chain A, Structure Of The Ankyrin Domain Of The Drosophila Notch Receptor Length = 239 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1AWC|B Chain B, Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 153 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F6Q|A Chain A, Crystal Structure Of Integrin-Linked Kinase Ankyrin Repeat Domain In Complex With Pinch1 Lim1 Domain Length = 179 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2KBX|A Chain A, Solution Structure Of Ilk-Pinch Complex Length = 171 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2CT2|A Chain A, Solution Structure Of The Ring Domain Of The Tripartite Motif Protein 32 Length = 88 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ZGG|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 92 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EU9|A Chain A, The Ankyrin Repeat Domain Of Huntingtin Interacting Protein 14 Length = 240 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3AAA|C Chain C, Crystal Structure Of Actin Capping Protein In Complex With V-1 Length = 123 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V30|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Rfxank Length = 172 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3UXG|A Chain A, Crystal Structure Of Rfxank Length = 172 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZGD|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 110 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2RFM|A Chain A, Structure Of A Thermophilic Ankyrin Repeat Protein Length = 192 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BD8|A Chain A, Structure Of Cdk Inhibitor P19ink4d Length = 156 | Back alignment and structure |
|
| >pdb|1BI8|B Chain B, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 166 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFA|A Chain A, Crystal Structure Of The Mouse Trpv6 Ankyrin Repeat Domain Length = 232 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OY3|D Chain D, Crystal Structure Of An IkbbetaNF-Kb P65 Homodimer Complex Length = 282 | Back alignment and structure |
|
| >pdb|1K3Z|D Chain D, X-Ray Crystal Structure Of The IkbbNF-Kb P65 Homodimer Complex Length = 282 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1MYO|A Chain A, Solution Structure Of Myotrophin, Nmr, 44 Structures Length = 118 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DEO|A Chain A, Structural Basis For Specific Substrate Recognition By The Chloroplast Signal Recognition Particle Protein Cpsrp43 Length = 183 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HRA|A Chain A, Crystal Structure Of Ef0377 An Ankyrin Repeat Protein Length = 201 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1AP7|A Chain A, P19-Ink4d From Mouse, Nmr, 20 Structures Length = 168 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UI2|A Chain A, Crystal Structure Of The Cpsrp54 Tail Bound To Cpsrp43 Length = 244 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1BLX|B Chain B, P19ink4dCDK6 COMPLEX Length = 166 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1WG0|A Chain A, Structural Comparison Of Nas6p Protein Structures In Two Different Crystal Forms Length = 243 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2DZN|A Chain A, Crystal Structure Analysis Of Yeast Nas6p Complexed With The Proteasome Subunit, Rpt3 Length = 228 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1NFI|E Chain E, I-Kappa-B-AlphaNF-Kappa-B Complex Length = 213 | Back alignment and structure |
|
| >pdb|1NFI|E Chain E, I-Kappa-B-AlphaNF-Kappa-B Complex Length = 213 | Back alignment and structure |
|
| >pdb|1IKN|D Chain D, IkappabalphaNF-Kappab Complex Length = 236 | Back alignment and structure |
|
| >pdb|1IKN|D Chain D, IkappabalphaNF-Kappab Complex Length = 236 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1IXV|A Chain A, Crystal Structure Analysis Of Homolog Of Oncoprotein Gankyrin, An Interactor Of Rb And Cdk46 Length = 231 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1MX4|A Chain A, Structure Of P18ink4c (F82q) Length = 168 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1MX2|A Chain A, Structure Of F71n Mutant Of P18ink4c Length = 168 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MX6|A Chain A, Structure Of P18ink4c (F92n) Length = 168 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WDY|A Chain A, Crystal Structure Of Ribonuclease Length = 285 | Back alignment and structure |
|
| >pdb|1WDY|A Chain A, Crystal Structure Of Ribonuclease Length = 285 | Back alignment and structure |
|
| >pdb|1WDY|A Chain A, Crystal Structure Of Ribonuclease Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1BU9|A Chain A, Solution Structure Of P18-Ink4c, 21 Structures Length = 168 | Back alignment and structure |
|
| >pdb|1IHB|A Chain A, Crystal Structure Of P18-Ink4c(Ink6) Length = 162 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4HBD|A Chain A, Crystal Structure Of Kank2 Ankyrin Repeats Length = 276 | Back alignment and structure |
|
| >pdb|4G8K|A Chain A, Intact Sensor Domain Of Human Rnase L In The Inactive Signaling State Length = 337 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C5R|A Chain A, Crystal Structure Of The Bard1 Ankyrin Repeat Domain And Its Functional Consequences Length = 137 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-61
Identities = 94/372 (25%), Positives = 149/372 (40%), Gaps = 35/372 (9%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + V+ LL NA+ N G T LH+A R G E V A+L
Sbjct: 84 LHCAARIGHTNMVKLLLENNANPN----------LATTAGHTPLHIAAREGHVETVLALL 133
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
E + + + K G PL A G L++R A+ + + G P HV +H
Sbjct: 134 EK-EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTP--LHVAVHHN 190
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---E 648
D ++ LL G P++ G + LH A + + A +L+ G N++
Sbjct: 191 NLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYG-----GSANAESVQG 245
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
+TPLHL + +V + + N+ + G T L + A ++ H +
Sbjct: 246 VTPLHLAAQEGHAEMVALLLSKQAN---GNLGNKSG--LTPLHLVA--QEGHV----PVA 294
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
+L+ G A T LH+AS +++LVK +L DVN + PLH A +
Sbjct: 295 DVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQ 354
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH 828
G V LLL GA N +G IA + L V+ + V V +
Sbjct: 355 GHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGY--ISVTDVLKVVTDE-TSFVLVSDK 411
Query: 829 SGKTLRDFLEGL 840
+ + ++ +
Sbjct: 412 HRMSFPETVDEI 423
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-59
Identities = 93/367 (25%), Positives = 145/367 (39%), Gaps = 44/367 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + V++LL + AS N N +T LH+A R G E+ + +L
Sbjct: 18 LHVASFMGHLPIVKNLLQRGASPN----------VSNVKVETPLHMAARAGHTEVAKYLL 67
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ V+ KD PL A G V L++ AN G P H+ A G
Sbjct: 68 QNK-AKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTP--LHIAAREG 124
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---E 648
+ + LL A + +G + LH A A ++LE A N+
Sbjct: 125 HVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERD-----AHPNAAGKNG 179
Query: 649 LTPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
LTPLH+ V N+ +VK + S + G T L +AA K++ E+
Sbjct: 180 LTPLHVAVHHNNLDIVKLLLPRGGS----PHSPAWNG--YTPLHIAA--KQNQV----EV 227
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
R LL G A+ Q T LH+A+ E+V ++L + N+ N PLH+
Sbjct: 228 ARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQ 287
Query: 768 RGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADA--AKMIRENLEWLIVMLSHPDAAVEV 825
G +L+ G + G H+A+ K++ ++L+ H A V
Sbjct: 288 EGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV----KFLL---QH-QADVNA 339
Query: 826 RNHSGKT 832
+ G +
Sbjct: 340 KTKLGYS 346
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 9e-59
Identities = 102/373 (27%), Positives = 148/373 (39%), Gaps = 56/373 (15%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + LL A N A+ D QT LH A R G +V+ +L
Sbjct: 51 LHMAARAGHTEVAKYLLQNKAKVN----------AKAKDDQTPLHCAARIGHTNMVKLLL 100
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
E + N ++ G PL A G E V AL+++ A+ ++GF P HV A +G
Sbjct: 101 ENNA-NPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP--LHVAAKYG 157
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---E 648
+ LL A PNA G + LH AV D ++L G +S
Sbjct: 158 KVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRG-----GSPHSPAWNG 212
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHE 701
TPLH+ A + VEVA N + G T L +AA ++ H
Sbjct: 213 YTPLHI-------AAKQNQVEVA---RSLLQYGGSANAESVQG--VTPLHLAA--QEGHA 258
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIP 761
E+V +LL+ A + T LH+ + V + +++ GV V+ P
Sbjct: 259 ----EMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTP 314
Query: 762 LHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIV--MLSHP 819
LHVA G V LL AD N + G + H AA + + + IV +L +
Sbjct: 315 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQ-----QGHTD--IVTLLLKN- 366
Query: 820 DAAVEVRNHSGKT 832
A+ + G T
Sbjct: 367 GASPNEVSSDGTT 379
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-53
Identities = 74/335 (22%), Positives = 120/335 (35%), Gaps = 71/335 (21%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQE-NVDVLDKDGDPPLVFALAAGSPECVHAL 564
G T LH+A G +V+ +L + + +V + + PL A AG E L
Sbjct: 9 GGGESGLTPLHVASFMGHLPIVKNLL--QRGASPNVSNVKVETPLHMAARAGHTEVAKYL 66
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624
++ A V ++ ++ P H A G + ++ LL A+PN G + LH A +
Sbjct: 67 LQNKAKVNAKAKDDQTP--LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREG 124
Query: 625 YTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVID 681
+ + + +LE A TPLH+
Sbjct: 125 HVETVLALLEKE-----ASQACMTKKGFTPLHV--------------------------- 152
Query: 682 IPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741
A K + +LL A P A T LH+A N++++V
Sbjct: 153 -------------AAKYGKV----RVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIV 195
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADA 801
K++L G + + PLH+A + LL G N + +G H+AA
Sbjct: 196 KLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA-- 253
Query: 802 AKMIREN----LEWLIVMLSHPDAAVEVRNHSGKT 832
+E + L+ S A + N SG T
Sbjct: 254 ----QEGHAEMVALLL---SK-QANGNLGNKSGLT 280
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 61/317 (19%), Positives = 101/317 (31%), Gaps = 71/317 (22%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH V ++ V+ LL + S + + +G T LH+A ++ E+ ++L
Sbjct: 183 LHVAVHHNNLDIVKLLLPRGGSPH----------SPAWNGYTPLHIAAKQNQVEVARSLL 232
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+Y + + G PL A G E V L+ + AN + G P H+ A G
Sbjct: 233 QYGG-SANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTP--LHLVAQEG 289
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTP 651
L+ G +A G + LH A +L++
Sbjct: 290 HVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQAD------------- 336
Query: 652 LHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRIL 711
VN G + L AA ++ H ++V +L
Sbjct: 337 -------------------------VNAKTKLG--YSPLHQAA--QQGH----TDIVTLL 363
Query: 712 LTAGAEPTAQDAQNRTALHIASMANDVELVKI---ILDAGVDVNIRNVHNTIPLHVALAR 768
L GA P + T L IA + + + + D V + + H
Sbjct: 364 LKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPET---- 419
Query: 769 GAKSCVGLLLSAGADCN 785
V +L D
Sbjct: 420 -----VDEILDVSEDEG 431
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 47/235 (20%), Positives = 71/235 (30%), Gaps = 62/235 (26%)
Query: 603 GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATW 659
G + G + LH A + +L+ G A N TPLH+
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRG-----ASPNVSNVKVETPLHM----- 53
Query: 660 NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT 719
AA EV + LL A+
Sbjct: 54 ----------------------------------AARAGHTEV-----AKYLLQNKAKVN 74
Query: 720 AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
A+ ++T LH A+ +VK++L+ + N+ PLH+A G V LL
Sbjct: 75 AKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLE 134
Query: 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVM--LSHPDAAVEVRNHSGKT 832
A +G H+AA + + L DA +G T
Sbjct: 135 KEASQACMTKKGFTPLHVAA-----KYGKVR--VAELLLER-DAHPNAAGKNGLT 181
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 4e-13
Identities = 28/140 (20%), Positives = 48/140 (34%), Gaps = 25/140 (17%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G++ V+ LL A N A+ G + LH A ++G ++V +L
Sbjct: 315 LHVASHYGNIKLVKFLLQHQADVN----------AKTKLGYSPLHQAAQQGHTDIVTLLL 364
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHAL---IKRGANVISRLREGFGPSVAHVCA 588
+ + + + DG PL A G L + V+ +
Sbjct: 365 KNGA-SPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSF------- 416
Query: 589 YHGQPDCMRELLLAGADPNA 608
P+ + E+L D
Sbjct: 417 ----PETVDEILDVSEDEGE 432
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-56
Identities = 81/376 (21%), Positives = 137/376 (36%), Gaps = 47/376 (12%)
Query: 459 ASDVEVFQDNPNNLHQLVSEGDVSGVRDLL-SKNASGNYSSSISSLLKAQNADGQTALHL 517
A V + + L + G+ + LL N + + A + T LHL
Sbjct: 15 AKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCH----------ASDGRKSTPLHL 64
Query: 518 ACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLRE 577
A +V+ +L++ +V DK G PL A + G E L+K GA V +
Sbjct: 65 AAGYNRVRIVQLLLQHG-ADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLW 123
Query: 578 GFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGG 637
F P H A + + LL GADP V+ G+S + A + + +
Sbjct: 124 QFTP--LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGH- 180
Query: 638 CRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALK 697
+ L ++A VK + + E I TAL A
Sbjct: 181 ------------SLLQAA-READLAKVK---KTLALEIINFKQPQSH--ETALHCAV--A 220
Query: 698 KDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVH 757
H + +++ +LL GA ++ T LH+A+ ++++++ G +N +
Sbjct: 221 SLHP-KRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSL 279
Query: 758 NTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLS 817
LH A G LLLS G+D + +G A + +A + I LS
Sbjct: 280 GQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGNEAVQQI----------LS 329
Query: 818 HPDAAVEVRNHSGKTL 833
+ + + L
Sbjct: 330 E-STPMRTSDVDYRLL 344
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-36
Identities = 68/351 (19%), Positives = 116/351 (33%), Gaps = 99/351 (28%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDG-DPPLVFALAAGSPECVHALIKRG 568
G++AL LA + + D L A + + + L
Sbjct: 3 FGKSALDLADPSA--------------KAVLTGEYKKDELLEAARSGNEEKLMALLTPLN 48
Query: 569 ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC 628
N + P H+ A + + ++ LL GAD +A D G LH A + + +
Sbjct: 49 VNCHASDGRKSTP--LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEV 106
Query: 629 AIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGP 685
++L++G A +N+ + TPLH
Sbjct: 107 TELLLKHG-----ACVNAMDLWQFTPLHE------------------------------- 130
Query: 686 VGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKI-- 743
AA K EV +LL+ GA+PT + ++A+ +A E +
Sbjct: 131 --------AASKNRVEV-----CSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEF 177
Query: 744 -------------------ILDAGVDVNIRNVHNTIPLHVALARG---AKSCVGLLLSAG 781
L + + + LH A+A K LLL G
Sbjct: 178 KGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKG 237
Query: 782 ADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
A+ N ++ + H+AA+ A + +E L H A + + G+T
Sbjct: 238 ANVNEKNKDFMTPLHVAAERAHN--DVMEVLH---KH-GAKMNALDSLGQT 282
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 5e-10
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 11/101 (10%)
Query: 735 ANDVELVKIILDAGVDVNIRNVHNTIPLHVALARG-AKSCVGLLLSAGADCNWQDDEGDN 793
+ + D + + L A G + + LL +C+ D
Sbjct: 1 GEFGKSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKST 60
Query: 794 AFHIAADAAKMIRENLEWLIVM--LSHPDAAVEVRNHSGKT 832
H+AA + IV L H A V ++ G
Sbjct: 61 PLHLAA-----GYNRVR--IVQLLLQH-GADVHAKDKGGLV 93
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 6e-50
Identities = 70/327 (21%), Positives = 122/327 (37%), Gaps = 35/327 (10%)
Query: 504 LKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA 563
+K +A + L GS +E + ++ V DG L A ++G E V
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVK-RKKTKVKFDDGAVFL-AACSSGDTEEVLR 58
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623
L++RGA++ +G H D ++ L+ GA+ N D+EG LH A +
Sbjct: 59 LLERGADINYANVDGLTA--LHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC 116
Query: 624 KYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
Y D A ++ G A + + TPL + +++ V +
Sbjct: 117 GYLDIAEYLISQG-----AHVGAVNSEGDTPLDIAEEEAMEELLQNEVNR-------QGV 164
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
DI A + R+ + L + TALH+A+ E+
Sbjct: 165 DIE----AARKEEE--RIML----RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEV 214
Query: 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
+K+++ A DVNI++ PLH A G + +L+ D + G AF +A
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVAD- 273
Query: 801 AAKMIRENLEWLIVMLSHPDAAVEVRN 827
+ L +L + + +
Sbjct: 274 -----EDILGYLEELQKKQNLLHSEKR 295
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 64/286 (22%), Positives = 104/286 (36%), Gaps = 23/286 (8%)
Query: 505 KAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
K + DG AC G E V +LE +++ + DG L A + + V L
Sbjct: 35 KVKFDDG-AVFLAACSSGDTEEVLRLLERG-ADINYANVDGLTALHQACIDDNVDMVKFL 92
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624
++ GAN+ EG+ P H A G D L+ GA AV+ EG++ L A +
Sbjct: 93 VENGANINQPDNEGWIP--LHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEA 150
Query: 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPG 684
+ + G A +E + W S G
Sbjct: 151 MEELLQNEVNRQGVDIEAARKEEE-RIMLRDARQWLN----------SGHINDVRHAKSG 199
Query: 685 PVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKII 744
GTAL +AAA K + E++++L+ A + +D T LH A+ E +I+
Sbjct: 200 --GTALHVAAA--KGYT----EVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRIL 251
Query: 745 LDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDE 790
++ D+ N VA L + + ++
Sbjct: 252 VENLCDMEAVNKVGQTAFDVADEDILGYLEELQKKQNLLHSEKREK 297
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 68/307 (22%), Positives = 109/307 (35%), Gaps = 57/307 (18%)
Query: 466 QDNPNN-LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSA 524
+ + S GD V LL + A N N DG TALH AC +
Sbjct: 37 KFDDGAVFLAACSSGDTEEVLRLLERGADIN----------YANVDGLTALHQACIDDNV 86
Query: 525 ELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVA 584
++V+ ++E N++ D +G PL A + G + LI +GA+V + EG P
Sbjct: 87 DMVKFLVENG-ANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPL-- 143
Query: 585 HVCAYHGQPDCMRELLLA--GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMA 642
+ + + + + G D A E E ++ R + L +G
Sbjct: 144 DIAEEEAMEELL-QNEVNRQGVDIEAARKEEERIMLRDARQ--------WLNSGH----I 190
Query: 643 ILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCM 692
T LH VA K + EV ++ VN+ D G T L
Sbjct: 191 NDVRHAKSGGTALH-------VAAAKGYTEVL---KLLIQARYDVNIKDYDG--WTPLHA 238
Query: 693 AAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVN 752
AA E E RIL+ + A + +TA +A L ++ + +
Sbjct: 239 AA--HWGKE----EACRILVENLCDMEAVNKVGQTAFDVADEDILGYLEELQKKQNLLHS 292
Query: 753 IRNVHNT 759
+ +
Sbjct: 293 EKREKKS 299
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 7e-24
Identities = 43/199 (21%), Positives = 71/199 (35%), Gaps = 31/199 (15%)
Query: 641 MAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNV-------IDIPGPVGTALCMA 693
M + ++K+ L W E + + G +A
Sbjct: 1 MKMADAKQKRNEQL--KRWI-----------GSETDLEPPVVKRKKTKVKFDDGAVF-LA 46
Query: 694 AALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNI 753
A D E V LL GA+ + TALH A + ++V++VK +++ G ++N
Sbjct: 47 ACSSGDTEE-----VLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQ 101
Query: 754 RNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLI 813
+ IPLH A + G L+S GA + EGD IA + E L
Sbjct: 102 PDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEE-----EAMEELLQ 156
Query: 814 VMLSHPDAAVEVRNHSGKT 832
++ +E +
Sbjct: 157 NEVNRQGVDIEAARKEEER 175
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-48
Identities = 61/381 (16%), Positives = 119/381 (31%), Gaps = 66/381 (17%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+H +G VR L+ S QN G TALHLAC+ G + + +
Sbjct: 24 IHVAARKGQTDEVRRLIETGVSPT----------IQNRFGCTALHLACKFGCVDTAKYLA 73
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
G P+ A+ A + V AL++ G +
Sbjct: 74 SV---GEVHSLWHGQKPIHLAVMANKTDLVVALVEGAKER--------GQMPESLLNECD 122
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVA--KKYTDCAIVILENGGCRSMAILNSK-- 647
+ + + + +G++ LH V +Y + ++++ G A +K
Sbjct: 123 ERE------VNEIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLG-----ASPTAKDK 171
Query: 648 -ELTPLHLCVATWNVAVVKRWVEVASPEEI--VNVIDIPGPVGTALCMAAALKKDHEVEG 704
+ TPL + N + ++ + ++ + G + L A + E
Sbjct: 172 ADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQG--NSHLHWAI--LINWE--- 224
Query: 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA-------------GVDV 751
++ + G + +D ++ L+++ A V L K +L G V
Sbjct: 225 -DVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTV 283
Query: 752 NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEW 811
V + A + + LL + + G +
Sbjct: 284 LPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKK-----KAAPAV 338
Query: 812 LIVMLSHPDAAVEVRNHSGKT 832
+ L+ A V R+ S
Sbjct: 339 KRMKLAP-SAPVRTRSRSRAR 358
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-43
Identities = 56/276 (20%), Positives = 102/276 (36%), Gaps = 32/276 (11%)
Query: 529 AILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCA 588
++ ++ + N D + + A G + V LI+ G + + R G H+
Sbjct: 4 SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTA--LHLAC 61
Query: 589 YHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE 648
G D + L G + G+ +H AV TD + ++E +
Sbjct: 62 KFGCVDTAKYLASVGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGA--------KERG 111
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
P L EV E +V G TAL L ++ E++
Sbjct: 112 QMPESL-------LNECDEREVN--EIGSHVKHCKG--QTALHWCVGLGPEY----LEMI 156
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-----AGVDVNIRNVHNTIPLH 763
+IL+ GA PTA+D + T L A + E + +++D + + ++ N LH
Sbjct: 157 KILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLH 216
Query: 764 VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
A+ + + G D N +D+E +++
Sbjct: 217 WAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSV 252
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-40
Identities = 39/320 (12%), Positives = 89/320 (27%), Gaps = 83/320 (25%)
Query: 503 LLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSP--EC 560
L++ GQ L E+ E V G L + + G E
Sbjct: 103 LVEGAKERGQMPESLLNECDEREVNEI-------GSHVKHCKGQTALHWCVGLGPEYLEM 155
Query: 561 VHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLL------AGADPNAVDDEGE 614
+ L++ GA+ ++ + P + + +L++ + + + +G
Sbjct: 156 IKILVQLGASPTAKDKADETP--LMRAMEFRNREAL-DLMMDTVPSKSSLRLDYANKQGN 212
Query: 615 SVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVA 671
S LH A+ + D A+ +E G +N + PL+L
Sbjct: 213 SHLHWAILINWEDVAMRFVEMG-----IDVNMEDNEHTVPLYL----------------- 250
Query: 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN------ 725
+++ L + LL Q
Sbjct: 251 -----------------------SVRAAMV----LLTKELLQKTDVFLIQACPYHNGTTV 283
Query: 726 -------RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
+ A+ + E+++++ + +V + A + + L
Sbjct: 284 LPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKL 343
Query: 779 SAGADCNWQDDEGDNAFHIA 798
+ A + + ++
Sbjct: 344 APSAPVRTRSRSRARSSAVS 363
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-48
Identities = 61/300 (20%), Positives = 92/300 (30%), Gaps = 37/300 (12%)
Query: 503 LLKAQNADGQTALHLACRRGSAELVEAILEY--SQENVDVLDKDGDPPLVFALAAGSPEC 560
+ DG TALHLA ++ +L + E +D+ + G L A G
Sbjct: 1 VFGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEAST 60
Query: 561 VHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA 620
V L GA V+ R G H+ C LL + +
Sbjct: 61 VEKLYAAGAGVLVAERGGHTA--LHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQD 118
Query: 621 VAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
P + + E +
Sbjct: 119 CTPD----------------------TSHAPAAVDSQPNPENEEEPRDE--DWRLQLEAE 154
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVE 739
+ G T L A + KD E+ VR+L AGA+ + RT LH+A A
Sbjct: 155 NYDG--HTPL-HVAVIHKDAEM-----VRLLRDAGADLNKPEPTCGRTPLHLAVEAQAAS 206
Query: 740 LVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
+++++L AG D R PL AL R LL + GA + + +
Sbjct: 207 VLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSG 266
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 62/293 (21%), Positives = 92/293 (31%), Gaps = 54/293 (18%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH V + LL +A Y L QN GQTALHLA G A VE +
Sbjct: 13 LHLAVIHQHEPFLDFLLGFSAGHEY-------LDLQNDLGQTALHLAAILGEASTVEKLY 65
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGP---------- 581
V V ++ G L A + C L++ + + +
Sbjct: 66 AAG-AGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTS 124
Query: 582 -SVAHVCAYHGQPDCMRELLL-AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCR 639
+ A V + + A + +G + LH AV K + ++ + G
Sbjct: 125 HAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAG--- 181
Query: 640 SMAILNSKE----LTPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGT 688
A LN E TPLHL AV + V E+ G T
Sbjct: 182 --ADLNKPEPTCGRTPLHL-------AVEAQAASVL---ELLLKAGADPTARMYGG--RT 227
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741
L A + + L R+L GA + + +D +
Sbjct: 228 PLGSAL--LRPNP----ILARLLRAHGAPEPEDGGDKLSPCSSSGSDSDSDNR 274
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 37/160 (23%), Positives = 56/160 (35%), Gaps = 25/160 (15%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN---RTALHIASMANDVELVKII 744
TAL +A HE + LL A D QN +TALH+A++ + V+ +
Sbjct: 11 TALHLAV--IHQHE----PFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKL 64
Query: 745 LDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEG----------DNA 794
AG V + LH+A A +C +LL + D +
Sbjct: 65 YAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTS 124
Query: 795 FHIAADAAKMIRENLEWLIVML--SHPDAAVEVRNHSGKT 832
AA ++ N E +E N+ G T
Sbjct: 125 HAPAAVDSQ---PNPENEEEPRDEDW-RLQLEAENYDGHT 160
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 16/97 (16%), Positives = 26/97 (26%), Gaps = 11/97 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH V S + LL A A+ G+T L A R + L +
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPT----------ARMYGGRTPLGSALLRPNPILARLLR 245
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRG 568
+ D P + + + +
Sbjct: 246 AHGA-PEPEDGGDKLSPCSSSGSDSDSDNRDEGDEYD 281
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 62/291 (21%)
Query: 503 LLKAQNADGQTALHLACRRGSAELVEAILEYSQE---NVDVLDKDGDPPLVFALAAGSPE 559
+ + DG T LH+A +G+ V ++ Q+ +D+ + PL A+ P
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 560 CVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGA----DPNAVDDEGES 615
V L+ GA+ ++ R G AH+ H P C+R LL + A D A + +G +
Sbjct: 61 VVRLLVTAGASPMALDRHGQTA--AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLT 118
Query: 616 VLHRAVAKKYTDCAIVILENGGCRSMAILNSKEL----TPLHLCVATWNVAVVKRWVEVA 671
LH AV + + ++LE G A +++ ++ +PL
Sbjct: 119 ALHVAVNTECQETVQLLLERG-----ADIDAVDIKSGRSPLIH----------------- 156
Query: 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHI 731
A++ + +V++LL GA AQ +ALH
Sbjct: 157 -----------------------AVENNSL----SMVQLLLQHGANVNAQMYSGSSALHS 189
Query: 732 ASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782
AS + LV+ ++ +G D +++N HN PL VA +R + + A
Sbjct: 190 ASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 1e-11
Identities = 25/99 (25%), Positives = 39/99 (39%), Gaps = 11/99 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L V +S V+ LL A+ N AQ G +ALH A RG LV ++
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVN----------AQMYSGSSALHSASGRGLLPLVRTLV 203
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
+ + + D PL+ A + + + R A+
Sbjct: 204 RSG-ADSSLKNCHNDTPLMVARSRRVIDILRGKATRPAS 241
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 55/304 (18%), Positives = 90/304 (29%), Gaps = 87/304 (28%)
Query: 505 KAQNADGQTALHLACRRGSAELVEAILEY---SQENVDVLDKDGDPPLVFALAAGSPECV 561
+ DG + LHLA L ++ ++ + PL
Sbjct: 2 QQLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPL------------ 49
Query: 562 HALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAV 621
H+ QP+ LL AG DP D G + LH A
Sbjct: 50 -----------------------HLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLAC 86
Query: 622 AKKYTDCAIVILENGG-CRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIV 677
+ V+ ++ +IL + T LHL
Sbjct: 87 EQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL----------------------- 123
Query: 678 NVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMAN 736
A++ + V +L++ GA+ AQ+ N RTALH+A
Sbjct: 124 ----------------ASIHGYLGI-----VELLVSLGADVNAQEPCNGRTALHLAVDLQ 162
Query: 737 DVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFH 796
+ +LV ++L G DVN P + R + L + E ++
Sbjct: 163 NPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEES 222
Query: 797 IAAD 800
+
Sbjct: 223 YDTE 226
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 48/268 (17%), Positives = 76/268 (28%), Gaps = 72/268 (26%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
+R + A N QN QT LHLA E+ EA+L + ++ D
Sbjct: 28 IRQVKGDLAFLN----------FQNNLQQTPLHLAVITNQPEIAEALLGAG-CDPELRDF 76
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRL------REGFGPSVAHVCAYHGQPDCMR 597
G+ PL A G V L + G H+ + HG +
Sbjct: 77 RGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTC--LHLASIHGYLGIVE 134
Query: 598 ELLLAGADPNAVDD-EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE---LTPLH 653
L+ GAD NA + G + LH AV + D ++L+ G A +N +P
Sbjct: 135 LLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCG-----ADVNRVTYQGYSPYQ 189
Query: 654 LCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLT 713
L + + + L
Sbjct: 190 L----------------------------------------TWGRPST----RIQQQLGQ 205
Query: 714 AGAEPTAQDAQNRTALHIASMANDVELV 741
E ++ + + E
Sbjct: 206 LTLENLQMLPESEDEESYDTESEFTEFT 233
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 35/152 (23%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
+ L +A + + E++R + A Q+ +T LH+A + N E+ + +L A
Sbjct: 10 SFLHLAI--IHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGA 67
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC------NWQDDEGDNAFHIAADA 801
G D +R+ PLH+A +G + VG+L + + G H+A+
Sbjct: 68 GCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLAS-- 125
Query: 802 AKMIRENLEWLIVMLSHPDAAVEVR-NHSGKT 832
I L + +++S A V + +G+T
Sbjct: 126 ---IHGYLGIVELLVSL-GADVNAQEPCNGRT 153
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 38/171 (22%), Positives = 57/171 (33%), Gaps = 18/171 (10%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH V LL ++ G T LHLAC +G V +
Sbjct: 49 LHLAVITNQPEIAEALLGAGCDPE----------LRDFRGNTPLHLACEQGCLASVGVLT 98
Query: 532 EY-----SQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGF-GPSVAH 585
+ + + +G L A G V L+ GA+V + +E G + H
Sbjct: 99 QSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNA--QEPCNGRTALH 156
Query: 586 VCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
+ PD + LL GAD N V +G S + T + +
Sbjct: 157 LAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLT 207
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 8/159 (5%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH +G ++ V L + + S + KA N +G T LHLA G +VE ++
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHSIL----KATNYNGHTCLHLASIHGYLGIVELLV 137
Query: 532 EYSQENVDVLDK-DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH 590
+V+ + +G L A+ +P+ V L+K GA+V +G+ P +
Sbjct: 138 SL-GADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPY--QLTWGR 194
Query: 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
++L + + E E ++T+
Sbjct: 195 PSTRIQQQLGQLTLENLQMLPESEDEESYDTESEFTEFT 233
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 24/122 (19%), Positives = 48/122 (39%), Gaps = 14/122 (11%)
Query: 720 AQDAQNRTALHIASMAND----VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVG 775
+ LH+A + + +E+++ + +N +N PLH+A+
Sbjct: 3 QLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAE 62
Query: 776 LLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSH-----PDAAVEVRNHSG 830
LL AG D +D G+ H+A + L + V+ + ++ N++G
Sbjct: 63 ALLGAGCDPELRDFRGNTPLHLAC-----EQGCLASVGVLTQSCTTPHLHSILKATNYNG 117
Query: 831 KT 832
T
Sbjct: 118 HT 119
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 164 bits (419), Expect = 2e-45
Identities = 63/336 (18%), Positives = 105/336 (31%), Gaps = 67/336 (19%)
Query: 477 SEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQE 536
S L+ + + K DG G L +
Sbjct: 4 SHHHHHHSSGLVPRGSHMASMDG-----KQGGMDGSKPAGPRDFPGIRLLSNPL------ 52
Query: 537 NVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCM 596
D P+ A G + LI +G V + P H G C+
Sbjct: 53 MGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSP--LHEACLGGHLSCV 108
Query: 597 RELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK--ELTPLHL 654
+ LL GA N V + + L A DC ++L++G A + + +P+H
Sbjct: 109 KILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHG-----ASVQPESDLASPIHE 163
Query: 655 CVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTA 714
AA ++ H E V L+
Sbjct: 164 ---------------------------------------AA-RRGHV----ECVNSLIAY 179
Query: 715 GAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
G + + T L++A VK +L++G DVN ++ PLH + ++
Sbjct: 180 GGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQGKGQDS-PLHAVVRTASEELA 238
Query: 775 GLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLE 810
LL+ GAD ++ EG + + + + LE
Sbjct: 239 CLLMDFGADTQAKNAEGKRPVELVPPESPLAQLFLE 274
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 1e-36
Identities = 60/323 (18%), Positives = 101/323 (31%), Gaps = 73/323 (22%)
Query: 517 LACRRGSAELVEAILEYSQENVDVLDK-----DGDPPLVFALAAGSPECVHALIKRGANV 571
+ ++ ++ +D DG P G + L+ +
Sbjct: 1 MGSSHHHHHHSSGLVPRG-SHMASMDGKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVS- 58
Query: 572 ISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIV 631
S H A HG +R L+ G N + + S LH A + C +
Sbjct: 59 --------DWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKI 110
Query: 632 ILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALC 691
+L++G A VN + T L
Sbjct: 111 LLKHG----------------------------------AQ----VNGVTADW--HTPLF 130
Query: 692 MAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDV 751
A + V +LL GA + + +H A+ VE V ++ G ++
Sbjct: 131 NAC--VSGSW----DCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNI 183
Query: 752 NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEW 811
+ + H PL++A ++CV LL +GAD N Q D+ H + E
Sbjct: 184 DHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR-----TASEE- 236
Query: 812 LIVML--SHPDAAVEVRNHSGKT 832
+ L A + +N GK
Sbjct: 237 -LACLLMDF-GADTQAKNAEGKR 257
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-44
Identities = 34/332 (10%), Positives = 82/332 (24%), Gaps = 71/332 (21%)
Query: 488 LSKNASGNYSSSISSLLK-----AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLD 542
LS+ + S + S L + G +A + A + LV +L
Sbjct: 4 LSRINTWK-SKQLKSFLSSKDTFKADVHGHSASYYAIADNNVRLVCTLLNA---GALKNL 59
Query: 543 KDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLA 602
+ + PL A + V L+ G + +G + G ++ +
Sbjct: 60 LENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTA--LYYAVDSGNMQTVKLFVKK 117
Query: 603 GADPNAVDDEG-ESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE--LTPLHLCVATW 659
G ++ + AV L L+ +H+
Sbjct: 118 NWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEI-----PSTFDLAILLSCIHI----- 167
Query: 660 NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT 719
++ + +LL
Sbjct: 168 ----------------------------------TIKNGHVDM-----MILLLDYMTSTN 188
Query: 720 AQDAQNRT-ALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
++ + +A D+E+++ + +++ + +++
Sbjct: 189 TNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDDAEIAKMII 241
Query: 779 SAGADCNWQDDEGDNAFHIAADAAKMIRENLE 810
+ D ++I +N E
Sbjct: 242 EKHVEYKSDSYTKDLDIVKNNKLDEIISKNKE 273
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 17/152 (11%)
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
+ + TW +K ++ D+ G +A A + + V
Sbjct: 2 MDLSR--INTWKSKQLKSFLSSKD----TFKADVHG--HSAS-YYAIADNNVRL-----V 47
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
LL AGA + N LH A+ D ++VKI+L +G+D + + L+ A+
Sbjct: 48 CTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDS 105
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDN-AFHIAA 799
G V L + + G +F+ A
Sbjct: 106 GNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAV 137
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 73/299 (24%), Positives = 117/299 (39%), Gaps = 46/299 (15%)
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDP-PLVFALAAGSPECVHALIK 566
+ L A + +LV+ +LE NV+ +++G PL A+ + V L++
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEG-GANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626
GA+ + R + G P + A G ++ L GAD N D G + A
Sbjct: 61 HGADPVLRKKNGATP--FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKV 118
Query: 627 DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPV 686
+ + G A +N + T +E + G
Sbjct: 119 KALKFLYKRG-----ANVNLRRKT-----------------------KEDQERLRKGG-- 148
Query: 687 GTALCMAAALKKDHEVEGRELVRILLT-AGAEPTAQDAQNRTALHIASMANDV----ELV 741
TAL AA +K H E+++ILL GA+ A D R AL A +++D +
Sbjct: 149 ATALMDAA--EKGHV----EVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAIT 202
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS-AGADCNWQDDEGDNAFHIAA 799
++LD G DVN+R PL +A+ + V LL + N D +G A +A
Sbjct: 203 HLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAV 261
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 70/320 (21%), Positives = 117/320 (36%), Gaps = 48/320 (15%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + V DV V+ LL A+ N + G T LH A + ++VE +L
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVN---------FQEEEGGWTPLHNAVQMSREDIVELLL 59
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ + + K+G P + A AGS + + + +GA+V GF A +G
Sbjct: 60 RHGA-DPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTA--FMEAAVYG 116
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTP 651
+ ++ L GA+ N E GG T
Sbjct: 117 KVKALKFLYKRGANVNLRRKTKEDQERL--------------RKGGA-----------TA 151
Query: 652 LHLCVATWN--VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVR 709
L A V V+K ++ + VN D G AL A + + +
Sbjct: 152 LMD--AAEKGHVEVLKILLDEMGAD--VNACDNMG--RNALIHAL--LSSDDSDVEAITH 203
Query: 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTIPLHVALAR 768
+LL GA+ + + +T L +A + LV+ +L+ +++N + L +A+
Sbjct: 204 LLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVEL 263
Query: 769 GAKSCVGLLLSAGADCNWQD 788
K LL GA + D
Sbjct: 264 KLKKIAELLCKRGASTDCGD 283
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 61/309 (19%), Positives = 97/309 (31%), Gaps = 73/309 (23%)
Query: 542 DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLL 601
+ + L+ A+ + V L++ GANV + EG G + H + D + LL
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEG-GWTPLHNAVQMSREDIVELLLR 60
Query: 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVAT 658
GADP G + A + L G A +N T
Sbjct: 61 HGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG-----ADVNECDFYGFTAFME---- 111
Query: 659 WNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEP 718
AA+ + ++ L GA
Sbjct: 112 -----------------------------------AAVYGKVKA-----LKFLYKRGANV 131
Query: 719 TAQDAQN----------RTALHIASMANDVELVKI-ILDAGVDVNIRNVHNTIPLHVALA 767
+ TAL A+ VE++KI + + G DVN + L AL
Sbjct: 132 NLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALL 191
Query: 768 RGAKSC----VGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAV 823
S LLL GAD N + + G +A + +++L + +L +
Sbjct: 192 SSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVE-----KKHLGLVQRLLEQEHIEI 246
Query: 824 EVRNHSGKT 832
+ GKT
Sbjct: 247 NDTDSDGKT 255
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/314 (21%), Positives = 103/314 (32%), Gaps = 77/314 (24%)
Query: 461 DVEVFQDNPNN---LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHL 517
+V Q+ LH V V LL A + +G T L
Sbjct: 30 NVNF-QEEEGGWTPLHNAVQMSREDIVELLLRHGADPV----------LRKKNGATPFLL 78
Query: 518 ACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLRE 577
A GS +L++ L +V+ D G + A G + + L KRGANV R +
Sbjct: 79 AAIAGSVKLLKLFLSKG-ADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKT 137
Query: 578 GFGPSVA--------HVCAYHGQPDCMRELLL--AGADPNAVDDEGESVLHRAVAKKYTD 627
A G + + ++LL GAD NA D+ G + L A+
Sbjct: 138 KEDQERLRKGGATALMDAAEKGHVEVL-KILLDEMGADVNACDNMGRNALIHALLSSDDS 196
Query: 628 CAIVI----LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIP 683
I L++G A VNV
Sbjct: 197 DVEAITHLLLDHG----------------------------------AD----VNVRGER 218
Query: 684 GPVGTALCMAAALKKDHEVEGRELVRILLT-AGAEPTAQDAQNRTALHIASMANDVELVK 742
G T L +A +K H LV+ LL E D+ +TAL +A ++ +
Sbjct: 219 G--KTPLILAV--EKKHL----GLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAE 270
Query: 743 IILDAGVDVNIRNV 756
++ G + ++
Sbjct: 271 LLCKRGASTDCGDL 284
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-42
Identities = 64/368 (17%), Positives = 127/368 (34%), Gaps = 54/368 (14%)
Query: 453 ETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQ 512
E E + + + ++L + +G + R+ L
Sbjct: 22 ENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHY-------------------SL 62
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
G+ L + + + + + L AAGS + + N+I
Sbjct: 63 YPNPQGYGNGNDFLGD-FNHTNLQIPTEPEPESPIKLHTE-AAGSYAITEPITRESVNII 120
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLL--------AGADPNAVDDEGESVLHRAVAKK 624
+V H A + + +L++ AGAD NA+D + + L AV +
Sbjct: 121 ---DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLAR 177
Query: 625 YTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVID 681
+++ G A E + LH A + ++ + + + +D
Sbjct: 178 RRRLVAYLMKAG-----ADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELD 232
Query: 682 IPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE--------PTAQDAQNRTALHIAS 733
G TAL M A + + ++L+ GA+ ++ + RTALH A+
Sbjct: 233 RNG--MTAL-MIVAHNEGRDQV--ASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAA 287
Query: 734 MANDVELVKI-ILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGD 792
+++ +VK + + G + + ++ P+ +A G V L+ GA D
Sbjct: 288 QVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDH 347
Query: 793 NAFHIAAD 800
A +A
Sbjct: 348 TARQLAQA 355
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-21
Identities = 41/240 (17%), Positives = 68/240 (28%), Gaps = 39/240 (16%)
Query: 603 GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVA 662
+ + L A Y L++ L P N
Sbjct: 27 NRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYS-----------LYPNPQGYGNGNDF 75
Query: 663 VVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD 722
+ + +I + P L A + +
Sbjct: 76 LGDFNH---TNLQIPTEPEPESP--IKLHTEA---AGSY----AITEPITRESVNI-IDP 122
Query: 723 AQNRTALHIASMANDVELV--------KIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
NRT LH + + E K + AG DVN + PL +A+ + V
Sbjct: 123 RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLV 182
Query: 775 GLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPD--AAVEVRNHSGKT 832
L+ AGAD + +A H AA + ++ ML+ +E + +G T
Sbjct: 183 AYLMKAGADPTIYNKSERSALHQAA-----ANRDFGMMVYMLNSTKLKGDIEELDRNGMT 237
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 3/67 (4%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQE-NVDVLDKDGDPPLVFALAAGSPECVHAL 564
Q+ DG+T + LA + G E+V ++ Q +V+ +D A A V
Sbjct: 308 KQDEDGKTPIMLAAQEGRIEVVMYLI--QQGASVEAVDATDHTARQLAQANNHHNIVDIF 365
Query: 565 IKRGANV 571
+
Sbjct: 366 DRCRPER 372
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 62/318 (19%), Positives = 112/318 (35%), Gaps = 77/318 (24%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
+ DG T L +A G G +P + I
Sbjct: 5 VRGPDGFTPLMIASCSG---------------------GGLETGNSEEEEDAPAVISDFI 43
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
+GA++ ++ + G + H+ A + + D + LL A AD N D+ G + LH AV+
Sbjct: 44 YQGASLHNQ-TDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADA 102
Query: 626 TDCAIVILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682
+++ N L+++ TPL L
Sbjct: 103 QGVFQILIRNRA----TDLDARMHDGTTPLIL---------------------------- 130
Query: 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVK 742
A + E ++ L+ + A+ A D ++ALH A+ N+V+
Sbjct: 131 ------------AARLAVE----GMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAV 174
Query: 743 IILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAA 802
++L G + +++N PL +A G+ +LL A+ + D IA +
Sbjct: 175 VLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQE-- 232
Query: 803 KMIRENLEWLIVMLSHPD 820
+M + + L L H
Sbjct: 233 RMHHDIVRLLD--LEHHH 248
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 63/292 (21%)
Query: 467 DNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAEL 526
+ E + + D + + AS L + G+TALHLA R ++
Sbjct: 22 GGLETGNSEEEEDAPAVISDFIYQGAS---------LHNQTDRTGETALHLAARYSRSDA 72
Query: 527 VEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV 586
+ +LE S + ++ D G PL A++A + LI+ A + R G + +
Sbjct: 73 AKRLLEAS-ADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDA-RMHDGTTPLIL 130
Query: 587 CAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNS 646
A + +L+ + AD NAVDD G+S LH A A D A+V+L+NG A +
Sbjct: 131 AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNG-----ANKDM 185
Query: 647 K---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
+ E TPL L AA + +E
Sbjct: 186 QNNREETPLFL---------------------------------------AAREGSYET- 205
Query: 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN 755
++LL A D +R IA ++V+++ + +
Sbjct: 206 ----AKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHHHHHH 253
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 47.8 bits (115), Expect = 1e-05
Identities = 25/103 (24%), Positives = 39/103 (37%), Gaps = 30/103 (29%)
Query: 749 VDVNIRNVHNTIPLHVALARGA-------------KSCVGLLLSAGAD-CNWQDDEGDNA 794
+DVN+R PL +A G + + + GA N D G+ A
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 795 FHIAA-----DAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
H+AA DAAK L+ A ++++ G+T
Sbjct: 61 LHLAARYSRSDAAKR-------LL---EA-SADANIQDNMGRT 92
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 57/287 (19%), Positives = 100/287 (34%), Gaps = 54/287 (18%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
+ + A + G E ++E +V DK+ L +A + V I
Sbjct: 4 HIDDYSTWDIVKATQYGIYERCRELVEAG-YDVRQPDKENVTLLHWAAINNRIDLVKYYI 62
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
+GA V + + H G + +L+ GADP+ +D EG S +H A +
Sbjct: 63 SKGAIVDQLGGD-LNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGH 121
Query: 626 TDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682
T ++ G ++ +TPL
Sbjct: 122 TSIVAYLIAKG-----QDVDMMDQNGMTPLMW---------------------------- 148
Query: 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELV 741
AA + H V+ R+LLT D + TALH A +A + ++
Sbjct: 149 -----------AA-YRTHSVD---PTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVI 193
Query: 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQD 788
++L+AG +V+ +N+ L +A R + L A + +
Sbjct: 194 SLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 51/269 (18%), Positives = 98/269 (36%), Gaps = 57/269 (21%)
Query: 537 NVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCM 596
++ +D +V A G E L++ G +V +E H A + + D +
Sbjct: 1 HMTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTL--LHWAAINNRIDLV 58
Query: 597 RELLLAGADPNAVD-DEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE---LTPL 652
+ + GA + + D + LH A + + + +++ G A + + + +
Sbjct: 59 KYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYG-----ADPSLIDGEGCSCI 113
Query: 653 HLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
HL A + H +V L+
Sbjct: 114 HL----------------------------------------AAQFGHT----SIVAYLI 129
Query: 713 TAGAEPTAQDAQNRTALHIASM-ANDVELVKIILDAGVDVNIR-NVHNTIPLHVALARGA 770
G + D T L A+ + V+ +++L V VN+ H LH A+ G
Sbjct: 130 AKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGN 189
Query: 771 KSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
+ + LLL AGA+ + Q+ +G++A +A
Sbjct: 190 TTVISLLLEAGANVDAQNIKGESALDLAK 218
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 9e-21
Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 15/167 (8%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH +G +S V L+ A + + +G + +HLA + G +V ++
Sbjct: 80 LHWATRQGHLSMVVQLMKYGADPS----------LIDGEGCSCIHLAAQFGHTSIVAYLI 129
Query: 532 EYSQENVDVLDKDGDPPLVFALAAG-SPECVHALIKRGANV-ISRLREGFGPSVAHVCAY 589
Q +VD++D++G PL++A S + L+ +V + H
Sbjct: 130 AKGQ-DVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTA--LHWAVL 186
Query: 590 HGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
G + LL AGA+ +A + +GES L A +K + E
Sbjct: 187 AGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEAR 233
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 9e-17
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 720 AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
D + + A+ E + +++AG DV + N LH A V +S
Sbjct: 4 HIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYIS 63
Query: 780 AGADCNWQD-DEGDNAFHIAADAAKMIREN-LEWLIVMLSHPDAAVEVRNHSGKT 832
GA + D H A R+ L ++ ++ + A + + G +
Sbjct: 64 KGAIVDQLGGDLNSTPLHWAT------RQGHLSMVVQLMKY-GADPSLIDGEGCS 111
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 43.6 bits (104), Expect = 2e-04
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 14/80 (17%)
Query: 461 DVEVFQDNPNN---LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHL 517
V + D + LH V G+ + + LL A+ + AQN G++AL L
Sbjct: 168 SVNL-GDKYHKNTALHWAVLAGNTTVISLLLEAGANVD----------AQNIKGESALDL 216
Query: 518 ACRRGSAELVEAILEYSQEN 537
A +R + ++ + E Q
Sbjct: 217 AKQRKNVWMINHLQEARQAK 236
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 63/283 (22%), Positives = 100/283 (35%), Gaps = 56/283 (19%)
Query: 505 KAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
K ++ + ++ LH A G ++ +++ N+D +D PL+ A E V L
Sbjct: 5 KMEHQNKRSPLHAAAEAGHVDICHMLVQAG-ANIDTCSEDQRTPLMEAAENNHLEAVKYL 63
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGA-DPNAVDDEGESVLHRAVAK 623
IK GA V + EG H+ A G + ++ LL G D N DD G + + A
Sbjct: 64 IKAGALVDPKDAEGSTC--LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEY 121
Query: 624 KYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
K+ D ++L G + +N + E LH
Sbjct: 122 KHVDLVKLLLSKG-----SDINIRDNEENICLHW-------------------------- 150
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
AA ++ ILL A + A + + LHIA+ N +
Sbjct: 151 -------------AAFSGCVDI-----AEILLAAKCDLHAVNIHGDSPLHIAARENRYDC 192
Query: 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783
V + L DV ++N PL A + A D
Sbjct: 193 VVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 66/243 (27%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 604 ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWN 660
+ S LH A + D ++++ G A +++ + TPL
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAG-----ANIDTCSEDQRTPLME------ 50
Query: 661 VAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLT 713
A +E + V+ D G T L AA K +EV V+ LL+
Sbjct: 51 -AAENNHLEAV---KYLIKAGALVDPKDAEG--STCL-HLAAKKGHYEV-----VQYLLS 98
Query: 714 AGA-EPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKS 772
G + QD T + A+ V+LVK++L G D+NIR+ I LH A G
Sbjct: 99 NGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVD 158
Query: 773 CVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIREN-LEWLIVML--SHPDAAVEVRNHS 829
+LL+A D + + GD+ HIAA REN + V+L S D+ V ++N
Sbjct: 159 IAEILLAAKCDLHAVNIHGDSPLHIAA------RENRYD--CVVLFLSR-DSDVTLKNKE 209
Query: 830 GKT 832
G+T
Sbjct: 210 GET 212
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 20/197 (10%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + + V+ L+ A + ++A+G T LHLA ++G E+V+ +L
Sbjct: 48 LMEAAENNHLEAVKYLIKAGALVD----------PKDAEGSTCLHLAAKKGHYEVVQYLL 97
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
Q +V+ D G P+++A + V L+ +G+++ R E H A+ G
Sbjct: 98 SNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENIC--LHWAAFSG 155
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---E 648
D LL A D +AV+ G+S LH A + DC ++ L + + K
Sbjct: 156 CVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRD-----SDVTLKNKEG 210
Query: 649 LTPLHLCVATWNVAVVK 665
TPL V
Sbjct: 211 ETPLQCASLNSQVWSAL 227
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 60/309 (19%), Positives = 124/309 (40%), Gaps = 39/309 (12%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
+++ + +G+GR +V+ GR VA++ + I + E QL +
Sbjct: 32 FEQLEIGELIGKGRFG--QVY-------HGRWHGEVAIRLIDIERDNE-----DQLKAFK 77
Query: 195 R-ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGA 248
R + + NV F G L ++ C ++ ++ + L + + +
Sbjct: 78 REVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
+I +G+ LHA G++ ++K N+ D +G+ V++D+GL + R
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF---------SISGVLQAGRR 187
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+ + APE +++ +D + S SD ++ G E+ P+
Sbjct: 188 EDKLRIQNGWLCHLAPE---IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
AE I + K + +G+ +E+ ++ C F+ +RPTF+ ++ L
Sbjct: 245 TQPAEAIIWQMGTGMKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM-LE 298
Query: 429 HLQELPRSP 437
L + R
Sbjct: 299 KLPKRNRRL 307
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 33/241 (13%)
Query: 555 AGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGE 614
+P + I +GA++ ++ + G + H+ A + + D + LL A AD N D+ G
Sbjct: 1 GDAPAVISDFIYQGASLHNQ-TDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGR 59
Query: 615 SVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVA 671
+ LH AV+ +++ N L+++ TPL L A +
Sbjct: 60 TPLHAAVSADAQGVFQILIRNRA----TDLDARMHDGTTPLIL-------AARLAVEGML 108
Query: 672 SPEEI-------VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQ 724
E VN +D G +AL AA ++ + +LL GA Q+ +
Sbjct: 109 ---EDLINSHADVNAVDDLG--KSALHWAA--AVNNV----DAAVVLLKNGANKDMQNNR 157
Query: 725 NRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784
T L +A+ E K++LD + +I + + +P +A R V LL
Sbjct: 158 EETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVR 217
Query: 785 N 785
+
Sbjct: 218 S 218
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 63/272 (23%), Positives = 105/272 (38%), Gaps = 63/272 (23%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
+ D + + AS L + G+TALHLA R ++ + +LE S + ++ D
Sbjct: 7 ISDFIYQGAS---------LHNQTDRTGETALHLAARYSRSDAAKRLLEAS-ADANIQDN 56
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
G PL A++A + LI+ A + R G + + A + +L+ +
Sbjct: 57 MGRTPLHAAVSADAQGVFQILIRNRATDLDA-RMHDGTTPLILAARLAVEGMLEDLINSH 115
Query: 604 ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWN 660
AD NAVDD G+S LH A A D A+V+L+NG A + + E TPL L
Sbjct: 116 ADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNG-----ANKDMQNNREETPLFL------ 164
Query: 661 VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTA 720
A ++ E ++LL A
Sbjct: 165 ----------------------------------AAREGSY----ETAKVLLDHFANRDI 186
Query: 721 QDAQNRTALHIASMANDVELVKIILDAGVDVN 752
D +R IA ++V+++ + + +
Sbjct: 187 TDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS 218
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 39/192 (20%), Positives = 67/192 (34%), Gaps = 22/192 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH + LL +A N Q+ G+T LH A + + + ++
Sbjct: 29 LHLAARYSRSDAAKRLLEASADAN----------IQDNMGRTPLHAAVSADAQGVFQILI 78
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
++D DG PL+ A + LI A+V + G H A
Sbjct: 79 RNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSA--LHWAAAVN 136
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---E 648
D LL GA+ + ++ E+ L A + + A V+L++ A + +
Sbjct: 137 NVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHF-----ANRDITDHMD 191
Query: 649 LTPLHLCVATWN 660
P +A
Sbjct: 192 RLPRD--IAQER 201
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 39/271 (14%), Positives = 75/271 (27%), Gaps = 53/271 (19%)
Query: 500 ISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPE 559
+S GQ + A + + + ++ + D + G
Sbjct: 1 MSKPPPKPVKPGQVKVFRALYTFEPRTPDELYI-EEGDIIYITDMSDTNWWKGTSKG--- 56
Query: 560 CVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHR 619
+ V + P H A G +RE L N +D G + L+
Sbjct: 57 --RTGLIPSNYVAEQAESIDNP--LHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYW 112
Query: 620 AVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNV 679
A + D ++ +N
Sbjct: 113 ACHGGHKDIVEMLFTQPNIE-------------------------------------LNQ 135
Query: 680 IDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVE 739
+ G TAL AA K + ++V++LL GA ++ + + A +A+ A
Sbjct: 136 QNKLG--DTALHAAA--WKGYA----DIVQLLLAKGARTDLRNIEKKLAFDMATNAACAS 187
Query: 740 LVKIILDAGVDVNIRNVHNTIPLHVALARGA 770
L+K + N + + +
Sbjct: 188 LLKKKQGTDAVRTLSNAEDYLDDEDSDLEHH 218
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 38/262 (14%), Positives = 67/262 (25%), Gaps = 60/262 (22%)
Query: 542 DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLL 601
K G + AL P L ++I G R L+
Sbjct: 9 VKPGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTN--WWKGTSKG-----RTGLI 61
Query: 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVAT 658
+ ++ LH A + L+N +N T L+
Sbjct: 62 PSNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNR-----VGVNGLDKAGSTALYW---- 112
Query: 659 WNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLT-AGAE 717
A ++ V +L T E
Sbjct: 113 -----------------------------------ACHGGHKDI-----VEMLFTQPNIE 132
Query: 718 PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLL 777
Q+ TALH A+ ++V+++L G ++RN+ + +A S +
Sbjct: 133 LNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKK 192
Query: 778 LSAGADCNWQDDEGDNAFHIAA 799
A + E +
Sbjct: 193 QGTDAVRTLSNAEDYLDDEDSD 214
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 41/249 (16%), Positives = 69/249 (27%), Gaps = 58/249 (23%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
Y +P EL + D + D ++ + +K T
Sbjct: 17 FRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQ------- 69
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
PLH AA + +
Sbjct: 70 AESIDNPLHE---------------------------------------AAKRGNLSW-- 88
Query: 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTIPLH 763
+R L D TAL+ A ++V+++ +++N +N LH
Sbjct: 89 ---LRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALH 145
Query: 764 VALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAV 823
A +G V LLL+ GA + ++ E AF +A + L DA
Sbjct: 146 AAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATN-----AACASLLKKKQGT-DAVR 199
Query: 824 EVRNHSGKT 832
+ N
Sbjct: 200 TLSNAEDYL 208
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 32/201 (15%), Positives = 61/201 (30%), Gaps = 24/201 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNA------------------SGNYSSSISSLLKAQNADGQT 513
+ + + + +L + G S+ + Q
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAESIDN 75
Query: 514 ALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI-KRGANVI 572
LH A +RG+ + L+ V+ LDK G L +A G + V L + +
Sbjct: 76 PLHEAAKRGNLSWLRECLDNRV-GVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELN 134
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI 632
+ + G H A+ G D ++ LL GA + + E + A
Sbjct: 135 QQNKLGDTAL--HAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKK 192
Query: 633 LENGGCRSMAILNSKELTPLH 653
+ N+++
Sbjct: 193 QGTD--AVRTLSNAEDYLDDE 211
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-22
Identities = 30/152 (19%), Positives = 53/152 (34%), Gaps = 12/152 (7%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH+ G++S +R+ L N + G TAL+ AC G ++VE +
Sbjct: 77 LHEAAKRGNLSWLRECLDNRVGVN----------GLDKAGSTALYWACHGGHKDIVEMLF 126
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
++ +K GD L A G + V L+ +GA R E +
Sbjct: 127 TQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAF--DMATNAA 184
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623
+++ A + E + +
Sbjct: 185 CASLLKKKQGTDAVRTLSNAEDYLDDEDSDLE 216
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 29/225 (12%)
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
++ +T A R+ + + +LE +VD +D++G L+F GS +CV L +
Sbjct: 42 VSEYETPWWTAARKADEQALSQLLEDR--DVDAVDENGRTALLFVAGLGSDKCVRLLAEA 99
Query: 568 GANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627
GA++ R G G + H+ A + +P+ + L+ GAD D+ G + L A T
Sbjct: 100 GADLDHRDMRG-GLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTT 158
Query: 628 CAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVG 687
++ G + +++ + V + EV +++ G
Sbjct: 159 PKGNPMQFG-----RRIGLEKVINVLE-------GQVFEYAEVD------EIVEKRGKGK 200
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIA 732
+ KD + + AE A+D L A
Sbjct: 201 DVEYLVRW--KDG----GDCEWVKGVHVAEDVAKD--YEDGLEYA 237
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 44/315 (13%), Positives = 76/315 (24%), Gaps = 103/315 (32%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
G+ + R +G + G A+
Sbjct: 1 GEVNKIIGSRTAG--------------------EGAMEYLIEWKDGHSPSWVPSSYIAAD 40
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V+S + A + LL D +AVD+ G + L C
Sbjct: 41 VVSE-----YETPWWTAARKADEQAL-SQLLEDRDVDAVDENGRTALLFVAGLGSDKCVR 94
Query: 631 VILENGGCRSMAILNSKEL----TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPV 686
++ E G A L+ +++ T LH
Sbjct: 95 LLAEAG-----ADLDHRDMRGGLTALH--------------------------------- 116
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
MAA E+V L+ GA+ +D + TAL +A +
Sbjct: 117 -----MAA--GYVRP----EVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQ 165
Query: 747 AGVDVNIRNV----------------------HNTIPLHVALARGAKSCVGLLLSAGADC 784
G + + V ++ + C + A+
Sbjct: 166 FGRRIGLEKVINVLEGQVFEYAEVDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAED 225
Query: 785 NWQDDEGDNAFHIAA 799
+D E A
Sbjct: 226 VAKDYED--GLEYAV 238
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 35/230 (15%), Positives = 72/230 (31%), Gaps = 42/230 (18%)
Query: 607 NAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKR 666
+ EG ++ + A + S+ TP + + +
Sbjct: 9 SRTAGEGAMEYLIEWKDGHSPSWVPSSYIA-----ADVVSEYETPWWTAARKADEQALSQ 63
Query: 667 WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN- 725
+E V+ +D G TAL A + + VR+L AGA+ +D +
Sbjct: 64 LLEDRD----VDAVDENG--RTALLFVA--GLGSD----KCVRLLAEAGADLDHRDMRGG 111
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
TALH+A+ E+V+ +++ G D+ + + L +A + G + G
Sbjct: 112 LTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIG 171
Query: 786 WQ----------------------DDEGDNAFHIAADAAKMIRENLEWLI 813
+ +G + ++ +
Sbjct: 172 LEKVINVLEGQVFEYAEVDEIVEKRGKGKDVEYLVRWKDG--GDCEWVKG 219
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 65/307 (21%), Positives = 125/307 (40%), Gaps = 47/307 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
+ + +++G G V+ +G+ VAVK + + P L
Sbjct: 23 DGQITVGQRIGSGSFG--TVY-------KGKWHGDVAVKMLNV-TAPTPQQLQ---AFKN 69
Query: 195 RASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
+ + N+ F G L +V C S+ + +E + +++++
Sbjct: 70 EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
ARG+ LHA ++ ++K +N+ L + D+GL A K+R
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL-------ATEKSRWSGSHQ--- 178
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
+ S + APE + D+ S +SD ++FG L E+ TG +P++
Sbjct: 179 --FEQLSGSILWMAPEV---------IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
Query: 370 LS-AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
++ ++I V + P S V P+ + +++ ECL+ K +RP+F + L
Sbjct: 228 INNRDQIIEMVGRGSLSPD--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI----LA 281
Query: 429 HLQELPR 435
++EL R
Sbjct: 282 EIEELAR 288
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/313 (18%), Positives = 101/313 (32%), Gaps = 92/313 (29%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
LH AC V+ +L + D+DG PL ++++ + E L+ + N
Sbjct: 2 SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMEN 61
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
V + DD G + H A + +
Sbjct: 62 VNLD--------------------------------DYPDDSGWTPFHIACSVGNLEVVK 89
Query: 631 VILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVG 687
+ + LN +T LHL
Sbjct: 90 SLYDRP---LKPDLNKITNQGVTCLHL--------------------------------- 113
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
A KK EV + L+ GA +D N+ LH A+ ++L++++
Sbjct: 114 ------AVGKKWFEV-----SQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGL 162
Query: 748 GV-DVNIRNVHNTIPLHVALARGAKSCVGLLLSA-GADCNWQDDEGDNAFHIAADAAKMI 805
G VN ++ PL ALA G LL+ GA+ + D++G A +A +
Sbjct: 163 GKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALN----- 217
Query: 806 RENLEWLIVMLSH 818
+ ++ + ++
Sbjct: 218 EQVKKFFL---NN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 117 bits (297), Expect = 9e-30
Identities = 50/263 (19%), Positives = 86/263 (32%), Gaps = 74/263 (28%)
Query: 585 HVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAI 643
H + ++ELL + + D +G LH +V+ + + +L
Sbjct: 7 HQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM-----EN 61
Query: 644 LNSKEL------TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALK 697
+N + TP H+ A
Sbjct: 62 VNLDDYPDDSGWTPFHI---------------------------------------ACSV 82
Query: 698 KDHEVEGRELVRILL--TAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN 755
+ EV V+ L + Q T LH+A E+ + +++ G V I++
Sbjct: 83 GNLEV-----VKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKD 137
Query: 756 VHNTIPLHVALARGAKSCVGLLLSAG-ADCNWQDDEGDNAFHIAA-----DAAKMIRENL 809
N IPLH A + G+ + LL G + NWQD +G A DAA +
Sbjct: 138 KFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVL----- 192
Query: 810 EWLIVMLSHPDAAVEVRNHSGKT 832
L+ A ++ ++ G
Sbjct: 193 --LV---EKYGAEYDLVDNKGAK 210
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 50/278 (17%), Positives = 87/278 (31%), Gaps = 69/278 (24%)
Query: 472 LHQLVSEGDVSGVRDLL-SKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAI 530
LHQ E + V++LL SK + ++ DG+ LH + + E+ +
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLL----------QKDQDGRIPLHWSVSFQAHEITSFL 55
Query: 531 LEY--SQENVDVLDKDGDPPLVFALAAGSPECVHALIKR--GANVISRLREGFGPSVAHV 586
L + D D G P A + G+ E V +L R ++ +G H+
Sbjct: 56 LSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTC--LHL 113
Query: 587 CAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNS 646
+ + L+ GA D + LHRA + ++ G + +N
Sbjct: 114 AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGK----SAVNW 169
Query: 647 KE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
++ TPL AL + H
Sbjct: 170 QDKQGWTPLFH----------------------------------------ALAEGHG-- 187
Query: 704 GRELVRILLTA-GAEPTAQDAQNRTALHIASMANDVEL 740
+ +L+ GAE D + A +A +
Sbjct: 188 --DAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQVKKF 223
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 67/278 (24%), Positives = 104/278 (37%), Gaps = 51/278 (18%)
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
+LA EL E IL D+D L +A +AG E V L++
Sbjct: 4 CVSNIMICNLAYSGKLDELKERILADK-SLATRTDQDSRTALHWACSAGHTEIVEFLLQL 62
Query: 568 GANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627
G V + G+ P H+ A G + ++ LL+ GA NAV+ G + LH A +K +
Sbjct: 63 GVPVNDKDDAGWSP--LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHE 120
Query: 628 CAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVG 687
A+++LE G + + + T +H
Sbjct: 121 IAVMLLEGGA--NPDAKDHYDATAMHR--------------------------------- 145
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
A K + ++V ILL A QD + T LH+A VE K ++
Sbjct: 146 -------AAAKGN----LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQ 194
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
G + I N PL VA +G + L+ G + +
Sbjct: 195 GASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEAS 230
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 63/267 (23%), Positives = 103/267 (38%), Gaps = 61/267 (22%)
Query: 487 LLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGD 546
+L+ + + D +TALH AC G E+VE +L+ V+ D G
Sbjct: 26 ILADKSLAT----------RTDQDSRTALHWACSAGHTEIVEFLLQLG-VPVNDKDDAGW 74
Query: 547 PPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADP 606
PL A +AG E V AL+ +GA+V + + G P H A + + LL GA+P
Sbjct: 75 SPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTP--LHYAASKNRHEIAVMLLEGGANP 132
Query: 607 NAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKR 666
+A D + +HRA AK ++L S I +++ TPLHL
Sbjct: 133 DAKDHYDATAMHRAAAKGNLKMVHILLFYKA--STNIQDTEGNTPLHL------------ 178
Query: 667 WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNR 726
A ++ E + L+T GA ++ + +
Sbjct: 179 ----------------------------ACDEER----VEEAKFLVTQGASIYIENKEEK 206
Query: 727 TALHIASMANDVELVKIILDAGVDVNI 753
T L +A + + L G + ++
Sbjct: 207 TPLQVAKGGLGL--ILKRLAEGEEASM 231
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 41/146 (28%), Positives = 61/146 (41%), Gaps = 11/146 (7%)
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
+C A + EL +L + T D +RTALH A A E+V+ +L
Sbjct: 7 NIMICNLAY-SGKLD----ELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQ 61
Query: 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIR 806
GV VN ++ PLH+A + G V LL GA N + G H AA +
Sbjct: 62 LGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAAS-----K 116
Query: 807 ENLEWLIVMLSHPDAAVEVRNHSGKT 832
E +++L A + ++H T
Sbjct: 117 NRHEIAVMLLEG-GANPDAKDHYDAT 141
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 14/156 (8%)
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAN 736
D TAL A H E+V LL G +D + LHIA+ A
Sbjct: 33 ATRTDQDS--RTALHWAC--SAGH----TEIVEFLLQLGVPVNDKDDAGWSPLHIAASAG 84
Query: 737 DVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFH 796
E+VK +L G VN N + PLH A ++ +LL GA+ + +D A H
Sbjct: 85 XDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMH 144
Query: 797 IAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
AA + NL+ + ++L + A+ +++ G T
Sbjct: 145 RAAA-----KGNLKMVHILLFY-KASTNIQDTEGNT 174
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 14/78 (17%), Positives = 29/78 (37%), Gaps = 6/78 (7%)
Query: 755 NVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIV 814
V N + ++A + +L+ + D + A H A A E +E+L+
Sbjct: 4 CVSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHT--EIVEFLL- 60
Query: 815 MLSHPDAAVEVRNHSGKT 832
V ++ +G +
Sbjct: 61 --QL-GVPVNDKDDAGWS 75
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 62/363 (17%), Positives = 118/363 (32%), Gaps = 54/363 (14%)
Query: 114 RGTHVSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH----- 168
G G +E+G +++ + L EG A V +
Sbjct: 7 LGGASGRDQSDFVGQTVELGELR-LRVRRVLAEGGFAFVYE-----------AQDVGSGR 54
Query: 169 SVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLG--------LVM 220
A+K+++ EE + + ++ +++ S N+ F + L+
Sbjct: 55 EYALKRLLSNEEEKNRAIIQEVCFMKKLS-GHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 221 DRCYGSVQLAM--QRNEGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDA 276
+ C G + + + G L+ + +L+ R V +H ++ ++K NLLL
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNL 336
G + D+G A + + + T +P Y PE +
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT--TPMYRTPEIIDLYSNF--- 228
Query: 337 FWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVG 396
I + D W+ GC L +C P+ + I QY
Sbjct: 229 ------PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYT------ 276
Query: 397 IPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEP 456
+I LQ +R + +A + LQE+ + +P + T+ N
Sbjct: 277 ---VFHSLIRAMLQVNPEERLS----IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYG 329
Query: 457 SPA 459
S
Sbjct: 330 SAT 332
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 47/214 (21%), Positives = 74/214 (34%), Gaps = 38/214 (17%)
Query: 472 LHQLVSEGDVSGVRDLL-SKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAI 530
L E DV + LL + + + A G+TALH+A + E +
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVH----------QRGAMGETALHIAALYDNLEAAMVL 56
Query: 531 LEY----SQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVA-- 584
+E E + +G L A+ + V AL+ RGA+V +R
Sbjct: 57 MEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHN 116
Query: 585 ---------HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILE- 634
A G + +R L+ GAD A D G +VLH + + A +
Sbjct: 117 LIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNL 176
Query: 635 --------NGGCRSMAILNSKELTPLHLCVATWN 660
+ + N++ LTP L A
Sbjct: 177 LLSYDGGDHLKS-LELVPNNQGLTPFKL--AGVE 207
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 33/165 (20%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
+ L +AA K++ + L ++L G E + A TALHIA++ +++E ++++A
Sbjct: 5 SPLLLAA--KENDV---QALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEA 59
Query: 748 GVDV-----NIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD------------- 789
++ LH+A+ + V LL+ GA + +
Sbjct: 60 APELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIY 119
Query: 790 EGDNAFHIAADAAKMIRENLEWLIVML--SHPDAAVEVRNHSGKT 832
G++ AA + E IV L H A + ++ G T
Sbjct: 120 YGEHPLSFAA-----CVGSEE--IVRLLIEH-GADIRAQDSLGNT 156
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 65/337 (19%), Positives = 115/337 (34%), Gaps = 63/337 (18%)
Query: 127 GPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEP 183
G ++ + + ++KLGEG + V++ H A+K+++ E+ +
Sbjct: 21 GHMVIID-NKHYLFIQKLGEGGFSYVDL---------VEGLHDGHFYALKRILCHEQQD- 69
Query: 184 DWLSGQLDNLRR-----ASMWCRNVCTFHGVLRMDSCLG----LVMDRCY-GSVQLAMQR 233
+ +R N+ + L++ G++ ++R
Sbjct: 70 ------REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 234 ---NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
LT +QIL I RG+ +HA G ++KP+N+LL G+ V+ D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
+ CT +Y APE + I +D
Sbjct: 184 ACIHVEGSRQALTLQDWAAQR--CT---ISYRAPELFSVQSHC---------VIDERTDV 229
Query: 351 WSFGCTLVEMCTGSIP--WAGLSAEEIYRAVVKNRKLP--PQYASIVGVGIPRELWKMIG 406
WS GC L M G P + + AV +P P++ LW+++
Sbjct: 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH--------SSALWQLLN 281
Query: 407 ECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDT 443
+ +RP + L L+ L P T
Sbjct: 282 SMMTVDPHQRPH----IPLLLSQLEALQPPAPGQHTT 314
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/318 (16%), Positives = 89/318 (27%), Gaps = 92/318 (28%)
Query: 468 NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLA---CRRGSA 524
+ + L +VS G + LL S ++ + + G+T L A + G
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRW--NSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVN 59
Query: 525 ELVEAILEYSQENVDVL----------DKDGDPPLVFALAAGSPECVHALIKRGANVISR 574
+ +L+ +++ + G L A+ S +CV L++ GA+V R
Sbjct: 60 ACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLR 119
Query: 575 LREGFGPSVA-----------HVCAYHGQPDCMRELL---LAGADPNAVDDEGESVLHRA 620
F + A Q D + LL A A D G +VLH
Sbjct: 120 ACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHAL 179
Query: 621 VAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
V NS E + L +
Sbjct: 180 VMIAD-------------------NSPENSALVI-------------------------- 194
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
+ ++ L + Q T L +A+ +E+
Sbjct: 195 --------------HMYDGLL----QMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEI 236
Query: 741 VKIILDAGVDVNIRNVHN 758
+ IL + H+
Sbjct: 237 FRHILQREFSGAAAHHHH 254
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 49/303 (16%), Positives = 80/303 (26%), Gaps = 73/303 (24%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVL-------DKDGDPPLVFALAA---GSPEC 560
+ L RG E + +LEY + N L G L+ A+ G C
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61
Query: 561 VHALIKRG-----------ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAV 609
+ L++ A +G H+ C++ L+ GAD +
Sbjct: 62 IMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSA--LHIAIEKRSLQCVKLLVENGADVHLR 119
Query: 610 DDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVE 669
H+ + G PL L T VV +E
Sbjct: 120 ACGRFFQKHQGTCFYF-----------GE-----------LPLSLAACTKQWDVVTYLLE 157
Query: 670 VASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTAL 729
+ D G T L + A ++ +AL
Sbjct: 158 NPHQPASLEATDSLG--NTVLHALVMI-----------------------ADNSPENSAL 192
Query: 730 HIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS---AGADCNW 786
I +++ + I N PL +A G +L +GA +
Sbjct: 193 VIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAAAHH 252
Query: 787 QDD 789
Sbjct: 253 HHH 255
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 59/325 (18%), Positives = 109/325 (33%), Gaps = 50/325 (15%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
D+ + LG+G + G+ + +K+++ +E L+
Sbjct: 11 DLIHGEVLGKGCFG--QAIKVTHRETGE-----VMVMKELIRFDEETQR------TFLKE 57
Query: 196 ASMWCR----NVCTFHGVLRMDSCLGLV---MDRCYGSVQLAMQRNEGRLTLEQILRYGA 248
+ NV F GVL D L + + G+++ ++ + + Q + +
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG--GTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
DIA G+ LH+ ++ ++ N L+ + VV+D+GLA ++ +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+ +P + APE +N D + D +SFG L E+
Sbjct: 176 RKKRYTVVGNPYWMAPEM-------INGRSYDE-----KVDVFSFGIVLCEIIGRVNADP 223
Query: 369 GLSAEEIYRAVVKN---RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS---AM 422
+ + + P P + + C KRP+F
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 423 LATFLRHLQELPRSPPASP--DTGF 445
L T HL P D GF
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGF 301
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 112 bits (284), Expect = 2e-28
Identities = 34/187 (18%), Positives = 66/187 (35%), Gaps = 18/187 (9%)
Query: 603 GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVA 662
+ EG ++ + A + S+ TP +
Sbjct: 4 KIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIA-----ADVVSEYETPWWTAARKADEQ 58
Query: 663 VVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQD 722
+ + +E V+ +D G TAL A + + VR+L AGA+ +D
Sbjct: 59 ALSQLLEDRD----VDAVDENG--RTALLFVA--GLGSD----KCVRLLAEAGADLDHRD 106
Query: 723 AQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781
+ TALH+A+ E+V+ +++ G D+ + + L +A + G + G
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFG 166
Query: 782 ADCNWQD 788
+
Sbjct: 167 RRIGLEK 173
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 37/256 (14%), Positives = 62/256 (24%), Gaps = 93/256 (36%)
Query: 505 KAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
+G + + G + DV + + P
Sbjct: 8 SRTAGEGAMEYLIEWKDGHSPSWVPSSYI---AADV-VSEYETPW--------------- 48
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624
A + LL D +AVD+ G + L
Sbjct: 49 --------------------WTAARKADEQAL-SQLLEDRDVDAVDENGRTALLFVAGLG 87
Query: 625 YTDCAIVILENGGCRSMAILNSKEL----TPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
C ++ E G A L+ +++ T LH
Sbjct: 88 SDKCVRLLAEAG-----ADLDHRDMRGGLTALH--------------------------- 115
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
MAA E+V L+ GA+ +D + TAL +A
Sbjct: 116 -----------MAA--GYVRP----EVVEALVELGADIEVEDERGLTALELAREILKTTP 158
Query: 741 VKIILDAGVDVNIRNV 756
+ G + + V
Sbjct: 159 KGNPMQFGRRIGLEKV 174
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 36/177 (20%), Positives = 67/177 (37%), Gaps = 21/177 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+G A ++ +T A R+ + + +L
Sbjct: 18 YLIEWKDGHSPSWVPSSYIAAD-------------VVSEYETPWWTAARKADEQALSQLL 64
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
E +VD +D++G L+F GS +CV L + GA++ R G G + H+ A +
Sbjct: 65 E--DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRG-GLTALHMAAGYV 121
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE 648
+P+ + L+ GAD D+ G + L A T ++ G + ++
Sbjct: 122 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFG-----RRIGLEK 173
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 18/184 (9%)
Query: 650 TPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
+H A + +K + + +VN D G T L A+ E V
Sbjct: 4 LSIHQLAAQGELDQLKEHLRKGDN---LVNKPDERG--FTPLIWAS--AFGEI----ETV 52
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
R LL GA+P + +AL +AS ++V ++L+ VD+NI + + PL A+
Sbjct: 53 RFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRG 112
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH 828
CV LL+ GAD + D G +A + V+ +H + N
Sbjct: 113 NHVKCVEALLARGADLTTEADSGYTPMDLAVA-----LGYRKVQQVIENH-ILKLFQSNL 166
Query: 829 SGKT 832
Sbjct: 167 VPAD 170
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-27
Identities = 40/165 (24%), Positives = 66/165 (40%), Gaps = 12/165 (7%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+HQL ++G++ +++ L K + L+ + G T L A G E V +L
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDN---------LVNKPDERGFTPLIWASAFGEIETVRFLL 56
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
E+ + +L K+ + L A G + V L++R ++ G P
Sbjct: 57 EWG-ADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTP--LLYAVRGN 113
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
C+ LL GAD D G + + AVA Y VI +
Sbjct: 114 HVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHI 158
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 97.1 bits (243), Expect = 4e-23
Identities = 37/220 (16%), Positives = 69/220 (31%), Gaps = 54/220 (24%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
++H +G + ++ L V+ D+ G PL++A A G E V L++ GA+
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
+E + + G D + LL D N D G + L AV + C
Sbjct: 62 PHILAKERESA--LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVE 119
Query: 631 VILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVG 687
+L G A L ++ TP+ L
Sbjct: 120 ALLARG-----ADLTTEADSGYTPMDL--------------------------------- 141
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRT 727
A+ + ++ +++ + +
Sbjct: 142 -------AVALGYR----KVQQVIENHILKLFQSNLVPAD 170
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 84.4 bits (210), Expect = 1e-18
Identities = 28/131 (21%), Positives = 53/131 (40%), Gaps = 13/131 (9%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
VR LL A + + ++AL LA G ++V +LE ++++ D
Sbjct: 52 VRFLLEWGADPH----------ILAKERESALSLASTGGYTDIVGLLLERD-VDINIYDW 100
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
+G PL++A+ +CV AL+ RGA++ + G+ P + G + +
Sbjct: 101 NGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTP--MDLAVALGYRKVQQVIENHI 158
Query: 604 ADPNAVDDEGE 614
+
Sbjct: 159 LKLFQSNLVPA 169
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 8e-16
Identities = 25/114 (21%), Positives = 46/114 (40%), Gaps = 17/114 (14%)
Query: 725 NRTALHIASMANDVELVKIILDAGVD-VNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783
+ ++H + +++ +K L G + VN + PL A A G V LL GAD
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 784 CNWQDDEGDNAFHIAA-----DAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ E ++A +A+ D + L+ D + + + +G T
Sbjct: 62 PHILAKERESALSLASTGGYTDIVGL-------LL---ER-DVDINIYDWNGGT 104
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 34/246 (13%), Positives = 69/246 (28%), Gaps = 57/246 (23%)
Query: 561 VHALIKRGANVISRLREGFGPSVA-HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHR 619
+ +++++ + R P V A G+ + +++ + DP+ ++EG + LH
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHN 60
Query: 620 AVAKKYTDCAIVILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEI 676
A+ ++ G A +NS + TPLH
Sbjct: 61 AICGANYSIVDFLITAG-----ANVNSPDSHGWTPLH----------------------- 92
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMA 735
A + + L+ GA A + TA
Sbjct: 93 -----------------CAASCNDT----VICMALVQHGAAIFATTLSDGATAFEKCDPY 131
Query: 736 ND--VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDN 793
+ + + D + + N L A + +D +
Sbjct: 132 REGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDE-LSFREGESVTVLRRDGPEET 190
Query: 794 AFHIAA 799
+ AA
Sbjct: 191 DWWWAA 196
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 40/286 (13%), Positives = 82/286 (28%), Gaps = 67/286 (23%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
+R +L K S + + L A G E+V+ ++ + ++
Sbjct: 1 MRSVLRKAGSPRKARRA-------RLNPLVLLLDAALTGELEVVQQAVKEM-NDPSQPNE 52
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
+G L H + L+ AG
Sbjct: 53 EGITAL-----------------------------------HNAICGANYSIVDFLITAG 77
Query: 604 ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKEL----TPLHLCVATW 659
A+ N+ D G + LH A + T + ++++G A + + L T C
Sbjct: 78 ANVNSPDSHGWTPLHCAASCNDTVICMALVQHG-----AAIFATTLSDGATAFEKCDPYR 132
Query: 660 NVA--VVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
+A E+ + +++ AL +A E + +
Sbjct: 133 EGYADCAT---YLADVEQSMGLMNSGA--VYALWDYSA-------EFGDELSFREGESVT 180
Query: 718 PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLH 763
+D T A++ V G+ ++ + + H
Sbjct: 181 VLRRDGPEETDWWWAALHGQEGYVPRNY-FGLFPRVKPQRSKVKHH 225
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 33/246 (13%), Positives = 58/246 (23%), Gaps = 65/246 (26%)
Query: 596 MRELLLAGADPNAVDDE---GESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE---L 649
MR +L P +L A + ++ + +
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEM-----NDPSQPNEEGI 55
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVR 709
T LH A+ + +V
Sbjct: 56 TALHN----------------------------------------AICGANY----SIVD 71
Query: 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHN-TIPLHVALA- 767
L+TAGA + D+ T LH A+ ND + ++ G + + +
Sbjct: 72 FLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPY 131
Query: 768 -RGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVR 826
G C L + A + E + L V R
Sbjct: 132 REGYADCATYLADVEQSMGLMNSGAVYALWDYS------AEFGDELSFREGE-SVTVLRR 184
Query: 827 NHSGKT 832
+ +T
Sbjct: 185 DGPEET 190
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 36/199 (18%), Positives = 66/199 (33%), Gaps = 21/199 (10%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L G++ V+ + + + N +G TALH A + +V+ ++
Sbjct: 25 LLDAALTGELEVVQQAVKEMNDPS----------QPNEEGITALHNAICGANYSIVDFLI 74
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH- 590
NV+ D G PL A + AL++ GA + + G + C +
Sbjct: 75 TAG-ANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLS-DGATAFEKCDPYR 132
Query: 591 -GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKEL 649
G DC L ++ L + ++ D + G ++ + E
Sbjct: 133 EGYADCATYLADVEQSMGLMNSGAVYALWDY-SAEFGD--ELSFREGESVTVLRRDGPEE 189
Query: 650 TPLHLCVATWN--VAVVKR 666
T A + V R
Sbjct: 190 TDWWW--AALHGQEGYVPR 206
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 50/279 (17%), Positives = 93/279 (33%), Gaps = 87/279 (31%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
+ + L A +R + ++ E + + + VD +D +G+ PL A+ E ALI
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTT-YQVDEVDTEGNTPLNIAVHNNDIEIAKALID 60
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626
RGA++ N + +S A A+ T
Sbjct: 61 RGADI-----------------------------------NLQNSISDSPYLYAGAQGRT 85
Query: 627 DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPV 686
+ +L++ +N + G
Sbjct: 86 EILAYMLKHATP-------------------------------------DLNKHNRYG-- 106
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAG-AEPTAQDAQNRTALHIASMAND-----VEL 740
G AL AA +K H + V++LL G + Q+ TAL A + ++
Sbjct: 107 GNALIPAA--EKGHI----DNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDI 160
Query: 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
VK++++ G D +I++ + A +G +L
Sbjct: 161 VKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQ 199
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 8e-25
Identities = 37/225 (16%), Positives = 68/225 (30%), Gaps = 59/225 (26%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
L + VD EG + L+ AV + A +++ G A +
Sbjct: 11 EAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRG-----ADI 65
Query: 645 NSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
N + +P A +
Sbjct: 66 NLQNSISDSPYLY----------------------------------------AGAQGRT 85
Query: 702 VEGRELVRILLTAGA-EPTAQDAQNRTALHIASMANDVELVKIILDAG-VDVNIRNVHNT 759
E++ +L + + AL A+ ++ VK++L+ G D++ +N
Sbjct: 86 ----EILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGY 141
Query: 760 IPLHVA-----LARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
L A + + V LL+ GAD + +D+ G A A
Sbjct: 142 TALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGRTAMDYAN 186
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 16/148 (10%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
L A ++D + ++ IL + D + T L+IA ND+E+ K ++D
Sbjct: 8 ALLEAAN--QRDTK----KVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA-DCNWQDDEGDNAFHIAADAAKMIR 806
G D+N++N + P A A+G + +L D N + G NA AA+ +
Sbjct: 62 GADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAE-----K 116
Query: 807 ENLEWLIV--MLSHPDAAVEVRNHSGKT 832
+++ V +L ++ +N G T
Sbjct: 117 GHID--NVKLLLEDGREDIDFQNDFGYT 142
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 3e-23
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 15/160 (9%)
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAN 736
V+ +D G T L A D E+ + L+ GA+ Q++ + + A
Sbjct: 32 VDEVDTEG--NTPL-NIAVHNNDIEI-----AKALIDRGADINLQNSISDSPYLYAGAQG 83
Query: 737 DVELVKIILDAG-VDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG-ADCNWQDDEGDNA 794
E++ +L D+N N + L A +G V LLL G D ++Q+D G A
Sbjct: 84 RTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTA 143
Query: 795 FHIAADAAKMIRENLEWLIV--MLSHPDAAVEVRNHSGKT 832
A + + + IV ++ + A ++++SG+T
Sbjct: 144 LIEAVGLREGNQLYQD--IVKLLMEN-GADQSIKDNSGRT 180
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 2e-19
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 5/112 (4%)
Query: 721 QDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSA 780
+ + L A+ + ++ +I+ D V+ + PL++A+ L+
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 781 GADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
GAD N Q+ D+ + A + E L ML H + N G
Sbjct: 62 GADINLQNSISDSPYLYAG-----AQGRTEILAYMLKHATPDLNKHNRYGGN 108
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 6e-19
Identities = 32/162 (19%), Positives = 69/162 (42%), Gaps = 14/162 (8%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L+ V D+ + L+ + A N QN+ + A +G E++ +L
Sbjct: 43 LNIAVHNNDIEIAKALIDRGADIN----------LQNSISDSPYLYAGAQGRTEILAYML 92
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRG-ANVISRLREGFGP---SVAHVC 587
+++ +++ ++ G L+ A G + V L++ G ++ + G+ +V
Sbjct: 93 KHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLRE 152
Query: 588 AYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
D ++ L+ GAD + D+ G + + A K YT+ +
Sbjct: 153 GNQLYQDIVKLLMENGADQSIKDNSGRTAMDYANQKGYTEIS 194
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 81.3 bits (202), Expect = 2e-17
Identities = 39/206 (18%), Positives = 73/206 (35%), Gaps = 32/206 (15%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L L + + +G T L++A E+ +A++
Sbjct: 10 LEAANQRDTKKVKEILQDTTYQVD----------EVDTEGNTPLNIAVHNNDIEIAKALI 59
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA-NVISRLREGFGPSVAHVCAYH 590
+ ++++ + D P ++A A G E + ++K ++ R G A
Sbjct: 60 DRG-ADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNA--LIPAAEK 116
Query: 591 GQPDCMRELLLAG-ADPNAVDDEGESVLHRAVA-----KKYTDCAIVILENGGCRSMAIL 644
G D ++ LL G D + +D G + L AV + Y D +++ENG A
Sbjct: 117 GHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENG-----ADQ 171
Query: 645 NSK---ELTPLHLCVATWN--VAVVK 665
+ K T + A + K
Sbjct: 172 SIKDNSGRTAMDY--ANQKGYTEISK 195
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 50.1 bits (121), Expect = 9e-07
Identities = 16/85 (18%), Positives = 27/85 (31%), Gaps = 16/85 (18%)
Query: 753 IRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA-----DAAKMIRE 807
++ L A R K +L + D EG+ +IA + AK
Sbjct: 1 MKTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKA--- 57
Query: 808 NLEWLIVMLSHPDAAVEVRNHSGKT 832
LI A + ++N +
Sbjct: 58 ----LI---DR-GADINLQNSISDS 74
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 44.0 bits (105), Expect = 1e-04
Identities = 15/66 (22%), Positives = 26/66 (39%), Gaps = 6/66 (9%)
Query: 506 AQNADGQTALHLAC-----RRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPEC 560
QN G TAL A + ++V+ ++E + + D G + +A G E
Sbjct: 135 FQNDFGYTALIEAVGLREGNQLYQDIVKLLMENG-ADQSIKDNSGRTAMDYANQKGYTEI 193
Query: 561 VHALIK 566
L +
Sbjct: 194 SKILAQ 199
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 75/320 (23%), Positives = 125/320 (39%), Gaps = 69/320 (21%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
D+ + +K+G G V W G VAVK +M E D+ + +++
Sbjct: 37 CDLNIKEKIGAGSFG--TVHRAEWHG-------SDVAVKILM-----EQDFHAERVNEFL 82
Query: 195 R-ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGR--LTLEQILRY 246
R ++ R N+ F G + L +V + GS+ + ++ R L + L
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 247 GADIARGVVELHAAGVVCM--NIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
D+A+G+ LH + N+K NLL+D V D+GL
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL----------------- 185
Query: 305 SSRIHSCMDCTMLS----PNYTAPEAW--EPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
SR+ + + S P + APE EP + +SD +SFG L
Sbjct: 186 -SRLKASTFLSSKSAAGTPEWMAPEVLRDEPS--------------NEKSDVYSFGVILW 230
Query: 359 EMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
E+ T PW L+ ++ AV K + + ++ +I C + KRP+
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLE-----IPRNLNPQVAAIIEGCWTNEPWKRPS 285
Query: 419 FSAMLATFLRHLQELPRSPP 438
F+ ++ LR L + PP
Sbjct: 286 FATIMDL-LRPLIKSAVPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/302 (16%), Positives = 103/302 (34%), Gaps = 57/302 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++++ K++G+G V G + VA+K +++ + + +
Sbjct: 18 DNEIEYEKQIGKGGFG--LVHKGRLVKDKS-----VVAIKSLILGDSEGETEMIEKFQEF 70
Query: 194 RR-ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYG 247
+R + N+ +G++ + VM+ G + + + LR
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 248 ADIARGVVELHAAGVVCM--NIKPSNLLLDASGRAV-----VSDYGLAAILKKPACRKAR 300
DIA G+ + + +++ N+ L + V+D+GL+ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
S + + + + APE + + ++D +SF L +
Sbjct: 178 QSVHS------VSGLLGNFQWMAPE----------TIGAEEESYTEKADTYSFAMILYTI 221
Query: 361 CTGSIPWAGLSAEEI--YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
TG P+ S +I + + P + P L +I C KRP
Sbjct: 222 LTGEGPFDEYSYGKIKFINMIREEGLRPT-----IPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 419 FS 420
FS
Sbjct: 277 FS 278
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 40/209 (19%), Positives = 64/209 (30%), Gaps = 52/209 (24%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
H A G+ + + N D+EG + L A A +L+NG A
Sbjct: 8 HQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNG-----ADP 62
Query: 645 NSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
+ L L A K +
Sbjct: 63 QLLGKGRESALSL---------------------------------------ACSKGYTD 83
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIP 761
+ V++LL G + D T L A N V+ VK++L++G D I
Sbjct: 84 I-----VKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNS 138
Query: 762 LHVALARGAKSCVGLLLSAGADCNWQDDE 790
+ +A+A G +S ++ S E
Sbjct: 139 MDLAVALGYRSVQQVIESHLLKLLQNIKE 167
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 13/165 (7%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+HQL ++G++ + + + N + +G T L A G +VE +L
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVIN----------HTDEEGFTPLMWAAAHGQIAVVEFLL 56
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ + +L K + L A + G + V L+ G +V G P +
Sbjct: 57 QNG-ADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTP--LLYAVHGN 113
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
C++ LL +GADP D G + + AVA Y VI +
Sbjct: 114 HVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHL 158
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 105 bits (266), Expect = 2e-26
Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 13/151 (8%)
Query: 650 TPLHLCVATWNVAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
+H A + + +E +N D G T L AA +V
Sbjct: 5 LSVHQLAAQGEMLYLATRIEQENV----INHTDEEG--FTPLMWAA--AHGQI----AVV 52
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
LL GA+P +AL +A ++VK++LD GVDVN + + PL A+
Sbjct: 53 EFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHG 112
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
CV +LL +GAD + D G N+ +A
Sbjct: 113 NHVKCVKMLLESGADPTIETDSGYNSMDLAV 143
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 97.5 bits (244), Expect = 2e-23
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 15/161 (9%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
++H +G + +E ++ D++G PL++A A G V L++ GA
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQE-NVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGA 60
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
+ + + G D ++ LL G D N D G + L AV + C
Sbjct: 61 DPQLLGKGRESAL--SLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCV 118
Query: 630 IVILENGGCRSMAILNSKE---LTPLHLCVATWN--VAVVK 665
++LE+G A + + L A +V +
Sbjct: 119 KMLLESG-----ADPTIETDSGYNSMDL--AVALGYRSVQQ 152
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 82.4 bits (205), Expect = 4e-18
Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 16/113 (14%)
Query: 725 NRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784
N ++H + ++ + ++ +N + PL A A G + V LL GAD
Sbjct: 3 NSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADP 62
Query: 785 NWQDDEGDNAFHIAA-----DAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
++A +A D KM L+ V + +G T
Sbjct: 63 QLLGKGRESALSLACSKGYTDIVKM-------LL---DC-GVDVNEYDWNGGT 104
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 9e-17
Identities = 28/141 (19%), Positives = 53/141 (37%), Gaps = 13/141 (9%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + G ++ V LL A ++AL LAC +G ++V+ +L
Sbjct: 40 LMWAAAHGQIAVVEFLLQNGADPQ----------LLGKGRESALSLACSKGYTDIVKMLL 89
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ +V+ D +G PL++A+ +CV L++ GA+ G+ + G
Sbjct: 90 DCG-VDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNS--MDLAVALG 146
Query: 592 QPDCMRELLLAGADPNAVDDE 612
+ + E
Sbjct: 147 YRSVQQVIESHLLKLLQNIKE 167
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 47.4 bits (114), Expect = 4e-06
Identities = 12/81 (14%), Positives = 26/81 (32%), Gaps = 16/81 (19%)
Query: 757 HNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA-----DAAKMIRENLEW 811
N++ +H A+G + + N D+EG AA +
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEF------- 54
Query: 812 LIVMLSHPDAAVEVRNHSGKT 832
L+ + A ++ ++
Sbjct: 55 LL---QN-GADPQLLGKGRES 71
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 51/353 (14%), Positives = 104/353 (29%), Gaps = 43/353 (12%)
Query: 460 SDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKA----------QNA 509
D+ N + +G + + + ++ SS ++KA Q
Sbjct: 2 DDINKGPSGDNENNGTDDNDRTAGPIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKM 61
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+ L E+ ++ S + + E A
Sbjct: 62 KLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQL 121
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK---KYT 626
N+ + E G + H + ++ L+ G++ D+ GES L +AV +
Sbjct: 122 NLNIPVDE-HGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDS 180
Query: 627 DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPV 686
+L+ + + +S T LH + T +
Sbjct: 181 GTFEALLDYLYP-CLILEDSMNRTILHHIIITSGMTGC---------------------- 217
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
+AA K ++ +V+ T + + + +E + +
Sbjct: 218 ------SAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWI 271
Query: 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
+N ++ + L++A G S V LL GAD + G A
Sbjct: 272 IANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 324
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 43/362 (11%), Positives = 91/362 (25%), Gaps = 94/362 (25%)
Query: 424 ATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSEGDVSG 483
+ FL ++ ++ P+ + N +
Sbjct: 36 SDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGS 95
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNAD--------GQTALHLACRRGSAELVEAILEYSQ 535
+ + ++ + G T LH + ELV+ ++++
Sbjct: 96 SNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHG- 154
Query: 536 ENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDC 595
N D G+ LV A+ + +
Sbjct: 155 SNRLYGDNMGESCLVKAVKSV-----NNYDSG---------------------------T 182
Query: 596 MRELL-LAGADPNAVDDEGESVLHRAV-----------AKKYTDCAIVILENGGCRSMAI 643
LL D ++LH + AK Y D + + R +
Sbjct: 183 FEALLDYLYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQS 242
Query: 644 LNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
+++ + + ++++ ++N
Sbjct: 243 GTNEKESKPNDKNGERKDSILENLDLKWIIANMLN------------------------- 277
Query: 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLH 763
AQD+ T L+IA+ ++ +V +LD G D I N P+
Sbjct: 278 ----------------AQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVD 321
Query: 764 VA 765
Sbjct: 322 FG 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 62/356 (17%), Positives = 114/356 (32%), Gaps = 74/356 (20%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+ ++++ + +G G V W VA+K++ E + +
Sbjct: 7 YKEIEVEEVVGRGAFG--VVCKAKWRA-------KDVAIKQIESESERK--------AFI 49
Query: 194 RRASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQ--LAMQRNEGRLTLEQILRY 246
R N+ +G CL VM+ GS+ L T + +
Sbjct: 50 VELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 247 GADIARGVVELHAAGVVCM---NIKPSNLLLDASGRAV-VSDYGLAAILKKPACRKARPE 302
++GV LH+ + ++KP NLLL A G + + D+G A
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------------ 155
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAW--EPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
I + M S + APE + + D +S+G L E+
Sbjct: 156 -----IQTHMTNNKGSAAWMAPEVFEGSNYSEK--------------CDVFSWGIILWEV 196
Query: 361 CTGSIPWAGLS--AEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRP 417
T P+ + A I AV + P + +P+ + ++ C S+RP
Sbjct: 197 ITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK-------NLPKPIESLMTRCWSKDPSQRP 249
Query: 418 TFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLH 473
+ ++ ++ P + + P D F + H
Sbjct: 250 SMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 47/227 (20%), Positives = 70/227 (30%), Gaps = 60/227 (26%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+ + CR G+A V L+ ++ +++ D G PL +A G V LI RGA
Sbjct: 4 EFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGA 63
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
+ R P H+ A HG D +++LL AD NAV++ G LH A A
Sbjct: 64 RINVMNRGDDTP--LHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVA 121
Query: 630 IVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPV 686
++ NG A+++ P+
Sbjct: 122 EDLVANG-----ALVSICNKYGEMPVDK-------------------------------- 144
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIAS 733
A E L G NR
Sbjct: 145 --------AKAPLRE----LLRERAEKMGQNL------NRIPYKDTF 173
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 10/151 (6%)
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
+ + N V+ W++ + E +N D G + L A ++ +V
Sbjct: 6 MDDIFTQCREGNAVAVRLWLD--NTENDLNQGDDHG--FSPLHWAC--REGRS----AVV 55
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
+L+ GA + + T LH+A+ ++V+ +L D+N N H +PLH A
Sbjct: 56 EMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFW 115
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
G L++ GA + + G+ A
Sbjct: 116 GQDQVAEDLVANGALVSICNKYGEMPVDKAK 146
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 105 bits (266), Expect = 3e-26
Identities = 41/189 (21%), Positives = 70/189 (37%), Gaps = 22/189 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+ EG+ VR L + L + G + LH ACR G + +VE ++
Sbjct: 9 IFTQCREGNAVAVRLWLDNTEND---------LNQGDDHGFSPLHWACREGRSAVVEMLI 59
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
++V+++ D PL A + G + V L++ A++ + G P H + G
Sbjct: 60 MRGA-RINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVP--LHYACFWG 116
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTP 651
Q +L+ GA + + GE + +A A + G LN P
Sbjct: 117 QDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMG-----QNLNR---IP 168
Query: 652 LHLCVATWN 660
W
Sbjct: 169 YK--DTFWK 175
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-26
Identities = 39/205 (19%), Positives = 63/205 (30%), Gaps = 53/205 (25%)
Query: 585 HVCAYHGQPDCMRELLLAGA-DPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAI 643
G +R L D N DD G S LH A + + +++ G A
Sbjct: 10 FTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRG-----AR 64
Query: 644 LNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700
+N + TPLHL AA
Sbjct: 65 INVMNRGDDTPLHL---------------------------------------AASHGHR 85
Query: 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTI 760
++ V+ LL A+ A + LH A ++ + ++ G V+I N + +
Sbjct: 86 DI-----VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEM 140
Query: 761 PLHVALARGAKSCVGLLLSAGADCN 785
P+ A A + G + N
Sbjct: 141 PVDKAKAPLRELLRERAEKMGQNLN 165
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 60/310 (19%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+ + KL E E+W G W G + + VK + DW + + +
Sbjct: 9 FKQLNFLTKLNENHSG--ELWKGRWQG-------NDIVVKVLK-----VRDWSTRKSRDF 54
Query: 194 RR-ASMWCR----NVCTFHGVLR--MDSCLGLVMDRC-YGSVQLAMQRNEGR-LTLEQIL 244
NV G + L+ YGS+ + + Q +
Sbjct: 55 NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV 114
Query: 245 RYGADIARGVVELHAAG--VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
++ D+ARG+ LH + + ++++D A +S + + P
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------- 167
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
M +P + APEA + KK + +D WSF L E+ T
Sbjct: 168 ------------RMYAPAWVAPEALQ--KKPEDTN-------RRSADMWSFAVLLWELVT 206
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
+P+A LS EI V P + GI + K++ C+ +KRP F M
Sbjct: 207 REVPFADLSNMEIGMKVALEGLRPT-----IPPGISPHVSKLMKICMNEDPAKRPKFD-M 260
Query: 423 LATFLRHLQE 432
+ L +Q+
Sbjct: 261 IVPILEKMQD 270
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 43/300 (14%), Positives = 87/300 (29%), Gaps = 59/300 (19%)
Query: 499 SISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQEN----VDVLDKDGDP---PLVF 551
S+S+ K + ++ A + + + +E++L + Q + D KD + L+
Sbjct: 1 SVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLK 60
Query: 552 ALAA---GSPECVHALIKRGA---------NVISRLREGFGPSVAHVCAYHGQPDCMREL 599
A+ G + + L+ N G + H+ + L
Sbjct: 61 AMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLL 120
Query: 600 LLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATW 659
+ GAD A + + Y PL L T
Sbjct: 121 VENGADVQAAANGDFFKKTKGRPGFYFGE---------------------LPLSLAACTN 159
Query: 660 NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGR----------ELVR 709
+A+VK ++ + ++ D G T L + + + L
Sbjct: 160 QLAIVKFLLQNSWQPADISARDSVG--NTVLHALVEVADNTVDNTKFVTSMYNEILILGA 217
Query: 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARG 769
L + + T L +A+ + + ++ IL + H A
Sbjct: 218 KLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHE------PE-CRHAAAHHH 270
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 42/230 (18%), Positives = 73/230 (31%), Gaps = 46/230 (20%)
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVA--SPEEIVNVIDIPGPVG-TALCMAA-ALKKDH 700
+ + VA N ++ + S + + + G T L A L
Sbjct: 10 RLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQ 69
Query: 701 EVEGRELVRILLTAGA-----------EPTAQDAQNRTALHIASMANDVELVKIILDAGV 749
+ + +LL T + +TALHIA ++ LV ++++ G
Sbjct: 70 N----DTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGA 125
Query: 750 DVNIRN--------------VHNTIPLHVALARGAKSCVGLLLSAG---ADCNWQDDEGD 792
DV +PL +A + V LL AD + +D G+
Sbjct: 126 DVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGN 185
Query: 793 NAFHIAADAAKMIRENLEWLIVM----------LSHPDAAVEVRNHSGKT 832
H + A +N +++ M L E+ N G T
Sbjct: 186 TVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLT 235
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 29/189 (15%), Positives = 57/189 (30%), Gaps = 34/189 (17%)
Query: 472 LHQLVSEGDVSGVRDLLSK----NASGNYSSSISSLLKAQNADGQTALHLACRRGSAELV 527
LH + +++ V L+ A+ N + + G+ L LA +V
Sbjct: 105 LHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIV 164
Query: 528 EAILEYSQE--NVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAH 585
+ +L+ S + ++ D G+ L HAL++ N + +
Sbjct: 165 KFLLQNSWQPADISARDSVGNTVL------------HALVEVADNTVDNTK-------FV 205
Query: 586 VCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILN 645
Y+ +L + +G + L A + IL+
Sbjct: 206 TSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQRE--------- 256
Query: 646 SKELTPLHL 654
E H
Sbjct: 257 IHEPECRHA 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 67/356 (18%), Positives = 119/356 (33%), Gaps = 54/356 (15%)
Query: 81 NTNQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSSGVGVCGPVIEVGVHHDVKL 140
+ + HH+S + ++ F + G E +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQR 61
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLS--GQLDNLRR 195
+ +LG G + EV+ + R + AVK+ M D ++ + +
Sbjct: 62 LSRLGHG--SYGEVF-------KVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
L L + C S+Q + L Q+ Y D +
Sbjct: 113 VGQ-HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
LH+ G+V +++KP+N+ L GR + D+GL L + + E D
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-EGD----------- 219
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-AGLSAEE 374
P Y APE + +D +S G T++E+ G ++
Sbjct: 220 ---PRYMAPELLQG-------------SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRH 429
+ LPP++ + G+ EL ++ L+ R T A+LA LR
Sbjct: 264 LR-----QGYLPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-26
Identities = 38/258 (14%), Positives = 74/258 (28%), Gaps = 43/258 (16%)
Query: 218 LVMDRCYGSVQ------LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
+ R ++Q L+ L L+ + R + LH G+V ++P +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331
++LD G ++ + A P TA +
Sbjct: 242 IVLDQRGGVFLTGFEHLVRDGASA----VSPIGR---------GFAPPETTAERMLPFGQ 288
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
++ D W+ G + + +P +A + ++ K
Sbjct: 289 -------HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK------- 334
Query: 392 IVGVGIPRELWKMIGECLQFKASKRPT-FSAMLATFLRHLQE-----LPRSPPASPDTGF 445
IP+ + ++ L++ R AM L+ LP T
Sbjct: 335 ----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTRE 390
Query: 446 TKFSTSNETEPSPASDVE 463
S ++P A E
Sbjct: 391 GGAPPSGTSQPDEAGAAE 408
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 46/201 (22%), Positives = 69/201 (34%), Gaps = 33/201 (16%)
Query: 607 NAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKR 666
+ +D GE V K + +S TPL + A +
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFLRNYR--------DSYNRTPLMV-------ACMLG 46
Query: 667 WVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT 719
+ + DI G TAL A K + + LL+ G+
Sbjct: 47 MENAI---DKLVENFDKLEDKDIEG--STALIWAV--KNNRL----GIAEKLLSKGSNVN 95
Query: 720 AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
+D +T L + + E+ +L+ G +VN RN+ PL VA G V LL
Sbjct: 96 TKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLE 155
Query: 780 AGADCNWQDDEGDNAFHIAAD 800
GAD + +D G A A
Sbjct: 156 LGADISARDLTGLTAEASARI 176
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 40/279 (14%), Positives = 77/279 (27%), Gaps = 94/279 (33%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
+ +G+ + + + ++ + Y D PL+ A G + L++
Sbjct: 4 MDKNGEIVEKIKDEKSINQNLDFLRNYR-------DSYNRTPLMVACMLGMENAIDKLVE 56
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT 626
+ D EG + L AV
Sbjct: 57 NFDKL-----------------------------------EDKDIEGSTALIWAVKNNRL 81
Query: 627 DCAIVILENGGCRSMAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIP 683
A +L G + +N+K TPL
Sbjct: 82 GIAEKLLSKG-----SNVNTKDFSGKTPLMW----------------------------- 107
Query: 684 GPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKI 743
++ + E+ LL GA ++ + T L +AS E+VK
Sbjct: 108 -----------SIIFGYS----EMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKK 152
Query: 744 ILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782
+L+ G D++ R++ A G + + +
Sbjct: 153 LLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 3e-21
Identities = 35/172 (20%), Positives = 70/172 (40%), Gaps = 13/172 (7%)
Query: 492 ASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVF 551
+ + ++ L +++ +T L +AC G ++ ++E ++ D +G L++
Sbjct: 16 DEKSINQNLDFLRNYRDSYNRTPLMVACMLGMENAIDKLVENFD-KLEDKDIEGSTALIW 74
Query: 552 ALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD 611
A+ L+ +G+NV ++ G P G + LL GA+ N +
Sbjct: 75 AVKNNRLGIAEKLLSKGSNVNTKDFSGKTP--LMWSIIFGYSEMSYFLLEHGANVNDRNL 132
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWN 660
EGE+ L A ++ +LE G A ++++ LT A
Sbjct: 133 EGETPLIVASKYGRSEIVKKLLELG-----ADISARDLTGLTAEAS--ARIF 177
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 22/155 (14%), Positives = 43/155 (27%), Gaps = 16/155 (10%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN---RTALHIASMANDVELVKII 744
+ AAA+ +E L G E ++ L + ++ +
Sbjct: 8 RTV-SAAAMLGTYED-----FLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFL 61
Query: 745 LDAGVDVNIRNVHNTIPLHVALARGAKSCVG------LLLSAGADCNWQDDEGDNAFHIA 798
++ G D+ R T G G + L GAD
Sbjct: 62 INKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKN 121
Query: 799 ADAAKMIRENLEWLI-VMLSHPDAAVEVRNHSGKT 832
+ + L ++ S + +++ G T
Sbjct: 122 IFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLT 156
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 32/257 (12%), Positives = 59/257 (22%), Gaps = 83/257 (32%)
Query: 508 NA-DGQTALHLACRRGSAELVEAILEYSQENVDV-LDKDGDPPLVFALAAGSPECVHALI 565
NA + A G+ E + E + + L L + E + +
Sbjct: 2 NAMSEYRTVSAAAMLGTYEDFLELFE---KGYEDKESVLKSNILYDVLRNNNDEARYKIS 58
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
L+ GAD + EG ++
Sbjct: 59 MF-------------------------------LINKGADIKSRTKEGTTLFFPLFQGGG 87
Query: 626 TDCAIVI------LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNV 679
D LE G A +
Sbjct: 88 NDITGTTELCKIFLEKG----------------------------------AD----ITA 109
Query: 680 IDIPGPVGTALCMAAALKKDHEVEGRELVRILLT-AGAEPTAQDAQNRTALHIASMANDV 738
+ P + E E L +++ + +G + +D TAL
Sbjct: 110 LYKPY--KIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKP 167
Query: 739 ELVKIILDAGVDVNIRN 755
+K++ D N++
Sbjct: 168 IALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 22/179 (12%), Positives = 46/179 (25%), Gaps = 26/179 (14%)
Query: 648 ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
E + E + + + L+ +++ ++
Sbjct: 6 EYRTVSAAAMLGTYEDFLELFEKG-----YEDKESVL--KSNILYDV-LRNNNDEARYKI 57
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMAN------DVELVKIILDAGVDVNIRNVHNTIP 761
L+ GA+ ++ + T EL KI L+ G D+ I
Sbjct: 58 SMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIV 117
Query: 762 LHVALARGAKSCVG-------LLLSAGADCNWQDDEGDNAFHIAA-----DAAKMIREN 808
+ + + +G +D G A A KM+ +
Sbjct: 118 VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDY 176
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 25/219 (11%), Positives = 54/219 (24%), Gaps = 58/219 (26%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI----LENGGCRS 640
A G + EL G + + ++L+ + + I + G
Sbjct: 11 SAAAMLGTYEDFLELFEKGYE-DKESVLKSNILYDVLRNNNDEARYKISMFLINKG---- 65
Query: 641 MAILNSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALK 697
A + S+ T
Sbjct: 66 -ADIKSRTKEGTTLFFP--------------------------------------LFQGG 86
Query: 698 KDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVK-------IILDAGVD 750
+ EL +I L GA+ TA + + V+ + I +G+
Sbjct: 87 GNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQ 146
Query: 751 VNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD 789
+ I++ L + ++ N +++
Sbjct: 147 LLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLKEN 185
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 17/178 (9%), Positives = 46/178 (25%), Gaps = 23/178 (12%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+ G +L K S ++ L ++ ++
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDKES-------VLKSNILYDVLRNNNDEARYKISMFLI 62
Query: 532 EYSQENVDVLDKDGDPPLVFALAAG------SPECVHALIKRGANVISRLREGFGPSVAH 585
++ K+G G + E +++GA++ + +
Sbjct: 63 NKG-ADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIV--VF 119
Query: 586 VCAYHGQPDCMR-----ELLLA--GADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
++ D +L+ + G D G + L + ++ +
Sbjct: 120 KNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 19/168 (11%), Positives = 50/168 (29%), Gaps = 30/168 (17%)
Query: 461 DVEVFQDNPNNLHQLVSEGDVSG----VRDLLSKNASGNYSSSISSLLKAQNADGQTALH 516
+ + N L+ ++ + L++K A +K++ +G T
Sbjct: 31 EDKESVLKSNILYDVLRNNNDEARYKISMFLINKGAD----------IKSRTKEGTTLFF 80
Query: 517 LACRRG------SAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA------- 563
+ G + EL + LE ++ L K + + +
Sbjct: 81 PLFQGGGNDITGTTELCKIFLEKGA-DITALYKPYKIVVFKNIFNYFVDENEMIPLYKLI 139
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD 611
+ G ++ + + G +P ++ + N ++
Sbjct: 140 FSQSGLQLLIKDKWGLTA--LEFVKRCQKPIALKMMEDYIKKYNLKEN 185
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 34/121 (28%), Positives = 52/121 (42%), Gaps = 10/121 (8%)
Query: 684 GPVG----TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVE 739
GP+G A K + V+ + G + R LH A+ +E
Sbjct: 1 GPLGSMCDKEFMWAL--KNGDL----DEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLE 54
Query: 740 LVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
+++ +L G D+N + H+ PL A+ G SCV LLLS GAD + +G AF
Sbjct: 55 ILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATD 114
Query: 800 D 800
+
Sbjct: 115 N 115
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 85.1 bits (212), Expect = 1e-19
Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 3/122 (2%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
+ A + G + V+ + E+V+ + G PL +A G E + L+
Sbjct: 2 PLGSMCDKEFMWALKNGDLDEVKDYVAKG-EDVNRTLEGGRKPLHYAADCGQLEILEFLL 60
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
+GA++ + + P Y G C++ LL GAD +G + +
Sbjct: 61 LKGADINAPDKHHITP--LLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAI 118
Query: 626 TD 627
Sbjct: 119 KA 120
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 7e-14
Identities = 28/128 (21%), Positives = 41/128 (32%), Gaps = 17/128 (13%)
Query: 650 TPLHLCVATWN--VAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706
A N + VK +V VN G L AA E
Sbjct: 9 KEFMW--ALKNGDLDEVKDYVAKGED----VNRTLEGG--RKPLHYAA--DCGQL----E 54
Query: 707 LVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVAL 766
++ LL GA+ A D + T L A V VK++L G D ++
Sbjct: 55 ILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATD 114
Query: 767 ARGAKSCV 774
+ K+ +
Sbjct: 115 NQAIKALL 122
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 64.3 bits (158), Expect = 3e-12
Identities = 27/161 (16%), Positives = 49/161 (30%), Gaps = 52/161 (32%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
+G D +++ + G D N + G LH A + +L G A +
Sbjct: 12 MWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKG-----ADI 66
Query: 645 NSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
N+ + +TPL +A+ + H
Sbjct: 67 NAPDKHHITPLL----------------------------------------SAVYEGHV 86
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVK 742
V++LL+ GA+ T + TA L++
Sbjct: 87 ----SCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 40.1 bits (95), Expect = 8e-04
Identities = 17/57 (29%), Positives = 22/57 (38%), Gaps = 10/57 (17%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVE 528
L V EG VS V+ LLSK A + DG TA + L++
Sbjct: 77 LLSAVYEGHVSCVKLLLSKGADKT----------VKGPDGLTAFEATDNQAIKALLQ 123
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 30/124 (24%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAN 736
++++ L AA + E VR LL AGA+P A + R + + M
Sbjct: 5 IHMLGGSS--DAGLATAA--ARGQV----ETVRQLLEAGADPNALNRFGRRPIQVMMM-G 55
Query: 737 DVELVKIILDAGVDVNIR-NVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAF 795
++ +++L G + N T P+H A G + +L AGA + D G
Sbjct: 56 SAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPV 115
Query: 796 HIAA 799
+A
Sbjct: 116 DLAE 119
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 97.1 bits (243), Expect = 1e-23
Identities = 27/183 (14%), Positives = 58/183 (31%), Gaps = 48/183 (26%)
Query: 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNV 661
+ + ++ L A A+ + +LE G
Sbjct: 1 GSPGIHMLGGSSDAGLATAAARGQVETVRQLLEAG------------------------- 35
Query: 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQ 721
A N ++ G + + ++ +LL GAEP
Sbjct: 36 ---------AD----PNALNRFG--RRPIQVMM---MGSA----QVAELLLLHGAEPNCA 73
Query: 722 DAQNRT-ALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSA 780
D T +H A+ ++ + ++ AG +++ + +P+ +A +G + L +A
Sbjct: 74 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAA 133
Query: 781 GAD 783
D
Sbjct: 134 TGD 136
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-23
Identities = 30/131 (22%), Positives = 44/131 (33%), Gaps = 3/131 (2%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
L A RG E V +LE + + L++ G P+ GS + L+
Sbjct: 7 MLGGSSDAGLATAAARGQVETVRQLLEAG-ADPNALNRFGRRPIQVM-MMGSAQVAELLL 64
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
GA V H A G D + L AGA + D G + A + +
Sbjct: 65 LHGAEPNCADPATLTRPV-HDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123
Query: 626 TDCAIVILENG 636
D A +
Sbjct: 124 RDIARYLHAAT 134
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 3e-20
Identities = 32/121 (26%), Positives = 47/121 (38%), Gaps = 10/121 (8%)
Query: 714 AGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSC 773
+ L A+ VE V+ +L+AG D N N P+ V G+
Sbjct: 1 GSPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVM-MMGSAQV 59
Query: 774 VGLLLSAGADCNWQDDEGD-NAFHIAADAAKMIREN-LEWLIVMLSHPDAAVEVRNHSGK 831
LLL GA+ N D H AA RE L+ L+V+ A ++V + G+
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAA------REGFLDTLVVLHRA-GARLDVCDAWGR 112
Query: 832 T 832
Sbjct: 113 L 113
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 5e-16
Identities = 34/135 (25%), Positives = 52/135 (38%), Gaps = 16/135 (11%)
Query: 537 NVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCM 596
+ +L D L A A G E V L++ GA+ + R G P V G
Sbjct: 4 GIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRP--IQVMMM-GSAQVA 60
Query: 597 RELLLAGADPNAVDDEGESV-LHRAVAKKYTDCAIVILENGGCRSMAILNSKE---LTPL 652
LLL GA+PN D + +H A + + D +V+ G A L+ + P+
Sbjct: 61 ELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG-----ARLDVCDAWGRLPV 115
Query: 653 HLCVATWN--VAVVK 665
L A + +
Sbjct: 116 DL--AEEQGHRDIAR 128
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 60.5 bits (148), Expect = 9e-11
Identities = 17/88 (19%), Positives = 26/88 (29%), Gaps = 12/88 (13%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQT-ALHLACRRGSAELVEAILEYSQENVDVLD 542
LL A N + T +H A R G + + + +DV D
Sbjct: 60 AELLLLHGAEPN----------CADPATLTRPVHDAAREGFLDTLVVLHRAGA-RLDVCD 108
Query: 543 KDGDPPLVFALAAGSPECVHALIKRGAN 570
G P+ A G + L +
Sbjct: 109 AWGRLPVDLAEEQGHRDIARYLHAATGD 136
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 63/353 (17%), Positives = 121/353 (34%), Gaps = 71/353 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNL 193
++K+GEG + + + +K++ I+ M + +
Sbjct: 27 VRLQKIGEG--SFGKAI---------LVKSTEDGRQYVIKEINISR-MSSK----EREES 70
Query: 194 RR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS--VQLAMQRNEGRLTLEQILRY 246
RR A+M N+ + + L +VMD C G + + +QIL +
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
I + +H ++ +IK N+ L G + D+G+A +L
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS------------- 177
Query: 307 RIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ + +P Y +PE E + +SD W+ GC L E+CT
Sbjct: 178 --TVELARACIGTPYYLSPEICE------------NKPYNNKSDIWALGCVLYELCTLKH 223
Query: 366 PWAGLSAEEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ S + + ++ + Y +L ++ + + RP+ +++L
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPVSLHY--------SYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 424 AT-FLRHLQELPRSPPASPD----TGFTKFSTSNETEPSPASDVEVFQDNPNN 471
F+ E SP + F+KF + PAS P
Sbjct: 276 EKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 52/300 (17%), Positives = 114/300 (38%), Gaps = 46/300 (15%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS----VAVKKV----MIAEEMEPDWLSGQL 190
++K++G G + +V+ + + A+K V + ++ ++
Sbjct: 12 SILKQIGSGGSS--KVF---------QVLNEKKQIYAIKYVNLEEADNQTLDS--YRNEI 58
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADI 250
L + + + D + +VM+ + +++ + + Y ++
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNM 117
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
V +H G+V ++KP+N L+ G + D+G+A ++ D++ +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP----------DTTSVV- 165
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
D + + NY PEA + S ISP+SD WS GC L M G P+ +
Sbjct: 166 -KDSQVGTVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 371 SAE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
+ A++ + ++ ++L ++ CL+ +R + L H
Sbjct: 224 INQISKLHAII-DPNHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPE----LLAH 274
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-25
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 10/159 (6%)
Query: 642 AILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
A+ NS+ L +V VK+ V S I+ T L AA +
Sbjct: 2 AMGNSEADRQLLEAAKAGDVETVKKLCTVQSVN--CRDIEGRQ--STPLHFAA--GYNRV 55
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIP 761
+V LL GA+ A+D LH A E+ ++++ G VN+ ++ P
Sbjct: 56 ----SVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTP 111
Query: 762 LHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
LH A A+G LLL GAD ++ +G+ + D
Sbjct: 112 LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKD 150
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 95.9 bits (240), Expect = 8e-23
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 10/150 (6%)
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
N++ L A + G E V+ + N ++ PL FA V L++
Sbjct: 5 NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64
Query: 568 GANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627
GA+V ++ + G P H +G + L+ GA N D + LH A AK +
Sbjct: 65 GADVHAKDKGGLVP--LHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYE 122
Query: 628 CAIVILENGGCRSMAILNSK---ELTPLHL 654
++L++G A K TPL L
Sbjct: 123 ICKLLLQHG-----ADPTKKNRDGNTPLDL 147
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 94.0 bits (235), Expect = 3e-22
Identities = 40/190 (21%), Positives = 55/190 (28%), Gaps = 36/190 (18%)
Query: 603 GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATW 659
GA + E + L A + + + TPLH
Sbjct: 1 GAM---GNSEADRQLLEAAKAGDVETVKKLCTVQS----VNCRDIEGRQSTPLHF----- 48
Query: 660 NVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILL 712
A V V E V+ D G L A H E+ +L+
Sbjct: 49 --AAGYNRVSVV---EYLLQHGADVHAKDKGG--LVPLHNAC--SYGH----YEVAELLV 95
Query: 713 TAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKS 772
GA D T LH A+ E+ K++L G D +N PL + G
Sbjct: 96 KHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLV-KDGDTD 154
Query: 773 CVGLLLSAGA 782
LL A
Sbjct: 155 IQDLLRGDAA 164
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-19
Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 18/174 (10%)
Query: 468 NPNN-----LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRG 522
N+ L + GDV V+ L + + N + T LH A
Sbjct: 3 MGNSEADRQLLEAAKAGDVETVKKLCTVQSV-N--------CRDIEGRQSTPLHFAAGYN 53
Query: 523 SAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPS 582
+VE +L++ +V DK G PL A + G E L+K GA V F P
Sbjct: 54 RVSVVEYLLQHGA-DVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTP- 111
Query: 583 VAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
H A G+ + + LL GADP + +G + L TD ++ +
Sbjct: 112 -LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLV-KDGDTDIQDLLRGDA 163
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 56/293 (19%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS----VAVKKVMI--AEEMEPDWLSGQLDN 192
++K++G G + +V+ + + A+K V + A+ D ++
Sbjct: 31 SILKQIGSGGSS--KVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLA-MQRNEGRLTLEQILRYGADIA 251
L + + + D + +VM+ G++ L + + + + Y ++
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
V +H G+V ++KP+N L+ G + D+G+A ++ D++ +
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP----------DTTSVV-- 184
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
D + + NY PEA + S ISP+SD WS GC L M G P+ +
Sbjct: 185 KDSQVGTVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243
Query: 372 AE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ A++ + ++ I ++L ++ CL+ +R + +L
Sbjct: 244 NQISKLHAII-DPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 56/293 (19%), Positives = 118/293 (40%), Gaps = 40/293 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS----VAVKKVMI--AEEMEPDWLSGQLDN 192
++K++G G + +V+ + + A+K V + A+ D ++
Sbjct: 59 SILKQIGSGGSS--KVF---------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 107
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLA-MQRNEGRLTLEQILRYGADIA 251
L + + + D + +VM+ G++ L + + + + Y ++
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNML 165
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
V +H G+V ++KP+N L+ G + D+G+A ++ D++ +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP----------DTTSVV-- 212
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
D + + NY PEA + S ISP+SD WS GC L M G P+ +
Sbjct: 213 KDSQVGAVNYMPPEAIKD-MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 372 AE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ A++ + ++ I ++L ++ CL+ +R + +L
Sbjct: 272 NQISKLHAII-DPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELL 319
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 37/257 (14%), Positives = 73/257 (28%), Gaps = 50/257 (19%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDV-LDKDGDPPLVFALAAGSPECVHALIKRG 568
GQ +L R + + + + V + L+ + G + V +I
Sbjct: 4 TGQVSLPPGKRTNLRKTGSERIAHG---MRVKFNPLPLALLLDSSLEGEFDLVQRIIYEV 60
Query: 569 ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC 628
+ EG H G + ++ L+ G + NA D +G + LH A +
Sbjct: 61 DDPSLPNDEGITA--LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 118
Query: 629 AIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGT 688
++E+G A + + D+
Sbjct: 119 CKFLVESG-----AAVFAM------------------------------TYSDMQTA--A 141
Query: 689 ALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
C ++ + + + L + + AL ND EL +
Sbjct: 142 DKCEEM--EEGYT----QCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDELP-MKEGDC 194
Query: 749 VDVNIRNVHNTIPLHVA 765
+ + R + I A
Sbjct: 195 MTIIHREDEDEIEWWWA 211
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 41/271 (15%), Positives = 78/271 (28%), Gaps = 65/271 (23%)
Query: 542 DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREG-FGPSVAHVCAYHGQPDCMRELL 600
+ G L + I G V + ++ + G+ D ++ ++
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRV----KFNPLPLALLLDSSLEGEFDLVQRII 57
Query: 601 LAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE---LTPLHLCVA 657
DP+ +DEG + LH AV +T+ +++ G +N+ + TPLH
Sbjct: 58 YEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFG-----VNVNAADSDGWTPLH---- 108
Query: 658 TWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717
AA + +V + L+ +GA
Sbjct: 109 -----------------------------------CAASCNNVQV-----CKFLVESGAA 128
Query: 718 PTAQ---DAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
A D Q + + + + I N L +
Sbjct: 129 VFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDE-- 186
Query: 775 GLLLSAGADCNW--QDDEGDNAFHIAADAAK 803
L + G ++DE + + A K
Sbjct: 187 -LPMKEGDCMTIIHREDEDEIEWWWARLNDK 216
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 17/146 (11%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
+L + + R+ + G L +S+ + +LV+ I+
Sbjct: 7 VSLPPGK--RTNL----RKTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYE 59
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRE 807
D ++ N LH A+ G V L+ G + N D +G H AA
Sbjct: 60 VDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAAS-----CN 114
Query: 808 NLEWLIV--MLSHPDAAVEVRNHSGK 831
N++ + ++ AAV +S
Sbjct: 115 NVQ--VCKFLVES-GAAVFAMTYSDM 137
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 23/195 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L EG+ V+ ++ + + N +G TALH A G E+V+ ++
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPS----------LPNDEGITALHNAVCAGHTEIVKFLV 90
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISR-LREGFGPSVAHVCAYH 590
++ NV+ D DG PL A + + + L++ GA V + + +
Sbjct: 91 QFG-VNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEE 149
Query: 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI------VILENGGCR----S 640
G C + L ++ L + + + I+
Sbjct: 150 GYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDELPMKEGDCMTIIHREDEDEIEWW 209
Query: 641 MAILNSKE-LTPLHL 654
A LN KE P +L
Sbjct: 210 WARLNDKEGYVPRNL 224
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 27/146 (18%), Positives = 54/146 (36%), Gaps = 11/146 (7%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
L ++ + +LV+ ++ +P+ + + TALH A A E+VK ++
Sbjct: 39 ALLLDSS--LEGEF----DLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQF 92
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD-EGDNAFHIAADAAKMIR 806
GV+VN + PLH A + L+ +GA + A + +
Sbjct: 93 GVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYT 152
Query: 807 ENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ ++L + + N
Sbjct: 153 QCSQFLY---GV-QEKMGIMNKGVIY 174
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 33/185 (17%), Positives = 64/185 (34%), Gaps = 19/185 (10%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + ++ + N L + G +LV+ I+
Sbjct: 9 LPPGKRTNLRKTGSERIAHGMRVKF-----------NPLPLALLLDSSLEGEFDLVQRII 57
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
++ + + +G L A+ AG E V L++ G NV + +G+ P H A
Sbjct: 58 YE-VDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPL--HCAASCN 114
Query: 592 QPDCMRELLLAGADPNAVDD---EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE 648
+ L+ +GA A+ + + + + YT C+ + M I+N
Sbjct: 115 NVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQE--KMGIMNKGV 172
Query: 649 LTPLH 653
+ L
Sbjct: 173 IYALW 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 66/319 (20%), Positives = 122/319 (38%), Gaps = 73/319 (22%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++ L + +G G +V+ WIG VAVK + + S ++N+
Sbjct: 6 FAELTLEEIIGIGGFG--KVYRAFWIG-------DEVAVKAARHDPDEDI---SQTIENV 53
Query: 194 RR-ASMWCR----NVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYG 247
R+ A ++ N+ GV + L LVM+ G + + R+ + ++ +
Sbjct: 54 RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWA 111
Query: 248 ADIARGVVELHAAGVVCM---NIKPSNLLLDASGRAV--------VSDYGLAAILKKPAC 296
IARG+ LH +V + ++K SN+L+ ++D+GLA
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-------- 163
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEA--WEPVKKSLNLFWDDAIGISPESDAWSFG 354
R ++++ + + + APE S SD WS+G
Sbjct: 164 ---REWHRTTKMSAA-----GAYAWMAPEVIRASMF--------------SKGSDVWSYG 201
Query: 355 CTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
L E+ TG +P+ G+ + V N+ P + P K++ +C
Sbjct: 202 VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-----IPSTCPEPFAKLMEDCWNPDPH 256
Query: 415 KRPTFSAMLATFLRHLQEL 433
RP+F+ + L L +
Sbjct: 257 SRPSFTNI----LDQLTTI 271
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 99.8 bits (250), Expect = 3e-24
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 12/151 (7%)
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVR 709
L A +V V+R + + ++ G TAL + +
Sbjct: 4 DRLSGAAARGDVQEVRRLLH--RELVHPDALNRFG--KTALQVMM---FGST----AIAL 52
Query: 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARG 769
LL GA P QD + +H A+ ++ +K++++ G DVN+ + +P+H+A+ G
Sbjct: 53 ELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEG 112
Query: 770 AKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
+ V L + +D + +D G +A
Sbjct: 113 HTAVVSFLAA-ESDLHRRDARGLTPLELALQ 142
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 1e-21
Identities = 39/200 (19%), Positives = 67/200 (33%), Gaps = 55/200 (27%)
Query: 584 AHVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMA 642
A G +R LL P+A++ G++ L T A+ +L+ G A
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVM-MFGSTAIALELLKQG-----A 59
Query: 643 ILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKD 699
N ++ +P+H AA
Sbjct: 60 SPNVQDTSGTSPVHD---------------------------------------AARTGF 80
Query: 700 HEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNT 759
+ +++L+ GA+ D +H+A +V L A D++ R+
Sbjct: 81 LDT-----LKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSF-LAAESDLHRRDARGL 134
Query: 760 IPLHVALARGAKSCVGLLLS 779
PL +AL RGA+ V +L
Sbjct: 135 TPLELALQRGAQDLVDILQG 154
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 2e-21
Identities = 40/158 (25%), Positives = 62/158 (39%), Gaps = 12/158 (7%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
L A RG + V +L + D L++ G L GS L+K+GA+
Sbjct: 2 AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVM-MFGSTAIALELLKQGAS 60
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
+ G P H A G D ++ L+ GAD N D G +H AV + +T
Sbjct: 61 PNVQDTSGTSP--VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVS 118
Query: 631 VILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVK 665
+ + L+ ++ LTPL L + +V
Sbjct: 119 FLAAE------SDLHRRDARGLTPLELALQRGAQDLVD 150
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 90.5 bits (226), Expect = 4e-21
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 16/159 (10%)
Query: 472 LHQLVSEGDVSGVRDLLSKN-ASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAI 530
L + GDV VR LL + + A N G+TAL + GS + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPD----------ALNRFGKTALQVMM-FGSTAIALEL 54
Query: 531 LEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH 590
L+ + +V D G P+ A G + + L++ GA+V G P H+
Sbjct: 55 LKQGA-SPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALP--IHLAVQE 111
Query: 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
G + L A +D + D G + L A+ + D
Sbjct: 112 GHTAVV-SFLAAESDLHRRDARGLTPLELALQRGAQDLV 149
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 58.2 bits (142), Expect = 9e-10
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 12/95 (12%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+H G + ++ L+ A N + G +HLA + G +V +
Sbjct: 72 VHDAARTGFLDTLKVLVEHGADVN----------VPDGTGALPIHLAVQEGHTAVVSFLA 121
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
++ ++ D G PL AL G+ + V L
Sbjct: 122 --AESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 70/330 (21%), Positives = 117/330 (35%), Gaps = 65/330 (19%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLS-GQLD 191
V D+ L++ +G+GR EVW G+W G +VAVK +E W +L
Sbjct: 6 VARDITLLECVGKGRYG--EVWRGSWQG-------ENVAVKIFSSRDEKS--WFRETELY 54
Query: 192 NLRRASMWCRNVCTFHGVLRMDSC----LGLVMDRC-YGSVQLAMQRNEGRLTLEQILRY 246
N + N+ F L L+ GS+ +Q L LR
Sbjct: 55 NTVM--LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRI 110
Query: 247 GADIARGVVELHAAGVVCMN--------IKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298
IA G+ LH +K N+L+ +G+ ++D GLA +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTN 168
Query: 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
++ R+ T Y APE + +++ + D+ D W+FG L
Sbjct: 169 QLDVGNNPRV-----GT---KRYMAPEVLD---ETIQVDCFDS---YKRVDIWAFGLVLW 214
Query: 359 EMCTGS----------IPWAGL-----SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK 403
E+ P+ + S E++ + V +++ P L K
Sbjct: 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274
Query: 404 MIGECLQFKASKRPTFSAMLATFLRHLQEL 433
++ EC S R T + T L ++
Sbjct: 275 LMKECWYQNPSARLTALRIKKT----LTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 72/350 (20%), Positives = 126/350 (36%), Gaps = 69/350 (19%)
Query: 117 HVSSSGVGVCGPVIE-VGVHHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKK 174
+++SG G P++ + + L + +G+GR EVW G W G VAVK
Sbjct: 22 DMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRG-------EEVAVKI 72
Query: 175 VMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS----CLGLVMDRC-YGSVQL 229
EE W + + + + N+ F D+ L LV D +GS+
Sbjct: 73 FSSREERS--WFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129
Query: 230 AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCM--------NIKPSNLLLDASGRAV 281
+ R +T+E +++ A G+ LH V ++K N+L+ +G
Sbjct: 130 YLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187
Query: 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS----PNYTAPEAWEPVKKSLNLF 337
++D GLA +D Y APE + S+N+
Sbjct: 188 IADLGLAVRH--------------DSATDTIDIAPNHRVGTKRYMAPEVLD---DSINMK 230
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGS----------IPWAGL-----SAEEIYRAVVKN 382
++ +D ++ G E+ +P+ L S EE+ + V +
Sbjct: 231 HFES---FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 383 RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
+ P R + K++ EC + R T + T L L +
Sbjct: 288 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT-LSQLSQ 336
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 37/229 (16%), Positives = 81/229 (35%), Gaps = 38/229 (16%)
Query: 218 LVMDRCYGSVQ------LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
+ R ++Q L+ L L+ + R + LH G+V ++P +
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331
++LD G ++ + D +R+ S + S + PE E +
Sbjct: 237 IVLDQRGGVFLTGFEHLVR-------------DGARVVSSV-----SRGFEPPE-LEARR 277
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
+++ D ++ DAW+ G + + +P +A + ++ K
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCK------- 330
Query: 392 IVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT--FLRHLQELPRSPP 438
IP+ + ++ L++ R + T + + EL + P
Sbjct: 331 ----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 98.2 bits (246), Expect = 1e-23
Identities = 49/158 (31%), Positives = 67/158 (42%), Gaps = 25/158 (15%)
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEV 702
L A + I VN D G T L +AA H
Sbjct: 16 KKLLE-------AARAGRDDEV---RILMANGADVNAEDASG--WTPLHLAA--FNGHL- 60
Query: 703 EGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPL 762
E+V +LL GA+ A D T L +A++ +E+V+++L G DVN ++ PL
Sbjct: 61 ---EIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPL 117
Query: 763 HVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
H+A G V +LL GAD N QD G AF I+ D
Sbjct: 118 HLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISID 155
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 94.7 bits (237), Expect = 2e-22
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 61/221 (27%)
Query: 562 HALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAV 621
H G+++ +L A G+ D +R L+ GAD NA D G + LH A
Sbjct: 5 HHHHHHGSDLGKKL---------LEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAA 55
Query: 622 AKKYTDCAIVILENGGCRSMAILNSKE---LTPLHLCVATWNVAVVKRWVEVASPEEIVN 678
+ + V+L+NG A +N+ + +TPL L
Sbjct: 56 FNGHLEIVEVLLKNG-----ADVNAVDHAGMTPLRL------------------------ 86
Query: 679 VIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDV 738
AAL E+ V +LL GA+ A D + T LH+A+M +
Sbjct: 87 ---------------AALFGHLEI-----VEVLLKNGADVNANDMEGHTPLHLAAMFGHL 126
Query: 739 ELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
E+V+++L G DVN ++ +++ G + +L
Sbjct: 127 EIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 92.8 bits (232), Expect = 9e-22
Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 15/168 (8%)
Query: 503 LLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVH 562
+D L A R G + V ++ +V+ D G PL A G E V
Sbjct: 6 HHHHHGSDLGKKLLEAARAGRDDEVRILMANG-ADVNAEDASGWTPLHLAAFNGHLEIVE 64
Query: 563 ALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVA 622
L+K GA+V + G P + A G + + LL GAD NA D EG + LH A
Sbjct: 65 VLLKNGADVNAVDHAGMTP--LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAM 122
Query: 623 KKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATWN--VAVVK 665
+ + V+L+NG A +N++ T + + N + +
Sbjct: 123 FGHLEIVEVLLKNG-----ADVNAQDKFGKTAFDI--SIDNGNEDLAE 163
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 82.0 bits (204), Expect = 6e-18
Identities = 33/119 (27%), Positives = 48/119 (40%), Gaps = 7/119 (5%)
Query: 715 GAEP-TAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSC 773
G+ + L A+ A + V+I++ G DVN + PLH+A G
Sbjct: 3 GSHHHHHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEI 62
Query: 774 VGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
V +LL GAD N D G +AA E +E L+ + A V + G T
Sbjct: 63 VEVLLKNGADVNAVDHAGMTPLRLAALFGH--LEIVEVLL---KN-GADVNANDMEGHT 115
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 53.5 bits (130), Expect = 5e-08
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 11/95 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L G + V LL A N A + +G T LHLA G E+VE +L
Sbjct: 84 LRLAALFGHLEIVEVLLKNGADVN----------ANDMEGHTPLHLAAMFGHLEIVEVLL 133
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
+ +V+ DK G ++ G+ + L K
Sbjct: 134 KNGA-DVNAQDKFGKTAFDISIDNGNEDLAEILQK 167
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 50/244 (20%), Positives = 84/244 (34%), Gaps = 52/244 (21%)
Query: 468 NPNNLHQLVSEGDVSGVRD----LLSKNASGNYSSSISSLLKAQNADGQTALHLA---CR 520
N L +VS G G+ LL+ ++ + + G+T L A
Sbjct: 5 NRPILFDIVSRGSPDGLEGLLSFLLTHKKR------LTDEEFREPSTGKTCLPKALLNLS 58
Query: 521 RGSAELVEAILEYSQE--------NVDVLDKD--GDPPLVFALAAGSPECVHALIKRGAN 570
G + + +L+ +++ N D G L A+ V L+++GA+
Sbjct: 59 AGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGAD 118
Query: 571 VISRLREGFGPSVA------------HVCAYHGQPDCMRELLLAG---ADPNAVDDEGES 615
V ++ R F + A QP + L G AD D G +
Sbjct: 119 VHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNT 178
Query: 616 VLHRAVA---------KKYTDCAIVILENGG-----CRSMAILNSKELTPLHLCVATWNV 661
VLH VA K T ++L A+LN+ L+PL + T +
Sbjct: 179 VLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKI 238
Query: 662 AVVK 665
+ +
Sbjct: 239 GIFQ 242
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 37/184 (20%), Positives = 57/184 (30%), Gaps = 43/184 (23%)
Query: 688 TALCMAAA-LKKDHEVEGRELVRILLTAG-----------AEPTAQDAQNRTALHIASMA 735
T L A L + + ILL + + +TALHIA
Sbjct: 48 TCLPKALLNLSAGRN----DTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIER 103
Query: 736 NDVELVKIILDAGVDVNIRNVHNTI--------------PLHVALARGAKSCVGLLLSAG 781
V+++++ G DV+ + PL +A V L G
Sbjct: 104 RCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENG 163
Query: 782 ---ADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVM----LSH------PDAAVEVRNH 828
AD QD G+ H A REN +++ M L + N+
Sbjct: 164 HKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNN 223
Query: 829 SGKT 832
G +
Sbjct: 224 DGLS 227
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 39/262 (14%), Positives = 75/262 (28%), Gaps = 73/262 (27%)
Query: 579 FGPSVAHVCAYHGQPDCMRE----LLLAGADPNAVD----DEGESVLHRAVAKKYTDCAI 630
F + G PD + LL + G++ L +A+
Sbjct: 4 FNRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSA---- 59
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTAL 690
+ P+ L +A ++ ++ D+ TAL
Sbjct: 60 --------------GRNDTIPILLDIA-EKTGNMREFI-------NSPFRDVYYRGQTAL 97
Query: 691 CMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN--------------RTALHIASMAN 736
+A ++ + V +L+ GA+ AQ L +A+ N
Sbjct: 98 HIAI--ERRCK----HYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTN 151
Query: 737 DVELVKIILDAG---VDVNIRNVHNTIPLHVALARG---------AKSCVGLLLSAGADC 784
+V + + G D+ ++ LH +A LLL A
Sbjct: 152 QPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKL 211
Query: 785 N-------WQDDEGDNAFHIAA 799
+++G + +AA
Sbjct: 212 FPDTNLEALLNNDGLSPLMMAA 233
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 21/160 (13%), Positives = 42/160 (26%), Gaps = 20/160 (12%)
Query: 472 LHQLVSEGDVSGVRDLLSK----NASGNYSSSISSLLKAQNADGQTALHLACRRGSAELV 527
LH + V L+ K +A G+ L LA +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 528 EAILEYSQE--NVDVLDKDGDPPLVFALAAGS---------PECVHALIKRGANVISRLR 576
+ E + ++ D G+ L +A + L+ + A +
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTN 216
Query: 577 EGFGPSVA-----HVCAYHGQPDCMRELLLAGADPNAVDD 611
+ + A G+ + ++ A
Sbjct: 217 LEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAHH 256
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 2e-23
Identities = 47/112 (41%), Positives = 67/112 (59%), Gaps = 6/112 (5%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L +AA + H E+V++LL AGA+ A+D RT LH+A+ +E+VK++L+A
Sbjct: 4 TPLHLAA--RNGHL----EVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEA 57
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
G DVN ++ + PLH+A G V LLL AGAD N +D G H+AA
Sbjct: 58 GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAA 109
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 2e-20
Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 3/127 (2%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+G+T LHLA R G E+V+ +LE +V+ DK+G PL A G E V L++ GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAG-ADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
+V ++ + G P H+ A +G + ++ LL AGAD NA D G + LH A + +
Sbjct: 60 DVNAKDKNGRTPL--HLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVV 117
Query: 630 IVILENG 636
++LE G
Sbjct: 118 KLLLEAG 124
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 82.0 bits (204), Expect = 2e-18
Identities = 56/136 (41%), Positives = 76/136 (55%), Gaps = 17/136 (12%)
Query: 650 TPLHLCVATWN--VAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706
TPLHL A N + VVK +E A VN D G T L +AA + H E
Sbjct: 4 TPLHL--AARNGHLEVVKLLLEAGAD----VNAKDKNG--RTPLHLAA--RNGHL----E 49
Query: 707 LVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVAL 766
+V++LL AGA+ A+D RT LH+A+ +E+VK++L+AG DVN ++ + PLH+A
Sbjct: 50 VVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAA 109
Query: 767 ARGAKSCVGLLLSAGA 782
G V LLL AGA
Sbjct: 110 RNGHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 78.2 bits (194), Expect = 5e-17
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 16/112 (14%)
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
RT LH+A+ +E+VK++L+AG DVN ++ + PLH+A G V LLL AGAD N
Sbjct: 3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVN 62
Query: 786 WQDDEGDNAFHIAA-----DAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+D G H+AA + K+ L+ A V ++ +G+T
Sbjct: 63 AKDKNGRTPLHLAARNGHLEVVKL-------LL---EA-GADVNAKDKNGRT 103
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 67.4 bits (166), Expect = 2e-13
Identities = 45/133 (33%), Positives = 68/133 (51%), Gaps = 13/133 (9%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + V+ LL A N A++ +G+T LHLA R G E+V+ +L
Sbjct: 6 LHLAARNGHLEVVKLLLEAGADVN----------AKDKNGRTPLHLAARNGHLEVVKLLL 55
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
E +V+ DK+G PL A G E V L++ GA+V ++ + G P H+ A +G
Sbjct: 56 EAG-ADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTP--LHLAARNG 112
Query: 592 QPDCMRELLLAGA 604
+ ++ LL AGA
Sbjct: 113 HLEVVKLLLEAGA 125
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 96.7 bits (242), Expect = 2e-23
Identities = 34/113 (30%), Positives = 46/113 (40%), Gaps = 6/113 (5%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L +A+ K V LL G++P +D T LH A +++V+++L
Sbjct: 12 TLLHIAS--IKGDI----PSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQH 65
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
VN N PLH A G V LLLS GA N + G D
Sbjct: 66 KALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDD 118
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 94.4 bits (236), Expect = 1e-22
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 3/132 (2%)
Query: 505 KAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
N G+T LH+A +G VE +L+ + +V D G PL A G + V L
Sbjct: 4 PFTNHRGETLLHIASIKGDIPSVEYLLQNGS-DPNVKDHAGWTPLHEACNHGHLKVVELL 62
Query: 565 IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624
++ A V + + P H A +G D ++ LL GA NAV+ G + +
Sbjct: 63 LQHKALVNTTGYQNDSP--LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDES 120
Query: 625 YTDCAIVILENG 636
++ +N
Sbjct: 121 MKSLLLLPEKNE 132
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 2e-19
Identities = 40/184 (21%), Positives = 58/184 (31%), Gaps = 53/184 (28%)
Query: 603 GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK---ELTPLHLCVATW 659
G DP + GE++LH A K +L+NG + N K TPLH
Sbjct: 1 GIDPFT-NHRGETLLHIASIKGDIPSVEYLLQNG-----SDPNVKDHAGWTPLHE----- 49
Query: 660 NVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT 719
A +V V +LL A
Sbjct: 50 ----------------------------------ACNHGHLKV-----VELLLQHKALVN 70
Query: 720 AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLS 779
QN + LH A+ V++VK++L G N N+ P+ KS + L
Sbjct: 71 TTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEK 130
Query: 780 AGAD 783
+
Sbjct: 131 NESS 134
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 79.8 bits (198), Expect = 2e-17
Identities = 36/123 (29%), Positives = 52/123 (42%), Gaps = 17/123 (13%)
Query: 715 GAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCV 774
G +P + + T LHIAS+ D+ V+ +L G D N+++ PLH A G V
Sbjct: 1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 775 GLLLSAGADCNWQDDEGDNAFHIAA-----DAAKMIRENLEWLIVMLSHPDAAVEVRNHS 829
LLL A N + D+ H AA D K+ L+ S+ A+ N
Sbjct: 60 ELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKL-------LL---SY-GASRNAVNIF 108
Query: 830 GKT 832
G
Sbjct: 109 GLR 111
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 3e-15
Identities = 29/171 (16%), Positives = 55/171 (32%), Gaps = 53/171 (30%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
H+ + G + LL G+DPN D G + LH A + ++L++ A++
Sbjct: 15 HIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHK-----ALV 69
Query: 645 NSKEL---TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
N+ +PLH A K H
Sbjct: 70 NTTGYQNDSPLHD----------------------------------------AAKNGHV 89
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVN 752
++V++LL+ GA A + + + L+ + + +
Sbjct: 90 ----DIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLL-LPEKNESSS 135
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 57.4 bits (140), Expect = 1e-09
Identities = 18/99 (18%), Positives = 36/99 (36%), Gaps = 11/99 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH+ + G + V LL A N + LH A + G ++V+ +L
Sbjct: 47 LHEACNHGHLKVVELLLQHKALVN----------TTGYQNDSPLHDAAKNGHVDIVKLLL 96
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
Y + + ++ G P+ + + K ++
Sbjct: 97 SYGA-SRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS 134
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 96.7 bits (242), Expect = 3e-23
Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
+ L +AA + H +LL AG A+ +RT LH+A+ +V+++L
Sbjct: 36 SPLHLAA--QYGHF----STTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKH 89
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
G DVN +++ LH A + V LL+ GAD + Q AF I+ D
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISID 142
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 4e-23
Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
G L AA + + + VRIL+ GA P D + LH+A+ +++L
Sbjct: 3 GKKLLEAA--RAGQD----DEVRILMANGA-PFTTDWLGTSPLHLAAQYGHFSTTEVLLR 55
Query: 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIR 806
AGV + R + PLH+A + G + V +LL GAD N +D A H A
Sbjct: 56 AGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWAT-----EH 110
Query: 807 ENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ E + +++ + A V ++ KT
Sbjct: 111 NHQEVVELLIKY-GADVHTQSKFCKT 135
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 87.8 bits (219), Expect = 3e-20
Identities = 34/155 (21%), Positives = 58/155 (37%), Gaps = 16/155 (10%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDV-LDKDGDPPLVFALAAGSPECVHALIKRG 568
D L A R G + V ++ D G PL A G L++ G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMAN---GAPFTTDWLGTSPLHLAAQYGHFSTTEVLLRAG 57
Query: 569 ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC 628
+ +R + P H+ A G + + LL GAD NA D + LH A + +
Sbjct: 58 VSRDARTKVDRTP--LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEV 115
Query: 629 AIVILENGGCRSMAILNSK---ELTPLHLCVATWN 660
++++ G A ++++ T + + N
Sbjct: 116 VELLIKYG-----ADVHTQSKFCKTAFDI--SIDN 143
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 6e-20
Identities = 34/158 (21%), Positives = 55/158 (34%), Gaps = 14/158 (8%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + G VR L++ A + G + LHLA + G E +L
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-----------TDWLGTSPLHLAAQYGHFSTTEVLL 54
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ D K PL A + G V L+K GA+V ++ H H
Sbjct: 55 RAG-VSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTA--LHWATEHN 111
Query: 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
+ + L+ GAD + ++ ++ D A
Sbjct: 112 HQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 1e-19
Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 53/196 (27%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
A GQ D +R L+ GA D G S LH A + V+L G
Sbjct: 7 LEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAG-----VSR 60
Query: 645 NSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
+++ + TPLH+ AA +
Sbjct: 61 DARTKVDRTPLHM---------------------------------------AASEGHAN 81
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIP 761
+ V +LL GA+ A+D TALH A+ N E+V++++ G DV+ ++
Sbjct: 82 I-----VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTA 136
Query: 762 LHVALARGAKSCVGLL 777
+++ G + +L
Sbjct: 137 FDISIDNGNEDLAEIL 152
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 50.1 bits (121), Expect = 5e-07
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 11/93 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH SEG + V LL A N A++ TALH A E+VE ++
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVN----------AKDMLKMTALHWATEHNHQEVVELLI 120
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHAL 564
+Y +V K ++ G+ + L
Sbjct: 121 KYGA-DVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 60/300 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
++ KK+G G EV+ + C VA+KKV I + M+ + +
Sbjct: 35 RIEKKIGRG--QFSEVY-------RAACLLDGVPVALKKVQIFDLMDAK----ARADCIK 81
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYG---SVQLAMQRNEGRLTLE-QILRY 246
+ NV ++ D+ L +V++ S + + + RL E + +Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
+ + +H+ V+ +IKP+N+ + A+G + D GL
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS------------- 188
Query: 307 RIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ +++ +P Y +PE G + +SD WS GC L EM
Sbjct: 189 --KTTAAHSLVGTPYYMSPERIH------------ENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 366 PWAGLSAEEIYRAVVK--NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
P+ G +Y K PP + EL +++ C+ KRP + +
Sbjct: 235 PFYG-DKMNLYSLCKKIEQCDYPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 69/344 (20%), Positives = 120/344 (34%), Gaps = 61/344 (17%)
Query: 119 SSSGVGVCGPVI-EVGVHHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVM 176
SSG G P++ + + +++VK++G+GR EVW G W G VAVK
Sbjct: 19 QSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRG-------EKVAVKVFF 69
Query: 177 IAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC----LGLVMDRC-YGSVQLAM 231
EE W + + + M N+ F + L L+ D GS+ +
Sbjct: 70 TTEEAS--WFR-ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126
Query: 232 QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMN--------IKPSNLLLDASGRAVVS 283
+ L + +L+ G+ LH +K N+L+ +G ++
Sbjct: 127 KSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
D GLA D++ + + + + Y PE + +
Sbjct: 185 DLGLAVKFIS----------DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA- 233
Query: 344 ISPESDAWSFGCTLVEMCTGS----------IPWAGL-----SAEEIYRAVVKNRKLPPQ 388
D +SFG L E+ +P+ L S E++ V + P
Sbjct: 234 -----DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 389 YASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
R++ K++ EC + R T + T L + E
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT-LAKMSE 331
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 8e-23
Identities = 32/149 (21%), Positives = 46/149 (30%), Gaps = 10/149 (6%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
+ L A RG E V A+LE N + + G P+ GS L+
Sbjct: 7 SSMEPSADWLATAAARGRVEEVRALLEAG-ANPNAPNSYGRRPIQVM-MMGSARVAELLL 64
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKY 625
GA V H A G D + L AGA + D G + A +
Sbjct: 65 LHGAEPNCADPATLTRPV-HDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 626 TDCAIVILENGGCRSMAILNSKELTPLHL 654
D A + G ++ +
Sbjct: 124 RDVARYLRAAAG-------GTRGSNHARI 145
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 3e-22
Identities = 30/154 (19%), Positives = 54/154 (35%), Gaps = 24/154 (15%)
Query: 650 TPLHLCVATWN--VAVVKRWVEV-ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706
L A V V+ +E A+ N + G + +
Sbjct: 14 DWLAT--AAARGRVEEVRALLEAGAN----PNAPNSYG--RRPIQVMM---MGSA----R 58
Query: 707 LVRILLTAGAEPTAQDAQNRT-ALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVA 765
+ +LL GAEP D T +H A+ ++ + ++ AG +++R+ +P+ +A
Sbjct: 59 VAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLA 118
Query: 766 LARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
G + L +A G N I A
Sbjct: 119 EELGHRDVARYLRAAAGGTR-----GSNHARIDA 147
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-17
Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 12/123 (9%)
Query: 712 LTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 771
+ A + + + L A+ VE V+ +L+AG + N N + P+ V G+
Sbjct: 1 MEPAAGSSMEP--SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSA 57
Query: 772 SCVGLLLSAGADCNWQDDEGD-NAFHIAADAAKMIREN-LEWLIVMLSHPDAAVEVRNHS 829
LLL GA+ N D H AA RE L+ L+V+ A ++VR+
Sbjct: 58 RVAELLLLHGAEPNCADPATLTRPVHDAA------REGFLDTLVVLHRA-GARLDVRDAW 110
Query: 830 GKT 832
G+
Sbjct: 111 GRL 113
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 74.8 bits (185), Expect = 1e-15
Identities = 37/208 (17%), Positives = 58/208 (27%), Gaps = 61/208 (29%)
Query: 538 VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMR 597
+ L A A G E V AL++ GAN + G P G
Sbjct: 5 AGSSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRP--IQ-VMMMGSARVAE 61
Query: 598 ELLLAGADPNAVDDEGESV-LHRAVAKKYTDCAIVILENGGCRSMAILNSKE---LTPLH 653
LLL GA+PN D + +H A + + D +V+ G A L+ ++ P+
Sbjct: 62 LLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG-----ARLDVRDAWGRLPVD 116
Query: 654 LCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLT 713
L A + H ++ R L
Sbjct: 117 L----------------------------------------AEELGHR----DVARYLRA 132
Query: 714 AGAEPTAQDAQNRTALHIASMANDVELV 741
A I + ++
Sbjct: 133 AAGGTRG-----SNHARIDAAEGPSDIP 155
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 94.8 bits (237), Expect = 9e-23
Identities = 39/114 (34%), Positives = 58/114 (50%), Gaps = 6/114 (5%)
Query: 686 VGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIIL 745
+G L AA + + + VRIL+ GA+ A+D T L++A+ +E+V+++L
Sbjct: 14 LGKKLLEAA--RAGQD----DEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLL 67
Query: 746 DAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
G DVN + PLH+A G +LL GAD N QD G AF I+
Sbjct: 68 KNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISI 121
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 83.6 bits (208), Expect = 7e-19
Identities = 38/126 (30%), Positives = 55/126 (43%), Gaps = 3/126 (2%)
Query: 504 LKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA 563
+D L A R G + V ++ +V+ D+ G PL A A G E V
Sbjct: 7 HHHHGSDLGKKLLEAARAGQDDEVRILMANGA-DVNAKDEYGLTPLYLATAHGHLEIVEV 65
Query: 564 LIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623
L+K GA+V + GF P H+ A+ G + LL GAD NA D G++ ++
Sbjct: 66 LLKNGADVNAVDAIGFTP--LHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGN 123
Query: 624 KYTDCA 629
D A
Sbjct: 124 GNEDLA 129
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 2e-17
Identities = 36/119 (30%), Positives = 53/119 (44%), Gaps = 7/119 (5%)
Query: 715 GAEP-TAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSC 773
G+ + L A+ A + V+I++ G DVN ++ + PL++A A G
Sbjct: 3 GSHHHHHHGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEI 62
Query: 774 VGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
V +LL GAD N D G H+AA E E L+ H A V ++ GKT
Sbjct: 63 VEVLLKNGADVNAVDAIGFTPLHLAAFIGH--LEIAEVLL---KH-GADVNAQDKFGKT 115
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 73.6 bits (182), Expect = 2e-15
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 25/137 (18%)
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEV 702
L A + I VN D G T L +A H
Sbjct: 16 KKLLE-------AARAGQDDEV---RILMANGADVNAKDEYG--LTPLYLAT--AHGHL- 60
Query: 703 EGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPL 762
E+V +LL GA+ A DA T LH+A+ +E+ +++L G DVN ++
Sbjct: 61 ---EIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAF 117
Query: 763 HVALARGAKSCVGLLLS 779
+++ G + +L
Sbjct: 118 DISIGNGNEDLAEILQK 134
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 50.1 bits (121), Expect = 4e-07
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 11/95 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L+ + G + V LL A N A +A G T LHLA G E+ E +L
Sbjct: 51 LYLATAHGHLEIVEVLLKNGADVN----------AVDAIGFTPLHLAAFIGHLEIAEVLL 100
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
++ +V+ DK G ++ G+ + L K
Sbjct: 101 KHGA-DVNAQDKFGKTAFDISIGNGNEDLAEILQK 134
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 51/366 (13%), Positives = 111/366 (30%), Gaps = 34/366 (9%)
Query: 437 PPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNY 496
P + F F ++NE S E L ++ VR LL +
Sbjct: 22 PWILWENLFQHFISANELSLMTLSYKEAIH------IFLPGTKNMEQVRQLLCLYYAHYN 75
Query: 497 SS--SISSLLKAQNADGQTALHLACRRGSAELVEAI--LEYSQENVDVLDKDGDPPLVFA 552
+ + S + + +A G + ++ + L S E V V+ + A
Sbjct: 76 RNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLA 135
Query: 553 LAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNA--VD 610
G ++ L + I + + + A +G + L +
Sbjct: 136 AENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQ 195
Query: 611 DEGESVLHRAVAKK-YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRW-- 667
E A + + + +L+ + A ++ E V + V R
Sbjct: 196 AENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE--YGEKYVNPFIARHVNRLKE 253
Query: 668 ----VEVASPEEIVNVID-IPGPVG-TALCMAAALKKDHEVEGRELVRILLT-----AGA 716
++++P+ + +++ G L +++ EV + +R LL+ A A
Sbjct: 254 MHDAFKLSNPDGVFDLVTKSECLQGFYMLRNLI--RRNDEVL-LDDIRFLLSIPGIKALA 310
Query: 717 EPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGL 776
L +A + ++L + + +N ++ G +
Sbjct: 311 PTATIPGDANELLRLALRLGNQGACALLLSIPSVLALTKANN---YYINETGGRLDLRAV 367
Query: 777 LLSAGA 782
L
Sbjct: 368 ALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 36/331 (10%), Positives = 74/331 (22%), Gaps = 68/331 (20%)
Query: 492 ASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVF 551
+ +Y +I L Q L + + +
Sbjct: 42 MTLSYKEAIHIFLPGTKNMEQVRQLLCLYYAHYNRNA---KQLWSDAHKKGIKSEVICFV 98
Query: 552 ALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD 611
A G + D + LL + +
Sbjct: 99 AAITGCSSAL--------------------------------DTLCLLLTSDEIVKVIQA 126
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWN--VAVVKRWVE 669
E A + + E MA++ ++ +A N + V+ R E
Sbjct: 127 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFR--LAAENGHLHVLNRLCE 184
Query: 670 VASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTAL 729
+A I A AA + H ++ LL +
Sbjct: 185 LAP---TEATAMIQAENYYAFRWAAV-GRGHH----NVINFLLDCPVMLAYAEIHEFEYG 236
Query: 730 H------IASMANDVELVKIILDAGVDVNIRNVHNT-------IPLHVALARGAKSCVGL 776
IA N ++ + + ++ L + R + +
Sbjct: 237 EKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDD 296
Query: 777 L--------LSAGADCNWQDDEGDNAFHIAA 799
+ + A A + + +A
Sbjct: 297 IRFLLSIPGIKALAPTATIPGDANELLRLAL 327
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 62/280 (22%), Positives = 112/280 (40%), Gaps = 47/280 (16%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQ 228
+A+K++ + L ++ + +N+ + G + + + M++ GS+
Sbjct: 50 IAIKEIPERDSRYSQPLHEEIALHKHLK--HKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 229 LAMQRNEGRLTL--EQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDY 285
++ G L + I Y I G+ LH +V +IK N+L++ SG +SD+
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167
Query: 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS 345
G + L + I+ C + + Y APE + K G
Sbjct: 168 GTSKRL--------------AGINPCTETFTGTLQYMAPEI---IDKGPR-------GYG 203
Query: 346 PESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK--NRKLPPQYASIVGVGIPRELWK 403
+D WS GCT++EM TG P+ L E A+ K K+ P+ IP +
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFKVGMFKVHPE--------IPESMSA 253
Query: 404 M----IGECLQFKASKRPTFSAMLA-TFLRHLQELPRSPP 438
I +C + KR + +L FL+ + ++ P
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 64/352 (18%), Positives = 115/352 (32%), Gaps = 75/352 (21%)
Query: 117 HVSSSGVGVCGPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVM 176
H S +G + ++L++ GR VW A + VAVK
Sbjct: 8 HSSGVDLGTENLYFQ---SMPLQLLEVKARGRFG--CVWKAQLLN------EYVAVKIFP 56
Query: 177 IAEEMEPDWLS----GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDRC-YGSV 227
I ++ W + L ++ N+ F G + + + L+ GS+
Sbjct: 57 IQDKQS--WQNEYEVYSLPGMK-----HENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109
Query: 228 QLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMN----------IKPSNLLLDAS 277
++ N ++ ++ +ARG+ LH + IK N+LL +
Sbjct: 110 SDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
Query: 278 GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLF 337
A ++D+GLA ++ + + + Y APE E ++N
Sbjct: 168 LTACIADFGLALKF------------EAGKSAGDTHGQVGTRRYMAPEVLE---GAINFQ 212
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL----------------SAEEIYRAVVK 381
D D ++ G L E+ + G S E++ VV
Sbjct: 213 RD----AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH 268
Query: 382 NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433
+K P L + I EC A R + + + +Q L
Sbjct: 269 KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER-ITQMQRL 319
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 3e-22
Identities = 48/346 (13%), Positives = 94/346 (27%), Gaps = 87/346 (25%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLD 191
+KLV+ L G R+ V+ R A+K + E +L+
Sbjct: 63 KLKLVEPLRVGDRS--VVF---------LVRDVERLEDFALKVFTMGAENSRS----ELE 107
Query: 192 NLRRASMWCRNV---------CTFHGVLRMDSC----------------------LGLVM 220
L A+ + +L D+ L+M
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 221 DRCYGSVQLAMQR------NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
++L G + + A + R L + G+V + P NL +
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI 227
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
GR ++ D ++ + + + Y E
Sbjct: 228 MPDGRLMLGDVSALW-----------------KVGTRGPASSVPVTYAPRE--------- 261
Query: 335 NLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS--AEEIYRAVVKNRKLPPQYASI 392
+ +AW G ++ + +P+ ++ + ++ A
Sbjct: 262 -FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG 320
Query: 393 VGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRHLQELPRSP 437
+P + +IG L F +R + T LQ S
Sbjct: 321 SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 51/247 (20%)
Query: 202 NVCTFHG--VLRMDSCLGLVMDRCYG----SVQLAMQRNEGRLTLEQILRYGADIARGVV 255
N+ ++ + R ++ L +VM+ C G SV + L E +LR + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 256 ELHAAGVVCMNI-----KPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
E H + KP+N+ LD + D+GLA IL +
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH---------------DT 170
Query: 311 CMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
T + +P Y +PE + S N +SD WS GC L E+C P+
Sbjct: 171 SFAKTFVGTPYYMSPEQMN--RMSYN----------EKSDIWSLGCLLYELCALMPPFTA 218
Query: 370 LSAEEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-- 425
S +E+ + + + ++P +Y EL ++I L K RP+ +L
Sbjct: 219 FSQKELAGKIREGKFRRIPYRY--------SDELNEIITRMLNLKDYHRPSVEEILENPL 270
Query: 426 FLRHLQE 432
L H
Sbjct: 271 ILEHHHH 277
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 93.2 bits (233), Expect = 6e-22
Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 27/159 (16%)
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEI-------VNVIDIPGPVGTALCMAAALKKDHEV 702
L A + +E VN + G TAL + +
Sbjct: 7 NELAS-------AAARGDLEQL---TSLLQNNVNVNAQNGFG--RTALQVMK---LGNP- 50
Query: 703 EGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPL 762
E+ R LL GA P +D +H A+ A ++ ++ +L+ DVNI + +PL
Sbjct: 51 ---EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPL 107
Query: 763 HVALARGAKSCVGLLLSAGA-DCNWQDDEGDNAFHIAAD 800
H+A G V L+ A + ++ +GD A +A
Sbjct: 108 HLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARL 146
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 2e-21
Identities = 33/202 (16%), Positives = 59/202 (29%), Gaps = 54/202 (26%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
A G + + LL + NA + G + L + A +L G A
Sbjct: 10 ASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVM-KLGNPEIARRLLLRG-----ANP 63
Query: 645 NSK---ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701
+ K +H AA +
Sbjct: 64 DLKDRTGFAVIHD---------------------------------------AARAGFLD 84
Query: 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG-VDVNIRNVHNTI 760
++ LL A+ +D + LH+A+ + +V+ ++ +V RN
Sbjct: 85 T-----LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDT 139
Query: 761 PLHVALARGAKSCVGLLLSAGA 782
+A G V L+ + GA
Sbjct: 140 ACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 3e-21
Identities = 41/162 (25%), Positives = 60/162 (37%), Gaps = 17/162 (10%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQE-NVDVLDKDGDPPLVFALAAGSPECVHALIKRG 568
L A RG E + ++L NV+ + G L G+PE L+ RG
Sbjct: 4 PWGNELASAAARGDLEQLTSLL--QNNVNVNAQNGFGRTALQVM-KLGNPEIARRLLLRG 60
Query: 569 ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC 628
AN + R GF H A G D ++ LL AD N D+EG LH A + +
Sbjct: 61 ANPDLKDRTGFAVI--HDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRV 118
Query: 629 AIVILENGGCRSMAILNSKE---LTPLHLCVATWN--VAVVK 665
++++ + + T L A VV
Sbjct: 119 VEFLVKHTASN----VGHRNHKGDTACDL--ARLYGRNEVVS 154
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 83.6 bits (208), Expect = 1e-18
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 15/166 (9%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
L + GD+ + LL N + N AQN G+TAL + + G+ E+ +L
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVN----------AQNGFGRTALQVM-KLGNPEIARRLL 57
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
N D+ D+ G + A AG + + L++ A+V EG P H+ A G
Sbjct: 58 LRGA-NPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLP--LHLAAKEG 114
Query: 592 QPDCMRELLLAGA-DPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
+ L+ A + + +G++ A + ++ NG
Sbjct: 115 HLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 160
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 81.3 bits (202), Expect = 8e-18
Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 7/107 (6%)
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
L A+ D+E + +L V+VN +N L V G LL GA+ +
Sbjct: 6 GNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVM-KLGNPEIARRLLLRGANPD 64
Query: 786 WQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+D G H AA A + + L+ L+ A V + ++ G
Sbjct: 65 LKDRTGFAVIHDAARAGFL--DTLQTLL---EF-QADVNIEDNEGNL 105
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 63.9 bits (157), Expect = 9e-12
Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 10/83 (12%)
Query: 487 LLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGD 546
LL A N ++ +G LHLA + G +VE +++++ NV + GD
Sbjct: 89 LLEFQADVN----------IEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGD 138
Query: 547 PPLVFALAAGSPECVHALIKRGA 569
A G E V + GA
Sbjct: 139 TACDLARLYGRNEVVSLMQANGA 161
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 47/275 (17%), Positives = 87/275 (31%), Gaps = 42/275 (15%)
Query: 170 VAVKKVMI--AEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GS 226
AVKKV + E + L + + +G +R + + M+ GS
Sbjct: 86 CAVKKVRLEVFRVEELVACA-GLSS--------PRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 227 VQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDY 285
+ + + G L ++ L Y G+ LH ++ ++K N+LL + G + D+
Sbjct: 137 LG-QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 286 GLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGI 344
G A L+ K+ D + + + APE V
Sbjct: 196 GHALCLQPDGLGKSLLTGDY----------IPGTETHMAPEV---VMGK---------PC 233
Query: 345 SPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKM 404
+ D WS C ++ M G PW + + + +
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPP----SCAPLTAQA 289
Query: 405 IGECLQFKASKRPTFSAMLA-TFLRHLQELPRSPP 438
I E L+ + R + + + P
Sbjct: 290 IQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324
|
| >2ct2_A Tripartite motif protein 32; zinc-finger protein HT2A, TAT- interacting protein, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-22
Identities = 22/69 (31%), Positives = 38/69 (55%), Gaps = 2/69 (2%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALR 67
C +C + E++ P LL CGH C++CL ++ ++S + + CP C ++ + S+T L
Sbjct: 18 CPICMESFTEEQLRPKLLHCGHTICRQCLEKLLASSIN-GVRCPFCSKITRI-TSLTQLT 75
Query: 68 KNFAVLALI 76
N VL
Sbjct: 76 DNLTVLKSG 84
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 2e-21
Identities = 38/109 (34%), Positives = 52/109 (47%), Gaps = 6/109 (5%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L AA K H E V+ LL+ GA+ A+ T LH+A+ E+VK++L
Sbjct: 11 TPLHNAA--KNGHA----EEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAK 64
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFH 796
G DVN R+ P H+A G V LL + GAD N + + H
Sbjct: 65 GADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHHH 113
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 79.3 bits (197), Expect = 1e-17
Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 14/111 (12%)
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
T LH A+ E VK +L G DVN R+ PLH+A G V LLL+ GAD N
Sbjct: 10 NTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVN 69
Query: 786 WQDDEGDNAFHIAADAAKMIREN----LEWLIVMLSHPDAAVEVRNHSGKT 832
+ +G+ H+A + ++ L + A V R+
Sbjct: 70 ARSKDGNTPEHLAK------KNGHHEIVKLLD---AK-GADVNARSWGSSH 110
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 2e-17
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 3/109 (2%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
DG T LH A + G AE V+ +L +V+ KDG+ PL A G E V L+ +GA
Sbjct: 8 DGNTPLHNAAKNGHAEEVKKLLSKG-ADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGA 66
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLH 618
+V +R ++G P H+ +G + ++ L GAD NA H
Sbjct: 67 DVNARSKDGNTP--EHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHHH 113
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 64.3 bits (158), Expect = 2e-12
Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G V+ LLSK A N A++ DG T LHLA + G AE+V+ +L
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVN----------ARSKDGNTPLHLAAKNGHAEIVKLLL 62
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANV 571
+V+ KDG+ P A G E V L +GA+V
Sbjct: 63 AKGA-DVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADV 101
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 39/234 (16%), Positives = 81/234 (34%), Gaps = 46/234 (19%)
Query: 207 HGVLRMDSCLGLVMDRC-YGSVQLAM-QRNEGRLTLEQILRYGADIARGVVELHAAGVVC 264
+ CL + M+ C G+++ + +R +L L I +GV +H+ ++
Sbjct: 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIN 145
Query: 265 MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTA 323
++KPSN+ L + + + D+GL LK + + Y +
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLK----------------NDGKRTRSKGTLRYMS 189
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
PE + E D ++ G L E+ + + +++
Sbjct: 190 PEQIS------------SQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTD-LRDG 234
Query: 384 KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSP 437
+ + ++ ++ + L K RP + LR L +SP
Sbjct: 235 IISDIF--------DKKEKTLLQKLLSKKPEDRPN----TSEILRTLTVWKKSP 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-21
Identities = 68/313 (21%), Positives = 127/313 (40%), Gaps = 60/313 (19%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
H D+ L +++G G EV+ G VAVK + + +++ +L
Sbjct: 113 HEDLVLGEQIGRG--NFGEVFSGRLRADNT-----LVAVKSCRETLPPDLKAKFLQEARI 165
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
Q N+ GV + +VM+ G ++ RL ++ +L+
Sbjct: 166 LKQYS--------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ 217
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
D A G+ L + + ++ N L+ +SD+G++ R E D
Sbjct: 218 MVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS-----------REEADG 266
Query: 306 SRIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-G 363
+++ P +TAPEA + + S ESD WSFG L E + G
Sbjct: 267 --VYAASGGLRQVPVKWTAPEAL-----NYGRY-------SSESDVWSFGILLWETFSLG 312
Query: 364 SIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
+ P+ LS ++ V K +LP P+ P +++++ +C ++ +RP+FS
Sbjct: 313 ASPYPNLSNQQTREFVEKGGRLPCPE-------LCPDAVFRLMEQCWAYEPGQRPSFST- 364
Query: 423 LATFLRHLQELPR 435
+ L+ +++ R
Sbjct: 365 IYQELQSIRKRHR 377
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-21
Identities = 65/322 (20%), Positives = 124/322 (38%), Gaps = 74/322 (22%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
+ K +K LG G G V+ G WI G + + VA+K + + + + L
Sbjct: 14 ETEFKKIKVLGSGA-FG-TVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGRLTLE 241
+DN +VC G+ CL L+ +G + ++ ++ + +
Sbjct: 71 MASVDN--------PHVCRLLGI-----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 242 QILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLA-AILKKPA 295
+L + IA+G+ L +V N+ L+ ++D+GLA + +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNV-----LVKTPQHVKITDFGLAKLLGAEEK 172
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
A + + A E+ ++ + +SD WS+G
Sbjct: 173 EYHAEG-------------GKVPIKWMALESI-----LHRIY-------THQSDVWSYGV 207
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKA 413
T+ E+ T GS P+ G+ A EI + K +LP P +++ ++ +C A
Sbjct: 208 TVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-------TIDVYMIMRKCWMIDA 260
Query: 414 SKRPTFSAMLATFLRHLQELPR 435
RP F ++ F + ++ R
Sbjct: 261 DSRPKFRELIIEFSKMARDPQR 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 47/312 (15%), Positives = 87/312 (27%), Gaps = 64/312 (20%)
Query: 159 IG-GGQGRC--------RHSVAVKKVMIAEEMEPDWLSGQLDNLRR-----ASMWCRNVC 204
+G GG G + A+K++ + E + + R A + +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELA-----REKVMREVKALAKLEHPGIV 66
Query: 205 TFHGV------------LRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLE--QILRYGAD 249
+ L + M C +++ M E L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
IA V LH+ G++ ++KPSN+ V D+GL + + + +
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 310 SCMDC-TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
T Y +PE S + D +S G L E+
Sbjct: 187 HTGQVGT---KLYMSPEQIH------------GNSYSHKVDIFSLGLILFELLY--PFST 229
Query: 369 GLSAEEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT- 425
+ V + L Q + M+ + L +RP ++
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQK--------YPCEYVMVQDMLSPSPMERPEAINIIENA 281
Query: 426 FLRHLQELPRSP 437
L ++
Sbjct: 282 VFEDLDFPGKTV 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 77/359 (21%), Positives = 138/359 (38%), Gaps = 74/359 (20%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS----- 187
+++ +K LG G V G WI G+ + V +K + +
Sbjct: 13 TELRKLKVLGSGVFG--TVHKGVWIPEGESI-KIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 188 GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGRLTLEQ 242
G LD+ ++ G+ C G LV GS+ ++++ G L +
Sbjct: 70 GSLDH--------AHIVRLLGL-----CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
+L +G IA+G+ L G+V N+ N+LL + + V+D+G+A +L + E
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ A E+ + + +SD WS+G T+ E+ T
Sbjct: 177 ------------AKTPIKWMALESI-----HFGKY-------THQSDVWSYGVTVWELMT 212
Query: 363 -GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420
G+ P+AGL E+ + K +L PQ +++ ++ +C + RPTF
Sbjct: 213 FGAEPYAGLRLAEVPDLLEKGERLAQPQIC-------TIDVYMVMVKCWMIDENIRPTFK 265
Query: 421 AMLATFLRHLQELPR------------SPPASPDTGFTKFSTSNETEPSPASDVEVFQD 467
+ F R ++ PR +P P K E EP D+++ +
Sbjct: 266 ELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAE 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 51/307 (16%), Positives = 92/307 (29%), Gaps = 35/307 (11%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGG-----QGRCRHSVAVKKVMIAEEMEPDWLSG 188
V +VK + KL V + AW+ + + + +
Sbjct: 51 VMREVKALAKLEHPGI--VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108
Query: 189 QLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLE--QILR 245
+ R +N L + M C +++ M R E L
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
IA V LH+ G++ ++KPSN+ V D+GL + + +
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 306 SRIHSCMDC-TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
+ T Y +PE S + D +S G L E+
Sbjct: 229 AYATHTGQVGT---KLYMSPEQIH------------GNNYSHKVDIFSLGLILFELLYS- 272
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
+ I V+N K P + + M+ + L ++RP + ++
Sbjct: 273 -FSTQMERVRIITD-VRNLKFPLLFTQ-----KYPQEHMMVQDMLSPSPTERPEATDIIE 325
Query: 425 T-FLRHL 430
+L
Sbjct: 326 NAIFENL 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 66/281 (23%), Positives = 103/281 (36%), Gaps = 60/281 (21%)
Query: 161 GGQGRC--------RHSVAVK---KVMIAEEMEPDWLSGQLDNLRR-----ASMWCRNVC 204
GG +C + A K K ++ + Q + + S+ ++V
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-------HQREKMSMEISIHRSLAHQHVV 78
Query: 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVC 264
FHG + + +V++ C L + + LT + Y I G LH V+
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 265 MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH-SCMDCTMLSPNYTA 323
++K NL L+ + D+GLA + E D R C +PNY A
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLA----------TKVEYDGERKKVLCG-----TPNYIA 183
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
PE KK G S E D WS GC + + G P+ +E Y + KN
Sbjct: 184 PEVLS--KK----------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
Query: 384 -KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+P I +I + LQ + RPT + +L
Sbjct: 232 YSIPKH--------INPVAASLIQKMLQTDPTARPTINELL 264
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 68/350 (19%), Positives = 133/350 (38%), Gaps = 65/350 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
+ K +K LG G V+ G WI G + + VA+K + + + + L
Sbjct: 14 ETEFKKIKVLGSGAFG--TVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGRLTLEQILR 245
+DN +VC G+ + S + L+ +G + ++ ++ + + +L
Sbjct: 71 MASVDN--------PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA-AILKKPACRKARPECD 304
+ IA+G+ L +V ++ N+L+ ++D+GLA + + A
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--- 178
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-G 363
+ + A E+ ++ + +SD WS+G T+ E+ T G
Sbjct: 179 ----------GKVPIKWMALESI-----LHRIY-------THQSDVWSYGVTVWELMTFG 216
Query: 364 SIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
S P+ G+ A EI + K +LP P +++ ++ +C A RP F +
Sbjct: 217 SKPYDGIPASEISSILEKGERLPQPPIC-------TIDVYMIMVKCWMIDADSRPKFREL 269
Query: 423 LATF---------LRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVE 463
+ F +Q R SP + +E + D +
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 62/347 (17%), Positives = 113/347 (32%), Gaps = 72/347 (20%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLS----GQLD 191
++KL++ +G GR V+ G+ VAVK A +++ ++
Sbjct: 14 NLKLLELIGRGRYG--AVYKGSLDE-------RPVAVKVFSFANRQN--FINEKNIYRVP 62
Query: 192 NLRRASMWCRNVCTFHGVLRMDSCLG-----LVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
+ N+ F + G LVM+ GS+ + + R
Sbjct: 63 LME-----HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCR 115
Query: 246 YGADIARGVVELHAAGVVCMN---------IKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+ RG+ LH + + N+L+ G V+SD+GL+ L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+ E +++ + Y APE E ++NL D + D ++ G
Sbjct: 176 VRPGEEDNAAISEVG------TIRYMAPEVLE---GAVNL--RDXESALKQVDMYALGLI 224
Query: 357 LVEM---CTGSIPWAGL---------------SAEEIYRAVVKNRK---LPPQYASIVGV 395
E+ CT P + + E++ V + ++ P +
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284
Query: 396 GIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPD 442
R L + I +C A R T + R+ SP
Sbjct: 285 --VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 68/336 (20%), Positives = 130/336 (38%), Gaps = 69/336 (20%)
Query: 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKV-MIAEEMEPDWLSGQ 189
+D++ + ++G G +VW + R +AVK++ + E +
Sbjct: 25 NDLENLGEMGSG--TCGQVW---------KMRFRKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
LD + ++ C + G ++ + + M+ + +R +G + E+IL
Sbjct: 74 LDVVLKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGK--- 128
Query: 250 IARGVVE----LHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
+ +V+ L GV+ ++KPSN+LLD G+ + D+G++ L D
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL-----------VD 177
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
C Y APE +P + +D WS G +LVE+ TG
Sbjct: 178 DKAKDRSAGC----AAYMAPERIDPPDPT-------KPDYDIRADVWSLGISLVELATGQ 226
Query: 365 IPWAGLSAE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
P+ + E+ V++ PP +G + + +CL KRP ++ +L
Sbjct: 227 FPYKNCKTDFEVLTKVLQEE--PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
Query: 424 ---------------ATFLRHLQELPRSPPASPDTG 444
A++ + + SP + P +G
Sbjct: 283 EHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSSG 318
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 58/225 (25%), Positives = 87/225 (38%), Gaps = 37/225 (16%)
Query: 201 RNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA 260
++V FHG + + +V++ C L + + LT + Y I G LH
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 261 GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH-SCMDCTMLSP 319
V+ ++K NL L+ + D+GLA + E D R C +P
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA----------TKVEYDGERKKVLCG-----TP 205
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
NY APE KK G S E D WS GC + + G P+ +E Y +
Sbjct: 206 NYIAPEVLS--KK----------GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 380 VKNR-KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
KN +P I +I + LQ + RPT + +L
Sbjct: 254 KKNEYSIPKH--------INPVAASLIQKMLQTDPTARPTINELL 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 46/266 (17%), Positives = 103/266 (38%), Gaps = 50/266 (18%)
Query: 170 VAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHG----VLRMDSCLGLVMDRC 223
VA ++ + + E + + L+ N+ F+ ++ C+ LV +
Sbjct: 54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWESTVKGKKCIVLVTELM 111
Query: 224 Y-GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCM--NIKPSNLLLDA-SGR 279
G+++ ++R + ++ + + I +G+ LH + ++K N+ + +G
Sbjct: 112 TSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170
Query: 280 AVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFW 338
+ D GLA + + + ++ +P + APE +E
Sbjct: 171 VKIGDLGLATLKRASFAK-----------------AVIGTPEFMAPEMYEE--------- 204
Query: 339 DDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS-AEEIYRAVVKNRKLPPQYASIVGVGI 397
D ++FG ++EM T P++ A +IYR V K P + +
Sbjct: 205 ----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV----A 255
Query: 398 PRELWKMIGECLQFKASKRPTFSAML 423
E+ ++I C++ +R + +L
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 73/320 (22%), Positives = 130/320 (40%), Gaps = 56/320 (17%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
+ + K +G G EV G GQ VA+K K E D+LS
Sbjct: 48 ASRIHIEKIIGSGDSG--EVCYGRLRVPGQRDVP--VAIKALKAGYTERQRRDFLSEASI 103
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
GQ D+ N+ GV+ +V + GS+ ++ ++G+ T+ Q++
Sbjct: 104 MGQFDH--------PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
+ G+ L G V ++ N+L+D++ VSD+GL+ R + D+
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS--------RVLEDDPDA 207
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
+ + + +TAPEA + F S SD WSFG + E+ G
Sbjct: 208 AYTTTG---GKIPIRWTAPEAI-----AFRTF-------SSASDVWSFGVVMWEVLAYGE 252
Query: 365 IPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS--- 420
P+ ++ ++ +V + +LP P P L +++ +C ++RP FS
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGC-------PHALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 421 AMLATFLRHLQELPRSPPAS 440
++L +R + L + S
Sbjct: 306 SVLDALIRSPESLRATATVS 325
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 75/339 (22%), Positives = 140/339 (41%), Gaps = 54/339 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
++ + K +G G EV G + SVA+K KV E+ D+L
Sbjct: 44 ATNISIDKVVGAGEFG--EVCSGRLKLPSKKE--ISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
GQ D N+ GV+ + +V + GS+ +++++ + T+ Q++
Sbjct: 100 MGQFD--------HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
IA G+ L G V ++ N+L++++ VSD+GL +L+ PE
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED------DPEAAY 205
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
+ + +T+PEA + F + SD WS+G L E+ + G
Sbjct: 206 TTRG-----GKIPIRWTSPEAI-----AYRKF-------TSASDVWSYGIVLWEVMSYGE 248
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS---A 421
P+ +S +++ +AV + +LPP + P L++++ +C Q + RP F +
Sbjct: 249 RPYWEMSNQDVIKAVDEGYRLPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 422 MLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPAS 460
+L +R+ L A+ SN + +
Sbjct: 303 ILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRT 341
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 41/288 (14%), Positives = 88/288 (30%), Gaps = 51/288 (17%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR-----ASMW-CRNV 203
IG G + R A+K+ D N R A + +V
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-----EQNALREVYAHAVLGQHSHV 73
Query: 204 CTFHGVLRMDSCLGLVMDRCY-GSVQLAMQ---RNEGRLTLEQILRYGADIARGVVELHA 259
+ D + + + C GS+ A+ R ++ + RG+ +H+
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD--SSRIHSCMDCTML 317
+V M+IKPSN+ + + + + D S
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK-IGDLGHVTRISSPQVEEG 192
Query: 318 SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377
+ A E + + P++D ++ T+V + +
Sbjct: 193 DSRFLANEVLQ-----------ENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWH 238
Query: 378 AVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+ + R ++P +E +++ + +RP+ A++
Sbjct: 239 EIRQGRLPRIPQVL--------SQEFTELLKVMIHPDPERRPSAMALV 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 49/293 (16%), Positives = 101/293 (34%), Gaps = 56/293 (19%)
Query: 156 GAWIG-GGQGR---CRH-----SVAVKKVMIAEEMEPDWLSGQLDNLRR-----ASMWCR 201
A +G G G+ R+ A+KK+ EE +L + AS+ +
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE--------KLSTILSEVMLLASLNHQ 62
Query: 202 NVCTFHGV-------------LRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYG 247
V ++ ++ S L + M+ C G++ + ++ R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
I + +H+ G++ ++KP N+ +D S + D+GLA + + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 308 IHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ + + + Y A E + + + D +S G EM
Sbjct: 183 SSDNLT-SAIGTAMYVATEVLD--GTG---------HYNEKIDMYSLGIIFFEMIYP--F 228
Query: 367 WAGLSAEEIYRAVVK-NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G+ I + + + + PP + + K+I + +KRP
Sbjct: 229 STGMERVNILKKLRSVSIEFPPDFDD----NKMKVEKKIIRLLIDHDPNKRPG 277
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 48/261 (18%), Positives = 92/261 (35%), Gaps = 34/261 (13%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQL 229
VAVK+++ + ++ LR S NV + + + ++ C ++Q
Sbjct: 51 VAVKRILPECF---SFADREVQLLRE-SDEHPNVIRYFCTEKDRQFQYIAIELCAATLQE 106
Query: 230 AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL-----DASGRAVVSD 284
+++ + + + G+ LH+ +V ++KP N+L+ +A++SD
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI 344
+GL L S + + APE L D
Sbjct: 167 FGLCKKLA-----------VGRHSFSRRSGVPGTEGWIAPEM---------LSEDCKENP 206
Query: 345 SPESDAWSFGCTLVEM-CTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK 403
+ D +S GC + GS P+ + ++ L + I REL
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLHPEKHEDVIAREL-- 263
Query: 404 MIGECLQFKASKRPTFSAMLA 424
I + + KRP+ +L
Sbjct: 264 -IEKMIAMDPQKRPSAKHVLK 283
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 3/95 (3%)
Query: 706 ELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVA 765
L+ G+ + L A+ A + V+I++ G DV ++ + + PLH+A
Sbjct: 8 HHSSGLVPRGSH---MGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLA 64
Query: 766 LARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
G V LLL AGAD QD G AF I+ D
Sbjct: 65 ARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISID 99
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-14
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 3/92 (3%)
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
+D L A R G + V ++ +V DK+G PL A G E V L++
Sbjct: 21 GSDLGKKLLEAARAGQDDEVRILMANG-ADVAAKDKNGSTPLHLAARNGHLEVVKLLLEA 79
Query: 568 GANVISRLREGFGPSVAHVCAYHGQPDCMREL 599
GA+V ++ + G + +G D L
Sbjct: 80 GADVXAQDKFGKTA--FDISIDNGNEDLAEIL 109
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-14
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 687 GTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
G L AA + + + VRIL+ GA+ A+D T LH+A+ +E+VK++L+
Sbjct: 25 GKKLLEAA--RAGQD----DEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLE 78
Query: 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLL 777
AG DV ++ +++ G + +L
Sbjct: 79 AGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-10
Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 732 ASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEG 791
S + ++ G + L A G V +L++ GAD +D G
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSDL--GK-KLLEAARAGQDDEVRILMANGADVAAKDKNG 57
Query: 792 DNAFHIAA 799
H+AA
Sbjct: 58 STPLHLAA 65
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 9/114 (7%)
Query: 554 AA--GSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD 611
+ L+ RG+++ S A GQ D +R L+ GAD A D
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSD-----LGKKLLEAARAGQDDEVRILMANGADVAAKDK 55
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVK 665
G + LH A + + ++LE G + + T + + N + +
Sbjct: 56 NGSTPLHLAARNGHLEVVKLLLEAGA--DVXAQDKFGKTAFDISIDNGNEDLAE 107
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-18
Identities = 64/307 (20%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
D+ + KLG G+ EV+ G W +VAVK + + ME + + L
Sbjct: 219 RTDITMKHKLGGGQYG--EVYEGVWKKYSL-----TVAVK-TLKEDTMEVE------EFL 264
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGR-LTLEQILRYG 247
+ A++ N+ GV + ++ + YG++ ++ + ++ +L
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
I+ + L + N+ N L+ + V+D+GL+ ++ +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-----------GDTY 373
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
+ +TAPE+ + N F S +SD W+FG L E+ T G P
Sbjct: 374 TAHAGAKFPIK--WTAPESL-----AYNKF-------SIKSDVWAFGVLLWEIATYGMSP 419
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+ G+ ++Y + K+ ++ P+ G P ++++++ C Q+ S RP+F+ +
Sbjct: 420 YPGIDLSQVYELLEKDYRMERPE-------GCPEKVYELMRACWQWNPSDRPSFAEIHQA 472
Query: 426 FLRHLQE 432
F QE
Sbjct: 473 FETMFQE 479
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 77/340 (22%), Positives = 124/340 (36%), Gaps = 74/340 (21%)
Query: 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKV-MIAEEMEPDWLSGQ 189
D+K + ++G G A V + H +AVK++ +E E L
Sbjct: 22 EDLKDLGEIGRG--AYGSVN---------KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD 70
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS----VQLAMQRNEGRLTLEQILR 245
LD + R+S C + F+G L + + M+ S + + + E+IL
Sbjct: 71 LDVVMRSSD-CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP-EEILG 128
Query: 246 YGADIARGVVE----LHAAG-VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
I V+ L ++ +IKPSN+LLD SG + D+G++ L
Sbjct: 129 K---ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--------- 176
Query: 301 PECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
+ S Y APE +P G SD WS G TL E
Sbjct: 177 -------VDSIAKTRDAGCRPYMAPERIDPSA--------SRQGYDVRSDVWSLGITLYE 221
Query: 360 MCTGSIPWAGLSAE-EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
+ TG P+ ++ + VVK PPQ ++ + CL SKRP
Sbjct: 222 LATGRFPYPKWNSVFDQLTQVVKGD--PPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279
Query: 419 FSAML---------------ATFLRHLQELPRSPPASPDT 443
+ +L A ++ + + + P+SP
Sbjct: 280 YKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMY 319
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-18
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 65/305 (21%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++L KLG+G EVW G W VA+K + M P+ L
Sbjct: 183 RESLRLEVKLGQGCFG--EVWMGTW------NGTTRVAIK-TLKPGTMSPE------AFL 227
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGR-LTLEQI 243
+ A + + + V +V + GS+ ++ G+ L L Q+
Sbjct: 228 QEAQVMKKLRHEKLVQLYAV-----VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
+ A IA G+ + V +++ +N+L+ + V+D+GLA R
Sbjct: 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-----------RLIE 331
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362
D+ +TAPEA F + +SD WSFG L E+ T
Sbjct: 332 DNEYTAR--QGAKFPIKWTAPEAA-----LYGRF-------TIKSDVWSFGILLTELTTK 377
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
G +P+ G+ E+ V + ++P P P L ++ +C + + +RPTF
Sbjct: 378 GRVPYPGMVNREVLDQVERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERPTFEY 430
Query: 422 MLATF 426
+ A
Sbjct: 431 LQAFL 435
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 71/314 (22%), Positives = 131/314 (41%), Gaps = 54/314 (17%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
V K +G G EV+ G G+ VA+K K E+ D+L
Sbjct: 43 PSCVTRQKVIGAGEFG--EVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
GQ N+ GV+ + ++ + G++ ++ +G ++ Q++
Sbjct: 100 MGQFS--------HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
IA G+ L V ++ N+L++++ VSD+GL+ +L+ PE
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED------DPEATY 205
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
+ + +TAPEA S F + SD WSFG + E+ T G
Sbjct: 206 TT-----SGGKIPIRWTAPEAI-----SYRKF-------TSASDVWSFGIVMWEVMTYGE 248
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
P+ LS E+ +A+ +LP + P +++++ +C Q + ++RP F+ +++
Sbjct: 249 RPYWELSNHEVMKAINDGFRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVS 302
Query: 425 TFLRHLQELPRSPP 438
L +L R+P
Sbjct: 303 I----LDKLIRAPD 312
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 58/317 (18%), Positives = 119/317 (37%), Gaps = 65/317 (20%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
++L + +GEG+ +V G ++ +VA+K K ++ + +L
Sbjct: 14 RERIELGRCIGEGQFG--DVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALT 69
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDR-CYGSVQLAMQRNEGRLTLE 241
Q D ++ GV ++M+ G ++ +Q + L L
Sbjct: 70 MRQFD--------HPHIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKYSLDLA 116
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
++ Y ++ + L + V +I N+L+ ++ + D+GL+ ++ KA
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
L + APE+ + F + SD W FG + E+
Sbjct: 177 -------------GKLPIKWMAPESI-----NFRRF-------TSASDVWMFGVCMWEIL 211
Query: 362 T-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
G P+ G+ ++ + +LP P P L+ ++ +C + S+RP F
Sbjct: 212 MHGVKPFQGVKNNDVIGRIENGERLPMPP-------NCPPTLYSLMTKCWAYDPSRRPRF 264
Query: 420 SAMLATFLRHLQELPRS 436
+ L L + E ++
Sbjct: 265 TE-LKAQLSTILEEEKA 280
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 63/322 (19%), Positives = 117/322 (36%), Gaps = 75/322 (23%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
DV L + LGEG EV+ G + + VAVK K + + ++S
Sbjct: 11 REDVVLNRILGEGFFG--EVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMSEAVI 66
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDR-CYGSVQLAMQRNEGRLTLE 241
LD ++ G+ ++M+ YG + ++RN+ L +
Sbjct: 67 MKNLD--------HPHIVKLIGI-----IEEEPTWIIMELYPYGELGHYLERNKNSLKVL 113
Query: 242 QILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
++ Y I + + L + V NI L+ + + D+GL+ ++
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNI-----LVASPECVKLGDFGLSRYIEDEDY 168
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
KA T L + +PE+ + F + SD W F
Sbjct: 169 YKASV-------------TRLPIKWMSPESI-----NFRRF-------TTASDVWMFAVC 203
Query: 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKAS 414
+ E+ + G P+ L +++ + K +LP P P L+ ++ C + S
Sbjct: 204 MWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC-------PPVLYTLMTRCWDYDPS 256
Query: 415 KRPTFSAMLATFLRHLQELPRS 436
RP F+ L L + ++ +
Sbjct: 257 DRPRFTE-LVCSLSDVYQMEKD 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-17
Identities = 60/319 (18%), Positives = 117/319 (36%), Gaps = 76/319 (23%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
++L + +GEG+ +V G ++ +VA+K K ++ + +L
Sbjct: 389 RERIELGRCIGEGQFG--DVHQGIYMSPENPA--MAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDRC-YGSVQLAMQRNEGRLTLE 241
Q D ++ GV ++M+ C G ++ +Q + L L
Sbjct: 445 MRQFD--------HPHIVKLIGV-----ITENPVWIIMELCTLGELRSFLQVRKFSLDLA 491
Query: 242 QILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGLAAILKKPA 295
++ Y ++ + L + V N+ L +S V + D+GL+ ++
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNV------LVSSNDCVKLGDFGLSRYMEDST 545
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
KA L + APE+ + F + SD W FG
Sbjct: 546 YYKASK-------------GKLPIKWMAPESI-----NFRRF-------TSASDVWMFGV 580
Query: 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKA 413
+ E+ G P+ G+ ++ + +LP P P L+ ++ +C +
Sbjct: 581 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-------NCPPTLYSLMTKCWAYDP 633
Query: 414 SKRPTFSAMLATFLRHLQE 432
S+RP F+ + A L+E
Sbjct: 634 SRRPRFTELKAQLSTILEE 652
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 65/305 (21%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++L KLG+G EVW G W VA+K + M P+ L
Sbjct: 266 RESLRLEVKLGQGCFG--EVWMGTW------NGTTRVAIK-TLKPGTMSPE------AFL 310
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGR-LTLEQI 243
+ A + + + V +V + GS+ ++ G+ L L Q+
Sbjct: 311 QEAQVMKKLRHEKLVQLYAV-----VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
+ A IA G+ + V +++ +N+L+ + V+D+GLA R
Sbjct: 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-----------RLIE 414
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362
D+ +TAPEA F + +SD WSFG L E+ T
Sbjct: 415 DNEYTAR--QGAKFPIKWTAPEAA-----LYGRF-------TIKSDVWSFGILLTELTTK 460
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
G +P+ G+ E+ V + ++P P P L ++ +C + + +RPTF
Sbjct: 461 GRVPYPGMVNREVLDQVERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERPTFEY 513
Query: 422 MLATF 426
+ A
Sbjct: 514 LQAFL 518
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 77.8 bits (193), Expect = 2e-17
Identities = 40/95 (42%), Positives = 58/95 (61%), Gaps = 6/95 (6%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L +AA + H E+V++LL AGA+ A+D RT LH+A+ +E+VK++L+A
Sbjct: 4 TPLHLAA--RNGHL----EVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEA 57
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782
G DVN ++ + PLH+A G V LLL AGA
Sbjct: 58 GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 1e-16
Identities = 33/74 (44%), Positives = 46/74 (62%)
Query: 726 RTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
RT LH+A+ +E+VK++L+AG DVN ++ + PLH+A G V LLL AGAD N
Sbjct: 3 RTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVN 62
Query: 786 WQDDEGDNAFHIAA 799
+D G H+AA
Sbjct: 63 AKDKNGRTPLHLAA 76
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 63.5 bits (156), Expect = 2e-12
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+G+T LHLA R G E+V+ +LE +V+ DK+G PL A G E V L++ GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAG-ADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGA 604
+V ++ + G P H+ A +G + ++ LL AGA
Sbjct: 60 DVNAKDKNGRTP--LHLAARNGHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 60.8 bits (149), Expect = 2e-11
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 13/99 (13%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + V+ LL A N A++ +G+T LHLA R G E+V+ +L
Sbjct: 6 LHLAARNGHLEVVKLLLEAGADVN----------AKDKNGRTPLHLAARNGHLEVVKLLL 55
Query: 532 EYSQE-NVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+V+ DK+G PL A G E V L++ GA
Sbjct: 56 --EAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 75/308 (24%), Positives = 119/308 (38%), Gaps = 65/308 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK----KVMIAEEMEPDWLS---- 187
D++L++KLG+G V G W SVAVK V+ E D++
Sbjct: 19 DLRLLEKLGDGSFG--VVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGRLTLE 241
LD+ RN+ +GV L +V + GS+ +++++G L
Sbjct: 75 MHSLDH--------RNLIRLYGV-----VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 121
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
+ RY +A G+ L + + ++ NLLL + D+GL R
Sbjct: 122 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM--------RALPQ 173
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
D + + + APE+ F S SD W FG TL EM
Sbjct: 174 NDDHYVMQEH---RKVPFAWCAPESL-----KTRTF-------SHASDTWMFGVTLWEMF 218
Query: 362 T-GSIPWAGLSAEEIYRAVVKN--RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
T G PW GL+ +I + K R P+ P++++ ++ +C K RPT
Sbjct: 219 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDC-------PQDIYNVMVQCWAHKPEDRPT 271
Query: 419 FSAMLATF 426
F A+
Sbjct: 272 FVALRDFL 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 71/303 (23%), Positives = 120/303 (39%), Gaps = 61/303 (20%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKV-MIAEEMEPDWLSGQL 190
D++ + +LG G A V + RH +AVK++ E L L
Sbjct: 8 DLEPIMELGRG--AYGVVE---------KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQR--NEGRLTLEQILRYGA 248
D R C TF+G L + + + M+ S+ ++ ++G+ E IL
Sbjct: 57 DISMRTVD-CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK-- 113
Query: 249 DIARGVVE----LHAAGVVC-MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
IA +V+ LH+ V ++KPSN+L++A G+ + D+G++ L
Sbjct: 114 -IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-----------V 161
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
D C Y APE P + G S +SD WS G T++E+
Sbjct: 162 DDVAKDIDAGC----KPYMAPERINPEL--------NQKGYSVKSDIWSLGITMIELAIL 209
Query: 364 SIPWAGLSAE-EIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS 420
P+ + + VV+ +LP S E +CL+ + +RPT+
Sbjct: 210 RFPYDSWGTPFQQLKQVVEEPSPQLPADKFS-------AEFVDFTSQCLKKNSKERPTYP 262
Query: 421 AML 423
++
Sbjct: 263 ELM 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 61/308 (19%), Positives = 120/308 (38%), Gaps = 63/308 (20%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS----- 187
V + +G G V+ G + + AVK + +L+
Sbjct: 25 LIVHFNEVIGRG--HFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 188 GQLDNLRRASMWCRNVCTFHGV-LRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
NV + G+ LR + +V+ +G ++ ++ T++ ++
Sbjct: 81 KDFS--------HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 246 YGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
+G +A+G+ L + V N +LD V+D+GLA R
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNC-----MLDEKFTVKVADFGLA--------RDMY 179
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
+ + +H+ L + A E+ + F + +SD WSFG L E+
Sbjct: 180 -DKEYYSVHN-KTGAKLPVKWMALESLQ-----TQKF-------TTKSDVWSFGVLLWEL 225
Query: 361 CT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
T G+ P+ ++ +I +++ R+L P+Y P L++++ +C KA RP+
Sbjct: 226 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPS 278
Query: 419 FSAMLATF 426
FS +++
Sbjct: 279 FSELVSRI 286
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 60/319 (18%), Positives = 120/319 (37%), Gaps = 67/319 (21%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
K+ LG+G AGV + H+ VA+K ++ + M +G + ++
Sbjct: 14 KVGNLLGKGSFAGVY---------RAESIHTGLEVAIK-MIDKKAMYK---AGMVQRVQN 60
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
+ ++ + + + LV++ C G + ++ + + +
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I G++ LH+ G++ ++ SNLLL + ++D+GLA + + + +
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------TQLKMPHEKHY 170
Query: 310 SCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
T+ +PNY +PE + ESD WS GC + G P+
Sbjct: 171 -----TLCGTPNYISPEIAT--RS----------AHGLESDVWSLGCMFYTLLIGRPPFD 213
Query: 369 GLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-- 425
+ + VV ++P + E +I + L+ + R + S++L
Sbjct: 214 TDTVKNTLNKVVLADYEMPSF--------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265
Query: 426 FLRHLQELPRSPPASPDTG 444
R+ S S D G
Sbjct: 266 MSRN------SSTKSKDEG 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 71/334 (21%), Positives = 117/334 (35%), Gaps = 80/334 (23%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
D+ L ++LGEG A +V+ + + VAVK + + + D
Sbjct: 14 RRDIVLKRELGEG--AFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAA----RKDFQ 65
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLGLVM----------------DRCYGSVQLAMQR 233
R A + ++ F+GV L +V V ++
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGL 287
+G L L Q+L + IA G+V L + V N L + V + D+G+
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC------LVGANLLVKIGDFGM 179
Query: 288 A-AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISP 346
+ + R TML + PE+ F +
Sbjct: 180 SRDVYSTDYYRVGG-------------HTMLPIRWMPPESIM-----YRKF-------TT 214
Query: 347 ESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKM 404
ESD WSFG L E+ T G PW LS E+ + + R L P+ P+E++ +
Sbjct: 215 ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR-------VCPKEVYDV 267
Query: 405 IGECLQFKASKRPTFSAMLATFLRHLQELPRSPP 438
+ C Q + +R + L L ++ P
Sbjct: 268 MLGCWQREPQQRLNIKEIYKI----LHALGKATP 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 77/338 (22%), Positives = 117/338 (34%), Gaps = 81/338 (23%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
D+ L +LGEG A +V+ + + VAVK + A E + D
Sbjct: 40 RRDIVLKWELGEG--AFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------RQDFQ 91
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLGLVM---------------DRCYGSVQLAMQRN 234
R A + +++ F GV L +V +
Sbjct: 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGLA 288
G L L Q+L + +A G+V L V N L G V + D+G++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC------LVGQGLVVKIGDFGMS 205
Query: 289 AILKKPACRKAR--PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISP 346
R D R+ TML + PE+ F +
Sbjct: 206 -----------RDIYSTDYYRVGGR---TMLPIRWMPPESIL-----YRKF-------TT 239
Query: 347 ESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKM 404
ESD WSFG L E+ T G PW LS E + + R+L P+ P E++ +
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-------ACPPEVYAI 292
Query: 405 IGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPD 442
+ C Q + +R + LQ L ++PP D
Sbjct: 293 MRGCWQREPQQRHSIK----DVHARLQALAQAPPVYLD 326
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 59/323 (18%), Positives = 114/323 (35%), Gaps = 69/323 (21%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAW--IGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLD 191
+ D+ + LG+G +++ G +G V +K ++ +
Sbjct: 7 NEDLIFNESLGQGTFT--KIFKGVRREVGDYGQLHETEVLLKV------LDKAHRNYSES 58
Query: 192 NLRRASM----WCRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRY 246
ASM +++ +GV LV + +GS+ +++N+ + + L
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 247 GADIARGVVELHAAGVV--------CMNIKPSNLLLDASGRAVVSDYGLA-AILKKPACR 297
+A + L ++ + I+ + +SD G++ +L K +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
+ RI + PE E K + +D WSFG TL
Sbjct: 179 E--------RI-----------PWVPPECIENPKN----L-------NLATDKWSFGTTL 208
Query: 358 VEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPR--ELWKMIGECLQFKAS 414
E+C+ G P + L ++ + +LP P+ EL +I C+ ++
Sbjct: 209 WEICSGGDKPLSALDSQRKLQFYEDRHQLPA----------PKAAELANLINNCMDYEPD 258
Query: 415 KRPTFSAMLATFLRHLQELPRSP 437
RP+F A + L L P
Sbjct: 259 HRPSFRA-IIRDLNSLFTPDLVP 280
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 72/356 (20%), Positives = 127/356 (35%), Gaps = 85/356 (23%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS----- 187
++ L++ LG G A EV+ G G VAVK + +E+ E D+L
Sbjct: 30 KNITLIRGLGHG--AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87
Query: 188 GQLDNLRRASMWCRNVCTFHGV-LRMDSCLGLVMDRC-YGSVQ--LAMQR----NEGRLT 239
+ + +N+ GV L+ ++M+ G ++ L R L
Sbjct: 88 SKFN--------HQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 240 LEQILRYGADIARGVVELHAAGVV--------CMNIKPSNLLLDASGRAV-VSDYGLAAI 290
+ +L DIA G L + C+ L GR + D+G+A
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCL------LTCPGPGRVAKIGDFGMA-- 190
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
R R C ML + PEA+ +F + ++D
Sbjct: 191 ------RDIY-RASYYRKGGC---AMLPVKWMPPEAF-----MEGIF-------TSKTDT 228
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGEC 408
WSFG L E+ + G +P+ S +E+ V ++ P+ P +++++ +C
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK-------NCPGPVYRIMTQC 281
Query: 409 LQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEV 464
Q + RP F+ L ++ + P + E P + +V
Sbjct: 282 WQHQPEDRPNFA----IILERIEYCTQDPD------VINTALPIEYGPLVEEEEKV 327
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 62/324 (19%), Positives = 119/324 (36%), Gaps = 73/324 (22%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
+ + ++LG+G + V+ G G + VA+K + ++L+
Sbjct: 24 REKITMSRELGQG--SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGS---------VQLAMQRNEG 236
+ + C +V GV+ ++M+ G +A
Sbjct: 82 MKEFN--------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 237 RLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGLAAI 290
+L ++++ +IA G+ L+A V N + A V + D+G+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC------MVAEDFTVKIGDFGMT-- 185
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
R E D R +L + +PE+ +F + SD
Sbjct: 186 ------RDIY-ETDYYRKGGK---GLLPVRWMSPESL-----KDGVF-------TTYSDV 223
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGEC 408
WSFG L E+ T P+ GLS E++ R V++ L P P L++++ C
Sbjct: 224 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD-------NCPDMLFELMRMC 276
Query: 409 LQFKASKRPTFSAMLATFLRHLQE 432
Q+ RP+F ++++ ++
Sbjct: 277 WQYNPKMRPSFLEIISSIKEEMEP 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 66/333 (19%), Positives = 120/333 (36%), Gaps = 85/333 (25%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+K +++LG+G V + VAVKK ++ D
Sbjct: 9 ERHLKFLQQLGKG--NFGSVEMCRYDPLQDNTGE-VVAVKK------LQHSTEEHLRDFE 59
Query: 194 RRA----SMWCRNVCTFHGVLRMDSCLG-------LVMD-RCYGSVQLAMQRNEGRLTLE 241
R S+ N+ + GV C L+M+ YGS++ +Q+++ R+
Sbjct: 60 REIEILKSLQHDNIVKYKGV-----CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 242 QILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
++L+Y + I +G+ L + NI L++ R + D+GL +L
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNI-----LVENENRVKIGDFGLTKVLP---- 165
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+ + APE+ + + F S SD WSFG
Sbjct: 166 -------QDKEFFKVKEPGESPIFWYAPESL-----TESKF-------SVASDVWSFGVV 206
Query: 357 LVEMCT----------------GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPR 399
L E+ T G+ + + + N +LP P G P
Sbjct: 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-------GCPD 259
Query: 400 ELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
E++ ++ EC ++RP+F LA + +++
Sbjct: 260 EIYMIMTECWNNNVNQRPSFRD-LALRVDQIRD 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 61/318 (19%), Positives = 120/318 (37%), Gaps = 63/318 (19%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS----- 187
V + +G G V+ G + + AVK + +L+
Sbjct: 89 LIVHFNEVIGRG--HFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 188 GQLDNLRRASMWCRNVCTFHGV-LRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILR 245
NV + G+ LR + +V+ +G ++ ++ T++ ++
Sbjct: 145 KDFS--------HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 246 YGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
+G +A+G+ L + V N +LD V+D+GLA R
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNC-----MLDEKFTVKVADFGLA--------RDMY 243
Query: 301 PECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
+ + +H+ L + A E+ + F + +SD WSFG L E+
Sbjct: 244 -DKEFDSVHN-KTGAKLPVKWMALESLQ-----TQKF-------TTKSDVWSFGVLLWEL 289
Query: 361 CT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
T G+ P+ ++ +I +++ R+L P+Y P L++++ +C KA RP+
Sbjct: 290 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPS 342
Query: 419 FSAMLATFLRHLQELPRS 436
FS +++
Sbjct: 343 FSELVSRISAIFSTFIGE 360
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 67/316 (21%), Positives = 127/316 (40%), Gaps = 57/316 (18%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNLR 194
+ +G+G V+ G +I Q R A+K + I E + + LR
Sbjct: 22 VTHSDRVIGKG--HFGVVYHGEYIDQAQNR--IQCAIKSLSRITEMQQVE------AFLR 71
Query: 195 RASM----WCRNVCTFHGV-LRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYGA 248
+ NV G+ L + +++ C+G + ++ + T++ ++ +G
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
+ARG+ L V ++ N +LD S V+D+GLA R + + +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA--------RDIL-DREYYSV 182
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPW 367
L +TA E+ + F + +SD WSFG L E+ T G+ P+
Sbjct: 183 QQ-HRHARLPVKWTALESLQ-----TYRF-------TTKSDVWSFGVLLWELLTRGAPPY 229
Query: 368 AGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS---AML 423
+ ++ + + R+LP P+Y P L++++ +C + + RPTF +
Sbjct: 230 RHIDPFDLTHFLAQGRRLPQPEYC-------PDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 424 ATFLR-----HLQELP 434
+ H +LP
Sbjct: 283 EQIVSALLGDHYVQLP 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 54/311 (17%), Positives = 109/311 (35%), Gaps = 60/311 (19%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D ++ + LG+G+ V + R + S +A+K V+ ++E +G L
Sbjct: 10 DFEIGRPLGKGKFGNVYL---------AREKQSKFILALK-VLFKAQLEK---AGVEHQL 56
Query: 194 RR-ASMWCR----NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGA 248
RR + N+ +G + + L+++ + + ++ Y
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
++A + H+ V+ +IKP NLLL ++G ++D+G + S R
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----------SSRRT 165
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
C + +Y PE ++ + D WS G E G P+
Sbjct: 166 DLCG-----TLDYLPPEM---IEGR---------MHDEKVDLWSLGVLCYEFLVGKPPFE 208
Query: 369 GLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-- 425
+ +E Y+ + + P + +I L+ S+RP +L
Sbjct: 209 ANTYQETYKRISRVEFTFPDF--------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
Query: 426 FLRHLQELPRS 436
+ +
Sbjct: 261 ITANSSKPSNC 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 66/332 (19%), Positives = 120/332 (36%), Gaps = 83/332 (25%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
+K +++LG+G V Q VAVKK ++ D R
Sbjct: 40 ERHLKFLQQLGKG--NFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFER 91
Query: 195 RASM----WCRNVCTFHGVLRMDSCLG-------LVMD-RCYGSVQLAMQRNEGRLTLEQ 242
+ N+ + GV C L+M+ YGS++ +Q+++ R+ +
Sbjct: 92 EIEILKSLQHDNIVKYKGV-----CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
Query: 243 ILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
+L+Y + I +G+ L + NI L++ R + D+GL +L
Sbjct: 147 LLQYTSQICKGMEYLGTKRYIHRDLATRNI-----LVENENRVKIGDFGLTKVLP----- 196
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
+ + + APE+ + + F S SD WSFG L
Sbjct: 197 ------QDKEYYKVKEPGESPIFWYAPESL-----TESKF-------SVASDVWSFGVVL 238
Query: 358 VEMCT----------------GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRE 400
E+ T G+ + + + N +LP P G P E
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-------GCPDE 291
Query: 401 LWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
++ ++ EC ++RP+F LA + +++
Sbjct: 292 IYMIMTECWNNNVNQRPSFRD-LALRVDQIRD 322
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 71/356 (19%), Positives = 126/356 (35%), Gaps = 85/356 (23%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
++ L++ LG G A EV+ G G VAVK + +E+ E D+L
Sbjct: 70 RKNITLIRGLGHG--AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 188 -GQLDNLRRASMWCRNVCTFHGV-LRMDSCLGLVMDRC-YGSVQ--LAMQR----NEGRL 238
+ + +N+ GV L+ ++++ G ++ L R L
Sbjct: 128 ISKFN--------HQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 239 TLEQILRYGADIARGVVELHAAGVV--------CMNIKPSNLLLDASGRAV-VSDYGLAA 289
+ +L DIA G L + C+ L GR + D+G+A
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL------LTCPGPGRVAKIGDFGMA- 231
Query: 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
R R C ML + PEA+ +F + ++D
Sbjct: 232 -------RDI-YRAGYYRKGGC---AMLPVKWMPPEAF-----MEGIF-------TSKTD 268
Query: 350 AWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGE 407
WSFG L E+ + G +P+ S +E+ V ++ P+ P +++++ +
Sbjct: 269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK-------NCPGPVYRIMTQ 321
Query: 408 CLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVE 463
C Q + RP F A L ++ + P + E P + +
Sbjct: 322 CWQHQPEDRPNF----AIILERIEYCTQDPD------VINTALPIEYGPLVEEEEK 367
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 64/326 (19%), Positives = 110/326 (33%), Gaps = 72/326 (22%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLSGQLD 191
L + LG+G V VAVK K I + + +
Sbjct: 22 EQQFTLGRMLGKG--EFGSVREAQLKQEDGSF--VKVAVKMLKADIIASSDIE------E 71
Query: 192 NLRRASM----WCRN------VCTFHGVLRMDSCLGLVMDRC-YGSV-----QLAMQRNE 235
LR A+ + V +++ +G + + N
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAI 290
L L+ ++R+ DIA G+ L + + N +L V+D+GL+
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC-----MLAEDMTVCVADFGLS-- 184
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
RK D R + L + A E+ NL+ + SD
Sbjct: 185 ------RKIY-SGDYYRQGCA---SKLPVKWLALESLA-----DNLY-------TVHSDV 222
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGEC 408
W+FG T+ E+ T G P+AG+ EIY ++ +L P E++ ++ +C
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP-------ECMEEVYDLMYQC 275
Query: 409 LQFKASKRPTFSAMLATFLRHLQELP 434
+RP+F+ + L L
Sbjct: 276 WSADPKQRPSFTCLRMELENILGHLS 301
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 41/303 (13%), Positives = 76/303 (25%), Gaps = 63/303 (20%)
Query: 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR-ASM 198
L+ G ++ W A VA+ V + D L L R + +
Sbjct: 35 LLIFHGGV--PPLQFWQAL----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELH 258
V V+ + +V + G L + + + +R +A H
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGG-SLQ-EVADTSPSPVGAIRAMQSLAAAADAAH 146
Query: 259 AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318
AGV PS + + G V++
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAY---------------------------------- 172
Query: 319 PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRA 378
P +P+ D G +L + P
Sbjct: 173 PATMPDA-------------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213
Query: 379 VVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPP 438
++ P + + IP ++ + +Q R S +L + R+
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
Query: 439 ASP 441
P
Sbjct: 273 LGP 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-16
Identities = 74/382 (19%), Positives = 137/382 (35%), Gaps = 100/382 (26%)
Query: 81 NTNQHHNSNTNHFDSDVTDDDDDDEDD-EVDEFGRGTHVSSSGVGVCGPVIEVGVHHDVK 139
++ HH+ +++ +++ + +D +D + +
Sbjct: 2 GSSHHHHHHSSGLVPRGSEELQNKLEDVVID------------------------RNLLI 37
Query: 140 LVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLSGQLDNLRRA 196
L K LGEG V G VAVK K+ + + E + + L A
Sbjct: 38 LGKILGEG--EFGSVMEGNLKQEDGTS--LKVAVKTMKLDNSSQREIE------EFLSEA 87
Query: 197 SM----WCRNVCTFHGV-LRMDSCLG----LVMDRC-YGSV-----QLAMQRNEGRLTLE 241
+ NV GV + M S +++ YG + ++ + L+
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 242 QILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+L++ DIA G+ L + N +L V+D+GL+
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNC-----MLRDDMTVCVADFGLS-------- 194
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWDDAIGISPESDAWSFG 354
+K D R + + A E SL ++ + +SD W+FG
Sbjct: 195 KKIY-SGDYYRQGRI---AKMPVKWIAIE-------SLADRVY-------TSKSDVWAFG 236
Query: 355 CTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFK 412
T+ E+ T G P+ G+ E+Y ++ +L P+ EL++++ C +
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC-------LDELYEIMYSCWRTD 289
Query: 413 ASKRPTFSAMLATFLRHLQELP 434
RPTFS + + L+ LP
Sbjct: 290 PLDRPTFSVLRLQLEKLLESLP 311
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 58/319 (18%), Positives = 108/319 (33%), Gaps = 64/319 (20%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D + + LG+G+ V R + + +A+K V+ ++E G L
Sbjct: 15 DFDIGRPLGKGKFGNVY---------LAREKQNKFIMALK-VLFKSQLEK---EGVEHQL 61
Query: 194 RR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGA 248
RR + + N+ + + L+++ + GR ++ +
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
++A + H V+ +IKP NLL+ G ++D+G + S R
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------HAPSLRR 169
Query: 309 HSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
TM + +Y PE E K + D W G E G P+
Sbjct: 170 R-----TMCGTLDYLPPEMIE--GK----------THDEKVDLWCAGVLCYEFLVGMPPF 212
Query: 368 AGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT- 425
S E +R +V K PP + +I + L++ +R ++
Sbjct: 213 DSPSHTETHRRIVNVDLKFPPF--------LSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
Query: 426 -FLRHLQELPRSPPASPDT 443
+ + + PP T
Sbjct: 265 WVKANSRRVL--PPVYQST 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 60/324 (18%), Positives = 107/324 (33%), Gaps = 77/324 (23%)
Query: 135 HHDVKLVK-KLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS--- 187
++ + +LG G V G + + + VA+K K + + +
Sbjct: 8 RDNLLIADIELGCGNFG--SVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 188 --GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDR-CYGSVQLAMQRNEGRLTL 240
QLDN + GV C LVM+ G + + + +
Sbjct: 63 IMHQLDN--------PYIVRLIGV-----CQAEALMLVMEMAGGGPLHKFLVGKREEIPV 109
Query: 241 EQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLA-AILKKP 294
+ ++ G+ L V N+ LL A +SD+GL+ A+
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNV-----LLVNRHYAKISDFGLSKALGADD 164
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
+ AR + APE + F S SD WS+G
Sbjct: 165 SYYTARSA------------GKWPLKWYAPECI-----NFRKF-------SSRSDVWSYG 200
Query: 355 CTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFK 412
T+ E + G P+ + E+ + + +++ P P EL+ ++ +C +K
Sbjct: 201 VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-------ECPPELYALMSDCWIYK 253
Query: 413 ASKRPTFSAMLATFLRHLQELPRS 436
RP F + +R S
Sbjct: 254 WEDRPDFLT-VEQRMRACYYSLAS 276
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 61/312 (19%), Positives = 117/312 (37%), Gaps = 61/312 (19%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
++ V+++G G+ V G W+ + VA+K I E M + D
Sbjct: 7 PSELTFVQEIGSGQFG--LVHLGYWLN------KDKVAIK--TIREGAMSEE------DF 50
Query: 193 LRRAS----MWCRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYG 247
+ A + + +GV + + LV + +G + ++ G E +L
Sbjct: 51 IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
D+ G+ L A V+ ++ N L+ + VSD+G+ + +
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-------- 162
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
T + +PE + S + + S +SD WSFG + E+ + G IP
Sbjct: 163 -----TGTKFPVKWASPEVF-----SFSRY-------SSKSDVWSFGVLMWEVFSEGKIP 205
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+ S E+ + +L P+ +++++ C + + RP FS +L
Sbjct: 206 YENRSNSEVVEDISTGFRLYKPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258
Query: 426 FLRHLQELPRSP 437
L E+ S
Sbjct: 259 ----LAEIAESG 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 59/307 (19%), Positives = 117/307 (38%), Gaps = 57/307 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
D+ +K+LG G+ V G W G ++ VA+K MI E M D +
Sbjct: 23 PKDLTFLKELGTGQFG--VVKYGKWRG------QYDVAIK--MIKEGSMSED------EF 66
Query: 193 LRRASM----WCRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYG 247
+ A + + +GV + ++ + G + ++ R +Q+L
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
D+ + L + + ++ N L++ G VSD+GL+ +
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-------------DD 173
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
++ + ++ PE + F S +SD W+FG + E+ + G +P
Sbjct: 174 EYTSSVGSKFPVRWSPPEVL-----MYSKF-------SSKSDIWAFGVLMWEIYSLGKMP 221
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+ + E + + +L P +++ ++ C KA +RPTF +L+
Sbjct: 222 YERFTNSETAEHIAQGLRLYRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSN 274
Query: 426 FLRHLQE 432
L + E
Sbjct: 275 ILDVMDE 281
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 70/340 (20%), Positives = 117/340 (34%), Gaps = 92/340 (27%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVM-IAEEMEPDWLS----- 187
+K + +LG+G V + G VAVK++ + + D+
Sbjct: 22 ERHLKYISQLGKG--NFGSVELCRYDPLGDNT-GALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 188 GQLDNLRRASMWCRNVCTFHGVLRMDSCLG-------LVMD-RCYGSVQLAMQRNEGRLT 239
L + + GV G LVM+ G ++ +QR+ RL
Sbjct: 79 KALH--------SDFIVKYRGV-----SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 240 LEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLA-AILKK 293
++L Y + I +G+ L + V NI L+++ ++D+GLA +
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI-----LVESEAHVKIADFGLAKLLPLD 180
Query: 294 PACRKARPECDSSRIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
R S P + APE+ S N+F S +SD WS
Sbjct: 181 KDYYVVREPGQS-------------PIFWYAPESL-----SDNIF-------SRQSDVWS 215
Query: 353 FGCTLVEMCT-GSIPWA--------------GLSAEEIYRAVVKNRKLP-PQYASIVGVG 396
FG L E+ T + + + + + ++LP P
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP-------A 268
Query: 397 IPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRS 436
P E+ +++ C RP+FSA L L L R
Sbjct: 269 CPAEVHELMKLCWAPSPQDRPSFSA-LGPQLDMLWSGSRG 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-15
Identities = 76/316 (24%), Positives = 134/316 (42%), Gaps = 64/316 (20%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+KL KKLG G+ EVW + VAVK M M + L
Sbjct: 187 RESLKLEKKLGAGQFG--EVWMATY------NKHTKVAVK-TMKPGSMSVE------AFL 231
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLGLVMD-RCYGSVQLAMQRNEGR-LTLEQILRYG 247
A++ + H V+ + ++ + GS+ ++ +EG L +++ +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
A IA G+ + + +++ +N+L+ AS ++D+GLA R D+
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA-----------RVIEDNEY 339
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
+ +TAPEA + F + +SD WSFG L+E+ T G IP
Sbjct: 340 TAR--EGAKFPIKWTAPEAI-----NFGSF-------TIKSDVWSFGILLMEIVTYGRIP 385
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS---AM 422
+ G+S E+ RA+ + ++P P+ P EL+ ++ C + + +RPTF ++
Sbjct: 386 YPGMSNPEVIRALERGYRMPRPE-------NCPEELYNIMMRCWKNRPEERPTFEYIQSV 438
Query: 423 LATFLRH----LQELP 434
L F +E+P
Sbjct: 439 LDDFYTATESQYEEIP 454
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 43/211 (20%), Positives = 79/211 (37%), Gaps = 34/211 (16%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
+ G L+++ + + I G+ H +V +IKP N+L+D++ + D+G+
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI----- 157
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG--ISPESDA 350
A+ ++S + + + Y +PE A G +D
Sbjct: 158 ------AKALSETSLTQTNH--VLGTVQYFSPE--------------QAKGEATDECTDI 195
Query: 351 WSFGCTLVEMCTGSIPWAGLSAEEI-YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECL 409
+S G L EM G P+ G +A I + + + P + V IP+ L +I
Sbjct: 196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHI---QDSVPNVTTDVRKDIPQSLSNVILRAT 252
Query: 410 QFKASKRP-TFSAMLATFLRHLQELPRSPPA 439
+ + R T M L E +
Sbjct: 253 EKDKANRYKTIQEMKDDLSSVLHENRANEDV 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 51/231 (22%), Positives = 91/231 (39%), Gaps = 34/231 (14%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
EG +T ++ + AD + + H G++ ++KP+N+++ A+ V D+G+A
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA---- 163
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG--ISPESDA 350
+A + +S + + + Y +PE A G + SD
Sbjct: 164 -----RAIADSGNSVTQTAA--VIGTAQYLSPE--------------QARGDSVDARSDV 202
Query: 351 WSFGCTLVEMCTGSIPWAGLSAEEI-YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECL 409
+S GC L E+ TG P+ G S + Y+ V ++ P G+ +L ++ + L
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE----GLSADLDAVVLKAL 258
Query: 410 QFKASKRP-TFSAMLATFLRHLQELPRS-PPASPDTGFTKFSTSNETEPSP 458
R T + M A +R P P D T +S S
Sbjct: 259 AKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLSG 309
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-15
Identities = 70/313 (22%), Positives = 120/313 (38%), Gaps = 68/313 (21%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++KL++ +G+G +V G + G + VAVK I + L
Sbjct: 192 MKELKLLQTIGKGEFG--DVMLGDYRG-------NKVAVK--CIKNDATAQ------AFL 234
Query: 194 RRASM----WCRNVCTFHGV-LRMDSCLGLVMD-RCYGSVQLAMQRNEGR-LTLEQILRY 246
AS+ N+ GV + L +V + GS+ ++ L + +L++
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
D+ + L V ++ N+L+ A VSD+GL ++A D+
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--------KEASSTQDTG 346
Query: 307 RIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
++ P +TAPEA F S +SD WSFG L E+ + G
Sbjct: 347 KL----------PVKWTAPEAL-----REKKF-------STKSDVWSFGILLWEIYSFGR 384
Query: 365 IPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS--- 420
+P+ + +++ V K K+ P G P ++ ++ C A+ RPTF
Sbjct: 385 VPYPRIPLKDVVPRVEKGYKMDAPD-------GCPPAVYDVMKNCWHLDAATRPTFLQLR 437
Query: 421 AMLATFLRHLQEL 433
L H L
Sbjct: 438 EQLEHIRTHELHL 450
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-15
Identities = 62/336 (18%), Positives = 112/336 (33%), Gaps = 88/336 (26%)
Query: 135 HHDVKLVK-KLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS--- 187
++ + +LG G V G + + + VA+K K + + +
Sbjct: 334 RDNLLIADIELGCGNFG--SVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 188 --GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDR-CYGSVQLAMQRNEGRLTL 240
QLDN + GV C LVM+ G + + + +
Sbjct: 389 IMHQLDN--------PYIVRLIGV-----CQAEALMLVMEMAGGGPLHKFLVGKREEIPV 435
Query: 241 EQILRYGADIARGVVEL------H---AAGVVCMNIKPSNLLLDASGRAVVSDYGLA-AI 290
+ ++ G+ L H AA N+LL A +SD+GL+ A+
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAA---------RNVLLVNRHYAKISDFGLSKAL 486
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
+ AR + APE + F S SD
Sbjct: 487 GADDSYYTARSA------------GKWPLKWYAPECI-----NFRKF-------SSRSDV 522
Query: 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGEC 408
WS+G T+ E + G P+ + E+ + + +++ P P EL+ ++ +C
Sbjct: 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-------ECPPELYALMSDC 575
Query: 409 LQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTG 444
+K RP F + ++ S + + G
Sbjct: 576 WIYKWEDRPDFLTVEQR----MRACYYSLASKVEGG 607
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 65/305 (21%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+KLV++LG G+ EVW G + G VAVK + M PD L
Sbjct: 12 RETLKLVERLGAGQFG--EVWMGYYNG------HTKVAVK-SLKQGSMSPD------AFL 56
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLG----LVMD-RCYGSVQLAMQRNEGR-LTLEQI 243
A++ + + + V ++ + GS+ ++ G LT+ ++
Sbjct: 57 AEANLMKQLQHQRLVRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
L A IA G+ + + +++ +N+L+ + ++D+GLA R
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-----------RLIE 160
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362
D+ + +TAPEA + F + +SD WSFG L E+ T
Sbjct: 161 DNEYTAR--EGAKFPIKWTAPEAI-----NYGTF-------TIKSDVWSFGILLTEIVTH 206
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
G IP+ G++ E+ + + + ++ P P EL++++ C + + RPTF
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPD-------NCPEELYQLMRLCWKERPEDRPTFDY 259
Query: 422 MLATF 426
+ +
Sbjct: 260 LRSVL 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-15
Identities = 76/397 (19%), Positives = 130/397 (32%), Gaps = 68/397 (17%)
Query: 128 PVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLS 187
P E + + V K LG G V G++ G VAVK+++I D
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQG-------RPVAVKRMLIDFC---DIAL 56
Query: 188 GQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQ------LAMQRNEGRLTLE 241
++ L S NV ++ D L + ++ C ++Q N
Sbjct: 57 MEIKLLTE-SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-------------RAVVSDYGLA 288
+ IA GV LH+ ++ ++KP N+L+ S R ++SD+GL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
L S + ++ + + APE E ++
Sbjct: 176 KKLDS----------GQSSFRTNLNNPSGTSGWRAPELLEESNNL-----QTKRRLTRSI 220
Query: 349 DAWSFGCTLVEM-CTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE 407
D +S GC + G P+ + E +++ + + + E +I +
Sbjct: 221 DIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 408 CLQFKASKRPTFSAMLA-----------TFLR----HLQELPRSPPASPDTGFTKFSTSN 452
+ KRPT +L FL L+ R PP++ F S
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFV 338
Query: 453 ETEPSPASDVEV-FQDNPNNLHQLVSEGDVSGVRDLL 488
+ F DN + S + DLL
Sbjct: 339 IPSGDWTVKFDKTFMDNLERYRK----YHSSKLMDLL 371
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 58/307 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
++ L+K+LG G+ V G W G ++ VAVK MI E M D +
Sbjct: 7 REEITLLKELGSGQFG--VVKLGKWKG------QYDVAVK--MIKEGSMSED------EF 50
Query: 193 LRRASM----WCRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGRLTLEQILRYG 247
+ A + F+GV + + +V + G + ++ + L Q+L
Sbjct: 51 FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
D+ G+ L + + ++ N L+D VSD+G+ R D
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-----------RYVLDDQY 159
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIP 366
+ S T ++APE + + S +SD W+FG + E+ + G +P
Sbjct: 160 VSS--VGTKFPVKWSAPEVF-----HYFKY-------SSKSDVWAFGILMWEVFSLGKMP 205
Query: 367 WAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+ + E+ V + +L P +++++ C KRPTF L +
Sbjct: 206 YDLYTNSEVVLKVSQGHRLYRPH-------LASDTIYQIMYSCWHELPEKRPTFQQ-LLS 257
Query: 426 FLRHLQE 432
+ L+E
Sbjct: 258 SIEPLRE 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 26/182 (14%)
Query: 202 NVCTFHGVLR--MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA 259
NV VL + L +V + + L+ +Q Y D+ +G+ LH
Sbjct: 97 NVVKLVEVLDDPNEDHLYMVFELVNQG-PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY 155
Query: 260 AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
++ +IKPSNLL+ G ++D+G++ K D+ ++ +P
Sbjct: 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS---------DALLSNTVG-----TP 201
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAV 379
+ APE+ +K + D W+ G TL G P+ ++ +
Sbjct: 202 AFMAPESLSETRKIFS---------GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 380 VK 381
Sbjct: 253 KS 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 60/339 (17%), Positives = 118/339 (34%), Gaps = 89/339 (26%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLD 191
++ L K LGEG G +V +VAVK M+ E + D
Sbjct: 22 RKNLVLGKTLGEG--EFG-KVVKATAFHLKGRAGYTTVAVK--MLKENASPSE----LRD 72
Query: 192 NLRRASM----WCRNVCTFHGV----------------------LRM--DSCLGLVMDRC 223
L ++ +V +G LR G +
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 224 YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASG 278
+ +E LT+ ++ + I++G+ L +V NI L+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI-----LVAEGR 187
Query: 279 RAVVSDYGLA-AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--N 335
+ +SD+GL+ + ++ + K + + A E SL +
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRS-------------QGRIPVKWMAIE-------SLFDH 227
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIV 393
++ + +SD WSFG L E+ T G P+ G+ E ++ + ++ P
Sbjct: 228 IY-------TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNC--- 277
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
E+++++ +C + + KRP F+ + + + +
Sbjct: 278 ----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 60/328 (18%), Positives = 113/328 (34%), Gaps = 79/328 (24%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS----- 187
+K ++ LGEG +V VAVK K D
Sbjct: 20 KRFLKRIRDLGEG--HFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 188 GQLDNLRRASMWCRNVCTFHGVLRMDSC--LGLVMD-RCYGSVQLAMQRNEGRLTLEQIL 244
L N+ + G+ D + L+M+ GS++ + +N+ ++ L+Q L
Sbjct: 78 RNLY--------HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 245 RYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299
+Y I +G+ L + V N+ L+++ + + D+GL ++
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNV-----LVESEHQVKIGDFGLTKAIE------- 177
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
++ D + APE + F SD WSFG TL E
Sbjct: 178 ----TDKEYYTVKDDRDSPVFWYAPECL-----MQSKF-------YIASDVWSFGVTLHE 221
Query: 360 MCT---------------GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWK 403
+ T ++ + + + ++LP P P E+++
Sbjct: 222 LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPP-------NCPDEVYQ 274
Query: 404 MIGECLQFKASKRPTFS---AMLATFLR 428
++ +C +F+ S R +F L+
Sbjct: 275 LMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 42/311 (13%), Positives = 83/311 (26%), Gaps = 60/311 (19%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM 198
+ LGEG A V + + +K A E + ++ L+
Sbjct: 68 YVHHLLGEGAFAQV-YEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK--PS 124
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRC-YGS----VQLAMQRNEGRLTLEQILRYGADIARG 253
F+ + LV + YG+ + L E + ++ + +
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 254 VVELHAAGVVCMNIKPSNLLL-----------DASGRAVVSDYGLAAILKKPACRKARPE 302
+ ++H ++ +IKP N +L D S + D G + +K
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP------- 237
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ + C + + E K W+ + D + T+ M
Sbjct: 238 -KGTIFTA--KCE--TSGFQCVEMLS--NKP----WN------YQIDYFGVAATVYCMLF 280
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMI-GECLQFKASKRPTFSA 421
G+ E + P ++W L
Sbjct: 281 GTYMKVKNEGGECKPE--GLFRRLPH----------LDMWNEFFHVMLNIPDCHHLP--- 325
Query: 422 MLATFLRHLQE 432
LR +
Sbjct: 326 -SLDLLRQKLK 335
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 60/338 (17%), Positives = 107/338 (31%), Gaps = 87/338 (25%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
++++ V+ +GEG A V+ G VAVK K + +M+ D+
Sbjct: 46 RNNIEYVRDIGEG--AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 188 -GQLDNLRRASMWCRNVCTFHGV----------------------LRM--DSCLGLVMDR 222
+ D N+ GV LR + +
Sbjct: 104 MAEFD--------NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 223 CYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDAS 277
+ L+ + L +A G+ L V N L
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC------LVGE 209
Query: 278 GRAV-VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNL 336
V ++D+GL+ R D + + + PE+ N
Sbjct: 210 NMVVKIADFGLS--------RNIY-SADYYKADGN---DAIPIRWMPPESIF-----YNR 252
Query: 337 FWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVG 394
+ + ESD W++G L E+ + G P+ G++ EE+ V L P+
Sbjct: 253 Y-------TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE------ 299
Query: 395 VGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
P EL+ ++ C + RP+F ++ R +
Sbjct: 300 -NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 68/315 (21%), Positives = 121/315 (38%), Gaps = 72/315 (22%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLS----- 187
++KL++ +G+G +V G + G + VAVK I + +L+
Sbjct: 20 MKELKLLQTIGKGEFG--DVMLGDYRG-------NKVAVK--CIKNDATAQAFLAEASVM 68
Query: 188 GQLDNLRRASMWCRNVCTFHGV-LRMDSCLGLVMDRC-YGSVQLAMQRNEGR-LTLEQIL 244
QL N+ GV + L +V + GS+ ++ L + +L
Sbjct: 69 TQLR--------HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 245 RYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
++ D+ + L V ++ N+L+ A VSD+GL ++A D
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--------KEASSTQD 172
Query: 305 SSRIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362
+ ++ P +TAPEA F S +SD WSFG L E+ +
Sbjct: 173 TGKL----------PVKWTAPEAL-----REKKF-------STKSDVWSFGILLWEIYSF 210
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFS- 420
G +P+ + +++ V K K+ P P +++++ C A+ RP+F
Sbjct: 211 GRVPYPRIPLKDVVPRVEKGYKMDAPDGC-------PPAVYEVMKNCWHLDAAMRPSFLQ 263
Query: 421 --AMLATFLRHLQEL 433
L H L
Sbjct: 264 LREQLEHIKTHELHL 278
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 69/333 (20%), Positives = 120/333 (36%), Gaps = 82/333 (24%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLD 191
+KL K LG G A G +V G + +VAVK M+ E +
Sbjct: 26 RDRLKLGKPLGRG--AFG-QVIEADAFGIDKTATCRTVAVK--MLKEGATHSE----HRA 76
Query: 192 NLRRASMWCR-----NVCTFHGV-LRMDSCLGLVMDRC-YGS---------------VQL 229
+ + NV G + L ++++ C +G+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 230 AMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSD 284
+ LTLE ++ Y +A+G+ L + + NI LL + D
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI-----LLSEKNVVKICD 191
Query: 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWDDAI 342
+GLA R + L + APE ++ ++
Sbjct: 192 FGLA--------RDIY-KDPDYVRKGD---ARLPLKWMAPE-------TIFDRVY----- 227
Query: 343 GISPESDAWSFGCTLVEMCT-GSIPWAGLSA-EEIYRAVVKNRKLP-PQYASIVGVGIPR 399
+ +SD WSFG L E+ + G+ P+ G+ EE R + + ++ P Y
Sbjct: 228 --TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT-------TP 278
Query: 400 ELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
E+++ + +C + S+RPTFS ++ LQ
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 64/315 (20%), Positives = 109/315 (34%), Gaps = 75/315 (23%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNL 193
V+ +++LGE R +V+ G G G +VA+K + ++ P + +
Sbjct: 9 SAVRFMEELGEDRFG--KVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPL----REEFR 60
Query: 194 RRASM----WCRNVCTFHGVLRMDSCLGLVM----------------DRCYGSVQLAMQR 233
A + NV GV+ D L ++ +
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGL 287
+ L + A IA G+ L + VV N+ L V +SD GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV------LVYDKLNVKISDLGL 174
Query: 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPE 347
+ D ++ ++L + APEA F S +
Sbjct: 175 FREVY---------AADYYKLLGN---SLLPIRWMAPEAIM-----YGKF-------SID 210
Query: 348 SDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMI 405
SD WS+G L E+ + G P+ G S +++ + + LP P P ++ ++
Sbjct: 211 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD-------DCPAWVYALM 263
Query: 406 GECLQFKASKRPTFS 420
EC S+RP F
Sbjct: 264 IECWNEFPSRRPRFK 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-14
Identities = 41/211 (19%), Positives = 66/211 (31%), Gaps = 33/211 (15%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
R +G L + + I + HAAG ++KP N+L+ A A + D+G+
Sbjct: 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI----- 180
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG--ISPESDA 350
A D T+ + Y APE + +D
Sbjct: 181 ------ASATTDEKLTQLGN--TVGTLYYMAPER--------------FSESHATYRADI 218
Query: 351 WSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQ 410
++ C L E TGS P+ G + + + S V GIP +I +
Sbjct: 219 YALTCVLYECLTGSPPYQGDQLSVMGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMA 274
Query: 411 FKASKRPTFSAMLATFLRHLQELPRSPPASP 441
R L+ A+
Sbjct: 275 KNPEDRYVTCGDLSAAAHAALATADQDRATD 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 70/332 (21%), Positives = 124/332 (37%), Gaps = 80/332 (24%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVWGA---WIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQ 189
+ L K LGEG G +V A I + + +VAVK M+ ++ E D
Sbjct: 80 RDKLTLGKPLGEG--CFG-QVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKD----L 130
Query: 190 LDNLRRASMWCR-----NVCTFHGVLRMDSCLGLVMDRC-YGS---------------VQ 228
D + M N+ G D L ++++ G+
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 229 LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVS 283
+ E ++T + ++ +ARG+ L + + N+ L+ + ++
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-----LVTENNVMKIA 245
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
D+GLA R D + + L + APEA LF
Sbjct: 246 DFGLA--------RDIN-NIDYYKKTTN---GRLPVKWMAPEA---------LFD----R 280
Query: 344 I-SPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRE 400
+ + +SD WSFG + E+ T G P+ G+ EE+++ + + ++ P E
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANC-------TNE 333
Query: 401 LWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
L+ M+ +C S+RPTF ++ R L
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 68/333 (20%), Positives = 120/333 (36%), Gaps = 82/333 (24%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVWGA---WIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQ 189
+ L K LGEG A G +V A + + VAVK M+ + E D
Sbjct: 68 RDRLVLGKPLGEG--AFG-QVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKD----L 118
Query: 190 LDNLRRASMWCR-----NVCTFHGVLRMDSCLGLVMDRC-YGS---------------VQ 228
D + M N+ G D L ++++ G+
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 229 LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVS 283
E +L+ + ++ +ARG+ L + + N+ L+ ++
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV-----LVTEDNVMKIA 233
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWDDA 341
D+GLA R D + + L + APE +L ++
Sbjct: 234 DFGLA--------RDIH-HIDYYKKTTN---GRLPVKWMAPE-------ALFDRIY---- 270
Query: 342 IGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPR 399
+ +SD WSFG L E+ T G P+ G+ EE+++ + + ++ P
Sbjct: 271 ---THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-------TN 320
Query: 400 ELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
EL+ M+ +C S+RPTF ++ R +
Sbjct: 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 67/317 (21%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+L + +G G A V C VA+K + E+ + +D L +
Sbjct: 18 ELQEVIGSGATA--VVQ-------AAYCAPKKEKVAIK-RINLEKCQTS-----MDELLK 62
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYG--------SVQLAMQRNEGRLTLEQ 242
+ N+ +++ + L LVM G + + G L
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 243 I---LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKA 299
I LR ++ G+ LH G + ++K N+LL G ++D+G++A L
Sbjct: 123 IATILR---EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 300 RPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
R T + +P + APE E V+ G ++D WSFG T +
Sbjct: 180 N----KVRK------TFVGTPCWMAPEVMEQVR-----------GYDFKADIWSFGITAI 218
Query: 359 EMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELW-----KMIGECLQFKA 413
E+ TG+ P+ ++ ++N PP + V + + KMI CLQ
Sbjct: 219 ELATGAAPYHKYPPMKVLMLTLQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276
Query: 414 SKRPTFSAMLAT-FLRH 429
KRPT + +L F +
Sbjct: 277 EKRPTAAELLRHKFFQK 293
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-14
Identities = 71/332 (21%), Positives = 125/332 (37%), Gaps = 80/332 (24%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVWGA---WIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQ 189
+ L K LGEG A G +V A I + + +VAVK M+ ++ E D
Sbjct: 34 RDKLTLGKPLGEG--AFG-QVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKD----L 84
Query: 190 LDNLRRASMWCR-----NVCTFHGVLRMDSCLGLVMDRC-YGS---------------VQ 228
D + M N+ G D L ++++ G+
Sbjct: 85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVS 283
+ E ++T + ++ +ARG+ L + + N+ L+ + ++
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-----LVTENNVMKIA 199
Query: 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIG 343
D+GLA R D + + L + APEA LF
Sbjct: 200 DFGLA--------RDIN-NIDYYKKTTN---GRLPVKWMAPEA---------LFD----R 234
Query: 344 I-SPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRE 400
+ + +SD WSFG + E+ T G P+ G+ EE+++ + + ++ P E
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANC-------TNE 287
Query: 401 LWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
L+ M+ +C S+RPTF ++ R L
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 52/352 (14%), Positives = 109/352 (30%), Gaps = 87/352 (24%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+L+ +G+G + V A R + + V V+++ + + L+
Sbjct: 28 ELLTVIGKGFEDLMTVNLA-------RYKPTGEYVTVRRINLEACSNEM-----VTFLQG 75
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRN-EGRLTLEQILRYGA 248
N+ + D+ L +V YGS + + + + I A
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI----A 131
Query: 249 DIARGVVE----LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
I +GV++ +H G V ++K S++L+ G+ +S + R+
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ------ 185
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
+H ++ + +PE + + G +SD +S G T E+ G
Sbjct: 186 -RVVHDFPKYSVKVLPWLSPEVLQ----------QNLQGYDAKSDIYSVGITACELANGH 234
Query: 365 IPWAGL----------------------------------SAEEIYRAVVKNRKLPPQYA 390
+P+ + S + P
Sbjct: 235 VPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 294
Query: 391 SIVGVGIPRELW-----KMIGECLQFKASKRPTFSAMLA-TFLRHLQELPRS 436
+ + +CLQ RP+ S +L +F + ++
Sbjct: 295 GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-13
Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 27/186 (14%)
Query: 213 DSCLGLVMDRCY---GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKP 269
D+ L LVMD Y G + + + E RL E Y A++ + +H V +IKP
Sbjct: 146 DNNLYLVMD--YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 270 SNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEP 329
N+L+D +G ++D+G L + ++ +P+Y +PE
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG-------------TPDYISPEI--- 247
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV--KNRKLPP 387
L PE D WS G + EM G P+ S E Y ++ K R P
Sbjct: 248 ----LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 388 QYASIV 393
+ V
Sbjct: 304 TQVTDV 309
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 68/334 (20%), Positives = 111/334 (33%), Gaps = 81/334 (24%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVK--KVMIAEEMEPDWLS---- 187
+K ++ LGEG +V + G VAVK K + W
Sbjct: 30 KRYLKKIRDLGEGHFG--KVSLYCYDPTNDGTGEM-VAVKALKADAGPQHRSGWKQEIDI 86
Query: 188 -GQLDNLRRASMWCRNVCTFHGVLRMDSC--LGLVMD-RCYGSVQLAMQRNEGRLTLEQI 243
L ++ + G L LVM+ GS++ + R+ + L Q+
Sbjct: 87 LRTLY--------HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQL 136
Query: 244 LRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRK 298
L + I G+ LHA + N+ LLD + D+GLA +
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNV-----LLDNDRLVKIGDFGLAKAVP------ 185
Query: 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
+ + + + APE F SD WSFG TL
Sbjct: 186 -----EGHEYYRVREDGDSPVFWYAPECL-----KEYKF-------YYASDVWSFGVTLY 228
Query: 359 EMCT---------------GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELW 402
E+ T I ++ + + + +LP P P E++
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD-------KCPAEVY 281
Query: 403 KMIGECLQFKASKRPTFSAMLATFLRHLQELPRS 436
++ C + +AS RPTF L L+ + E +
Sbjct: 282 HLMKNCWETEASFRPTFEN-LIPILKTVHEKYQG 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 65/326 (19%), Positives = 112/326 (34%), Gaps = 78/326 (23%)
Query: 135 HHDVKLV-KKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLS----- 187
+ L K+LG G V G + +VAVK ++ E +P
Sbjct: 15 RKLLTLEDKELGSGNFG--TVKKGYYQMKKV---VKTVAVK-ILKNEANDPALKDELLAE 68
Query: 188 ----GQLDNLRRASMWCRNVCTFHGVLRMDSCLG----LVMDR-CYGSVQLAMQRNEGRL 238
QLDN + G+ C LVM+ G + + +
Sbjct: 69 ANVMQQLDN--------PYIVRMIGI-----CEAESWMLVMEMAELGPL-NKYLQQNRHV 114
Query: 239 TLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGLAAILKK 293
+ I+ ++ G+ L + V N+ LL A +SD+GL+ L+
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV-----LLVTQHYAKISDFGLSKALR- 168
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
A ++ H + APE + F S +SD WSF
Sbjct: 169 -----ADENYYKAQTH-----GKWPVKWYAPECI-----NYYKF-------SSKSDVWSF 206
Query: 354 GCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQF 411
G + E + G P+ G+ E+ + K ++ P G PRE++ ++ C +
Sbjct: 207 GVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-------GCPREMYDLMNLCWTY 259
Query: 412 KASKRPTFSAMLATFLRHLQELPRSP 437
RP F+A+ + ++
Sbjct: 260 DVENRPGFAAVELRLRNYYYDVVNEG 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 64/309 (20%), Positives = 128/309 (41%), Gaps = 59/309 (19%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
D+ + KLG G+ EV+ G W +VAVK + E+ ME + +
Sbjct: 12 RTDITMKHKLGGGQYG--EVYEGVWKKYSL-----TVAVK--TLKEDTMEVE------EF 56
Query: 193 LRRASM----WCRNVCTFHGVLRMDSCLGLVMDR-CYGSVQLAMQRNEGR-LTLEQILRY 246
L+ A++ N+ GV + ++ + YG++ ++ + ++ +L
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
I+ + L + ++ N L+ + V+D+GL+ ++ +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGA 172
Query: 307 RIHSCMDCTMLSP-NYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GS 364
+ P +TAPE+ + N F S +SD W+FG L E+ T G
Sbjct: 173 KF----------PIKWTAPESL-----AYNKF-------SIKSDVWAFGVLLWEIATYGM 210
Query: 365 IPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
P+ G+ ++Y + K+ ++ P+ P ++++++ C Q+ S RP+F+ +
Sbjct: 211 SPYPGIDLSQVYELLEKDYRMERPEGC-------PEKVYELMRACWQWNPSDRPSFAEIH 263
Query: 424 ATFLRHLQE 432
F QE
Sbjct: 264 QAFETMFQE 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 65/336 (19%), Positives = 116/336 (34%), Gaps = 87/336 (25%)
Query: 135 HHDVKLVKKLGEGRRA-GVEVW-GAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLD 191
+ + K LG G A G +V G + +VAVK + A E +
Sbjct: 22 RNRLSFGKTLGAG--AFG-KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE------A 72
Query: 192 NLRRASMWCR-----NVCTFHGVLRMDSCLGLVM------------------DRCYGSVQ 228
+ + N+ G + ++ C +
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 229 LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-V 282
M+ +E L LE +L + +A+G+ L + + NI L GR +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI------LLTHGRITKI 186
Query: 283 SDYGLA-AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWD 339
D+GLA I L + APE S+ ++
Sbjct: 187 CDFGLARDIKNDSNYVVKG-------------NARLPVKWMAPE-------SIFNCVY-- 224
Query: 340 DAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA-EEIYRAVVKNRKLP-PQYASIVGVG 396
+ ESD WS+G L E+ + GS P+ G+ + Y+ + + ++ P++A
Sbjct: 225 -----TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHA------ 273
Query: 397 IPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
P E++ ++ C KRPTF ++ + + E
Sbjct: 274 -PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 53/297 (17%), Positives = 100/297 (33%), Gaps = 59/297 (19%)
Query: 159 IGGG------QGRCRHS---VAVKKV-MIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHG 208
IG G R + VA+KK+ ++ W + + N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 209 VLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVE----LHAAGVVC 264
+ LVM+ C GS ++ ++ L +I A + G ++ LH+ ++
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI----AAVTHGALQGLAYLHSHNMIH 177
Query: 265 MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTA 323
++K N+LL G + D+G A+I+ + + +P + A
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAP---AN----------------SFVGTPYWMA 218
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
PE + + + D WS G T +E+ P ++A A+
Sbjct: 219 PEVILAMDEG---------QYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA 266
Query: 384 KLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML-------ATFLRHLQEL 433
+ ++ + CLQ RPT +L + +L
Sbjct: 267 QNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 33/176 (18%), Positives = 56/176 (31%), Gaps = 43/176 (24%)
Query: 462 VEVFQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRR 521
P L + D+ V + + A + LHLA +
Sbjct: 145 ARRCTPEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPD----AQAPEELVLHLAVKV 200
Query: 522 G---SAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREG 578
S LV+ I++ ++D DG+ L
Sbjct: 201 ANQASLPLVDFIIQNGG-HLDAKAADGNTAL----------------------------- 230
Query: 579 FGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILE 634
H A + QPDC++ LL A V++ GE+ L A K + +C ++ +
Sbjct: 231 ------HYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQ 280
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 3/122 (2%)
Query: 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQ 721
+V++ + + + D P L +A + + + ++ G A+
Sbjct: 166 SVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDF---IIQNGGHLDAK 222
Query: 722 DAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781
A TALH A++ N + +K++L V N L +A + K C LL A
Sbjct: 223 AADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQ 282
Query: 782 AD 783
A
Sbjct: 283 AG 284
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 3/80 (3%)
Query: 726 RTALHIASMAND---VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGA 782
LH+A + + LV I+ G ++ + LH A C+ LLL A
Sbjct: 191 ELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRA 250
Query: 783 DCNWQDDEGDNAFHIAADAA 802
++ G+ A IA
Sbjct: 251 LVGTVNEAGETALDIARKKH 270
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 13/79 (16%), Positives = 27/79 (34%), Gaps = 3/79 (3%)
Query: 577 EGFGPSVAHVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILEN 635
V + + + ++ G +A +G + LH A DC ++L+
Sbjct: 189 PEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKG 248
Query: 636 GGCRSMAILNSKELTPLHL 654
+ +N T L +
Sbjct: 249 RA--LVGTVNEAGETALDI 265
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 4e-13
Identities = 37/200 (18%), Positives = 61/200 (30%), Gaps = 60/200 (30%)
Query: 449 STSNETEPSPASDVEV-----------------FQDNPNNLHQLVSEGDVSGVRDLLSKN 491
+ +PS SD+ P L + D+ V + +
Sbjct: 96 PSHGGPKPSAESDMGTRRDYIMAKYVEHRFARRCTPEPQRLWTAICNRDLLSVLEAFANG 155
Query: 492 ASGNYSSSISSLLKAQNADGQTALHLACR---RGSAELVEAILEYSQENVDVLDKDGDPP 548
A + LHLA + + S LV+ I++ ++D DG+
Sbjct: 156 QDFGQPLPGPDA----QAPEELVLHLAVKVANQASLPLVDFIIQNGG-HLDAKAADGNTA 210
Query: 549 LVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNA 608
L H A + QPDC++ LL A
Sbjct: 211 L-----------------------------------HYAALYNQPDCLKLLLKGRALVGT 235
Query: 609 VDDEGESVLHRAVAKKYTDC 628
V++ GE+ L A K + +C
Sbjct: 236 VNEAGETALDIARKKHHKEC 255
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 11/108 (10%)
Query: 702 VEGRELVRIL--LTAGAEPTAQ------DAQNRTALHIASMAND---VELVKIILDAGVD 750
+ R+L+ +L G + A LH+A + + LV I+ G
Sbjct: 140 ICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGH 199
Query: 751 VNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798
++ + LH A C+ LLL A ++ G+ A IA
Sbjct: 200 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA 247
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 7e-05
Identities = 25/117 (21%), Positives = 43/117 (36%), Gaps = 16/117 (13%)
Query: 452 NETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVR--DLLSKNASGNYSSSISSLLKAQNA 509
+ P P + LH V + + + D + +N L A+ A
Sbjct: 159 GQPLPGPDAQ----APEELVLHLAVKVANQASLPLVDFIIQNGGH---------LDAKAA 205
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
DG TALH A + ++ +L+ V +++ G+ L A EC L +
Sbjct: 206 DGNTALHYAALYNQPDCLKLLLKGRA-LVGTVNEAGETALDIARKKHHKECEELLEQ 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 61/323 (18%), Positives = 113/323 (34%), Gaps = 69/323 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKV-MIAEEMEPDWLSGQL 190
D + + +LG G G V+ + H +A K + + + + + +L
Sbjct: 34 DFEKISELGAG--NGGVVF---------KVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
L + + F+G D + + M+ GS+ +++ GR+ EQIL
Sbjct: 83 QVLHECN--SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIP-EQIL---GK 135
Query: 250 IARGVVE----LHAAG-VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD 304
++ V++ L ++ ++KPSN+L+++ G + D+G++ L
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------------I 183
Query: 305 SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364
S +S + +Y +PE + S +SD WS G +LVEM G
Sbjct: 184 DSMANSFVGT----RSYMSPERLQGT------------HYSVQSDIWSMGLSLVEMAVGR 227
Query: 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
P A+E+ + R L +A
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL-----------NKFGMDSRPPMA 276
Query: 425 TFLRHLQELPRSPPASPDTGFTK 447
F + PP P F+
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSL 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 60/291 (20%), Positives = 100/291 (34%), Gaps = 54/291 (18%)
Query: 168 HSVAVK-----KVMIAEEMEPDWLSGQLDNLRR--ASMWC---RNVCTFHGVLRMDS--C 215
AVK K+ E N+++ + +NV VL +
Sbjct: 31 CRRAVKILKKKKLRRIPNGEA--------NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82
Query: 216 LGLVMDRCYGSVQ-LAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
+ +VM+ C +Q + E R + Q Y + G+ LH+ G+V +IKP NLLL
Sbjct: 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL 142
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIH-SCMDCTMLSPNYTAPEAWEPVKKS 333
G +S G+A L P S SP + PE +
Sbjct: 143 TTGGTLKISALGVAEALH--------PFAADDTCRTSQG-----SPAFQPPEIANGLDT- 188
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ + D WS G TL + TG P+ G + +++ + K P
Sbjct: 189 ----FS-----GFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD---- 235
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLAT--FLRHLQELPRSPPASPD 442
L ++ L+++ +KR + + F + P P
Sbjct: 236 ---CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPS 283
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 36/206 (17%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA-A 289
+ LTLE ++ Y +A+G+ L + + ++ N+LL + D+GLA
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
I K P + L + APE ++ + +SD
Sbjct: 243 IYKDPDYVRKG-------------DARLPLKWMAPETIFD-----RVY-------TIQSD 277
Query: 350 AWSFGCTLVEMCT-GSIPWAGLSA-EEIYRAVVKNRKLP-PQYASIVGVGIPRELWKMIG 406
WSFG L E+ + G+ P+ G+ EE R + + ++ P Y E+++ +
Sbjct: 278 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT-------TPEMYQTML 330
Query: 407 ECLQFKASKRPTFSAMLATFLRHLQE 432
+C + S+RPTFS ++ LQ
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 67/338 (19%), Positives = 116/338 (34%), Gaps = 86/338 (25%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
+++ K LG G A +V G + VAVK M+ E+ + +
Sbjct: 44 RENLEFGKVLGSG--AFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSE----REAL 95
Query: 193 LRRASMWCR-----NVCTFHGV----------------------LRMDSCLGLVMDRCYG 225
+ M + N+ G LR + Y
Sbjct: 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 226 SVQLAMQRNEGR-LTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGR 279
+ + + + LT E +L + +A+G+ L V N+ L G+
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV------LVTHGK 209
Query: 280 AV-VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFW 338
V + D+GLA R + + L + APE+ LF
Sbjct: 210 VVKICDFGLA--------RDIM-SDSNYVVRGN---ARLPVKWMAPES---------LFE 248
Query: 339 DDAIGI-SPESDAWSFGCTLVEMCT-GSIPWAGLSA-EEIYRAVVKNRKLP-PQYASIVG 394
GI + +SD WS+G L E+ + G P+ G+ Y+ + K+ P YA
Sbjct: 249 ----GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYA---- 300
Query: 395 VGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
E++ ++ C F + KRP+F + + L +
Sbjct: 301 ---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 9e-13
Identities = 44/180 (24%), Positives = 64/180 (35%), Gaps = 32/180 (17%)
Query: 216 LGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLL 274
L ++D G L G + + Y A+I G+ +H VV ++KP+N+LL
Sbjct: 267 LSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 275 DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL 334
D G +SD GLA + +K + Y APE
Sbjct: 326 DEHGHVRISDLGLA---CDFSKKKPHASVG-------------THGYMAPEV-------- 361
Query: 335 NLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA---EEIYRAVVKNRKLPPQYAS 391
L A S D +S GC L ++ G P+ EI R + P S
Sbjct: 362 -LQKGVAYDSSA--DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 418
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-12
Identities = 77/505 (15%), Positives = 141/505 (27%), Gaps = 107/505 (21%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNL 193
++ ++LG G V W H VA+K +E+ P +
Sbjct: 17 EMKERLGTGGFGYVLRW-----------IHQDTGEQVAIK--QCRQELSPK----NRERW 59
Query: 194 RRASMWCR-----NVCTFHGVLRMDSCLG------LVMDRCYG---SVQLAMQRNEGRLT 239
+ NV + V L L M+ C G L N L
Sbjct: 60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 240 LEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV---VSDYGLAAILKKPAC 296
I +DI+ + LH ++ ++KP N++L + + + D G A L
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---- 175
Query: 297 RKARPECDSSRIHSCMDCTML-----SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351
+ + Y APE L D W
Sbjct: 176 ----------------QGELCTEFVGTLQYLAPE----------LLEQKKYT--VTVDYW 207
Query: 352 SFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGEC--- 408
SFG E TG P+ + V+ + G + +
Sbjct: 208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLS 267
Query: 409 --------------LQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNET 454
L + +R T + Q L + S T
Sbjct: 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPN--VGCFQALDSILSLKLLSVMNMVSGRVHT 325
Query: 455 EP-SPASDVEVFQD------NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQ 507
P + +++ + Q + + SG+ ++ + +
Sbjct: 326 YPVTENENLQNLKSWLQQDTGIPEEEQELLQA--SGLALNSAQPLTQYVIDCTVIDGRQG 383
Query: 508 NADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
D + L R + + L E+V ++ +D PL + + I+
Sbjct: 384 EGD---LIFLFDNRKTVYEPQISLPAHPESVSIVLQDPKRPLTYTHLRRVWGQIWQTIRA 440
Query: 568 GANVISRLREGFGPSVAHVCAYHGQ 592
+RL +G S+ ++ Y+ +
Sbjct: 441 LKEDCARLLQGQRTSMVNLLRYNTE 465
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 59/311 (18%), Positives = 94/311 (30%), Gaps = 55/311 (17%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNL 193
L LG+G A V+ R RH A+K +D
Sbjct: 12 LLSDILGQGATA--NVF---------RGRHKKTGDLFAIKV------FNNISFLRPVDVQ 54
Query: 194 RRASMWCR-----NVCTFHGVLRMDSCLG--LVMDRCYG---SVQLAMQRNEGRLTLEQI 243
R + N+ + + L+M+ C L N L +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS--GRAVV--SDYGLAAILKKPACRKA 299
L D+ G+ L G+V NIKP N++ G++V +D+G A L+
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------- 167
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
D + S + Y P+ + + L D D WS G T
Sbjct: 168 ----DDEQFVSL--YG--TEEYLHPD----MYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 360 MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
TGS+P+ + V+ +I GV + S
Sbjct: 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
Query: 420 SAMLATFLRHL 430
+L L ++
Sbjct: 276 QVLLTPVLANI 286
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 45/186 (24%), Positives = 73/186 (39%), Gaps = 25/186 (13%)
Query: 213 DSCLGLVMDRCY---GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKP 269
++ L LVM+ Y G + + + R+ E Y A+I + +H G V +IKP
Sbjct: 133 ENYLYLVME--YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 270 SNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEP 329
N+LLD G ++D+G L+ ++ +P+Y +PE
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG-------------TPDYLSPE---- 233
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVV--KNRKLPP 387
+ +++ PE D W+ G EM G P+ S E Y +V K P
Sbjct: 234 ILQAVGGGPGTG-SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 388 QYASIV 393
V
Sbjct: 293 LVDEGV 298
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 62/332 (18%), Positives = 116/332 (34%), Gaps = 79/332 (23%)
Query: 136 HDVKLVKKLGEGRRA-GVEVW-GAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDN 192
++++ K LG G A G +V G G+ VAVK M+ + +
Sbjct: 46 NNLQFGKTLGAG--AFG-KVVEATAFGLGKEDAVLKVAVK--MLKSTAHADE----KEAL 96
Query: 193 LRRASMWCR-----NVCTFHGVLRMDSCLGLVMDRC-YGS-------------VQLAMQR 233
+ + N+ G + ++ + C YG A
Sbjct: 97 MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 234 NEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAV-VSDYGL 287
+ +L + + +A+G+ L + + N+ L +G + D+GL
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV------LLTNGHVAKIGDFGL 210
Query: 288 A-AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISP 346
A I+ L + APE+ +F D + +
Sbjct: 211 ARDIMNDSNYIVKG-------------NARLPVKWMAPES---------IF--DCV-YTV 245
Query: 347 ESDAWSFGCTLVEMCT-GSIPWAG-LSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWK 403
+SD WS+G L E+ + G P+ G L + Y+ V ++ P +A P+ ++
Sbjct: 246 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA-------PKNIYS 298
Query: 404 MIGECLQFKASKRPTFSAMLATFLRHLQELPR 435
++ C + + RPTF + + QE R
Sbjct: 299 IMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 2e-12
Identities = 73/631 (11%), Positives = 173/631 (27%), Gaps = 193/631 (30%)
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432
+++ ++++ + I+ + L K + M+ F+ +
Sbjct: 39 QDMPKSILSKE----EIDHIIMSKDAVSGTLRLFWTLLSKQEE------MVQKFVEEVLR 88
Query: 433 LPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLH---QLVSEGDVSGVRDLLS 489
+ F E P+ ++ + + L+ Q+ ++ +VS ++ L
Sbjct: 89 --------INYKFLMSPIKTEQR-QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 490 -KNASGNYSSSISSLLKAQNADGQTALH--LACRRGSAELVEAILEYSQENVDVLDKDGD 546
+ A LL+ + A + L G + + + V K
Sbjct: 140 LRQA----------LLELRPAKN-VLIDGVLGS--GKTWVALDVCL----SYKVQCKMDF 182
Query: 547 PPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADP 606
+F L + +++ ++ ++ + + D + L
Sbjct: 183 K--IFWLNLKNCNSPETVLEMLQKLLYQID----------PNWTSRSDHSSNIKL---RI 227
Query: 607 NAVDDEGESVLHRAVAKKYTDCAIV--------ILE--NGGCRSMAILNSKELTPLHLCV 656
+++ E +L K Y +C +V N C+ + K++T
Sbjct: 228 HSIQAELRRLLKS---KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 657 ATWNVAVVK---------------RWVEVAS---PEEIVNVIDIPGPVGTALCMAAALKK 698
T ++++ ++++ P E++ P L + A +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPR--RLSIIAESIR 338
Query: 699 DH---------------------------EVEGREL----------VRI----LLTAGAE 717
D E R++ I L +
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD 398
Query: 718 PTAQDAQNRTA-LHIASMAND------VELVKIILDAGVDV-NIRNVHNTIPLHVALARG 769
D LH S+ + + I L+ V + N +H +I H + +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK- 457
Query: 770 AKSCVGLLLSAGADCNWQ--DDEGDNAF--HIA--------ADAAKMIRE---NLEWLIV 814
+ D F HI + + R + +L
Sbjct: 458 ------------TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 815 MLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFE--IGDWVK 872
+ H A TL+ + +I ++ P +E + +
Sbjct: 506 KIRHDSTAWNASGSILNTLQQL--KFYKPYICDN------------DPK-YERLVNAILD 550
Query: 873 FKRRVTTPTYGWQGAKHKSVGFVQSVLDKDN 903
F ++ K ++ L ++
Sbjct: 551 FLPKIEENLI-----CSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.0 bits (173), Expect = 3e-12
Identities = 75/568 (13%), Positives = 155/568 (27%), Gaps = 209/568 (36%)
Query: 81 NTNQHHNSNTN---HFDSDVTDDDD--DDED--------DEVDEFGRGTHVSSSGVGVCG 127
T +H + F+ D+ D D +D +E+D
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHI--------------- 54
Query: 128 PVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPD--W 185
+ V +L W + + + E + + +
Sbjct: 55 ----IMSKDAVSGTLRL------------FWT-----LLSKQEEMVQKFVEEVLRINYKF 93
Query: 186 LSGQL-DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQIL 244
L + R+ SM R DR Y Q+ + N RL L
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQR-------------DRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 245 R---YGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKAR 300
R A+ V+ + G SG+ +A C +
Sbjct: 141 RQALLELRPAKNVL-IDGVLG---------------SGKTW-----VAL----DVCLSYK 175
Query: 301 PEC------------DSSRIHSCMD-----CTMLSPNYTAPE------------------ 325
+C + + + ++ + PN+T+
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 326 ---AWEPVKKSLNLFWDDAIGI-SPES-DAWSFGC-TLV-----------------EMCT 362
+P + L L + + + ++ +A++ C L+ +
Sbjct: 236 RLLKSKPYENCL-LVLLN---VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 363 GSIPWAGLS---AEEIYRAVVKNR--KLPPQYASIVGVGIPRELWKMIGECLQ------- 410
L+ + + + R LP + + PR L +I E ++
Sbjct: 292 DHHSM-TLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPRRL-SIIAESIRDGLATWD 345
Query: 411 -FKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVF---- 465
+K + ++ + L L+ PA F + S + P + +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLE------PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 466 --QDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSL---LKAQNADGQTALHLACR 520
D +++L L+ K + SI S+ LK + + + ALH
Sbjct: 400 IKSDVMVVVNKLHK-------YSLVEKQPK-ESTISIPSIYLELKVKL-ENEYALH---- 446
Query: 521 RGSAELVEA---ILEYSQENVDVLDKDG 545
+V+ + +++ D
Sbjct: 447 ---RSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 2e-07
Identities = 93/715 (13%), Positives = 193/715 (26%), Gaps = 221/715 (30%)
Query: 678 NVIDIPGPVGTALCMAAALKKDHEVEG-RELVRILLTAGAEPTAQ-----DAQNRTAL-- 729
+V D+P + + + + V G L LL+ E + N L
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 730 HIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD 789
I + ++ + D + +V+ R
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS--R--------------------- 133
Query: 790 EGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH----SGKT------LRD--FL 837
+R+ L L P V + SGKT
Sbjct: 134 ---------LQPYLKLRQALLEL-----RPAKNVLI--DGVLGSGKTWVALDVCLSYKVQ 177
Query: 838 EGLPRE--WIS-------EDLMEALMNRGVHLSPTIFEIGDWVKFKRRVTTPTYGWQGAK 888
+ + W++ E ++E L + P D + +
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD------HSSNIKLRIHSIQ 231
Query: 889 HKSVGFVQSVLDKDNLIVSFCSGEVRVLASEVLKLIPLDRGQHVKLKPDVKEPR----FG 944
+ ++S ++ L+V L +V+ + F
Sbjct: 232 AELRRLLKSKPYENCLLV-------------------LL---------NVQNAKAWNAFN 263
Query: 945 WRGQSRDSIGTVLCVDDDGILRVGFPGASRGWKADPAEMERVEEFKVGDWVRIRPTLTTA 1004
+ +L + D + TLT
Sbjct: 264 --LSCK----ILLTTRFKQV-------------TDFLSAATTTHISLDH---HSMTLT-- 299
Query: 1005 KHGLGSVTPGSIGIVYCIRPDSSLLLELSYLPNPWHCEPEEVEPVPPFRIGNRVCVKRSV 1064
PD L L YL P EV P R+ + S+
Sbjct: 300 -------------------PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESI 337
Query: 1065 AEPRYAWGGETHHSVGKISEIENDGLLIIEIPNRPIPWQADPSDMEKV-EDFKV-GDWVR 1122
+ W H + K++ I L ++ +P++ K+ + V
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVL-----------EPAEYRKMFDRLSVFPPSAH 386
Query: 1123 VKASVSSPKYGWEDITRNSIGIIHSLEEDGDVGIAFCFRSKPFCCSVTDV--EKVPPFEV 1180
+ + S W D+ ++ + ++ + + + + K S+ + E E
Sbjct: 387 IPTILLS-LI-WFDVIKSDVMVV--VNKLHKYSLVEK-QPKESTISIPSIYLELKVKLEN 441
Query: 1181 GQEIH--VMPSVTQPRLGWSKETPATVGKIVKIDMDGALNVKVAGRHSLWKVSPGDAERL 1238
+H ++ P+ + + ++ +D + G H L + ER+
Sbjct: 442 EYALHRSIVDHYNIPK-TFDSD------DLIPPYLDQYFYSHI-GHH-LKNIEH--PERM 490
Query: 1239 SGFEVG----DWVRSKPSIGTRPSYDWNTVGKESLAVVHSIQDNGYLELACCFRKGRWST 1294
+ F + ++ K I S WN G ++++++Q + +
Sbjct: 491 TLFRMVFLDFRFLEQK--I-RHDSTAWNASG----SILNTLQQ---------LKF--YKP 532
Query: 1295 HYTDVEKIPSYKVGQHVRFRSGLAEPRWGWRGAQLDSRGIITSVHADGEVRVAFF 1349
+ D + V + F + E +I S + D +R+A
Sbjct: 533 YICDNDPKYERLVNAILDFLPKIEE-------------NLICSKYTD-LLRIALM 573
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 36/279 (12%), Positives = 88/279 (31%), Gaps = 66/279 (23%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVK----------KVMIAEEMEPDW 185
++++ L +G+ + + C A+K + +
Sbjct: 34 RIIRTLNQGKFNKIIL-----------CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKIS 82
Query: 186 LSGQLDNLRR--ASMW-CR--NVCTFHGVLRMDSCLGLVMDRCYG--------SVQLAMQ 232
+ + D+ + + + T G++ + ++ + + +
Sbjct: 83 IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291
+ ++ I + +H + ++KPSN+L+D +GR +SD+G + +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351
D S + + PE F +++ + D W
Sbjct: 203 V-----------DKKIKGSRG-----TYEFMPPE----------FFSNESSYNGAKVDIW 236
Query: 352 SFGCTLVEMCTGSIP-WAGLSAEEIYRAVVKNR-KLPPQ 388
S G L M +P +S E++ + + P
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 62/303 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM 198
+++KLGEG V VA+K+V + +++ + ++ +++
Sbjct: 32 DVLEKLGEGSYGSV------YKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCD- 82
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIARGVVEL 257
+V ++G ++ L +VM+ C GSV ++ LT ++I +G+ L
Sbjct: 83 -SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 258 HAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML 317
H + +IK N+LL+ G A ++D+G+A L ++ T++
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---------------TVI 186
Query: 318 -SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIY 376
+P + APE +++ G + +D WS G T +EM G P+A +
Sbjct: 187 GTPFWMAPEV---IQEI---------GYNCVADIWSLGITAIEMAEGKPPYADIHP---M 231
Query: 377 RAVVKNRKLPPQYASIVGVGIPR----ELW-----KMIGECLQFKASKRPTFSAMLAT-F 426
RA+ PP P ELW + +CL +R T + +L F
Sbjct: 232 RAIFMIPTNPP----------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281
Query: 427 LRH 429
+R
Sbjct: 282 VRS 284
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 41/208 (19%), Positives = 74/208 (35%), Gaps = 39/208 (18%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
D L + L R G Y A+I + LH G++ ++KP N+
Sbjct: 102 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 161
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWEP 329
LL+ ++D+G + PE +R +S + Y +PE +
Sbjct: 162 LLNEDMHIQITDFGT--------AKVLSPESKQARANSFV-----GTAQYVSPELLTEKS 208
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR-KLPPQ 388
KS SD W+ GC + ++ G P+ + I++ ++K P
Sbjct: 209 ACKS--------------SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE- 253
Query: 389 YASIVGVGIPRELWKMIGECLQFKASKR 416
+ ++ + L A+KR
Sbjct: 254 -------KFFPKARDLVEKLLVLDATKR 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 54/287 (18%), Positives = 103/287 (35%), Gaps = 61/287 (21%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209
+G G + + + + A K + E E + +++ L + G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--HPYIVKLLGA 84
Query: 210 LRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIK 268
D L ++++ C G+V M + LT QI + + LH+ ++ ++K
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 269 PSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPE-- 325
N+L+ G ++D+G++A K ++ + + +P + APE
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---------------SFIGTPYWMAPEVV 189
Query: 326 AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKL 385
E +K + ++D WS G TL+EM P L+ R ++K K
Sbjct: 190 MCETMKDT---------PYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKS 237
Query: 386 PPQYASIVGVGIPR----ELW-----KMIGECLQFKASKRPTFSAML 423
P P W + L RP+ + +L
Sbjct: 238 DP----------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 69/287 (24%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209
IG G +G + VA+K ++ EE E + Q + + V ++G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 210 LRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIARGVVE----LHAAGVVC 264
D+ L ++M+ GS ++ G L QI A I R +++ LH+ +
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQI----ATILREILKGLDYLHSEKKIH 142
Query: 265 MNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTA 323
+IK +N+LL G ++D+G+A L ++ T + +P + A
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN---------------TFVGTPFWMA 187
Query: 324 PEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR 383
PE +K+S ++D WS G T +E+ G P + L + +
Sbjct: 188 PEV---IKQS---------AYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIP 232
Query: 384 KLPPQYASIVGVGIPR-------ELWKMIGECLQFKASKRPTFSAML 423
K P P L + + CL + S RPT +L
Sbjct: 233 KNNP----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 60/268 (22%), Positives = 87/268 (32%), Gaps = 66/268 (24%)
Query: 168 HSVAVK---KVMIAEEMEPDWLSGQL----DNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220
VA+K K I++ E ++ L++ S V L++
Sbjct: 69 LPVAIKHVEKDRISDWGELPNG-TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 221 DRCYGSVQL--------AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
+R L A+Q R Q+L V H GV+ +IK N+
Sbjct: 128 ERPEPVQDLFDFITERGALQEELARSFFWQVLE-------AVRHCHNCGVLHRDIKDENI 180
Query: 273 LLDA-SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVK 331
L+D G + D+G A+LK D+ + Y+ PE
Sbjct: 181 LIDLNRGELKLIDFGSGALLK-----------DTVYTDFDG-----TRVYSPPE------ 218
Query: 332 KSLNLFWDDA-IGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYA 390
G + WS G L +M G IP+ EEI R V Q
Sbjct: 219 ----WIRYHRYHG--RSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVF----FRQRV 266
Query: 391 SIVGVGIPRELWKMIGECLQFKASKRPT 418
S E +I CL + S RPT
Sbjct: 267 S-------SECQHLIRWCLALRPSDRPT 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 32/162 (19%), Positives = 54/162 (33%), Gaps = 27/162 (16%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
+ E + + ++ + L ++ ++KP N+LLD G ++D+ +AA+L
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166
Query: 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
+ + + Y APE G S D WS
Sbjct: 167 RE--TQITTMAG-------------TKPYMAPEM---------FSSRKGAGYSFAVDWWS 202
Query: 353 FGCTLVEMCTGSIPWAGLSAE---EIYRAVVKNRKLPPQYAS 391
G T E+ G P+ S+ EI P S
Sbjct: 203 LGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 66/331 (19%), Positives = 122/331 (36%), Gaps = 82/331 (24%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNL 193
+D+K +GEG +V A I R A+K + E + D D
Sbjct: 24 WNDIKFQDVIGEG--NFGQVLKARIKKDGLRMD--AAIK--RMKEYASKDD----HRDFA 73
Query: 194 RRASMWCR-----NVCTFHGVLRMDSCLGLVMDRC-YGS---------------VQLAMQ 232
+ C+ N+ G L L ++ +G+
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVV-----CMNIKPSNLLLDASGRAVVSDYGL 287
L+ +Q+L + AD+ARG+ L + NI L+ + A ++D+GL
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI-----LVGENYVAKIADFGL 188
Query: 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSL--NLFWDDAIGIS 345
+ R + + L + A E SL +++ +
Sbjct: 189 S--------RGQ----EVYVKKTM---GRLPVRWMAIE-------SLNYSVY-------T 219
Query: 346 PESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLP-PQYASIVGVGIPRELWK 403
SD WS+G L E+ + G P+ G++ E+Y + + +L P E++
Sbjct: 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-------DDEVYD 272
Query: 404 MIGECLQFKASKRPTFSAMLATFLRHLQELP 434
++ +C + K +RP+F+ +L + R L+E
Sbjct: 273 LMRQCWREKPYERPSFAQILVSLNRMLEERK 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 58/311 (18%), Positives = 92/311 (29%), Gaps = 55/311 (17%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNL 193
L LG+G A V+ R RH A+K +D
Sbjct: 12 LLSDILGQGATA--NVF---------RGRHKKTGDLFAIK------VFNNISFLRPVDVQ 54
Query: 194 RRASMWCR-----NVCTFHGVLRMDSCLG--LVMDRCYG---SVQLAMQRNEGRLTLEQI 243
R + N+ + + L+M+ C L N L +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLL----DASGRAVVSDYGLAAILKKPACRKA 299
L D+ G+ L G+V NIKP N++ D ++D+G A L+
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------- 167
Query: 300 RPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVE 359
D + S + Y P+ + + L D D WS G T
Sbjct: 168 ----DDEQFVSL--YG--TEEYLHPD----MYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 360 MCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTF 419
TGS+P+ + V+ +I GV + S
Sbjct: 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
Query: 420 SAMLATFLRHL 430
+L L ++
Sbjct: 276 QVLLTPVLANI 286
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-12
Identities = 37/176 (21%), Positives = 61/176 (34%), Gaps = 32/176 (18%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+ + + + Y A I G+ LH ++ ++KP N+LLD G +SD GLA
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-- 336
Query: 291 LKKPACRKARPECDSSRIHSCMDC-TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
++ T P + APE L + S D
Sbjct: 337 -------VELKA-GQTKTKGY--AGT---PGFMAPE----------LLLGEEYDFSV--D 371
Query: 350 AWSFGCTLVEMCTGSIPWAG----LSAEEIYRAVVKNRKLPPQYASIVGVGIPREL 401
++ G TL EM P+ + +E+ + V++ P S L
Sbjct: 372 YFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 24/119 (20%), Positives = 46/119 (38%), Gaps = 3/119 (2%)
Query: 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQ 721
+++ + + E + + + P TAL +A + + L+ Q
Sbjct: 145 GLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDF---LVQNSGNLDKQ 201
Query: 722 DAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSA 780
+ TALH + ++ E +K++L + I N PL +A + C LL A
Sbjct: 202 TGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQA 260
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 33/171 (19%), Positives = 49/171 (28%), Gaps = 38/171 (22%)
Query: 466 QDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAE 525
D LH L + LL A G + L +TALHLA R
Sbjct: 125 ADTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHE-PDETALHLAVRSVDRT 183
Query: 526 LVEAILEYSQE--NVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSV 583
+ + Q N+D G L
Sbjct: 184 SLHIVDFLVQNSGNLDKQTGKGSTAL---------------------------------- 209
Query: 584 AHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILE 634
H C +C++ LL A ++ GE+ L A K+ C ++ +
Sbjct: 210 -HYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQ 259
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 17/84 (20%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 722 DAQNRTALHIASMAND---VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
+ TALH+A + D + +V ++ +++ + + LH C+ LLL
Sbjct: 166 HEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLL 225
Query: 779 SAGADCNWQDDEGDNAFHIAADAA 802
A ++ G+ IA
Sbjct: 226 RGKASIEIANESGETPLDIAKRLK 249
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 12/107 (11%)
Query: 466 QDNPNNLHQLVSEGDVSGVR--DLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGS 523
+ + LH V D + + D L +N S L Q G TALH C +
Sbjct: 167 EPDETALHLAVRSVDRTSLHIVDFLVQN---------SGNLDKQTGKGSTALHYCCLTDN 217
Query: 524 AELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
AE ++ +L ++++ ++ G+ PL A C L + +
Sbjct: 218 AECLKLLLRGKA-SIEIANESGETPLDIAKRLKHEHCEELLTQALSG 263
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 17/138 (12%), Positives = 37/138 (26%), Gaps = 13/138 (9%)
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591
+ + L+ A A G + + H+
Sbjct: 129 AKLHSLCEAVKTRDIFGLLQAYADGV--------DLTEKIPLANGHEPDETALHLAVRSV 180
Query: 592 QPDCMR--ELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKE 648
+ + L+ + + +G + LH +C ++L S+ I N
Sbjct: 181 DRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKA--SIEIANESG 238
Query: 649 LTPLHLCVATWNVAVVKR 666
TPL + + +
Sbjct: 239 ETPLDIAKRLKHEHCEEL 256
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 35/233 (15%), Positives = 72/233 (30%), Gaps = 50/233 (21%)
Query: 232 QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291
+ +L + + + Y +I + LH+ G+V ++KP N++L + + D G
Sbjct: 173 RSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAV--- 228
Query: 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAW 351
+ +P + APE G + +D +
Sbjct: 229 --------SRINSFGYL-------YGTPGFQAPEIVRT-------------GPTVATDIY 260
Query: 352 SFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQF 411
+ G TL + G + + + P + +++ +
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGL-------PEDDPV------LKTYDSYGRLLRRAIDP 307
Query: 412 KASKRPT----FSAMLATFLRHLQEL-PRSPPASPDTGFTKFSTSNETEPSPA 459
+R T SA L LR + P T F+ ++ + A
Sbjct: 308 DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVA 360
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 54/265 (20%), Positives = 88/265 (33%), Gaps = 43/265 (16%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
NV F+G R + L ++ C G + + R+ + GVV LH G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+ +IKP NLLLD +SD+GLA + R ++ C + Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATV--------FRYNNRERLLNKM--CG--TLPY 173
Query: 322 TAPEAWEPVKKSLNLFWDDAIGIS------PESDAWSFGCTLVEMCTGSIPWAGLSAE-E 374
APE + D WS G L M G +PW S +
Sbjct: 174 VAPEL-----------------LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT--FLRHLQE 432
Y + + + I ++ + L S R T + + + L++
Sbjct: 217 EYSDWKEKKTYLNPWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
Query: 433 LPRSPPASPDTGFTKFSTSNETEPS 457
+ P + S ++ S
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQS 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 52/245 (21%), Positives = 83/245 (33%), Gaps = 43/245 (17%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
NV F+G R + L ++ C G + + R+ + GVV LH G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+ +IKP NLLLD +SD+GLA + R ++ C + Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATV--------FRYNNRERLLNKM--CG--TLPY 173
Query: 322 TAPEAWEPVKKSLNLFWDDAIGIS------PESDAWSFGCTLVEMCTGSIPWAGLSAE-E 374
APE + D WS G L M G +PW S +
Sbjct: 174 VAPEL-----------------LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT--FLRHLQE 432
Y + + + I ++ + L S R T + + + L++
Sbjct: 217 EYSDWKEKKTYLNPWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
Query: 433 LPRSP 437
+ P
Sbjct: 272 GAKRP 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 35/184 (19%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
GR+ ++ I V H +V ++K NLLLDA ++D+G +
Sbjct: 109 GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--- 165
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDA-IGISPESDAWSFG 354
++ + C +P Y APE LF G PE D WS G
Sbjct: 166 --------VGGKLDAF--CG--APPYAAPE----------LFQGKKYDG--PEVDVWSLG 201
Query: 355 CTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
L + +GS+P+ G + +E+ V++ + P Y S + ++ L
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS-------TDCENLLKRFLVLNPI 254
Query: 415 KRPT 418
KR T
Sbjct: 255 KRGT 258
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 42/175 (24%), Positives = 67/175 (38%), Gaps = 33/175 (18%)
Query: 232 QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291
+ + + Y A+I G+ +LH +V ++KP N+LLD G +SD GLA +
Sbjct: 277 HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336
Query: 292 KKPACRKARPECDSSRIHSCMDC-TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350
+ I T Y APE + ++ SP D
Sbjct: 337 P-----------EGQTIKGR--VGT---VGYMAPE----------VVKNERYTFSP--DW 368
Query: 351 WSFGCTLVEMCTGSIPWAG----LSAEEIYRAVVKNRKLPPQYASIVGVGIPREL 401
W+ GC L EM G P+ + EE+ R V + + + S + +L
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 34/148 (22%), Positives = 46/148 (31%), Gaps = 3/148 (2%)
Query: 489 SKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQE-NVDVLDKDGDP 547
+ S S G + S + L + + N +D
Sbjct: 178 PRPGSLRSKPEPPSEDLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNAT 237
Query: 548 PLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPN 607
PL+ A AA S L++ GANV G GP H G L GAD
Sbjct: 238 PLIQATAANSLLACEFLLQNGANVNQADSAGRGP--LHHATILGHTGLACLFLKRGADLG 295
Query: 608 AVDDEGESVLHRAVAKKYTDCAIVILEN 635
A D EG L A+ D ++
Sbjct: 296 ARDSEGRDPLTIAMETANADIVTLLRLA 323
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 8e-09
Identities = 30/121 (24%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAN 736
VN ++ T L A A E LL GA D+ R LH A++
Sbjct: 226 VNWVNGGQDNATPLIQATAANSLLACE------FLLQNGANVNQADSAGRGPLHHATILG 279
Query: 737 DVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDE--GDNA 794
L + L G D+ R+ PL +A+ V LL A GD
Sbjct: 280 HTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMREAEAAQGQAGDET 339
Query: 795 F 795
+
Sbjct: 340 Y 340
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 2e-08
Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 711 LLTAGAEPTAQDA--QNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
L GA+ + N T L A+ AN + + +L G +VN + PLH A
Sbjct: 219 ALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATIL 278
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAA 802
G L L GAD +D EG + IA + A
Sbjct: 279 GHTGLACLFLKRGADLGARDSEGRDPLTIAMETA 312
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 4e-06
Identities = 28/141 (19%), Positives = 45/141 (31%), Gaps = 3/141 (2%)
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
G + S + + GA+V + LL G
Sbjct: 199 PGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNG 258
Query: 604 ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAV 663
A+ N D G LH A +T A + L+ G + +S+ PL + + T N +
Sbjct: 259 ANVNQADSAGRGPLHHATILGHTGLACLFLKRG--ADLGARDSEGRDPLTIAMETANADI 316
Query: 664 VKRWVEVASPEEIVNVIDIPG 684
V + +A E G
Sbjct: 317 VTL-LRLAKMREAEAAQGQAG 336
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
L++D G +L R T ++ Y +I + LH G++ +IK N+LLD+
Sbjct: 136 LILDYINGG-ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC-TMLSPNYTAPEAWEPVKKSLN 335
+G V++D+GL+ K ++ R + C T Y AP+
Sbjct: 195 NGHVVLTDFGLS---------KEFVADETERAYDF--CGT---IEYMAPDIVRGGDS--- 237
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL----SAEEIYRAVVKNRKLPPQYAS 391
G D WS G + E+ TG+ P+ S EI R ++K+ PQ S
Sbjct: 238 -------GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 48/268 (17%)
Query: 170 VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHG------VLRMDSCLGLVMDRC 223
A+K VM E + + +++ L++ S RN+ T++G MD L LVM+ C
Sbjct: 52 AAIK-VMDVTGDEEEEIKQEINMLKKYSH-HRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 224 -YGSVQ-LAMQRNEGRLTLEQI---LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG 278
GSV L L E I R +I RG+ LH V+ +IK N+LL +
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICR---EILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
Query: 279 RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLF 337
+ D+G++A L + R+ T + +P + APE V
Sbjct: 167 EVKLVDFGVSAQLDRTVGRRN---------------TFIGTPYWMAPE----VIACDE-- 205
Query: 338 WDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR--KLPPQYASIVGV 395
+ +SD WS G T +EM G+ P + + +N +L + S
Sbjct: 206 -NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS---- 260
Query: 396 GIPRELWKMIGECLQFKASKRPTFSAML 423
++ I CL S+RP ++
Sbjct: 261 ---KKFQSFIESCLVKNHSQRPATEQLM 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 68/306 (22%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
K+GEG + V R +HS VAVK + + ++ + L ++ +R
Sbjct: 48 DSYVKIGEG--STGIVC-------LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
NV + + L ++M+ G++ + + RL EQI + + +
Sbjct: 99 YQ--HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQAL 154
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
LHA GV+ +IK ++LL GR +SD+G A + K ++
Sbjct: 155 AYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--------------- 199
Query: 315 TML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373
+++ +P + APE + +S + E D WS G ++EM G P+ S
Sbjct: 200 SLVGTPYWMAPEV---ISRS---------LYATEVDIWSLGIMVIEMVDGEPPYFSDSP- 246
Query: 374 EIYRAVVKNRKLPPQYASIVGVGIPR---------ELWKMIGECLQFKASKRPTFSAMLA 424
+A+ + R PP P+ L + L +R T +L
Sbjct: 247 --VQAMKRLRDSPP----------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294
Query: 425 -TFLRH 429
FL
Sbjct: 295 HPFLLQ 300
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 34/193 (17%)
Query: 213 DSCLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
L VM+ G +L E T E+ YGA+I + LH+ VV +IK N
Sbjct: 77 HDRLCFVMEYANGG-ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 272 LLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWE 328
L+LD G ++D+GL K D + + + C +P Y APE
Sbjct: 136 LMLDKDGHIKITDFGLC----KEGIS------DGATMKTFCG-----TPEYLAPEVLEDN 180
Query: 329 PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ 388
+++ D W G + EM G +P+ E ++ ++ P+
Sbjct: 181 DYGRAV--------------DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
Query: 389 YASIVGVGIPREL 401
S + L
Sbjct: 227 TLSPEAKSLLAGL 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 34/188 (18%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
VM+ G L + GR + Y A+IA G+ L + G++ ++K N++LD+
Sbjct: 98 FVMEYVNGG-DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPE--AWEPVKKS 333
G ++D+G+ C++ + +++ T +P+Y APE A++P KS
Sbjct: 157 EGHIKIADFGM--------CKENIWDGVTTK-------TFCGTPDYIAPEIIAYQPYGKS 201
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ D W+FG L EM G P+ G +E++++++++ P+ S
Sbjct: 202 V--------------DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247
Query: 394 GVGIPREL 401
V I + L
Sbjct: 248 AVAICKGL 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 37/172 (21%), Positives = 65/172 (37%), Gaps = 22/172 (12%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
D L +VM+ G L + + + Y A++ + +H+ G + ++KP N+
Sbjct: 141 DRYLYMVMEYMPGG-DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKK 332
LLD SG ++D+G + K + +P+Y +PE
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG-------------TPDYISPE------- 239
Query: 333 SLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRK 384
+ E D WS G L EM G P+ S Y ++ ++
Sbjct: 240 -VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 56/293 (19%), Positives = 90/293 (30%), Gaps = 66/293 (22%)
Query: 168 HSVAVK---KVMIAEEMEPDWLSG-----QLDNLRRASMWCRNVCTFHGVLRMDSCLGLV 219
VA+K + + L A V LV
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 220 MDRCYGSVQL--------AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
++R + L + R Q++ + H+ GVV +IK N
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------AIQHCHSRGVVHRDIKDEN 169
Query: 272 LLLDA-SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPV 330
+L+D G A + D+G A+L D + Y+ PE W
Sbjct: 170 ILIDLRRGCAKLIDFGSGALLH-----------DEPYTDFDG-----TRVYSPPE-WISR 212
Query: 331 KKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYA 390
+ A + WS G L +M G IP+ +EI A + P +
Sbjct: 213 HQ------YHA----LPATVWSLGILLYDMVCGDIPFER--DQEILEAELH----FPAHV 256
Query: 391 SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT--FLRHLQELPRSPPASP 441
S + +I CL K S RP+ +L +++P +P
Sbjct: 257 S-------PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-10
Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 34/188 (18%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
VM+ G L + GR + Y A+IA G+ L + G++ ++K N++LD+
Sbjct: 419 FVMEYVNGG-DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPE--AWEPVKKS 333
G ++D+G+ C++ + +++ T +P+Y APE A++P KS
Sbjct: 478 EGHIKIADFGM--------CKENIWDGVTTK-------TFCGTPDYIAPEIIAYQPYGKS 522
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ D W+FG L EM G P+ G +E++++++++ P+ S
Sbjct: 523 V--------------DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568
Query: 394 GVGIPREL 401
V I + L
Sbjct: 569 AVAICKGL 576
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 34/188 (18%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
VM+ G L ++ + L + Y A+I G+ LH+ G+V ++K N+LLD
Sbjct: 95 FVMEYLNGG-DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWEPVKKS 333
G ++D+G+ K ++ ++ C +P+Y APE + S
Sbjct: 154 DGHIKIADFGMC----KENML------GDAKTNTFCG-----TPDYIAPEILLGQKYNHS 198
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ D WSFG L EM G P+ G EE++ ++ + P++
Sbjct: 199 V--------------DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244
Query: 394 GVGIPREL 401
+ +L
Sbjct: 245 AKDLLVKL 252
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 41/192 (21%), Positives = 71/192 (36%), Gaps = 31/192 (16%)
Query: 213 DSCLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPS 270
L VM+ G +L E + ++ YGA+I + LH+ VV ++K
Sbjct: 220 HDRLCFVMEYANGG-ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278
Query: 271 NLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEP 329
NL+LD G ++D+GL C++ + + + T +P Y APE E
Sbjct: 279 NLMLDKDGHIKITDFGL--------CKEGIKDGATMK-------TFCGTPEYLAPEVLE- 322
Query: 330 VKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQY 389
D W G + EM G +P+ E+++ ++ P+
Sbjct: 323 -----------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371
Query: 390 ASIVGVGIPREL 401
+ L
Sbjct: 372 LGPEAKSLLSGL 383
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 53/292 (18%), Positives = 103/292 (35%), Gaps = 65/292 (22%)
Query: 159 IGGG------QGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGV 209
IG G + VA++++ + ++ + + + ++ +R N+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDS 85
Query: 210 LRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIK 268
+ L +VM+ GS+ + E + QI + + + LH+ V+ +IK
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 269 PSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAW 327
N+LL G ++D+G A + +++ TM+ +P + APE
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMVGTPYWMAPEV- 187
Query: 328 EPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPP 387
V + P+ D WS G +EM G P+ + RA+
Sbjct: 188 --VTRK---------AYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGT 233
Query: 388 QYASIVGVGIPR---------ELWKMIGECLQFKASKRPTFSAMLA-TFLRH 429
P + CL+ KR + +L FL+
Sbjct: 234 ----------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-10
Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 34/188 (18%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
VM+ G L + R + Y A+I ++ LH G++ ++K N+LLD
Sbjct: 101 FVMEFVNGG-DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWEPVKKS 333
G ++D+G+ K C+ + C +P+Y APE +
Sbjct: 160 EGHCKLADFGMC----KEGI------CNGVTTATFCG-----TPDYIAPEILQEMLYGPA 204
Query: 334 LNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIV 393
+ D W+ G L EM G P+ + ++++ A++ + + P +
Sbjct: 205 V--------------DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 394 GVGIPREL 401
GI +
Sbjct: 251 ATGILKSF 258
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-10
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 30/176 (17%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
L++D G L + E T E + Y A++A + LH+ G++ ++KP N+LLD
Sbjct: 103 LILDFLRGG-DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE 161
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLN 335
G ++D+GL +++ + + + Y APE V +
Sbjct: 162 EGHIKLTDFGL--------SKESIDHEKKAY-------SFCGTVEYMAPEV---VNRR-- 201
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYAS 391
G + +D WSFG + EM TG++P+ G +E ++K + PQ+ S
Sbjct: 202 -------GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 6e-10
Identities = 42/186 (22%), Positives = 83/186 (44%), Gaps = 30/186 (16%)
Query: 218 LVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276
L+++ G +L MQ EG + Y A+I+ + LH G++ ++KP N++L+
Sbjct: 98 LILEYLSGG-ELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH 156
Query: 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLN 335
G ++D+GL C+++ + + T + Y APE + +S
Sbjct: 157 QGHVKLTDFGL--------CKESIHDGTVTH-------TFCGTIEYMAPEI---LMRS-- 196
Query: 336 LFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGV 395
G + D WS G + +M TG+ P+ G + ++ ++K + P Y +
Sbjct: 197 -------GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249
Query: 396 GIPREL 401
+ ++L
Sbjct: 250 DLLKKL 255
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-10
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 56/231 (24%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ + LVM+ G G L ++I+ A I + V
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKG----------GEL-FDEIIHRMKFNEVDAAVIIKQV 145
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ LH +V ++KP NLLL + + D+GL+A+ + + +
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-----------NQKK 194
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + + Y APE ++K + D WS G L + G P+
Sbjct: 195 MKERLG----TAYYIAPEV---LRKK----------YDEKCDVWSIGVILFILLAGYPPF 237
Query: 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G + +EI R V K + + S + +I + LQF + +R +
Sbjct: 238 GGQTDQEILRKVEKGK---YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >1bor_A Transcription factor PML; proto-oncogene, nuclear bodies (PODS), leukemia, transcription regulation; NMR {Homo sapiens} SCOP: g.44.1.1 Length = 56 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-10
Identities = 17/60 (28%), Positives = 20/60 (33%), Gaps = 11/60 (18%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C CQ P LL C H C CL + CP C+ +G AL
Sbjct: 8 RCQQCQAEAKC----PKLLPCLHTLCSGCLEAS-------GMQCPICQAPWPLGADTPAL 56
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 41/172 (23%), Positives = 65/172 (37%), Gaps = 29/172 (16%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+QR E + Y A+IA + LH+ +V ++KP N+LLD+ G V++D+GL
Sbjct: 130 LQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-- 186
Query: 291 LKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
K +S + C +P Y APE + K D
Sbjct: 187 --KENIE------HNSTTSTFCG-----TPEYLAPEV---LHKQ---------PYDRTVD 221
Query: 350 AWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPREL 401
W G L EM G P+ + E+Y ++ + + L
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 42/231 (18%), Positives = 77/231 (33%), Gaps = 56/231 (24%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ + LV + G G L ++I+ A I R V
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTG----------GEL-FDEIISRKRFSEVDAARIIRQV 135
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ +H +V ++KP NLLL + D+GL+ + S +
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-----------ASKK 184
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + + Y APE + + + D WS G L + +G P+
Sbjct: 185 MKDKIG----TAYYIAPEV---LHGT----------YDEKCDVWSTGVILYILLSGCPPF 227
Query: 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G + +I + V K + + + +I + L + S R +
Sbjct: 228 NGANEYDILKKVEKGK---YTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 47/231 (20%), Positives = 83/231 (35%), Gaps = 56/231 (24%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ V LV + G G L EQI+ A+I + +
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEG----------GEL-FEQIINRHKFDECDAANIMKQI 155
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ LH +V +IKP N+LL ++ + D+GL++ +
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-----------KDYK 204
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + + Y APE +KK + + D WS G + + G P+
Sbjct: 205 LRDRLG----TAYYIAPEV---LKKK----------YNEKCDVWSCGVIMYILLCGYPPF 247
Query: 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G + ++I + V K + + I E ++I L + +KR T
Sbjct: 248 GGQNDQDIIKKVEKGK---YYFDFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 48/255 (18%), Positives = 77/255 (30%), Gaps = 63/255 (24%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
RL + V L ++ +IK N+++ + D+G AA L+
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--- 181
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS------PESD 349
++ C + Y APE + PE +
Sbjct: 182 --------RGKLFYTF--CG--TIEYCAPEV-----------------LMGNPYRGPELE 212
Query: 350 AWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECL 409
WS G TL + P+ L EE A + PP S +EL ++ L
Sbjct: 213 MWSLGVTLYTLVFEENPFCEL--EETVEAAIH----PPYLVS-------KELMSLVSGLL 259
Query: 410 QFKASKRPTFSAMLA-------TFLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDV 462
Q +R T ++ L P++G + S E SDV
Sbjct: 260 QPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLS-AASLEMGNRSLSDV 318
Query: 463 EVFQ----DNPNNLH 473
Q ++ H
Sbjct: 319 AQAQELCGGEGHHHH 333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 43/190 (22%), Positives = 71/190 (37%), Gaps = 47/190 (24%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
R+T ++ R+ I + H +V ++KP NLLLD + ++D+GL+ I+
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--- 159
Query: 296 CRKARPECDSSRIH-SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS------PES 348
D + + SC SPNY APE I+ PE
Sbjct: 160 --------DGNFLKTSCG-----SPNYAAPEV-----------------INGKLYAGPEV 189
Query: 349 DAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGEC 408
D WS G L M G +P+ +++ V + P + + +I
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQSLIRRM 242
Query: 409 LQFKASKRPT 418
+ +R T
Sbjct: 243 IVADPMQRIT 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-09
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
++ + V+ + +VM+ G GR+ + R I V H
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH-SCMDCTMLSPN 320
VV ++KP N+LLDA A ++D+GL+ ++ D + SC SPN
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-----------DGEFLRTSCG-----SPN 175
Query: 321 YTAPEAWEPVKKSLNLFWDDAIGIS------PESDAWSFGCTLVEMCTGSIPWAGLSAEE 374
Y APE IS PE D WS G L + G++P+
Sbjct: 176 YAAPEV-----------------ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+++ + P+Y + R + ++ LQ KR T +
Sbjct: 219 LFKKIRGGVFYIPEY-------LNRSVATLLMHMLQVDPLKRATIKDIR 260
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 39/183 (21%), Positives = 75/183 (40%), Gaps = 42/183 (22%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
MQR + +L E Y A+I+ + LH G++ ++K N+LLD+ G ++DYG+
Sbjct: 144 MQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM--- 199
Query: 291 LKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWEPVKKSLNLFWDDAIGISPE 347
C++ + C +PNY APE E S+
Sbjct: 200 -----CKEGL--RPGDTTSTFCG-----TPNYIAPEILRGEDYGFSV------------- 234
Query: 348 SDAWSFGCTLVEMCTGSIPWAGLSA---------EEIYRAVVKNRKLPPQYASIVGVGIP 398
D W+ G + EM G P+ + + + +++ +++ + P+ S+ +
Sbjct: 235 -DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 293
Query: 399 REL 401
+
Sbjct: 294 KSF 296
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-09
Identities = 39/183 (21%), Positives = 75/183 (40%), Gaps = 42/183 (22%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
MQR + +L E Y A+I+ + LH G++ ++K N+LLD+ G ++DYG+
Sbjct: 101 MQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM--- 156
Query: 291 LKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPE--AWEPVKKSLNLFWDDAIGISPE 347
C++ + C +PNY APE E S+
Sbjct: 157 -----CKEGL--RPGDTTSTFCG-----TPNYIAPEILRGEDYGFSV------------- 191
Query: 348 SDAWSFGCTLVEMCTGSIPWAGLSA---------EEIYRAVVKNRKLPPQYASIVGVGIP 398
D W+ G + EM G P+ + + + +++ +++ + P+ S+ +
Sbjct: 192 -DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 250
Query: 399 REL 401
+
Sbjct: 251 KSF 253
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 49/350 (14%), Positives = 98/350 (28%), Gaps = 104/350 (29%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSG 188
+ L +G+G V A+K ++ +
Sbjct: 24 LQKKYHLKGAIGQGSYG--VVR---------VAIENQTRAIRAIK--IMNKNKIRQINPK 70
Query: 189 QLDNLRR--ASMWC---RNVCTFHGVLRMDSCLGLVMDRCYG------------------ 225
++ ++ M N+ + V + + LVM+ C+G
Sbjct: 71 DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 226 ----------------------SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVV 263
S+ + + + I I + LH G+
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190
Query: 264 CMNIKPSNLLLDASGRAVV--SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
+IKP N L + + D+GL+ K ++ + M +P +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKL----------NNGEYYGMTTKAGTPYF 240
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVK 381
APE +S P+ DAWS G L + G++P+ G++ + V+
Sbjct: 241 VAPEVLNTTNES----------YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
Query: 382 NRKLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPTFSAML 423
+ + + ++ L +R L
Sbjct: 291 KK-----------LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-08
Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 45/189 (23%)
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
GRL ++ R I GV H VV ++KP N+LLDA A ++D+GL+ ++
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--- 167
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS------PESD 349
D + + C SPNY APE IS PE D
Sbjct: 168 --------DGEFLRTS--CG--SPNYAAPEV-----------------ISGRLYAGPEVD 198
Query: 350 AWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECL 409
WS G L + G++P+ +++ + PQY + + ++ L
Sbjct: 199 IWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------LNPSVISLLKHML 251
Query: 410 QFKASKRPT 418
Q KR T
Sbjct: 252 QVDPMKRAT 260
|
| >1z6u_A NP95-like ring finger protein isoform B; structural genomics consortium, ligase, ubiquitin-protein ligase, cell cycle regulation, SGC; 2.10A {Homo sapiens} Length = 150 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 21/70 (30%), Positives = 28/70 (40%), Gaps = 10/70 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C CQ + P+ +C H CK+CL R F A SCP CRH +
Sbjct: 80 MCVCCQELVYQ----PVTTECFHNVCKDCLQRSFKAQ---VFSCPACRHDLGQNYI---M 129
Query: 67 RKNFAVLALI 76
N + L+
Sbjct: 130 IPNEILQTLL 139
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 42/231 (18%), Positives = 83/231 (35%), Gaps = 56/231 (24%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ +L S +V + G G L ++I++ A I + V
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTG----------GEL-FDEIIKRKRFSEHDAARIIKQV 130
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+H +V ++KP N+LL + + D+GL+ + +++
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-----------QNTK 179
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + + Y APE ++ + + D WS G L + +G+ P+
Sbjct: 180 MKDRIG----TAYYIAPEV---LRGT----------YDEKCDVWSAGVILYILLSGTPPF 222
Query: 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT 418
G + +I + V + + I + +I + L F S R T
Sbjct: 223 YGKNEYDILKRVETGK---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2ecw_A Tripartite motif-containing protein 30; metal binding protein, structural genomics, NPPSFA; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-08
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 10/65 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMF--SASTDTTLSCPRCRHVSVVGNSVT 64
C +C E P+ C H FC+ C++ + + +TD +CP CR GN
Sbjct: 21 TCPICLELLKE----PVSADCNHSFCRACITLNYESNRNTDGKGNCPVCRVPYPFGN--- 73
Query: 65 ALRKN 69
L+ N
Sbjct: 74 -LKPN 77
|
| >3fl2_A E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA damage, DNA repair, ring finger domain, metal binding, DNA replication; 1.75A {Homo sapiens} Length = 124 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 20/70 (28%), Positives = 28/70 (40%), Gaps = 10/70 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C CQ P+ C H CK+CL R F A SCP CR+ A+
Sbjct: 54 QCICCQELVFR----PITTVCQHNVCKDCLDRSFRAQ---VFSCPACRYDL---GRSYAM 103
Query: 67 RKNFAVLALI 76
+ N + ++
Sbjct: 104 QVNQPLQTVL 113
|
| >3l11_A E3 ubiquitin-protein ligase RNF168; E3 ligase, ring domain, DNA damage, chromatin regulator, chromosomal protein, DNA repair, metal-binding; 2.12A {Homo sapiens} Length = 115 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-08
Identities = 17/69 (24%), Positives = 23/69 (33%), Gaps = 7/69 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C +C E P+ L C H CK C + +L CP CR
Sbjct: 17 QCGICMEILVE----PVTLPCNHTLCKPCFQSTVEKA---SLCCPFCRRRVSSWTRYHTR 69
Query: 67 RKNFAVLAL 75
R + + L
Sbjct: 70 RNSLVNVEL 78
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 54/225 (24%), Positives = 82/225 (36%), Gaps = 73/225 (32%)
Query: 225 GSVQLAMQRNEGRLTLEQILRY--GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVV 282
GS+ + +G L +R A G+ LH + +IK +N+LLD + A +
Sbjct: 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKI 174
Query: 283 SDYGLAAILKKPACRKARPECD----SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFW 338
SD+GLA +A + +SRI + + Y APEA
Sbjct: 175 SDFGLA---------RASEKFAQTVMTSRI-------VGTTAYMAPEALR---------- 208
Query: 339 DDAIG-ISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQY-------- 389
G I+P+SD +SFG L+E+ TG AV ++R PQ
Sbjct: 209 ----GEITPKSDIYSFGVVLLEIITGL------------PAVDEHR--EPQLLLDIKEEI 250
Query: 390 -------ASIV----GVGIPRELWKMIG---ECLQFKASKRPTFS 420
+ + M +CL K +KRP
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 40/206 (19%)
Query: 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNL 272
+S L +VM+ G + R GR + Y A I LH+ ++ ++KP NL
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172
Query: 273 LLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS-CMDCTMLSPNYTAPEAWEPVK 331
L+D G V+D+G A K+ R + C +P APE
Sbjct: 173 LIDQQGYIQVTDFGFA---KR----------VKGRTWTLCG-----TPEALAPEII---- 210
Query: 332 KSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNR-KLPPQYA 390
L+ ++ A+ D W+ G + EM G P+ +IY +V + + P
Sbjct: 211 --LSKGYNKAV------DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-- 260
Query: 391 SIVGVGIPRELWKMIGECLQFKASKR 416
+L ++ LQ +KR
Sbjct: 261 ------FSSDLKDLLRNLLQVDLTKR 280
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 42/203 (20%), Positives = 71/203 (34%), Gaps = 48/203 (23%)
Query: 233 RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292
++ EQ L ARG+ LH ++ ++K N+LLD + ++D+G++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS---- 186
Query: 293 KPACRKARPECD----SSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
K E D S+ + + Y PE + L + +S
Sbjct: 187 -----KKGTELDQTHLSTVV-------KGTLGYIDPEYF----IKGRL--------TEKS 222
Query: 349 DAWSFGCTLVEMCTGSIP-WAGLSAEEIY-----RAVVKNRKLP----PQYASIVGVGIP 398
D +SFG L E+ L E + N +L P ++ P
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP---NLADKIRP 279
Query: 399 RELWKMIG---ECLQFKASKRPT 418
L K +CL + RP+
Sbjct: 280 ESLRKFGDTAVKCLALSSEDRPS 302
|
| >2egp_A Tripartite motif-containing protein 34; ZF-C3HC4 domain, tripartite motif protein 34, interferon- responsive finger protein 1; NMR {Homo sapiens} Length = 79 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-08
Identities = 18/69 (26%), Positives = 25/69 (36%), Gaps = 11/69 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMF---SASTDTTLSCPRCRHVSVVGNSV 63
C +C E PL L CGH C+ C++ S SCP C +
Sbjct: 14 TCPICLELLTE----PLSLDCGHSLCRACITVSNKEAVTSMGGKSSCPVCGISYSFEH-- 67
Query: 64 TALRKNFAV 72
L+ N +
Sbjct: 68 --LQANQHL 74
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 74/360 (20%), Positives = 125/360 (34%), Gaps = 89/360 (24%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKV-MIAEEMEPDWLSGQLDNLRRA 196
+ KLGEG A V +G+ + + VA+K++ + EE P +R
Sbjct: 7 LDKLGEGTYATVY---------KGKSKLTDNLVALKEIRLEHEEGAP------CTAIREV 51
Query: 197 S----MWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
S + N+ T H ++ + L LV + ++ + + + + + + R
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ H V+ ++KP NLL++ G ++D+GL AR + ++ +
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL-----------ARAKSIPTKTYDNE 160
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
T+ Y P+ L + S + D W GC EM TG + G +
Sbjct: 161 VVTLW---YRPPDI---------LLG--STDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206
Query: 373 EE----IYRAV----------------VKNRKLPPQYASIVGVGIPRELWKMIGE----- 407
EE I+R + K P A + +
Sbjct: 207 EEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEAL-----LSHAPRLDSDGADL 261
Query: 408 ---CLQFKASKRPTFSAMLATFLRH--LQELPRSPPASPDTG--FTKFSTSNETEPSPAS 460
LQF+ R SA A ++H L PDT F + E S S
Sbjct: 262 LTKLLQFEGRNRI--SAEDA--MKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRS 317
|
| >2ecv_A Tripartite motif-containing protein 5; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 85 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-08
Identities = 21/65 (32%), Positives = 26/65 (40%), Gaps = 10/65 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMF--SASTDTTLSCPRCRHVSVVGNSVT 64
C +C + PL L CGH FC+ CL+ S SCP CR N
Sbjct: 21 TCPICLELLTQ----PLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPEN--- 73
Query: 65 ALRKN 69
+R N
Sbjct: 74 -IRPN 77
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 32/162 (19%)
Query: 231 MQRNEGR-LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV--VSDYGL 287
+++N+ + +L + ++ I + + LH ++ ++KP N+LL GR+ V D+G
Sbjct: 189 IKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPE 347
+ C + + S Y APE L + I
Sbjct: 249 S--------------CYEHQRVYT---YIQSRFYRAPEVI------LGARYGMPI----- 280
Query: 348 SDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQY 389
D WS GC L E+ TG G + +++ +P Q
Sbjct: 281 -DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321
|
| >1jm7_A BRCA1, breast cancer type 1 susceptibility protein; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 Length = 112 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 14/66 (21%), Positives = 25/66 (37%), Gaps = 9/66 (13%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C +C E P+ +C H FCK C+ + CP C++ + L
Sbjct: 23 ECPICLELIKE----PVSTKCDHIFCKFCMLK-LLNQKKGPSQCPLCKNDITKRS----L 73
Query: 67 RKNFAV 72
+++
Sbjct: 74 QESTRF 79
|
| >2ecy_A TNF receptor-associated factor 3; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 66 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 7e-08
Identities = 13/49 (26%), Positives = 21/49 (42%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C C P +CGH FC+ C++ + S+S+ C C+
Sbjct: 17 KCEKCHLVLCS----PKQTECGHRFCESCMAALLSSSSPK---CTACQE 58
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 54.8 bits (133), Expect = 1e-07
Identities = 40/183 (21%), Positives = 69/183 (37%), Gaps = 37/183 (20%)
Query: 213 DSCLGLVMDRCYGS---VQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKP 269
+ ++MD G L R R Y A++ + LH+ ++ ++KP
Sbjct: 78 AQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 134
Query: 270 SNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC-TMLSPNYTAPEAWE 328
N+LLD +G ++D+G A K ++ C T P+Y APE
Sbjct: 135 ENILLDKNGHIKITDFGFA---KY----------VPDVTYTL--CGT---PDYIAPE--- 173
Query: 329 PVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQ 388
V + + D WSFG + EM G P+ + + Y ++ P
Sbjct: 174 -VVSTK--------PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 224
Query: 389 YAS 391
+ +
Sbjct: 225 FFN 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 80/356 (22%), Positives = 126/356 (35%), Gaps = 96/356 (26%)
Query: 139 KLVKKLGEGRRA-GVEVWGAWIGGGQGRCRHS--VAVKKVMIAEEMEPDWLSGQLDNLRR 195
K +G G + GV V+ Q + S VA+KKV+ + + + +L +R
Sbjct: 43 TNCKVIGNG--SFGV-VF-------QAKLVESDEVAIKKVLQDKRFK----NRELQIMRI 88
Query: 196 ASMWCRNVCTFHGVL------RMDSCLGLVMD----------RCYGSVQLAMQRNEGRLT 239
+ NV + + L LV++ R Y ++ M +L
Sbjct: 89 --VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 240 LEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKKPACRK 298
+ Q+LR + +H+ G+ +IKP NLLLD SG + D+G A IL
Sbjct: 147 MYQLLR-------SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA----- 194
Query: 299 ARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLV 358
E + S I C+ Y APE +F A + D WS GC +
Sbjct: 195 --GEPNVSYI-----CSRY---YRAPEL---------IF--GATNYTTNIDIWSTGCVMA 233
Query: 359 EMCTGSIPWAGLSA---------------EEIYRAVVKNRKLP--PQY-----ASIVGVG 396
E+ G + G S E + + N PQ + +
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR 293
Query: 397 IPRELWKMIGECLQFKASKRPT-FSAMLATFLRHL----QELPRSPPASPDTGFTK 447
P + +I L++ S R T A+ F L +P P +TK
Sbjct: 294 TPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349
|
| >2ysl_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 73 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-07
Identities = 12/51 (23%), Positives = 23/51 (45%), Gaps = 5/51 (9%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVS 57
C +C + P+ + CGH FC +C+++ ++ CP C+
Sbjct: 22 ICPICLDILQK----PVTIDCGHNFCLKCITQ-IGETSCGFFKCPLCKTSV 67
|
| >1g25_A CDK-activating kinase assembly factor MAT1; ring finger (C3HC4), metal binding protein; NMR {Homo sapiens} SCOP: g.44.1.1 Length = 65 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 2e-07
Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 13/63 (20%)
Query: 8 CSVCQT-RYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C C+T +Y ++ CGH C+ C+ +F +CP C T L
Sbjct: 6 CPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAG---NCPECG---------TPL 53
Query: 67 RKN 69
RK+
Sbjct: 54 RKS 56
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 3e-07
Identities = 54/256 (21%), Positives = 86/256 (33%), Gaps = 68/256 (26%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ K+GEG GV V+ +CR+ VA+KK E + + LR
Sbjct: 8 IGKIGEGSY-GV-VF---------KCRNRDTGQIVAIKK--FLESEDDPVIKKI--ALRE 52
Query: 196 ASMWCR----NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251
M + N+ V R L LV + C +V + R + + +
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
+ V H + ++KP N+L+ + D+G A +L P
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP----------------- 155
Query: 312 MDCTMLSPNYT---------APEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
S Y +PE L D P D W+ GC E+ +
Sbjct: 156 ------SDYYDDEVATRWYRSPEL---------LVGDTQ--YGPPVDVWAIGCVFAELLS 198
Query: 363 GSIPWAGLS-AEEIYR 377
G W G S +++Y
Sbjct: 199 GVPLWPGKSDVDQLYL 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 38/170 (22%), Positives = 58/170 (34%), Gaps = 41/170 (24%)
Query: 200 CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGA----------- 248
RNV + LV ++ G G + L I +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRG----------GSI-LSHIHKRRHFNELEASVVVQ 118
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLL-DASGRAVV--SDYGLAAILKKPACRKARPECDS 305
D+A + LH G+ ++KP N+L + + V D+ L + +K D
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK--------LNGDC 170
Query: 306 SRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
S I + T S Y APE V + F ++A D WS G
Sbjct: 171 SPISTPELLTPCGSAEYMAPE----V---VEAFSEEASIYDKRCDLWSLG 213
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 34/137 (24%), Positives = 46/137 (33%), Gaps = 26/137 (18%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
+E I Y +I + + L + ++KP N+LLD K
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 298 KARPECDSSRIH------SCMDCTMLSP-----NYTAPEAWEPVKKSLNLFWDDAIGISP 346
S+ I + Y APE V LNL WD +
Sbjct: 194 YRT---KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPE----V--ILNLGWDVSS---- 240
Query: 347 ESDAWSFGCTLVEMCTG 363
D WSFGC L E+ TG
Sbjct: 241 --DMWSFGCVLAELYTG 255
|
| >2y43_A E3 ubiquitin-protein ligase RAD18; DNA repair, metal-binding, translesion synthesis, UB conjugation pathway; 1.80A {Homo sapiens} Length = 99 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 15/67 (22%), Positives = 25/67 (37%), Gaps = 13/67 (19%)
Query: 7 CCSVCQTRYNEKERVP-LLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTA 65
C +C +N ++ QC H +C C+ + S T CP C +
Sbjct: 24 RCGICFEYFNI----AMIIPQCSHNYCSLCIRKFLSYKT----QCPTCCVTVTEPD---- 71
Query: 66 LRKNFAV 72
L+ N +
Sbjct: 72 LKNNRIL 78
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-07
Identities = 75/369 (20%), Positives = 119/369 (32%), Gaps = 105/369 (28%)
Query: 139 KLVKKLGEGRRA-GVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLR 194
K +G G + GV V+ Q + S VA+KKV+ + + R
Sbjct: 57 TDTKVIGNG--SFGV-VY-------QAKLCDSGELVAIKKVLQDKRFK----------NR 96
Query: 195 RASMWCR----NVCTFHGVL------RMDSCLGLVMD----------RCYGSVQLAMQRN 234
+ + N+ + + L LV+D R Y + +
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 235 EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKK 293
+L + Q+ R + +H+ G+ +IKP NLLLD + + D+G A L +
Sbjct: 157 YVKLYMYQLFR-------SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
E + S I C+ Y APE +F A + D WS
Sbjct: 210 -------GEPNVSYI-----CSRY---YRAPEL---------IF--GATDYTSSIDVWSA 243
Query: 354 GCTLVEMCTGSIPWAGLSA---------------EEIYRAV---VKNRKLPP----QYAS 391
GC L E+ G + G S E R + K P +
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 392 IVGVGIPRELWKMIGECLQFKASKRPT-FSAMLATFLRHL----QELPRSPPASPDTGFT 446
+ P E + L++ + R T A +F L +LP FT
Sbjct: 304 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFT 363
Query: 447 KFSTSNETE 455
S+
Sbjct: 364 TQELSSNPP 372
|
| >4epo_C E3 ubiquitin-protein ligase RNF8; coiled-coil, E3 ubiquitin ligase, protein binding complex; 4.80A {Homo sapiens} Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 13/49 (26%), Positives = 19/49 (38%), Gaps = 8/49 (16%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + E + L C H FC C++ + CP CR
Sbjct: 66 QCIICSEYFIE----AVTLNCAHSFCSYCINEWM----KRKIECPICRK 106
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 25/139 (17%), Positives = 40/139 (28%), Gaps = 32/139 (23%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L + + + LH + ++KP N+L S + + + K
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV--- 176
Query: 298 KARPECDSSRIH------SCMDCTMLSP-----NYTAPEAWEPVKKSLNLFWDDAIGISP 346
++ I + D + +Y PE L L W
Sbjct: 177 ------KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEV------ILELGWAQPC---- 220
Query: 347 ESDAWSFGCTLVEMCTGSI 365
D WS GC L E G
Sbjct: 221 --DVWSIGCILFEYYRGFT 237
|
| >2ecj_A Tripartite motif-containing protein 39; TRIM39, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 58 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-07
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 5/47 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRC 53
CSVC E P++++CGH FCK C++R + + CP C
Sbjct: 17 SCSVCLEYLKE----PVIIECGHNFCKACITR-WWEDLERDFPCPVC 58
|
| >2ysj_A Tripartite motif-containing protein 31; ring-type zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 63 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-07
Identities = 12/47 (25%), Positives = 22/47 (46%), Gaps = 5/47 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRC 53
C +C + P+ + CGH FC +C+++ ++ CP C
Sbjct: 22 ICPICLDILQK----PVTIDCGHNFCLKCITQ-IGETSCGFFKCPLC 63
|
| >2ckl_A Polycomb group ring finger protein 4; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_B 2h0d_A Length = 108 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C +C + + +++C H FCK C+ R +T+ CP C + +
Sbjct: 17 MCVLCGGYFIDA---TTIIECLHSFCKTCIVRYL----ETSKYCPICDVQVHKTRPLLNI 69
Query: 67 RKNFAVLALI 76
R + + ++
Sbjct: 70 RSDKTLQDIV 79
|
| >2ea6_A Ring finger protein 4; RNF4, RES4-26, ring domain, zinc- binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 69 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-06
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 7/51 (13%)
Query: 8 CSVCQTRYNEKE---RVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C Y+E R+ + +CGH FC +CL + +CP CR
Sbjct: 18 CPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNAN----TCPTCRK 64
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 45/232 (19%), Positives = 77/232 (33%), Gaps = 57/232 (24%)
Query: 165 RCRHS-----VAVKKVMIAEEMEPDWLSGQLDNLRRASM----WCRNVCTFHGVLRMDSC 215
+CR+ VA+KK E + + +R + N+ V +
Sbjct: 43 KCRNKDTGRIVAIKK--FLESDDDKMVKKI--AMREIKLLKQLRHENLVNLLEVCKKKKR 98
Query: 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275
LV + ++ ++ L + + +Y I G+ H+ ++ +IKP N+L+
Sbjct: 99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158
Query: 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYT---------APEA 326
SG + D+G A L P Y APE
Sbjct: 159 QSGVVKLCDFGFARTLAAP-----------------------GEVYDDEVATRWYRAPEL 195
Query: 327 WEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS-AEEIYR 377
L D D W+ GC + EM G + G S +++Y
Sbjct: 196 ---------LVGDVK--YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
|
| >2d8t_A Dactylidin, ring finger protein 146; RNF146, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 12/47 (25%), Positives = 16/47 (34%), Gaps = 8/47 (17%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR 54
C++C P+ L C H FC C+ C CR
Sbjct: 18 CAICLQTCVH----PVSLPCKHVFCYLCVKGASWLGK----RCALCR 56
|
| >2yur_A Retinoblastoma-binding protein 6; P53-associated cellular protein of testis, proliferation potential-related protein, protein P2P-R; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 12/53 (22%), Positives = 22/53 (41%), Gaps = 7/53 (13%)
Query: 7 CCSVCQTRYNEKERVPLLL-QCGHGFCKECLSRMFSASTDTTLSCPRCRHVSV 58
C +C+ + +++ CG+ +C EC+ S +CP C V
Sbjct: 17 LCLICKDIMTD----AVVIPCCGNSYCDECIRTALLES--DEHTCPTCHQNDV 63
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 25/165 (15%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ H VL D L LV + C ++ G L E + + + +G+ H+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
V+ ++KP NLL++ +G ++++GL AR R +S T+ Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGL-----------ARAFGIPVRCYSAEVVTLW---Y 167
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
P+ LF A S D WS GC E+ P
Sbjct: 168 RPPDV---------LFG--AKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2csy_A Zinc finger protein 183-like 1; ring finger protein 161, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 81 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-06
Identities = 14/62 (22%), Positives = 23/62 (37%), Gaps = 9/62 (14%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR-HVSVVGNSVTAL 66
C +C+ + P++ +C H FC+ C F A+ C C + N L
Sbjct: 18 CFICRQAFQN----PVVTKCRHYFCESCALEHFRATP----RCYICDQPTGGIFNPAKEL 69
Query: 67 RK 68
Sbjct: 70 MA 71
|
| >2xeu_A Ring finger protein 4; transcription, zinc-finger, metal-binding; HET: SUC; 1.50A {Homo sapiens} Length = 64 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-06
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 7/51 (13%)
Query: 8 CSVCQTRYNE---KERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C Y+E R+ + +CGH FC +CL + +CP CR
Sbjct: 6 CPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNAN----TCPTCRK 52
|
| >3ng2_A RNF4, snurf, ring finger protein 4; ring domain, E3 ligase, ubiquitylation, sumoylation, zinc-FI metal binding protein; 1.80A {Rattus norvegicus} Length = 71 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-06
Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 7/51 (13%)
Query: 8 CSVCQTRYNE---KERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C Y+E R+ + +CGH FC +CL + +CP CR
Sbjct: 13 CPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNAN----TCPTCRK 59
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 37/192 (19%), Positives = 66/192 (34%), Gaps = 45/192 (23%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ ++ LV D G L + + I R +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKK----------GEL-FDYLTEKVTLSEKETRKIMRAL 133
Query: 255 VE----LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
+E LH +V ++KP N+LLD ++D+G + L ++
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-----------PGEKLR- 181
Query: 311 CMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
+ +P+Y APE + + D+ G E D WS G + + GS P+
Sbjct: 182 ----EVCGTPSYLAPE----IIE--CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 370 LSAEEIYRAVVK 381
+ R ++
Sbjct: 232 RKQMLMLRMIMS 243
|
| >2ecm_A Ring finger and CHY zinc finger domain- containing protein 1; RCHY1, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Mus musculus} PDB: 2jrj_A Length = 55 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-06
Identities = 13/53 (24%), Positives = 17/53 (32%), Gaps = 5/53 (9%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVG 60
C +C + V +L CGH + C M CP C G
Sbjct: 8 CPICLEDIHTSRVVAHVLPCGHLLHRTCYEEMLKEGY----RCPLCSG-PSSG 55
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-06
Identities = 39/184 (21%), Positives = 63/184 (34%), Gaps = 40/184 (21%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ F V+ + L ++M+ G N GR + ++ + + GV H+
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 262 VVCMNIKPSNLLLDAS--GRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSP 319
+ ++K N LLD S R + D+G + S+ S +P
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-----------LHSQPKST--VG--TP 181
Query: 320 NYTAPEAWEPVKKSLNLFWDDAIGIS------PESDAWSFGCTLVEMCTGSIPWAGLSAE 373
Y APE + +D WS G TL M G+ P+
Sbjct: 182 AYIAPEV-----------------LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224
Query: 374 EIYR 377
YR
Sbjct: 225 RDYR 228
|
| >1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 18/80 (22%), Positives = 28/80 (35%), Gaps = 15/80 (18%)
Query: 7 CCSVCQTRYNEKERVPL-LLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTA 65
CS C E P+ L C H FC C+S CP C + + +
Sbjct: 24 RCSRCTNILRE----PVCLGGCEHIFCSNCVSDCIGT------GCPVCYTPAWIQD---- 69
Query: 66 LRKNFAVLALILSANNTNQH 85
L+ N + ++I +
Sbjct: 70 LKINRQLDSMIQLCSKLRNL 89
|
| >3hct_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 3hcu_A 2eci_A 2jmd_A Length = 118 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 16/72 (22%), Positives = 24/72 (33%), Gaps = 11/72 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C +C E + CGH FCK C+ + + CP + + L
Sbjct: 20 ECPICLMALRE----AVQTPCGHRFCKACIIKSIRDAGHK---CPVDNEILLENQ----L 68
Query: 67 RKNFAVLALILS 78
+ ILS
Sbjct: 69 FPDNFAKREILS 80
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 26/146 (17%), Positives = 47/146 (32%), Gaps = 38/146 (26%)
Query: 228 QLAMQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAV----- 281
L + + L + + + G+ +H G++ +IKP N+L++
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 282 -VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPN-YTAPEAWEPVKKSLNLFWD 339
++D G A C ++ + Y +PE L W
Sbjct: 178 KIADLGNA--------------CWYDEHYT----NSIQTREYRSPEV------LLGAPWG 213
Query: 340 DAIGISPESDAWSFGCTLVEMCTGSI 365
D WS C + E+ TG
Sbjct: 214 CGA------DIWSTACLIFELITGDF 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-06
Identities = 30/139 (21%), Positives = 45/139 (32%), Gaps = 32/139 (23%)
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L+ I + I + V LH+ + ++KP N+L S + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL--- 171
Query: 298 KARPECDSSRIH------SCMDCTMLSP-----NYTAPEAWEPVKKSLNLFWDDAIGISP 346
+ I + D S +Y APE V L L W
Sbjct: 172 ------INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPE----V--ILALGWSQPC---- 215
Query: 347 ESDAWSFGCTLVEMCTGSI 365
D WS GC L+E G
Sbjct: 216 --DVWSIGCILIEYYLGFT 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 4e-06
Identities = 37/162 (22%), Positives = 60/162 (37%), Gaps = 25/162 (15%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ + V+ L LV + ++ + EG L + + G+ H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
V+ ++KP NLL++ G ++D+GL AR R ++ T+ Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGL-----------ARAFGIPVRKYTHEIVTLW---Y 166
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
AP+ L + S D WS GC EM G
Sbjct: 167 RAPDV---------LMG--SKKYSTTIDIWSVGCIFAEMVNG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-06
Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 25/162 (15%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ + V+ + CL LV + ++ + N+ L QI Y + RGV H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 262 VVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNY 321
++ ++KP NLL+++ G ++D+GL AR R ++ T+ Y
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGL-----------ARAFGIPVRSYTHEVVTLW---Y 185
Query: 322 TAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
AP+ L S D WS GC EM TG
Sbjct: 186 RAPDV---------LMGSKK--YSTSVDIWSIGCIFAEMITG 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-06
Identities = 70/322 (21%), Positives = 114/322 (35%), Gaps = 93/322 (28%)
Query: 162 GQG------RCRH-----SVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVL 210
G+G +C H + AVK +I++ ME + ++ L+ N+ H V
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVK--IISKRMEAN-TQKEITALKLCEG-HPNIVKLHEVF 75
Query: 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGVVE----LHA 259
LVM+ G G L E+I + + I R +V +H
Sbjct: 76 HDQLHTFLVMELLNG----------GEL-FERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 260 AGVVCMNIKPSNLLL-DASGRAVV--SDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
GVV ++KP NLL D + + D+G A + P + + C
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCF------------ 171
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP-WA------G 369
+ +Y APE + ++ G D WS G L M +G +P +
Sbjct: 172 -TLHYAAPEL---LNQN---------GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPTFSA 421
SA EI + + K E WK + + L +KR S
Sbjct: 219 TSAVEIMKKIKKGD-----------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 422 MLA-TFLRHLQELPRSPPASPD 442
+ +L+ +L +P +PD
Sbjct: 268 LRYNEWLQDGSQLSSNPLMTPD 289
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 32/148 (21%), Positives = 52/148 (35%), Gaps = 37/148 (25%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
+L GV +H+AG++ ++KP+N L++ V D+GLA + P ++
Sbjct: 164 NLLV-------GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 302 ECDSSRIHSCMDCTMLSPN-------------YTAPEAWEPVKKSLNLFWDD---AIGIS 345
+ + N Y APE L L ++ AI
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE--------LILLQENYTEAI--- 265
Query: 346 PESDAWSFGCTLVEMCTGSIPWAGLSAE 373
D WS GC E+ A+
Sbjct: 266 ---DVWSIGCIFAELLNMIKENVAYHAD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-06
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 35/157 (22%)
Query: 238 LTLEQILRYGADIARGVVELHA--AGVVCMNIKPSNLLLDASGRAV--VSDYGLAAILKK 293
++L ++ + ++ L ++ ++KP N+LL R+ + D+G +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 294 PACRKARPECDSSRIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWS 352
C + + S Y +PE L + +D AI D WS
Sbjct: 209 ---------CQLGQRIY----QYIQSRFYRSPEV------LLGMPYDLAI------DMWS 243
Query: 353 FGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQY 389
GC LVEM TG ++G + + +V+ +PP +
Sbjct: 244 LGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280
|
| >3ztg_A E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mRNA processing, mRNA splicing; NMR {Homo sapiens} Length = 92 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-06
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 10/71 (14%)
Query: 7 CCSVCQTRYNEKERVPLLL-QCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTA 65
C +C+ + +++ CG+ +C EC+ S + +CP C V S A
Sbjct: 15 LCLICKDIMTD----AVVIPCCGNSYCDECIRTALLESDE--HTCPTCHQNDV---SPDA 65
Query: 66 LRKNFAVLALI 76
L N + +
Sbjct: 66 LIANKFLRQAV 76
|
| >1v87_A Deltex protein 2; ring-H2 domain, zinc-binding domain, notch signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: g.44.1.1 Length = 114 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 7e-06
Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 1/57 (1%)
Query: 1 MKMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSAST-DTTLSCPRCRHV 56
+ + + ++ V L +C H F CL M+ D +L CP C+ +
Sbjct: 35 LAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTI 91
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 43/206 (20%), Positives = 72/206 (34%), Gaps = 33/206 (16%)
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277
++MDR +Q + N R + + +L+ I + +H V +IK SNLLL+
Sbjct: 129 MIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188
Query: 278 GRAVV--SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
V DYGLA KA C D T +T S++
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAA----DPKRCHDGT---IEFT----------SID 231
Query: 336 LFWDDA---IGISPESDAWSFGCTLVEMCTGSIPWAGLSA--EEIYRAVVKNRKLPPQYA 390
A + S D G +++ TG +PW + + + ++ R+
Sbjct: 232 -----AHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLM 286
Query: 391 SI--VGVGIPRELWKMIGEC--LQFK 412
P E+ K + L +
Sbjct: 287 DKCFPAANAPGEIAKYMETVKLLDYT 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-06
Identities = 54/298 (18%), Positives = 99/298 (33%), Gaps = 73/298 (24%)
Query: 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSN 271
+ L V+ S + + + I Y + R V +H+ G+ +IKP N
Sbjct: 120 VPDTLHKVLKSFIRSGR--------SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 272 LLLDA-SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPV 330
LL+++ + D+G A L E + I C+ Y APE
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIP-------SEPSVAYI-----CSRF---YRAPE----- 211
Query: 331 KKSLNLFWDD---AIGISPESDAWSFGCTLVEMCTGSIPWAGLSA--------------- 372
L L + +I D WS GC E+ G ++G ++
Sbjct: 212 ---LMLGATEYTPSI------DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 373 EEIYRAVVKN---RKLPP----QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425
+E + + + P + I+ G P ++ + L+++ R A
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN--PYEA- 319
Query: 426 FLRH--LQELPRSPPASPDTGFTKFSTSNETEPSPA---SDVEVFQDNPNNLHQLVSE 478
+ H L R+ S + F S E+ N L++++ +
Sbjct: 320 -MAHPFFDHL-RNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPK 375
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 45/273 (16%), Positives = 90/273 (32%), Gaps = 43/273 (15%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRAS- 197
+++KLG G + V W +W + VA+K V+ + E + ++ L+
Sbjct: 40 HVIRKLGWGHFSTV--WLSWD---IQGKKF-VAMK-VVKSAEHYTETALDEIRLLKSVRN 92
Query: 198 --------MWCRNVC---TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGR-LTLEQILR 245
+ GV C+ V + + + ++ + L L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 246 YGADIARGVVELHA-AGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK-PACRKARPEC 303
+ +G+ LH ++ +IKP N+LL + + + A ++ A +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDA-------------------IGI 344
++ + A + + N W G
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 345 SPESDAWSFGCTLVEMCTGSIPWAGLSAEEIYR 377
+ +D WS C E+ TG + S EE R
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >2djb_A Polycomb group ring finger protein 6; PCGF6, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 72 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-06
Identities = 16/49 (32%), Positives = 23/49 (46%), Gaps = 7/49 (14%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHV 56
CS+C+ + + +C H FCK C+ R F S CP+C V
Sbjct: 18 CSICKGYLIDA---TTITECLHTFCKSCIVRHFYYSN----RCPKCNIV 59
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-06
Identities = 40/192 (20%), Positives = 68/192 (35%), Gaps = 45/192 (23%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIAR-- 252
++ T S + LV D G L + + I R
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRK----------GEL-FDYLTEKVALSEKETRSIMRSL 209
Query: 253 --GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
V LHA +V ++KP N+LLD + + +SD+G + L+ ++
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-----------PGEKLR- 257
Query: 311 CMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
+ +P Y APE + K + G E D W+ G L + GS P+
Sbjct: 258 ----ELCGTPGYLAPE----ILK--CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
Query: 370 LSAEEIYRAVVK 381
+ R +++
Sbjct: 308 RRQILMLRMIME 319
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 31/147 (21%), Positives = 51/147 (34%), Gaps = 48/147 (32%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
+L G +H +G++ ++KP+N LL+ V D+GLA R
Sbjct: 137 NLLL-------GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA--------RTINS 181
Query: 302 ECDSSRIHSCMDCTMLSPN----------------YTAPEAWEPVKKSLNLFWDD---AI 342
E D++ ++ + P+ Y APE L L ++ +I
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE--------LILLQENYTKSI 233
Query: 343 GISPESDAWSFGCTLVEMCTGSIPWAG 369
D WS GC E+
Sbjct: 234 ------DIWSTGCIFAELLNMLQSHIN 254
|
| >1iym_A EL5; ring-H2 finger, ubiquitin ligase, DNA binding protein; NMR {Oryza sativa} SCOP: g.44.1.1 Length = 55 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 18/53 (33%), Positives = 25/53 (47%), Gaps = 4/53 (7%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVV 59
C+VC + E L +CGHGF EC+ + + +CP CR VV
Sbjct: 7 ECAVCLAELEDGEEARFLPRCGHGFHAECVDMWLGSHS----TCPLCRLTVVV 55
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 35/182 (19%), Positives = 56/182 (30%), Gaps = 49/182 (26%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAV---VSDYGLAAILKKPACRKARPECDSS 306
+ V LH G++ ++KP N+LL + ++D+G + IL +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------------- 294
Query: 307 RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
S M +P Y APE L G + D WS G L +G P
Sbjct: 295 --TSLMRTLCGTPTYLAPEV---------LVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
Query: 367 -WAGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKR 416
+ + + + P+ W + E L R
Sbjct: 344 FSEHRTQVSLKDQITSGKYNFIPEV------------WAEVSEKALDLVKKLLVVDPKAR 391
Query: 417 PT 418
T
Sbjct: 392 FT 393
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 33/134 (24%)
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPA 295
LT I Y +I + + H+ G++ ++KP N+++D R + + D+GLA
Sbjct: 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA------- 178
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFW---DDAIGISPESDAWS 352
P + + + S + PE L + + D ++ D WS
Sbjct: 179 -EFYHPGQE-------YNVRVASRYFKGPE--------LLVDYQMYDYSL------DMWS 216
Query: 353 FGCTLVEMCTGSIP 366
GC L M P
Sbjct: 217 LGCMLASMIFRKEP 230
|
| >1rmd_A RAG1; V(D)J recombination, antibody, MAD, ring finger, zinc binuclear cluster, zinc finger, DNA-binding protein; 2.10A {Mus musculus} SCOP: g.37.1.1 g.44.1.1 Length = 116 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 13/49 (26%), Positives = 20/49 (40%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C+ + P+ C H FC+ C+ R CP CR+
Sbjct: 25 SCQICEHILAD----PVETSCKHLFCRICILRCLKVMGSY---CPSCRY 66
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 37/173 (21%), Positives = 60/173 (34%), Gaps = 28/173 (16%)
Query: 218 LVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS 277
+VM+R +Q +N G +L+ G + + +H V +IK +NLLL
Sbjct: 129 MVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187
Query: 278 GRAVV--SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLN 335
V +DYGL+ K E + T +T SL+
Sbjct: 188 NPDQVYLADYGLSYRYCPNGNHKQYQE----NPRKGHNGT---IEFT----------SLD 230
Query: 336 LFWDDA-IGISP--ESDAWSFGCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKL 385
A G++ SD G ++ G +PW + + K L
Sbjct: 231 -----AHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 37/189 (19%), Positives = 64/189 (33%), Gaps = 39/189 (20%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQL-----AMQRNEGRLTLEQILRYGADIARGVVE 256
N+ V + +VM+ C G +L + Q L+ + + +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGG-ELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 257 LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
H+ VV ++KP N+L + D+GLA + K
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-----------SDEHST---- 184
Query: 314 CTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+ Y APE K+ + + D WS G + + TG +P+ G S
Sbjct: 185 -NAAGTALYMAPEV---FKRDVT----------FKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 373 EEIYRAVVK 381
EE+ +
Sbjct: 231 EEVQQKATY 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 44/127 (34%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
Q+L G+ LH+AG++ ++KPSN+++ + + D+GLA R A
Sbjct: 135 QMLC-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 179
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
M++P Y APE L + + + + D WS GC
Sbjct: 180 S------------FMMTPYVVTRYYRAPEVI------LGMGYKENV------DIWSVGCI 215
Query: 357 LVEMCTG 363
+ EM G
Sbjct: 216 MGEMIKG 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 50/234 (21%)
Query: 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKV-MIAEEMEPDWLSGQLDNLRRA 196
+ LGEG+ A V + R +++ VA+KK+ + D ++ LR
Sbjct: 15 LDFLGEGQFATVY---------KARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREI 63
Query: 197 S----MWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
+ N+ S + LV D +++ ++ N LT I Y +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH ++ ++KP+NLLLD +G ++D+GL A+ +R ++
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL-----------AKSFGSPNRAYTHQ 172
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGI---SPESDAWSFGCTLVEMCTG 363
T Y APE LF G D W+ GC L E+
Sbjct: 173 VVTRW---YRAPEL---------LF-----GARMYGVGVDMWAVGCILAELLLR 209
|
| >3knv_A TNF receptor-associated factor 2; cross-brace, alternative splicing, apoptosis, cytoplasm, metal-binding, UBL conjugation, zinc, zinc-finger; 1.90A {Homo sapiens} Length = 141 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 15/49 (30%), Positives = 21/49 (42%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
CS C+ P QCGH +C CL+ + S+ +C C H
Sbjct: 33 LCSACRNVLRR----PFQAQCGHRYCSFCLASILSSGPQ---NCAACVH 74
|
| >1chc_A Equine herpes virus-1 ring domain; viral protein; NMR {Equid herpesvirus 1} SCOP: g.44.1.1 Length = 68 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 12/49 (24%), Positives = 19/49 (38%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + L C H FC C++R + +CP C+
Sbjct: 7 RCPICLEDPSNYSM---ALPCLHAFCYVCITRWIRQNP----TCPLCKV 48
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 32/187 (17%), Positives = 68/187 (36%), Gaps = 36/187 (19%)
Query: 201 RNVCTFHGVLRMDSCLGLVMDRCYGSVQL--AMQRNEGRLTLEQILRYGADIARGVVELH 258
+ H D+ + ++ + G +L + +++ ++ + Y + +G+ +H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSG-GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 259 AAGVVCMNIKPSNLLL-DASGRAV-VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
V +++KP N++ + + D+GL A L + T
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---------------KQSVKVTT 317
Query: 317 LSPNYTAPE--AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374
+ + APE +PV +D WS G + +G P+ G + +E
Sbjct: 318 GTAEFAAPEVAEGKPV--------------GYYTDMWSVGVLSYILLSGLSPFGGENDDE 363
Query: 375 IYRAVVK 381
R V
Sbjct: 364 TLRNVKS 370
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 47/318 (14%), Positives = 98/318 (30%), Gaps = 76/318 (23%)
Query: 83 NQHHNSNTNHFDSDVTDDDDDDEDDEVDEFGRGTHVSSSGVGVCGPVIEVGVHHDVKLVK 142
+ HH+ + + +D D ++ + V + V+ +++
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEV------KQGSVYDYYDILE 57
Query: 143 KLGEGRRAGVEVWGAWIGGGQGRCRH-----SVAVKKVMIAEEMEPDWLSGQLDNLRRAS 197
+LG G V RC K + ++ + ++ + +
Sbjct: 58 ELGSGAFGVVH-----------RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 198 MWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG--------AD 249
+ H + L+++ G G L ++I +
Sbjct: 107 H--PKLINLHDAFEDKYEMVLILEFLSG----------GEL-FDRIAAEDYKMSEAEVIN 153
Query: 250 IARGVVE----LHAAGVVCMNIKPSNLLLDASGRAVV--SDYGLAAILKKPACRKARPEC 303
R E +H +V ++IKP N++ + + V D+GLA L
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---------- 203
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
+ T + + APE V + + +D W+ G + +G
Sbjct: 204 -----DEIVKVTTATAEFAAPEI---VDRE---------PVGFYTDMWAIGVLGYVLLSG 246
Query: 364 SIPWAGLSAEEIYRAVVK 381
P+AG E + V +
Sbjct: 247 LSPFAGEDDLETLQNVKR 264
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 39/127 (30%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
QILR G+ +H+A V+ ++KPSNLLL+ + + D+GLA R A P
Sbjct: 136 QILR-------GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA--------RVADP 180
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+ D + L+ Y APE + L + D WS GC
Sbjct: 181 DHDHT--------GFLTEYVATRWYRAPE--------IMLNSKGY---TKSIDIWSVGCI 221
Query: 357 LVEMCTG 363
L EM +
Sbjct: 222 LAEMLSN 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 70/324 (21%), Positives = 107/324 (33%), Gaps = 101/324 (31%)
Query: 162 GQG------RCRH-----SVAVK-----KVMIAEEMEPDWLSGQLDNLRRASMWCRNVCT 205
G G RC H AVK K EE+E L R N+ T
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---------ILLRYGQ-HPNIIT 80
Query: 206 FHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGVVE-- 256
V + +V + G G L L++ILR + + + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKG----------GEL-LDKILRQKFFSEREASAVLFTITKTV 129
Query: 257 --LHAAGVVCMNIKPSNLLL-DASGRAV---VSDYGLAAILKKPACRKARPECDSSRIHS 310
LHA GVV ++KPSN+L D SG + D+G A L+ +
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--------------NG 175
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP-WAG 369
+ + N+ APE +++ G D WS G L M TG P G
Sbjct: 176 LLMTPCYTANFVAPEV---LERQ---------GYDAACDIWSLGVLLYTMLTGYTPFANG 223
Query: 370 L--SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPTF 419
+ EEI + + + W + + L +R T
Sbjct: 224 PDDTPEEILARIGSGK-----------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA 272
Query: 420 SAMLA-TFLRHLQELPRSPPASPD 442
+ +L ++ H +LP+ D
Sbjct: 273 ALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 33/128 (25%), Positives = 47/128 (36%), Gaps = 34/128 (26%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
Q LR V LH + V+ ++KPSNLL++++ V D+GLA R
Sbjct: 120 QTLR-------AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA--------RIIDE 164
Query: 302 ECDSSRIHSCMDCTMLSPNY--T----APEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
+ + M + T APE + L S D WS GC
Sbjct: 165 SAADNSEPTGQQSGM--VEFVATRWYRAPE--------VMLTSAKY---SRAMDVWSCGC 211
Query: 356 TLVEMCTG 363
L E+
Sbjct: 212 ILAELFLR 219
|
| >2ecl_A Ring-box protein 2; RNF7, ring domian, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 81 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 12/48 (25%), Positives = 20/48 (41%), Gaps = 4/48 (8%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR 54
C CQ +++ V + +C H F C+S + CP C+
Sbjct: 28 ACLRCQAENKQEDCVVVWGECNHSFHNCCMSLWVKQNN----RCPLCQ 71
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-05
Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 31/132 (23%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA-AILKKPACRKAR 300
Q+++ + LH+ G++ ++KPSN+LL+A V+D+GL+ + +
Sbjct: 117 QLIK-------VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 301 PECDSSRIHSCMDCTMLSPNY--T----APEAWEPVKKSLNLFWDD---AIGISPESDAW 351
P + + D + +Y T APE + L I D W
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPE--------ILLGSTKYTKGI------DMW 215
Query: 352 SFGCTLVEMCTG 363
S GC L E+ G
Sbjct: 216 SLGCILGEILCG 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-04
Identities = 42/240 (17%), Positives = 74/240 (30%), Gaps = 74/240 (30%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIAR-- 252
N+ + ++ + LVM+ C G G L E+++ A I +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTG----------GEL-FERVVHKRVFRESDAARIMKDV 115
Query: 253 --GVVELHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
V H V ++KP N L + D+GLAA K
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-----------PGKM 164
Query: 308 IHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ T + +P Y +P+ ++ PE D WS G + + G P
Sbjct: 165 MR-----TKVGTPYYVSPQV---LEGLYG----------PECDEWSAGVMMYVLLCGYPP 206
Query: 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPT 418
++ + E+ + + P + W + L +R T
Sbjct: 207 FSAPTDSEVMLKIREGT-----------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 33/122 (27%), Positives = 50/122 (40%), Gaps = 35/122 (28%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
QILR G+ +H+A ++ ++KPSNL ++ + D+GLA R
Sbjct: 140 QILR-------GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------RHTAD 184
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
E M + + Y APE + L W + D WS GC + E+
Sbjct: 185 E---------MTGYVATRWYRAPE--------IMLNWMHY---NQTVDIWSVGCIMAELL 224
Query: 362 TG 363
TG
Sbjct: 225 TG 226
|
| >2y1n_A E3 ubiquitin-protein ligase; ligase-transferase complex, ubiquitin ring E3 ligase; HET: PTR; 2.00A {Homo sapiens} PDB: 2y1m_A* 4a4c_A* 4a4b_A* 1fbv_A* 3vgo_A 4a49_A* 2k4d_A 2ldr_A* Length = 389 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 13/47 (27%), Positives = 19/47 (40%), Gaps = 7/47 (14%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR 54
C +C E ++ + CGH C CL+ + CP CR
Sbjct: 335 CKICA----ENDKDVKIEPCGHLMCTSCLTSWQESEGQG---CPFCR 374
|
| >1e4u_A Transcriptional repressor NOT4; gene regulation, transcriptional control; NMR {Homo sapiens} SCOP: g.44.1.1 PDB: 1ur6_B Length = 78 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 1e-04
Identities = 13/48 (27%), Positives = 18/48 (37%), Gaps = 3/48 (6%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + CG+ C+ C R+ TD CP CR
Sbjct: 14 CPLCMEPLEIDDINFFPCTCGYQICRFCWHRI---RTDENGLCPACRK 58
|
| >4ap4_A E3 ubiquitin ligase RNF4; ligase-signalling protein complex, chimera; 2.21A {Rattus norvegicus} Length = 133 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 1e-04
Identities = 17/51 (33%), Positives = 24/51 (47%), Gaps = 7/51 (13%)
Query: 8 CSVCQTRYNEKE---RVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C Y+E R+ + +CGH FC +CL S +CP CR
Sbjct: 10 CPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRD----SLKNANTCPTCRK 56
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 29/119 (24%), Positives = 49/119 (41%), Gaps = 37/119 (31%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
+ G+ LH+AG++ ++KPSN+++ + + D+GLA R A
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTS------- 217
Query: 310 SCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
M++P Y APE L + + + + D WS GC + EM
Sbjct: 218 -----FMMTPYVVTRYYRAPEVI------LGMGYKENV------DIWSVGCIMGEMVRH 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 33/127 (25%), Positives = 51/127 (40%), Gaps = 45/127 (35%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
Q+L+ G+ +HAAG++ ++KP NL ++ + D+GLA R+A
Sbjct: 136 QMLK-------GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------RQADS 180
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
E ++ Y APE + L W + D WS GC
Sbjct: 181 E--------------MTGYVVTRWYRAPE--------VILNWMRY---TQTVDIWSVGCI 215
Query: 357 LVEMCTG 363
+ EM TG
Sbjct: 216 MAEMITG 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 34/127 (26%), Positives = 50/127 (39%), Gaps = 45/127 (35%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
Q+L+ G+ +H+AGVV ++KP NL ++ + D+GLA R A
Sbjct: 134 QMLK-------GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------RHADA 178
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
E ++ Y APE + L W + D WS GC
Sbjct: 179 E--------------MTGYVVTRWYRAPE--------VILSWMHY---NQTVDIWSVGCI 213
Query: 357 LVEMCTG 363
+ EM TG
Sbjct: 214 MAEMLTG 220
|
| >2l0b_A E3 ubiquitin-protein ligase praja-1; zinc finger, NESG, structural genomics, PSI-2, protein struc initiative; NMR {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 16/49 (32%), Positives = 22/49 (44%), Gaps = 5/49 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
CC +C + Y + + L C H F K C+S S +CP CR
Sbjct: 42 CCPICCSEYVKGDVA-TELPCHHYFHKPCVSIWLQKSG----TCPVCRC 85
|
| >2ecn_A Ring finger protein 141; RNF141, ring domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 70 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 13/48 (27%), Positives = 20/48 (41%), Gaps = 9/48 (18%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C L+L C H FC++C+ + +CP CR
Sbjct: 18 CCICMDGRA-----DLILPCAHSFCQKCIDKWSDRHR----NCPICRL 56
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 31/128 (24%), Positives = 49/128 (38%), Gaps = 40/128 (31%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPACRKAR 300
Q+LR G+ +H+A V+ ++KP+NL ++ + + D+GLA R
Sbjct: 128 QLLR-------GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA--------RIMD 172
Query: 301 PECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
P LS Y +P L L ++ + D W+ GC
Sbjct: 173 PHYSHK--------GHLSEGLVTKWYRSPR--------LLLSPNNY---TKAIDMWAAGC 213
Query: 356 TLVEMCTG 363
EM TG
Sbjct: 214 IFAEMLTG 221
|
| >3hcs_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.20A {Homo sapiens} Length = 170 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 16/72 (22%), Positives = 23/72 (31%), Gaps = 11/72 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C +C E + CGH FCK C+ + + CP + L
Sbjct: 20 ECPICLMALRE----AVQTPCGHRFCKACIIKSIRDAGHK---CPVDNEI----LLENQL 68
Query: 67 RKNFAVLALILS 78
+ ILS
Sbjct: 69 FPDNFAKREILS 80
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 44/242 (18%), Positives = 79/242 (32%), Gaps = 76/242 (31%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ + + + LV++ G G L ++I+ G AD + +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTG----------GEL-FDRIVEKGYYSERDAADAVKQI 157
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+E LH G+V ++KP NLL ++D+GL+ I++ K
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK--------- 208
Query: 308 IHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
T+ +P Y APE ++ PE D WS G + G P
Sbjct: 209 -------TVCGTPGYCAPEI---LRGC---------AYGPEVDMWSVGIITYILLCGFEP 249
Query: 367 -WAGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKR 416
+ + ++R ++ + W + + KR
Sbjct: 250 FYDERGDQFMFRRILNCEYYFISPW------------WDEVSLNAKDLVRKLIVLDPKKR 297
Query: 417 PT 418
T
Sbjct: 298 LT 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 34/183 (18%), Positives = 58/183 (31%), Gaps = 51/183 (27%)
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAV---VSDYGLAAILKKPACRKARPECDSS 306
+ V LH G++ ++KP N+LL + ++D+G + IL + + +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-------- 174
Query: 307 RIHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
T+ +P Y APE L G + D WS G L +G
Sbjct: 175 --------TLCGTPTYLAPEV---------LVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 366 P-WAGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASK 415
P + + + + P+ W + E L
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIPEV------------WAEVSEKALDLVKKLLVVDPKA 265
Query: 416 RPT 418
R T
Sbjct: 266 RFT 268
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 30/167 (17%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSV-----QLAMQRNEGRLTLEQILRYGADIARGVVE 256
N+ + V+ ++ L LV + + + L L + + + +G+
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 257 LHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
H ++ ++KP NLL++ G+ + D+GL AR S T+
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGL-----------ARAFGIPVNTFSSEVVTL 172
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
Y AP+ L + S D WS GC L EM TG
Sbjct: 173 W---YRAPDV---------LMG--SRTYSTSIDIWSCGCILAEMITG 205
|
| >2ckl_B Ubiquitin ligase protein RING2; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_C 2h0d_B Length = 165 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 16/50 (32%), Positives = 20/50 (40%), Gaps = 6/50 (12%)
Query: 27 CGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALI 76
C H FC +C+ + CP CR V S LR + ALI
Sbjct: 73 CLHRFCADCIITALRSGNK---ECPTCRKKLVSKRS---LRPDPNFDALI 116
|
| >2ep4_A Ring finger protein 24; zinc binding, ubiquitin, E3 enzyme, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 74 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 11/49 (22%), Positives = 20/49 (40%), Gaps = 5/49 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C+VC + ++ + + C H F ++CL + CP C
Sbjct: 17 LCAVCLEDFKPRDEL-GICPCKHAFHRKCLIKWLEVRK----VCPLCNM 60
|
| >3lrq_A E3 ubiquitin-protein ligase TRIM37; structural genomics, PSI-2, protein structure initiative, northeast structural genomics consortium, NESG; HET: MSE; 2.29A {Homo sapiens} Length = 100 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 11/47 (23%), Positives = 16/47 (34%), Gaps = 6/47 (12%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR 54
C +C + + P C C C+ R + CP CR
Sbjct: 25 CFICMEKLRDARLCP---HCSKLCCFSCIRRWLTEQRAQ---CPHCR 65
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 29/145 (20%), Positives = 47/145 (32%), Gaps = 45/145 (31%)
Query: 231 MQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290
+ + TL +I R + G+ +H ++ ++K +N+L+ G ++D+GLA
Sbjct: 114 LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYT---------APEAWEPVKKSLNLFWDDA 341
+ YT PE L L
Sbjct: 174 FSLAKNSQPNR-------------------YTNRVVTLWYRPPE--------LLL----- 201
Query: 342 IGI---SPESDAWSFGCTLVEMCTG 363
G P D W GC + EM T
Sbjct: 202 -GERDYGPPIDLWGAGCIMAEMWTR 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 4e-04
Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 61/201 (30%)
Query: 250 IARGVVELHAAGVVCM---NIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECD-- 304
ARG+ LH + ++K +N+LLD AVV D+GLA K D
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---------KLMDYKDTH 190
Query: 305 -SSRIHSCMDCTMLSPNYTAPE---AWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEM 360
++ + T+ + APE + +K +D + +G L+E+
Sbjct: 191 VTTAVRG----TI---GHIAPEYLSTGKSSEK---------------TDVFGYGVMLLEL 228
Query: 361 CTG--SIPWAGLSAEEIY------RAVVKNRKLP----PQYASIVGVGIPRELWKMIG-- 406
TG + A L+ ++ + ++K +KL + G E+ ++I
Sbjct: 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV---DLQGNYKDEEVEQLIQVA 285
Query: 407 -ECLQFKASKRPTFS---AML 423
C Q +RP S ML
Sbjct: 286 LLCTQSSPMERPKMSEVVRML 306
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 4e-04
Identities = 44/240 (18%), Positives = 82/240 (34%), Gaps = 74/240 (30%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ T + + LVM G G L ++IL G + + + V
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSG----------GEL-FDRILERGVYTEKDASLVIQQV 115
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ LH G+V ++KP NLL + + + +++D+GL+ + + A C
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA---CG--- 169
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+P Y APE + + S D WS G + G P+
Sbjct: 170 ----------TPGYVAPEV---LAQK---------PYSKAVDCWSIGVITYILLCGYPPF 207
Query: 368 AGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPT 418
+ +++ + + + + W I E L+ ++R T
Sbjct: 208 YEETESKLFEKIKEGYYEFESPF------------WDDISESAKDFICHLLEKDPNERYT 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-04
Identities = 44/240 (18%), Positives = 70/240 (29%), Gaps = 72/240 (30%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ H + + L+ D G G L E I+ + + +
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTG----------GEL-FEDIVAREYYSEADASHCIQQI 119
Query: 255 VE----LHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+E H GVV N+KP NLLL ++D+GLA ++
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE------------- 166
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+P Y +PE ++K D W+ G L + G P+
Sbjct: 167 -QQAWFGFAGTPGYLSPEV---LRKD---------PYGKPVDLWACGVILYILLVGYPPF 213
Query: 368 AGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRPT 418
+Y+ + P W + L SKR T
Sbjct: 214 WDEDQHRLYQQIKAGAYDFPSPE------------WDTVTPEAKDLINKMLTINPSKRIT 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 42/241 (17%), Positives = 84/241 (34%), Gaps = 76/241 (31%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG-------ADIARGV 254
N+ +L S +V + G G L ++I++ A I + V
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTG----------GEL-FDEIIKRKRFSEHDAARIIKQV 130
Query: 255 VE----LHAAGVVCMNIKPSNLLLDASGRAV---VSDYGLAAILKKPACRKARPECDSSR 307
+H +V ++KP N+LL++ + + D+GL+ + +++
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-----------QNTK 179
Query: 308 IHSCMDCTML-SPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ + + Y APE ++ + + + D WS G L + +G+ P
Sbjct: 180 MK-----DRIGTAYYIAPEV---LRGTYD----------EKCDVWSAGVILYILLSGTPP 221
Query: 367 WAGLSAEEIYRAVVKNR-KLPPQYASIVGVGIPRELWKMIGE--------CLQFKASKRP 417
+ G + +I + V + W+ I + L F S R
Sbjct: 222 FYGKNEYDILKRVETGKYAFDLPQ------------WRTISDDAKDLIRKMLTFHPSLRI 269
Query: 418 T 418
T
Sbjct: 270 T 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-04
Identities = 31/195 (15%), Positives = 60/195 (30%), Gaps = 52/195 (26%)
Query: 201 RNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG--------ADIAR 252
RN+ H L ++ + G + E+I
Sbjct: 61 RNILHLHESFESMEELVMIFEFISG----------LDI-FERINTSAFELNEREIVSYVH 109
Query: 253 GVVE----LHAAGVVCMNIKPSNLLLDASGRAVV--SDYGLAAILKKPACRKARPECDSS 306
V E LH+ + +I+P N++ + + ++G A LK
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP------------- 156
Query: 307 RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+P Y APE + +S +D WS G + + +G P
Sbjct: 157 --GDNFRLLFTAPEYYAPEV---HQHD---------VVSTATDMWSLGTLVYVLLSGINP 202
Query: 367 WAGLSAEEIYRAVVK 381
+ + ++I ++
Sbjct: 203 FLAETNQQIIENIMN 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-04
Identities = 29/127 (22%), Positives = 43/127 (33%), Gaps = 43/127 (33%)
Query: 242 QILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
IL G+ LH AGVV ++ P N+LL + + D+ LA R+
Sbjct: 142 HILL-------GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA--------REDTA 186
Query: 302 ECDSSRIHSCMDCTMLSPN-----YTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+ + Y APE L + + + D WS GC
Sbjct: 187 D------------ANKTHYVTHRWYRAPE--------LVMQFKGF---TKLVDMWSAGCV 223
Query: 357 LVEMCTG 363
+ EM
Sbjct: 224 MAEMFNR 230
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 35/167 (20%), Positives = 58/167 (34%), Gaps = 31/167 (18%)
Query: 202 NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG 261
N+ V+ + L L+ + ++ M +N +++ I + + GV H+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 262 VVCMNIKPSNLLLDASGRAV-----VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTM 316
+ ++KP NLLL S + + D+GL AR R + T+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGL-----------ARAFGIPIRQFTHEIITL 201
Query: 317 LSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363
Y PE L + S D WS C EM
Sbjct: 202 W---YRPPEI---------LLG--SRHYSTSVDIWSIACIWAEMLMK 234
|
| >2ect_A Ring finger protein 126; metal binding protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 78 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 16/49 (32%), Positives = 18/49 (36%), Gaps = 5/49 (10%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C VC+ Y E V L C H F C+ SCP CR
Sbjct: 17 ECPVCKEDYALGESV-RQLPCNHLFHDSCIVPWLEQHD----SCPVCRK 60
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1630 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-43 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-40 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-38 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 6e-33 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-32 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-32 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-25 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-21 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 4e-20 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 5e-12 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-09 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 0.001 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-32 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-31 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-28 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-26 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-26 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-21 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-18 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-13 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-04 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 8e-24 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-14 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 5e-05 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-04 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-04 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-23 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-23 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 1e-10 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-21 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-21 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-19 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 0.002 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-19 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 7e-19 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 5e-07 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 8e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 3e-19 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 8e-08 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-07 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-04 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 0.003 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 7e-17 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-16 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-04 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 0.002 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 5e-16 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-14 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 5e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 0.004 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-16 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-14 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 4e-11 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 2e-06 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-05 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 2e-04 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 5e-04 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 6e-13 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-11 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 3e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-12 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 5e-11 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 2e-06 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 1e-05 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 9e-05 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 2e-04 | |
| d1iyma_ | 55 | g.44.1.1 (A:) EL5 RING-H2 domain {Rice (Oryza sati | 1e-08 | |
| d1ur6b_ | 52 | g.44.1.1 (B:) Not-4 N-terminal RING finger domain | 1e-07 | |
| d1chca_ | 68 | g.44.1.1 (A:) Immediate early protein, IEEHV {Equi | 4e-07 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 1e-06 | |
| d1bora_ | 56 | g.44.1.1 (A:) Acute promyelocytic leukaemia proto- | 1e-06 | |
| d1fbva4 | 79 | g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [Ta | 2e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 2e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 8e-04 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 0.002 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-05 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-05 | |
| d1g25a_ | 65 | g.44.1.1 (A:) TFIIH Mat1 subunit {Human (Homo sapi | 1e-05 | |
| d1rmda2 | 86 | g.44.1.1 (A:1-86) V(D)J recombination activating p | 2e-05 | |
| d1v87a_ | 114 | g.44.1.1 (A:) Deltex protein 2 RING-H2 domain {Mou | 2e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 6e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 5e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 7e-04 | |
| d1wima_ | 94 | g.44.1.1 (A:) UbcM4-interacting protein 4 (KIAA016 | 7e-04 | |
| d1jm7b_ | 97 | g.44.1.1 (B:) bard1 RING domain {Human (Homo sapie | 7e-04 | |
| d3dplr1 | 88 | g.44.1.1 (R:19-106) RIGG-box protein 1 (RBX1) of S | 7e-04 | |
| d1vyxa_ | 60 | g.44.1.3 (A:) IE1B protein (ORF K3), N-terminal do | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 61/310 (19%), Positives = 118/310 (38%), Gaps = 47/310 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
+ + +++G G V+ +G+ VAVK + + QL +
Sbjct: 7 DGQITVGQRIGSGSFG--TVY-------KGKWHGDVAVKMLNVTAPTP-----QQLQAFK 52
Query: 195 R-----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGA 248
N+ F G L +V C S+ + E + + +++
Sbjct: 53 NEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 111
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
A+G+ LHA ++ ++K +N+ L + D+GLA +
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK------------SRWSG 159
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+ S + APE + D S +SD ++FG L E+ TG +P++
Sbjct: 160 SHQFEQLSGSILWMAPEV---------IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
++ + +V L P + + P+ + +++ ECL+ K +RP F + L
Sbjct: 211 NINNRDQIIFMVGRGYLSPDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQI----LA 265
Query: 429 HLQELPRSPP 438
++ L RS P
Sbjct: 266 SIELLARSLP 275
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-40
Identities = 89/399 (22%), Positives = 142/399 (35%), Gaps = 60/399 (15%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + LL A N A+ D QT LH A R G +V+ +L
Sbjct: 37 LHMAARAGHTEVAKYLLQNKAKVN----------AKAKDDQTPLHCAARIGHTNMVKLLL 86
Query: 532 EYSQE--------------------------------NVDVLDKDGDPPLVFALAAGSPE 559
E + + + K G PL A G
Sbjct: 87 ENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVR 146
Query: 560 CVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHR 619
L++R A+ + + G P HV +H D ++ LL G P++ G + LH
Sbjct: 147 VAELLLERDAHPNAAGKNGLTP--LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHI 204
Query: 620 AVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNV 679
A + + A +L+ S + + +TPLHL + +V + + N+
Sbjct: 205 AAKQNQVEVARSLLQY--GGSANAESVQGVTPLHLAAQEGHAEMVALLLS---KQANGNL 259
Query: 680 IDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVE 739
+ G T L + + + +L+ G A T LH+AS +++
Sbjct: 260 GNKSGL--TPLHLV------AQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIK 311
Query: 740 LVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
LVK +L DVN + PLH A +G V LLL GA N +G IA
Sbjct: 312 LVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAK 371
Query: 800 DAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLE 838
+ L V+ + V V + + + ++
Sbjct: 372 RLGY--ISVTDVLKVVTDET-SFVLVSDKHRMSFPETVD 407
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-38
Identities = 93/392 (23%), Positives = 139/392 (35%), Gaps = 61/392 (15%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH G + V++LL + AS N N +T LH+A R G E+ + +L
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPN----------VSNVKVETPLHMAARAGHTEVAKYLL 53
Query: 532 EYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISR----------------- 574
+ V+ KD PL A G V L++ AN
Sbjct: 54 QNKA-KVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHV 112
Query: 575 --------------LREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA 620
G + HV A +G+ LL A PNA G + LH A
Sbjct: 113 ETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVA 172
Query: 621 VAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
V D ++L GG S TPLH+ V+ + N
Sbjct: 173 VHHNNLDIVKLLLPRGG--SPHSPAWNGYTPLHIA---AKQNQVEVARSLLQYGGSANAE 227
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
+ G T L +AA E+V +LL+ A + T LH+ + V +
Sbjct: 228 SVQGV--TPLHLAAQEGHA------EMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPV 279
Query: 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAAD 800
+++ GV V+ PLHVA G V LL AD N + G + H AA
Sbjct: 280 ADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAA- 338
Query: 801 AAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ + + + ++L + A+ + G T
Sbjct: 339 ----QQGHTDIVTLLLKN-GASPNEVSSDGTT 365
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-33
Identities = 73/380 (19%), Positives = 129/380 (33%), Gaps = 57/380 (15%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
T LH+A G +V+ +L+ + +V + + PL A AG E L++ A V
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRG-ASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKV- 59
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI 632
NA + ++ LH A +T+ ++
Sbjct: 60 ----------------------------------NAKAKDDQTPLHCAARIGHTNMVKLL 85
Query: 633 LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCM 692
LEN A N V+ + + E + G T L +
Sbjct: 86 LEN-----NANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGF--TPLHV 138
Query: 693 AAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVN 752
AA K + +LL A P A T LH+A N++++VK++L G +
Sbjct: 139 AA--KYGKV----RVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPH 192
Query: 753 IRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWL 812
+ PLH+A + LL G N + +G H+AA +E +
Sbjct: 193 SPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA------QEGHAEM 246
Query: 813 IVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLME--ALMNRGVHLSPTIFEIGDW 870
+ +L A + N SG T + +++ L++ +++ + T +
Sbjct: 247 VALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASH 306
Query: 871 VKFKRRVTTPTYGWQGAKHK 890
+ V K
Sbjct: 307 YGNIKLVKFLLQHQADVNAK 326
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (190), Expect = 3e-15
Identities = 45/183 (24%), Positives = 75/183 (40%), Gaps = 17/183 (9%)
Query: 649 LTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELV 708
LTPLH+ ++ +VK ++ + NV ++ T L MAA + H E+
Sbjct: 1 LTPLHVASFMGHLPIVKNLLQRGAS---PNVSNVKV--ETPLHMAA--RAGHT----EVA 49
Query: 709 RILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALAR 768
+ LL A+ A+ ++T LH A+ +VK++L+ + N+ PLH+A
Sbjct: 50 KYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAARE 109
Query: 769 GAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNH 828
G V LL A +G H+AA + ++L DA
Sbjct: 110 GHVETVLALLEKEASQACMTKKGFTPLHVAA-----KYGKVRVAELLLER-DAHPNAAGK 163
Query: 829 SGK 831
+G
Sbjct: 164 NGL 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-40
Identities = 53/290 (18%), Positives = 103/290 (35%), Gaps = 40/290 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+++ +LG+G +V+ + + + + A K + E E + ++D L
Sbjct: 15 EIIGELGDGAFG--KVY-------KAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 65
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
N+ ++ L ++++ C G+V M E LT QI +
Sbjct: 66 CD--HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
LH ++ ++K N+L G ++D+G++A + D
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--------------IQRRDS 169
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEE 374
+ +P + APE + ++D WS G TL+EM P L+
Sbjct: 170 FIGTPYWMAPE-------VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
+ + K+ S + +CL+ R T S +L
Sbjct: 223 VLLKIAKSEPPTLAQPS----RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (355), Expect = 4e-37
Identities = 52/293 (17%), Positives = 101/293 (34%), Gaps = 53/293 (18%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
++++G G V+ R + VA+KK+ + + + + ++ +
Sbjct: 18 SDLREIGHGSFG--AVY-------FARDVRNSEVVAIKKMSYSGKQSNE----KWQDIIK 64
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADI 250
+ N + G + LVM+ C GS ++ ++ L +I
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
+G+ LH+ ++ ++K N+LL G + D+G A I +
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA------------------SIMA 166
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
+ + +P + APE + D + D WS G T +E+ P +
Sbjct: 167 PANSFVGTPYWMAPEV---------ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+A + +N Q + CLQ RPT +L
Sbjct: 218 NAMSALYHIAQNESPALQSG-----HWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 51/292 (17%), Positives = 104/292 (35%), Gaps = 50/292 (17%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D ++ + LG+G+ V+ R + S +A+K V+ ++E + QL
Sbjct: 7 DFEIGRPLGKGKFG--NVY-------LAREKQSKFILALK-VLFKAQLEKAGVEHQLRRE 56
Query: 194 RR--ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251
+ + N+ +G + + L+++ + + ++ Y ++A
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
+ H+ V+ +IKP NLLL ++G ++D+G + S
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----------------SSR 160
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
+ +Y PE E + D WS G E G P+ +
Sbjct: 161 RTTLCGTLDYLPPEMIE------------GRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423
+E Y+ + + P + + +I L+ S+RP +L
Sbjct: 209 YQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-36
Identities = 53/304 (17%), Positives = 102/304 (33%), Gaps = 46/304 (15%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+K+G+G V+ + VA++++ + ++ + + + ++ +R
Sbjct: 23 TRFEKIGQGASG--TVY-------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
N+ + + L +VM+ G L E + QI + + +
Sbjct: 74 NK--NPNIVNYLDSYLVGDELWVVMEYLAGG-SLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
LH+ V+ +IK N+LL G ++D+G A + S
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------------QSKRSTM 176
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375
+ +P + APE P+ D WS G +EM G P+ +
Sbjct: 177 VGTPYWMAPEVVTR------------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-TFLRHLQELP 434
+ N Q + + CL KR + +L FL+ + L
Sbjct: 225 LYLIATNGTPELQNPE----KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 435 RSPP 438
P
Sbjct: 281 SLTP 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 7e-36
Identities = 63/308 (20%), Positives = 130/308 (42%), Gaps = 47/308 (15%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR- 195
VK+ + +G G EV + G+ VA+K ++ + Q +
Sbjct: 27 CVKIEQVIGAGEFG--EVCSGHLKLP-GKREIFVAIKT------LKSGYTEKQRRDFLSE 77
Query: 196 ----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADI 250
NV GV+ + + ++ + GS+ +++N+G+ T+ Q++ I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
A G+ L V ++ N+L++++ VSD+GL+ L + S ++
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---------EDDTSDPTYT 188
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369
+ +TAPEA + K + SD WS+G + E+ + G P+
Sbjct: 189 SALGGKIPIRWTAPEAIQYRK------------FTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
++ +++ A+ ++ +LPP + P L +++ +C Q + RP F + +
Sbjct: 237 MTNQDVINAIEQDYRLPPP------MDCPSALHQLMLDCWQKDRNHRPKFGQI----VNT 286
Query: 430 LQELPRSP 437
L ++ R+P
Sbjct: 287 LDKMIRNP 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 49/299 (16%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRA 196
D+ +K+LG G+ V G VA+K + E +++ + +
Sbjct: 5 DLTFLKELGTGQFG--VVKYGKWRGQY-----DVAIKMIKEGSMSEDEFIE-EAKVMMNL 56
Query: 197 SMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
S + +GV + ++ + G + ++ R +Q+L D+ +
Sbjct: 57 S--HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 256 ELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCT 315
L + + ++ N L++ G VSD+GL+ + ++ +
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-------------LDDEYTSSVGS 161
Query: 316 MLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEE 374
++ PE S +SD W+FG + E+ + G +P+ + E
Sbjct: 162 KFPVRWSPPE------------VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 375 IYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433
+ + +L + +++ ++ C KA +RPTF + L ++ ++
Sbjct: 210 TAEHIAQGLRLYRPH------LASEKVYTIMYSCWHEKADERPTFKIL----LSNILDV 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 71/302 (23%), Positives = 125/302 (41%), Gaps = 44/302 (14%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR- 195
D++L++KLG+G V G+ VAVK + +P+ +D+ R
Sbjct: 9 DLRLLEKLGDGSFG--VVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPE----AMDDFIRE 61
Query: 196 ----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADI 250
S+ RN+ +GV+ + + +V + GS+ +++++G L + RY +
Sbjct: 62 VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
A G+ L + + ++ NLLL + D+GL L + +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL-----------PQNDDHYV 169
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369
+ + + APE+ + S SD W FG TL EM T G PW G
Sbjct: 170 MQEHRKVPFAWCAPESLKTRT------------FSHASDTWMFGVTLWEMFTYGQEPWIG 217
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
L+ +I + K + P+ P++++ ++ +C K RPTF A+ FL
Sbjct: 218 LNGSQILHKIDKEGERLPRPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALR-DFLLE 271
Query: 430 LQ 431
Q
Sbjct: 272 AQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (337), Expect = 2e-34
Identities = 56/360 (15%), Positives = 112/360 (31%), Gaps = 54/360 (15%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ ++LG G V + R + A K VM E + + + ++ +
Sbjct: 29 DIHEELGTGAFG--VVH-------RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
+ H D+ + ++ + G + + +++ ++ + Y + +G+
Sbjct: 80 LR--HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 255 VELHAAGVVCMNIKPSNLLL--DASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+H V +++KP N++ S + D+GL A L +
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---------------KQSV 182
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
T + + APE E + +D WS G + +G P+ G +
Sbjct: 183 KVTTGTAEFAAPEVAE------------GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-TFLR--- 428
+E R V GI + I + L + R T L +L
Sbjct: 231 DETLRNVKSCDWNMD---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
Query: 429 ---HLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNLHQLVSEGDVSGVR 485
++P S + P + + + Q S D R
Sbjct: 288 APGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDR 347
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-34
Identities = 60/333 (18%), Positives = 123/333 (36%), Gaps = 44/333 (13%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR- 195
+ K +K LG G V+ + + VA+K++ A + +
Sbjct: 10 EFKKIKVLGSGAFG--TVYKGLWIPEGEKVKIPVAIKELREATSPK------ANKEILDE 61
Query: 196 ----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251
AS+ +VC G+ + + +G + ++ ++ + + +L + IA
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
+G+ L +V ++ N+L+ ++D+GLA +L +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL------------GAEEKEYH 169
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGL 370
+ + + A E+ + +SD WS+G T+ E+ T GS P+ G+
Sbjct: 170 AEGGKVPIKWMALESILHRI------------YTHQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
A EI + K +LP +++ ++ +C A RP F ++ F +
Sbjct: 218 PASEISSILEKGERLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
Query: 431 QELPRSPPASPDTGFTKFSTSNETEPSPASDVE 463
++ R D S ++ D E
Sbjct: 272 RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 62/314 (19%), Positives = 121/314 (38%), Gaps = 45/314 (14%)
Query: 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
V K +G G EV+ + G+ VA+K ++ + Q +
Sbjct: 7 SCVTRQKVIGAGEFG--EVYKGMLKTSSGKKEVPVAIKT------LKAGYTEKQRVDFLG 58
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGAD 249
N+ GV+ + ++ + G++ ++ +G ++ Q++
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
IA G+ L V ++ N+L++++ VSD+GL+ +L+ D
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-----------DDPEAT 167
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA- 368
+ +TAPEA K + SD WSFG + E+ T
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRK------------FTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
LS E+ +A+ +LP + P +++++ +C Q + ++RP F+ +++ L
Sbjct: 216 ELSNHEVMKAINDGFRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVS-ILD 268
Query: 429 HLQELPRSPPASPD 442
L P S D
Sbjct: 269 KLIRAPDSLKTLAD 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 64/307 (20%), Positives = 113/307 (36%), Gaps = 52/307 (16%)
Query: 134 VHHDVKLV----KKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSG 188
V+ D KL+ K+LG G V G + + +VAVK ++ E +P
Sbjct: 1 VYLDRKLLTLEDKELGSGNFG--TVKKGYYQMKKVVK---TVAVK-ILKNEANDPA---- 50
Query: 189 QLDNLRR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQI 243
D L + + G+ +S + LVM+ + + + I
Sbjct: 51 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPEC 303
+ ++ G+ L + V ++ N+LL A +SD+GL+ L+
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR----------- 158
Query: 304 DSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT- 362
+ + APE K S +SD WSFG + E +
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYK------------FSSKSDVWSFGVLMWEAFSY 206
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
G P+ G+ E+ + K ++ G PRE++ ++ C + RP F+A
Sbjct: 207 GQKPYRGMKGSEVTAMLEKGERMGCP------AGCPREMYDLMNLCWTYDVENRPGFAA- 259
Query: 423 LATFLRH 429
+ LR+
Sbjct: 260 VELRLRN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 64/310 (20%), Positives = 122/310 (39%), Gaps = 47/310 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
++L KLG+G EVW G W G + VA+K + M P+ + +
Sbjct: 16 RESLRLEVKLGQGCFG--EVWMGTWNGTTR------VAIK-TLKPGTMSPEAFLQEAQVM 66
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLT-LEQILRYGADIAR 252
++ + + + V+ + + GS+ ++ G+ L Q++ A IA
Sbjct: 67 KK--LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ + V +++ +N+L+ + V+D+GLA ++ ++
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-------------EDNEYTAR 171
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371
+TAPEA + + +SD WSFG L E+ T G +P+ G+
Sbjct: 172 QGAKFPIKWTAPEAALYGR------------FTIKSDVWSFGILLTELTTKGRVPYPGMV 219
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431
E+ V + ++P P L ++ +C + + +RPTF + A +
Sbjct: 220 NREVLDQVERGYRMPCP------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
Query: 432 ELPRSPPASP 441
P P
Sbjct: 274 STE--PQYQP 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (326), Expect = 5e-33
Identities = 51/339 (15%), Positives = 114/339 (33%), Gaps = 52/339 (15%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQL 190
V+ ++++LG G V + + + K + ++ + ++
Sbjct: 27 VYDYYDILEELGSGAFG--VVH-------RCVEKATGRVFVAKFINTPYPLDKYTVKNEI 77
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGAD 249
+ + + H + L+++ G + + + +++ +++ Y
Sbjct: 78 SIMNQLH--HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 135
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDA--SGRAVVSDYGLAAILKKPACRKARPECDSSR 307
G+ +H +V ++IKP N++ + + + D+GLA L
Sbjct: 136 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-------------- 181
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ T + + APE + + +D W+ G + +G P+
Sbjct: 182 -DEIVKVTTATAEFAAPEIVDR------------EPVGFYTDMWAIGVLGYVLLSGLSPF 228
Query: 368 AGLSAEEIYRAVVK-NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-T 425
AG E + V + + + S + E I LQ + KR T L
Sbjct: 229 AGEDDLETLQNVKRCDWEFDEDAFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284
Query: 426 FLR--HLQELPRSPPASPDTGFTKFSTSNETEPSPASDV 462
+L+ H R P + + K P+P +
Sbjct: 285 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAI 323
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (326), Expect = 7e-33
Identities = 69/406 (16%), Positives = 131/406 (32%), Gaps = 77/406 (18%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKV----MIAEEMEPDWLSGQ 189
D + + +G G EV+ R + A+K + + ++ E L+ +
Sbjct: 5 DFSVHRIIGRGGFG--EVY-------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
+ ++ C + L ++D G G + + Y A+
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
I G+ +H VV ++KP+N+LLD G +SD GLA K
Sbjct: 116 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---------------- 159
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
++ + Y APE + + +D +S GC L ++ G P+
Sbjct: 160 KKPHASVGTHGYMAPEVLQ-----------KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLR 428
++ + + + EL ++ LQ ++R A
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 429 H------------LQELPRSPPASPDTGFTK----FSTSNETE------PSPASDVEVFQ 466
LQ+ P PP P G F + E SD E+++
Sbjct: 265 SPFFRSLDWQMVFLQKYP--PPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYR 322
Query: 467 DNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQ 512
+ P + + + V D ++ + + + K +N
Sbjct: 323 NFPLTISERWQQEVAETVFDTINAE-----TDRLEARKKTKNKQLG 363
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (318), Expect = 1e-32
Identities = 53/302 (17%), Positives = 98/302 (32%), Gaps = 46/302 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQ-- 189
+ + + + LG G + V + + + AVK + + Q
Sbjct: 2 YENYEPKEILGRGVSS--VVR-------RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 52
Query: 190 -------LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQ 242
+D LR+ S + ++ LV D + L+ ++
Sbjct: 53 REATLKEVDILRKVSGHPNIIQ-LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 111
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
+ + + LH +V ++KP N+LLD ++D+G + L
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--------- 162
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ +P+Y APE E D+ G E D WS G + +
Sbjct: 163 ------GEKLREVCGTPSYLAPEIIECSMN------DNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
GS P+ + R ++ Q+ S + ++ L + KR T
Sbjct: 211 GSPPFWHRKQMLMLRMIMSG---NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 423 LA 424
LA
Sbjct: 268 LA 269
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 19/289 (6%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKD-GDPPLVFALAAGSPECVHALIKRG 568
+ L A + +LV+ +LE NV+ +++ G PL A+ + V L++
Sbjct: 4 EDNHLLIKAVQNEDVDLVQQLLEGG-ANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH- 61
Query: 569 ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDC 628
LR+ G + + A G ++ L GAD N D G + A
Sbjct: 62 -GADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKA 120
Query: 629 AIVILE--------NGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVI 680
+ + L T L +V V+K ++ + VN
Sbjct: 121 LKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGAD--VNAC 178
Query: 681 DIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740
D G + ++ D E + +LL GA+ + + +T L +A + L
Sbjct: 179 DNMGRNALIHALLSSDDSDVE----AITHLLLDHGADVNVRGERGKTPLILAVEKKHLGL 234
Query: 741 VKIILD-AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQD 788
V+ +L+ +++N + L +A+ K LL GA + D
Sbjct: 235 VQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 58/301 (19%), Positives = 111/301 (36%), Gaps = 31/301 (10%)
Query: 467 DNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAEL 526
++ + L + V DV V+ LL A+ N+ + G T LH A + ++
Sbjct: 4 EDNHLLIKAVQNEDVDLVQQLLEGGANVNF---------QEEEGGWTPLHNAVQMSREDI 54
Query: 527 VEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV 586
VE +L + + V + + F LAA + + + +G +
Sbjct: 55 VELLLRHGADPVL---RKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFME 111
Query: 587 CAYHGQPDCMRELLLAGADPN----------AVDDEGESVLHRAVAKKYTDCAIVILENG 636
A +G+ ++ L GA+ N + G + L A K + + ++L+
Sbjct: 112 AAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEM 171
Query: 637 GCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAAL 696
G A N +H +++ + V + VNV G T L +A
Sbjct: 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERG--KTPLILA--- 226
Query: 697 KKDHEVEGRELVRILLT-AGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN 755
E + LV+ LL E D+ +TAL +A ++ +++ G + +
Sbjct: 227 ---VEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283
Query: 756 V 756
+
Sbjct: 284 L 284
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (233), Expect = 2e-21
Identities = 61/258 (23%), Positives = 94/258 (36%), Gaps = 22/258 (8%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDE-GESVLHRAVAKKYTDCAIVILENGGCRSMAI 643
+ D +++LL GA+ N ++E G + LH AV D ++L +G +
Sbjct: 10 IKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRK 69
Query: 644 LNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEV- 702
N L + S VN D G TA AA K +
Sbjct: 70 KNGATPFLLAAIAGSVK-----LLKLFLSKGADVNECDFYGF--TAFMEAAVYGKVKALK 122
Query: 703 ---EGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHN 758
+ V + + TAL A+ VE++KI+LD G DVN +
Sbjct: 123 FLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMG 182
Query: 759 TIPLHVALARGAKSCVG----LLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIV 814
L AL S V LLL GAD N + + G +A + +++L +
Sbjct: 183 RNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILA-----VEKKHLGLVQR 237
Query: 815 MLSHPDAAVEVRNHSGKT 832
+L + + GKT
Sbjct: 238 LLEQEHIEINDTDSDGKT 255
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 4e-20
Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 7/176 (3%)
Query: 466 QDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAE 525
+ G V ++ L + A+ N + G TAL A +G E
Sbjct: 103 FYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVE 162
Query: 526 LVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHA----LIKRGANVISRLREGFGP 581
+++ +L+ +V+ D G L+ AL + V A L+ GA+V R G P
Sbjct: 163 VLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTP 222
Query: 582 SVAHVCAYHGQPDCMRELLL-AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636
+ ++ LL + N D +G++ L AV K A ++ + G
Sbjct: 223 --LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRG 276
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.1 bits (160), Expect = 5e-12
Identities = 52/232 (22%), Positives = 82/232 (35%), Gaps = 25/232 (10%)
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVA 671
E +L +AV + D +LE G TPLH V +V+ +
Sbjct: 4 EDNHLLIKAVQNEDVDLVQQLLEGG-ANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62
Query: 672 SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHI 731
+ + + A+ + L K + GA+ D TA
Sbjct: 63 ADPVLRKKNGATPFLLAAIAGSVKLLKLFL-----------SKGADVNECDFYGFTAFME 111
Query: 732 ASMANDVELVKIILDAGVDVNIRNVHNTI----------PLHVALARGAKSCVGLLLS-A 780
A++ V+ +K + G +VN+R L A +G + +LL
Sbjct: 112 AAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEM 171
Query: 781 GADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
GAD N D+ G NA A + ++E + +L A V VR GKT
Sbjct: 172 GADVNACDNMGRNALIHALLS--SDDSDVEAITHLLLDHGADVNVRGERGKT 221
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 38/215 (17%), Positives = 68/215 (31%), Gaps = 55/215 (25%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIIL- 745
L A + + +LV+ LL GA Q+ + T LH A + ++V+++L
Sbjct: 7 HLLIKAV--QNEDV----DLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60
Query: 746 --------------------------------DAGVDVNIRNVHNTIPLHVALARGAKSC 773
G DVN + + A G
Sbjct: 61 HGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKA 120
Query: 774 VGLLLSAGADCNWQD----------DEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAV 823
+ L GA+ N + G A AA+ + ++E L ++L A V
Sbjct: 121 LKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAE-----KGHVEVLKILLDEMGADV 175
Query: 824 EVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGV 858
++ G+ + E + L++ G
Sbjct: 176 NACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 0.001
Identities = 14/45 (31%), Positives = 20/45 (44%), Gaps = 1/45 (2%)
Query: 756 VHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDE-GDNAFHIAA 799
V + L A+ V LL GA+ N+Q++E G H A
Sbjct: 3 VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAV 47
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 58/303 (19%), Positives = 117/303 (38%), Gaps = 49/303 (16%)
Query: 137 DVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR 195
++ V+++G G+ V G W+ + VA+K + E D++ + + + +
Sbjct: 6 ELTFVQEIGSGQFG--LVHLGYWLNKDK------VAIKTIREGAMSEEDFIE-EAEVMMK 56
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
S + +GV + + LV + +G + ++ G E +L D+ G+
Sbjct: 57 LS--HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L A V+ ++ N L+ + VSD+G+ + ++
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-------------LDDQYTSSTG 161
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
T + +PE + + S +SD WSFG + E+ + G IP+ S
Sbjct: 162 TKFPVKWASPEVFSFSR------------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQEL 433
E+ + +L +++++ C + + RP FS + LR L E+
Sbjct: 210 EVVEDISTGFRLYKPR------LASTHVYQIMNHCWKERPEDRPAFSRL----LRQLAEI 259
Query: 434 PRS 436
S
Sbjct: 260 AES 262
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 3e-32
Identities = 57/301 (18%), Positives = 103/301 (34%), Gaps = 50/301 (16%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKV---MIAEEMEPDWLSGQL 190
D K K LGEG + V R + A+K + I +E + +++ +
Sbjct: 9 DFKFGKILGEGSFS--TVV-------LARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 191 DNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADI 250
D + R + + D L + L R G Y A+I
Sbjct: 60 DVMSRLD--HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
+ LH G++ ++KP N+LL+ ++D+G A + PE +R +S
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA--------KVLSPESKQARANS 169
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
+ Y +PE SD W+ GC + ++ G P+
Sbjct: 170 FVGT----AQYVSPELLTE------------KSACKSSDLWALGCIIYQLVAGLPPFRAG 213
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML--ATFLR 428
+ I++ ++K P+ + ++ + L A+KR M
Sbjct: 214 NEYLIFQKIIKLEYDFPEK-------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
Query: 429 H 429
H
Sbjct: 267 H 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 62/303 (20%), Positives = 113/303 (37%), Gaps = 55/303 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
++KL++ +G+G +V G + VAVK I + + +
Sbjct: 6 MKELKLLQTIGKGEFG--DVMLGDYRGNK------VAVKC--IKNDATAQAFLAEASVMT 55
Query: 195 RASMWCRNVCTFHGV-LRMDSCLGLVMDRCYGSVQLAMQRNEGR--LTLEQILRYGADIA 251
+ N+ GV + L +V + + R+ GR L + +L++ D+
Sbjct: 56 QLR--HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
+ L V ++ N+L+ A VSD+G + S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG-----------------LTKEASST 156
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGL 370
D L +TAPEA K S +SD WSFG L E+ + G +P+ +
Sbjct: 157 QDTGKLPVKWTAPEALREKK------------FSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
+++ V K K+ G P +++++ C A+ RP+F + L
Sbjct: 205 PLKDVVPRVEKGYKMDAPD------GCPPAVYEVMKNCWHLDAAMRPSFLQL----REQL 254
Query: 431 QEL 433
+ +
Sbjct: 255 EHI 257
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 66/306 (21%), Positives = 107/306 (34%), Gaps = 52/306 (16%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D LV+ LGEG EV R + VAVK V + ++ +N+
Sbjct: 6 DWDLVQTLGEGAYG--EVQ-------LAVNRVTEEAVAVKIVDMKRAVD------CPENI 50
Query: 194 RR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGA 248
++ + NV F+G R + L ++ C G + + R+
Sbjct: 51 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 110
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
+ GVV LH G+ +IKP NLLLD +SD+GLA + +
Sbjct: 111 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF------------RYNNR 158
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
++ + Y APE + + + D WS G L M G +PW
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFH-----------AEPVDVWSCGIVLTAMLAGELPWD 207
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT--F 426
S + K +K I ++ + L S R T + +
Sbjct: 208 QPSDSCQEYSDWKEKKTYLNPWK----KIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
Query: 427 LRHLQE 432
+ L++
Sbjct: 264 NKPLKK 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 9e-32
Identities = 57/293 (19%), Positives = 122/293 (41%), Gaps = 45/293 (15%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
+KLV++LG G+ EVW + G VAVK + +L+ + + ++
Sbjct: 12 RETLKLVERLGAGQFG--EVWMGYYNGHT-----KVAVKSLKQGSMSPDAFLA-EANLMK 63
Query: 195 RASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS--VQLAMQRNEGRLTLEQILRYGADIAR 252
+ + + + V+ + ++ + V + +LT+ ++L A IA
Sbjct: 64 QLQ--HQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ + + +++ +N+L+ + ++D+GLA ++ ++
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-------------EDNEYTAR 167
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371
+ +TAPEA + +SD WSFG L E+ T G IP+ G++
Sbjct: 168 EGAKFPIKWTAPEAINYGT------------FTIKSDVWSFGILLTEIVTHGRIPYPGMT 215
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
E+ + + + ++ P EL++++ C + + RPTF + +
Sbjct: 216 NPEVIQNLERGYRMVRPD------NCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-31
Identities = 57/316 (18%), Positives = 111/316 (35%), Gaps = 58/316 (18%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDN 192
+++ K LG G +V G + VAVK + A+ E + L +L
Sbjct: 36 RENLEFGKVLGSGAFG--KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG-----------------------SVQL 229
+ + N+ G + + L+ + C +L
Sbjct: 94 MTQLG-SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 230 AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAA 289
+ + LT E +L + +A+G+ L V ++ N+L+ + D+GLA
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349
+ S + L + APE+ + +SD
Sbjct: 213 DI------------MSDSNYVVRGNARLPVKWMAPESLFEGI------------YTIKSD 248
Query: 350 AWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGEC 408
WS+G L E+ + G P+ G+ + + +++N Q E++ ++ C
Sbjct: 249 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-----PFYATEEIYIIMQSC 303
Query: 409 LQFKASKRPTFSAMLA 424
F + KRP+F + +
Sbjct: 304 WAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 123 bits (309), Expect = 2e-31
Identities = 59/302 (19%), Positives = 117/302 (38%), Gaps = 45/302 (14%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
D+ + KLG G+ EV+ G W +VAVK + + ME + + +
Sbjct: 16 RTDITMKHKLGGGQYG--EVYEGVWKKYSL-----TVAVK-TLKEDTMEVEEFLKEAAVM 67
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLA--MQRNEGRLTLEQILRYGADIA 251
+ N+ GV + ++ + L + N ++ +L I+
Sbjct: 68 KEIK--HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
+ L + ++ N L+ + V+D+GL+ ++ + ++
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------TGDTYTA 172
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGL 370
+TAPE+ K S +SD W+FG L E+ T G P+ G+
Sbjct: 173 HAGAKFPIKWTAPESLAYNK------------FSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
++Y + K+ ++ G P ++++++ C Q+ S RP+F+ + F
Sbjct: 221 DLSQVYELLEKDYRMERPE------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
Query: 431 QE 432
QE
Sbjct: 275 QE 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-31
Identities = 50/297 (16%), Positives = 101/297 (34%), Gaps = 50/297 (16%)
Query: 142 KKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR----- 195
+LG G V G + + VA+K ++ + + R
Sbjct: 15 IELGCGNFG--SVRQGVYRMRKKQI---DVAIKV------LKQGTEKADTEEMMREAQIM 63
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGV 254
+ + GV + ++ + LVM+ G + + + + + ++ G+
Sbjct: 64 HQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDC 314
L V ++ N+LL A +SD+GL ++ ++
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL-----------SKALGADDSYYTARSA 171
Query: 315 TMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373
+ APE K S SD WS+G T+ E + G P+ +
Sbjct: 172 GKWPLKWYAPECINFRK------------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219
Query: 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
E+ + + +++ P EL+ ++ +C +K RP F + +R
Sbjct: 220 EVMAFIEQGKRMECPP------ECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 59/306 (19%), Positives = 104/306 (33%), Gaps = 65/306 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D +++ +G G + R + + K++ E + L
Sbjct: 5 DYEVLYTIGTGSYG--RCQ-------KIRRKSDGKILVWKELDYGSMTE-----AEKQML 50
Query: 194 RR-----ASMWCRNVCTFHGVL--RMDSCLGLVMDRCYG----SVQLAMQRNEGRLTLEQ 242
+ N+ ++ + R ++ L +VM+ C G SV + L E
Sbjct: 51 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110
Query: 243 ILRYGADIARGVVELHAAGVVCMNI-----KPSNLLLDASGRAVVSDYGLAAILKKPACR 297
+LR + + E H + KP+N+ LD + D+GLA IL
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-- 168
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
S + +P Y +PE + + +SD WS GC L
Sbjct: 169 ------------SFAKAFVGTPYYMSPEQMNRMS------------YNEKSDIWSLGCLL 204
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP 417
E+C P+ S +E+ + + + Y EL ++I L K RP
Sbjct: 205 YELCALMPPFTAFSQKELAGKIREGKFRRIPY------RYSDELNEIITRMLNLKDYHRP 258
Query: 418 TFSAML 423
+ +L
Sbjct: 259 SVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 63/345 (18%), Positives = 137/345 (39%), Gaps = 66/345 (19%)
Query: 128 PVIEVGVHHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKV--MIAEEMEPD 184
PV++ +D+K +GEG +V G R A+K++ +++ D
Sbjct: 5 PVLD---WNDIKFQDVIGEGNFG--QVLKARIKKDGL---RMDAAIKRMKEYASKDDHRD 56
Query: 185 WLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRN--------- 234
+ +L+ L + N+ G L L ++ +G++ ++++
Sbjct: 57 FAG-ELEVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 235 ------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLA 288
L+ +Q+L + AD+ARG+ L + ++ N+L+ + A ++D+GL+
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 289 AILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPES 348
++ L + A E+ + S
Sbjct: 175 ---------------RGQEVYVKKTMGRLPVRWMAIESLNYSV------------YTTNS 207
Query: 349 DAWSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGE 407
D WS+G L E+ + G P+ G++ E+Y + + +L + E++ ++ +
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP------LNCDDEVYDLMRQ 261
Query: 408 CLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKFSTSN 452
C + K +RP+F+ +L + R L+E + + KF+ +
Sbjct: 262 CWREKPYERPSFAQILVSLNRMLEERKTYVNTTL---YEKFTYAG 303
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-30
Identities = 54/328 (16%), Positives = 113/328 (34%), Gaps = 70/328 (21%)
Query: 136 HDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLR 194
++++ V+ +GEG V+ G VAVK ++ + + + +
Sbjct: 13 NNIEYVRDIGEGAFG--RVFQARAPGLLPYEPFTMVAVKM------LKEEASADMQADFQ 64
Query: 195 R-----ASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGR----------- 237
R A N+ GV + + L+ + YG + ++
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 238 ------------LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285
L+ + L +A G+ L V ++ N L+ + ++D+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGIS 345
GL+ + S+ + + + PE+ + +
Sbjct: 185 GLSRNI------------YSADYYKADGNDAIPIRWMPPESIFYNR------------YT 220
Query: 346 PESDAWSFGCTLVEMCTGSI-PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKM 404
ESD W++G L E+ + + P+ G++ EE+ V L P EL+ +
Sbjct: 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP------ENCPLELYNL 274
Query: 405 IGECLQFKASKRPTFSAMLATFLRHLQE 432
+ C + RP+F ++ L+ + E
Sbjct: 275 MRLCWSKLPADRPSFCSIHR-ILQRMCE 301
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-30
Identities = 57/298 (19%), Positives = 108/298 (36%), Gaps = 50/298 (16%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D L K LG+G +V+ + + A+K + + D + +
Sbjct: 3 DFILHKMLGKGSFG--KVF-------LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 194 RRASMWCR--NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIA 251
R S+ + + L VM+ G + ++ + L + Y A+I
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 113
Query: 252 RGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
G+ LH+ G+V ++K N+LLD G ++D+G+ +
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--------------DAK 159
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
+ +P+Y APE K + D WSFG L EM G P+ G
Sbjct: 160 TNTFCGTPDYIAPEILLGQK------------YNHSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
EE++ ++ + P++ + +E ++ + + KR + +H
Sbjct: 208 EEELFHSIRMDNPFYPRW-------LEKEAKDLLVKLFVREPEKRLGVRGDI---RQH 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (298), Expect = 5e-30
Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 52/303 (17%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+L + LG G + EV R VAVK + +P RR
Sbjct: 10 ELGEILGFGGMS--EVH-------LARDLRLHRDVAVKVLRADLARDPS----FYLRFRR 56
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLG----LVMDRCYGSVQLAMQRNEGRLTLEQILRY 246
A++ + + ++ G +VM+ G + EG +T ++ +
Sbjct: 57 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 116
Query: 247 GADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSS 306
AD + + H G++ ++KP+N+++ A+ V D+G+A + DS
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI-----------ADSG 165
Query: 307 RIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366
+ + + Y +PE + SD +S GC L E+ TG P
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQAR------------GDSVDARSDVYSLGCVLYEVLTGEPP 213
Query: 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-TFSAMLAT 425
+ G S + V+ +PP S G+ +L ++ + L R T + M A
Sbjct: 214 FTGDSPVSVAYQHVREDPIPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 426 FLR 428
+R
Sbjct: 271 LVR 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 7e-30
Identities = 46/310 (14%), Positives = 106/310 (34%), Gaps = 65/310 (20%)
Query: 132 VGVHHD---VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDW 185
VG+ +D +K ++G G V+ +G + VA ++ + +
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFK--TVY-------KGLDTETTVEVAWCELQDRKLTK--- 49
Query: 186 LSGQLDNLRR-----ASMWCRNVCTFHGV----LRMDSCLGLVMDRCYGSVQLAMQRNEG 236
+ + + N+ F+ ++ C+ LV + +
Sbjct: 50 --SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 107
Query: 237 RLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLDA-SGRAVVSDYGLAAILKK 293
+ ++ + + I +G+ LH ++ ++K N+ + +G + D GLA + +
Sbjct: 108 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166
Query: 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSF 353
S + +P + APE +E D ++F
Sbjct: 167 ---------------ASFAKAVIGTPEFMAPEMYEE-------------KYDESVDVYAF 198
Query: 354 GCTLVEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKA 413
G ++EM T P++ V + P + + E+ ++I C++
Sbjct: 199 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV----AIPEVKEIIEGCIRQNK 254
Query: 414 SKRPTFSAML 423
+R + +L
Sbjct: 255 DERYSIKDLL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-29
Identities = 51/301 (16%), Positives = 115/301 (38%), Gaps = 40/301 (13%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNL 193
++L + +GEG+ +V + VA+K + + + +
Sbjct: 6 RERIELGRCIGEGQFG--DVHQGIYMSPENPALA-VAIKTCKNCTSDSVREKFLQEALTM 62
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIAR 252
R+ ++ GV+ ++ + ++M+ C G ++ +Q + L L ++ Y ++
Sbjct: 63 RQFD--HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+ L + V +I N+L+ ++ + D+GL+ + +
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-------------EDSTYYKA 166
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371
L + APE+ + + SD W FG + E+ G P+ G+
Sbjct: 167 SKGKLPIKWMAPESINFRR------------FTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431
++ + +LP + P L+ ++ +C + S+RP F+ + A L+
Sbjct: 215 NNDVIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
Query: 432 E 432
E
Sbjct: 269 E 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 2e-29
Identities = 47/305 (15%), Positives = 100/305 (32%), Gaps = 42/305 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
K+ +++GEG ++ +G + VA+K + L + +
Sbjct: 8 KVGRRIGEGSFG--VIF-------EGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKL 56
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
+ C + + + LV+D S++ + + +++ + + V
Sbjct: 57 LA-GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 256 ELHAAGVVCMNIKPSNLLLDA-----SGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
+H +V +IKP N L+ + V D+G+ + P ++ P + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL-- 173
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
+ Y + S D + G + GS+PW GL
Sbjct: 174 -----SGTARYMSINTHLG------------REQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 371 SAEEIYRAV--VKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428
A + + +K + G P E +K + P + + F +
Sbjct: 217 KAATNKQKYERIGEKKQSTPLRELCA-GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
Query: 429 HLQEL 433
L+ L
Sbjct: 276 VLERL 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 61/299 (20%), Positives = 121/299 (40%), Gaps = 39/299 (13%)
Query: 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNLRRASMWC 200
+ +G G V+ + G+ H AVK + I + E + ++ S
Sbjct: 33 EVIGRGHFG--CVYHGTLLDNDGKKIH-CAVKSLNRITDIGEVSQFLTEGIIMKDFS--H 87
Query: 201 RNVCTFHGV-LRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIARGVVELH 258
NV + G+ LR + +V+ +G ++ ++ T++ ++ +G +A+G+ L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 259 AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLS 318
+ V ++ N +LD V+D+GLA + L
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----------YDKEFDSVHNKTGAKLP 197
Query: 319 PNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAEEIYR 377
+ A E+ + K + +SD WSFG L E+ T G+ P+ ++ +I
Sbjct: 198 VKWMALESLQTQK------------FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 378 AVVKNRKLP-PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435
+++ R+L P+Y P L++++ +C KA RP+FS +++
Sbjct: 246 YLLQGRRLLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-29
Identities = 50/314 (15%), Positives = 99/314 (31%), Gaps = 55/314 (17%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIAEEMEPDWLSGQLDNL 193
+ + LG G V RC + K V + + + + ++ L
Sbjct: 8 MIAEDLGRGEFG--IVH---------RCVETSSKKTYMAKFVKV-KGTDQVLVKKEISIL 55
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRC-YGSVQLAMQRNEGRLTLEQILRYGADIAR 252
A RN+ H L ++ + + + + L +I+ Y +
Sbjct: 56 NIAR--HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVV--SDYGLAAILKKPACRKARPECDSSRIHS 310
+ LH+ + +I+P N++ + + ++G A LK
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---------------PGD 158
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370
+P Y APE + +S +D WS G + + +G P+
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDV------------VSTATDMWSLGTLVYVLLSGINPFLAE 206
Query: 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-TFLRH 429
+ ++I ++ I E + L + R T S L +L+
Sbjct: 207 TNQQIIENIMNAEYTFD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK- 262
Query: 430 LQELPRSPPASPDT 443
Q++ R T
Sbjct: 263 -QKIERVSTKVIRT 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 9e-29
Identities = 56/316 (17%), Positives = 116/316 (36%), Gaps = 47/316 (14%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDN 192
+ + ++LG+G V+ G G + VA+K V A E +
Sbjct: 19 REKITMSRELGQGSFG--MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGS----------VQLAMQRNEGRLTLEQ 242
++ C +V GV+ ++M+ +A +L +
Sbjct: 77 MKE--FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 243 ILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPE 302
+++ +IA G+ L+A V ++ N ++ + D+G+ +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI----------- 183
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ + +L + +PE+ + + SD WSFG L E+ T
Sbjct: 184 -YETDYYRKGGKGLLPVRWMSPESLKDGV------------FTTYSDVWSFGVVLWEIAT 230
Query: 363 GS-IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
+ P+ GLS E++ R V++ L P L++++ C Q+ RP+F
Sbjct: 231 LAEQPYQGLSNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQYNPKMRPSFLE 284
Query: 422 MLATFLRHLQELPRSP 437
++++ ++ R
Sbjct: 285 IISSIKEEMEPGFREV 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-28
Identities = 53/347 (15%), Positives = 111/347 (31%), Gaps = 56/347 (16%)
Query: 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRRA 196
+ LG G +V Q + + A+K + + +++ RA
Sbjct: 16 TSQVLGLGING--KVL-------QIFNKRTQEKFALKMLQDCPKAR-----REVELHWRA 61
Query: 197 SMWCRNVCTFHGVLR----MDSCLGLVMDRCYGS--VQLAMQRNEGRLTLEQILRYGADI 250
S C ++ V CL +VM+ G R + T + I
Sbjct: 62 SQ-CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDA---SGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ LH+ + ++KP NLL + + ++D+G A
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-------------- 166
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
H+ + +P Y APE P D WS G + + G P+
Sbjct: 167 -HNSLTTPCYTPYYVAPEVLGP------------EKYDKSCDMWSLGVIMYILLCGYPPF 213
Query: 368 AGLSAEEIYRAVVKN-RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA-T 425
I + R ++ + + E+ +I L+ + ++R T + +
Sbjct: 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 426 FLRHLQELPRSPPASPDTGFTKFSTSNETEPSPASDVEVFQDNPNNL 472
++ ++P++P + + + S + + + +
Sbjct: 274 WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQI 320
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 2e-28
Identities = 59/360 (16%), Positives = 115/360 (31%), Gaps = 78/360 (21%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D ++++ LG G V R RH+ A+K + + Q+++
Sbjct: 5 DFQILRTLGTGSFG--RVH-------LIRSRHNGRYYAMKVLKKEIVVRLK----QVEHT 51
Query: 194 RR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGA 248
+ + + G + + ++MD G ++ R R Y A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 111
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRI 308
++ + LH+ ++ ++KP N+LLD +G ++D+G + +
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG-----------------FAKYV 154
Query: 309 HSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA 368
+P+Y APE + D WSFG + EM G P+
Sbjct: 155 PDVTYTLCGTPDYIAPEVVSTKP------------YNKSIDWWSFGILIYEMLAGYTPFY 202
Query: 369 GLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FL 427
+ + Y ++ P + ++ ++ + S+R
Sbjct: 203 DSNTMKTYEKILNAELRFPPF-------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 428 RH----------LQELPRSPPASP-------DTG-FTKFSTSNETEPSPASDV--EVFQD 467
H L P P DT F K+ + D ++F+D
Sbjct: 256 NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLFRD 315
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-28
Identities = 59/318 (18%), Positives = 108/318 (33%), Gaps = 51/318 (16%)
Query: 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDNL 193
+ + K LG G V V G + +VAVK + A E + L +L L
Sbjct: 22 RNRLSFGKTLGAGAFGKV-VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 194 RRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG------------------SVQLAMQRNE 235
N+ G + ++ + C + M+ +E
Sbjct: 81 SYLGN-HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 236 GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295
L LE +L + +A+G+ L + + ++ N+LL + D+GLA +K +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355
+ L + APE+ + ESD WS+G
Sbjct: 200 N------------YVVKGNARLPVKWMAPESIFNCV------------YTFESDVWSYGI 235
Query: 356 TLVEMCTGSIPW-AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKAS 414
L E+ + G+ + + ++K P E++ ++ C
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-----PEHAPAEMYDIMKTCWDADPL 290
Query: 415 KRPTFSAMLATFLRHLQE 432
KRPTF ++ + + E
Sbjct: 291 KRPTFKQIVQLIEKQISE 308
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 3e-28
Identities = 57/331 (17%), Positives = 98/331 (29%), Gaps = 57/331 (17%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQL 190
+ LG G + EV + + VA+K + L G+
Sbjct: 7 IRDIYDFRDVLGTGAFS--EVI-------LAEDKRTQKLVAIKC------IAKKALEGKE 51
Query: 191 DNLRR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILR 245
++ + N+ + L L+M G +G T R
Sbjct: 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 111
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLL---DASGRAVVSDYGLAAILKKPACRKARPE 302
+ V LH G+V ++KP NLL D + ++SD+GL+ +
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--------- 162
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
S + +P Y APE S D WS G +
Sbjct: 163 ------GSVLSTACGTPGYVAPEVLAQ------------KPYSKAVDCWSIGVIAYILLC 204
Query: 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422
G P+ + +++ ++K S I I ++ KR T
Sbjct: 205 GYPPFYDENDAKLFEQILKAEYEFD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
Query: 423 LA-TFLRHLQELPRSPPASPDTGFTKFSTSN 452
L ++ L ++ S K +
Sbjct: 262 LQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-28
Identities = 59/326 (18%), Positives = 107/326 (32%), Gaps = 62/326 (19%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
+ L + +G+GR EVW R + VAVK + E W + +
Sbjct: 4 TIVLQESIGKGRFG--EVW---------RGKWRGEEVAVKI--FSSREERSWFR-EAEIY 49
Query: 194 RRASMWCRNVCTFHGVLRMD----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
+ + N+ F D + L LV D L N +T+E +++
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG-SLFDYLNRYTVTVEGMIKLALS 108
Query: 250 IARGVVELHAA--------GVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
A G+ LH + ++K N+L+ +G ++D GL R
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL----------AVRH 158
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
+ + I + + + Y APE + + +D ++ G E+
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF------ESFKRADIYAMGLVFWEIA 212
Query: 362 TGSIP---------------WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIG 406
+ S EE+ + V + + P R + K++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 407 ECLQFKASKRPTFSAMLATFLRHLQE 432
EC + R T + T L L +
Sbjct: 273 ECWYANGAARLTALRIKKT-LSQLSQ 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-28
Identities = 61/331 (18%), Positives = 105/331 (31%), Gaps = 71/331 (21%)
Query: 142 KKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR--- 195
LGEG+ A V+ + R +++ VA+KK+ + E G R
Sbjct: 4 DFLGEGQFA--TVY-------KARDKNTNQIVAIKKIKLGHRSEAK--DGINRTALREIK 52
Query: 196 --ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARG 253
+ N+ S + LV D +++ ++ N LT I Y +G
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 112
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
+ LH ++ ++KP+NLLLD +G ++D+GLA P +
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--------------NRAYT 158
Query: 314 CTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373
+++ Y APE + D W+ GC L E+ G S
Sbjct: 159 HQVVTRWYRAPELLFGAR-----------MYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
Query: 374 EIYRAVVKN---------------------RKLPPQYASIVGVGIPRELWKMIGECLQFK 412
+ + + + P + +L +I F
Sbjct: 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
Query: 413 ASKRPTFSAMLATFLRH--LQELPRSPPASP 441
R T + L+ P P
Sbjct: 268 PCARITATQA----LKMKYFSNRPGPTPGCQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-27
Identities = 51/330 (15%), Positives = 108/330 (32%), Gaps = 81/330 (24%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIA-EEMEPDWLSGQLDN 192
D + + +LG G V+ + + S +A K + + + + + +L
Sbjct: 7 DFEKISELGAGNGG--VVF-------KVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
L + + F+G D + + M+ G + + GR+ + + + + +
Sbjct: 58 LHECN--SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115
Query: 253 GVVELH-AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSC 311
G+ L ++ ++KPSN+L+++ G + D+G++ L S +S
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------------IDSMANSF 163
Query: 312 MDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371
+ +Y +PE + S +SD WS G +LVEM G P
Sbjct: 164 VGT----RSYMSPERLQ------------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
Query: 372 AEEIYRAVVKNRKLPPQ-------------------------------------YASIVG 394
A+E+ + +
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
Query: 395 VGIPRELWKMIGECLQFKASKRPTFSAMLA 424
E + +CL ++R ++
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-26
Identities = 57/298 (19%), Positives = 97/298 (32%), Gaps = 47/298 (15%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
D +K LG+G +V R + + A+K + + D ++ +
Sbjct: 6 DFDYLKLLGKGTFG--KVI-------LVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 194 RR-ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
R + + + L VM+ G E T E+ YGA+I
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+ LH+ VV +IK NL+LD G ++D+GL + M
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--------------GATM 162
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+P Y APE E D W G + EM G +P+
Sbjct: 163 KTFCGTPEYLAPEVLED------------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRH 429
E ++ ++ P+ + E ++ L+ +R A + H
Sbjct: 211 ERLFELILMEEIRFPR-------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 60/297 (20%), Positives = 93/297 (31%), Gaps = 60/297 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQ------ 189
++ LG G V+ G VA+K V + L
Sbjct: 7 QVGPLLGSGGFG--SVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 190 LDNLRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAM-QRNEGRLTLEQILRYGA 248
+ L++ S V L+++R L G L E +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ V H GV+ +IK N+L+D + G + D+G A+LK
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--------------- 162
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ + Y+ PE + + WS G L +M G IP+
Sbjct: 163 -DTVYTDFDGTRVYSPPEWIRYHR-----------YHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 368 AGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
EEI R V R+ + E +I CL + S RPTF +
Sbjct: 211 EH--DEEIIRGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 109 bits (274), Expect = 3e-26
Identities = 34/304 (11%), Positives = 74/304 (24%), Gaps = 41/304 (13%)
Query: 487 LLSKNASGN-YSSSISSLLKAQNADGQTALHLACRRGSAELVEAI--LEYSQENVDVLDK 543
L A N + + S + + +A G + ++ + L S E V V+
Sbjct: 65 LCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQA 124
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
+ A G ++ L + I + + + A +G + L
Sbjct: 125 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELA 184
Query: 604 ADPNAV---DDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWN 660
+ + AV + + + +L+ +
Sbjct: 185 PTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA---------YAEIHEFEYGE 235
Query: 661 VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTA 720
V + + A ++
Sbjct: 236 KYVNPFIARHV---------NRLKEMHDAFKLSNP--DGV----------FDLVTKSECL 274
Query: 721 QDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTI-----PLHVALARGAKSCVG 775
Q L + ++ ++ +L + L +AL G +
Sbjct: 275 QGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACA 334
Query: 776 LLLS 779
LLLS
Sbjct: 335 LLLS 338
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 94.6 bits (234), Expect = 4e-21
Identities = 37/353 (10%), Positives = 84/353 (23%), Gaps = 58/353 (16%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
+N + L L L + + ++ ++ L + + L
Sbjct: 8 ENYENDPQLRLIPWILWENLFQHFISANELSLMTLSYKEAIHIFLPGTKNMEQVRQLLCL 67
Query: 567 RGANVISRLREGF---------GPSVAHVCAYHGQPD---CMRELLLAGADPNAVDDEGE 614
A+ ++ + + V A G + LL + + E
Sbjct: 68 YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127
Query: 615 SVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPE 674
A + + E MA++ ++ L ++ V+ R E+A E
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTE 187
Query: 675 EIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT--------------- 719
+ + ++ LL
Sbjct: 188 ATAMIQAENYYAFRWAAV--------GRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVN 239
Query: 720 -------AQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKS 772
+ + A +++ +LV ++ + L
Sbjct: 240 PFIARHVNRLKEMHDAFKLSNPDGVFDLVT------KSECLQGFYMLRNLIRRNDEVLLD 293
Query: 773 CVGLLLSAGADC-----NWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPD 820
+ LLS + + +A N ++LS P
Sbjct: 294 DIRFLLSIPGIKALAPTATIPGDANELLRLALR-----LGNQGACALLLSIPS 341
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 87.3 bits (215), Expect = 1e-18
Identities = 27/270 (10%), Positives = 63/270 (23%), Gaps = 47/270 (17%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEY-SQENVDVLD 542
+ LL+ + +K A+ A LA G ++ + E E + ++
Sbjct: 109 LCLLLTSDEI----------VKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQ 158
Query: 543 KDGDPPLVFALAAGSPECVHALIKRGANVISRLREGF-GPSVAHVCAYHGQPDCMRELLL 601
+ A G ++ L + + + + + G + + LL
Sbjct: 159 AENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLD 218
Query: 602 AGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNV 661
+ + V + E L
Sbjct: 219 CPVMLAYAEIHEFEYGEKYVNPFIARHVNRLKEMH-------------DAFKLSNPDGVF 265
Query: 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPT-- 719
+V + + + L + + +R LL+
Sbjct: 266 DLVTKSECLQGFYML-----------RNLIRRN--DEVLL----DDIRFLLSIPGIKALA 308
Query: 720 ---AQDAQNRTALHIASMANDVELVKIILD 746
L +A + ++L
Sbjct: 309 PTATIPGDANELLRLALRLGNQGACALLLS 338
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 70.3 bits (171), Expect = 4e-13
Identities = 25/204 (12%), Positives = 60/204 (29%), Gaps = 13/204 (6%)
Query: 640 SMAILNSKELTPLHLCVATWNVAVVKRWV-----EVASPEEIVNVIDIPGPVGTALCMAA 694
S+ L+ KE + L V + + +++ + G +C A
Sbjct: 38 SLMTLSYKEAIHIFLPGTKNMEQVRQLLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVA 97
Query: 695 ALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIR 754
A+ + + +LLT+ A+N A +A+ + ++ + + +
Sbjct: 98 AITGCSSAL--DTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMA 155
Query: 755 NVHNT--IPLHVALARGAKSCVGLLLSAGADCN-WQDDEGDNAFHIAADAAKMIRENLEW 811
+ +A G + L + A + + +
Sbjct: 156 MIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINF 215
Query: 812 LI---VMLSHPDAAVEVRNHSGKT 832
L+ VML++ +
Sbjct: 216 LLDCPVMLAYAEIHEFEYGEKYVN 239
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 43.3 bits (101), Expect = 2e-04
Identities = 14/64 (21%), Positives = 21/64 (32%), Gaps = 5/64 (7%)
Query: 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEA 529
NL + E + +R LLS + + D L LA R G+
Sbjct: 281 RNLIRRNDEVLLDDIRFLLSIPGIKALAPTA-----TIPGDANELLRLALRLGNQGACAL 335
Query: 530 ILEY 533
+L
Sbjct: 336 LLSI 339
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-26
Identities = 59/300 (19%), Positives = 96/300 (32%), Gaps = 56/300 (18%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS-----VAVKKVMIAEEMEPDWLSGQLDNL 193
++LG G+ A V +CR A K + + D
Sbjct: 13 DTGEELGSGQFA--VVK---------KCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 194 RRASMWCR----NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGAD 249
R S+ NV T H V + + L+++ G + LT E+ +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASG----RAVVSDYGLAAILKKPACRKARPECDS 305
I GV LH+ + ++KP N++L R + D+GLA +
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF------------ 169
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ +P + APE + E+D WS G + +G+
Sbjct: 170 ---GNEFKNIFGTPEFVAPEIVN------------YEPLGLEADMWSIGVITYILLSGAS 214
Query: 366 PWAGLSAEEIYRAVVK-NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLA 424
P+ G + +E V N + +Y S I L KR T L
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 5e-26
Identities = 62/323 (19%), Positives = 111/323 (34%), Gaps = 58/323 (17%)
Query: 135 HHDVKLVKKLGEGRRAGVEVW-GAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNL 193
+KL K LG G +V G + +VAVK + E + L
Sbjct: 12 RDRLKLGKPLGRGAFG--QVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSEL 67
Query: 194 RRASMWCR--NVCTFHGV-LRMDSCLGLVMDRCYGSVQLAMQRNEGR------------- 237
+ NV G + L ++++ C R++
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 238 ---LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
LTLE ++ Y +A+G+ L + + ++ N+LL + D+GLA +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI--- 184
Query: 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354
+ L + APE + +SD WSFG
Sbjct: 185 ---------YKDPDYVRKGDARLPLKWMAPETIFDRV------------YTIQSDVWSFG 223
Query: 355 CTLVEMCTGSI-PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKA 413
L E+ + P+ G+ +E + +K E+++ + +C +
Sbjct: 224 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----APDYTTPEMYQTMLDCWHGEP 278
Query: 414 SKRPTFSAMLATFLRHLQELPRS 436
S+RPTFS + + HL L ++
Sbjct: 279 SQRPTFSEL----VEHLGNLLQA 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-25
Identities = 59/318 (18%), Positives = 113/318 (35%), Gaps = 54/318 (16%)
Query: 135 HHDVKLVKKLGEGRRAGV-EVWGAWIGGGQGRCRHSVAVKKV-MIAEEMEPDWLSGQLDN 192
+ L K LGEG V + + VAVK + A E + L +++
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 193 LRRASMWCRNVCTFHGVLRMDSCLGLVMDRCYG----------------SVQLAMQRNEG 236
++ +N+ G D L ++++ E
Sbjct: 72 MKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 237 RLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPAC 296
+L+ + ++ +ARG+ L + + ++ N+L+ ++D+GLA +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 297 RKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356
+ L + APEA + +SD WSFG
Sbjct: 186 -------HHIDYYKKTTNGRLPVKWMAPEALFDRI------------YTHQSDVWSFGVL 226
Query: 357 LVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASK 415
L E+ T G P+ G+ EE+++ + + ++ EL+ M+ +C S+
Sbjct: 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQ 280
Query: 416 RPTFSAMLATFLRHLQEL 433
RPTF + + L +
Sbjct: 281 RPTFKQL----VEDLDRI 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (264), Expect = 2e-25
Identities = 59/313 (18%), Positives = 105/313 (33%), Gaps = 64/313 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRR--- 195
++K+GEG V+ A G+ + A+KK+ + +E E G R
Sbjct: 5 HGLEKIGEGTYG--VVYKAQNNYGE-----TFALKKIRLEKEDE-----GIPSTTIREIS 52
Query: 196 --ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARG 253
+ N+ + V+ L LV + ++ + EG L + + G
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
+ H V+ ++KP NLL++ G ++D+GLA P
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--------------VRKYT 158
Query: 314 CTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373
+++ Y AP+ KK S D WS GC EM G+ + G+S
Sbjct: 159 HEIVTLWYRAPDVLMGSKK-----------YSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
Query: 374 EIYRAVVKNRKLP----------------------PQYASIVGVGIPRELWKMIGECLQF 411
+ + + P P G+ ++ + L+
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267
Query: 412 KASKRPTFSAMLA 424
++R T L
Sbjct: 268 DPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 5e-25
Identities = 49/299 (16%), Positives = 98/299 (32%), Gaps = 39/299 (13%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+L +K+G G +++ G + VA+K + + P + +
Sbjct: 10 RLGRKIGSGSFG--DIY-------LGTDIAAGEEVAIK-LECVKTKHPQLHI-ESKIYKM 58
Query: 196 ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVV 255
+ T +VM+ S++ + +L+ +L + +
Sbjct: 59 MQG-GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 256 ELHAAGVVCMNIKPSNLL---LDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
+H+ + ++KP N L + D+GLA + + P ++ +
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL---- 173
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+ Y + I S D S G L+ GS+PW GL A
Sbjct: 174 ---TGTARYASINTHL------------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 373 EEIYRAVVK-NRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430
+ + + K ++ G P E + C + +P +S L R+L
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNL 276
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-25
Identities = 57/298 (19%), Positives = 101/298 (33%), Gaps = 35/298 (11%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRA 196
+ +L+K LG G +V+ G + A+K + A ++ + R+
Sbjct: 25 NFELLKVLGTGAYG--KVFLVRKISGHDTGKL-YAMKVLKKATIVQKAKTTEHTRTERQV 81
Query: 197 SMWCR---NVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARG 253
R + T H + ++ L L++D G R T ++ Y +I
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 254 VVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMD 313
+ LH G++ +IK N+LLD++G V++D+GL+ +
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-------------VADETERAY 188
Query: 314 CTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373
+ Y AP+ G D WS G + E+ TG+ P+ +
Sbjct: 189 DFCGTIEYMAPDIVRGGDS----------GHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 374 EIYRAVVKN-RKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRH 429
+ + K P Y + +I L KR A H
Sbjct: 239 NSQAEISRRILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 1e-24
Identities = 57/298 (19%), Positives = 99/298 (33%), Gaps = 50/298 (16%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
+K LG G V + + S A+K + + ++ + L+
Sbjct: 42 QFDRIKTLGTGSFG--RVM-------LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 194 RR-ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
R ++ + + +S L +VM+ G + R GR + Y A I
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
LH+ ++ ++KP NLL+D G V+D+G A R+
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----------------KRVKGRT 195
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
+P APE + G + D W+ G + EM G P+
Sbjct: 196 WTLCGTPEALAPEIIL------------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT-FLRH 429
+IY +V + P + +L ++ LQ +KR H
Sbjct: 244 IQIYEKIVSGKVRFPSH-------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (248), Expect = 8e-24
Identities = 44/243 (18%), Positives = 72/243 (29%), Gaps = 6/243 (2%)
Query: 510 DGQTALHLACRRGSAELVEAILEY--SQENVDVLDKDGDPPLVFALAAGSPECVHALIKR 567
DG TALHLA ++ +L + E +D+ + G L A G V L
Sbjct: 8 DGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAA 67
Query: 568 GANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTD 627
+ E G + H+ C LL + + +
Sbjct: 68 --GAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSH 125
Query: 628 CAIVI--LENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGP 685
+ N L V + A ++
Sbjct: 126 APAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLN 185
Query: 686 VGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIIL 745
C L E + ++ +LL AGA+PTA+ RT L A + + L +++
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245
Query: 746 DAG 748
G
Sbjct: 246 AHG 248
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 73.6 bits (179), Expect = 1e-14
Identities = 48/239 (20%), Positives = 75/239 (31%), Gaps = 10/239 (4%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAV---DDEGESVLHRAVAKKYTDCAIVILENGGCRSM 641
H+ H + LL A + +D G++ LH A + G +
Sbjct: 14 HLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLV 73
Query: 642 AILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTA-LCMAAALKKDH 700
A L V A V + P + + T A A
Sbjct: 74 AERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQ 133
Query: 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTI 760
E + A++ T LH+A + D E+V+++ DAG D+N
Sbjct: 134 PNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGR 193
Query: 761 PLHVALAR-GAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSH 818
A S + LLL AGAD + G A +R N ++ +H
Sbjct: 194 TPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSAL-----LRPNPILARLLRAH 247
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 44.3 bits (103), Expect = 5e-05
Identities = 17/58 (29%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+T LHLA +A ++E +L+ + G PL AL +P L GA
Sbjct: 193 RTPLHLAVEAQAASVLELLLKAGA-DPTARMYGGRTPLGSALLRPNPILARLLRAHGA 249
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.4 bits (98), Expect = 3e-04
Identities = 15/68 (22%), Positives = 22/68 (32%), Gaps = 11/68 (16%)
Query: 473 HQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILE 532
H V S + LL A A+ G+T L A R + L +
Sbjct: 197 HLAVEAQAASVLELLLKAGADPT----------ARMYGGRTPLGSALLRPNPILARLLRA 246
Query: 533 Y-SQENVD 539
+ + E D
Sbjct: 247 HGAPEPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.0 bits (97), Expect = 3e-04
Identities = 13/42 (30%), Positives = 20/42 (47%), Gaps = 3/42 (7%)
Query: 761 PLHVALARGAKSCVGLLLSAGADC---NWQDDEGDNAFHIAA 799
LH+A+ + + LL A + Q+D G A H+AA
Sbjct: 12 ALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAA 53
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-23
Identities = 70/354 (19%), Positives = 117/354 (33%), Gaps = 73/354 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
K +G G V+ Q + S VA+KKV+ + + +L +R+
Sbjct: 23 TDTKVIGNGSFG--VVY-------QAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRK 69
Query: 196 AS----MWCRNVCTFHGVLRMDSCLGLVMDRCYGS---VQLAMQRNEGRLTLEQILRYGA 248
+ R G + + L LV+D + V R + L + + Y
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 249 DIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPACRKARPECDSSR 307
+ R + +H+ G+ +IKP NLLLD + + D+G A L +
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-------------- 175
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ S Y APE A + D WS GC L E+ G +
Sbjct: 176 -GEPNVSYICSRYYRAPE-----------LIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 368 AGLSAEEIYRAVVKNRKLPPQ----------------------YASIVGVGIPRELWKMI 405
G S + ++K P + + + P E +
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 406 GECLQFKASKRPTFSAMLA-TFLRHLQELPRSPPASPDTGFTKFSTSNETEPSP 458
L++ + R T A +F L++ P DT T+ E +P
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-23
Identities = 62/349 (17%), Positives = 113/349 (32%), Gaps = 71/349 (20%)
Query: 127 GPVIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWL 186
G V +VG + + +GEG V A+ + VA+KK+ E
Sbjct: 1 GQVFDVGPRY--TNLSYIGEGAYG--MVCSAY----DNVNKVRVAIKKISPFEH------ 46
Query: 187 SGQLDNLRR-----ASMWCRNVCTFHGVLRMDSC----LGLVMDRCYGSVQLAMQRNEGR 237
R N+ + ++R + ++ G+ + +
Sbjct: 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QH 105
Query: 238 LTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACR 297
L+ + I + I RG+ +H+A V+ ++KPSNLLL+ + + D+GLA +
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 298 KARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTL 357
+ + + Y APE ++ G + D WS GC L
Sbjct: 166 -----------TGFLTEYVATRWYRAPE-----------IMLNSKGYTKSIDIWSVGCIL 203
Query: 358 VEMCTGSIPWAGLSAEEIYRAVVKNRKLPPQYA------------------------SIV 393
EM + + G + ++ P Q + +
Sbjct: 204 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263
Query: 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLA-TFLRHLQELPRSPPASP 441
+ ++ + L F KR LA +L + P A
Sbjct: 264 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA 312
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.4 bits (246), Expect = 4e-23
Identities = 46/305 (15%), Positives = 96/305 (31%), Gaps = 22/305 (7%)
Query: 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEA 529
++L + ++ L S + N Q + L E+ +
Sbjct: 8 HDLTSDFLSSPLKIMKALPSPVVNDNE----------QKMKLEAFLQRLLFPEIQEMPTS 57
Query: 530 ILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAY 589
+ S + + E A N+ + E G + H
Sbjct: 58 LNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDE-HGNTPLHWLTS 116
Query: 590 HGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILE--NGGCRSMAILNSK 647
+ ++ L+ G++ D+ GES L +AV + + + + +S
Sbjct: 117 IANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSM 176
Query: 648 ELTPLHLCVA----TWNVAVVKRWVEVASPEEIV---NVIDIPGPVGTALCMAAALKKDH 700
T LH + T A K ++++ + I + ++
Sbjct: 177 NRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKD 236
Query: 701 EVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTI 760
+ ++ ++ AQD+ T L+IA+ ++ +V +LD G D I N
Sbjct: 237 SILENLDLKWIIANMLN--AQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLR 294
Query: 761 PLHVA 765
P+
Sbjct: 295 PVDFG 299
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 62.4 bits (150), Expect = 1e-10
Identities = 28/212 (13%), Positives = 62/212 (29%), Gaps = 42/212 (19%)
Query: 452 NETEPSPASDVEVFQDNPNN--LHQLVSEGDVSGVRDLLSKNASGNYSSS---------- 499
N+ P+ ++ + D N LH L S ++ V+ L+ ++ Y +
Sbjct: 89 NDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAV 148
Query: 500 -----------------ISSLLKAQNADGQTALHLACRRGSAEL------------VEAI 530
+ L +++ +T LH + I
Sbjct: 149 KSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWI 208
Query: 531 LEYSQENVDVLDKDGDPPLVFALAAGSPECVHAL-IKRGANVISRLREGFGPSVAHVCAY 589
++ + + + + L +K + ++ G + ++ A
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268
Query: 590 HGQPDCMRELLLAGADPNAVDDEGESVLHRAV 621
G + LL GADP + G +
Sbjct: 269 LGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 2e-22
Identities = 71/328 (21%), Positives = 118/328 (35%), Gaps = 67/328 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQ--LDNLRRA 196
+ V ++GEG +V+ A GR VA+K+V + E LS + LR
Sbjct: 10 ECVAEIGEGAYG--KVFKARDLKNGGRF---VALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 197 SMW-CRNVCTFHGV-----LRMDSCLGLVMDRCYGS-VQLAMQRNEGRLTLEQILRYGAD 249
+ NV V ++ L LV + + E + E I
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 250 IARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIH 309
+ RG+ LH+ VV ++KP N+L+ +SG+ ++D+GLA I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---------------Q 169
Query: 310 SCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369
+ +++ Y APE + D WS GC EM + G
Sbjct: 170 MALTSVVVTLWYRAPEVLL------------QSSYATPVDLWSVGCIFAEMFRRKPLFRG 217
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWK--------------------MIGECL 409
S + ++ LP + V +PR+ + ++ +CL
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 277
Query: 410 QFKASKRPTFSAMLATFLRH--LQELPR 435
F +KR + + L H Q+L R
Sbjct: 278 TFNPAKRISAYSA----LSHPYFQDLER 301
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 64/335 (19%), Positives = 115/335 (34%), Gaps = 76/335 (22%)
Query: 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNL 193
+ + V+K+GEG V+ + R + + VA+KK+ + E E G
Sbjct: 3 NFQKVEKIGEGTYG--VVY-------KARNKLTGEVVALKKIRLDTETE-----GVPSTA 48
Query: 194 RR-----ASMWCRNVCTFHGVLRMDSCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYG 247
R + N+ V+ ++ L LV + + + + L I Y
Sbjct: 49 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ +G+ H+ V+ ++KP NLL++ G ++D+GLA P
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------------- 155
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+++ Y APE K S D WS GC EM T +
Sbjct: 156 -VRTYTHEVVTLWYRAPEILLGCKY-----------YSTAVDIWSLGCIFAEMVTRRALF 203
Query: 368 AGLSAEEIYRAVVKNRKLPPQYA----------------------SIVGVGIPRELWKMI 405
G S + + + P + S V + + ++
Sbjct: 204 PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL 263
Query: 406 GECLQFKASKRPTFSAMLATFLRH--LQELPRSPP 438
+ L + +KR + A L H Q++ + P
Sbjct: 264 SQMLHYDPNKRISAKA----ALAHPFFQDVTKPVP 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 8e-22
Identities = 52/322 (16%), Positives = 101/322 (31%), Gaps = 66/322 (20%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ + K+G+G EV+ + R R + VA+KKV++ E E ++ +
Sbjct: 13 EKLAKIGQGTFG--EVF-------KARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 63
Query: 196 ASMWCRNVCTFHGV--------LRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYG 247
+ NV + R + LV D C + + + TL +I R
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 248 ADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSR 307
+ G+ +H ++ ++K +N+L+ G ++D+GLA +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF----------SLAKNS 173
Query: 308 IHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367
+ +++ Y PE + P D W GC + EM T S
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGER-----------DYGPPIDLWGAGCIMAEMWTRSPIM 222
Query: 368 AGLSAEEIYRAVVKNRKLPPQYA-------------------------SIVGVGIPRELW 402
G + + + + +
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 403 KMIGECLQFKASKRPTFSAMLA 424
+I + L ++R L
Sbjct: 283 DLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 1e-21
Identities = 57/301 (18%), Positives = 110/301 (36%), Gaps = 48/301 (15%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ ++K+GEG V+ + + R + VA+K+V + ++ E G + R
Sbjct: 5 EKLEKIGEGTYG--TVF-------KAKNRETHEIVALKRVRLDDDDE-----GVPSSALR 50
Query: 196 -----ASMWCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADI 250
+ +N+ H VL D L LV + C ++ G L E + + +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 251 ARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHS 310
+G+ H+ V+ ++KP NLL++ +G ++++GLA P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--------------VR 156
Query: 311 CMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-AG 369
C +++ Y P+ K S D WS GC E+ P G
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKL-----------YSTSIDMWSAGCIFAELANAGRPLFPG 205
Query: 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429
++ + + + P + +P + + P +A L++
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 430 L 430
L
Sbjct: 266 L 266
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (226), Expect = 4e-21
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 14/223 (6%)
Query: 588 AYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNS 646
AY G+ + ++E +LA + D + + LH A + +T+ +L+ G +
Sbjct: 11 AYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAG 70
Query: 647 KELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRE 706
+ + + VN ++ G T L AA K+ E
Sbjct: 71 WSPLHIAASAGRDEI-----VKALLGKGAQVNAVNQNG--CTPLHYAA--SKNRH----E 117
Query: 707 LVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVAL 766
+ +LL GA P A+D TA+H A+ +++++ I+L NI++ PLH+A
Sbjct: 118 IAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLAC 177
Query: 767 ARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENL 809
LL+S GA ++ E +A +I + +
Sbjct: 178 DEERVEEAKLLVSQGASIYIENKEEKTPLQVAKGGLGLILKRM 220
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (212), Expect = 3e-19
Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 59/279 (21%)
Query: 468 NPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELV 527
+ + L G + +++ + + S L + D +TALH AC G E+V
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKS---------LATRTDQDSRTALHWACSAGHTEIV 53
Query: 528 EAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVC 587
E +L+ D D G PL A +AG E V AL+ +GA V + + G P H
Sbjct: 54 EFLLQLGVPVNDK-DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTP--LHYA 110
Query: 588 AYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSK 647
A + + LL GA+P+A D + +HRA AK ++L S I +++
Sbjct: 111 ASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYY--KASTNIQDTE 168
Query: 648 ELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGREL 707
TPLHL V E
Sbjct: 169 GNTPLHLACDEERV--------------------------------------------EE 184
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
++L++ GA ++ + +T L +A ++K +++
Sbjct: 185 AKLLVSQGASIYIENKEEKTPLQVAKGGLG-LILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 0.002
Identities = 23/142 (16%), Positives = 40/142 (28%), Gaps = 40/142 (28%)
Query: 725 NRTALHIASMANDVELVK-IILDAGVDVNIRNVHNTIPLHVALARG-------------- 769
+ + + + +E +K IL + + LH A + G
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVP 62
Query: 770 -------------------AKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLE 810
V LL GA N + G H AA + E
Sbjct: 63 VNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAAS-----KNRHE 117
Query: 811 WLIVMLSHPDAAVEVRNHSGKT 832
+++L A + ++H T
Sbjct: 118 IAVMLLEG-GANPDAKDHYEAT 138
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 59/276 (21%), Positives = 97/276 (35%), Gaps = 26/276 (9%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
D AC G E V +LE +++ + DG L A + + V L++ GA
Sbjct: 39 DDGAVFLAACSSGDTEEVLRLLERGA-DINYANVDGLTALHQACIDDNVDMVKFLVENGA 97
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
N+ EG+ P H A G D L+ GA AV+ EG++ L A + +
Sbjct: 98 NINQPDNEGWIPL--HAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELL 155
Query: 630 IVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTA 689
+ G + + + S G TA
Sbjct: 156 QNEVNRQGVDIE-----------AARKEEERIMLRDARQWLNSGHINDVRHAKSGG--TA 202
Query: 690 LCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGV 749
L +AA K + E++++L+ A + +D T LH A+ E +I+++
Sbjct: 203 LHVAA--AKGYT----EVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLC 256
Query: 750 DVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCN 785
D+ N VA + +G L N
Sbjct: 257 DMEAVNKVGQTAFDVA----DEDILGYLEELQKKQN 288
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 86.7 bits (213), Expect = 7e-19
Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 15/247 (6%)
Query: 579 FGPSVA-HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGG 637
F G + + LL GAD N + +G + LH+A D ++ENG
Sbjct: 38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGA 97
Query: 638 CRSMAILNSKELTPLHLC--------------VATWNVAVVKRWVEVASPEEIVNVIDIP 683
+ V + EE + +
Sbjct: 98 NINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQN 157
Query: 684 GPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKI 743
+ + AA K++ + R+ + L + TALH+A+ E++K+
Sbjct: 158 EVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKL 217
Query: 744 ILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAK 803
++ A DVNI++ PLH A G + +L+ D + G AF +A +
Sbjct: 218 LIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277
Query: 804 MIRENLE 810
E L+
Sbjct: 278 GYLEELQ 284
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 50.9 bits (120), Expect = 5e-07
Identities = 20/76 (26%), Positives = 37/76 (48%), Gaps = 1/76 (1%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
G TALH+A +G E+++ +L ++ +V++ D DG PL A G E L+
Sbjct: 194 RHAKSGGTALHVAAAKGYTEVLK-LLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILV 252
Query: 566 KRGANVISRLREGFGP 581
+ ++ + + G
Sbjct: 253 ENLCDMEAVNKVGQTA 268
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 47.4 bits (111), Expect = 8e-06
Identities = 49/240 (20%), Positives = 81/240 (33%), Gaps = 24/240 (10%)
Query: 609 VDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWV 668
V + +V A + T+ + +LE G + N LT LH NV +VK V
Sbjct: 36 VKFDDGAVFLAACSSGDTEEVLRLLERGA--DINYANVDGLTALHQACIDDNVDMVKFLV 93
Query: 669 EVASPEEIVNVIDI----------PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEP 718
E + + + L A EG + I E
Sbjct: 94 ENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEE 153
Query: 719 TAQDAQNRTALHIASMAND------VELVKIILDAGVDVNIRNVHNTIPLHVALARGAKS 772
Q+ NR + I + + + + + ++ LHVA A+G
Sbjct: 154 LLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTE 213
Query: 773 CVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKT 832
+ LL+ A D N +D +G H AA E +++ + +E N G+T
Sbjct: 214 VLKLLIQARYDVNIKDYDGWTPLHAAA-----HWGKEEACRILVEN-LCDMEAVNKVGQT 267
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 87.5 bits (215), Expect = 3e-19
Identities = 52/286 (18%), Positives = 100/286 (34%), Gaps = 31/286 (10%)
Query: 512 QTALHLACR-RGSAELVEAILEYSQENVDVLD-KDGDPPLVFALAAGSPECVHAL----- 564
++ + L GS + E I +E+V+++D + L + + S E L
Sbjct: 1 ESPIKLHTEAAGSYAITEPIT---RESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEA 57
Query: 565 ---IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAV 621
I GA+V + + P + + + L+ AGADP + S LH+A
Sbjct: 58 KECIAAGADVNAMDCDENTP--LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAA 115
Query: 622 AKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVA---------TWNVAVVKRWVEVAS 672
A + + +L + + + + VA + + V K
Sbjct: 116 ANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYD 175
Query: 673 PEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIA 732
+ G TAL AA + V+ + G+ QD +T + +A
Sbjct: 176 GAARKDSEKYKG--RTALHYAAQVSNMPIVKYLVGEK-----GSNKDKQDEDGKTPIMLA 228
Query: 733 SMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLL 778
+ +E+V ++ G V + + +A A + V +
Sbjct: 229 AQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 53.2 bits (126), Expect = 8e-08
Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
Q+ DG+T + LA + G E+V +++ +V+ +D A A V +
Sbjct: 217 QDEDGKTPIMLAAQEGRIEVVMYLIQQGA-SVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 2/95 (2%)
Query: 506 AQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALI 565
++ G+TALH A + + +V+ ++ N D D+DG P++ A G E V LI
Sbjct: 182 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLI 241
Query: 566 KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELL 600
++GA+V + + + + +
Sbjct: 242 QQGASVEAVDATDHTA--RQLAQANNHHNIVDIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 43.2 bits (100), Expect = 2e-04
Identities = 13/62 (20%), Positives = 20/62 (32%), Gaps = 10/62 (16%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
+ EG + V L+ + AS A +A TA LA +V+
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVE----------AVDATDHTARQLAQANNHHNIVDIFD 274
Query: 532 EY 533
Sbjct: 275 RC 276
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 39.3 bits (90), Expect = 0.003
Identities = 39/193 (20%), Positives = 65/193 (33%), Gaps = 15/193 (7%)
Query: 650 TPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE--GREL 707
+P+ L + + E VN+ID P T L A+ + E
Sbjct: 2 SPIKLHTEAAGSYAITEPIT----RESVNIID-PRHNRTVLHWIASNSSAEKSEDLIVHE 56
Query: 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALA 767
+ + AGA+ A D T L +A +A LV ++ AG D I N LH A A
Sbjct: 57 AKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAA 116
Query: 768 RGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAK--------MIRENLEWLIVMLSHP 819
+ +L++ ++ N A + +E +
Sbjct: 117 NRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDG 176
Query: 820 DAAVEVRNHSGKT 832
A + + G+T
Sbjct: 177 AARKDSEKYKGRT 189
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.0 bits (217), Expect = 4e-19
Identities = 58/333 (17%), Positives = 113/333 (33%), Gaps = 79/333 (23%)
Query: 129 VIEVGVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDW 185
V+E G D +LV+KLG G+ + EV+ + + V VK + ++ +
Sbjct: 28 VVEWGNQDDYQLVRKLGRGKYS--EVF-------EAINITNNEKVVVKILKPVKKKK--- 75
Query: 186 LSGQLDNLRRASMWCRNVCTFHGVLR--MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQI 243
+ ++ L N+ T +++ + LV + + ++ LT I
Sbjct: 76 IKREIKILENL-RGGPNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDI 131
Query: 244 LRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAV-VSDYGLAAILKKPACRKARPE 302
Y +I + + H+ G++ ++KP N+++D R + + D+GLA
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--------- 182
Query: 303 CDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362
+ + S + PE + D WS GC L M
Sbjct: 183 ------GQEYNVRVASRYFKGPELLVDYQ-----------MYDYSLDMWSLGCMLASMIF 225
Query: 363 GSIPW-AGLSAEEIYRAVVK--------------NRKLPPQYASIVGV------------ 395
P+ G + + K N +L P++ I+G
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 396 ----GIPRELWKMIGECLQFKASKRPTFSAMLA 424
+ E + + L++ R T +
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-18
Identities = 66/341 (19%), Positives = 112/341 (32%), Gaps = 71/341 (20%)
Query: 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVM--IAEEMEPDWLSGQLD 191
V + ++ +G G V A GR VA+KK+ E+ +L
Sbjct: 16 VRAVYRDLQPVGSGAYG--AVCSAV----DGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69
Query: 192 NLRRASMWCRNVCTFHGVLRMDSCLG------LVMDRCYGSVQLAMQRNEGRLTLEQILR 245
L+ M NV V D L LVM + M+ +L ++I
Sbjct: 70 LLKH--MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQF 125
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
+ +G+ +HAAG++ ++KP NL ++ + D+GLA
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------------- 168
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
+ S M +++ Y APE + + D WS GC + EM TG
Sbjct: 169 RQADSEMTGYVVTRWYRAPEVILNWMR-----------YTQTVDIWSVGCIMAEMITGKT 217
Query: 366 PWAGLSAEEIYRAVVKNRKLPPQYA------------------------SIVGVGIPREL 401
+ G + + ++K PP + +
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277
Query: 402 WKMIGECLQFKASKRPTFSAMLA-TFLRHLQELPRSPPASP 441
++ + L A +R T LA + L + P
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-17
Identities = 56/341 (16%), Positives = 106/341 (31%), Gaps = 81/341 (23%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLSGQLDNLRR 195
+ + +G G V + VAVKK+ + R
Sbjct: 21 QNLSPVGSGAYG--SVC-------AAFDTKTGLRVAVKKLSRPFQSI-----IHAKRTYR 66
Query: 196 -----ASMWCRNVCTFHGVLR-----MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILR 245
M NV V + ++ G+ + + +LT + +
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQF 125
Query: 246 YGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDS 305
I RG+ +H+A ++ ++KPSNL ++ + D+GLA
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------------- 168
Query: 306 SRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365
M + + Y APE + + + D WS GC + E+ TG
Sbjct: 169 RHTDDEMTGYVATRWYRAPE-----------IMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 366 PWAGLSAEEIYRAVVKN------------------------RKLPPQYASIVGVGIPREL 401
+ G + + +++ ++P + V +G
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 277
Query: 402 WKMIGECLQFKASKRPTFSAMLA-TFLRHLQELPRSPPASP 441
++ + L + KR T + LA + + P A P
Sbjct: 278 VDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.5 bits (194), Expect = 7e-17
Identities = 44/242 (18%), Positives = 87/242 (35%), Gaps = 19/242 (7%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
LH AC V+ +L + D+DG PL ++++ + E L+ + NV
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMREL---LLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
A + + D N + ++G + LH AV KK+ + +
Sbjct: 62 LDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVS 121
Query: 630 IVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTA 689
++ENG + + PLH + ++ +++ + ++ G
Sbjct: 122 QFLIENGASVRIK--DKFNQIPLHRAASVGSLKLIELL-----CGLGKSAVNWQDKQGWT 174
Query: 690 LCMAAALKKDHEVEGRELVRILLTA-GAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
A + + +L+ GAE D + A +A + ++ K L+
Sbjct: 175 PLFHALAEGHGDA-----AVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNNV 226
Query: 749 VD 750
VD
Sbjct: 227 VD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.4 bits (186), Expect = 9e-16
Identities = 43/229 (18%), Positives = 82/229 (35%), Gaps = 13/229 (5%)
Query: 585 HVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAI 643
H + ++ELL + + D +G LH +V+ + + +L ++
Sbjct: 5 HQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDD 64
Query: 644 LNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
+ V + + + +N I L +
Sbjct: 65 YPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITN--------QGVTCLHLAVGKK 116
Query: 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVD-VNIRNVHNTIPL 762
E+ + L+ GA +D N+ LH A+ ++L++++ G VN ++ PL
Sbjct: 117 WFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL 176
Query: 763 HVALARGAKSCVGLLLSA-GADCNWQDDEGDNAFHIAA--DAAKMIREN 808
ALA G LL+ GA+ + D++G A +A K N
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQVKKFFLNN 225
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.3 bits (95), Expect = 4e-04
Identities = 12/64 (18%), Positives = 22/64 (34%), Gaps = 3/64 (4%)
Query: 507 QNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIK 566
Q+ G T L A G + ++E D++D G AL + + +
Sbjct: 168 QDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLN 224
Query: 567 RGAN 570
+
Sbjct: 225 NVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.4 bits (90), Expect = 0.002
Identities = 23/214 (10%), Positives = 59/214 (27%), Gaps = 21/214 (9%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
L A ++ + + +L + + +D R LH + E+ +L
Sbjct: 2 YPL-HQACMENEFFK----VQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSK 56
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRE 807
+VN+ + + + + ++ S D + + ++
Sbjct: 57 MENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKK 116
Query: 808 NLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLSPTIFEI 867
E L A+V +++ + L A + L + +
Sbjct: 117 WFEV-SQFLIENGASVRIKDKFNQIP---------------LHRAASVGSLKLIELLCGL 160
Query: 868 GDWVKFKRRVTTPTYGWQGAKHKSVGFVQSVLDK 901
G + T + +++K
Sbjct: 161 GKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEK 194
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (187), Expect = 5e-16
Identities = 50/240 (20%), Positives = 101/240 (42%), Gaps = 21/240 (8%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQE---NVDVLDKDGDPPLVFALAAGSPECVHALIK 566
DG T LH+A +G+ V ++ Q+ +D+ + PL A+ P V +
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVR--LL 59
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDD----EGESVLHRAVA 622
A + G + AH+ H P C+R LL + A + +G + LH AV
Sbjct: 60 VTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVN 119
Query: 623 KKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682
+ + ++LE G + S +PL V ++++V+ + ++
Sbjct: 120 TECQETVQLLLERGADIDAVDIKSGR-SPLIHAVENNSLSMVQLL------LQHGANVNA 172
Query: 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVK 742
G++ +A+ + + VR L+ +GA+ + ++ N T L +A +++++
Sbjct: 173 QMYSGSSALHSASGRGLLPL-----VRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (174), Expect = 3e-14
Identities = 42/220 (19%), Positives = 76/220 (34%), Gaps = 14/220 (6%)
Query: 585 HVCAYHGQPDCMRELL----LAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRS 640
H+ G + L+ G + + ++ ++ LH AV +++ G
Sbjct: 8 HIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPM 67
Query: 641 MAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700
++A R AL
Sbjct: 68 ALD---------RHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 118
Query: 701 EVEGRELVRILLTAGAEPTAQDAQNRT-ALHIASMANDVELVKIILDAGVDVNIRNVHNT 759
E +E V++LL GA+ A D ++ L A N + +V+++L G +VN + +
Sbjct: 119 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGS 178
Query: 760 IPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAA 799
LH A RG V L+ +GAD + ++ D +A
Sbjct: 179 SALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR 218
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 5e-04
Identities = 25/146 (17%), Positives = 49/146 (33%), Gaps = 2/146 (1%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDA 747
T L +A + + LV + G E + +T LH+A + +V++++ A
Sbjct: 5 TPLHIAV--VQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTA 62
Query: 748 GVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRE 807
G + H H+A + +C+ LL + A + + A A
Sbjct: 63 GASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTEC 122
Query: 808 NLEWLIVMLSHPDAAVEVRNHSGKTL 833
+++ D L
Sbjct: 123 QETVQLLLERGADIDAVDIKSGRSPL 148
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.004
Identities = 12/63 (19%), Positives = 21/63 (33%), Gaps = 10/63 (15%)
Query: 465 FQDNPNNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSA 524
+ LH G + VR L+ A + +N T L +A R
Sbjct: 174 MYSGSSALHSASGRGLLPLVRTLVRSGADSS----------LKNCHNDTPLMVARSRRVI 223
Query: 525 ELV 527
+++
Sbjct: 224 DIL 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 5e-16
Identities = 63/352 (17%), Positives = 114/352 (32%), Gaps = 81/352 (23%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKV--MIAEEMEPDWLSGQLDNLRRA 196
+ +K +G G A V A+ +VA+KK+ + +L ++
Sbjct: 20 QNLKPIGSG--AQGIVCAAY----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 197 SMWC----RNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIAR 252
+ NV T L + LVM+ ++ Q + L E++ +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLC 130
Query: 253 GVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCM 312
G+ LH+AG++ ++KPSN+++ + + D+GLA +S + +
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------------AGTSFMMTPY 178
Query: 313 DCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372
T Y APE +G D WS GC + EM I + G
Sbjct: 179 VVT---RYYRAPE------------VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 373 EEIYRAVVKNRKLP-------------------PQYASI----------------VGVGI 397
+ + V++ P P+YA +
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 398 PRELWKMIGECLQFKASKRPTFSAMLA----TFLRHLQELPRSPPASPDTGF 445
+ ++ + L +KR + L E+ PP D
Sbjct: 284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQL 335
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (176), Expect = 1e-14
Identities = 39/214 (18%), Positives = 72/214 (33%), Gaps = 12/214 (5%)
Query: 585 HVCAYHGQPDCMRELL----LAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRS 640
H+ H + E++ A N ++ ++ LH AV + A +L G
Sbjct: 7 HLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPE 66
Query: 641 MAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDH 700
+ + + ++ I C+ A +
Sbjct: 67 L---RDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGY 123
Query: 701 EVEGRELVRILLTAGAEPTAQDAQN-RTALHIASMANDVELVKIILDAGVDVNIRNVHNT 759
+V +L++ GA+ AQ+ N RTALH+A + +LV ++L G DVN
Sbjct: 124 ----LGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGY 179
Query: 760 IPLHVALARGAKSCVGLLLSAGADCNWQDDEGDN 793
P + R + L + E ++
Sbjct: 180 SPYQLTWGRPSTRIQQQLGQLTLENLQMLPESED 213
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.6 bits (150), Expect = 4e-11
Identities = 38/248 (15%), Positives = 67/248 (27%), Gaps = 52/248 (20%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQE---NVDVLDKDGDPPLVFALAAGSPECVHALIK 566
DG + LHLA L ++ + ++ + PL A+ PE AL+
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLG 60
Query: 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLA----GADPNAVDDEGESVLHRAVA 622
G + R G P + + A + G + LH A
Sbjct: 61 AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASI 120
Query: 623 KKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDI 682
Y +++ G + + T LHL V N
Sbjct: 121 HGYLGIVELLVSLGADVNAQEPCNGR-TALHLAVDLQNP--------------------- 158
Query: 683 PGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVK 742
+LV +LL GA+ Q + + + +
Sbjct: 159 -----------------------DLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQ 195
Query: 743 IILDAGVD 750
+ ++
Sbjct: 196 QLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 39/191 (20%), Positives = 71/191 (37%), Gaps = 8/191 (4%)
Query: 612 EGESVLHRAVAKKYTDCAIVILENGGCRSMAI--LNSKELTPLHLCVATWNVAVVKRWVE 669
+G+S LH A+ + + ++ + N+ + TPLHL V T + + +
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLG 60
Query: 670 VASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTAL 729
E+ + A + A + T L
Sbjct: 61 AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLH-----SILKATNYNGHTCL 115
Query: 730 HIASMANDVELVKIILDAGVDVNIRNVHN-TIPLHVALARGAKSCVGLLLSAGADCNWQD 788
H+AS+ + +V++++ G DVN + N LH+A+ V LLL GAD N
Sbjct: 116 HLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVT 175
Query: 789 DEGDNAFHIAA 799
+G + + +
Sbjct: 176 YQGYSPYQLTW 186
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 37/203 (18%), Positives = 61/203 (30%), Gaps = 45/203 (22%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAI- 530
LH + + + +++ + L QN QT LHLA E+ EA+
Sbjct: 6 LHLAIIHEEKALTMEVIR------QVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALL 59
Query: 531 -------------------------------------LEYSQENVDVLDKDGDPPLVFAL 553
+ + + +G L A
Sbjct: 60 GAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLAS 119
Query: 554 AAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEG 613
G V L+ GA+V ++ G + H+ PD + LL GAD N V +G
Sbjct: 120 IHGYLGIVELLVSLGADVNAQ-EPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 178
Query: 614 ESVLHRAVAKKYTDCAIVILENG 636
S + T + +
Sbjct: 179 YSPYQLTWGRPSTRIQQQLGQLT 201
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 16/75 (21%), Positives = 26/75 (34%), Gaps = 10/75 (13%)
Query: 472 LHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAIL 531
LH V + V LL A N G + L R S + + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVN----------RVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 532 EYSQENVDVLDKDGD 546
+ + EN+ +L + D
Sbjct: 199 QLTLENLQMLPESED 213
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
+G+TALHLA + +LV +L+ +V+ + G P S L +
Sbjct: 144 NGRTALHLAVDLQNPDLVSLLLKCGA-DVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTL 202
Query: 570 NVISRLRE 577
+ L E
Sbjct: 203 ENLQMLPE 210
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 67.5 bits (163), Expect = 6e-13
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 13/208 (6%)
Query: 593 PDCMRELLLAGADPNA-VDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTP 651
+ +LL GA+ NA +D GE+ LH A D A +L+ G + +
Sbjct: 2 AQVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLH 61
Query: 652 LHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRIL 711
+ V + + ++ L + +V L
Sbjct: 62 AAVAADAMGVFQILLRNRATNLNARMH------------DGTTPLILAARLAIEGMVEDL 109
Query: 712 LTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAK 771
+TA A+ A D +TALH A+ N+ E V I+L + + ++ + PL +A G+
Sbjct: 110 ITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSY 169
Query: 772 SCVGLLLSAGADCNWQDDEGDNAFHIAA 799
LL A+ D +A+
Sbjct: 170 EASKALLDNFANREITDHMDRLPRDVAS 197
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 63.3 bits (152), Expect = 2e-11
Identities = 49/260 (18%), Positives = 85/260 (32%), Gaps = 57/260 (21%)
Query: 484 VRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDK 543
+ DLL++ A N + + G+T+LHLA R A+ + +L+ + +
Sbjct: 5 ISDLLAQGAELNAT---------MDKTGETSLHLAARFARADAAKRLLDAGADANSQDNT 55
Query: 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG 603
P A V ++ R R G + + A + +L+ A
Sbjct: 56 GRTPLHAA--VAADAMGVFQILLRNRATNLNARMHDGTTPLILAARLAIEGMVEDLITAD 113
Query: 604 ADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAV 663
AD NA D+ G++ LH A A T+ V + + + K+ TPL L +
Sbjct: 114 ADINAADNSGKTALHWAAAVNNTEA--VNILLMHHANRDAQDDKDETPLFLAAREGSY-- 169
Query: 664 VKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDA 723
E + LL A D
Sbjct: 170 ------------------------------------------EASKALLDNFANREITDH 187
Query: 724 QNRTALHIASMANDVELVKI 743
+R +AS ++V++
Sbjct: 188 MDRLPRDVASERLHHDIVRL 207
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 62.5 bits (150), Expect = 3e-11
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 13/221 (5%)
Query: 557 SPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESV 616
+ + + L+ +GA + + + + G + H+ A + D + LL AGAD N+ D+ G +
Sbjct: 1 TAQVISDLLAQGAELNATMDK-TGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTP 59
Query: 617 LHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEI 676
LH AVA ++L N A ++ + V A
Sbjct: 60 LHAAVAADAMGVFQILLRNRATNLNARMHDGTTPLILAARLAIEGMVEDLITADAD---- 115
Query: 677 VNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMAN 736
+N D G TAL AAA+ V + AQD ++ T L +A+
Sbjct: 116 INAADNSG--KTALHWAAAVNNTEAVNILLMHHA------NRDAQDDKDETPLFLAAREG 167
Query: 737 DVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLL 777
E K +LD + I + + +P VA R V LL
Sbjct: 168 SYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.4 bits (163), Expect = 4e-12
Identities = 55/328 (16%), Positives = 101/328 (30%), Gaps = 63/328 (19%)
Query: 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHS---VAVKKVMIAEEMEPDWLS-------- 187
LV+KLG G + VW + + VA+K V +
Sbjct: 16 ILVRKLGWGHFS--TVW-------LAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 188 GQLDNLRRASMWCRNVCTF--HGVLRMDSCLGLVMDRCYGSV---QLAMQRNEGRLTLEQ 242
DN + SM ++ H + + + +VM L + + L
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 243 ILRYGADIARGVVELH-AAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPACRKARP 301
+ + + G+ +H G++ +IKP N+L++ + K
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-----------ENLIQIKIAD 175
Query: 302 ECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361
++ ++ + Y +PE +D WS C + E+
Sbjct: 176 LGNACWYDEHYTNSIQTREYRSPEVLLG------------APWGCGADIWSTACLIFELI 223
Query: 362 TGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421
TG + K+ Q ++G +P L + F S+
Sbjct: 224 TGDFLFEPDEGHSYT----KDDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRG----- 273
Query: 422 MLATFLRHLQELPRSPPASPDTGFTKFS 449
LR++ +L P T KFS
Sbjct: 274 ----LLRNISKLKFWPLEDVLTEKYKFS 297
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.4 bits (145), Expect = 5e-11
Identities = 22/139 (15%), Positives = 46/139 (33%), Gaps = 13/139 (9%)
Query: 509 ADGQTALHLACRRGSAELVEAILEYSQENVDVL--------DKDGDPPL---VFALAAGS 557
AD LH C + +L+ + VD+ + + L V ++ S
Sbjct: 1 ADTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTS 60
Query: 558 PECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVL 617
V L++ N+ + +G + + + A ++ GE+ L
Sbjct: 61 LHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLL--RGKASIEIANESGETPL 118
Query: 618 HRAVAKKYTDCAIVILENG 636
A K+ C ++ +
Sbjct: 119 DIAKRLKHEHCEELLTQAL 137
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 29/140 (20%), Positives = 55/140 (39%), Gaps = 4/140 (2%)
Query: 645 NSKELTPLHLCVATWNVAVVKR-WVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
+ +L L V T ++ + + + + E + + + P TAL +A +
Sbjct: 3 TAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLH 62
Query: 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLH 763
+V L+ Q + TALH + ++ E +K++L + I N PL
Sbjct: 63 ---IVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLD 119
Query: 764 VALARGAKSCVGLLLSAGAD 783
+A + C LL A +
Sbjct: 120 IAKRLKHEHCEELLTQALSG 139
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 23/135 (17%), Positives = 49/135 (36%), Gaps = 20/135 (14%)
Query: 688 TALCMAAALKKDHEVEGRELVRILLTAGAEPTAQ------DAQNRTALHIASMAND---V 738
+LC A K ++ + G + T + + TALH+A + D +
Sbjct: 8 HSLCEAV---KTRDIF---GLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61
Query: 739 ELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798
+V ++ +++ + + LH C+ LLL A ++ G+ IA
Sbjct: 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121
Query: 799 A-----DAAKMIREN 808
+++ +
Sbjct: 122 KRLKHEHCEELLTQA 136
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 18/146 (12%)
Query: 723 AQNRTALHIASMA---NDVELVKIILDAGVDVNIRNVHNTI------PLHV---ALARGA 770
A LH A D+ + GVD+ + LH+ ++ R +
Sbjct: 1 ADTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTS 60
Query: 771 KSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSG 830
V L+ + + Q +G A H + + +L A++E+ N SG
Sbjct: 61 LHIVDFLVQNSGNLDKQTGKGSTALHY------CCLTDNAECLKLLLRGKASIEIANESG 114
Query: 831 KTLRDFLEGLPREWISEDLMEALMNR 856
+T D + L E E L +AL R
Sbjct: 115 ETPLDIAKRLKHEHCEELLTQALSGR 140
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 25/147 (17%), Positives = 46/147 (31%), Gaps = 16/147 (10%)
Query: 617 LHRAVAKKYTDCAIVILENG----GCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVAS 672
L AV + + +G +A + + T LHL V + + +
Sbjct: 10 LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL-------- 61
Query: 673 PEEIVNVIDIPG--PVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALH 730
IV+ + + AL + E +++LL A + T L
Sbjct: 62 --HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLD 119
Query: 731 IASMANDVELVKIILDAGVDVNIRNVH 757
IA +++ A +VH
Sbjct: 120 IAKRLKHEHCEELLTQALSGRFNSHVH 146
|
| >d1iyma_ g.44.1.1 (A:) EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 4530]} Length = 55 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: EL5 RING-H2 domain species: Rice (Oryza sativa) [TaxId: 4530]
Score = 50.6 bits (121), Expect = 1e-08
Identities = 18/52 (34%), Positives = 25/52 (48%), Gaps = 4/52 (7%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVV 59
C+VC + E L +CGHGF EC+ + + +CP CR VV
Sbjct: 8 CAVCLAELEDGEEARFLPRCGHGFHAECVDMWLGSHS----TCPLCRLTVVV 55
|
| >d1ur6b_ g.44.1.1 (B:) Not-4 N-terminal RING finger domain {Human (Homo sapiens) [TaxId: 9606]} Length = 52 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Not-4 N-terminal RING finger domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (112), Expect = 1e-07
Identities = 11/48 (22%), Positives = 17/48 (35%), Gaps = 3/48 (6%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + CG+ C+ C R+ + CP CR
Sbjct: 3 CPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDE---NGLCPACRK 47
|
| >d1chca_ g.44.1.1 (A:) Immediate early protein, IEEHV {Equine herpesvirus 1 [TaxId: 10326]} Length = 68 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Immediate early protein, IEEHV species: Equine herpesvirus 1 [TaxId: 10326]
Score = 46.9 bits (111), Expect = 4e-07
Identities = 12/48 (25%), Positives = 19/48 (39%), Gaps = 7/48 (14%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C + L C H FC C++R + +CP C+
Sbjct: 8 CPICLEDPSNYSMA---LPCLHAFCYVCITRWIRQNP----TCPLCKV 48
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 9/69 (13%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALR 67
C +C E P+ +C H FCK C+ ++ CP C++ + +L+
Sbjct: 24 CPICLELIKE----PVSTKCDHIFCKFCMLKLL-NQKKGPSQCPLCKNDI----TKRSLQ 74
Query: 68 KNFAVLALI 76
++ L+
Sbjct: 75 ESTRFSQLV 83
|
| >d1bora_ g.44.1.1 (A:) Acute promyelocytic leukaemia proto-oncoprotein PML {Human (Homo sapiens) [TaxId: 9606]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Acute promyelocytic leukaemia proto-oncoprotein PML species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (105), Expect = 1e-06
Identities = 17/59 (28%), Positives = 20/59 (33%), Gaps = 11/59 (18%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
C CQ P LL C H C CL + CP C+ +G AL
Sbjct: 9 CQQCQAEAKC----PKLLPCLHTLCSGCLEAS-------GMQCPICQAPWPLGADTPAL 56
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} Length = 79 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 2e-06
Identities = 13/49 (26%), Positives = 19/49 (38%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C E ++ + CGH C CL+ + CP CR
Sbjct: 25 LCKICA----ENDKDVKIEPCGHLMCTSCLTSWQESEGQG---CPFCRC 66
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 2e-06
Identities = 17/164 (10%), Positives = 40/164 (24%), Gaps = 13/164 (7%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
A G + + LL + NA + G + L ++L
Sbjct: 6 ASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDLKDRT 65
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
+ + + + + E+ + + H
Sbjct: 66 GFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTAS- 124
Query: 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG 748
++ + TA +A + E+V ++ G
Sbjct: 125 ------------NVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 9/32 (28%), Positives = 15/32 (46%)
Query: 727 TALHIASMANDVELVKIILDAGVDVNIRNVHN 758
L A+ D+E + +L V+VN +N
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 23/153 (15%), Positives = 43/153 (28%), Gaps = 5/153 (3%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
L A RG E + ++L+ + NV+ + G L L++ +
Sbjct: 3 NELASAAARGDLEQLTSLLQNN-VNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDL 61
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVI 632
A + + E ++D ++ AK+ +
Sbjct: 62 KDRTGFAVIHDAARAGFLDTLQTLLE----FQADVNIEDNEGNLPLHLAAKEGHLRVVEF 117
Query: 633 LENGGCRSMAILNSKELTPLHLCVATWNVAVVK 665
L ++ N K T L VV
Sbjct: 118 LVKHTASNVGHRNHKGDTACDLARLYGRNEVVS 150
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 24/163 (14%), Positives = 46/163 (28%), Gaps = 16/163 (9%)
Query: 585 HVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAI 643
A G +R LL P+A++ G++ L + ++ +
Sbjct: 7 SGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTAIALELLKQGASPNVQDT 66
Query: 644 LNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703
+ + + VNV D G + L +
Sbjct: 67 ------SGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFL 120
Query: 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD 746
A ++ +DA+ T L +A +LV I+
Sbjct: 121 A---------AESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 6/155 (3%)
Query: 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGAN 570
L A RG + V +L + D L++ G L + + + L + +
Sbjct: 2 AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTAIALELLKQGASP 61
Query: 571 VISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAI 630
+ A + + E GAD N D G +H AV + +T
Sbjct: 62 NVQDTSGTSPVHDAARTGFLDTLKVLVE---HGADVNVPDGTGALPIHLAVQEGHTAVVS 118
Query: 631 VILENGGCRSMAILNSKELTPLHLCVATWNVAVVK 665
+ + +++ LTPL L + +V
Sbjct: 119 FLAAES---DLHRRDARGLTPLELALQRGAQDLVD 150
|
| >d1g25a_ g.44.1.1 (A:) TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9606]} Length = 65 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: TFIIH Mat1 subunit species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 1e-05
Identities = 14/54 (25%), Positives = 21/54 (38%), Gaps = 4/54 (7%)
Query: 3 MKVPCCSVCQ-TRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
M C C+ T+Y ++ CGH C+ C+ +F CP C
Sbjct: 1 MDDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGN---CPECGT 51
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 86 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.2 bits (99), Expect = 2e-05
Identities = 13/49 (26%), Positives = 20/49 (40%), Gaps = 7/49 (14%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
C +C+ + P+ C H FC+ C+ R CP CR+
Sbjct: 25 SCQICEHILAD----PVETSCKHLFCRICILRCLKVMGSY---CPSCRY 66
|
| >d1v87a_ g.44.1.1 (A:) Deltex protein 2 RING-H2 domain {Mouse (Mus musculus) [TaxId: 10090]} Length = 114 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Deltex protein 2 RING-H2 domain species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.1 bits (100), Expect = 2e-05
Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 1/57 (1%)
Query: 1 MKMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSAST-DTTLSCPRCRHV 56
+ + + ++ V L +C H F CL M+ D +L CP C+ +
Sbjct: 35 LAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTI 91
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 6e-05
Identities = 19/127 (14%), Positives = 37/127 (29%), Gaps = 6/127 (4%)
Query: 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVI 572
L + G +LV+ I+ E D + + A + V
Sbjct: 3 ALLLDSSLEGEFDLVQRIIY---EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVN 59
Query: 573 SRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGE---SVLHRAVAKKYTDCA 629
+ G + H A + L+ +GA A+ + + + YT C+
Sbjct: 60 VNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCS 119
Query: 630 IVILENG 636
+
Sbjct: 120 QFLYGVQ 126
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.3 bits (96), Expect = 3e-04
Identities = 22/160 (13%), Positives = 54/160 (33%), Gaps = 13/160 (8%)
Query: 140 LVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASM 198
+ K +GEG+ + V+ + VK + + +L + +
Sbjct: 4 IGKLMGEGKES--AVFNCYSEKFG-----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 199 WCRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQ----RNEGRLTLEQILRYGADIARGV 254
R+ L+ L + + + M+ + R+ +E I V
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 255 VELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294
+ + G+V ++ N+L+ G + D+ + + +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE 155
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 34/160 (21%), Positives = 54/160 (33%), Gaps = 14/160 (8%)
Query: 585 HVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAIL 644
A GQ D +R L+ GA D G S LH A + V+L G R
Sbjct: 7 LEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTK 65
Query: 645 NSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704
+ + N+ V + + AL E
Sbjct: 66 VDRTPLHMAASEGHANIVEVLLKHGADVNAKDM-------------LKMTALHWATEHNH 112
Query: 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKII 744
+E+V +L+ GA+ Q +TA I+ + +L +I+
Sbjct: 113 QEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 31/156 (19%), Positives = 49/156 (31%), Gaps = 6/156 (3%)
Query: 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGA 569
D L A R G + V ++ D LAA + A
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPF----TTDWLGTSPLHLAAQYGHFSTTEVLLRA 56
Query: 570 NVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCA 629
V R + H+ A G + + LL GAD NA D + LH A ++
Sbjct: 57 GVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHW--ATEHNHQE 114
Query: 630 IVILENGGCRSMAILNSKELTPLHLCVATWNVAVVK 665
+V L + + T + + N + +
Sbjct: 115 VVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAE 150
|
| >d1wima_ g.44.1.1 (A:) UbcM4-interacting protein 4 (KIAA0161) {Human (Homo sapiens) [TaxId: 9606]} Length = 94 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: UbcM4-interacting protein 4 (KIAA0161) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.1 bits (88), Expect = 7e-04
Identities = 14/51 (27%), Positives = 21/51 (41%), Gaps = 5/51 (9%)
Query: 8 CSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSA----STDTTLSCPRCR 54
C +C Y E++ + QC FC CL + +T +SCP
Sbjct: 8 CKLCLGEY-PVEQMTTIAQCQCIFCTLCLKQYVELLIKEGLETAISCPDAA 57
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 97 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 13/83 (15%)
Query: 7 CCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTAL 66
CS C E + C H FC C+S CP C + + L
Sbjct: 24 RCSRCTNILREPVCLG---GCEHIFCSNCVSDCIGT------GCPVCYTPA----WIQDL 70
Query: 67 RKNFAVLALILSANNTNQHHNSN 89
+ N + ++I + + N
Sbjct: 71 KINRQLDSMIQLCSKLRNLLHDN 93
|
| >d3dplr1 g.44.1.1 (R:19-106) RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex {Human (Homo sapiens) [TaxId: 9606]} Length = 88 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 11/54 (20%), Positives = 14/54 (25%), Gaps = 4/54 (7%)
Query: 1 MKMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCR 54
+ C Q +E C H F C+SR CP
Sbjct: 31 IMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKTRQ----VCPLDN 80
|
| >d1vyxa_ g.44.1.3 (A:) IE1B protein (ORF K3), N-terminal domain {Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]} Length = 60 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: Variant RING domain domain: IE1B protein (ORF K3), N-terminal domain species: Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]
Score = 36.4 bits (83), Expect = 0.002
Identities = 14/52 (26%), Positives = 19/52 (36%), Gaps = 3/52 (5%)
Query: 5 VPCCSVCQTRY-NEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRH 55
VP C +C NE+ R + CLS + S +T C C
Sbjct: 6 VPVCWICNEELGNERFRACGCTGELENVHRSCLSTWLTISRNTA--CQICGV 55
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1630 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 100.0 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 100.0 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 100.0 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 100.0 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 100.0 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 100.0 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 100.0 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 100.0 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.98 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.97 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.97 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.97 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.94 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.94 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.94 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.9 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.9 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.88 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.87 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.87 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.87 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.86 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.86 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.84 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.76 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.75 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.75 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.73 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.73 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.72 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.7 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.69 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.68 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 98.88 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 98.86 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 98.77 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 98.68 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 98.61 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 98.58 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 98.39 | |
| d1bora_ | 56 | Acute promyelocytic leukaemia proto-oncoprotein PM | 98.34 | |
| d1g25a_ | 65 | TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9 | 98.28 | |
| d1ur6b_ | 52 | Not-4 N-terminal RING finger domain {Human (Homo s | 98.24 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1v87a_ | 114 | Deltex protein 2 RING-H2 domain {Mouse (Mus muscul | 97.96 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 97.91 | |
| d1iyma_ | 55 | EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 45 | 97.83 | |
| d1chca_ | 68 | Immediate early protein, IEEHV {Equine herpesvirus | 97.79 | |
| d1wima_ | 94 | UbcM4-interacting protein 4 (KIAA0161) {Human (Hom | 97.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.16 | |
| d1vyxa_ | 60 | IE1B protein (ORF K3), N-terminal domain {Kaposi's | 97.14 | |
| d3dplr1 | 88 | RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase | 97.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.39 | |
| d1nppa2 | 58 | N-utilization substance G protein NusG, C-terminal | 87.8 | |
| d1nz9a_ | 58 | N-utilization substance G protein NusG, C-terminal | 86.61 | |
| d1nz9a_ | 58 | N-utilization substance G protein NusG, C-terminal | 82.78 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.76 Aligned_cols=255 Identities=18% Similarity=0.280 Sum_probs=222.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||+ |.++.+++.||+|.+........+.+.+|+.+|+.++ ||||++++++|.+.+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~------a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYT------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEE------EEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC--CTTBCCEEEEEEETTE
T ss_pred CCCEEEEEEECCCCCEEEE------EEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCE
T ss_conf 0538878981285829999------9998999899999984301727999999999998679--9988058577988999
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECCCC
Q ss_conf 99999358998388998707999999999999999999999994997332023554698789969994021003405753
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKPA 295 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~~~ 295 (1630)
+|+|||||+++++..+..+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 8999970379808988641-599999999999999999999998797226776888688789968642515641321366
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 45799888977743344444489887896433632112454556767789442010136699988409999989998999
Q 000343 296 CRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAEEI 375 (1630)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~~ei 375 (1630)
......+||+.|+|||++.+.. |+.++||||+||++|+|++|.+||.+.+..+.
T Consensus 171 --------------~~~~~~~gt~~Y~aPE~~~~~~------------~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 224 (293)
T d1yhwa1 171 --------------SKRSTMVGTPYWMAPEVVTRKA------------YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (293)
T ss_dssp --------------CCBCCCCSCGGGCCHHHHSSSC------------BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred --------------CCCCCCCCCCCCCCHHHHCCCC------------CCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf --------------6444444477736826644799------------88012031372999998048899899799999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC
Q ss_conf 999982278998854435789987799999984125958998822577885510
Q 000343 376 YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 376 ~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~ 429 (1630)
+..+.......... +..+++++++||.+||+.||.+|||+.|+|+|.+..
T Consensus 225 ~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 225 LYLIATNGTPELQN----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp HHHHHHHCSCCCSS----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred HHHHHHCCCCCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf 99998579998888----553799999999998669966890999996499657
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.37 Aligned_cols=360 Identities=26% Similarity=0.312 Sum_probs=314.2
Q ss_pred CCCCHHHCCCCHHHHHHHHCCCCCCCCCCCHHHHHHHCCCCCCHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf 73001110388065554210147899873033563300269982999999839999999999815988645789999999
Q 000343 470 NNLHQLVSEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPL 549 (1630)
Q Consensus 470 t~Lh~Av~~Gdl~~Vk~LL~~~a~~n~~~~i~~ll~~~d~~G~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpL 549 (1630)
|+||.||..|+++.|+.|++.|+++| ..|..|.||||+||..|+.+++++||+. |++++..+..|.|||
T Consensus 2 TpL~~Aa~~g~~~~v~~Ll~~g~~in----------~~d~~g~TpL~~A~~~g~~~iv~~Ll~~-gadi~~~~~~g~t~L 70 (408)
T d1n11a_ 2 TPLHVASFMGHLPIVKNLLQRGASPN----------VSNVKVETPLHMAARAGHTEVAKYLLQN-KAKVNAKAKDDQTPL 70 (408)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSC----------CSSSCCCCHHHHHHHHTCHHHHHHHHHH-TCCSSCCCTTSCCHH
T ss_pred CHHHHHHHCCCHHHHHHHHHCCCCCC----------CCCCCCCCHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCHH
T ss_conf 86999998848999999997878999----------8899998899999986889999999988-599887799989999
Q ss_pred HHHHHCCCHHHHHHHHHCCCCCCCC-------------------------------CCCCCCCHHHHHHHHCCCHHHHHH
Q ss_conf 8999829999999999879995433-------------------------------335999619999998299899999
Q 000343 550 VFALAAGSPECVHALIKRGANVISR-------------------------------LREGFGPSVAHVCAYHGQPDCMRE 598 (1630)
Q Consensus 550 h~Aa~~G~~eiVk~LL~~GAdin~~-------------------------------~~d~~G~T~Lh~Aa~~G~~eivk~ 598 (1630)
|+|+..|+.+++++|+..+++.... ..+..+.++|+.|+..++.++++.
T Consensus 71 ~~A~~~g~~~~~~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~v~~ 150 (408)
T d1n11a_ 71 HCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAEL 150 (408)
T ss_dssp HHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHH
T ss_pred HHHHHCCCHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHH
T ss_conf 99998699779999987410012321112202455543033222222221100100145646428999987598999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 99869999987898888000344318947999999809955320024799968889998099999999997059421102
Q 000343 599 LLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVN 678 (1630)
Q Consensus 599 LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~ 678 (1630)
|+++|++++..+.+|.+|||+|+..++.+++++|+.+|+ +++..+..|.||||++......++...++.........
T Consensus 151 ll~~~~~~~~~~~~~~~~L~~A~~~~~~~~~~~Ll~~g~--~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~- 227 (408)
T d1n11a_ 151 LLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGG--SPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAE- 227 (408)
T ss_dssp HHHTTCCTTCCCSSCCCHHHHHHHTTCHHHHHHHGGGTC--CSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC-
T ss_pred HHHCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCC--CCCCCCCCCCCCCHHHHCCCHHHHHHHHHHCCCCCCCC-
T ss_conf 997699888678767409999998599999999986588--40045778997102432021045555543200122124-
Q ss_pred CCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 35899997608999998405731024999999996299998210147600236651598999999998799954356899
Q 000343 679 VIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHN 758 (1630)
Q Consensus 679 ~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G 758 (1630)
.....++++.++.. +..++++.++..+.+.+..+..|.|||+.|+..++.+++++|+++|++++..+..+
T Consensus 228 ----~~~~~t~l~~a~~~------~~~~~~~~~~~~~~~~~~~~~~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~ 297 (408)
T d1n11a_ 228 ----SVQGVTPLHLAAQE------GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMG 297 (408)
T ss_dssp ----CTTCCCHHHHHHHT------TCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSC
T ss_pred ----CCCCCCHHHHHHHH------CCHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf ----77899999999980------86767544200221111124789973345430284899999997799656210234
Q ss_pred CCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 97889999849999999999699997767899992999999842378864999999950899763233789999999996
Q 000343 759 TIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLE 838 (1630)
Q Consensus 759 ~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~~gadin~kN~~GkTpL~lA~ 838 (1630)
.||||.|+..++.+++++|++.|+++|.+|.+|+||||+|++.++ . .++++|++.||++|++|++|+||+++|.
T Consensus 298 ~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~-----~-~iv~~Ll~~GAd~n~~d~~G~t~L~~A~ 371 (408)
T d1n11a_ 298 YTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH-----T-DIVTLLLKNGASPNEVSSDGTTPLAIAK 371 (408)
T ss_dssp CCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC-----H-HHHHHHHHTTCCSCCCCSSSCCHHHHHH
T ss_pred CCCCHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCHHHHHHHCCC-----H-HHHHHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf 453022100586213553013333223468999999999998688-----9-9999999878899887999989999999
Q ss_pred HCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 2999874799999999569988
Q 000343 839 GLPREWISEDLMEALMNRGVHL 860 (1630)
Q Consensus 839 ~~~~~~~~~~lve~Ll~~Ga~v 860 (1630)
+.+...+ .++++.|+..+++.
T Consensus 372 ~~~~~~i-v~~L~~~~~~~~~~ 392 (408)
T d1n11a_ 372 RLGYISV-TDVLKVVTDETSFV 392 (408)
T ss_dssp HTTCHHH-HHHHHHHCCCCSSC
T ss_pred HCCCHHH-HHHHHHHHHCCCCC
T ss_conf 8399999-99999987365645
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.33 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=221.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 57828998847678502999527981443668958999996315---768966899999999981159988221679999
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
.++|++++.||+|+||.||+ ++++.+++.||+|.+.+. .......+.+|+.+|+.+. ||||++++++|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~------~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQ 75 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEE------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEC
T ss_conf 47428988983176849999------9998999899999981565449799999999999998679--998877876403
Q ss_pred ECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEE
Q ss_conf 49979999935899838899870799999999999999999999999499733202355469878996999402100340
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+...+|+||||++|+.+..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CCCCCCCCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 56421110003579860555532567759999999999965211343159622464777847658998888205652003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
.... ......+||+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.+
T Consensus 156 ~~~~--------------~~~~~~~GT~~Y~aPE~~~~~~------------y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 156 ISDG--------------ATMKTFCGTPEYLAPEVLEDND------------YGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCTT--------------CCBCCCEECGGGCCGGGGSSSC------------BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCC--------------CCCCCCEECHHHHHHHHCCCCC------------CCHHHCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 5678--------------6205510088996666504898------------8833310223067889987899999969
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHH
Q ss_conf 89999999822789988544357899877999999841259589988-----2257788551
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPS-----a~eiL~~L~~ 428 (1630)
..+++..+.......+ ..+++++++||.+||+.||.+|++ +.++++|.+.
T Consensus 210 ~~~~~~~i~~~~~~~p-------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 210 HERLFELILMEEIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp HHHHHHHHHHCCCCCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HHHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCC
T ss_conf 9999999852899898-------668999999998666389344225652349999729150
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.13 Aligned_cols=250 Identities=18% Similarity=0.273 Sum_probs=219.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 78289988476785029995279814436689589999963157---689668999999999811599882216799994
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
++|++.+.||+|+||.||+ |.++.+++.||+|.+.+.. ......+.+|+.+++.++ ||||+++++++.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~ 77 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYL------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR--HPNILRLYGYFHD 77 (263)
T ss_dssp GGEEEEEEEEECSSEEEEE------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC--CTTBCCEEEEEEC
T ss_pred HHEEEEEEEECCCCCEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEE
T ss_conf 3769988985177858999------9998999499999981688567689999999999998568--8888859999998
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 99799999358998388998707999999999999999999999994997332023554698789969994021003405
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+.+|+|||||+++++..++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECC
T ss_conf 99989998504798589887504899999999999999999999998894652202344146689987115556335448
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
... .....||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+.
T Consensus 158 ~~~----------------~~~~~Gt~~Y~APE~~~~~~------------~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 158 SSR----------------RTTLCGTLDYLPPEMIEGRM------------HDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp CCC----------------CEETTEEGGGCCHHHHTTCC------------CCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CCC----------------CCCCCCCCCCCCHHHHCCCC------------CCCHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 885----------------23557887634999975899------------89314404675999998329999888999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999998227899885443578998779999998412595899882257788551
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
.+.+..+.+.....+ ..+++++.+||.+||+.||.+|||+.|+|+|.+.
T Consensus 210 ~~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 210 QETYKRISRVEFTFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp HHHHHHHHTTCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred HHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 999999971899998-------6689999999999764797689099999719070
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.17 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=219.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 578289988476785029995279814436689589999963157---68966899999999981159988221679999
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
.++|++.+.||+|+||.||+ |.++.+++.||||.+.+.. ......+.+|+++|+.++ ||||++++++|+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~------a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVL------ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--HPFFVKLYFTFQ 78 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEE------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC--STTBCCEEEEEE
T ss_pred CCCCEEEEEEEECCCEEEEE------EEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE
T ss_conf 98778988985087909999------9998999799999986577557778999999999998768--888617999999
Q ss_pred ECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEE
Q ss_conf 49979999935899838899870799999999999999999999999499733202355469878996999402100340
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+.+.+|+|||||+++.+..+....+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEEC
T ss_conf 89988999970489877776531599999999999999999997621650884767741236688853886032102422
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
.... ........+||+.|+|||++.+.. |+.++||||+||++|+|++|..||.+.+
T Consensus 159 ~~~~------------~~~~~~~~~GT~~Y~APE~~~~~~------------~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 159 SPES------------KQARANSFVGTAQYVSPELLTEKS------------ACKSSDLWALGCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp C----------------------CCCCGGGCCHHHHHTCC------------CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCC------------CCCCCCCCCCCCCCCCCEEECCCC------------CCCCCCEEHHHHHHHHHHHCCCCCCCCC
T ss_conf 5677------------643335556775525844002689------------8966623045699999803889989959
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHH
Q ss_conf 899999998227899885443578998779999998412595899882257788
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLAT 425 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~ 425 (1630)
..+++..+.......+ ..+++++++||.+||+.||.+|||+.|++.+
T Consensus 215 ~~~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 215 EYLIFQKIIKLEYDFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHHHHHTTCCCCC-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 9999999971899998-------5479999999999855797689197897377
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=383.88 Aligned_cols=257 Identities=19% Similarity=0.275 Sum_probs=221.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 45782899884767850299952798144366895899999631576896689999999998115998822167999949
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
..++|++.+.||+|+||.||+ |.++.+++.||+|++........+.+.+|+.+|+.++ |||||+++++|.+.
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~------~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HPTLVNLHDAFEDD 95 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEE------EEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC--CTTBCCEEEEEEET
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEEEC
T ss_conf 865758988984076819999------9988999899999984524316999999999998679--97999299999989
Q ss_pred CEEEEEEECCCCCHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC--CCCEEEEECCEEEE
Q ss_conf 9799999358998388998-70799999999999999999999999499733202355469878--99699940210034
Q 000343 214 SCLGLVMDRCYGSVQLAMQ-RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA--SGRAVVSDYGLAAI 290 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~-~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~--~g~vKL~DFGla~~ 290 (1630)
+.+|||||||+|+.|..++ ...+++++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEE
T ss_conf 99999998579988999997623789999999999999999999975697600015467364168898699954521044
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 05753457998889777433444444898878964336321124545567677894420101366999884099999899
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~ 370 (1630)
+.... ......||+.|||||++.+.. |+.++||||+||++|+|++|..||.+.
T Consensus 176 ~~~~~---------------~~~~~~gT~~Y~aPEv~~~~~------------~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 176 LDPKQ---------------SVKVTTGTAEFAAPEVAEGKP------------VGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp CCTTS---------------CEEEECSCTTTCCHHHHHTCC------------BCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCC---------------CCCEECCCCCCCCHHHHCCCC------------CCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 25654---------------320006862421889975899------------872676554659999998598998997
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9899999998227899885443578998779999998412595899882257788551
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 371 ~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
+..+.+..+.......+. .....+++++++||.+||+.||.+|||+.++|+|.+.
T Consensus 229 ~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 229 NDDETLRNVKSCDWNMDD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp SHHHHHHHHHHTCCCSCC---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred CHHHHHHHHHHCCCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 999999999847889894---2235899999999999756896679089998629132
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.58 Aligned_cols=261 Identities=20% Similarity=0.228 Sum_probs=221.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 57828998847678502999527981443668958999996315768966899999999981159988221679999499
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
.+.|++.++||+|+||.||+ |.++.++..||+|.+........+.+.+|+++|+.++ |||||++++++.+.+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYK------AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNIVKLLDAFYYEN 82 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEE------EEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC--CTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEEECCCCEEEE------EEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
T ss_conf 03759847993077819999------9999999399999987289999999999999998679--999884988980099
Q ss_pred EEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 7999993589983889987-079999999999999999999999949973320235546987899699940210034057
Q 000343 215 CLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|||||||+++++..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC
T ss_conf 58999962799818899986289999999999999999999999988988714070031487899989971612303577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 53457998889777433444444898878964336321124545567677894420101366999884099999899989
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~~ 373 (1630)
.. ......+||+.|+|||++..... ....|+.++|||||||++|+|++|.+||.+.+..
T Consensus 163 ~~--------------~~~~~~~Gt~~y~APE~l~~~~~-------~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 163 TI--------------QRRDSFIGTPYWMAPEVVMCETS-------KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp HH--------------HHHTCCCSCCTTCCHHHHTTCST-------TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred CC--------------CCCCCCCCCCCCCCHHHHHHCCC-------CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 86--------------41001025626479999832025-------7888880665787899999982088999998999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999998227899885443578998779999998412595899882257788551
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 374 ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
+.+..+......... .+..+++++.+||.+||+.||.+|||+.|+++|.+.
T Consensus 222 ~~~~~i~~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 222 RVLLKIAKSEPPTLA----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp GHHHHHHHSCCCCCS----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHHHHHHCCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 999999707998777----656699999999999766996689199999629231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=381.27 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=220.3
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 457828998847678502999527981443668958999996315768-9668999999999811599882216799994
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
+.+.|++.+.||+|+||.||+ |.++.+++.||+|.+.+.... ....+.+|+.+|+.++ ||||++++++|++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVIL------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK--HPNIVALDDIYES 78 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEE------EEETTTCCEEEEEEEEC----------CHHHHHHHTCC--CTTBCCEEEEEEC
T ss_pred CCCCEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEEE
T ss_conf 766669988994065839999------99999998999999815773128999999999998679--9899919899998
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC---CCCCEEEEECCEEE
Q ss_conf 997999993589983889987079999999999999999999999949973320235546987---89969994021003
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD---ASGRAVVSDYGLAA 289 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld---~~g~vKL~DFGla~ 289 (1630)
.+.+|||||||+|+.|..++...+.+++..++.++.||+.||.|||+++|+||||||+|||+. .++.+||+|||+|+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred CCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf 99888988526898488865303678878999999999999875241305568704630011046888249983154358
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 40575345799888977743344444489887896433632112454556767789442010136699988409999989
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~ 369 (1630)
...... .....+||+.|||||++.+.. |+.++||||+||++|+|++|.+||.+
T Consensus 159 ~~~~~~---------------~~~~~~GT~~y~APE~~~~~~------------~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 159 MEDPGS---------------VLSTACGTPGYVAPEVLAQKP------------YSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp -----------------------------CTTSCHHHHTTCC------------CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ECCCCC---------------EEEEEEECCCCCCCHHHCCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 725897---------------044003284225918873799------------98078734515999999859799999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 9989999999822789988544357899877999999841259589988225778855
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 370 ~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
.+..++...+.......+. .....+|+++.+||.+||+.||.+|||+.|+++|.+
T Consensus 212 ~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 212 ENDAKLFEQILKAEYEFDS---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp SSHHHHHHHHHTTCCCCCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred CCHHHHHHHHHCCCCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 8999999998616877787---666678999999999976089757918999862984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=380.80 Aligned_cols=256 Identities=17% Similarity=0.234 Sum_probs=220.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 45782899884767850299952798144366895899999631576896689999999998115998822167999949
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
+.++|++.+.||+|+||.||+ |.++.+++.||+|.+......+...+.+|+.+|+.+. |||||+++++|.+.
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~------a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHR------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH--HPKLINLHDAFEDK 98 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEE------EEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC--STTBCCEEEEEECS
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEEEC
T ss_conf 540359989993177829999------9998999799999988726467999999999998679--97989199999989
Q ss_pred CEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC--CCCCEEEEECCEEEE
Q ss_conf 97999993589983889987-079999999999999999999999949973320235546987--899699940210034
Q 000343 214 SCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD--ASGRAVVSDYGLAAI 290 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld--~~g~vKL~DFGla~~ 290 (1630)
..+|||||||+|+.|..+.. ...++++..++.|+.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|..
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEE
T ss_conf 99999998289980888898638998999999999999999999997792651314455311346788489952563034
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 05753457998889777433444444898878964336321124545567677894420101366999884099999899
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~ 370 (1630)
+.... ......||+.|+|||++.+.. |+.++||||+||++|+|++|.+||.+.
T Consensus 179 ~~~~~---------------~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 179 LNPDE---------------IVKVTTATAEFAAPEIVDREP------------VGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp CCTTS---------------CEEEECSSGGGCCHHHHTTCC------------BCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCCC---------------CEEECCCCCCCCCHHHHCCCC------------CCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 37887---------------201004764534899974799------------897633389899999999688998997
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 989999999822789988544357899877999999841259589988225778855
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 371 ~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
+..+.+..+......++. .....+++++.+||.+||+.||.+|||+.++|+|.+
T Consensus 232 ~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 232 DDLETLQNVKRCDWEFDE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp SHHHHHHHHHHCCCCCCS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CHHHHHHHHHHCCCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 999999999847889893---002479999999999975699668918999960973
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=372.14 Aligned_cols=249 Identities=21% Similarity=0.259 Sum_probs=219.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 78289988476785029995279814436689589999963157---689668999999999811599882216799994
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
++|+++++||+|+||.||+ |.++.+++.||||.+.+.. ......+.+|+.+|+.+. ||||++++++|.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~------a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVML------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--FPFLVKLEFSFKD 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEE------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC--CTTBCCEEEEEEC
T ss_pred CCEEEEEEEECCCCCEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCC
T ss_conf 3708988961176808999------9998999899999982677458899999999999999748--7727403444432
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 99799999358998388998707999999999999999999999994997332023554698789969994021003405
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+||||+.++.+..++.+.+.+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCCCCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECC
T ss_conf 22223222233466226667515898999999999999998999985998617679999360778978861010333225
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
.. .....||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+.
T Consensus 193 ~~-----------------~~~~~Gt~~Y~APE~~~~~~------------~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 193 GR-----------------TWTLCGTPEALAPEIILSKG------------YNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp SC-----------------BCCCEECGGGCCHHHHTTCC------------BCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC-----------------CCCCCCCCCCCCHHHHCCCC------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf 66-----------------64336763567889971799------------88533114500789999758899899599
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf 999999982278998854435789987799999984125958998-----82257788551
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RP-----Sa~eiL~~L~~ 428 (1630)
..++..+.......+ ..+++++.+||.+||+.||.+|+ |+.++++|.+.
T Consensus 244 ~~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 244 IQIYEKIVSGKVRFP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp HHHHHHHHHCCCCCC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCC
T ss_conf 999999861798897-------668999999999983409986065534549999719051
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.04 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=213.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 457828998847678502999527981443668958999996315768-9668999999999811599882216799994
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
+.++|++.++||+|+||.||+ |.++.+++.||+|.+...... ..+.+.+|+.+|+.++ ||||+++++++.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQL------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--HENVVKFYGHRRE 74 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEE------EEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC--CTTBCCEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCC--CCCEEEEEEEECC
T ss_conf 874608998972174809999------99999997999999845664127999999999998579--9888469654046
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 99799999358998388998707999999999999999999999994997332023554698789969994021003405
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+.+|||||||+++.|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred CCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEEC
T ss_conf 74367988645898089997537999999999999999999999997598357546899788789987983231422404
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
... ........+||+.|||||++.+..+ ++.++||||+||++|+|++|.+||...+.
T Consensus 155 ~~~------------~~~~~~~~~GT~~Y~APE~~~~~~~-----------~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 155 YNN------------RERLLNKMCGTLPYVAPELLKRREF-----------HAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ETT------------EECCBCCCCSCGGGSCTHHHHCSSB-----------CHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred CCC------------CCCCCCCEEECCCCCCHHHHCCCCC-----------CCCCEEEEHHHHHHHHHHHCCCCCCCCCH
T ss_conf 688------------6531113255747428728618999-----------99710161737999999829978888985
Q ss_pred HHH-HHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 999-9999822789988544357899877999999841259589988225778855
Q 000343 373 EEI-YRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei-~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
... +..+......... ...+++++.+||.+||+.||.+|||+.++++|.+
T Consensus 212 ~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 212 SCQEYSDWKEKKTYLNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp TSHHHHHHHTTCTTSTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHHHHCCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 99999998638887886-----4469999999999976799668909999961984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.64 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=217.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 78289988476785029995279814436689589999963157689---668999999999811599882216799994
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
..|+.+++||+|+||.||+ |+++.+++.||||.+....... ...+.+|+.+|+.++ |||||++++++.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~------a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYF------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR--HPNTIQYRGCYLR 86 (309)
T ss_dssp HHEEEEEEEEECSSSEEEE------EEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEE
T ss_conf 8567627970188809999------9998999399999984444358899999999999999778--9998238999998
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 99799999358998388998707999999999999999999999994997332023554698789969994021003405
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
...+|+|||||.++++..+......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC
T ss_conf 99889999806999457899737999999999999999999999986897666788421798799978984436533467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
. ....+||+.|||||++.+... ..|+.++|||||||++|||++|..||.+.+.
T Consensus 167 ~------------------~~~~~GT~~Y~APE~~~~~~~---------~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 167 P------------------ANSFVGTPYWMAPEVILAMDE---------GQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp S------------------BCCCCSCGGGCCHHHHTTTTS---------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred C------------------CCCCCCCCCCCCHHHHHCCCC---------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 7------------------873134766368899834678---------8867214545589999999878899999799
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999998227899885443578998779999998412595899882257788551
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
.+.+..+......... ...+|+++.+||.+||+.||.+|||+.++|+|.+.
T Consensus 220 ~~~~~~i~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp HHHHHHHHHSCCCCCS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHHHCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf 9999999828999888-----78889999999999773796579189999719975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.44 Aligned_cols=255 Identities=20% Similarity=0.345 Sum_probs=208.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC-HHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 578289988476785029995279814436689589999963157689-6689999999998115998822167999949
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~-~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
.++|++.++||+|+||.||+ |+++.++..||+|.++...... ...+.+|+.+|+.++ |||||+++++|.+.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSD 76 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEE------EEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC--CTTBCCEEEEEECS
T ss_pred CCCCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEEEC
T ss_conf 56888978971277809999------99989996999999875409789999999999998679--99999499999989
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 97999993589983889987079999999999999999999999949-97332023554698789969994021003405
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAA-GVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~-gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+|+||||++++++..++.+.+.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 99999997679986899874249999999999999999999999985999714457799468789989995487762567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
.. .....+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+.
T Consensus 157 ~~----------------~~~~~~GT~~Y~APEvl~~~~------------y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 157 DS----------------MANSFVGTRSYMSPERLQGTH------------YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HH----------------TC---CCSSCCCCHHHHHCSC------------CCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CC----------------CCCCCCCCCCCCCCHHHCCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 88----------------621113771411946875899------------89488899899999999988899899887
Q ss_pred HHHHHHH---HHCC-------------------------------------CCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 9999999---8227-------------------------------------89988544357899877999999841259
Q 000343 373 EEIYRAV---VKNR-------------------------------------KLPPQYASIVGVGIPRELWKMIGECLQFK 412 (1630)
Q Consensus 373 ~ei~~~I---~~~~-------------------------------------~~~~~~~~~~~~~~s~el~~LI~~cL~~d 412 (1630)
.+..... ..+. ..++. .....++.++.+||.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~d 285 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKN 285 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCC---CCBTTBCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC---CCCCCCCHHHHHHHHHHCCCC
T ss_conf 89999998875177545774212333221111222354134778876650268766---764448999999999986899
Q ss_pred CCCCCCHHHHHHHHHH
Q ss_conf 5899882257788551
Q 000343 413 ASKRPTFSAMLATFLR 428 (1630)
Q Consensus 413 P~~RPSa~eiL~~L~~ 428 (1630)
|.+|||+.|+|+|.+.
T Consensus 286 P~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 286 PAERADLKQLMVHAFI 301 (322)
T ss_dssp TTTSCCHHHHHTSHHH
T ss_pred HHHCCCHHHHHHCHHH
T ss_conf 4679089999609864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=374.63 Aligned_cols=250 Identities=18% Similarity=0.265 Sum_probs=221.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 57828998847678502999527981443668958999996315---768966899999999981159988221679999
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA---EEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~---~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
.++|++.+.||+|+||.||+ |+++.+++.||+|.+++. .....+.+.+|+.+|+.++ ||||+++++++.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~------a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~ 74 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--HPFIIRMWGTFQ 74 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEE------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--BTTBCCEEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCHHHEEEEEE
T ss_conf 54708888972076808999------9998999799999984577548899999999999998636--967533035685
Q ss_pred ECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEE
Q ss_conf 49979999935899838899870799999999999999999999999499733202355469878996999402100340
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+...+|+|||||.|+++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred ECCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEE
T ss_conf 28800567650378632234322221110079999999987655412476770556810503868998898317521671
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
... ....+||+.|||||++.+.. |+.++||||+||++|+|++|..||.+.+
T Consensus 155 ~~~-----------------~~~~~Gt~~Y~APE~l~~~~------------y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 155 PDV-----------------TYTLCGTPDYIAPEVVSTKP------------YNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp SSC-----------------BCCCCSCTTTCCHHHHTTCC------------BCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCC-----------------CCCCCCCCCCCCHHHHCCCC------------CCCHHHCCCCCHHHHHHHHCCCCCCCCC
T ss_conf 245-----------------64345763435999983899------------9804304653336899975989999969
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHH
Q ss_conf 8999999982278998854435789987799999984125958998-----82257788551
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-----TFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RP-----Sa~eiL~~L~~ 428 (1630)
..+++..+..+....+ ..+++++.++|.+||..||.+|+ |+.++++|.+.
T Consensus 206 ~~~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 206 TMKTYEKILNAELRFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp HHHHHHHHHHCCCCCC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCC
T ss_conf 9999999970898899-------778999999999995449976664310219999819351
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.86 Aligned_cols=258 Identities=21% Similarity=0.220 Sum_probs=221.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC------CHHHHHHHHHHHHHHCCCCCCCCEE
Q ss_conf 3457828998847678502999527981443668958999996315768------9668999999999811599882216
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM------EPDWLSGQLDNLRRASMWCRNVCTF 206 (1630)
Q Consensus 133 ~~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~------~~~~~~~Ei~iL~~l~l~HpNIV~L 206 (1630)
.+.++|++.++||+|+||.||+ |+++.+++.||+|.+.+.... ..+.+.+|+.+|+.++ |||||++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~------~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~ 78 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ--HPNVITL 78 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEE------EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC--CTTBCCE
T ss_pred CCCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCE
T ss_conf 8556779827981178959999------9999999899999987566321340689999999999998679--9899938
Q ss_pred EEEEEECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC----CEEE
Q ss_conf 799994997999993589983889987079999999999999999999999949973320235546987899----6999
Q 000343 207 HGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG----RAVV 282 (1630)
Q Consensus 207 ~~~~~~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g----~vKL 282 (1630)
+++|++...+|||||||++++|..++...+.+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEEECCEEEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEE
T ss_conf 89999799899999867786431001035642155789999999999876662542211333012798258986664696
Q ss_pred EECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 40210034057534579988897774334444448988789643363211245455676778944201013669998840
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt 362 (1630)
+|||+|....... ......||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus 159 ~DfG~a~~~~~~~---------------~~~~~~~t~~y~APE~~~~~~------------~~~~~DiwSlGvilyell~ 211 (293)
T d1jksa_ 159 IDFGLAHKIDFGN---------------EFKNIFGTPEFVAPEIVNYEP------------LGLEADMWSIGVITYILLS 211 (293)
T ss_dssp CCCTTCEECTTSC---------------BCSCCCCCGGGCCHHHHTTCC------------BCTHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHCCCCC---------------CCCCCCCCCCCCCHHHHCCCC------------CCCCCCCHHHHHHHHHHHC
T ss_conf 4334421057776---------------312247777430999981899------------9976652214099999970
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 999998999899999998227899885443578998779999998412595899882257788551
Q 000343 363 GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 363 G~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
|..||.+.+..+.+..+.......+ ......+|+++++||.+||+.||.+|||+.++++|.+.
T Consensus 212 g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 212 GASPFLGDTKQETLANVSAVNYEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp SSCSSCCSSHHHHHHHHHTTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCCC---CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 8899889999999999981688887---01047889999999999863896689199999619041
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=371.06 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=208.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHC-CCCCCCCEEEEEE
Q ss_conf 578289988476785029995279814436689589999963157---689668999999999811-5998822167999
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRAS-MWCRNVCTFHGVL 210 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~-l~HpNIV~L~~~~ 210 (1630)
.++|++.+.||+|+||.||+ |.++.+++.||+|.+.+.. ......+.+|..++..++ ++|||||+++++|
T Consensus 3 lddy~i~~~lG~G~fg~Vy~------~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp STTEEEEEEEEECSSCEEEE------EEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 77685101884288909999------999999979999998458754266799999999999998508998588999999
Q ss_pred EECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf 94997999993589983889987079999999999999999999999949973320235546987899699940210034
Q 000343 211 RMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
.+.+.+|+|||||+++.|..++.+...+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EECCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 98998899999148983899987325532789999999999999999977962204442216785889679822010233
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 05753457998889777433444444898878964336321124545567677894420101366999884099999899
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGL 370 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~ 370 (1630)
+.... ....+||+.|+|||++..... |+.++|||||||++|||++|..||.+.
T Consensus 157 ~~~~~----------------~~~~~GT~~y~APE~~~~~~~-----------~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 157 FSKKK----------------PHASVGTHGYMAPEVLQKGVA-----------YDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CSSSC----------------CCSCCSCGGGCCHHHHSTTCC-----------CCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCCC----------------CCCCCCCCCCCHHHHHHCCCC-----------CCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 37886----------------433113455421687603899-----------984410467789999998599988889
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHH
Q ss_conf 989999999822789988544357899877999999841259589988-----2257788551
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFLR 428 (1630)
Q Consensus 371 ~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPS-----a~eiL~~L~~ 428 (1630)
+..+...........+.. .+..+++++.+||.+||+.||.+||| +.++++|.+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 210 KTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp CSSCHHHHHHHSSSCCCC----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred CHHHHHHHHHHCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCC
T ss_conf 989999999860468887----88778999999999985669888088743579999749102
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=367.79 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=217.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 78289988476785029995279814436689589999963157---689668999999999811599882216799994
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE---EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~---~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
++|++.++||+|+||.||+ |.++.+++.||+|.+++.. ......+.+|..++... ++||||+++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~------~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFL------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEE------EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-TTCTTBCCEEEEEEC
T ss_pred CCEEEEEEEECCCCCEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHH-CCCCCEEEEEEEECC
T ss_conf 9718865894087828999------999999989999998055533848999999999999984-799968789889704
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 99799999358998388998707999999999999999999999994997332023554698789969994021003405
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
.+.+||||||++++++..++.....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCEEEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 98316777503798089986404789999999999999999999986893403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
... .......||+.|+|||++.+.. |+.++||||+||++|+|++|..||.+.+.
T Consensus 155 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 155 LGD--------------AKTNTFCGTPDYIAPEILLGQK------------YNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp CTT--------------CCBCCCCSCGGGCCHHHHTTCC------------BCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCC--------------CCCCCCCCCCCCCCHHHHCCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 665--------------3345457877768999982799------------88323201122789898738899999899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Q ss_conf 999999982278998854435789987799999984125958998822-57788551
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFS-AMLATFLR 428 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~-eiL~~L~~ 428 (1630)
.+++..+..+.+..+ ..+|+++.+||.+||..||.+||++. ++++|.+.
T Consensus 209 ~~~~~~i~~~~~~~p-------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 209 EELFHSIRMDNPFYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp HHHHHHHHHCCCCCC-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHH
T ss_conf 999999971899897-------56799999999996544898783889999809013
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.82 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=213.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 578289988476785029995279814436689589999963157689--668999999999811599882216799994
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
.++|++.+.||+|+||.||+ +.++.+++.||+|.+......+ .+.+.+|+++|+.++ ||||+++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~ 74 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--HPNIVRYYDRIID 74 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEE------EEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC--CTTBCCEEEEEEC
T ss_pred CHHCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEE
T ss_conf 33379967983088919999------999999979999998746579799999999999999778--9998248999991
Q ss_pred --CCEEEEEEECCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEE
Q ss_conf --997999993589983889987----0799999999999999999999999499-----73320235546987899699
Q 000343 213 --DSCLGLVMDRCYGSVQLAMQR----NEGRLTLEQILRYGADIARGVVELHAAG-----VVCMNIKPSNLLLDASGRAV 281 (1630)
Q Consensus 213 --~~~~~LVmEy~~gsll~~l~~----~~~~L~~~~~~~Ia~QIl~aL~yLHs~g-----IIHrDLKP~NILld~~g~vK 281 (1630)
...+|+|||||++++|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEE
T ss_conf 78998999995689993899998515457899999999999999999999997167788788586765425747888579
Q ss_pred EEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 94021003405753457998889777433444444898878964336321124545567677894420101366999884
Q 000343 282 VSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMC 361 (1630)
Q Consensus 282 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ell 361 (1630)
|+|||+|+.+.... ......+||+.|+|||++.+.. |+.++|||||||++|||+
T Consensus 155 l~DFG~a~~~~~~~--------------~~~~~~~gt~~Y~APE~l~~~~------------~~~~~DIwSlGvilyel~ 208 (269)
T d2java1 155 LGDFGLARILNHDT--------------SFAKAFVGTPYYMSPEQMNRMS------------YNEKSDIWSLGCLLYELC 208 (269)
T ss_dssp ECCHHHHHHC-------------------------CCCSCCCHHHHTTCC------------CCHHHHHHHHHHHHHHHH
T ss_pred EEECCCEEECCCCC--------------CCCCCCCCCCCCCCHHHHCCCC------------CCHHHHHHHHCHHHHHHH
T ss_conf 80010003224577--------------7556677882327999983999------------993898875278999980
Q ss_pred HCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 099999899989999999822789988544357899877999999841259589988225778855
Q 000343 362 TGSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 362 tG~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
+|.+||.+.+..+++..+..+.... .+..+|+++.+||.+||+.||.+|||+.|+++|.+
T Consensus 209 tg~~Pf~~~~~~~~~~~i~~~~~~~------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 209 ALMPPFTAFSQKELAGKIREGKFRR------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HCCCCCCCCCHHHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf 1889989989999999997189988------97435999999999976799557918999972981
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=366.56 Aligned_cols=249 Identities=19% Similarity=0.330 Sum_probs=204.7
Q ss_pred CE-EEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-
Q ss_conf 82-8998847678502999527981443668958999996315768--9668999999999811599882216799994-
Q 000343 137 DV-KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 137 ~Y-~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~- 212 (1630)
+| ++.++||+|+||.|| +|.++.++..||+|.+...... ..+.+.+|+++|+.++ |||||+++++|.+
T Consensus 9 ry~~~~~~iG~G~fg~Vy------~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVY------KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ--HPNIVRFYDSWEST 80 (270)
T ss_dssp CEEEEEEEEEECSSEEEE------EEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEEEE
T ss_pred CEEEEEEEEECCCCCEEE------EEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEEC
T ss_conf 778851697008284999------9999999959999998512279899999999999998579--99850699998403
Q ss_pred ---CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEC-CCCCEEEEECC
Q ss_conf ---9979999935899838899870799999999999999999999999499--73320235546987-89969994021
Q 000343 213 ---DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAG--VVCMNIKPSNLLLD-ASGRAVVSDYG 286 (1630)
Q Consensus 213 ---~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~g--IIHrDLKP~NILld-~~g~vKL~DFG 286 (1630)
...+|+||||+++++|..++.+...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCCCCEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECC
T ss_conf 34588899999578989489997513554699999999999999999997899799687674351166799988980057
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 00340575345799888977743344444489887896433632112454556767789442010136699988409999
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~P 366 (1630)
+|+..... .....+||+.|||||++.+ . ++.++|||||||++|||++|..|
T Consensus 161 la~~~~~~----------------~~~~~~GT~~Y~aPE~~~~-~------------~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 161 LATLKRAS----------------FAKAVIGTPEFMAPEMYEE-K------------YDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp GGGGCCTT----------------SBEESCSSCCCCCGGGGGT-C------------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCEECCCC----------------CCCCCCCCCCCCCHHHHCC-C------------CCCCCCHHHHHHHHHHHHHCCCC
T ss_conf 65423687----------------6677553813008988478-9------------99867110079999999878899
Q ss_pred CCCCCH-HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 989998-9999999822789988544357899877999999841259589988225778855
Q 000343 367 WAGLSA-EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 367 F~~~~~-~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
|.+... ..++..+..+. .++.+ +...++++.+||.+||+.||.+|||+.|+++|.+
T Consensus 212 f~~~~~~~~~~~~i~~~~-~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 212 YSECQNAAQIYRRVTSGV-KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp TTTCSSHHHHHHHHTTTC-CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCCHHHHHHHHHCCC-CCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 987655999999997389-98656----7557899999999976379758929999967754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=369.66 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=212.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCC-CCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 7828998847678502999527981443-6689589999963157-6896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQ-GRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~-~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|++.++||+|+||.||. ..++... ......||+|.+.... ......+.+|+.+|..+. +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~--a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMN--ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-SHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEE--EEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred HHEEEEEEEEECCCEEEEE--EEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEEC
T ss_conf 9939701983078819999--9985788554204999999663358789999999999999715-899686877888629
Q ss_pred CEEEEEEECCCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9799999358998388998707-----------------------99999999999999999999999499733202355
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE-----------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPS 270 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~-----------------------~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~ 270 (1630)
+.+|+|||||+++.+..++... ..+++..++.|+.||+.||+|||+++|+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHH
T ss_conf 95899997279995999998625777510221000012220012577899999999999999999997399050527032
Q ss_pred CEEECCCCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 46987899699940210034057534579988897774334444448988789643363211245455676778944201
Q 000343 271 NLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDA 350 (1630)
Q Consensus 271 NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDV 350 (1630)
|||++.++.+||+|||+|+...... .........||+.|||||++.+.. ++.++||
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~~------------~~~~~Di 249 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDS------------NYVVRGNARLPVKWMAPESLFEGI------------YTIKSDV 249 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCT------------TSEEETTEEECGGGCCHHHHHHCC------------CCHHHHH
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCC------------CEEEECCCCCCCCCCCHHHHCCCC------------CCCCEEC
T ss_conf 1443459828985142222045778------------615623435787657838872799------------9963303
Q ss_pred HHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 013669998840-999998999899999998227899885443578998779999998412595899882257788551
Q 000343 351 WSFGCTLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 351 WSlGviL~Ellt-G~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
|||||++|||++ |.+||.+.+..+.+..+......++. +..+|+++.+||.+||+.||.+|||+.+++++|..
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 000399999983899999998989999999856998998-----87678999999999758896689399999999748
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-45 Score=364.00 Aligned_cols=263 Identities=19% Similarity=0.203 Sum_probs=222.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC---------HHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 4578289988476785029995279814436689589999963157689---------6689999999998115998822
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---------PDWLSGQLDNLRRASMWCRNVC 204 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~---------~~~~~~Ei~iL~~l~l~HpNIV 204 (1630)
|.++|++.+.||+|+||.||+ ++++.+++.||||++.+..... .+.+.+|+.+++.++ .||||+
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~------~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv 73 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRR------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-GHPNII 73 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEE------EEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-TCTTBC
T ss_pred CCCCCEECEEEECCCCEEEEE------EEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHC-CCCCEE
T ss_conf 966388852884176849999------9999999899999996244641147888999999999999999850-799747
Q ss_pred EEEEEEEECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEE
Q ss_conf 16799994997999993589983889987079999999999999999999999949973320235546987899699940
Q 000343 205 TFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSD 284 (1630)
Q Consensus 205 ~L~~~~~~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~D 284 (1630)
+++++|.+.+.+||||||+++++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECC
T ss_conf 99762146760599997689866899998659999999999999999999999875994323462548986899838712
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 21003405753457998889777433444444898878964336321124545567677894420101366999884099
Q 000343 285 YGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS 364 (1630)
Q Consensus 285 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~ 364 (1630)
||+|+.+.... ......||+.|+|||++.+.... ....++.++||||+||++|+|++|.
T Consensus 154 FG~a~~~~~~~---------------~~~~~~gt~~y~~PE~~~~~~~~------~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 154 FGFSCQLDPGE---------------KLREVCGTPSYLAPEIIECSMND------NHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CTTCEECCTTC---------------CBCCCCSCGGGCCHHHHHHHHCT------TSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHEEECCCCC---------------CEEEEECCCCCCCHHHHHCCCCC------CCCCCCCHHEECCCCHHHHHHCCCC
T ss_conf 40316726887---------------21345246788898886053445------6788992331856560231032288
Q ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 999899989999999822789988544357899877999999841259589988225778855
Q 000343 365 IPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 365 ~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
.||.+.+..+....+..+....+. .....+|+++++||.+||+.||.+|||+.++++|.+
T Consensus 213 ~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 213 PPFWHRKQMLMLRMIMSGNYQFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 898899999999999818988898---543468999999999976589668919999973978
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=365.40 Aligned_cols=255 Identities=18% Similarity=0.226 Sum_probs=218.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 57828998847678502999527981443668958999996315768966899999999981159988221679999499
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
-++|++.++||+|+||.||+ |.++.+++.||+|.++... .+...+.+|+++|+.++ ||||++++++|++..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~------~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~--HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHR------CVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR--HRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEE------EEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSC--CTTBCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
T ss_conf 01058878983177839999------9998999699999975786-65999999999998579--979890989998899
Q ss_pred EEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEEEECCEEEEE
Q ss_conf 799999358998388998707-999999999999999999999994997332023554698789--96999402100340
Q 000343 215 CLGLVMDRCYGSVQLAMQRNE-GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS--GRAVVSDYGLAAIL 291 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~~~-~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~--g~vKL~DFGla~~~ 291 (1630)
.+|||||||+|+.|..++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 88999953899808899875389999999999999999999999876997513554443443788518997644111003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
.... ......+|+.|+|||.+.+.. |+.++||||+||++|+|++|.+||.+.+
T Consensus 155 ~~~~---------------~~~~~~~t~~y~ape~~~~~~------------~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 155 KPGD---------------NFRLLFTAPEYYAPEVHQHDV------------VSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CTTC---------------EEEEEESCGGGSCHHHHTTCE------------ECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCC---------------CCCCCCCCCCCCCCHHCCCCC------------CCCHHHCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 4677---------------532122332223402104877------------7840113027999999982899999989
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 899999998227899885443578998779999998412595899882257788551
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
..+.+..|.......+. .....+++++++||.+||..||.+|||+.++++|.+.
T Consensus 208 ~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 208 NQQIIENIMNAEYTFDE---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHHHHHHHTCCCCCH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHCCCCCCH---HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 99999999838999880---2236789999999999866996689099999639965
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=368.31 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=216.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCC---CEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 78289988476785029995279814436689---58999996315768-966899999999981159988221679999
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCR---HSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g---~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
++|++.+.||+|+||.||. |.++.++ ..||+|.+...... ....+.+|+.+|+.++ |||||++++++.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~------~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCS------GHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD--HPNVIHLEGVVT 97 (299)
T ss_dssp GGEEEEEEEEECSSSEEEE------EEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEEC
T ss_pred HHCEEEEEEEECCCEEEEE------EEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEE
T ss_conf 0427856980278829999------99957997889999999784459899999999999998579--988861899996
Q ss_pred ECCEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf 49979999935899838899870-79999999999999999999999949973320235546987899699940210034
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~-~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+.+.+|+|||||+++++..+... .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred ECCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
T ss_conf 28877999972279853002104567999999999999999988988527983576150448988999199888443157
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCC
Q ss_conf 057534579988897774334444448988789643363211245455676778944201013669998840-9999989
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~ 369 (1630)
+....... .........||+.|||||++.+.. ++.++|||||||++|||+| |.+||.+
T Consensus 178 ~~~~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~------------~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 178 LEDDTSDP---------TYTSALGGKIPIRWTAPEAIQYRK------------FTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------CGGGSCHHHHHSCC------------CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCCCCC---------EEEECCCCCCCCCCCCHHHHHCCC------------CCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 56777765---------365025666883003878883699------------786121445357899998679999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 998999999982278998854435789987799999984125958998822577885510257
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 370 ~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~ 432 (1630)
.+..+++..+..+...+. +..+|+++.+||.+||+.||.+|||+.++++.|...++.
T Consensus 237 ~~~~~~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 237 MTNQDVINAIEQDYRLPP------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCHHHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHHCCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 999999999973788999------742269999999997587976892999999999998418
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=369.27 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=212.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 782899884767850299952798144366895899999631576--896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|++.++||+|+||.||. |. .+..||||.++.... .....+.+|+.+|..++ |||||++++++. .
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~------~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~-~ 75 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYK------GK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR--HVNILLFMGYST-A 75 (276)
T ss_dssp TCCCCCSEEEECSSCEEEE------EE---SSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEC-S
T ss_pred CCEEEEEEEEECCCCEEEE------EE---ECCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE-C
T ss_conf 5189988983078858999------99---9998999999734699899999999999998479--987864567971-5
Q ss_pred CEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 97999993589983889987-07999999999999999999999994997332023554698789969994021003405
Q 000343 214 SCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+|+|||||+++.|..++. ...++++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 58999996589988899985235789999999999999999888750999516147899798189978875002213335
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
... .........||+.|||||++.+... ..|+.++|||||||++|||++|..||.+.+.
T Consensus 156 ~~~------------~~~~~~~~~gt~~y~APE~l~~~~~---------~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 156 RWS------------GSHQFEQLSGSILWMAPEVIRMQDK---------NPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ----------------------CCCCGGGCCHHHHTTCSS---------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCC------------CCCCCCCCCCCCCCCCHHHHHCCCC---------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 567------------7631256655743179999950568---------9999531516359999999978899899896
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 999999982278998854435789987799999984125958998822577885510257899
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~l~~ 435 (1630)
...+..+.......+.. ...+..+|+++.+||.+||+.||.+|||+.+++++|....+.+|+
T Consensus 215 ~~~~~~~~~~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp HHHHHHHHHHTSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHCCCCCCCC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf 99999999658889860-003655549999999997588976892999999999999970989
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=366.08 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=212.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||. |.++.++..||||+++.. ....+.+.+|+.+|+.++ |||||++++++.+.+.
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~------a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYE------GVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK--HPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGEEEEEETTTTTTSSEEE------EEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEE------EEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCC--CCCEECCCCCEEECCE
T ss_conf 9939865982088808999------999999969999997776-103999999999998679--9988267752745785
Q ss_pred EEEEEECCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 9999935899838899870--79999999999999999999999949973320235546987899699940210034057
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~~--~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+|+|||||+++++..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 47876314676067775303554157999999999999978889878930576045768998999289832445465378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCH
Q ss_conf 53457998889777433444444898878964336321124545567677894420101366999884099-99989998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGS-IPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~-~PF~~~~~ 372 (1630)
.. ........|++.|+|||++.+.. |+.++|||||||++|||+++. +||.+.+.
T Consensus 168 ~~-------------~~~~~~~~g~~~y~aPE~~~~~~------------~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 168 DT-------------YTAHAGAKFPIKWTAPESLAYNK------------FSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp SS-------------SEEETTEEECGGGCCHHHHHHCC------------CSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CC-------------CEEECCCCCCCCCCCHHHHCCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 87-------------22103556654666927872799------------981043021789999998679988774259
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 99999998227899885443578998779999998412595899882257788551025
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
..++..+..+... + .+..+|+++.+||.+||+.||.+|||+.++++.|...++
T Consensus 223 ~~~~~~i~~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 223 SQVYELLEKDYRM-E-----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHTTCCC-C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHCCCCC-C-----CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999998558888-8-----874330999999999757797689399999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=365.48 Aligned_cols=257 Identities=23% Similarity=0.275 Sum_probs=213.3
Q ss_pred EEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 89988476785029995279814436689589999963157689-----6689999999998115998822167999949
Q 000343 139 KLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME-----PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 139 ~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~-----~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
+.++.||+|+||.||+ |.++.+++.||||+++...... ...+.+|+.+|+.++ |||||+++++|.+.
T Consensus 1 E~l~~lG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYK------ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPNIIGLLDAFGHK 72 (299)
T ss_dssp CEEEEEEEETTEEEEE------EECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC--CTTBCCEEEEECCT
T ss_pred CCCEEECCCCCEEEEE------EEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCC--CCCEEEEEEEECCC
T ss_conf 9563851272829999------999999969999998420212456799999999999998679--99986898542258
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 97999993589983889987079999999999999999999999949973320235546987899699940210034057
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+.+|+||||+.++++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred CCEEEHHHHHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCC
T ss_conf 74022045534507765541266778999999999999999886316355035776258853778411465761000578
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 53457998889777433444444898878964336321124545567677894420101366999884099999899989
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~~ 373 (1630)
.. ......+||+.|+|||++.+... |+.++||||+||++|||++|.+||.+.+..
T Consensus 153 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 153 PN--------------RAYTHQVVTRWYRAPELLFGARM-----------YGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp CC--------------CCCCCSCCCCTTCCHHHHTTCSC-----------CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CC--------------CCCCCEECCHHHCCHHHHCCCCC-----------CCHHHHHHHCCHHHHHHHHCCCCCCCCCHH
T ss_conf 75--------------54330204733363999726778-----------880564363042899998596999999999
Q ss_pred HHHHHHHHCCCCCCCC---------------------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999998227899885---------------------443578998779999998412595899882257788551
Q 000343 374 EIYRAVVKNRKLPPQY---------------------ASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 374 ei~~~I~~~~~~~~~~---------------------~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
+.+..|.+....+... .......+++++.+||.+||+.||.+|||+.|+|+|-+.
T Consensus 208 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 9999999851899725452100021344303478988678565689999999999763894569089999679965
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=361.17 Aligned_cols=255 Identities=20% Similarity=0.337 Sum_probs=215.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||. |..+ ++..||||+++.. ....+.+.+|+++++.++ ||||+++++++...+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~------~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHL------GYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLS--HPKLVQLYGVCLEQAP 74 (263)
T ss_dssp SCEEEEEEEECCSSCCEEE------EEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECSSSS
T ss_pred HHCEEEEEEEECCCEEEEE------EEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCC--CCCCCCCCCEECCCCC
T ss_conf 9958888982088829999------9988-9999999998788-676899999999999668--9975653524315993
Q ss_pred EEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECCC
Q ss_conf 999993589983889987-0799999999999999999999999499733202355469878996999402100340575
Q 000343 216 LGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+|+||||++++.+..++. ....+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCC
T ss_conf 37999836999189975201347889999999999999877653164310443153266668877686553210023688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 34579988897774334444448988789643363211245455676778944201013669998840-99999899989
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~~ 373 (1630)
. ........||+.|+|||++.+.. ++.++|||||||++|||++ |.+||...+..
T Consensus 155 ~-------------~~~~~~~~gt~~y~aPE~l~~~~------------~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 155 Q-------------YTSSTGTKFPVKWASPEVFSFSR------------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------CTTSCCHHHHTTCC------------CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred C-------------CEEECCEECCCCCCCHHHHCCCC------------CCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 7-------------33504300176667857860799------------9840332105999999987898887789999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9999998227899885443578998779999998412595899882257788551025
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 374 ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
+++..+..+..... +..+++++.+||.+||+.||.+|||+.+++++|.+..+
T Consensus 210 ~~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 210 EVVEDISTGFRLYK------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999980688899------54367999999999765797689199999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=362.56 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=205.3
Q ss_pred CCCCEEEEE-EECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 457828998-8476785029995279814436689589999963157689668999999999811599882216799994
Q 000343 134 VHHDVKLVK-KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~Y~i~k-~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
+.++|.+.. .||+|+||.||+ |.++.+++.||||.++. ...+.+|+.++.++. +||||++++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~------a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~-~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQ------IFNKRTQEKFALKMLQD-----CPKARREVELHWRAS-QCPHIVRIVDVYEN 76 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEE------EEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHT-TSTTBCCEEEEEEE
T ss_pred CCCCEEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
T ss_conf 0148798107965454869999------99889998999999897-----477999999999866-99997829899950
Q ss_pred ----CCEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEE
Q ss_conf ----99799999358998388998707--99999999999999999999999499733202355469878---9969994
Q 000343 213 ----DSCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA---SGRAVVS 283 (1630)
Q Consensus 213 ----~~~~~LVmEy~~gsll~~l~~~~--~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~---~g~vKL~ 283 (1630)
...+|+|||||+|+.|..++.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 34689789999977899849999986278775799999999999999999997698644410022011355556631135
Q ss_pred ECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 02100340575345799888977743344444489887896433632112454556767789442010136699988409
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG 363 (1630)
|||+|+...... .....+||+.|+|||++.+.. |+.++||||+||++|+|++|
T Consensus 157 DFG~a~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~~------------y~~~~DiwSlGvily~lltg 209 (335)
T d2ozaa1 157 DFGFAKETTSHN---------------SLTTPCYTPYYVAPEVLGPEK------------YDKSCDMWSLGVIMYILLCG 209 (335)
T ss_dssp CCTTCEECCCCC---------------CCCCCSCCCSSCCCCCCCGGG------------GSHHHHHHHHHHHHHHHTTS
T ss_pred CCCEEEECCCCC---------------CCCCCCCCCCCCCCHHHCCCC------------CCHHHHHHHHCHHHHHHHHC
T ss_conf 455123336888---------------643226775637927774898------------88888887645167788658
Q ss_pred CCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 9999899989999999822789-988544357899877999999841259589988225778855
Q 000343 364 SIPWAGLSAEEIYRAVVKNRKL-PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~I~~~~~~-~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
.+||.+.+.......+...... ...+.......+++++.+||.+||+.||.+|||+.++++|.+
T Consensus 210 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 210 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 89988988778899999998538888898543469999999999975699657909999970987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-44 Score=359.60 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=220.3
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 4578289988476785029995279814436689589999963157689---6689999999998115998822167999
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVL 210 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~L~~~~ 210 (1630)
+.++|++.+.||+|+||.||+ |.++.+++.||+|.+++....+ ...+.+|+.+++.++ ||||+++++++
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~------a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~--hpniv~~~~~~ 76 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHL------ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTG 76 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEE------EEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCCCCCCCEE
T ss_conf 062069868996089929999------9999999899999985566469899999999999998569--99887311435
Q ss_pred EECC----EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECC
Q ss_conf 9499----799999358998388998707999999999999999999999994997332023554698789969994021
Q 000343 211 RMDS----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 211 ~~~~----~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFG 286 (1630)
.... .+||||||++|+.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++..+++|||
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EECCCCCCEEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHH
T ss_conf 43268876699999778898710112035899999999999999999999985795276346755665754320100344
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 00340575345799888977743344444489887896433632112454556767789442010136699988409999
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~P 366 (1630)
.+........ ........+||+.|+|||++.+.. +++++||||+||++|+|++|.+|
T Consensus 157 ~~~~~~~~~~-----------~~~~~~~~~Gt~~Y~aPE~~~~~~------------~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 157 IARAIADSGN-----------SVTQTAAVIGTAQYLSPEQARGDS------------VDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp TCEECC---------------------------TTCCHHHHTTCC------------CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHHHCCCCC-----------CCCCCCCCCCCCCCCCHHHHCCCC------------CCCCEECCCCHHHHHHHHHCCCC
T ss_conf 4322123544-----------333346425762436999983999------------99663202652899999769799
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHC
Q ss_conf 989998999999982278998854435789987799999984125958998-822577885510
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRP-TFSAMLATFLRH 429 (1630)
Q Consensus 367 F~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RP-Sa~eiL~~L~~~ 429 (1630)
|.+.+..+.+..+......++. .....+|+++.+||.+||+.||.+|| |+.+++..|...
T Consensus 214 f~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 214 FTGDSPVSVAYQHVREDPIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCSSHHHHHHHHHHCCCCCGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCCCC---HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf 8996999999999846999971---003478999999999986679767773999999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=356.07 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=216.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 782899884767850299952798144366895899999631576--896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|+++++||+|+||.||+ |.+..+++.||+|.++.... .....+.+|+++|+.+. ||||++++++|++.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYK------ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--HPNIVKLLDVIHTE 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEE------EEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC--CTTBCCEEEEEEET
T ss_pred CCCEECCEEECCCCEEEEE------EEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCC
T ss_conf 9977651772376809999------999999979999998022257589999999999998679--98388744533224
Q ss_pred CEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 979999935899838899870-7999999999999999999999994997332023554698789969994021003405
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN-EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~-~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
..+|+||||+.++++..+... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred CCEEEEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECC
T ss_conf 32037886237744555442025688889999999999999998652889921357114011346762103578613436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCH
Q ss_conf 75345799888977743344444489887896433632112454556767789442010136699988409999989998
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSA 372 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~ 372 (1630)
... .......||+.|+|||++....+ ++.++||||+||++|+|++|+.||.+.+.
T Consensus 154 ~~~--------------~~~~~~~gt~~y~apE~~~~~~~-----------~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 154 VPV--------------RTYTHEVVTLWYRAPEILLGCKY-----------YSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp CCS--------------BCTTCCBCCCTTCCHHHHTTCSS-----------CCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCC--------------CCCEEECCCCEEEEHHHHCCCCC-----------CCCCCCCCCCCHHHHHHHHCCCCCCCCCH
T ss_conf 886--------------41001036521541122136657-----------77422103333134279668799898899
Q ss_pred HHHHHHHHHCCCCCCCC-----------C-----------CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 99999998227899885-----------4-----------4357899877999999841259589988225778855102
Q 000343 373 EEIYRAVVKNRKLPPQY-----------A-----------SIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~-----------~-----------~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l 430 (1630)
.+.+..+......+... . ......+++++.+||.+||+.||.+|||+.|+++|-+ +
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f--f 286 (298)
T d1gz8a_ 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF--F 286 (298)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG--G
T ss_pred HHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH--H
T ss_conf 99999999832898333144422242124345432222044416678999999999976399557918999967870--1
Q ss_pred CCCCC
Q ss_conf 57899
Q 000343 431 QELPR 435 (1630)
Q Consensus 431 ~~l~~ 435 (1630)
+..++
T Consensus 287 ~~~~~ 291 (298)
T d1gz8a_ 287 QDVTK 291 (298)
T ss_dssp TTCCC
T ss_pred CCCCC
T ss_conf 46999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=352.12 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=212.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCC-CCEEEEEEEECCCC--CCHHHHHHHHHHHHHHC-CCCCCCCEEEEE
Q ss_conf 457828998847678502999527981443668-95899999631576--89668999999999811-599882216799
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRC-RHSVAVKKVMIAEE--MEPDWLSGQLDNLRRAS-MWCRNVCTFHGV 209 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~-g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~-l~HpNIV~L~~~ 209 (1630)
..++|+++++||+|+||.||+ |++..+ ++.||||+++.... .....+.+|+.+|+.++ .+||||++++++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~------a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEE------EEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 758979888992155869999------99988899899999980232451679999999999998742589880236632
Q ss_pred EEE-----CCEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 994-----997999993589983889987-07999999999999999999999994997332023554698789969994
Q 000343 210 LRM-----DSCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 210 ~~~-----~~~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~ 283 (1630)
|.. ...+|++|||+.++++..... ....+++..++.++.|++.||+|||+++|+||||||+|||++..+.+||+
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ECCCCCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEEC
T ss_conf 21466666746999997405871444443037899989999999999999999975889835798627898589975421
Q ss_pred ECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 02100340575345799888977743344444489887896433632112454556767789442010136699988409
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG 363 (1630)
|||+++..... .......||+.|+|||++.+.. |+.++||||+||++|||++|
T Consensus 159 dfg~~~~~~~~---------------~~~~~~~gT~~Y~APE~~~~~~------------y~~~~DiwSlG~il~ell~g 211 (305)
T d1blxa_ 159 DFGLARIYSFQ---------------MALTSVVVTLWYRAPEVLLQSS------------YATPVDLWSVGCIFAEMFRR 211 (305)
T ss_dssp SCCSCCCCCGG---------------GGGCCCCCCCTTCCHHHHTTCC------------CCTHHHHHHHHHHHHHHHHS
T ss_pred CHHHHHHHCCC---------------CCCCCCCCCHHHCCCCHHCCCC------------CCHHEHHHCHHHHHHHHHHC
T ss_conf 00010110023---------------4577765485114831001798------------88111000328999999878
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCC--------------------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 999989998999999982278998--------------------854435789987799999984125958998822577
Q 000343 364 SIPWAGLSAEEIYRAVVKNRKLPP--------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 364 ~~PF~~~~~~ei~~~I~~~~~~~~--------------------~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL 423 (1630)
.+||.+.+..+.+..+......+. .........+++.+.+||.+||++||.+|||+.|+|
T Consensus 212 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 79989989899999999840799611053211110333022345645440445899999999998748966791899996
Q ss_pred HHHH
Q ss_conf 8855
Q 000343 424 ATFL 427 (1630)
Q Consensus 424 ~~L~ 427 (1630)
+|.+
T Consensus 292 ~Hpf 295 (305)
T d1blxa_ 292 SHPY 295 (305)
T ss_dssp TSGG
T ss_pred CCHH
T ss_conf 6963
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=356.82 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=210.7
Q ss_pred EEEE-EEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 2899-88476785029995279814436689589999963157689--66899999999981159988221679999499
Q 000343 138 VKLV-KKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 138 Y~i~-k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
+.+. ++||+|+||.||. ..+. .+.+++.||||.++...... .+.+.+|+.+|++++ |||||+++++++++
T Consensus 8 ~~le~k~iG~G~fG~Vy~--~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~g~~~~~- 80 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKK--GYYQ--MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--NPYIVRMIGICEAE- 80 (277)
T ss_dssp EEEEEEEEEECSSEEEEE--EEEE--CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC--CTTBCCEEEEEESS-
T ss_pred CEECCCCCCCCCCEEEEE--EEEC--CCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEECCC-
T ss_conf 700187834587829999--9981--6973859999998801089899999999999998679--98985277775059-
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECCC
Q ss_conf 79999935899838899870799999999999999999999999499733202355469878996999402100340575
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
.+||||||++++++..++.+...+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCC
T ss_conf 77999974788968999752257899999999999999976687479556777611310235675123413453313432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 34579988897774334444448988789643363211245455676778944201013669998840-99999899989
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~~ 373 (1630)
.. .........||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..
T Consensus 161 ~~-----------~~~~~~~~~gt~~y~APE~l~~~~------------~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 161 EN-----------YYKAQTHGKWPVKWYAPECINYYK------------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp CS-----------EEEC----CCCGGGCCHHHHHHCE------------EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred CC-----------CCCCCCCCCCCCEECCCHHHCCCC------------CCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 34-----------432244567784203916653799------------9843443034031328965899999998999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 999999822789988544357899877999999841259589988225778855102
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 374 ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l 430 (1630)
++...+..+.+.+ .+..+|+++.+||.+||+.||.+|||+.++++.|...+
T Consensus 218 ~~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 218 EVTAMLEKGERMG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf 9999998289999------98656799999999975889768909899999852887
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=356.54 Aligned_cols=261 Identities=19% Similarity=0.303 Sum_probs=213.4
Q ss_pred CCEEEEE-EECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 7828998-84767850299952798144366895899999631576-896689999999998115998822167999949
Q 000343 136 HDVKLVK-KLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k-~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|.+.. +||+|+||.||. .+++ ....+..||||.++.... .....+.+|+++|..++ |||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~--~~~~--~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQ--GVYR--MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQA- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEE--EEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC--CTTBCCEEEEEES-
T ss_pred CCEEECCCEEECCCCEEEEE--EEEE--CCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEECC-
T ss_conf 47188784873060809999--9996--089768999999882039789999999999998679--9888068656036-
Q ss_pred CEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 97999993589983889987-07999999999999999999999994997332023554698789969994021003405
Q 000343 214 SCLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
+.+||||||+++++|..++. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 80799998078996899752125699999999999999998789986881057676466045468854203313421155
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 7534579988897774334444448988789643363211245455676778944201013669998840-999998999
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~ 371 (1630)
.... .........||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+
T Consensus 161 ~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~------------~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 161 ADDS-----------YYTARSAGKWPLKWYAPECINFRK------------FSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TCSC-----------EECCCCSSCCCGGGCCHHHHHHCE------------ECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCC-----------CCCCCCCCCCCCCCCCHHHHHCCC------------CCCCCHHHCCHHHHHHHHHCCCCCCCCCC
T ss_conf 4343-----------211356211374335868872799------------99541232201789999938999999979
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 8999999982278998854435789987799999984125958998822577885510257
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~ 432 (1630)
..+++..+..+...+ .+..+|+++.+||.+||+.||.+|||+.++++.|...+..
T Consensus 218 ~~~~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKRME------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCCCC------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 999999998189999------9976789999999997577976890999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=356.79 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=215.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||+ |.. .++..||||.++... ...+.+.+|+.++..++ ||||+++++++.+...
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~------~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~--HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKY------GKW-RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLS--HEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCEETTEEEEE------EEE-TTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCC--CTTBCCEEEEECCSSS
T ss_pred HHCEEEEEEECCCCEEEEE------EEE-CCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCC
T ss_conf 9979968982078839999------998-899899999987475-77899999999999668--9860158899850781
Q ss_pred EEEEEECCCCCHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECCC
Q ss_conf 9999935899838899-870799999999999999999999999499733202355469878996999402100340575
Q 000343 216 LGLVMDRCYGSVQLAM-QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKKP 294 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l-~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~~ 294 (1630)
+++||||+.++++..+ ......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC
T ss_conf 69999704899388864102467768999999999999999875468434665413588769984798861442023578
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 34579988897774334444448988789643363211245455676778944201013669998840-99999899989
Q 000343 295 ACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSAE 373 (1630)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~~ 373 (1630)
.. .......||+.|+|||++.+.. ++.++||||||+++|||++ |..||.+.+..
T Consensus 154 ~~-------------~~~~~~~~t~~y~aPE~~~~~~------------~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 154 EY-------------TSSVGSKFPVRWSPPEVLMYSK------------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp SC-------------CCCCCSCCCGGGCCHHHHHHCC------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred CC-------------EEECCCCCCCCCCCCHHHCCCC------------CCCCEEECCCCHHHHHHHHCCCCCCCCCCHH
T ss_conf 72-------------2524657887757807863799------------8852103364324673975599998899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999998227899885443578998779999998412595899882257788551
Q 000343 374 EIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 374 ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
++...+..+...+. +..+++++.+||.+||+.||.+|||+.++++||.+
T Consensus 209 ~~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 209 ETAEHIAQGLRLYR------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 99999980797899------65465999999999766897689399999987418
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=352.69 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=211.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 578289988476785029995279814436689589999963157-6896689999999998115998822167999949
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
..+|+++++||+|+||.||. ..+..........||+|+++... ......+.+|+.+++.++ |||||++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~--~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD--NPHVCRLLGICLTS 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEE--EEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC--CTTBCCEEEEEESS
T ss_pred HHHCEEEEEEECCCCEEEEE--EEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEECC
T ss_conf 89997831982089929999--999589988989999999651349799999999999998679--98881589999619
Q ss_pred CEEEEEEECCC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEEC
Q ss_conf 97999993589-98388998707999999999999999999999994997332023554698789969994021003405
Q 000343 214 SCLGLVMDRCY-GSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILK 292 (1630)
Q Consensus 214 ~~~~LVmEy~~-gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~ 292 (1630)
. .+++|||+. ++++..+......+++..++.|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred C-EEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 8-369998426874010111334579999999999999999999987695047621203116799875860255222335
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 7534579988897774334444448988789643363211245455676778944201013669998840-999998999
Q 000343 293 KPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLS 371 (1630)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~ 371 (1630)
... .........||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+
T Consensus 163 ~~~------------~~~~~~~~~gt~~y~APE~l~~~~------------~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 163 AEE------------KEYHAEGGKVPIKWMALESILHRI------------YTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTC------------C--------CCTTTSCHHHHHHCC------------CCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CCC------------CCCCCCCCCCCCCCCCHHHHHCCC------------CCHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 444------------532236510586446708874699------------98356544079999999977999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 899999998227899885443578998779999998412595899882257788551025
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
..++...+..+...+. +..+++++.+||.+||+.||.+|||+.+++.+|....+
T Consensus 219 ~~~~~~~i~~~~~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 219 ASEISSILEKGERLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp GGGHHHHHHHTCCCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8999999975998999------85568999999998478993469199999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=353.99 Aligned_cols=254 Identities=22% Similarity=0.413 Sum_probs=210.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||. |.. .++..||||+++.. ....+.+.+|+.++..++ |||||++++++. .+.
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~------~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWM------GYY-NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQ--HQRLVRLYAVVT-QEP 81 (272)
T ss_dssp GGEEEEEEEEEETTEEEEE------EEE-TTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEEC-SSS
T ss_pred HHEEEEEEEECCCCCEEEE------EEE-CCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCC--CCCEEEEEEEEC-CCC
T ss_conf 9938867981079828999------999-99999999998647-688899999999998679--998857873104-597
Q ss_pred EEEEEECCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 9999935899838899870--79999999999999999999999949973320235546987899699940210034057
Q 000343 216 LGLVMDRCYGSVQLAMQRN--EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~~--~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+|+||||++++++..+... ..++++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCC
T ss_conf 69999957898288887514789887889999999999999999748954675642251562024404234101477358
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 534579988897774334444448988789643363211245455676778944201013669998840-9999989998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~ 372 (1630)
.. ........||+.|+|||++.+.. ++.++|||||||++|||++ |.+||...+.
T Consensus 162 ~~-------------~~~~~~~~gt~~y~APE~~~~~~------------~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~ 216 (272)
T d1qpca_ 162 NE-------------YTAREGAKFPIKWTAPEAINYGT------------FTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (272)
T ss_dssp SC-------------EECCTTCCCCTTTSCHHHHHHCE------------ECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CC-------------CCCCCCCCCCCCCCCHHHHHCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 86-------------44203567744445828983799------------982456452579999999689888888899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 99999998227899885443578998779999998412595899882257788551025
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
.+++..+..+...+. +..+++++.+||.+||+.||.+|||+.++++.|...+.
T Consensus 217 ~~~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 217 PEVIQNLERGYRMVR------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999999970688889------65571999999999758897689399999998611321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=351.91 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=213.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 7828998847678502999527981443668958999996315768-966899999999981159988221679999499
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
+.|++.+.||+|+||.|| ...++.........||||+++..... ....+.+|+.++..++ |||||++++++.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy--~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~--H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVY--KGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEE--EEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEE--EEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEECCC
T ss_conf 996861598117790999--9999689987879999999884459689999999999998568--987832367783388
Q ss_pred EEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 7999993589983889987-079999999999999999999999949973320235546987899699940210034057
Q 000343 215 CLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++||||+.++++..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 03899972135740222102345420899999999999854121212342576564427888998499845510300357
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 534579988897774334444448988789643363211245455676778944201013669998840-9999989998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~ 372 (1630)
... .........||+.|+|||++.+.. ++.++|||||||++|||++ +.+||...+.
T Consensus 163 ~~~-----------~~~~~~~~~gt~~Y~APE~l~~~~------------~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 163 DPE-----------ATYTTSGGKIPIRWTAPEAISYRK------------FTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp ----------------------CCCGGGSCHHHHHSCC------------CCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCC-----------CCEEECCCCCCCCCCCHHHHCCCC------------CCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 876-----------526742677773434888870499------------997355634489899999679886556899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 999999982278998854435789987799999984125958998822577885510257
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~ 432 (1630)
.+++..+..+...+. +..+|+++.+||.+||+.||.+|||+.++++.|....+.
T Consensus 220 ~~~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 220 HEVMKAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHTTCCCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHCCCCCCC------CHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 999999863578998------504579999999997767976893999999999998669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=345.09 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=206.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC--
Q ss_conf 782899884767850299952798144366895899999631576896689999999998115998822167999949--
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD-- 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~-- 213 (1630)
.+|+..++||+|+||+||+ |+++.+++.||||++...... ..+|+++|+.++ ||||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~------a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~--h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQ------AKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD--HCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEE------EEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCC--CTTBCCEEEEEEEC--
T ss_pred CCCEEEEEEEECCCEEEEE------EEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCC--CCCCCCEEEEEEECCC
T ss_conf 7767516982176839999------999999979999998816068----999999998668--9898738789974476
Q ss_pred ----CEEEEEEECCCCCHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEEEEC
Q ss_conf ----9799999358998388998---7079999999999999999999999949973320235546987899-6999402
Q 000343 214 ----SCLGLVMDRCYGSVQLAMQ---RNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDY 285 (1630)
Q Consensus 214 ----~~~~LVmEy~~gsll~~l~---~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g-~vKL~DF 285 (1630)
.++|||||||+++++..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECC
T ss_conf 57731899998416886078888631036899999999999999999999986687645788603787358971167336
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 10034057534579988897774334444448988789643363211245455676778944201013669998840999
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~ 365 (1630)
|++....... .....+||..|+|||.+.+... |+.++||||+||++|||++|.+
T Consensus 168 G~a~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 168 GSAKQLVRGE---------------PNVSYICSRYYRAPELIFGATD-----------YTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp TTCEECCTTS---------------CCCSCCSCTTSCCHHHHTTCSS-----------CCTHHHHHHHHHHHHHHHHTSC
T ss_pred CCHHHCCCCC---------------CCCCCCCCCCCCCHHHHHCCCC-----------CCCCEEECCCCEEEEEHHHCCC
T ss_conf 6054404776---------------5320025555568277640468-----------8821000246527785502879
Q ss_pred CCCCCCHHHHHHHHHHCCCC----------------------CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 99899989999999822789----------------------98854435789987799999984125958998822577
Q 000343 366 PWAGLSAEEIYRAVVKNRKL----------------------PPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 366 PF~~~~~~ei~~~I~~~~~~----------------------~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL 423 (1630)
||...+..+.+..+...... ...+.......+++++.+||.+||+.||.+|||+.|+|
T Consensus 222 pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 222 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 98987999999999997489817765430621011035544567444431568999999999997658955792999996
Q ss_pred HHHHH
Q ss_conf 88551
Q 000343 424 ATFLR 428 (1630)
Q Consensus 424 ~~L~~ 428 (1630)
+|.+.
T Consensus 302 ~Hp~f 306 (350)
T d1q5ka_ 302 AHSFF 306 (350)
T ss_dssp TSGGG
T ss_pred CCHHH
T ss_conf 69845
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=355.40 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=206.3
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC------HHHHHHHHHHHHHHCCCCCCCCEEE
Q ss_conf 4578289988476785029995279814436689589999963157689------6689999999998115998822167
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME------PDWLSGQLDNLRRASMWCRNVCTFH 207 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~------~~~~~~Ei~iL~~l~l~HpNIV~L~ 207 (1630)
+.++|++.+.||+|+||.||+ |.++.+++.||||.+.+..... ...+.+|+.+|+.++..||||++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~------a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~ 75 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYS------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEE------EEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred CCCEEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEE
T ss_conf 788379967984087839999------99999997999999856884433455679999999999997435898812799
Q ss_pred EEEEECCEEEEEEECCCC-CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC-CCEEEEEC
Q ss_conf 999949979999935899-8388998707999999999999999999999994997332023554698789-96999402
Q 000343 208 GVLRMDSCLGLVMDRCYG-SVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDAS-GRAVVSDY 285 (1630)
Q Consensus 208 ~~~~~~~~~~LVmEy~~g-sll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~-g~vKL~DF 285 (1630)
++|.+.+.+|+||||+.+ +++..+..+...+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+||
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 76 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEECCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 99830996899998336862289998615899999999999999999999987797556676111477447884897754
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 10034057534579988897774334444448988789643363211245455676778944201013669998840999
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~ 365 (1630)
|+|+..... ......||+.|+|||++.+..+ ++.++||||+||++|+|++|..
T Consensus 156 G~a~~~~~~----------------~~~~~~GT~~y~aPE~~~~~~~-----------~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 156 GSGALLKDT----------------VYTDFDGTRVYSPPEWIRYHRY-----------HGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp TTCEECCSS----------------CBCCCCSCGGGSCHHHHHHSCB-----------CHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCEECCCC----------------CCCCCCCCCCCCCHHHHCCCCC-----------CCCCCCCCCCEEEEHHHHHCCC
T ss_conf 653532444----------------5566565877479999848997-----------8865332554034536756889
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 99899989999999822789988544357899877999999841259589988225778855
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 366 PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
||...+ .+....... +..+|+++++||.+||+.||.+|||+.|+++|.+
T Consensus 209 Pf~~~~------~i~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 209 PFEHDE------EIIRGQVFF-------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp SCCSHH------HHHHCCCCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCH------HHHHCCCCC-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 988736------776154477-------8779999999999976089758939999853986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=348.24 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=215.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCC--EEEEEEEECCC-CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 782899884767850299952798144366895--89999963157-689668999999999811599882216799994
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRH--SVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~--~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
++|++.++||+|+||.||. |..+.++. .||||++.... ....+.+.+|+++|..+. +||||+++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~------~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLK------ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-HHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEE------EEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-CCTTBCCEEEEEEE
T ss_pred HHCEEEEEEEECCCCEEEE------EEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC
T ss_conf 9968877982078828999------9998999699999999782338579999999999998622-89988367888841
Q ss_pred CCEEEEEEECCCCCHHHHHHHC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf 9979999935899838899870----------------799999999999999999999999499733202355469878
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRN----------------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~----------------~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~ 276 (1630)
.+.+|+||||++++.+..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
T ss_conf 87369999802898699998640355555123101234578999999999999999987663089545550520489868
Q ss_pred CCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 99699940210034057534579988897774334444448988789643363211245455676778944201013669
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGvi 356 (1630)
++.+||+|||+|+...... ......||..|+|||.+.+.. ++.++||||||++
T Consensus 163 ~~~~kl~DfG~a~~~~~~~---------------~~~~~~gt~~y~aPE~l~~~~------------~~~~sDvwSfGvi 215 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV---------------KKTMGRLPVRWMAIESLNYSV------------YTTNSDVWSYGVL 215 (309)
T ss_dssp GGCEEECCTTCEESSCEEC---------------CC----CCTTTCCHHHHHHCE------------ECHHHHHHHHHHH
T ss_pred CCCEEECCCCCCCCCCCCC---------------CCCCEECCCCCCCHHHHCCCC------------CCCCCEEEHHHHH
T ss_conf 8763874344322444223---------------455301377555538752699------------9962215313889
Q ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 9988409-99998999899999998227899885443578998779999998412595899882257788551025789
Q 000343 357 LVEMCTG-SIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELP 434 (1630)
Q Consensus 357 L~ElltG-~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~l~ 434 (1630)
+|||++| .+||.+.+..+++..+..+...+ .+..+++++.+||.+||+.||++|||+.+++++|...++..+
T Consensus 216 l~ell~~~~~p~~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 9999836899999999999999998268888------876678999999999767896689499999999999986186
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=345.79 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=209.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 457828998847678502999527981443668958999996315768--966899999999981159988221679999
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
+.++|+++++||+|+||.||+ |.++.+++.||||+++..... ..+.+.+|+.+|+.++ |||||+++++|.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpniv~l~~~~~ 87 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCS------AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR--HENVIGLLDVFT 87 (346)
T ss_dssp CBSSEEEEEEC------CEEE------EEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC--BTTBCCCSEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEC
T ss_conf 477189988980177819999------999999989999998522259699999999999998668--987547999863
Q ss_pred ECC------EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 499------79999935899838899870799999999999999999999999499733202355469878996999402
Q 000343 212 MDS------CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~~~------~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DF 285 (1630)
..+ .+|+||||++. ++..+..+ .++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFMGT-DLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp SCSSTTTCCCCEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred CCCCCCCCCEEEEEEECCCC-CHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf 57655554159999840552-18999874-02269999999999999999987378764566851111210012211343
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 10034057534579988897774334444448988789643363211245455676778944201013669998840999
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~ 365 (1630)
|+|+..... .....||+.|+|||++.+..+ ++.++||||+||++|+|++|.+
T Consensus 166 g~a~~~~~~-----------------~~~~~~t~~y~aPE~~~~~~~-----------~~~~~DiwSlGvil~ell~g~~ 217 (346)
T d1cm8a_ 166 GLARQADSE-----------------MTGYVVTRWYRAPEVILNWMR-----------YTQTVDIWSVGCIMAEMITGKT 217 (346)
T ss_dssp TTCEECCSS-----------------CCSSCSCGGGCCTHHHHTTTC-----------CCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCEECCCCC-----------------CCCCCCCCCCCCHHHHCCCCC-----------CCCCCHHHCCHHHHHHHHHCCC
T ss_conf 102206876-----------------310245533358899817878-----------9965010300389999997869
Q ss_pred CCCCCCHHHHHHHHHHCCCCC------------------------CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 998999899999998227899------------------------88544357899877999999841259589988225
Q 000343 366 PWAGLSAEEIYRAVVKNRKLP------------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSA 421 (1630)
Q Consensus 366 PF~~~~~~ei~~~I~~~~~~~------------------------~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~e 421 (1630)
||.+.+..+.+..+......+ ..........+++++.+||.+||..||.+|||+.+
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 98889768999999850378848888653000344331157866655667755689999999999977299557929999
Q ss_pred HHHHHH
Q ss_conf 778855
Q 000343 422 MLATFL 427 (1630)
Q Consensus 422 iL~~L~ 427 (1630)
+|+|.+
T Consensus 298 iL~Hp~ 303 (346)
T d1cm8a_ 298 ALAHPY 303 (346)
T ss_dssp HHHSGG
T ss_pred HHCCHH
T ss_conf 963962
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=352.12 Aligned_cols=264 Identities=25% Similarity=0.282 Sum_probs=207.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCC-CCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 782899884767850299952798144-366895899999631576-896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~-~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|++.++||+|+||.||. ..+.+. ...+++.||+|+++.... .....+.+|...+.++. +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~--a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIE--ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKP 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEE--EEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECST
T ss_pred HHEEEEEEEEECCCEEEEE--EEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCEEEEEEEEECCC
T ss_conf 9979844984167839999--9986777555783999999860017178999999999988614-998499741154047
Q ss_pred -CEEEEEEECCCCCHHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf -9799999358998388998707----------------99999999999999999999999499733202355469878
Q 000343 214 -SCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA 276 (1630)
Q Consensus 214 -~~~~LVmEy~~gsll~~l~~~~----------------~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~ 276 (1630)
..+++|||||+++.+..++... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
T ss_conf 97579999845899299999853666665322202332146899999999999999999887379717867731065779
Q ss_pred CCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 99699940210034057534579988897774334444448988789643363211245455676778944201013669
Q 000343 277 SGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCT 356 (1630)
Q Consensus 277 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGvi 356 (1630)
++.+||+|||+|+...... .........||+.|+|||++.+.. ++.++|||||||+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~------------~~~~sDiwS~Gvi 225 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDP------------DYVRKGDARLPLKWMAPETIFDRV------------YTIQSDVWSFGVL 225 (299)
T ss_dssp GGCEEECC------CCSCT------------TSCCTTSCCCGGGGCCHHHHHHCC------------CCHHHHHHHHHHH
T ss_pred CCCEEECCCCCHHHCCCCC------------CCCCCCCEEECCCCCCHHHHHCCC------------CCCCCCEEEHHHH
T ss_conf 9828984575200113566------------522247516672102036864688------------9966322136789
Q ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9988409-99998999899999998227899885443578998779999998412595899882257788551025
Q 000343 357 LVEMCTG-SIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 357 L~ElltG-~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
+|||+++ .+||.+.+..+.+..+......++ .+..+++++.+||.+||+.||.+|||+.++++||...++
T Consensus 226 l~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99998688999989998999999996389888-----886578999999999767796679199999999979986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=347.84 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=212.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
++|++.++||+|+||.||+ |.++.+ ..||||+++.. ....+.+.+|+.++..++ |||||++++++.+ +.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~------~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWM------GTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLR--HEKLVQLYAVVSE-EP 85 (285)
T ss_dssp GGEEEEEEEEECSSCEEEE------EEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCC--CTTBCCEEEEECS-SS
T ss_pred HHEEEEEEEEECCCEEEEE------EEECCC-CEEEEEEECCC-CCCHHHHHHHHHHHHHCC--CCCEEEEEEEEEC-CC
T ss_conf 9979846993079809999------999999-99999998804-488899999999998666--6788689999823-97
Q ss_pred EEEEEECCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 999993589983889987--079999999999999999999999949973320235546987899699940210034057
Q 000343 216 LGLVMDRCYGSVQLAMQR--NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~--~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+|+||||++++++..+.. ....+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCC
T ss_conf 59999944799435420000355305999999999999999987541143353123079998999299844255542568
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 534579988897774334444448988789643363211245455676778944201013669998840-9999989998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~ 372 (1630)
.. ........||+.|+|||++.... ++.++||||||+++|||++ |.+||...+.
T Consensus 166 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~------------~~~ksDI~S~Giil~el~t~~~p~~~~~~~ 220 (285)
T d1fmka3 166 NE-------------YTARQGAKFPIKWTAPEAALYGR------------FTIKSDVWSFGILLTELTTKGRVPYPGMVN 220 (285)
T ss_dssp -----------------------CCGGGSCHHHHHHCC------------CCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CC-------------CEEECCCCCCCCCCCHHHHHCCC------------CCCHHHHHCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 87-------------33524545566545808983799------------891774132358999998689999988889
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 999999982278998854435789987799999984125958998822577885510257899
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPR 435 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~l~~ 435 (1630)
.+++..+..+...+ .+..+++++.+||.+||+.||++|||+.++++.|...+...++
T Consensus 221 ~~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 221 REVLDQVERGYRMP------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHHHHHTTCCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHHHCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCC
T ss_conf 99999998268999------9832379999999997566975891999999987666238999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-43 Score=347.49 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=215.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 78289988476785029995279814436689589999963157--6896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE--EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~--~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|+++++||+|+||.||+ |.++ +++.||+|+++... ......+.+|+.+|+.++ ||||++++++|...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~------~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~~~~~~~~~ 72 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYK------AQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK--HSNIVKLYDVIHTK 72 (286)
T ss_dssp CSEEEEEEEEEETTEEEEE------EEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC--CTTBCCEEEEEECS
T ss_pred CCCEECCEEECCCCCEEEE------EEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEECCCC
T ss_conf 9963431872277818999------9968-9999999998123268589999999999998679--98687660120467
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 97999993589983889987079999999999999999999999949973320235546987899699940210034057
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
+..|++|||+.++++..+....+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||.|.....
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred CCEEEEEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 73158997400456789986047751445689999999999986057488267877505686899787323664301146
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 53457998889777433444444898878964336321124545567677894420101366999884099999899989
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLSAE 373 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~~~ 373 (1630)
+.. ......+++.|+|||.+.+..+ ++.++||||+||++|||++|++||.+.+..
T Consensus 153 ~~~--------------~~~~~~~~~~y~~pE~~~~~~~-----------~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 153 PVR--------------KYTHEIVTLWYRAPDVLMGSKK-----------YSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp -----------------------CCCTTCCHHHHTTCCS-----------CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCC--------------CCCEECCCCHHHHHHHHHCCCC-----------CCCCEEEHHCCCHHHHHHHCCCCCCCCCHH
T ss_conf 765--------------4101024311013788717888-----------884100211175899997797998988989
Q ss_pred HHHHHHHHCCCCC----------------------CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 9999998227899----------------------88544357899877999999841259589988225778855
Q 000343 374 EIYRAVVKNRKLP----------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 374 ei~~~I~~~~~~~----------------------~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
+.+.++......+ +.........+++++.+||.+||+.||++|||+.|+++|.+
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 9999999863899711042123332214333335676466651258999999999986689668909999856922
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=343.19 Aligned_cols=264 Identities=19% Similarity=0.224 Sum_probs=213.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-
Q ss_conf 782899884767850299952798144366895899999631576--89668999999999811599882216799994-
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE--MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM- 212 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~--~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~- 212 (1630)
++|+++++||+|+||+||+ |+++.+++.||||++..... .....+.+|+.+|+.++ ||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~------a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~nii~~~~~~~~~ 81 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFK------ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--HENVVNLIEICRTK 81 (318)
T ss_dssp GGEEEEEEEEECSSSEEEE------EEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC--CTTBCCEEEEEEC-
T ss_pred CCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHC--CCCCCCEEEEEECC
T ss_conf 7988999972274829999------999899979999998422246378999999999999835--99966067654024
Q ss_pred -------CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf -------9979999935899838899870799999999999999999999999499733202355469878996999402
Q 000343 213 -------DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 213 -------~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DF 285 (1630)
...+|++|||+.++++..+......+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCCCCCCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEEC
T ss_conf 65444457638999853578741012220344330899999999999998852299885676722203668996876313
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 10034057534579988897774334444448988789643363211245455676778944201013669998840999
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~ 365 (1630)
|++......... ........+||+.|+|||++.+... |+.++||||+||++|||++|++
T Consensus 162 g~~~~~~~~~~~----------~~~~~~~~~gT~~Y~aPE~~~~~~~-----------~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 162 GLARAFSLAKNS----------QPNRYTNRVVTLWYRPPELLLGERD-----------YGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp TTCEECCC---------------CCCCCSCCSCGGGCCHHHHTTCSS-----------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEEEECCCCCCC----------CCCCCCCEECCHHHHHHHHHCCCCC-----------CCCHHHCCCCCCEEEEHHHCCC
T ss_conf 500223554443----------2113566024978742899707999-----------8917870067864661744879
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCC-CCC------------------------CCCCCHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 9989998999999982278998854-435------------------------789987799999984125958998822
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQYA-SIV------------------------GVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 366 PF~~~~~~ei~~~I~~~~~~~~~~~-~~~------------------------~~~~s~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
||.+.+..+....+......+.... ... ....++++.+||.+||+.||.+|||+.
T Consensus 221 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~ 300 (318)
T d3blha1 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300 (318)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 98998999999999984189982553443203444332013344555033404445998999999998738965890999
Q ss_pred HHHHHHHH
Q ss_conf 57788551
Q 000343 421 AMLATFLR 428 (1630)
Q Consensus 421 eiL~~L~~ 428 (1630)
|+|+|.+.
T Consensus 301 elL~Hpff 308 (318)
T d3blha1 301 DALNHDFF 308 (318)
T ss_dssp HHHHSGGG
T ss_pred HHHCCHHH
T ss_conf 99749501
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=346.84 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=217.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 57828998847678502999527981443668958999996315768-96689999999998115998822167999949
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
.++|++.++||+|+||.||. +..+...+..++..||||+++..... ....+.+|+.++..+. +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~-a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVE-ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-NHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEE-EEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCEEEEE-EEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEEC
T ss_conf 89969854982068829999-9980664477886999999874248779999999999987626-999887899898319
Q ss_pred CEEEEEEECCCCCHHHHHHHCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 9799999358998388998707------------------9999999999999999999999949973320235546987
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~------------------~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld 275 (1630)
..+|++||||+++++..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCC
T ss_conf 97899997379987999998535665444445332223345889999999999999999988757926662410210000
Q ss_pred CCCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 89969994021003405753457998889777433444444898878964336321124545567677894420101366
Q 000343 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355 (1630)
Q Consensus 276 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGv 355 (1630)
.++.+|++|||+++...... .........||+.|+|||++.+.. ++.++||||||+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DIwS~G~ 235 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDS------------NYVVKGNARLPVKWMAPESIFNCV------------YTFESDVWSYGI 235 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCT------------TSEECSSSEECGGGCCHHHHHHCC------------CCHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHEECCCCC------------CCEEEEECCCCHHHCCHHHHCCCC------------CCCCCCCCCHHH
T ss_conf 25752102340102336788------------615862013596876778861799------------997400102589
Q ss_pred HHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 9998840-9999989998999999982278998854435789987799999984125958998822577885510257
Q 000343 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 356 iL~Ellt-G~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~ 432 (1630)
++|||++ |.+||...+..+.+..+......+.. +..+|+++.+||.+||+.||.+|||+.++++.|.+.+..
T Consensus 236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9999985899887789989999999866898898-----543659999999997577965792999999999876534
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=326.24 Aligned_cols=324 Identities=24% Similarity=0.305 Sum_probs=212.1
Q ss_pred CHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 82999999839999999999815988645789999999899982999999999987999543333599961999999829
Q 000343 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591 (1630)
Q Consensus 512 ~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G 591 (1630)
.||||+||..|+.++|++||+. |+++|..|..|.||||+|+..|+.+++++|+++|++++.. +..|.||||+|+..|
T Consensus 1 ~TpL~~Aa~~g~~~~v~~Ll~~-g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~--~~~g~t~L~~A~~~g 77 (408)
T d1n11a_ 1 LTPLHVASFMGHLPIVKNLLQR-GASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAK--AKDDQTPLHCAARIG 77 (408)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHT-TCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCC--CTTSCCHHHHHHHHT
T ss_pred CCHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCC--CCCCCCHHHHHHHCC
T ss_conf 9869999988489999999978-7899988999988999999868899999999885998877--999899999999869
Q ss_pred CHHHHHHHHHCCCCC---------------------------------CCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 989999999869999---------------------------------98789888800034431894799999980995
Q 000343 592 QPDCMRELLLAGADP---------------------------------NAVDDEGESVLHRAVAKKYTDCAIVILENGGC 638 (1630)
Q Consensus 592 ~~eivk~LL~~GADv---------------------------------N~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~ 638 (1630)
+.+++++|+..+++. +..+.++.++|+.|+..++.+++++|+++++
T Consensus 78 ~~~~~~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~v~~ll~~~~- 156 (408)
T d1n11a_ 78 HTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDA- 156 (408)
T ss_dssp CHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTC-
T ss_pred CHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCC-
T ss_conf 9779999987410012321112202455543033222222221100100145646428999987598999999997699-
Q ss_pred CCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 53200247999688899980999999999970594211023589999760899999840573102499999999629999
Q 000343 639 RSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEP 718 (1630)
Q Consensus 639 ~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADi 718 (1630)
+++..+.++.+|||+|+..++.++++.|+..++.... .+ ....++++.+... ...+....|+..+...
T Consensus 157 -~~~~~~~~~~~~L~~A~~~~~~~~~~~Ll~~g~~~~~---~~--~~~~t~l~~~~~~------~~~~~~~~l~~~~~~~ 224 (408)
T d1n11a_ 157 -HPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHS---PA--WNGYTPLHIAAKQ------NQVEVARSLLQYGGSA 224 (408)
T ss_dssp -CTTCCCSSCCCHHHHHHHTTCHHHHHHHGGGTCCSCC---CC--TTCCCHHHHHHHT------TCHHHHHHHHHTTCCT
T ss_pred -CCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCC---CC--CCCCCCCHHHHCC------CHHHHHHHHHHCCCCC
T ss_conf -8886787674099999985999999999865884004---57--7899710243202------1045555543200122
Q ss_pred CCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 82101476002366515989999999987999543568999788999984999999999969999776789999299999
Q 000343 719 TAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIA 798 (1630)
Q Consensus 719 n~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLhlA 798 (1630)
...+..+.||||+|+..++.+++++++..+++.+..+..|.||||.|+..++.+++++|+++|++++..+..+.||||+|
T Consensus 225 ~~~~~~~~t~l~~a~~~~~~~~~~~~~~~~~~~~~~~~~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~ 304 (408)
T d1n11a_ 225 NAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVA 304 (408)
T ss_dssp TCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHCCHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHH
T ss_conf 12477899999999980867675442002211111247899733454302848999999977996562102344530221
Q ss_pred HHHCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 984237886499999995089976323378999999999629998747999999995699888
Q 000343 799 ADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVHLS 861 (1630)
Q Consensus 799 a~~g~~~~~~~e~vi~LL~~~gadin~kN~~GkTpL~lA~~~~~~~~~~~lve~Ll~~Ga~v~ 861 (1630)
+..+.. .++..+...|+++|.+|.+|.|||++|.+.+ ..+++++|+++||+++
T Consensus 305 ~~~~~~------~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g----~~~iv~~Ll~~GAd~n 357 (408)
T d1n11a_ 305 SHYGNI------KLVKFLLQHQADVNAKTKLGYSPLHQAAQQG----HTDIVTLLLKNGASPN 357 (408)
T ss_dssp HHSSCS------HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT----CHHHHHHHHHTTCCSC
T ss_pred CCCCCC------EEEEEECCCCCCCCCCCCCCCCHHHHHHHCC----CHHHHHHHHHCCCCCC
T ss_conf 005862------1355301333322346899999999999868----8999999998788998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=350.34 Aligned_cols=259 Identities=19% Similarity=0.349 Sum_probs=213.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 7828998847678502999527981443668958999996315768-966899999999981159988221679999499
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
++|++.+.||+|+||.||. ..+.. ....+..||+|.+...... ....+.+|+.+|+.++ ||||+++++++. .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~--a~~~~-~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQ--GIYMS-PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD--HPHIVKLIGVIT-EN 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEE--EEECC-C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEC-SS
T ss_pred HHEEEEEEEEECCCCEEEE--EEEEC-CCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE-CC
T ss_conf 9969877993078829999--99936-996449999999365668799999999999998689--999856988995-37
Q ss_pred EEEEEEECCCCCHHHHH-HHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 79999935899838899-87079999999999999999999999949973320235546987899699940210034057
Q 000343 215 CLGLVMDRCYGSVQLAM-QRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l-~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+|+||||++++.+..+ ......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 47999984069807765422478999999999999998775230226744141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 534579988897774334444448988789643363211245455676778944201013669998840-9999989998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~~~ 372 (1630)
.. ........||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+.
T Consensus 161 ~~-------------~~~~~~~~gt~~y~apE~l~~~~------------~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 161 ST-------------YYKASKGKLPIKWMAPESINFRR------------FTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp -----------------------CCGGGCCHHHHHHCC------------CSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CC-------------CEECCCEECCCCCCHHHHHCCCC------------CCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 76-------------23305400583103266751699------------887452444247899998269999888999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 99999998227899885443578998779999998412595899882257788551025
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
.+++..+..+...+ .++.+|+++.+||.+||+.||.+|||+.+++++|...++
T Consensus 216 ~~~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 216 NDVIGRIENGERLP------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp GGHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999998189998------987779999999999768797689299999999999977
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-43 Score=347.61 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=215.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCC-CCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 782899884767850299952798144-3668958999996315768-96689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~-~~~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|++.++||+|+||.||. ..+++. +..++..||||+++..... ....+.+|+.+|+.++ ||||+++++++...
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~--a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQ--ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD--NPNIVKLLGVCAVG 88 (301)
T ss_dssp GGCEEEEEEEECSSCEEEE--EEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEECSS
T ss_pred HHCEEEEEEEECCCEEEEE--EEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC--CCCCCCCEEEECCC
T ss_conf 8938867982078839999--9988876577882999999882108579999999999999668--99765524666059
Q ss_pred CEEEEEEECCCCCHHHHHHHCC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9799999358998388998707------------------------9999999999999999999999949973320235
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE------------------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKP 269 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~------------------------~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP 269 (1630)
..++++|||+.++.+..++... ..+++..++.|+.|++.||+|||+++|+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECC
T ss_conf 80389998158992999998527554210000111001210346788989999999999999985541357868548840
Q ss_pred CCEEECCCCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 54698789969994021003405753457998889777433444444898878964336321124545567677894420
Q 000343 270 SNLLLDASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESD 349 (1630)
Q Consensus 270 ~NILld~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksD 349 (1630)
+|||++.++.+||+|||+|+.+..... ........+++.|+|||++.+.. |+.++|
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~------------~t~ksD 224 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADY------------YKADGNDAIPIRWMPPESIFYNR------------YTTESD 224 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC------------BC----CCBCGGGCCHHHHHHCC------------CCHHHH
T ss_pred CCEEECCCCCEEECCCHHHEECCCCCC------------CCCCCCCCCCCCCCCHHHHCCCC------------CCHHHH
T ss_conf 116898999289833144211367764------------11157777676767989972688------------980563
Q ss_pred CHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10136699988409-99998999899999998227899885443578998779999998412595899882257788551
Q 000343 350 AWSFGCTLVEMCTG-SIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 350 VWSlGviL~ElltG-~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
||||||++|||+++ .+||.+.+..+++..+..+..++ .+..+|+++.+||.+||+.||.+|||+.++++.|.+
T Consensus 225 VwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 02523629999806899999989999999997399788------873252999999999748896579399999999998
Q ss_pred CC
Q ss_conf 02
Q 000343 429 HL 430 (1630)
Q Consensus 429 ~l 430 (1630)
..
T Consensus 299 i~ 300 (301)
T d1lufa_ 299 MC 300 (301)
T ss_dssp TT
T ss_pred HC
T ss_conf 42
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=343.23 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=215.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCC---CCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 78289988476785029995279814436---68958999996315768-966899999999981159988221679999
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQG---RCRHSVAVKKVMIAEEM-EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~---~~g~~VAIK~i~~~~~~-~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
++|++.+.||+|+||.||+ ..+.+.++ ..+..||||+++..... ....+.+|...+..+. +|||||++++++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~--~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVL--AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACT 89 (299)
T ss_dssp GGEEEEEECC-----CEEE--EEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred HHEEEEEEEEECCCCEEEE--EEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-CCCEEEECCCCCC
T ss_conf 9969700985167828999--998578755566754999999881128688999999999999813-9996973465220
Q ss_pred ECCEEEEEEECCCCCHHHHHHHCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 499799999358998388998707----------------9999999999999999999999949973320235546987
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNE----------------GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLD 275 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~~----------------~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld 275 (1630)
+...+|+||||+.++.+..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEEC
T ss_conf 18868999973699909999986067764322233457434679999999999999999876637978630221022454
Q ss_pred CCCCEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 89969994021003405753457998889777433444444898878964336321124545567677894420101366
Q 000343 276 ASGRAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGC 355 (1630)
Q Consensus 276 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGv 355 (1630)
.++.+||+|||+++....... ........+++.|+|||.+.+.. |+.++||||||+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~l~~~~------------y~~k~DiwS~Gv 225 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDY------------YKKTTNGRLPVKWMAPEALFDRI------------YTHQSDVWSFGV 225 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCT------------TCCCTTSCCGGGGSCHHHHHHCC------------CCHHHHHHHHHH
T ss_pred CCCCEEECCCHHHCCCCCCCC------------CCCCCCCCCCHHHHHHHHHCCCC------------CCCHHHHHHHHH
T ss_conf 789767622111011355555------------43146678884663266751798------------882555477588
Q ss_pred HHHHHHH-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 9998840-99999899989999999822789988544357899877999999841259589988225778855102
Q 000343 356 TLVEMCT-GSIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHL 430 (1630)
Q Consensus 356 iL~Ellt-G~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l 430 (1630)
++|||++ |.+||.+.+..+++..+..+...+ .+..+++++.+||.+||+.||.+|||+.++++.|.+..
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCC------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 88874017989899999999999997288889------87435299999999976679767939999999998886
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=341.66 Aligned_cols=288 Identities=17% Similarity=0.199 Sum_probs=217.7
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 34578289988476785029995279814436689589999963157689668999999999811599882216799994
Q 000343 133 GVHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 133 ~~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
.+.++|++.++||+|+||.||+ |++..+++.||||.+..... ...+.+|+++++.++ .|++|+.+++++.+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~------a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~-~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYL------GTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ-GGVGIPTIRWCGAE 74 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEE------EEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHST-TSTTCCCEEEEEEE
T ss_pred EECCEEEEEEEEEECCCCEEEE------EEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCC-CCCCCCEEEEEEEC
T ss_conf 1888899968985078809999------99988998999999721005--888999999999703-89960179999951
Q ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEEEECCEEE
Q ss_conf 9979999935899838899870799999999999999999999999499733202355469878---9969994021003
Q 000343 213 DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA---SGRAVVSDYGLAA 289 (1630)
Q Consensus 213 ~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~---~g~vKL~DFGla~ 289 (1630)
....++||||+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+
T Consensus 75 ~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CCEEEEEEEECCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCE
T ss_conf 98778999873871333244306887689999999999999999997994426678766064335777615650467513
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 40575345799888977743344444489887896433632112454556767789442010136699988409999989
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~ 369 (1630)
.+....... ...........||+.|+|||++.+.. ++.++|||||||++|||++|..||..
T Consensus 155 ~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 155 KYRDARTHQ-------HIPYRENKNLTGTARYASINTHLGIE------------QSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp ECBCTTTCC-------BCCCCBCCSCCCCSSSCCHHHHTTBC------------CCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ECCCCCCCC-------CEECCCCCCCCCCCCCCCHHHHHCCC------------CCCHHHEEECCHHHHHHHHCCCCCCC
T ss_conf 425544554-------10001357767873532999991899------------89832188617789999849876655
Q ss_pred CCHHHHHHHHHHCCC-CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf 998999999982278-9988544357899877999999841259589988225778855102578999999999896433
Q 000343 370 LSAEEIYRAVVKNRK-LPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPASPDTGFTKF 448 (1630)
Q Consensus 370 ~~~~ei~~~I~~~~~-~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~l~~~pp~~~s~~~~kF 448 (1630)
.........+..... ............+|+++.+||.+||+.||.+||++.++.+.|...+.....+...+.++...++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~ 295 (299)
T d1ckia_ 216 LKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295 (299)
T ss_dssp CC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGG
T ss_pred CCHHHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHCC
T ss_conf 30577999999852356789835753478899999999984399557919999999999999976999788938544367
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=337.13 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=205.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE
Q ss_conf 45782899884767850299952798144366895899999631576-89668999999999811599882216799994
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM 212 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~ 212 (1630)
+..+|+++++||+|+||.||+ |.++.+++.||||++.+... .....+.+|+.+|+.++ ||||+++++++..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~--hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCS------AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR--HENIIGINDIIRA 77 (345)
T ss_dssp CCTTEEEEEECC---CCCEEE------EEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC--CTTBCCCCEEECC
T ss_pred CCCCEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCC--CCCCCCEEEEEEE
T ss_conf 389859978994064809999------99999994999999803109589999999999999768--9898858889950
Q ss_pred CC-----EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCE
Q ss_conf 99-----7999993589983889987079999999999999999999999949973320235546987899699940210
Q 000343 213 DS-----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGL 287 (1630)
Q Consensus 213 ~~-----~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGl 287 (1630)
.. .+|++|+++ ++.|..++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~~~l~~~~~-~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLM-GADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp SSTTTCCCEEEEEECC-CEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCCCCEEEEEEEEC-CCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 5645541499999625-9865664405-8999999999999999999999978986777876437887999778754570
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 03405753457998889777433444444898878964336321124545567677894420101366999884099999
Q 000343 288 AAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW 367 (1630)
Q Consensus 288 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF 367 (1630)
|......... .......+||+.|+|||++..... ++.++||||+||++|+|++|..||
T Consensus 156 a~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~l~~~~~-----------~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 156 ARVADPDHDH-----------TGFLTEYVATRWYRAPEIMLNSKG-----------YTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp CEECCGGGCB-----------CCTTCCCCSCGGGCCGGGTTTBCS-----------CSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEECCCCCCC-----------CEEECCCCCCCEECHHHHHHCCCC-----------CCCHHHHHCCCCEEHHHHHCCCCC
T ss_conf 5650477764-----------101011026520003878604788-----------874101004670133776697997
Q ss_pred CCCCHHHHHHHHHHCCCCC------------------------CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 8999899999998227899------------------------8854435789987799999984125958998822577
Q 000343 368 AGLSAEEIYRAVVKNRKLP------------------------PQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAML 423 (1630)
Q Consensus 368 ~~~~~~ei~~~I~~~~~~~------------------------~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL 423 (1630)
.+.+..+...........+ ........+.+++++.+||.+||+.||.+|||+.++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 88888999998765206997566423433222202446775577877783789999999999997648956790899986
Q ss_pred HHHH
Q ss_conf 8855
Q 000343 424 ATFL 427 (1630)
Q Consensus 424 ~~L~ 427 (1630)
+|.+
T Consensus 294 ~hpf 297 (345)
T d1pmea_ 294 AHPY 297 (345)
T ss_dssp TSGG
T ss_pred CCHH
T ss_conf 1986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=344.02 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=211.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 578289988476785029995279814436689589999963157689---66899999999981159988221679999
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME---PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~---~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
.++|++.++||+|+||.||. ..+... ......||||.+.+..... .+.+.+|+.+|+.++ ||||+++++++.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~--~~~~~~-~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~~~g~~~ 81 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRR--GEWDAP-SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD--HRNLIRLYGVVL 81 (273)
T ss_dssp GGGEEEEEECC----CCCEE--EEEECT-TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC--CTTBCCEEEEEC
T ss_pred HHHEEEEEEEECCCCEEEEE--EEEECC-CCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE
T ss_conf 48919978980388839999--999889-9907999999998355579899999999999998689--999878987774
Q ss_pred ECCEEEEEEECCCCCHHH-HHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf 499799999358998388-9987079999999999999999999999949973320235546987899699940210034
Q 000343 212 MDSCLGLVMDRCYGSVQL-AMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~-~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+ ..+++||||++++.+. .+..+.+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred E-CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 0-100114654238612544421268999999999999999999875217875205668881565565433256115553
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCC
Q ss_conf 057534579988897774334444448988789643363211245455676778944201013669998840-9999989
Q 000343 291 LKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAG 369 (1630)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~ 369 (1630)
...... .........|+..|+|||++.+.. ++.++||||||+++|||++ |.+||.+
T Consensus 161 ~~~~~~-----------~~~~~~~~~~~~~~~aPE~~~~~~------------~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 161 LPQNDD-----------HYVMQEHRKVPFAWCAPESLKTRT------------FSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CCC-CC-----------EEEC-----CCGGGCCHHHHHHCE------------EEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCCC-----------CCEECCCCCCCCCCCCHHHHHCCC------------CCCCHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 035887-----------526547632573107999983799------------994215661489999999689999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 99899999998227899885443578998779999998412595899882257788551
Q 000343 370 LSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 370 ~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
.+..+.+..+......++. +..+|+++.+||.+||+.||.+|||+.++++.|.+
T Consensus 218 ~~~~~~~~~i~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 218 LNGSQILHKIDKEGERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCHHHHHHHHHTSCCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 6999999999847999998-----54453999999999768896679299999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=330.96 Aligned_cols=259 Identities=21% Similarity=0.344 Sum_probs=212.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 78289988476785029995279814436689589999963157689--6689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|+++++||+|+||.||+ |.++.+++.||||+++...... ...+.+|+.+|+.++ ||||+++++++.+.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~------~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFK------AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--HKNIVRLHDVLHSD 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEE------EEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC--CTTBCCEEEEEECS
T ss_pred CCCEEEEEEECCCCEEEEE------EEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCC
T ss_conf 9978626971286819999------999999969999998032178689999999999998567--57888213544444
Q ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 97999993589983889987079999999999999999999999949973320235546987899699940210034057
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
..++++||++.++++..+....+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+....
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCEEEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCC
T ss_conf 31158863023322211212356540367899999999998774339986001467612113378266520460110468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC-CCCCH
Q ss_conf 53457998889777433444444898878964336321124545567677894420101366999884099999-89998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPW-AGLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF-~~~~~ 372 (1630)
... ......++..|+|||++..... ++.++||||+||++|||++|..|| .+.+.
T Consensus 154 ~~~--------------~~~~~~~~~~~~~pe~~~~~~~-----------~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 154 PVR--------------CYSAEVVTLWYRPPDVLFGAKL-----------YSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp CCS--------------CCCSCCSCGGGCCHHHHTTCSC-----------CCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred CCC--------------CCEEECCCCCHHHHHHHCCCCC-----------CCCHHHCCCCCHHHHHHHHCCCCCCCCCCH
T ss_conf 875--------------1001034431014667506988-----------880444026541889985189999889999
Q ss_pred HHHHHHHHHCCCCCC----------------------CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 999999982278998----------------------8544357899877999999841259589988225778855
Q 000343 373 EEIYRAVVKNRKLPP----------------------QYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~----------------------~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
.+.+..+......+. .........+++++.+||.+||+.||.+|||+.|+|+|.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 99999998611899735513443222113344454431043306568999999999986499668909999964953
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=339.18 Aligned_cols=263 Identities=19% Similarity=0.222 Sum_probs=211.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC----CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 78289988476785029995279814436689589999963157----68966899999999981159988221679999
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE----EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~----~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
++|+++++||+|+||.||+.. ...++.+++.||+|.+++.. ....+.+.+|+++|++++ +||||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~---~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~-h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVR---KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEE---ECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-TCTTBCCEEEEEE
T ss_pred HCEEEEEEEECCCCEEEEEEE---ECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC
T ss_conf 025999898328783999999---876588794899999836772101689999999999998646-7983999620002
Q ss_pred ECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEE
Q ss_conf 49979999935899838899870799999999999999999999999499733202355469878996999402100340
Q 000343 212 MDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 212 ~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
+...+|++|||+.++.+..++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 48730012312341179999873045437888888999999998851499896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
.... ........|++.|+|||.+.+... .++.++||||+||+||+|++|..||.+.+
T Consensus 180 ~~~~-------------~~~~~~~~g~~~~~~pe~~~~~~~----------~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 180 VADE-------------TERAYDFCGTIEYMAPDIVRGGDS----------GHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp CGGG-------------GGGGCGGGSCCTTCCHHHHTTCC-------------CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CCCC-------------CCCCCCCCCCCCCCHHHHHHCCCC----------CCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 3444-------------432212223333310687605776----------88713251777799999976899988887
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHH
Q ss_conf 89999999822789988544357899877999999841259589988-----2257788551
Q 000343 372 AEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPT-----FSAMLATFLR 428 (1630)
Q Consensus 372 ~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPS-----a~eiL~~L~~ 428 (1630)
..+....+.+...... ...+..+++++.+||.+||++||.+||| +.|+++|.+.
T Consensus 237 ~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 237 EKNSQAEISRRILKSE---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp SCCCHHHHHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHHHHHHHHCCCCC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHH
T ss_conf 7779999998335689---9886547999999999974458988199974509999749723
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-42 Score=337.49 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=214.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCC-CCCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf 782899884767850299952798144-366895899999631576-896689999999998115998822167999949
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEE-MEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD 213 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~-~~~~g~~VAIK~i~~~~~-~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~ 213 (1630)
++|++.++||+|+||.||. ..+.+. ....+..||||+++.... .....+.+|+.++++++ ||||+++++++...
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~--a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYE--GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN--CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGEEEEEEEEECSSSEEEE--EEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC--CTTBCCEEEEECSS
T ss_pred HHEEEEEEEEECCCEEEEE--EEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEECC
T ss_conf 9918835982078818999--9987864477896899999870128689999999999999769--99884125478428
Q ss_pred CEEEEEEECCCCCHHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 979999935899838899870----------7999999999999999999999994997332023554698789969994
Q 000343 214 SCLGLVMDRCYGSVQLAMQRN----------EGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVS 283 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~----------~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~ 283 (1630)
..+++||||+.++++..+... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEE
T ss_conf 81067776048998899987503321134446887999999999999999998764796543286775403599649994
Q ss_pred ECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 02100340575345799888977743344444489887896433632112454556767789442010136699988409
Q 000343 284 DYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTG 363 (1630)
Q Consensus 284 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG 363 (1630)
|||+|+.+.... .........+|+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 176 DFGla~~~~~~~------------~~~~~~~~~~t~~y~aPe~l~~~~------------~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 176 DFGMTRDIYETD------------YYRKGGKGLLPVRWMSPESLKDGV------------FTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp CTTCCCGGGGGG------------CEEGGGSSEECGGGCCHHHHHHCC------------CCHHHHHHHHHHHHHHHHHT
T ss_pred ECCCCEECCCCC------------CEEECCCEECCCCCCCHHHHCCCC------------CCCCCCCCCHHHHHHHHHHC
T ss_conf 245420235776------------303134023163237888873699------------88333444378999999968
Q ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf -99998999899999998227899885443578998779999998412595899882257788551025
Q 000343 364 -SIPWAGLSAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQ 431 (1630)
Q Consensus 364 -~~PF~~~~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~ 431 (1630)
.+||.+.+..+.+..+..+...+. +..+++.+.++|.+||+.||.+|||+.+++++|....+
T Consensus 232 ~~~p~~~~~~~~~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 232 AEQPYQGLSNEQVLRFVMEGGLLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 9999999899999999980888888------63353999999999757796589399999999787617
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=335.32 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=202.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC-
Q ss_conf 5782899884767850299952798144366895899999631576896689999999998115998822167999949-
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMD- 213 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~- 213 (1630)
.++|+++++||+|+||.||+ |+++.+++.||||+++.. ....+.+|+++|+.++ .||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~------a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~-~hpnIv~~~~~~~~~~ 103 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFE------AINITNNEKVVVKILKPV---KKKKIKREIKILENLR-GGPNIITLADIVKDPV 103 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEE------EEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHT-TSTTBCCEEEEEECTT
T ss_pred CCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCC-CCCCCCEEEEEEEECC
T ss_conf 86718978983174819999------998899979999998889---9999999999998515-7998767999998168
Q ss_pred -CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEEEECCEEEEE
Q ss_conf -97999993589983889987079999999999999999999999949973320235546987899-6999402100340
Q 000343 214 -SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASG-RAVVSDYGLAAIL 291 (1630)
Q Consensus 214 -~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g-~vKL~DFGla~~~ 291 (1630)
..+|+||||+.++++..+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 104 ~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 104 SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred CCCEEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 77126888631798589974---689999999999999999988764334434564412377489983664156542664
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840999998999
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAGLS 371 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~~~ 371 (1630)
.... .....++|+.|+|||++.+... ++.++||||+||++|+|++|..||....
T Consensus 181 ~~~~---------------~~~~~~~t~~y~aPE~~~~~~~-----------~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 181 HPGQ---------------EYNVRVASRYFKGPELLVDYQM-----------YDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CTTC---------------CCCSCCSCGGGCCHHHHTTCCC-----------CCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCC---------------CCCCCCCCCCCCCCCCCCCCCC-----------CCCCCCHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 6887---------------4443224864247610268888-----------8845232335455587604889998876
Q ss_pred -HHHHHHHHHHC-------------C-CCCCC----------------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf -89999999822-------------7-89988----------------54435789987799999984125958998822
Q 000343 372 -AEEIYRAVVKN-------------R-KLPPQ----------------YASIVGVGIPRELWKMIGECLQFKASKRPTFS 420 (1630)
Q Consensus 372 -~~ei~~~I~~~-------------~-~~~~~----------------~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~ 420 (1630)
..+....+... . ...+. ........+++++.+||.+||.+||.+|||+.
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 01899999999878841555554225444743000003334331121155211244899999999998669956890899
Q ss_pred HHHHHHHH
Q ss_conf 57788551
Q 000343 421 AMLATFLR 428 (1630)
Q Consensus 421 eiL~~L~~ 428 (1630)
|+|+|.+.
T Consensus 315 e~L~Hp~F 322 (328)
T d3bqca1 315 EAMEHPYF 322 (328)
T ss_dssp HHHTSGGG
T ss_pred HHHCCCCC
T ss_conf 99649355
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-40 Score=329.12 Aligned_cols=275 Identities=17% Similarity=0.246 Sum_probs=217.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 57828998847678502999527981443668958999996315768966899999999981159988221679999499
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
.++|++.++||+|+||.||+ |++..+++.||+|.+.... ....+.+|++++..++ +|+||+.+++++....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~------a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFE------GTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLA-GCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEE------EEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTT-TCTTCCCEEEEEEETT
T ss_pred CCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCC
T ss_conf 98069979984178829999------9998899799999975025--8299999999999964-8999877999960188
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC-----CCCEEEEECCEEE
Q ss_conf 79999935899838899870799999999999999999999999499733202355469878-----9969994021003
Q 000343 215 CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDA-----SGRAVVSDYGLAA 289 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~-----~g~vKL~DFGla~ 289 (1630)
..|+||||+.+++...+......++...+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred CCEEEEEECCCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 11799996488879999752031106899999999999999999779662667713152347543447956872366057
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 40575345799888977743344444489887896433632112454556767789442010136699988409999989
Q 000343 290 ILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWAG 369 (1630)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~~ 369 (1630)
......... ..........+||+.|||||++.+.. ++.++||||||+++|||++|..||.+
T Consensus 155 ~~~~~~~~~-------~~~~~~~~~~~GT~~y~aPE~~~~~~------------~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 155 FYRDPVTKQ-------HIPYREKKNLSGTARYMSINTHLGRE------------QSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp ESBCTTTCC-------BCCCCCCCCCCSCTTTCCHHHHTTCC------------CCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ECCCCCCCC-------CEEECCCCCEEECHHHCCHHHHCCCC------------CCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 714676654-------11102467627751026798964888------------88699989831999999869876788
Q ss_pred C---CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 9---989999999822789988544357899877999999841259589988225778855102578999999
Q 000343 370 L---SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQELPRSPPA 439 (1630)
Q Consensus 370 ~---~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~l~~~pp~ 439 (1630)
. +....+..+.......+ ...+...+|+++.+++..|+..+|++||++..+.+.|.+.++......+.
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~--~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~ 286 (293)
T d1csna_ 216 LKAATNKQKYERIGEKKQSTP--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286 (293)
T ss_dssp CCSCCHHHHHHHHHHHHHHSC--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred CCCHHHHHHHHHHHHCCCCCC--HHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
T ss_conf 530219999999970567999--58965799899999999984399300859999999999999975999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=337.20 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=208.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 4578289988476785029995279814436689589999963157689--66899999999981159988221679999
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEME--PDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~--~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
..++|+++++||+|+||+||+ |+++.+++.||||++....... ...+.+|+.+|+.++ ||||++++++|.
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~------~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~~~~~f~ 86 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCA------AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN--HKNIISLLNVFT 86 (355)
T ss_dssp EETTEEEEEECSCC--CEEEE------EEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEEC
T ss_pred ECCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE
T ss_conf 337759988962175859999------999999989999998823369799999999999998648--987648998970
Q ss_pred E------CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 4------9979999935899838899870799999999999999999999999499733202355469878996999402
Q 000343 212 M------DSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDY 285 (1630)
Q Consensus 212 ~------~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DF 285 (1630)
. ...+|+||||+.++++..+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCCCCCCCEEEEEEECCCHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECH
T ss_conf 256434576269998414467787650---38999999999999999998865221124567763211365443132010
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 10034057534579988897774334444448988789643363211245455676778944201013669998840999
Q 000343 286 GLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSI 365 (1630)
Q Consensus 286 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~ 365 (1630)
|+++...... .....++|+.|+|||++.+.. +++++||||+||++|+|++|++
T Consensus 164 ~~~~~~~~~~---------------~~~~~~~t~~y~aPE~l~~~~------------~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 164 GLARTAGTSF---------------MMTPYVVTRYYRAPEVILGMG------------YKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp CC------------------------------CCTTCCHHHHTTCC------------CCTTHHHHHHHHHHHHHHHSSC
T ss_pred HHHHCCCCCC---------------CCCCCCCCCCCCCHHHHCCCC------------CCCCCCCCCCCCHHHHHHHCCC
T ss_conf 2321146665---------------533221465555813314777------------7877433356625789865989
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCC-------------------C-----C-----C------CCCCCCCHHHHHHHHHHHC
Q ss_conf 99899989999999822789988-------------------5-----4-----4------3578998779999998412
Q 000343 366 PWAGLSAEEIYRAVVKNRKLPPQ-------------------Y-----A-----S------IVGVGIPRELWKMIGECLQ 410 (1630)
Q Consensus 366 PF~~~~~~ei~~~I~~~~~~~~~-------------------~-----~-----~------~~~~~~s~el~~LI~~cL~ 410 (1630)
||.+.+.......+......+.. . . . ......++++.+||.+||.
T Consensus 217 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 296 (355)
T d2b1pa1 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 98889778899999972058987999876566777764175435666421264333543210133379999999999876
Q ss_pred CCCCCCCCHHHHHHHHHHC
Q ss_conf 5958998822577885510
Q 000343 411 FKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 411 ~dP~~RPSa~eiL~~L~~~ 429 (1630)
.||++|||+.|+|+|.+..
T Consensus 297 ~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 297 IDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp SSTTTSCCHHHHHTSTTTG
T ss_pred CCHHHCCCHHHHHCCCCCC
T ss_conf 9945790899996694208
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=337.87 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=207.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-C
Q ss_conf 578289988476785029995279814436689589999963157689668999999999811599882216799994-9
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-D 213 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~-~ 213 (1630)
.++|++.++||+|+||.||. |.. .+..||||.++.. ...+.+.+|++++++++ ||||+++++++.+ .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~------~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVML------GDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLR--HSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEE------EEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCC--CTTBCCEEEEECCC-
T ss_pred HHHEEEEEEEECCCCEEEEE------EEE--CCEEEEEEEECCH--HHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECC
T ss_conf 89948857982079808999------999--9909999998857--77999999999998678--989854987887238
Q ss_pred CEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEE
Q ss_conf 9799999358998388998707--99999999999999999999999499733202355469878996999402100340
Q 000343 214 SCLGLVMDRCYGSVQLAMQRNE--GRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAIL 291 (1630)
Q Consensus 214 ~~~~LVmEy~~gsll~~l~~~~--~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~ 291 (1630)
..+|+||||++++++..++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEEC
T ss_conf 92899996369998999987457888899999999999985232113376553666567601468997763245600344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 57534579988897774334444448988789643363211245455676778944201013669998840-99999899
Q 000343 292 KKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT-GSIPWAGL 370 (1630)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt-G~~PF~~~ 370 (1630)
... .....++..|+|||++.+.. +++++||||||+++|||++ |.+||...
T Consensus 154 ~~~-----------------~~~~~~~~~y~aPE~l~~~~------------~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 154 SST-----------------QDTGKLPVKWTAPEALREKK------------FSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------CCTTTSCHHHHHHCC------------CCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred CCC-----------------CCCCCCCCCCCCHHHHHCCC------------CCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 787-----------------76556664677817872798------------8858877757999999997899999999
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC
Q ss_conf 98999999982278998854435789987799999984125958998822577885510
Q 000343 371 SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRH 429 (1630)
Q Consensus 371 ~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~ 429 (1630)
+..+++..+..+...+ .+..+++++.+||.+||+.||.+|||+.+++++|...
T Consensus 205 ~~~~~~~~i~~~~~~~------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 205 PLKDVVPRVEKGYKMD------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CGGGHHHHHTTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9999999998089999------9765799999999997566976893999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=333.60 Aligned_cols=257 Identities=21% Similarity=0.243 Sum_probs=207.2
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
Q ss_conf 457828998847678502999527981443668958999996315768--966899999999981159988221679999
Q 000343 134 VHHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM--EPDWLSGQLDNLRRASMWCRNVCTFHGVLR 211 (1630)
Q Consensus 134 ~~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~--~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~ 211 (1630)
+.++|+++++||+|+||.||+ |+++.+++.||||++.+.... ....+.+|+.+|+.++ ||||++++++|.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~------a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~--h~~iv~~~~~~~ 87 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCA------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK--HENVIGLLDVFT 87 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEE------EEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC--CTTBCCCSEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEE------EEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEE
T ss_conf 898718888983178839999------999999979999998820028689999999999998668--987425999996
Q ss_pred EC-----CEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECC
Q ss_conf 49-----9799999358998388998707999999999999999999999994997332023554698789969994021
Q 000343 212 MD-----SCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYG 286 (1630)
Q Consensus 212 ~~-----~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFG 286 (1630)
.. ...+++|+|+.+++|..+... .++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ECCCCCCCCEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3464566864999996258862320022-453099999999999999999973887651667763345543220013210
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 00340575345799888977743344444489887896433632112454556767789442010136699988409999
Q 000343 287 LAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIP 366 (1630)
Q Consensus 287 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~P 366 (1630)
++...... .....|++.|+|||++.+..+ ++.++||||+||++|+|++|.+|
T Consensus 167 ~a~~~~~~-----------------~~~~~g~~~y~apE~~~~~~~-----------~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 167 LARHTDDE-----------------MTGYVATRWYRAPEIMLNWMH-----------YNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp ---CCTGG-----------------GSSSCHHHHTSCHHHHTTCSC-----------CCTTHHHHHHHHHHHHHHHSSCS
T ss_pred HHCCCCCC-----------------CCCCCCCCCCCCCHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHCCCC
T ss_conf 00125754-----------------444345435558355337756-----------78551243205899999768899
Q ss_pred CCCCCHHHHHHHHHHCCCCCCC------------------------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 9899989999999822789988------------------------5443578998779999998412595899882257
Q 000343 367 WAGLSAEEIYRAVVKNRKLPPQ------------------------YASIVGVGIPRELWKMIGECLQFKASKRPTFSAM 422 (1630)
Q Consensus 367 F~~~~~~ei~~~I~~~~~~~~~------------------------~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~ei 422 (1630)
|.+.+.......+......+.. ........+++++.+||.+||..||.+|||+.|+
T Consensus 219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el 298 (348)
T d2gfsa1 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298 (348)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 78898899999999730799757732001024454443035578755566267899999999999775883459389998
Q ss_pred HHHHH
Q ss_conf 78855
Q 000343 423 LATFL 427 (1630)
Q Consensus 423 L~~L~ 427 (1630)
|+|-+
T Consensus 299 L~Hp~ 303 (348)
T d2gfsa1 299 LAHAY 303 (348)
T ss_dssp HTSGG
T ss_pred HCCHH
T ss_conf 55995
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=328.63 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=206.5
Q ss_pred CEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCC-CCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-CC
Q ss_conf 8289988476785029995279814436689589999963157-689668999999999811599882216799994-99
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAE-EMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRM-DS 214 (1630)
Q Consensus 137 ~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~-~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~-~~ 214 (1630)
.+.+.++||+|+||+||. ..+.. ...+...||||+++... ......+.+|+++|.+++ ||||+++++++.. +.
T Consensus 28 ~~~~~~~iG~G~fg~Vyk--~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYH--GTLLD-NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS--HPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEEEETTEEEEE--EEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC--CTTBCCCCEEEEETTT
T ss_pred EECCCEEEEECCCEEEEE--EEEEC-CCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEEEECCC
T ss_conf 552666981368809999--99977-998799999999884369789999999999998678--9998678678980699
Q ss_pred EEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCEEEEECC
Q ss_conf 7999993589983889987-079999999999999999999999949973320235546987899699940210034057
Q 000343 215 CLGLVMDRCYGSVQLAMQR-NEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGRAVVSDYGLAAILKK 293 (1630)
Q Consensus 215 ~~~LVmEy~~gsll~~l~~-~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~vKL~DFGla~~~~~ 293 (1630)
.+++|||||+++++..+.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred CEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCC
T ss_conf 43899987406741442101345404899999999988765200336762577668757677999889910652322556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC-CCCH
Q ss_conf 534579988897774334444448988789643363211245455676778944201013669998840999998-9998
Q 000343 294 PACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCTGSIPWA-GLSA 372 (1630)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~ElltG~~PF~-~~~~ 372 (1630)
.... .........||+.|+|||.+.... ++.++||||||+++|||++|..||. ..+.
T Consensus 183 ~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~------------~~~ksDI~SfGivl~El~t~~~p~~~~~~~ 240 (311)
T d1r0pa_ 183 KEFD----------SVHNKTGAKLPVKWMALESLQTQK------------FTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240 (311)
T ss_dssp TTCC----------CTTCTTCSSCCGGGSCHHHHHHCC------------CCHHHHHHHHHHHHHHHHTTSCCSCC----
T ss_pred CCCC----------CCEECCCCCCCCCCCCHHHHHCCC------------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 6555----------310025655564556768874379------------997457466199999999789999888999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 999999982278998854435789987799999984125958998822577885510257
Q 000343 373 EEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFLRHLQE 432 (1630)
Q Consensus 373 ~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~~l~~ 432 (1630)
.++...+..+.... .+..+++++.+||.+||+.||.+|||+.+++++|....+.
T Consensus 241 ~~~~~~i~~g~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 241 FDITVYLLQGRRLL------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99999998089889------9644759999999997688976893999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=328.88 Aligned_cols=269 Identities=20% Similarity=0.211 Sum_probs=199.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
Q ss_conf 57828998847678502999527981443668958999996315768966899999999981159988221679999499
Q 000343 135 HHDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDS 214 (1630)
Q Consensus 135 ~~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~ 214 (1630)
.++|.+.++||+|+||.||. |. .++..||||.+... ......+|.+++...+++||||+++++++.+..
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~------~~--~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWR------GK--WRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEE------EE--ETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCEEEEEEEEEECCCEEEEE------EE--ECCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 86899988982078819999------99--99989999998720---046799999999996279986832688998379
Q ss_pred ----EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCEEE
Q ss_conf ----799999358998388998707999999999999999999999994--------99733202355469878996999
Q 000343 215 ----CLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA--------AGVVCMNIKPSNLLLDASGRAVV 282 (1630)
Q Consensus 215 ----~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs--------~gIIHrDLKP~NILld~~g~vKL 282 (1630)
.+|+||||++++++..++.+. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEE
T ss_conf 8604899999646698989998658-999899999999999999998876652046898661531731357868877688
Q ss_pred EECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 40210034057534579988897774334444448988789643363211245455676778944201013669998840
Q 000343 283 SDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFGCTLVEMCT 362 (1630)
Q Consensus 283 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlGviL~Ellt 362 (1630)
+|||+++....... ..........||+.|+|||++.+.... ....++.++|||||||++|||++
T Consensus 150 ~DFGl~~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 150 ADLGLAVRHDSATD----------TIDIAPNHRVGTKRYMAPEVLDDSINM------KHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCCTTCEEEETTTT----------EECC----CCSCGGGCCHHHHTTCSCT------TCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCCCCCCCCC----------CEECCCCCEECCCCCCCHHHCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 76386623467776----------200135525035476782210565454------67776750122015999999962
Q ss_pred CCCCCCCC---------------CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 99999899---------------989999999822789988544357899877999999841259589988225778855
Q 000343 363 GSIPWAGL---------------SAEEIYRAVVKNRKLPPQYASIVGVGIPRELWKMIGECLQFKASKRPTFSAMLATFL 427 (1630)
Q Consensus 363 G~~PF~~~---------------~~~ei~~~I~~~~~~~~~~~~~~~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~ 427 (1630)
|.+||... +.......+......+...........+..+.+|+.+||+.||.+|||+.|++++|.
T Consensus 214 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 89988766311241012255643099999987502468887765577689999999999976069858959999999999
Q ss_pred HCCC
Q ss_conf 1025
Q 000343 428 RHLQ 431 (1630)
Q Consensus 428 ~~l~ 431 (1630)
+..+
T Consensus 294 ~i~~ 297 (303)
T d1vjya_ 294 QLSQ 297 (303)
T ss_dssp HHHH
T ss_pred HHHH
T ss_conf 8888
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-36 Score=291.95 Aligned_cols=257 Identities=17% Similarity=0.208 Sum_probs=191.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHC---------CCCCCCCEE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811---------599882216
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRAS---------MWCRNVCTF 206 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~---------l~HpNIV~L 206 (1630)
.+|+++++||+|+||.||+ |.++.+++.||||++++... ..+...+|+.+++.+. ++|+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~------~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWL------AKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEE------EEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCEEEEEEEEECCCEEEEE------EEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEE
T ss_conf 8579989975077818999------99999997999999834313-3689999999999840145555542276764789
Q ss_pred EEEEEE--CCEEEEEEECCCCC--HHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCC--
Q ss_conf 799994--99799999358998--3889-98707999999999999999999999994-9973320235546987899--
Q 000343 207 HGVLRM--DSCLGLVMDRCYGS--VQLA-MQRNEGRLTLEQILRYGADIARGVVELHA-AGVVCMNIKPSNLLLDASG-- 278 (1630)
Q Consensus 207 ~~~~~~--~~~~~LVmEy~~gs--ll~~-l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs-~gIIHrDLKP~NILld~~g-- 278 (1630)
++++.. ....+++|+++... .... .......+++..++.++.||+.||+|||+ .||+||||||+|||++..+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCC
T ss_conf 98763125652023432000354200000122346786899999999999998887640586465677057056305765
Q ss_pred ----CEEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf ----6999402100340575345799888977743344444489887896433632112454556767789442010136
Q 000343 279 ----RAVVSDYGLAAILKKPACRKARPECDSSRIHSCMDCTMLSPNYTAPEAWEPVKKSLNLFWDDAIGISPESDAWSFG 354 (1630)
Q Consensus 279 ----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~~~~~~~~~~~~~s~ksDVWSlG 354 (1630)
.+|++|||.+...... ....+||+.|+|||++.+.. ++.++|+||+|
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~------------~~~~~DiwSlG 216 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH-----------------YTNSIQTREYRSPEVLLGAP------------WGCGADIWSTA 216 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC-----------------CCSCCSCGGGCCHHHHHTCC------------CCTHHHHHHHH
T ss_pred CCCCEEEEEECCCCCCCCCC-----------------CCCCCCCCCCCCHHHCCCCC------------CCCCCCCCCHH
T ss_conf 64430567531442123445-----------------42236652105713214667------------77643201237
Q ss_pred HHHHHHHHCCCCCCCCCHH------HHHHHHHHCCCCC---------------------CCCCC--------------CC
Q ss_conf 6999884099999899989------9999998227899---------------------88544--------------35
Q 000343 355 CTLVEMCTGSIPWAGLSAE------EIYRAVVKNRKLP---------------------PQYAS--------------IV 393 (1630)
Q Consensus 355 viL~ElltG~~PF~~~~~~------ei~~~I~~~~~~~---------------------~~~~~--------------~~ 393 (1630)
|++++|++|+.||...+.. +............ ..... ..
T Consensus 217 ~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (362)
T d1q8ya_ 217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296 (362)
T ss_dssp HHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCC
T ss_conf 89999987889989875543210268999999983799878862453220001320122024323577644421000156
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 78998779999998412595899882257788551
Q 000343 394 GVGIPRELWKMIGECLQFKASKRPTFSAMLATFLR 428 (1630)
Q Consensus 394 ~~~~s~el~~LI~~cL~~dP~~RPSa~eiL~~L~~ 428 (1630)
....++++.+||.+||.+||.+|||+.|+|+|.+.
T Consensus 297 ~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f 331 (362)
T d1q8ya_ 297 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331 (362)
T ss_dssp CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 74358999999999877994579089999669340
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-32 Score=264.19 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=196.8
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHHCCCCCCCCC-CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 998299999983999999999981598864578-9999999899982999999999987999543333599961999999
Q 000343 510 DGQTALHLACRRGSAELVEAILEYSQENVDVLD-KDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCA 588 (1630)
Q Consensus 510 ~G~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d-~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa 588 (1630)
++.|+||.|+++|+.++|++||+. |+++|..+ ..|.||||+|+..|+.+++++|++.+++..... ....++.+.|+
T Consensus 4 ~~~~~L~~Ai~~~~~e~vk~Ll~~-G~din~~~~~~g~tpL~~A~~~~~~eiv~~L~~~~~~~~~~~--~~~~~~~~~~~ 80 (285)
T d1wdya_ 4 EDNHLLIKAVQNEDVDLVQQLLEG-GANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRK--KNGATPFLLAA 80 (285)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHT-TCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC--TTCCCHHHHHH
T ss_pred CCCHHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHCCCCCCCCCCC--CCCCHHHHHHH
T ss_conf 884899999982999999999987-989682489999799999998599988655202343222222--11111467776
Q ss_pred HCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCC--------CCCCCCCCCHHHHHHHCCC
Q ss_conf 82998999999986999998789888800034431894799999980995532--------0024799968889998099
Q 000343 589 YHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSM--------AILNSKELTPLHLCVATWN 660 (1630)
Q Consensus 589 ~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di--------~~~d~~G~TPLh~Aa~~g~ 660 (1630)
..+..+....++.+..+....+..+.++|+.|+..++...+..++......+. ......|.||||+|+..++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~ 160 (285)
T d1wdya_ 81 IAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGH 160 (285)
T ss_dssp HHTCHHHHHHHHHTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCCCCHHHHHTTCCCCCHHHHHHHHTC
T ss_pred HCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHCCC
T ss_conf 43875322113431022101356898636788874001254454431001132321012222201468569999998689
Q ss_pred HHHHHHHHHHC-CCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHH
Q ss_conf 99999999705-94211023589999760899999840573102499999999629999821014760023665159899
Q 000343 661 VAVVKRWVEVA-SPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVE 739 (1630)
Q Consensus 661 ~~ivk~LL~~g-a~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~e 739 (1630)
.++++.|++.. ++. +..+.. ..++...... .........++++|+++|++++.++..|.||||.|+..++.+
T Consensus 161 ~~~~~~Ll~~~~~~i---~~~~~~--~~~~~~~~~~--~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~ 233 (285)
T d1wdya_ 161 VEVLKILLDEMGADV---NACDNM--GRNALIHALL--SSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLG 233 (285)
T ss_dssp HHHHHHHHHTSCCCT---TCCCTT--SCCHHHHHHH--CSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHH
T ss_pred HHHHHHHHHCCCCCC---CCCCCC--CCCCCCCCCC--CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCHH
T ss_conf 999999984569894---554678--9833223322--343017999999999779998866899998241122138699
Q ss_pred HHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 9999998-7999543568999788999984999999999969999776789
Q 000343 740 LVKIILD-AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDD 789 (1630)
Q Consensus 740 iVklLL~-~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~ 789 (1630)
++++||+ .|+|+|.+|.+|.||||+|+..++.+++++||++|||+|++|.
T Consensus 234 ~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 234 LVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp HHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred HHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCC
T ss_conf 999999808999868799998999999985979999999987989986017
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-32 Score=262.03 Aligned_cols=272 Identities=23% Similarity=0.233 Sum_probs=213.7
Q ss_pred CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
Q ss_conf 99999899982999999999987999543333599961999999829989999999869999987898888000344318
Q 000343 545 GDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624 (1630)
Q Consensus 545 G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g 624 (1630)
+.|+||.|+.+|+.++|++|+++|++++.. .+..|.||||+|+..|+.+++++|++.+++.+..+..+.+|.+.|+..+
T Consensus 5 ~~~~L~~Ai~~~~~e~vk~Ll~~G~din~~-~~~~g~tpL~~A~~~~~~eiv~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (285)
T d1wdya_ 5 DNHLLIKAVQNEDVDLVQQLLEGGANVNFQ-EEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAG 83 (285)
T ss_dssp HHHHHHHHHHTTCHHHHHHHHHTTCCTTCC-CTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHT
T ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCCCCC-CCCCCCCHHHHHHHCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 848999999829999999999879896824-8999979999999859998865520234322222211111467776438
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHH
Q ss_conf 94799999980995532002479996888999809999999999705942110235899997608999998405731024
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704 (1630)
Q Consensus 625 ~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~ 704 (1630)
..+....+++... +....+..+.++++.|+..++...+..++.............
T Consensus 84 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------- 138 (285)
T d1wdya_ 84 SVKLLKLFLSKGA--DVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTK----------------------- 138 (285)
T ss_dssp CHHHHHHHHHTTC--CTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCCCC-----------------------
T ss_pred CCCCCCHHHHHCC--CCCCCCCCCCCHHHHHHHHCCHHHHHHHHHHCCCCCCCCCCH-----------------------
T ss_conf 7532211343102--210135689863678887400125445443100113232101-----------------------
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCC----CHHHHHHHHH
Q ss_conf 999999996299998210147600236651598999999998-79995435689997889999849----9999999996
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILD-AGVDVNIRNVHNTIPLHVALARG----AKSCVGLLLS 779 (1630)
Q Consensus 705 ~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~-~GADin~~d~~G~TPLH~Aa~~G----~~eiVklLL~ 779 (1630)
.. .+..+..|.||||+|+..++.+++++||+ .|++++..+..|.++++.+...+ ..+++++|++
T Consensus 139 -~~----------~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~ 207 (285)
T d1wdya_ 139 -ED----------QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLD 207 (285)
T ss_dssp -HH----------HHHTTCCCCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHH
T ss_pred -HH----------HHHHCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf -22----------2220146856999999868999999998456989455467898332233223430179999999997
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCCCCHHHHHHHHHHCCCC
Q ss_conf 99997767899992999999842378864999999950899763233789999999996299987479999999956998
Q 000343 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEGLPREWISEDLMEALMNRGVH 859 (1630)
Q Consensus 780 ~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~~gadin~kN~~GkTpL~lA~~~~~~~~~~~lve~Ll~~Ga~ 859 (1630)
+|+++|.+|..|.||||+|++.+ +.+.+..+|...|+++|.+|.+|.|||++|...+ ..++++.|+++||+
T Consensus 208 ~ga~~n~~~~~g~t~L~~a~~~~-----~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~----~~eiv~~Ll~~GAd 278 (285)
T d1wdya_ 208 HGADVNVRGERGKTPLILAVEKK-----HLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK----LKKIAELLCKRGAS 278 (285)
T ss_dssp TTCCSSCCCTTSCCHHHHHHHTT-----CHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTT----CHHHHHHHHHHSSC
T ss_pred CCCCCCCCCCCCCCCCCHHHHCC-----CHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCC----CHHHHHHHHHCCCC
T ss_conf 79998866899998241122138-----6999999998089998687999989999999859----79999999987989
Q ss_pred CCC
Q ss_conf 888
Q 000343 860 LSP 862 (1630)
Q Consensus 860 v~~ 862 (1630)
++.
T Consensus 279 ~n~ 281 (285)
T d1wdya_ 279 TDC 281 (285)
T ss_dssp SCC
T ss_pred CCC
T ss_conf 986
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-32 Score=265.32 Aligned_cols=220 Identities=27% Similarity=0.369 Sum_probs=159.6
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHC
Q ss_conf 98299999983999999999981598864578999999989998299999999998799954333359996199999982
Q 000343 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH 590 (1630)
Q Consensus 511 G~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~ 590 (1630)
..+.|+.+|..|+.+.++.+|...+.+++..|..|+||||+||..|+.+++++|+..+.+.... ...+.++++.|+..
T Consensus 3 ~~~~~~~~a~~G~~~~v~~~l~~~~~~~~~~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~ 80 (223)
T d1uoha_ 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK--DDAGWSPLHIAASA 80 (223)
T ss_dssp SSSHHHHHHHTTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCC--CTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHHCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 7799999999699999999999499747674899988899999851102433222223333322--22222332222221
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHH
Q ss_conf 99899999998699999878988880003443189479999998099553200247999688899980999999999970
Q 000343 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEV 670 (1630)
Q Consensus 591 G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ 670 (1630)
++.+++++|+++|++++..|.+|.||||+|+..++.+++++|++.|+ +++..+..|.||||+|+..++.
T Consensus 81 ~~~~i~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~--d~~~~~~~~~t~L~~a~~~~~~--------- 149 (223)
T d1uoha_ 81 GRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGA--NPDAKDHYEATAMHRAAAKGNL--------- 149 (223)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTC--CTTCCCTTSCCHHHHHHHTTCH---------
T ss_pred CCCCHHHHHHCCCCEEEEECCCCCCHHHHHHHCCCHHHHHHHHHCCC--CCCCCCCCCCCCCHHHHHCCCC---------
T ss_conf 11101677740686467548999966269887698999999998789--9987689999501023213874---------
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 59421102358999976089999984057310249999999962999982101476002366515989999999987999
Q 000343 671 ASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVD 750 (1630)
Q Consensus 671 ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GAD 750 (1630)
+++++|++.+.+++.+|..|+||||.|+..++.+++++||++|||
T Consensus 150 -----------------------------------~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad 194 (223)
T d1uoha_ 150 -----------------------------------KMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGAS 194 (223)
T ss_dssp -----------------------------------HHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred -----------------------------------CHHHHHCCCCCEEEECCCCCCCEECCCCCCCCHHHHHHHHHCCCC
T ss_conf -----------------------------------202332022320120368887411210025849999999987799
Q ss_pred CCCCCCCCCCHHHHHHHCCCHHHHHHHHH
Q ss_conf 54356899978899998499999999996
Q 000343 751 VNIRNVHNTIPLHVALARGAKSCVGLLLS 779 (1630)
Q Consensus 751 in~~d~~G~TPLH~Aa~~G~~eiVklLL~ 779 (1630)
++.+|.+|+||||+| .+|+.+++++||+
T Consensus 195 ~~~~d~~g~tpl~~A-~~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 195 IYIENKEEKTPLQVA-KGGLGLILKRMVE 222 (223)
T ss_dssp SCCCCTTSCCHHHHC-CTTHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHH-HCCCHHHHHCCCC
T ss_conf 988799999999998-7789999830047
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-33 Score=270.46 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=157.8
Q ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCC-CCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Q ss_conf 5789999999899982999999999987999543-333599961999999829989999999869999987898888000
Q 000343 540 VLDKDGDPPLVFALAAGSPECVHALIKRGANVIS-RLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLH 618 (1630)
Q Consensus 540 ~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~-~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh 618 (1630)
..+.+|.||||+||.+|+.+++++|+++|+++.. ...+..|.||||+|+..|+.+++++|+++||+++..|.+|.||||
T Consensus 4 ~i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~ 83 (255)
T d1oy3d_ 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALH 83 (255)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCHHHH
T ss_conf 58959978999999858899999999869990011575899997240687624543232222333332232222210233
Q ss_pred HHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 34431894799999980995532002479996888999809999999999705942110235899997608999998405
Q 000343 619 RAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKK 698 (1630)
Q Consensus 619 ~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~ 698 (1630)
+|+..++.+++++|++....... .....+................ .....
T Consensus 84 ~A~~~~~~~~~~~Ll~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~--- 133 (255)
T d1oy3d_ 84 LACRVRAHTCACVLLQPRPSHPR-----DASDTYLTQSQDCTPDTSHAPA----------------------AVDSQ--- 133 (255)
T ss_dssp HHTTTTCHHHHHHHSSSCCSSCC-----CC--------------------------------------------------
T ss_pred HHHCCCCHHHHHHHHHHCCCHHC-----CCCHHHHHHHHHHCCCCHHHHH----------------------HHHHH---
T ss_conf 33226825899999861420101-----2202566677652243067799----------------------99862---
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCC-CCCCCCCHHHHHHHCCCHHHHHHH
Q ss_conf 7310249999999962999982101476002366515989999999987999543-568999788999984999999999
Q 000343 699 DHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNI-RNVHNTIPLHVALARGAKSCVGLL 777 (1630)
Q Consensus 699 ~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~-~d~~G~TPLH~Aa~~G~~eiVklL 777 (1630)
..........+...+.+++.+|..|.||||+|+..++.+++++|++.+++++. .+..|.||||+|+..++.+++++|
T Consensus 134 --~~~~~~~~~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~L 211 (255)
T d1oy3d_ 134 --PNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELL 211 (255)
T ss_dssp ------------CCCGGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHH
T ss_pred --CCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf --030678998765328663310046763223332232222221000013331221334443322001233399999999
Q ss_pred HHCCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 96999977678999929999998423788649999999508997632337899
Q 000343 778 LSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSG 830 (1630)
Q Consensus 778 L~~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~~gadin~kN~~G 830 (1630)
+++|||+|.+|+.|+||||+|+..++ ..++++|+++||+ ++++|
T Consensus 212 l~~gadin~~d~~g~t~L~~A~~~~~------~~i~~~Ll~~Ga~---~~~~~ 255 (255)
T d1oy3d_ 212 LKAGADPTARMYGGRTPLGSALLRPN------PILARLLRAHGAP---EPEDG 255 (255)
T ss_dssp HHTTCCTTCCCTTSCCHHHHHHTSSC------HHHHHHHHHTTCC---CCCCC
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHCCC------HHHHHHHHHCCCC---CCCCC
T ss_conf 98789988879999999999998788------9999999976989---99998
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-32 Score=262.34 Aligned_cols=231 Identities=25% Similarity=0.306 Sum_probs=179.0
Q ss_pred HCCCCCCHHHHHHHHCCCHHHHHHHHHHCCCC---CCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 00269982999999839999999999815988---645789999999899982999999999987999543333599961
Q 000343 506 AQNADGQTALHLACRRGSAELVEAILEYSQEN---VDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPS 582 (1630)
Q Consensus 506 ~~d~~G~TpLh~Aa~~G~~eiVk~LL~~~gad---vn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T 582 (1630)
..+++|.||||+||..|+.+++++||+.+ ++ ++..|..|.||||+||..|+.+++++|+++|++++.. +..|.|
T Consensus 4 ~i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~-a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~--d~~g~t 80 (255)
T d1oy3d_ 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFS-AGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVA--ERGGHT 80 (255)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHH-TTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCC--CTTSCC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCC-CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC--CCCCCH
T ss_conf 58959978999999858899999999869-990011575899997240687624543232222333332232--222210
Q ss_pred HHHHHHHCCCHHHHHHHHHCCCCCCCCCCC----------CCCHHHHHHHCCCHHH--HHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 999999829989999999869999987898----------8880003443189479--9999980995532002479996
Q 000343 583 VAHVCAYHGQPDCMRELLLAGADPNAVDDE----------GESVLHRAVAKKYTDC--AIVILENGGCRSMAILNSKELT 650 (1630)
Q Consensus 583 ~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~----------G~TpLh~Aa~~g~~ei--vk~LL~~Ga~~di~~~d~~G~T 650 (1630)
|||+|+..++.+++++|++.+......... ..+.+..+........ ....+......+++..+..|.|
T Consensus 81 pL~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~d~~g~T 160 (255)
T d1oy3d_ 81 ALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHT 160 (255)
T ss_dssp HHHHHTTTTCHHHHHHHSSSCCSSCCCC-----------------------------------CCCGGGGTTCCCTTSCC
T ss_pred HHHHHHCCCCHHHHHHHHHHCCCHHCCCCHHHHHHHHHHCCCCHHHHHHHHHHCCHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 23333226825899999861420101220256667765224306779999862030678998765328663310046763
Q ss_pred HHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCC-CCCCCCCCH
Q ss_conf 8889998099999999997059421102358999976089999984057310249999999962999982-101476002
Q 000343 651 PLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTA-QDAQNRTAL 729 (1630)
Q Consensus 651 PLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~-~d~~G~TPL 729 (1630)
|||+|+..++.++++ +|++.+++.+. .+..|.|||
T Consensus 161 pLh~A~~~~~~~~v~--------------------------------------------~Ll~~~~~~~~~~~~~g~TpL 196 (255)
T d1oy3d_ 161 PLHVAVIHKDAEMVR--------------------------------------------LLRDAGADLNKPEPTCGRTPL 196 (255)
T ss_dssp HHHHHHHTTCHHHHH--------------------------------------------HHHHHTCCTTCCCTTTCCCHH
T ss_pred CCCCCCCCCCCCCCC--------------------------------------------CHHCCCCCCCCCCCCCCCCCC
T ss_conf 223332232222221--------------------------------------------000013331221334443322
Q ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 366515989999999987999543568999788999984999999999969999
Q 000343 730 HIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783 (1630)
Q Consensus 730 H~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GAD 783 (1630)
|+|++.++.+++++||++|+|+|.+|.+|+||||+|+.+++.+++++|+++||+
T Consensus 197 ~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTSSCHHHHHHHHHTTCC
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCC
T ss_conf 001233399999999987899888799999999999987889999999976989
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=100.00 E-value=4.8e-33 Score=269.76 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=214.8
Q ss_pred CCCCHHHHHHHHCCCCCCCCCCCHHHHHHHCCCCCCHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
Q ss_conf 03880655542101478998730335633002699829999998399999999998159886457899999998999829
Q 000343 477 SEGDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAG 556 (1630)
Q Consensus 477 ~~Gdl~~Vk~LL~~~a~~n~~~~i~~ll~~~d~~G~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G 556 (1630)
.....+.++.++....+.+....... -...+.++.|+|+.||..|+.++|++||+. |+++|..|.+|.||||+|+.+|
T Consensus 7 ~~~r~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~t~l~~A~~~G~~~~v~~Ll~~-Gadvn~~d~~G~T~L~~A~~~g 84 (291)
T d1s70b_ 7 KQKRNEQLKRWIGSETDLEPPVVKRK-KTKVKFDDGAVFLAACSSGDTEEVLRLLER-GADINYANVDGLTALHQACIDD 84 (291)
T ss_dssp HHHHHHHHHHHHHTTTSSCCSCCCCS-CCCCEECHHHHHHHHHHHTCHHHHHHHHHH-CCCTTCBCTTCCBHHHHHHHTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCHHHCC-CCCCCCCCCHHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHCC
T ss_conf 67359999999737643367112113-445688996699999985889999999987-9998866899996999998619
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCC
Q ss_conf 99999999987999543333599961999999829989999999869999987898888000344318947999999809
Q 000343 557 SPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENG 636 (1630)
Q Consensus 557 ~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~G 636 (1630)
+.+++++|+++|++.... +..+.++|+.|+..++.++++.|+++|+..+..+..+.+++++|+..++.+++..++...
T Consensus 85 ~~eiv~~Ll~~~~~~~~~--~~~~~~~L~~a~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~ 162 (291)
T d1s70b_ 85 NVDMVKFLVENGANINQP--DNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQ 162 (291)
T ss_dssp CHHHHHHHHHTTCCTTCC--CTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHH
T ss_pred CCEEEEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCC
T ss_conf 731211001222333332--223233333332222110011012467642222246764222211122200010000024
Q ss_pred CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCC
Q ss_conf 95532002479996888999809999999999705942110235899997608999998405731024999999996299
Q 000343 637 GCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGA 716 (1630)
Q Consensus 637 a~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GA 716 (1630)
+. +..........+ ........+.....
T Consensus 163 ~~-~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~~ 190 (291)
T d1s70b_ 163 GV-DIEAARKEEERI---------------------------------------------------MLRDARQWLNSGHI 190 (291)
T ss_dssp TC-CHHHHHHHHHHH---------------------------------------------------HHHHHHHHHHHTCC
T ss_pred CC-CCCCCCCCCCCC---------------------------------------------------CCCCCHHHHCCCCC
T ss_conf 65-321100001333---------------------------------------------------22110011012321
Q ss_pred CCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Q ss_conf 99821014760023665159899999999879995435689997889999849999999999699997767899992999
Q 000343 717 EPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFH 796 (1630)
Q Consensus 717 Din~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLh 796 (1630)
+....+..|.||||.|+..++.+++++|++.|+|+|.++..|+||||+|+..|+.+++++|+++|||+|.+|+.|+||||
T Consensus 191 ~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~ 270 (291)
T d1s70b_ 191 NDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFD 270 (291)
T ss_dssp CCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTT
T ss_pred CCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCEECCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf 10024678987304888769954410134410112421257988999999859899999999879999886899999999
Q ss_pred HHHH
Q ss_conf 9998
Q 000343 797 IAAD 800 (1630)
Q Consensus 797 lAa~ 800 (1630)
+|++
T Consensus 271 ~A~e 274 (291)
T d1s70b_ 271 VADE 274 (291)
T ss_dssp SCCS
T ss_pred HHHH
T ss_conf 9999
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-31 Score=253.87 Aligned_cols=224 Identities=21% Similarity=0.296 Sum_probs=171.2
Q ss_pred CHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCC-CCCCCCCHHHHHHHHC
Q ss_conf 829999998399999999998159886457899999998999829999999999879995433-3359996199999982
Q 000343 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISR-LREGFGPSVAHVCAYH 590 (1630)
Q Consensus 512 ~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~-~~d~~G~T~Lh~Aa~~ 590 (1630)
+||||+||..|+.++++.||+..+.+++..|.+|.||||+|+..|+.+++++|+++|++++.. ..+..+.+++|+|+..
T Consensus 1 n~pLh~A~~~g~~~~v~~Ll~~~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~ 80 (229)
T d1ixva_ 1 NYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSV 80 (229)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHHCGGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHTTCTTCCGGGCCCTTSCCHHHHHHHH
T ss_pred CHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 97699999868999999999809986656599999899999986996544135443012333222322222222211112
Q ss_pred CCHHHHHHHHHCCCCCCC--CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHH
Q ss_conf 998999999986999998--789888800034431894799999980995532002479996888999809999999999
Q 000343 591 GQPDCMRELLLAGADPNA--VDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWV 668 (1630)
Q Consensus 591 G~~eivk~LL~~GADvN~--~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL 668 (1630)
+..++++.++..+++.+. .+..+.|+|+.++..++.+++++|+..+. +....+..|.||||+|+..++.++++.|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~--~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll 158 (229)
T d1ixva_ 81 GNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA--SVRIKDKFNQIPLHRAASVGSLKLIELLC 158 (229)
T ss_dssp TCHHHHHHHHSSSSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTC--CSCCCCTTSCCHHHHHHHHTCHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 3323333322222222222232233443322123200343222211002--32124788997350232124533233332
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHCCCHHHHHHHHH-
Q ss_conf 70594211023589999760899999840573102499999999629-9998210147600236651598999999998-
Q 000343 669 EVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG-AEPTAQDAQNRTALHIASMANDVELVKIILD- 746 (1630)
Q Consensus 669 ~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~G-ADin~~d~~G~TPLH~Aa~~g~~eiVklLL~- 746 (1630)
+.+ .++|.+|..|.||||+|+..++.+++++||+
T Consensus 159 --------------------------------------------~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~ 194 (229)
T d1ixva_ 159 --------------------------------------------GLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEK 194 (229)
T ss_dssp --------------------------------------------TTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHH
T ss_pred --------------------------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf --------------------------------------------222222223566667810221012519999999996
Q ss_pred CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 79995435689997889999849999999999699997
Q 000343 747 AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 747 ~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADv 784 (1630)
.|+|++.+|.+|+||||+|+. .+++++|+++|+|.
T Consensus 195 ~gad~~~~d~~g~t~l~~A~~---~~~~~~Ll~~g~d~ 229 (229)
T d1ixva_ 195 YGAEYDLVDNKGAKAEDVALN---EQVKKFFLNNVVDA 229 (229)
T ss_dssp HCCCSCCCCTTSCCTGGGCSC---HHHHHHHHHHCCCC
T ss_pred CCCCCCCCCCCCCCHHHHHHH---HHHHHHHHHCCCCC
T ss_conf 599988858999999999846---78999999769999
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-30 Score=248.68 Aligned_cols=218 Identities=23% Similarity=0.319 Sum_probs=164.0
Q ss_pred CCHHHHHHHCCCHHHHHHHH-HCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
Q ss_conf 99998999829999999999-87999543333599961999999829989999999869999987898888000344318
Q 000343 546 DPPLVFALAAGSPECVHALI-KRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKK 624 (1630)
Q Consensus 546 ~TpLh~Aa~~G~~eiVk~LL-~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g 624 (1630)
.+.|+.+|..|+.+.++.++ ..++.++. +|..|.||||+||..|+.+++++|+..+.+....+..+.++++.|+..+
T Consensus 4 ~~~~~~~a~~G~~~~v~~~l~~~~~~~~~--~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (223)
T d1uoha_ 4 NLMVCNLAYSGKLEELKESILADKSLATR--TDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAG 81 (223)
T ss_dssp SSHHHHHHHTTCHHHHHHHHHHCGGGGGC--CCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTCCCHHHHHHHHT
T ss_pred HHHHHHHHHHCCHHHHHHHHHHCCCCCCC--CCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 79999999969999999999949974767--4899988899999851102433222223333322222223322222211
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHH
Q ss_conf 94799999980995532002479996888999809999999999705942110235899997608999998405731024
Q 000343 625 YTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEG 704 (1630)
Q Consensus 625 ~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~ 704 (1630)
+.+++++|+++++ +++..+..|.||||+|+..++.
T Consensus 82 ~~~i~~~Ll~~~~--d~~~~d~~g~tpL~~A~~~~~~------------------------------------------- 116 (223)
T d1uoha_ 82 RDEIVKALLGKGA--QVNAVNQNGCTPLHYAASKNRH------------------------------------------- 116 (223)
T ss_dssp CHHHHHHHHHTTC--CTTCCCTTCCCHHHHHHHHTCH-------------------------------------------
T ss_pred CCCHHHHHHCCCC--EEEEECCCCCCHHHHHHHCCCH-------------------------------------------
T ss_conf 1101677740686--4675489999662698876989-------------------------------------------
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 99999999629999821014760023665159899999999879995435689997889999849999999999699997
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 705 ~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADv 784 (1630)
+++++|+++|+|++.++..|.||||+|+..++.+++++|++.++++|.+|.+|+||||+|+..|+.+++++|+++|||+
T Consensus 117 -e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~ 195 (223)
T d1uoha_ 117 -EIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195 (223)
T ss_dssp -HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCS
T ss_pred -HHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHCCCCCEEEECCCCCCCEECCCCCCCCHHHHHHHHHCCCCC
T ss_conf -9999999878999876899995010232138742023320223201203688874112100258499999999877999
Q ss_pred CCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHC
Q ss_conf 7678999929999998423788649999999508
Q 000343 785 NWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSH 818 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~ 818 (1630)
+.+|++|+||||+|+. +...++++|++
T Consensus 196 ~~~d~~g~tpl~~A~~-------~~~~i~~~Ll~ 222 (223)
T d1uoha_ 196 YIENKEEKTPLQVAKG-------GLGLILKRMVE 222 (223)
T ss_dssp CCCCTTSCCHHHHCCT-------THHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHC-------CCHHHHHCCCC
T ss_conf 8879999999999877-------89999830047
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.98 E-value=4.2e-31 Score=254.66 Aligned_cols=231 Identities=20% Similarity=0.255 Sum_probs=149.0
Q ss_pred CCCCHHHHHHHCCCHHHHHHH--------HHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 999999899982999999999--------987999543333599961999999829989999999869999987898888
Q 000343 544 DGDPPLVFALAAGSPECVHAL--------IKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGES 615 (1630)
Q Consensus 544 ~G~TpLh~Aa~~G~~eiVk~L--------L~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~T 615 (1630)
+|+||||+||.+|+.+++++| ++.|||+|. +|..|.||||+|+..|+.+++++|+++|||+|..+.+|.|
T Consensus 32 ~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~--~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t 109 (277)
T d2fo1e1 32 HNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNA--MDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109 (277)
T ss_dssp SCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTC--CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHCCHHHHHHCCCCCCC--CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99669999998689999999996523679876997645--4788885100343333333333332232223322222222
Q ss_pred HHHHHHHCCCHHHHHHHHHCCCC-CCCCCCCCCCCCHHHHHHHCCCHHHH---HHHHHHCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 00034431894799999980995-53200247999688899980999999---999970594211023589999760899
Q 000343 616 VLHRAVAKKYTDCAIVILENGGC-RSMAILNSKELTPLHLCVATWNVAVV---KRWVEVASPEEIVNVIDIPGPVGTALC 691 (1630)
Q Consensus 616 pLh~Aa~~g~~eivk~LL~~Ga~-~di~~~d~~G~TPLh~Aa~~g~~~iv---k~LL~~ga~~~~~~~~d~~~~~~t~L~ 691 (1630)
||++|+..++.++..++...... ..++..+....++.+.+......... ..+.......
T Consensus 110 ~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 172 (277)
T d2fo1e1 110 ALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKV----------------- 172 (277)
T ss_dssp HHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCS-----------------
T ss_pred CCCCHHHHCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCC-----------------
T ss_conf 221001100001234443114542222222221103678887503433222221001123322-----------------
Q ss_pred HHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHH-HCCCCCCCCCCCCCCHHHHHHHCCC
Q ss_conf 999840573102499999999629999821014760023665159899999999-8799954356899978899998499
Q 000343 692 MAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIIL-DAGVDVNIRNVHNTIPLHVALARGA 770 (1630)
Q Consensus 692 ~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL-~~GADin~~d~~G~TPLH~Aa~~G~ 770 (1630)
........+..+..|.||||.++..++.+++++++ ..+.+++.+|..|+||||+|+..|+
T Consensus 173 -------------------~~~~~~~~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~ 233 (277)
T d2fo1e1 173 -------------------DYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGR 233 (277)
T ss_dssp -------------------SCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTC
T ss_pred -------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCC
T ss_conf -------------------2222345554466898700001223332222232223454333468999989999998598
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHC
Q ss_conf 999999996999977678999929999998423788649999999508
Q 000343 771 KSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSH 818 (1630)
Q Consensus 771 ~eiVklLL~~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~ 818 (1630)
.+++++|+++|||+|.+|..|+||||+|++.++ . .++++|.+
T Consensus 234 ~~iv~~Ll~~gadin~~d~~G~T~L~~A~~~~~-----~-~iv~lL~~ 275 (277)
T d2fo1e1 234 IEVVMYLIQQGASVEAVDATDHTARQLAQANNH-----H-NIVDIFDR 275 (277)
T ss_dssp HHHHHHHHHTTCCSSCCCSSSCCHHHHHHHTTC-----H-HHHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCC-----H-HHHHHHHH
T ss_conf 999999998769998869999999999998598-----9-99999997
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.97 E-value=5.5e-32 Score=261.52 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=202.7
Q ss_pred CCCCHHHCC-CCHHHHHHHHCCCCCCCCCCCHHHHHHHCCCCCCHHHHHHHHCCCHHHHHHHHHH-------CCCCCCCC
Q ss_conf 730011103-8806555421014789987303356330026998299999983999999999981-------59886457
Q 000343 470 NNLHQLVSE-GDVSGVRDLLSKNASGNYSSSISSLLKAQNADGQTALHLACRRGSAELVEAILEY-------SQENVDVL 541 (1630)
Q Consensus 470 t~Lh~Av~~-Gdl~~Vk~LL~~~a~~n~~~~i~~ll~~~d~~G~TpLh~Aa~~G~~eiVk~LL~~-------~gadvn~~ 541 (1630)
+|||.++.. |....++.|.+.+.+. ..+.+|+||||+||.+|+.+++++|+.+ .|+++|..
T Consensus 2 ~p~~~~~~~~~~~~~~~~l~~~~~n~-----------~~~~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~ 70 (277)
T d2fo1e1 2 SPIKLHTEAAGSYAITEPITRESVNI-----------IDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAM 70 (277)
T ss_dssp CCCHHHHHHHSSSCCCSCCSTTTTTT-----------CCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCC
T ss_pred CHHHHHHHHCCCHHHHHHHHHCCCCC-----------CCCCCCCCHHHHHHHCCCHHHHHHHHHCCHHHHHHCCCCCCCC
T ss_conf 86999998179888999998669986-----------7799996699999986899999999965236798769976454
Q ss_pred CCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCC---CCCCCCCCCCCCHHH
Q ss_conf 89999999899982999999999987999543333599961999999829989999999869---999987898888000
Q 000343 542 DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAG---ADPNAVDDEGESVLH 618 (1630)
Q Consensus 542 d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~G---ADvN~~d~~G~TpLh 618 (1630)
|.+|.||||+|+..|+.+++++|+++||+++.. +..|.|+|+.|+..++.++++.++..+ ..++..+..+.++.+
T Consensus 71 d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~--~~~g~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 148 (277)
T d2fo1e1 71 DCDENTPLMLAVLARRRRLVAYLMKAGADPTIY--NKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALM 148 (277)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCC--CTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCHHHHCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHH
T ss_conf 788885100343333333333332232223322--222222221001100001234443114542222222221103678
Q ss_pred HHHHCCCHHH---HHHHHHCCCCC------CCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCH
Q ss_conf 3443189479---99999809955------32002479996888999809999999999705942110235899997608
Q 000343 619 RAVAKKYTDC---AIVILENGGCR------SMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTA 689 (1630)
Q Consensus 619 ~Aa~~g~~ei---vk~LL~~Ga~~------di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~ 689 (1630)
.+......+. +..+....... ..+..+..|.||||+++..++.++++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~~~~~~~~~~~~~----------------------- 205 (277)
T d2fo1e1 149 IVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKY----------------------- 205 (277)
T ss_dssp HHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHH-----------------------
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----------------------
T ss_conf 887503433222221001123322222234555446689870000122333222223-----------------------
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
Q ss_conf 99999840573102499999999629999821014760023665159899999999879995435689997889999849
Q 000343 690 LCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARG 769 (1630)
Q Consensus 690 L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G 769 (1630)
++...+.+++.+|..|.||||+|+..|+.+++++||++|||+|.+|.+|+||||+|+.+|
T Consensus 206 --------------------~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~~A~~~~ 265 (277)
T d2fo1e1 206 --------------------LVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANN 265 (277)
T ss_dssp --------------------HHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHHHHTT
T ss_pred --------------------CCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
T ss_conf --------------------222345433346899998999999859899999999876999886999999999999859
Q ss_pred CHHHHHHHHHC
Q ss_conf 99999999969
Q 000343 770 AKSCVGLLLSA 780 (1630)
Q Consensus 770 ~~eiVklLL~~ 780 (1630)
+.+++++|++.
T Consensus 266 ~~~iv~lL~~c 276 (277)
T d2fo1e1 266 HHNIVDIFDRC 276 (277)
T ss_dssp CHHHHHHHHTT
T ss_pred CHHHHHHHHHH
T ss_conf 89999999971
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.1e-29 Score=243.48 Aligned_cols=222 Identities=21% Similarity=0.238 Sum_probs=151.4
Q ss_pred CCHHHHHHHCCCHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCC---CCCCCCCHHHHHH
Q ss_conf 99998999829999999999879-9954333359996199999982998999999986999998---7898888000344
Q 000343 546 DPPLVFALAAGSPECVHALIKRG-ANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNA---VDDEGESVLHRAV 621 (1630)
Q Consensus 546 ~TpLh~Aa~~G~~eiVk~LL~~G-Adin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~---~d~~G~TpLh~Aa 621 (1630)
.||||+||..|+.++++.|+..+ ++++. ++..|.||||+|+..|+.+++++||++|++++. .+..|.+|+|+|+
T Consensus 1 n~pLh~A~~~g~~~~v~~Ll~~~~~~~~~--~d~~G~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~~~~ 78 (229)
T d1ixva_ 1 NYPLHQACMENEFFKVQELLHSKPSLLLQ--KDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIAC 78 (229)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHHCGGGTTC--CCTTSCCHHHHHHHTTCHHHHHHHHTTCTTCCGGGCCCTTSCCHHHHHH
T ss_pred CHHHHHHHHCCCHHHHHHHHHCCCCCCCC--CCCCCCCHHHHHHHCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 97699999868999999999809986656--5999998999999869965441354430123332223222222222111
Q ss_pred HCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 31894799999980995532002479996888999809999999999705942110235899997608999998405731
Q 000343 622 AKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHE 701 (1630)
Q Consensus 622 ~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~ 701 (1630)
..+..++++.++..+...+....+..+.+|++.++..++.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~---------------------------------------- 118 (229)
T d1ixva_ 79 SVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWF---------------------------------------- 118 (229)
T ss_dssp HHTCHHHHHHHHSSSSCCCTTCCCTTSCCHHHHHHHTTCH----------------------------------------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH----------------------------------------
T ss_conf 1233233333222222222222322334433221232003----------------------------------------
Q ss_pred CHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHCCCHHHHHHHHH-
Q ss_conf 02499999999629999821014760023665159899999999879-9954356899978899998499999999996-
Q 000343 702 VEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAG-VDVNIRNVHNTIPLHVALARGAKSCVGLLLS- 779 (1630)
Q Consensus 702 ~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~G-ADin~~d~~G~TPLH~Aa~~G~~eiVklLL~- 779 (1630)
+++++|++.|.+.+.++..|+||||+|+..++.+++++|++.+ .++|.+|..|+||||+|+.+++.+++++||+
T Consensus 119 ----~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~ 194 (229)
T d1ixva_ 119 ----EVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEK 194 (229)
T ss_dssp ----HHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHH
T ss_pred ----HHHHHHHHHCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf ----4322221100232124788997350232124533233332222222223566667810221012519999999996
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 9999776789999299999984237886499999995089976
Q 000343 780 AGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAA 822 (1630)
Q Consensus 780 ~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~~gad 822 (1630)
.|+|+|.+|.+|+||||+|++. .++.+|++.|+|
T Consensus 195 ~gad~~~~d~~g~t~l~~A~~~---------~~~~~Ll~~g~d 228 (229)
T d1ixva_ 195 YGAEYDLVDNKGAKAEDVALNE---------QVKKFFLNNVVD 228 (229)
T ss_dssp HCCCSCCCCTTSCCTGGGCSCH---------HHHHHHHHHCCC
T ss_pred CCCCCCCCCCCCCCHHHHHHHH---------HHHHHHHHCCCC
T ss_conf 5999888589999999998467---------899999976999
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.97 E-value=4.2e-29 Score=239.05 Aligned_cols=236 Identities=24% Similarity=0.265 Sum_probs=188.6
Q ss_pred CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHC
Q ss_conf 99999989998299999999998799954333359996199999982998999999986999998789888800034431
Q 000343 544 DGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAK 623 (1630)
Q Consensus 544 ~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~ 623 (1630)
.+.|+||.||..|+.++|++||++|+|+|.. +..|.||||+|+..|+.+++++|+++|++.+..+..+.+||+.|+..
T Consensus 39 ~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~--d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~ 116 (291)
T d1s70b_ 39 DDGAVFLAACSSGDTEEVLRLLERGADINYA--NVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC 116 (291)
T ss_dssp CHHHHHHHHHHHTCHHHHHHHHHHCCCTTCB--CTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCCCCCC--CCCCCCHHHHHHHCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9966999999858899999999879998866--89999699999861973121100122233333222323333333222
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCH
Q ss_conf 89479999998099553200247999688899980999999999970594211023589999760899999840573102
Q 000343 624 KYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVE 703 (1630)
Q Consensus 624 g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~ 703 (1630)
++.++++.|+++++ .....+..+.+|+++|+..++.+.++.++...
T Consensus 117 ~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~-------------------------------- 162 (291)
T d1s70b_ 117 GYLDIAEYLISQGA--HVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQ-------------------------------- 162 (291)
T ss_dssp TCHHHHHHHHHTTC--CTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHH--------------------------------
T ss_pred CCCCHHHCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCC--------------------------------
T ss_conf 21100110124676--42222246764222211122200010000024--------------------------------
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 49999999962999982101476002366515989999999987999543568999788999984999999999969999
Q 000343 704 GRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGAD 783 (1630)
Q Consensus 704 ~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GAD 783 (1630)
+.+++........+. .......+.....+....+..|.||||+|+..++.+++++|+++|+|
T Consensus 163 -----------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~d 224 (291)
T d1s70b_ 163 -----------GVDIEAARKEEERIM-------LRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYD 224 (291)
T ss_dssp -----------TCCHHHHHHHHHHHH-------HHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCC
T ss_pred -----------CCCCCCCCCCCCCCC-------CCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHCCCCCCEEC
T ss_conf -----------653211000013332-------21100110123211002467898730488876995441013441011
Q ss_pred CCCCCCCCCCHHHHHHHHCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 77678999929999998423788649999999508997632337899999999962
Q 000343 784 CNWQDDEGDNAFHIAADAAKMIRENLEWLIVMLSHPDAAVEVRNHSGKTLRDFLEG 839 (1630)
Q Consensus 784 vN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~LL~~~gadin~kN~~GkTpL~lA~~ 839 (1630)
+|.+|..|+||||+|++.++ . .++.+|+++|||++++|+.|+|||++|.+
T Consensus 225 in~~~~~g~TpL~~A~~~g~-----~-~iv~lLl~~Gadv~~~d~~G~TaL~~A~e 274 (291)
T d1s70b_ 225 VNIKDYDGWTPLHAAAHWGK-----E-EACRILVENLCDMEAVNKVGQTAFDVADE 274 (291)
T ss_dssp TTCCCTTCCCHHHHHHHTTC-----H-HHHHHHHHTTCCTTCCCTTSCCTTTSCCS
T ss_pred CCCCCCCCCCHHHHHHHCCC-----H-HHHHHHHHCCCCCCCCCCCCCCHHHHHHH
T ss_conf 24212579889999998598-----9-99999998799998868999999999999
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.3e-27 Score=220.82 Aligned_cols=214 Identities=26% Similarity=0.392 Sum_probs=133.6
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHH---HCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf 99829999998399999999998---159886457899999998999829999999999879995433335999619999
Q 000343 510 DGQTALHLACRRGSAELVEAILE---YSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHV 586 (1630)
Q Consensus 510 ~G~TpLh~Aa~~G~~eiVk~LL~---~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~ 586 (1630)
+|.||||+||..|+.++++.|++ ..++++|..|..|.||||+|+..|+.+++++|+++|++.
T Consensus 2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~--------------- 66 (228)
T d1k1aa_ 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP--------------- 66 (228)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCT---------------
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEHHCCCCCCCCCCCCCCCCCC---------------
T ss_conf 88429999998399999999999899779977766899996241000135533333332222233---------------
Q ss_pred HHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCC--CCCCCCCCCCCHHHHHHHCCCHHHH
Q ss_conf 99829989999999869999987898888000344318947999999809955--3200247999688899980999999
Q 000343 587 CAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCR--SMAILNSKELTPLHLCVATWNVAVV 664 (1630)
Q Consensus 587 Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~--di~~~d~~G~TPLh~Aa~~g~~~iv 664 (1630)
+..+..+.++++.|....+.++++.+....... ..+.......++|+.+.........
T Consensus 67 --------------------~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 126 (228)
T d1k1aa_ 67 --------------------MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETV 126 (228)
T ss_dssp --------------------TCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHH
T ss_pred --------------------CCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
T ss_conf --------------------433332223332222234521002344204543223223333222222222222210013
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCC-CCCCCCCCCCHHHHHHCCCHHHHHH
Q ss_conf 999970594211023589999760899999840573102499999999629999-8210147600236651598999999
Q 000343 665 KRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEP-TAQDAQNRTALHIASMANDVELVKI 743 (1630)
Q Consensus 665 k~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADi-n~~d~~G~TPLH~Aa~~g~~eiVkl 743 (1630)
+.| .....+. ......+.++|+.|+..+...+++.
T Consensus 127 ~~l--------------------------------------------~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~ 162 (228)
T d1k1aa_ 127 QLL--------------------------------------------LERGADIDAVDIKSGRSPLIHAVENNSLSMVQL 162 (228)
T ss_dssp HHH--------------------------------------------HHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHH
T ss_pred HHH--------------------------------------------HCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 443--------------------------------------------001233222210002557889887510023443
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99879995435689997889999849999999999699997767899992999999842
Q 000343 744 ILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAA 802 (1630)
Q Consensus 744 LL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLhlAa~~g 802 (1630)
+++.|.+++.+|..|.||||+|+..|+.+++++|+++|||+|.+|.+|+||||+|++.+
T Consensus 163 ~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~~~~ 221 (228)
T d1k1aa_ 163 LLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRR 221 (228)
T ss_dssp HHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCSSHH
T ss_pred HHHHCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCC
T ss_conf 22202232221236861689999858799999999878999887899999999998687
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-25 Score=212.25 Aligned_cols=213 Identities=23% Similarity=0.308 Sum_probs=164.7
Q ss_pred CCHHHHHHHHCCCHHHHHHH----HHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 96199999982998999999----98699999878988880003443189479999998099553200247999688899
Q 000343 580 GPSVAHVCAYHGQPDCMREL----LLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLC 655 (1630)
Q Consensus 580 G~T~Lh~Aa~~G~~eivk~L----L~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~A 655 (1630)
|.||||+||.+|+.++++.| +++|+++|..|.+|.||||+|+..++.+++++|+++|+ +.+.....+.++++.|
T Consensus 3 G~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga--~~~~~~~~~~~~~~~a 80 (228)
T d1k1aa_ 3 GDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGA--SPMALDRHGQTAAHLA 80 (228)
T ss_dssp TCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTC--CTTCCCTTSCCHHHHH
T ss_pred CCCHHHHHHHCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEHHCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf 84299999983999999999998997799777668999962410001355333333322222--3343333222333222
Q ss_pred HHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHC
Q ss_conf 98099999999997059421102358999976089999984057310249999999962999982101476002366515
Q 000343 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMA 735 (1630)
Q Consensus 656 a~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~ 735 (1630)
....+..+++.+...... .....+.......++|+.+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~l~~~~~~ 120 (228)
T d1k1aa_ 81 CEHRSPTCLRALLDSAAP----------------------------------------GTLDLEARNYDGLTALHVAVNT 120 (228)
T ss_dssp HHTTCHHHHHHHHHHSCT----------------------------------------TSCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCCCCCCHHHHHHCCCC----------------------------------------CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 223452100234420454----------------------------------------3223223333222222222222
Q ss_pred CCHHHHHHHHHCCCCCC-CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHCHHHHHHHHHHHH
Q ss_conf 98999999998799954-35689997889999849999999999699997767899992999999842378864999999
Q 000343 736 NDVELVKIILDAGVDVN-IRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHIAADAAKMIRENLEWLIV 814 (1630)
Q Consensus 736 g~~eiVklLL~~GADin-~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLhlAa~~g~~~~~~~e~vi~ 814 (1630)
........|.....+.. .....+.+||+.|+..+...+++.++++|.+++.+|..|+||||+|+..++ . .+++
T Consensus 121 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~-----~-~~v~ 194 (228)
T d1k1aa_ 121 ECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGL-----L-PLVR 194 (228)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTC-----H-HHHH
T ss_pred CCCHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHCCC-----H-HHHH
T ss_conf 210013443001233222210002557889887510023443222022322212368616899998587-----9-9999
Q ss_pred HHHCCCCCCCCCCCCCCCHHHHHHHC
Q ss_conf 95089976323378999999999629
Q 000343 815 MLSHPDAAVEVRNHSGKTLRDFLEGL 840 (1630)
Q Consensus 815 LL~~~gadin~kN~~GkTpL~lA~~~ 840 (1630)
+|++.|+|+|++|.+|.|||++|...
T Consensus 195 ~Ll~~Gad~n~~d~~G~TpL~~A~~~ 220 (228)
T d1k1aa_ 195 TLVRSGADSSLKNCHNDTPLMVARSR 220 (228)
T ss_dssp HHHHTTCCTTCCCTTSCCTTTTCSSH
T ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHC
T ss_conf 99987899988789999999999868
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.94 E-value=1.3e-29 Score=242.97 Aligned_cols=240 Identities=13% Similarity=0.046 Sum_probs=173.9
Q ss_pred HHHHHHCCCCCCHHHHHHHHCCCHHHHHH---HHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 35633002699829999998399999999---998159886457899999998999829999999999879995433335
Q 000343 501 SSLLKAQNADGQTALHLACRRGSAELVEA---ILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLRE 577 (1630)
Q Consensus 501 ~~ll~~~d~~G~TpLh~Aa~~G~~eiVk~---LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d 577 (1630)
...++.++..|.||||+||++|+.+++++ |++ .++++|..|.+|.||||+||.+|+.++|++|+++|++++....+
T Consensus 80 ~~~~~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~-~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~ 158 (346)
T d2ajaa1 80 WSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLT-SDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQ 158 (346)
T ss_dssp HHHHHHHTCCHHHHHHHHHHHCCHHHHHHHTTC---CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHS
T ss_pred HHHHHHCCCCCCCHHHHHHHHCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCC
T ss_conf 12787636788849999998599889999999983-89855336899997999999878999999999869970214555
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCCCC---CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHH
Q ss_conf 999619999998299899999998699999---87898888000344318947999999809955320024799968889
Q 000343 578 GFGPSVAHVCAYHGQPDCMRELLLAGADPN---AVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHL 654 (1630)
Q Consensus 578 ~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN---~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~ 654 (1630)
..|.||||+||.+||.+++++|+++|++.+ ..+.++.||++.|+.+|+.+++++|++.|+ +++ ++++.
T Consensus 159 ~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga--~~~-------~~~~~ 229 (346)
T d2ajaa1 159 AENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPV--MLA-------YAEIH 229 (346)
T ss_dssp HHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHH--HHH-------HHHHC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCHHHHHHHHHHCCC--CCC-------HHHHH
T ss_conf 699874389988756799999997699420120016899631157762488999999996899--866-------37799
Q ss_pred HHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCC--CCCCC-------CCCCC
Q ss_conf 9980999999999970594211023589999760899999840573102499999999629--99982-------10147
Q 000343 655 CVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG--AEPTA-------QDAQN 725 (1630)
Q Consensus 655 Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~G--ADin~-------~d~~G 725 (1630)
+...++..+...++..... ..+....+.... ...+. ....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~ 279 (346)
T d2ajaa1 230 EFEYGEKYVNPFIARHVNR------------------------------LKEMHDAFKLSNPDGVFDLVTKSECLQGFYM 279 (346)
T ss_dssp TTTTTTTTHHHHHHHHHHH------------------------------HHHHHTTTTTTSSSSCCCCSSHHHHHHHHHH
T ss_pred HHHCCCHHHHHHHHHHHCC------------------------------CHHHHHHHHHHCCCCCHHHHHCCCCCCCCHH
T ss_conf 9875947666889976304------------------------------4378999997362656767733332356244
Q ss_pred CCCHHHHHHCCCHHHHHHHHHCCCC-----CCCCCCCCCCHHHHHHHCCCHHHHHHHHHC
Q ss_conf 6002366515989999999987999-----543568999788999984999999999969
Q 000343 726 RTALHIASMANDVELVKIILDAGVD-----VNIRNVHNTIPLHVALARGAKSCVGLLLSA 780 (1630)
Q Consensus 726 ~TPLH~Aa~~g~~eiVklLL~~GAD-----in~~d~~G~TPLH~Aa~~G~~eiVklLL~~ 780 (1630)
.++|+.|+..++.+++++|++.++. .+..+.+|+||||+||..|+.+++++||+.
T Consensus 280 ~~~l~~a~~~~~ld~v~~Ll~~~~~~~~~~~~~~~~~g~T~LhlA~~~Gn~e~v~lLL~~ 339 (346)
T d2ajaa1 280 LRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLSI 339 (346)
T ss_dssp HHHHHHHCCGGGHHHHHHHHTSTTTGGGSSCCSSTTCCCHHHHHHHHHTCTTHHHHHTTS
T ss_pred HHHHHHHHCCCHHHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCC
T ss_conf 229999861795999999986867555364456799998199999984819999998589
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.94 E-value=2e-25 Score=210.52 Aligned_cols=200 Identities=27% Similarity=0.340 Sum_probs=150.0
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCC
Q ss_conf 99999999879995433335999619999998299899999998699999878988880003443189479999998099
Q 000343 558 PECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGG 637 (1630)
Q Consensus 558 ~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga 637 (1630)
.|+|++|+++|+|++.. .|..|.||||+||.+|+.+++++|+++|+++|..+..+.++++.++...+............
T Consensus 2 ~~~v~~Ll~~g~din~~-~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (209)
T d1ot8a_ 2 AQVISDLLAQGAELNAT-MDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRA 80 (209)
T ss_dssp HHHHHHHHHHHHHHHHH-HHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTT
T ss_pred HHHHHHHHHCCCCCCCC-CCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89999999878986867-69999889999998399999999875022332222222222222222222222222222222
Q ss_pred CCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 55320024799968889998099999999997059421102358999976089999984057310249999999962999
Q 000343 638 CRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAE 717 (1630)
Q Consensus 638 ~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GAD 717 (1630)
.........+.++.+.+..... ....+.|...+++
T Consensus 81 -~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~L~~~~~~ 115 (209)
T d1ot8a_ 81 -TNLNARMHDGTTPLILAARLAI--------------------------------------------EGMVEDLITADAD 115 (209)
T ss_dssp -CCTTCCCTTCCCHHHHHHHTTC--------------------------------------------TTHHHHHHHTTCC
T ss_pred -CCCCCCCCCCCCCCCCCCCCCC--------------------------------------------HHHHHHHHHHCCC
T ss_conf -2232222223332222222210--------------------------------------------1235555310146
Q ss_pred CCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 98210147600236651598999999998799954356899978899998499999999996999977678999929999
Q 000343 718 PTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEGDNAFHI 797 (1630)
Q Consensus 718 in~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G~TpLhl 797 (1630)
++.++..|.|||+.|+..+..++++.|++.++++|..|..|.||||+|+..|+.+++++||++|||+|.+|..|.||||+
T Consensus 116 ~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~Tpl~~ 195 (209)
T d1ot8a_ 116 INAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDV 195 (209)
T ss_dssp TTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCCCCCCCHHHCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCHHCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHH
T ss_conf 55557799982300003686314532012222345443444552112103249999999998799998868999999999
Q ss_pred HHHHCH
Q ss_conf 998423
Q 000343 798 AADAAK 803 (1630)
Q Consensus 798 Aa~~g~ 803 (1630)
|++.++
T Consensus 196 A~~~~~ 201 (209)
T d1ot8a_ 196 ASERLH 201 (209)
T ss_dssp HHHTTC
T ss_pred HHHCCC
T ss_conf 998687
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-26 Score=218.84 Aligned_cols=193 Identities=25% Similarity=0.305 Sum_probs=95.4
Q ss_pred CCCHHHHHHHCCCH----HHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf 99999899982999----99999998799954333359996199999982998999999986999998789888800034
Q 000343 545 GDPPLVFALAAGSP----ECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRA 620 (1630)
Q Consensus 545 G~TpLh~Aa~~G~~----eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~A 620 (1630)
|.||||+|+..|+. ++++.|+..|+++|. ++..|.||||+|+..++.+++++|+++|+|++..|.+|.|||+.|
T Consensus 2 G~t~Lh~A~~~g~~~~~~~li~~~~~~~~~in~--~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~ 79 (221)
T d1iknd_ 2 GDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNF--QNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLA 79 (221)
T ss_dssp CCCTTHHHHHTTCSSSSSCCCC-----CCCCCC--CCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHH
T ss_pred CCHHHHHHHHCCCHHHHHHHHHHHHHCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 872999999858999999999999867997536--789999546343343322233332222222222322322222223
Q ss_pred HHCCCHHHHHHHHHCCCCC----CCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 4318947999999809955----320024799968889998099999999997059421102358999976089999984
Q 000343 621 VAKKYTDCAIVILENGGCR----SMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAAL 696 (1630)
Q Consensus 621 a~~g~~eivk~LL~~Ga~~----di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~ 696 (1630)
+..++.++++.|+..+... ........+.||||.|+..++.++++
T Consensus 80 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~------------------------------- 128 (221)
T d1iknd_ 80 CEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVE------------------------------- 128 (221)
T ss_dssp HHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHH-------------------------------
T ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCHHHEE-------------------------------
T ss_conf 3322222111011101323332222222334321356775559822301-------------------------------
Q ss_pred CCCCCCHHHHHHHHHHHCCCCCCCCC-CCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHH
Q ss_conf 05731024999999996299998210-14760023665159899999999879995435689997889999849999999
Q 000343 697 KKDHEVEGRELVRILLTAGAEPTAQD-AQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVG 775 (1630)
Q Consensus 697 ~~~~~~~~~eiVklLLe~GADin~~d-~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVk 775 (1630)
+|+..|++++..+ .+|.||||+|+..|+.+++++||++|+|++.+|..|+||||+|+..++.++++
T Consensus 129 -------------~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~~~~~~~ 195 (221)
T d1iknd_ 129 -------------LLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQ 195 (221)
T ss_dssp -------------HHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCHHHHH
T ss_pred -------------EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHH
T ss_conf -------------0013686311224467778431111222489888898638864566999989999999878899999
Q ss_pred HHHHCCCC
Q ss_conf 99969999
Q 000343 776 LLLSAGAD 783 (1630)
Q Consensus 776 lLL~~GAD 783 (1630)
+|++.+.+
T Consensus 196 ~l~~~~~~ 203 (221)
T d1iknd_ 196 QLGQLTLE 203 (221)
T ss_dssp HHHTTSCG
T ss_pred HHHHCCCC
T ss_conf 99982873
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.94 E-value=5.6e-25 Score=207.00 Aligned_cols=205 Identities=24% Similarity=0.294 Sum_probs=160.1
Q ss_pred HHHHHHHHHHCCCCCCC-CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHC
Q ss_conf 99999999815988645-78999999989998299999999998799954333359996199999982998999999986
Q 000343 524 AELVEAILEYSQENVDV-LDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLA 602 (1630)
Q Consensus 524 ~eiVk~LL~~~gadvn~-~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~ 602 (1630)
.++|++||+. |+++|. .|.+|.||||+||.+|+.+++++|+..|++++.. +..+.++++.++..++..........
T Consensus 2 ~~~v~~Ll~~-g~din~~~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (209)
T d1ot8a_ 2 AQVISDLLAQ-GAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQ--DNTGRTPLHAAVAADAMGVFQILLRN 78 (209)
T ss_dssp HHHHHHHHHH-HHHHHHHHHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC--CTTSCCHHHHHHHTTCHHHHHHHHTC
T ss_pred HHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999999987-89868676999988999999839999999987502233222--22222222222222222222222222
Q ss_pred CCC-CCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 999-9987898888000344318947999999809955320024799968889998099999999997059421102358
Q 000343 603 GAD-PNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEEIVNVID 681 (1630)
Q Consensus 603 GAD-vN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~~~~~~d 681 (1630)
... .......+.++.+.+.........+.|+..++ +++..+..|.|||++|+..+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~~~--~~~~~~~~~~t~l~~~~~~~~~-------------------- 136 (209)
T d1ot8a_ 79 RATNLNARMHDGTTPLILAARLAIEGMVEDLITADA--DINAADNSGKTALHWAAAVNNT-------------------- 136 (209)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCTTHHHHHHHTTC--CTTCBCTTSCBHHHHHHHTTCH--------------------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCC--CCCCCCCCCCCCCHHHCCCCCC--------------------
T ss_conf 222232222223332222222210123555531014--6555577999823000036863--------------------
Q ss_pred CCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCH
Q ss_conf 99997608999998405731024999999996299998210147600236651598999999998799954356899978
Q 000343 682 IPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIP 761 (1630)
Q Consensus 682 ~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TP 761 (1630)
.+++.+++.+++++.+|..|.||||+|+..|+.+++++||++|||+|.+|..|+||
T Consensus 137 ------------------------~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~Tp 192 (209)
T d1ot8a_ 137 ------------------------EAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLP 192 (209)
T ss_dssp ------------------------HHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ------------------------EEEEEECCCCCCCCCCCCCCCCCCCHHCCCCHHHHHHHHHHCCCCCCCCCCCCCCH
T ss_conf ------------------------14532012222345443444552112103249999999998799998868999999
Q ss_pred HHHHHHCCCHHHHHHH
Q ss_conf 8999984999999999
Q 000343 762 LHVALARGAKSCVGLL 777 (1630)
Q Consensus 762 LH~Aa~~G~~eiVklL 777 (1630)
||+|+.+|+.++|++|
T Consensus 193 l~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 193 RDVASERLHHDIVRLL 208 (209)
T ss_dssp HHHHHHTTCHHHHHHH
T ss_pred HHHHHHCCCHHHHHHC
T ss_conf 9999986879899643
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.9e-25 Score=210.55 Aligned_cols=192 Identities=21% Similarity=0.271 Sum_probs=95.9
Q ss_pred CCCHHHHHHHHCCCHHH----HHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHH
Q ss_conf 99829999998399999----99999815988645789999999899982999999999987999543333599961999
Q 000343 510 DGQTALHLACRRGSAEL----VEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAH 585 (1630)
Q Consensus 510 ~G~TpLh~Aa~~G~~ei----Vk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh 585 (1630)
+|.||||+|+..|+.++ +++++. .++++|..|.+|.||||+|+..|+.+++++|+++|++++. .+..|.+||+
T Consensus 1 dG~t~Lh~A~~~g~~~~~~~li~~~~~-~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~--~d~~g~t~l~ 77 (221)
T d1iknd_ 1 DGDSFLHLAIIHEEKALTMEVIRQVKG-DLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPEL--RDFRGNTPLH 77 (221)
T ss_dssp CCCCTTHHHHHTTCSSSSSCCCC------CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCC--CCTTCCCHHH
T ss_pred CCCHHHHHHHHCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 987299999985899999999999986-7997536789999546343343322233332222222222--3223222222
Q ss_pred HHHHCCCHHHHHHHHHCCCCCCC------CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCC-CCCCCCCHHHHHHHC
Q ss_conf 99982998999999986999998------78988880003443189479999998099553200-247999688899980
Q 000343 586 VCAYHGQPDCMRELLLAGADPNA------VDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAI-LNSKELTPLHLCVAT 658 (1630)
Q Consensus 586 ~Aa~~G~~eivk~LL~~GADvN~------~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~-~d~~G~TPLh~Aa~~ 658 (1630)
.|+..++.++++.|+..+.+... ....|.||||.|+..++.+++.+|+..++. ++. .+.+|.||||+|+..
T Consensus 78 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~--~~~~~~~~G~T~L~~A~~~ 155 (221)
T d1iknd_ 78 LACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGAD--VNAQEPCNGRTALHLAVDL 155 (221)
T ss_dssp HHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCC--TTCCCTTTCCCHHHHHHHT
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCHHHEEEECCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 23332222211101110132333222222233432135677555982230100136863--1122446777843111122
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCH
Q ss_conf 99999999997059421102358999976089999984057310249999999962999982101476002366515989
Q 000343 659 WNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDV 738 (1630)
Q Consensus 659 g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~ 738 (1630)
|+. +++++|+++|+|++.+|..|.||||+|+..++.
T Consensus 156 g~~--------------------------------------------~~v~~Ll~~gad~~~~~~~G~tpl~~A~~~~~~ 191 (221)
T d1iknd_ 156 QNP--------------------------------------------DLVSLLLKCGADVNRVTYQGYSPYQLTWGRPST 191 (221)
T ss_dssp TCH--------------------------------------------HHHHHHHTTTCCSCCCCTTCCCGGGGCTTSSCH
T ss_pred CCH--------------------------------------------HHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH
T ss_conf 248--------------------------------------------988889863886456699998999999987889
Q ss_pred HHHHHHHHCCCC
Q ss_conf 999999987999
Q 000343 739 ELVKIILDAGVD 750 (1630)
Q Consensus 739 eiVklLL~~GAD 750 (1630)
+++++|++.+.+
T Consensus 192 ~~~~~l~~~~~~ 203 (221)
T d1iknd_ 192 RIQQQLGQLTLE 203 (221)
T ss_dssp HHHHHHHTTSCG
T ss_pred HHHHHHHHCCCC
T ss_conf 999999982873
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.90 E-value=3.5e-27 Score=224.13 Aligned_cols=263 Identities=9% Similarity=-0.015 Sum_probs=173.8
Q ss_pred CHHHHHHHHCCCHHHHHHHHHHCC----------CCCCCCCCCCCCHHHHHHHCCCHHHHHH---HHHCCCCCCCCCCCC
Q ss_conf 829999998399999999998159----------8864578999999989998299999999---998799954333359
Q 000343 512 QTALHLACRRGSAELVEAILEYSQ----------ENVDVLDKDGDPPLVFALAAGSPECVHA---LIKRGANVISRLREG 578 (1630)
Q Consensus 512 ~TpLh~Aa~~G~~eiVk~LL~~~g----------advn~~d~~G~TpLh~Aa~~G~~eiVk~---LL~~GAdin~~~~d~ 578 (1630)
.+.++.+...+..++.+.+..... .+++..+..|.||||+||.+|+.+++++ |+..|++++... .
T Consensus 47 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~--~ 124 (346)
T d2ajaa1 47 AIHIFLPGTKNMEQVRQLLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ--A 124 (346)
T ss_dssp HHHHCCCCSSHHHHHHHHHHHHHHHTTTTCTTHHHHHHHHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--C--H
T ss_pred HHHHHHHHHCCHHHHHHHHHHCCHHHCCCHHHHHHHHHHCCCCCCCHHHHHHHHCCHHHHHHHHHHHHCCCCCCCCC--C
T ss_conf 78998886543799999999750022001143212787636788849999998599889999999983898553368--9
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCC--CCCCCHHHHHHHCCCHHHHHHHHHCCCCCC-CCCCCCCCCCHHHHH
Q ss_conf 99619999998299899999998699999878--988880003443189479999998099553-200247999688899
Q 000343 579 FGPSVAHVCAYHGQPDCMRELLLAGADPNAVD--DEGESVLHRAVAKKYTDCAIVILENGGCRS-MAILNSKELTPLHLC 655 (1630)
Q Consensus 579 ~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d--~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~d-i~~~d~~G~TPLh~A 655 (1630)
.|.||||+||.+||.+++++|+++|++++..+ .+|.||||+|+..|+.+++++|++.|+... .+..+.++.||++.|
T Consensus 125 ~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A 204 (346)
T d2ajaa1 125 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAA 204 (346)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHH
T ss_conf 99979999998789999999998699702145556998743899887567999999976994201200168996311577
Q ss_pred HHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHC
Q ss_conf 98099999999997059421102358999976089999984057310249999999962999982101476002366515
Q 000343 656 VATWNVAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMA 735 (1630)
Q Consensus 656 a~~g~~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~ 735 (1630)
+.+|+.+++++|++.++..... .. ..+ .....+.++++.++..
T Consensus 205 ~~~g~~~iv~~Ll~~ga~~~~~------------~~----------------------~~~---~~~~~~~~~~~~~~~~ 247 (346)
T d2ajaa1 205 VGRGHHNVINFLLDCPVMLAYA------------EI----------------------HEF---EYGEKYVNPFIARHVN 247 (346)
T ss_dssp STTCCHHHHHHHTTSHHHHHHH------------HH----------------------CTT---TTTTTTHHHHHHHHHH
T ss_pred HHCCHHHHHHHHHHCCCCCCHH------------HH----------------------HHH---HCCCHHHHHHHHHHHC
T ss_conf 6248899999999689986637------------79----------------------998---7594766688997630
Q ss_pred CCHHHHHHHHHCCCC--CCCC-------CCCCCCHHHHHHHCCCHHHHHHHHHCCCC-----CCCCCCCCCCHHHHHHHH
Q ss_conf 989999999987999--5435-------68999788999984999999999969999-----776789999299999984
Q 000343 736 NDVELVKIILDAGVD--VNIR-------NVHNTIPLHVALARGAKSCVGLLLSAGAD-----CNWQDDEGDNAFHIAADA 801 (1630)
Q Consensus 736 g~~eiVklLL~~GAD--in~~-------d~~G~TPLH~Aa~~G~~eiVklLL~~GAD-----vN~~D~~G~TpLhlAa~~ 801 (1630)
+..+....|+....+ .+.. ...+.++|+.|+..++.+++++|++.++. .+..+.+|+||||+|++.
T Consensus 248 ~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~~l~~a~~~~~ld~v~~Ll~~~~~~~~~~~~~~~~~g~T~LhlA~~~ 327 (346)
T d2ajaa1 248 RLKEMHDAFKLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRL 327 (346)
T ss_dssp HHHHHHTTTTTTSSSSCCCCSSHHHHHHHHHHHHHHHHHCCGGGHHHHHHHHTSTTTGGGSSCCSSTTCCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCHHHHHCCCCCCCCHHHHHHHHHHCCCHHHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHC
T ss_conf 44378999997362656767733332356244229999861795999999986867555364456799998199999984
Q ss_pred CHHHHHHHHHHHHHHHC
Q ss_conf 23788649999999508
Q 000343 802 AKMIRENLEWLIVMLSH 818 (1630)
Q Consensus 802 g~~~~~~~e~vi~LL~~ 818 (1630)
|+ .+.+..||..
T Consensus 328 Gn-----~e~v~lLL~~ 339 (346)
T d2ajaa1 328 GN-----QGACALLLSI 339 (346)
T ss_dssp TC-----TTHHHHHTTS
T ss_pred CC-----HHHHHHHHCC
T ss_conf 81-----9999998589
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.90 E-value=8.4e-24 Score=197.84 Aligned_cols=191 Identities=18% Similarity=0.178 Sum_probs=114.8
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH-------HHHHHHHHCCCCC
Q ss_conf 799954333359996199999982998999999986999998789888800034431894-------7999999809955
Q 000343 567 RGANVISRLREGFGPSVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYT-------DCAIVILENGGCR 639 (1630)
Q Consensus 567 ~GAdin~~~~d~~G~T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~-------eivk~LL~~Ga~~ 639 (1630)
.+.++|.. .|..|.||||+||..|+.+++++||++|||++.+|..|.||||.|+..++. ++++++..
T Consensus 95 ~~~dvn~~-~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~----- 168 (301)
T d1sw6a_ 95 TQLNLNIP-VDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYP----- 168 (301)
T ss_dssp SCCCSCSC-CSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGG-----
T ss_pred CCCCCCCC-CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCCHHHHHHHHHHHHHHH-----
T ss_conf 68786868-689998889999986799999999987899776776435177774220220246669999999764-----
Q ss_pred CCCCCCCCCCCHHHHHHHCCC----HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCC
Q ss_conf 320024799968889998099----9999999970594211023589999760899999840573102499999999629
Q 000343 640 SMAILNSKELTPLHLCVATWN----VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAG 715 (1630)
Q Consensus 640 di~~~d~~G~TPLh~Aa~~g~----~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~G 715 (1630)
.+...|..|.||||.++..+. ...+++.+ ..++.+++..+
T Consensus 169 ~~~~~d~~g~t~lh~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~l~~~~ 212 (301)
T d1sw6a_ 169 CLILEDSMNRTILHHIIITSGMTGCSAAAKYYL------------------------------------DILMGWIVKKQ 212 (301)
T ss_dssp GGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHH------------------------------------HHHHHHHHHGG
T ss_pred HHHHCCCCCCCHHHHHHHHHCCCCCHHHHHHHH------------------------------------HHHHHHHHHCC
T ss_conf 555134532778799999837554189999989------------------------------------99999998658
Q ss_pred CCC-CCCCCCCCCCHHHHHHCCCHHHHHHH-HH--CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 999-82101476002366515989999999-98--799954356899978899998499999999996999977678999
Q 000343 716 AEP-TAQDAQNRTALHIASMANDVELVKII-LD--AGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNWQDDEG 791 (1630)
Q Consensus 716 ADi-n~~d~~G~TPLH~Aa~~g~~eiVklL-L~--~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~~D~~G 791 (1630)
... ......+.++++.+........+..+ +. .+..+|.+|.+|+||||+|+.+|+.+++++||++|||+|.+|+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G 292 (301)
T d1sw6a_ 213 NRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSG 292 (301)
T ss_dssp GCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTS
T ss_pred CCCHHCCCCCCCCHHHHHHHCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 72000024566404689886014889999866778860766878999889999998687999999998799999989999
Q ss_pred CCHHHHHH
Q ss_conf 92999999
Q 000343 792 DNAFHIAA 799 (1630)
Q Consensus 792 ~TpLhlAa 799 (1630)
.|||++|+
T Consensus 293 ~Tpl~~A~ 300 (301)
T d1sw6a_ 293 LRPVDFGA 300 (301)
T ss_dssp CCGGGGTC
T ss_pred CCHHHHCC
T ss_conf 99999737
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1e-21 Score=181.68 Aligned_cols=153 Identities=18% Similarity=0.247 Sum_probs=99.0
Q ss_pred HHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCH
Q ss_conf 19999998299899999998699999878988880003443189479999998099553200247999688899980999
Q 000343 582 SVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNV 661 (1630)
Q Consensus 582 T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~ 661 (1630)
++||.||..|+.+++++|+++|+|+|..|.+|.||||+|+ .++.+++++|++.++ +++..+..+.+||+.++..++.
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a--~~~~~~~~~~~~l~~~~~~~~~ 79 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGA--NPDLKDRTGFAVIHDAARAGFL 79 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTC--CTTCCCTTSCCHHHHHHHHTCH
T ss_pred HHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999999867999999999878796746774453212222-222222222222222--2212123575322233222222
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHH
Q ss_conf 99999997059421102358999976089999984057310249999999962999982101476002366515989999
Q 000343 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741 (1630)
Q Consensus 662 ~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiV 741 (1630)
..+..|+..+.+++..+..|.+|||.|+..++.+++
T Consensus 80 --------------------------------------------~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~ 115 (156)
T d1ihba_ 80 --------------------------------------------DTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVV 115 (156)
T ss_dssp --------------------------------------------HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred --------------------------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf --------------------------------------------222222112222223564432112233332212222
Q ss_pred HHHHHCCC-CCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCC
Q ss_conf 99998799-95435689997889999849999999999699
Q 000343 742 KIILDAGV-DVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781 (1630)
Q Consensus 742 klLL~~GA-Din~~d~~G~TPLH~Aa~~G~~eiVklLL~~G 781 (1630)
++||++++ +++.+|..|+||||+|+..++.+++++|+++|
T Consensus 116 ~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G 156 (156)
T d1ihba_ 116 EFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156 (156)
T ss_dssp HHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCC
T ss_conf 22221220112245899989999999839899999999667
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=9.5e-23 Score=189.62 Aligned_cols=184 Identities=18% Similarity=0.206 Sum_probs=102.7
Q ss_pred CCCCCC-CCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCH-------HHHHHHHHCCCCCC
Q ss_conf 886457-8999999989998299999999998799954333359996199999982998-------99999998699999
Q 000343 536 ENVDVL-DKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQP-------DCMRELLLAGADPN 607 (1630)
Q Consensus 536 advn~~-d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~-------eivk~LL~~GADvN 607 (1630)
.++|.. |.+|+||||+||..|+.++|++|+++||+++. +|..|.||||.|+..++. +++++|. .+++
T Consensus 97 ~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~--~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~---~~~~ 171 (301)
T d1sw6a_ 97 LNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLY--GDNMGESCLVKAVKSVNNYDSGTFEALLDYLY---PCLI 171 (301)
T ss_dssp CCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTB--CCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHG---GGGG
T ss_pred CCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCC--CCCCCCCHHHHHHHCCCCHHHHHHHHHHHHHH---HHHH
T ss_conf 786868689998889999986799999999987899776--77643517777422022024666999999976---4555
Q ss_pred CCCCCCCCHHHHHHHCCCH------------HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCCCCC
Q ss_conf 8789888800034431894------------7999999809955320024799968889998099999999997059421
Q 000343 608 AVDDEGESVLHRAVAKKYT------------DCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVASPEE 675 (1630)
Q Consensus 608 ~~d~~G~TpLh~Aa~~g~~------------eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~ga~~~ 675 (1630)
..|..|+||||.|+..+.. .++.+++..+.. ........+.++++.+........+..
T Consensus 172 ~~d~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 241 (301)
T d1sw6a_ 172 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNR-PIQSGTNEKESKPNDKNGERKDSILEN--------- 241 (301)
T ss_dssp EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGC-CEEEC----------------CHHHHH---------
T ss_pred HCCCCCCCHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCC-CHHCCCCCCCCHHHHHHHCCHHHHHHH---------
T ss_conf 1345327787999998375541899999899999999865872-000024566404689886014889999---------
Q ss_pred CCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 10235899997608999998405731024999999996299998210147600236651598999999998799954356
Q 000343 676 IVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRN 755 (1630)
Q Consensus 676 ~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d 755 (1630)
.....++. ..+|.+|.+|+||||+|++.|+.++|++||++|||++++|
T Consensus 242 ------------------------------~~~~~~~~--~~in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n 289 (301)
T d1sw6a_ 242 ------------------------------LDLKWIIA--NMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIAN 289 (301)
T ss_dssp ------------------------------CSHHHHHH--HTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCC
T ss_pred ------------------------------HHHHHHHH--CCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCC
T ss_conf ------------------------------86677886--0766878999889999998687999999998799999989
Q ss_pred CCCCCHHHHHH
Q ss_conf 89997889999
Q 000343 756 VHNTIPLHVAL 766 (1630)
Q Consensus 756 ~~G~TPLH~Aa 766 (1630)
..|.|||++|+
T Consensus 290 ~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 290 KSGLRPVDFGA 300 (301)
T ss_dssp TTSCCGGGGTC
T ss_pred CCCCCHHHHCC
T ss_conf 99999999737
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.1e-20 Score=173.68 Aligned_cols=148 Identities=26% Similarity=0.309 Sum_probs=65.6
Q ss_pred HHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCCHH
Q ss_conf 99999839999999999815988645789999999899982999999999987999543333599961999999829989
Q 000343 515 LHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQPD 594 (1630)
Q Consensus 515 Lh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~~e 594 (1630)
|+.||..|+.++|+.||...+++++..|..|.||||+|+ .++.+++++|++++++++.. +..+.++++.++..++.+
T Consensus 6 L~~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~--~~~~~~~l~~~~~~~~~~ 82 (156)
T d1bd8a_ 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ--DTSGTSPVHDAARTGFLD 82 (156)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCC--CTTSCCHHHHHHHTTCHH
T ss_pred HHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 999999589999999999589998864899984133432-22222222222222222222--222222222222222222
Q ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHH
Q ss_conf 99999986999998789888800034431894799999980995532002479996888999809999999999
Q 000343 595 CMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWV 668 (1630)
Q Consensus 595 ivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL 668 (1630)
+++.++++|+++|.+|.+|.||||+|+..++.+++++|+ .|+ +++..|..|.||||+|+..++.+++++|+
T Consensus 83 ~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~--~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll 153 (156)
T d1bd8a_ 83 TLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AES--DLHRRDARGLTPLELALQRGAQDLVDILQ 153 (156)
T ss_dssp HHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTS--CTTCCCTTSCCHHHHHHHSCCHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC-CCC--CCCCCCCCCCCHHHHHHHCCCHHHHHHHH
T ss_conf 222222221221123677872221222233222211112-225--66466899999999999859899999999
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=9.5e-21 Score=174.06 Aligned_cols=154 Identities=27% Similarity=0.257 Sum_probs=124.2
Q ss_pred HHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 29999998399999999998159886457899999998999829999999999879995433335999619999998299
Q 000343 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592 (1630)
Q Consensus 513 TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~ 592 (1630)
+|||+||..|+.++|++|++. +++++..|.+|.||||+|+ .|+.+++++|+++|++++.. +..+.++|+.++..++
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~-g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~--~~~~~~~l~~~~~~~~ 78 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQN-NVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLK--DRTGFAVIHDAARAGF 78 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTS-CCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCC--CTTSCCHHHHHHHHTC
T ss_pred HHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf 899999986799999999987-8796746774453212222-22222222222222222121--2357532223322222
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHC
Q ss_conf 8999999986999998789888800034431894799999980995532002479996888999809999999999705
Q 000343 593 PDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRWVEVA 671 (1630)
Q Consensus 593 ~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~LL~~g 671 (1630)
.++++.|+..+.+++..+..|.+|||+|+..++.+++++|+++++ .+.+..+..|.||||+|+..++.+++++|+++|
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~-~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G 156 (156)
T d1ihba_ 79 LDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTA-SNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156 (156)
T ss_dssp HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSC-CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCC
T ss_conf 222222211222222356443211223333221222222221220-112245899989999999839899999999667
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.6e-20 Score=172.21 Aligned_cols=151 Identities=24% Similarity=0.362 Sum_probs=124.3
Q ss_pred HHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCC
Q ss_conf 199999982998999999986-9999987898888000344318947999999809955320024799968889998099
Q 000343 582 SVAHVCAYHGQPDCMRELLLA-GADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWN 660 (1630)
Q Consensus 582 T~Lh~Aa~~G~~eivk~LL~~-GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~ 660 (1630)
..|+.||..|+.++++.||+. ++++|..|..|.||||+|+. ++.+++++|+++++ +++..+..+.+||+.|+..++
T Consensus 4 ~~L~~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~~-~~~~~v~~Ll~~~~--~~~~~~~~~~~~l~~~~~~~~ 80 (156)
T d1bd8a_ 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF-GSTAIALELLKQGA--SPNVQDTSGTSPVHDAARTGF 80 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSCT-TCHHHHHHHHHTTC--CTTCCCTTSCCHHHHHHHTTC
T ss_pred HHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC
T ss_conf 799999995899999999995899988648999841334322-22222222222222--222222222222222222222
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHH
Q ss_conf 99999999705942110235899997608999998405731024999999996299998210147600236651598999
Q 000343 661 VAVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVEL 740 (1630)
Q Consensus 661 ~~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~ei 740 (1630)
. ++++.++++|+++|.+|..|.||||+|+..++.++
T Consensus 81 ~--------------------------------------------~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i 116 (156)
T d1bd8a_ 81 L--------------------------------------------DTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAV 116 (156)
T ss_dssp H--------------------------------------------HHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHH
T ss_pred C--------------------------------------------CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
T ss_conf 2--------------------------------------------22222222212211236778722212222332222
Q ss_pred HHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHC
Q ss_conf 9999987999543568999788999984999999999969
Q 000343 741 VKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSA 780 (1630)
Q Consensus 741 VklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~ 780 (1630)
+++|+ .|+|++.+|.+|+||||+|+..|+.+++++|++|
T Consensus 117 ~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 117 VSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp HHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCCCC-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHH
T ss_conf 11112-2256646689999999999985989999999966
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=2.8e-20 Score=170.40 Aligned_cols=149 Identities=28% Similarity=0.352 Sum_probs=74.0
Q ss_pred HHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCH
Q ss_conf 19999998299899999998699999878988880003443189479999998099553200247999688899980999
Q 000343 582 SVAHVCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNV 661 (1630)
Q Consensus 582 T~Lh~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~ 661 (1630)
||||.||..|+.+++++||++|++++ .|..|.||||+|+..++.+++..++.... .....+..+.++++.++...+
T Consensus 4 t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~- 79 (153)
T d1awcb_ 4 KKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV--SRDARTKVDRTPLHMAASEGH- 79 (153)
T ss_dssp HHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTC--CTTCCCTTCCCHHHHHHHHTC-
T ss_pred HHHHHHHHCCCHHHHHHHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-
T ss_conf 79999998789999999998699834-24478753334323222222222222222--222122223332322223311-
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHH
Q ss_conf 99999997059421102358999976089999984057310249999999962999982101476002366515989999
Q 000343 662 AVVKRWVEVASPEEIVNVIDIPGPVGTALCMAAALKKDHEVEGRELVRILLTAGAEPTAQDAQNRTALHIASMANDVELV 741 (1630)
Q Consensus 662 ~ivk~LL~~ga~~~~~~~~d~~~~~~t~L~~aaa~~~~~~~~~~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiV 741 (1630)
.+.+++++.++++++.++..|.||||+|+..|+.+++
T Consensus 80 -------------------------------------------~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv 116 (153)
T d1awcb_ 80 -------------------------------------------ANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVV 116 (153)
T ss_dssp -------------------------------------------HHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred -------------------------------------------CEEEECCCCCCCCCCCCCCCCCHHHHHHHHCCHHHEE
T ss_conf -------------------------------------------0122122246876123224673477766430222412
Q ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHH
Q ss_conf 999987999543568999788999984999999999
Q 000343 742 KIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLL 777 (1630)
Q Consensus 742 klLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklL 777 (1630)
++|++.|+|+|.+|.+|.||||+|+.+|+.+++++|
T Consensus 117 ~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 117 ELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred EECCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHC
T ss_conf 311434467726689899999999985999999867
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.84 E-value=1.4e-19 Score=164.95 Aligned_cols=150 Identities=21% Similarity=0.242 Sum_probs=117.3
Q ss_pred CHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 82999999839999999999815988645789999999899982999999999987999543333599961999999829
Q 000343 512 QTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHG 591 (1630)
Q Consensus 512 ~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G 591 (1630)
.||||.||+.|+.++|++||+. +++++ .|..|.||||+|+..++.++++.++........ .+....++++.++...
T Consensus 3 ~t~L~~Aa~~g~~~~v~~LL~~-ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 78 (153)
T d1awcb_ 3 GKKLLEAARAGQDDEVRILMAN-GAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDA--RTKVDRTPLHMAASEG 78 (153)
T ss_dssp HHHHHHHHHHTCHHHHHHHHHH-TCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTC--CCTTCCCHHHHHHHHT
T ss_pred CHHHHHHHHCCCHHHHHHHHHC-CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf 9799999987899999999986-99834-244787533343232222222222222222221--2222333232222331
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHH
Q ss_conf 9899999998699999878988880003443189479999998099553200247999688899980999999999
Q 000343 592 QPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGGCRSMAILNSKELTPLHLCVATWNVAVVKRW 667 (1630)
Q Consensus 592 ~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga~~di~~~d~~G~TPLh~Aa~~g~~~ivk~L 667 (1630)
+.+++++|+.+|++.+.++.+|.||||+|+..++.+++++|++.|+ +++..|..|.||||+|+.+|+.+++++|
T Consensus 79 ~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~ga--d~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 79 HANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGA--DVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp CHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTC--CTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred CCEEEECCCCCCCCCCCCCCCCCHHHHHHHHCCHHHEEEECCCCCC--CCCCCCCCCCCHHHHHHHCCCHHHHHHC
T ss_conf 1012212224687612322467347776643022241231143446--7726689899999999985999999867
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.5e-18 Score=156.89 Aligned_cols=121 Identities=25% Similarity=0.197 Sum_probs=76.5
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHC
Q ss_conf 98299999983999999999981598864578999999989998299999999998799954333359996199999982
Q 000343 511 GQTALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYH 590 (1630)
Q Consensus 511 G~TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~ 590 (1630)
+.++||+||..|+.+++++|++. ++++|..+..|.||||+|+ .|+.+++++|+++|++++....++ +.+|||+|+..
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~-gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~-~~~~L~~A~~~ 79 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEA-GANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPAT-LTRPVHDAARE 79 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTT-TCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTT-CCCHHHHHHHH
T ss_pred CHHHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCC
T ss_conf 70599999987799999999985-9741332221222222222-222222221222222222222222-22222222232
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHH
Q ss_conf 99899999998699999878988880003443189479999998
Q 000343 591 GQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILE 634 (1630)
Q Consensus 591 G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~ 634 (1630)
|+.+++++|+++|+|++.+|.+|.||||+|+..|+.+++++|+.
T Consensus 80 g~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 80 GFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp TCHHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHH
T ss_conf 22222222212222233245789899999998687999999995
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.75 E-value=3.4e-18 Score=154.22 Aligned_cols=135 Identities=14% Similarity=0.068 Sum_probs=101.2
Q ss_pred EEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCC-------------C-----HHHHHHHHHHHHHHCCC
Q ss_conf 28998847678502999527981443668958999996315768-------------9-----66899999999981159
Q 000343 138 VKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEM-------------E-----PDWLSGQLDNLRRASMW 199 (1630)
Q Consensus 138 Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~-------------~-----~~~~~~Ei~iL~~l~l~ 199 (1630)
+.+.++||+|+||.||. |.+ .+++.||||.++..... . .....+|...+..+ .
T Consensus 2 ~~vg~~IG~G~~g~Vy~------a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~ 72 (191)
T d1zara2 2 DAIGKLMGEGKESAVFN------CYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL--Q 72 (191)
T ss_dssp SEEEEEEEECSSEEEEE------EEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT--T
T ss_pred CHHCCEEEECCCEEEEE------EEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHC--C
T ss_conf 02277802485659999------997-99999999998604434666556563000888999999778999999981--6
Q ss_pred CCCCCEEEEEEEECCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC
Q ss_conf 98822167999949979999935899838899870799999999999999999999999499733202355469878996
Q 000343 200 CRNVCTFHGVLRMDSCLGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHAAGVVCMNIKPSNLLLDASGR 279 (1630)
Q Consensus 200 HpNIV~L~~~~~~~~~~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs~gIIHrDLKP~NILld~~g~ 279 (1630)
|++++..+++.. .+++|||+++.... .++...+..++.|++.+|.|||++||+||||||+|||++.. .
T Consensus 73 ~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 73 GLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp TSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-E
T ss_pred CCCCCEEEEECC----CEEEEEEECCCCCC-------CHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-C
T ss_conf 999144998628----88999950456542-------00157899999999999999826888983689036114289-8
Q ss_pred EEEEECCEEEEECC
Q ss_conf 99940210034057
Q 000343 280 AVVSDYGLAAILKK 293 (1630)
Q Consensus 280 vKL~DFGla~~~~~ 293 (1630)
++|+|||+|.....
T Consensus 141 ~~liDFG~a~~~~~ 154 (191)
T d1zara2 141 IWIIDFPQSVEVGE 154 (191)
T ss_dssp EEECCCTTCEETTS
T ss_pred EEEEECCCCCCCCC
T ss_conf 99987788430899
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=8.6e-18 Score=151.06 Aligned_cols=92 Identities=26% Similarity=0.382 Sum_probs=38.6
Q ss_pred HHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCC-CHHHHHHHCCCHHHHHHHHHCCCCCCC
Q ss_conf 9999962999982101476002366515989999999987999543568999-788999984999999999969999776
Q 000343 708 VRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNT-IPLHVALARGAKSCVGLLLSAGADCNW 786 (1630)
Q Consensus 708 VklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~-TPLH~Aa~~G~~eiVklLL~~GADvN~ 786 (1630)
+++|+++|+|+|.++..|.||||+|+ .|+.+++++|+++|+++|.++..+. ||||+|+..|+.+++++|+++|+|+|.
T Consensus 19 v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~ 97 (125)
T d1bi7b_ 19 VRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDV 97 (125)
T ss_dssp HHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSC
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99999859741332221222222222-22222222122222222222222222222222232222222222122222332
Q ss_pred CCCCCCCHHHHHHH
Q ss_conf 78999929999998
Q 000343 787 QDDEGDNAFHIAAD 800 (1630)
Q Consensus 787 ~D~~G~TpLhlAa~ 800 (1630)
+|..|+||||+|++
T Consensus 98 ~d~~G~T~l~~A~~ 111 (125)
T d1bi7b_ 98 RDAWGRLPVDLAEE 111 (125)
T ss_dssp CCTTCCCHHHHHHH
T ss_pred CCCCCCCHHHHHHH
T ss_conf 45789899999998
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.73 E-value=2.7e-18 Score=154.96 Aligned_cols=106 Identities=23% Similarity=0.357 Sum_probs=70.6
Q ss_pred HHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 29999998399999999998159886457899999998999829999999999879995433335999619999998299
Q 000343 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592 (1630)
Q Consensus 513 TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~ 592 (1630)
|||++||++|+.+++++|++. +++++..+..|.||||+|+..|+.+++++|+++|++++.. +..|.||||+|+.+|+
T Consensus 4 tpL~~A~~~g~~~~v~~Ll~~-g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~--d~~g~tpLh~A~~~~~ 80 (118)
T d1myoa_ 4 KEFMWALKNGDLDEVKDYVAK-GEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAP--DKHHITPLLSAVYEGH 80 (118)
T ss_dssp HHHHHHHHTTCHHHHHHHHTT-TCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCC--SSSCSCHHHHHHTTTC
T ss_pred HHHHHHHHCCCHHHHHHHHHH-HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEC--CCCCCCCHHHHHHCCC
T ss_conf 289999987799999999984-2012232222222222222222222222233432023310--1233210223320473
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf 89999999869999987898888000344
Q 000343 593 PDCMRELLLAGADPNAVDDEGESVLHRAV 621 (1630)
Q Consensus 593 ~eivk~LL~~GADvN~~d~~G~TpLh~Aa 621 (1630)
.+++++|+++|+|+|.+|.+|.||||+|.
T Consensus 81 ~~~v~~Ll~~Gad~~~~d~~G~t~l~~a~ 109 (118)
T d1myoa_ 81 VSCVKLLLSKGADKTVKGPDGLTALEATD 109 (118)
T ss_dssp CHHHHHHHTTCCCSSSSSSSTCCCCCTCS
T ss_pred HHHHHHHHCCCCCCEEECCCCCCHHHHHH
T ss_conf 24324331020000003899999999986
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.3e-17 Score=145.64 Aligned_cols=121 Identities=21% Similarity=0.269 Sum_probs=102.5
Q ss_pred HHHHHHHHCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 29999998399999999998159886457899999998999829999999999879995433335999619999998299
Q 000343 513 TALHLACRRGSAELVEAILEYSQENVDVLDKDGDPPLVFALAAGSPECVHALIKRGANVISRLREGFGPSVAHVCAYHGQ 592 (1630)
Q Consensus 513 TpLh~Aa~~G~~eiVk~LL~~~gadvn~~d~~G~TpLh~Aa~~G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh~Aa~~G~ 592 (1630)
++|+.||..|+.++|++|++. ++++|..|.+|.||||+|+..|+.+++++|+++|++++.. |..|.||||+|+.+|+
T Consensus 3 ~lL~~A~~~G~~~~v~~Ll~~-g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~--d~~g~tpLh~A~~~g~ 79 (130)
T d1ycsb1 3 ALLLDSSLEGEFDLVQRIIYE-VDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAA--DSDGWTPLHCAASCNN 79 (130)
T ss_dssp HHHHHHHHHTCHHHHHHHTST-TSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCC--CTTCCCHHHHHHHTTC
T ss_pred HHHHHHHHCCCHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCHHHH
T ss_conf 999999993999999999986-9975610021111112222222222222222222222221--2367642223210268
Q ss_pred HHHHHHHHHCCCCCCCCCC-CCCCHHHHH--HHCCCHHHHHHHHHCC
Q ss_conf 8999999986999998789-888800034--4318947999999809
Q 000343 593 PDCMRELLLAGADPNAVDD-EGESVLHRA--VAKKYTDCAIVILENG 636 (1630)
Q Consensus 593 ~eivk~LL~~GADvN~~d~-~G~TpLh~A--a~~g~~eivk~LL~~G 636 (1630)
.+++++|+++|||+|..+. ++.||+++| +..|+.+++++|+...
T Consensus 80 ~~~v~~Ll~~ga~v~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~ 126 (130)
T d1ycsb1 80 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ 126 (130)
T ss_dssp HHHHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHHH
T ss_conf 89999999869986646689998899999999868299999998678
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.72 E-value=5.2e-18 Score=152.77 Aligned_cols=95 Identities=29% Similarity=0.436 Sum_probs=70.9
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 99999999629999821014760023665159899999999879995435689997889999849999999999699997
Q 000343 705 RELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADC 784 (1630)
Q Consensus 705 ~eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADv 784 (1630)
.+++++|+++|+|+|.++..|.||||+|+..++.+++++|+++|+|+|.+|..|+||||+|+.+|+.+++++|+++|||+
T Consensus 15 ~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~ 94 (118)
T d1myoa_ 15 LDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADK 94 (118)
T ss_dssp HHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCHHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 99999999842012232222222222222222222222233432023310123321022332047324324331020000
Q ss_pred CCCCCCCCCHHHHHH
Q ss_conf 767899992999999
Q 000343 785 NWQDDEGDNAFHIAA 799 (1630)
Q Consensus 785 N~~D~~G~TpLhlAa 799 (1630)
|.+|++|+||||+|.
T Consensus 95 ~~~d~~G~t~l~~a~ 109 (118)
T d1myoa_ 95 TVKGPDGLTALEATD 109 (118)
T ss_dssp SSSSSSTCCCCCTCS
T ss_pred EEECCCCCCHHHHHH
T ss_conf 003899999999986
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=1.6e-16 Score=141.20 Aligned_cols=76 Identities=25% Similarity=0.396 Sum_probs=33.1
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCC
Q ss_conf 9999999629999821014760023665159899999999879995435689997889999849999999999699
Q 000343 706 ELVRILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAG 781 (1630)
Q Consensus 706 eiVklLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~G 781 (1630)
+++++|+++|+|+|.+|..|+||||+||..|+.+++++||++|+|++.+|..|+||||+|+.+|+.+++++|++.+
T Consensus 62 ~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~ 137 (154)
T d1dcqa1 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQAL 137 (154)
T ss_dssp HHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHC
T ss_conf 9999999749973331312101000111123333221221357550244789999999999939999999999938
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.69 E-value=4.4e-16 Score=137.72 Aligned_cols=120 Identities=18% Similarity=0.251 Sum_probs=59.4
Q ss_pred HHHHHHCCCHHHHHHHHHHCCCCCCCC------CCCCCCHHHHHHHC---CCHHHHHHHHHCCCCCCCCCCCCCCCHHHH
Q ss_conf 999998399999999998159886457------89999999899982---999999999987999543333599961999
Q 000343 515 LHLACRRGSAELVEAILEYSQENVDVL------DKDGDPPLVFALAA---GSPECVHALIKRGANVISRLREGFGPSVAH 585 (1630)
Q Consensus 515 Lh~Aa~~G~~eiVk~LL~~~gadvn~~------d~~G~TpLh~Aa~~---G~~eiVk~LL~~GAdin~~~~d~~G~T~Lh 585 (1630)
|..|+..+++..+..++.. +.+++.. +..|+||||+|+.. ++.+++++|+++|++++. ++..|.||||
T Consensus 10 L~~Av~~~dl~~l~~~~~~-g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~--~d~~g~TpLh 86 (154)
T d1dcqa1 10 LCEAVKTRDIFGLLQAYAD-GVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDK--QTGKGSTALH 86 (154)
T ss_dssp HHHHHHTTCHHHHHHHHHT-TCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTC--CCTTCCCHHH
T ss_pred HHHHHHHCCHHHHHHHHHC-CCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCHHHHHHHHHCCCCHHH--HHHHHCCCCC
T ss_conf 9999995889999999986-998677777545789998269999983289989999999974997333--1312101000
Q ss_pred HHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCC
Q ss_conf 9998299899999998699999878988880003443189479999998099
Q 000343 586 VCAYHGQPDCMRELLLAGADPNAVDDEGESVLHRAVAKKYTDCAIVILENGG 637 (1630)
Q Consensus 586 ~Aa~~G~~eivk~LL~~GADvN~~d~~G~TpLh~Aa~~g~~eivk~LL~~Ga 637 (1630)
+|+..|+.+++++|+++|+|++.+|.+|.||||+|+..++.+++++|++.++
T Consensus 87 ~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~ 138 (154)
T d1dcqa1 87 YCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALS 138 (154)
T ss_dssp HHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHHCC
T ss_conf 1111233332212213575502447899999999999399999999999388
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=6.9e-17 Score=143.99 Aligned_cols=77 Identities=27% Similarity=0.369 Sum_probs=27.0
Q ss_pred HHHHCCCCCCCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCC
Q ss_conf 99962999982101476002366515989999999987999543568999788999984999999999969999776
Q 000343 710 ILLTAGAEPTAQDAQNRTALHIASMANDVELVKIILDAGVDVNIRNVHNTIPLHVALARGAKSCVGLLLSAGADCNW 786 (1630)
Q Consensus 710 lLLe~GADin~~d~~G~TPLH~Aa~~g~~eiVklLL~~GADin~~d~~G~TPLH~Aa~~G~~eiVklLL~~GADvN~ 786 (1630)
+|+++|+|+|.+|..|+||||+|+..++.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|||+|.
T Consensus 19 ~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~ 95 (130)
T d1ycsb1 19 RIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFA 95 (130)
T ss_dssp HHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf 99986997561002111111222222222222222222222222123676422232102688999999986998664
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=8e-11 Score=96.82 Aligned_cols=68 Identities=24% Similarity=0.557 Sum_probs=54.9
Q ss_pred CCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 88524033335207999866931698214986997671399980049997510002662000121079999886503
Q 000343 4 KVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALILSAN 80 (1630)
Q Consensus 4 ~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~l~~N~~l~~lie~~k 80 (1630)
+.|+||||++.|.+ |+.++|||+||+.|+.+.+... .....||.||+.... ..|+.|+.+.++++.+.
T Consensus 20 ~~l~CpIC~~~~~~----pv~~~CgH~fC~~Ci~~~~~~~-~~~~~CP~Cr~~~~~----~~l~~n~~l~~~ve~l~ 87 (103)
T d1jm7a_ 20 KILECPICLELIKE----PVSTKCDHIFCKFCMLKLLNQK-KGPSQCPLCKNDITK----RSLQESTRFSQLVEELL 87 (103)
T ss_dssp HHTSCSSSCCCCSS----CCBCTTSCCCCSHHHHHHHHSS-SSSCCCTTTSCCCCT----TTCBCCCSSSHHHHHHH
T ss_pred CCCCCCCCCCHHCC----EEECCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCH----HHCCCCHHHHHHHHHHH
T ss_conf 58499721823189----1883799864167899999977-999809698883875----52875789999999999
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.86 E-value=7.4e-10 Score=89.26 Aligned_cols=70 Identities=16% Similarity=0.144 Sum_probs=58.0
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 98852403333520799986693169821498699767139998004999751000266200012107999988650376
Q 000343 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALILSANNT 82 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~l~~N~~l~~lie~~k~t 82 (1630)
-+.|.||||++.|.+ |++++||||||+.||.+.+... .-.||+||+.... ..|..|++|.++++.+.++
T Consensus 5 P~~l~CpIc~~l~~d----Pv~~~cGhtfc~~ci~~~l~~~---~~~cP~c~~~l~~----~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 5 PDYLCGKISFELMRE----PCITPSGITYDRKDIEEHLQRV---GHFNPVTRSPLTQ----EQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CSTTBCTTTCSBCSS----EEECSSCCEEETTHHHHHHHHT---CSSCTTTCCCCCG----GGCEECHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCHHHH----HCCCCCCCEECHHHHHHHHHCC---CCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHH
T ss_conf 700118583732340----3305886856388999998637---7657875666542----3555199999999999998
Q ss_pred C
Q ss_conf 7
Q 000343 83 N 83 (1630)
Q Consensus 83 ~ 83 (1630)
+
T Consensus 74 ~ 74 (80)
T d2c2la2 74 N 74 (80)
T ss_dssp C
T ss_pred C
T ss_conf 7
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.77 E-value=1.3e-09 Score=87.43 Aligned_cols=71 Identities=15% Similarity=0.381 Sum_probs=58.0
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 98852403333520799986693169821498699767139998004999751000266200012107999988650376
Q 000343 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALILSANNT 82 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~l~~N~~l~~lie~~k~t 82 (1630)
-++|.||||++.|.+ |++++||||||+.||.+.+... .-.||.|+..... ..+..|++|.++|+++..+
T Consensus 6 P~~l~CpIc~~~m~d----PV~~~cgh~fc~~ci~~~~~~~---~~~cP~~~~~l~~----~~l~pN~~L~~~I~~~~~~ 74 (78)
T d1t1ha_ 6 PEYFRCPISLELMKD----PVIVSTGQTYERSSIQKWLDAG---HKTCPKSQETLLH----AGLTPNYVLKSLIALWCES 74 (78)
T ss_dssp SSSSSCTTTSCCCSS----EEEETTTEEEEHHHHHHHHTTT---CCBCTTTCCBCSS----CCCEECTTTHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHC----CEECCCCCCCHHHHHHHHHHHC---CCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHH
T ss_conf 962799171812108----3372677743399999999988---8878865563775----6562469999999999999
Q ss_pred CC
Q ss_conf 76
Q 000343 83 NQ 84 (1630)
Q Consensus 83 ~q 84 (1630)
+.
T Consensus 75 ~~ 76 (78)
T d1t1ha_ 75 NG 76 (78)
T ss_dssp SC
T ss_pred HC
T ss_conf 58
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=7e-10 Score=89.46 Aligned_cols=68 Identities=29% Similarity=0.588 Sum_probs=54.9
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEE-CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 98852403333520799986693-16982149869976713999800499975100026620001210799998865037
Q 000343 3 MKVPCCSVCQTRYNEKERVPLLL-QCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALILSANN 81 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~~~~P~~L-~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~l~~N~~l~~lie~~k~ 81 (1630)
.+.|+||||++.|.+ |+.+ +|||+||+.|+.+.+. . .||.||..... ..|..|..+.++++.++.
T Consensus 20 ~~~l~C~IC~~~~~~----pv~~~~CgH~fC~~Ci~~~~~----~--~CP~Cr~~~~~----~~l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 20 EKLLRCSRCTNILRE----PVCLGGCEHIFCSNCVSDCIG----T--GCPVCYTPAWI----QDLKINRQLDSMIQLCSK 85 (97)
T ss_dssp HHTTSCSSSCSCCSS----CBCCCSSSCCBCTTTGGGGTT----T--BCSSSCCBCSC----SSCCCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCHHHC----CCEECCCCCCHHHHHHHHHHH----C--CCCCCCCCCCH----HHCCCCHHHHHHHHHHHH
T ss_conf 122899258722112----746588999302999999985----3--66622786765----518605899999999999
Q ss_pred CCC
Q ss_conf 676
Q 000343 82 TNQ 84 (1630)
Q Consensus 82 t~q 84 (1630)
..+
T Consensus 86 ~~~ 88 (97)
T d1jm7b_ 86 LRN 88 (97)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 998
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.61 E-value=1.1e-08 Score=80.28 Aligned_cols=48 Identities=29% Similarity=0.739 Sum_probs=40.8
Q ss_pred CCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 8852403333520799986693169821498699767139998004999751000
Q 000343 4 KVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSV 58 (1630)
Q Consensus 4 ~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~ 58 (1630)
+.++||||++.|.+ |++++|||+||+.||.+.++... -.||.||....
T Consensus 22 ~~l~C~IC~~~~~~----pv~~~CgH~FC~~Ci~~~~~~~~---~~CP~Cr~p~~ 69 (86)
T d1rmda2 22 KSISCQICEHILAD----PVETSCKHLFCRICILRCLKVMG---SYCPSCRYPCF 69 (86)
T ss_dssp HHTBCTTTCSBCSS----EEECTTSCEEEHHHHHHHHHHTC---SBCTTTCCBCC
T ss_pred CCCCCCCCCCCHHC----CEECCCCCHHHHHHHHHHHHHCC---CCCCCCCCCCC
T ss_conf 67599567844415----55267887631999999996487---90703699799
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=2.4e-08 Score=77.54 Aligned_cols=72 Identities=14% Similarity=0.131 Sum_probs=58.3
Q ss_pred CCCCCCCCCHHHHCCCCCCEEECCC-CHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 8852403333520799986693169-821498699767139998004999751000266200012107999988650376
Q 000343 4 KVPCCSVCQTRYNEKERVPLLLQCG-HGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTALRKNFAVLALILSANNT 82 (1630)
Q Consensus 4 ~~l~C~iC~~~f~~~~~~P~~L~Cg-HtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~l~~N~~l~~lie~~k~t 82 (1630)
+.|.||||+++|.+ |++++|| ||||+.||.+.+.. +. .||+||+.... ..|..|.+|.+.|+.+...
T Consensus 21 ~~f~CPI~~~lm~d----PV~~~~~~~ty~r~~I~~~l~~--~~--~~P~~~~~l~~----~~L~pN~~Lr~~I~~~~~~ 88 (98)
T d1wgma_ 21 DEFLDPIMSTLMCD----PVVLPSSRVTVDRSTIARHLLS--DQ--TDPFNRSPLTM----DQIRPNTELKEKIQRWLAE 88 (98)
T ss_dssp TTTBCTTTCSBCSS----EEECTTTCCEEEHHHHHHHTTT--SC--BCTTTCSBCCT----TTSEECHHHHHHHHHHHHH
T ss_pred HHHCCCCCHHHHHH----HHHCCCCCCHHHHHHHHHHHHH--CC--CCCCCCCCCCC----HHHCCHHHHHHHHHHHHHH
T ss_conf 77488673468877----7762355320149999999870--68--76655566640----1120139999999999999
Q ss_pred CCCCC
Q ss_conf 76678
Q 000343 83 NQHHN 87 (1630)
Q Consensus 83 ~q~~n 87 (1630)
.+..+
T Consensus 89 ~~~~~ 93 (98)
T d1wgma_ 89 RKQQS 93 (98)
T ss_dssp STTCS
T ss_pred HHHHC
T ss_conf 98730
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=8.8e-08 Score=73.13 Aligned_cols=50 Identities=24% Similarity=0.599 Sum_probs=40.7
Q ss_pred CCCCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 998852403333520799986693169821498699767139998004999751000
Q 000343 2 KMKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSV 58 (1630)
Q Consensus 2 ~~~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~ 58 (1630)
+.+...|+||++.+++ |++++|||+||..|+.+.+..+ .-.||+||+...
T Consensus 20 ~~~~~~C~IC~~~~~~----~~~~~CgH~fC~~Ci~~wl~~~---~~~CP~Cr~~i~ 69 (79)
T d1fbva4 20 GSTFQLCKICAENDKD----VKIEPCGHLMCTSCLTSWQESE---GQGCPFCRCEIK 69 (79)
T ss_dssp SCCTTBCTTTSSSBCC----EECSSSCCEECHHHHHHHHHTT---CCSCTTTCCCCC
T ss_pred CCCCCCCCCCCCCCCC----EEEECCCCEEEHHHHHHHHHHC---CCCCCCCCCCCC
T ss_conf 9998999358976899----6995899935299999999978---581899795864
|
| >d1bora_ g.44.1.1 (A:) Acute promyelocytic leukaemia proto-oncoprotein PML {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Acute promyelocytic leukaemia proto-oncoprotein PML species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=2.2e-08 Score=77.89 Aligned_cols=52 Identities=31% Similarity=0.683 Sum_probs=41.5
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 988524033335207999866931698214986997671399980049997510002662000
Q 000343 3 MKVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVVGNSVTA 65 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~~~~v~~ 65 (1630)
.+.|+|+||++.|.+ |++|+|||+||+.|+++. ...||.||+......+..+
T Consensus 4 ~~~l~C~IC~~~~~~----p~~lpCgH~fC~~Ci~~~-------~~~CP~Cr~~~~~~~~~~a 55 (56)
T d1bora_ 4 FQFLRCQQCQAEAKC----PKLLPCLHTLCSGCLEAS-------GMQCPICQAPWPLGADTPA 55 (56)
T ss_dssp CCCSSCSSSCSSCBC----CSCSTTSCCSBTTTCSSS-------SSSCSSCCSSSSCCSSCCC
T ss_pred CCCCCCCCCCCCCCC----CEEECCCCHHHHHHHHCC-------CCCCCCCCCCCCCCCCCCC
T ss_conf 678898402941589----789017777859988729-------7968497996669989888
|
| >d1g25a_ g.44.1.1 (A:) TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: TFIIH Mat1 subunit species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=3.6e-07 Score=68.37 Aligned_cols=52 Identities=25% Similarity=0.618 Sum_probs=40.6
Q ss_pred CCCCCCCCCCHHHHC-CCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 988524033335207-9998669316982149869976713999800499975100
Q 000343 3 MKVPCCSVCQTRYNE-KERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVS 57 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~-~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~ 57 (1630)
||+.+||||++.+.. ......+++|||+||..||.+.+.... -.||.||+..
T Consensus 1 ~dd~~CpIC~~~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~~~---~~CP~CR~~i 53 (65)
T d1g25a_ 1 MDDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGA---GNCPECGTPL 53 (65)
T ss_dssp CCTTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTS---SSCTTTCCCC
T ss_pred CCCCCCCCCCCEEECCCCEEEEECCCCHHHHHHHHHHHHCCCC---CCCCCCCCCC
T ss_conf 9989987088260039956798476372764889999857081---9799998681
|
| >d1ur6b_ g.44.1.1 (B:) Not-4 N-terminal RING finger domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Not-4 N-terminal RING finger domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=1.1e-07 Score=72.32 Aligned_cols=49 Identities=22% Similarity=0.527 Sum_probs=41.1
Q ss_pred CCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 5240333352079998669316982149869976713999800499975100
Q 000343 6 PCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVS 57 (1630)
Q Consensus 6 l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~ 57 (1630)
|+||||++.|++....+++++|||+||+.|+.+.++.. ...||+||+..
T Consensus 1 leCpICl~~~~~~~~~~~~~~CgH~~c~~C~~~w~~~~---~~~CP~CR~~~ 49 (52)
T d1ur6b_ 1 VECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDE---NGLCPACRKPY 49 (52)
T ss_dssp CEETTTTEECCGGGTTCCSSSSSCCCCHHHHHHHTTTS---CCBCTTTCCBC
T ss_pred CCCCCCCHHHHCCCCEEEECCCCCCCCHHHHHHHHHHC---CCCCCCCCCCC
T ss_conf 99958782351898259866997704558999999664---89898657948
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=5e-05 Score=51.68 Aligned_cols=141 Identities=13% Similarity=-0.036 Sum_probs=93.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf 78289988476785029995279814436689589999963157689668999999999811599882216799994997
Q 000343 136 HDVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSC 215 (1630)
Q Consensus 136 ~~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~ 215 (1630)
..|+..+..+.++...||... ..+..+.+|+...........+.+|...+..+. .+-.+.+++.+....+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--------~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~-~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLE-GKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHT-TTSCCCCEEEEEEETTE
T ss_pred HCEEEEECCCCCCCCCEEEEE--------ECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCEEEEEECCCC
T ss_conf 352799767899877189999--------089869999848876532556999999999876-06998728999750896
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q ss_conf 99999358998388998707999999999999999999999994------------------------------------
Q 000343 216 LGLVMDRCYGSVQLAMQRNEGRLTLEQILRYGADIARGVVELHA------------------------------------ 259 (1630)
Q Consensus 216 ~~LVmEy~~gsll~~l~~~~~~L~~~~~~~Ia~QIl~aL~yLHs------------------------------------ 259 (1630)
.|+||++++|..+...... ......++.++...|..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEEECCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 4999986043343543344-----02699999989999999855684214357644656555778998776555543033
Q ss_pred -----------------------CCCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf -----------------------9973320235546987899699940210034
Q 000343 260 -----------------------AGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 260 -----------------------~gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 232005799999999844986781789860047642364996599960231441
|
| >d1v87a_ g.44.1.1 (A:) Deltex protein 2 RING-H2 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Deltex protein 2 RING-H2 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.96 E-value=2.4e-06 Score=61.93 Aligned_cols=54 Identities=28% Similarity=0.632 Sum_probs=40.5
Q ss_pred CCCCCCCCCHHHHCC--------------CCCCEEECCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCCC
Q ss_conf 885240333352079--------------99866931698214986997671399-9800499975100
Q 000343 4 KVPCCSVCQTRYNEK--------------ERVPLLLQCGHGFCKECLSRMFSAST-DTTLSCPRCRHVS 57 (1630)
Q Consensus 4 ~~l~C~iC~~~f~~~--------------~~~P~~L~CgHtfC~~Cl~~l~~~~~-~~~~~CP~Cr~~~ 57 (1630)
..-.|+||++.|.+. ....++++|||.||..||.+.+.... ...+.||.||.+.
T Consensus 24 ~~~~C~IC~e~l~~~~~~~~~~~~~~~~~~~~~~~~~CgH~FH~~Ci~~Wl~~~~~~~~~~CP~CR~~~ 92 (114)
T d1v87a_ 24 PEEDCIICMEKLAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIY 92 (114)
T ss_dssp CSCEETTTTEETTSCCSTTTTCCCSSSCSSCCEEESSSCCEECHHHHHHHHHHTCCSSCCBCTTTCCBS
T ss_pred CCCCCCCHHHEECCCCCCCCCCCCCCCCCCCCEEECCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
T ss_conf 565345301000134443354333454554346879999905699999999966757897665501220
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.91 E-value=1.7e-06 Score=63.09 Aligned_cols=46 Identities=15% Similarity=0.171 Sum_probs=39.2
Q ss_pred CCCCCCCHHHHCCCCCCEEE-CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 52403333520799986693-1698214986997671399980049997510002
Q 000343 6 PCCSVCQTRYNEKERVPLLL-QCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVV 59 (1630)
Q Consensus 6 l~C~iC~~~f~~~~~~P~~L-~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~ 59 (1630)
|.|+||++.+.+ |.++ .|||+||+.||.+.++.+ -.||.||+....
T Consensus 1 l~C~Ic~~~~~~----Pv~~~~cGh~fc~~cI~~~l~~~----~~CP~c~~~l~~ 47 (56)
T d2baya1 1 MLCAISGKVPRR----PVLSPKSRTIFEKSLLEQYVKDT----GNDPITNEPLSI 47 (56)
T ss_dssp CCCTTTCSCCSS----EEEETTTTEEEEHHHHHHHHHHH----SBCTTTCCBCCG
T ss_pred CCCCCCCCHHHH----CCCCCCCCCCCCHHHHHHHHHHC----CCCCCCCCCCCH
T ss_conf 999367856886----57457899845599999987603----679854781887
|
| >d1iyma_ g.44.1.1 (A:) EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 4530]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: EL5 RING-H2 domain species: Rice (Oryza sativa) [TaxId: 4530]
Probab=97.83 E-value=2.8e-06 Score=61.49 Aligned_cols=50 Identities=32% Similarity=0.751 Sum_probs=38.6
Q ss_pred CCCCCCCCCCHHHHCCCCCCEEE-CCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 98852403333520799986693-16982149869976713999800499975100
Q 000343 3 MKVPCCSVCQTRYNEKERVPLLL-QCGHGFCKECLSRMFSASTDTTLSCPRCRHVS 57 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~~~~P~~L-~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~ 57 (1630)
.|..+|+||++.|.+++. .+.| .|||.||..|+.+-++. . -.||.||+..
T Consensus 3 ed~~~C~ICl~~~~~~~~-~~~l~~C~H~Fh~~Ci~~Wl~~--~--~~CP~CR~~i 53 (55)
T d1iyma_ 3 DDGVECAVCLAELEDGEE-ARFLPRCGHGFHAECVDMWLGS--H--STCPLCRLTV 53 (55)
T ss_dssp CCSCCCTTTCCCCCTTSC-CEECSSSCCEECTTHHHHTTTT--C--CSCSSSCCCS
T ss_pred CCCCCCEEECCCCCCCCE-EEEECCCCCCCCHHHHHHHHHH--C--CCCCCCCCEE
T ss_conf 899998497900107988-9990898981059999999984--9--9387889784
|
| >d1chca_ g.44.1.1 (A:) Immediate early protein, IEEHV {Equine herpesvirus 1 [TaxId: 10326]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Immediate early protein, IEEHV species: Equine herpesvirus 1 [TaxId: 10326]
Probab=97.79 E-value=4.3e-06 Score=59.98 Aligned_cols=48 Identities=27% Similarity=0.695 Sum_probs=37.8
Q ss_pred CCCCCCCCCCCCHHHHCCCCCC-EEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 9998852403333520799986-6931698214986997671399980049997510
Q 000343 1 MKMKVPCCSVCQTRYNEKERVP-LLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHV 56 (1630)
Q Consensus 1 m~~~~l~C~iC~~~f~~~~~~P-~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~ 56 (1630)
|...-=+|+||++.|.+ | ++++|||+||..|+.+.++.+ -.||.||..
T Consensus 1 ~~~~~d~C~IC~~~~~~----~~~~~~C~H~Fc~~Ci~~w~~~~----~~CP~CR~~ 49 (68)
T d1chca_ 1 MATVAERCPICLEDPSN----YSMALPCLHAFCYVCITRWIRQN----PTCPLCKVP 49 (68)
T ss_dssp CCCCCCCCSSCCSCCCS----CEEETTTTEEESTTHHHHHHHHS----CSTTTTCCC
T ss_pred CCCCCCCCCCCCCCCCC----CCEEECCCCCCCHHHHHHHHHHC----CCCCCCCCC
T ss_conf 97979999449939668----83882899917689999999829----908887816
|
| >d1wima_ g.44.1.1 (A:) UbcM4-interacting protein 4 (KIAA0161) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: UbcM4-interacting protein 4 (KIAA0161) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=6.9e-06 Score=58.40 Aligned_cols=51 Identities=27% Similarity=0.621 Sum_probs=39.7
Q ss_pred CCCCCCCCCHHHHCCCCCCEEECCCCHHHHHHHHHHHHCC----CCCCCCCCCCCC
Q ss_conf 8852403333520799986693169821498699767139----998004999751
Q 000343 4 KVPCCSVCQTRYNEKERVPLLLQCGHGFCKECLSRMFSAS----TDTTLSCPRCRH 55 (1630)
Q Consensus 4 ~~l~C~iC~~~f~~~~~~P~~L~CgHtfC~~Cl~~l~~~~----~~~~~~CP~Cr~ 55 (1630)
...+|+||++.+.. +..+++++|||.||+.|+.++++.. ....+.||.|+.
T Consensus 4 ~~~~C~IC~~~~~~-~~~~~~~~C~H~fC~~Cl~~~~~~~i~~~~~~~i~CP~~~C 58 (94)
T d1wima_ 4 GSSGCKLCLGEYPV-EQMTTIAQCQCIFCTLCLKQYVELLIKEGLETAISCPDAAC 58 (94)
T ss_dssp SBCCCSSSCCCCBG-GGEEEETTTTEEEEHHHHHHHHHHHHHHCSCCCEECSCTTC
T ss_pred CCCCCCCCCCCCCC-CCEEEECCCCCEECCCCHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 89849317983607-75577789999848817999999998517966558919998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.42 E-value=0.0019 Score=39.43 Aligned_cols=78 Identities=13% Similarity=-0.035 Sum_probs=48.8
Q ss_pred EEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECC-------CCCCHHHHHHHHHHHHHHCCCCC-CCCEEEEEEEE
Q ss_conf 98847678502999527981443668958999996315-------76896689999999998115998-82216799994
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIA-------EEMEPDWLSGQLDNLRRASMWCR-NVCTFHGVLRM 212 (1630)
Q Consensus 141 ~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~-------~~~~~~~~~~Ei~iL~~l~l~Hp-NIV~L~~~~~~ 212 (1630)
.+.||.|....||. ..+...++.+.+|+-... .....++...|.+.|..+....| .+++++.+ +
T Consensus 31 ~~eig~G~~N~vfr------V~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d 102 (392)
T d2pula1 31 CQEIGDGNLNYVFH------IYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 102 (392)
T ss_dssp EEECCSSSSEEEEE------EEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred EEEECCCCEEEEEE------EEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--C
T ss_conf 99807985276899------995799848999617713034677788877899999999998650579885528998--5
Q ss_pred CCEEEEEEECCCCC
Q ss_conf 99799999358998
Q 000343 213 DSCLGLVMDRCYGS 226 (1630)
Q Consensus 213 ~~~~~LVmEy~~gs 226 (1630)
....++|||++.+.
T Consensus 103 ~~~~~lvmE~L~~~ 116 (392)
T d2pula1 103 TEMAVTVMEDLSHL 116 (392)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCCCEEEEECCCCC
T ss_conf 98877987135776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.16 E-value=0.0064 Score=35.31 Aligned_cols=139 Identities=15% Similarity=0.061 Sum_probs=78.9
Q ss_pred EEECCCCC-EEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 88476785-02999527981443668958999996315768966899999999981159988221679999499799999
Q 000343 142 KKLGEGRR-AGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLVM 220 (1630)
Q Consensus 142 k~IG~G~f-g~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~~~LVm 220 (1630)
..+..|.. ..||.. ....+..+.+|...... ...+.+|...++.+....-.+.+++.+..+.+..++||
T Consensus 16 ~~~~~G~s~~~v~r~-------~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRL-------SAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEE-------ECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred EECCCCCCCCEEEEE-------EECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEE
T ss_conf 876786547758999-------93898789999589667---76899999999999865999886132224566159998
Q ss_pred ECCCCCHHHH-----------H---HHC-------CCCCC--HHHHHHHH--------------------HHHHHHHHHH
Q ss_conf 3589983889-----------9---870-------79999--99999999--------------------9999999999
Q 000343 221 DRCYGSVQLA-----------M---QRN-------EGRLT--LEQILRYG--------------------ADIARGVVEL 257 (1630)
Q Consensus 221 Ey~~gsll~~-----------l---~~~-------~~~L~--~~~~~~Ia--------------------~QIl~aL~yL 257 (1630)
++++|..+.. + +.+ ...+. ......-. ......+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
T ss_conf 74413554322126899999999999987368854488755412468899999987541101134011213799999999
Q ss_pred HHC-------CCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf 949-------973320235546987899699940210034
Q 000343 258 HAA-------GVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 258 Hs~-------gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
... .++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 8718765795678678887635773796589998533265
|
| >d1vyxa_ g.44.1.3 (A:) IE1B protein (ORF K3), N-terminal domain {Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: Variant RING domain domain: IE1B protein (ORF K3), N-terminal domain species: Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]
Probab=97.14 E-value=8.4e-05 Score=49.95 Aligned_cols=56 Identities=21% Similarity=0.380 Sum_probs=41.0
Q ss_pred CC-CCCCCCCCCCHHHHCCCCCC-EEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 99-98852403333520799986-693169821498699767139998004999751000
Q 000343 1 MK-MKVPCCSVCQTRYNEKERVP-LLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSV 58 (1630)
Q Consensus 1 m~-~~~l~C~iC~~~f~~~~~~P-~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~ 58 (1630)
|+ .+...|+||++.+++....| .-..|+|.||+.||.+-+..+.+ ..||+||....
T Consensus 1 ~eded~~~C~IC~~~~~~~~~~~c~c~~c~h~~H~~Cl~~W~~~~~~--~~CP~Cr~~~~ 58 (60)
T d1vyxa_ 1 MEDEDVPVCWICNEELGNERFRACGCTGELENVHRSCLSTWLTISRN--TACQICGVVYN 58 (60)
T ss_dssp CTTCSCCEETTTTEECSCCCCCSCCCSSGGGSCCHHHHHHHHHHHTC--SBCTTTCCBCC
T ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCCCCEECHHHHHHHHHHCCC--CCCCCCCCEEE
T ss_conf 97888999923886277751673145897788738999999710789--88916697124
|
| >d3dplr1 g.44.1.1 (R:19-106) RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.11 E-value=0.00023 Score=46.58 Aligned_cols=53 Identities=23% Similarity=0.441 Sum_probs=38.9
Q ss_pred CCCCCCCCCCHHHHCC--------------CCCCEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 9885240333352079--------------99866931698214986997671399980049997510002
Q 000343 3 MKVPCCSVCQTRYNEK--------------ERVPLLLQCGHGFCKECLSRMFSASTDTTLSCPRCRHVSVV 59 (1630)
Q Consensus 3 ~~~l~C~iC~~~f~~~--------------~~~P~~L~CgHtfC~~Cl~~l~~~~~~~~~~CP~Cr~~~~~ 59 (1630)
+..=.|+||++.+++. ...+..++|||.||..||.+=++.+ -.||.||+....
T Consensus 19 ~~~d~C~IC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~H~FH~~Ci~~Wl~~~----~~CP~CR~~~~~ 85 (88)
T d3dplr1 19 IVVDNCAICRNHIMDLCIECQANQASATSEECTVAWGVCNHAFHFHCISRWLKTR----QVCPLDNREWEF 85 (88)
T ss_dssp SCSCCCSSSCSCTTSCCTTHHHHTTCC---CCCEEEETTSCEEEHHHHHHHHTTC----SBCSSSCSBCCE
T ss_pred CCCCCCEECCCHHHCCCCCCCCCCCCCCCCCCCEEECCCCCCCCHHHHHHHHHHC----CCCCCCCCCCCC
T ss_conf 8998287836024186543233332133556872872654746579999999879----968788972312
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.047 Score=28.53 Aligned_cols=81 Identities=7% Similarity=-0.103 Sum_probs=46.2
Q ss_pred EEEECCCCCEEEEEEEEEECCC-CCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 9884767850299952798144-366895899999631576896689999999998115998822167999949979999
Q 000343 141 VKKLGEGRRAGVEVWGAWIGGG-QGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASMWCRNVCTFHGVLRMDSCLGLV 219 (1630)
Q Consensus 141 ~k~IG~G~fg~V~l~~~vy~a~-~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l~HpNIV~L~~~~~~~~~~~LV 219 (1630)
++.|+.|---.+|++...-... .+...+.|.++..- . ........+|..+++.+. .+.-..++++++.. ++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls-~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLS-ERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHH-HTTSSSCEEEEETT----EEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHH-HCCCCCEEEEECCC----CEE
T ss_conf 9991785334348999688775445789817999659-9-611658999999999997-57999808998189----569
Q ss_pred EECCCCCHH
Q ss_conf 935899838
Q 000343 220 MDRCYGSVQ 228 (1630)
Q Consensus 220 mEy~~gsll 228 (1630)
|||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEECCCCC
T ss_conf 997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.49 E-value=0.22 Score=23.37 Aligned_cols=123 Identities=15% Similarity=0.074 Sum_probs=67.9
Q ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCC---CCCCCCEEE--EEEEECCEEEEEEECCCCCHHH-----HHH--
Q ss_conf 6895899999631576896689999999998115---998822167--9999499799999358998388-----998--
Q 000343 165 RCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM---WCRNVCTFH--GVLRMDSCLGLVMDRCYGSVQL-----AMQ-- 232 (1630)
Q Consensus 165 ~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l---~HpNIV~L~--~~~~~~~~~~LVmEy~~gsll~-----~l~-- 232 (1630)
.+|..+++|.... .......+..|...+..+.- ..+..+..- ..+......+.++++++|.... .+.
T Consensus 44 ~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~l 122 (325)
T d1zyla1 44 EDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAV 122 (325)
T ss_dssp TTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHH
T ss_pred CCCCEEEEEEECC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCCCHHHHHHH
T ss_conf 8999799998478-778899999999999999855998787520689805665347999986527768899999999998
Q ss_pred --------H--C------CCCCCHH----------------------HHHHHHHHHHHHHHHHHH----CCCCCCCCCCC
Q ss_conf --------7--0------7999999----------------------999999999999999994----99733202355
Q 000343 233 --------R--N------EGRLTLE----------------------QILRYGADIARGVVELHA----AGVVCMNIKPS 270 (1630)
Q Consensus 233 --------~--~------~~~L~~~----------------------~~~~Ia~QIl~aL~yLHs----~gIIHrDLKP~ 270 (1630)
. . ...++.. .....+.++...+.-+-. .++||+|+.+.
T Consensus 123 G~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~ 202 (325)
T d1zyla1 123 GRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAG 202 (325)
T ss_dssp HHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGG
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 99999988630357865567789788766568999874769988989999999999999998454568712024788804
Q ss_pred CEEECCCCCEEEEECCEEEE
Q ss_conf 46987899699940210034
Q 000343 271 NLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 271 NILld~~g~vKL~DFGla~~ 290 (1630)
|||++. + ..++||+.|..
T Consensus 203 NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 203 NILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp GEEESS-S-EEECCCTTCCE
T ss_pred CEEEEC-C-CEEEECHHCCC
T ss_conf 287838-9-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.39 E-value=0.34 Score=21.82 Aligned_cols=144 Identities=10% Similarity=0.015 Sum_probs=74.6
Q ss_pred CEEEEEEECCCCCEEEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHCC---CCCCCCEEEE---EE
Q ss_conf 82899884767850299952798144366895899999631576896689999999998115---9988221679---99
Q 000343 137 DVKLVKKLGEGRRAGVEVWGAWIGGGQGRCRHSVAVKKVMIAEEMEPDWLSGQLDNLRRASM---WCRNVCTFHG---VL 210 (1630)
Q Consensus 137 ~Y~i~k~IG~G~fg~V~l~~~vy~a~~~~~g~~VAIK~i~~~~~~~~~~~~~Ei~iL~~l~l---~HpNIV~L~~---~~ 210 (1630)
+..-.+.|..|.--+.|+.. .++..+++|...... ....+..+++.+..+.. ..|..+...+ +.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~--------t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLH--------TTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CEEEEEEECC---EEEEEEE--------ESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCEEEECCCCCCCCCEEEEE--------ECCCCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCE
T ss_conf 85685237888526738999--------789728999807899--98899999999875430255545564104897621
Q ss_pred EECCEEEEEEECCCCCHHH-----HHH-----------H-C------CCCC------------------CHHHHHHHHHH
Q ss_conf 9499799999358998388-----998-----------7-0------7999------------------99999999999
Q 000343 211 RMDSCLGLVMDRCYGSVQL-----AMQ-----------R-N------EGRL------------------TLEQILRYGAD 249 (1630)
Q Consensus 211 ~~~~~~~LVmEy~~gsll~-----~l~-----------~-~------~~~L------------------~~~~~~~Ia~Q 249 (1630)
......+.++.+..+.... ... . . .... ........+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHH
T ss_conf 34125502453114655333204678888899876454443202453101110120024567777653114127999999
Q ss_pred HHHHHHHHHH----CCCCCCCCCCCCEEECCCCCEEEEECCEEEE
Q ss_conf 9999999994----9973320235546987899699940210034
Q 000343 250 IARGVVELHA----AGVVCMNIKPSNLLLDASGRAVVSDYGLAAI 290 (1630)
Q Consensus 250 Il~aL~yLHs----~gIIHrDLKP~NILld~~g~vKL~DFGla~~ 290 (1630)
+...+..... .|+||+|+.++||+++.+...-++||+.|..
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 987642048554545033378636564020454126742221236
|
| >d1nppa2 b.34.5.4 (A:191-248) N-utilization substance G protein NusG, C-terminal domain {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: Translation proteins SH3-like domain family: N-utilization substance G protein NusG, C-terminal domain domain: N-utilization substance G protein NusG, C-terminal domain species: Aquifex aeolicus [TaxId: 63363]
Probab=87.80 E-value=0.29 Score=22.39 Aligned_cols=35 Identities=20% Similarity=0.358 Sum_probs=13.1
Q ss_pred CCEEEEEEECCC-CCEEEEEEE--CCCCCCCCCCCCCC
Q ss_conf 522689852578-955899861--49981013575000
Q 000343 1140 NSIGIIHSLEED-GDVGIAFCF--RSKPFCCSVTDVEK 1174 (1630)
Q Consensus 1140 ~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~ 1174 (1630)
+-+|.|..++.+ +.+.|.+.. +.+|---.++++||
T Consensus 20 g~~g~V~~i~~~~~rv~V~v~~fGr~t~vel~~~~vek 57 (58)
T d1nppa2 20 NFTGTVEEVHPEKRKLTVMISIFGRMTPVELDFDQVEK 57 (58)
T ss_dssp TCEEEEEEEEGGGTEEEEEEEETTEEEEEEEEGGGEEE
T ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEECHHHEEE
T ss_conf 98999999828899999999600998358668899894
|
| >d1nz9a_ b.34.5.4 (A:) N-utilization substance G protein NusG, C-terminal domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: Translation proteins SH3-like domain family: N-utilization substance G protein NusG, C-terminal domain domain: N-utilization substance G protein NusG, C-terminal domain species: Thermus thermophilus [TaxId: 274]
Probab=86.61 E-value=0.38 Score=21.48 Aligned_cols=33 Identities=18% Similarity=0.245 Sum_probs=11.6
Q ss_pred EEEEEEECCCC-C--EEEEEECCCCCCCCCCCCCCC
Q ss_conf 27997646999-7--699960689862027887321
Q 000343 1016 IGIVYCIRPDS-S--LLLELSYLPNPWHCEPEEVEP 1048 (1630)
Q Consensus 1016 ~g~~~~i~~~~-~--~~v~~~~~~~~~~~~~~~~~~ 1048 (1630)
+|.|..|+.+. . +++.+.|..++-.-..++++|
T Consensus 22 ~g~V~~i~~~k~rv~V~v~ifGr~t~vel~~~~ieK 57 (58)
T d1nz9a_ 22 TGTVTEINPERGKVKVMVTIFGRETPVELDFSQVVK 57 (58)
T ss_dssp EEEEEEEETTTTEEEEEEESSSSEEEEEECGGGEEE
T ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEECHHHEEC
T ss_conf 899999928899999999953998458569999870
|
| >d1nz9a_ b.34.5.4 (A:) N-utilization substance G protein NusG, C-terminal domain {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: SH3-like barrel superfamily: Translation proteins SH3-like domain family: N-utilization substance G protein NusG, C-terminal domain domain: N-utilization substance G protein NusG, C-terminal domain species: Thermus thermophilus [TaxId: 274]
Probab=82.78 E-value=0.74 Score=19.22 Aligned_cols=51 Identities=25% Similarity=0.432 Sum_probs=23.2
Q ss_pred CCCCCCEEEEECCCCCCCCCCCCCCCCCEEEEEEECCC-CCEEEEEEE--CCCCCCCCCCCCCC
Q ss_conf 53367489950256899878754432522689852578-955899861--49981013575000
Q 000343 1114 DFKVGDWVRVKASVSSPKYGWEDITRNSIGIIHSLEED-GDVGIAFCF--RSKPFCCSVTDVEK 1174 (1630)
Q Consensus 1114 ~~~~gd~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~ 1174 (1630)
+|++||+||+...+=+ +..|.|.+++.+ +.+.|.+.. +.+|---.++++||
T Consensus 4 ~F~~Gd~V~I~~GpF~----------g~~g~V~~i~~~k~rv~V~v~ifGr~t~vel~~~~ieK 57 (58)
T d1nz9a_ 4 AFREGDQVRVVSGPFA----------DFTGTVTEINPERGKVKVMVTIFGRETPVELDFSQVVK 57 (58)
T ss_dssp SCCTTCEEEECSGGGT----------TCEEEEEEEETTTTEEEEEEESSSSEEEEEECGGGEEE
T ss_pred CCCCCCEEEEECCCCC----------CCEEEEEEECCCCCEEEEEEEECCCCCEEEECHHHEEC
T ss_conf 2069999999005899----------98899999928899999999953998458569999870
|